[["Chronic heart failure (CHF) is the leading cause of all hospitalisations and readmissions in older people, accounting for a large proportion of developed countries' national health care expenditure.", {"entities": []}], ["CHF can severely affect people's quality of life by reducing their independence and ability to undertake certain activities of daily living, as well as affecting their psychosocial and economic capacity.", {"entities": []}], ["This paper reports the findings of a systematic narrative review of qualitative studies concerning people's experience of living with CHF, aiming to develop a wide-ranging understanding of what is known about the patient experience.", {"entities": []}], ["We searched eight relevant electronic databases using the terms based on the diagnosis of 'chronic heart failure', 'heart failure' and 'congestive heart failure' and qualitative methods, with restrictions to the years 1990-May 2008.", {"entities": [[136, 160, "DISEASE"]]}], ["We also used snowballing, hand searching and the expert knowledge of the research team to ensure all relevant papers were included in the review.", {"entities": []}], ["Of 65 papers collected less than half (n = 30) were found relevant for this review.", {"entities": []}], ["These papers were subsequently summarised and entered into QSR NVivo7 for data management and analysis.", {"entities": []}], ["The review has identified the most prominent impacts of CHF on a person's everyday life including social isolation, living in fear and losing a sense of control.", {"entities": []}], ["It has also identified common strategies through which patients with CHF manage their illness such as sharing experiences and burdens with others and being flexible to changing circumstances.", {"entities": []}], ["Finally, there are multiple factors that commonly impact on patients' self care and self-management in the disease trajectory including knowledge, understanding and health service encounters.", {"entities": []}], ["These health service encounters encompass access, continuity and quality of care, co-morbid conditions, and personal relationships.", {"entities": []}], ["The core and sub-concepts identified within this study provide health professionals, service providers, policy makers and educators with broad insights into common elements of people's experiences of CHF and potential options for improving their health and wellbeing.", {"entities": []}], ["Future studies should focus on building a comprehensive picture of CHF through examination of differences between genders, and differences within age groups, socioeconomic groups and cultural groups.", {"entities": []}], ["We describe the epidemiology of a pertussis outbreak in Japan in 2010\u20132011 and Bordetella holmesii transmission.", {"entities": [[34, 43, "DISEASE"]]}], ["Six patients were infected; 4 patients were students and a teacher at the same junior high school.", {"entities": []}], ["Epidemiologic links were found between 5 patients.", {"entities": []}], ["B. holmesii may have been transmitted from person to person.", {"entities": []}], ["Inhalation of Yersinia pestis causes primary pneumonic plague, a highly lethal syndrome with mortality rates approaching 100%.", {"entities": [[55, 61, "DISEASE"], [45, 61, "DISEASE"], [79, 87, "DISEASE"]]}], ["Pneumonic plague progression is biphasic, with an initial pre-inflammatory phase facilitating bacterial growth in the absence of host inflammation, followed by a pro-inflammatory phase marked by extensive neutrophil influx, an inflammatory cytokine storm, and severe tissue destruction.", {"entities": [[10, 16, "DISEASE"], [0, 16, "DISEASE"]]}], ["Using a FRET-based probe to quantitate injection of effector proteins by the Y. pestis type III secretion system, we show that these bacteria target alveolar macrophages early during infection of mice, followed by a switch in host cell preference to neutrophils.", {"entities": []}], ["We also demonstrate that neutrophil influx is unable to limit bacterial growth in the lung and is ultimately responsible for the severe inflammation during the lethal pro-inflammatory phase.", {"entities": []}], ["Inhalation of the bacterium Yersinia pestis results in primary pneumonic plague, a severe necrotizing pneumonia with mortality rates approaching 100% in the absence of timely antibiotic administration.", {"entities": [[102, 111, "DISEASE"], [73, 79, "DISEASE"], [63, 79, "DISEASE"]]}], ["Despite the notoriety of Y. pestis as a potential biological weapon and its well-established pandemic potential, very little is known regarding early host-pathogen interactions that lead to the progression of pulmonary infection.", {"entities": []}], ["Y. pestis harbors a type III secretion system (T3SS) for delivery of Yersinia outer protein (Yop) effectors into host cells, an early and essential step in pathogenesis.", {"entities": []}], ["In the work presented here, we identify the host cell targets of Y. pestis Yop secretion in the lung.", {"entities": []}], ["We show that Y. pestis initially targets alveolar macrophages, followed by a shift in host cell preference to neutrophils.", {"entities": []}], ["Through cellular depletion studies, we demonstrate that Y. pestis is highly resistant to macrophage- and neutrophil-mediated clearance, and that the accumulation of neutrophils in the lung is responsible for the severe necrotizing pneumonia that develops during the pro-inflammatory phase of pneumonic plague.", {"entities": [[231, 240, "DISEASE"], [302, 308, "DISEASE"], [292, 308, "DISEASE"]]}], ["The epidemic of encephalitis lethargica (EL), called classical EL, was rampant throughout the world during 1917\u20131926, affecting half a million persons.", {"entities": [[16, 28, "DISEASE"]]}], ["The acute phase was lethal for many victims.", {"entities": []}], ["Post-encephalitic parkinsonism (PEP) affected patients for decades.", {"entities": []}], ["Our purpose was to investigate the cause of classical EL by studying the few available brain specimens.", {"entities": []}], ["Cases of PEP and modern EL were also studied.", {"entities": []}], ["Transmission electron microscopy (TEM) and immunohistochemistry were employed to examine brain from four classical EL cases, two modern EL cases and one PEP case.", {"entities": []}], ["Standard methods for TEM, immunohistochemistry and RTPCR were applied.", {"entities": []}], ["27\u2009nm virus-like particles (VLP) were observed in the cytoplasm and nuclei of midbrain neurons in all classical EL cases studied.", {"entities": []}], ["Large (50\u2009nm) VLP and 27\u2009nm intranuclear VLP were observed in the modern EL cases and the PEP case.", {"entities": []}], ["Influenza virus particles were not found.", {"entities": []}], ["VLP were not observed in the control cases.", {"entities": []}], ["TEM of cell cultures inoculated with coxsackievirus B4 and poliovirus revealed both small and large intranuclear virus particles and small cytoplasmic particles, similar to the VLP in EL neurons.", {"entities": []}], ["In the EL brains, nascent VLP were embedded in putative virus factories and on endoplasmic reticulum (ER).", {"entities": []}], ["The VLP in the cases of classical EL survived, whereas ribosomes underwent autolysis due to the lack of refrigeration and slow formaldehyde fixation of whole brain.", {"entities": []}], ["The VLP were larger than ribosomes from well preserved brain.", {"entities": []}], ["Immunohistochemistry of classical EL cases using anti-poliovirus and anti-coxsackievirus B polyclonal antibodies showed significant staining of cytoplasm and nuclei of neurons as well as microglia and neuropil.", {"entities": []}], ["Purkinje cells were strongly stained.", {"entities": []}], ["A 97-bp RNA fragment of a unique virus was isolated from brain tissue from acute EL case #91558.", {"entities": []}], ["Sequence analysis revealed up to 95% identity to multiple human Enteroviruses.", {"entities": []}], ["Additional cases had Enterovirus positive reactions by real time PCR.", {"entities": []}], ["The data presented here support the hypothesis that the VLP observed in EL tissue is an Enterovirus.", {"entities": []}], ["Langerhans cells (LCs) are antigen-presenting dendritic cells located in the skin.", {"entities": []}], ["It has been reported that LC activation is associated with painful diabetic neuropathy (PDN); however, the mechanism of LC activation is still unclear.", {"entities": [[67, 86, "DISEASE"], [76, 86, "DISEASE"]]}], ["The db/db mouse, a rodent model of PDN, was used to study the roles of LCs in the development of PDN in type 2 diabetes.", {"entities": []}], ["Hind foot pads from db/db and control db/+ mice from 5 to 24 weeks of age (encompassing the period of mechanical allodynia development and its abatement) were collected and processed for immunohistochemistry studies.", {"entities": []}], ["LCs were identified with immunohistochemistry using an antibody against CD207 (Langerin).", {"entities": [[72, 77, "GENE"]]}], ["The intraepidermal nerve fibers and subepidermal nerve plexus were identified by immunohistochemistry of protein gene product 9.5 (PGP 9.5) and tropomyosin-receptor kinase (Trk) A, the high affinity nerve growth factor receptor.", {"entities": [[131, 134, "GENE"]]}], ["CD207-positive LCs increased in the db/db mouse during the period of mechanical allodynia, from 8 to 10 weeks of age, in both the epidermis and subepidermal plexus.", {"entities": []}], ["At 16 weeks of age, when mechanical allodynia diminishes, LC populations were reduced in the epidermis and subepidermal plexus.", {"entities": []}], ["Epidermal LCs (ELCs) were positive for Trk A. Subepidermal LCs (SLCs) were positive for CD68, suggesting that they are immature LCs.", {"entities": [[88, 92, "GENE"]]}], ["Additionally, these SLCs were positive for the receptor of advanced glycation end products (RAGE) and were in direct contact with TNF-\u03b1-positive nerve fibers in the subepidermal nerve plexus during the period of mechanical allodynia.", {"entities": []}], ["Intrathecal administration of SB203580, a p38 kinase inhibitor, significantly reduced mechanical allodynia, TNF-\u03b1 expression in the subepidermal plexus, and increased both ELC and SLC populations during the period of mechanical allodynia.", {"entities": []}], ["Our data support the hypothesis that increased LC populations in PDN are activated by p38-dependent neurogenic factors and may be involved in the pathogenesis of PDN.", {"entities": []}], ["Respiratory viral infections are a major cause of asthma exacerbations.", {"entities": [[50, 56, "DISEASE"]]}], ["Neutrophils accumulate in the airways and the mechanisms that link neutrophilic inflammation, viral infections and exacerbations are unclear.", {"entities": []}], ["This study aims to investigate anti\u2010viral responses in neutrophils from patients with and without asthma and to investigate if neutrophils can be directly activated by respiratory viruses.", {"entities": [[98, 104, "DISEASE"]]}], ["Neutrophils from peripheral blood from asthmatic and non\u2010asthmatic individuals were isolated and stimulated with lipopolysaccharide ( LPS ) (1\u2009\u03bcg/mL), f\u2010met\u2010leu\u2010phe (f MLP ) (100\u2009nM), imiquimod (3\u2009\u03bcg/mL), R 848 (1.5\u2009\u03bcg/mL), poly I : C (10\u2009\u03bcg/mL), RV 16 (multiplicity of infection ( MOI )1), respiratory syncytial virus ( RSV ) ( MOI 1) or influenza virus ( MOI 1).", {"entities": [[339, 348, "DISEASE"]]}], ["Cell\u2010free supernatants were collected after 1\u2009h of neutrophil elastase ( NE ) and matrix metalloproteinase ( MMP )\u20109 release, or after 24\u2009h for CXCL 8 release.", {"entities": []}], ["LPS , f MLP , imiquimod and R 848 stimulated the release of CXCL 8, NE and MMP \u20109 whereas poly I : C selectively induced CXCL 8 release only.", {"entities": []}], ["R 848\u2010induced CXCL 8 release was enhanced in neutrophils from asthmatics compared with non\u2010asthmatic cells ( P \u2009<\u20090.01).", {"entities": []}], ["RSV triggered the release of CXCL 8 and NE from neutrophils, whereas RV 16 or influenza had no effect.", {"entities": [[78, 87, "DISEASE"]]}], ["Neutrophils release CXCL 8, NE and MMP \u20109 in response to viral surrogates with R 848\u2010induced CXCL 8 release being specifically enhanced in asthmatic neutrophils.", {"entities": []}], ["Toll\u2010like receptor ( TLR 7/8) dysregulation may play a role in neutrophilic inflammation in viral\u2010induced exacerbations.", {"entities": []}], ["We aimed to investigate and compare neutrophil responses to bacterial compounds and viral mimetics as well as compare responses between people with and without asthma.", {"entities": [[160, 166, "DISEASE"]]}], ["We also investigated neutrophil responses to live respiratory viruses.", {"entities": []}], ["Here we provide a novel comprehensive comparison showing differential and specific activation in innate immune cells.", {"entities": []}], ["See Editorial, page 10", {"entities": []}], ["To the authors\u2019 knowledge, there are few valid data that describe the prevalence of comorbidity in type 2 diabetes mellitus (T2DM) patients seen in family practice.", {"entities": [[106, 123, "DISEASE"], [99, 123, "DISEASE"]]}], ["This study aimed to investigate the prevalence of comorbidities and their association with elevated (\u2265\u20097.0%) haemoglobin A1c (HbA1c) using a large sample of T2DM patients from primary care practices.", {"entities": []}], ["A cross-sectional study in which multivariate logistic regression was applied to explore the association of comorbidities with elevated HbA1c.", {"entities": []}], ["Primary care practices in Croatia.", {"entities": []}], ["Altogether, 10 264 patients with diabetes in 449 practices.", {"entities": []}], ["Comorbidities and elevated HbA1c.", {"entities": []}], ["In total 7979 (77.7%) participants had comorbidity.", {"entities": []}], ["The mean number of comorbidities was 1.6 (SD 1.28).", {"entities": []}], ["Diseases of the circulatory system were the most common (7157, 69.7%), followed by endocrine and metabolic diseases (3093, 30.1%), and diseases of the musculoskeletal system and connective tissue (1437, 14.0%).", {"entities": []}], ["After adjustment for age and sex, the number of comorbidities was significantly associated with HbA1c.", {"entities": []}], ["The higher the number of comorbidities, the lower the HbA1c.", {"entities": []}], ["The prevalence of physicians\u2019 inertia was statistically significantly and negatively associated with the number of comorbidities (Mann\u2013Whitney U test, Z\u2009=\u2009\u201312.34; p\u2009<\u20090.001; r\u2009=\u2009\u20130.12).", {"entities": []}], ["There is a high prevalence of comorbidity among T2DM patients in primary care.", {"entities": []}], ["A negative association of number of comorbidities and HbA1c is probably moderated by physicians\u2019 inertia in treatment of T2DM strictly according to guidelines.", {"entities": []}], ["Key points There is a high prevalence of comorbidity among T2DM patients in primary care.", {"entities": []}], ["Patients with breast cancer, obese patients, and those with dyslipidaemia and ischaemic heart disease were more likely to have increased HbA1c.", {"entities": [[88, 101, "DISEASE"], [14, 27, "DISEASE"], [21, 27, "DISEASE"]]}], ["The higher the number of comorbidities, the lower the HbA1c.", {"entities": []}], ["There is a high prevalence of comorbidity among T2DM patients in primary care.", {"entities": []}], ["Patients with breast cancer, obese patients, and those with dyslipidaemia and ischaemic heart disease were more likely to have increased HbA1c.", {"entities": [[88, 101, "DISEASE"], [14, 27, "DISEASE"], [21, 27, "DISEASE"]]}], ["The higher the number of comorbidities, the lower the HbA1c.", {"entities": []}], ["A newly discovered negative glucocorticoid response element (nGRE) mediates DNA-dependent transrepression by the glucocorticoid receptor (GR) across the genome and plays a major role in immunosuppressive therapy.", {"entities": []}], ["The nGRE differs dramatically from activating response elements and the mechanism driving GR binding and transrepression is unknown.", {"entities": []}], ["To unravel the mechanism of nGRE-mediated transrepression by the glucocorticoid receptor, we characterize the interaction between GR and a nGRE in the thymic stromal lymphopoetin ( TSLP ) promoter.", {"entities": [[181, 185, "GENE"]]}], ["We show using structural and mechanistic approaches that nGRE binding represents a new mode of sequence recognition by human GR and that nGREs prevent receptor dimerization through a unique GR-binding orientation and strong negative cooperativity, ensuring the presence of monomeric GR at repressive elements.", {"entities": []}], ["The mistletoe Loranthus parasiticus has been used as a compound for traditional medicine in Northeast Asia for a long time and is known to possess neuroprotective action.", {"entities": []}], ["Nonetheless, the effect of Loranthus parasiticus on allergic responses remains unknown.", {"entities": []}], ["In the present study, we evaluated whether the water extract of Loranthus parasiticus (LPE) could inhibit IgE-mediated allergic responses in RBL-2H3 cells.", {"entities": []}], ["LPE inhibited the release of \u03b2 -hexosaminidase (IC 50 , 184.5\u2009 \u03bc g/mL) and the formation of tumor necrosis factor- \u03b1 (IC 50 , 84.27\u2009 \u03bc g/mL), interleukin-4 (IC 50 , 93.43\u2009 \u03bc g/mL), prostaglandin E 2 (IC 50 , 84.10\u2009 \u03bc g/mL), prostaglandin D 2 , and leukotriene C 4 (IC 50 , 43.27\u2009 \u03bc g/mL) in a concentration-dependent manner.", {"entities": []}], ["Moreover, LPE inhibited phosphorylation of Syk, PLC \u03b3 1/2, PKC \u03b4 , ERK, JNK, p38, and Akt.", {"entities": [[43, 46, "GENE"]]}], ["In the late phase, LPE decreased 5-lipoxygenase phosphorylation and COX-2 expression but not cPLA 2 phosphorylation.", {"entities": []}], ["Additionally, LPE included total phenolic compounds (10.72\u2009mg/g dry weight) and total flavonoids (56.20\u2009mg/g dry weight).", {"entities": []}], ["These results suggest that the phenolic compounds or flavonoids contained in LPE may be associated with antiallergic activity.", {"entities": []}], ["The phenolic compounds and flavonoids in LPE are antiallergic phytochemicals capable of inhibiting the activation of the Fc \u03b5 RI signaling cascade in mast cells.", {"entities": []}], ["Such effects may provide further information for the development of a phytomedicine for allergic diseases.", {"entities": []}], ["Founder populations are ideally suited for studies on the clinical effects of alleles that are rare in general populations but occur at higher frequencies in these isolated populations.", {"entities": []}], ["Whole genome sequencing in 98 Hutterites, a founder population of European descent, and subsequent imputation revealed 660,238 single nucleotide polymorphisms that are rare (<1%) or absent in European populations, but occur at frequencies\u2009>1% in the Hutterites.", {"entities": []}], ["We examined the effects of these rare in European variants on plasma lipid levels in 828 Hutterites and applied a Bayesian hierarchical framework to prioritize potentially causal variants based on functional annotations.", {"entities": []}], ["We identified two novel non-coding rare variants associated with LDL cholesterol (rs17242388 in LDLR ) and HDL cholesterol (rs189679427 between GOT2 and APOOP5 ), and replicated previous associations of a splice variant in APOC3 (rs138326449) with triglycerides and HDL-C. All three variants are at well-replicated loci in GWAS but are independent from and have larger effect sizes than the known common variation in these regions.", {"entities": [[96, 100, "GENE"], [144, 148, "GENE"], [223, 228, "GENE"]]}], ["Candidate eQTL analyses in in LCLs in the Hutterites suggest that these rare non-coding variants are likely to mediate their effects on lipid traits by regulating gene expression.", {"entities": []}], ["Xindening oral liquid (Xin) is a widely used traditional Chinese medicine for the treatment of chronic heart failure (CHF).", {"entities": []}], ["However, the exact mechanisms related to its therapeutic effects against CHF remain unclear.", {"entities": []}], ["In the present study, we investigate the effects of Xin on cardiac function in CHF rats and the possible mechanisms involved.", {"entities": []}], ["Transverse aortic constriction (TAC) was conducted to induce a CHF rat model in this study.", {"entities": []}], ["Sixty male Wistar rats were randomly assigned to six groups 28 days after TAC: sham; CHF model; Xin at concentrations of 5 ml/kg, 10 mL/kg, and 20 mL/kg; and QiLi 0.6 g/kg.", {"entities": []}], ["After four weeks, the rats were treated with Xin (5, 10, or 20 mL/kg/d) for six weeks consecutively.", {"entities": []}], ["At the end of the study, the cardiac function, heart weight index (HWI) and left ventricular mass index (LVMI), serum level of LDH, B-type natriuretic peptide (BNP), cTnI and CK-MB, and collagen volume fraction were studied.", {"entities": []}], ["The expression of transforming growth factor-b1 (TGF-b1), drosophila mothers against decapentaplegic protein 3 (Smad3), and p38 mitogen activated protein kinase (p38 MAPK) were detected.", {"entities": [[112, 117, "GENE"]]}], ["The results showed that Xin treatment significantly improved cardiac function but decreased the serum level of LDH, BNP, cTnI, and CK-MB of CHF rats.", {"entities": []}], ["In addition, it reduced the HWI, LVMI, and collagen volume fraction compared with the model group.", {"entities": []}], ["Xin treatment significantly improved cardiac function and attenuated cardiac fibrosis by suppressing the p38 MAPK and TGF-b1/Smad3 signaling pathway in CHF rats.", {"entities": []}], ["These results suggested that Xin might be a promising complementary treatment for CHF.", {"entities": []}], ["More detailed experimental studies will be carried out in our subsequent research.", {"entities": []}], ["COPD has attracted widespread attention worldwide.", {"entities": []}], ["The prevalence of COPD in Taiwan has been reported, but little is known about trends in health care resource utilization and pharmacologic management in COPD treatment.", {"entities": []}], ["The objective of this article was to study trends in health care resource utilization, pharmacologic management, and medical costs of COPD treatment in Taiwan.", {"entities": []}], ["Reimbursement claims in the Taiwan National Health Insurance System from 2004 to 2010 were collected.", {"entities": []}], ["The disease burden of COPD, including health care resource utilization and medical costs, was evaluated.", {"entities": []}], ["The pharmacy cost of COPD increased from 2004 to 2010 due to the increased utilization of long-acting muscarinic antagonist (LAMA) and fixed-dose combination of long-acting \u03b22-agonist and inhaled corticosteroid (LABA/ICS), whereas the cost of all other COPD-related medications decreased.", {"entities": []}], ["The average outpatient department (OPD) cost per patient increased 29.3% from 1,070 USD in 2004 to 1,383 USD in 2010.", {"entities": []}], ["The highest average total medical cost per patient was 3,434 USD in 2005, and it decreased 12.4% to 3,008 USD in 2010.", {"entities": []}], ["There was no significant difference in the average number of OPD visits and emergency department visits per patient.", {"entities": []}], ["The highest average number of hospital admissions was 0.81 in 2005, and it decreased to 0.65 in 2010.", {"entities": []}], ["The average number of intensive care unit (ICU) admissions decreased from 0.52 in 2005 to 0.31 in 2010.", {"entities": []}], ["From 2004 to 2010, the average total medical cost per patient of COPD was slightly decreased because of the decreased average number of hospital admissions and ICU admissions.", {"entities": []}], ["The costs of both LAMA and LABA/ICS increased, while the cost for all other COPD-related medications decreased.", {"entities": []}], ["These findings suggest that the increased utilization of LAMA and LABA/ICS may have contributed to the decreased average number of hospital admissions and ICU admissions in COPD patients from 2004 to 2010.", {"entities": []}], ["Mammalian experiments provide clear evidence of male line transgenerational effects on health and development from paternal or ancestral early-life exposures such as diet or stress.", {"entities": []}], ["The few human observational studies to date suggest (male line) transgenerational effects exist that cannot easily be attributed to cultural and/or genetic inheritance.", {"entities": []}], ["Here we summarise relevant studies, drawing attention to exposure sensitive periods in early life and sex differences in transmission and offspring outcomes.", {"entities": []}], ["Thus, variation, or changes, in the parental/ancestral environment may influence phenotypic variation for better or worse in the next generation(s), and so contribute to common, non-communicable disease risk including sex differences.", {"entities": []}], ["We argue that life-course epidemiology should be reframed to include exposures from previous generations, keeping an open mind as to the mechanisms that transmit this information to offspring.", {"entities": []}], ["Finally, we discuss animal experiments, including the role of epigenetic inheritance and non-coding RNAs, in terms of what lessons can be learnt for designing and interpreting human studies.", {"entities": []}], ["This review was developed initially as a position paper by the multidisciplinary Network in Epigenetic Epidemiology to encourage transgenerational research in human cohorts.", {"entities": []}], ["We reported previously that increases in ambient air pollution in the Los Angeles basin increased the risk of low weight and premature birth.", {"entities": []}], ["However, ambient concentrations measured at monitoring stations may not take into account differential exposure to pollutants found in elevated concentrations near heavy-traffic roadways.", {"entities": []}], ["Therefore, we used an epidemiologic case-control study design to examine whether residential proximity to heavy-traffic roadways influenced the occurrence of low birth weight (LBW) and/or preterm birth in Los Angeles County between 1994 and 1996.", {"entities": []}], ["We mapped subject home locations at birth and estimated exposure to traffic-related air pollution using a distance-weighted traffic density (DWTD) measure.", {"entities": []}], ["This measure takes into account residential proximity to and level of traffic on roadways surrounding homes.", {"entities": []}], ["We calculated odds ratios (ORs) and risk ratios (RRs) for being LBW and/or preterm per quintile of DWTD.", {"entities": []}], ["The clearest exposure-response pattern was observed for preterm birth, with an RR of 1.08 [95% confidence interval (CI), 1.01-1.15] for infants in the highest DWTD quintile.", {"entities": []}], ["Although higher risks were observed for LBW infants, exposure-response relations were less consistent.", {"entities": []}], ["Examining the influence of season, we found elevated risks primarily for women whose third trimester fell during fall/winter months (OR(term LBW) = 1.39; 95% CI, 1.16-1.67; OR(preterm and LBW) = 1.24; 95% CI = 1.03-1.48; RR(all preterm) = 1.15; 95% CI, 1.05-1.26), and exposure-response relations were stronger for all outcomes.", {"entities": []}], ["This result is consistent with elevated pollution in proximity to sources during more stagnant air conditions present in winter months.", {"entities": []}], ["Our previous research and these latest results suggest exposure to traffic-related pollutants may be important.", {"entities": []}], ["Background: Prenatal and early-life periods may be critical windows for harmful effects of air pollution on infant health.", {"entities": []}], ["Objectives: We studied the association of air pollution exposure during pregnancy and the first year of life with respiratory illnesses, ear infections, and eczema during the first 12\u201318 months of age in a Spanish birth cohort of 2,199 infants.", {"entities": []}], ["Methods: We obtained parentally reported information on doctor-diagnosed lower respiratory tract infections (LRTI) and parental reports of wheezing, eczema, and ear infections.", {"entities": []}], ["We estimated individual exposures to nitrogen dioxide (NO 2 ) and benzene with temporally adjusted land use regression models.", {"entities": []}], ["We used log-binomial regression models and a combined random-effects meta-analysis to estimate the effects of air pollution exposure on health outcomes across the four study locations.", {"entities": []}], ["Results: A 10-\u00b5g/m 2 during pregnancy was associated with LRTI [relative risk (RR) = 1.05; 95% CI: 0.98, 1.12] and ear infections (RR = 1.18; 95% CI: 0.98, 1.41).", {"entities": []}], ["The RRs for an interquartile range (IQR) increase in NO 2 were 1.08 (95% CI: 0.97, 1.21) for LRTI and 1.31 (95% CI: 0.97, 1.76) for ear infections.", {"entities": []}], ["Compared with NO 2 , the association for an IQR increase in average benzene exposure was similar for LRTI (RR = 1.06; 95% CI: 0.94, 1.19) and slightly lower for ear infections (RR = 1.17; 95% CI: 0.93, 1.46).", {"entities": []}], ["Associations were slightly stronger among infants whose mothers spent more time at home during pregnancy.", {"entities": []}], ["Air pollution exposure during the first year was highly correlated with prenatal exposure, so we were unable to discern the relative importance of each exposure period.", {"entities": []}], ["Conclusions: Our findings support the hypothesis that early-life exposure to ambient air pollution may increase the risk of upper and lower respiratory tract infections in infants.", {"entities": []}], ["Although many studies on evaluating the safety of liver resection in obese patients have been conducted, the results remain contradictory.", {"entities": []}], ["The aim of our study was to investigate the safety of overweight and obese patients undergoing liver resection for hepatitis B-related hepatocellular carcinoma in a large sample.", {"entities": [[135, 159, "DISEASE"], [150, 159, "DISEASE"], [115, 124, "DISEASE"]]}], ["In a retrospective cohort with 1543 hepatitis B-related hepatocellular carcinoma patients, the subjects were stratified into four groups according to their body mass index(BMI): obesity(BMI\u226528), overweight(BMI:24.0\u201327.9), normal weight(BMI:18.5\u201323.9) and underweight(BMI<18.5).", {"entities": [[56, 80, "DISEASE"], [71, 80, "DISEASE"], [178, 185, "DISEASE"], [36, 45, "DISEASE"]]}], ["The Dindo\u2013Clavien classification system was used for grading complications.", {"entities": []}], ["Clinical characteristics and operative outcomes were compared among the four groups.", {"entities": []}], ["Risk factors for postoperative complications were evaluated by multivariate analysis.", {"entities": []}], ["According to the category criteria of the Working Group on Obesity in China (WGOC) criteria, 73(4.7%) obese, 412(26.7%) overweight, 982(63.6%) normal weight and 76(4.9%) underweight patients were included in our cohort.", {"entities": [[59, 66, "DISEASE"]]}], ["Overweight and obese patients had more preoperative comorbidities such as hypertension(P<0.001).", {"entities": [[74, 86, "DISEASE"]]}], ["Mortality, total complications and complications classified by Clavien system were similar among the four groups except that the underweight patients had fewer total complications.", {"entities": []}], ["However, postoperative wound complication was more common in overweight and obese patients(6.3% vs 2.5%,P<0.001,11.0% vs 2.5%,P\u200a=\u200a0.001).", {"entities": []}], ["Multivariate analysis revealed that BMI was not an independently significant factor for postoperative complications.", {"entities": []}], ["Liver resection for obese and overweight patients is safe and BMI itself is not a risk factor for mortality and morbidity.", {"entities": []}], ["There is a lack of health-related quality of life (HRQOL) questionnaires to evaluate pediatric musculoskeletal diseases in Brazil.", {"entities": []}], ["The Pediatric Outcome Data Collection Instrument (PODCI) is widely used elsewhere for pediatric patients with musculoskeletal disorders, but it has not been fully validated in Brazil.", {"entities": []}], ["Validation of the PODCI in the Brazilian Portuguese language is important to improve the assessment of pediatric patients with musculoskeletal diseases and to compare Brazilian study results with results from the international literature.", {"entities": []}], ["This study aimed to analyze the test\u2013re-test reliability and the convergent validity indicators for the quality of life scores obtained by application of the PODCI to children and adolescents with juvenile idiopathic arthritis (JIA).", {"entities": [[217, 226, "DISEASE"]]}], ["The PODCI underwent translation, transcultural adaptation, and field testing.", {"entities": []}], ["Fifty-seven children and adolescents with JIA were administered the PODCI questionnaire.", {"entities": []}], ["The Child Health Questionnaire - Parent Form 28 (CHQ PF-28) was used as the gold standard.", {"entities": []}], ["Pain scales were employed, clinical examinations were performed, and laboratory inflammatory activity tests were conducted.", {"entities": []}], ["The three versions of the PODCI exhibited good internal consistency (Cronbach\u2019s alpha coefficient >0.70), good reproducibility (p\u2009<\u20090.05), and good correlation compared with the gold standard (CHQ), as shown by a Spearman coefficient (Rho) >0.40 (p\u2009<\u20090.05).", {"entities": []}], ["The PODCI was validated in patients with JIA in Brazil.", {"entities": []}], ["This questionnaire was found to be valid, precise, and reliable.", {"entities": []}], ["It can be successfully applied in research conducted by healthcare professionals who work with children and adolescents with musculoskeletal system disorders.", {"entities": []}], ["\u2022 Patients with chronic hypersecretion (CH) of tracheobronchial mucus are a clinical challenge.", {"entities": []}], ["They have an impaired quality of life, frequent exacerbations, and hospitalizations with need of antibiotics and other type of expensive treatments.", {"entities": []}], ["\u2022 Chest physical therapy evolved along the last decades and new techniques are currently used to help patients clear the airways efficiently.", {"entities": []}], ["Among these airway clearance techniques (ACTs), the use of positive expiratory pressure (PEP) is considered one of the most effective.", {"entities": []}], ["\u2022 We report the retrospective evaluation of 162 patients with CH due to chronic obstructive pulmonary disease or bronchiectasis undergoing ACT in our Pulmonary Rehabilitation Department.", {"entities": [[72, 109, "DISEASE"], [113, 127, "DISEASE"]]}], ["They were treated either with PEP or with a new PEP device called UNIKO \u2022 Comparing the two groups of patients, both treatments (i.e., PEP and TPEP) were followed by great improvements in physiological parameters of spirometry and gas exchange.", {"entities": []}], ["However, subdividing patients, it was evident that TPEP had better effects than PEP in patients with emphysema and in patients on long-term oxygen treatment, while PEP was superior at least in some parameters in patients on mechanical ventilation.", {"entities": []}], ["\u2022 This study, albeit retrospective and calling for controlled clinical trials, suggests that different ACTs can be applied in different populations of patients.", {"entities": []}], ["Patients with chronic hypersecretion (CH) of tracheobronchial mucus are a clinical challenge.", {"entities": []}], ["They have an impaired quality of life, frequent exacerbations, and hospitalizations with need of antibiotics and other type of expensive treatments.", {"entities": []}], ["Chest physical therapy evolved along the last decades and new techniques are currently used to help patients clear the airways efficiently.", {"entities": []}], ["Among these airway clearance techniques (ACTs), the use of positive expiratory pressure (PEP) is considered one of the most effective.", {"entities": []}], ["We report the retrospective evaluation of 162 patients with CH due to chronic obstructive pulmonary disease or bronchiectasis undergoing ACT in our Pulmonary Rehabilitation Department.", {"entities": [[70, 107, "DISEASE"], [111, 125, "DISEASE"]]}], ["They were treated either with PEP or with a new PEP device called UNIKO Comparing the two groups of patients, both treatments (i.e., PEP and TPEP) were followed by great improvements in physiological parameters of spirometry and gas exchange.", {"entities": []}], ["However, subdividing patients, it was evident that TPEP had better effects than PEP in patients with emphysema and in patients on long-term oxygen treatment, while PEP was superior at least in some parameters in patients on mechanical ventilation.", {"entities": []}], ["This study, albeit retrospective and calling for controlled clinical trials, suggests that different ACTs can be applied in different populations of patients.", {"entities": []}], ["Airway clearance techniques include positive expiratory pressure, commonly used in our clinical practice, and a recently introduced temporary positive expiratory pressure device called UNIKO The aim of this observational 4-year study was to retrospectively compare the efficacy of and specific indications for temporary positive expiratory pressure compared to positive expiratory pressure in a standard rehabilitation program.", {"entities": []}], ["We retrospectively collected data from 162 subjects (107 males, mean age 70\u00a0\u00b1\u00a09 years, 97 with primary diagnosis of chronic obstructive pulmonary disease, 65 with bronchiectasis), 51 treated with temporary positive expiratory pressure and 111 with positive expiratory pressure.", {"entities": [[116, 153, "DISEASE"], [163, 177, "DISEASE"]]}], ["Subjects showed significant improvement in ratio of partial pressure arterial oxygen and fraction of inspired oxygen ( p \u00a0<\u00a00.001), forced vital capacity, forced expiratory volume in one second, peak expiratory flow, arterial oxygen saturation, and partial pressure arterial oxygen with no significant difference between positive expiratory pressure and temporary positive expiratory pressure groups apart from forced expiratory flow, which increased only in the positive expiratory pressure group.", {"entities": []}], ["Evaluating specific subgroups, temporary positive expiratory pressure was more effective than positive expiratory pressure in improving gas transfer in subjects with emphysema and in those on oxygen therapy, as the effective supplement oxygen flow decreased significantly ( p \u00a0=\u00a00.034 and 0.046 respectively for temporary positive expiratory pressure vs. positive expiratory pressure).", {"entities": []}], ["In subjects on mechanical ventilation, positive expiratory pressure was superior to temporary positive expiratory pressure in increasing forced expiratory flow ( p \u00a0=\u00a00.018).", {"entities": []}], ["The physiological parameters of both groups improved significantly and similarly.", {"entities": []}], ["Subgroup analysis suggests that temporary positive expiratory pressure could provide some advantage to subjects with emphysema and those on oxygen therapy, while positive expiratory pressure would benefit patients on mechanical ventilation.", {"entities": []}], ["Randomized clinical trials are necessary to confirm our preliminary results indicating that different subgroups/phenotypes can benefit more from one type of treatment.", {"entities": []}], ["Polychlorinated biphenyls (PCBs) are widely distributed environmental toxicants that contribute to numerous disease states.", {"entities": []}], ["The main route of exposure to PCBs is through the gastrointestinal tract; however, little is known about the effects of PCBs on intestinal epithelial barrier functions.", {"entities": []}], ["The aim of the present study was to address the hypothesis that highly chlorinated PCBs can disrupt gut integrity at the level of tight junction (TJ) proteins.", {"entities": []}], ["Caco-2 human colon adenocarcinoma cells were exposed to one of the following PCB congeners: PCB153, PCB118, PCB104, and PCB126.", {"entities": [[19, 33, "DISEASE"], [13, 33, "DISEASE"]]}], ["We then assessed NAD(P)H oxidase (NOX) activity and expression and the barrier function of Caco-2 cells.", {"entities": []}], ["In addition, the integrity of intestinal barrier function and expression of TJ proteins were evaluated in C57BL/6 mice exposed to individual PCBs by oral gavage.", {"entities": []}], ["Exposure of Caco-2 cells to individual PCB congeners resulted in activation of NOX and increased permeability of fluorescein isothiocyanate (FITC)-labeled dextran (4 kDa).", {"entities": []}], ["Treatment with PCB congeners also disrupted expression of TJ proteins zonula occludens-1 (ZO-1) and occludin in Caco-2 cells.", {"entities": []}], ["Importantly, inhibition of NOX by apocynin significantly protected against PCB-mediated increase in epithelial permeability and alterations of ZO-1 protein expression.", {"entities": []}], ["Exposure to PCBs also resulted in alterations of gut permeability via decreased expression of TJ proteins in an intact physiological animal model.", {"entities": []}], ["These results suggest that oral exposure to highly chlorinated PCBs disrupts intestinal epithelial integrity and may directly contribute to the systemic effects of these toxicants.", {"entities": []}], ["Chebulic acid (CA) isolated from T. chebula , which has been reported for treating asthma, as a potent anti-oxidant resources.", {"entities": [[83, 89, "DISEASE"]]}], ["Exposure to ambient urban particulate matter (UPM) considered as a risk for cardiopulmonary vascular dysfunction.", {"entities": []}], ["To investigate the protective effect of CA against UPM-mediated collapse of the pulmonary alveolar epithelial (PAE) cell (NCI-H441), barrier integrity parameters, and their elements were evaluated in PAE.", {"entities": []}], ["CA was acquired from the laboratory previous reports.", {"entities": []}], ["UPM was obtained from the National Institutes of Standards and Technology, and these were collected in St. Louis, MO, over a 24-month period and used as a standard reference.", {"entities": []}], ["To confirm the protection of PAE barrier integrity, paracellular permeability and the junctional molecules were estimated with determination of transepithelial electrical resistance, Western Blotting, RT-PCR, and fluorescent staining.", {"entities": []}], ["UPM aggravated the generation of reactive oxygen species (ROS) in PAE and also decreased mRNA and protein levels of junction molecules and barrier integrity in NCI-H441.", {"entities": []}], ["However, CA repressed the ROS in PAE, also improved barrier integrity by protecting the junctional parameters in NCI-H411.", {"entities": []}], ["These data showed that CA resulted in decreased UPM-induced ROS formation, and the protected the integrity of the tight junctions against UPM exposure to PAE barrier.", {"entities": []}], ["The online version of this article (doi:10.1186/s12906-017-1870-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To improve medication appropriateness and adherence in elderly patients with multimorbidity, we developed a complex intervention involving general practitioners (GPs) and their healthcare assistants (HCA).", {"entities": []}], ["In accordance with the Medical Research Council guidance on developing and evaluating complex interventions, we prepared for the main study by testing the feasibility of the intervention and study design in a cluster randomised pilot study.", {"entities": []}], ["20 general practices in Hesse, Germany.", {"entities": []}], ["100 cognitively intact patients \u226565\u2005years with \u22653 chronic conditions, \u22655 chronic prescriptions and capable of participating in telephone interviews; 94 patients completed the study.", {"entities": []}], ["The HCA conducted a checklist-based interview with patients on medication-related problems and reconciled their medications.", {"entities": []}], ["Assisted by a computerised decision-support system (CDSS), the GPs discussed medication intake with patients and adjusted their medication regimens.", {"entities": []}], ["The control group continued with usual care.", {"entities": []}], ["Feasibility of the intervention and required time were assessed for GPs, HCAs and patients using mixed methods (questionnaires, interviews and case vignettes after completion of the study).", {"entities": []}], ["The feasibility of the study was assessed concerning success of achieving recruitment targets, balancing cluster sizes and minimising drop-out rates.", {"entities": []}], ["Exploratory outcomes included the medication appropriateness index (MAI), quality of life, functional status and adherence-related measures.", {"entities": []}], ["MAI was evaluated blinded to group assignment, and intra-rater/inter-rater reliability was assessed for a subsample of prescriptions.", {"entities": []}], ["10 practices were randomised and analysed per group.", {"entities": []}], ["GPs/HCAs were satisfied with the interventions despite the time required (35/45\u2005min/patient).", {"entities": []}], ["In case vignettes, GPs/HCAs needed help using the CDSS.", {"entities": []}], ["The study made no patients feel uneasy.", {"entities": []}], ["Intra-rater/inter-rater reliability for MAI was excellent.", {"entities": []}], ["Inclusion criteria were challenging and potentially inadequate, and should therefore be adjusted.", {"entities": []}], ["Outcome measures on pain, functionality and self-reported adherence were unfeasible due to frequent missing values, an incorrect manual or potentially invalid results.", {"entities": []}], ["Intervention and trial design were feasible.", {"entities": []}], ["The pilot study revealed important limitations that influenced the design and conduct of the main study, thus highlighting the value of piloting complex interventions.", {"entities": []}], ["ISRCTN99691973; Results.", {"entities": []}], ["The National Institute for Health and Clinical Excellence in the UK has recommended that the effectiveness of ongoing exercise referral schemes to promote physical activity should be examined in research trials.", {"entities": []}], ["Recent empirical evidence in health care and physical activity promotion contexts provides a foundation for testing the feasibility and impact of a Self Determination Theory-based (SDT) exercise referral consultation.", {"entities": []}], ["An exploratory cluster randomised controlled trial comparing standard provision exercise referral with an exercise referral intervention grounded in Self Determination Theory.", {"entities": []}], ["Individuals (N\u2009=\u2009347) referred to an exercise referral scheme were recruited into the trial from 13 centres.", {"entities": []}], ["Outcomes and processes of change measured at baseline, 3 and 6-months: Minutes of self-reported moderate or vigorous physical activity (PA) per week (primary outcome), health status, positive and negative indicators of emotional well-being, anxiety, depression, quality of life (QOL), vitality, and perceptions of autonomy support from the advisor, need satisfaction (3 and 6\u00a0months only), intentions to be active, and motivational regulations for exercise.", {"entities": []}], ["Blood pressure and weight were assessed at baseline and 6\u00a0months.", {"entities": []}], ["Perceptions of the autonomy support provided by the health and fitness advisor (HFA) did not differ by arm.", {"entities": []}], ["Between group changes over the 6-months revealed significant differences for reported anxiety only.", {"entities": []}], ["Within arm contrasts revealed significant improvements in anxiety and most of the Dartmouth CO-OP domains in the SDT arm at 6\u00a0months, which were not seen in the standard exercise referral group.", {"entities": []}], ["A process model depicting hypothesized relationships between advisor autonomy support, need satisfaction and more autonomous motivation, enhanced well being and PA engagement at follow up was supported.", {"entities": []}], ["Significant gains in physical activity and improvements in quality of life and well-being outcomes emerged in both the standard provision exercise referral and the SDT-based intervention at programme end.", {"entities": []}], ["At 6-months, observed between arm and within intervention arm differences for indicators of emotional health, and the results of the process model, were in line with SDT.", {"entities": []}], ["The challenges in optimising recruitment and implementation of SDT-based training in the context of health and leisure services are discussed.", {"entities": []}], ["The trial is registered as Current Controlled trials ISRCTN07682833 .", {"entities": []}], ["In some patients, eosinophilic gastroenteritis(EG) occurs in those with food allergy.", {"entities": [[18, 46, "DISEASE"], [72, 84, "DISEASE"], [31, 46, "DISEASE"]]}], ["We experienced a non-atopic asthmatic who had an EG associated with food allergy to fish and eggs, and blood eosinophilia.", {"entities": [[68, 80, "DISEASE"], [109, 121, "DISEASE"]]}], ["A skin prick test and RAST to causative food allergens showed a negative result.", {"entities": []}], ["A fiber-optic endoscopic biopsy from the gastric mucosa showed an intense eosinophilic infiltration.", {"entities": []}], ["We could find symptomatic improvement and a disappearance of eosinophilic infiltration in gastric mucosa after complete avoidance from the causative food and oral cortcosteroid.", {"entities": []}], ["It was suggested that fiber-optic endoscopic biopsy might be needed to identify coexisting EG if an allergic patient with blood eosinophilia complains of severe gastrointestinal symptoms.", {"entities": [[128, 140, "DISEASE"]]}], ["Little is known about the current health status of US metal and nonmetal (MNM) miners, in part because no health surveillance systems exist for this population.", {"entities": []}], ["The National Institute for Occupational Safety and Health (NIOSH) is developing a program to characterize burden of disease among MNM miners.", {"entities": []}], ["This report discusses current knowledge and potential data sources of MNM miner health.", {"entities": []}], ["Recent national surveys were analyzed, and literature specific to MNM miner health status was reviewed.", {"entities": []}], ["No robust estimates of disease prevalence were identified, and national surveys did not provide information specific to MNM miners.", {"entities": []}], ["Because substantial gaps exist in the understanding of MNM miners' current health status, NIOSH plans to develop a health surveillance program for this population to guide intervention efforts to reduce occupational and personal risks for chronic illness.", {"entities": []}], ["Mesenchymal stem cells (MSCs) are the nonhematopoietic multipotent progenitor cells found in various adult tissues.", {"entities": []}], ["They are characterized by their ease of isolation and their rapid growth in vitro while maintaining their differentiation potential, allowing for extensive expansion in culture that yields large quantities suitable for therapeutic use.", {"entities": []}], ["This article reviews the immunomodulatory activities associated with MSCs.", {"entities": []}], ["Numerous studies have demonstrated that MSCs are potently immunosuppressive in vitro and in vivo .", {"entities": []}], ["However, this article presents a new paradigm in MSC biology, in which MSCs, at least in vitro , can undergo polarization into either a pro-inflammatory or an immunosuppressive phenotype.", {"entities": [[49, 52, "GENE"]]}], ["Biomarkers unrelated to myocardial necrosis, such as cystatin C, copeptin, and mid-regional pro-adrenomedullin (MR-proADM), showed promise for cardiovascular risk prediction.", {"entities": []}], ["Knowing whether they are comparable to cardiac biomarkers such as high-sensitive cardiac-troponin T (hs-cTnT) or N-terminal pro-Brain natriuretic peptide (NT-proBNP) in elderly patients with acute non-massive pulmonary embolism (NMPE) remains elusive.", {"entities": [[209, 227, "DISEASE"]]}], ["This study aims at comparing the prognostic accuracy of cardiac and non-cardiac biomarkers in patients with NMPE aged \u226565 years over time.", {"entities": []}], ["In the context of the SWITCO65+ cohort, we evaluated 227 elderly patients with an available blood sample taken within one day from diagnosis.", {"entities": []}], ["The primary study endpoint was defined as PE-related mortality and the secondary endpoint as PE-related complications.", {"entities": []}], ["The biomarkers\u2019 predictive ability at 1, 3, 12 and 24 months was determined using C-statistics and Cox regression.", {"entities": []}], ["For both study endpoints, C-statistics (95% confidence interval) were stable over time for all biomarkers, with the highest value for hs-cTnT, ranging between 0.84 (0.68\u20131.00) and 0.80 (0.70\u20130.90) for the primary endpoint, and between 0.74 (0.63\u20130.86) and 0.65 (0.57\u20130.73) for the secondary endpoint.", {"entities": []}], ["For both study endpoints, cardiac biomarkers were found to be independently associated with risk, NT-proBNP displaying a negative predictive value of 100%.", {"entities": []}], ["Among non-cardiac biomarkers, only copeptin and MR-proADM were independent predictors of PE-related mortality but they were not independent predictors of PE-related complications, and displayed lower negative predictive values.", {"entities": []}], ["In elderly NMPE patients, cardiac biomarkers appear to be valuable prognostic to identify very low-risk individuals.", {"entities": []}], ["Trial Registration : ClinicalTrials.gov NCT00973596", {"entities": []}], ["Common bile duct (CBD) stones are common in patients even after cholecystectomy.", {"entities": []}], ["Besides endoscopic retrograde cholangiography (ERCP), laparoscopic common bile duct exploration (LCBDE) is also applied.", {"entities": []}], ["This study aims to compare clinical indications, therapeutic benefits and complications for these two managements.", {"entities": []}], ["From October 2012 to February 2015, 1072 consecutive patients were diagnosed as choledocholithiasis in our single hospital.", {"entities": [[80, 99, "DISEASE"]]}], ["Post-cholecystectomy patients who underwent ERCP or LCBDE were included.", {"entities": []}], ["Clinical data were analyzed, such as success rate, complications, procedure duration, postoperative hospital stay, total cost and recurrence of ductal stones.", {"entities": []}], ["Prior ERCP, previous biliary anatomic alteration surgeries and lost to follow up were the excluding criteria.", {"entities": []}], ["141 patients were included according to the criteria, and 87 cases underwent ERCP and 54 cases underwent LCBDE.", {"entities": []}], ["Age and sex distribution of patients were comparable between the two groups.", {"entities": []}], ["The success rate for CBD stones clearance was 97.7% in the ERCP group, compared with 87.0% in the LCBDE group ( p =0.03).", {"entities": []}], ["The mean procedure duration was also significantly shorter in ERCP group (52.0\u00b115.8 vs. 102.9\u00b140.1 min; p <0.001).", {"entities": []}], ["Postoperative hospital stay was similar (5.5\u00b12.6 vs. 5.9\u00b12.3 days; p =0.40).", {"entities": []}], ["And no significant difference for postoperative complications (3.4% vs. 11.1%; p =0.15), total cost ($3787.1\u00b11061.5 vs. $3983.54\u00b11257.1, p =0.32), and the rate of bile duct stones recurrence (6.9% vs. 7.4%, p =1.00).", {"entities": []}], ["For clearing CBD stones in patients after cholecystectomy, ERCP was more efficient and might be the first choice, while LCBDE might be beneficial for patients with large stones.", {"entities": []}], ["There is limited information on whether the incidence of acute kidney injury (AKI) in critically ill patients has changed over time and there is controversy on whether its outcome has improved.", {"entities": []}], ["We interrogated the Australian New Zealand Intensive Care Society Adult Patient Database to obtain data on all adult admissions to 20 Australian intensive care units (ICUs) for \u2265 24 hours from 1 January 1996 to 31 December 2005.", {"entities": []}], ["Trends in incidence and mortality for ICU admissions associated with early AKI were assessed.", {"entities": []}], ["There were 91,254 patient admissions to the 20 study ICUs, with 4,754 cases of AKI, for an estimated crude cumulative incidence of 5.2% (95% confidence interval, 5.1 to 5.4).", {"entities": []}], ["The incidence of AKI increased during the study period, with an estimated annual increment of 2.8% (95% confidence interval, 1.0 to 5.6, P = 0.04).", {"entities": []}], ["The crude hospital mortality was significantly higher for patients with AKI than those without (42.7% versus 13.4%; odds ratio, 4.8; 95% confidence interval, 4.5 to 5.1; P < 0.0001).", {"entities": []}], ["There was also a decrease in AKI crude mortality (annual percentage change, -3.4%; 95% confidence interval, -4.7 to -2.12; P < 0.001), however, which was not seen in patients without AKI.", {"entities": []}], ["After covariate adjustment, AKI remained associated with a higher mortality (odds ratio, 1.23; 95% confidence interval, 1.14 to 1.32; P < 0.001) and there was a declining trend in the odds ratio for hospital mortality.", {"entities": []}], ["Over the past decade, in a large cohort of critically ill patients admitted to 20 Australian ICUs, there has been a significant rise in the incidence of early AKI while the mortality associated with AKI has declined.", {"entities": []}], ["Most of herbal medicines are used without any standard safety and toxicological trials although common assumption is that these products are nontoxic.", {"entities": []}], ["However, this assumption is incorrect and dangerous, so toxicological studies should be done for herbal drugs.", {"entities": []}], ["Although Pterolobium stellatum , Otostegia integrifolia and Vernonia amygdalina root extracts are frequently used in Ethiopian traditional medicine, there are no evidences of their active toxic compounds.", {"entities": []}], ["Therefore, we made an effort to assess probable genotoxic effect of these plant extracts on DNA of human hematoma (HepG 2 ) cells using alkaline comet assay.", {"entities": []}], ["Genotoxic effects of extracts were evaluated using single cell gel electrophoresis (SCGE) method on HepG 2 cell.", {"entities": []}], ["Regarding comet data, the average mean tail intensities (TI) from each individual experiment and treatment (usually at least 3 cultures/treatment) were pooled and the average mean TI was used as an indicator of DNA damage and the standard error of mean (SEM) as the measure of variance.", {"entities": []}], ["DNA damage in the form of comet tail has been observed for 1 and 0.5\u00a0mg/ml P. stellatum chloroform and 80% methanol extracts on HepG 2 cells, respectively.", {"entities": []}], ["The chloroform extract of P. stellatum showed increased tail DNA percentage in a concentration dependent manner.", {"entities": []}], ["Comet tail length in the chloroform P. stellatum extract treated cells (1\u00a0mg/ml) was significantly higher by 89% ( p \u2009<\u20090.05) compared to vehicle treated controls.", {"entities": []}], ["The rest of test extracts seemed to be without genotoxic effect up to a concentration of 0.5\u00a0mg/ml.", {"entities": []}], ["Our findings show that two extracts from one plant evaluated have a genotoxic potential in vitro which calls for a more thorough safety evaluation.", {"entities": []}], ["Such evaluation should include other end-points of genotoxicity apart from DNA damage, and possibly also pure compounds.", {"entities": []}], ["Diagnosis of community-acquired pneumonia (CAP) in the elderly is often delayed because of atypical presentation and non-specific symptoms, such as appetite loss, falls and disturbance in consciousness.", {"entities": [[32, 41, "DISEASE"]]}], ["The aim of this study was to investigate the external validity of existing prediction models and the added value of the non-specific symptoms for the diagnosis of CAP in elderly patients.", {"entities": []}], ["Prospective cohort study.", {"entities": []}], ["General medicine departments of three teaching hospitals in Japan.", {"entities": []}], ["A total of 109 elderly patients who consulted for upper respiratory symptoms between 1 October 2014 and 30 September 2016.", {"entities": []}], ["The reference standard for CAP was chest radiograph evaluated by two certified radiologists.", {"entities": []}], ["The existing models were externally validated for diagnostic performance by calibration plot and discrimination.", {"entities": []}], ["To evaluate the additional value of the non-specific symptoms to the existing prediction models, we developed an extended logistic regression model.", {"entities": []}], ["Calibration, discrimination, category-free net reclassification improvement (NRI) and decision curve analysis (DCA) were investigated in the extended model.", {"entities": []}], ["Among the existing models, the model by van Vugt demonstrated the best performance, with an area under the curve of 0.75(95% CI 0.63 to 0.88); calibration plot showed good fit despite a significant Hosmer-Lemeshow test (p=0.017).", {"entities": []}], ["Among the non-specific symptoms, appetite loss had positive likelihood ratio of 3.2 (2.0\u20135.3), negative likelihood ratio of 0.4 (0.2\u20130.7) and OR of 7.7 (3.0\u201319.7).", {"entities": []}], ["Addition of appetite loss to the model by van Vugt led to improved calibration at p=0.48, NRI of 0.53 (p=0.019) and higher net benefit by DCA.", {"entities": []}], ["Information on appetite loss improved the performance of an existing model for the diagnosis of CAP in the elderly.", {"entities": []}], ["The clinical relevance of infections with the novel human coronavirus NL63 (HCoV-NL63) has not been investigated systematically.", {"entities": []}], ["We therefore determined its association with disease in young children with lower respiratory tract infection (LRTI).", {"entities": []}], ["Nine hundred forty-nine samples of nasopharyngeal secretions from children under 3 y of age with LRTIs were analysed by a quantitative HCoV-NL63-specific real-time PCR.", {"entities": []}], ["The samples had been collected from hospitalised patients and outpatients from December 1999 to October 2001 in four different regions in Germany as part of the prospective population-based PRI.DE study and analysed for RNA from respiratory viruses.", {"entities": []}], ["Forty-nine samples (5.2%), mainly derived from the winter season, were positive for HCoV-NL63 RNA.", {"entities": []}], ["The viral RNA was more prevalent in samples from outpatients (7.9%) than from hospitalised patients (3.2%, p = 0.003), and co-infection with either respiratory syncytial virus or parainfluenza virus 3 was observed frequently.", {"entities": []}], ["Samples in which only HCoV-NL63 RNA could be detected had a significantly higher viral load than samples containing additional respiratory viruses (median 2.1 \u00d7 10 p = 0.0006).", {"entities": []}], ["A strong association with croup was apparent: 43% of the HCoV-NL63-positive patients with high HCoV-NL63 load and absence of co-infection suffered from croup, compared to 6% in the HCoV-NL63-negative group, p < 0.0001.", {"entities": [[26, 31, "DISEASE"], [152, 157, "DISEASE"]]}], ["A significantly higher fraction (17.4%) of samples from croup patients than from non-croup patients (4.2%) contained HCoV-NL63 RNA.", {"entities": [[56, 61, "DISEASE"], [85, 90, "DISEASE"]]}], ["HCoV-NL63 infections occur frequently in young children with LRTI and show a strong association with croup, suggesting a causal relationship.", {"entities": [[101, 106, "DISEASE"]]}], ["The novel human coronavirus HCoV-NL63 shows a strong association with croup.", {"entities": [[70, 75, "DISEASE"]]}], ["Motivation: Approaches to identifying new risk loci, training risk prediction models, imputing untyped variants and fine-mapping causal variants from summary statistics of genome-wide association studies are playing an increasingly important role in the human genetics community.", {"entities": []}], ["Current summary statistics-based methods rely on global \u2018best guess\u2019 reference panels to model the genetic correlation structure of the dataset being studied.", {"entities": []}], ["This approach, especially in admixed populations, has the potential to produce misleading results, ignores variation in local structure and is not feasible when appropriate reference panels are missing or small.", {"entities": []}], ["Here, we develop a method, Adapt-Mix, that combines information across all available reference panels to produce estimates of local genetic correlation structure for summary statistics-based methods in arbitrary populations.", {"entities": []}], ["Results: We applied Adapt-Mix to estimate the genetic correlation structure of both admixed and non-admixed individuals using simulated and real data.", {"entities": []}], ["We evaluated our method by measuring the performance of two summary statistics-based methods: imputation and joint-testing.", {"entities": []}], ["When using our method as opposed to the current standard of \u2018best guess\u2019 reference panels, we observed a 28% decrease in mean-squared error for imputation and a 73.7% decrease in mean-squared error for joint-testing.", {"entities": []}], ["Availability and implementation: Our method is publicly available in a software package called ADAPT-Mix available at https://github.com/dpark27/adapt_mix .", {"entities": []}], ["Contact: noah.zaitlen@ucsf.edu", {"entities": []}], ["The only Na\u2010nutrient cotransporter described in mammalian small intestinal crypt cells is SN2/SNAT5, which facilitates glutamine uptake.", {"entities": []}], ["In a rabbit model of chronic intestinal inflammation, SN2 stimulation is secondary to an increase in affinity of the cotransporter for glutamine.", {"entities": []}], ["However, the immune regulation of SN2 in the crypt cells during chronic intestinal inflammation is unknown.", {"entities": []}], ["We sought to determine the mechanism of regulation of Na\u2010nutrient cotransporter SN2 by arachidonic acid metabolites in crypt cells.", {"entities": []}], ["The small intestines of New Zealand white male rabbits were inflamed via inoculation with Eimeria magna oocytes.", {"entities": []}], ["After 2\u2010week incubation, control and inflamed rabbits were subjected to intramuscular injections of arachidonyl trifluoromethyl ketone (ATK), piroxicam and MK886 for 48 hrs.", {"entities": []}], ["After injections, the rabbits were euthanized and crypt cells from small intestines were harvested and used.", {"entities": []}], ["Results: Treatment of rabbits with ATK prevented the release of AA and reversed stimulation of SN2.", {"entities": []}], ["Inhibition of cyclooxygenase (COX) with piroxicam did not affect stimulation of SN2.", {"entities": []}], ["However, inhibition of lipoxygenase (LOX) with MK886, thus reducing leukotriene formation during chronic enteritis, reversed the stimulation of SN2.", {"entities": []}], ["Kinetic studies showed that the mechanism of restoration of SN2 by ATK or MK886 was secondary to the restoration of the affinity of the cotransporter for glutamine.", {"entities": []}], ["For all treatment conditions, Western blot analysis revealed no change in SN2 protein levels.", {"entities": []}], ["COX inhibition proved ineffective at reversing the stimulation of SN2.", {"entities": []}], ["Thus, this study provides evidence that SN2 stimulation in crypt cells is mediated by the leukotriene pathway during chronic intestinal inflammation.", {"entities": []}], ["Atmospheric pollution-induced cellular oxidative stress is probably one of the pathogenic mechanisms involved in most of the common autophagy-mediated aging diseases, including neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer\u2019s, disease, as well as Paget\u2019s disease of bone with or without frontotemporal dementia and inclusion body myopathy.", {"entities": [[212, 241, "DISEASE"], [337, 345, "DISEASE"], [365, 373, "DISEASE"], [224, 241, "DISEASE"], [322, 345, "DISEASE"]]}], ["Oxidative stress has serious damaging effects on the cellular contents: DNA, RNA, cellular proteins, and cellular organelles.", {"entities": []}], ["Autophagy has a pivotal role in recycling these damaged non-functional organelles and misfolded or unfolded proteins.", {"entities": []}], ["In this paper, we highlight, through a narrative review of the literature, that when autophagy processes are impaired during aging, in presence of cumulative air pollution-induced cellular oxidative stress and due to a direct effect on air pollutant, autophagy-mediated aging diseases may occur.", {"entities": []}], ["Few studies have comprehensively described tropical respiratory disease surveillance in military populations.", {"entities": []}], ["There is also a lack of studies comparing clinical characteristics of the non-influenza pathogens with influenza and amongst themselves.", {"entities": [[78, 87, "DISEASE"], [103, 112, "DISEASE"]]}], ["From May 2009 through October 2012, 7733 consenting cases of febrile respiratory illness (FRI) (temperature [greater than or equal to]37.5degreesC with cough or sorethroat) and controls in the Singapore military had clinical data and nasal washes collected prospectively.", {"entities": []}], ["Nasal washes underwent multiplex PCR, and the analysis was limited to viral mono-infections.", {"entities": []}], ["49% of cases tested positive for at least one virus, of whom 10% had multiple infections.", {"entities": []}], ["53% of the FRI cases fulfilled the definition of influenza-like illness (ILI), of whom 52% were positive for at least one virus.", {"entities": [[49, 58, "DISEASE"]]}], ["The most frequent etiologies for mono-infections among FRI cases were Influenza A(H1N1)pdm09 (13%), Influenza B (13%) and coxsackevirus (9%).", {"entities": [[70, 79, "DISEASE"], [100, 109, "DISEASE"]]}], ["The sensitivity, specificity, positive predictive value and negative predictive value of ILI for influenza among FRI cases were 72%, 48%, 40% and 69% respectively.", {"entities": [[97, 106, "DISEASE"]]}], ["On logistic regression, there were marked differences in the prevalence of different symptoms and signs between viruses with fever more prevalent amongst influenza and adenovirus infections than other viruses.", {"entities": [[154, 163, "DISEASE"]]}], ["There are multiple viral etiologies for FRI and ILI with differing clinical symptoms in the Singapore military.", {"entities": []}], ["Influenza and coxsackevirus were the most common etiology for FRI, while influenza and adenoviruses displayed the most febrile symptoms.", {"entities": [[0, 9, "DISEASE"], [73, 82, "DISEASE"]]}], ["Further studies should explore these differences and possible interventions.", {"entities": []}], ["We have implemented an unbiased cell morphology\u2013based screen to identify small-molecule modulators of cellular processes using the Cytometrix (TM) automated imaging and analysis system.", {"entities": []}], ["This assay format provides unbiased analysis of morphological effects induced by small molecules by capturing phenotypic readouts of most known classes of pharmacological agents and has the potential to read out pathways for which little is known.", {"entities": []}], ["Four human-cancer cell lines and one noncancerous primary cell type were treated with 107 small molecules comprising four different protein kinase\u2013inhibitor scaffolds.", {"entities": [[11, 17, "DISEASE"]]}], ["Cellular phenotypes induced by each compound were quantified by multivariate statistical analysis of the morphology, staining intensity, and spatial attributes of the cellular nuclei, microtubules, and Golgi compartments.", {"entities": []}], ["Principal component analysis was used to identify inhibitors of cellular components not targeted by known protein kinase inhibitors.", {"entities": []}], ["Here we focus on a hydroxyl-substituted analog (hydroxy-PP) of the known Src-family kinase inhibitor PP2 because it induced cell-specific morphological features distinct from all known kinase inhibitors in the collection.", {"entities": []}], ["We used affinity purification to identify a target of hydroxy-PP, carbonyl reductase 1 (CBR1), a short-chain dehydrogenase-reductase.", {"entities": [[88, 92, "GENE"]]}], ["We solved the X-ray crystal structure of the CBR1/hydroxy-PP complex to 1.24 \u00c5 resolution.", {"entities": []}], ["Structure-based design of more potent and selective CBR1 inhibitors provided probes for analyzing the biological function of CBR1 in A549 cells.", {"entities": [[52, 56, "GENE"], [125, 129, "GENE"], [52, 56, "GENE"], [125, 129, "GENE"]]}], ["These studies revealed a previously unknown function for CBR1 in serum-withdrawal-induced apoptosis.", {"entities": [[57, 61, "GENE"]]}], ["Further studies indicate CBR1 inhibitors may enhance the effectiveness of anticancer anthracyclines.", {"entities": [[25, 29, "GENE"]]}], ["Morphology-based screening of diverse cancer cell types has provided a method for discovering potent new small-molecule probes for cell biological studies and anticancer drug candidates.", {"entities": [[38, 44, "DISEASE"]]}], ["An imaging-based screen, followed by structural and functional analysis, led to the discovery of new inhibitors of carbonyl reductase 1, a potential anticancer target", {"entities": []}], ["Environmental tobacco smoke (ETS) has adverse effects on the health of asthmatics, however the harmful consequences of ETS in relation to asthma severity are unknown.", {"entities": [[138, 144, "DISEASE"]]}], ["In a multicenter study of severe asthma, we assessed the impact of ETS exposure on morbidity, health care utilization and lung functions; and activity of systemic superoxide dismutase (SOD), a potential oxidative target of ETS that is negatively associated with asthma severity.", {"entities": [[33, 39, "DISEASE"], [262, 268, "DISEASE"]]}], ["From 2002\u20132006, 654 asthmatics (non-severe 366, severe 288) were enrolled, among whom 109 non-severe and 67 severe asthmatics were routinely exposed to ETS as ascertained by history and validated by urine cotinine levels.", {"entities": []}], ["ETS-exposure was associated with lower quality of life scores; greater rescue inhaler use; lower lung function; greater bronchodilator responsiveness; and greater risk for emergency room visits, hospitalization and intensive care unit admission.", {"entities": []}], ["ETS-exposure was associated with lower levels of serum SOD activity, particularly in asthmatic women of African heritage.", {"entities": []}], ["ETS-exposure of asthmatic individuals is associated with worse lung function, higher acuity of exacerbations, more health care utilization, and greater bronchial hyperreactivity.", {"entities": []}], ["The association of diminished systemic SOD activity to ETS exposure provides for the first time a specific oxidant mechanism by which ETS may adversely affect patients with asthma.", {"entities": [[173, 179, "DISEASE"]]}], ["The immune response plays an important role in the pathophysiology of numerous diseases including asthma, autoimmunity and cancer.", {"entities": [[98, 104, "DISEASE"], [123, 129, "DISEASE"]]}], ["Application of biomarkers of immunotoxicity in epidemiology studies and human clinical trials can improve our understanding of the mechanisms that underlie the associations between environmental exposures and development of these immune-mediated diseases.", {"entities": []}], ["Immunological biomarkers currently used in environmental health studies include detection of key components of innate and adaptive immunity (e.g., complement, immunoglobulin and cell subsets) as well as functional responses and activation of key immune cells.", {"entities": []}], ["The use of high-throughput assays, including flow cytometry, Luminex, and Multi-spot cytokine detection methods can further provide quantitative analysis of immune effects.", {"entities": []}], ["Due to the complexity and redundancy of the immune response, an integrated assessment of several components of the immune responses is needed.", {"entities": []}], ["The rapidly expanding field of immunoinformatics will also aid in the synthesis of the vast amount of data being generated.", {"entities": []}], ["This review discusses and provides examples of how the identification and development of immunological biomarkers for use in studies of environmental exposures and immune-mediated disorders can be achieved.", {"entities": []}], ["Six hospitals instituted a voluntary, system-wide, pathway for community acquired pneumonia (CAP).", {"entities": [[82, 91, "DISEASE"]]}], ["We proposed this study to determine the impact of pathway antibiotics on patient survival, hospital length of stay (LOS), and total hospital cost.", {"entities": []}], ["Data were collected for adults from six U.S. hospitals with a principal CAP discharge diagnosis code, a chest infiltrate, and medical notes indicative of CAP from 2005-2007.", {"entities": []}], ["Pathway and non-pathway cohorts were assigned according to antibiotics received within 48 hours of admission.", {"entities": []}], ["Pathway antibiotics included levofloxacin 750 mg monotherapy or ceftriaxone 1000 mg plus azithromycin 500 mg daily.", {"entities": []}], ["Multivariable regression models assessed 90-day mortality, hospital LOS, total hospital cost, and total pharmacy cost.", {"entities": []}], ["Overall, 792 patients met study criteria.", {"entities": []}], ["Of these, 505 (64%) received pathway antibiotics and 287 (36%) received non-pathway antibiotics.", {"entities": []}], ["Adjusted means and p-values were derived from Least Squares regression models that included Pneumonia Severity Index risk class, patient age, heart failure, chronic obstructive pulmonary disease, and admitting hospital as covariates.", {"entities": [[92, 101, "DISEASE"], [157, 194, "DISEASE"]]}], ["After adjustment, patients who received pathway antibiotics experienced lower adjusted 90-day mortality ( p = 0.02), shorter mean hospital LOS (3.9 vs. 5.0 days, p < 0.01), lower mean hospital costs ($2,485 vs. $3,281, p = 0.02), and similar mean pharmacy costs ($356 vs. $442, p = 0.11).", {"entities": []}], ["Pathway antibiotics were associated with improved patient survival, hospital LOS, and total hospital cost for patients admitted to the hospital with CAP.", {"entities": []}], ["Mast cell (MC) activation contributes considerably to immune responses, such as host protection and allergy.", {"entities": []}], ["Cell surface immunoreceptors expressed on MCs play an important role in MC activation.", {"entities": []}], ["Although various immunoreceptors on MCs have been identified, the regulatory mechanism of MC activation is not fully understood.", {"entities": []}], ["To understand the regulatory mechanisms of MC activation, we used gene expression analyses of human and mouse MCs to identify a novel immunoreceptor expressed on MCs.", {"entities": []}], ["We found that Tek , which encodes Tie2, was preferentially expressed in the MCs of both humans and mice.", {"entities": [[14, 17, "GENE"]]}], ["However, Tie2 was not detected on the cell surface of the mouse MCs of the peritoneal cavity, ear skin, or colon lamina propria.", {"entities": []}], ["In contrast, it was expressed on mouse bone marrow\u2013derived MCs and bone marrow MC progenitors (BM-MCps).", {"entities": []}], ["Stimulation of Tie2 by its ligand angiopoietin-1 induced tyrosine phosphorylation of Tie2 in MEDMC-BRC6, a mouse embryonic stem cell-derived mast cell line, and enhanced MEDMC-BRC6 and mouse BM-MCp adhesion to vascular cell adhesion molecule-1 (VCAM-1) through \u03b14\u03b21 integrin.", {"entities": []}], ["These results suggest that Tie2 signaling induces \u03b14\u03b21 integrin activation on BM-MCps for adhesion to VCAM-1.", {"entities": []}], ["The time of year when patients experience exacerbations of chronic obstructive pulmonary disease is a much-overlooked feature of the disease.", {"entities": [[59, 96, "DISEASE"]]}], ["The higher incidence of exacerbations in winter has important consequences for patients in terms of increased morbidity and mortality.", {"entities": []}], ["The seasonality also imposes a considerable burden on already-overloaded health care services, with both primary care consultations and hospital admissions increasing in number.", {"entities": []}], ["The seasonality of exacerbations varies with latitude, and is greater in more temperate climates, where there may be less protection from outdoor and indoor cold exposure.", {"entities": []}], ["The precise causes of the seasonality are unknown, but thought to be partly due to the increased prevalence of respiratory viral infections circulating in cold, damp conditions.", {"entities": []}], ["Increased susceptibility to viral infection may also be a mechanism mediated through increased airway inflammation or possibly reduced vitamin D levels.", {"entities": []}], ["The seasonality of exacerbations informs us about the triggers of exacerbations and suggests possible strategies to reduce their number.", {"entities": []}], ["CONSTANCES is a general-purpose cohort with a focus on occupational and environmental factors.", {"entities": []}], ["CONSTANCES was designed as a randomly selected sample of French adults aged 18\u201369\u2005years at inception; 200\u2005000 participants will be included.", {"entities": []}], ["At enrolment, the participants are invited to complete questionnaires and to attend a health screening centre (HSC) for a health examination.", {"entities": []}], ["A biobank will be set up.", {"entities": []}], ["The follow-up includes an yearly self-administered questionnaire, a periodic visit to an HSC and linkage to social and national health administrative databases.", {"entities": []}], ["Data collected for participants include social and demographic characteristics, socioeconomic status, life events and behaviours.", {"entities": []}], ["Regarding occupational and environmental factors, a wealth of data on organisational, chemical, biological, biomechanical and psychosocial lifelong exposure, as well as residential characteristics, are collected at enrolment and during follow-up.", {"entities": []}], ["The health data cover a wide spectrum: self-reported health scales, reported prevalent and incident diseases, long-term chronic diseases and hospitalisations, sick-leaves, handicaps, limitations, disabilities and injuries, healthcare usage and services provided, and causes of death.", {"entities": []}], ["To take into account non-participation and attrition, a random cohort of non-participants was set up and will be followed through the same national databases as participants.", {"entities": []}], ["Inclusions begun at the end of 2012 and more than 110\u2005000 participants were already included by September 2016.", {"entities": []}], ["Several projects on occupational and environmental risks already applied to a public call for nested research projects.", {"entities": []}], ["Vitamin D deficiency is associated with increased cardiovascular disease risk in observational studies.", {"entities": []}], ["Whether these associations are causal is not clear.", {"entities": []}], ["Loss-of-function mutations in the filaggrin gene result in up to 10% higher serum vitamin D concentrations, supposedly due to a decreased UV-protection of the keratinocytes.", {"entities": []}], ["We used a Mendelian randomization approach to estimate the causal effect of vitamin D status on serum lipids, blood pressure, body mass index, waist circumference, and the metabolic syndrome.", {"entities": [[182, 190, "DISEASE"]]}], ["Three population based studies were included, Monica10 (2,656 individuals aged 40\u201371 years), Inter99 (6,784 individuals aged 30\u201360 years), and Health2006 (3,471 individuals aged 18\u201369 years) conducted in 1993\u201394, 1999\u20132001, and 2006\u20132008, respectively.", {"entities": []}], ["Participants were genotyped for the two most common filaggrin gene mutations in European descendants R501X and 2282del4, in all three studies and further for the R2447X mutation in the Inter99 and Health2006 studies.", {"entities": []}], ["Filaggrin genotype was used as instrumental variable for vitamin D status.", {"entities": []}], ["Baseline measurements of serum 25-hydroxyvitamin D were performed in all three studies.", {"entities": []}], ["Instrumental variable analyses showed a 23.8% (95% confidence interval, CI 3.0, 48.6) higher HDL cholesterol level and a 30.5% (95% CI: 0.8, 51.3) lower serum level of triglycerides per doubling of vitamin D. These associations were, however, not statistically significant when applying the Bonferroni adjusted significance level.", {"entities": []}], ["The remaining lipids showed non-significant changes in a favorable direction.", {"entities": []}], ["Doubling of vitamin D gave a non-significantly lower odds ratio\u200a=\u200a0.26 (95% CI: 0.06, 1.17) of the metabolic syndrome.", {"entities": [[109, 117, "DISEASE"]]}], ["There were no statistically significant causal effects of vitamin D status on blood pressure, body mass index, or waist circumference.", {"entities": []}], ["Our results support a causal effect of higher vitamin D status on a more favorable lipid profile, although more studies in other populations are needed to confirm our results.", {"entities": []}], ["We investigated a large population of patients with chronic obstructive pulmonary disease (COPD) to determine their frequency of medication use and patterns of pharmacotherapy.", {"entities": [[52, 89, "DISEASE"]]}], ["Medical and pharmacy claims data were retrospectively analyzed from 19 health plans (>7.79 million members) across the US.", {"entities": []}], ["Eligible patients were aged \u226540 years, continuously enrolled during July 2004 to June 2005, and had at least one inpatient or at least two outpatient claims coded for COPD.", {"entities": []}], ["As a surrogate for severity of illness, COPD patients were stratified by complexity of illness using predefined International Classification of Diseases, Ninth Revision, Clinical Modification, Current Procedural Terminology, Fourth Edition, and Healthcare Common Procedure Coding System codes.", {"entities": []}], ["A total of 42,565 patients with commercial insurance and 8507 Medicare patients were identified.", {"entities": []}], ["Their mean age was 54.7 years and 74.8 years, and 48.7% and 46.9% were male, respectively.", {"entities": []}], ["In total, 66.3% of commercial patients (n = 28,206) were not prescribed any maintenance COPD pharmacotherapy (59.1% no medication; 7.2% inhaled short-acting \u03b22-agonist only).", {"entities": []}], ["In the Medicare population, 70.9% (n = 6031) were not prescribed any maintenance COPD pharmacotherapy (66.0% no medication; 4.9% short-acting \u03b22-agonist only).", {"entities": []}], ["A subset of patients classified as high-complexity were similarly undertreated, with 58.7% (5358/9121) of commercial and 68.8% (1616/2350) of Medicare patients not prescribed maintenance COPD pharmacotherapy.", {"entities": []}], ["Only 18.0% and 9.8% of diagnosed smokers in the commercial and Medicare cohorts had a claim for a smoking cessation intervention and just 16.6% and 23.5%, respectively, had claims for an influenza vaccination.", {"entities": [[187, 196, "DISEASE"]]}], ["This study highlights a high degree of undertreatment of COPD in both commercial and Medicare patients, with most patients receiving no maintenance pharmacotherapy or influenza vaccination.", {"entities": [[167, 176, "DISEASE"]]}], ["Physicians of the Spanish Influenza Sentinel Surveillance System report and systematically swab patients attended to their practices for influenza-like illness (ILI).", {"entities": [[26, 35, "DISEASE"], [137, 146, "DISEASE"]]}], ["Within the surveillance system, some Spanish regions also participated in an observational study aiming at estimating influenza vaccine effectiveness (cycEVA study).", {"entities": [[118, 127, "DISEASE"]]}], ["During the season 2009-2010, we estimated pandemic influenza vaccine effectiveness using both the influenza surveillance data and the cycEVA study.", {"entities": [[51, 60, "DISEASE"], [98, 107, "DISEASE"]]}], ["We conducted two case-control studies using the test-negative design, between weeks 48/2009 and 8/2010 of the pandemic season.", {"entities": []}], ["The surveillance-based study included all swabbed patients in the sentinel surveillance system.", {"entities": []}], ["The cycEVA study included swabbed patients from seven Spanish regions.", {"entities": []}], ["Cases were laboratory-confirmed pandemic influenza A(H1N1)2009.", {"entities": [[41, 50, "DISEASE"]]}], ["Controls were ILI patients testing negative for any type of influenza.", {"entities": [[60, 69, "DISEASE"]]}], ["Variables collected in both studies included demographic data, vaccination status, laboratory results, chronic conditions, and pregnancy.", {"entities": []}], ["Additionally, cycEVA questionnaire collected data on previous influenza vaccination, smoking, functional status, hospitalisations, visits to the general practitioners, and obesity.", {"entities": [[62, 71, "DISEASE"], [172, 179, "DISEASE"]]}], ["We used logistic regression to calculate adjusted odds ratios (OR), computing pandemic influenza vaccine effectiveness as (1-OR)*100.", {"entities": [[87, 96, "DISEASE"]]}], ["We included 331 cases and 995 controls in the surveillance-based study and 85 cases and 351 controls in the cycEVA study.", {"entities": []}], ["We detected nine (2.7%) and two (2.4%) vaccine failures in the surveillance-based and cycEVA studies, respectively.", {"entities": []}], ["Adjusting for variables collected in surveillance database and swabbing month, pandemic influenza vaccine effectiveness was 62% (95% confidence interval (CI): -5; 87).", {"entities": [[88, 97, "DISEASE"]]}], ["The cycEVA vaccine effectiveness was 64% (95%CI: -225; 96) when adjusting for common variables with the surveillance system and 75% (95%CI: -293; 98) adjusting for all variables collected.", {"entities": []}], ["Point estimates of the pandemic influenza vaccine effectiveness suggested a protective effect of the pandemic vaccine against laboratory-confirmed influenza A(H1N1)2009 in the season 2009-2010.", {"entities": [[32, 41, "DISEASE"], [147, 156, "DISEASE"]]}], ["Both studies were limited by the low vaccine coverage and the late start of the vaccination campaign.", {"entities": []}], ["Routine influenza surveillance provides reliable estimates and could be used for influenza vaccine effectiveness studies in future seasons taken into account the surveillance system limitations.", {"entities": [[8, 17, "DISEASE"], [81, 90, "DISEASE"]]}], ["This review describes the properties and activities of lipopeptides and peptide hormones and how the lipidation of peptide hormones could potentially produce therapeutic agents combating some of the most prevalent diseases and conditions.", {"entities": []}], ["The self\u2010assembly of these types of molecules is outlined, and how this can impact on bioactivity.", {"entities": []}], ["Peptide hormones specific to the uptake of food and produced in the gastrointestinal tract are discussed in detail.", {"entities": []}], ["The advantages of lipidated peptide hormones over natural peptide hormones are summarised, in terms of stability and renal clearance, with potential application as therapeutic agents.", {"entities": []}], ["\u00a9 2017 The Authors Journal of Peptide Science published by European Peptide Society and John Wiley & Sons Ltd.", {"entities": []}], ["An epidemiological survey was conducted in Houston, Texas on five trace metals in policemen, parking garage attendants, women living near freeways and three control groups of subjects.", {"entities": []}], ["The controls were matched with the exposed groups for covariate information such as age, sex, smoking habits, ethnic background, socioeconomic status, hair color, and education.", {"entities": []}], ["Each subject was sampled four times for blood, urine, hair, and feces, and these samples were analyzed for lead, cadmium, zinc, manganese, and copper.", {"entities": []}], ["Lead and cadmium were correlated with airborne exposures but zinc, manganese and copper were not.", {"entities": []}], ["The second part of this paper deals with a market study of platinum and palladium markets and a design of an epidemiology survey of individuals occupationally and nonoccupationally exposed to these two metals.", {"entities": []}], ["The market survey shows that although the catalytic muffler will have a major impact on the market, it is predicted that producers can meet these demands.", {"entities": []}], ["Protocatechuic acid (PCA) was first purified from green tea and has shown numerous biological activities, including anti-apoptotic, anti-inflammatory, and anti-atherosclerotic effects.", {"entities": []}], ["The effect of PCA on traumatic brain injury (TBI)-induced neuronal death has not previously been evaluated.", {"entities": []}], ["TBI is defined as damage to the brain resulting from external mechanical force, such as rapid acceleration or deceleration, impact, blast waves, or penetration by a projectile.", {"entities": []}], ["TBI causes neuronal death in the hippocampus and cerebral cortex.", {"entities": []}], ["The present study aimed to evaluate the therapeutic potential of PCA on TBI-induced neuronal death.", {"entities": []}], ["Here, TBI was induced by a controlled cortical impact model using rats.", {"entities": []}], ["PCA (30 mg/kg) was injected into the intraperitoneal (ip) space immediately after TBI.", {"entities": []}], ["Neuronal death was evaluated with Fluoro Jade-B (FJB) staining at 24 h after TBI.", {"entities": []}], ["Oxidative injury was detected by 4-hydroxy-2-nonenal (4HNE), glutathione (GSH) concentration was analyzed by glutathione adduct with N -ethylmaleimide (GS-NEM) staining at 24 h after TBI, and microglial activation in the hippocampus was detected by CD11b immunohistochemistry at one week after TBI.", {"entities": []}], ["We found that the proportion of degenerating neurons, oxidative injury, GSH depletion, and microglia activation in the hippocampus and cortex were all reduced by PCA treatment following TBI.", {"entities": []}], ["Therefore, our study suggests that PCA may have therapeutic potential in preventing TBI-induced neuronal death.", {"entities": []}], ["Co-morbidities are common in chronic obstructive pulmonary disease (COPD).", {"entities": [[29, 66, "DISEASE"]]}], ["We assessed the contribution of common co-morbidities on health related quality of life (HRQoL) among COPD patients.", {"entities": []}], ["Using both generic (15D) and respiratory-specific (AQ20) instruments, HRQoL was assessed in a hospital based COPD population (N\u2009=\u2009739, 64% males, mean age 64\u00a0years, SD 7\u00a0years) in this observational study with inferential analysis.", {"entities": []}], ["The prevalence of their co-morbidities was compared with those of 5000 population controls.", {"entities": []}], ["The patients represented all severity stages of COPD and the patterns of common concomitant disorders differed between patients.", {"entities": []}], ["Co-morbidities such as psychiatric conditions, alcohol abuse, cardiovascular diseases, and diabetes were more common among COPD patients than in age and gender matched controls.", {"entities": [[47, 60, "DISEASE"]]}], ["Psychiatric conditions and alcohol abuse were the strongest determinants of HRQoL in COPD and could be detected by both 15D (Odds Ratio 4.7 and 2.3 respectively) and AQ20 (OR 2.0 and 3.0) instruments.", {"entities": [[27, 40, "DISEASE"]]}], ["Compared to respiratory specific AQ20, generic 15D was more sensitive to the effects of comorbidities while AQ20 was slightly more sensitive for the low FEV 1 .", {"entities": [[153, 156, "GENE"]]}], ["FEV 1 was a strong determinant of HRQoL only at more severe stages of disease (FEV 1 \u2009<\u200940% of predicted).", {"entities": [[0, 3, "GENE"], [79, 82, "GENE"], [0, 3, "GENE"], [79, 82, "GENE"]]}], ["Poor HRQoL also predicted death during the next five years.", {"entities": []}], ["The results suggest that co-morbidities may impair HRQoL at an early stage of the disease, while bronchial obstruction becomes a significant determinant of HRQoL only in severe COPD.", {"entities": []}], ["Infectious microorganisms often play a role in modulating the immune responses of their infected hosts.", {"entities": []}], ["We demonstrate that Cryptococcus neoformans signals through the Rim101 transcription factor to regulate cell wall composition and the host-pathogen interface.", {"entities": []}], ["In the absence of Rim101, C .", {"entities": []}], ["neoformans exhibits an altered cell surface in response to host signals, generating an excessive and ineffective immune response that results in accelerated host death.", {"entities": []}], ["This host immune response to the rim101 \u0394 mutant strain is characterized by increased neutrophil influx into the infected lungs and an altered pattern of host cytokine expression compared to the response to wild-type cryptococcal infection.", {"entities": []}], ["To identify genes associated with the observed phenotypes, we performed whole-genome RNA sequencing experiments under capsule-inducing conditions.", {"entities": []}], ["We defined the downstream regulon of the Rim101 transcription factor and determined potential cell wall processes involved in the capsule attachment defects and altered mechanisms of virulence in the rim101 \u0394 mutant.", {"entities": []}], ["The cell wall generates structural stability for the cell and allows the attachment of surface molecules such as capsule polysaccharides.", {"entities": []}], ["In turn, the capsule provides an effective mask for the immunogenic cell wall, shielding it from recognition by the host immune system.", {"entities": []}], ["Cryptococcus neoformans is an opportunistic human pathogen that is a significant cause of death in immunocompromised individuals.", {"entities": []}], ["There are two major causes of death due to this pathogen: meningitis due to uncontrolled fungal proliferation in the brain in the face of a weakened immune system and immune reconstitution inflammatory syndrome characterized by an overactive immune response to subclinical levels of the pathogen.", {"entities": [[202, 210, "DISEASE"], [58, 68, "DISEASE"]]}], ["In this study, we examined how C .", {"entities": []}], ["neoformans uses the conserved Rim101 transcription factor to specifically remodel the host-pathogen interface, thus regulating the host immune response.", {"entities": []}], ["These studies explored the complex ways in which successful microbial pathogens induce phenotypes that ensure their own survival while simultaneously controlling the nature and degree of the associated host response.", {"entities": []}], ["The number of pollinosis patients in Japan has significantly increased over the past 20 years.", {"entities": []}], ["The majority of genome-wide association studies (GWAS) on pollinosis have been conducted in subjects of European descent, with few studies in Japanese populations.", {"entities": []}], ["The aim of our GWAS was to identify genetic loci associated with self-reported pollinosis in a Japanese population and to understand its molecular background using a combination of single nucleotide polymorphisms (SNPs) and gene- and pathway-based analyses.", {"entities": []}], ["A total of 731 and 560 individuals who were recruited as participants of the Japan Multi-Institutional Collaborative Cohort Study participated in the discovery and replication phases, respectively.", {"entities": []}], ["The phenotype of pollinosis was based on the information from a self-administered questionnaire.", {"entities": []}], ["In the single-SNP analysis, four SNPs (rs11975199, rs11979076, rs11979422, and rs12669708) reached suggestive significance level (P < 1 \u00d7 10", {"entities": []}], ["The purpose of this study was to test a two-phased nutrition and exercise education, coping skills training, and exercise intervention program for overweight or obese low-income ethnic minority 2nd to 4th grade children and their parents in rural North Carolina, USA.", {"entities": []}], ["A cluster randomized controlled trial was carried out with 358 children (7\u201310 years) and a parent for each child ( n =358).", {"entities": []}], ["General linear mixed models were used to determine the effects of the intervention on weight, adiposity, health behaviors, and eating and exercise self-efficacy by examining changes in children and parents from baseline to completion of the study (18 months).", {"entities": []}], ["At 18 months, children in the experimental group did not have a significantly decreased body mass index (BMI) percentile ( P =0.470); however, they showed a reduction in the growth rate of their triceps ( P =0.001) and subscapular skinfolds ( P <0.001) and an improvement in dietary knowledge ( P =0.018) and drank less than one glass of soda per day ( P =0.052) compared with the control group.", {"entities": []}], ["Parents in the experimental group had decreased BMI ( P =0.001), triceps ( P <0.001) and subscapular skinfolds ( P <0.001) and increased nutrition ( P =0.003) and exercise ( P <0.001) knowledge and more often drank water or unsweetened drinks ( P =0.029).", {"entities": []}], ["At 18 months, children in the experimental group did not show significant improvement in eating ( P =0.956) or exercise self-efficacy ( P =0.976).", {"entities": []}], ["Experimental parents demonstrated improved socially acceptable eating self-efficacy ( P =0.013); however, they did not show significant improvement in self-efficacy pertaining to emotional eating ( P =0.155) and exercise ( P =0.680).", {"entities": []}], ["The results suggest that inclusion of children and parents in the same intervention program is an effective way to decrease adiposity and improve nutrition behaviors in both children and parents and improve weight and eating self-efficacy in parents.", {"entities": []}], ["Intra-arterial (IA) vasodilator therapy is one of the recommended treatments to minimize the impact of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm refractory to standard management.", {"entities": []}], ["However, its usefulness and efficacy is not well established.", {"entities": []}], ["We evaluated the effect IA vasodilator therapy on middle cerebral artery blood flow and on discharge outcome.", {"entities": []}], ["We reviewed records for 115 adults admitted to Neurointensive Care Unit to test whether there was a difference in clinical outcome (discharge mRS) in those who received IA infusions.", {"entities": []}], ["In a subset of 19 patients (33 vessels) treated using IA therapy, we tested whether therapy was effective in reversing the trends in blood flow.", {"entities": []}], ["All measures of MCA blood flow increased from day -2 to -1 before infusion (maximum Peak Systolic Velocity (PSV) 232.2\u00b19.4 to 262.4\u00b112.5 cm/s [ p = 0.02]; average PSV 202.1\u00b18.5 to 229.9\u00b110.9 [ p = 0.02]; highest Mean Flow Velocity (MFV) 154.3\u00b18.3 to 172.9\u00b110.5 [ p = 0.10]; average MFV 125.5\u00b16.3 to 147.8\u00b19.5 cm/s, [ p = 0.02]) but not post-infusion (maximum PSV 261.2\u00b114.6 cm/s [ p = .89]; average PSV 223.4\u00b111.4 [ p = 0.56]; highest MFV 182.9\u00b112.4 cm/s [ p = 0.38]; average MFV 153.0\u00b110.2 cm/s [ p = 0.54]).", {"entities": []}], ["After IA therapy, flow velocities were consistently reduced (day X infusion interaction p <0.01 for all measures).", {"entities": []}], ["However, discharge mRS was higher in IA infusion group, even after adjusting for sex, age, and admission grades.", {"entities": []}], ["Thus, while IA vasodilator therapy was effective in reversing the vasospasm-mediated deterioration in blood flow, clinical outcomes in the treated group were worse than the untreated group.", {"entities": []}], ["There is need for a prospective randomized controlled trial to avoid potential confounding effect of selection bias.", {"entities": []}], ["To investigate the association between retinitis pigmentosa (RP) and acute angle closure during a 15-year follow-up period.", {"entities": [[39, 48, "DISEASE"], [39, 59, "DISEASE"]]}], ["Using the Taiwan Longitudinal Health Insurance Database 2000, we identified 382 RP patients based on the diagnostic code of RP (International Classification of Diseases, 9 The mean age at the diagnosis of RP was 51.1years (standard deviation [SD] 16.7).", {"entities": []}], ["Acute angle closure occurred in 5 RP patients (1.3%) and in 15 controls (0.4%).", {"entities": []}], ["The mean age with the acute angle closure was 53.3 years (SD 8.0) in RP patients and 64.6 years (SD 8.4) in controls ( P \u200a=\u200a0.015).", {"entities": []}], ["After adjusting for age, gender and comorbid disorders, RP patients had 3.64-fold (95% confidence interval [CI], 1.29\u201310.25, P <0.001) greater odds of having acute angle closure.", {"entities": []}], ["After stratification for gender and age, the risk of acute angle closure in RP was higher in patients under age of 60 years (adjusted OR 11.84; 95% CI, 2.84\u201349.48) and male patients (adjusted OR 19.36; 95% CI, 3.43\u2013109.40)(both P \u200a=\u200a0.001).", {"entities": []}], ["RP patients had increased risk of acute angle closure than controls.", {"entities": []}], ["Contrary to the fact that angle closure disease is more prevalent in elderly females in general population, acute angle closure attack occurred earlier in life and the risk was higher in males among RP patients.", {"entities": []}], ["This paper examines the associations between average daily particulate matter less than 10 microns in diameter (PM10) and temperature with daily outpatient visits for respiratory disease including asthma, bronchitis, and upper respiratory illness in Anchorage, Alaska, where there are few industrial sources of air pollution.", {"entities": [[197, 203, "DISEASE"], [205, 215, "DISEASE"]]}], ["In Anchorage, PM10 is composed primarily of earth crustal material and volcanic ash.", {"entities": []}], ["Carbon monoxide is measured only during the winter months.", {"entities": []}], ["The number of outpatients visits for respiratory diagnoses during the period 1 May 1992 to 1 March 1994 were derived from medical insurance claims for state and municipal employees and their dependents covered by Aetna insurance.", {"entities": []}], ["The data were filtered to reduce seasonal trends and serial autocorrelation and adjusted for day of the week.", {"entities": []}], ["The results show that an increase of 10 micrograms/m3 in PM10 resulted in a 3-6% increase in visits for asthma and a 1-3% increase in visits for upper respiratory diseases.", {"entities": [[104, 110, "DISEASE"]]}], ["Winter CO concentrations were significantly associated with bronchitis and upper respiratory illness, but not with asthma.", {"entities": [[115, 121, "DISEASE"], [60, 70, "DISEASE"]]}], ["Winter CO was highly correlated with automobile exhaust emissions.", {"entities": []}], ["These findings are consistent with the results of previous studies of particulate pollution in other urban areas and provide evidence that the coarse fraction of PM10 may affect the health of working people.", {"entities": []}], ["Asthma is a common complex disease responsible for considerable morbidity and mortality, particularly in urban minority populations.", {"entities": [[0, 6, "DISEASE"]]}], ["The Mechanistic Indicators of Childhood Asthma study was designed to pilot an integrative approach in children's health research.", {"entities": [[40, 46, "DISEASE"]]}], ["The study incorporates exposure metrics, internal dose measures, and clinical indicators to decipher the biological complexity inherent in diseases such as asthma and cardiovascular disease with etiology related to gene-environment interactions.", {"entities": [[156, 162, "DISEASE"]]}], ["205 non-asthmatic and asthmatic children, (9-12 years of age) from Detroit, Michigan were recruited.", {"entities": []}], ["The study includes environmental measures (indoor and outdoor air, vacuum dust), biomarkers of exposure (cotinine, metals, total and allergen specific Immunoglobulin E, polycyclic aromatic hydrocarbons, volatile organic carbon metabolites) and clinical indicators of health outcome (immunological, cardiovascular and respiratory).", {"entities": []}], ["In addition, blood gene expression and candidate SNP analyses were conducted.", {"entities": []}], ["Based on an integrative design, the MICA study provides an opportunity to evaluate complex relationships between environmental factors, physiological biomarkers, genetic susceptibility and health outcomes.", {"entities": []}], ["IRB Number 05-EPA-2637: The human subjects' research protocol was reviewed by the Institutional Review Board (IRB) of the University of North Carolina; the IRB of Westat, Inc., the IRB of the Henry Ford Health System; and EPA's Human Subjects' Research Review Official.", {"entities": []}], ["Real-life studies are needed to determine the cost-effectiveness of asthma therapies in clinical practice.", {"entities": [[68, 74, "DISEASE"]]}], ["To compare the cost-effectiveness of extrafine-particle inhaled corticosteroid (ICS) with standard size-particle ICS in the United Kingdom (UK) and United States (US).", {"entities": []}], ["These retrospective matched cohort analyses used large electronic databases to study asthma-related outcomes for patients in the UK (12\u201360 years old; n =1730) and US (12\u201380 years; n =10,312) prescribed extrafine beclomethasone or fluticasone as their first ICS therapy for asthma.", {"entities": [[85, 91, "DISEASE"], [273, 279, "DISEASE"]]}], ["Patients were matched on demographic characteristics and asthma severity during 1 baseline year, and asthma control and asthma-related costs were compared during 1 outcome year.", {"entities": [[57, 63, "DISEASE"], [101, 107, "DISEASE"], [120, 126, "DISEASE"]]}], ["In both the UK and US, adjusted odds of risk-domain asthma control were similar, whereas the odds of overall control (no hospitalisation or oral steroids for asthma, no antibiotics for lower respiratory infection, limited reliever use) were greater for extrafine ICS in both countries (UK odds ratio, 1.23; 95% confidence interval (CI), 1.01\u20131.50).", {"entities": [[52, 58, "DISEASE"], [158, 164, "DISEASE"]]}], ["Asthma-related annual costs, adjusted for baseline, were significantly lower for extrafine-particle ICS cohorts in both countries (UK difference, \u2212\u00a366 (95% CI,\u221293 to \u221237)).", {"entities": [[0, 6, "DISEASE"]]}], ["Cost-effectiveness analyses using the two measures of asthma control found 92 and 98% probabilities of extrafine-particle ICS being the preferred treatment strategy (less costly and more effective than standard size-particle ICS) in the UK, and 84 and 100% probabilities in the US.", {"entities": [[54, 60, "DISEASE"]]}], ["Initiating ICS therapy for asthma as extrafine-particle ICS seems the dominant treatment option (less costly and more effective) compared with standard size-particle ICS in both the UK and the US.", {"entities": [[27, 33, "DISEASE"]]}], ["Salbutamol abuse detection by athletes is based on a urinary upper threshold defined by the World Anti-Doping Agency (WADA).", {"entities": []}], ["However, this threshold was determined in healthy, untrained individuals and after a dose of salbutamol inhaled that might not really mirror the condition of asthmatic athletes and the experts\u2019s guidelines for asthma management.", {"entities": [[210, 216, "DISEASE"]]}], ["We aimed to revise this threshold in accordance with recommended clinical practice (that appear to be different from the actual WADA recommendation) and in exercise conditions.", {"entities": []}], ["For the present open-label design study, we included 12 trained male cyclists (20 to 40 y/o) with asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["Differently from the previous pharmacokinetic study supporting the actual salbutamol urinary upper threshold, we decided to administer a close to recommended clinical practice daily dose of 3x200 \u03bcg.d The maximum urine salbutamol concentration value peaked after the cycling effort and was 510\u00a0ng.mL By using conditions in accordance with the experts\u2019 clinical and safety guidelines for asthma management in athletes undergoing an intense exercise bout, our study suggests that the urine salbutamol concentration threshold could be lowered to redefine the rule supporting the decision to sanction an athlete for salbutamol abuse.", {"entities": [[387, 393, "DISEASE"]]}], ["Patients with advanced COPD and acute or chronic respiratory failure are at high risk for death.", {"entities": [[49, 68, "DISEASE"]]}], ["Beyond pharmacological treatment, supplemental oxygen and mechanical ventilation are major treatment options.", {"entities": []}], ["This review describes the physiological concepts underlying respiratory failure and its therapy, as well as important treatment outcomes.", {"entities": [[60, 79, "DISEASE"]]}], ["The rationale for the controlled supply of oxygen in acute hypoxic respiratory failure is undisputed.", {"entities": [[67, 86, "DISEASE"]]}], ["There is also a clear survival benefit from long-term oxygen therapy in patients with chronic hypoxia, while in mild, nocturnal, or exercise-induced hypoxemia such long-term benefits appear questionable.", {"entities": []}], ["Furthermore, much evidence supports the use of non-invasive positive pressure ventilation in acute hypercapnic respiratory failure.", {"entities": [[111, 130, "DISEASE"]]}], ["It application reduces intubation and mortality rates, and the duration of intensive care unit or hospital stays, particularly in the presence of mild to moderate respiratory acidosis.", {"entities": []}], ["COPD with chronic hypercapnic respiratory failure became a major indication for domiciliary mechanical ventilation, based on pathophysiological reasoning and on data regarding symptoms and quality of life.", {"entities": [[30, 49, "DISEASE"]]}], ["Still, however, its relevance for long-term survival has to be substantiated in prospective controlled studies.", {"entities": []}], ["Such studies might preferentially recruit patients with repeated hypercapnic decompensation or a high risk for death, while ensuring effective ventilation and the patients\u2019 adherence to therapy.", {"entities": []}], ["Physical activity, sedentary and sleep behaviours have strong associations with health.", {"entities": []}], ["This systematic review aimed to identify how clinical practice guidelines (CPGs) for the management of chronic obstructive pulmonary disease (COPD) report specific recommendations and strategies for these movement behaviours.", {"entities": [[103, 140, "DISEASE"]]}], ["A systematic search of databases (Medline, Scopus, CiNAHL, EMbase, Clinical Guideline), reference lists and websites identified current versions of CPGs published since 2005.", {"entities": []}], ["Specific recommendations and strategies concerning physical activity, sedentary behaviour and sleep were extracted verbatim.", {"entities": []}], ["The proportions of CPGs providing specific recommendations and strategies were reported.", {"entities": []}], ["From 2370 citations identified, 35 CPGs were eligible for inclusion.", {"entities": []}], ["Of these, 21 (60%) provided specific recommendations for physical activity, while none provided specific recommendations for sedentary behaviour or sleep.", {"entities": []}], ["The most commonly suggested strategies to improve movement behaviours were encouragement from a healthcare provider (physical activity n = 20; sedentary behaviour n = 2) and referral for a diagnostic sleep study (sleep n = 4).", {"entities": []}], ["Since optimal physical activity, sedentary behaviour and sleep durations and patterns are likely to be associated with mitigating the effects of COPD, as well as with general health and well-being, there is a need for further COPD-specific research, consensus and incorporation of recommendations and strategies into CPGs.", {"entities": []}], ["In 2011, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification categorized chronic obstructive pulmonary disease (COPD) patients into 4 groups.", {"entities": [[102, 139, "DISEASE"]]}], ["A report demonstrated that the mortality in Group B was higher than that in Group C. Ischemic heart disease and cancer were suggested to be the cause.", {"entities": [[94, 107, "DISEASE"], [112, 118, "DISEASE"]]}], ["The aim of the present study was to test the hypothesis that interstitial lung abnormalities (ILAs) are more prevalent in Group B than Group C and that they may be responsible for the higher mortality in Group B.", {"entities": []}], ["Patients were selected based on their pulmonary function test results.", {"entities": []}], ["The inclusion criterion was a forced expiratory volume in 1 second (FEV 1 )/forced vital capacity (FVC) of \uff1c70% after the inhalation of a bronchodilator.", {"entities": [[68, 71, "GENE"]]}], ["Patients without a smoking history or computed tomography (CT) scan were excluded.", {"entities": []}], ["The medical records of the patients were retrospectively reviewed, and the selected patients were categorized into Groups A to D. High-resolution CT scans were used to investigate the presence of ILAs and determine the low attenuation area (LAA).", {"entities": []}], ["Among the 349 COPD patients, ILAs were detected in 10.3% of the patients in Group A, 22.5% of the patients in Group B, 5.6% of the patients in Group C, and 23.1% of the patients in Group D. In Group B, the frequency of ILAs was significantly higher and the area affected by the ILAs was significantly greater in comparison to Group C. Among the patterns of interstitial abnormalities, the area of honeycombing in Group B was significantly greater than that in Group C. Furthermore, among the patients in Group B, the LAA in the ILA-positive patients was significantly greater than that in the ILA-negative patients.", {"entities": []}], ["In Group B, the area occupied by ILAs-especially honeycombing-was greater than that in Group C. This contributed to the preserved %FEV 1 and possibly to the poorer prognosis of the patients in Group B.", {"entities": [[131, 134, "GENE"]]}], ["\u03b1 1 -Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary tissues from proteolytic damage.", {"entities": []}], ["The Z mutant (Glu342Lys) undergoes inactivating conformational change and polymerises.", {"entities": []}], ["Polymers are retained within the hepatocyte endoplasmic reticulum (ER) in homozygous (PiZZ) individuals, predisposing the individuals to hepatic cirrhosis and emphysema.", {"entities": []}], ["Latency is an analogous process of inactivating, intra-molecular conformational change and may co-occur with polymerisation.", {"entities": []}], ["However, the relationship between latency and polymerisation remained unexplored in the absence of a suitable probe.", {"entities": []}], ["We have developed a novel monoclonal antibody specific for latent \u03b1 1 -antitrypsin and used it in combination with a polymer-specific antibody, to assess the association of both conformers in vitro , in disease and during augmentation therapy.", {"entities": []}], ["In vitro kinetics analysis showed polymerisation dominated the pathway but latency could be promoted by stabilising monomeric \u03b1 1 -antitrypsin.", {"entities": []}], ["Polymers were extensively produced in hepatocytes and a cell line expressing Z \u03b1 1 -antitrypsin but the latent protein was not detected despite manipulation of the secretory pathway.", {"entities": []}], ["However, \u03b1 1 -antitrypsin augmentation therapy contains latent \u03b1 1 -antitrypsin, as did the plasma of 63/274 PiZZ individuals treated with augmentation therapy but 0/264 who were not receiving this medication ( p \u00a0<\u00a010 1 -antitrypsin is a by-product of the polymerisation pathway, that the intracellular folding environment is resistant to formation of the latent conformer but that augmentation therapy introduces latent \u03b1 1 -antitrypsin into the circulation.", {"entities": []}], ["A suite of monoclonal antibodies and methodologies developed in this study can characterise \u03b1 1 -antitrypsin folding and conformational transitions, and screen methods to improve augmentation therapy.", {"entities": []}], ["Global phthalate ester production has increased from very low levels at the end of World War II to approximately 3.5 million metric tons/year.", {"entities": []}], ["The aim of the present study was to investigate potential associations between persistent allergic symptoms in children, which have increased markedly in developed countries over the past three decades, and the concentration of phthalates in dust collected from their homes.", {"entities": []}], ["This investigation is a case\u2013control study nested within a cohort of 10,852 children.", {"entities": []}], ["From the cohort, we selected 198 cases with persistent allergic symptoms and 202 controls without allergic symptoms.", {"entities": []}], ["A clinical and a technical team investigated each child and her or his environment.", {"entities": []}], ["We found higher median concentrations of butyl benzyl phthalate (BBzP) in dust among cases than among controls (0.15 vs. 0.12 mg/g dust).", {"entities": []}], ["Analyzing the case group by symptoms showed that BBzP was associated with rhinitis ( p = 0.001) and eczema ( p = 0.001), whereas di(2-ethylhexyl) phthalate (DEHP) was associated with asthma ( p = 0.022).", {"entities": [[74, 82, "DISEASE"], [183, 189, "DISEASE"]]}], ["Furthermore, dose\u2013response relationships for these associations are supported by trend analyses.", {"entities": []}], ["This study shows that phthalates, within the range of what is normally found in indoor environments, are associated with allergic symptoms in children.", {"entities": []}], ["We believe that the different associations of symptoms for the three major phthalates\u2014BBzP, DEHP, and di- n -butyl phthalate\u2014can be explained by a combination of chemical physical properties and toxicologic potential.", {"entities": []}], ["Given the phthalate exposures of children worldwide, the results from this study of Swedish children have global implications.", {"entities": []}], ["Since the microbiome has a significant impact on human health and disease, microbe-disease associations can be utilized as a valuable resource for understanding disease pathogenesis and promoting disease diagnosis and prognosis.", {"entities": []}], ["Accordingly, it is necessary for researchers to achieve a comprehensive and deep understanding of the associations between microbes and diseases.", {"entities": []}], ["Nevertheless, to date, little work has been achieved in implementing novel human microbe-disease association prediction models.", {"entities": []}], ["In this paper, we develop a novel computational model to predict potential microbe-disease associations by bi-random walk on the heterogeneous network (BiRWHMDA).", {"entities": []}], ["The heterogeneous network was constructed by connecting the microbe similarity network and the disease similarity network via known microbe-disease associations.", {"entities": []}], ["Microbe similarity and disease similarity were calculated by the Gaussian interaction profile kernel similarity measure; moreover, a logistic function was applied to regulate disease similarity.", {"entities": []}], ["Additionally, leave-one-out cross validation and 5-fold cross validation were implemented to evaluate the predictive performance of our method; both cross validation methods performed well.", {"entities": []}], ["The leave-one-out cross validation experiment results illustrate that our method outperforms other previously proposed methods.", {"entities": []}], ["Furthermore, case studies on asthma and inflammatory bowel disease prove the favorable performance of our method.", {"entities": [[40, 66, "DISEASE"], [29, 35, "DISEASE"]]}], ["In conclusion, our method can be considered as an effective computational model for predicting novel microbe-disease associations.", {"entities": []}], ["Sleep abnormalities, including obstructive sleep apnea (OSA), have been associated with insulin resistance.", {"entities": []}], ["To determine the relationship between sleep, including OSA, and glucose parameters in a prospectively assembled cohort of chronically sleep-deprived obese subjects.", {"entities": []}], ["Cross-sectional evaluation of a prospective cohort study.", {"entities": []}], ["Tertiary Referral Research Clinical Center.", {"entities": []}], ["Sleep duration and quality assessed by actigraphy, sleep diaries and questionnaires, OSA determined by a portable device; glucose metabolism assessed by oral glucose tolerance test (oGTT), and HbA 1 c concentrations in 96 obese individuals reporting sleeping less than 6.5 h on a regular basis.", {"entities": []}], ["Sixty % of subjects had an abnormal respiratory disturbance index (RDI\u22655) and 44% of these subjects had abnormal oGTT results.", {"entities": []}], ["Severity of OSA as assessed by RDI score was associated with fasting glucose (R\u200a=\u200a0.325, p \u200a=\u200a0.001) and fasting insulin levels (\u03c1\u200a=\u200a0.217, p \u200a=\u200a0.033).", {"entities": []}], ["Subjects with moderate to severe OSA (RDI>15) had higher glucose concentrations at 120 min than those without OSA (RDI<5) ( p \u200a=\u200a0.017).", {"entities": []}], ["Subjects with OSA also had significantly higher concentrations of plasma ACTH ( p \u200a=\u200a0.009).", {"entities": []}], ["Several pro-inflammatory cytokines were higher in subjects with OSA ( p <0.050).", {"entities": []}], ["CRP levels were elevated in this sample, suggesting increased cardiovascular risk.", {"entities": [[0, 3, "GENE"]]}], ["OSA is associated with impaired glucose metabolism in obese, sleep deprived individuals.", {"entities": []}], ["Since sleep apnea is common and frequently undiagnosed, health care providers should be aware of its occurrence and associated risks.", {"entities": []}], ["This study was conducted under the NIDDK protocol 06-DK-0036 and is listed in ClinicalTrials.gov NCT00261898", {"entities": []}], ["Kaempferol is a flavonoid compound that has gained widespread attention due to its antitumor functions.", {"entities": []}], ["However, the underlying mechanisms are still not clear.", {"entities": []}], ["The present study investigated the effect of kaempferol on hepatocellular carcinoma and its underlying mechanisms.", {"entities": [[59, 83, "DISEASE"], [74, 83, "DISEASE"]]}], ["Kaempferol induced autophagy in a concentration- and time-dependent manner in HepG2 or Huh7 cells, which was evidenced by the significant increase of autophagy-related genes.", {"entities": []}], ["Inhibition of autophagy pathway, through 3-methyladenine or Atg7 siRNA, strongly diminished kaempferol-induced apoptosis.", {"entities": [[60, 64, "GENE"]]}], ["We further hypothesized that kaempferol can induce autophagy via endoplasmic reticulum (ER) stress pathway.", {"entities": []}], ["Indeed, blocking ER stress by 4-phenyl butyric acid (4-PBA) or knockdown of CCAAT/enhancer-binding protein homologous protein (CHOP) with siRNA alleviated kaempferol-induced HepG2 or Huh7 cells autophagy; while transfection with plasmid overexpressing CHOP reversed the effect of 4-PBA on kaempferol-induced autophagy.", {"entities": []}], ["Our results demonstrated that kaempferol induced hepatocarcinoma cell death via ER stress and CHOP-autophagy signaling pathway; kaempferol may be used as a potential chemopreventive agent for patients with hepatocellular carcinoma.", {"entities": [[206, 230, "DISEASE"], [221, 230, "DISEASE"]]}], ["The bed bug, Cimex lectularius , has re-established itself as a ubiquitous human ectoparasite throughout much of the world during the past two decades.", {"entities": []}], ["This global resurgence is likely linked to increased international travel and commerce in addition to widespread insecticide resistance.", {"entities": []}], ["Analyses of the C. lectularius sequenced genome (650\u2009Mb) and 14,220 predicted protein-coding genes provide a comprehensive representation of genes that are linked to traumatic insemination, a reduced chemosensory repertoire of genes related to obligate hematophagy, host\u2013symbiont interactions, and several mechanisms of insecticide resistance.", {"entities": [[53, 55, "GENE"]]}], ["In addition, we document the presence of multiple putative lateral gene transfer events.", {"entities": []}], ["Genome sequencing and annotation establish a solid foundation for future research on mechanisms of insecticide resistance, human\u2013bed bug and symbiont\u2013bed bug associations, and unique features of bed bug biology that contribute to the unprecedented success of C. lectularius as a human ectoparasite.", {"entities": []}], ["The bed bug, Cimex lectularius , is a ubiquitous human ectoparasite with global distribution.", {"entities": []}], ["Here, the authors sequence the genome of the bed bug and identify reductions in chemosensory genes, expansion of genes associated with blood digestion and genes linked to pesticide resistance.", {"entities": []}], ["Interleukin (IL)-25 has been shown to play an important role in the pathogenesis of chronic rhinosinusitis with nasal polyps.", {"entities": []}], ["Nasal polyps are associated with chronic inflammation of the mucous membranes in the paranasal sinuses and are involved in extracellular matrix (ECM) accumulation.", {"entities": []}], ["The aim of this study is to evaluate the effects of IL-25 on myofibroblast differentiation, ECM production and the expression of matrix metalloproteinases in nasal polyp derived fibroblasts (NPDFs) and to determine the molecular mechanism underlying these processes.", {"entities": []}], ["A total of 40 patients were enrolled in this study for Immunofluorescence studies.", {"entities": []}], ["Expression of IL17 receptor B was evaluated by real time reverse transcription polymerase chain reaction (PCR) in NPDFs.", {"entities": []}], ["NPDFs were stimulated with IL-25 for 48 h in the presence or absence of mitogen-activated protein kinase (MAPK) and NF-\u03baB inhibitors or small interfering RNAs (siRNA).", {"entities": []}], ["The protein levels of fibrosis active mediators were examined using western blotting.", {"entities": []}], ["Fibroblast migration was evaluated with a scratch assay.", {"entities": []}], ["The total collagen amount was analyzed with the Sircol collagen assay.", {"entities": []}], ["IL-25 induced \u03b1-SMA, fibronectin, and MMP-1 and -13, which were dependent on IL-17RB.", {"entities": []}], ["IL-25 also induced activation of NF-\u03baB and mitogen-activated protein kinase (MAPKs).", {"entities": []}], ["By using the specific inhibitor of ERK, p38, JNK and NF-\u03baB (U, SB, SP and Bay), we found that IL-25-induced expressions of \u03b1-SMA, fibronectin, and MMPs was regulated by the signaling pathways of MAPKs and NF-\u03baB.", {"entities": []}], ["IL-25 also induces \u03b1-SMA, fibronectin, and MMPs expression through IL-17RB-dependent pathways in NPDFs.", {"entities": []}], ["The increased migration ability induced by IL-25 was suppressed by the specific inhibitors of MAPKs and NF-\u03baB.", {"entities": []}], ["Our data indicate that IL-25 induced myofibroblast differentiation, fibronectin production, and MMP-1 and -13 expressions through the signaling pathways of MAPKs and NF-\u03baB.", {"entities": []}], ["in NPDFs and increased expression of IL-25 were also involved in the pathogenesis of nasal polyposis by affecting nasal fibroblasts in chronic rhinosinusitis with nasal polyps.", {"entities": []}], ["Human colon cancers express higher levels of NADPH oxidase 1 [NOX1] than adjacent normal epithelium.", {"entities": [[62, 66, "GENE"]]}], ["It has been suggested that reactive oxygen species [ROS] derived from NOX1 contribute to DNA damage and neoplastic transformation in the colon, particularly during chronic inflammatory stress.", {"entities": [[70, 74, "GENE"]]}], ["However, the mechanism(s) underlying increased NOX1 expression in malignant tumors or chronic inflammatory states involving the intestine are poorly characterized.", {"entities": [[47, 51, "GENE"]]}], ["We examined the effects of two pro-inflammatory cytokines, IL-4 and IL-13, on the regulation of NOX1.", {"entities": [[96, 100, "GENE"]]}], ["NOX1 expression was increased 4- to 5-fold in a time- and concentration-dependent manner by both cytokines in human colon cancer cell lines when a functional Type II IL-4 receptor was present.", {"entities": [[116, 128, "DISEASE"], [122, 128, "DISEASE"], [0, 4, "GENE"]]}], ["Increased NOX1 transcription following IL-4/IL-13 exposure was mediated by JAK1/STAT6 signaling, was associated with a ROS-related inhibition of protein tyrosine phosphatase activity, and was dependent upon activation and specific binding of GATA3 to the NOX1 promoter.", {"entities": [[10, 14, "GENE"], [255, 259, "GENE"], [242, 247, "GENE"], [10, 14, "GENE"], [255, 259, "GENE"]]}], ["NOX1-mediated ROS production increased cell cycle progression through S-phase leading to a significant increase in cellular proliferation.", {"entities": []}], ["Evaluation of twenty pairs of surgically-resected colon cancers and their associated uninvolved adjacent colonic epithelium demonstrated a significant increase in the active form of NOX1, NOX1-L, in tumors compared to normal tissues, and a significant correlation between the expression levels of NOX1 and the Type II IL-4 receptor in tumor and the uninvolved colon.", {"entities": [[182, 186, "GENE"], [188, 192, "GENE"], [297, 301, "GENE"], [182, 186, "GENE"], [188, 192, "GENE"], [297, 301, "GENE"]]}], ["These studies imply that NOX1 expression, mediated by IL-4/IL-13, could contribute to an oxidant milieu capable of supporting the initiation or progression of colonic cancer, suggesting a role for NOX1 as a therapeutic target.", {"entities": [[167, 173, "DISEASE"], [25, 29, "GENE"], [197, 201, "GENE"], [25, 29, "GENE"], [197, 201, "GENE"]]}], ["To reduce readmissions, it may be cost-effective to consider risk stratification, with targeting intervention programs to patients at high risk of readmissions.", {"entities": []}], ["In this study, we aimed to derive and validate a prediction model including several novel markers of hospitalization severity, and compare the model with the LACE index (Length of stay, Acuity of admission, Charlson comorbidity index, Emergency department visits in past 6 months), an established risk stratification tool.", {"entities": []}], ["This was a retrospective cohort study of all patients \u2265 21 years of age, who were admitted to a tertiary hospital in Singapore from January 1, 2013 through May 31, 2015.", {"entities": []}], ["Data were extracted from the hospital\u2019s electronic health records.", {"entities": []}], ["The outcome was defined as unplanned readmissions within 30 days of discharge from the index hospitalization.", {"entities": []}], ["Candidate predictive variables were broadly grouped into five categories: Patient demographics, social determinants of health, past healthcare utilization, medical comorbidities, and markers of hospitalization severity.", {"entities": []}], ["Multivariable logistic regression was used to predict the outcome, and receiver operating characteristic analysis was performed to compare our model with the LACE index.", {"entities": []}], ["74,102 cases were enrolled for analysis.", {"entities": []}], ["Of these, 11,492 patient cases (15.5%) were readmitted within 30 days of discharge.", {"entities": []}], ["A total of fifteen predictive variables were strongly associated with the risk of 30-day readmissions, including number of emergency department visits in the past 6 months, Charlson Comorbidity Index, markers of hospitalization severity such as \u2018requiring inpatient dialysis during index admission, and \u2018treatment with intravenous furosemide 40 milligrams or more\u2019 during index admission.", {"entities": []}], ["Our predictive model outperformed the LACE index by achieving larger area under the curve values: 0.78 (95% confidence interval [CI]: 0.77\u20130.79) versus 0.70 (95% CI: 0.69\u20130.71).", {"entities": []}], ["Several factors are important for the risk of 30-day readmissions, including proxy markers of hospitalization severity.", {"entities": []}], ["There is increasing evidence that biomarkers of exhaled gases or exhaled breath condensate (EBC) may help in detecting abnormalities in respiratory diseases mirroring increased, oxidative stress, airways inflammation and endothelial dysfunction.", {"entities": []}], ["Beside the traditional techniques to investigate biomarker profiles, \u201c omics \u201d sciences have raised interest in the clinical field as potentially improving disease phenotyping.", {"entities": []}], ["In particular, metabonomics appears to be an important tool to gain qualitative and quantitative information on low-molecular weight metabolites present in cells, tissues, and fluids.", {"entities": []}], ["Here, we review the potential use of EBC as a suitable matrix for metabonomic studies using nuclear magnetic resonance (NMR) spectroscopy.", {"entities": []}], ["By using this approach in airway diseases, it is now possible to separate specific EBC profiles, with implication in disease phenotyping and personalized therapy.", {"entities": []}], ["Populations exposed to Plasmodium falciparum infection develop genetic mechanisms of protection against severe malarial disease.", {"entities": []}], ["Despite decades of genetic epidemiological research, the sickle cell trait (HbAS) sickle cell polymorphism, ABO blood group, and other hemoglobinopathies remain the few major determinants in severe malaria to be replicated across different African populations and study designs.", {"entities": [[198, 205, "DISEASE"], [108, 111, "GENE"]]}], ["Within a case-control study in a region of high transmission in Tanzania (n = 983), we investigated the role of 40 new loci identified in recent genome-wide studies.", {"entities": []}], ["In 32 loci passing quality control procedures, we found polymorphisms in USP38, FREM3, SDC1, DDC, and LOC727982 genes to be putatively associated with differential susceptibility to severe malaria.", {"entities": [[189, 196, "DISEASE"], [73, 78, "GENE"], [80, 85, "GENE"], [87, 91, "GENE"], [93, 96, "GENE"]]}], ["Established candidates explained 7.4% of variation in severe malaria risk (HbAS polymorphism, 6.3%; \u03b1-thalassemia, 0.3%; ABO group, 0.3%; and glucose-6-phosphate dehydrogenase deficiency, 0.5%) and the new polymorphisms, another 4.3%.", {"entities": [[102, 113, "DISEASE"], [61, 68, "DISEASE"], [121, 124, "GENE"]]}], ["The regions encompassing the loci identified are promising targets for the design of future treatment and control interventions.", {"entities": []}], ["The production of anti\u2010drug antibodies can impact significantly upon the safety and efficacy of biotherapeutics.", {"entities": []}], ["It is known that various factors, including aggregation and the presence of process\u2010related impurities, can modify and augment the immunogenic potential of proteins.", {"entities": []}], ["The purpose of the investigations reported here was to characterize in mice the influence of aggregation and host cell protein impurities on the immunogenicity of a humanized single\u2010chain antibody variable fragment (scFv), and mouse albumin.", {"entities": []}], ["Host cell protein impurities within an scFv preparation purified from Escherichia coli displayed adjuvant\u2010like activity for responses to the scFv in BALB /c strain mice.", {"entities": []}], ["The 70 000 MW E. coli chaperone protein DnaK was identified as a key contaminant of scFv by mass spectrometric analysis.", {"entities": []}], ["Preparations of scFv lacking detectable DnaK were spiked with recombinant E. coli DnaK to mimic the process\u2010related impurity.", {"entities": []}], ["Mice were immunized with monomeric and aggregated preparations, with and without 0\u00b71% DnaK by mass.", {"entities": []}], ["Aggregation alone enhanced IgM and IgG2a antibody responses, but had no significant effect on total IgG or IgG1 responses.", {"entities": []}], ["The addition of DnaK further enhanced IgG and IgG2a antibody responses, but only in the presence of aggregated protein.", {"entities": []}], ["DnaK was shown to be associated with the aggregated scFv by Western blot analysis.", {"entities": []}], ["Experiments with mouse albumin showed an overall increase in immunogenicity with protein aggregation alone, and the presence of DnaK increased the vigour of the IgG2a antibody response further.", {"entities": []}], ["Collectively these data reveal that DnaK has the potential to modify and enhance immunogenicity when associated with aggregated protein.", {"entities": []}], ["Integrins are heterodimeric, transmembrane receptors that function as mechanosensors, adhesion molecules and signal transduction platforms in a multitude of biological processes.", {"entities": []}], ["As such, integrins are central to the etiology and pathology of many disease states.", {"entities": []}], ["Therefore, pharmacological inhibition of integrins is of great interest for the treatment and prevention of disease.", {"entities": []}], ["In the last two decades several integrin-targeted drugs have made their way into clinical use, many others are in clinical trials and still more are showing promise as they advance through preclinical development.", {"entities": []}], ["Herein, this review examines and evaluates the various drugs and compounds targeting integrins and the disease states in which they are implicated.", {"entities": []}], ["The objective of this study was to assess trends in health insurance coverage, health service utilization, and health care access among working-age adults with and without disabilities before and after full implementation of the Affordable Care Act (ACA), and to identify current disability-based disparities following full implementation of the ACA.", {"entities": []}], ["The ACA was expected to have a disproportionate impact on working-age adults with disabilities, because of their high health care usage as well as their previously limited insurance options.", {"entities": []}], ["However, most published research on this population does not systematically look at effects before and after full implementation of the ACA.", {"entities": []}], ["As the US Congress considers new health policy reforms, current and accurate data on this vulnerable population are essential.", {"entities": []}], ["Weighted estimates, trend analyses and analytic models were conducted using the 1998-2016 National Health Interview Surveys (NHIS) and the 2014 Medical Expenditure Panel Survey.", {"entities": []}], ["Compared with working-age adults without disabilities, those with disabilities are less likely to work, more likely to earn below the federal poverty level, and more likely to use public insurance.", {"entities": []}], ["Average health costs for this population are 3 to 7 times higher, and access problems are far more common.", {"entities": []}], ["Repeal of key features of the ACA, like Medicaid expansion and marketplace subsidies, would likely diminish health care access for working-age adults with disabilities.", {"entities": []}], ["Asthma represents an episodic and fluctuating behavior characterized with decreased complexity of respiratory dynamics.", {"entities": [[0, 6, "DISEASE"]]}], ["Several evidence indicate that asthma severity or control is associated with alteration in variability of lung function.", {"entities": [[31, 37, "DISEASE"]]}], ["The pathophysiological basis of alteration in complexity of breathing pattern in asthma has remained poorly understood.", {"entities": [[81, 87, "DISEASE"]]}], ["Regarding the point that Rho-kinase is involved in pathophysiology of asthma, in present study we investigated the effect of Rho-kinase inhibition on complexity of respiratory dynamics in a guinea pig model of asthma.", {"entities": [[70, 76, "DISEASE"], [210, 216, "DISEASE"]]}], ["Male Dunkin Hartley guinea pigs were exposed to 12 series of inhalations with ovalbumin or saline.", {"entities": []}], ["Animals were treated by the Rho-kinase inhibitor Y-27632 (1mM aerosols) prior to each allergen challenge.", {"entities": []}], ["We recorded respiration of conscious animals using whole-body plethysmography.", {"entities": []}], ["Exposure to ovalbumin induced lung inflammation, airway hyperresponsiveness and remodeling including goblet cell hyperplasia, increase in the thickness of airways smooth muscles and subepithelial collagen deposition.", {"entities": []}], ["Complexity analysis of respiratory dynamics revealed a dramatic decrease in irregularity of respiratory rhythm representing less complexity in asthmatic guinea pigs.", {"entities": []}], ["Inhibition of Rho-kinase reduced the airway remodeling and hyperreponsiveness, but had no significant effect on lung inflammation and complexity of respiratory dynamics in asthmatic animals.", {"entities": []}], ["It seems that airway hyperresponsiveness and remodeling do not significantly affect the complexity of respiratory dynamics.", {"entities": []}], ["Our results suggest that inflammation might be the probable cause of shift in the respiratory dynamics away from the normal fluctuation in asthma.", {"entities": [[139, 145, "DISEASE"]]}], ["To implement personalized medicine, we established a large-scale patient cohort, BioBank Japan, in 2003.", {"entities": []}], ["BioBank Japan contains DNA, serum, and clinical information derived from approximately 200,000 patients with 47 diseases.", {"entities": []}], ["Serum and clinical information were collected annually until 2012.", {"entities": []}], ["We analyzed clinical information of participants at enrollment, including age, sex, body mass index, hypertension, and smoking and drinking status, across 47 diseases, and compared the results with the Japanese database on Patient Survey and National Health and Nutrition Survey.", {"entities": [[101, 113, "DISEASE"]]}], ["We conducted multivariate logistic regression analysis, adjusting for sex and age, to assess the association between family history and disease development.", {"entities": []}], ["Distribution of age at enrollment reflected the typical age of disease onset.", {"entities": []}], ["Analysis of the clinical information revealed strong associations between smoking and chronic obstructive pulmonary disease, drinking and esophageal cancer, high body mass index and metabolic disease, and hypertension and cardiovascular disease.", {"entities": [[205, 217, "DISEASE"], [138, 155, "DISEASE"], [86, 123, "DISEASE"], [149, 155, "DISEASE"]]}], ["Logistic regression analysis showed that individuals with a family history of keloid exhibited a higher odds ratio than those without a family history, highlighting the strong impact of host genetic factor(s) on disease onset.", {"entities": []}], ["Cross-sectional analysis of the clinical information of participants at enrollment revealed characteristics of the present cohort.", {"entities": []}], ["Analysis of family history revealed the impact of host genetic factors on each disease.", {"entities": []}], ["BioBank Japan, by publicly distributing DNA, serum, and clinical information, could be a fundamental infrastructure for the implementation of personalized medicine.", {"entities": []}], ["\u2022 The BioBank Japan Project (BBJ) annually collected clinical information.", {"entities": []}], ["\u2022 Analysis of the clinical information at enrollment characterized the BBJ cohort.", {"entities": []}], ["\u2022 Analysis of family history revealed impacts of host genetic factors on the diseases.", {"entities": []}], ["The BioBank Japan Project (BBJ) annually collected clinical information.", {"entities": []}], ["Analysis of the clinical information at enrollment characterized the BBJ cohort.", {"entities": []}], ["Analysis of family history revealed impacts of host genetic factors on the diseases.", {"entities": []}], ["When comparing chronic obstructive lung disease (COPD) interventions in database research, it is important to adjust for severity.", {"entities": [[23, 47, "DISEASE"], [35, 47, "DISEASE"]]}], ["Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines grade severity according to lung function.", {"entities": [[30, 54, "DISEASE"], [42, 54, "DISEASE"]]}], ["Most databases lack data on lung function.", {"entities": []}], ["Previous database research has approximated COPD severity using demographics and healthcare utilization.", {"entities": []}], ["This study aims to derive an algorithm for COPD severity using baseline data from a large respiratory trial (UPLIFT).", {"entities": []}], ["Partial proportional odds logit models were developed for probabilities of being in GOLD stages II, III and IV.", {"entities": []}], ["Concordance between predicted and observed stage was assessed using kappa-statistics.", {"entities": []}], ["Models were estimated in a random selection of 2/3 of patients and validated in the remainder.", {"entities": []}], ["The analysis was repeated in a subsample with a balanced distribution across severity stages.", {"entities": []}], ["Univariate associations of COPD severity with the covariates were tested as well.", {"entities": []}], ["More severe COPD was associated with being male and younger, having quit smoking, lower BMI, osteoporosis, hospitalizations, using certain medications, and oxygen.", {"entities": [[93, 105, "DISEASE"]]}], ["After adjusting for these variables, co-morbidities, previous healthcare resource use (eg, emergency room, hospitalizations) and inhaled corticosteroids, xanthines, or mucolytics were no longer independently associated with COPD severity, although they were in univariate tests.", {"entities": []}], ["The concordance was poor (kappa = 0.151) and only slightly better in the balanced sample (kappa = 0.215).", {"entities": []}], ["COPD severity cannot be reliably predicted from demographics and healthcare use.", {"entities": []}], ["This limitation should be considered when interpreting findings from database studies, and additional research should explore other methods to account for COPD severity.", {"entities": []}], ["Marine natural products have been the focus of discovery for new products of chemical and pharmacological interest.", {"entities": []}], ["The aim of this study was to evaluate the antinociceptive activity of the methanolic (ME), acetate (AE), hexanic (HE) and chloroform (CE) extracts obtained from Caulerpa mexicana , and ME, CE and HE obtained from Caulerpa sertularioides .", {"entities": []}], ["These marine algae are found all over the world, mainly in tropical regions.", {"entities": []}], ["Models such as the writhing test, the hot plate test and formalin-induced nociception test were used to evaluate antinociceptive activity in laboratory mice.", {"entities": []}], ["In the writhing test, all the extracts were administered orally at a concentration of 100 mg/kg, and induced high peripheral antinociceptive activity, with a reduction in the nociception induced by acetic acid above 65%.", {"entities": []}], ["In the hot plate test, treatment with extracts from C. sertularioides (100 mg/kg, p.o.)", {"entities": []}], ["did not significantly increase the latency of response, although the ME, AE and HE from C. mexicana showed activity in this model.", {"entities": []}], ["This result suggests that these extracts exhibit antinociceptive activity.", {"entities": []}], ["In the formalin test, it was observed that ME, AE and HE obtained from C. mexicana reduced the effects of formalin in both phases.", {"entities": []}], ["On the other hand only CE from C. sertularioides induced significant inhibition of the nociceptive response in the first phase.", {"entities": []}], ["To better assess the potential anti-inflammatory activity of the extracts, the carrageenan-induced peritonitis test was used to test Caulerpa spp.", {"entities": [[99, 110, "DISEASE"]]}], ["extracts on cell migration into the peritoneal cavity.", {"entities": []}], ["In this assay, all extracts evaluated were able to significantly inhibit leukocyte migration into the peritoneal cavity in comparison with carrageenan.", {"entities": []}], ["These data demonstrate that extracts from Caulerpa species elicit pronounced antinociceptive and anti-inflamatory activity against several nociception models.", {"entities": []}], ["However, pharmacological and chemical studies are continuing in order to characterize the mechanism(s) responsible for the antinociceptive action and also to identify the active principles present in the Caulerpa species.", {"entities": []}], ["Chronic diseases (CD) are generating a dramatic societal burden worldwide that is expected to persist over the next decades.", {"entities": []}], ["The challenges posed by the epidemics of CD have triggered a novel health paradigm with major consequences on the traditional concept of disease and with a profound impact on key aspects of healthcare systems.", {"entities": []}], ["We hypothesized that the development of a systems approach to understand CD together with the generation of an ecosystem to transfer the acquired knowledge into the novel healthcare scenario may contribute to a cost-effective enhancement of health outcomes.", {"entities": []}], ["To this end, we designed the Synergy-COPD project wherein the heterogeneity of chronic obstructive pulmonary disease (COPD) was addressed as a use case representative of CD.", {"entities": [[79, 116, "DISEASE"]]}], ["The current manuscript describes main features of the project design and the strategies put in place for its development, as well the expected outcomes during the project life-span.", {"entities": []}], ["Moreover, the manuscript serves as introductory and unifying chapter of the different papers associated to the Supplement describing the characteristics, tools and the objectives of Synergy-COPD", {"entities": []}], ["Crack cocaine can cause a variety of pulmonary and cardiac complications.", {"entities": []}], ["Pulmonary findings in a 65- year-old man with non-Hodgkin lymphoma who presented with shortness of breath not resolving with antibiotics are presented here.", {"entities": [[58, 66, "DISEASE"]]}], ["The usual manifestation of \u201ccrack lung\u201d in an unusual clinical circumstance underlines the importance of a clinical history in such cases.", {"entities": []}], ["The finding of \u201ccrack lung\u201d preceded the diagnosis of probable \u201ccrack heart.\u201d No other similar published case reports could be identified in the literature.", {"entities": []}], ["The Medical Outcomes General Health Survey (SF-36) is a widely used health status measure; however, limited evidence is available for its performance in orthopedic settings.", {"entities": []}], ["The aim of this study was to examine the magnitude and meaningfulness of change and sensitivity of SF-36 subscales following orthopedic surgery.", {"entities": []}], ["Longitudinal data on outcomes of total hip replacement (THR, n = 255), total knee replacement (TKR, n = 103), arthroscopic partial meniscectomy (APM, n = 74) and anterior cruciate ligament reconstruction (ACL, n = 62) were used to estimate the effect sizes (ES, magnitude of change) and minimal detectable change (sensitivity) at the group and individual level.", {"entities": []}], ["To provide context for interpreting the magnitude of changes in SF-36 scores, we also compared patients' scores with age and sex-matched population norms.", {"entities": []}], ["The studies were conducted in Sweden.", {"entities": []}], ["Follow-up was five years in THR and TKR studies, two years in ACL, and three months in APM.", {"entities": []}], ["On average, large effect sizes (ES\u22650.80) were found after orthopedic surgery in SF-36 subscales measuring physical aspects (physical functioning, role physical, and bodily pain).", {"entities": []}], ["Small (0.20\u20130.49) to moderate (0.50\u20130.79) effect sizes were found in subscales measuring mental and social aspects (role emotional, vitality, social functioning, and mental health).", {"entities": []}], ["General health scores remained relatively unchanged during the follow-up.", {"entities": []}], ["Despite improvements, post-surgery mean scores of patients were still below the age and sex matched population norms on physical subscales.", {"entities": []}], ["Patients' scores on mental and social subscales approached population norms following the surgery.", {"entities": []}], ["At the individual level, scores of a large proportion of patients were affected by floor or ceiling effects on several subscales and the sensitivity to individual change was very low.", {"entities": []}], ["Large to moderate meaningful changes in group scores were observed in all SF-36 subscales except General Health across the intervention groups.", {"entities": []}], ["Therefore, in orthopedic settings, the SF-36 can be used to show changes for groups in physical, mental, and social dimensions and in comparison with population norms.", {"entities": []}], ["However, SF-36 subscales have low sensitivity to individual change and so we caution against using SF-36 to monitor the health status of individual patients undergoing orthopedic surgery.", {"entities": []}], ["Restrictive cardiomyopathy (RCM) is the least common cardiomyopathy in which the walls are rigid and the heart is restricted from stretching and filling properly.", {"entities": [[12, 26, "DISEASE"], [53, 67, "DISEASE"]]}], ["Cardiac troponin I (cTnI) mutation-caused myofibril Ca Five sporadic pediatric RCM patients confirmed by echocardiography were enrolled in this study.", {"entities": []}], ["Whole-exome sequencing (WES) was performed for the cohort to find out candidate causative gene variants.", {"entities": []}], ["Sanger sequencing confirmed the WES-identified variants.", {"entities": []}], ["TNNI3 variants were found in all of the five patients.", {"entities": [[0, 5, "GENE"]]}], ["R192H mutation was shared in four patients while R204H mutation was found only in one patient.", {"entities": []}], ["Structure investigation showed that the C terminus of TNNI3 was flexible and mutation on the C terminus was possible to cause the RCM.", {"entities": [[54, 59, "GENE"]]}], ["Catechins were prescribed for the five patients once genotype was confirmed.", {"entities": []}], ["Ventricular diastolic function was improved in three patients during the follow-up.", {"entities": []}], ["Our data demonstrated that TNNI3 mutation-induced RCM1 is the most common type of pediatric RCM in this study.", {"entities": [[27, 32, "GENE"]]}], ["In addition, WES is a reliable approach to identify likely pathogenic genes of RCM and might be useful for the guidance of clinical treatment scheme.", {"entities": []}], ["Obesity prevalence is increasing worldwide and is accompanied by low-grade inflammation with macrophage infiltration, which is linked with a poorer breast cancer prognosis.", {"entities": [[148, 161, "DISEASE"], [0, 7, "DISEASE"], [155, 161, "DISEASE"]]}], ["Lunasin is a natural seed peptide with chemopreventive properties and multiple bioactivities.", {"entities": []}], ["This is the first study to explore the chemopreventive effects of lunasin in the obesity-related breast cancer condition using 4T1 breast cancer cells, 3T3-L1 adipocytes, and conditioned media.", {"entities": [[97, 110, "DISEASE"], [131, 144, "DISEASE"], [81, 88, "DISEASE"], [104, 110, "DISEASE"], [138, 144, "DISEASE"]]}], ["An obesity-related environment, such as leptin-treatment or adipocyte-conditioned medium (Ad-CM), promoted 4T1 cell proliferation and metastasis.", {"entities": [[3, 10, "DISEASE"]]}], ["Lunasin treatment inhibited metastasis of breast cancer cells, partially through modestly inhibiting production of the angiogenesis-mediator vascular endothelial growth factor (VEGF) and significantly by inhibiting secretion in the Ad-CM condition.", {"entities": [[42, 55, "DISEASE"], [49, 55, "DISEASE"]]}], ["Subsequently, two adipocytes inflammation models, 3T3-L1 adipocytes were stimulated by tumor necrosis factor (TNF)-\u03b1, and RAW 264.7 cell-conditioned medium (RAW-CM) was used to mimic the obese microenvironment.", {"entities": [[110, 113, "GENE"]]}], ["Lunasin significantly inhibited interleukin (IL)-6 and macrophage chemoattractant protein (MCP)-1 secretion by TNF-\u03b1 stimulation, and MCP-1 secretion in the RAW-CM model.", {"entities": []}], ["This study highlights that lunasin suppressed 3T3-L1 adipocyte inflammation and inhibited 4T1 breast cancer cell migration.", {"entities": [[94, 107, "DISEASE"], [101, 107, "DISEASE"]]}], ["Interestingly, lunasin exerted more effective anti-metastasis activity in the obesity-related condition models, indicating that it possesses anti-inflammatory properties and blocks adipocyte-cancer cell cross-talk.", {"entities": [[78, 85, "DISEASE"], [191, 197, "DISEASE"]]}], ["Incidence and prognosis for severe asthma\u2013COPD overlap is poorly characterized.", {"entities": [[35, 41, "DISEASE"]]}], ["We investigated incidence and long-term outcome for patients with asthma\u2013COPD overlap compared to asthma and COPD alone.", {"entities": [[66, 72, "DISEASE"], [98, 104, "DISEASE"]]}], ["A total of 57,053 adults (aged 50\u201364 years) enrolled in the Danish Diet, Cancer, and Health cohort (1993\u20131997) were followed in the National Patients Registry for admissions for asthma (DJ45\u201346) and COPD (DJ40\u201344) and vital status.", {"entities": [[178, 184, "DISEASE"]]}], ["Asthma\u2013COPD overlap was defined as at least one hospital admission for asthma and one for COPD (different time points), and incident asthma\u2013COPD overlap as at least one of the diagnoses occurring after enrollment into the Diet, Cancer, and Health cohort.", {"entities": [[0, 6, "DISEASE"], [71, 77, "DISEASE"], [133, 139, "DISEASE"]]}], ["A total of 1,845 (3.2%) and 4,037 (7.1%) participants had admissions for asthma and COPD, respectively, with 662 (1.2%) participants with asthma\u2013COPD overlap.", {"entities": [[73, 79, "DISEASE"], [138, 144, "DISEASE"]]}], ["Incidence rate of asthma\u2013COPD overlap per 1,000 person-years was higher in women (0.73) than in men (0.54) ( P <0.02).", {"entities": [[18, 24, "DISEASE"]]}], ["Mortality rate was higher in asthma\u2013COPD overlap (25.9 per 1,000 person-years) compared with COPD (23.1, P <0.05) and asthma (7.9, P <0.001) alone.", {"entities": [[29, 35, "DISEASE"], [118, 124, "DISEASE"]]}], ["Compared to COPD alone, mortality was higher in women with asthma\u2013COPD overlap (19.6 and 25.5, respectively; P <0.01), and the excess mortality rate for asthma\u2013COPD overlap patients was most prominent for younger age groups (12.9 compared to 7.2 and 4.6 for COPD and asthma alone, respectively; P <0.01).", {"entities": [[59, 65, "DISEASE"], [153, 159, "DISEASE"], [267, 273, "DISEASE"]]}], ["This large population-based study revealed a higher incidence of severe asthma\u2013COPD overlap in women compared to men, and furthermore that all-cause mortality is higher in women and younger subjects with asthma\u2013COPD overlap compared with those with asthma or COPD alone.", {"entities": [[72, 78, "DISEASE"], [204, 210, "DISEASE"], [249, 255, "DISEASE"]]}], ["Proline\u2013glycine\u2013proline (PGP), a neutrophil chemoattractant derived from the enzymatic breakdown of collagen, is elevated in sputum of patients with chronic obstructive pulmonary disease (COPD) and may contribute to disease progression.", {"entities": [[149, 186, "DISEASE"], [25, 28, "GENE"]]}], ["Whether sputum levels of PGP respond to therapy for COPD or predict outcomes is unknown.", {"entities": [[25, 28, "GENE"]]}], ["We conducted a study ancillary to a multicenter trial of the efficacy of azithromycin treatment for 1\u2005year in preventing COPD exacerbations to test whether sputum levels of PGP were altered by treatment or associated with exacerbation frequency.", {"entities": [[173, 176, "GENE"]]}], ["We collected remnant sputa from trial participants and assayed them in a blinded fashion for PGP, myeloperoxidase and matrix metalloproteinase (MMP)-9 and for the ability to generate PGP from collagen ex vivo .", {"entities": [[93, 96, "GENE"], [183, 186, "GENE"], [93, 96, "GENE"], [183, 186, "GENE"]]}], ["Once the parent trial was unblinded, the results were correlated with use of azithromycin or placebo and exacerbations in participants.", {"entities": []}], ["Azithromycin treatment significantly reduced sputum levels of PGP and myeloperoxidase in patients with COPD, particularly with increased duration of therapy.", {"entities": [[62, 65, "GENE"]]}], ["We found no difference in sputum MMP-9 or PGP generation between participants taking azithromycin or placebo.", {"entities": [[42, 45, "GENE"]]}], ["Sputum PGP levels were highest around the time of an exacerbation and declined with successful treatment.", {"entities": [[7, 10, "GENE"]]}], ["These data support a role for PGP in the airway and parenchymal neutrophilic inflammation that drives COPD progression and exacerbations, and provide new information on the anti-inflammatory properties of macrolides.", {"entities": [[30, 33, "GENE"]]}], ["PGP may have potential as a target for novel anti-inflammatory therapies in COPD and as a biomarker for clinical trials.", {"entities": [[0, 3, "GENE"]]}], ["Variety of pulmonary lesions are thought to be associated with rheumatoid arthritis (RA).", {"entities": [[63, 83, "DISEASE"], [74, 83, "DISEASE"]]}], ["These lesions traditionally have included pleurisy with or without effusion, Caplan\u2019s syndrome, pulmonary rheumatoid nodules, diffuse interstitial fibrosis, and pulmonary arteritis and hypertension.", {"entities": [[185, 197, "DISEASE"], [42, 50, "DISEASE"], [86, 94, "DISEASE"]]}], ["But little attention has been paid to the airways in RA.", {"entities": []}], ["Recently, several repots have suggested an association between airflow limitation and RA, but its incidence is not known.", {"entities": []}], ["Also whether there exists a parameter of disease activity of RA, suggesting the presence of small airway disease (SAD) is not clear.", {"entities": []}], ["To answer these questions, the serologic parameters which reflect the disease activity of RA and pulmonary function tests which reflect small airway dysfunction were performed on 36 lifetime nonsmokers with RA who had normal chest x-ray findings.", {"entities": []}], ["The prevalence of SAD and the relationships between the disease activity parameters of RA and pulmonary function were observed.", {"entities": []}], ["The results were as follows.", {"entities": []}], ["The percentages of patients with abnormal values for diffusing capacity, frequency dependence of compliance (C 1.0 /C 0.0 ), forced expiratory flow 25\u201375% , V max50% and V max75% were 45.5%, 62.5%, 40%, 22.8% and 11.4%, respectively.", {"entities": []}], ["There was statistically significant negative correlation between C 1.0 /C 0.0 and ESR.", {"entities": []}], ["But consistent correlation between other pulmonary function tests and clinical and serologic parameters of RA, and differences in pulmonary function between patients who were serologically positive and negative for CRP and FANA, were not found.", {"entities": [[215, 218, "GENE"]]}], ["In conclusion, SAD, without the influence of smoking, is frequently associated with RA, but, the presence of SAD cannot be predicted from any clinical and seologic parameters of RA currently in use.", {"entities": []}], ["The ambient air quality standard established in 1973 is 0.03 ppm annual average for sulfur dioxide and 0.075 mg/m3 for particulates.", {"entities": []}], ["It is now generally believed that the toxicity of sulfur oxides in ambient air is significantly influenced by the coincident presence of particulates.", {"entities": []}], ["Inhalation of 1 ppm of sulfur dioxide for 2 hr may produce alterations in pulmonary ventilatory function, both in normal and asthmatic subjects.", {"entities": [[44, 46, "GENE"]]}], ["Effects obtained at 0.5 ppm of sulfur dioxide are controversial and of questionable biological significance.", {"entities": []}], ["No clear evidence exists that sulfur dioxide or bisulfite causes mutagenicity in mammals, and it is concluded from a variety of animal experiments that long-term exposure to sulfur dioxide alone does not cause cancer.", {"entities": [[210, 216, "DISEASE"]]}], ["The inbred mouse strain C57BL/6J is widely used in models of immunological and infectious diseases.", {"entities": []}], ["Here we show that C57BL/6J mice have a defect in neutrophil recruitment to a range of inflammatory stimuli compared with the related C57BL/6N substrain.", {"entities": []}], ["This immune perturbation is associated with a missense mutation in Nlrp12 in C57BL/6J mice.", {"entities": [[67, 73, "GENE"]]}], ["Both C57BL/6J and NLRP12-deficient mice have increased susceptibility to bacterial infection that correlates with defective neutrophil migration.", {"entities": []}], ["C57BL/6J and NLRP12-deficient macrophages have impaired CXCL1 production and the neutrophil defect observed in C57BL/6J and NLRP12-deficient mice is rescued by restoration of macrophage NLRP12.", {"entities": [[56, 61, "GENE"], [13, 19, "GENE"], [124, 130, "GENE"], [186, 192, "GENE"]]}], ["These results demonstrate that C57BL/6J mice have a functional defect in NLRP12 and that macrophages require NLRP12 expression for effective recruitment of neutrophils to inflammatory sites.", {"entities": [[73, 79, "GENE"], [109, 115, "GENE"], [73, 79, "GENE"], [109, 115, "GENE"]]}], ["The role of NLRP12 in immunity to bacterial infection is controversial as varied and contrasting results have been published using C57BL/6 mice.", {"entities": [[12, 18, "GENE"]]}], ["Here the authors shed light on this issue, showing that unlike C57BL/6N mice, C57BL/6J mice have a missense point mutation in NLRP12 that is associated with defective neutrophil recruitment.", {"entities": [[126, 132, "GENE"]]}], ["General practice staff are reluctant to discuss sexual health opportunistically in all consultations.", {"entities": []}], ["Health promotion materials may help alleviate this barrier.", {"entities": []}], ["Chlamydia screening promotion posters and leaflets, produced by the English National Chlamydia Screening Programme (NCSP), have been available to general practices, through local chlamydia screening offices, since its launch.", {"entities": []}], ["In this study we explored the attitudes of general practice staff to these screening promotional materials, how they used them, and explored other promotional strategies to encourage chlamydia screening.", {"entities": []}], ["Twenty-five general practices with a range of screening rates, were purposively selected from six NCSP areas in England.", {"entities": []}], ["In focus groups doctors, nurses, administrative staff and receptionists were encouraged to discuss candidly their experiences about their use and opinions of posters, leaflets and advertising to promote chlamydia screening.", {"entities": []}], ["Researchers observed whether posters and leaflets were on display in reception and/or waiting areas.", {"entities": []}], ["Data were collected and analysed concurrently using a stepwise framework analytical approach.", {"entities": []}], ["Although two-thirds of screening practices reported that they displayed posters and leaflets, they were not prominently displayed in most practices.", {"entities": []}], ["Only a minority of practices reported actively using screening promotional materials on an ongoing basis.", {"entities": []}], ["Most staff in all practices were not following up the advertising in posters and leaflets by routinely offering opportunistic screening to their target population.", {"entities": []}], ["Some staff in many practices thought posters and leaflets would cause offence or embarrassment to their patients.", {"entities": []}], ["Distribution of chlamydia leaflets by receptionists was thought to be inappropriate by some practices, as they thought patients would be offended when being offered a leaflet in a public area.", {"entities": []}], ["Practice staff suggested the development of pocket-sized leaflets.", {"entities": []}], ["The NCSP should consider developing a range of more discrete but eye catching posters and small leaflets specifically to promote chlamydia screening in different scenarios within general practice; coordinators should audit their use.", {"entities": []}], ["Practice staff need to discuss, with their screening co-ordinator, how different practice staff can promote chlamydia screening most effectively using the NCSP promotional materials, and change them regularly so that they do not loose their impact.", {"entities": []}], ["Education to change all practice staff's attitudes towards sexual health is needed to reduce their worries about displaying the chlamydia materials, and how they may follow up the advertising up with a verbal offer of screening opportunistically to 15-24 year olds whenever they visit the practice.", {"entities": []}], ["This report updates surveillance results for COPD in the United States.", {"entities": []}], ["For 1999 to 2011, data from national data systems for adults aged \u2265 25 years were analyzed.", {"entities": []}], ["In 2011, 6.5% of adults (approximately 13.7 million) reported having been diagnosed with COPD.", {"entities": []}], ["From 1999 to 2011, the overall age-adjusted prevalence of having been diagnosed with COPD declined ( P = .019).", {"entities": []}], ["In 2010, there were 10.3 million (494.8 per 10,000) physician office visits, 1.5 million (72.0 per 10,000) ED visits, and 699,000 (32.2 per 10,000) hospital discharges for COPD.", {"entities": []}], ["From 1999 to 2010, no significant overall trends were noted for physician office visits and ED visits; however, the age-adjusted hospital discharge rate for COPD declined significantly ( P = .001).", {"entities": []}], ["In 2010 there were 312,654 (11.2 per 1,000) Medicare hospital discharge claims submitted for COPD.", {"entities": []}], ["Medicare claims (1999-2010) declined overall ( P = .045), among men ( P = .022) and among enrollees aged 65 to 74 years ( P = .033).", {"entities": []}], ["There were 133,575 deaths (63.1 per 100,000) from COPD in 2010.", {"entities": []}], ["The overall age-adjusted death rate for COPD did not change during 1999 to 2010 ( P = .163).", {"entities": []}], ["Death rates (1999-2010) increased among adults aged 45 to 54 years ( P < .001) and among American Indian/Alaska Natives ( P = .008) but declined among those aged 55 to 64 years ( P = .002) and 65 to 74 years ( P < .001), Hispanics ( P = .038), Asian/Pacific Islanders ( P < .001), and men ( P = .001).", {"entities": []}], ["Geographic clustering of prevalence, Medicare hospitalizations, and deaths were observed.", {"entities": []}], ["Declines in the age-adjusted prevalence, death rate in men, and hospitalizations for COPD since 1999 suggest progress in the prevention of COPD in the United States.", {"entities": []}], ["Our aim was to analyze the impact of a concurrent autoimmune disease on outcome of patients with early breast cancer.", {"entities": [[103, 116, "DISEASE"], [110, 116, "DISEASE"]]}], ["We reviewed medical charts of patients with a diagnosis of autoimmune diseases (AD) among a population of 17.153 cases.", {"entities": []}], ["We categorized ADs as endocrine, rheumatic, systemic, neurological diseases and vasculitis.", {"entities": [[80, 90, "DISEASE"]]}], ["For each patient in the study group, we matched 2 patients.", {"entities": []}], ["The events to determine overall survival (OS) and disease free survival (DFS) were identified from follow-up data.", {"entities": []}], ["We identified 279 (1.62%) patients with early breast cancer and concurrent ADs.", {"entities": [[46, 59, "DISEASE"], [53, 59, "DISEASE"]]}], ["The median follow-up was 7.0 years.", {"entities": []}], ["The 10-year OS rate was 86% (95% CI, 80% to 91%) in the study group and 90% (95% CI, 86% to 93%) for the control group ( p = 0.011).", {"entities": []}], ["In patients with ER positive/HER2 negative subtype a worse OS was observed in the study group when compared to the control group ( p = 0.0046); this difference remained statistically significant when the analysis was restricted to breast cancer mortality ( p = 0.045).", {"entities": [[231, 244, "DISEASE"], [238, 244, "DISEASE"]]}], ["The 10-year DFS rate was 69% (95% CI, 61% to 76%) in the study group and 72% (95% CI, 66% to 77%) for the control group ( p = 0.22).", {"entities": []}], ["Autoimmunity at diagnosis of early breast cancer is associated with worse survival.", {"entities": [[35, 48, "DISEASE"], [42, 48, "DISEASE"]]}], ["Chronic inflammation in asthmatic airways leads to bronchial hyper-responsiveness (BHR) and the development of structural changes.", {"entities": []}], ["Important features of remodeling include the formation of subepithelial fibrosis due to increased collagen deposition in the reticular basement membrane.", {"entities": []}], ["Transforming growth factor (TGF)-\u03b2 might be a central mediator of tissue fibrosis and remodeling.", {"entities": []}], ["Immunohistochemistry was used to measure collagen III deposition and TGF-\u03b2 1 expression in biopsies from patients with long-standing asthma treated with inhaled corticosteroids, patients with recently diagnosed asthma, and control subjects.", {"entities": [[133, 139, "DISEASE"], [211, 217, "DISEASE"]]}], ["Computer-assisted image analysis was used to evaluate total basement membrane (TBM) thickness.", {"entities": []}], ["Asthmatics, particularly those with long-standing asthma, had thicker TBMs than healthy subjects.", {"entities": [[50, 56, "DISEASE"]]}], ["Collagen III deposition was comparable in the studied groups.", {"entities": []}], ["BHR was not correlated with features of mucosal inflammation and was lower in steroid-treated patients with long-standing asthma than in subjects with newly diagnosed asthma untreated with steroids.", {"entities": [[122, 128, "DISEASE"], [167, 173, "DISEASE"]]}], ["Epithelial TGF-\u03b2 1 expression negatively correlated with collagen III deposition and TBM thickness.", {"entities": []}], ["The study showed that TBM thickness, but not collagen III deposition, could be a differentiating marker of asthmatics of different disease duration and treatment.", {"entities": []}], ["The lack of correlation between BHR and features of mucosal inflammation suggests the complexity of BHR development.", {"entities": []}], ["Corticosteroids can reduce BHR in asthmatics, but it seems to be less effective in reducing subepithelial fibrosis.", {"entities": []}], ["The role of epithelial TGF-\u03b2 1 needs to be further investigated since the possibility that it plays a protective and anti-inflammatory role in asthmatic airways cannot be excluded.", {"entities": []}], ["The objectives of this report are to review the assessment of patient-focused outcomes in pediatric orthopedic surgery, to describe a framework for identifying appropriate sets of measures, and to illustrate an application of the framework to a challenging orthopedic problem.", {"entities": []}], ["A detailed framework of study design and measurement factors is described.", {"entities": []}], ["The factors are important for selecting appropriate instruments to measure health status and health-related quality of life (HRQL) in a particular context.", {"entities": []}], ["A study to evaluate treatment alternatives for patients with neurofibromatosis type 1 and congenital tibial dysplasia (NF1-CTD) provides a rich illustration of the application of the framework.", {"entities": [[61, 78, "DISEASE"]]}], ["The application involves great variability in the instrument selection factors.", {"entities": []}], ["Furthermore, these patients and their supportive caregivers face numerous complex health challenges with long-term implications for HRQL.", {"entities": []}], ["Detailed summaries of important generic preference-based multi-attribute measurement systems, pediatric health profile instruments, and pediatric orthopedic-specific instruments are presented.", {"entities": []}], ["Age-appropriate generic and specific measures are identified for study of NF1-CTD patients.", {"entities": []}], ["Selected measures include the Activities Scale for Children, Gillette Functional Assessment Questionnaire Walking Scale, Health Utilities Index, and Pediatric Inventory of Quality of Life.", {"entities": []}], ["Reliable and valid measures for application to pediatric orthopedics are available.", {"entities": []}], ["There are important differences among measures.", {"entities": []}], ["The selected measures complement each other.", {"entities": []}], ["The framework in this report provides a guide for selecting appropriate measures.", {"entities": []}], ["Application of appropriate sets of measures will enhance the ability to describe the morbidity of pediatric orthopedic patients and to assess the effectiveness of alternative clinical interventions.", {"entities": []}], ["The framework for measurement of health status and HRQL from a patient perspective has relevance to many other areas of orthopedic practice.", {"entities": []}], ["Neuroendocrine tumours (NETs) are often thought to be rare and rather recherch\u00e9 cancers which are of little concern to the general physician, surgeon or radiologist because of their rarity and esoteric nature.", {"entities": []}], ["In fact, while relatively uncommon, the total group of gastro-entero-pancreatic (GEP) tumours incorporates the spectrum of all types of carcinoids, incuding bronchial carcinoids, and the whole gamut of islet-cell tumours.", {"entities": []}], ["Some of these may present as functioning tumours, with a plethora of hormonal secretions and concomitant clinical syndromes, and GEPs in general have an incidence around 30 per million population per year.", {"entities": []}], ["This means that in the whole European Union, for example, there will be in the region of 12000 new patients every year presenting with one or another manifestation of these tumours.", {"entities": []}], ["Furthermore, the comparatively long survival of many of these patients, compared to more common adenocarcinomas or epithelial tumours, implies that the point prevalence is also not inconsiderable.", {"entities": []}], ["However, it is undoubtedly true that these tumours can be difficult to identify, especially in their early stages, and it is then that radiological investigation becomes of paramount importance.", {"entities": []}], ["Having taken into account all these considerations, most investigators would initiate investigation of a suspected or biochemically proven islet-cell tumour with cross-sectional imaging\u2014either CT or MRI.", {"entities": []}], ["This will clearly identify the larger lesions, allow assessment of the entire abdomen, and provide valuable information on the presence of hepatic metastates.", {"entities": []}], ["Preterm premature rupture of membrane (pPROM) is associated with 30\u201340% of preterm births.", {"entities": []}], ["Infection is considered a leading cause of pPROM due to increased levels of proinflammatory cytokines in amniotic fluid.", {"entities": []}], ["Only 30%, however, are positive for microbial organisms by amniotic fluid culture.", {"entities": []}], ["Interestingly, in some pregnancies complicated by preterm premature rupture of membranes (pPROM), membranes heal spontaneously and pregnancy continues until term.", {"entities": []}], ["Here, we investigated mechanisms of amnion healing.", {"entities": []}], ["Using a preclinical mouse model, we found that small ruptures of the fetal membrane closed within 72\u2009h whereas healing of large ruptures was only 40%.", {"entities": []}], ["Small rupture induced transient upregulation of cytokines whereas large ruptures elicited sustained upregulation of proinflammatory cytokines in the fetal membranes.", {"entities": []}], ["Fetal macrophages from amniotic fluid were recruited to the wounded amnion where macrophage adhesion molecules were highly expressed.", {"entities": []}], ["Recruited macrophages released limited and well-localized amounts of IL-1\u03b2 and TNF which facilitated epithelial-mesenchymal transition (EMT) and epithelial cell migration.", {"entities": [[79, 82, "GENE"]]}], ["Arg1\u2009+\u2009macrophages dominated within 24\u2009h. Migration and healing of the amnion mesenchymal compartment, however, remained compromised.", {"entities": [[0, 4, "GENE"]]}], ["These findings provide novel insights regarding unique healing mechanisms of amnion.", {"entities": []}], ["Allergic rhinitis (AR) is the most common chronic disorder in the pediatric population.", {"entities": [[9, 17, "DISEASE"]]}], ["Although several studies have investigated the correlation between AR and sleep-related issues, the association between the duration and time of sleep and AR has not been analyzed in long-term national data.", {"entities": []}], ["This study investigated the relationship between sleep time and duration and AR risk in middle- and high-school students (adolescents aged 12\u201318).", {"entities": []}], ["We analyzed national data from the Korea Youth Risk Behavior Web-based Survey by the Korea Centers for Disease Control and Prevention from 2007\u20132012.", {"entities": []}], ["The sample size was 274,480, with an average response rate of 96.2%.", {"entities": []}], ["Multivariate logistic regression analyses were conducted to determine the relationship between sleep and AR risk.", {"entities": []}], ["Furthermore, to determine the best-fitted model among independent variables such as sleep duration, sleep time, and the combination of sleep duration and sleep time, we used Akaike Information Criteria (AIC) to compare models.", {"entities": []}], ["A total of 43,337 boys and 41,665 girls reported a diagnosis of AR at baseline.", {"entities": []}], ["The odds ratio increased with age and with higher education and economic status of the parents.", {"entities": []}], ["Further, students in mid-sized and large cities had stronger relationships to AR than those in small cities.", {"entities": []}], ["In both genders, AR was associated with depression and suicidal ideation.", {"entities": []}], ["In the analysis of sleep duration and sleep time, the odds ratio increased in both genders when sleep duration was <7 hours, and when the time of sleep was later than 24\u223600 hours.", {"entities": []}], ["Our results indicate an association between sleep time and duration and AR.", {"entities": []}], ["This study is the first to focus on the relationship between sleep duration and time and AR in national survey data collected over 6 years.", {"entities": []}], ["Florida red tides annually occur in the Gulf of Mexico, resulting from blooms of the marine dinoflagellate Karenia brevis .", {"entities": []}], ["K. brevis produces highly potent natural polyether toxins, known as brevetoxins, that activate voltage-sensitive sodium channels.", {"entities": []}], ["In experimental animals, brevetoxins cause significant bronchoconstriction.", {"entities": []}], ["A study of persons who visited the beach recreationally found a significant increase in self-reported respiratory symptoms after exposure to aerosolized Florida red tides.", {"entities": []}], ["Anecdotal reports indicate that persons with underlying respiratory diseases may be particularly susceptible to adverse health effects from these aerosolized toxins.", {"entities": []}], ["Fifty-nine persons with physician-diagnosed asthma were evaluated for 1 hr before and after going to the beach on days with and without Florida red tide.", {"entities": [[44, 50, "DISEASE"], [72, 74, "GENE"]]}], ["Study participants were evaluated with a brief symptom questionnaire, nose and throat swabs, and spirometry approved by the National Institute for Occupational Safety and Health.", {"entities": []}], ["Environmental monitoring, water and air sampling (i.e., K. brevis , brevetoxins, and particulate size distribution), and personal monitoring (for toxins) were performed.", {"entities": []}], ["Brevetoxin concentrations were measured by liquid chromatography mass spectrometry, high-performance liquid chromatography, and a newly developed brevetoxin enzyme-linked immunosorbent assay.", {"entities": []}], ["Participants were significantly more likely to report respiratory symptoms after Florida red tide exposure.", {"entities": []}], ["Participants demonstrated small but statistically significant decreases in forced expiratory volume in 1 sec, forced expiratory flow between 25 and 75%, and peak expiratory flow after exposure, particularly those regularly using asthma medications.", {"entities": [[229, 235, "DISEASE"]]}], ["Similar evaluation during nonexposure periods did not significantly differ.", {"entities": []}], ["This is the first study to show objectively measurable adverse health effects from exposure to aerosolized Florida red tide toxins in persons with asthma.", {"entities": [[147, 153, "DISEASE"]]}], ["Future studies will examine the possible chronic effects of these toxins among persons with asthma and other chronic respiratory impairment.", {"entities": [[92, 98, "DISEASE"]]}], ["The purpose of this study was to investigate whether common variants across the nuclear factor erythroid 2-like 2 ( NFE2L2 ) gene contribute to the development of the acute respiratory distress syndrome (ARDS) in patients with severe sepsis.", {"entities": [[194, 202, "DISEASE"], [116, 122, "GENE"]]}], ["NFE2L2 is involved in the response to oxidative stress, and it has been shown to be associated with the development of ARDS in trauma patients.", {"entities": [[0, 6, "GENE"]]}], ["We performed a case\u2013control study of 321 patients fulfilling international criteria for severe sepsis and ARDS who were admitted to a Spanish network of post-surgical and critical care units, as well as 871 population-based controls.", {"entities": []}], ["Six tagging single-nucleotide polymorphisms (SNPs) of NFE2L2 were genotyped, and, after further imputation of additional 34 SNPs, association testing with ARDS susceptibility was conducted using logistic regression analysis.", {"entities": [[54, 60, "GENE"]]}], ["After multiple testing adjustments, our analysis revealed 10 non-coding SNPs in tight linkage disequilibrium (0.75\u2009\u2264\u2009 r NFE2L2 gene, showing an odds ratio of 1.93 per T allele (95 % confidence interval, 1.17\u20133.18; p \u2009=\u20090.0089).", {"entities": [[120, 126, "GENE"]]}], ["Our findings support the involvement of NFE2L2 gene variants in ARDS susceptibility and reinforce further exploration of the role of oxidant stress response as a risk factor for ARDS in critically ill patients.", {"entities": [[40, 46, "GENE"]]}], ["Anaemia is common in patients undergoing major surgery.", {"entities": []}], ["The current standard of care for patients with low haemoglobin in the peri-operative period is blood transfusion.", {"entities": []}], ["The presence of preoperative anaemia is associated with an increased likelihood of the patient receiving peri-operative transfusion and worsened outcomes following surgery, more post-operative complications, delayed recovery and greater length of hospital stay.", {"entities": []}], ["Intravenous iron, if applied in the preoperative setting, may correct anaemia by the time of surgery and reduce the need for blood transfusion and improve outcomes.", {"entities": []}], ["PREVENTT is a phase III double-blind randomised controlled trial that will compare the use of intravenous ferric carboxymaltose (dose 1000\u00a0mg) with placebo 10\u201342 days before major open abdominal surgery in 500 patients with anaemia (haemoglobin\u2009<\u2009120\u00a0g/L).", {"entities": []}], ["The primary outcome measure will be the need for blood transfusion and secondary endpoints will include post-operative recovery, length of hospital stay, health care utilisation and cost analysis.", {"entities": []}], ["ISRCTN67322816 \u2013 registered 9 October 2012.", {"entities": []}], ["ClinicalTrials.gov identifier: NCT01692418 .", {"entities": []}], ["Background : High serumMBL level as well as polymorphisms in the mannose-binding lectin 2 (MBL2) gene resulting in MBL deficiency are involved in the mechanism of a number of non-infectious diseases such as asthma, conferring either risk or protection in different population studies.", {"entities": [[207, 213, "DISEASE"], [91, 95, "GENE"]]}], ["MBL being the first reactant of the MBL pathway is also a major determinant of the fate of the anaphylatoxins such as C3a and C5a, which are also pro-inflammatory mediators.", {"entities": []}], ["The MBL2 gene polymorphisms thus control the serum levels of MBL as well as C3a and C5a.", {"entities": [[4, 8, "GENE"]]}], ["Objective : This is the first case-control study conducted in India, investigating the role of MBL2 codon 54 A/B polymorphism in asthma pathogenesis.", {"entities": [[129, 135, "DISEASE"], [95, 99, "GENE"]]}], ["Methods : A case-control study was performed with a total of 992 adult subjects, including 410 adult asthmatics and 582 healthy controls from regions of North India.", {"entities": []}], ["The MBL2 codon 54 A/B polymorphism was genotyped by PCR-RFLP.", {"entities": [[4, 8, "GENE"]]}], ["Results : Statistical analysis for the codon 54 polymorphism revealed that the wild (A) allele was significantly associated with asthma with OR = 1.9, 95% CI (1.4\u20132.4), and p < 0.001.", {"entities": [[129, 135, "DISEASE"]]}], ["Conclusion : The MBL2 codon 54 A/B polymorphism is significantly associated with asthma and its phenotypic traits as the wild (A/A) genotype confers a significant risk towards the disease in the studied North Indian population.", {"entities": [[81, 87, "DISEASE"], [17, 21, "GENE"]]}], ["Recent 16S ribosomal RNA gene (rRNA) molecular profiling of the stomach mucosa revealed a surprising complexity of microbiota.", {"entities": []}], ["Helicobacter pylori infection and non-steroidal anti-inflammatory drug (NSAID) use are two main contributors to gastritis and peptic ulcer.", {"entities": [[126, 138, "DISEASE"], [112, 121, "DISEASE"]]}], ["However, little is known about the association between other members of the stomach microbiota and gastric diseases.", {"entities": []}], ["In this study, cloning and sequencing of the 16S rRNA was used to profile the stomach microbiota from normal and gastritis patients.", {"entities": [[113, 122, "DISEASE"]]}], ["One hundred and thirty three phylotypes from eight bacterial phyla were identified.", {"entities": []}], ["The stomach microbiota was found to be closely adhered to the mucosa.", {"entities": []}], ["Eleven Streptococcus phylotypes were successfully cultivated from the biopsies.", {"entities": []}], ["One to two genera represented a majority of clones within any of the identified phyla.", {"entities": []}], ["We further developed two real-time quantitative PCR assays to quantify the relative abundance of the Firmicutes phylum and the Streptococcus genus.", {"entities": []}], ["Significantly higher abundance of the Firmicutes phylum and the Streptococcus genus within the Firmicutes phylum was observed in patients with antral gastritis, compared with normal controls.", {"entities": [[150, 159, "DISEASE"]]}], ["This study suggests that the genus taxon level can largely represent much higher taxa such as the phylum.", {"entities": []}], ["The clinical relevance and the mechanism underlying the altered microbiota composition in gastritis require further functional studies.", {"entities": [[90, 99, "DISEASE"]]}], ["It has been reported that waist circumference (WC) is a better predictor of cardiovascular risk factors than body mass index (BMI), although the findings have not been consistent.", {"entities": []}], ["The aim of this study was to assess which measurement, BMI or WC, is more strongly associated with blood pressure, homeostatic model assessment (HOMA) and blood lipids in young Chilean adults.", {"entities": []}], ["999 subjects aged 22 to 28\u2009years were randomly selected from a registry of individuals born between 1974 and 1978 at the Hospital of Limache, Chile.", {"entities": []}], ["Weight, height, WC, blood pressure, HOMA and lipoproteins were assessed in a cross-sectional study.", {"entities": []}], ["In multivariable regressions BMI and WC were associated with blood pressure, HOMA and lipoproteins at similar level of explained variation (R The strength of the associations of WC and BMI for any cardiovascular risk factors was similar, but highest for HOMA and triglycerides.", {"entities": []}], ["WC and BMI are equally useful for monitoring the consequences of obesity in young adults.", {"entities": [[65, 72, "DISEASE"]]}], ["In lung adenocarcinoma, the mutational spectrum is dominated by EGFR and KRAS mutations.", {"entities": [[8, 22, "DISEASE"], [3, 22, "DISEASE"], [64, 68, "GENE"]]}], ["Improved knowledge about genomic and transcriptional alterations in and between mutation-defined subgroups may identify genes involved in disease development or progression.", {"entities": []}], ["Genomic profiles from 457 adenocarcinomas, including 113 EGFR -mutated, 134 KRAS -mutated and 210 EGFR and KRAS -wild type tumors (EGFRwt/KRASwt), and gene expression profiles from 914 adenocarcinomas, including 309 EGFR -mutated, 192 KRAS -mutated, and 413 EGFRwt/KRASwt tumors, were assembled from different repositories.", {"entities": [[57, 61, "GENE"], [98, 102, "GENE"], [216, 220, "GENE"], [57, 61, "GENE"], [98, 102, "GENE"], [216, 220, "GENE"], [57, 61, "GENE"], [98, 102, "GENE"], [216, 220, "GENE"]]}], ["Genomic and transcriptional differences between the three mutational groups were analyzed by both supervised and unsupervised methods.", {"entities": []}], ["EGFR -mutated adenocarcinomas displayed a larger number of copy number alterations and recurrent amplifications, a higher fraction of total loss-of-heterozygosity, higher genomic complexity, and a more distinct expression pattern than EGFR -wild type adenocarcinomas.", {"entities": [[0, 4, "GENE"], [235, 239, "GENE"], [0, 4, "GENE"], [235, 239, "GENE"]]}], ["Several of these differences were also consistent when the three mutational groups were stratified by stage, gender and smoking status.", {"entities": []}], ["Specific copy number alterations were associated with mutation status, predominantly including regions of gain with the highest frequency in EGFR -mutated tumors.", {"entities": [[141, 145, "GENE"]]}], ["Differential regions included both large and small regions of gain on 1p, 5q34-q35.3, 7p, 7q11.21, 12p12.1, 16p, and 21q, and losses on 6q16.3-q21, 8p, and 9p, with 20-40% frequency differences between the mutational groups.", {"entities": []}], ["Supervised gene expression analyses identified 96 consistently differentially expressed genes between the mutational groups, and together with unsupervised analyses these analyses highlighted the difficulty in broadly resolving the three mutational groups into distinct transcriptional entities.", {"entities": []}], ["We provide a comprehensive overview of the genomic and transcriptional landscape in lung adenocarcinoma stratified by EGFR and KRAS mutations.", {"entities": [[89, 103, "DISEASE"], [84, 103, "DISEASE"], [118, 122, "GENE"]]}], ["Our analyses suggest that the overall genomic and transcriptional landscape of lung adenocarcinoma is affected, but only to a minor extent, by EGFR and KRAS mutation status.", {"entities": [[84, 98, "DISEASE"], [79, 98, "DISEASE"], [143, 147, "GENE"]]}], ["Acne is a very common skin condition during adolescence and adulthood.", {"entities": [[0, 4, "DISEASE"]]}], ["Patients with uterovaginal agenesis (Mayer-Rokitansky-K\u00fcster-Hauser syndrome, MRKH) treated at the T\u00fcbingen University Center for Rare Female Genital Malformations, however, clinically appeared to be less frequently affected by acne.", {"entities": [[228, 232, "DISEASE"], [68, 76, "DISEASE"]]}], ["The etiology of MRKH syndrome remains unknown.", {"entities": [[21, 29, "DISEASE"]]}], ["The only known MRKH-associated mutations are located within the WNT4 gene and lead to an atypical form of MRKH syndrome associated with clinical and biochemical hyperandrogenism.", {"entities": [[161, 177, "DISEASE"], [111, 119, "DISEASE"], [64, 68, "GENE"]]}], ["Our study aimed to assess the frequency, severity, and self-evaluation of acne in MRKH patients and to correlate the clinical findings with hormone analyses.", {"entities": [[74, 78, "DISEASE"]]}], ["As part of a cross-sectional longterm follow-up study after laparoscopic assisted creation of a neovagina a questionnaire was sent to 149 MRKH patients aged 16\u201344\u00a0years comprising 26 items concerning prevalence and self-evaluation of acne, and the effects of acne on quality of life.", {"entities": [[234, 238, "DISEASE"], [259, 263, "DISEASE"]]}], ["The questionnaire was derived from one used in a former epidemiological study of acne in 4,000 women.", {"entities": [[81, 85, "DISEASE"]]}], ["Blood for hormone analyses was collected routinely during the clinical visit.", {"entities": []}], ["Fully completed, evaluable questionnaires were returned by 69/149 (46%) women.", {"entities": []}], ["Of these respondents, 42 (60.1%) showed hyperandrogenemia without other clinical signs of virilization but only 17 (24.6%) reported acne (8 (11.6%) had physiological acne and 9 (13.0%) clinical acne) and only 10 (14.5%) reported receiving medical treatment for their acne.", {"entities": [[132, 136, "DISEASE"], [166, 170, "DISEASE"], [194, 198, "DISEASE"], [267, 271, "DISEASE"]]}], ["Effects of acne on quality of life were minor.", {"entities": [[11, 15, "DISEASE"]]}], ["Only 4 patients (5.8%) with PCOS were identified, among them one with physiological acne, the other three within the acne-free group.", {"entities": [[84, 88, "DISEASE"], [117, 121, "DISEASE"]]}], ["Although hyperandrogenemia is common, acne is significantly less frequent in women with MRKH than reported in the literature for non-MRKH women, and is seldom treated medically.", {"entities": [[38, 42, "DISEASE"]]}], ["Patients in this study appeared resistant to acne to some extent, possibly due to the sebaceous glands in the acne regions being less sensitive to androgens compared to the normal population.", {"entities": [[45, 49, "DISEASE"], [110, 114, "DISEASE"]]}], ["A WNT4 mutation is unlikely to be the main cause of MRKH syndrome in our hyperandrogenemic patients.", {"entities": [[57, 65, "DISEASE"], [2, 6, "GENE"]]}], ["Vascular endothelial growth factor (VEGF) is a key mediator of angiogenesis and critical for normal embryonic development and repair of pathophysiological conditions in adults.", {"entities": []}], ["Although phospholipase D (PLD) activity has been implicated in angiogenic processes, its role in VEGF signaling during angiogenesis in mammals is unclear.", {"entities": []}], ["Here, we found that silencing of PLD2 by siRNA blocked VEGF-mediated signaling in immortalized human umbilical vein endothelial cells (iHUVECs).", {"entities": [[33, 37, "GENE"]]}], ["Also, VEGF-induced endothelial cell survival, proliferation, migration, and tube formation were inhibited by PLD2 silencing.", {"entities": [[109, 113, "GENE"]]}], ["Furthermore, while Pld2 -knockout mice exhibited normal development, loss of PLD2 inhibited VEGF-mediated ex vivo angiogenesis.", {"entities": [[19, 23, "GENE"], [77, 81, "GENE"], [19, 23, "GENE"], [77, 81, "GENE"]]}], ["These findings suggest that PLD2 functions as a key mediator in the VEGF-mediated angiogenic functions of endothelial cells.", {"entities": [[28, 32, "GENE"]]}], ["[BMB Reports 2016; 49(3): 191-196]", {"entities": []}], ["Data on determinants of long-term disease progression in HIV-infected patients on antiretroviral therapy (ART) are limited in low and middle-income settings.", {"entities": []}], ["Effects of current CD4 count, viral load and haemoglobin and diagnosis of AIDS-defining events (ADEs) after start of combination ART (cART) on death and new ADEs were assessed using Poisson regression, in patient aged \u226518 years within a multi-centre cohort in Thailand.", {"entities": [[19, 22, "GENE"]]}], ["Among 1,572 patients, median follow-up from cART initiation was 4.4 (IQR 3.6\u20136.3) years.", {"entities": []}], ["The analysis of death was based on 60 events during 6,573 person-years; 30/50 (60%) deaths with underlying cause ascertained were attributable to infections.", {"entities": []}], ["Analysis of new ADE included 192 events during 5,865 person-years; TB and Pneumocystis jiroveci pneumonia were the most commonly presented first new ADE (35% and 20% of cases, respectively).", {"entities": [[96, 105, "DISEASE"]]}], ["In multivariable analyses, low current CD4 count after starting cART was the strongest predictor of death and of new ADE.", {"entities": [[39, 42, "GENE"]]}], ["Even at CD4 above 200 cells/mm Patients with low CD4 count or haemoglobin require more intensive diagnostic and treatment of underlying causes.", {"entities": [[8, 11, "GENE"], [49, 52, "GENE"], [8, 11, "GENE"], [49, 52, "GENE"]]}], ["Maintaining CD4\u2265500 cells/mm", {"entities": []}], ["We investigated the consequences of feeding with a Lactobacillus species on the immune environment in GALT, and the role of dendritic cells and heme oxygenase-1 in mediating these responses.", {"entities": []}], ["Feeding with a specific strain of Lactobacillus rhamnosus induced a significant increase in CD4+CD25+Foxp3+ functional regulatory T cells in GALT.", {"entities": []}], ["This increase was greatest in the mesenteric lymph nodes and associated with a marked decrease in TNF and IFN\u03b3 production.", {"entities": [[98, 101, "GENE"]]}], ["Dendritic cell regulatory function and HO-1 expression was also increased.", {"entities": []}], ["The increase in Foxp3+ T cells could be prevented by treatment with a heme oxygenase inhibitor.", {"entities": []}], ["However, neither inhibition of heme oxygenase nor blockade of IL-10 and TGF\u03b2 prevented the inhibition of inflammatory cytokine production.", {"entities": []}], ["In conclusion Lactobacillus feeding induced a tolerogenic environment in GALT.", {"entities": []}], ["HO-1 was critical to the enhancement of Foxp3+ regulatory T cells while additional, as yet unknown, pathways were involved in the down-regulation of inflammatory cytokine production by T cells.", {"entities": []}], ["Asthma remains a serious global health challenge.", {"entities": [[0, 6, "DISEASE"]]}], ["Poor control of asthma symptoms is due in part to incorrect use of oral inhaler devices that deliver asthma medications, such as poor inhalation technique or use of a metered dose inhaler (MDI) after the recommended number of doses is expelled.", {"entities": [[16, 22, "DISEASE"], [101, 107, "DISEASE"]]}], ["To review published research on the potential for patients to overestimate or underestimate the amount of asthma rescue medication in MDIs without integrated dose-counting mechanisms.", {"entities": [[106, 112, "DISEASE"]]}], ["We searched PubMed and EMBASE using search terms \u201cdose counter and asthma\u201d and \u201cdose counter and metered dose inhaler\u201d for English language publications up to July, 2012, with a manual search of references from relevant articles.", {"entities": [[67, 73, "DISEASE"]]}], ["Up to 40% of patients believe they are taking their asthma medication when they actually are activating an empty or nearly empty MDI.", {"entities": [[52, 58, "DISEASE"]]}], ["Device design makes it impossible for an MDI to cease delivering drug doses at an exact point, and the number of actuations in an MDI may be twice the nominal number of recommended medication doses.", {"entities": []}], ["Once the recommended number of medication doses is expelled, remaining actuations deliver decreasing concentrations of active medication and increasing concentrations of propellants and excipients.", {"entities": []}], ["This phenomenon, called \u201ctail-off,\u201d is particularly problematic when medications are formulated as suspensions, as are rescue medications to control acute bronchospasm.", {"entities": []}], ["Reliable inhalation of rescue medication could reduce asthma-related morbidity.", {"entities": [[54, 60, "DISEASE"]]}], ["By helping to ensure that patients receive accurate metered doses of asthma rescue medication to relieve bronchoconstriction, dose counters may help to improve asthma management.", {"entities": [[69, 75, "DISEASE"], [160, 166, "DISEASE"]]}], ["Exposure to air pollution resulting from fossil fuel combustion has been linked to multiple short-term and long term health effects.", {"entities": []}], ["In a previous study, exposure of lung epithelial cells to engine exhaust from heavy fuel oil (HFO) and diesel fuel (DF), two of the main fuels used in marine engines, led to an increased regulation of several pathways associated with adverse cellular effects, including pro-inflammatory pathways.", {"entities": []}], ["In addition, DF exhaust exposure was shown to have a wider response on multiple cellular regulatory levels compared to HFO emissions, suggesting a potentially higher toxicity of DF emissions over HFO.", {"entities": []}], ["In order to further understand these effects, as well as to validate these findings in another cell line, we investigated macrophages under the same conditions as a more inflammation-relevant model.", {"entities": []}], ["An air-liquid interface aerosol exposure system was used to provide a more biologically relevant exposure system compared to submerged experiments, with cells exposed to either the complete aerosol (particle and gas phase), or the gas phase only (with particles filtered out).", {"entities": []}], ["Data from cytotoxicity assays were integrated with metabolomics and proteomics analyses, including stable isotope-assisted metabolomics, in order to uncover pathways affected by combustion aerosol exposure in macrophages.", {"entities": []}], ["Through this approach, we determined differing phenotypic effects associated with the different components of aerosol.", {"entities": []}], ["The particle phase of diluted combustion aerosols was found to induce increased cell death in macrophages, while the gas phase was found more to affect the metabolic profile.", {"entities": []}], ["In particular, a higher cytotoxicity of DF aerosol emission was observed in relation to the HFO aerosol.", {"entities": []}], ["Furthermore, macrophage exposure to the gas phase of HFO leads to an induction of a pro-inflammatory metabolic and proteomic phenotype.", {"entities": []}], ["These results validate the effects found in lung epithelial cells, confirming the role of inflammation and cellular stress in the response to combustion aerosols.", {"entities": []}], ["Objective : although numerous studies have reported the association between birth season and sex ratio, few studies have been conducted in subtropical regions in a non-Western setting.", {"entities": []}], ["The present study assessed the effects of pregnancy season on birth sex ratio in China.", {"entities": []}], ["Methods : We conducted a national population-based retrospective study from 2006\u20132008 with 3175 children-parents pairs enrolled in the Northeast regions of China.", {"entities": []}], ["Demographics and data relating to pregnancy and birth were collected and analyzed.", {"entities": []}], ["A multiple logistical regression model was fitted to estimate the regression coefficient and 95% confidence interval (CI) of refractive error for mother pregnancy season, adjusting for potential confounders.", {"entities": [[125, 141, "DISEASE"]]}], ["Results : After adjusting for parental age (cut-off point was 30 years), region, nationality, mother education level, and mother miscarriage history, there is a significant statistical different mother pregnancy season on birth-sex.", {"entities": []}], ["Compared with mothers who were pregnant in spring, those pregnant in summer or winter had a high probability of delivering girls ( p < 0.05).", {"entities": []}], ["The birth-sex ratio varied with months.", {"entities": []}], ["Conclusions : Our results suggested that mothers pregnant in summer and winter were more likely to deliver girls, compared with those pregnant in spring.", {"entities": []}], ["Pregnancy season may play an important role in the birth-sex.", {"entities": []}], ["We previously observed greater ozone-induced lung function decrements in obese than non-obese women.", {"entities": []}], ["Animal models suggest that obesity enhances ozone-induced airway reactivity and inflammation.", {"entities": [[27, 34, "DISEASE"]]}], ["In a controlled exposure study, we compared the acute effect of randomized 0.4ppm ozone and air exposures (2 h with intermittent light exercise) in obese (N = 20) (30<BMI<40Kg/m2) vs. non-obese (N = 20) (BMI<25Kg/m2) non-smoking 18\u201335 year old women.", {"entities": []}], ["We measured spirometry and bronchial reactivity to inhaled methacholine (3h post-exposure).", {"entities": []}], ["Inflammation and obesity markers were assessed in the blood (pre, 4h post, and 20h post exposures) and induced-sputum (4h post-exposures and on 24h pre-exposure training day, no exercise): measures of C reactive protein (CRP) (blood only), leptin (blood only), adiponectin, interleukins IL-6, IL-1b, and IL-8, and tumor necrosis factor alpha, and sputum cell differential cell counts.", {"entities": [[17, 24, "DISEASE"], [221, 224, "GENE"]]}], ["The pre- to post-exposure decrease in forced vital capacity after ozone (adjusted for the change after air exposure) was significantly greater in the obese group (12.5+/-7.5 vs. 8.0+/-5.8%, p<0.05).", {"entities": []}], ["Post ozone exposure, 6 obese and 6 non-obese subjects responded to methacholine at \u2264 10mg/ml (the maximum dose); the degree of hyperresponsiveness was similar for the two groups.", {"entities": []}], ["Both BMI groups showed similar and significant ozone-induced increases in sputum neutrophils.", {"entities": []}], ["Plasma IL-6 was increased by exercise (4 hr post air exposure vs. pre) only in the obese but returned to pre-air exposure levels at 20hr post-exposure.", {"entities": [[41, 43, "GENE"]]}], ["Plasma IL-6 was significantly increased at 4hr post ozone exposure in both groups and returned to pre-exposure levels by 20h post-exposure.", {"entities": []}], ["These results confirm our previous findings of greater post-ozone spirometric decrements in obese young women.", {"entities": []}], ["However, acute ozone-induced airway reactivity to methacholine and airway inflammation did not differ by obesity at the exposure and exercise levels used.", {"entities": [[105, 112, "DISEASE"]]}], ["Khellin and visnagin are two furanochromones that can be frequently found in ethnomedical formulations in Asia and the Middle East.", {"entities": []}], ["Both compounds possess anti-inflammatory and analgesic properties, therefore modern medicine uses these compounds or structurally related derivatives for treatment of vitiligo, bronchial asthma and renal colics.", {"entities": [[167, 175, "DISEASE"], [187, 193, "DISEASE"]]}], ["Despite their frequent usage, the potential toxic properties of visnagin and khellin are not well characterized up-to-now.", {"entities": []}], ["Many natural compounds modulate the expression and activity of cytochrome P450 1A1 (CYP1A1), which is well-known to bioactivate pro-carcinogens.", {"entities": [[84, 90, "GENE"]]}], ["The expression of this enzyme is controlled by the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor and regulator of drug metabolism.", {"entities": [[78, 81, "GENE"]]}], ["Here, we investigated the influence of both furanochromones on AHR signaling in human HepG2 hepatocarcinoma cells and primary human hepatocytes.", {"entities": [[63, 66, "GENE"]]}], ["Both compounds transactivated xenobiotic response element (XRE)-driven reporter gene activity in a dose-dependent manner and induced CYP1A1 transcription in HepG2 cells and primary hepatocytes.", {"entities": [[133, 139, "GENE"]]}], ["The latter was abolished in presence of a specific AHR antagonist.", {"entities": [[51, 54, "GENE"]]}], ["CYP1A enzyme activity assays done in HepG2 cells and primary hepatocytes revealed an inhibition of enzyme activity by both furanochromones, which may become relevant regarding the metabolism of xenobiotics and co-administered therapeutic drugs.", {"entities": []}], ["The observed induction of several other members of the AHR gene battery, whose gene products are involved in regulation of cell growth, differentiation and migration, indicates that a further toxicological characterization of visnagin and khelllin is urgently required in order to minimize potential drug-drug interactions and other toxic side-effects that may occur during therapeutic usage of these furanochromones.", {"entities": [[55, 58, "GENE"]]}], ["Maintenance of fluid homeostasis is critical to establishing and maintaining normal physiology.", {"entities": []}], ["The landmark discovery of membrane water channels (aquaporins; AQPs) ushered in a new area in osmoregulatory biology that has drawn from and contributed to diverse branches of biology, from molecular biology and genomics to systems biology and evolution, and from microbial and plant biology to animal and translational physiology.", {"entities": []}], ["As a result, the study of AQPs provides a unique and integrated backdrop for exploring the relationships between genes and genome systems, the regulation of gene expression, and the physiologic consequences of genetic variation.", {"entities": []}], ["The wide species distribution of AQP family members and the evolutionary conservation of the family indicate that the control of membrane water flux is a critical biological process.", {"entities": []}], ["AQP function and regulation is proving to be central to many of the pathways involved in individual physiologic systems in both mammals and anurans.", {"entities": []}], ["In mammals, AQPs are essential to normal secretory and absorptive functions of the eye, lung, salivary gland, sweat glands, gastrointestinal tract, and kidney.", {"entities": []}], ["In urinary, respiratory, and gastrointestinal systems, AQPs are required for proper urine concentration, fluid reabsorption, and glandular secretions.", {"entities": []}], ["In anurans, AQPs are important in mediating physiologic responses to changes in the external environment, including those that occur during metamorphosis and adaptation from an aquatic to terrestrial environment and thermal acclimation in anticipation of freezing.", {"entities": []}], ["Therefore, an understanding of AQP function and regulation is an important aspect of an integrated approach to basic biological research.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal fibrotic lung disease characterized by profound changes in stem cell differentiation, epithelial cell phenotypes and fibroblast proliferation.", {"entities": [[11, 29, "DISEASE"], [81, 93, "DISEASE"]]}], ["In our study, we found that miR-497-5p was significantly upregulated both during myofibroblast differentiation of lung resident mesenchymal stem cells (LR-MSCs) and in the lung tissues of a pulmonary fibrosis model.", {"entities": [[190, 208, "DISEASE"]]}], ["In addition, as determined by luciferase assays and Western blot analysis, reversion-inducing cysteine-rich protein with kazal motifs ( Reck ) was identified to be one of the target genes of miR-497-5p, and Reck could suppress the expression of matrix metalloproteinase-2 (Mmp2) and Mmp9, which could activate latent transforming growth factor-\u03b21 (TGF-\u03b21).", {"entities": [[273, 277, "GENE"], [283, 287, "GENE"]]}], ["To test the potential therapeutic significance of this miRNA, we modulated the expression of miR-497-5p in LR-MSCs and relevant animal models.", {"entities": []}], ["The results demonstrated that upregulation of miR-497-5p could induce LR-MSCs to differentiate into myofibroblasts and promote pulmonary fibrogenesis, while inhibition of its expression could effectively retard these processes.", {"entities": []}], ["In conclusion, our work supports that controlling pulmonary fibrogenesis via inhibition of miR-497-5p expression may provide a potential therapeutic strategy for IPF.", {"entities": []}], ["We surveyed two general population samples aged 8 to 64 living in the unpolluted, rural area of the Po Delta (northern Italy) (n = 3289) and in the urban area of Pisa (central Italy) (n = 2917).", {"entities": []}], ["Each subject filled out a standardized interviewer-administered questionnaire.", {"entities": []}], ["The Pisa sample was divided into three groups according to their residence in the urban-suburban areas and to outdoor air pollution exposure (automobile exhaust only or industrial fumes as well).", {"entities": []}], ["Significantly higher prevalence rates of all the respiratory symptoms and diseases were found in Pisa compared with the Po Delta.", {"entities": []}], ["In particular, rhinitis and wheezing symptoms were higher in all the three urban zones; chronic cough and phlegm were higher in the zone with the automobile exhaust and the additional industrial exposure.", {"entities": [[15, 23, "DISEASE"]]}], ["Current smoking was more frequent in the rural area, but the urban smokers had a higher lifetime cigarette consumption.", {"entities": []}], ["Childhood respiratory trouble and recurrent respiratory illnesses were evenly distributed.", {"entities": []}], ["Exposure to parental smoking in childhood and lower educational level were more frequent in Po Delta, whereas familial history of respiratory/allergic disorders and work and indoor exposures were more often reported in the city.", {"entities": []}], ["Multiple logistic regression models estimating independently the role of the various risk factors showed significant odds ratios associated with residence in Pisa for all the symptoms but chronic phlegm.", {"entities": []}], ["For example, those living in the urban-industrial zone had an odds ratio of 4.0 (4.3-3.7) for rhinitis and 2.8 (3.0-2.6) for wheeze with respect to those living in the Po Delta.", {"entities": [[94, 102, "DISEASE"]]}], ["(ABSTRACT TRUNCATED AT 250 WORDS)", {"entities": []}], ["Using a phenome-wide association study (PheWAS) approach, we comprehensively tested genetic variants for association with phenotypes available for 70,061 study participants in the Population Architecture using Genomics and Epidemiology (PAGE) network.", {"entities": []}], ["Our aim was to better characterize the genetic architecture of complex traits and identify novel pleiotropic relationships.", {"entities": []}], ["This PheWAS drew on five population-based studies representing four major racial/ethnic groups (European Americans (EA), African Americans (AA), Hispanics/Mexican-Americans, and Asian/Pacific Islanders) in PAGE, each site with measurements for multiple traits, associated laboratory measures, and intermediate biomarkers.", {"entities": []}], ["A total of 83 single nucleotide polymorphisms (SNPs) identified by genome-wide association studies (GWAS) were genotyped across two or more PAGE study sites.", {"entities": []}], ["Comprehensive tests of association, stratified by race/ethnicity, were performed, encompassing 4,706 phenotypes mapped to 105 phenotype-classes, and association results were compared across study sites.", {"entities": []}], ["A total of 111 PheWAS results had significant associations for two or more PAGE study sites with consistent direction of effect with a significance threshold of p<0.01 for the same racial/ethnic group, SNP, and phenotype-class.", {"entities": []}], ["Among results identified for SNPs previously associated with phenotypes such as lipid traits, type 2 diabetes, and body mass index, 52 replicated previously published genotype\u2013phenotype associations, 26 represented phenotypes closely related to previously known genotype\u2013phenotype associations, and 33 represented potentially novel genotype\u2013phenotype associations with pleiotropic effects.", {"entities": []}], ["The majority of the potentially novel results were for single PheWAS phenotype-classes, for example, for CDKN2A/B rs1333049 (previously associated with type 2 diabetes in EA) a PheWAS association was identified for hemoglobin levels in AA.", {"entities": []}], ["Of note, however, GALNT2 rs2144300 (previously associated with high-density lipoprotein cholesterol levels in EA) had multiple potentially novel PheWAS associations, with hypertension related phenotypes in AA and with serum calcium levels and coronary artery disease phenotypes in EA.", {"entities": [[171, 183, "DISEASE"], [18, 24, "GENE"]]}], ["PheWAS identifies associations for hypothesis generation and exploration of the genetic architecture of complex traits.", {"entities": []}], ["In phenome-wide association studies (PheWAS) all potential genetic variants in a dataset are systematically tested for association with all available phenotypes and traits that have been measured in study participants.", {"entities": []}], ["By investigating the relationship between genetic variation and a diversity of phenotypes, there is the potential for uncovering novel relationships between single nucleotide polymorphisms (SNPs), phenotypes, and networks of interrelated phenotypes.", {"entities": []}], ["PheWAS also can expose pleiotropy, provide novel mechanistic insights, and foster hypothesis generation.", {"entities": []}], ["This approach is complementary to genome-wide association studies (GWAS) that test the association between hundreds of thousands, to over a million, single nucleotide polymorphisms and a single phenotype or limited phenotypic domain.", {"entities": []}], ["The Population Architecture using Genomics and Epidemiology (PAGE) network has measures for a wide array of phenotypes and traits, including prevalent and incident status for clinical conditions and risk factors, as well as clinical parameters and intermediate biomarkers.", {"entities": []}], ["We performed tests of association between a series of genome-wide association study (GWAS)\u2013identified SNPs and a comprehensive range of phenotypes from the PAGE network in a high-throughput manner.", {"entities": []}], ["We replicated a number of previously reported associations, validating the PheWAS approach.", {"entities": []}], ["We also identified novel genotype\u2013phenotype associations possibly representing pleiotropic effects.", {"entities": []}], ["Salivary immunoglobulin A (IgA) serves as a major effector in mucosal immunity by preventing submucosal invasion of pathogens.", {"entities": []}], ["However, the mechanism by which consumption of fermentable fibers increases IgA in saliva was not fully elucidated.", {"entities": []}], ["This study investigated the effects of fructooligosaccharides (FOS) intake and time after feeding on IgA levels in the saliva and cecal digesta and on the concentration of short-chain fatty acids (SCFA) in the cecum in rats.", {"entities": [[63, 66, "GENE"]]}], ["Five-week-old rats were fed a fiber-free diet or a diet with 50 g/kg FOS for zero, one, four, and eight weeks.", {"entities": [[69, 72, "GENE"]]}], ["Ingestion of FOS at one and eight weeks led to a higher IgA flow rate of saliva per weight of submandibular gland tissue ( p < 0.05), which positively correlated with the concentration of SCFA in the cecal digesta ( r s = 0.86, p = 0.0006, n = 12), but showed no correlation with the concentration of IgA in the cecal digesta ( r s = 0.15, p = 0.3, n = 48).", {"entities": [[13, 16, "GENE"]]}], ["These results suggested that ingestion of FOS increased salivary IgA secretion through high levels of SCFA in the large intestine, which was produced by fermentation of FOS.", {"entities": [[42, 45, "GENE"], [169, 172, "GENE"], [42, 45, "GENE"], [169, 172, "GENE"]]}], ["Thus, continuously ingesting FOS for more than one week could increase secretion of salivary IgA.", {"entities": [[29, 32, "GENE"]]}], ["Chikungunya virus (CHIKV) causes endemic or epidemic outbreaks of CHIKV fever, which is a mosquitoe-transmitted viral disease in Africa, India, South-East Asia, and recently Southern Europe.", {"entities": [[0, 11, "DISEASE"]]}], ["Currently, serological diagnostic tests such as hemagglutination inhibition test (HI test), in-house IgM capture enzyme-linked immunosorbent assays (ELISA), and indirect immunofluorescence test were used for diagnosis of chikungunya fever, which are based on whole virus antigens.", {"entities": [[221, 232, "DISEASE"]]}], ["CHIKV E1, and E2 envelope proteins for the CHIKV-specific serodiagnostic reagents for chikungunya fever were expressed in baculovirus expression system.", {"entities": [[86, 97, "DISEASE"]]}], ["The seroreactivity of recombinant CHIKV E1 and E2 envelope proteins were evaluated using sera panels of patients from Laboratoire Marcel Merieux by indirect IgM capture ELISA.", {"entities": []}], ["The recombinant CHIKV E1 and E2 envelope protein showed sensitivity of 77.5% and 90%, respectively.", {"entities": []}], ["The specificities of both CHIKV E1 and E2 envelope proteins were 100%.", {"entities": []}], ["The recombinant CHIKV E1 and E2 envelope proteins could be a useful diagnostic reagent for CHIKV infection.", {"entities": []}], ["Many patients with proportional reductions in FVC and FEV 1 on spirometry show no reduction in TLC.", {"entities": [[54, 57, "GENE"]]}], ["The aim of this study was to evaluate the role that measuring lung volumes and airway resistance plays in the correct classification of patients with a possible restrictive pattern on spirometry.", {"entities": []}], ["This was a prospective study involving adults with reduced FVC and FEV 1 , as well as an FEV 1 /FV(C) ratio within the predicted range.", {"entities": [[67, 70, "GENE"], [89, 92, "GENE"], [67, 70, "GENE"], [89, 92, "GENE"]]}], ["Restrictive lung disease (RLD) was characterized by TLC below the 5th percentile, as determined by plethysmography.", {"entities": [[12, 24, "DISEASE"]]}], ["Obstructive lung disease (OLD) was characterized by high specific airway resistance, significant changes in post-bronchodilator FEV 1 , or an FEF 25-75% < 50% of predicted, together with a high RV/TLC ratio.", {"entities": [[12, 24, "DISEASE"], [128, 131, "GENE"]]}], ["Nonspecific lung disease (NLD) was characterized by TLC within the predicted range and no obstruction.", {"entities": [[12, 24, "DISEASE"]]}], ["Combined lung disease (CLD) was characterized by reduced TLC and findings indicative of airflow obstruction.", {"entities": [[9, 21, "DISEASE"]]}], ["Clinical diagnoses were based on clinical suspicion, a respiratory questionnaire, and the review of tests of interest.", {"entities": []}], ["We included 300 patients in the study, of whom 108 (36%) were diagnosed with RLD.", {"entities": []}], ["In addition, 120 (40%) and 72 (24%) were diagnosed with OLD/CLD and NLD, respectively.", {"entities": []}], ["Among the latter, 24 (33%) were clinically diagnosed with OLD.", {"entities": []}], ["In this sample, 151 patients (50.3%) were obese, and obesity was associated with all patterns of lung disease.", {"entities": [[53, 60, "DISEASE"], [97, 109, "DISEASE"]]}], ["Measuring lung volumes and airway resistance is often necessary in order to provide an appropriate characterization of the pattern of lung disease in patients presenting with a spirometry pattern suggestive of restriction.", {"entities": [[134, 146, "DISEASE"]]}], ["Airflow obstruction is common in such cases.", {"entities": []}], ["Symptoms of an adverse reaction to contrast agents for computed tomography are diverse ranging, and sometimes serious.", {"entities": []}], ["The goal of this study is to create a scoring rule to predict adverse reactions to contrast agents used in computed tomography.", {"entities": []}], ["This was a retrospective cohort study of all adult patients undergoing contrast enhanced CT scan for 7\u2009years.", {"entities": []}], ["The subjects were randomly divided into either a derivation or validation group.", {"entities": []}], ["Baseline data and clinically relevant factors were collected from the electronic chart.", {"entities": []}], ["Primary outcome was any acute adverse reactions to contrast media, observed for during 24\u2009hours after administration.", {"entities": []}], ["All potential candidate predictors were included in a forward stepwise logistic regression model.", {"entities": []}], ["Prediction scores were assigned based on \u03b2 coefficient.", {"entities": []}], ["A receiver operating characteristic (ROC) curve was drawn, and the area under the curve (AUC) and incidence of acute adverse reactions at each point were obtained.", {"entities": []}], ["The same process was performed in the validation group.", {"entities": []}], ["36,472 patients underwent enhanced CT imaging: 20,000 patients in the derivation group and 16,472 in the validation group.", {"entities": []}], ["A total of 409 (2.0%, 95% CI:1.9-2.3) and 347 (2.1%, 95% CI:1.9-2.3) acute adverse reactions were seen in the derivation and validation groups.", {"entities": []}], ["Logistic regression analysis revealed that prior adverse reaction to contrast agents, urticaria, an allergic history to drugs other than contrast agents, contrast agent concentration >70%, age <50\u2009years, and total contrast agent dose >65\u2009g were significant predictors of an acute adverse reaction.", {"entities": [[86, 95, "DISEASE"]]}], ["AUC was 0.70 (95% CI:0.67-0.73) and 0.67 (95% CI:0.64-0.70) in the derivation and validation groups.", {"entities": []}], ["We suggest a prediction model consisting of six predictors for acute adverse reactions to contrast agents used in CT.", {"entities": []}], ["Migraine is one of the most frequent headache diseases and impairs patients\u2019 quality of life.", {"entities": [[0, 8, "DISEASE"]]}], ["Up to now, many randomized studies reported efficacy of prophylactic therapy with medications such as beta-blockers or anti-epileptic drugs.", {"entities": []}], ["Non-medical treatment, like aerobic endurance training, is considered to be an encouraging alternative in migraine prophylaxis.", {"entities": [[106, 114, "DISEASE"]]}], ["However, there is still a lack of prospective, high-quality randomized trials.", {"entities": []}], ["We therefore designed a randomized controlled trial to evaluate the efficacy of aerobic endurance training versus relaxation training in patients with migraine (ARMIG).", {"entities": [[151, 159, "DISEASE"]]}], ["This is a single-center, open-label, prospective, randomized trial.", {"entities": []}], ["Sixty participants with migraine are randomly allocated to either endurance training or a relaxation group.", {"entities": [[24, 32, "DISEASE"]]}], ["After baseline headache diary documentation over at least 4\u2009weeks, participants in the exercise group will start moderate aerobic endurance training under a sport therapist\u2019s supervision at least 3 times a week over a 12-week period.", {"entities": []}], ["The second group will perform Jacobson\u2019s progressive muscle relaxation training guided by a trained relaxation therapist, also at least 3 times a week over a 12-week period.", {"entities": []}], ["Both study arms will train in groups of up to 10 participants.", {"entities": []}], ["More frequent individual training is possible.", {"entities": []}], ["The follow-up period will be 12\u2009weeks after the training period.", {"entities": []}], ["The general state of health, possible state of anxiety or depression, impairments due to the headache disorder, pain-related disabilities, the headache-specific locus of control, and the motor fitness status are measured with standardized questionnaires.", {"entities": []}], ["The study design is adequate to generate meaningful results.", {"entities": []}], ["The trial will be helpful in gaining important data on exercise training for non-medical migraine prophylaxis.", {"entities": [[89, 97, "DISEASE"]]}], ["The trial is registered at ClinicalTrials.gov: NCT01407861.", {"entities": []}], ["The controlled in\u00a0situ delivery of biologics (e.g.", {"entities": []}], ["enzymes, cytokines, antibodies) by engineered bacteria of our microbiome will allow the sustainable production of these complex and expensive drugs locally in the human body, overcoming many of the technical and economical barriers currently associated with the global use of these potent medicines.", {"entities": []}], ["We provide examples showing how engineered bacteria can be effective treatments against multiple pathologies, including autoimmune and inflammatory diseases, metabolic disorders, diabetes, obesity, infectious diseases and cancer, hence contributing to achieve the Global Sustainable Goal 3: ensure healthy lives and promote well\u2010being for all at all ages.", {"entities": [[189, 196, "DISEASE"], [222, 228, "DISEASE"]]}], ["Isoflavones have multiple actions on cell functions.", {"entities": []}], ["The most prominent one is the activation of estrogen receptors.", {"entities": []}], ["Other functions are often overlooked, but are equally important and explain the beneficial health effects of isoflavones.", {"entities": []}], ["Isoflavones are potent dual PPAR\u03b1/\u03b3 agonists and exert anti-inflammatory activity, which may contribute to the prevention of metabolic syndrome, atherosclerosis and various other inflammatory diseases.", {"entities": [[145, 160, "DISEASE"], [135, 143, "DISEASE"]]}], ["Some isoflavones are potent aryl hydrocarbon receptor (AhR) agonists and induce cell cycle arrest, chemoprevention and modulate xenobiotic metabolism.", {"entities": [[55, 58, "GENE"]]}], ["This review discusses effects mediated by the activation of AhR and PPARs and casts a light on the concerted action of isoflavones.", {"entities": [[60, 63, "GENE"]]}], ["Anaphylaxis is a serious, generalized allergic reaction typically triggered by drugs, food, and bee venom, which can be life-threatening.", {"entities": []}], ["Seeds are one of the major food allergens and can cause anaphylaxis as well as systemic hypersensitivity reactions.", {"entities": []}], ["Flaxseed has been widely used crop for numerous purposes, such as in alternative medicine and as a dietary supplement, hypersensitivity to it has rarely been reported.", {"entities": []}], ["A 42-year-old female presenting with facial edema, dyspnea and urticaria after ingested half teaspoon of flaxseed flour 30 minutes previously.", {"entities": [[63, 72, "DISEASE"]]}], ["A skin prick test for heated flaxseed flour extract showed negative responses, but intradermal test showed positivity which suggested an Immunoglobulin E-mediated reaction.", {"entities": []}], ["The patient was instructed to avoid future ingestion of flaxseed.", {"entities": []}], ["The patient had no recurrence of symptoms at 1-year follow-up.", {"entities": []}], ["This is the first case of flaxseed-induced anaphylaxis in Korea, confirmed by an intradermal skin test.", {"entities": []}], ["Rheumatoid arthritis is a chronic inflammatory joint disorder characterised by erosive inflammation of the articular cartilage and by destruction of the synovial joints.", {"entities": [[0, 20, "DISEASE"], [11, 20, "DISEASE"]]}], ["It is regulated by both genetic and environmental factors, and, currently, there is no preventative treatment or cure for this disease.", {"entities": []}], ["Genome-wide association studies have identified \u223c100 new loci associated with rheumatoid arthritis, in addition to the already known locus within the major histocompatibility complex II region.", {"entities": [[78, 98, "DISEASE"], [89, 98, "DISEASE"]]}], ["However, together, these loci account for only a modest fraction of the genetic variance associated with this disease and very little is known about the pathogenic roles of most of the risk loci identified.", {"entities": []}], ["Here, we discuss how rat models of rheumatoid arthritis are being used to detect quantitative trait loci that regulate different arthritic traits by genetic linkage analysis and to positionally clone the underlying causative genes using congenic strains.", {"entities": [[35, 55, "DISEASE"], [46, 55, "DISEASE"]]}], ["By isolating specific loci on a fixed genetic background, congenic strains overcome the challenges of genetic heterogeneity and environmental interactions associated with human studies.", {"entities": []}], ["Most importantly, congenic strains allow functional experimental studies be performed to investigate the pathological consequences of natural genetic polymorphisms, as illustrated by the discovery of several major disease genes that contribute to arthritis in rats.", {"entities": [[247, 256, "DISEASE"]]}], ["We discuss how these advances have provided new biological insights into arthritis in humans.", {"entities": [[73, 82, "DISEASE"]]}], ["Summary: Using experimental models of rheumatoid arthritis, natural genetic polymorphisms associated with arthritis are identified and characterised in rats, bringing in new biological insights into arthritis in humans.", {"entities": [[38, 58, "DISEASE"], [49, 58, "DISEASE"], [106, 115, "DISEASE"], [199, 208, "DISEASE"]]}], ["To investigate the association of Arg16Gly and Gln27Glu polymorphisms of \u03b22-adrenergic receptor gene ( ADRB2 ) with the occurrence of asthma and overweight and the gene's influence on anthropometric, clinic, biochemical and physical fitness variables in children and adolescents.", {"entities": [[134, 140, "DISEASE"], [103, 108, "GENE"]]}], ["Subjects were evaluated for allelic frequencies of the \u03b22-adrenergic receptor gene, height, weight, body mass index (BMI), BMI Z -score, waist circumference (WC), pubertal stage, resting heart rate (HRres), blood pressure (BP), total cholesterol (TC), glucose, insulin, high density lipoprotein (HDL-C), low density lipoprotein (LDL-C), triglyceride (TG), Homeostasis Metabolic Assessment (HOMA2-IR), Quantitative Insulin Sensitivity Check Index (QUICKI) and maximal oxygen uptake (VO 2max ).", {"entities": [[351, 353, "GENE"]]}], ["The participants were divided in four groups: overweight asthmatic ( n =39), overweight non-asthmatic ( n =115), normal weight asthmatic ( n =12), and normal weight non-asthmatic ( n =40).", {"entities": []}], ["Regarding the Gln27Glu polymorphism, higher total cholesterol was observed in usual genotype individuals than in genetic variant carriers ( p =0.04).", {"entities": []}], ["No evidence was found that the evaluated polymorphisms are influencing the physical fitness.", {"entities": []}], ["The Arg16 allele was found more frequently among the normal weight asthmatic group when compared to the normal weight non-asthmatic group ( p =0.02), and the Glu27 allele was more frequently found in the overweight asthmatics group when compared to the normal weight non-asthmatic group ( p =0.03).", {"entities": []}], ["The association of Arg16 allele with the occurrence of asthma and of the Glu27 allele with overweight asthmatic adolescents evidenced the contribution of the \u03b22-adrenergic receptor gene to the development of obesity and asthma.", {"entities": [[208, 215, "DISEASE"], [55, 61, "DISEASE"], [220, 226, "DISEASE"]]}], ["Investigar a associa\u00e7\u00e3o dos polimorfismos Arg16Gly e Gln27Glu do gene receptor \u03b22-adren\u00e9rgico ( ADRB2 ) com a ocorr\u00eancia de asma e sobrepeso, bem como a influ\u00eancia do gene sobre vari\u00e1veis antropom\u00e9tricas, cl\u00ednicas, bioqu\u00edmicas e de aptid\u00e3o f\u00edsica em crian\u00e7as e adolescentes.", {"entities": [[96, 101, "GENE"]]}], ["Os indiv\u00edduos foram avaliados quanto \u00e0 frequ\u00eancia al\u00e9lica do gene ADRB2 , estatura, peso, \u00edndice de massa corporal, IMC-escore Z, circunfer\u00eancia abdominal, est\u00e1gio puberal, frequ\u00eancia card\u00edaca de repouso, press\u00e3o arterial, colesterol total, glicose, insulina, lipoprote\u00edna de alta densidade, lipoprote\u00edna de baixa densidade, triglicer\u00eddeos, Homeostasis Metabolic Assessment (HOMA2-IR), Quantitative Insulin Sensitivity Check Index (QUICKI) e consumo m\u00e1ximo de oxig\u00eanio (VO 2max ).", {"entities": [[66, 71, "GENE"]]}], ["Os participantes foram divididos em quatro grupos: sobrepeso asm\u00e1tico (n=39), sobrepeso n\u00e3o asm\u00e1tico (n=115), peso normal asm\u00e1tico (n=12) e peso normal n\u00e3o asm\u00e1tico (n=40).", {"entities": []}], ["Com rela\u00e7\u00e3o ao polimorfismo Gln27Glu , foi observado maior valor de colesterol total nos indiv\u00edduos do gen\u00f3tipo usual do que naqueles que carregam a variante ( p =0,04).", {"entities": []}], ["N\u00e3o foi encontrada evid\u00eancia de que os polimorfismos avaliados influenciem a aptid\u00e3o f\u00edsica.", {"entities": []}], ["O alelo Arg16 foi encontrado em maior frequ\u00eancia no grupo de peso normal asm\u00e1tico comparado com o grupo de peso normal n\u00e3o asm\u00e1tico ( p =0,02) e o alelo Glu27 foi mais frequentemente encontrado no grupo de sobrepeso asm\u00e1tico comparado com o grupo de peso normal n\u00e3o asm\u00e1tico ( p =0,03).", {"entities": []}], ["A associa\u00e7\u00e3o do alelo Arg16 com a ocorr\u00eancia de asma e a associa\u00e7\u00e3o do alelo Glu27 com adolescentes com sobrepeso asm\u00e1ticos evidenciam a contribui\u00e7\u00e3o do gene ADBR2 para o desenvolvimento da obesidade e da asma.", {"entities": []}], ["The airway epithelium is exposed to alcohol during drinking through direct exhalation of volatized ethanol from the bronchial circulation.", {"entities": []}], ["Alcohol exposure leads to a rapid increase in the cilia beat frequency (CBF) of bronchial epithelial cells followed by a chronic desensitization of cilia stimulatory responses.", {"entities": []}], ["This effect is governed in part by the nitric oxide regulation of cyclic guanosine and adenosine monophosphate-dependent protein kinases (PKG and PKA) and is not fully understood.", {"entities": []}], ["Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is implicated in the pathogenesis of several pulmonary disorders.", {"entities": []}], ["We hypothesized that the inhibition of nitric oxide synthase by ADMA blocks alcohol-stimulated increases in CBF.", {"entities": []}], ["To test this hypothesis, ciliated primary bovine bronchial epithelial cells (BBEC) were preincubated with ADMA (100\u2009 \u00b5 M) and stimulated with 100\u2009mM ethanol.", {"entities": []}], ["CBF was measured and PKA assayed.", {"entities": []}], ["By 1\u2009hr, ethanol activated PKA, resulting in elevated CBF.", {"entities": [[5, 7, "GENE"]]}], ["Both alcohol-induced PKA activation and CBF were inhibited in the presence of ADMA.", {"entities": []}], ["ADMA alone had no effect on PKA activity or CBF.", {"entities": []}], ["Using a mouse model overexpressing the ADMA-degrading enzyme, dimethylarginine dimethylaminohydrolase (DDAH), we examined PKA and CBF in precision-cut mouse lung slices.", {"entities": [[103, 107, "GENE"]]}], ["Alcohol-stimulated increases in lung slice PKA and CBF were temporally enhanced in the DDAH mice versus control mice.", {"entities": [[87, 91, "GENE"]]}], ["The TNF family cytokines BAFF (B-cell activating factor of the TNF family) and APRIL (a proliferation-inducing ligand) are crucial survival factors for B-cell development and activation.", {"entities": [[4, 7, "GENE"], [63, 66, "GENE"], [4, 7, "GENE"], [63, 66, "GENE"]]}], ["B-cell directed treatments have been shown to improve atopic eczema (AE), suggesting the involvement of these cytokines in the pathogenesis of AE.", {"entities": []}], ["We therefore analyzed the expression of these TNF cytokines in AE, seborrheic eczema (SE) and healthy controls (HC).", {"entities": [[46, 49, "GENE"]]}], ["The serum/plasma concentration of BAFF, APRIL and a close TNF member TWEAK (TNF-like weak inducer of apoptosis) was measured by ELISA.", {"entities": [[58, 61, "GENE"], [76, 79, "GENE"]]}], ["The expression of these cytokines and their receptors in skin was analyzed by quantitative RT-PCR and immunofluorescence.", {"entities": []}], ["Unlike other inflammatory diseases including autoimmune diseases and asthma, the circulating levels of BAFF, APRIL and TWEAK were not elevated in AE or SE patients compared with HCs and did not correlate with the disease severity or systemic IgE levels in AE patients.", {"entities": [[69, 75, "DISEASE"]]}], ["Interestingly, we found that the expression of these cytokines and their receptors was altered in positive atopy patch test reactions in AE patients (APT-AE) and in lesional skin of AE and SE patients.", {"entities": []}], ["The expression of APRIL was decreased and the expression of BAFF was increased in eczema skin of AE and SE, which could contribute to a reduced negative regulatory input on B-cells.", {"entities": []}], ["This was found to be more pronounced in APT-AE, the initiating acute stage of AE, which may result in dysregulation of over-activated B-cells.", {"entities": []}], ["Furthermore, the expression levels of TWEAK and its receptor positively correlated to each other in SE lesions, but inversely correlated in AE lesions.", {"entities": []}], ["These results shed light on potential pathogenic roles of these TNF factors in AE and SE, and pinpoint a potential of tailored treatments towards these factors in AE and SE.", {"entities": [[64, 67, "GENE"]]}], ["Humidex is a meteorological index that combines the impacts of temperature and humidity, and is directly comparable with dry temperature in degrees Celsius.", {"entities": []}], ["However, to date, no research has focused on the effect of humidex on hand, foot and mouth disease (HFMD).", {"entities": [[70, 98, "DISEASE"], [85, 98, "DISEASE"]]}], ["The current study was designed to address this research need.", {"entities": []}], ["Case-based HFMD surveillance data and daily meteorological data collected between 2010 and 2012 was obtained from the China CDC and the National Meteorological Information Center, respectively.", {"entities": []}], ["Distributed lag nonlinear models were applied to assess the impact of humidex on HFMD among children under 15 years oldin Guangdong, and its variability across social-economic status and age groups.", {"entities": []}], ["We found that relative risk ( RR) largely increased with humidex.", {"entities": []}], ["Lag-specific and cumulative humidex- RR curves for children from the Pearl-River Delta Region as well as older children were more likely to show two-peak distribution patterns.", {"entities": []}], ["One RR peak occurred at a humidex of between 15 and 20, and the other occurred between 30 and 35.", {"entities": []}], ["This study provides a comprehensive picture of the impact of humidex on HFMD incidence in Guangdong Province.", {"entities": []}], ["Results from the present study should be important in the development of area-and-age-targeted control programs.", {"entities": []}], ["Mesenchymal stem/stromal cells (MSCs) derived from placental tissue show great therapeutic potential and have been used in medical treatment, but the similarity and differences between the MSCs derived from various parts of the placenta remain unclear.", {"entities": []}], ["In this study, we compared MSCs derived from different perinatal tissues, including the umbilical cord (UC), amniotic membrane (AM), chorionic plate (CP) and decidua parietalis (DP).", {"entities": [[150, 152, "GENE"]]}], ["Using human leukocyte antigen (HLA) typing and karyotype analysis, we found that the first three cell types were derived from the foetus, while the MSCs from the decidua parietalis were derived from the maternal portion of the placental tissue.", {"entities": [[31, 34, "GENE"]]}], ["Our results indicate that both foetal and maternal MSCs share a similar phenotype and multi-lineage differentiation potential, but foetal MSCs show a significantly higher expansion capacity than do maternal MSCs.", {"entities": []}], ["Furthermore, MSCs from all sources showed significant differences in the levels of several paracrine factors.", {"entities": []}], ["In developing countries, mortality and disability from non-communicable diseases (NCDs) is rising considerably.", {"entities": []}], ["The effect of social determinants of NCDs-attributed mortality, from the context of developing countries, is poorly understood.", {"entities": []}], ["This study examines the burden and socio-economic determinants of adult mortality attributed to NCDs in eastern Tigray, Ethiopia.", {"entities": []}], ["We followed 45,982 adults implementing a community based dynamic cohort design recording mortality events from September 2009 to April 2015.", {"entities": []}], ["A physician review based Verbal autopsy was used to identify the most probable causes of death.", {"entities": []}], ["Multivariable Cox proportional hazards regression was performed to identify social determinants of NCD mortality.", {"entities": []}], ["Across the 193,758.7 person-years, we recorded 1,091 adult deaths.", {"entities": []}], ["Compared to communicable diseases, NCDs accounted for a slightly higher proportion of adult deaths; 33% vs 34.5% respectively.", {"entities": []}], ["The incidence density rate (IDR) of NCD attributed mortality was 194.1 deaths (IDR = 194.1; 95% CI = 175.4, 214.7) per 100,000 person-years.", {"entities": []}], ["One hundred fifty-seven (41.8%), 68 (18.1%) and 34 (9%) of the 376 NCD deaths were due to cardiovascular disease, cancer and renal failure, respectively.", {"entities": [[114, 120, "DISEASE"]]}], ["In the multivariable analysis, age per 5-year increase (HR = 1.35; 95% CI: 1.30, 1.41), and extended family and non-family household members (HR = 2.86; 95% CI: 2.05, 3.98) compared to household heads were associated with a significantly increased hazard of NCD mortality.", {"entities": [[56, 58, "GENE"], [142, 144, "GENE"], [56, 58, "GENE"], [142, 144, "GENE"]]}], ["Although the difference was not statistically significant, compared to poor adults, those who were wealthy had a 15% (HR = 0.85; 95% CI: 0.65, 1.11) lower hazard of mortality from NCDs.", {"entities": [[118, 120, "GENE"]]}], ["On the other hand, literate adults (HR = 0.35; 95% CI: 0.13, 0.9) had a significantly decreased hazard of NCD attributed mortality compared to those adults who were unable to read and write.", {"entities": [[36, 38, "GENE"]]}], ["The effect of literacy was modified by age and its effect reduced by 18% for every 5-year increase of age among literate adults.", {"entities": []}], ["In summary, the study indicates that double mortality burden from both NCDs and communicable diseases was evident in northern rural Ethiopia.", {"entities": []}], ["Public health intervention measures that prioritise disadvantaged NCD patients such as those who are unable to read and write, the elders, the extended family and non-family household co-residents could significantly reduce NCD mortality among the adult population.", {"entities": []}], ["Skeletal muscle impairment is a recognized complication of COPD, predicting mortality in severe disease.", {"entities": []}], ["Increasing evidence implicates the renin-angiotensin system in control of muscle phenotype.", {"entities": []}], ["We hypothesized that angiotensin-converting enzyme (ACE) inhibition would improve quadriceps function and exercise performance in COPD.", {"entities": []}], ["This double-blind, randomized placebo-controlled trial investigated the effect of the ACE inhibitor, fosinopril, on quadriceps function in patients with COPD with quadriceps weakness.", {"entities": []}], ["Primary outcomes were change in quadriceps endurance and atrophy signaling at 3 months.", {"entities": []}], ["Quadriceps maximum voluntary contraction (QMVC), mid-thigh CT scan of the cross-sectional area (MTCSA), and incremental shuttle walk distance (ISWD) were secondary outcomes.", {"entities": []}], ["Eighty patients were enrolled (mean [SD], 65 [8] years, FEV 1 43% [21%] predicted, 53% men).", {"entities": [[56, 59, "GENE"]]}], ["Sixty-seven patients (31 fosinopril, 36 placebo) completed the trial.", {"entities": []}], ["The treatment group demonstrated a significant reduction in systolic BP (\u0394\u221210.5 mm Hg; 95% CI, \u221219.9 to \u22121.1; P = .03) and serum ACE activity (\u0394\u221220.4 IU/L; 95% CI, \u221231.0 to \u22129.8; P < .001) compared with placebo.", {"entities": []}], ["No significant between-group differences were observed in the primary end points of quadriceps endurance half-time (\u03940.5 s; 95% CI, \u221213.3-14.3; P = .94) or atrogin-1 messenger RNA expression (\u0394\u22120.03 arbitrary units; 95% CI, \u22120.32-0.26; P = .84).", {"entities": []}], ["QMVC improved in both groups (fosinopril: \u03941.1 kg; 95% CI, 0.03-2.2; P = .045 vs placebo: \u03943.6 kg; 95% CI, 2.1-5.0; P < .0001) with a greater increase in the placebo arm (between-group, P = .009).", {"entities": []}], ["No change was shown in the MTCSA ( P = .09) or ISWD ( P = .51).", {"entities": []}], ["This randomized controlled trial found that ACE inhibition, using fosinopril for 3 months, did not improve quadriceps function or exercise performance in patients with COPD with quadriceps weakness.", {"entities": []}], ["Current Controlled Trials; No.", {"entities": []}], [": ISRCTN05581879; URL: www.controlled-trials.com", {"entities": []}], ["Polycomb group member protein BMI1 is involved in maintaining cell identity, proliferation, differentiation and human oncogenesis.", {"entities": [[30, 34, "GENE"]]}], ["In the present study, we determined BMI1 mRNA expression in whole blood and evaluated the impact of the expression level on the treatment response and survival of 96 advanced NSCLC patients treated with first-line platinum-based chemotherapy.", {"entities": [[36, 40, "GENE"]]}], ["We also determined BMI1 mRNA expression in primary tumors from 22 operable NSCLC patients treated with radical surgery.", {"entities": [[19, 23, "GENE"]]}], ["We found that compared with control subjects, BMI1 mRNA expression in whole blood of advanced NSCLC patients was decreased ( P <0.001).", {"entities": [[46, 50, "GENE"]]}], ["Similarly, we observed decreased BMI1 mRNA expression in primary tumors compared to normal lungs from operable NSCLC patients ( P =0.001).", {"entities": [[33, 37, "GENE"]]}], ["We found high BMI1 mRNA expression in blood was associated with longer progression-free survival (PFS) ( P =0.049) and overall survival (OS) ( P =0.012) in advanced NSCLC patients treated with first-line platinum-based chemotherapy.", {"entities": [[14, 18, "GENE"]]}], ["However, no association between the BMI1 mRNA level and response to chemotherapy was found ( P =0.21).", {"entities": [[36, 40, "GENE"]]}], ["Multivariate Cox proportional hazards regression analysis showed elevated BMI1 mRNA level in whole blood was an independent prognostic factor for longer PFS ( P =0.012) and OS ( P <0.001).", {"entities": [[74, 78, "GENE"]]}], ["In conclusion, BMI1 mRNA expression in whole blood might represent a new biomarker for the diagnosis and prognosis of NSCLC.", {"entities": [[15, 19, "GENE"]]}], ["Prophylactic administration of hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NAs) is the standard treatment for controlling hepatitis B virus (HBV) recurrence after liver transplantation (LT).", {"entities": [[31, 40, "DISEASE"], [141, 150, "DISEASE"], [205, 207, "GENE"]]}], ["Since lifelong use of HBIG is expensive and inconvenient and the antibodies level in anti-hepatitis B surface (HBs) is not sustainable and stable, an alternative strategy is to produce anti-HBs antibodies by active immunization.", {"entities": [[90, 99, "DISEASE"]]}], ["Our present study aimed to prospectively investigate the efficacy and safety of procedural HBV vaccination in transplanted patients.", {"entities": []}], ["Recipients who had undergone LT for hepatitis B related liver diseases more than one year before, with no evidence of HBV recurrence or rejection and normal liver function were enrolled.", {"entities": [[36, 45, "DISEASE"], [29, 31, "GENE"]]}], ["All subjects received the hepatitis B vaccine (40 \u03bcg) by intramuscular injection at months 0, 1, 2, 6 and 12 after enrollment with continuous administration of NAs.", {"entities": [[26, 35, "DISEASE"]]}], ["The liver function and anti-HBs titers were measured before each vaccination and HBIG (400U) was administrated intramuscularly when anti-HBs titer was lower than 30 IU/L during the course.", {"entities": []}], ["The results of routine blood tests, liver function, concentration of immunosuppressant, and HBV-DNA copies were monitored during the research.", {"entities": []}], ["After completion of the vaccination procedure, recipients were regarded as responders if their anti-HBs greater than 30 IU/L were maintained for up to six months without using HBIG and vaccine.", {"entities": []}], ["Twenty-seven patients were enrolled in this study and the average anti-HBs titer before vaccination was 19.86\u00b114.80 IU/L.", {"entities": []}], ["The average anti-HBs titer of the nine responders at the end of the follow-up was 57.14\u00b122.75 IU/L, giving an overall response rate of 33.3% (9/27).", {"entities": []}], ["There were no reports of reactivation of HBV, rejection, severe anaphylaxis or other adverse events.", {"entities": []}], ["Responders and non-responders showed their significant difference in anti-HBs titers after the fourth vaccination (P<0.01).", {"entities": []}], ["Moreover, the majority of non-responders (11/18, 63.64%) had high LY/EO rates (lymphocyte number/eosinophil number>15) while most responders (8/9, 88.89%) had low LY/EO rates at the beginning of vaccination (P = 0.019).", {"entities": []}], ["Active immunization is an effective, cost-saving, and safe method for the prevention of HBV reactivation in patients transplanted for hepatitis B virus related liver diseases.", {"entities": [[134, 143, "DISEASE"]]}], ["The LY/EO rate may be a valuable indicator in selecting potential recipients for vaccination.", {"entities": []}], ["The role of proteases in viral infection of the lung is poorly understood.", {"entities": []}], ["Thus, we examined MMP and cathepsin proteases in respiratory syncytial virus (RSV) infected mouse lungs.", {"entities": []}], ["RSV induced gene expression for matrix metalloproteinases (MMP) -2, -3, -7, -8, -9, -10, -12, -13, -14, -16, -17, -19, -20, -25, -27, -28 and cathepsins B, C, E, G, H, K, L1, S, W and Z in the airways of FVB/NJ mice.", {"entities": []}], ["Increased proteases were present in the bronchoalveolar lavage fluid (BALF) and lung tissue during infection.", {"entities": []}], ["Mitochondrial antiviral-signaling protein ( Mavs ) and Trif deficient mice were exposed to RSV.", {"entities": [[44, 48, "GENE"]]}], ["Mavs deficient mice had significantly lower expression of airway MMP-2, -3, -7, -8, -9, -10, -12, -13 and -28 and cathepsins C, G, K, S, W and Z.", {"entities": [[0, 4, "GENE"]]}], ["In lung epithelial cells, retinoic acid\u2013inducible gene-1 (RIG-I) was identified as the major RIG-I- like receptor (RLR) required for RSV induced protease expression via MAVS.", {"entities": [[169, 173, "GENE"]]}], ["Overexpression of RIG-I or treatment with IFN-\u03b2 in these cells induced MMP and cathepsin gene and protein expression.", {"entities": []}], ["The significance of RIG-1 protease induction was demonstrated by the fact that inhibiting proteases with batimastat, E64 or ribavirin prevented airway hyperresponsiveness and enhanced viral clearance in RSV infected mice.", {"entities": []}], ["Adenoid hypertrophy (AH) is associated with pediatric chronic rhinosinusitis (pCRS), but its role in the inflammatory process of pCRS is unclear.", {"entities": []}], ["It is thought that innate immunity gene expression is disrupted in the epithelium of patients with chronic rhinosinusitis (CRS), including antimicrobial peptides and pattern recognition receptors (PRRs).", {"entities": []}], ["The aim of this preliminary study was to detect the expression of innate immunity genes in epithelial cells of hypertrophic adenoids with and without pCRS to better understand their role in pCRS.", {"entities": []}], ["Nine pCRS patients and nine simple AH patients undergoing adenoidectomy were recruited for the study.", {"entities": []}], ["Adenoidal epithelium was isolated, and real-time quantitative polymerase chain reaction (RT-qPCR) was employed to measure relative expression levels of the following messenger RNAs in hypertrophic adenoid epithelial cells of pediatric patients with and without CRS: Human \u03b2-defensin (HBD) 2 and 3, surfactant protein (SP)-A and D, toll-like receptors 1\u201310, nucleotide-binding oligomerization domain (NOD)-like receptors NOD 1, NOD 2, and NACHT, LRR and PYD domains-containing protein 3, retinoic acid-induced gene 1, melanoma differentiation-associated gene 5, and nuclear factor-\u03baB (NF-\u03baB).", {"entities": [[517, 525, "DISEASE"], [284, 287, "GENE"]]}], ["RT-qPCR data from two groups were analyzed by independent sample t -tests and Mann-Whitney U -tests.", {"entities": []}], ["The relative expression of SP-D in adenoidal epithelium of pCRS group was significantly lower than that in AH group (pCRS 0.73 \u00b1 0.10 vs. AH 1.21 \u00b1 0.15; P = 0.0173, t = 2.654).", {"entities": []}], ["The relative expression levels of all tested PRRs and NF-\u03baB, as well as HBD-2, HBD-3, and SP-A, showed no statistically significant differences in isolated adenoidal epithelium between pCRS group and AH group.", {"entities": []}], ["Down-regulated SP-D levels in adenoidal epithelium may contribute to the development of pCRS.", {"entities": []}], ["PRRs, however, are unlikely to play a significant role in the inflammatory process of pCRS.", {"entities": []}], ["Thrombospondin 1 (TSP1)-producing B cells are an important immune regulatory cell fraction in the body, which are compromised in a number of immune diseases.", {"entities": []}], ["miRs are involved in the immune regulation.", {"entities": []}], ["The present study aims to elucidate the mechanism by which miR-98 interferes with the expression of TSP1 in B cells of the peripheral blood system.", {"entities": [[59, 65, "GENE"]]}], ["In the present study, peripheral blood samples were collected from patients with allergic asthma.", {"entities": [[81, 96, "DISEASE"], [90, 96, "DISEASE"]]}], ["The B cells were isolated from the blood samples to be analyzed for the expression of miR-98 and TSP1.", {"entities": [[86, 92, "GENE"]]}], ["The results showed that the levels of miR-98 were higher, the levels of TSP1 were lower, in B cells isolated from the peripheral blood in patients with asthma.", {"entities": [[152, 158, "DISEASE"], [38, 44, "GENE"]]}], ["A negative correlation was identified between the data of miR-98 and TSP1 in B cells.", {"entities": [[58, 64, "GENE"]]}], ["Exposure to T helper (Th) 2 (Th2) cytokine, interleukin (IL)-13, increased the expression of miR-98 and suppressed the expression of TSP1 in peripheral B cells, which was abolished by knocking down the miR-98 gene.", {"entities": [[93, 99, "GENE"], [202, 208, "GENE"], [93, 99, "GENE"], [202, 208, "GENE"]]}], ["In conclusion, miR-98 can suppress the expression of TSP1 in the peripheral B cells of patients with allergic asthma.", {"entities": [[101, 116, "DISEASE"], [110, 116, "DISEASE"], [15, 21, "GENE"]]}], ["Total laryngectomy (TL) is an appropriate oncologic operation for many patients with laryngeal cancer delivering excellent oncologic outcomes, however it remains beset with significant functional consequences.", {"entities": [[95, 101, "DISEASE"]]}], ["Following TL, the upper and lower airways are permanently disconnected, which causes unfiltered, cold air with reduced humidity to enter the tracheobronchial tree, resulting in mucus overproduction and an increase in the viscosity of the mucus.", {"entities": []}], ["In response to this, Heat and moisture exchangers were developed to compensate for the lost functions of the upper respiratory tract and their effect on the patients\u2019 respiratory performance in addition to their quality of life.", {"entities": []}], ["The case records of 48 patients undergoing total laryngectomy were reviewed and data concerning demographics, surgical details, post-operative care requirements and adverse events was retrieved.", {"entities": []}], ["Post hoc analysis of the case patients was undertaken to identify any benefit of using a heat and moisture exchanger (HME) system with particular reference to post-operative respiratory outcomes.", {"entities": []}], ["There was no significant difference between case and control subjects based on demographics, extent of surgery or need for flap repair.", {"entities": []}], ["16 patients had used a HME and 32 patients had used external humidification (EH).", {"entities": []}], ["Of those experiencing mucous plugging, only 3/24 (12.5\u00a0%) had used a HME system, in contrast to 21/24 (87.5\u00a0%) who used EH (Chi square\u2009=\u20099.375, p \u2009=\u20090.002).", {"entities": []}], ["The odds ratio of having an adverse event if not using HME was 8.27 (CI\u2009=\u20091.94 \u2013 35.71).", {"entities": []}], ["Use of HME also significantly reduced the number of days requiring physiotherapy (1.75\u00a0days vs. 3.20\u00a0days, p \u2009=\u20090.034).", {"entities": []}], ["Use of an HME system can reduce in-hospital complications, in particular episodes of mucus plugging, and post-operative care requirements.", {"entities": []}], ["Furthermore, there is a cost benefit to using HME systems that warrants more widespread introduction of these devices in head and neck surgery centers.", {"entities": []}], ["Several authors have considered the importance of exposure timing and how this affects the outcomes observed, but no one has systematically compiled preconceptional, prenatal, and postnatal developmental exposures and subsequent outcomes.", {"entities": []}], ["Efforts were undertaken to examine the information available and to evaluate implications for risk assessment for several areas: a) respiratory and immune systems, b) reproductive system, c) nervous system, d) cardiovascular system, endocrine system, and general growth, and e) cancer.", {"entities": [[278, 284, "DISEASE"]]}], ["Major conclusions from a workshop on \"Critical Windows of Exposure for Children's Health\" included a) broad windows of sensitivity can be identified for many systems but detailed information is limited; b) cross-species comparisons of dose to target tissue and better data on the exposure-dose-outcome continuum are needed; c) increased interaction among scientific disciplines can further understanding by using laboratory animal results in designing epidemiological studies and human data to suggest specific laboratory studies on mechanisms and agent-target interactions; and d) thus far, only limited attention has been given to peripubertal/adolescent exposures, adult consequences of developmental exposures, and genome-environment interactions.", {"entities": []}], ["More specific information on developmental windows will improve risk assessment by identifying the most sensitive window(s) for evaluation of dose-response relationships and exposure, evaluation of biological plausibility of research findings in humans, and comparison of data across species.", {"entities": []}], ["In public health and risk management, information on critical windows may help identify especially susceptible subgroups for specific interventions.", {"entities": []}], ["In restless legs syndrome (RLS), the isolated involvement of other body parts in the absence of leg involvement is rare.", {"entities": [[17, 25, "DISEASE"]]}], ["We report an 82-year-old male with a 1-year history of Parkinson\u2019s disease (PD) who developed an abnormal sensation limited to his \u201clower back.\u201d He fulfilled the four essential RLS criteria, with the major caveat that the criteria were applied in a modified manner to his lower back rather than his legs.", {"entities": []}], ["The administration of a dopamine agonist completely eliminated his symptoms.", {"entities": []}], ["Our patient\u2019s \u201crestless lower back\u201d may be a variant of RLS.", {"entities": []}], ["Clinicians should pay attention to restlessness in other body parts in addition to the legs.", {"entities": []}], ["As many neglected tropical diseases are co-endemic and have common risk factors, integrated control can efficiently reduce disease burden and relieve resource-strained public health budgets.", {"entities": []}], ["Diarrheal diseases and dengue fever are major global health problems sharing common risk factors in water storage containers.", {"entities": []}], ["Where provision of clean water is inadequate, water storage is crucial.", {"entities": []}], ["Fecal contamination of stored water is a common source of diarrheal illness, but stored water also provides breeding sites for dengue vector mosquitoes.", {"entities": []}], ["Integrating improved water management and educational strategies for both diseases in the school environment can potentially improve the health situation for students and the larger community.", {"entities": []}], ["The objective of this trial was to investigate whether interventions targeting diarrhea and dengue risk factors would significantly reduce absence due to diarrheal disease and dengue entomological risk factors in schools.", {"entities": [[79, 87, "DISEASE"]]}], ["A factorial cluster randomized controlled trial was carried out in 34 rural primary schools (1,301 pupils) in La Mesa and Anapoima municipalities, Cundinamarca, Colombia.", {"entities": []}], ["Schools were randomized to one of four study arms: diarrhea interventions (DIA), dengue interventions (DEN), combined diarrhea and dengue interventions (DIADEN), and control (CON).", {"entities": [[51, 59, "DISEASE"], [118, 126, "DISEASE"]]}], ["Interventions had no apparent effect on pupil school absence due to diarrheal disease (p = 0.45) or on adult female Aedes aegypti density (p = 0.32) (primary outcomes).", {"entities": []}], ["However, the dengue interventions reduced the Breteau Index on average by 78% (p = 0.029), with Breteau indices of 10.8 and 6.2 in the DEN and DIADEN arms, respectively compared to 37.5 and 46.9 in the DIA and CON arms, respectively.", {"entities": []}], ["The diarrhea interventions improved water quality as assessed by the amount of Escherichia coli colony forming units (CFU); the ratio of Williams mean E .", {"entities": [[4, 12, "DISEASE"]]}], ["coli CFU being 0.22, or 78% reduction (p = 0.008).", {"entities": []}], ["Integrated control of dengue and diarrhea has never been conducted before.", {"entities": [[33, 41, "DISEASE"]]}], ["This trial presents an example for application of control strategies that may affect both diseases and the first study to apply such an approach in school settings.", {"entities": []}], ["The interventions were well received and highly appreciated by students and teachers.", {"entities": []}], ["An apparent absence of effect in primary outcome indicators could be the result of pupils being exposed to risk factors outside the school area and mosquitoes flying in from nearby uncontrolled breeding sites.", {"entities": []}], ["Integrated interventions targeting these diseases in a school context remain promising because of the reduced mosquito breeding and improved water quality, as well as educational benefits.", {"entities": []}], ["However, to improve outcomes in future integrated approaches, simultaneous interventions in communities, in addition to schools, should be considered; using appropriate combinations of site-specific, effective, acceptable, and affordable interventions.", {"entities": []}], ["ClinicalTrials.gov no.", {"entities": []}], ["ISRCTN40195031 Many tropical diseases co-occur in the same areas and have overlapping risk factors and strategies for control and prevention.", {"entities": []}], ["Therefore, integrating several diseases in control activities can be both effective and cost-efficient.", {"entities": []}], ["We evaluated sets of diarrhea and dengue interventions in rural primary schools in Colombia to reduce absence due to diarrheal disease among pupils and dengue risk factors.", {"entities": [[21, 29, "DISEASE"]]}], ["Integrating the control of these two diseases is justified because of the potential joint risk factor of water storage behavior.", {"entities": []}], ["Stored drinking water may be contaminated with enteric pathogens and such containers also provide breeding opportunities for dengue vectors.", {"entities": []}], ["Water storage is common in schools in many tropical countries.", {"entities": []}], ["Although the study did not demonstrate clear evidence of a reduction in pupil absence due to diarrhea or reductions of adult mosquito densities in schools, significant reductions were detected in the number of mosquito breeding sites and drinking water quality was significantly improved.", {"entities": [[93, 101, "DISEASE"]]}], ["Integrated disease control interventions in school settings should be further explored to prevent diseases with overlapping etiologies amongst pupils and school staff.", {"entities": []}], ["Rheumatoid arthritis (RA) is a chronic inflammatory and destructive joint disease characterized by overexpression of pro-inflammatory/pro-destructive genes and other activating genes (for example, proto-oncogenes) in the synovial membrane (SM).", {"entities": [[11, 20, "DISEASE"]]}], ["The gene expression in disease is often characterized by significant inter-individual variances via specific synchronization/desynchronization of gene expression.", {"entities": []}], ["To elucidate the contribution of the variance to the pathogenesis of disease, expression variances were tested in SM samples of RA patients, osteoarthritis (OA) patients, and normal controls (NCs).", {"entities": [[141, 155, "DISEASE"]]}], ["Analysis of gene expression in RA, OA, and NC samples was carried out using Affymetrix U133A/B oligonucleotide arrays, and the results were validated by real-time reverse transcription-polymerase chain reaction.", {"entities": []}], ["For the comparison between RA and NC, 568 genes with significantly different variances in the two groups ( P \u2264 0.05; Bonferroni/Holm corrected Brown-Forsythe version of the Levene test) were selected.", {"entities": []}], ["For the comparison between RA and OA, 333 genes were selected.", {"entities": []}], ["By means of the Kyoto Encyclopedia of Genes and Genomes , the pathways/complexes significantly affected by higher gene expression variances were identified in each group.", {"entities": []}], ["Ten pathways/complexes significantly affected by higher gene expression variances were identified in RA compared with NC, including cytokine\u2013cytokine receptor interactions, the transforming growth factor-beta pathway, and anti-apoptosis.", {"entities": []}], ["Compared with OA, three pathways with significantly higher variances were identified in RA (for example, B-cell receptor signaling and vascular endothelial growth factor signaling).", {"entities": []}], ["Functionally, the majority of the identified pathways are involved in the regulation of inflammation, proliferation, cell survival, and angiogenesis.", {"entities": []}], ["In RA, a number of disease-relevant or even disease-specific pathways/complexes are characterized by broad intra-group inter-individual expression variances.", {"entities": []}], ["Thus, RA pathogenesis in different individuals may depend to a lesser extent on common alterations of the expression of specific key genes, and rather on individual-specific alterations of different genes resulting in common disturbances of key pathways.", {"entities": []}], ["Lung deflation and inflation during cardiac surgery with cardiopulmonary bypass contributes to pulmonary dysfunction postoperatively.", {"entities": []}], ["Theophylline treatment for lung diseases has traditionally been thought to act by phosphodiesterase inhibition; however, increasing evidence has suggested other plausible mechanisms.", {"entities": []}], ["We investigated the effects of deflation and reinflation on signaling pathways (p38-mitogen-activated protein kinase [MAPK], extracellular signal-regulated kinase 1 and 2 [ERK1/2], and Akt) and whether theophylline influences the deflation-induced lung injury and associated signaling.", {"entities": []}], ["Isolated rat lungs were perfused (15 mL/min) with deoxygenated rat blood in bicarbonate buffer and ventilated.", {"entities": []}], ["After 20 minutes' equilibration, the lungs were deflated (60 minutes, aerobic perfusion 1.5 mL/min), followed by reinflation (60 minutes, anaerobic reperfusion 15 mL/min).", {"entities": []}], ["Compliance, vascular resistance, and kinase phosphorylation were assessed during deflation and reinflation.", {"entities": []}], ["The effects of SB203580 (50 \u03bcM), a p38-MAPK inhibitor, and theophylline (0.083 mM [therapeutic] or 3 mM [supratherapeutic]) on physiology and signaling were studied.", {"entities": []}], ["Deflation reduced compliance by 44% compared with continuously ventilated lungs.", {"entities": []}], ["p38-MAPK and Akt phosphorylation increased (three to fivefold) during deflation and reinflation, and ERK1/2 phosphorylation increased (approximately twofold) during reinflation.", {"entities": []}], ["SB203580 had no effect on lung physiology or ERK1/2 and Akt activation.", {"entities": []}], ["Both theophylline doses increased cyclic adenosine monophosphate, but only 3 mM theophylline improved compliance.", {"entities": []}], ["p38-MAPK phosphorylation was not affected by theophylline; 0.083 mM theophylline inhibited reinflation-induced ERK1/2 phosphorylation (72% \u00b1 3%); and 3 mM theophylline inhibited Akt phosphorylation during deflation (75% \u00b1 5%) and reinflation (87% \u00b1 4%).", {"entities": []}], ["Lung deflation and reinflation stimulates differential p38-MAPK, ERK1/2, and Akt activation, suggesting a role in lung injury during cardiopulmonary bypass.", {"entities": []}], ["However, p38-MAPK was not involved in the compromised compliance.", {"entities": []}], ["A supratherapeutic theophylline dose protected lungs against deflation-induced injury and was associated with inhibition of phosphoinositide 3-kinase/Akt rather than phosphodiesterase.", {"entities": []}], ["Nephropathia epidemica (NE) is a Scandinavian type of hemorrhagic fever with renal syndrome caused by Puumala hantavirus.", {"entities": [[83, 91, "DISEASE"], [54, 91, "DISEASE"]]}], ["The clinical course of the disease varies greatly in severity.", {"entities": []}], ["The aim of the present study was to evaluate whether plasma C-reactive protein (CRP) and interleukin (IL)-6 levels associate with the severity of NE.", {"entities": [[80, 83, "GENE"]]}], ["A prospectively collected cohort of 118 consecutive hospital-treated patients with acute serologically confirmed NE was examined.", {"entities": []}], ["Plasma IL-6, CRP, and creatinine, as well as blood cell count and daily urinary protein excretion were measured on three consecutive days after admission.", {"entities": [[13, 16, "GENE"]]}], ["Plasma IL-6 and CRP levels higher than the median were considered high.", {"entities": [[16, 19, "GENE"]]}], ["We found that high IL-6 associated with most variables reflecting the severity of the disease.", {"entities": []}], ["When compared to patients with low IL-6, patients with high IL-6 had higher maximum blood leukocyte count (11.9 vs 9.0 \u00d7 10 P = 0.001) and urinary protein excretion (2.51 vs 1.68 g/day, P = 0.017), as well as a lower minimum blood platelet count (55 vs 80 \u00d7 10 P < 0.001), hematocrit (0.34 vs 0.38, P = 0.001), and urinary output (1040 vs 2180 ml/day, P < 0.001).", {"entities": []}], ["They also stayed longer in hospital than patients with low IL-6 (8 vs 6 days, P < 0.001).", {"entities": []}], ["In contrast, high CRP did not associate with severe disease.", {"entities": [[18, 21, "GENE"]]}], ["High plasma IL-6 concentrations associate with a clinically severe acute Puumala hantavirus infection, whereas high plasma CRP as such does not reflect the severity of the disease.", {"entities": [[123, 126, "GENE"]]}], ["Leukocytes must traverse inflamed tissues to effectively control local infection.", {"entities": []}], ["Although motility in dense tissues appears to be integrin-independent actin-myosin based, during inflammation changes to the extracellular matrix (ECM) may necessitate distinct motility requirements.", {"entities": []}], ["Indeed, we found that T cell interstitial motility was critically dependent on RGD-binding integrins in the inflamed dermis.", {"entities": []}], ["Inflammation-induced deposition of fibronectin was functionally linked to increased \u03b1 v integrin expression on effector CD4 v expression.", {"entities": [[120, 123, "GENE"]]}], ["Selective \u03b1 v blockade or knockdown arrested T H 1 motility in the inflamed tissue and attenuated local effector function.", {"entities": []}], ["These data show a context-dependent specificity of lymphocyte movement in inflamed tissues that is essential for protective immunity.", {"entities": []}], ["Between 1991 and 2000, ambient air pollution in East Germany changed to resemble West German pollution levels: The concentration of total suspended particles (TSPs) decreased on a broad scale while traffic increased.", {"entities": []}], ["During that time, we analyzed total lung capacity (TLC) and airway resistance ( R aw ) of East and West German children.", {"entities": []}], ["We tested children 5\u20137 years of age ( n = 2,574) with cooperation-independent body plethysmography in repeated cross sections.", {"entities": []}], ["We used random-effect models to determine the mutually adjusted association between lung function and short-term and chronic particle exposure and its interaction with living near a busy road.", {"entities": []}], ["Annual averages of TSPs declined from 77 to 44 \u03bcg/m R aw and TLC was stronger in children living > 50 m away from busy roads.", {"entities": []}], ["East German children from this group had an R aw 2.5% higher [95% confidence interval (CI), 0.0\u20135.1%] per 40-\u03bcg/m", {"entities": []}], ["To assess the comorbidity of dry eye syndrome (DES) and changes in corneal curvature in children with allergies.", {"entities": [[29, 45, "DISEASE"], [37, 45, "DISEASE"], [47, 50, "GENE"]]}], ["This prospective, comparative, and observational interventional study included 49 patients, who presented to the Ophthalmology Clinic of a State Hospital in Turkey.", {"entities": []}], ["There were 25 patients with clinically diagnosed seasonal allergic conjunctivitis (AC) (with complaints of itching and papilla formation of conjunctiva; AC group) and 24 healthy children (control group).", {"entities": [[58, 81, "DISEASE"], [67, 81, "DISEASE"]]}], ["There with no significant differences in age between groups.", {"entities": []}], ["Using the ocular surface disease index (OSDI) questionnaire, we performed tear film break-up time (BUT), central reflex tear meniscus height (TMH-R) measurement, Schirmer test on both groups and evaluated keratometry (K1, K2) and spherical equivalent (SE).", {"entities": []}], ["Patients ranged in age from 6 to 18 years (median age, 11.79 years; 46.9% male; 53.1% female).", {"entities": []}], ["The papillary reaction was severe in 10% of patients with AC.", {"entities": []}], ["The prevalence of dry eye in children with AC was 12%.", {"entities": []}], ["There was no statistically significant difference between groups for K1, K2, and SE ( P > 0.05, all comparisons).", {"entities": []}], ["BUT was statistically different ( P = 0.004) between groups, indicating that a higher OSDI the tear film BUT was lower (\u03c1 = 0.567).", {"entities": []}], ["Statistically, significant negative moderate correlations were found between papillary reaction and the Schirmer test, BUT, and TMH-R (\u03c1 = 0.454, \u22120.412, \u22120.419, and P = 0.001, 0.003, 0.002, respectively) The evaluation of pediatric patients with AC requires further attention to ensure an adequate diagnosis of DES.", {"entities": [[312, 315, "GENE"]]}], ["In this paper, a smartphone-based lung function test, developed to estimate lung function parameters using a high-resolution time-frequency spectrum from a smartphone built-in microphone is presented.", {"entities": []}], ["A method of estimation of the forced expiratory volume in 1 s divided by forced vital capacity (FEV 1 /FVC) based on the variable frequency complex demodulation method (VFCDM) is first proposed.", {"entities": [[96, 99, "GENE"]]}], ["We evaluated our proposed method on 26 subjects, including 13 healthy subjects and 13 chronic obstructive pulmonary disease (COPD) patients, by comparing with the parameters clinically obtained from pulmonary function tests (PFTs).", {"entities": [[86, 123, "DISEASE"]]}], ["For the healthy subjects, we found that an absolute error (AE) and a root mean squared error (RMSE) of the FEV 1 /FVC ratio were 4.49% \u00b1 3.38% and 5.54%, respectively.", {"entities": [[107, 110, "GENE"]]}], ["For the COPD patients, we found that AE and RMSE from COPD patients were 10.30% \u00b1 10.59% and 14.48%, respectively.", {"entities": []}], ["For both groups, we compared the results using the continuous wavelet transform (CWT) and short-time Fourier transform (STFT), and found that VFCDM was superior to CWT and STFT.", {"entities": []}], ["Further, to estimate other parameters, including forced vital capacity (FVC), forced expiratory volume in 1 s (FEV 1 ), and peak expiratory flow (PEF), regression analysis was conducted to establish a linear transformation.", {"entities": [[111, 114, "GENE"]]}], ["However, the parameters FVC, FEV1, and PEF had correlation factor r values of 0.323, 0.275, and \u22120.257, respectively, while FEV 1 /FVC had an r value of 0.814.", {"entities": [[124, 127, "GENE"]]}], ["The results obtained suggest that only the FEV1/FVC ratio can be accurately estimated from a smartphone built-in microphone.", {"entities": []}], ["The other parameters, including FVC, FEV1, and PEF, were subjective and dependent on the subject\u2019s familiarization with the test and performance of forced exhalation toward the microphone.", {"entities": []}], ["Demographic ageing, and the health transition will soon lead to large increases in the number of dependent older people in low and middle income countries.", {"entities": []}], ["Despite its importance, this topic has not previously been studied.", {"entities": []}], ["A cross sectional catchment area one-phase survey of health conditions, dependency, care arrangements and caregiver strain among 2011 people aged 65 years and over in Santo Domingo, Dominican Republic 7.1% of participants required much care and a further 4.7% required at least some care.", {"entities": []}], ["The prevalence of dependency increased sharply with increasing age.", {"entities": []}], ["Dependent older people were less likely than others to have a pension and much less likely to have paid work, but no more likely to benefit from financial support from their family.", {"entities": []}], ["Needing much care was strongly associated with comorbidity between cognitive, psychological and physical health problems.", {"entities": []}], ["However, dementia made the strongest independent contribution.", {"entities": [[9, 17, "DISEASE"]]}], ["Among those needing care, those with dementia stood out as being more disabled, as needing more care (particularly support with core activities of daily living), and as being more likely to have paid caregivers.", {"entities": [[37, 45, "DISEASE"]]}], ["Dementia caregivers experienced more strain than caregivers of those with other health conditions, an effect mediated by behavioural and psychological symptoms.", {"entities": [[0, 8, "DISEASE"]]}], ["Dependency among older people is nearly as prevalent in Dominican Republic as in developed western settings.", {"entities": []}], ["Non-communicable diseases, particularly dementia are the main contributing factors.", {"entities": [[40, 48, "DISEASE"]]}], ["Attention needs to be directed towards the development of age-appropriate healthcare, a long-term care policy, and mechanisms for ensuring the social protection of older persons.", {"entities": []}], ["Effective promotion of exercise could result in substantial savings in healthcare cost expenses in terms of direct medical costs, such as the number of medical appointments.", {"entities": []}], ["However, this is hampered by our limited knowledge of how to achieve sustained increases in physical activity.", {"entities": []}], ["To assess the effectiveness of a Primary Health Care (PHC) based physical activity program in reducing the total number of visits to the healthcare center among inactive patients, over a 15-month period.", {"entities": []}], ["Randomized controlled trial.", {"entities": []}], ["Three hundred and sixty-two (n\u200a=\u200a362) inactive patients suffering from at least one chronic condition were included.", {"entities": []}], ["One hundred and eighty-three patients (n\u200a=\u200a183; mean (SD); 68.3 (8.8) years; 118 women) were randomly allocated to the physical activity program (IG).", {"entities": []}], ["One hundred and seventy-nine patients (n\u200a=\u200a179; 67.2 (9.1) years; 106 women) were allocated to the control group (CG).", {"entities": []}], ["The IG went through a three-month standardized physical activity program led by physical activity specialists and linked to community resources.", {"entities": []}], ["The total number of medical appointments to the PHC, during twelve months before and after the program, was registered.", {"entities": []}], ["Self-reported health status (SF-12 version 2) was assessed at baseline (month 0), at the end of the intervention (month 3), and at 12 months follow-up after the end of the intervention (month 15).", {"entities": []}], ["The IG had a significantly reduced number of visits during the 12 months after the intervention: 14.8 (8.5).", {"entities": []}], ["The CG remained about the same: 18.2 (11.1) ( P \u200a=\u200a.002).", {"entities": []}], ["Our findings indicate that a 3-month physical activity program linked to community resources is a short-duration, effective and sustainable intervention in inactive patients to decrease rates of PHC visits.", {"entities": []}], ["ClinicalTrials.gov NCT00714831", {"entities": []}], ["Quality of care from the perspective of users is increasingly used in evaluating health care performance.", {"entities": []}], ["Going beyond satisfaction studies, quality of care from the users' perspective is conceptualised in two dimensions: the importance users attach to aspects of care and their actual experience with these aspects.", {"entities": []}], ["It is well established that health care systems differ in performance.", {"entities": []}], ["The question in this article is whether there are also differences in what people in different health care systems view as important aspects of health care quality.", {"entities": []}], ["The aim is to describe and explain international differences in the importance that health care users attach to different aspects of health care.", {"entities": []}], ["Data were used from different studies that all used a version of the QUOTE-questionnaire that measures user views of health care quality in two dimensions: the importance that users attach to aspects of care and their actual experience.", {"entities": []}], ["Data from 12 European countries and 5133 individuals were used.", {"entities": []}], ["They were analysed using multi-level analysis.", {"entities": []}], ["Although most of the variations in importance people attach to aspects of health care is located at the individual level, there are also differences between countries.", {"entities": []}], ["The ranking of aspects shows similarities.", {"entities": []}], ["'My GP should always take me seriously' was in nearly all countries ranked first, while an item about waiting time in the GP's office was always ranked lowest.", {"entities": []}], ["Differences between countries in how health care users value different aspects of care are difficult to explain.", {"entities": []}], ["Further theorising should take into account that importance and performance ratings are positively related, that people compare their experiences with those of others, and that general and instrumental values might be related through the institutions of the health care system.", {"entities": []}], ["The relationship between particulate air pollutants and respiratory symptoms in children has not been consistent among studies, potentially owing to differences in the inflammatory response to different particulate air pollutants.", {"entities": []}], ["This study aimed to investigate the effect of particulate air pollutants on respiratory symptoms and the inflammatory response in schoolchildren.", {"entities": []}], ["Three hundred-and-sixty children were included in the study.", {"entities": []}], ["The children recorded daily respiratory symptom scores for October 2015.", {"entities": []}], ["In addition, the daily amount of interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-\u03b1 production was assessed in THP1 cells stimulated with suspended particulate matter (SPM), which was collected every day during the study period.", {"entities": [[86, 89, "GENE"]]}], ["Generalized estimating equation logistic regression analyses were used to estimate the associations among respiratory symptoms and the daily levels of SPM, IL-6, IL-8, and TNF-\u03b1.", {"entities": []}], ["Daily SPM levels were not associated with respiratory symptoms or the daily IL-6, IL-8, and TNF-\u03b1 levels.", {"entities": []}], ["Conversely, there was a significant association between respiratory symptoms and the daily IL-6, IL-8, and TNF-\u03b1 levels.", {"entities": []}], ["These results suggested that the effects of particulate air pollutants on respiratory symptoms in schoolchildren might depend more on the pro-inflammatory response to them than on their mass concentration.", {"entities": []}], ["Exposure to cigarette smoke can initiate sterile inflammatory responses in the lung and activate myeloid dendritic cells (mDCs) that induce differentiation of T helper type 1 (Th1) and Th17 cells in the emphysematous lungs.", {"entities": []}], ["Consumption of complement proteins increases in acute inflammation, but the contribution of complement protein 3 (C3) to chronic cigarette smoke-induced immune responses in the lung is not clear.", {"entities": [[114, 116, "GENE"]]}], ["Here we show that following chronic exposure to cigarette smoke, C3 deficient ( C3 ) mice develop less emphysema and have fewer CD11b C3ar ) partially phenocopy the attenuated responses to chronic smoke observed in C3 mice.", {"entities": [[65, 67, "GENE"], [80, 82, "GENE"], [215, 217, "GENE"], [65, 67, "GENE"], [80, 82, "GENE"], [215, 217, "GENE"], [65, 67, "GENE"], [80, 82, "GENE"], [215, 217, "GENE"]]}], ["Consistent with a role for C3 in emphysema C3 and its active fragments are deposited on the lung tissue of smokers with emphysema, and smoke exposed mice.", {"entities": [[27, 29, "GENE"], [43, 45, "GENE"], [27, 29, "GENE"], [43, 45, "GENE"]]}], ["Together, these findings suggest a critical role for C3a through autocrine/paracrine induction of C3aR in the pathogenesis of cigarette smoke induced sterile inflammation and provide new therapeutic targets for the treatment of emphysema.", {"entities": []}], ["During pathogen infection, innate immunity is initiated via the recognition of microbial products by pattern recognition receptors and the subsequent activation of transcription factors that upregulate proinflammatory genes.", {"entities": []}], ["By controlling the expression of cytokines, chemokines, anti-bacterial peptides and adhesion molecules, the transcription factor nuclear factor-kappa B (NF-\u03baB) has a central function in this process.", {"entities": []}], ["In a typical model of NF-\u03baB activation, the recognition of pathogen associated molecules triggers the canonical NF-\u03baB pathway that depends on the phosphorylation of Inhibitor of NF-\u03baB (I\u03baB) by the catalytic subunit I\u03baB kinase \u03b2 (IKK\u03b2), its degradation and the nuclear translocation of NF-\u03baB dimers.", {"entities": []}], ["Here, we performed an RNA interference (RNAi) screen on Shigella flexneri -induced NF-\u03baB activation to identify new factors involved in the regulation of NF-\u03baB following infection of epithelial cells by invasive bacteria.", {"entities": []}], ["By targeting a subset of the human signaling proteome, we found that the catalytic subunit IKK\u03b1 is also required for complete NF-\u03baB activation during infection.", {"entities": []}], ["Depletion of IKK\u03b1 by RNAi strongly reduces the nuclear translocation of NF-\u03baB p65 during S. flexneri infection as well as the expression of the proinflammatory chemokine interleukin-8.", {"entities": []}], ["Similar to IKK\u03b2, IKK\u03b1 contributes to the phosphorylation of I\u03baB\u03b1 on serines 32 and 36, and to its degradation.", {"entities": []}], ["Experiments performed with the synthetic Nod1 ligand L-Ala-D-\u03b3-Glu-meso-diaminopimelic acid confirmed that IKK\u03b1 is involved in NF-\u03baB activation triggered downstream of Nod1-mediated peptidoglycan recognition.", {"entities": [[41, 45, "GENE"], [168, 172, "GENE"]]}], ["Taken together, these results demonstrate the unexpected role of IKK\u03b1 in the canonical NF-\u03baB pathway triggered by peptidoglycan recognition during bacterial infection.", {"entities": []}], ["In addition, they suggest that IKK\u03b1 may be an important drug target for the development of treatments that aim at limiting inflammation in bacterial infection.", {"entities": []}], ["South Korea has maintained a dual healthcare delivery system that incorporates both traditional Korean and Western medicine.", {"entities": []}], ["In this research, we identified the determinants of the frequency of using traditional Korean medicine among musculoskeletal patients, who are known to be the most frequent users of complementary and alternative medicine.", {"entities": []}], ["In this research, we reviewed 2 consecutive years of nationally representative survey data from the 2008 and 2009 Korea Health Panel Survey.", {"entities": []}], ["We analyzed the utilization of outpatient services by musculoskeletal patients within 12 months of the 2009 survey date.", {"entities": []}], ["A two-part model was used because some patients did not use traditional Korean medicine and skewness was present in the data on traditional Korean medicine use.", {"entities": []}], ["In the first part, logistic regression analysis was performed to investigate the use of traditional Korean medicine.", {"entities": []}], ["In the second part, multiple regression analysis was performed to analyze the frequency of traditional Korean medicine usage among the subjects who visited traditional Korean medical institutions.", {"entities": []}], ["The frequency of traditional Korean medicine usage was positively associated with ages of 40\u201349 years and over 60, restrictions on daily life, a greater number of chronic diseases, not being hospitalized, and more frequent visits (more than five times) to conventional hospitals or clinics for musculoskeletal disorders.", {"entities": []}], ["The important determinants of the frequency of traditional Korean medicine usage were age, activity restrictions, the number of chronic diseases, hospitalization history, and the number of visits to conventional hospitals for musculoskeletal disorders.", {"entities": []}], ["The results contribute to our understanding of the characteristics of traditional Korean medicine users and may be used as a basic resource for related policymaking by government officials and medical professionals.", {"entities": []}], ["The prevalence of childhood obesity has increased worldwide, which is a serious concern as obesity is associated with many negative immediate and long-term health consequences.", {"entities": [[28, 35, "DISEASE"], [91, 98, "DISEASE"]]}], ["Therefore, the treatment of overweight and obesity in children and adolescents is strongly recommended.", {"entities": [[43, 50, "DISEASE"]]}], ["Inpatient weight-loss programs have shown to be effective particularly regarding short-term weight-loss, whilst little is known both on the long-term effects of this treatment and the determinants of successful weight-loss and subsequent weight maintenance.", {"entities": []}], ["The purpose of this study is to evaluate the short, middle and long-term effects of an inpatient weight-loss program for children and adolescents and to investigate the likely determinants of weight changes, whereby the primary focus lies on the potential role of differences in polymorphisms of adiposity-relevant genes.", {"entities": []}], ["The study involves overweight and obese children and adolescents aged 6 to 19 years, who participate in an inpatient weight-loss program for 4 to 6 weeks.", {"entities": []}], ["It started in 2006 and it is planned to include 1,500 participants by 2013.", {"entities": []}], ["The intervention focuses on diet, physical activity and behavior therapy.", {"entities": []}], ["Measurements are taken at the start and the end of the intervention and comprise blood analyses (DNA, lipid and glucose metabolism, adipokines and inflammatory markers), anthropometry (body weight, height and waist circumference), blood pressure, pubertal stage, and exercise capacity.", {"entities": []}], ["Physical activity, dietary habits, quality of life, and family background are assessed by questionnaires.", {"entities": []}], ["Follow-up assessments are performed 6 months, 1, 2, 5 and 10 years after the intervention: Children will complete the same questionnaires at all time points and visit their general practitioner for examination of anthropometric parameters, blood pressure and assessment of pubertal stage.", {"entities": []}], ["At the 5 and 10 year follow-ups, blood parameters and exercise capacity will be additionally measured.", {"entities": []}], ["Apart from illustrating the short, middle and long-term effects of an inpatient weight-loss program, this study will contribute to a better understanding of inter-individual differences in the regulation of body weight, taking into account the role of genetic predisposition and lifestyle factors.", {"entities": []}], ["NCT01067157 .", {"entities": []}], ["Changes in airway calibre have the potential to modify exhaled nitric oxide fraction ( F ENO ) values and could hamper how F ENO captures changes in asthma control.", {"entities": [[149, 155, "DISEASE"]]}], ["Here, our objective was to assess whether forced expiratory volume in 1\u2005s (FEV 1 ) variations alter the ability of F ENO to reflect asthma control.", {"entities": [[132, 138, "DISEASE"], [75, 78, "GENE"]]}], ["F ENO , asthma control (Asthma Control Questionnaire (ACQ)) and FEV 1 were measured at least two times in 527 patients during 1819 pairs of visits.", {"entities": [[8, 14, "DISEASE"], [24, 30, "DISEASE"], [64, 67, "GENE"]]}], ["Determinants of F ENO \u2013ACQ discordance probability were evaluated through a logistic regression analysis.", {"entities": []}], ["The effectiveness of F ENO at capturing either asthma control worsening or improvement between two visits was then assessed by undertaking a stratified receiver operating characteristic curves analysis.", {"entities": [[47, 53, "DISEASE"]]}], ["When FEV 1 and F ENO change in the same direction, the odds of F ENO \u2013ACQ being discordant are multiplied by 3 (p<0.001).", {"entities": [[5, 8, "GENE"]]}], ["The area under the curve values were 0.765 (95% CI 0.713\u20130.805) (improvement; p<0.001) and 0.769 (95% 0.706\u20130.810) (worsening; p<0.001) or 0.590 (95% 0.531\u20130.653) (improvement; p=0.001) and 0.498 (95% 0.416\u20130.567) (worsening; p=0.482) when FEV 1 and F ENO changed in the opposite or same direction, respectively.", {"entities": [[240, 243, "GENE"]]}], ["The manner in which F ENO and FEV 1 vary concomitantly when asthma control changes determines the ability of F ENO to capture this change: parallel or opposite changes in FEV 1 and F ENO either decrease or increase this ability to capture asthma control changes.", {"entities": [[60, 66, "DISEASE"], [239, 245, "DISEASE"], [30, 33, "GENE"], [171, 174, "GENE"], [30, 33, "GENE"], [171, 174, "GENE"]]}], ["Clinicians must take into account FEV 1 changes when using F ENO as a marker of asthma control http://ow.ly/XFmp30c4emj", {"entities": [[80, 86, "DISEASE"], [34, 37, "GENE"]]}], ["Severe influenza infection represents a leading cause of global morbidity and mortality.", {"entities": [[7, 16, "DISEASE"]]}], ["Although influenza is primarily considered a viral infection that results in pathology limited to the respiratory system, clinical reports suggest that influenza infection is frequently associated with a number of clinical syndromes that involve organ systems outside the respiratory tract.", {"entities": [[9, 18, "DISEASE"], [152, 161, "DISEASE"]]}], ["A comprehensive MEDLINE literature review of articles pertaining to extra\u2010pulmonary complications of influenza infection, using organ\u2010specific search terms, yielded 218 articles including case reports, epidemiologic investigations, and autopsy studies that were reviewed to determine the clinical involvement of other organs.", {"entities": [[101, 110, "DISEASE"]]}], ["The most frequently described clinical entities were viral myocarditis and viral encephalitis.", {"entities": [[59, 70, "DISEASE"], [75, 93, "DISEASE"], [81, 93, "DISEASE"]]}], ["Recognition of these extra\u2010pulmonary complications is critical to determining the true burden of influenza infection and initiating organ\u2010specific supportive care.", {"entities": [[97, 106, "DISEASE"]]}], ["It is well established that caspase-1 exerts its biological activities through its downstream targets such as IL-1\u03b2, IL-18, and Sirt-1.", {"entities": []}], ["The microarray datasets derived from various caspase-1 knockout tissues indicated that caspase-1 can significantly impact the transcriptome.", {"entities": []}], ["However, it is not known whether all the effects exerted by caspase-1 on transcriptome are mediated only by its well-known substrates.", {"entities": []}], ["Therefore, we hypothesized that the effects of caspase-1 on transcriptome may be partially independent from IL-1\u03b2, IL-18, and Sirt-1.", {"entities": []}], ["To determine new global and tissue-specific gene regulatory effects of caspase-1, we took novel microarray data analysis approaches including Venn analysis, cooperation analysis, and meta-analysis methods.", {"entities": []}], ["We used these statistical methods to integrate different microarray datasets conducted on different caspase-1 knockout tissues and datasets where caspase-1 downstream targets were manipulated.", {"entities": []}], ["We made the following important findings: (1) Caspase-1 exerts its regulatory effects on the majority of genes in a tissue-specific manner; (2) Caspase-1 regulatory genes partially cooperates with genes regulated by sirtuin-1 during organ injury and inflammation in adipose tissue but not in the liver; (3) Caspase-1 cooperates with IL-1\u03b2 in regulating less than half of the genes involved in cardiovascular disease, organismal injury, and cancer in mouse liver; (4) The meta-analysis identifies 40 caspase-1 globally regulated genes across tissues, suggesting that caspase-1 globally regulates many novel pathways; and (5) The meta-analysis identified new cooperatively and non-cooperatively regulated genes in caspase-1, IL-1\u03b2, IL-18, and Sirt-1 pathways.", {"entities": [[440, 446, "DISEASE"]]}], ["Our findings suggest that caspase-1 regulates many new signaling pathways potentially via its known substrates and also via transcription factors and other proteins that are yet to be identified.", {"entities": []}], ["The online version of this article (doi:10.1186/s13045-017-0406-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although more than 100 Chlamydia pneumoniae hypothetical proteins have been predicted to be inclusion membrane proteins, only a few have been experimentally demonstrated to be in the inclusion membrane.", {"entities": []}], ["Using antibodies raised with fusion proteins, we characterized four such hypothetical proteins encoded by two gene clusters ( Cpn0146-147 and Cpn0284-285 ) in the C. pneumoniae genome.", {"entities": []}], ["Cpn0146 and 0147 were detected in the inclusion membrane while Cpn0284 and 0285 inside inclusion and mainly associated with reticulate bodies although all four proteins contain an N-terminal bi-lobed hydrophobic region, a signature motif assigned to inclusion membrane proteins.", {"entities": []}], ["These four hypothetical proteins were only detected in cells infected with C. pneumoniae but not other chlamydial species, with Cpn0147 at 6 hours and Cpn0146, 0284 & 0285 at 24 hours after infection.", {"entities": []}], ["Cpn0146 & 147 but not Cpn0284 and 285 co-localized with a host cell endoplasmic reticulum marker, a property known to be possessed by some chlamydial inclusion membrane proteins, when expressed in the host cell cytosol via transgenes.", {"entities": []}], ["However, the endoplasmic reticulum localization of the C. pneumoniae inclusion membrane proteins did not result in inhibition of the subsequent C. pneumoniae infection.", {"entities": []}], ["The hypothetical proteins Cpn0146 & 0147 were localized in the C. pneumoniae inclusion membrane while Cpn0284 & 0285 within the inclusion although all four were predicted to be Inc proteins, suggesting the need to experimentally characterize the predicted Inc proteins.", {"entities": []}], ["This multicenter, randomized, placebo-controlled study evaluated the efficacy and side effects of parecoxib during patient-controlled epidural analgesia (PCEA) after abdominal hysterectomy.", {"entities": []}], ["A total of 240 patients who were scheduled for elective abdominal hysterectomy under combined spinal-epidural anesthesia received PCEA plus postoperative intravenous parecoxib 40 mg or saline every 12 h for 48 h after an initial preoperative dose of parecoxib 40 mg or saline.", {"entities": []}], ["An epidural loading dose of a mixture of 6 mL of 0.25% ropivacaine and 2 mg morphine was administered 30 min before the end of surgery, and PCEA was initiated using 1.25 mg/mL ropivacaine and 0.05 mg/mL morphine with a 2-mL/h background infusion and 2-mL bolus with a 15-min lockout.", {"entities": []}], ["The primary end point of this study was the quantification of the PCEA-sparing effect of parecoxib.", {"entities": []}], ["Demographic data were similar between the two groups.", {"entities": []}], ["Patients in the parecoxib group received significantly fewer self-administrated boluses (0 (0, 3) vs. 7 (2, 15), P < 0.001) and less epidural morphine (5.01 \u00b1 0.44 vs. 5.95 \u00b1 1.29 mg, P < 0.001) but experienced greater pain relief compared with the control group ( P < 0.001).", {"entities": []}], ["Patient global satisfaction was higher in the parecoxib group than the control group ( P < 0.001).", {"entities": []}], ["Length of hospitalization (9.50 \u00b1 2.1, 95% CI 9.12~9.88 vs. 10.41 \u00b1 2.6, 95% CI 9.95~10.87, P = 0.003) and postoperative vomiting (17% vs. 29%, P < 0.05) were also reduced in the parecoxib group.", {"entities": []}], ["There were no serious adverse effects in either group.", {"entities": []}], ["Our data suggest that adjunctive parecoxib during PCEA following abdominal hysterectomy is safe and efficacious in reducing pain, requirements of epidural analgesics, and side effects.", {"entities": []}], ["ClinicalTrials.gov ( NCT01566669 )", {"entities": []}], ["Cyclooxygenase-2 (COX-2) plays an important role in memory consolidation and synaptic activity, the most fundamental functions of the brain.", {"entities": []}], ["It converts arachidonic acid to prostaglandin endoperoxide H2.", {"entities": []}], ["In contrast, if over-expressed, it causes inflammation in response to cytokine, pro-inflammatory molecule, and growth factor.", {"entities": []}], ["Anti-inflammatory agents, by allosteric or competitive inhibition of COX-2, alleviate the symptoms of inflammation.", {"entities": []}], ["Coxib family drugs, particularly celecoxib, are the most famous anti-inflammatory agents available in the market showing significant inhibitory effect on COX-2 activity.", {"entities": []}], ["Due to high cardiovascular risk of this drug group, recent researches are focused on the investigation of new safer drugs for anti-inflammatory diseases.", {"entities": []}], ["Natural compounds, particularly, phytochemicals are found to be good candidates for drug designing and discovery.", {"entities": []}], ["In the present study, we performed in silico studies to quantitatively scrutinize the molecular interaction of curcumin and its structural analogs with COX-2, COX-1, FXa and integrin \u03b1IIb\u03b2III to investigate their therapeutic potential as a cardiovascular-safe anti-inflammatory medicine (CVSAIM).", {"entities": []}], ["The results of both ADMET and docking study indicated that out of all the 39 compounds studied, caffeic acid had remarkable interaction with proteins involved in inflammatory response.", {"entities": []}], ["It was also found to inhibit the proteins that are involved in thrombosis, thereby, having the potential to be developed as therapeutic agent.", {"entities": []}], ["CD147 is a widely expressed integral plasma membrane glycoprotein and has been involved in a variety of physiological and pathological activities in combination with different partners, including cyclophilins, caveolin-1, monocarboxylate transporters, and integrins.", {"entities": []}], ["Recent data demonstrate that both CyPA and CD147 significantly contribute to renal inflammation, acute kidney injury, renal fibrosis, and renal cell carcinoma.", {"entities": [[149, 158, "DISEASE"], [138, 158, "DISEASE"]]}], ["Here we review the current understanding of cyclophilin A and CD147 expression and functions in kidney diseases and potential implications for treatment of kidney diseases.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality in industrialized countries.", {"entities": []}], ["Recent studies investigated the impact of comorbidities on the survival in COPD, but most of them lacked a referent group of comorbidity-matched, nonobstructed individuals.", {"entities": []}], ["We examined the 10-year mortality in a sample of 200 COPD patients and 201 nonobstructed controls.", {"entities": []}], ["They were part of a larger cohort enrolled in a European case\u2013control study aimed at assessing genetic susceptibility to COPD.", {"entities": []}], ["By design, the COPD group included patients with a forced expiratory volume in 1 second (FEV 1 ) \u226470% predicted.", {"entities": [[89, 92, "GENE"]]}], ["Cases and controls were matched on age, sex, and cumulative smoking history, and shared a nearly identical prevalence of cardiovascular and metabolic disorders.", {"entities": []}], ["We estimated the hazard of death with Cox regression and percentiles of survival with Laplace regression.", {"entities": []}], ["COPD was the main exposure variable of interest.", {"entities": []}], ["Five comorbidities (hypertension, coronary artery disease, prior myocardial infarction, chronic heart failure, and diabetes) were included as covariates in multiple regression models.", {"entities": [[20, 32, "DISEASE"], [65, 86, "DISEASE"]]}], ["The all-cause mortality rate was significantly higher in cases than in controls (43% vs 16%, P \u2009<\u20090.001).", {"entities": []}], ["The unadjusted hazard of death for COPD was 3-fold higher than the referent category ( P \u2009<\u20090.001), and remained nearly unchanged after introducing the 5 comorbidities in multiple regression.", {"entities": []}], ["Patients with COPD had significantly shorter survival percentiles than comorbidity-matched controls ( P \u2009<\u20090.001).", {"entities": []}], ["Notably, 15% of the nonobstructed controls died by 10.3 years into the study; the same proportion of COPD patients had died some 6 years earlier, at 4.6 years.", {"entities": []}], ["In a separate analysis, we split the whole sample into 2 groups based on the lower tertile of FEV 1 and carbon monoxide lung diffusing capacity (DL CO ).", {"entities": [[94, 97, "GENE"]]}], ["The hazard of death for COPD patients with low FEV 1 and DL CO was nearly 3.5-fold higher than in all the others ( P \u2009<\u20090.001), and decreased only slightly after introducing age and chronic heart failure as relevant covariates.", {"entities": [[47, 50, "GENE"]]}], ["COPD is a strong predictor of reduced survival independently of coexisting cardiovascular and metabolic disorders.", {"entities": []}], ["Efforts should be made to identify patients at risk and to ensure adherence to prescribed therapeutic regimens.", {"entities": []}], ["Antigen-specific CD4 T helper type 2 (Th2) cells play a pivotal role in the induction of allergic asthma, but the mechanisms regulating their recruitment into the airways are unknown.", {"entities": [[89, 104, "DISEASE"], [98, 104, "DISEASE"], [17, 20, "GENE"]]}], ["Signal transducer and activator of transcription factor (Stat)6 is a transcription factor essential for Th2 cell differentiation.", {"entities": []}], ["Here we show that Stat6 also controls Th2 cell recruitment and effector function in allergic inflammation in vivo.", {"entities": [[18, 23, "GENE"]]}], ["To isolate the role of Stat6 in regulating Th2 cell trafficking and effector function from its role in Th2 cell differentiation, we used a murine model of asthma in which in vitro\u2013differentiated Stat6", {"entities": [[155, 161, "DISEASE"], [23, 28, "GENE"], [195, 200, "GENE"], [23, 28, "GENE"], [195, 200, "GENE"]]}], ["Enhancers regulate spatiotemporal gene expression and impart cell-specific transcriptional outputs that drive cell identity Bach2 , a key negative regulator of effector differentiation, emerged as the most prominent T cell SE, revealing a network wherein SE-associated genes critical for T cell biology are repressed by BACH2.", {"entities": [[124, 129, "GENE"], [320, 325, "GENE"], [124, 129, "GENE"], [320, 325, "GENE"]]}], ["Disease-associated SNPs for immune-mediated disorders, including rheumatoid arthritis (RA), were highly enriched for T cell-SEs versus typical enhancers (TEs) or SEs in other cell lineages", {"entities": [[65, 85, "DISEASE"], [76, 85, "DISEASE"], [154, 157, "GENE"]]}], ["Acute heart failure is a common condition associated with considerable morbidity, mortality, and cost.", {"entities": []}], ["However, evidence-based data on treating heart failure in the acute setting are limited, and current individual treatment options have variable efficacy.", {"entities": []}], ["The healthcare team must often individualize patient care in ways that may extend beyond available clinical guidelines.", {"entities": []}], ["In this review, we address the question, \u201cHow do you do the best you can clinically with incomplete evidence and imperfect drugs?\u201d Expert opinion is provided to supplement guideline-based recommendations and help address the typical challenges that are involved in the management of patients with acute heart failure.", {"entities": []}], ["Specifically, we discuss 4 key areas that are important in the continuum of patient care: differential diagnosis and risk stratification; choice and implementation of initial therapy; assessment of the adequacy of therapy during hospitalization or observation; and considerations for discharge/transition of care.", {"entities": []}], ["A case study is presented to highlight the decision-making process throughout each of these areas.", {"entities": []}], ["Evidence is accumulating that should help guide patients and healthcare providers on a path to better quality of care.", {"entities": []}], ["Most textbooks contains messages relating to health.", {"entities": []}], ["This profuse information requires analysis with regards to the quality of such information.", {"entities": []}], ["The objective was to identify the scientific evidence on which the health messages in textbooks are based.", {"entities": []}], ["The degree of evidence on which such messages are based was identified and the messages were subsequently classified into three categories: Messages with high, medium or low levels of evidence; Messages with an unknown level of evidence; and Messages with no known evidence.", {"entities": []}], ["844 messages were studied.", {"entities": []}], ["Of this total, 61% were classified as messages with an unknown level of evidence.", {"entities": []}], ["Less than 15% fell into the category where the level of evidence was known and less than 6% were classified as possessing high levels of evidence.", {"entities": []}], ["More than 70% of the messages relating to \"Balanced Diets and Malnutrition\", \"Food Hygiene\", \"Tobacco\", \"Sexual behaviour and AIDS\" and \"Rest and ergonomics\" are based on an unknown level of evidence.", {"entities": []}], ["\"Oral health\" registered the highest percentage of messages based on a high level of evidence (37.5%), followed by \"Pregnancy and newly born infants\" (35%).", {"entities": []}], ["Of the total, 24.6% are not based on any known evidence.", {"entities": []}], ["Two of the messages appeared to contravene known evidence.", {"entities": []}], ["Many of the messages included in school textbooks are not based on scientific evidence.", {"entities": []}], ["Standards must be established to facilitate the production of texts that include messages that are based on the best available evidence and which can improve children's health more effectively.", {"entities": []}], ["In addition to the HLA -locus, six genetic risk factors for primary biliary cirrhosis (PBC) have been identified in recent genome-wide association studies (GWAS).", {"entities": [[60, 85, "DISEASE"], [19, 22, "GENE"]]}], ["To identify additional loci, we carried out a GWAS using 1,840 cases from the UK PBC Consortium and 5,163 UK population controls as part of the Wellcome Trust Case Control Consortium 3 (WTCCC3).", {"entities": []}], ["Twenty-eight loci were followed up in an additional UK cohort of 620 PBC cases and 2,514 population controls.", {"entities": []}], ["We identified 12 novel risk loci (P<5\u00d710 STAT4 , DENND1B , CD80 , IL7R , CXCR5 , TNFRSF1A , CLEC16A , and NFKB1 .", {"entities": [[41, 46, "GENE"], [49, 56, "GENE"], [59, 63, "GENE"], [66, 70, "GENE"], [73, 78, "GENE"], [81, 89, "GENE"], [92, 99, "GENE"], [106, 111, "GENE"]]}], ["This study has considerably expanded our knowledge of the genetic architecture of PBC.", {"entities": []}], ["This paper briefly describes some of the work developed by the World Health Organization in the field of health, disability and burden of diseases and how this work has relevant implications for migraine and, in general, for headache disorders.", {"entities": [[195, 203, "DISEASE"]]}], ["It presents some of the basic principles of the Global Burden of Diseases (GBD) study, its goals and some of its outcomes as related to neurological and psychiatric disorders as well as the implications for neuropsychiatric disorders to move from mortality towards disability indicators.", {"entities": []}], ["It also presents some of the World Health Report 2001's data, where migraine has been reported as a leading cause of years lived with disability.", {"entities": [[68, 76, "DISEASE"]]}], ["A brief presentation of the basic principles of the WHO Classification of Functioning Disability and Health (ICF) is provided as well as the reasons why ICF answers the pressing need for new measures for health.", {"entities": []}], ["This WHO's instrument will be useful for the classification of functioning and disability in the field of headache disorders.", {"entities": []}], ["Interstitial lung disease (ILD) describes a group of diseases that cause progressive scarring of the lung tissue through inflammation and fibrosis.", {"entities": [[13, 25, "DISEASE"]]}], ["The most common form of ILD is idiopathic pulmonary fibrosis, which has a poor prognosis.", {"entities": [[42, 60, "DISEASE"], [31, 60, "DISEASE"]]}], ["ILD is rare and mainly a disease of the middle-aged and elderly.", {"entities": []}], ["The symptoms of ILD\u2014chronic dyspnoea and cough\u2014are easily confused with the symptoms of more common diseases, particularly chronic obstructive pulmonary disease and heart failure.", {"entities": [[123, 160, "DISEASE"]]}], ["ILD is infrequently seen in primary care and a precise diagnosis of these disorders can be challenging for physicians who rarely encounter them.", {"entities": []}], ["Confirming a diagnosis of ILD requires specialist expertise and review of a high-resolution computed tomography scan (HRCT).", {"entities": []}], ["Primary care physicians (PCPs) play a key role in facilitating the diagnosis of ILD by referring patients with concerning symptoms to a pulmonologist and, in some cases, by ordering HRCTs.", {"entities": []}], ["In our article, we highlight the importance of prompt diagnosis of ILD and describe the circumstances in which a PCP\u2019s suspicion for ILD should be raised in a patient presenting with chronic dyspnoea on exertion, once more common causes of dyspnoea have been investigated and excluded.", {"entities": []}], ["The aim of the present study was to test the hypothesis that increasing kidney tissue concentrations of epoxyeicosatrienoic acids (EETs) by preventing their degradation to the biologically inactive dihydroxyeicosatrienoic acids (DHETEs) using blockade of soluble epoxide hydrolase (sEH) would attenuate the progression of chronic kidney disease (CKD).", {"entities": [[330, 344, "DISEASE"]]}], ["Ren-2 transgenic rats (TGR) after 5/6 renal mass reduction (5/6 NX) served as a model of CKD associated with angiotensin (Ang) II-dependent hypertension.", {"entities": [[140, 152, "DISEASE"], [122, 125, "GENE"]]}], ["Soluble epoxide hydrolase was inhibited using cis -4-[4-(3-adamantan-1-yl-ureido)cyclohexyloxy]benzoic acid ( c -AUCB; 3 mg/L drinking water) for 20 weeks after 5/6 NX.", {"entities": []}], ["Sham-operated normotensive transgene-negative Hannover Sprague-Dawley (HanSD) rats served as controls.", {"entities": []}], ["When applied in TGR subjected to 5/6 NX, c- AUCB treatment improved survival rate, prevented the increase in blood pressure, retarded the progression of cardiac hypertrophy, reduced proteinuria and the degree of glomerular and tubulointerstitial injury and reduced glomerular volume.", {"entities": [[182, 193, "DISEASE"]]}], ["All these organ-protective actions were associated with normalization of the intrarenal EETs : DHETEs ratio, an index of the availability of biologically active EETs, to levels observed in sham-operated HanSD rats.", {"entities": []}], ["There were no significant concurrent changes of increased intrarenal AngII content.", {"entities": []}], ["Together, these results show that 5/6 NX TGR exhibit a profound deficiency of intrarenal availability of active epoxygenase metabolites (EETs), which probably contributes to the progression of CKD in this model of AngII-dependent hypertension, and that restoration of intrarenal availability of EETs using long-term c- AUCB treatment exhibits substantial renoprotective actions.", {"entities": [[230, 242, "DISEASE"]]}], ["Human exposure assessment tools represent a means for understanding human exposure to pesticides in agricultural activities and managing possible health risks.", {"entities": []}], ["This paper presents a pesticide flow analysis modeling approach developed to assess human exposure to pesticide use in greenhouse flower crops in Colombia, focusing on dermal and inhalation exposure.", {"entities": []}], ["This approach is based on the material flow analysis methodology.", {"entities": []}], ["The transfer coefficients were obtained using the whole body dosimetry method for dermal exposure and the button personal inhalable aerosol sampler for inhalation exposure, using the tracer uranine as a pesticide surrogate.", {"entities": []}], ["The case study was a greenhouse rose farm in the Bogota Plateau in Colombia.", {"entities": []}], ["The approach was applied to estimate the exposure to pesticides such as mancozeb, carbendazim, propamocarb hydrochloride, fosetyl, carboxin, thiram, dimethomorph and mandipropamide.", {"entities": []}], ["We found dermal absorption estimations close to the AOEL reference values for the pesticides carbendazim, mancozeb, thiram and mandipropamide during the study period.", {"entities": []}], ["In addition, high values of dermal exposure were found on the forearms, hands, chest and legs of study participants, indicating weaknesses in the overlapping areas of the personal protective equipment parts.", {"entities": []}], ["These results show how the material flow analysis methodology can be applied in the field of human exposure for early recognition of the dispersion of pesticides and support the development of measures to improve operational safety during pesticide management.", {"entities": []}], ["Furthermore, the model makes it possible to identify the status quo of the health risk faced by workers in the study area.", {"entities": []}], ["Store-operated Ca Store-operated Ca", {"entities": []}], ["Infection of healthcare workers with the severe acute respiratory syndrome\u2013associated coronavirus (SARS-CoV) is thought to occur primarily by either contact or large respiratory droplet transmission.", {"entities": [[66, 74, "DISEASE"], [41, 74, "DISEASE"]]}], ["However, infrequent healthcare worker infections occurred despite the use of contact and droplet precautions, particularly during certain aerosol-generating medical procedures.", {"entities": []}], ["We investigated a possible cluster of SARS-CoV infections in healthcare workers who used contact and droplet precautions during attempted cardiopulmonary resuscitation of a SARS patient.", {"entities": [[38, 42, "GENE"], [173, 177, "GENE"]]}], ["Unlike previously reported instances of transmission during aerosol-generating procedures, the index case-patient was unresponsive, and the intubation procedure was performed quickly and without difficulty.", {"entities": []}], ["However, before intubation, the patient was ventilated with a bag-valve-mask that may have contributed to aerosolization of SARS-CoV.", {"entities": []}], ["On the basis of the results of this investigation and previous reports of SARS transmission during aerosol-generating procedures, a systematic approach to the problem is outlined, including the use of the following: 1) administrative controls, 2) environmental engineering controls, 3) personal protective equipment, and 4) quality control.", {"entities": [[74, 78, "GENE"]]}], ["An increasing body of evidence links the occurrence of sleep continuity disturbances with increased inflammation and both sleep disturbances and inflammation are associated with clinical depression.", {"entities": []}], ["Typhoid vaccination results in a mild inflammatory response that significantly increases levels of the proinflammatory cytokine, interleukin (IL)-6.", {"entities": []}], ["The present exploratory study aimed to enhance our understanding of the link between inflammation, sleep and depression by examining the effects of typhoid vaccine on the sleep polysomnogram.", {"entities": []}], ["We studied the effects of a single injection of typhoid polysaccharide vaccine and placebo (saline solution) on sleep in 16 healthy male and female participants aged 20\u201338\u00a0years, sleeping at home in a randomized, double-blind, balanced order, crossover design.", {"entities": []}], ["Subjective measures of mood, sleep and adverse effects were elicited and plasma samples analysed for IL-6 levels.", {"entities": []}], ["IL-6 levels (in picogramme per millilitre) significantly increased 2\u00a0h post vaccine compared to placebo (0.90 vs 0.53, p \u00a0=\u00a00.026, r \u00a0=\u00a00.55).", {"entities": []}], ["Relative to placebo, typhoid vaccination produced significant impairment in several measures of sleep continuity.", {"entities": []}], ["Total sleep time (in minute) (426.1 vs 410.7, p \u00a0=\u00a00.005, r \u00a0=\u00a00.62) and sleep efficiency percent (94.3 vs 91.5, p \u00a0=\u00a00.007, r \u00a0=\u00a00.65) were decreased; with increases in wake after sleep onset (in minute) (25.5 vs 38.8, p \u00a0=\u00a00.007, r \u00a0=\u00a00.65), total wake (in minute) (34.9 vs 50.3, p \u00a0=\u00a00.005, r \u00a0=\u00a00.67), sleep stage transitions (155.9 vs 173.1, p \u00a0=\u00a00.026, r \u00a0=\u00a00.56), number of awakenings (27.2 vs 36.1, p \u00a0=\u00a00.007, r \u00a0=\u00a00.64) and awakening index (3.8 vs 5.3, p \u00a0=\u00a00.005, r \u00a0=\u00a00.67) (means, significance level and effect size).", {"entities": []}], ["Inflammatory mechanisms may underlie the impairment in sleep efficiency which is a hallmark of major depression.", {"entities": []}], ["Because impaired sleep is also a predictor of major depression, there may be a role for suitable anti-inflammatory approaches in strategies designed to prevent the onset of depression.", {"entities": []}], ["ClinicalTrials.gov ( http://www.clinicaltrials.gov ): NCT02628054 The online version of this article (doi:10.1007/s00213-016-4381-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The conceptualization of patient complexity is just beginning in clinical medicine.", {"entities": []}], ["This study aims (1) to propose a conceptual approach to complex patients; (2) to demonstrate how this approach promotes achieving congruence between patient and provider, a critical step in the development of maximally effective treatment plans; and (3) to examine availability of evidence to guide trade-off decisions and assess healthcare quality for complex patients.", {"entities": []}], ["The Vector Model of Complexity portrays interactions between biological, socioeconomic, cultural, environmental and behavioral forces as health determinants.", {"entities": []}], ["These forces are not easily discerned but exert profound influences on processes and outcomes of care for chronic medical conditions.", {"entities": []}], ["Achieving congruence between patient, physician, and healthcare system is essential for effective, patient-centered care; requires assessment of all axes of the Vector Model; and, frequently, requires trade-off decisions to develop a tailored treatment plan.", {"entities": []}], ["Most evidence-based guidelines rarely provide guidance for trade-off decisions.", {"entities": []}], ["Quality measures often exclude complex patients and are not designed explicitly to assess their overall healthcare.", {"entities": []}], ["We urgently need to expand the evidence base to inform the care of complex patients of all kinds, especially for the clinical trade-off decisions that are central to tailoring care.", {"entities": []}], ["We offer long- and short-term strategies to begin to incorporate complexity into quality measurement and performance profiling, guided by the Vector Model.", {"entities": []}], ["Interdisciplinary research should lay the foundation for a deeper understanding of the multiple sources of patient complexity and their interactions, and how provision of healthcare should be harmonized with complexity to optimize health.", {"entities": []}], ["Exacerbations of chronic obstructive pulmonary disease (COPD) are a major burden to patients and to society.", {"entities": [[17, 54, "DISEASE"]]}], ["Little is known about the possible role of day-to-day patient-reported outcomes during an exacerbation.", {"entities": []}], ["This study aims to describe the day-to-day course of patient-reported health status during exacerbations of COPD and to assess its value in predicting clinical outcomes.", {"entities": []}], ["Data from two randomized controlled COPD exacerbation trials (n = 210 and n = 45 patients) were used to describe both the feasibility of daily collection of and the day-to-day course of patient-reported outcomes during outpatient treatment or admission to hospital.", {"entities": []}], ["In addition to clinical parameters, the BORG dyspnea score, the Clinical COPD Questionnaire (CCQ), and the St George\u2019s Respiratory Questionnaire were used in Cox regression models to predict treatment failure, time to next exacerbation, and mortality in the hospital study.", {"entities": []}], ["All patient-reported outcomes showed a distinct pattern of improvement.", {"entities": []}], ["In the multivariate models, absence of improvement in CCQ symptom score and impaired lung function were independent predictors of treatment failure.", {"entities": []}], ["Health status and gender predicted time to next exacerbation.", {"entities": []}], ["Five-year mortality was predicted by age, forced expiratory flow in one second % predicted, smoking status, and CCQ score.", {"entities": []}], ["In outpatient management of exacerbations, health status was found to be less impaired than in hospitalized patients, while the rate and pattern of recovery was remarkably similar.", {"entities": []}], ["Daily health status measurements were found to predict treatment failure, which could help decision-making for patients hospitalized due to an exacerbation of COPD.", {"entities": []}], ["Lung ischemia-reperfusion (IR) injury after transplantation as well as acute shortage of suitable donor lungs are two critical issues impacting lung transplant patients.", {"entities": [[5, 13, "DISEASE"]]}], ["This study investigates the anti-inflammatory and immunomodulatory role of human mesenchymal stromal cells (MSCs) and MSC-derived extracellular vesicles (EVs) to attenuate lung IR injury and improve of ex-vivo lung perfusion (EVLP)-mediated rehabilitation in donation after circulatory death (DCD) lungs.", {"entities": [[293, 296, "GENE"]]}], ["C57BL/6 wild-type (WT) mice underwent sham surgery or lung IR using an in vivo hilar-ligation model with or without MSCs or EVs.", {"entities": []}], ["In vitro studies used primary iNKT cells and macrophages (MH-S cells) were exposed to hypoxia/reoxygenation with/without co-cultures with MSCs or EVs.", {"entities": []}], ["Also, separate groups of WT mice underwent euthanasia and 1\u00a0h of warm ischemia and stored at 4\u00a0 \u00b0 C for 1\u00a0h followed by 1\u00a0h of normothermic EVLP using Steen solution or Steen solution containing MSCs or EVs.", {"entities": [[70, 78, "DISEASE"]]}], ["Lungs from MSCs or EV-treated mice had significant attenuation of lung dysfunction and injury (decreased edema, neutrophil infiltration and myeloperoxidase levels) compared to IR alone.", {"entities": []}], ["A significant decrease in proinflammatory cytokines (IL-17, TNF-\u03b1, CXCL1 and HMGB1) and upregulation of keratinocyte growth factor, prostaglandin E2 and IL-10 occurred in the BAL fluid from MSC or EV-treated mice after IR compared to IR alone.", {"entities": [[67, 72, "GENE"], [77, 82, "GENE"], [190, 193, "GENE"]]}], ["Furthermore, MSCs or EVs significantly downregulated iNKT cell-produced IL-17 and macrophage-produced HMGB1 and TNF-\u03b1 after hypoxia/reoxygenation.", {"entities": [[102, 107, "GENE"]]}], ["Finally, EVLP of DCD lungs with Steen solution including MSCs or EVs provided significantly enhanced protection versus Steen solution alone.", {"entities": [[17, 20, "GENE"]]}], ["Co-cultures of MSCs or EVs with lung endothelial cells prevents neutrophil transendothelial migration after exposure to hypoxia/reoxygenation and TNF-\u03b1/HMGB1 cytomix.", {"entities": []}], ["These results suggest that MSC-derived EVs can attenuate lung inflammation and injury after IR as well as enhance EVLP-mediated reconditioning of donor lungs.", {"entities": []}], ["The therapeutic benefits of EVs are in part mediated through anti-inflammatory promoting mechanisms via attenuation of immune cell activation as well as prevention of endothelial barrier integrity to prevent lung edema.", {"entities": []}], ["Therefore, MSC-derived EVs offer a potential therapeutic strategy to treat post-transplant IR injury as well as rehabilitation of DCD lungs.", {"entities": [[130, 133, "GENE"]]}], ["Despite the burgeoning burden of diabetes mellitus (DM) and cardiovascular diseases (CVD) in low and middle income countries (LMIC), access to affordable essential medicines and diagnostic tests for DM and CVD still remain a challenge in clinical practice.", {"entities": [[33, 50, "DISEASE"]]}], ["The Access to Cardiovascular diseases, Chronic Obstructive pulmonary disease, Diabetes mellitus and Asthma Drugs and diagnostics (ACCODAD) study aimed at providing contemporary information about the availability, cost and affordability of medicines and diagnostic tests integral in the management of DM and CVD in Uganda.", {"entities": [[78, 95, "DISEASE"]]}], ["The study assessed the availability, cost and affordability of 37 medicines and 19 diagnostic tests in 22 public hospitals, 23 private hospitals and 100 private pharmacies in Uganda.", {"entities": []}], ["Availability expressed as a percentage, median cost of the available lowest priced generic medicine and the diagnostic tests and affordability in terms of the number of days\u2019 wages it would cost the least paid public servant to pay for one month of treatment and the diagnostic tests were calculated.", {"entities": []}], ["The availability of the medicines and diagnostic tests in all the study sites ranged from 20.1% for unfractionated heparin (UFH) to 100% for oral hypoglycaemic agents (OHA) and from 6.8% for microalbuminuria to 100% for urinalysis respectively.", {"entities": []}], ["The only affordable tests were blood glucose, urinalysis and serum ketone, urea, creatinine and uric acid.", {"entities": []}], ["Parenteral benzathine penicillin, oral furosemide, glibenclamide, bendrofluazide, atenolol, cardiac aspirin, digoxin, metformin, captopril and nifedipine were the only affordable drugs.", {"entities": []}], ["This study demonstrates that the majority of medicines and diagnostic tests essential in the management of DM and CVD are generally unavailable and unaffordable in Uganda.", {"entities": []}], ["National strategies promoting improved access to affordable medicines and diagnostic tests and primary prevention measures of DM and CVD should be prioritised in Uganda.", {"entities": []}], ["Young people with eating disorders are at risk of harm to their social, emotional and physical development and life chances.", {"entities": []}], ["Although they can be reluctant to seek help, they may access social media for information, advice or support.", {"entities": []}], ["The relationship between social media and youth well\u2010being is an emotive subject, but not clearly understood.", {"entities": []}], ["This qualitative study aimed to explore how young people used a youth\u2010orientated, moderated, online, eating disorders discussion forum, run by an eating disorders charity.", {"entities": []}], ["We applied a netnographic approach involving downloading and thematically analysing over 400 messages posted A ugust\u2013 N ovember 2012.", {"entities": []}], ["Data analysis generated five themes: Taking on the role of mentor; the online discussion forum as a safe space; Friendship within the online forum; F lexible help; and P eer support for recovery and relapse prevention.", {"entities": []}], ["Forum moderation may have influenced the forum culture.", {"entities": []}], ["Our findings are consistent with literature about youth preferences for mental health self\u2010care support.", {"entities": []}], ["A young person's decision to use this discussion forum can be construed as pro\u2010active self\u2010care.", {"entities": []}], ["A moderated online discussion forum can make a positive contribution to support for youth with eating disorders, countering negative media perceptions of online groups.", {"entities": []}], ["This study adds to knowledge about how young people access support via social media.", {"entities": []}], ["Online discussion forums can be safe and acceptable spaces for youth to access help.", {"entities": []}], ["Further research could provide insights into the impact of forum moderation.", {"entities": []}], ["Truck driving is the second most common occupation among Canadian men.", {"entities": []}], ["Transportation of goods via roads is of crucial importance for the Canadian economy.", {"entities": []}], ["The industry is responsible annually for $17 billion in GDP and is projected to increase by 28% over the next 10\u00a0years.", {"entities": []}], ["Recruitment is an issue with 20% of drivers projected to retire or leave the profession in the next 10\u00a0years.", {"entities": []}], ["Despite the reliance on transport truck drivers for the delivery of goods which affects Canada\u2019s economy and daily living of residents, little is known about the health care needs of this large cohort of primarily male lone workers from a drivers\u2019 perspective.", {"entities": []}], ["Transport truck drivers are independent workers whose non traditional workplace is their tractor, the truck stops and the journey on the road.", {"entities": []}], ["The objective of this study was to obtain a contextually informed description of lifestyle issues, health and disease risk factors experienced by drivers and perceived by their managers in the truck driving occupation.", {"entities": []}], ["Using a grounded theory approach, 4 focus groups were conducted with drivers (n\u2009=\u200916) and managers (n\u2009=\u200910) from two trucking companies in Southwestern Ontario to identify the lived experience of the drivers as it relates to preventable risks to health and wellness.", {"entities": []}], ["A semi structured guided interview was used to explore the lifestyle context of transport truck driving and organizational aspects of the occupation (workplace culture, working conditions and health and wellness promotion).", {"entities": []}], ["The predominant themes described stress, workplace, communication, lifestyle, driving culture, family, and fatigue concerns.", {"entities": []}], ["In terms of the transportation work environment, drivers and managers were aware of the profession\u2019s potential to foster lifestyle related chronic diseases but described challenges in making the profession more amenable to a healthy lifestyle.", {"entities": []}], ["Workplace environmental determinants are significant in shaping health behaviours.", {"entities": []}], ["Chronic disease health risks were the main health concerns identified.", {"entities": []}], ["Health risks were exacerbated by working conditions (job demands, work hours, financial pressure and the sedentary nature of the job).", {"entities": []}], ["Workplace health strategies will need to take into account the unique challenges of the occupation.", {"entities": []}], ["Detailed data are lacking on influenza burden in the United Kingdom (UK).", {"entities": [[29, 38, "DISEASE"]]}], ["The objective of this study was to estimate the disease burden associated with influenza-like illness (ILI) in the United Kingdom stratified by age, risk and influenza vaccination status.", {"entities": [[79, 88, "DISEASE"], [158, 167, "DISEASE"]]}], ["This retrospective, cross-sectional, exploratory, observational study used linked data from the General Practice Research Database and the Hospital Episode Statistics databases to estimate resource use and cost associated with ILI in the UK.", {"entities": []}], ["Data were included from 156,193 patients with \u22651 general practitioner visit with ILI.", {"entities": []}], ["There were 21,518 high-risk patients, of whom 12,514 (58.2%) were vaccinated and 9,004 (41.8%) were not vaccinated, and 134,675 low-risk patients, of whom 17,482 (13.0%) were vaccinated and 117,193 (87.0%) were not vaccinated.", {"entities": []}], ["High-risk vaccinated patients were older (p<0.001) and had more risk conditions (p<0.001).", {"entities": []}], ["High-risk (odds ratio [OR] 2.16) or vaccinated (OR 1.19) patients had a higher probability of >1 general practitioner visit compared with low-risk and unvaccinated patients.", {"entities": []}], ["Patients who were high-risk and vaccinated had a reduced risk of >1 general practitioner visit (OR 0.82; p<0.001).", {"entities": []}], ["High-risk individuals who were also vaccinated had a lower probability of ILI-related hospitalisation than individuals who were high-risk or vaccinated alone (OR 0.59).", {"entities": []}], ["In people aged \u226565 years, the mortality rate was lower in vaccinated than unvaccinated individuals (OR 0.75).", {"entities": []}], ["The cost of ILI-related GP visits and hospital admissions in the UK over the study period in low-risk vaccinated patients was \u00a327,391,142 and \u00a3141,932,471, respectively.", {"entities": []}], ["In low-risk unvaccinated patients the corresponding values were \u00a3168,318,709 and \u00a3112,534,130, respectively.", {"entities": []}], ["Although vaccination rates in target groups have increased, many people are still not receiving influenza vaccination, and the burden of ILI in the United Kingdom remains substantial.", {"entities": [[96, 105, "DISEASE"]]}], ["Improving influenza vaccination uptake may have the potential to reduce this burden.", {"entities": [[10, 19, "DISEASE"]]}], ["The present study examined the exploitation of bird species by the residents of a rural community in the Brazilian semi-arid zone, and their preferences for species with different characteristics.", {"entities": []}], ["The 24 informants were identified using the \u201csnowball\u201d approach, and were interviewed using semi-structured questionnaires and check-sheets for the collection of data on their relationship with the bird species that occur in the region.", {"entities": []}], ["The characteristics that most attract the attention of the interviewees were the song and the coloration of the plumage of a bird, as well as its body size, which determines its potential as a game species, given that hunting is an important activity in the region.", {"entities": []}], ["A total of 98 species representing 32 families (50.7% of the species known to occur in the region) were reported during interviews, being used for meat, pets, and medicinal purposes.", {"entities": []}], ["Three species were used as zootherapeutics \u2013 White-naped Jay was eaten whole as a cure for speech problems, the feathers of Yellow-legged Tinamou were used for snakebite, Smooth-billed Ani was eaten for \u201cchronic cough\u201d and Small-billed Tinamou and Tataupa Tinamou used for locomotion problems.", {"entities": []}], ["The preference of the informants for characteristics such as birdsong and colorful plumage was a significant determinant of their preference for the species exploited.", {"entities": []}], ["Birds with cynegetic potential and high use values were also among the most preferred species.", {"entities": []}], ["Despite the highly significant preferences for certain species, some birds, such as those of the families Trochilidae, Thamnophilidae, and Tyrannidae are hunted randomly, independently of their attributes.", {"entities": []}], ["The evidence collected on the criteria applied by local specialists for the exploitation of the bird fauna permitted the identification of the species that suffer hunting pressure, providing guidelines for the development of conservation and management strategies that will guarantee the long-term survival of the populations of these bird species in the region.", {"entities": []}], ["Short-acting \u03b2 2 -agonist bronchodilators are the most common medications used in treating chronic obstructive pulmonary disease (COPD).", {"entities": [[91, 128, "DISEASE"]]}], ["Genetic variants determining bronchodilator responsiveness (BDR) in COPD have not been identified.", {"entities": []}], ["We performed a genome-wide association study (GWAS) of BDR in 5789 current or former smokers with COPD in one African American and four white populations.", {"entities": []}], ["BDR was defined as the quantitative spirometric response to inhaled \u03b2 2 -agonists.", {"entities": []}], ["We combined results in a meta-analysis.", {"entities": []}], ["In the meta-analysis, SNPs in the genes KCNK1 (P=2.02\u00d710 KCNJ2 (P=1.79\u00d710 CDH13 were significantly associated with BDR (P=5.1\u00d710 CDH13 was identified in a gene-based analysis in all subjects.", {"entities": [[40, 45, "GENE"], [57, 62, "GENE"], [74, 79, "GENE"], [129, 134, "GENE"], [74, 79, "GENE"], [129, 134, "GENE"]]}], ["We identified suggestive association with BDR among COPD subjects for variants near two potassium channel genes ( KCNK1 and KCNJ2 ).", {"entities": [[114, 119, "GENE"], [124, 129, "GENE"]]}], ["SNPs in CDH13 were significantly associated with BDR in African Americans.", {"entities": [[8, 13, "GENE"]]}], ["Ceramic gas sensors used for measuring ambient air quality have features suitable for practical applications such as healthcare and air quality management, but have a major drawback\u2014large power consumption to preheat the sensor for accurate measurements.", {"entities": []}], ["In this paper; the adaptive preheating duration control (APC) method is proposed to reduce the power consumption of ambient air quality sensor networks.", {"entities": [[57, 60, "GENE"]]}], ["APC reduces the duration of unnecessary preheating, thereby alleviating power consumption.", {"entities": [[0, 3, "GENE"]]}], ["Furthermore, the APC can allow systems to meet user requirements such as accuracy and periodicity factor when detecting the concentration of a target gas.", {"entities": [[17, 20, "GENE"]]}], ["A performance evaluation of the power consumption of gas sensors is conducted with various user requirements and factors that affect the preheating duration of the gas sensor.", {"entities": []}], ["This shows that the power consumption of the APC is lower than that of continuous power supply methods and constant power supply/cutoff methods.", {"entities": [[45, 48, "GENE"]]}], ["Remifentanil and dexmedetomidine are well known to suppress airway reflexes during airway procedures.", {"entities": []}], ["Smooth tracheal extubation is important after otologic surgery.", {"entities": []}], ["The purpose of this study is to compare the effectiveness of dexmedetomidine or remifentanil infusion for producing smooth tracheal extubation in deeply anesthetized patients after otologic surgery.", {"entities": []}], ["Seventy-four ASA I-II adult patients (18-60 years old) scheduled for elective otologic surgery were randomly assigned to one of three groups: sevoflurane-remifentanil (Group SR, n \u2009=\u200925), sevoflurane-dexmedetomidine (0.5\u00a0\u03bcg/kg) (Group SD5, n \u2009=\u200924), or sevoflurane-dexmedetomidine (0.7\u00a0\u03bcg/kg) (Group SD7, n \u2009=\u200925).", {"entities": []}], ["Remifentanil or dexmedetomidine were administered for 10\u00a0min at the end of surgery.", {"entities": []}], ["The primary outcome was the rate of smooth extubation.", {"entities": []}], ["Respiratory pattern, airway obstruction, hemodynamic and respiratory profiles, time to awake, rescue analgesics in the post-anesthesia care unit (PACU), and postoperative nausea and vomiting (PONV) were also recorded.", {"entities": []}], ["The rate of smooth tracheal extubation as defined 1\u00a0min post-extubation was the same for Groups SR and SD7 ( P \u2009>\u20090.05), but the rate of smooth extubation was lower for Group SD5 than for the other two groups ( p \u2009<\u20090.05).", {"entities": []}], ["During extubation, the respiratory rate was lower in Group SR than in both dexmedetomidine groups ( p \u2009<\u20090.05).", {"entities": []}], ["The hemodynamic profiles at extubation were similar between groups ( p \u2009>\u20090.05), but the mean arterial pressure and heart rate were higher in Group SR at 10 and 15\u00a0min after extubation ( p \u2009<\u20090.05).", {"entities": []}], ["The incidence of airway obstruction and time to awake were comparable for all groups ( p \u2009>\u20090.05).", {"entities": []}], ["The need for rescue analgesic in the PACU was more common in Group SR than in both dexmedetomidine groups ( P \u2009<\u20090.01).", {"entities": []}], ["Compared to Group SR, both dexmedetomidine groups had less PONV on postoperative day 1 ( p \u2009<\u20090.05).", {"entities": []}], ["Combined with 1 MAC sevoflurane, dexmedetomidine 0.7 ug/kg and remifentanil provided similar rates for smooth tracheal extubation in spontaneously breathing, anesthetized adults.", {"entities": []}], ["Dexmedetomidine exhibited opioid-sparing effects postoperatively and was associated with less PONV than remifentanil.", {"entities": []}], ["Mannose-binding lectin is a collectin involved in host defense against infection.", {"entities": []}], ["Whether mannose-binding lectin deficiency is associated with acute exacerbations of chronic obstructive pulmonary disease is debated.", {"entities": [[84, 121, "DISEASE"]]}], ["Participants in a study designed to determine if azithromycin taken daily for one year decreased acute exacerbations had serum mannose-binding lectin concentrations measured at the time of enrollment.", {"entities": []}], ["Samples were obtained from 1037 subjects (91%) in the trial.", {"entities": []}], ["The prevalence of mannose-binding lectin deficiency ranged from 0.5% to 52.2%, depending on how deficiency was defined.", {"entities": []}], ["No differences in the prevalence of deficiency were observed with respect to any demographic variable assessed, and no differences were observed in time to first exacerbation, rate of exacerbations, or percentage of subjects requiring hospitalization for exacerbations in those with deficiency versus those without, regardless of how deficiency was defined.", {"entities": []}], ["In a large sample of subjects with chronic obstructive pulmonary disease selected for having an increased risk of experiencing an acute exacerbation of chronic obstructive pulmonary disease, only 1.9% had mannose-binding lectin concentrations below the normal range and we found no association between mannose-binding lectin concentrations and time to first acute exacerbation or frequency of acute exacerbations during one year of prospective follow-up.", {"entities": [[35, 72, "DISEASE"], [152, 189, "DISEASE"]]}], ["Epidemiological evidence confirmed that raw cow\u2019s milk consumption in the first year of life protects against the development of atopic diseases and increases the number of regulatory T-cells (Tregs).", {"entities": []}], ["However, milk\u2019s atopy-protective mode of action remains elusive.", {"entities": []}], ["This review supported by translational research proposes that milk-derived microRNAs (miRs) may represent the missing candidates that promote long-term lineage commitment of Tregs downregulating IL-4/Th2-mediated atopic sensitization and effector immune responses.", {"entities": []}], ["Milk transfers exosomal miRs including the ancient miR-155, which is important for the development of the immune system and controls pivotal target genes involved in the regulation of FoxP3 expression, IL-4 signaling, immunoglobulin class switching to IgE and Fc\u03f5RI expression.", {"entities": [[51, 58, "GENE"], [184, 189, "GENE"]]}], ["Boiling of milk abolishes milk\u2019s exosomal miR-mediated bioactivity.", {"entities": []}], ["Infant formula in comparison to human breast- or cow\u2019s milk is deficient in bioactive exosomal miRs that may impair FoxP3 expression.", {"entities": [[116, 121, "GENE"]]}], ["The boost of milk-mediated miR may induce pivotal immunoregulatory and epigenetic modifications required for long-term thymic Treg lineage commitment explaining the atopy-protective effect of raw cow\u2019s milk consumption.", {"entities": []}], ["The presented concept offers a new option for the prevention of atopic diseases by the addition of physiological amounts of miR-155-enriched exosomes to infant formula for mothers incapable of breastfeeding.", {"entities": []}], ["A smoke-free home can have multiple benefits by reducing exposure to secondhand smoke (SHS), supporting quit attempts among active smokers, and discouraging adolescents from taking up smoking.", {"entities": []}], ["The aim of this review was to summarize the literature on the establishment of smoke-free homes in Indigenous populations and identify the supporting influences and barriers, using the Social Cognitive Theory lens.", {"entities": []}], ["A search of the Medline, CINAHL, Cochrane Collaboration and PyscINFO databases and manual searches of relevant peer-reviewed literature was completed, focusing on Indigenous populations in developed economies of North America and Oceania.", {"entities": []}], ["Of 2567 articles identified, 15 studies were included.", {"entities": []}], ["Ten studies included Indigenous participants only, and of these just three focused entirely on SHS in the home.", {"entities": []}], ["Knowledge of the harms associated with SHS was the most common theme represented in all the studies.", {"entities": []}], ["This knowledge fueled parents\u2019 motivation to protect their children from SHS by establishing smoke-free homes.", {"entities": []}], ["Individuals who approached implementation with confidence, coupled with clear communication about smoke-free home rules were more successful.", {"entities": []}], ["Barriers included challenges for families with multiple smokers living in the same dwelling.", {"entities": []}], ["There is limited research regarding managing smoking behaviors in the home among Indigenous populations, even though this approach is a successful catalyst for smoking prevention and cessation.", {"entities": []}], ["Research to understand the influences that support the establishment of smoke-free homes is required for better-informed intervention studies.", {"entities": []}], ["It has been more than 25 years since HGF was discovered as a mitogen of hepatocytes.", {"entities": [[37, 40, "GENE"]]}], ["HGF is produced by stromal cells, and stimulates epithelial cell proliferation, motility, morphogenesis and angiogenesis in various organs via tyrosine phosphorylation of its receptor, c-Met.", {"entities": [[0, 3, "GENE"]]}], ["In fetal stages, HGF-neutralization, or c-Met gene destruction, leads to hypoplasia of many organs, indicating that HGF signals are essential for organ development.", {"entities": [[17, 20, "GENE"], [116, 119, "GENE"]]}], ["Endogenous HGF is required for self-repair of injured livers, kidneys, lungs and so on.", {"entities": [[11, 14, "GENE"]]}], ["In addition, HGF exerts protective effects on epithelial and non-epithelial organs (including the heart and brain) via anti-apoptotic and anti-inflammatory signals.", {"entities": [[13, 16, "GENE"]]}], ["During organ diseases, plasma HGF levels significantly increased, while anti-HGF antibody infusion accelerated tissue destruction in rodents.", {"entities": [[30, 33, "GENE"], [77, 80, "GENE"]]}], ["Thus, endogenous HGF is required for minimization of diseases, while insufficient production of HGF leads to organ failure.", {"entities": [[17, 20, "GENE"], [96, 99, "GENE"], [17, 20, "GENE"], [96, 99, "GENE"]]}], ["This is the reason why HGF supplementation produces therapeutic outcomes under pathological conditions.", {"entities": [[23, 26, "GENE"]]}], ["Moreover, emerging studies delineated key roles of HGF during tumor metastasis, while HGF-antagonism leads to anti-tumor outcomes.", {"entities": [[51, 54, "GENE"], [86, 89, "GENE"]]}], ["Taken together, HGF-based molecules, including HGF-variants, HGF-fragments and c-Met-binders are available as regenerative or anti-tumor drugs.", {"entities": []}], ["Molecular analysis of the HGF-c-Met system could provide bridges between basic biology and clinical medicine.", {"entities": []}], ["Unilateral absence of the pulmonary artery (UAPA) or pulmonary artery agenesis is a rare congenital disorder presenting with a wide spectrum of symptoms.", {"entities": []}], ["The clinical presentation is variable and many patients can be asymptomatic for many years and even throughout their lives.", {"entities": []}], ["We report the case of a 53-year-old African-American woman who was diagnosed with right pulmonary artery agenesis after presenting with uncontrolled asthma and recurrent bronchopulmonary infections.", {"entities": [[149, 155, "DISEASE"]]}], ["In an unexplained case of recurrent respiratory infections and shortness of breath, the possibility of a rare congenital anomaly like UAPA should be considered and an appropriate evaluation should be done.", {"entities": []}], ["In Nigeria, access to malaria diagnostics may be expanded if drug retailers were allowed to administer malaria rapid diagnostic tests (RDTs).", {"entities": [[22, 29, "DISEASE"], [103, 110, "DISEASE"]]}], ["A 2012 pilot intervention showed that short message service (SMS) reminder messages could boost treatment adherence to RDT results by 10\u201314% points.", {"entities": [[61, 64, "GENE"]]}], ["This study aimed to replicate the SMS intervention in a different population, and additionally test the effect of an expanded message about anticipated RDT access policy change on customers\u2019 acceptability for drug retailers\u2019 administration of RDTs.", {"entities": [[34, 37, "GENE"]]}], ["One day after being tested with an RDT, participants who purchased malaria treatment from drug shops were randomized to receive (1) a basic SMS reminder repeating the RDT result and appropriate treatment actions, (2) an expanded SMS reminder additionally saying that the \u2018government might allow pharmacists/chemists to do RDTs\u2019 or (3) no SMS reminders (i.e.", {"entities": [[67, 74, "DISEASE"], [140, 143, "GENE"], [229, 232, "GENE"], [338, 341, "GENE"], [140, 143, "GENE"], [229, 232, "GENE"], [338, 341, "GENE"], [140, 143, "GENE"], [229, 232, "GENE"], [338, 341, "GENE"]]}], ["Using regression analysis, we estimate intent-to-treat (ITT) and treatment effects on the treated for 686 study participants.", {"entities": []}], ["Results corroborate previous findings that a basic SMS reminder increased treatment adherence [odds ratio (OR)\u2009=\u20091.53, 95% CI 0.96\u20132.44] and decreased use of unnecessary anti-malarials for RDT-negative adults [OR\u2009=\u20090.63, 95% CI 0.39\u20131.00].", {"entities": [[51, 54, "GENE"]]}], ["The expanded SMS also increased adherence for adults [OR\u2009=\u20091.42, 95% CI 0.97\u20132.07], but the effects for sick children differed\u2014the basic SMS did not have any measurable impact on treatment adherence [OR\u2009=\u20090.87, 95% CI 0.24\u20133.09] or use of unnecessary anti-malarials [OR\u2009=\u20091.27, 95% CI 0.32\u20131.93], and the expanded SMS actually led to poorer treatment adherence [OR\u2009=\u20090.26, 95% CI 0.10\u20130.66] and increased use of unnecessary anti-malarials [OR\u2009=\u20094.67, 95% CI 1.76\u201312.43].", {"entities": [[13, 16, "GENE"], [137, 140, "GENE"], [314, 317, "GENE"], [13, 16, "GENE"], [137, 140, "GENE"], [314, 317, "GENE"], [13, 16, "GENE"], [137, 140, "GENE"], [314, 317, "GENE"]]}], ["Further, the targeted but neutral message in the expanded SMS lowered acceptance for drug retailers' administration of RDTs [OR\u2009=\u20090.55, 95% CI 0.10\u20132.93], counter to what we hypothesized.", {"entities": [[58, 61, "GENE"]]}], ["Future SMS interventions should show consistent positive results across populations and be attuned to message length and content before initiating a larger messaging campaign.", {"entities": [[7, 10, "GENE"]]}], ["Individuals with mental illnesses are overrepresented among the homeless.", {"entities": []}], ["Housing First (HF) has been shown to promote positive outcomes in this population.", {"entities": []}], ["However, key questions remain unresolved, including: how to match support services to client needs, the benefits of housing in scattered sites versus single congregate building, and the effectiveness of HF with individuals actively using substances.", {"entities": []}], ["The present study aimed to recruit two samples of homeless mentally ill participants who differed in the complexity of their needs.", {"entities": []}], ["Study details, including recruitment, randomization, and follow-up, are presented.", {"entities": []}], ["Eligibility was based on homeless status and current mental disorder.", {"entities": []}], ["Participants were classified as either moderate needs (MN) or high needs (HN).", {"entities": []}], ["Those with MN were randomized to HF with Intensive Case Management (HF-ICM) or usual care.", {"entities": []}], ["Those with HN were randomized to HF with Assertive Community Treatment (HF-ACT), congregate housing with support, or usual care.", {"entities": []}], ["Participants were interviewed every 3\u00a0months for 2\u00a0years.", {"entities": []}], ["Separate consent was sought to access administrative data.", {"entities": []}], ["Participants met eligibility for either MN (n\u2009=\u2009200) or HN (n\u2009=\u2009297) and were randomized accordingly.", {"entities": []}], ["Both samples were primarily male and white.", {"entities": []}], ["Compared to participants designated MN, HN participants had higher rates of hospitalization for psychiatric reasons prior to randomization, were younger at the time of recruitment, younger when first homeless, more likely to meet criteria for substance dependence, and less likely to have completed high school.", {"entities": [[243, 263, "DISEASE"]]}], ["Across all study arms, between 92% and 100% of participants were followed over 24\u00a0months post-randomization.", {"entities": []}], ["Minimal significant differences were found between study arms following randomization.", {"entities": []}], ["438 participants (88%) provided consent to access administrative data.", {"entities": []}], ["The study successfully recruited participants meeting criteria for homelessness and current mental disorder.", {"entities": []}], ["Both MN and HN groups had high rates of substance dependence, suicidality, and physical illness.", {"entities": [[40, 60, "DISEASE"]]}], ["Randomization resulted in no meaningful detectable differences between study arms.", {"entities": []}], ["Current Controlled Trials: ISRCTN57595077 (Vancouver at Home study: Housing First plus Assertive Community Treatment versus congregate housing plus supports versus treatment as usual) and ISRCTN66721740 (Vancouver At Home study: Housing First plus Intensive Case Management versus treatment as usual).", {"entities": []}], ["In order to study social health inequalities, contextual (or ecologic) data may constitute an appropriate alternative to individual socioeconomic characteristics.", {"entities": []}], ["Indices can be used to summarize the multiple dimensions of the neighborhood socioeconomic status.", {"entities": []}], ["This work proposes a statistical procedure to create a neighborhood socioeconomic index.", {"entities": []}], ["The study setting is composed of three French urban areas.", {"entities": []}], ["Socioeconomic data at the census block scale come from the 1999 census.", {"entities": []}], ["Successive principal components analyses are used to select variables and create the index.", {"entities": []}], ["Both metropolitan area-specific and global indices are tested and compared.", {"entities": []}], ["Socioeconomic categories are drawn with hierarchical clustering as a reference to determine \u201coptimal\u201d thresholds able to create categories along a one-dimensional index.", {"entities": []}], ["Among the twenty variables finally selected in the index, 15 are common to the three metropolitan areas.", {"entities": []}], ["The index explains at least 57% of the variance of these variables in each metropolitan area, with a contribution of more than 80% of the 15 common variables.", {"entities": []}], ["The proposed procedure is statistically justified and robust.", {"entities": []}], ["It can be applied to multiple geographical areas or socioeconomic variables and provides meaningful information to public health bodies.", {"entities": []}], ["We highlight the importance of the classification method.", {"entities": []}], ["We propose an R package in order to use this procedure.", {"entities": []}], ["Unplanned hospital admissions place a large and increasing strain on healthcare budgets worldwide.", {"entities": []}], ["Many admissions for ambulatory care sensitive conditions (ACSCs) are thought to be preventable, a belief supported by significant geographic variations in admission rates.", {"entities": []}], ["We conducted a systematic review of the evidence on the magnitude and correlates of geographic variation in ACSC admission rates and length of stay (LOS).", {"entities": []}], ["We performed a search of Medline and Embase databases for English language cross-sectional and cohort studies on 28th March 2013 reporting geographic variation in admission rates or LOS for patients receiving unplanned care across at least 10 geographical units for one of 35 previously defined ACSCs.", {"entities": []}], ["Forward and backward citation searches were undertaken on all included studies.", {"entities": []}], ["We provide a narrative synthesis of study findings.", {"entities": []}], ["Study quality was assessed using a modified Newcastle-Ottawa scale.", {"entities": []}], ["We included 39 studies comprising 25 on admission rates and 14 on LOS.", {"entities": []}], ["Studies generally compared admission rates between regions (e.g.", {"entities": []}], ["states) and LOS between hospitals.", {"entities": []}], ["Most of the published research was undertaken in the US, UK or Canada and often focussed on patients with pneumonia, COPD or heart failure.", {"entities": [[106, 115, "DISEASE"]]}], ["35 (90\u00a0%) studies concluded that geographic variation was present.", {"entities": []}], ["Primary care quality and secondary care access were frequently suggested as drivers of admission rate variation whilst secondary care quality and adherence to clinical guidelines were often listed as contributors to LOS variation.", {"entities": []}], ["Several different methods were used to quantify variation, some studies listed raw data, failed to control for confounders and used naive statistical methods which limited their utility.", {"entities": []}], ["The substantial geographical variations in the admission rates and LOS of potentially avoidable conditions could be a symptom of variable quality of care and should be a concern for clinicians and policymakers.", {"entities": []}], ["Policymakers targeting a reduction in unplanned admissions could introduce initiatives to improve primary care access and quality or develop alternatives to admission.", {"entities": []}], ["Those attempting to curb unnecessarily long LOS could introduce care pathways or guidelines.", {"entities": []}], ["Methodological work on the quantification and reporting of geographic variation is needed to aid inter-study comparisons.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-0964-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Sub-epithelial extracellular matrix deposition is a feature of asthmatic airway remodelling associated with severity of disease, decline in lung function and airway hyperresponsiveness.", {"entities": []}], ["The composition of, and mechanisms leading to, this increase in subepithelial matrix, and its importance in the pathogenesis of asthma are unclear.", {"entities": [[128, 134, "DISEASE"]]}], ["This is partly due to limitations of the current models and techniques to assess airway remodelling.", {"entities": []}], ["In this study we used a modified murine model of ovalbumin sensitisation and challenge to reproduce features of airway remodelling, including a sustained increase in sub-epithelial matrix deposition.", {"entities": []}], ["In addition, we have established techniques to accurately and specifically measure changes in sub-epithelial matrix deposition, using histochemical and immunohistochemical staining in conjunction with digital image analysis, and applied these to the measurement of collagen and proteoglycans.", {"entities": []}], ["24 hours after final ovalbumin challenge, changes similar to those associated with acute asthma were observed, including inflammatory cell infiltration, epithelial cell shedding and goblet cell hyperplasia.", {"entities": [[89, 95, "DISEASE"]]}], ["Effects were restricted to the bronchial and peribronchial regions with parenchymal lung of ovalbumin sensitised and challenged mice appearing histologically normal.", {"entities": []}], ["By 12 days, the acute inflammatory changes had largely resolved and increased sub-epithelial staining for collagen and proteoglycans was observed.", {"entities": []}], ["Quantitative digital image analysis confirmed the increased deposition of sub-epithelial collagen (33%, p < 0.01) and proteoglycans (32%, p < 0.05), including decorin (66%, p < 0.01).", {"entities": []}], ["In addition, the increase in sub-epithelial collagen deposition was maintained for at least 28 days (48%, p < 0.001).", {"entities": []}], ["This animal model reproduces many of the features of airway remodelling found in asthma and allows accurate and reproducible measurement of sub-epithelial extra-cellular matrix deposition.", {"entities": [[81, 87, "DISEASE"]]}], ["As far as we are aware, this is the first demonstration of increased sub-epithelial proteoglycan deposition in an animal model of airway remodelling.", {"entities": []}], ["This model will be useful for measurement of other matrix components, as well as for assessment of the molecular mechanisms contributing to, and agents to modulate airway remodelling.", {"entities": []}], ["Many breastfeeding women seek medical care from general practitioners (GPs) for various health problems and GPs may consider prescribing medicines in these consultations.", {"entities": []}], ["Prescribing medicines to a breastfeeding mother may lead to untimely cessation of breastfeeding or a breastfeeding mother may be denied medicines due to the possible risk to her infant, both of which may lead to unwanted consequences.", {"entities": []}], ["Information on factors governing GPs' decision-making and their views in such situations is limited.", {"entities": []}], ["GPs providing shared maternity care at the Royal Women's Hospital, Melbourne were surveyed using an anonymous postal survey to determine their knowledge, attitudes and practices on medicines and breastfeeding, in 2007/2008 (n = 640).", {"entities": []}], ["Content analysis of their response to a question concerning decision-making about the use of medicine for a breastfeeding woman was conducted.", {"entities": []}], ["A thematic network was constructed with basic, organising and global themes.", {"entities": []}], ["335 (52%) GPs responded to the survey, and 253 (76%) provided information on the last time they had to decide about the use of medicine for a breastfeeding woman.", {"entities": []}], ["Conditions reported were mastitis (24%), other infections (24%) and depressive disorders (21%).", {"entities": [[25, 33, "DISEASE"]]}], ["The global theme that emerged was \" complexity of managing risk in prescribing for breastfeeding women\" .", {"entities": []}], ["The organising themes were: certainty around decision-making; uncertainty around decision-making; need for drug information to be available, consistent and reliable; joint decision-making; the vulnerable \"third party\" and infant feeding decision .", {"entities": []}], ["Decision-making is a spectrum from a straight forward decision, such as treatment of mastitis, to a complicated one requiring multiple inputs and consideration.", {"entities": [[85, 93, "DISEASE"]]}], ["GPs use more information seeking and collaboration in decision-making when they perceive the problem to be more complex, for example, in postnatal depression.", {"entities": []}], ["GPs feel that prescribing medicines for breastfeeding women is a contentious issue.", {"entities": []}], ["They manage the risk of prescribing by gathering information and assessing the possible effects on the breastfed infant.", {"entities": []}], ["Without evidence-based information, they sometimes recommend cessation of breastfeeding unnecessarily.", {"entities": []}], ["(1) Background: Transient receptor potential vanilloid 3 ( TRPV3 ) is a member of the TRP channels family of Ca TRPV3 in NSCLC tissues and adjacent noncancerous lung tissues.", {"entities": [[59, 64, "GENE"], [112, 117, "GENE"], [59, 64, "GENE"], [112, 117, "GENE"]]}], ["Western blot was used to detect the protein expressions of TRPV3 , CaMKII , p-CaMKII , CyclinA , CyclinD , CyclinE1 , CDK2 , CDK4 , and P27 .", {"entities": [[59, 64, "GENE"], [118, 122, "GENE"], [125, 129, "GENE"]]}], ["Small interfering RNA was used to deplete TRPV3 expression.", {"entities": [[42, 47, "GENE"]]}], ["A laser scanning confocal microscope was used to measure intracellular calcium concentration ([Ca i ).", {"entities": []}], ["Flow cytometry was used to analyze cell cycle; (3) Results: TRPV3 was overexpressed in 65 of 96 (67.7%) human lung cancer cases and correlated with differentiation ( p = 0.001) and TNM stage ( p = 0.004).", {"entities": [[110, 121, "DISEASE"], [115, 121, "DISEASE"], [60, 65, "GENE"]]}], ["Importantly, TRPV3 expression was associated with short overall survival.", {"entities": [[13, 18, "GENE"]]}], ["In addition, blocking or knockdown of TRPV3 could inhibit lung cancer cell proliferation.", {"entities": [[58, 69, "DISEASE"], [63, 69, "DISEASE"], [38, 43, "GENE"]]}], ["Moreover, TRPV3 inhibition could decrease [Ca i of lung cancer cells and arrest cell cycle at the G1/S boundary.", {"entities": [[51, 62, "DISEASE"], [56, 62, "DISEASE"], [10, 15, "GENE"]]}], ["Further results revealed that TRPV3 inhibition decreased expressions of p-CaMKII , CyclinA , CyclinD1 , CyclinE , and increased P27 level; (4) Conclusions: Our findings demonstrate that TRPV3 was overexpressed in NSCLC and correlated with lung cancer progression.", {"entities": [[239, 250, "DISEASE"], [244, 250, "DISEASE"], [30, 35, "GENE"], [186, 191, "GENE"], [30, 35, "GENE"], [186, 191, "GENE"]]}], ["TRPV3 activation could promote proliferation of lung cancer cells.", {"entities": [[48, 59, "DISEASE"], [53, 59, "DISEASE"], [0, 5, "GENE"]]}], ["TRPV3 might serve as a potential companion drug target in NSCLC.", {"entities": [[0, 5, "GENE"]]}], ["We undertook a 2X2 factorial, randomized controlled trial (RCT) to assess whether vitamin D 3 supplementation (10,000 international units per week) versus placebo and gargling versus no gargling could prevent viral, clinical upper respiratory tract infection (URTI) in university students.", {"entities": []}], ["We randomized 600 students into 4 treatment arms: 1) vitamin D 3 and gargling, 2) placebo and gargling, 3) vitamin D 3 and no gargling, and 4) placebo and no gargling.", {"entities": []}], ["Students completed weekly electronic surveys and submitted self-collected mid-turbinate nasal flocked swabs during September and October in 2010 or 2011.", {"entities": []}], ["Symptomatic students also completed an electronic symptom diary.", {"entities": []}], ["The primary and secondary outcomes were the occurrence of symptomatic clinical URTI and laboratory confirmed URTI respectively.", {"entities": []}], ["Of 600 participants, 471 (78.5%) completed all surveys while 43 (7.2%) completed none; 150 (25.0%) reported clinical URTI.", {"entities": []}], ["Seventy participants (23.3%) randomized to vitamin D 3 reported clinical URTI compared to 80 (26.7%) randomized to placebo (RR:0.79, CI 95 :0.61-1.03, p\u2009=\u20090.09).", {"entities": []}], ["Eighty-five participants (28.3%) randomized to gargling reported clinical URTI compared to 65 participants (21.7%) randomized to the no gargling arm (RR:1.3, CI 95 :0.92-1.57, p\u2009=\u20090.19).", {"entities": []}], ["Laboratory testing identified 70 infections (46.7 per 100 URTIs).", {"entities": []}], ["Vitamin D 3 treatment was associated with a significantly lower risk for laboratory confirmed URTI (RR: 0.54, CI 95 :0.34-0.84, p\u2009=\u20090.007) and with a significantly lower mean viral load measured as log 10 viral copies/mL (mean difference: -0.89, CI 95: -1.7, -0.06, p\u2009=\u20090.04).", {"entities": []}], ["Fewer students assigned to gargling experienced laboratory confirmed URTI, however this was not statistically significant (RR:0.82, CI 95 :0.53-1.26, p\u2009=\u20090.36).", {"entities": []}], ["These results suggest that vitamin D 3 is a promising intervention for the prevention of URTI.", {"entities": []}], ["Vitamin D 3 significantly reduced the risk of laboratory confirmed URTI and may reduce the risk of clinical infections.", {"entities": []}], ["Clinical Trials Registration: NCT01158560 .", {"entities": []}], ["This study identifies several characteristics of individuals who report their physical and/or mental health as being adversely affected by summertime heat and humidity, within the most disadvantaged neighbourhoods of the nine largest cities of Qu\u00e9bec (Canada).", {"entities": []}], ["The study is cross-sectional by stratified representative sample; 3485 people were interviewed in their residence.", {"entities": []}], ["The prevalence of reported impacts was 46%, mostly physical health.", {"entities": []}], ["Female gender and long-term medical leave are two impact risk indicators in people <65 years of age.", {"entities": []}], ["Low income and air conditioning at home are risk indicators at all ages.", {"entities": []}], ["Results for having \u22652 diagnoses of chronic diseases, particularly for people self-describing as in poor health (odds ratio, OR <65 = 5.6; OR \u226565 = 4.2), and perceiving daily stress, are independent of age.", {"entities": []}], ["The prevalence of reported heat-related health impacts is thus very high in those inner cities, with notable differences according to age, stress levels and long-term medical leave, previously unmentioned in the literature.", {"entities": []}], ["Finally, the total number of pre-existing medical conditions seems to be a preponderant risk factor.", {"entities": []}], ["This study complements the epidemiologic studies based on mortality or severe morbidity and shows that the heat-related burden of disease appears very important in those communities, affecting several subgroups differentially.", {"entities": []}], ["The pivotal role of spleen CD4 Plasmodium infection.", {"entities": [[27, 30, "GENE"]]}], ["Herein, we examined in detail the behaviour of non-conventional and conventional splenic CD4 P. chabaudi malaria.", {"entities": [[105, 112, "DISEASE"], [89, 92, "GENE"]]}], ["We took advantage of the fact that a great proportion of CD4 P. chabaudi malaria, acting in parallel with non-conventional CD4 Plasmodium infection.", {"entities": [[73, 80, "DISEASE"], [57, 60, "GENE"], [123, 126, "GENE"], [57, 60, "GENE"], [123, 126, "GENE"]]}], ["The family of Toll-like receptors (TLRs) is critical in linking innate and acquired immunity.", {"entities": []}], ["Polymorphisms in the genes encoding TLRs have been associated with autoimmune diseases and cancer.", {"entities": [[91, 97, "DISEASE"]]}], ["We investigated the genetic variation of TLR genes and its potential impact on melanoma susceptibility and patient survival.", {"entities": [[79, 87, "DISEASE"]]}], ["The study included 763 cutaneous melanoma cases recruited in Germany and 736 matched controls that were genotyped for 47 single nucleotide polymorphisms (SNPs) in 8 TLR genes.", {"entities": [[33, 41, "DISEASE"]]}], ["The relationship between genotype, disease status and survival was investigated taking into account patient and tumor characteristics, and melanoma treatment.", {"entities": [[139, 147, "DISEASE"]]}], ["Analysis of 7 SNPs in TLR2 , 7 SNPs in TLR3 and 8 SNPs in TLR4 showed statistically significant differences in distribution of inferred haplotypes between cases and controls.", {"entities": [[22, 26, "GENE"], [39, 43, "GENE"], [58, 62, "GENE"]]}], ["No individual polymorphism was associated with disease susceptibility except for the observed tendency for TLR 2-rs3804099 (odds ratio OR \u200a=\u200a1.15, 95% CI 0.99\u20131.34, p\u200a=\u200a0.07) and TLR4 -rs2149356 (OR\u200a=\u200a0.85, 95% CI 0.73\u20131.00, p\u200a=\u200a0.06).", {"entities": [[179, 183, "GENE"]]}], ["Both polymorphisms were part of the haplotypes associated with risk modulation.", {"entities": []}], ["An improved overall survival (Hazard ratio HR 0.53, 95% CI 0.32\u20130.88) and survival following metastasis (HR 0.55, 95% CI 0.34\u20130.91) were observed in carriers of the variant allele (D299G) of TLR4 -rs4986790.", {"entities": [[43, 45, "GENE"], [105, 107, "GENE"], [43, 45, "GENE"], [105, 107, "GENE"], [191, 195, "GENE"]]}], ["In addition various TLR2, TLR4 and TLR5 haplotypes were associated with increased overall survival.", {"entities": [[20, 24, "GENE"], [26, 30, "GENE"], [35, 39, "GENE"]]}], ["Our results point to a novel association between TLR gene variants and haplotypes with melanoma survival.", {"entities": [[87, 95, "DISEASE"]]}], ["Our data suggest a role for the D299G polymorphism in the TLR4 gene in overall survival and a potential link with systemic treatment at stage IV of the disease.", {"entities": [[58, 62, "GENE"]]}], ["The polymorphic amino acid residue, located in the ectodomain of TLR4 , can have functional consequences.", {"entities": [[65, 69, "GENE"]]}], ["Combination therapies exploit the chances for better efficacy, decreased toxicity, and reduced development of drug resistance and owing to these advantages, have become a standard for the treatment of several diseases and continue to represent a promising approach in indications of unmet medical need.", {"entities": []}], ["In this context, studying the effects of a combination of drugs in order to provide evidence of a significant superiority compared to the single agents is of particular interest.", {"entities": []}], ["Research in this field has resulted in a large number of papers and revealed several issues.", {"entities": []}], ["Here, we propose an overview of the current methodological landscape concerning the study of combination effects.", {"entities": []}], ["First, we aim to provide the minimal set of mathematical and pharmacological concepts necessary to understand the most commonly used approaches, divided into effect-based approaches and dose\u2013effect-based approaches, and introduced in light of their respective practical advantages and limitations.", {"entities": []}], ["Then, we discuss six main common methodological issues that scientists have to face at each step of the development of new combination therapies.", {"entities": []}], ["In particular, in the absence of a reference methodology suitable for all biomedical situations, the analysis of drug combinations should benefit from a collective, appropriate, and rigorous application of the concepts and methods reviewed here.", {"entities": []}], ["The role of obesity in the prevalence and clustering of multimorbidity, the occurrence of two or more chronic conditions, is understudied.", {"entities": [[12, 19, "DISEASE"]]}], ["We estimated the prevalence of multimorbidity by obesity status, and the interaction of obesity with other predictors of multimorbidity.", {"entities": [[49, 56, "DISEASE"], [88, 95, "DISEASE"]]}], ["Data from adult respondents (18\u00a0years and over) to the Health Quality Council of Alberta 2012 Patient Experience Survey were analyzed.", {"entities": []}], ["Multivariable regression models were fitted to test for associations.", {"entities": []}], ["The survey sample included 4803 respondents; 55.8% were female and the mean age was 47.8\u00a0years (SD, 17.1).", {"entities": []}], ["The majority (62.0%) of respondents reported having at least one chronic condition.", {"entities": []}], ["The prevalence of multimorbidity, including obesity, was 36.0% (95% CI, 34.8 \u2013 37.3).", {"entities": [[44, 51, "DISEASE"]]}], ["The prevalence of obesity alone was 28.1% (95% CI 26.6 \u2013 29.5).", {"entities": [[18, 25, "DISEASE"]]}], ["Having obesity was associated with more than double the odds of multimorbidity (odds ratio\u2009=\u20092.2, 95% CI 1.9 \u2013 2.7) compared to non-obese.", {"entities": [[7, 14, "DISEASE"]]}], ["The prevalence of multimorbidity in the general population is high, but even higher in obese than non-obese persons.", {"entities": []}], ["These findings may be relevant for surveillance, prevention and management strategies for multimorbidity.", {"entities": []}], ["Mountain ecosystems all over the world support a high biological diversity and provide home and services to some 12% of the global human population, who use their traditional ecological knowledge to utilise local natural resources.", {"entities": []}], ["The Himalayas are the world's youngest, highest and largest mountain range and support a high plant biodiversity.", {"entities": []}], ["In this remote mountainous region of the Himalaya, people depend upon local plant resources to supply a range of goods and services, including grazing for livestock and medicinal supplies for themselves.", {"entities": []}], ["Due to their remote location, harsh climate, rough terrain and topography, many areas within this region still remain poorly known for its floristic diversity, plant species distribution and vegetation ecosystem service.", {"entities": []}], ["The Naran valley in the north-western Pakistan is among such valleys and occupies a distinctive geographical location on the edge of the Western Himalaya range, close to the Hindu Kush range to the west and the Karakorum Mountains to the north.", {"entities": []}], ["It is also located on climatic and geological divides, which further add to its botanical interest.", {"entities": []}], ["In the present project 120 informants were interviewed at 12 main localities along the 60 km long valley.", {"entities": []}], ["This paper focuses on assessment of medicinal plant species valued by local communities using their traditional knowledge.", {"entities": []}], ["Results revealed that 101 species belonging to 52 families (51.5% of the total plants) were used for 97 prominent therapeutic purposes.", {"entities": []}], ["The largest number of ailments cured with medicinal plants were associated with the digestive system (32.76% responses) followed by those associated with the respiratory and urinary systems (13.72% and 9.13% respectively).", {"entities": []}], ["The ailments associated with the blood circulatory and reproductive systems and the skin were 7.37%, 7.04% and 7.03%, respectively.", {"entities": []}], ["The results also indicate that whole plants were used in 54% of recipes followed by rhizomes (21%), fruits (9.5%) and roots (5.5%).", {"entities": []}], ["Our findings demonstrate the range of ecosystem services that are provided by the vegetation and assess how utilisation of plants will impact on future resource sustainability.", {"entities": []}], ["The study not only contributes to an improved understanding of traditional ethno-ecological knowledge amongst the peoples of the Western Himalaya but also identifies priorities at species and habitat level for local and regional plant conservation strategies.", {"entities": []}], ["Scientifically based clinical guidelines are increasingly directing medical care.", {"entities": []}], ["Two such guidelines are the National Asthma Education Program 2 (NAEP2) and the ATS/CDC Tuberculosis Guidelines.", {"entities": [[37, 43, "DISEASE"]]}], ["While these expert-derived guidelines are potentially very useful, it is difficult for individual physicians to be knowledgeable about all these guidelines and even more difficult for them to apply the guidelines to a specific patient care setting.", {"entities": []}], ["Computer networks offer the potential to bridge this need and individualize guidelines to providers at the point of clinical contact.", {"entities": []}], ["Using content from the NAEP2 and the TB Guidelines, we developed two computer-based delivery systems using the Internet.", {"entities": []}], ["Using CGI and NAEP2, we developed an algorithm to stage acute asthma disease severity and deliver specific recommendations to physicians.", {"entities": [[62, 68, "DISEASE"]]}], ["We tested the computer-delivered algorithm using patient scenarios.", {"entities": []}], ["Using the TB Guidelines, we also developed an html-linked decision support tool to deliver appropriate treatment recommendations based on answering three clinical questions.", {"entities": []}], ["We again tested the utility of the program using patient scenario testing.", {"entities": []}], ["We first validated the asthma algorithm by comparing asthma expert's decisions with the decisions reached by non-pulmonary nurses using the computerized decision support system (DSS).", {"entities": [[23, 29, "DISEASE"], [53, 59, "DISEASE"]]}], ["Using the DSS, nurses scored the same as experts (89 \u00b1 1.4% vs. 88 \u00b1 3%; p=NS).", {"entities": []}], ["Using the same test, we next compared internal medicine residents using the computerized DSS to residents using the paper version of NAEP2 asthma guidelines.", {"entities": [[139, 145, "DISEASE"]]}], ["Residents using the computerized DSS scored significantly better than residents using the paper-based NAEP2 guidelines (92 \u00b1 1.7% vs. 84 \u00b1 1.5%; p<.002).", {"entities": []}], ["When we similarly compared residents using the computerized TB DSS to residents using a reference card, the residents using the computerized DSS scored significantly better (95.8% correct vs. 56.6%; p<.01).", {"entities": []}], ["Clinical guidelines are increasingly common in chronic disease management.", {"entities": []}], ["Previous work has demonstrated that traditional educational interventions are minimally effective at altering physician behavior.", {"entities": []}], ["In other settings, learning occurs best when coupled to relevant activity.", {"entities": []}], ["Computers can aid with this learning by providing relevant information to the clinician when they need it to make clinical decisions.", {"entities": []}], ["Using two different sets of guidelines, we have demonstrated that computer-based DSS's delivered over the Internet are more effective than traditional resources in improving physician performance as measured by compliance with guidelines.", {"entities": []}], ["We conclude that guidelines can be adapted to deliver individualized recommendations using the Internet and that computer-delivered recommendations are effective at improving physician compliance.", {"entities": []}], ["Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung diseases has been associated with a higher risk of pneumonia, particularly in COPD.", {"entities": [[130, 139, "DISEASE"]]}], ["The risk of pneumonia has not been previously evaluated in relation to ICS particle size and dose used.", {"entities": [[12, 21, "DISEASE"]]}], ["Historical cohort, UK database study of 23,013 patients with obstructive lung disease aged 12\u201380 years prescribed extra-fine or fine-particle ICS.", {"entities": [[61, 85, "DISEASE"], [73, 85, "DISEASE"]]}], ["The endpoints assessed during the outcome year were diagnosis of pneumonia, acute exacerbations and acute respiratory events in relation to ICS dose.", {"entities": [[65, 74, "DISEASE"]]}], ["To determine the association between ICS particle size, dose and risk of pneumonia in unmatched and matched treatment groups, logistic and conditional logistic regression models were used.", {"entities": [[73, 82, "DISEASE"]]}], ["14788 patients were stepped-up to fine-particle ICS and 8225 to extra-fine ICS.", {"entities": []}], ["On unmatched analysis, patients stepping-up to extra-fine ICS were significantly less likely to be coded for pneumonia (adjusted odds ratio [aOR] 0.60; 95% CI 0.37, 0.97]); experience acute exacerbations (adjusted risk ratio [aRR] 0.91; 95%CI 0.85, 0.97); and acute respiratory events (aRR 0.90; 95%CI 0.86, 0.94) compared with patients stepping-up to fine-particle ICS.", {"entities": [[109, 118, "DISEASE"]]}], ["Patients prescribed daily ICS doses in excess of 700 mcg (fluticasone propionate equivalent) had a significantly higher risk of pneumonia (OR [95%CI] 2.38 [1.17, 4.83]) compared with patients prescribed lower doses, irrespective of particle size.", {"entities": [[128, 137, "DISEASE"]]}], ["These findings suggest that patients with obstructive lung disease on extra-fine particle ICS have a lower risk of pneumonia than those on fine-particle ICS, with those receiving higher ICS doses being at a greater risk.", {"entities": [[42, 66, "DISEASE"], [115, 124, "DISEASE"], [54, 66, "DISEASE"]]}], ["To evaluate the hypoglycemic activity of various extracts, petroleum ether, chloroform and aqueous extract of Cassia occidentalis in normal and alloxan-induced diabetic rats.", {"entities": []}], ["Petroleum ether, chloroform and aqueous extract of whole plant of Cassia occidentalis were orally tested at the dose of 200 mg/kg for hypoglycemic effect in normal and alloxan-induced diabetic rats.", {"entities": []}], ["In addition, changes in body weight, serum cholesterol, triglyceride and total protein levels, assessed in the ethanol extract-treated diabetic rats, were compared with diabetic control and normal animals.", {"entities": []}], ["Histopathological observations during 21 days treatment were also evaluated.", {"entities": []}], ["Aqueous extract of C. occidentalis produced a significant reduction in fasting blood glucose levels in the normal and alloxan-induced diabetic rats.", {"entities": []}], ["Apart from aqueous extract, petroleum ether extract showed activity from day 14 and chloroform extract showed activity from 7 days.", {"entities": []}], ["Significant differences were observed in serum lipid profiles (cholesterol and triglyceride), serum protein, and changes in body weight by aqueous extract treated-diabetic animals, when compared with the diabetic control and normal animals.", {"entities": []}], ["Concurrent histopathological studies of the pancreas of these animals showed comparable regeneration by extract which were earlier necrosed by alloxan.", {"entities": []}], ["Aqueous extract of C. occidentalis exhibited significant antihyperglycemic activity in normal and alloxan-induced diabetic rats.", {"entities": []}], ["They also showed improvement in parameters like body weight and serum lipid profiles as well as histopathological studies showed regeneration of \u03b2-cells of pancreas and so might be of value in diabetes treatment.", {"entities": []}], ["Quality measurement and feedback programs have become widespread and are looked upon as a cornerstone of quality improvement efforts.", {"entities": []}], ["Often, such programs are used to motivate consumer choice through public report cards or to reward high quality care through pay for performance programs.", {"entities": []}], ["Physicians\u2019 views on performance measurement and feedback programs, however, are rarely sought, despite the potential usefulness for improving the impact of such programs.", {"entities": []}], ["The new IJHPR paper by Nissanholtz-Gannot and colleagues provides important data on physicians\u2019 views of the Israeli quality measurement program that demonstrates strong support for the program among Israeli physicians while also identifying potential areas for improvement.", {"entities": []}], ["Respiratory virus infections are commonly associated with COPD exacerbations, but little is known about the mechanisms linking virus infection to exacerbations.", {"entities": []}], ["Pathogenic mechanisms in stable COPD include oxidative and nitrosative stress and reduced activity of histone deacetylase-2 (HDAC2), but their roles in COPD exacerbations is unknown.", {"entities": [[125, 130, "GENE"]]}], ["We investigated oxidative and nitrosative stress (O&NS) and HDAC2 in COPD exacerbations using experimental rhinovirus infection.", {"entities": [[60, 65, "GENE"]]}], ["Nine subjects with COPD (Global Initiative for Chronic Obstructive Lung Disease stage II), 10 smokers, and 11 nonsmokers were successfully infected with rhinovirus.", {"entities": []}], ["Markers of O&NS-associated cellular damage, and inflammatory mediators and proteases were measured in sputum, and HDAC2 activity was measured in sputum and bronchoalveolar macrophages.", {"entities": [[114, 119, "GENE"]]}], ["In an in\u00a0vitro model, monocyte-derived THP-1 cells were infected with rhinovirus and nitrosylation and activity of HDAC2 was measured.", {"entities": [[115, 120, "GENE"]]}], ["Rhinovirus infection induced significant increases in airways inflammation and markers of O&NS in subjects with COPD.", {"entities": []}], ["O&NS markers correlated with virus load and inflammatory markers.", {"entities": []}], ["Macrophage HDAC2 activity was reduced during exacerbation and correlated inversely with virus load, inflammatory markers, and nitrosative stress.", {"entities": [[11, 16, "GENE"]]}], ["Sputum macrophage HDAC2 activity pre-infection was inversely associated with sputum virus load and inflammatory markers during exacerbation.", {"entities": [[18, 23, "GENE"]]}], ["Rhinovirus infection of monocytes induced nitrosylation of HDAC2 and reduced HDAC2 activity; inhibition of O&NS inhibited rhinovirus-induced inflammatory cytokines.", {"entities": [[59, 64, "GENE"], [77, 82, "GENE"], [59, 64, "GENE"], [77, 82, "GENE"]]}], ["O&NS, airways inflammation, and impaired HDAC2 may be important mechanisms of virus-induced COPD exacerbations.", {"entities": [[41, 46, "GENE"]]}], ["Therapies targeting these mechanisms offer potential new treatments for COPD exacerbations.", {"entities": []}], ["Activation of the immune system occurs in response to the recognition of foreign antigens and receipt of optimal stimulatory signals by immune cells, a process that requires energy.", {"entities": []}], ["Energy is also needed to support cellular growth, differentiation, proliferation, and effector functions of immune cells.", {"entities": []}], ["In HIV-infected individuals, persistent viral replication, together with inflammatory stimuli contributes to chronic immune activation and oxidative stress.", {"entities": []}], ["These conditions remain even in subjects with sustained virologic suppression on antiretroviral therapy.", {"entities": []}], ["Here we highlight recent studies demonstrating the importance of metabolic pathways, particularly those involving glucose metabolism, in differentiation and maintenance of the activation states of T cells and monocytes.", {"entities": []}], ["We also discuss how changes in the metabolic status of these cells may contribute to ongoing immune activation and inflammation in HIV- infected persons and how this may contribute to disease progression, establishment and persistence of the HIV reservoir, and the development of co-morbidities.", {"entities": []}], ["We provide evidence that other viruses such as Epstein\u2013Barr and Flu virus also disrupt the metabolic machinery of their host cells.", {"entities": []}], ["Finally, we discuss how redox signaling mediated by oxidative stress may regulate metabolic responses in T cells and monocytes during HIV infection.", {"entities": []}], ["\u2022 Dysfunctional glucose metabolism in CD4+ T cells and monocytes is a hallmark of HIV+ infection.", {"entities": []}], ["\u2022 Increased glycolysis in CD4+ T cells in HIV+ individuals is associated with immune activation and low CD4+ T cell counts.", {"entities": []}], ["\u2022 Increased glycolytic flux is required for virion production and increases CD4+ T cell propensity to apoptosis.", {"entities": []}], ["\u2022 Glycolytic metabolites can disengage metabolism to control immune cell functions and promote survival of HIV-infected cells.", {"entities": []}], ["\u2022 Immunometabolism offers novel opportunities for HIV cure and remission strategies.", {"entities": []}], ["\u2022 Elevated Glut1 on pro-inflammatory monocyte is a potential biomarker for HIV-associated co-morbidities.", {"entities": []}], ["Dysfunctional glucose metabolism in CD4+ T cells and monocytes is a hallmark of HIV+ infection.", {"entities": []}], ["Increased glycolysis in CD4+ T cells in HIV+ individuals is associated with immune activation and low CD4+ T cell counts.", {"entities": []}], ["Increased glycolytic flux is required for virion production and increases CD4+ T cell propensity to apoptosis.", {"entities": []}], ["Glycolytic metabolites can disengage metabolism to control immune cell functions and promote survival of HIV-infected cells.", {"entities": []}], ["Immunometabolism offers novel opportunities for HIV cure and remission strategies.", {"entities": []}], ["Elevated Glut1 on pro-inflammatory monocyte is a potential biomarker for HIV-associated co-morbidities.", {"entities": []}], ["The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure.", {"entities": []}], ["Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 10 The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05).", {"entities": [[21, 40, "DISEASE"]]}], ["However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules.", {"entities": []}], ["With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group.", {"entities": []}], ["The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span.", {"entities": []}], ["At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women.", {"entities": []}], ["Comparison of the two groups regarding \"Time from cure to relapse\" was statistically significant (p = 0.027) in favour of the lactobacilli treatment.", {"entities": []}], ["Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54\u20130.98) (p < 0.05) The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up.", {"entities": [[124, 126, "GENE"]]}], ["ISRCTN62879834", {"entities": []}], ["Gastroesophageal reflux (GER) has been implicated in the pathogenesis of chronic cough.", {"entities": []}], ["The aims of this study were to evaluate the diagnostic usefulness of multichannel intraluminal impedance combined with pH monitoring (MII/pH monitoring) in patients with suspected symptoms of gastroesophageal reflux disease (GERD) and to assess the correlation between GER symptoms and reflux nature.", {"entities": [[192, 223, "DISEASE"]]}], ["Seventy patients with suspected symptoms of GERD (such as heartburn, acid regurgitation, non-cardiac chest pain, globus and chronic cough) were enrolled.", {"entities": []}], ["All patients were asked to discontinue medications that would influence esophageal motor function and gastric acid secretion at least one week ago.", {"entities": []}], ["All subjects underwent MII/pH monitoring.", {"entities": []}], ["Forty-five patients (64.3%) were diagnosed with GERD.", {"entities": []}], ["Among these patients, eleven patients (15.7%) had pathologic acid reflux by pH data and thirty-four patients (48.6%) had pathologic bolus exposure by impedance.", {"entities": []}], ["Subjects with chronic cough had a higher DeMeester score (p=0.009), percentage of acid exposure time (p=0.007), acid bolus exposure % time (p=0.027), distal acid reflux episodes (p=0.015) and proximal acid reflux episodes (p=0.030) than subjects without chronic cough.", {"entities": []}], ["The results of this study showed that the impedance monitoring enhanced diagnostic sensitivity than pH-monitoring alone by 48.6%.", {"entities": []}], ["In addition, reflux episodes at the distal and proximal esophagus were noted to be important factors associated with chronic cough.", {"entities": []}], ["The analysis of complex diseases is an important problem in human genetics.", {"entities": []}], ["Because multifactoriality is expected to play a pivotal role, many studies are currently focused on collecting information on the genetic and environmental factors that potentially influence these diseases.", {"entities": []}], ["However, there is still a lack of efficient and thoroughly tested statistical models that can be used to identify implicated features and their interactions.", {"entities": []}], ["Simulations using large biologically realistic data sets with known gene-gene and gene-environment interactions that influence the risk of a complex disease are a convenient and useful way to assess the performance of statistical methods.", {"entities": []}], ["The Gene-Environment iNteraction Simulator 2 (GENS2) simulates interactions among two genetic and one environmental factor and also allows for epistatic interactions.", {"entities": []}], ["GENS2 is based on data with realistic patterns of linkage disequilibrium, and imposes no limitations either on the number of individuals to be simulated or on number of non-predisposing genetic/environmental factors to be considered.", {"entities": []}], ["The GENS2 tool is able to simulate gene-environment and gene-gene interactions.", {"entities": []}], ["To make the Simulator more intuitive, the input parameters are expressed as standard epidemiological quantities.", {"entities": []}], ["GENS2 is written in Python language and takes advantage of operators and modules provided by the simuPOP simulation environment.", {"entities": []}], ["It can be used through a graphical or a command-line interface and is freely available from http://sourceforge.net/projects/gensim .", {"entities": []}], ["The software is released under the GNU General Public License version 3.0.", {"entities": []}], ["Data produced by GENS2 can be used as a benchmark for evaluating statistical tools designed for the identification of gene-gene and gene-environment interactions.", {"entities": []}], ["The TNF-family cytokine TL1A (TNFSF15) costimulates T cells and promotes diverse T-cell dependent models of autoimmune disease through its receptor DR3.", {"entities": [[30, 37, "GENE"]]}], ["TL1A polymorphisms also confer susceptibility to inflammatory bowel disease.", {"entities": [[49, 75, "DISEASE"]]}], ["Here we find that allergic pathology driven by constitutive TL1A expression depends on IL-13, but not T, NKT, mast cells or commensal intestinal flora.", {"entities": []}], ["Group 2 innate lymphoid cells (ILC2) express surface DR3 and produce IL-13 and other type 2 cytokines in response to TL1A.", {"entities": []}], ["DR3 is required for ILC2 expansion and function in the setting of T cell dependent and independent models of allergic disease.", {"entities": []}], ["By contrast, DR3 deficient ILC2 can still differentiate, expand and produce IL-13 when stimulated by IL-25 or IL-33, and mediate expulsion of intestinal helminths.", {"entities": []}], ["These data identify costimulation of ILC2 as a novel function of TL1A important for allergic lung disease, and suggest that TL1A may be a therapeutic target in these settings.", {"entities": [[93, 105, "DISEASE"]]}], ["Universities Allied for Essential Medicines organized its first Neglected Diseases and Innovation Symposium to address expanding roles of public sector research institutions in innovation in research and development of biomedical technologies for treatment of diseases, particularly neglected tropical diseases.", {"entities": []}], ["Universities and other public research institutions are increasingly integrated into the pharmaceutical innovation system.", {"entities": []}], ["Academic entities now routinely undertake robust high-throughput screening and medicinal chemistry research programs to identify lead compounds for small molecule drugs and novel drug targets.", {"entities": []}], ["Furthermore, product development partnerships are emerging between academic institutions, non-profit entities, and biotechnology and pharmaceutical companies to create diagnostics, therapies, and vaccines for diseases of the poor.", {"entities": []}], ["With not for profit mission statements, open access publishing standards, open source platforms for data sharing and collaboration, and a shift in focus to more translational research, universities and other public research institutions are well-placed to accelerate development of medical technologies, particularly for neglected tropical diseases.", {"entities": []}], ["Oral bisphosphonates are commonly used to prevent / treat osteoporosis.", {"entities": [[58, 70, "DISEASE"]]}], ["However, bisphosphonate treatment is not without risk and serious adverse effects, including upper gastrointestinal bleeding (UGIB) have been described.", {"entities": []}], ["We sought to determine if new users of bisphosphonate drugs were more likely to suffer a serious UGIB within 120\u00a0days of drug initiation.", {"entities": []}], ["This was a population-based nested cohort study utilizing administrative healthcare data in British Columbia, Canada.", {"entities": []}], ["Community based individuals \u2265 65\u00a0years with a new prescription for a bisphosphonate between 1991 and 2007 were included.", {"entities": []}], ["A multivariate logistic regression model was used to examine the relationship between older age and the development of a serious UGIB within 120\u00a0days of new exposure to oral bisphosphonate drugs.", {"entities": []}], ["Within the exposure cohort (n = 26,223), 117 individuals had suffered a serious UGIB within 120\u00a0days of incident bisphosphonate use.", {"entities": []}], ["Cases tended to be > 80\u00a0years old, and were significantly more likely to have had a past history of gastric ulcer disease, a remote history of serious UGIB, and had been dispensed proton pump inhibitor (PPI) medications (p < 0.001 for all comparisons).", {"entities": [[100, 113, "DISEASE"]]}], ["After adjustment for confounding covariates, those > 80\u00a0years were more than twice as likely to suffer a UGIB when compared to those \u2264 80\u00a0years (adjusted OR = 2.03; 95% CI 1.40\u20132.94).", {"entities": []}], ["A past history of serious UGIB was the strongest predictor of UGIB within 120\u00a0days of incident bisphosphonate use (adjusted OR = 2.28; 95% CI = 1.29\u20134.03) followed by PPI use (adjusted OR = 2.04; 95% CI = 1.35\u20133.07).", {"entities": []}], ["Males were 70% more likely to suffer an UGIB compared to females (adjusted OR = 1.69; 95% CI = 1.05\u20132.72).", {"entities": []}], ["Upper GIB is a rare, but serious, side effect of bisphosphonate therapy more often afflicting older individuals.", {"entities": []}], ["At the same time, concern about potential rare adverse events should not discourage clinicians from prescribing bisphosphonate drugs, particularly in older patients who have already sustained a fragility fracture.", {"entities": []}], ["Clinicians must remain cognizant of potential adverse events associated with bisphosphonate use and should routinely ask about pre-existing GI disorders and concurrent medication history prior to prescribing these drugs.", {"entities": []}], ["Hereditary angioedema ( HAE ) due to C1 inhibitor deficiency manifests as recurrent swelling attacks that can be disabling and sometimes fatal.", {"entities": [[11, 21, "DISEASE"]]}], ["Long\u2010term prophylaxis with twice\u2010weekly intravenous injections of plasma\u2010derived C1\u2010inhibitor (pdC1\u2010 INH ) has been established as an effective treatment.", {"entities": []}], ["Subcutaneous ( SC ) administration of pdC1\u2010 INH has not been studied in patients with HAE .", {"entities": []}], ["This open\u2010label, dose\u2010ranging, crossover study ( COMPACT Phase II ) was conducted in 18 patients with type I or II HAE who received two of twice\u2010weekly 1500, 3000, or 6000\u00a0IU SC doses of highly concentrated volume\u2010reduced CSL 830 for 4\u00a0weeks each.", {"entities": []}], ["The mean trough plasma levels of C1\u2010 INH functional activity, C1\u2010 INH and C4 antigen levels during Week 4, and overall safety and tolerability were evaluated.", {"entities": []}], ["The primary outcome was model\u2010derived steady\u2010state trough C1\u2010 INH functional activity.", {"entities": []}], ["After SC CSL 830 administration, a dose\u2010dependent increase in trough functional C1\u2010 INH activity was observed.", {"entities": []}], ["C1\u2010 INH and C4 levels both increased.", {"entities": []}], ["The two highest dose groups (3000 and 6000\u00a0IU) achieved constant C1\u2010 INH activity levels above 40% values, a threshold that was assumed to provide clinical protection against angioedema attacks.", {"entities": [[175, 185, "DISEASE"]]}], ["Compared with intravenous injection, pdC1\u2010 INH SC injection with CSL 830 showed a lower peak\u2010to\u2010trough ratio and more consistent exposures.", {"entities": []}], ["All doses were well tolerated.", {"entities": []}], ["Mild\u2010to\u2010moderate local site reactions were noted with pain and swelling being the most common adverse event.", {"entities": []}], ["Subcutaneous volume\u2010reduced CSL 830 was well tolerated and led to a dose\u2010dependent increase in physiologically relevant functional C1\u2010 INH plasma levels.", {"entities": []}], ["A clinical outcome study of SC CSL 830 in patients with HAE warrants further investigation.", {"entities": []}], ["Clinical management of diabetic ketoacidosis (DKA) continues to be suboptimal; simulation-based training may bridge this gap and is particularly applicable to teaching DKA management skills given it enables learning of basic knowledge, as well as clinical reasoning and patient management skills.", {"entities": [[23, 44, "DISEASE"]]}], ["1) To develop, test, and refine a computer-based simulator of DKA management; 2) to collect validity evidence, according to National Standard\u2019s validity framework; and 3) to judge whether the simulator scoring system is an appropriate measure of DKA management skills of undergraduate and postgraduate medical trainees.", {"entities": []}], ["After developing the DKA simulator, we completed usability testing to optimize its functionality.", {"entities": []}], ["We then conducted a preliminary validation of the scoring system for measuring trainees\u2019 DKA management skills.", {"entities": []}], ["We recruited year 1 and year 3 medical students, year 2 postgraduate trainees, and endocrinologists ( n \u2009=\u200975); each completed a simulator run, and we collected their simulator-computed scores.", {"entities": []}], ["We collected validity evidence related to content, internal structure, relations with other variables, and consequences.", {"entities": []}], ["Our simulator consists of six cases highlighting DKA management priorities.", {"entities": []}], ["Real-time progression of each case includes interactive order entry, laboratory and clinical data, and individualised feedback.", {"entities": []}], ["Usability assessment identified issues with clarity of system status, user control, efficiency of use, and error prevention.", {"entities": []}], ["Regarding validity evidence, Cronbach\u2019s \u03b1 was 0.795 for the seven subscales indicating favorable internal structure evidence.", {"entities": []}], ["Participants\u2019 scores showed a significant effect of training level (p\u2009<\u20090.001).", {"entities": []}], ["Scores also correlated with the number of DKA patients they reported treating, weeks on Medicine rotation, and comfort with managing DKA.", {"entities": []}], ["A score on the simulation exercise of 75\u00a0% had a sensitivity and specificity of 94.7\u00a0% and 51.8%, respectively, for delineating between expert staff physicians and trainees.", {"entities": []}], ["We demonstrate how a simulator and scoring system can be developed, tested, and refined to determine its quality for use as an assessment modality.", {"entities": []}], ["Our evidence suggests that it can be used for formative assessment of trainees\u2019 DKA management skills.", {"entities": []}], ["Diabetes affects over 20 million Americans, resulting in substantial morbidity, mortality, and costs.", {"entities": []}], ["While medications are the cornerstone of secondary prevention, many evidence-based therapies are underutilized, and patients often cite out-of-pocket costs as the reason.", {"entities": []}], ["Value-based insurance design (VBID) is a 'clinically sensitive' refinement to benefit design which links patient cost-sharing to therapy value; the more clinically beneficial (and valuable) a therapy is for a patient, the lower that patient's cost-sharing should be.", {"entities": []}], ["We describe the design and implementation of MHealthy: Focus on Diabetes (FOD), a prospective, controlled trial of targeted co-payment reductions for high value, underutilized therapies for individuals with diabetes.", {"entities": []}], ["The FOD trial includes 2,507 employees and dependents with diabetes insured by one large employer.", {"entities": []}], ["Approximately 81% are enrolled in a single independent-practice association model health maintenance organization.", {"entities": []}], ["The control group includes 8,637 patients with diabetes covered by other employers and enrolled in the same managed care organization.", {"entities": []}], ["Both groups received written materials about the importance of adherence to secondary prevention therapies, while only the intervention group received targeted co-payment reductions for glycemic agents, antihypertensives, lipid-lowering agents, antidepressants, and diabetic eye exams.", {"entities": []}], ["Primary outcomes include medication uptake and adherence.", {"entities": []}], ["Secondary outcomes include health care utilization and expenditures.", {"entities": []}], ["An interrupted time series, control group design will allow rigorous assessment of the intervention's impact, while controlling for unrelated temporal trends.", {"entities": []}], ["Individual patient-level baseline data are presented.", {"entities": []}], ["To our knowledge, this is the first prospective controlled trial of co-payment reductions targeted to high-value services for high-risk patients.", {"entities": []}], ["It will provide important information on feasibility of implementation and effectiveness of VBID in a real-world setting.", {"entities": []}], ["This program has the potential for broad dissemination to other employers and insurers wishing to improve the value of their health care spending.", {"entities": []}], ["Patient:Female, 55 Final Diagnosis: Autoimmune pancreatitis Symptoms: Abdominal pain \u2022 weight loss Medication: Prednisone Clinical Procedure: Admitted to the hospital Specialty: Gastroenterology and Hepatology Challenging differential diagnosis Autoimmune pancreatitis is an IgG4-related fibroinflammatory condition often associated with obstructive jaundice, as most lesions are located at the head of the pancreas.", {"entities": [[338, 358, "DISEASE"], [47, 59, "DISEASE"], [256, 268, "DISEASE"]]}], ["IgG4 level can help in the diagnosis, but it is normal in nearly 30% of affected patients.", {"entities": []}], ["A 55-year-old woman presented with a 5-month history of 20-pound unintentional weight loss and intermittent abdominal pain.", {"entities": []}], ["She had an unremarkable abdominal exam and significant findings included a small, non-mobile rubbery left axillary lymph node.", {"entities": []}], ["Complete blood count, complete metabolic panel, amylase, anti-smooth muscle antibody, antimitochondrial antibody, carcinoembryonic antigen, Ca 19-9, complement C3 and C4, antinuclear antibody, anti-Smith double-strand antibody, and IgG4 were all within normal limits.", {"entities": [[160, 162, "GENE"]]}], ["CT of the abdomen showed a mass in the junction of the body and tail of the pancreas and endoscopic ultrasound showed it as encasing the splenic artery.", {"entities": []}], ["Fine-needle aspiration cytology demonstrated follicular hyperplasia, obliterative phlebitis, storiform fibrosis, and negative staining for IgG4 and malignancy.", {"entities": [[82, 91, "DISEASE"]]}], ["Left axillary lymph node biopsy demonstrated follicular hyperplasia.", {"entities": []}], ["PET scan revealed hypermetabolic uptake of the pancreas tail, bone marrow, and spleen, as well as diffuse lymphadenopathy.", {"entities": []}], ["Bone marrow biopsy showed follicular hyperplasia and was negative for malignancy.", {"entities": []}], ["The patient was started on 40 mg of oral prednisone for possible autoimmune disease.", {"entities": []}], ["During follow-up, she reported progressive improvement and a repeat PET scan 6 months later showed marked improvement.", {"entities": []}], ["A normal IgG4 value should not decrease the clinical suspicion of IgG4-related disease.", {"entities": []}], ["If clinical, histological, and radiological findings coincide, glucocorticoids should be initiated with subsequent follow-up to evaluate for a response.", {"entities": []}], ["The X-ray repair cross-complementing group 1 (XRCC1) protein plays a crucial role in base excision repair (BER) pathway by acting as a scaffold for other BER enzymes.", {"entities": [[46, 51, "GENE"]]}], ["Variants in the XRCC1 gene might alter protein structure or function or create alternatively spliced proteins which may influence BER efficiency and hence affect individual susceptibility to bladder cancer.", {"entities": [[199, 205, "DISEASE"], [16, 21, "GENE"]]}], ["Recent epidemiological studies have shown inconsistent associations between these polymorphisms and bladder cancer.", {"entities": [[108, 114, "DISEASE"]]}], ["To clarify the situation, a comprehensive meta-analysis of all available studies was performed in this study.", {"entities": []}], ["PubMed, EMBASE, and Chinese Biomedical Literature database (CBM) databases have been systematically searched to identify all relevant studies for the period up to February 2013.", {"entities": []}], ["Data were abstracted independently by two reviewers and Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.", {"entities": []}], ["Subgroup analyses were performed mainly by ethnicity and smoking status.", {"entities": []}], ["A total of 26 case-control studies, including 24 studies for R399Q polymorphism, 15 studies for R194W polymorphism, and 7 studies for R280H polymorphism met the inclusion criteria and were selected.", {"entities": []}], ["With respect to R399Q polymorphism, significantly decreased bladder cancer risk was found among smokers (AA vs. GG: OR=0.693, 95%CI= 0.515-0.932, P =0.015 and recessive model AA vs. GA+GG: OR=0.680, 95%CI= 0.515-0.898, P =0.007, respectively).", {"entities": [[68, 74, "DISEASE"]]}], ["With respect to R194W and R280H polymorphism, significantly increased bladder cancer risk were observed among Asians (TT+CT vs. CC:OR = 1.327, 95% CI 1.086-1.622, P =0.006 for R194W, and AA+GA vs. GG: OR=2.094, 95% CI 1.211\u20133.621, P =0.008 for R280H, respectively).", {"entities": [[78, 84, "DISEASE"]]}], ["This meta-analysis suggests that the XRCC1 R399Q polymorphism may play a protective role against bladder cancer among smokers.", {"entities": [[105, 111, "DISEASE"], [37, 42, "GENE"]]}], ["However, the XRCC1 R194W and R280H polymorphisms were both associated with increased bladder cancer risk among Asians.", {"entities": [[93, 99, "DISEASE"], [13, 18, "GENE"]]}], ["Further studies with larger sample sizes are needed to validate our finds.", {"entities": []}], ["Asthmatics treated with long-acting beta-agonists have a reduced bronchodilator response to moderate doses of inhaled short acting beta-agonists during acute bronchoconstriction.", {"entities": []}], ["It is not known if the response to higher doses of nebulised beta-agonists or other bronchodilators is impaired.", {"entities": []}], ["We assessed the effect of long-acting beta-agonist treatment on the response to 5 mg nebulised salbutamol and to ipratropium bromide.", {"entities": []}], ["Two double-blind, placebo-controlled, crossover studies of inhaled formoterol 12 \u03bcg twice daily in patients with asthma.", {"entities": [[113, 119, "DISEASE"]]}], ["High-dose salbutamol : 36 hours after the last dose of 1 week of formoterol or placebo treatment, 11 subjects inhaled methacholine to produce a 20% fall in FEV 1 .", {"entities": [[156, 159, "GENE"]]}], ["Salbutamol 5 mg was then administered via nebuliser and the FEV 1 was monitored for 20 minutes.", {"entities": [[60, 63, "GENE"]]}], ["Ipratropium : 36 hours after the last dose of 1 week of formoterol or placebo treatment, 11 subjects inhaled 4.5% saline to produce a 20% fall in FEV 1 .", {"entities": [[146, 149, "GENE"]]}], ["Salbutamol 200 \u03bcg or ipratropium bromide 40 \u03bcg was then inhaled and the FEV 1 was monitored for 30 minutes.", {"entities": [[72, 75, "GENE"]]}], ["Four study arms compared the response to each bronchodilator after formoterol and placebo.", {"entities": []}], ["Analyses compared the area under the bronchodilator response curves, adjusting for changes in pre-challenge FEV 1 , dose of provocational agent and FEV 1 fall during the challenge procedure.", {"entities": [[108, 111, "GENE"], [148, 151, "GENE"], [108, 111, "GENE"], [148, 151, "GENE"]]}], ["The response to nebulised salbutamol was 15% lower after formoterol therapy compared to placebo (95% confidence 5 to 25%, p = 0.008).", {"entities": []}], ["The response to ipratropium was unchanged.", {"entities": []}], ["Long-acting beta-agonist treatment induces tolerance to the bronchodilator effect of beta-agonists, which is not overcome by higher dose nebulised salbutamol.", {"entities": []}], ["However, the bronchodilator response to ipratropium bromide is unaffected.", {"entities": []}], ["Objective To establish whether an interactive booklet on respiratory tract infections in children reduces reconsultation for the same illness episode, reduces antibiotic use, and affects future consulting intentions, while maintaining parental satisfaction with care.", {"entities": []}], ["Design Pragmatic cluster randomised controlled trial.", {"entities": []}], ["Setting 61 general practices in Wales and England.", {"entities": []}], ["Participants 558 children (6 months to 14 years) presenting to primary care with an acute respiratory tract infection (7 days or less).", {"entities": []}], ["Children with suspected pneumonia, asthma or a serious concomitant illness, or needing immediate hospital admission were excluded.", {"entities": [[24, 33, "DISEASE"], [35, 41, "DISEASE"]]}], ["Three withdrew and 27 were lost to follow-up, leaving 528 (94.6%) with main outcome data.", {"entities": []}], ["Interventions Clinicians in the intervention group were trained in the use of an interactive booklet on respiratory tract infections and asked to use the booklet during consultations with recruited patients (and provide it as a take home resource).", {"entities": []}], ["Clinicians in the control group conducted their consultations as usual.", {"entities": []}], ["Main outcome measures The proportion of children who attended a face-to-face consultation about the same illness during the two week follow-up period.", {"entities": []}], ["Secondary outcomes included antibiotic prescribing, antibiotic consumption, future consulting intentions, and parental satisfaction, reassurance, and enablement.", {"entities": []}], ["Results Reconsultation occurred in 12.9% of children in the intervention group and 16.2% in the control group (absolute risk reduction 3.3%, 95% confidence interval \u22122.7% to 9.3%, P=0.29).", {"entities": []}], ["Using multilevel modelling (at the practice and individual level) to account for clustering, no significant difference in reconsulting was noted (odds ratio 0.75; 0.41 to 1.38).", {"entities": []}], ["Antibiotics were prescribed at the index consultation to 19.5% of children in the intervention group and 40.8% of children in the control group (absolute risk reduction 21.3%, 95% confidence interval 13.7 to 28.9), P<0.001).", {"entities": []}], ["A significant difference was still present after adjusting for clustering (odds ratio 0.29; 0.14 to 0.60).", {"entities": []}], ["There was also a significant difference in the proportion of parents who said they would consult in the future if their child developed a similar illness (odds ratio 0.34; 0.20 to 0.57).", {"entities": []}], ["Satisfaction, reassurance, and parental enablement scores were not significantly different between the two groups.", {"entities": []}], ["Conclusions Use of a booklet on respiratory tract infections in children within primary care consultations led to important reductions in antibiotic prescribing and reduced intention to consult without reducing satisfaction with care.", {"entities": []}], ["Trial registration Current Controlled Trials ISRCTN46104365", {"entities": []}], ["Clinical practice guidelines are ubiquitous and are developed to provide recommendations for the management of many diseases, including chronic obstructive pulmonary disease.", {"entities": [[136, 173, "DISEASE"]]}], ["The development of these guidelines is burdensome, demanding a significant investment of time and money.", {"entities": []}], ["In Europe, the majority of countries develop their own national guidelines, despite the potential for overlap or duplication of effort.", {"entities": []}], ["A concerted effort and consolidation of resources between countries may alleviate the resource-intensity of maintaining individual national guidelines.", {"entities": []}], ["Despite significant resource investment into the development and maintenance of clinical practice guidelines, their implementation is suboptimal.", {"entities": []}], ["Effective strategies of guideline dissemination must be given more consideration, to ensure adequate implementation and improved patient care management in the future.", {"entities": []}], ["Anti-tumor immunity is a new line of research for the treatment of patients with solid tumors.", {"entities": []}], ["In this field, negative regulators of the immune system called immune checkpoints play a key role in limiting antitumor immunologic responses.", {"entities": []}], ["For this reason, immune checkpoint-inhibiting agents, such as those directed against cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed death-1 receptor (PD1) and its ligand PD-L1, have been developed as antitumor drugs, producing interesting results in preclinical and clinical studies.", {"entities": []}], ["We present an updated review of the biological background and clinical development of immune checkpoint inhibitors in colorectal cancer (CRC).", {"entities": [[118, 135, "DISEASE"], [129, 135, "DISEASE"]]}], ["Early trial results on PD1 and PD-L1 blockade appear promising, especially in CRC patients with microsatellite instability (MSI).", {"entities": []}], ["Clinical trials are ongoing to confirm these preliminary results, evaluate combination strategies and identify biomarkers to predict which patients are most likely to benefit from, or show resistance to, the effects of checkpoint inhibition.", {"entities": []}], ["Lowering plasma low density lipoprotein-cholesterol (LDL-C), blood pressure, homocysteine, and preventing platelet aggregation using a combination of a statin, three blood pressure lowering drugs such as a thiazide, a \u03b2 blocker, and an angiotensin converting enzyme (ACE) inhibitor each at half standard dose; folic acid; and aspirin-called as polypill- was estimated to reduce cardiovascular events by ~80%.", {"entities": []}], ["Essential fatty acids (EFAs) and their long-chain metabolites: \u03b3-linolenic acid (GLA), dihomo-GLA (DGLA), arachidonic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) and other products such as prostaglandins E 1 (PGE 1 ), prostacyclin (PGI 2 ), PGI 3 , lipoxins (LXs), resolvins, protectins including neuroprotectin D 1 (NPD 1 ) prevent platelet aggregation, lower blood pressure, have anti-arrhythmic action, reduce LDL-C, ameliorate the adverse actions of homocysteine, show anti-inflammatory actions, activate telomerase, and have cytoprotective properties.", {"entities": [[81, 84, "GENE"], [94, 97, "GENE"]]}], ["Thus, EFAs and their metabolites show all the classic actions expected of the \"polypill\".", {"entities": []}], ["Unlike the proposed \"polypill\", EFAs are endogenous molecules present in almost all tissues, have no significant or few side effects, can be taken orally for long periods of time even by pregnant women, lactating mothers, and infants, children, and adults; and have been known to reduce the incidence cardiovascular diseases including stroke.", {"entities": []}], ["In addition, various EFAs and their long-chain metabolites not only enhance nitric oxide generation but also react with nitric oxide to yield their respective nitroalkene derivatives that produce vascular relaxation, inhibit neutrophil degranulation and superoxide formation, inhibit platelet activation, and possess PPAR-\u03b3 ligand activity and release NO, thus prevent platelet aggregation, thrombus formation, atherosclerosis, and cardiovascular diseases.", {"entities": [[411, 426, "DISEASE"]]}], ["Based on these evidences, I propose that a rational combination of \u03c9-3 and \u03c9-6 fatty acids and the co-factors that are necessary for their appropriate action/metabolism is as beneficial as that of the combined use of a statin, thiazide, a \u03b2 blocker, and an angiotensin converting enzyme (ACE) inhibitor, folic acid, and aspirin.", {"entities": []}], ["Furthermore, appropriate combination of \u03c9-3 and \u03c9-6 fatty acids may even show additional benefits in the form of protection from depression, schizophrenia, Alzheimer's disease, and enhances cognitive function; and serve as endogenous anti-inflammatory molecules; and could be administered from childhood for life long.", {"entities": [[141, 154, "DISEASE"]]}], ["Accurate and efficient evaluation of acute chest pain remains clinically challenging because traditional diagnostic modalities have many limitations.", {"entities": []}], ["Recent improvement in non-invasive imaging technologies could potentially improve both diagnostic efficiency and clinical outcomes of patients with acute chest pain while reducing unnecessary hospitalizations.", {"entities": []}], ["However, there is still controversy regarding much of the evidence for these technologies.", {"entities": []}], ["This article reviews the role of coronary artery calcium score and the coronary computed tomography in the assessment of individual coronary risk and their usefulness in the emergency department in facilitating appropriate disposition decisions.", {"entities": []}], ["The evidence base and clinical applications for both techniques are also described, together with cost- effectiveness and radiation exposure considerations.", {"entities": []}], ["Fibroblast-like synoviocytes (FLS) play an important role in the pathologic processes of destructive arthritis by producing a number of catabolic cytokines and metalloproteinases (MMPs).", {"entities": [[101, 110, "DISEASE"]]}], ["The expression of these mediators is controlled at the transcriptional level.", {"entities": []}], ["The purposes of this study were to evaluate the anti-arthritic effects of magnolol (5,5\u2032-Diallyl-biphenyl-2,2\u2032-diol), the major bioactive component of the bark of Magnolia officinalis , by examining its inhibitory effects on inflammatory mediator secretion and the NF-\u03baB and AP-1 activation pathways and to investigate its therapeutic effects on the development of arthritis in a rat model.", {"entities": [[365, 374, "DISEASE"]]}], ["The in vitro anti-arthritic activity of magnolol was tested on interleukin (IL)-1\u03b2-stimulated FLS by measuring levels of IL-6, cyclooxygenase-2, prostaglandin E 2 , and matrix metalloproteinases (MMPs) by ELISA and RT-PCR.", {"entities": []}], ["Further studies on how magnolol inhibits IL-1\u03b2-stimulated cytokine expression were performed using Western blots, reporter gene assay, electrophoretic mobility shift assay, and confocal microscope analysis.", {"entities": []}], ["The in vivo anti-arthritic effects of magnolol were evaluated in a Mycobacterium butyricum -induced arthritis model in rats.", {"entities": [[100, 109, "DISEASE"]]}], ["Magnolol markedly inhibited IL-1\u03b2 (10 ng/mL)-induced cytokine expression in a concentration-dependent manner (2.5\u201325 \u00b5g/mL).", {"entities": []}], ["In clarifying the mechanisms involved, magnolol was found to inhibit the IL-1\u03b2-induced activation of the IKK/I\u03baB/NF-\u03baB and MAPKs pathways by suppressing the nuclear translocation and DNA binding activity of both transcription factors.", {"entities": []}], ["In the animal model, magnolol (100 mg/kg) significantly inhibited paw swelling and reduced serum cytokine levels.", {"entities": []}], ["Our results demonstrate that magnolol inhibits the development of arthritis, suggesting that it might provide a new therapeutic approach to inflammatory arthritis diseases.", {"entities": [[66, 75, "DISEASE"], [153, 162, "DISEASE"]]}], ["Although caffeine and glucocorticoids are frequently used to treat chronic lung disease in preterm neonates, potential interactions are largely unknown.", {"entities": [[75, 87, "DISEASE"]]}], ["While anti-inflammatory effects of glucocorticoids are well defined, their impact on airway remodeling is less characterized.", {"entities": []}], ["Caffeine has been ascribed to positive effects on airway inflammation as well as remodeling.", {"entities": []}], ["Connective tissue growth factor (CTGF, CCN2) plays a key role in airway remodeling and has been implicated in the pathogenesis of chronic lung diseases such as bronchopulmonary dysplasia (BPD) in preterm infants.", {"entities": [[33, 37, "GENE"]]}], ["The current study addressed the impact of glucocorticoids on the regulation of CTGF in the presence of caffeine using human lung epithelial and fibroblast cells.", {"entities": [[79, 83, "GENE"]]}], ["The human airway epithelial cell line H441 and the fetal lung fibroblast strain IMR-90 were exposed to different glucocorticoids (dexamethasone, budesonide, betamethasone, prednisolone, hydrocortisone) and caffeine.", {"entities": []}], ["mRNA and protein expression of CTGF, TGF-\u03b21-3, and TNF-\u03b1 were determined by means of quantitative real-time PCR and immunoblotting.", {"entities": [[31, 35, "GENE"]]}], ["H441 cells were additionally treated with cAMP, the adenylyl cyclase activator forskolin, and the selective phosphodiesterase (PDE)-4 inhibitor cilomilast to mimic caffeine-mediated PDE inhibition.", {"entities": []}], ["Treatment with different glucocorticoids (1\u00a0\u03bcM) significantly increased CTGF mRNA levels in H441 ( p \u2009<\u20090.0001) and IMR-90 cells ( p \u2009<\u20090.01).", {"entities": [[72, 76, "GENE"]]}], ["Upon simultaneous exposure to caffeine (10\u00a0mM), both glucocorticoid-induced mRNA and protein expression were significantly reduced in IMR-90 cells ( p \u2009<\u20090.0001).", {"entities": []}], ["Of note, 24\u00a0h exposure to caffeine alone significantly suppressed basal expression of CTGF mRNA and protein in IMR-90 cells.", {"entities": [[86, 90, "GENE"]]}], ["Caffeine-induced reduction of CTGF mRNA expression seemed to be independent of cAMP levels, adenylyl cyclase activation, or PDE-4 inhibition.", {"entities": [[30, 34, "GENE"]]}], ["While dexamethasone or caffeine treatment did not affect TGF-\u03b21 mRNA in H441 cells, increased expression of TGF-\u03b22 and TGF-\u03b23 mRNA was detected upon exposure to dexamethasone or dexamethasone and caffeine, respectively.", {"entities": []}], ["Moreover, caffeine increased TNF-\u03b1 mRNA in H441 cells (6.5\u2009\u00b1\u20092.2-fold, p \u2009<\u20090.05) which has been described as potent inhibitor of CTGF expression.", {"entities": [[130, 134, "GENE"]]}], ["In addition to well-known anti-inflammatory features, glucocorticoids may have adverse effects on long-term remodeling by TGF-\u03b21-independent induction of CTGF in lung cells.", {"entities": [[154, 158, "GENE"]]}], ["Simultaneous treatment with caffeine may attenuate glucocorticoid-induced expression of CTGF, thereby promoting restoration of lung homeostasis.", {"entities": [[88, 92, "GENE"]]}], ["Hepatic ischemia/reperfusion (ISCH/REP) is a major clinical problem that is considered to be the most common cause of postoperative liver failure.", {"entities": [[8, 16, "DISEASE"]]}], ["Recently, mast cells have been proposed to play an important role in the pathophysiology of ISCH/REP in many organs.", {"entities": []}], ["In contrast, the role played by mast cells during ISCH/REP-induced liver damage has remained an issue of debate.", {"entities": []}], ["This study aimed to investigate the protective role of mast cells in order to search for an effective therapeutic agent that could protect against fatal ISCH/REP-induced liver damage.", {"entities": []}], ["A model of warm ISCH/REP was induced in the liver of rats.", {"entities": []}], ["Four groups of rats were used in this study: Group I: SHAM (normal saline, intravenously [iv]); Group II: ISCH/REP; Group III: sodium cromoglycate + ISCH/REP (CROM + ISCH/REP), and Group IV: ketotifen (KET) + ISCH/REP (KET + ISCH/REP).", {"entities": []}], ["Liver damage was assessed both histopathologically and biochemically.", {"entities": []}], ["Mast cell degranulation was assessed histochemically.", {"entities": []}], ["Lipid peroxidation (malondialdehyde [MDA]) as well as the levels of glutathione (GSH), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-\u03b1), the formation of nitric oxide (NO), and the expression of inducible NO synthase (iNOS) were determined.", {"entities": []}], ["The results of this study revealed increased mast cell degranulation in the liver during the acute phase of ISCH/REP.", {"entities": []}], ["Moreover, CROM, but not KET, decreased the activity of alanine aminotransferase, aspartate aminotransferase, and lactic dehydrogenase and maintained normal liver tissue histology.", {"entities": []}], ["Both CROM and KET protected against mast cell degranulation in the liver.", {"entities": []}], ["In addition, both CROM and KET decreased IL-6 and TNF-\u03b1.", {"entities": []}], ["However, CROM, but not KET, decreased MDA formation and increased GSH.", {"entities": []}], ["Furthermore, KET, but not CROM, increased both NO formation and iNOS expression.", {"entities": []}], ["In conclusion, this study clearly demonstrated mast cell degranulation in warm ISCH/REP in the liver of rats.", {"entities": []}], ["More importantly, CROM, but not KET, ameliorated the effect of ISCH/REP-induced injury in rat liver.", {"entities": []}], ["CROM may protect the liver through mast cell stabilization, inhibition of TNF-\u03b1, IL-6, MDA, and iNOS and increased GSH.", {"entities": []}], ["KET may maintain ISCH/REP-induced liver injury through the NO/iNOS pathway.", {"entities": []}], ["Potential xeroderma pigmentosum group D (XPD), also called excision repair cross-complimentary group two (ERCC2), Lys751Gln and Asp312Asn polymorphisms have been implicated in gastric cancer risk among different ethnicities.", {"entities": [[10, 31, "DISEASE"], [184, 190, "DISEASE"], [106, 111, "GENE"]]}], ["We aimed to explore the effect of XPD Lys751Gln and Asp312Asn polymorphisms on the susceptibility to gastric cancer among different ethnicities through a systematic review and meta-analysis.", {"entities": [[109, 115, "DISEASE"]]}], ["Each initially included article was scored for quality appraisal.", {"entities": []}], ["Desirable data were extracted and registered into databases.", {"entities": []}], ["13 studies were ultimately eligible for the meta-analysis of Lys751Gln polymorphism and 9 studies for the meta-analysis of Asp312Asn polymorphism.", {"entities": []}], ["We adopted the most probably appropriate genetic model (recessive model) for both Lys751Gln and Asp312Asn polymorphisms.", {"entities": []}], ["Potential sources of heterogeneity were sought out via subgroup and sensitivity analyses, and publication biases were estimated.", {"entities": []}], ["Statistically significant findings were apparently noted in Asians but not in Caucasians for both XPD Lys751Gln and XPD Asp312Asn polymorphisms.", {"entities": []}], ["A statistically significant finding could be seen in noncardia-type gastric cancer for XPD Lys751Gln polymorphism.", {"entities": [[76, 82, "DISEASE"]]}], ["A statistically significant finding could also be seen in high quality subgroup, small-and-moderate sample size subgroup, articles published after 2007, or PCR-RFLP genotyping subgroup for XPD Asp312Asn polymorphism.", {"entities": []}], ["Our meta-analysis indicates that XPD Gln751Gln (CC) genotype and Asn312Asn (AA) genotype may seem to be more susceptible to gastric cancer in Asian populations but not in Caucasian populations, suggesting that the two genotypes may be important biomarkers of gastric cancer susceptibility for Asian populations, the assumption that needs to be further confirmed in well-designed studies among different ethnicities.", {"entities": [[132, 138, "DISEASE"], [267, 273, "DISEASE"]]}], ["Gln751Gln (CC) genotype may also be associated with noncardia-type gastric cancer risk, which should also be confirmed among different ethnicities in the future.", {"entities": [[75, 81, "DISEASE"]]}], ["Specific IgE ( sIgE ) is often used to predict oral food challenge ( OFC ) outcomes in food allergy, but interpretation of the results may vary depending on the assay method employed and the patient population tested.", {"entities": [[87, 99, "DISEASE"]]}], ["The aim of this study was to use two commercial assay systems to determine egg\u2010 sIgE values predictive of allergy within the most common populations treated at pediatric clinics.", {"entities": []}], ["In a multicenter prospective study, 433 children with suspected or confirmed egg allergy underwent oral challenge ( OFC ) using cooked egg ( CE ) and raw egg ( RE ) powders to diagnose either true allergy in 1\u2010year\u2010old (group A, n = 220) or tolerance in 2\u2010 to 6\u2010year\u2010old (group B, n = 213).", {"entities": [[77, 88, "DISEASE"]]}], ["Egg white ( EW )\u2010 and ovomucoid ( OM )\u2010 sIgE values were measured using the Immuno CAP sIgE (Immuno CAP ) and the IMMULITE Receiver\u2010operating characteristic ( ROC ) curve analysis yielded similar areas under the curve ( AUC ) for the two assays (0.7\u20130.8).", {"entities": []}], ["The optimal cutoff values and the probability curves ( PC s) of the sIgE by the two assays to predict CE and RE OFC outcomes were determined for both groups.", {"entities": [[55, 57, "GENE"]]}], ["Values for 3gAllergy were higher than for Immuno CAP ; however, correlation of sIgE and predicted probability calculated by PC s were strong between the two methods.", {"entities": [[124, 126, "GENE"]]}], ["Cutoff values and PC s for egg\u2010 sIgE established using both Immuno CAP and 3gAllergy may be useful for predicting egg allergy in early childhood patient populations.", {"entities": [[114, 125, "DISEASE"], [18, 20, "GENE"]]}], ["Pattern recognition underpins innate immunity; the accurate identification of danger, including infection, injury, or tumor, is key to an appropriately targeted immune response.", {"entities": []}], ["Pathogen detection is increasingly well defined mechanistically, but the discrimination of endogenous inflammatory triggers remains unclear.", {"entities": []}], ["Tenascin-C, a matrix protein induced upon tissue damage and expressed by tumors, activates toll-like receptor 4 (TLR4)-mediated sterile inflammation.", {"entities": [[113, 117, "GENE"]]}], ["Here we map three sites within tenascin-C that directly and cooperatively interact with TLR4.", {"entities": [[88, 92, "GENE"]]}], ["We also identify a conserved inflammatory epitope in related proteins from diverse families, and demonstrate that its presence targets molecules for TLR detection, while its absence enables escape of innate immune surveillance.", {"entities": []}], ["These data reveal a unique molecular code that defines endogenous proteins as inflammatory stimuli by marking them for recognition by TLRs.", {"entities": []}], ["Although detection of pathogens by pattern recognition receptors is increasingly well defined, recognition of endogenous triggers remains poorly understood.", {"entities": []}], ["By examining the interface between tenascin-C and TLR4, the authors identify a molecular code that identifies endogenous proteins as inflammatory stimuli.", {"entities": [[50, 54, "GENE"]]}], ["Background Previous studies have shown disparities between Black and Hispanic patients compared with other populations in response to asthma medications.", {"entities": [[134, 140, "DISEASE"]]}], ["Objective: The aim of this analysis was to assess the effect of budesonide/formoterol pressurized metered-dose inhaler (BUD/FM pMDI) and BUD on predefined criteria for asthma worsening, an asthma control metric generally aligned with definitions of moderate asthma exacerbations, across four different populations.", {"entities": [[168, 174, "DISEASE"], [189, 195, "DISEASE"], [258, 264, "DISEASE"]]}], ["Methods: Data were from four 12-week, randomized, double-blind,US studies of BUD/FM pMDI treatment in patients aged 12 years or older with varying asthma severities and of varying races.", {"entities": [[147, 153, "DISEASE"]]}], ["Predefined asthma events and withdrawals due to predefined events were assessed as secondary study endpoints.", {"entities": [[11, 17, "DISEASE"]]}], ["Study I (NCT00651651) includes data from predominantly White patients with mild to moderate asthma who were randomized to BUD/FM pMDI 160/9 \u03bcg twice daily (bid; n = 123) or BUDpMDI 160 \u03bcg bid (n = 121).", {"entities": [[92, 98, "DISEASE"]]}], ["Study II (NCT00652002) includes data from predominantly White patients withmoderate to severe asthma who were randomized to BUD/FM pMDI 320/9 \u03bcg bid (n = 124) or BUD pMDI 320 \u03bcg bid (n = 109).", {"entities": [[94, 100, "DISEASE"]]}], ["Study III (NCT00702325) included self-reported Black patients with moderate to severe asthma who were randomized to BUD/FM pMDI 320/9 \u03bcg bid (n = 153) or BUD dry powder inhaler 360 \u03bcg bid (n = 148).", {"entities": [[86, 92, "DISEASE"]]}], ["Study IV (NCT00419757) included self-reported Hispanic patients with moderate to severe asthma who were randomized to BUD/FM pMDI 320/9 \u03bcg bid (n = 127) or BUD pMDI 320 \u03bcg bid (n = 123).", {"entities": [[88, 94, "DISEASE"]]}], ["Patients were to be withdrawn from the studies if they developed an asthma event, as determined by predefined criteria, except for night-time awakenings, where withdrawal was left to the study physician\u2019s judgment.", {"entities": [[68, 74, "DISEASE"]]}], ["Results: Overall, fewer patients in the studies (study I, II, III, and IV, respectively) experienced \u22671 asthma event in the BUD/FM group (18.7%, 29.8%, 37.3%, 25.2%) versus the BUD group (21.5%, 44.0%, 45.3%, 31.7%); only study II results showed a statistically significant difference between treatments.", {"entities": [[104, 110, "DISEASE"]]}], ["Fewer patients with moderate to severe asthma (studies II, III, and IV) were withdrawn due to \u22671 asthma event in the BUD/FM group (10.5%, 11.8%, 3.1%, respectively) than in the BUD group (20.2%, 18.9%, 6.5%, respectively); however, percentages were similar in the BUD/FM (7.3%) and BUD (6.6%) groups in patients with mild to moderate asthma (study I).", {"entities": [[39, 45, "DISEASE"], [97, 103, "DISEASE"], [334, 340, "DISEASE"]]}], ["Conclusions: Predefined asthma event rates were numerically or significantly lower for patients with asthma receiving BUD/FMpMDI versusBUD, regardless of race or disease severity.", {"entities": [[24, 30, "DISEASE"], [101, 107, "DISEASE"]]}], ["Differences between the BUD/FM pMDI and BUD groupswere smaller in patients with mild to moderate asthma than in those with moderate to severe asthma, most likely because patients with milder disease had lower asthma event rates.", {"entities": [[97, 103, "DISEASE"], [142, 148, "DISEASE"], [209, 215, "DISEASE"]]}], ["Overall, these findings support the efficacy of BUD/FM pMDI in achieving asthma control in patients with moderate to severe asthma.", {"entities": [[73, 79, "DISEASE"], [124, 130, "DISEASE"]]}], ["Although cesarean delivery and prenatal exposure to antibiotics are likely to affect the gut microbiome in infancy, their effect on the development of atopic dermatitis (AD) in infancy is unclear.", {"entities": [[151, 168, "DISEASE"], [158, 168, "DISEASE"]]}], ["The influence of individual genotypes on these relationships is also unclear.", {"entities": []}], ["To evaluate with a prospective birth cohort study whether cesarean section, prenatal exposure to antibiotics, and susceptible genotypes act additively to promote the development of AD in infancy.", {"entities": []}], ["The Cohort for Childhood of Asthma and Allergic Diseases (COCOA) was selected from the general Korean population.", {"entities": []}], ["A pediatric allergist assessed 412 infants for the presence of AD at 1 year of age.", {"entities": []}], ["Their cord blood DNA was subjected to interleukin (IL)-13 (rs20541) and cluster-of-differentiation (CD)14 (rs2569190) genotype analysis.", {"entities": []}], ["The combination of cesarean delivery and prenatal exposure to antibiotics associated significantly and positively with AD (adjusted odds ratio, 5.70; 95% CI, 1.19\u201327.3).", {"entities": []}], ["The association between cesarean delivery and AD was significantly modified by parental history of allergic diseases or risk-associated IL-13 (rs20541) and CD14 (rs2569190) genotypes.", {"entities": [[156, 160, "GENE"]]}], ["There was a trend of interaction between IL-13 (rs20541) and delivery mode with respect to the subsequent risk of AD.", {"entities": []}], ["( P for interaction\u200a=\u200a0.039) Infants who were exposed prenatally to antibiotics and were born by cesarean delivery had a lower total microbiota diversity in stool samples at 6 months of age than the control group.", {"entities": []}], ["As the number of these risk factors increased, the AD risk rose (trend p<0.05).", {"entities": []}], ["Cesarean delivery and prenatal antibiotic exposure may affect the gut microbiota, which may in turn influence the risk of AD in infants.", {"entities": []}], ["These relationships may be shaped by the genetic predisposition.", {"entities": []}], ["Glucocorticoid (GC) therapy remains important in improving the prognosis of patients with systemic lupus erythematosus (SLE).", {"entities": [[99, 118, "DISEASE"], [90, 118, "DISEASE"], [16, 18, "GENE"]]}], ["However, some patients do not achieve an effective response with GC treatment, creating an obstacle to the remission of SLE.", {"entities": [[65, 67, "GENE"]]}], ["Identification of the underlying mechanisms responsible for steroid resistance can be significant.", {"entities": []}], ["Macrophage migration inhibitory factor (MIF) arouses our interest because of its reciprocal relationship with GCs.", {"entities": [[40, 43, "GENE"]]}], ["In the present study, we investigated for the first time whether MIF correlated with steroid resistance in SLE and explored potential mechanisms of action.", {"entities": [[65, 68, "GENE"]]}], ["Sixty-two patients with SLE (40 steroid sensitive and 22 steroid resistant) and 21 normal controls were recruited.", {"entities": []}], ["Serum levels of MIF were measured by ELISA.", {"entities": [[16, 19, "GENE"]]}], ["Cytosolic MIF and I\u03baB expression in peripheral blood mononuclear cells (PBMCs) were determined by western blotting.", {"entities": [[10, 13, "GENE"]]}], ["The electrophoretic mobility shift assay was assessed by NF-\u03baB in nuclear aliquots.", {"entities": []}], ["Gene silencing was applied to reduce expression of MIF in PBMCs in steroid-resistant patients.", {"entities": [[51, 54, "GENE"]]}], ["PBMCs obtained from steroid-sensitive patients were treated with recombinant human MIF of different concentrations.", {"entities": [[83, 86, "GENE"]]}], ["MIF levels in serum and PBMCs were higher in steroid-resistant patients compared with steroid-sensitive patients and controls.", {"entities": [[0, 3, "GENE"]]}], ["In contrast to the steroid-sensitive group, NF-\u03baB levels were significantly higher and I\u03baB levels lower in steroid-resistant patients.", {"entities": []}], ["After MIF gene silencing, I\u03baB levels in cells from steroid-resistant patients were increased.", {"entities": [[6, 9, "GENE"]]}], ["In steroid-sensitive patients, a decrease in I\u03baB levels and an increase in NF-\u03baB expression from baseline were detected in PBMCs treated with a higher concentration of recombinant human MIF.", {"entities": [[186, 189, "GENE"]]}], ["Treatment with recombinant human MIF did not regulate expression of I\u03baB and NF-\u03baB in PBMCs from patients treated with an anti-MIF monoclonal antibody.", {"entities": [[33, 36, "GENE"], [126, 129, "GENE"]]}], ["Our results indicated that MIF may play a role in the formation of steroid resistance in SLE by affecting the NF-\u03baB/I\u03baB signaling cascade.", {"entities": [[27, 30, "GENE"]]}], ["As a regulator of glucocorticoid sensitivity, MIF may be a potential target for steroid sparing.", {"entities": [[46, 49, "GENE"]]}], ["We reviewed epidemiologic evidence related to occupational pesticide exposures and cancer incidence in the Agricultural Health Study (AHS) cohort.", {"entities": [[83, 89, "DISEASE"]]}], ["Studies were identified from the AHS publication list available at http://aghealth.nci.nih.gov as well as through a Medline/PubMed database search in March 2009.", {"entities": []}], ["We also examined citation lists.", {"entities": []}], ["Findings related to lifetime-days and/or intensity-weighted lifetime-days of pesticide use are the primary focus of this review, because these measures allow for the evaluation of potential exposure\u2013response relationships.", {"entities": []}], ["We reviewed 28 studies; most of the 32 pesticides examined were not strongly associated with cancer incidence in pesticide applicators.", {"entities": [[93, 99, "DISEASE"]]}], ["Increased rate ratios (or odds ratios) and positive exposure\u2013response patterns were reported for 12 pesticides currently registered in Canada and/or the United States (alachlor, aldicarb, carbaryl, chlorpyrifos, diazinon, dicamba, S -ethyl- N , N -dipropylthiocarbamate, imazethapyr, metolachlor, pendimethalin, permethrin, trifluralin).", {"entities": []}], ["However, estimates of association for specific cancers were often imprecise because of small numbers of exposed cases, and clear monotonic exposure\u2013response patterns were not always apparent.", {"entities": []}], ["Exposure misclassification is also a concern in the AHS and may limit the analysis of exposure\u2013response patterns.", {"entities": []}], ["Epidemiologic evidence outside the AHS remains limited with respect to most of the observed associations, but animal toxicity data support the biological plausibility of relationships observed for alachlor, carbaryl, metolachlor, pendimethalin, permethrin, and trifluralin.", {"entities": []}], ["Continued follow-up is needed to clarify associations reported to date.", {"entities": []}], ["In particular, further evaluation of registered pesticides is warranted.", {"entities": []}], ["During the 2009 influenza A H1N1 pandemic, it became difficult to differentiate viral infections from other conditions in patients admitted to the intensive care unit.", {"entities": [[16, 25, "DISEASE"]]}], ["We sought to evaluate the behavior and diagnostic utility of procalcitonin, C-reactive protein and four other molecules in patients with suspected 2009 Influenza A H1N1 infection.", {"entities": [[152, 161, "DISEASE"]]}], ["The serum levels of procalcitonin, C-reactive protein, tumor necrosis factor \u03b1, interferon \u03b3, interleukin 1\u03b2, and interleukin 10 were tested on admission and on days 3, 5, and 7 in 35 patients with suspected 2009 H1N1 infection who were admitted to two ICUs.", {"entities": []}], ["Twelve patients had confirmed 2009 influenza A H1N1 infections, 6 had seasonal influenza infections, and 17 patients had negative swabs.", {"entities": [[35, 44, "DISEASE"], [79, 88, "DISEASE"]]}], ["The procalcitonin levels at inclusion and on day 3, and the C-reactive protein levels on day 3 were higher among subjects with 2009 influenza A H1N1 infections.", {"entities": [[132, 141, "DISEASE"]]}], ["The baseline levels of interleukin 1\u03b2 were higher among the 2009 influenza A H1N1 patients compared with the other groups.", {"entities": [[65, 74, "DISEASE"]]}], ["The C-reactive protein levels on days 3, 5, and 7 and procalcitonin on days 5 and 7 were greater in non-surviving patients.", {"entities": []}], ["Higher levels of procalcitonin, C-reactive protein and interleukin-1\u03b2 might occur in critically ill patients who had a 2009 H1N1 infection.", {"entities": []}], ["Neither procalcitonin nor CRP were useful in discriminating severe 2009 H1N1 pneumonia.", {"entities": [[77, 86, "DISEASE"], [26, 29, "GENE"]]}], ["Higher levels of CRP and procalcitonin appeared to identify patients with worse outcomes.", {"entities": [[17, 20, "GENE"]]}], ["Chronic obstructive pulmonary disease (COPD) is accompanied by pulmonary inflammation and associated with extra-pulmonary manifestations, including skeletal muscle atrophy.", {"entities": []}], ["Glycogen synthase kinase-3 (GSK-3) has been implicated in the regulation of muscle protein- and myonuclear turnover; two crucial processes that determine muscle mass.", {"entities": []}], ["In the present study we investigated the effect of the selective GSK-3 inhibitor SB216763 on muscle mass in a guinea pig model of lipopolysaccharide (LPS)-induced pulmonary inflammation-associated muscle atrophy.", {"entities": []}], ["Guinea pigs were pretreated with either intranasally instilled SB216763 or corresponding vehicle prior to each LPS/saline challenge twice weekly.", {"entities": []}], ["Pulmonary inflammation was confirmed and indices of muscle mass were determined after 12\u00a0weeks.", {"entities": []}], ["Additionally, cultured skeletal muscle cells were incubated with tumor necrosis factor \u03b1 (TNF-\u03b1) or glucocorticoids (GCs) to model the systemic effects of pulmonary inflammation on myogenesis, in the presence or absence of GSK-3 inhibitors.", {"entities": []}], ["Repeated LPS instillation induced muscle atrophy based on muscle weight and muscle fiber cross sectional area.", {"entities": []}], ["Intriguingly, GSK-3 inhibition using SB216763 prevented the LPS-induced muscle mass decreases and myofiber atrophy.", {"entities": []}], ["Indices of protein turnover signaling were unaltered in guinea pig muscle.", {"entities": []}], ["Interestingly, inhibition of myogenesis of cultured muscle cells by TNF-\u03b1 or synthetic GCs was prevented by GSK-3 inhibitors.", {"entities": []}], ["In a guinea pig model of LPS-induced pulmonary inflammation, GSK-3 inhibition prevents skeletal muscle atrophy without affecting pulmonary inflammation.", {"entities": []}], ["Resistance to inflammation- or GC-induced impairment of myogenic differentiation, imposed by GSK-3 inhibition, suggests that sustained myogenesis may contribute to muscle mass maintenance despite persistent pulmonary inflammation.", {"entities": []}], ["Collectively, these results warrant further exploration of GSK-3 as a potential novel drug target to prevent or reverse muscle wasting in COPD.", {"entities": []}], ["Docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (ARA, 20:4n-6) are the major long chain polyunsaturated fatty acids (LCPUFA) of the central nervous system (CNS).", {"entities": []}], ["These nutrients are present in most infant formulas at modest levels, intended to support visual and neural development.", {"entities": []}], ["There are no investigations in primates of the biological consequences of dietary DHA at levels above those present in formulas but within normal breastmilk levels.", {"entities": []}], ["Twelve baboons were divided into three formula groups: Control, with no DHA-ARA; \u201cL\u201d, LCPUFA, with 0.33%DHA-0.67%ARA; \u201cL3\u201d, LCPUFA, with 1.00%DHA-0.67%ARA.", {"entities": []}], ["All the samples are from the precentral gyrus of cerebral cortex brain regions.", {"entities": []}], ["At 12 weeks of age, changes in gene expression were detected in 1,108 of 54,000 probe sets (2.05%), with most showing <2-fold change.", {"entities": []}], ["Gene ontology analysis assigns them to diverse biological functions, notably lipid metabolism and transport, G-protein and signal transduction, development, visual perception, cytoskeleton, peptidases, stress response, transcription regulation, and 400 transcripts having no defined function.", {"entities": []}], ["PLA2G6 , a phospholipase recently associated with infantile neuroaxonal dystrophy, was downregulated in both LCPUFA groups.", {"entities": [[60, 81, "DISEASE"], [0, 6, "GENE"]]}], ["ELOVL5 , a PUFA elongase, was the only LCPUFA biosynthetic enzyme that was differentially expressed.", {"entities": [[0, 6, "GENE"]]}], ["Mitochondrial fatty acid carrier, CPT2 , was among several genes associated with mitochondrial fatty acid oxidation to be downregulated by high DHA, while the mitochondrial proton carrier, UCP2 , was upregulated.", {"entities": [[34, 38, "GENE"], [189, 193, "GENE"]]}], ["TIMM8A , also known as deafness/dystonia peptide 1, was among several differentially expressed neural development genes.", {"entities": [[32, 40, "DISEASE"], [0, 6, "GENE"]]}], ["LUM and TIMP3 , associated with corneal structure and age-related macular degeneration, respectively, were among visual perception genes influenced by LCPUFA.", {"entities": [[66, 86, "DISEASE"], [8, 13, "GENE"]]}], ["TIA1 , a silencer of COX2 gene translation, is upregulated by high DHA.", {"entities": [[0, 4, "GENE"]]}], ["Ingenuity pathway analysis identified a highly significant nervous system network, with epidermal growth factor receptor (EGFR) as the outstanding interaction partner.", {"entities": [[122, 126, "GENE"]]}], ["These data indicate that LCPUFA concentrations within the normal range of human breastmilk induce global changes in gene expression across a wide array of processes, in addition to changes in visual and neural function normally associated with formula LCPUFA.", {"entities": []}], ["We conducted a case\u2013control study to describe the clinical and epidemiologic characteristics of an outbreak of pandemic (H1N1) 2009 at a Canadian military cadet training center.", {"entities": []}], ["We found that asthma and obesity confer greater risk for infection.", {"entities": [[25, 32, "DISEASE"], [14, 20, "DISEASE"]]}], ["Viral shedding was detected by PCR up to 18 days after symptom onset.", {"entities": []}], ["Systemic inflammation is a whole body reaction having an infection-positive (i.e., sepsis) or infection-negative origin.", {"entities": []}], ["It is important to distinguish between these two etiologies early and accurately because this has significant therapeutic implications for critically ill patients.", {"entities": []}], ["We hypothesized that a molecular classifier based on peripheral blood RNAs could be discovered that would (1) determine which patients with systemic inflammation had sepsis, (2) be robust across independent patient cohorts, (3) be insensitive to disease severity, and (4) provide diagnostic utility.", {"entities": []}], ["The goal of this study was to identify and validate such a molecular classifier.", {"entities": []}], ["We conducted an observational, non-interventional study of adult patients recruited from tertiary intensive care units (ICUs).", {"entities": []}], ["Biomarker discovery utilized an Australian cohort ( n = 105) consisting of 74 cases (sepsis patients) and 31 controls (post-surgical patients with infection-negative systemic inflammation) recruited at five tertiary care settings in Brisbane, Australia, from June 3, 2008, to December 22, 2011.", {"entities": []}], ["A four-gene classifier combining CEACAM4 , LAMP1 , PLA2G7 , and PLAC8 RNA biomarkers was identified.", {"entities": [[33, 40, "GENE"], [43, 48, "GENE"], [51, 57, "GENE"], [64, 69, "GENE"]]}], ["This classifier, designated SeptiCyte Lab, was validated using reverse transcription quantitative PCR and receiver operating characteristic (ROC) curve analysis in five cohorts ( n = 345) from the Netherlands.", {"entities": []}], ["Patients for validation were selected from the Molecular Diagnosis and Risk Stratification of Sepsis study ( ClinicalTrials.gov , NCT01905033), which recruited ICU patients from the Academic Medical Center in Amsterdam and the University Medical Center Utrecht.", {"entities": []}], ["Patients recruited from November 30, 2012, to August 5, 2013, were eligible for inclusion in the present study.", {"entities": []}], ["Validation cohort 1 ( n = 59) consisted entirely of unambiguous cases and controls; SeptiCyte Lab gave an area under curve (AUC) of 0.95 (95% CI 0.91\u20131.00) in this cohort.", {"entities": []}], ["ROC curve analysis of an independent, more heterogeneous group of patients (validation cohorts 2\u20135; 249 patients after excluding 37 patients with an infection likelihood of \u201cpossible\u201d) gave an AUC of 0.89 (95% CI 0.85\u20130.93).", {"entities": []}], ["Disease severity, as measured by Sequential Organ Failure Assessment (SOFA) score or Acute Physiology and Chronic Health Evaluation (APACHE) IV score, was not a significant confounding variable.", {"entities": []}], ["The diagnostic utility of SeptiCyte Lab was evaluated by comparison to various clinical and laboratory parameters available to a clinician within 24 h of ICU admission.", {"entities": []}], ["SeptiCyte Lab was significantly better at differentiating cases from controls than all tested parameters, both singly and in various logistic combinations, and more than halved the diagnostic error rate compared to procalcitonin in all tested cohorts and cohort combinations.", {"entities": []}], ["Limitations of this study relate to (1) cohort compositions that do not perfectly reflect the composition of the intended use population, (2) potential biases that could be introduced as a result of the current lack of a gold standard for diagnosing sepsis, and (3) lack of a complete, unbiased comparison to C-reactive protein.", {"entities": []}], ["SeptiCyte Lab is a rapid molecular assay that may be clinically useful in managing ICU patients with systemic inflammation.", {"entities": []}], ["Further study in population-based cohorts is needed to validate this assay for clinical use.", {"entities": []}], ["Thomas Yager and colleagues develop and validate a molecular host assay to discriminate between sepsis and infection-negative systemic inflammation in critically ill patients.", {"entities": []}], ["Our immune system protects us from disease by recognizing and killing bacteria and other infectious organisms (pathogens).", {"entities": []}], ["An important part of the immune response is inflammation, a process that is triggered by infection, tissue injury, and other stimuli.", {"entities": []}], ["Localized inflammation, which is characterized by swelling, redness, heat, pain, and loss of function, restricts the tissue damage caused by these stimuli to the affected site.", {"entities": []}], ["Unfortunately, the immune system occasionally initiates a series of reactions that lead to widespread (systemic) inflammation.", {"entities": []}], ["Systemic inflammation can damage vital organs and can be life-threatening.", {"entities": []}], ["For example, it has been estimated that 30%\u201350% of people who develop severe infection-positive systemic inflammation (sepsis) die.", {"entities": []}], ["Clinical management of systemic inflammation depends on whether the condition is caused by an infection or by another stimulus: many patients with systemic inflammation need to be given corticosteroids and other anti-inflammatory agents, but only patients with infection-positive systemic inflammation need to be given antibiotics.", {"entities": []}], ["Clinicians need to be able to distinguish between sepsis and infection-negative systemic inflammation quickly and accurately when treating critically ill patients.", {"entities": []}], ["Patients with sepsis need to be given antibiotics as soon as possible to clear the infection, but giving antibiotics to someone with infection-negative systemic inflammation may do more harm than good.", {"entities": []}], ["Current diagnostic approaches for identifying patients with sepsis rely on isolating and identifying the causative pathogen, but it can take more than 24 hours to obtain a result and pathogens are only isolated from about 30% of patients with clinically confirmed sepsis.", {"entities": []}], ["Analysis of the host immune response might provide a quicker, more accurate way to differentiate between sepsis and infection-negative systemic inflammation.", {"entities": []}], ["Thus, measurement of blood levels of procalcitonin (a pro-inflammatory biomarker) or of C-reactive protein (which the liver releases in response to inflammation) can sometimes differentiate between the two conditions.", {"entities": []}], ["However, because the immune response is complex, measurement of a single biomarker in the blood is unlikely to be diagnostically helpful in every patient.", {"entities": []}], ["Here, the researchers identify and validate a set of RNA molecules present in the blood capable of discriminating between sepsis and infection-negative systemic inflammation in critically ill patients (a \u201cmolecular classifier\u201d).", {"entities": []}], ["Using microarray analysis (a technique that measures the RNA levels of thousands of different genes) to compare the RNA molecules present in the blood in a discovery cohort of 74 patients with sepsis and 31 post-surgical patients with infection-negative systemic inflammation, the researchers identified a molecular classifier (SeptiCyte Lab) consisting of four RNA biomarkers.", {"entities": []}], ["They validated this classifier using five additional patient cohorts, RT-qPCR (a technique that measures the amounts of specific RNAs in biological samples), and receiver operating characteristic (ROC) curve analysis (a graphical method for determining diagnostic test performance).", {"entities": []}], ["The overall AUC for the test in the five validation cohorts was 0.88.", {"entities": []}], ["The AUC (area under a ROC curve) quantifies the ability of a test to discriminate between individuals with and without a disease.", {"entities": []}], ["A perfect test that yields no false positives or false negatives has an AUC of 1.00; a test no better at identifying true positives than flipping a coin has an AUC of 0.5.", {"entities": []}], ["Importantly, disease severity did not affect the performance of SeptiCyte Lab, and the assay was better at discriminating sepsis from infection-negative systemic inflammation than all tested clinical and laboratory parameters (singly and in combination) that can currently be obtained within 24 hours of admission to an intensive care unit.", {"entities": []}], ["These findings suggest that SeptiCyte Lab might be useful in the management of critically ill patients with systemic inflammation.", {"entities": []}], ["In the validation cohorts tested, this rapid diagnostic test (SeptiCyte Lab currently takes 4\u20136 hours to perform but could be developed to provide a result in about 90 minutes) was able to correctly identify 90% of patients with sepsis, although it also mistakenly identified some patients as having sepsis when they had infection-negative systemic inflammation.", {"entities": []}], ["Further clinical studies are needed before SeptiCyte Lab can be used clinically because of limitations in the current study.", {"entities": []}], ["For example, the patients in the validation cohorts imperfectly reflect the composition of real-world patients with systemic inflammation.", {"entities": []}], ["However, the researchers suggest that, in combination with other clinical parameters and clinical judgment, SeptiCyte Lab might help physicians make appropriate therapeutic decisions for patients with systemic inflammation.", {"entities": []}], ["This list of resources contains links that can be accessed when viewing the PDF on a device or via the online version of the article at http://dx.doi.org/10.1371/journal.pmed.1001916 .", {"entities": []}], ["The UK National Health Service Choices website provides information on sepsis The US National Institute of General Medical Sciences provides a fact sheet on sepsis The UK Sepsis Trust is a not-for-profit organization that provides information and personal stories about sepsis The World Sepsis Day website also provides information and personal stories about sepsis MedlinePlus provides links to further information about sepsis (in English and Spanish) Wikipedia has pages on sepsis , systemic inflammatory response syndrome , and ROC curve analysis (note that Wikipedia is a free online encyclopedia that anyone can edit; available in several languages)", {"entities": [[517, 525, "DISEASE"]]}], ["Farmers are exposed to multiple air contaminants that may interact with tobacco smoking in the development of respiratory diseases.", {"entities": []}], ["Farmers are currently considered to smoke less than non-farmers, but precise data in different categories of age and farming activities are lacking.", {"entities": []}], ["Smoking habits were studied in a cross-sectional study involving 4105 farmers and 996 non-farming controls aged 40\u201374 years in 9 French departments between October 2012 and May 2013.", {"entities": []}], ["Three age groups were defined (40\u201354, 55\u201364 and 65-74years).", {"entities": []}], ["Farmers were divided into four activity groups, namely cattle breeders, livestock farmers working in confined spaces, crop farmers and others.", {"entities": []}], ["Smoking prevalence was compared between farmers and controls, and odds ratios (ORs) for smoking adjusted for age were calculated.", {"entities": []}], ["The adjusted OR for ever-smoking was lower among farmers than among non-farmers in all age categories, but the ORs for current smoking were similar in farmers and controls.", {"entities": []}], ["Smoking prevalence varied according to the type of farming activity, and was lower than in non-farming controls only among cattle breeders and confined livestock farmers.", {"entities": []}], ["In farmers, the proportion of smokers was higher in the youngest age categories compared with the older age classes.", {"entities": []}], ["Our results confirm that the prevalence of ever-smokers is lower in farmers than in non-farmers.", {"entities": []}], ["Nevertheless, our data show that active smoking prevalence is similar in farmers and in non-farmers.", {"entities": []}], ["This suggests that farmers, just like non-farmers, should be targeted by primary prevention campaigns against smoking.", {"entities": []}], ["Bronchiolitis, often caused by respiratory syncytial virus (RSV), is the commonest cause of hospitalisation in infancy.", {"entities": [[0, 13, "DISEASE"]]}], ["Serum transaminases are sometimes raised in children with bronchiolitis.", {"entities": [[58, 71, "DISEASE"]]}], ["We tested the hypothesis that raised transaminases are associated with increased disease severity in children ventilated for bronchiolitis.", {"entities": [[125, 138, "DISEASE"]]}], ["Prospective observational cohort study of mechanically ventilated children with community-acquired RSV bronchiolitis.", {"entities": [[103, 116, "DISEASE"]]}], ["Alanine transaminase (ALT) and aspartate transaminase (AST) levels were measured daily.", {"entities": []}], ["Children with normal transaminases were compared with those with elevated levels.", {"entities": []}], ["Over 11 consecutive winters, 556 children with RSV bronchiolitis were mechanically ventilated \u2013 226 had comorbidities and therefore excluded; 313 of remaining 330 were under 2 years age; 305 had early transaminase measurements.", {"entities": [[51, 64, "DISEASE"]]}], ["57/305 (19%) had elevated transaminase (AST and/or ALT) levels.", {"entities": []}], ["For the first time we show that duration of ventilation and length of admission were both significantly longer, and paediatric index of mortality and C-reactive protein higher, in those with elevated AST levels on admission (but not those with elevated ALT levels).", {"entities": []}], ["Furthermore, transaminase elevations were transient, generally having normalised by seven days following admission.", {"entities": []}], ["RSV bronchiolitis was more severe in children with early elevated AST levels and could be used early in the illness as a predictor for disease severity.", {"entities": [[4, 17, "DISEASE"]]}], ["Hypertension has been the leading risk factor contributing to cardiovascular morbidity and mortality, which needs comprehensive measures to manage and can be controlled effectively in primary care.", {"entities": [[0, 12, "DISEASE"]]}], ["In the health care context of South Korea, where specialists can see patients directly at their own community clinics and there has been no consensus on the definition of primary care, the authors used the nationally representative 2013 Korea Health Panel data, categorized adults (\u226518 years) with hypertension by types of usual source of care (USC), and analyzed the association of having a comprehensive community clinic (i.e., primary care) physician as a USC with experience of emergency department (ED) visits and hospitalization within a year.", {"entities": [[298, 310, "DISEASE"]]}], ["After adjusting for cofounding variables including Charlson comorbidity index scores, those having a primary care physician as a USC remained associated with a decrease in an experience of ED visits (OR: 0.61, 95% CI: 0.40\u20130.93) and hospitalization (OR: 0.69, 95% CI: 0.49\u20130.96), compared to those not having a usual physician.", {"entities": []}], ["Health policies that promote having a primary care physician as a USC could decrease unnecessary experience of ED visits and hospitalization by adults with hypertension.", {"entities": [[156, 168, "DISEASE"]]}], ["This can partly reduce ED overcrowding and avoidable hospitalization in Korea.", {"entities": []}], ["The aim of this study was to evaluate the responsiveness of the 3-minute constant rate step test (3-MST) to detect the relief of exertional dyspnea (respiratory discomfort) after acute bronchodilation in COPD patients.", {"entities": []}], ["A total of 40 patients with moderate-to-severe COPD (mean forced expiratory volume in 1 second: 45.7 (\u00b114.7), % predicted) performed four 3-MSTs at randomly assigned stepping rates of 14, 16, 20 and 24 steps/min after inhalation of nebulized ipratropium bromide (500 \u00b5g)/salbutamol (2.5 mg) and saline placebo, which were randomized to order.", {"entities": []}], ["Patients rated their intensity of perceived dyspnea at the end of each 3-MST using Borg 0\u201310 category ratio scale.", {"entities": []}], ["A total of 37 (92.5%), 36 (90%), 34 (85%) and 27 (67.5%) patients completed all 3 minutes of exercise at 14, 16, 20 and 24 steps/min under both treatment conditions, respectively.", {"entities": []}], ["Compared with placebo, ipratropium bromide/salbutamol significantly decreased dyspnea at the end of the third minute of exercise at 14 steps/min (by 0.6\u00b11.0 Borg 0\u201310 scale units, P <0.01) and 16 steps/min (by 0.7\u00b11.3 Borg 0\u201310 scale units, P <0.01); however, no statically significant differences were observed between treatments at 20 and 24 steps/min (both P >0.05).", {"entities": []}], ["The 3-MST, when performed at 14 and 16 steps/min, was responsive to detect the relief of exertional dyspnea after acute bronchodilation in patients with moderate-to-severe COPD.", {"entities": []}], ["Peripheral-blood basophils were counted, in thick smears, in samples from patients with primary bronchial carcinoma, from patients in the same wards and from normal individuals.", {"entities": [[106, 115, "DISEASE"]]}], ["The median counts for patients with other chest conditions (15.5/microliter) and bronchial-carcinoma patients free of tumour months to years after resection (16/microliter) did not differ from those for normal individuals (19/microliter), but tumour-bearers showed higher counts (median 33/microliter), 24/41 having counts above the highest count in normal individuals (29/microliter): P less than 0.002).", {"entities": [[91, 100, "DISEASE"]]}], ["The highest values were in patients with squamous bronchial carcinoma, apparently reflecting spontaneous challenge of an anti-tumour immune response.", {"entities": [[60, 69, "DISEASE"]]}], ["In those tested at the time of diagnosis, higher values in both lymphocyte and basophil counts were related to surgical resectability.", {"entities": []}], ["Measurement of inspiratory capacity (IC) as a marker of dynamic lung hyperinflation has been shown to correlate with dyspnea and exercise performance in stable COPD, and is therefore of potential utility in the management of this condition.", {"entities": []}], ["We have examined whether similar relationships exist during acute exacerbations of COPD and asthma in order to determine whether there is a role for IC monitoring in acute management of these conditions.", {"entities": [[92, 98, "DISEASE"]]}], ["Eight patients with COPD and ten with asthma requiring hospital admission for acute exacerbations were studied with spirometry (including IC) at admission and at discharge and had concurrent self-perceived resting dyspnea ratings recorded.", {"entities": [[38, 44, "DISEASE"]]}], ["Over the admission there were significant improvements in resting dyspnea for the COPD group only, and improvements in spirometric indices in the asthma group only.", {"entities": [[146, 152, "DISEASE"]]}], ["No significant correlations were found between changes in dyspnea and changes in IC, in terms of acute responses to bronchodilator and in response to treatment over the hospital admission.", {"entities": []}], ["These data suggest that dynamic hyperinflation during acute exacerbations of COPD and asthma is not as sensitive an indicator of resting dyspnea as in stable disease.", {"entities": [[86, 92, "DISEASE"]]}], ["A role for IC monitoring in the management of acute exacerbations of these diseases has not been identified.", {"entities": []}], ["Drug-Related Problems (DRPs) commonly occur among type 2 diabetes mellitus (T2DM) patients.", {"entities": [[57, 74, "DISEASE"], [50, 74, "DISEASE"]]}], ["However, few studies have been performed on T2DM patients with dyslipidemia.", {"entities": []}], ["This purpose of this study was to assess drug-related problems (DRPs) and factors associated with its occurrence.", {"entities": []}], ["The retrospective study involved 208 T2DM in-patients and out-patients with dyslipidemia, and was conducted at a tertiary hospital in Malaysia from January 2009 to December 2011.", {"entities": []}], ["The identification and assessment of DRPs were based on the Pharmaceutical Care Network Europe (PCNE) tool version 5.01.", {"entities": []}], ["The potentially inappropriate medication use in older adults was assessed based on the American Geriatrics Society updated Beers Criteria.", {"entities": []}], ["A total of 406 DRPs were identified.", {"entities": []}], ["Among these patients, 91.8% had at least one DRP, averaging 1.94\u2009\u00b1\u20091.10 problems per patient.", {"entities": []}], ["The majority of T2DM patients with dyslipidemia (91.8%) had at least one DRP.", {"entities": []}], ["The most frequent types of DRP were potential drug-drug interaction (18.0%), drug not taken or administered (14.3%) and insufficient awareness of health and diseases (11.8%).", {"entities": []}], ["Anti-hypertensive, lipid-modifying and anti-diabetic agents were the drug classes that were most likely to be associated with DRPs.", {"entities": []}], ["Male gender, renal impairment, polypharmacy and poor lipid control were factors that were significantly associated with DRP in diabetic dyslipidemia patients.", {"entities": []}], ["Early identification of DRPs and factors associated with them are essential to prevent and resolve DRPs in T2DM patients with dyslipidemia.", {"entities": []}], ["Alleles derived from skin tumor\u2212resistant Car-R mice provide resistance to both skin and lung tumorigenesis over the susceptibility of the SWR/J strain.", {"entities": []}], ["In an effort to map tumor modifier loci affecting both tumor types, we carried out a genetic linkage analysis in backcross SWR/J x (SWR/J x Car-R) mice and identified a locus ( Lsktm1 ) on chromosome 1 linked to both skin (LOD score = 3.93) and lung (LOD score = 8.74) tumorigenesis.", {"entities": []}], ["Two genes, Igfbp5 and Igfbp2 , residing in this locus and belonging to the insulin-like growth factor binding protein family were expressed at significantly greater levels in normal lung tissue from cancer-resistant Car-R mice than in cancer-susceptible SWR/J mice.", {"entities": [[199, 205, "DISEASE"], [235, 241, "DISEASE"], [11, 17, "GENE"], [22, 28, "GENE"]]}], ["Overexpression of the recombinant Igfbp5 and Igfbp2 genes in two lung cancer cell lines significantly inhibited clonogenicity ( P < 0.0001).", {"entities": [[65, 76, "DISEASE"], [70, 76, "DISEASE"], [34, 40, "GENE"], [45, 51, "GENE"]]}], ["Collectively, we have identified a single polymorphic locus that affects skin and lung tumorigenesis and identify Igfbp5 and Igfbp2 as candidate modifier genes of lung tumorigenesis.", {"entities": [[114, 120, "GENE"], [125, 131, "GENE"]]}], ["Population structure and admixture have strong confounding effects on genetic association studies.", {"entities": []}], ["Discordant frequencies for age-related macular degeneration (AMD) risk alleles and for AMD incidence and prevalence rates are reported across different ethnic groups.", {"entities": [[39, 59, "DISEASE"]]}], ["We examined the genomic ancestry characterizing 538 Latinos drawn from the Los Angeles Latino Eye Study [LALES] as part of an ongoing AMD-association study.", {"entities": []}], ["To help assess the degree of Native American ancestry inherited by Latino populations we sampled 25 Mayans and 5 Mexican Indians collected through Coriell's Institute.", {"entities": []}], ["Levels of European, Asian, and African descent in Latinos were inferred through the USC Multiethnic Panel (USC MEP), formed from a sample from the Multiethnic Cohort (MEC) study, the Yoruba African samples from HapMap II, the Singapore Chinese Health Study, and a prospective cohort from Shanghai, China.", {"entities": []}], ["A total of 233 ancestry informative markers were genotyped for 538 LALES Latinos, 30 Native Americans, and 355 USC MEP individuals (African Americans, Japanese, Chinese, European Americans, Latinos, and Native Hawaiians).", {"entities": []}], ["Sensitivity of ancestry estimates to relative sample size was considered.", {"entities": []}], ["We detected strong evidence for recent population admixture in LALES Latinos.", {"entities": []}], ["Gradients of increasing Native American background and of correspondingly decreasing European ancestry were observed as a function of birth origin from North to South.", {"entities": []}], ["The strongest excess of homozygosity, a reflection of recent population admixture, was observed in non-US born Latinos that recently populated the US.", {"entities": []}], ["A set of 42 SNPs especially informative for distinguishing between Native Americans and Europeans were identified.", {"entities": []}], ["These findings reflect the historic migration patterns of Native Americans and suggest that while the 'Latino' label is used to categorize the entire population, there exists a strong degree of heterogeneity within that population, and that it will be important to assess this heterogeneity within future association studies on Latino populations.", {"entities": []}], ["Our study raises awareness of the diversity within \"Latinos\" and the necessity to assess appropriate risk and treatment management.", {"entities": []}], ["Heme oxygenase-1 (HO-1) is an important anti-inflammatory, antioxidative and cytoprotective enzyme that is regulated by the activation of the major transcription factor, nuclear factor (erythroid-derived 2)-like 2 (Nrf2).", {"entities": []}], ["In the present study, six stilbene derivatives isolated from Rheum undulatum L. were assessed for their antioxidative potential.", {"entities": []}], ["In the tert -butylhydroperoxide ( t -BHP)-induced RAW 264.7 macrophage cell line, desoxyrhapontigenin was the most potent component that reduced intracellular reactive oxygen species (ROS) and peroxynitrite.", {"entities": [[7, 11, "GENE"]]}], ["In response to desoxyrhapontigenin, the mRNA expression levels of antioxidant enzymes were up-regulated.", {"entities": []}], ["An electrophoretic mobility shift assay (EMSA) confirmed that desoxyrhapontigenin promoted the DNA binding of Nrf2 and increased the expression of antioxidant proteins and enzymes regulated by Nrf2.", {"entities": []}], ["Further investigation utilizing specific inhibitors of Akt, p38, JNK and ERK demonstrated that the phosphatidylinositol 3-kinase (PI3K)/Akt pathway mediates HO-1 expression.", {"entities": []}], ["Moreover, the increase in Nrf2 expression mediated by treatment with desoxyrhapontigenin was reversed by Nrf2 or Akt gene knock-down.", {"entities": []}], ["In the LPS-induced in vivo lung inflammation model, pretreatment with desoxyrhapontigenin markedly ameliorated LPS-induced lung inflammation and histological changes.", {"entities": []}], ["Immunohistochemical analysis of Nrf2, HO-1 and p65 was conducted and confirmed that treatment with desoxyrhapontigenin induced Nrf2 and HO-1 expression but reduced p65 expression.", {"entities": []}], ["These findings suggest that desoxyrhapontigenin may be a potential therapeutic candidate as an antioxidant or an anti-inflammatory agent.", {"entities": []}], ["A proposed pathway for desoxyrhapontigenin-induced Nrf/ARE-mediated up-regulation of antioxidant genes via the activation of Nrf2 signaling.", {"entities": []}], ["\u2022 Enhancement of the levels of antioxidant enzymes by desoxyrhapontigenin.", {"entities": []}], ["\u2022 Promotion of DNA binding affinity of Nrf2 in RAW 264.7 macrophages.", {"entities": []}], ["\u2022 Induction of HO-1 expression and inhibition of Keap1 by desoxyrhapontigenin via the Akt pathway.", {"entities": [[49, 54, "GENE"]]}], ["\u2022 Amelioration of LPS-induced inflammatory lung injury in mice.", {"entities": []}], ["Enhancement of the levels of antioxidant enzymes by desoxyrhapontigenin.", {"entities": []}], ["Promotion of DNA binding affinity of Nrf2 in RAW 264.7 macrophages.", {"entities": []}], ["Induction of HO-1 expression and inhibition of Keap1 by desoxyrhapontigenin via the Akt pathway.", {"entities": [[47, 52, "GENE"]]}], ["Amelioration of LPS-induced inflammatory lung injury in mice.", {"entities": []}], ["Stressful life events occurring in adulthood have been found able to affect mood and behavior, thus increasing the vulnerability for several stress-related psychiatric disorders.", {"entities": []}], ["However, although there is plenty of clinical data supporting an association between stressful life events in adulthood and an enhanced vulnerability for psychopathology, the underlying molecular mechanisms are still poorly investigated.", {"entities": []}], ["Thus, in this study we performed peripheral/whole-genome transcriptomic analyses in blood samples obtained from 53 adult subjects characterized for recent stressful life events occurred within the previous 6 months.", {"entities": []}], ["Transcriptomic data were analyzed using Partek Genomics Suite; pathway and network analyses were performed using Ingenuity Pathway Analysis and GeneMANIA Software.", {"entities": []}], ["We found 207 genes significantly differentially expressed in adult subjects who reported recent stressful life experiences ( n =21) compared with those without such experiences ( n =32).", {"entities": []}], ["Moreover, the same subjects exposed to such stressful experiences showed a reduction in leukocyte telomere length.", {"entities": []}], ["A correlation analyses between telomere length and transcriptomic data indicated an association between the exposures to recent stressful life events and the modulation of several pathways, mainly involved in immune-inflammatory-related processes and oxidative stress, such as natural killer cell signaling, interleukin-1 (IL-1) signaling, MIF regulation of innate immunity and IL-6 signaling.", {"entities": [[340, 343, "GENE"]]}], ["Our data suggest an association between exposures to recent stressful life events in adulthood and alterations in the immune, inflammatory and oxidative stress pathways, which could be also involved in the negative effect of stressful life events on leukocyte telomere length.", {"entities": []}], ["The modulation of these mechanisms may underlie the clinical association between the exposure to recent Stressful life events in adulthood and an enhanced vulnerability to develop psychiatric diseases in adulthood.", {"entities": []}], ["TOC summary: Pregnancy, asthma, diabetes, and a history of smoking were among risk factors found.", {"entities": [[24, 30, "DISEASE"]]}], ["We conducted a case\u2013control study to identify risk factors for hospitalization from pandemic (H1N1) 2009 virus infection among persons >16 years of age in Sydney, Australia.", {"entities": []}], ["The study comprised 302 case-patients and 603 controls.", {"entities": []}], ["In a logistic regression model, after adjusting for age and sex, risk factors for hospitalization were pregnancy (odds ratio [OR] 22.4, 95% confidence interval [CI] 9.2\u201354.5), immune suppression (OR 5.5, 95% CI 2.8\u201310.9), pre-existing lung disease (OR 6.6, 95% CI 3.8\u201311.6), asthma requiring regular preventive medication (OR 4.3, 95% CI 2.7\u20136.8), heart disease (OR 2.3, 95% CI 1.2\u20134.1), diabetes (OR 3.8, 95% CI 2.2\u20136.5), and current smoker (OR 2.0, 95% CI 1.3\u20133.2) or previously smoked (OR 2.0, 95% CI 1.3\u20133.0).", {"entities": [[348, 361, "DISEASE"], [275, 281, "DISEASE"], [235, 247, "DISEASE"]]}], ["Although obesity was not independently associated with hospitalization, it was associated with an increased risk of requiring mechanical ventilation.", {"entities": [[9, 16, "DISEASE"]]}], ["Public health messages should give greater emphasis on the risk for severe disease among pregnant women and smokers.", {"entities": []}], ["Isolated central nervous system (CNS) vasculitis is a rare and complicated disorder.", {"entities": [[38, 48, "DISEASE"]]}], ["Patients typically present with nonspecific neurologic symptoms such as headache and encephalopathy, and have variable progression and severity of the disease.", {"entities": []}], ["Challenges to definitive diagnosis include the limitations of currently available diagnostic modalities with high likelihood of false-positive or false-negative findings.", {"entities": []}], ["Imaging, serologic, and cerebrospinal fluid (CSF) evaluation, and even angiography can fail to establish the diagnosis.", {"entities": []}], ["Often, brain biopsy is required.", {"entities": []}], ["In order to illustrate these challenges, we report the case of a patient who presented with subacute cognitive decline and was ultimately diagnosed with isolated CNS eosinophilic vasculitis.", {"entities": [[179, 189, "DISEASE"]]}], ["Initial work-up included CSF and serologic analyses, magnetic resonance imaging (MRI), and cerebral angiography, but definitive diagnosis required brain biopsy.", {"entities": []}], ["Immunosuppressive therapy resulted in clinical improvement and stabilization.", {"entities": []}], ["To our knowledge, only one other case of isolated CNS eosinophilic vasculitis has been reported in the literature.", {"entities": [[67, 77, "DISEASE"]]}], ["We discuss the importance of a high index of clinical suspicion in cases of progressive nonspecific neurologic symptoms.", {"entities": []}], ["Accumulating evidence demonstrated that obesity is a risk factor for renal structural and functional changes, leading to the end-stage renal disease which imposes a heavy economic burden on the community.", {"entities": [[40, 47, "DISEASE"]]}], ["However, no effective therapeutic method for obesity-associated kidney disease is available.", {"entities": [[64, 78, "DISEASE"], [45, 52, "DISEASE"]]}], ["In the present study, we explored the therapeutic potential of a magnolia extract (BL153) for treating obesity-associated kidney damage in a high fat diet- (HFD-) induced mouse model.", {"entities": [[103, 110, "DISEASE"]]}], ["The results showed that inflammation markers (tumor necrosis factor- \u03b1 and plasminogen activator inhibitor-1) and oxidative stress markers (3-nitrotyrosine and 4-hydroxy-2-nonenal) were all significantly increased in the kidney of HFD-fed mice compared to mice fed with a low fat diet (LFD).", {"entities": []}], ["Additionally, proteinuria and renal structure changes in HFD-fed mice were much more severe than that in LFD-fed mice.", {"entities": [[14, 25, "DISEASE"]]}], ["However, all these alterations were attenuated by BL153 treatment, accompanied by upregulation of peroxisome proliferator-activated receptor- \u03b3 coactivator-1 \u03b1 (PGC-1 \u03b1 ) and hexokinase II (HK II) expression in the kidney.", {"entities": []}], ["The present study indicates that BL153 administration may be a novel approach for renoprotection in obese individuals by antiinflammation and anti-oxidative stress most likely via upregulation of PGC-1 \u03b1 and HK II signal in the kidney.", {"entities": []}], ["A typical indicator of sepsis is the development of progressive subcutaneous and body-cavity edema, which is caused by the breakdown of endothelial barrier function, leading to a marked increase in vascular permeability.", {"entities": []}], ["Microvascular leakage predisposes to microvascular thrombosis, breakdown of microcirculatory flow and organ failure, which are common events preceding mortality in patients with severe sepsis.", {"entities": []}], ["Melilotus suaveolens (M. suaveolens) is a Traditional Tibetan Medicine.", {"entities": []}], ["Previous pharmacological studies have demonstrated that an ethanolic extract of M. suaveolens has powerful anti-inflammatory activity and leads to an improvement in capillary permeability.", {"entities": []}], ["However, the mechanisms underlying its pharmacological activity remain elusive.", {"entities": []}], ["The present study aimed to assess the impact of M. suaveolens extract tablets on pulmonary vascular permeability, and their effect on regulating lung inflammation and the expression of vascular endothelial growth factor (VEGF) in the lung tissue of rats with sepsis.", {"entities": []}], ["A cecal ligation and puncture (CLP) sepsis model was established for both the control and treatment groups.", {"entities": []}], ["~2 h prior to surgery, 25 mg/kg of M. suaveolens extract tablet was administered to the treatment group.", {"entities": []}], ["Polymerase chain reaction and western blot analyses were used to assess the expression of nuclear factor (NF)-\u03baB and VEGF in the lung tissue, and ELISA was applied to detect changes in serum tumor necrosis factor-\u03b1 as well as interleukins (IL) -1, -4, -6, and -10.", {"entities": []}], ["The lung permeability, wet/dry weight ratio and lung pathology were determined.", {"entities": []}], ["The results demonstrated that in the lung tissue of CLP-rats with sepsis, M. suaveolens extract inhibited the expression of NF-\u03baB, reduced the inflammatory response and blocked the expression of VEGF, and thus significantly decreased lung microvascular permeability.", {"entities": []}], ["The effects of M. Suaveolens extract may be of potential use in the treatment of CLP-mediated lung microvascular permeability.", {"entities": []}], ["This study was conducted to investigate the association between the chronic obstructive pulmonary disease (COPD) assessment test (CAT) and depression in COPD patients.", {"entities": [[68, 105, "DISEASE"]]}], ["The Korean versions of the CAT and patient health questionnaire-9 (PHQ-9) were used to assess COPD symptoms and depressive disorder, respectively.", {"entities": []}], ["In total, 803 patients with COPD were enrolled from 32 hospitals and the prevalence of depression was 23.8%.", {"entities": []}], ["The CAT score correlated well with the PHQ-9 score (r=0.631; P <0.001) and was significantly associated with the presence of depression (\u03b2\u00b1standard error, 0.452\u00b10.020; P <0.001).", {"entities": []}], ["There was a tendency toward increasing severity of depression in patients with higher CAT scores.", {"entities": []}], ["By assessment groups based on the 2011 Global Initiative for Chronic Obstructive Lung Disease guidelines, the prevalence of depression was affected more by current symptoms than by airway limitation.", {"entities": []}], ["The area under the receiver operating characteristic curve for the CAT was 0.849 for predicting depression, and CAT scores \u226521 had the highest accuracy rate (80.6%).", {"entities": []}], ["Among the eight CAT items, energy score showed the best correlation and highest power of discrimination.", {"entities": []}], ["CAT scores are significantly associated with the presence of depression and have good performance for predicting depression in COPD patients.", {"entities": []}], ["Improving patients' health status is one of the major goals in COPD treatment.", {"entities": []}], ["Questionnaires could facilitate the guidance of patient-tailored disease management by exploring which aspects of health status are problematic, and which aspects are not.", {"entities": []}], ["Health status consists of four main domains (physiological functioning, symptoms, functional impairment, and quality of life), and at least sixteen sub-domains.", {"entities": []}], ["A prerequisite for patient-tailored treatment is a detailed assessment of all these sub-domains.", {"entities": []}], ["Most questionnaires developed to measure health status consist of one or a few subscales and measure merely some aspects of health status.", {"entities": []}], ["The question then rises which aspects of health status are measured by these instruments, and which aspects are not covered.", {"entities": []}], ["As it is one of the most frequently used questionnaires in COPD, we evaluated which aspects of health status are measured and which aspects are not measured by the St George's Respiratory Questionnaire (SGRQ).", {"entities": []}], ["One hundred and forty-six outpatients with COPD participated.", {"entities": []}], ["Correlations were calculated between the three sections of the SGRQ and ten sub-domains of the Nijmegen Integral Assessment Framework, covering Symptoms, Functional Impairment, and Quality of Life.", {"entities": []}], ["As the SGRQ was not expected to measure physiological functioning, we did not include this main domain in the statistical analyses.", {"entities": []}], ["Pearson's r \u2265 0.70 was used as criterion for conceptual similarity.", {"entities": []}], ["The SGRQ sections Symptoms and Total showed conceptual similarity with the sub-domain Subjective Symptoms (main domain Symptoms).", {"entities": []}], ["The sections Activity, Impacts and Total were conceptual similar to Subjective Impairment (main domain Functional Impairment).", {"entities": []}], ["The SGRQ sections were not conceptual similar to other sub-domains of Symptoms, Functional Impairment, nor to any sub-domain of Quality of Life.", {"entities": []}], ["The SGRQ could facilitate the guidance of disease management in COPD only partially.", {"entities": []}], ["The SGRQ is appropriately only for measuring problems in the sub-domains Subjective Symptoms and Subjective Impairment, and not for measuring problems in other sub-domains of health status, such as Quality of Life.", {"entities": []}], ["Patients with a chronic disease often suffer from other diseases called comorbidities, which can be important factors in the assessment of risks associated with the disease and its management.", {"entities": []}], ["However, comorbidities can pose important methodological issues because factors such as time, age, duration and the disease can influence their impact on the risk of interest.", {"entities": []}], ["To identify comorbidities of a chronic disease, it is common practice to construct 2 separate cohorts of patients\u2014a set with the disease and another as a random sample of patients free of the disease\u2014and compare the event rates for each candidate's comorbidity over a specific period between the 2, while accounting for factors which may confound the results.", {"entities": []}], ["We describe an incidence-based alternative approach that exploits the longitudinal properties of observational databases to track incident event rates along the natural history of the chronic disease.", {"entities": []}], ["We illustrate it in a retrospective cohort of patients with chronic obstructive pulmonary disease (COPD) aged 50 and above\u2014each patient with COPD was matched with another without COPD on certain confounding factors.", {"entities": [[60, 97, "DISEASE"]]}], ["We obtained 24\u2005079 matched pairs.", {"entities": []}], ["We found that chronic conditions such as lung cancer, asthma, fracture and osteoporosis were more common in patients with COPD.", {"entities": [[41, 52, "DISEASE"], [75, 87, "DISEASE"], [54, 60, "DISEASE"], [46, 52, "DISEASE"]]}], ["We also found evidence of time-varying associations.", {"entities": []}], ["Our findings in COPD suggest that time is an important factor and comorbidity studies which are based on information in a single fixed period (such as first year postdiagnosis of COPD) are more likely to report spurious associations.", {"entities": []}], ["Prostaglandins (PGs) play key roles in development and maintenance of homeostasis of the adult body.", {"entities": []}], ["Despite these important roles, it remains unclear whether the PG pathway is a target for endocrine disruption.", {"entities": []}], ["However, several known endocrine-disrupting compounds (EDCs) share a high degree of structural similarity with mild analgesics.", {"entities": []}], ["Using cell-based transfection and transduction experiments, mass spectrometry, and organotypic assays together with molecular modeling, we investigated whether inhibition of the PG pathway by known EDCs could be a novel point of endocrine disruption.", {"entities": []}], ["We found that many known EDCs inhibit the PG pathway in a mouse Sertoli cell line and in human primary mast cells.", {"entities": []}], ["The EDCs also reduced PG synthesis in ex vivo rat testis, and this reduction was correlated with a reduced testosterone production.", {"entities": []}], ["The inhibition of PG synthesis occurred without involvement of canonical PG receptors or the peroxisome proliferator\u2013activated receptors (PPARs), which have previously been described as targets of EDCs.", {"entities": []}], ["Instead, our results suggest that the compounds may bind directly into the active site of the cyclooxygenase (COX) enzymes, thereby obstructing the conversion of arachidonic acid to PG precursors without interfering with the expression of the COX enzymes.", {"entities": []}], ["A common feature of the PG inhibitory EDCs is the presence of aromatic groups that may stabilize binding in the hydrophobic active site of the COX enzymes.", {"entities": []}], ["Our findings suggest a hitherto unknown mode of action by EDCs through inhibition of the PG pathway and suggest new avenues to investigate effects of EDCs on reproductive and immunological disorders that have become increasingly common in recent decades.", {"entities": []}], ["To investigate the effects of icariin, a major constituent of flavonoids isolated from the herb Epimedium , on cigarette smoke (CS) induced inflammatory responses in vivo and in vitro .", {"entities": [[128, 130, "GENE"]]}], ["In vivo , BALB/c mice were exposed to smoke of 15 cigarettes for 1 h/day, 6 days/week for 3 months and dosed with icariin (25, 50 and 100 mg/kg) or dexamethasone (1 mg/kg).", {"entities": []}], ["In vitro , A549 cells were incubated with icariin (10, 50 and 100 \u00b5M) followed by treatments with CSE (2.5%).", {"entities": []}], ["We found that icariin significantly protected pulmonary function and attenuated CS-induced inflammatory response by decreasing inflammatory cells and production of TNF-\u03b1, IL-8 and MMP-9 in both the serum and BALF of CS-exposed mice and decreasing production of TNF-\u03b1 and IL-8 in the supernatant of CSE-exposed A549 cells.", {"entities": []}], ["Icariin also showed properties in inhibiting the phosphorylation of NF-\u03baB p65 protein and blocking the degradation of I\u039aB-\u03b1 protein.", {"entities": []}], ["Further studies revealed that icariin administration markedly restore CS-reduced GR protein and mRNA expression, which might subsequently contribute to the attenuation of CS-induced respiratory inflammatory response.", {"entities": []}], ["Together these results suggest that icariin has anti-inflammatory effects in cigarette smoke induced inflammatory models in vivo and in vitro , possibly achieved by suppressing NF-\u03baB activation and modulating GR protein expression.", {"entities": []}], ["Mechanical ventilation at high tidal volume (HTV) may cause pulmonary capillary leakage and acute lung inflammation resulting in ventilator-induced lung injury.", {"entities": []}], ["Besides blunting the Toll-like receptor-4-induced inflammatory cascade and lung dysfunction in a model of lipopolysaccharide-induced lung injury, oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC) exerts direct barrier-protective effects on pulmonary endothelial cells in vitro via activation of the small GTPases Rac and Cdc42.", {"entities": [[347, 352, "GENE"]]}], ["To test the hypothesis that OxPAPC may attenuate lung inflammation and barrier disruption caused by pathologic lung distension, we used a rodent model of ventilator-induced lung injury and an in vitro model of pulmonary endothelial cells exposed to pathologic mechanochemical stimulation.", {"entities": []}], ["Rats received a single intravenous injection of OxPAPC (1.5 mg/kg) followed by mechanical ventilation at low tidal volume (LTV) (7 mL/kg) or HTV (20 mL/kg).", {"entities": []}], ["Bronchoalveolar lavage was performed and lung tissue was stained for histological analysis.", {"entities": []}], ["In vitro , the effects of OxPAPC on endothelial barrier dysfunction and GTPase activation were assessed in cells exposed to thrombin and pathologic (18%) cyclic stretch.", {"entities": []}], ["HTV induced profound increases in bronchoalveolar lavage and tissue neutrophils and in lavage protein.", {"entities": []}], ["Intravenous OxPAPC markedly attenuated HTV-induced protein and inflammatory cell accumulation in bronchoalveolar lavage fluid and lung tissue.", {"entities": []}], ["In vitro , high-magnitude stretch enhanced thrombin-induced endothelial paracellular gap formation associated with Rho activation.", {"entities": []}], ["These effects were dramatically attenuated by OxPAPC and were associated with OxPAPC-induced activation of Rac.", {"entities": []}], ["OxPAPC exhibits protective effects in these models of ventilator-induced lung injury.", {"entities": []}], ["Previous epidemiologic studies have reported that a history of allergy is associated with reduced risk of colorectal cancer and other malignancies.", {"entities": [[106, 123, "DISEASE"], [117, 123, "DISEASE"]]}], ["However, no information is available for the association between allergy and the risk of lymph node metastasis.", {"entities": []}], ["Our study was designed to determine this association in rectal cancer.", {"entities": [[63, 69, "DISEASE"]]}], ["Patients who were treated at our hospital in the period from January 2003 to June 2011, and with a pathologically hospital discharge diagnosis of rectal adencarcinoma, were included.", {"entities": []}], ["The clinical, laboratory, and pathologic parameters were analyzed.", {"entities": []}], ["A multivariate logistic regression model was used to determine the association.", {"entities": []}], ["Moreover, for type of allergic drug, sub-group analysis was performed.", {"entities": []}], ["469 patients were included, including 231 with pathological lymph node metastasis (pLNM) (49.3%) and 238 without pLNM.", {"entities": []}], ["Univariate analysis showed, compared with patients without pLNM, patients with pLNM had a younger age (60.6\u00b112.8 yr vs. 63.6\u00b112.2 yr, P\u200a=\u200a0.012), a lower percentage of drug allergy (8.7% vs. 16.0%, P\u200a=\u200a0.016), an increased CEA (median/interquartile-range 5.40/2.40\u201313.95 vs. 3.50/2.08\u20138.67, P\u200a=\u200a0.009), and a lower serum sodium (141\u00b13.1 mmol/L vs. 142\u00b12.9 mmol/L, P\u200a=\u200a0.028).", {"entities": []}], ["Multivariate analysis showed that drug allergy was associated with a reduced risk of pLNM (OR\u200a=\u200a0.553; 95% CI, 0.308\u20130.994; P\u200a=\u200a0.048).", {"entities": []}], ["In addition, our results showed that: (1) for tumor classification, patients with drug allergy had a higher percentage of group patients with pT1/pT2; and (2) for type of allergic drug, this inverse association was found for penicillins, not for other allergic drugs.", {"entities": []}], ["Drug allergy is associated with a reduced risk of pLNM in rectal cancer.", {"entities": [[65, 71, "DISEASE"]]}], ["Graves\u2019 disease (GD) is the most common cause of hyperthyroidism in children.", {"entities": [[49, 64, "DISEASE"]]}], ["This review gives an overview and update of management of GD.", {"entities": []}], ["Antithyroid drugs (ATD) are recommended as the initial treatment, but the major problem is the high relapse rate (30%) as remission is achieved after a first course of ATD.", {"entities": []}], ["More prolonged medical treatment may increase the remission rate up to 50%.", {"entities": []}], ["Alternative treatments, such as radioactive iodine or thyroidectomy, are considered in cases of relapse, lack of compliance, or ATD toxicity.", {"entities": []}], ["Therefore, clinicians have sought prognostic indicators of remission.", {"entities": []}], ["Relapse risk decreases with longer duration of the first course of ATD treatment, highlighting the positive impact of a long period of primary ATD treatment on outcome.", {"entities": []}], ["The identification of other predictive factors such as severe biochemical hyperthyroidism at diagnosis, young age, and absence of other autoimmune conditions has made it possible to stratify patients according to the risk of relapse after ATD treatment, leading to improvement in patient management by facilitating the identification of patients requiring long-term ATD or early alternative therapy.", {"entities": [[74, 89, "DISEASE"]]}], ["Neonatal autoimmune hyperthyroidism is generally transient, occurring in only about 2% of the offspring of mothers with GD.", {"entities": [[20, 35, "DISEASE"]]}], ["Cardiac insufficiency, intrauterine growth retardation, craniostenosis, microcephaly and psychomotor disabilities are the major risks in these infants and highlight the importance of thyroid hormone receptor antibody determination throughout pregnancy in women with GD, as well as highlighting the need for early diagnosis and treatment of hyperthyroidism.", {"entities": [[340, 355, "DISEASE"], [72, 84, "DISEASE"]]}], ["Conflict of interest: None declared.", {"entities": []}], ["Respiratory tract infections (RTIs) are a major morbidity factor contributing largely to health care costs and individual quality of life.", {"entities": []}], ["The aim of the study was to test whether obesity (BMI\u2009\u2265\u200930\u00a0kg/m We recruited 1455 individuals between 18 to 70\u00a0years from a cross-sectional survey on airway infections in Germany and invited them to self-report in diaries incident RTIs experienced during three consecutive winter/spring seasons.", {"entities": [[41, 48, "DISEASE"]]}], ["RTIs reported in these 18\u00a0months and summary measures adding-up individual RTIs were the outcomes of interest.", {"entities": []}], ["Compared to individuals with normal weight, obese individuals reported a consistently higher frequency of upper and lower RTIs and predominantly fell in the upper 10% group of a diary sumscore adding-up 10 different RTI symptoms over time.", {"entities": []}], ["Obesity was associated both with lower RTIs ( adjusted OR\u2009=\u20092.02, 95%CI\u2009=\u20091.36\u20133.00) and upper RTIs ( adjusted OR\u2009=\u20091.55, 95%CI\u2009=\u20091.22\u20131.96).", {"entities": [[0, 7, "DISEASE"]]}], ["Adjusting for demographic and lifestyle variables did only marginally affect ORs.", {"entities": []}], ["Stratified analyses suggested a stronger association for women and effect modifications by sports activity and dietary habits.", {"entities": []}], ["We confirm the association of obesity with infection burden and present evidence for putative interaction with sports activity and dietary patterns.", {"entities": [[30, 37, "DISEASE"]]}], ["The online version of this article (10.1186/s12889-018-5172-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The objectives of this study were to: (i) to develop questionnaires that can identify never-smoking children and adults experiencing increased exposure to secondhand smoke (SHS+), (ii) to determine their validity against hair nicotine, and (iii) assess their reliability.", {"entities": []}], ["A sample of 191 children (85 males; 106 females; 7\u201318 years) and 95 adult (23 males; 72 females; 18\u201362 years) never-smokers consented to hair nicotine analysis and answered a large number of questions assessing all sources of SHS.", {"entities": []}], ["A randomly-selected 30% answered the questions again after 20\u201330 days.", {"entities": []}], ["Prevalence of SHS+ in children and adults was 0.52\u00b10.07 and 0.67\u00b10.10, respectively (p<0.05).", {"entities": []}], ["The Smoke Scale for Children (SS-C) and the Smoke Scale for Adults (SS-A) were developed via factor analysis and included nine questions each.", {"entities": []}], ["Positivity criteria for SS-C and SS-A via receiver operating characteristics curve analysis were identified at >16.5 and >16, respectively.", {"entities": []}], ["Significant Kappa agreement (p<0.05) was confirmed when comparing the SS-C and SS-A to hair nicotine concentration.", {"entities": []}], ["Reliability analyses demonstrated that the SS-C and SS-A scores obtained on two different days are highly correlated (p<0.001) and not significantly different (p>0.05).", {"entities": []}], ["Area under the curve and McNemar's Chi-square showed no pair-wise differences in sensitivity and specificity at the cutoff point between the two different days for SS-C and SS-A (p>0.05).", {"entities": []}], ["We conclude that the SS-C and the SS-A represent valid, reliable, practical, and inexpensive instruments to identify children and adult never-smokers exposed to increased SHS.", {"entities": []}], ["Future research should aim to further increase the validity of the two questionnaires.", {"entities": []}], ["Individuals seeking to change their alcohol use form a heterogeneous group with varied treatment goals\u2014including moderation and abstinence\u2014that therefore requires flexible treatment options.", {"entities": []}], ["The availability of alcohol in the United States, and the pervasive social pressure to drink, warrant treatments that support individuals outside the treatment environment and that foster coping and self-regulation in the face of these demands.", {"entities": []}], ["Emerging digital technologies show promise for helping both to hone therapies to clients\u2019 individual needs and to support clients in settings beyond the clinic.", {"entities": []}], ["In the broader health care arena, digital health technologies (DHTs) are transforming how health professionals assess, prevent, and treat both physical and mental health problems.", {"entities": []}], ["DHTs include assessments and interventions delivered via computer, Internet, mobile phone, and wireless or wearable device technologies.", {"entities": []}], ["The emerging literature examining within-treatment and mobile DHTs highlights an opportunity to create personalized alcohol treatments for every person seeking care.", {"entities": []}], ["Despite the promises DHTs may hold, however, there still are many potential risks to using them and a number of challenges regarding how to integrate them into treatment successfully.", {"entities": []}], ["This article will review the current and potential advantages of DHTs in alcohol treatment and the technological, personal, organizational, and systemic limitations of integrating various technology-based assessment and intervention programs into care.", {"entities": []}], ["Compliance with a gluten-free diet (GFD) is difficult at all ages but particularly for teenagers due to social, cultural, economic, and practical pressures.", {"entities": []}], ["The multidisciplinary team responsible for the treatment of patients with celiac disease and give support to their parents plays a special role on strengthening GFD and assessing the nutritional and physical health.", {"entities": [[74, 88, "DISEASE"]]}], ["A cross-sectional and retrospective study including patients under 20\u00a0years of age, with biopsy-confirmed CD, followed regularly at the Department of Pediatrics, Division of Gastroenterology, Hospital das Cl\u00ednicas , University of Sao Paulo, School of Medicine, Sao Paulo, Brazil, were surveyed using a questionnaire and serologic test applied between November 2011 and February 2012.", {"entities": []}], ["A retrospective chart review of these patients was performed to collect the anthropometric data along with the results of the serologic test performed at the time of diagnosis and after at least 1\u00a0year of treatment with a GFD.", {"entities": []}], ["We evaluated 35 patients aged between 2.4 and 19.9\u00a0years.", {"entities": []}], ["Of these 68.6% were female, 88.6% had the typical form of the disease and 51.4% had other comorbidities.", {"entities": []}], ["The mean age at diagnosis was 5.4\u00a0years.", {"entities": []}], ["Despite dietary guidance, 20% reported non-adherence to the diet.", {"entities": []}], ["Most children recovered the weight and height deficit after 5\u00a0years of treatment, and in some children, excessive weight gain became a concern.", {"entities": []}], ["The majority of transgressions occurred intentionally at home or at parties.", {"entities": []}], ["There was a risk of excessive weight gain, especially in the first two years of treatment.", {"entities": []}], ["More alternatives and easier access to low cost gluten-free foods, increasing the discussion about the benefits of adhering to a GFD among patients, families, and the general population, besides the acquisition of self-management skills, are crucial to fostering independent children and adolescents who have the knowledge and tools to manage life with CD.", {"entities": []}], ["The online version of this article (10.1186/s12876-018-0740-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The purpose of this systematic review is to investigate the efficacy of the oral administration of herbal medicines for otitis media with effusion through analysing trial data.", {"entities": [[120, 132, "DISEASE"]]}], ["Electronic searches of the following 11 databases will be performed: MEDLINE, CINAHL, EMBASE, AMED, the Cochrane CENTRAL, 3 Chinese databases (CNKI, Wangfang Data and VIP Information) and 5 Korean databases (KoreaMed, Research Information Service System, Korea Studies Information System, Oriental Medicine Advanced Searching Integrated System (OASIS) and DBpia).", {"entities": [[167, 170, "GENE"]]}], ["The selection of the studies, data abstraction and validations will be performed independently by two researchers.", {"entities": []}], ["The systematic review will be published in a peer-reviewed journal.", {"entities": []}], ["The review will also be disseminated electronically and in print.", {"entities": []}], ["The review will be updated to inform and guide healthcare practice and policy.", {"entities": []}], ["PROSPERO 2013: CRD42013005430.", {"entities": []}], ["Necrotizing enterocolitis (NEC) affects predominantly preterm infants, who have specific risk factors leading to intestinal dysbiosis .", {"entities": []}], ["Manipulations of gut microbiota through probiotics have the potential to prevent NEC.", {"entities": []}], ["The aim of this systematic review and meta-analysis was to evaluate the effect of probiotics for NEC prevention in preterm infants, with a focus on specific strains, microbiological strength of currently available studies, and high-risk populations.", {"entities": []}], ["PubMed and the Cochrane Library were searched for trials published within 4th February 2015.", {"entities": []}], ["Randomized-controlled trials reporting on NEC and involving preterm infants who were given probiotics in the first month of life were included in the systematic review.", {"entities": []}], ["Twenty-six studies were suitable for inclusion in the meta-analysis.", {"entities": []}], ["Data about study design, population, intervention and outcome were extracted and summarized independently by two observers.", {"entities": []}], ["Study quality and quality of evidence were also evaluated.", {"entities": []}], ["Fixed-effects models were used and random-effects models where significant heterogeneity was present.", {"entities": []}], ["Subgroup analyses were performed to explore sources of heterogeneity among studies.", {"entities": []}], ["Results were expresses as risk ratio (RR) with 95\u00a0% confidence interval (CI).", {"entities": []}], ["The main outcome was incidence of NEC stage \u22652 according to Bell\u2019s criteria.", {"entities": []}], ["Probiotics prevented NEC in preterm infants (RR 0.47 [95 % CI 0.36\u20130.60], p \u2009<\u20090.00001).", {"entities": []}], ["Strain-specific sub-meta-analyses showed a significant effect for Bifidobacteria (RR 0.24 [95 % CI 0.10\u20130.54], p \u2009=\u20090.0006) and for probiotic mixtures (RR 0.39 [95 % CI 0.27\u20130.56], p \u2009<\u20090.00001).", {"entities": []}], ["Probiotics prevented NEC in very-low-birth-weight infants (RR 0.48 [95 % CI 0.37\u20130.62], p \u2009<\u20090.00001); there were insufficient data for extremely-low-birth-weight infants.", {"entities": []}], ["The majority of studies presented severe or moderate microbiological flaws.", {"entities": []}], ["Probiotics had an overall preventive effect on NEC in preterm infants.", {"entities": []}], ["However, there are still insufficient data on the specific probiotic strain to be used and on the effect of probiotics in high-risk populations such as extremely-low-birth-weight infants, before a widespread use of these products can be recommended.", {"entities": []}], ["The increase in asthma incidence, prevalence, and morbidity over recent decades presents a significant challenge to public health.", {"entities": [[16, 22, "DISEASE"]]}], ["Pollen is an important trigger of some types of asthma, and both pollen quantity and season depend on climatic and meteorologic variables.", {"entities": [[48, 54, "DISEASE"]]}], ["Over the same period as the global rise in asthma, there have been considerable increases in atmospheric carbon dioxide concentration and global average surface temperature.", {"entities": [[43, 49, "DISEASE"]]}], ["We hypothesize anthropogenic climate change as a plausible contributor to the rise in asthma.", {"entities": [[86, 92, "DISEASE"]]}], ["Greater concentrations of carbon dioxide and higher temperatures may increase pollen quantity and induce longer pollen seasons.", {"entities": []}], ["Pollen allergenicity can also increase as a result of these changes in climate.", {"entities": []}], ["Exposure in early life to a more allergenic environment may also provoke the development of other atopic conditions, such as eczema and allergic rhinitis.", {"entities": [[136, 153, "DISEASE"], [145, 153, "DISEASE"]]}], ["Although the etiology of asthma is complex, the recent global rise in asthma could be an early health effect of anthropogenic climate change.", {"entities": [[25, 31, "DISEASE"], [70, 76, "DISEASE"]]}], ["Airways hyperresponsiveness is a cardinal feature of asthma but remains unexplained.", {"entities": [[53, 59, "DISEASE"]]}], ["In asthma, the airway smooth muscle cell is the key end-effector of bronchospasm and acute airway narrowing, but in just the past five years our understanding of the relationship of responsiveness to muscle biophysics has dramatically changed.", {"entities": [[3, 9, "DISEASE"]]}], ["It has become well established, for example, that muscle length is equilibrated dynamically rather than statically, and that non-classical features of muscle biophysics come to the forefront, including unanticipated interactions between the muscle and its time-varying load, as well as the ability of the muscle cell to adapt rapidly to changes in its dynamic microenvironment.", {"entities": []}], ["These newly discovered phenomena have been described empirically, but a mechanistic basis to explain them is only beginning to emerge.", {"entities": []}], ["Men and women differ in terms of presentation and management in coronary artery disease (CAD).", {"entities": []}], ["Whether these differences translate into different clinical outcomes in stable CAD is unclear.", {"entities": []}], ["We analysed data from the international prospective CLARIFY registry to compare cardiovascular clinical outcomes in men and women with stable CAD.", {"entities": []}], ["We analysed 1-year outcomes in 30 977 outpatients with stable CAD [23 975 (77.4%) men; 7002 (22.6%) women].", {"entities": []}], ["Women were older than men, more likely to have hypertension and diabetes, and less likely to exercise or smoke.", {"entities": [[47, 59, "DISEASE"]]}], ["They had more frequent angina, but were less likely to have undergone diagnostic non-invasive testing or coronary angiography.", {"entities": []}], ["Women received less optimized treatment for stable CAD.", {"entities": []}], ["One-year outcomes were similar for men and women for the composite of cardiovascular death, non-fatal myocardial infarction, or stroke [adjusted rates 1.7 vs. 1.8%, respectively, odds ratio (OR) 0.93, 95% confidence interval (CI) 0.75\u20131.15]; all-cause death (adjusted 1.5 vs. 1.6%, OR: 0.91, 95% CI: 0.72\u20131.13); fatal or non-fatal myocardial infarction (adjusted 1.0 vs. 0.9%, OR: 0.81, 95 CI: 0.60\u20131.08); and cardiovascular death or non-fatal myocardial infarction (adjusted 1.4 vs. 1.4%, OR: 0.89, 95% CI: 0.70\u20131.12).", {"entities": [[102, 123, "DISEASE"], [331, 352, "DISEASE"], [444, 465, "DISEASE"]]}], ["Fewer women underwent revascularization (2.6 vs. 2.2%, OR: 0.77, 95% CI: 0.64\u20130.93), although appropriateness was not analysed.", {"entities": []}], ["The risk profiles of women and men with stable CAD differ substantially.", {"entities": []}], ["However, 1-year outcomes were similar.", {"entities": []}], ["Fewer women underwent revascularization.", {"entities": []}], ["Further research is needed to better understand gender determinants of outcome and devise strategies to minimize bias in the management and treatment of women.", {"entities": []}], ["One group often identified as having low socioeconomic status, those living in remote or rural areas, are often recognised as bearing an unequal burden of illness in society.", {"entities": []}], ["This paper aims to examine equity of utilisation of general practitioner services in Australia.", {"entities": []}], ["Using the 2005 National Health Survey undertaken by the Australian Bureau of Statistics, a microsimulation model was developed to determine the distribution of GP services that would occur if all Australians had equal utilisation of health services relative to need.", {"entities": []}], ["It was estimated that those who are unemployed would experience a 19% increase in GP services.", {"entities": []}], ["Persons residing in regional areas would receive about 5.7 million additional GP visits per year if they had the same access to care as Australians residing in major cities.", {"entities": []}], ["This would be a 18% increase.", {"entities": []}], ["There would be a 20% increase for inner regional residents and a 14% increase for residents of more remote regional areas.", {"entities": []}], ["Overall there would be a 5% increase in GP visits nationally if those in regional areas had the same access to care as those in major cities.", {"entities": []}], ["Parity is an insufficient goal and disadvantaged persons and underserved areas require greater access to health services than the well served metropolitan areas due to their greater poverty and poorer health status.", {"entities": []}], ["Currently underserved Australians suffer a double disadvantage: poorer health and poorer access to health services.", {"entities": []}], ["Exposure to ultrafine particles (UFPs) from vehicle exhaust has been related to risk of cardiovascular and pulmonary disease and cancer, even though exposure assessment is difficult.", {"entities": [[129, 135, "DISEASE"]]}], ["We studied personal exposure in terms of number concentrations of UFPs in the breathing zone, using portable instruments in six 18-hr periods in 15 healthy nonsmoking subjects.", {"entities": []}], ["Exposure contrasts of outdoor pollution were achieved by bicycling in traffic for 5 days and in the laboratory for 1 day.", {"entities": []}], ["Oxidative DNA damage was assessed as strand breaks and oxidized purines in mononuclear cells isolated from venous blood the morning after exposure measurement.", {"entities": []}], ["Cumulated outdoor and cumulated indoor exposures to UFPs each were independent significant predictors of the level of purine oxidation in DNA but not of strand breaks.", {"entities": []}], ["Ambient air concentrations of particulate matter with an aero-dynamic diameter of \u226410 \u03bcm (PM 10 ), nitrous oxide, nitrogen dioxide, carbon monoxide, and/or number concentration of UFPs at urban background or busy street monitoring stations was not a significant predictor of DNA damage, although personal UFP exposure was correlated with urban background concentrations of CO and NO 2 , particularly during bicycling in traffic.", {"entities": []}], ["The results indicate that biologic effects of UFPs occur at modest exposure, such as that occurring in traffic, which supports the relationship of UFPs and the adverse health effects of air pollution.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a 5-year survival of approximately 20%.", {"entities": [[11, 29, "DISEASE"]]}], ["The disease primarily occurs in elderly patients.", {"entities": []}], ["IPF is a highly heterogeneous disorder with a clinical course that varies from prolonged periods of stability to episodes of rapid deterioration.", {"entities": []}], ["In the last decade, improved understanding of disease mechanisms along with a more precise disease definition has allowed the design and completion of a number of high-quality clinical trials.", {"entities": []}], ["Yet, until recently, IPF was essentially an untreatable disease.", {"entities": []}], ["Finally, pirfenidone and nintedanib, two compounds with antifibrotic properties, have consistently proven effective in reducing functional decline and disease progression in IPF.", {"entities": []}], ["This is a major breakthrough for patients and physicians alike, but there is still a long way to go.", {"entities": []}], ["In fact, neither pirfenidone nor nintedanib is a cure for IPF, and most patients continue to progress despite treatment.", {"entities": []}], ["As such, comprehensive care of patients with IPF, including management of comorbidities/complications and physical debility and timely referral for palliative care or, in a small number of highly selected patients, lung transplantation, remains essential.", {"entities": []}], ["Several agents with high potential are currently being tested and many more are ready to be evaluated in clinical trials.", {"entities": []}], ["The reported incidence of acute respiratory illness in families exposed to different concentrations of air pollution was studied during two consecutive school years.", {"entities": []}], ["The purpose of the study was to determine the effect of increased exposure to sulfur dioxide and suspended particulate matter.", {"entities": []}], ["In each of four study communities, the mothers of approximately 250 white families were contacted biweekly to obtain information regarding the occurrence of respiratory symptoms in each family member.", {"entities": []}], ["Annual mean ambient sulfur dioxide concentrations in one community for the three years included in the study (1971-1973) were well above the current air quality standard of 80 micrograms/m3, while in the other three communities the annual sulfur dioxide concentrations were much lower (usually less than 40 micrograms/m3).", {"entities": []}], ["Suspended particulate matter concentrations in high sulfur dioxide community were close to the limit designated by the annual standard (75 micrograms/m3) but actual exposures in the four communities probably were not excessive.", {"entities": []}], ["Regression analyses of the data collected showed inconsistent associations between illness rates and educational attainment of the head of household, crowding in the home, bronchitis in parents or smoking of parents.", {"entities": [[172, 182, "DISEASE"]]}], ["However, once the effects of these factors were removed the adjusted rates showed little association with community of residence.", {"entities": []}], ["It was concluded that the higher concentrations of sulfur dioxide in the Utah atmosphere could not be the cause of increases in acute respiratory illness in the exposed populations.", {"entities": []}], ["The extracellular matrix (ECM) plays a significant role in the mechanical behaviour of the lung parenchyma.", {"entities": []}], ["The ECM is composed of a three-dimensional fibre mesh that is filled with various macromolecules, among which are the glycosaminoglycans (GAGs).", {"entities": []}], ["GAGs are long, linear and highly charged heterogeneous polysaccharides that are composed of a variable number of repeating disaccharide units.", {"entities": []}], ["There are two main types of GAGs: nonsulphated GAG (hyaluronic acid) and sulphated GAGs (heparan sulphate and heparin, chondroitin sulphate, dermatan sulphate, and keratan sulphate).", {"entities": []}], ["With the exception of hyaluronic acid, GAGs are usually covalently attached to a protein core, forming an overall structure that is referred to as proteoglycan.", {"entities": []}], ["In the lungs, GAGs are distributed in the interstitium, in the sub-epithelial tissue and bronchial walls, and in airway secretions.", {"entities": []}], ["GAGs have important functions in lung ECM: they regulate hydration and water homeostasis; they maintain structure and function; they modulate the inflammatory response; and they influence tissue repair and remodelling.", {"entities": []}], ["Given the great diversity of GAG structures and the evidence that GAGs may have a protective effect against injury in various respiratory diseases, an understanding of changes in GAG expression that occur in disease may lead to opportunities to develop innovative and selective therapies in the future.", {"entities": []}], ["The aim of this study was to estimate the prevalent use of drugs targeting obstructive lung diseases among adults aged 50 or above in Greenland and to assess the use of spirometry testing among these medication users.", {"entities": []}], ["Observational cross-sectional study based on reviews of electronic medical records.", {"entities": []}], ["The study was performed in the 6 largest primary healthcare clinics in Greenland, representing approximately 67.0% of the population in Greenland.", {"entities": []}], ["Adults aged 50 years or above, who had at least one electronically prescribed drug targeting obstructive lung diseases within a 15-month time interval, were identified.", {"entities": []}], ["We assessed whether a spirometry test was registered in their medical records within previous 2- and 4-year periods.", {"entities": []}], ["A total of 565 persons were identified.", {"entities": []}], ["This corresponds to a prevalent medication use of 6.1% (565/9,023) among adults aged 50 years or above.", {"entities": []}], ["Among these medication users, 14.1% (80/565) had a spirometry test performed within 2 years.", {"entities": []}], ["Within the 4-year period this increased to 17.9% (101/565).", {"entities": []}], ["The use of medication targeting obstructive lung diseases in Greenland among adults aged 50 years or above is common.", {"entities": []}], ["However, spirometry testing among medication users is low and interventions aiming to increase focus on spirometry testing should be integrated in the primary healthcare system.", {"entities": []}], ["Inflammation is an important factor in the development of insulin resistance, type 2 diabetes, and fatty liver disease.", {"entities": [[99, 118, "DISEASE"], [105, 118, "DISEASE"]]}], ["As a member of the tumor necrosis factor receptor superfamily (TNFRSF9) expressed on immune cells, 4-1BB/CD137 provides a bidirectional inflammatory signal through binding to its ligand 4-1BBL.", {"entities": [[63, 70, "GENE"]]}], ["Both 4-1BB and 4-1BBL have been shown to play an important role in the pathogenesis of various inflammatory diseases.", {"entities": []}], ["Eight-week-old male 4-1BB\u2013deficient and wild-type (WT) mice were fed a high-fat diet (HFD) or a regular diet for 9 weeks.", {"entities": []}], ["We demonstrate that 4-1BB deficiency protects against HFD-induced obesity, glucose intolerance, and fatty liver disease.", {"entities": [[100, 119, "DISEASE"], [106, 119, "DISEASE"], [75, 94, "DISEASE"], [66, 73, "DISEASE"]]}], ["The 4-1BB\u2013deficient mice fed an HFD showed less body weight gain, adiposity, adipose infiltration of macrophages/T cells, and tissue levels of inflammatory cytokines (e.g., TNF-\u03b1, interleukin-6, and monocyte chemoattractant protein-1 [MCP-1]) compared with HFD-fed control mice.", {"entities": []}], ["HFD-induced glucose intolerance/insulin resistance and fatty liver were also markedly attenuated in the 4-1BB\u2013deficient mice.", {"entities": [[12, 31, "DISEASE"]]}], ["These findings suggest that 4-1BB and 4-1BBL may be useful therapeutic targets for combating obesity-induced inflammation and metabolic disorders.", {"entities": [[93, 100, "DISEASE"]]}], ["Modern therapeutic medicine is historically based on indigenous therapies and ethnopharmacological uses, which have become recognized tools in the search for new sources of pharmaceuticals.", {"entities": []}], ["Globalization of herbal medicine along with uncontrolled exploitative practices and lack of concerted conservation efforts, have pushed many of Nepal's medicinal plants to the verge of extinction.", {"entities": []}], ["Sustainable utilization and management of medicinal plants, based on traditional knowledge, is therefore necessary.", {"entities": []}], ["After establishing verbal informed consent with participating communities, five field surveys, roughly 20 days in duration, were carried out.", {"entities": []}], ["In all, 176 schedules were surveyed, and 52 participants were consulted through focus group discussions and informal meetings.", {"entities": []}], ["Altogether, 24 key informants were surveyed to verify and validate the data.", {"entities": []}], ["A total of 252 individuals, representing non-timber forest product (NTFP) collectors, cultivators, traders, traditional healers ( Baidhya ), community members, etc.", {"entities": []}], ["participated in study.", {"entities": []}], ["Medicinal plants were free-listed and their vernacular names and folk uses were collected, recorded, and applied to assess agreement among respondents about traditional medicines, markets and management.", {"entities": []}], ["Within the study area, medicinal herbs were the main ingredients of traditional therapies, and they were considered a main lifeline and frequently were the first choice.", {"entities": []}], ["About 55% plants were ethnomedicinal, and about 37% of ethnomedicinal plants possessed the highest informant consensus value (0.86\u20131.00).", {"entities": []}], ["Use of Cordyceps sinensis as an aphrodisiac, Berberis asiatica for eye problems, Bergenia ciliata for disintegration of calculi, Sapindus mukorossi for dandruff, and Zanthoxylum armatum for toothache were the most frequently mentioned.", {"entities": []}], ["These species possess potential for pharmacology.", {"entities": []}], ["Medicinal plants are inseparable from local livelihoods because they have long been collected, consumed, and managed through local customs and knowledge.", {"entities": []}], ["Management of traditional therapies is urged, because the therapies are empirically and knowledge based, often culturally inherited and important to pharmacology and local livelihoods.", {"entities": []}], ["However, traditional therapies are currently being eroded due to changing lifestyles, perceptions, social transformations, and acculturation.", {"entities": []}], ["Despite continuous contact with fungi, immunocompetent individuals rarely develop pro-inflammatory antifungal immune responses.", {"entities": []}], ["The underlying tolerogenic mechanisms are incompletely understood.", {"entities": []}], ["Using both mouse models and human patients, we show that infection with the human pathogenic fungi Aspergillus fumigatus and Candida albicans induces a distinct subset of neutrophilic myeloid-derived suppressor cells (MDSCs), which functionally suppress T and NK cell responses.", {"entities": []}], ["Mechanistically, pathogenic fungi induce neutrophilic MDSCs through the pattern recognition receptor Dectin-1 and its downstream adaptor protein\u00a0CARD9.", {"entities": [[145, 150, "GENE"]]}], ["Fungal MDSC induction is further dependent on pathways downstream of Dectin-1 signaling, notably reactive oxygen species (ROS) generation as well as caspase-8 activity and interleukin-1 (IL-1) production.", {"entities": []}], ["Additionally, exogenous\u00a0IL-1\u03b2 induces MDSCs to comparable levels observed during C.\u00a0albicans infection.", {"entities": []}], ["Adoptive transfer and survival experiments show that MDSCs are protective during invasive C.\u00a0albicans infection, but not A.\u00a0fumigatus infection.", {"entities": []}], ["These studies define an innate immune mechanism by which pathogenic fungi regulate host defense.", {"entities": []}], ["\u2022 Pathogenic fungi induce myeloid-derived suppressor cells (MDSCs) \u2022 MDSC induction involves Dectin-1/CARD9, ROS, caspase-8, and IL-1 \u2022 MDSCs dampen T and NK cell immune responses \u2022 Adoptive transfer of MDSCs improves survival in Candida infection in\u00a0vivo Pathogenic fungi induce myeloid-derived suppressor cells (MDSCs) MDSC induction involves Dectin-1/CARD9, ROS, caspase-8, and IL-1 MDSCs dampen T and NK cell immune responses Adoptive transfer of MDSCs improves survival in Candida infection in\u00a0vivo Myeloid-derived suppressor cells (MDSCs) are innate immune cells that suppress T\u00a0cell responses.", {"entities": []}], ["Rieber et\u00a0al.", {"entities": []}], ["show that pathogenic fungi Aspergillus fumigatus and Candida albicans induce MDSCs through mechanisms involving Dectin-1/CARD as well as downstream ROS and IL-1\u03b2 production, and that transfer of MDSCs protects against invasive Candida infection.", {"entities": []}], ["A diagnostic signature for sepsis caused by Burkholderia pseudomallei infection was identified from transcriptional profiling of the blood of septicemia patients.", {"entities": []}], ["Melioidosis is a severe infectious disease caused by Burkholderia pseudomallei , a Gram-negative bacillus classified by the National Institute of Allergy and Infectious Diseases (NIAID) as a category B priority agent.", {"entities": [[0, 11, "DISEASE"]]}], ["Septicemia is the most common presentation of the disease with a 40% mortality rate even with appropriate treatments.", {"entities": []}], ["Better diagnostic tests are therefore needed to improve therapeutic efficacy and survival rates.", {"entities": []}], ["We have used microarray technology to generate genome-wide transcriptional profiles (>48,000 transcripts) from the whole blood of patients with septicemic melioidosis (n = 32), patients with sepsis caused by other pathogens (n = 31), and uninfected controls (n = 29).", {"entities": [[155, 166, "DISEASE"]]}], ["Unsupervised analyses demonstrated the existence of a whole blood transcriptional signature distinguishing patients with sepsis from control subjects.", {"entities": []}], ["The majority of changes observed were common to both septicemic melioidosis and sepsis caused by other infections, including genes related to inflammation, interferon-related genes, neutrophils, cytotoxic cells, and T-cells.", {"entities": [[64, 75, "DISEASE"]]}], ["Finally, class prediction analysis identified a 37 transcript candidate diagnostic signature that distinguished melioidosis from sepsis caused by other organisms with 100% accuracy in a training set.", {"entities": [[112, 123, "DISEASE"]]}], ["This finding was confirmed in 2 independent validation sets, which gave high prediction accuracies of 78% and 80%, respectively.", {"entities": []}], ["This signature was significantly enriched in genes coding for products involved in the MHC class II antigen processing and presentation pathway.", {"entities": []}], ["Blood transcriptional patterns distinguish patients with septicemic melioidosis from patients with sepsis caused by other pathogens.", {"entities": [[68, 79, "DISEASE"]]}], ["Once confirmed in a large scale trial this diagnostic signature might constitute the basis of a differential diagnostic assay.", {"entities": []}], ["Platelet-activating factor (PAF) is known to be an important mediator of anaphylaxis.", {"entities": []}], ["However, there is a lack of information in the literature about the role of PAF in food allergy.", {"entities": [[83, 95, "DISEASE"]]}], ["The aim of this work was to elucidate the participation of PAF during food allergy development and the consequent adipose tissue inflammation along with its alterations.", {"entities": [[70, 82, "DISEASE"]]}], ["Our data demonstrated that, both before oral challenge and after 7 days receiving ovalbumin (OVA) diet, OVA-sensitized mice lacking the PAF receptor (PAFR) showed a decreased level of anti-OVA IgE associated with attenuated allergic markers in comparison to wild type (WT) mice.", {"entities": []}], ["Moreover, there was less body weight and adipose tissue loss in PAFR-deficient mice.", {"entities": []}], ["However, some features of inflamed adipose tissue presented by sensitized PAFR-deficient and WT mice after oral challenge were similar, such as a higher rate of rolling leukocytes in this tissue and lower circulating levels of adipokines (resistin and adiponectin) in comparison to nonsensitized mice.", {"entities": []}], ["Therefore, PAF signaling through PAFR is important for the allergic response to OVA but not for the adipokine alterations caused by this inflammatory process.", {"entities": []}], ["Our work clarifies some effects of PAF during food allergy along with its role on the metabolic consequences of this inflammatory process.", {"entities": [[46, 58, "DISEASE"]]}], ["We introduce this special issue of Medial Anthropology Quarterly on public health genomics by exploring both the unique contribution of ethnographic sensibility that medical anthropologists bring to the study of genomics and some of the key insights offered by the essays in this collection.", {"entities": []}], ["As anthropologists, we are concerned with the power dynamics and larger cultural commitments embedded in practices associated with public health.", {"entities": []}], ["We seek to understand, first, the broad significance of genomics as a cultural object and, second, the social action set into motion as researchers seek to translate genomic knowledge and technology into public health benefits.", {"entities": []}], ["It is well known that the interaction between platelets (PLTs), endothelial cells, and leukocytes contributes to thrombosis in patients with acute coronary syndrome.", {"entities": [[156, 164, "DISEASE"]]}], ["The aim of this study was to investigate the significance of PLTs and eosinophils (EOS) in coronary arterial thrombi.", {"entities": []}], ["PLT count, mean PLT volume, PLT mass, EOS count, EOS percentage, and troponin I level in peripheral blood were determined in 81 patients with angina pectoris (AP) and 49 patients with acute myocardial infarction (AMI).", {"entities": [[190, 211, "DISEASE"], [184, 211, "DISEASE"]]}], ["A total of 12 thrombus specimens from AMI patients were submitted for histopathological analysis.", {"entities": []}], ["EOS presence in thrombectomy specimens were checked by hematoxylin\u2013eosin staining and confirmed by Luna staining.", {"entities": []}], ["Results showed that EOS were present in all 12 samples (100%).", {"entities": []}], ["Cell count and percentage of EOS in peripheral blood of patients with AMI were lower than those in patients with AP (both P <0.00001).", {"entities": []}], ["A higher PLT count was observed in AMI patients (243\u00b170), especially among female patients or those who were older than 60 years, when compared with AP patients (216\u00b160; all P <0.05).", {"entities": []}], ["According to the troponin I level, we divided AMI patients into groups I (\u226520\u2009ng/ml) and II (<20\u2009ng/ml).", {"entities": []}], ["Group I had a lower EOS percentage compared with group II ( P =0.0496).", {"entities": []}], ["PLT count was also lower in group I with no statistical difference found ( P =0.1202).", {"entities": []}], ["Moreover, there was an inverse correlation between the EOS percentage and the troponin I level ( r =\u22120.434).", {"entities": []}], ["In conclusion, patients with AMI presented with a decreased EOS percentage and an increased PLT count.", {"entities": []}], ["The decreased EOS percentage suggested serious myocardial damage.", {"entities": []}], ["The study indicated that EOS play an important role in thrombosis in patients with acute coronary syndrome.", {"entities": [[98, 106, "DISEASE"]]}], ["Compound A (CpdA) is a dissociating non-steroidal glucocorticoid receptor (GR) ligand which has anti-inflammatory properties exerted by down-modulating proinflammatory gene expression.", {"entities": []}], ["By favouring GR monomer formation, CpdA does not enhance glucocorticoid (GC) response element-driven gene expression, resulting in a reduced side effect profile as compared to GCs.", {"entities": [[73, 75, "GENE"]]}], ["Considering the importance of Th1/Th2 balance in the final outcome of immune and inflammatory responses, we analyzed how selective GR modulation differentially regulates the activity of T-bet and GATA-3, master drivers of Th1 and Th2 differentiation, respectively.", {"entities": []}], ["Using Western analysis and reporter gene assays, we show in murine T cells that, similar to GCs, CpdA inhibits T-bet activity via a transrepressive mechanism.", {"entities": []}], ["Different from GCs, CpdA induces GATA-3 activity by p38 MAPK-induction of GATA-3 phosphorylation and nuclear translocation.", {"entities": []}], ["CpdA effects are reversed by the GR antagonist RU38486, proving the involvement of GR in these actions.", {"entities": []}], ["ELISA assays demonstrate that modulation of T-bet and GATA-3 impacts on cytokine production shown by a decrease in IFN-\u03b3 and an increase in IL-5 production, respectively.", {"entities": []}], ["Taken together, through their effect favoring Th2 over Th1 responses, particular dissociated GR ligands, for which CpdA represents a paradigm, hold potential for the application in Th1-mediated immune disorders.", {"entities": []}], ["Skin prick test (SPT) is the most effective diagnostic test to detect IgE mediated type I allergic reactions like allergic rhinitis, atopic asthma, acute urticaria, food allergy etc.", {"entities": [[114, 131, "DISEASE"], [154, 163, "DISEASE"], [123, 131, "DISEASE"], [165, 177, "DISEASE"], [140, 146, "DISEASE"]]}], ["SPTs are done to know allergic sensitivity and applied for devising immunotherapy as the therapeutic modality.", {"entities": []}], ["This prospective study was conducted in the department of Immunology and Molecular medicine at SKIMS.", {"entities": []}], ["A total of 400 patients suffering from allergic rhinitis, asthma and urticaria were recruited in this study.", {"entities": [[39, 56, "DISEASE"], [69, 78, "DISEASE"], [48, 56, "DISEASE"], [58, 64, "DISEASE"]]}], ["SPT was performed with panel of allergens including house dust mite, pollens, fungi, dusts, cockroach, sheep wool and dog epithelia.", {"entities": []}], ["Allergen immunotherapy was given to allergic rhinitis and asthmatic patients as therapeutic modality.", {"entities": [[36, 53, "DISEASE"], [45, 53, "DISEASE"]]}], ["In our study, age of patients ranged from 6 to 65 years.", {"entities": []}], ["Majority of patients were in the age group of 20-30 years (72%) with Male to female ratio of 1:1.5.", {"entities": []}], ["Of the 400 patients, 248 (62%) had urticaria, 108 (27%) patients had allergic rhinitis and 44 (11%) patients had asthma.", {"entities": [[69, 86, "DISEASE"], [35, 44, "DISEASE"], [78, 86, "DISEASE"], [113, 119, "DISEASE"]]}], ["SPT reaction was positive in 38 (86.4%) with allergic asthma, 74 (68.5%) patients with allergic rhinitis and 4 (1.6%) patient with urticaria, respectively.", {"entities": [[87, 104, "DISEASE"], [131, 140, "DISEASE"], [45, 60, "DISEASE"], [96, 104, "DISEASE"], [54, 60, "DISEASE"]]}], ["Allergen immunotherapy was effective in 58% patients with allergic rhinitis and 42% allergic asthma.", {"entities": [[58, 75, "DISEASE"], [84, 99, "DISEASE"], [67, 75, "DISEASE"], [93, 99, "DISEASE"]]}], ["Identifiable aeroallergen could be detected in 86.4% allergic asthma and 68.5% allergic rhinitis patients by SPT alone.", {"entities": [[79, 96, "DISEASE"], [53, 68, "DISEASE"], [88, 96, "DISEASE"], [62, 68, "DISEASE"]]}], ["Pollens were the most prevalent causative allergen.", {"entities": []}], ["There was significant relief in the severity of symptoms, medication intake with the help of allergen immunotherapy.", {"entities": []}], ["In the era of highly active antiretroviral therapy HIV is now viewed as a chronic disease.", {"entities": []}], ["Although people living with HIV are living longer lives, they are prone to a number of disabilities.", {"entities": []}], ["Home-based rehabilitation has been shown to be an effective means of improving quality of life and function for people with a wide range of chronic diseases.", {"entities": []}], ["There is a dearth of evidence, however, related to home-based rehabilitation interventions for people living with HIV, particularly in sub-Saharan Africa \u2014 the region with the highest global prevalence of HIV.", {"entities": []}], ["A randomised controlled trial design will be employed.", {"entities": []}], ["Adults living with HIV who have been on antiretroviral therapy for at least six months and with defined limited mobility will be randomly allocated to either an intervention group or the control group.", {"entities": []}], ["Pre and post-intervention testing will be conducted at a public hospital in KwaZulu-Natal, South Africa in order to assess the participants\u2019 quality of life, perceived level of disability, functional ability and endurance.", {"entities": []}], ["Individuals randomly allocated to the intervention group will participate in a four-month home-based rehabilitation programme, conducted once a week in their homes.", {"entities": []}], ["This programme will be implemented by community workers who will be trained and supervised by a qualified physiotherapist.", {"entities": []}], ["The participants in the control group will continue with the standard clinic management offered to them.", {"entities": []}], ["On completion of the intervention, all participants will be re-assessed using the same outcome measures.", {"entities": []}], ["Analysis of results will be carried out on intention-to-treat basis in order to identify any changes between intervention and control groups.", {"entities": []}], ["The researchers aim to employ a novel task shifting approach to implement a needs-based home-based rehabilitation programme for people living with HIV in order to improve their quality of life and functional ability.", {"entities": []}], ["It is hoped that this study will provide rehabilitation professionals and researchers with evidence that can be utilised to improve existing rehabilitation interventions for people living with HIV.", {"entities": []}], ["South African National Clinical Trials Register: NHREC#4094 (Date of registration: 21 July 2015).", {"entities": []}], ["Several meta-analyses have demonstrated that the combination of electrical muscle activity and Temperature Biofeedback could be regarded as gold standard in chronic pediatric headaches.", {"entities": []}], ["However, these techniques seem to be uneconomical and furthermore they are not directed to improve the social competence as well as resolve possible impairments in daily activities of the child.", {"entities": []}], ["Therefore, multi-modal behavioral techniques have been proposed, but no studies comparing these with the gold standard were conducted.", {"entities": []}], ["The present study compared the impact of a new multi-modal behavioral education and training program\u2014MIPAS-Family\u2014with a combined Biofeedback treatment, evaluating clinical efficacy as well as the effect on the quality of life (QoL) of children with chronic headaches.", {"entities": []}], ["Thirty-four children and adolescents with recurrent headache, ranging from 7 to 16\u00a0years, were randomly assigned to the MIPAS-Family ( N \u00a0=\u00a019) or the Biofeedback ( N \u00a0=\u00a015) condition.", {"entities": []}], ["All patients were diagnosed by the criteria of the International Headache Society.", {"entities": []}], ["The children and their parents completed headache diaries, diaries of daily living activities and a QoL questionnaire (KINDL", {"entities": []}], ["CC Chemokine Ligand 2 (CCL2) is a potent chemoattractant produced by macrophages and activated astrocytes during periods of inflammation within the central nervous system.", {"entities": [[23, 27, "GENE"]]}], ["Increased CCL2 expression is correlated with disease progression and severity, as observed in pulmonary tuberculosis, HCV-related liver disease, and HIV-associated dementia.", {"entities": [[164, 172, "DISEASE"], [130, 143, "DISEASE"], [104, 116, "DISEASE"], [94, 116, "DISEASE"], [10, 14, "GENE"]]}], ["The CCL2 distal promoter contains an A/G polymorphism at position -2578 and the homozygous -2578 G/G genotype is associated with increased CCL2 production and inflammation.", {"entities": [[4, 8, "GENE"], [139, 143, "GENE"], [4, 8, "GENE"], [139, 143, "GENE"]]}], ["However, the mechanisms that contribute to the phenotypic differences in CCL2 expression are poorly understood.", {"entities": [[73, 77, "GENE"]]}], ["We previously demonstrated that the -2578 G polymorphism creates a TALE homeodomain protein binding site (TALE binding site) for PREP1/PBX2 transcription factors.", {"entities": []}], ["In this study, we identified the presence of an additional TALE binding site 22 bp upstream of the site created by the -2578 G polymorphism and demonstrated the synergistic effects of the two sites on the activation of the CCL2 promoter.", {"entities": [[223, 227, "GENE"]]}], ["Using chromatin immunoprecipitation (ChIP) assays, we demonstrated increased binding of the TALE proteins PREP1 and PBX2 to the -2578 G allele, and binding of IRF1 to both the A and G alleles.", {"entities": [[116, 120, "GENE"], [159, 163, "GENE"]]}], ["The presence of TALE binding sites that form inverted repeats within the -2578 G allele results in increased transcriptional activation of the CCL2 distal promoter while the presence of only the upstream TALE binding site within the -2578 A allele exerts repression of promoter activity.", {"entities": [[143, 147, "GENE"]]}], ["Patients with Disorders of Sex Development (DSD), especially those with gonadal dysgenesis and hypovirilization are at risk of developing malignant type II germ cell tumors/cancer (GCC) (seminoma/dysgerminoma and nonseminoma), with either carcinoma in situ (CIS) or gonadoblastoma (GB) as precursor lesion.", {"entities": [[239, 248, "DISEASE"], [72, 90, "DISEASE"], [187, 195, "DISEASE"], [196, 208, "DISEASE"], [266, 280, "DISEASE"], [173, 179, "DISEASE"]]}], ["In 10\u201315% of 46,XY gonadal dysgenesis cases (i.e., Swyer syndrome), SRY mutations, residing in the HMG (High Mobility Group) domain, are found to affect nuclear transport or binding to and bending of DNA.", {"entities": [[57, 65, "DISEASE"], [19, 37, "DISEASE"], [68, 71, "GENE"]]}], ["Frasier syndrome (FS) is characterized by gonadal dysgenesis with a high risk for development of GB as well as chronic renal failure in early adulthood, and is known to arise from a splice site mutation in intron 9 of the Wilms\u2019 tumor 1 gene ( WT1 ).", {"entities": [[8, 16, "DISEASE"], [42, 60, "DISEASE"], [244, 247, "GENE"]]}], ["Mutations in SRY as well as WT1 can lead to diminished expression and function of SRY, resulting in sub-optimal SOX9 expression, Sertoli cell formation and subsequent lack of proper testicular development.", {"entities": [[13, 16, "GENE"], [82, 85, "GENE"], [28, 31, "GENE"], [13, 16, "GENE"], [82, 85, "GENE"], [112, 116, "GENE"]]}], ["Embryonic germ cells residing in this unfavourable micro-environment have an increased risk for malignant transformation.", {"entities": []}], ["Here a unique case of a phenotypically normal female (age 22 years) is reported, presenting with primary amenorrhoea, later diagnosed as hypergonadotropic hypogonadism on the basis of 46,XY gonadal dygenesis with a novel missense mutation in SRY .", {"entities": [[155, 167, "DISEASE"], [242, 245, "GENE"]]}], ["Functional in vitro studies showed no convincing protein malfunctioning.", {"entities": []}], ["Laparoscopic examination revealed streak ovaries and a normal, but small, uterus.", {"entities": []}], ["Pathological examination demonstrated bilateral GB and dysgerminoma, confirmed by immunohistochemistry.", {"entities": [[55, 67, "DISEASE"]]}], ["Occurrence of a delayed progressive kidney failure (focal segmental glomerular sclerosis) triggered analysis of WT1 , revealing a pathogenic splice\u2013site mutation in intron 9.", {"entities": [[36, 50, "DISEASE"], [112, 115, "GENE"]]}], ["Analysis of the SRY gene in an additional five FS cases did not reveal any mutations.", {"entities": [[16, 19, "GENE"]]}], ["The case presented shows the importance of multi-gene based diagnosis of DSD patients, allowing early diagnosis and treatment, thus preventing putative development of an invasive cancer.", {"entities": [[179, 185, "DISEASE"]]}], ["Typical survival studies follow individuals to an event and measure explanatory variables for that event, sometimes repeatedly over the course of follow up.", {"entities": []}], ["The Cox regression model has been used widely in the analyses of time to diagnosis or death from disease.", {"entities": []}], ["The associations between the survival outcome and time dependent measures may be biased unless they are modeled appropriately.", {"entities": []}], ["In this paper we explore the Time Dependent Cox Regression Model (TDCM), which quantifies the effect of repeated measures of covariates in the analysis of time to event data.", {"entities": []}], ["This model is commonly used in biomedical research but sometimes does not explicitly adjust for the times at which time dependent explanatory variables are measured.", {"entities": []}], ["This approach can yield different estimates of association compared to a model that adjusts for these times.", {"entities": []}], ["In order to address the question of how different these estimates are from a statistical perspective, we compare the TDCM to Pooled Logistic Regression (PLR) and Cross Sectional Pooling (CSP), considering models that adjust and do not adjust for time in PLR and CSP.", {"entities": []}], ["In a series of simulations we found that time adjusted CSP provided identical results to the TDCM while the PLR showed larger parameter estimates compared to the time adjusted CSP and the TDCM in scenarios with high event rates.", {"entities": []}], ["We also observed upwardly biased estimates in the unadjusted CSP and unadjusted PLR methods.", {"entities": []}], ["The time adjusted PLR had a positive bias in the time dependent Age effect with reduced bias when the event rate is low.", {"entities": []}], ["The PLR methods showed a negative bias in the Sex effect, a subject level covariate, when compared to the other methods.", {"entities": []}], ["The Cox models yielded reliable estimates for the Sex effect in all scenarios considered.", {"entities": []}], ["We conclude that survival analyses that explicitly account in the statistical model for the times at which time dependent covariates are measured provide more reliable estimates compared to unadjusted analyses.", {"entities": []}], ["We present results from the Framingham Heart Study in which lipid measurements and myocardial infarction data events were collected over a period of 26\u00a0years.", {"entities": [[83, 104, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12874-016-0248-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study estimates the potential population health burden from exposure to combustion-derived particulate air pollution in domestic settings in Ireland and Scotland.", {"entities": []}], ["The study focused on solid fuel combustion used for heating and the use of gas for cooking.", {"entities": []}], ["PM 2.5 (particulate matter with an aerodynamic diameter\u2009<\u20092.5 \u03bcm) was used as the pollutant mixture indicator.", {"entities": []}], ["Measured PM 2.5 concentrations in homes using solid fuels were adjusted for other sources of PM 2.5 by subtracting PM 2.5 concentrations in homes using gas for cooking but not solid fuel heating.", {"entities": []}], ["Health burden was estimated for exposure indoors 6 pm - midnight, or all day (24-hour), by combining estimated attributable annual PM 2.5 exposures with (i) selected epidemiological functions linking PM 2.5 with mortality and morbidity (involving some re-scaling from PM 10 to PM 2.5 , and adjustments \u2018translating\u2019 from concentrations to exposures) and (ii) on the current population exposed and background rates of morbidity and mortality.", {"entities": []}], ["PM 2.5 concentrations in coal and wood burning homes were similar to homes using gas for cooking, used here as a baseline (mean 24-hr PM 2.5 concentrations 8.6 \u03bcg/m 2.5 in homes using peat were higher (24-hr mean 15.6 \u03bcg/m New methods for estimating the potential health burden of combustion-generated pollution from solid fuels in Irish and Scottish homes are provided.", {"entities": []}], ["The methodology involves several approximations and uncertainties but is consistent with a wider movement towards quantifying risks in PM 2.5 irrespective of source.", {"entities": []}], ["Results show an effect of indoor smoke from using peat (but not wood or coal) for heating and cooking; but they do not suggest that this is a major public health issue.", {"entities": []}], ["The Whole Child approach and the coordinated school health (CSH) approach both address the physical and emotional needs of students.", {"entities": []}], ["However, a unified approach acceptable to both the health and education communities is needed to assure that students are healthy and ready to learn.", {"entities": []}], ["During spring 2013, the ASCD (formerly known as the Association for Supervision and Curriculum Development) and the US Centers for Disease Control and Prevention (CDC) convened experts from the field of education and health to discuss lessons learned from implementation of the CSH and Whole Child approaches and to explore the development of a new model that would incorporate the knowledge gained through implementation to date.", {"entities": []}], ["As a result of multiple discussions and review, the Whole School, Whole Community, Whole Child (WSCC) approach was developed.", {"entities": []}], ["The WSCC approach builds upon the traditional CSH model and ASCD's Whole Child approach to learning and promotes greater alignment between health and educational outcomes.", {"entities": []}], ["By focusing on children and youth as students, addressing critical education and health outcomes, organizing collaborative actions and initiatives that support students, and strongly engaging community resources, the WSCC approach offers important opportunities that will improve educational attainment and healthy development for students.", {"entities": []}], ["Reactive oxygen species (ROS) play important roles in peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) signaling and cell-cycle regulation.", {"entities": []}], ["However, the PPAR\u03b3 redox-signaling pathways in lung alveolar epithelial cells remain unclear.", {"entities": []}], ["In this study, we investigated the in vivo and in vitro effects of PPAR\u03b3 activation on the levels of lung ROS production and cell-cycle progression using C57BL/6J wild-type and Nox2 knockout mice ( n \u00a0=\u00a010) after intraperitoneal injection of a selective PPAR\u03b3 agonist (GW1929, 5\u00a0mg/kg body wt, daily) for 14\u00a0days.", {"entities": []}], ["Compared to vehicle-treated mice, GW1929 increased significantly the levels of ROS production in wild-type lungs, and this was accompanied by significant up-regulation of PPAR\u03b3, Nox2, PCNA, and cyclin D1 and phosphorylation of ERK1/2 and p38MAPK.", {"entities": [[184, 188, "GENE"]]}], ["These effects were absent in Nox2 knockout mice.", {"entities": []}], ["In cultured alveolar epithelial cells, GW1929 (5\u00a0\u03bcM for 24\u00a0h) increased ROS production and promoted cell-cycle progression from G0/G1 into S and G2/M phases, and these effects were abolished by (1) adding a PPAR\u03b3 antagonist (BADGE, 1\u00a0\u03bcM), (2) knockdown of PPAR\u03b3 using siRNA, or (3) knockout of Nox2.", {"entities": []}], ["In conclusion, PPAR\u03b3 activation through Nox2-derived ROS promotes cell-cycle progression in normal mouse lungs and in cultured normal alveolar epithelial cells.", {"entities": []}], ["Anti-angiogenesis targeting VEGFR2 has been considered as an important strategy for cancer therapy.", {"entities": [[84, 90, "DISEASE"]]}], ["Tylophorine is known to possess anti-inflammatory and antitumor activity, but its roles in tumor angiogenesis, the key step involved in tumor growth and metastasis, and the involved molecular mechanism is still unknown.", {"entities": []}], ["Therefore, we examined its anti-angiogenic effects and mechanisms in vitro and in vivo.", {"entities": []}], ["We used tylophorine and analyzed its inhibitory effects on human umbilical vein endothelial cells (HUVEC) in vitro and Ehrlich ascites carcinoma (EAC) tumor in vivo .", {"entities": [[135, 144, "DISEASE"]]}], ["Tylophorine significantly inhibited a series of VEGF-induced angiogenesis processes including proliferation, migration, and tube formation of endothelial cells.", {"entities": []}], ["Besides, it directly inhibited VEGFR2 tyrosine kinase activity and its downstream signaling pathways including Akt, Erk and ROS in endothelial cells.", {"entities": []}], ["Using HUVECs we demonstrated that tylophorine inhibited VEGF-stimulated inflammatory responses including IL-6, IL-8, TNF-\u03b1, IFN-\u03b3, MMP-2 and NO secretion.", {"entities": []}], ["Tylophorine significantly inhibited neovascularization in sponge implant angiogenesis assay and also inhibited tumor angiogenesis and tumor growth in vivo .", {"entities": []}], ["Molecular docking simulation indicated that tylophorine could form hydrogen bonds and aromatic interactions within the ATP-binding region of the VEGFR2 kinase unit.", {"entities": []}], ["Tylophorine exerts anti-angiogenesis effects via VEGFR2 signaling pathway thus, may be a viable drug candidate in anti-angiogenesis and anti-cancer therapies.", {"entities": [[141, 147, "DISEASE"]]}], ["We prepared 0.1 wt%\u201330 wt% Pd-loaded Co 3 O 4 by a colloidal mixing method and investigated the sensing properties of a Pd-loaded Co 3 O 4 sensor element, such as the sensor response, 90% response time, 90% recovery time, and signal-to-noise ( S/N ) ratio, toward low nitric oxide (NO) gas levels in the range from 50 to 200 parts per billion.", {"entities": []}], ["The structural properties of the Pd-loaded Co 3 O 4 powder were investigated using X-ray diffraction analysis and transmission electron microscopy.", {"entities": []}], ["Pd in the powder existed as PdO.", {"entities": []}], ["The sensor elements with 0.1 wt%\u201310 wt% Pd content have higher sensor properties than those without any Pd content.", {"entities": []}], ["The response of the sensor element with a 30 wt% Pd content decreased markedly because of the aggregation and poor dispersibility of the PdO particles.", {"entities": []}], ["High sensor response and S/N ratio toward the NO gas were achieved when a sensor element with 10 wt% Pd content was used.", {"entities": []}], ["Both environmental tobacco smoke and indoor allergens can exacerbate already established childhood albeit primarily through quite disparate mechanisms.", {"entities": []}], ["In infancy and childhood, environmental tobacco smoke (ETS) exposure is associated with measures of decreased flow in the airways, bronchial hyperresponsiveness, and increased respiratory infections, but the relationship between ETS and allergy is poorly understood.", {"entities": []}], ["Indoor allergens from dust mite, cockroach, and cat can be associated with asthma exacerbation in children sensitized to the specific allergens.", {"entities": [[75, 81, "DISEASE"]]}], ["The precise role of either ETS or indoor allergens in the development of asthma is less well understood.", {"entities": [[73, 79, "DISEASE"]]}], ["The strong and consistent association between ETS and asthma development in young children may relate to both prenatal and postnatal influences on airway caliber or bronchial responsiveness.", {"entities": [[54, 60, "DISEASE"]]}], ["Dust mite allergen levels predict asthma in children sensitized to dust mite.", {"entities": [[34, 40, "DISEASE"]]}], ["The tendency to develop specific IgE antibodies to allergens (sensitization) is associated with and may be preceded by the development of a T-helper (Th)2 profile of cytokine release.", {"entities": []}], ["The importance of either ETS or indoor allergens in the differentiation of T cells into a Th2-type profile of cytokine release or in the localization of immediate-type allergic responses to the lung is unknown.", {"entities": []}], ["This article evaluates the strength of the evidence that ETS or indoor allergens influence asthma exacerbation and asthma development in children.", {"entities": [[91, 97, "DISEASE"], [115, 121, "DISEASE"]]}], ["We also selectively review data for the effectiveness of allergen reduction in reducing asthma symptoms and present a potential research agenda regarding these two broad areas of environmental exposure and their relationship to childhood asthma.", {"entities": [[88, 94, "DISEASE"], [238, 244, "DISEASE"]]}], ["Asthma is a heterogeneous syndrome with different clinical subtypes that is associated with an increased risk for cardiovascular disease (CVD).", {"entities": [[26, 34, "DISEASE"], [0, 6, "DISEASE"]]}], ["We hypothesized that the late\u2010onset subtype of asthma is associated with a higher risk of incident CVD.", {"entities": [[47, 53, "DISEASE"]]}], ["Participants from the Wisconsin Sleep Cohort free of CVD at baseline were followed for a mean (SD) of 13.9 (5.9) years for development of CVD (myocardial infarction, angina, stroke, coronary revascularization, heart failure, or CVD death).", {"entities": [[143, 164, "DISEASE"]]}], ["Late\u2010onset asthma was defined as physician\u2010diagnosed asthma at age \u226518\u00a0years.", {"entities": [[11, 17, "DISEASE"], [53, 59, "DISEASE"]]}], ["Multivariable Cox regression models adjusted for age, sex, and CVD risk factors were used to assess associations of late\u2010onset asthma and incident CVD.", {"entities": [[127, 133, "DISEASE"]]}], ["The 1269 participants were 47.3 (8.0) years old; 166 participants had asthma (111 late\u2010onset, 55 early\u2010onset).", {"entities": [[70, 76, "DISEASE"]]}], ["Participants with late\u2010onset asthma compared to nonasthmatics were more likely to be female (67% versus 44%) and to have a higher body\u2010mass index (32.2 versus 29.4\u00a0kg/m P <0.05).", {"entities": [[29, 35, "DISEASE"]]}], ["Mean age of asthma diagnosis in the late\u2010onset group was 39.5 (9.6) years versus 8.9 (5.7) years in the early\u2010onset group ( P <0.0001).", {"entities": [[12, 18, "DISEASE"]]}], ["Late\u2010onset asthmatics had a higher adjusted risk of incident CVD than nonasthmatics (hazard ratio 1.57, 95% CI 1.01\u20132.45, P =0.045).", {"entities": []}], ["There was no interaction between body\u2010mass index and age of asthma diagnosis on incident CVD ( P =0.83).", {"entities": [[60, 66, "DISEASE"]]}], ["In a large cohort study of adults followed prospectively for over a decade, late\u2010onset asthmatics had an increased risk of incident CVD events that persisted after adjustment for age, sex, and CVD risk factors.", {"entities": []}], ["The human \u03b2-defensins (hBDs) are a highly conserved family of cationic antimicrobial and immunomodulatory peptides expressed primarily by epithelial cells in response to invasion by bacteria, fungi and some viruses.", {"entities": []}], ["To date, the most studied members of this family of peptides are hBD-1, -2, and -3.", {"entities": []}], ["Expression of hBD-1 and -2 has been demonstrated previously in cultured microglia and astrocytes of both mouse and human brain.", {"entities": []}], ["Unlike inducible hBD-2 and -3, hBD-1 is constitutively expressed and is not generally upregulated by proinflammatory factors.", {"entities": []}], ["In this study, we investigated whether hBDs, as active components of the innate immune response, are affected by pathological events in the Alzheimer\u2019s disease (AD) brain.", {"entities": []}], ["We assessed the expression of hBD-1, -2, and -3 in tissue obtained at autopsy from AD and age-matched control brains.", {"entities": []}], ["Fixed and frozen choroid plexus and the CA1 region of the hippocampus were obtained at autopsy from individuals diagnosed with AD, or from age-matched control brains without diagnosed neurodegenerative disease.", {"entities": [[184, 209, "DISEASE"], [40, 43, "GENE"]]}], ["Histopathologically diagnosed AD brain tissue was obtained for our study.", {"entities": []}], ["Immunocytochemical analysis was performed using affinity purified polyclonal antibodies directed against hBD-1, -2, or -3.", {"entities": []}], ["TaqMan gene expression assays were used to quantify the mRNA of hBD-1, -2, and -3 in the choroid plexus and hippocampus.", {"entities": []}], ["Immunocytochemical detection of iron deposits was achieved using a modified Perl\u2019s stain for redox-active iron.", {"entities": []}], ["In vitro experiments were performed on human primary oral epithelial cells to model the human choroid plexus epithelial response to ferric chloride.", {"entities": []}], ["Cells were then exposed to ferric chloride added to selected wells at 0, 1, or 10 mM concentrations for 24 h at 37\u00b0C.", {"entities": []}], ["Total mRNA was isolated to quantify hBD-1 mRNA expression by RTqPCR.", {"entities": []}], ["hBD-1 peptide is apparent in astrocytes of the AD hippocampus and hippocampal neurons, notably within granulovacuolar degeneration structures (GVD).", {"entities": []}], ["A higher level of hBD-1 was also seen in the choroid plexus of AD brain in comparison to age-matched control tissue.", {"entities": []}], ["Increased expression of hBD-1 mRNA was observed only in the choroid plexus of the AD brain when compared to expression level in age-matched control brain.", {"entities": []}], ["Redox-active iron was also elevated in the AD choroid plexus and in vitro addition of Fe 3 to cultured epithelial cells induced hBD-1 mRNA expression.", {"entities": []}], ["Our findings suggest interplay between hBD-1 and neuroimmunological responses in AD, marked by microglial and astrocytic activation, and increased expression of the peptide within the choroid plexus and accumulation within GVD.", {"entities": []}], ["As a constitutively expressed component of the innate immune system, we propose that hBD-1 may be of considerable importance early in the disease process.", {"entities": []}], ["We also demonstrate that increased iron deposition in AD may contribute to the elevated expression of hBD-1 within the choroid plexus.", {"entities": []}], ["These findings represent a potentially important etiological aspect of Alzheimer\u2019s disease neuropathology not previously reported.", {"entities": []}], ["Acute viral bronchiolitis is a common respiratory infectious disease of infancy.", {"entities": [[12, 25, "DISEASE"]]}], ["A prospective study was carried out with 175 infants aged up to six months to evaluate their nutritional and breastfeeding status as possible risk factors for unfavourable evolution of previously-healthy infants from a care hospital.", {"entities": []}], ["Immunofluorescence test for virus and anthropometric assessment were performed.", {"entities": []}], ["Outcomes were length of oxygen-use, length of hospital stay, and type of hospital unit needed.", {"entities": []}], ["Seventy-three percent of the infants were well-nourished, 6% undernourished, 8.6% at a nutritional risk, 10.9% overweight, and 1.7% obese.", {"entities": []}], ["Eighty-one percent of the undernourished and nutritionally at-risk infants and 72% of the well-nourished, overweight, and obese infants did not receive exclusive breastfeeding.", {"entities": []}], ["The median length of hospital stay was four days and of oxygen-use was 60 hours.", {"entities": []}], ["The nutritional status did not affect the clinical course of previously-healthy infants with acute viral brochiolitis.", {"entities": []}], ["The duration of exclusive breastfeeding, but not type of breastfeeding, was inversely related to the length of oxygen-use and the length of hospital stay.", {"entities": []}], ["Shorter exclusive breastfeeding was observed in infants who were assigned to a paediatric ward or to an intensive care unit.", {"entities": []}], ["In conclusion, longer duration of breastfeeding was associated with better clinical outcomes.", {"entities": []}], ["To explore the association between host serum 25-hydroxyvitamin D (25(OH)D) and the susceptibility and severity of COPD.", {"entities": []}], ["Previous studies on the association between host 25(OH)D and the susceptibility and severity of COPD were collected on the basis of a systematic literature search of PubMed and Web of Science up to June 2015.", {"entities": []}], ["Continuous variable data were presented as standard mean difference (SMD) or weighted mean difference with 95% confidence interval (CI).", {"entities": []}], ["The dichotomous variable data were analyzed as relative ratio (RR) or odds ratio with 95% CI for cohort and case-control studies.", {"entities": []}], ["A systematic review was conducted to understand the curative and side effects of vitamin D intake.", {"entities": []}], ["A total of 18 studies including eight cohort, five case-control, and five randomized studies met the inclusion criteria.", {"entities": []}], ["The serum level of 25(OH)D in COPD patients was comparable with controls with a pooled SMD of 0.191 (95% CI: \u22120.126 to 0.508, P =0.237) based on pooled analyses of cohort studies.", {"entities": []}], ["However, the serum level of 25(OH)D in COPD patients was lower with a pooled SMD of 0.961 (95% CI: 0.476\u20131.446, P <0.001) compared with controls based on pooled analyses of case-control studies.", {"entities": []}], ["The deficiency rates of 25(OH)D were comparable between controls and COPD patients with a pooled RR of 0.955 (95% CI: 0.754\u20131.211, P =0.705) based on analyses of cohort studies, and the same results were observed based on pooled analyses of case-control studies.", {"entities": []}], ["Interestingly, the deficiency rate of 25(OH)D was significantly lower in moderate or severe COPD patients with a pooled RR of 0.723 (95% CI: 0.632\u20130.828, P <0.001) compared with that in mild COPD patients.", {"entities": []}], ["The same results were obtained from the pooled analysis between moderate and severe COPD patients.", {"entities": []}], ["The four randomized studies showed that vitamin D intake provided benefit for COPD patients.", {"entities": []}], ["Low serum levels of 25(OH)D were not associated with COPD susceptibility, but the high deficiency rate of 25(OH)D was associated with COPD severity.", {"entities": []}], ["Vitamin D supplementation may prevent COPD exacerbation.", {"entities": []}], ["Elastase released from neutrophils as part of the innate immune system has been implicated in chronic diseases such as emphysema and cardiovascular disease.", {"entities": []}], ["We have previously shown that neutrophil elastase targets vascular endothelial growth factor-A (VEGF) for partial degradation to generate a fragment of VEGF (VEGFf) that has distinct activities.", {"entities": []}], ["Namely, VEGFf binds to VEGF receptor 1 but not to VEGF receptor 2 and shows altered signaling compared to intact VEGF.", {"entities": []}], ["In the present study we investigated the chemotactic function of VEGF and VEGFf released from cells by neutrophil elastase.", {"entities": []}], ["We found that endothelial cells migrated in response to intact VEGF but not VEGFf whereas RAW 264.7 macrophages/monocytes and embryonic endothelial progenitor cells were stimulated to migrate by either VEGF or VEGFf.", {"entities": []}], ["To investigate the role of elastase-mediated release of VEGF from cells/extracellular matrices, a co-culture system was established.", {"entities": []}], ["High or low VEGF producing cells were co-cultured with macrophages, endothelial or endothelial progenitor cells and treated with neutrophil elastase.", {"entities": []}], ["Elastase treatment stimulated macrophage and endothelial progenitor cell migration with the response being greater with the high VEGF expressing cells.", {"entities": []}], ["However, elastase treatment led to decreased endothelial cell migration due to VEGF cleavage to VEGF fragment.", {"entities": []}], ["These findings suggest that the tissue response to NE-mediated injury might involve the generation of diffusible VEGF fragments that stimulate inflammatory cell recruitment.", {"entities": []}], ["The prevalence of symptomatic adverse reactions to gluten and adherence to gluten-free diet in Latin American countries is unknown.", {"entities": []}], ["These measurements are strongly linked to gluten-related disorders.", {"entities": []}], ["This work aimed to estimate the prevalence of adverse reactions to oral gluten and the adherence to gluten-free diet in the adult Mexican population.", {"entities": []}], ["To reach this aim, a self-administered questionnaire was designed and tested for clarity/comprehension and reproducibility.", {"entities": []}], ["Then, a self-administered questionnaire-based cross-sectional study was conducted in the Mexican population.", {"entities": []}], ["The estimated prevalence rates were (95% CI): 11.9% (9.9\u201313.5) and 7.8 (6.4\u20139.4) for adverse and recurrent adverse reactions to gluten respectively; adherence to gluten-free diet 3.7% (2.7\u20134.8), wheat allergy 0.72% (0.38\u20131.37); celiac disease 0.08% (0.01\u20130.45), and NCGS 0.97% (0.55\u20131.68).", {"entities": [[228, 242, "DISEASE"]]}], ["Estimated pooled prevalence of self-reported physician-diagnosis of gluten-related disorders was 0.88% (0.49\u20131.5), and 93.3% respondents reported adherence to gluten-free diet without a physician-diagnosis of gluten-related disorders.", {"entities": []}], ["Symptom comparisons between those who reported recurrent adverse reactions to gluten and other foods showed statistically significant differences for bloating, constipation, and tiredness ( p < 0.05).", {"entities": [[160, 172, "DISEASE"]]}], ["Gluten-related disorders may be underdiagnosed in the Mexican population and most people adhering to a gluten-free diet are doing it without proper diagnostic work-up of these disorders, and probably without medical/dietician advice.", {"entities": []}], ["It is well-established that bacterial and viral infections have an exacerbating effect on allergic asthma, particularly aggravating respiratory symptoms, such as airway hyperresponsiveness (AHR).", {"entities": [[90, 105, "DISEASE"], [99, 105, "DISEASE"], [190, 193, "GENE"]]}], ["The mechanism by which these infections alter AHR is unclear, but some studies suggest that Toll-like receptors (TLRs) play a role.", {"entities": [[46, 49, "GENE"]]}], ["In this study, we investigated the impact of TLR3 and TLR4 ligands on AHR and airway inflammation in a model of pre-established allergic inflammation.", {"entities": [[45, 49, "GENE"], [54, 58, "GENE"], [70, 73, "GENE"]]}], ["Female BALB/c mice were sensitised and challenged intranasally (i.n.)", {"entities": []}], ["with either PBS or ovalbumin (OVA) and subsequently i.n.", {"entities": []}], ["challenged with poly (I:C) (TLR3) or LPS (TLR4) for four consecutive days.", {"entities": [[28, 32, "GENE"], [42, 46, "GENE"]]}], ["The response to methacholine was measured in vivo ; cellular and inflammatory mediators were measured in blood, lung tissue and broncheoalveolar lavage fluid (BALF).", {"entities": []}], ["OVA challenge resulted in an increase in AHR to methacholine, as well as increased airway eosinophilia and TH2 cytokine production.", {"entities": [[90, 102, "DISEASE"], [41, 44, "GENE"]]}], ["Subsequent challenge with TLR agonists resulted in a significant increase in AHR, but decreased TLR-specific cellular inflammation and production of immune mediators.", {"entities": [[77, 80, "GENE"]]}], ["Particularly evident was a decline in LPS-induced neutrophilia and neutrophil-associated cytokines following LPS and poly (I:C) treatment.", {"entities": []}], ["The present data indicates that TLRs may play a pivotal role in AHR in response to microbial infection in allergic lung inflammation.", {"entities": [[64, 67, "GENE"]]}], ["These data also demonstrate that aggravated AHR occurs in the absence of an exacerbation in airway inflammation and that allergic inflammation impedes a subsequent inflammatory response to TLRs.", {"entities": [[44, 47, "GENE"]]}], ["These results may parallel clinical signs of microbial asthma exacerbation, including an extended duration of illness and increased respiratory symptoms.", {"entities": [[55, 61, "DISEASE"]]}], ["To study patients\u2019 levels of exercise activity and the clinical characteristics that relate to physical activity and inactivity among patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[148, 185, "DISEASE"]]}], ["A postal questionnaire was administered to 719 patients with COPD in 2010; patients were recruited from the Helsinki and Turku University Central Hospitals in Finland and have been followed since 2005.", {"entities": []}], ["The questionnaire asked participants about their exercise routines and other daily activities, potential restrictions to exercise, health-related quality of life, and subjective sensations of dyspnea upon exertion.", {"entities": []}], ["A total of 50% of the participants reported exercising > 2 times a week throughout the year.", {"entities": []}], ["The proportion of the exercise inactive patients increased in parallel with disease progression, but the participants exhibited great variation in the degree of activity as well as in sport choices.", {"entities": []}], ["Year-round activity was better maintained among patients who exercised both indoors and outdoors.", {"entities": []}], ["Training activity was significantly correlated with patients\u2019 reported subjective dyspnea ( r = 0.32, P < 0.001), health-related quality of life ( r = 0.25, P < 0.001), mobility score ( r = 0.37, P < 0.001), and bronchial obstruction ( r = 0.18, P < 0.001).", {"entities": []}], ["Active patients did not differ from inactive patients in terms of sex, age, smoking status, somatic comorbidities, or body mass index.", {"entities": []}], ["Irrespective of the level of severity of patients\u2019 COPD, the most significant barrier to exercising was the subjective sensation of dyspnea.", {"entities": []}], ["When a patient with COPD suffers from dyspnea and does not have regular exercise routines, the patient will most likely benefit from an exercise program tailored to his or her physical capabilities.", {"entities": []}], ["T helper (Th) cells play a major role in the immune response and pathology at the gastric mucosa during Helicobacter pylori infection.", {"entities": []}], ["There is a limited mechanistic understanding regarding the contributions of CD4+ T cell subsets to gastritis development during H. pylori colonization.", {"entities": [[99, 108, "DISEASE"]]}], ["We used two computational approaches: ordinary differential equation (ODE)-based and agent-based modeling (ABM) to study the mechanisms underlying cellular immune responses to H. pylori and how CD4+ T cell subsets influenced initiation, progression and outcome of disease.", {"entities": []}], ["To calibrate the model, in vivo experimentation was performed by infecting C57BL/6 mice intragastrically with H. pylori and assaying immune cell subsets in the stomach and gastric lymph nodes (GLN) on days 0, 7, 14, 30 and 60 post-infection.", {"entities": []}], ["Our computational model reproduced the dynamics of effector and regulatory pathways in the gastric lamina propria (LP) in silico .", {"entities": []}], ["Simulation results show the induction of a Th17 response and a dominant Th1 response, together with a regulatory response characterized by high levels of mucosal Treg) cells.", {"entities": []}], ["We also investigated the potential role of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) activation on the modulation of host responses to H. pylori by using loss-of-function approaches.", {"entities": []}], ["Specifically, in silico results showed a predominance of Th1 and Th17 cells in the stomach of the cell-specific PPAR\u03b3 knockout system when compared to the wild-type simulation.", {"entities": []}], ["Spatio-temporal, object-oriented ABM approaches suggested similar dynamics in induction of host responses showing analogous T cell distributions to ODE modeling and facilitated tracking lesion formation.", {"entities": []}], ["In addition, sensitivity analysis predicted a crucial contribution of Th1 and Th17 effector responses as mediators of histopathological changes in the gastric mucosa during chronic stages of infection, which were experimentally validated in mice.", {"entities": []}], ["These integrated immunoinformatics approaches characterized the induction of mucosal effector and regulatory pathways controlled by PPAR\u03b3 during H. pylori infection affecting disease outcomes.", {"entities": []}], ["To compare infection with the tapeworm, Hymenolepis diminuta , with steroid (dexamethasone) administration in the inhibition of dinitrobenzene sulfonic acid- (DNBS-) induced colitis in mice.", {"entities": []}], ["Procedures .", {"entities": []}], ["Mice were treated with DNBS \u00b1 infected with H. diminuta or treated with daily dexamethasone (2\u2009mg/Kg, ip.)", {"entities": []}], ["and were assessed 72 hours post-DNBS by the calculation of disease activity and histological damage scores, and spleen cell cytokine production.", {"entities": []}], ["H. diminuta -infected mice showed increased IL-4 and IL-10 production by spleen cells compared to other groups and were protected from DNBS-induced colitis.", {"entities": []}], ["In contrast, there was little benefit of dexamethasone in the treatment of colitis.", {"entities": []}], ["Collagen deposition in the colon was not different between the groups.", {"entities": []}], ["Conclusions .", {"entities": []}], ["H. diminuta was superior to dexamethasone in the prevention of DNBS-induced colitis and did not result in additional side effects (i.e., collagen deposition).", {"entities": []}], ["Comparisons with current therapeutics and long-term followup to studies are essential if \u201chelminth therapy\u201d is to become a viable treatment for specific inflammatory diseases in the gut or other tissues.", {"entities": []}], ["With the introduction and implementation of a variety of government programs and policies to encourage adoption of electronic medical records (EMRs), EMRs are being increasingly adopted in North America.", {"entities": []}], ["We sought to evaluate the completeness of a variety of EMR fields to determine if family physicians were comprehensively using their EMRs and the suitability of use of the data for secondary purposes in Ontario, Canada.", {"entities": []}], ["We examined EMR data from a convenience sample of family physicians distributed throughout Ontario within the E lectronic M edical R ecord A dministrative data L inked D atabase (EMRALD) as extracted in the summer of 2012.", {"entities": []}], ["We identified all physicians with at least one year of EMR use.", {"entities": []}], ["Measures were developed and rates of physician documentation of clinical encounters, electronic prescriptions, laboratory tests, blood pressure and weight, referrals, consultation letters, and all fields in the cumulative patient profile were calculated as a function of physician and patient time since starting on the EMR.", {"entities": []}], ["Of the 167 physicians with at least one year of EMR use, we identified 186,237 patients.", {"entities": []}], ["Overall, the fields with the highest level of completeness were for visit documentations and prescriptions (>70\u00a0%).", {"entities": []}], ["Improvements were observed with increasing trends of completeness overtime for almost all EMR fields according to increasing physician time on EMR.", {"entities": []}], ["Assessment of the influence of patient time on EMR demonstrated an increasing likelihood of the population of EMR fields overtime, with the largest improvements occurring between the first and second years.", {"entities": []}], ["All of the data fields examined appear to be reasonably complete within the first year of adoption with the biggest increase occurring the first to second year.", {"entities": []}], ["Using all of the basic functions of the EMR appears to be occurring in the current environment of EMR adoption in Ontario.", {"entities": []}], ["Thus the data appears to be suitable for secondary use.", {"entities": []}], ["Leishmaniasis, a vector borne tropical/subtropical disease caused by the protozoan Leishmania is transmitted to humans by sandfly vectors Phlebotomus and Lutzomyia .", {"entities": [[0, 13, "DISEASE"]]}], ["The principal form found in Sri Lanka is cutaneous leishmaniasis (CL) and is caused by Leishmania donovani .", {"entities": [[51, 64, "DISEASE"], [41, 64, "DISEASE"]]}], ["A rising trend in disease prevalence has been observed recently in Sri Lanka and the island is in fact the newest endemic focus in South Asia.", {"entities": []}], ["Determining the prevalence of smear positivity among clinically suspected CL patients, identifying risk factors and specific clinical presentations of CL in order to implement preventive and early treatment strategies were the objectives of this study.", {"entities": []}], ["A sample of 509 clinically suspected cases of CL referred to the Department of Parasitology from all across Sri Lanka between 2005 and 2015 was selected consecutively.", {"entities": []}], ["Diagnosis was confirmed by microscopic visualization of the Leishmania amastigote from the slit skin smear.", {"entities": []}], ["A structured questionnaire was used to identify exposure related risk factors and a clinical examination was performed to identify lesion characteristics.", {"entities": []}], ["Out of 509 clinical cases, 41.5% ( n \u2009=\u2009211) were smear positive.", {"entities": []}], ["The study population ranged from ages 1 to 80\u00a0years (mean age\u2009=\u200934.76) and the most affected age group was 40\u201349.", {"entities": []}], ["Of the smear positives, 58.85% were males.", {"entities": []}], ["Majority (47.86%) were from the North Western region (Kurunegala) of the country and were exposed to scrub jungles.", {"entities": []}], ["Sand fly exposure ( p \u2009=\u20090.04) and positive contact history ( p \u2009=\u20090.005) were significant risk factors for smear positivity.", {"entities": []}], ["Erythema ( p \u2009=\u20090.02), lack of pruritus ( p \u2009=\u20090.02) and scaly appearance ( p \u2009=\u20090.003) were significant lesion characteristics in smear positivity.", {"entities": []}], ["Lesions were commonly found in the exposed areas and the commonest morphological type was papulo-nodular.", {"entities": []}], ["An increasing trend in the spread of cutaneous leishmaniasis from endemic to non-endemic areas has become evident.", {"entities": [[47, 60, "DISEASE"], [37, 60, "DISEASE"]]}], ["Positive contact history and sandfly exposure were significant risk factors for smear positivity which may indicate the possibility of human reservoir hosts in infection transmission.", {"entities": []}], ["Lack of pruritus, scaly appearance and erythema were highly significant lesion characteristics associated with Leishmania positive smears which can be used for the clinical diagnosis of CL.", {"entities": []}], ["Virtual worlds provide a promising means of delivering simulations for developing interprofessional health skills.", {"entities": []}], ["However, developing and implementing a virtual world simulation is a challenging process, in part because of the novelty of virtual worlds as a simulation platform and also because of the degree of collaboration required among technical and subject experts.", {"entities": []}], ["Thus, it can be difficult to ensure that the simulation is both technically satisfactory and educationally appropriate.", {"entities": []}], ["To address this challenge, we propose the use of de Freitas and Oliver's four-dimensional framework as a means of guiding the development process.", {"entities": []}], ["We give an overview of the framework and describe how its principles can be applied to the development of virtual world simulations.", {"entities": []}], ["We present two virtual world simulation pilot projects that adopted this approach, and describe our development experience in these projects.", {"entities": []}], ["We directly connect this experience to the four-dimensional framework, thus validating the framework's applicability to the projects and to the context of virtual world simulations in general.", {"entities": []}], ["We present a series of recommendations for developing virtual world simulations for interprofessional health education.", {"entities": []}], ["These recommendations are based on the four-dimensional framework and are also informed by our experience with the pilot projects.", {"entities": []}], ["Lung function is a strong predictor of cardiovascular and all-cause mortality.", {"entities": []}], ["Previous studies suggest that alcohol exposure may be linked to impaired pulmonary function through oxidant-antioxidant mechanisms.", {"entities": []}], ["Alcohol may be an important source of oxidants; however, wine contains several antioxidants.", {"entities": []}], ["In this study we analyzed the relation of beverage specific alcohol intake with forced expiratory volume in one second (FEV 1 ) and forced vital capacity (FVC) in a random sample of 1555 residents of Western New York, USA.", {"entities": [[120, 123, "GENE"]]}], ["We expressed pulmonary function as percent of predicted normal FEV 1 (FEV 1 %) and FVC (FVC%) after adjustment for height, age, gender and race.", {"entities": [[63, 66, "GENE"], [70, 73, "GENE"], [63, 66, "GENE"], [70, 73, "GENE"]]}], ["To obtain information on alcohol intake we used a questionnaire that reliably queries total alcohol and beverage specific recent (past 30 days) and lifetime alcohol consumption.", {"entities": []}], ["Results: Using multiple linear regression analysis after adjustment for covariates (pack-years of smoking, weight, smoking status, education, nutritional factors and for FEV 1 %, in addition, eosinophil count), we observed no significant correlation between total alcohol intake and lung function.", {"entities": [[170, 173, "GENE"]]}], ["However, we found positive associations of recent and lifetime wine intake with FEV 1 % and FVC%.", {"entities": [[80, 83, "GENE"]]}], ["When we analyzed white and red wine intake separately, the association of lung function with red wine was weaker than for white wine.", {"entities": []}], ["While total alcohol intake was not related to lung function, wine intake showed a positive association with lung function.", {"entities": []}], ["Although we cannot exclude residual confounding by healthier lifestyle in wine drinkers, differential effects of alcoholic beverages on lung health may exist.", {"entities": []}], ["The gut microbiome is the term given to describe the vast collection of symbiotic microorganisms in the human gastrointestinal system and their collective interacting genomes.", {"entities": []}], ["Recent studies have suggested that the gut microbiome performs numerous important biochemical functions for the host, and disorders of the microbiome are associated with many and diverse human disease processes.", {"entities": []}], ["Systems biology approaches based on next generation 'omics' technologies are now able to describe the gut microbiome at a detailed genetic and functional (transcriptomic, proteomic and metabolic) level, providing new insights into the importance of the gut microbiome in human health, and they are able to map microbiome variability between species, individuals and populations.", {"entities": []}], ["This has established the importance of the gut microbiome in the disease pathogenesis for numerous systemic disease states, such as obesity and cardiovascular disease, and in intestinal conditions, such as inflammatory bowel disease.", {"entities": [[206, 232, "DISEASE"], [132, 139, "DISEASE"]]}], ["Thus, understanding microbiome activity is essential to the development of future personalized strategies of healthcare, as well as potentially providing new targets for drug development.", {"entities": []}], ["Here, we review recent metagenomic and metabonomic approaches that have enabled advances in understanding gut microbiome activity in relation to human health, and gut microbial modulation for the treatment of disease.", {"entities": []}], ["We also describe possible avenues of research in this rapidly growing field with respect to future personalized healthcare strategies.", {"entities": []}], ["Heart failure (HF) is a complex clinical syndrome characterized by impaired cardiac function and poor exercise tolerance.", {"entities": [[41, 49, "DISEASE"]]}], ["Enhanced inflammation is associated with worsening outcomes in HF patients and may play a direct role in disease progression.", {"entities": []}], ["Interleukin-1\u03b2 (IL-1\u03b2) is a pro-inflammatory cytokine that becomes chronically elevated in HF and exerts putative negative inotropic effects.", {"entities": []}], ["We developed a model of IL-1\u03b2-induced left ventricular (LV) dysfunction in healthy mice that exhibited a 32% reduction in LV fractional shortening (P<0.001) and a 76% reduction in isoproterenol response (P<0.01) at 4 hours following a single dose of IL-1\u03b2 3 mcg/kg.", {"entities": []}], ["This phenotype was reproducible in mice injected with plasma from HF patients and fully preventable by pretreatment with IL-1 receptor antagonist (anakinra).", {"entities": []}], ["This led to the design and conduct of a pilot clinical to test the effect of anakinra on cardiopulmonary exercise performance in patients with HF and evidence of elevated inflammatory signaling (n\u200a=\u200a7).", {"entities": []}], ["The median peak oxygen consumption (VO 2 ) improved from 12.3 [10.0, 15.2] to 15.1 [13.7, 19.3] mL\u00b7kg E /VCO 2 slope) improved from 28.1 [22.8, 31.7] to 24.9 [22.9, 28.3] (P\u200a=\u200a0.031 vs. baseline).", {"entities": []}], ["These findings suggest that IL-1\u03b2 activity contributes to poor exercise tolerance in patients with systolic HF and identifies IL-1\u03b2 blockade as a novel strategy for pharmacologic intervention.", {"entities": []}], ["ClinicalTrials.gov NCT01300650", {"entities": []}], ["The mechanism of eosinophil secretion was studied in guinea pig eosinophils by measuring release of hexosaminidase from cell suspensions (greater than 98% pure) permeabilized with streptolysin-O and by whole-cell patch-clamp capacitance measurements.", {"entities": []}], ["It is shown that release of eosinophil granule components occurs by an exocytotic mechanism in which individual granules fuse with the plasma membrane.", {"entities": []}], ["Exocytosis can be induced by intracellular application of the nonhydrolyzable GTP analog guanosine-5'-O-(3-thiotriphosphate) (GTP- gamma-S), suggesting the involvement of a GTP-binding protein.", {"entities": []}], ["The activation is modulated by the intracellular calcium concentration, with activation by GTP-gamma-S inducing transient elevations in the concentration of Ca2+.", {"entities": []}], ["Thus, the nature and regulation of the release mechanism appear to be very similar to that of the mast cell and neutrophil.", {"entities": []}], ["To determine if chronic pulmonary diseases adversely impact selected outcomes in hospitalised patients who have various allergic conditions including anaphylaxis.", {"entities": []}], ["A population-based cohort study.", {"entities": []}], ["A statewide hospital inpatient discharge database from Texas, USA, covering the years 2004\u20132007 was analysed.", {"entities": []}], ["Patients with anaphylaxis and other allergic conditions were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification codes.", {"entities": []}], ["Within each group of patients (the overall group with various selected allergic conditions and the subgroup with anaphylaxis), the exposure variables were 11 chronic pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis.", {"entities": [[203, 240, "DISEASE"], [252, 267, "DISEASE"], [195, 201, "DISEASE"]]}], ["Admission to an intensive care unit, a prolonged (>3\u2005days) hospital stay, receipt of mechanical ventilation and death in hospital.", {"entities": []}], ["Logistic regression was used to calculate adjusted OR and 95% CI for these four outcomes.", {"entities": []}], ["30\u2005390 patients with allergic conditions were identified, of whom 2410 had anaphylaxis.", {"entities": []}], ["The following results pertain to the subcohort of patients with anaphylaxis.", {"entities": []}], ["Median age was 50\u2005years (range 0\u201395\u2005years) and 1470 (61%) were female.", {"entities": []}], ["The hospital mortality was 2.7%.", {"entities": []}], ["Although asthma was not associated with hospital mortality (OR=1.27, 95% CI 0.55 to 2.90), asthmatics had more than twice the odds of non-asthmatics of receiving mechanical ventilation (OR=2.45, 95% CI 1.81 to 3.33).", {"entities": [[9, 15, "DISEASE"]]}], ["Chronic bronchitis, COPD, emphysema and interstitial lung diseases (ILDs) were also associated with an increased risk of requiring mechanical ventilation.", {"entities": [[8, 18, "DISEASE"]]}], ["Chronic bronchitis and COPD were associated with a prolonged length of stay: OR=2.69 (95% CI 1.45 to 4.98) and OR=1.86 (95% CI 1.30 to 2.66), respectively.", {"entities": [[8, 18, "DISEASE"]]}], ["ILD was the only chronic pulmonary disease associated with an elevated risk of hospital mortality: OR=8.71 (95% CI 1.48 to 51.20).", {"entities": []}], ["In this unique analysis of a large database, we found that asthma, COPD and other chronic pulmonary diseases increased the risk of adverse outcomes among hospitalised patients with anaphylaxis.", {"entities": [[59, 65, "DISEASE"]]}], ["There is a substantive lack of knowledge about comorbidity in patients with frozen shoulder.", {"entities": [[76, 91, "DISEASE"]]}], ["The aim of this study was to investigate whether subjective health complaints and Neuroticism would predict treatment outcome in patients diagnosed with frozen shoulder as measured by the Shoulder Pain and Disability Index (SPADI) and change in SPADI.", {"entities": [[153, 168, "DISEASE"]]}], ["A total of 105 patients with frozen shoulder were recruited for a randomised controlled trial, where 69 were in the intervention group and received intraarticular corticosteroid injections and 36 patients served as control group.", {"entities": [[29, 44, "DISEASE"]]}], ["The SPADI was used as the outcome measure after 8\u00a0weeks, and change in SPADI from baseline to 8\u00a0weeks as a measure of rate of recovery.", {"entities": []}], ["To examine comorbidities, all participants completed the Subjective Health Complaints (SHC) questionnaire with its five subscales, and the Neuroticism (N) component of the Eysenck Personality Questionnaire Revised.", {"entities": []}], ["Multiple regression analysis was performed with the baseline comorbidity variables that correlated significantly with SPADI after 8\u00a0weeks, and with change in SPADI from baseline to 8\u00a0weeks, controlling for the variables intervention, age, gender and duration of pain.", {"entities": []}], ["In this study, patients with frozen shoulder had little comorbidity as measured with SHC and scored normally with respect to Neuroticism.", {"entities": [[29, 44, "DISEASE"]]}], ["Only the Pseudoneurology subscale in SHC correlated significantly with SPADI and had significant predictive power ( p \u00a0<\u00a00.001) for the outcome at 8\u00a0weeks.", {"entities": []}], ["The intervention group exhibited significant statistical predictive power ( p \u00a0<\u00a00.001) for the treatment outcome as measured by a change in SPADI from baseline to 8\u00a0weeks.", {"entities": []}], ["Being female also had some predictive significance for change in SPADI ( p \u00a0<\u00a00.005).", {"entities": []}], ["Psychometric parameters as measured by the Pseudoneurology subscale in SHC questionnaire did predict the treatment outcome in frozen shoulder as measured by SPADI at 8\u00a0weeks, but not by change in SPADI from baseline to 8\u00a0weeks.", {"entities": [[126, 141, "DISEASE"]]}], ["One may conclude that psychometric parameters may affect symptoms, but do not predict the rate of recovery in frozen shoulder.", {"entities": [[110, 125, "DISEASE"]]}], ["ClinicalTrials.gov, identifier: NCT01570985 .", {"entities": []}], ["Benign prostatic hyperplasia is a frequent disease among elderly, and is responsible for considerable disability.", {"entities": []}], ["Benign prostatic hyperplasia can be clinically significant due to lower urinary tract symptoms that take place because the gland is enlarged and obstructs urine flow.", {"entities": []}], ["Transurethral resection of the prostate remains the gold standard treatment for patients with moderate or severe symptoms who need active treatment or who either fail or do not want medical therapy.", {"entities": []}], ["Moreover, perioperative and postoperative surgery complications as cardiovascular ones still occur.", {"entities": []}], ["The incidence of acute myocardial infarction in patients undergoing transurethral resection of the prostate is controversial.", {"entities": [[23, 44, "DISEASE"], [17, 44, "DISEASE"]]}], ["The first studies showed an increase in mortality and relative risk of death from myocardial infarction in transurethral resection of the prostate group vs open prostatectomy but these results are in contrast with more recent data.", {"entities": [[82, 103, "DISEASE"]]}], ["Given the conflicting evidence of the studies in the literature, in this review we are going to discuss the factors that may influence the risk of myocardial infarction in elderly patients undergoing prostate surgery.", {"entities": [[147, 168, "DISEASE"]]}], ["We analyzed the possible common factors that lead to the development of myocardial infarction and benign prostatic hyperplasia (cardiovascular and metabolic), the stressor factors related to prostatectomy (surgical and haemodynamic) and the risk factors specific of the elderly population (comorbidity and therapies).", {"entities": [[72, 93, "DISEASE"]]}], ["Although transurethral resection of the prostate is considered at low risk for severe complications, there are several reports indicating that cardiovascular events in elderly patients undergoing this surgical operation are more common than in the general population.", {"entities": []}], ["Several cardio-metabolic, surgical and aging-related factors may help explain this observation but results in literature are not concord, especially due to the fact that most data derive from retrospective studies in which selection bias cannot be excluded.", {"entities": []}], ["Subsequently, further studies are necessary to clarify the incidence of acute myocardial infarction in old people.", {"entities": [[78, 99, "DISEASE"], [72, 99, "DISEASE"]]}], ["Tropomyosin-related kinase A (TRKA) is a nerve growth factor (NGF) receptor that belongs to the tyrosine kinase receptor family.", {"entities": [[62, 65, "GENE"]]}], ["It is critical for the correct development of many types of neurons including pain-mediating sensory neurons and also controls proliferation, differentiation and survival of many neuronal and non-neuronal cells.", {"entities": []}], ["TRKA (also known as NTRK1 ) gene is a target of alternative splicing which can result in several different protein isoforms.", {"entities": [[20, 25, "GENE"]]}], ["Presently, three human isoforms (TRKAI, TRKAII and TRKAIII) and two rat isoforms (TRKA L0 and TRKA L1) have been described.", {"entities": []}], ["We show here that human TRKA gene is overlapped by two genes and spans 67\u00a0kb\u2014almost three times the size that has been previously described.", {"entities": []}], ["Numerous transcription initiation sites from eight different 5\u2032 exons and a sophisticated splicing pattern among exons encoding the extracellular part of TRKA receptor indicate that there might be a large variety of alternative protein isoforms.", {"entities": []}], ["TrkA genes in rat and mouse appear to be considerably shorter, are not overlapped by other genes and display more straightforward splicing patterns.", {"entities": []}], ["We describe the expression profile of alternatively spliced TRKA transcripts in different tissues of human, rat and mouse, as well as analyze putative endogenous TRKA protein isoforms in human SH-SY5Y and rat PC12 cells.", {"entities": []}], ["We also characterize a selection of novel putative protein isoforms by portraying their phosphorylation, glycosylation and intracellular localization patterns.", {"entities": []}], ["Our findings show that an isoform comprising mainly of TRKA kinase domain is capable of entering the nucleus.", {"entities": []}], ["Results obtained in this study refer to the existence of a multitude of TRKA mRNA and protein isoforms, with some putative proteins possessing very distinct properties.", {"entities": []}], ["The online version of this article (doi:10.1186/s12868-015-0215-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Carboxymethyl-\u03b2-cyclodextrin (CM\u03b2-CD)-modified glycol chitosan (GCS) nanoparticles (GCS-CM\u03b2-CD NPs) were synthesized, and their pH-sensitive drug-release properties were investigated.", {"entities": [[95, 98, "GENE"]]}], ["GCS-CM\u03b2-CD NPs could encapsulate doxorubicin hydrochloride (DOX), and the encapsulation efficiency and loading capacity increased with the amount of CM\u03b2-CD.", {"entities": [[11, 14, "GENE"]]}], ["Drug-release studies indicate that DOX released was greater in acidic medium (pH 5.0) than in weakly basic medium (pH 7.4).", {"entities": []}], ["The mechanism underlying the pH-sensitive properties of the carrier was analyzed.", {"entities": []}], ["Finally, the MCF-7 (human breast cancer) and SW480 cell lines (human colon cancer) were used to evaluate the cytotoxicity of the NPs.", {"entities": [[26, 39, "DISEASE"], [69, 81, "DISEASE"], [33, 39, "DISEASE"], [75, 81, "DISEASE"], [129, 132, "GENE"]]}], ["The drug-loaded carriers show good inhibition of the growth of cancer cells compared with free DOX, and the carriers have good biocompatibility.", {"entities": [[63, 69, "DISEASE"]]}], ["In addition, the drug-loaded NPs have sustained drug-release properties.", {"entities": [[29, 32, "GENE"]]}], ["All these properties of the newly synthesized GCS-CM\u03b2-CD NPs suggest a promising potential as an effective anticancer drug-delivery system for controlled drug release.", {"entities": [[57, 60, "GENE"]]}], ["The term severe acute respiratory infection (SARI) encompasses a heterogeneous group of respiratory illnesses.", {"entities": []}], ["Grading the severity of SARI is currently reliant on indirect disease severity measures such as respiratory and heart rate, and the need for oxygen or intensive care.", {"entities": []}], ["With the lungs being the primary organ system involved in SARI, chest radiographs (CXRs) are potentially useful for describing disease severity.", {"entities": []}], ["Our objective was to develop and validate a SARI CXR severity scoring system.", {"entities": []}], ["We completed validation within an active SARI surveillance project, with SARI defined using the World Health Organization case definition of an acute respiratory infection with a history of fever, or measured fever of \u2265 38 \u00b0C; and cough; and with onset within the last 10 days; and requiring hospital admission.", {"entities": []}], ["We randomly selected 250 SARI cases.", {"entities": []}], ["Admission CXR findings were categorized as: 1 = normal; 2 = patchy atelectasis and/or hyperinflation and/or bronchial wall thickening; 3 = focal consolidation; 4 = multifocal consolidation; and 5 = diffuse alveolar changes.", {"entities": []}], ["Initially, four radiologists scored CXRs independently.", {"entities": []}], ["Subsequently, a pediatrician, physician, two residents, two medical students, and a research nurse independently scored CXR reports.", {"entities": []}], ["Inter-observer reliability was determined using a weighted Kappa (\u03ba) for comparisons between radiologists; radiologists and clinicians; and clinicians.", {"entities": []}], ["Agreement was defined as moderate (\u03ba > 0.4\u20130.6), good (\u03ba > 0.6\u20130.8) and very good (\u03ba > 0.8\u20131.0).", {"entities": []}], ["Agreement between the two pediatric radiologists was very good (\u03ba = 0.83, 95 % CI 0.65\u20131.00) and between the two adult radiologists was good (\u03ba = 0.75, 95 % CI 0.57\u20130.", {"entities": []}], ["Agreement of the clinicians with the radiologists was moderate-to-good (pediatrician:\u03ba = 0.65; pediatric resident:\u03ba = 0.69; physician:\u03ba = 0.68; resident:\u03ba = 0.67; research nurse:\u03ba = 0.49, medical students: \u03ba = 0.53 and \u03ba = 0.56).", {"entities": []}], ["Agreement between clinicians was good-to-very good (pediatrician vs. physician:\u03ba = 0.85; vs. pediatric resident:\u03ba = 0.81; vs. medicine resident:\u03ba = 0.76; vs. research nurse:\u03ba = 0.75; vs. medical students:\u03ba = 0.63 and 0.66).", {"entities": []}], ["Following review of discrepant CXR report scores by clinician pairs, \u03ba values for radiologist-clinician agreement ranged from 0.59 to 0.70 and for clinician-clinician agreement from 0.97 to 0.99.", {"entities": []}], ["This five-point CXR scoring tool, suitable for use in poorly- and well-resourced settings and by clinicians of varying experience levels, reliably describes SARI severity.", {"entities": []}], ["The resulting numerical data enables epidemiological comparisons of SARI severity between different countries and settings.", {"entities": []}], ["The Chronic Care Model (CCM) emerged in the 1990s as an approach to re-organize primary care and implement critical elements that enable it to proactively attend to patients with chronic conditions.", {"entities": []}], ["The chronic care landscape has evolved further, as most patients now present with multiple chronic conditions and increasing psychosocial complexity.", {"entities": []}], ["These patients face accumulating and overwhelming complexity resulting from the sum of uncoordinated responses to each of their problems.", {"entities": []}], ["Minimally Disruptive Medicine (MDM) was proposed to respond to this challenge, aiming at improving outcomes that matter to patients with the smallest burden of treatment.", {"entities": []}], ["We sought to critically appraise the extent to which MDM constructs (e.g., reducing patient work, improving patients\u2019 capacity) have been adopted within CCM implementations.", {"entities": []}], ["We conducted a systematic review and qualitative thematic synthesis of reports of CCM implementations published from 2011\u20132016.", {"entities": []}], ["CCM implementations were mostly aligned with the healthcare system\u2019s goals, condition-specific, and targeted disease-specific outcomes or healthcare utilization.", {"entities": []}], ["No CCM implementation addressed patient work.", {"entities": []}], ["Few reduced treatment workload without adding additional tasks.", {"entities": []}], ["Implementations supported patient capacity by offering information, but rarely offered practical resources (e.g., financial assistance, transportation), helped patients reframe their biography with chronic illness, or assisted them in engaging with a supportive social network.", {"entities": []}], ["Few implementations aimed at improving functional status or quality of life, and only one-third of studies were targeted for patients of low socioeconomic status.", {"entities": []}], ["MDM provides a lens to operationalize how to care for patients with multiple chronic conditions, but its constructs remain mostly absent from how implementations of the CCM are currently reported.", {"entities": []}], ["Improvements to the primary care of patients with multimorbidity may benefit from the application of MDM, and the current CCM implementations that do apply MDM constructs should be considered exemplars for future implementation work.", {"entities": []}], ["North African populations are distinct from sub-Saharan Africans based on cultural, linguistic, and phenotypic attributes; however, the time and the extent of genetic divergence between populations north and south of the Sahara remain poorly understood.", {"entities": []}], ["Here, we interrogate the multilayered history of North Africa by characterizing the effect of hypothesized migrations from the Near East, Europe, and sub-Saharan Africa on current genetic diversity.", {"entities": []}], ["We present dense, genome-wide SNP genotyping array data (730,000 sites) from seven North African populations, spanning from Egypt to Morocco, and one Spanish population.", {"entities": []}], ["We identify a gradient of likely autochthonous Maghrebi ancestry that increases from east to west across northern Africa; this ancestry is likely derived from \u201cback-to-Africa\u201d gene flow more than 12,000 years ago (ya), prior to the Holocene.", {"entities": []}], ["The indigenous North African ancestry is more frequent in populations with historical Berber ethnicity.", {"entities": []}], ["In most North African populations we also see substantial shared ancestry with the Near East, and to a lesser extent sub-Saharan Africa and Europe.", {"entities": []}], ["To estimate the time of migration from sub-Saharan populations into North Africa, we implement a maximum likelihood dating method based on the distribution of migrant tracts.", {"entities": []}], ["In order to first identify migrant tracts, we assign local ancestry to haplotypes using a novel, principal component-based analysis of three ancestral populations.", {"entities": []}], ["We estimate that a migration of western African origin into Morocco began about 40 generations ago (approximately 1,200 ya); a migration of individuals with Nilotic ancestry into Egypt occurred about 25 generations ago (approximately 750 ya).", {"entities": []}], ["Our genomic data reveal an extraordinarily complex history of migrations, involving at least five ancestral populations, into North Africa.", {"entities": []}], ["Proposed migrations between North Africa and neighboring regions have included Paleolithic gene flow from the Near East, an Arabic migration across the whole of North Africa 1,400 years ago (ya), and trans-Saharan transport of slaves from sub-Saharan Africa.", {"entities": []}], ["Historical records, archaeology, and mitochondrial and Y-chromosome DNA have been marshaled in support of one theory or another, but there is little consensus regarding the overall genetic background of North African populations or their origin and expansion.", {"entities": []}], ["We characterize the patterns of genetic variation in North Africa using \u223c730,000 single nucleotide polymorphisms from across the genome for seven populations.", {"entities": []}], ["We observe two distinct, opposite gradients of ancestry: an east-to-west increase in likely autochthonous North African ancestry and an east-to-west decrease in likely Near Eastern Arabic ancestry.", {"entities": []}], ["The indigenous North African ancestry may have been more common in Berber populations and appears most closely related to populations outside of Africa, but divergence between Maghrebi peoples and Near Eastern/Europeans likely precedes the Holocene (>12,000 ya).", {"entities": []}], ["We also find significant signatures of sub-Saharan African ancestry that vary substantially among populations.", {"entities": []}], ["These sub-Saharan ancestries appear to be a recent introduction into North African populations, dating to about 1,200 years ago in southern Morocco and about 750 years ago into Egypt, possibly reflecting the patterns of the trans-Saharan slave trade that occurred during this period.", {"entities": []}], ["Macrophages are heterogeneous and thus can be correlated with distinct tissue outcomes after injury.", {"entities": []}], ["Conflicting data have indicated that the M2\u2010related phenotype directly triggers fibrosis.", {"entities": []}], ["Conversely, we hypothesize here that the inflammatory milieu provided by early infiltration of pro\u2010inflammatory macrophages dictates tissue scarring after injury.", {"entities": []}], ["We first determined that tissue\u2010localized macrophages exhibit a pro\u2010inflammatory phenotype (p40IL12 Our results suggest that pro\u2010inflammatory macrophages promote microenvironmental changes that may lead to fibrogenesis by inducing an inflammatory milieu that alters a network of extracellular\u2010related genes, culminating in tissue fibrosis.", {"entities": []}], ["Chronic migraine (CM; \u226515 headache days per month, \u22653\u00a0months) is associated with a higher prevalence of comorbidities than episodic migraine (<15 headache days per month).", {"entities": [[8, 16, "DISEASE"], [132, 140, "DISEASE"]]}], ["However, it is unclear whether a similar pattern exists in Asian patients.", {"entities": []}], ["To examine this, a retrospective matched cohort study was conducted using the Taiwan National Health Insurance Research Database.", {"entities": []}], ["CM cases were defined as patients with at least one neurological outpatient visit with a primary or secondary ICD-9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) code of 346.11, diagnosed by neurologists at medical centers during 2007\u20132008.", {"entities": []}], ["The study group was compared with patients suffering from other migraine subtypes and non-migraineurs in the general population.", {"entities": [[64, 72, "DISEASE"]]}], ["Both comparison groups were matched with CM sufferers at a 4:1 ratio by age, gender, urbanization level of the residence, income, and hospital setting.", {"entities": []}], ["Relative risk (RR) was calculated using conditional logistic regression.", {"entities": []}], ["Compared with patients with other migraines ( n \u00a0=\u00a02,226), CM sufferers ( n \u00a0=\u00a0681) had a higher risk of hyperlipidemia (RR\u00a0=\u00a01.32; P \u00a0=\u00a00.041), asthma (RR\u00a0=\u00a01.77; P \u00a0=\u00a00.007), depression (RR\u00a0=\u00a01.88; P \u00a0<\u00a00.0001), bipolar disorder (RR\u00a0=\u00a01.81; P \u00a0=\u00a00.022) and anxiety disorders (RR\u00a0=\u00a01.48; P \u00a0=\u00a0<0.0001).", {"entities": [[214, 230, "DISEASE"], [145, 151, "DISEASE"]]}], ["Compared with the non-migraineurs ( n \u00a0=\u00a03,790), CM sufferers ( n \u00a0=\u00a0948) had significantly increased risks of cardiovascular disease, sinusitis, asthma, gastrointestinal ulcers, vertigo and psychiatric disorders by 1.6\u20133.9-fold.", {"entities": [[135, 144, "DISEASE"], [146, 152, "DISEASE"]]}], ["In conclusion, CM is associated with significant comorbidities in Asian patients.", {"entities": []}], ["Differences in the comorbidity profiles of CM compared with other migraines have highlighted that patients with CM differ not just in terms of headache frequency but also in other important aspects.", {"entities": []}], ["S. aureus community-acquired pneumonia has been reported from 9 states.", {"entities": [[29, 38, "DISEASE"]]}], ["During the 2003\u201304 influenza season, 17 cases of Staphylococcus aureus community-acquired pneumonia (CAP) were reported from 9 states; 15 (88%) were associated with methicillin-resistant S. aureus (MRSA).", {"entities": [[19, 28, "DISEASE"], [90, 99, "DISEASE"]]}], ["The median age of patients was 21 years; 5 (29%) had underlying diseases, and 4 (24%) had risk factors for MRSA.", {"entities": []}], ["Twelve (71%) had laboratory evidence of influenza virus infection.", {"entities": [[40, 49, "DISEASE"]]}], ["All but 1 patient, who died on arrival, were hospitalized.", {"entities": []}], ["Death occurred in 5 (4 with MRSA).", {"entities": []}], ["S. aureus isolates were available from 13 (76%) patients (11 MRSA).", {"entities": []}], ["Toxin genes were detected in all isolates; 11 (85%) had only genes for Panton-Valentine leukocidin.", {"entities": []}], ["All isolates had community-associated pulsed-field gel electrophoresis patterns; all MRSA isolates had the staphylococcal cassette chromosome mec type IVa.", {"entities": []}], ["In communities with a high prevalence of MRSA, empiric therapy of severe CAP during periods of high influenza activity should include consideration for MRSA.", {"entities": [[100, 109, "DISEASE"]]}], ["In patients with short-term exposure to the sulfur mustard gas, the delayed cellular effects on lungs have not been well understood yet.", {"entities": []}], ["The lung pathology shows a dominant feature consistent with obliterative bronchiolitis, in which fibroblasts play a central role.", {"entities": [[73, 86, "DISEASE"]]}], ["This study aims to characterize alterations to lung fibroblasts, at the cellular level, in patients with delayed respiratory complications after short-term exposure to the sulfur mustard gas.", {"entities": []}], ["Fibroblasts were isolated from the transbronchial biopsies of patients with documented history of exposure to single high-dose sulfur mustard during 1985\u20137 and compared with the fibroblasts of control subjects.", {"entities": []}], ["Compared with controls, patients\u2019 fibroblasts were thinner and shorter, and showed a higher population doubling level, migration capacity and number of filopodia.", {"entities": []}], ["Sulfur mustard decreased the in vitro viability of fibroblasts and increased their sensitivity to induction of apoptosis, but did not change the rate of spontaneous apoptosis.", {"entities": []}], ["In addition, higher expression of alpha smooth muscle actin showed that the lung's microenvironment in these patients is permissive for myofibroblastic differentiation.", {"entities": []}], ["These findings suggest that in patients under the study, the delayed pulmonary complications of sulfur mustard should be considered as a unique pathology, which might need a specific management by manipulation of cellular components.", {"entities": []}], ["The health of the agricultural population has been previously explored, particularly in relation to the farming exposures and among professionally active individuals.", {"entities": []}], ["However, few studies specifically focused on health and aging among elders retired from agriculture.", {"entities": []}], ["Yet, this population faces the long-term effects of occupational exposures and multiple difficulties related to living and aging in rural area (limited access to shops, services, and practitioners).", {"entities": []}], ["However, these difficulties may be counter-balanced by advantages related to healthier lifestyle, richer social support and better living environment.", {"entities": []}], ["The general aim of the AMI cohort was to study health and aging in elderly farmers living in rural area through a multidisciplinary approach, with a main focus on dementia.", {"entities": [[163, 171, "DISEASE"]]}], ["The study initially included 1 002 participants, randomly selected from the Farmer Health Insurance rolls.", {"entities": []}], ["Selection criteria were: being 65\u2009years and older; living in rural area in Gironde (South-Western France); being retired from agriculture after at least 20\u2009years of activity and being affiliated to the Health Insurance under own name.", {"entities": []}], ["The study started in 2007, with two follow-up visits over 5\u2009years.", {"entities": []}], ["Baseline visits were conducted at home by a neuropsychologist then by a geriatrician for all cases suspected of dementia, Parkinson\u2019s disease and depression (to confirm the diagnosis), and by a nurse for others.", {"entities": [[112, 120, "DISEASE"]]}], ["A large panel of data were collected through standardised questionnaires: complete neuropsychological assessment, material and social living environment, psychological transition to retirement, lifestyle (smoking, alcohol and diet), medications, disability in daily living, sensory impairments and some clinical measures (blood pressure, depression symptomatology, anxiety, visual test, anthropometry\u2026).", {"entities": []}], ["A blood sampling was performed with biological measurements and constitution of a biological bank, including DNA.", {"entities": []}], ["Brain MRI were also performed on 316 of the participants.", {"entities": []}], ["Finally, the three-year data on health-related reimbursements were extracted from the Health System database (medications, medical and paramedical consultations, biological examinations and medical devices), and the registered Long-Term Diseases (30 chronic diseases 100% covered by the Insurance System).", {"entities": []}], ["AMI is the first French longitudinal study on health and aging set up in a population of elderly farmers living in rural area through a multidisciplinary approach.", {"entities": []}], ["The Air-Smart Spirometer is the first portable device accepted by the European Community (EC) that performs spirometric measurements by a turbine mechanism and displays the results on a smartphone or a tablet.", {"entities": []}], ["In this multicenter, descriptive and cross-sectional prospective study carried out in 2 hospital centers, we compare FEV1, FVC, FEV1/FVC ratio measured with the Air Smart-Spirometer device and a conventional spirometer, and analyze the ability of this new portable device to detect obstructions.", {"entities": []}], ["Patients were included for 2 consecutive months.", {"entities": []}], ["We calculate sensitivity, specificity, positive and negative predictive value (PPV and NPV) and likelihood ratio (LR +, LR-) as well as the Kappa Index to evaluate the concordance between the two devices for the detection of obstruction.", {"entities": []}], ["The agreement and relation between the values of FEV1 and FVC in absolute value and the FEV1/FVC ratio measured by both devices were analyzed by calculating the intraclass correlation coefficient (ICC) and the Pearson correlation coefficient (r) respectively.", {"entities": []}], ["200 patients (100 from each center) were included with a mean age of 57 (\u00b1 14) years, 110 were men (55%).", {"entities": []}], ["Obstruction was detected by conventional spirometry in 73 patients (40.1%).", {"entities": []}], ["Using a FEV1/FVC ratio smaller than 0.7 to detect obstruction with the Air Smart-Spirometer, the kappa index was 0.88, sensitivity (90.4%), specificity (97.2%), PPV (95.7%), NPV (93.7%), positive likelihood ratio (32.29), and negative likelihood ratio (0.10).", {"entities": []}], ["The ICC and r between FEV1, FVC, and FEV1 / FVC ratio measured by the Air Smart Spirometer and the conventional spirometer were all higher than 0.94.", {"entities": []}], ["The Air-Smart Spirometer is a simple and very precise instrument for detecting obstructive airway diseases.", {"entities": []}], ["It is easy to use, which could make it especially useful non-specialized care and in other areas.", {"entities": []}], ["The major cell types expressing Golli in the immune system are the T-lineage cells.", {"entities": []}], ["The aim of the current study was to investigate the changes of gene expression in T lymphocytes subsequent to downregulation of the Golli-myelin basic protein (MBP) gene.", {"entities": [[160, 163, "GENE"]]}], ["RNA interference technology was used to suppress the expression of Golli-MBP in Jurkat cells and DNA microarray techniques were applied to investigate the alterations of gene expression profiles.", {"entities": []}], ["The results indicated that there were 387 differentially expressed genes.", {"entities": []}], ["In the Golli-MBP knockdown Jurkat cells, the expression of 108 genes was enhanced, 279 genes were suppressed.", {"entities": []}], ["Gene ontology analysis identified differentially expressed genes involved in several biological progresses, including cell adhesion and immune responses.", {"entities": []}], ["Pathway analysis demonstrated that the majority of the differentially expressed genes (23.3%) were involved in cytokine-cytokine receptor interaction.", {"entities": []}], ["Subsequent to Golli-MBP knockdown, the mechanisms that changed the biological characteristics of Jurkat cells were complex, involving numerous types of functional proteins, and metabolic and signaling pathways.", {"entities": []}], ["However, further experiments are required to confirm these results.", {"entities": []}], ["Smoking prevalence in human immunodeficiency virus (HIV) positive subjects is about three times of that in the general population.", {"entities": []}], ["However, whether the extremely high smoking prevalence in HIV-positive subjects affects their lung function is unclear, particularly whether smoking decreases lung function more in HIV-positive subjects, compared to the general population.", {"entities": []}], ["We conducted this study to determine the association between smoking and lung function, respiratory symptoms and diseases amongst HIV-positive subjects.", {"entities": []}], ["Of 120 enrolled HIV-positive subjects, 119 had an acceptable spirogram.", {"entities": []}], ["Ninety-four (79%) subjects were men, and 96 (81%) were white.", {"entities": []}], ["Mean (standard deviation [SD]) age was 43.4 (8.4) years.", {"entities": []}], ["Mean (SD) of forced expiratory volume in one second (FEV 1 ) percent of age, gender, race and height predicted value (%FEV 1 ) was 93.1% (15.7%).", {"entities": [[53, 56, "GENE"], [119, 122, "GENE"], [53, 56, "GENE"], [119, 122, "GENE"]]}], ["Seventy-five (63%) subjects had smoked 24.0 (18.0) pack-years.", {"entities": []}], ["For every ten pack-years of smoking increment, %FEV 1 decreased by 2.1% (95% confidence interval [CI]: -3.6%, -0.6%), after controlling for gender, race and restrictive lung function (R 1 in our subjects was comparable to the general population.", {"entities": [[48, 51, "GENE"]]}], ["Compared to non-smokers, current smokers had higher odds of cough, sputum or breathlessness, after adjusting for highly active anti-retroviral therapy (HAART) use, odds ratio OR = 4.9 (95% CI: 2.0, 11.8).", {"entities": []}], ["However respiratory symptom presence was similar between non-smokers and former smokers, OR = 1.0 (95% CI: 0.3, 2.8).", {"entities": []}], ["All four cases of COPD (chronic obstructive pulmonary disease) had smoked.", {"entities": [[24, 61, "DISEASE"]]}], ["Four of ten cases of restrictive lung disease had smoked (p = 0.170), and three of five asthmatic subjects had smoked (p = 1.000).", {"entities": [[33, 45, "DISEASE"]]}], ["Cumulative cigarette consumption was associated with worse lung function; however the loss of %FEV 1 did not accelerate in HIV-positive population compared to the general population.", {"entities": [[95, 98, "GENE"]]}], ["Current smokers had higher odds of respiratory symptoms than non-smokers, while former smokers had the same odds of respiratory symptoms as non-smokers.", {"entities": []}], ["Cigarette consumption was likely associated with more COPD cases in HIV-positive population; however more participants and longer follow up would be needed to estimate the effect of smoking on COPD development.", {"entities": []}], ["Effective smoking cessation strategies are required for HIV-positive subjects.", {"entities": []}], ["Housing for the twenty-first century will be shaped by the changes that are occurring in society.", {"entities": []}], ["These include the demographics of the occupant, the products and materials used for construction and furnishing, and the basic use of the structure.", {"entities": []}], ["An aging population will have different demands on design and function.", {"entities": []}], ["The health concerns of an aging population encompass chronic degenerative diseases as well as injury.", {"entities": []}], ["The lessons of the past must make us mindful that chronic, low-level exposures to substances can occur at home.", {"entities": []}], ["Products and materials used in homes can release vapors that may affect immunologic and neurologic function.", {"entities": []}], ["Manifestations of dysfunctions will be more important as our population ages and if there is a continued reliance on new chemical formulation for products used in homes and workplaces.", {"entities": []}], ["The future portends changes in functional use of residences.", {"entities": []}], ["Electronic communications and robotics will decentralize our work force.", {"entities": []}], ["Manufacturing or office functions will occur at home.", {"entities": []}], ["This will present new challenges for health and safety for both monitoring and prevention.", {"entities": []}], ["This study was conducted in a free-living setting to investigate the measurement validity of a research-based actigraph for strolling and jogging, and to provide a reference for actual practice and research.", {"entities": []}], ["Because inadequate physical activity (PA) or sedentary lifestyle has become the fourth leading risk factor for mortality worldwide, many countries have been vigorously promoting the concept of \u201cactive living\u201d, and the public has been investing greater effort into intensifying their PA.", {"entities": []}], ["Although research-grade actigraphs have been widely applied to evaluate PA in routine environments, the measurement results may not accurately reflect the wearers\u2019 PA.", {"entities": []}], ["Unlike most relevant research, which is conducted in well-controlled laboratory environments, the present study was implemented in the field to examine the sensitivity and convergent validity of the MicroMini Motionlogger", {"entities": []}], ["Multiple transforming growth factor (TGF)-\u03b2-induced fibrogenic signals have been described in vitro.", {"entities": []}], ["To evaluate mechanisms in vivo , we used an adriamycin nephropathy model in 129x1/Svj mice that display massive proteinuria by day 5 to7 and pathological findings similar to human focal segmental glomerulosclerosis by day 14.", {"entities": [[112, 123, "DISEASE"], [180, 214, "DISEASE"]]}], ["TGF-\u03b2 mRNA expression increased after day 7 along with nuclear translocation of the TGF-\u03b2 receptor-specific transcription factor Smad3.", {"entities": [[129, 134, "GENE"]]}], ["Inhibiting TGF-\u03b2 prevented both pathological changes and type-I collagen and fibronectin mRNA expression, but proteinuria persisted.", {"entities": [[110, 121, "DISEASE"]]}], ["Renal Akt was phosphorylated in adriamycin-treated mice, suggesting PI3-kinase activation.", {"entities": []}], ["Expression of mRNA for the p110\u03b3 isozyme of PI3-kinase was specifically increased and p110\u03b3 colocalized with nephrin by immunohistochemistry early in disease.", {"entities": []}], ["Nephrin levels subsequently decreased.", {"entities": []}], ["Inhibition of p110\u03b3 by AS605240 preserved nephrin expression and prevented proteinuria.", {"entities": [[75, 86, "DISEASE"]]}], ["In cultured podocytes, adriamycin stimulated p110\u03b3 expression.", {"entities": []}], ["AS605240, but not a TGF-\u03b2 receptor kinase inhibitor, prevented adriamycin-induced cytoskeletal disorganization and apoptosis, supporting a role for p110\u03b3 in podocyte injury.", {"entities": []}], ["AS605240, at a dose that decreased proteinuria, prevented renal collagen mRNA expression in vivo but did not affect TGF-\u03b2-stimulated collagen induction in vitro .", {"entities": [[35, 46, "DISEASE"]]}], ["Thus, PI3-kinase p110\u03b3 mediates initial podocyte injury and proteinuria, both of which precede TGF-\u03b2-mediated glomerular scarring.", {"entities": [[60, 71, "DISEASE"]]}], ["Kimura\u2019s disease (KD; eosinophilic granuloma of soft tissue) is an inflammatory granulomatous disorder of unknown cause with eosinophilic infiltration that occurs mainly in soft tissue.", {"entities": []}], ["KD occurs mainly in the head and neck, but development in the axillary region is very rare.", {"entities": []}], ["A 74-year-old Japanese woman was evaluated for a mass that she noted in the left axillary region.", {"entities": []}], ["On physical examination, there was a palpable, thumb-sized, hard, elastic, freely movable mass in the left axilla.", {"entities": []}], ["Blood tests showed elevated soluble interleukin-2 receptor (sIL-2R), normal serum immunoglobulin (Ig) G4, and elevated serum IgE.", {"entities": []}], ["Ultrasonography of the left axilla showed multiple lymph nodes (LNs) with irregular margins in which central hyperechogenicity was lost.", {"entities": []}], ["A systemic search by computed tomography (CT) showed no systemic lymphadenopathy or other mass-like lesions suspicious for a primary tumour other than in the left axillary LNs.", {"entities": []}], ["Biopsy of an excised LN was performed under local anaesthesia for a definitive diagnosis.", {"entities": []}], ["Histopathology showed various-sized lymphoid follicles, large nodular lesions with an enlarged mantle zone, multiple various-sized germinal centres in single nodules, and eosinophilic infiltration between the nodes.", {"entities": []}], ["Immunohistochemical (IHC) staining of the germinal centres was positive for cluster of differentiation (CD) 10, positive for B-cell lymphoma (bcl)-6, and negative for bcl-2.", {"entities": [[132, 140, "DISEASE"]]}], ["These findings led to a diagnosis of KD.", {"entities": []}], ["Ultrasound after 3\u00a0months of follow-up showed disappearance of the axillary lymphadenopathy.", {"entities": []}], ["A very rare case of KD in the axillary LNs was described.", {"entities": []}], ["KD has the potential to occur in any region.", {"entities": []}], ["Allergic rhinitis (AR), the most common chronic disease in childhood is often ignored, misdiagnosed and/or mistreated.", {"entities": [[9, 17, "DISEASE"]]}], ["Undertreated AR impairs quality of life, exacerbates asthma and is a major factor in asthma development.", {"entities": [[53, 59, "DISEASE"], [85, 91, "DISEASE"]]}], ["It can involve the nose itself, as well as the organs connected with the nose manifesting a variety of symptoms.", {"entities": []}], ["Evidence-based guidelines for AR therapy improve disease control.", {"entities": []}], ["Recently, paediatric AR guidelines have been published by the European Academy of Allergy and Clinical Immunology and are available online, as are a patient care pathway for children with AR and asthma from the Royal College of Paediatrics and Child Health.", {"entities": [[195, 201, "DISEASE"]]}], ["Management involves diagnosis, followed by avoidance of relevant allergens, with additional pharmacotherapy needed for most sufferers.", {"entities": []}], ["This ranges, according to severity, from saline sprays, through non-sedating antihistamines, oral or topical, with minimally bioavailable intranasal corticosteroids for moderate/severe disease, possibly plus additional antihistamine or antileukotriene.", {"entities": []}], ["The concept of rhinitis control is emerging, but there is no universally accepted definition.", {"entities": [[15, 23, "DISEASE"]]}], ["Where pharmacotherapy fails, allergen-specific immunotherapy, which is uniquely able to alter long-term disease outcomes, should be considered.", {"entities": []}], ["The subcutaneous form (subcutaneous immunotherapy) in children has been underused because of concerns regarding safety and acceptability of injections.", {"entities": []}], ["Sublingual immunotherapy is both efficacious and safe for grass pollen allergy.", {"entities": []}], ["Further studies on other allergens in children are needed.", {"entities": []}], ["Patient, carer and practitioner education into AR and its treatment are a vital part of management.", {"entities": []}], ["Respiratory syncytial virus (RSV) is an important cause of serious lower respiratory tract disease in infants.", {"entities": [[67, 98, "DISEASE"]]}], ["Several studies have shown evidence pointing to the genome of the host as an important factor determining susceptibility to respiratory disease caused by RSV.", {"entities": []}], ["We sequenced the complete exomes of 54 patients infected by RSV that needed hospitalization due to development of severe bronchiolitis.", {"entities": [[121, 134, "DISEASE"]]}], ["The Iberian sample (IBS) from The 1000 Genomes Project (1000G) was used as control group; all the association results were pseudo-replicated using other 1000G-European controls and Spanish controls.", {"entities": []}], ["The study points to SNP rs199665292 in the olfactory receptor (OR) gene OR13C5 as the best candidate variant ( P -value\u2009=\u20091.16\u2009\u00d7\u200910 HLA-DQA1 , HLA-DPB1 ), and in the mucin 4 gene ( MUC4 ) also emerge as susceptibility candidates.", {"entities": [[132, 140, "GENE"], [143, 151, "GENE"], [181, 185, "GENE"]]}], ["By collapsing rare variants in genes and weighing by pathogenicity, we obtained confirmatory signals of association in the OR gene OR8U1 / OR8U8 , the taste receptor TAS2R19 , and another mucin gene ( MUC6 ).", {"entities": [[131, 136, "GENE"], [201, 205, "GENE"]]}], ["Overall, we identified new predisposition variants and genes related to RSV infection.", {"entities": []}], ["Of special interest is the association of RSV to olfactory and taste receptors; this finding is in line with recent evidence pointing to their role in viral infectious diseases.", {"entities": []}], ["Despite research efforts, cell uptake processes determining siRNA silencing efficiency remain unclear.", {"entities": []}], ["Here, we examine the relationship between in\u00a0vitro cell culture models, cellular trafficking and siRNA silencing efficiency to provide a mechanistic insight on siRNA delivery system design.", {"entities": []}], ["Model siRNA-polyplexes, based on chitosan as a \u2018classical\u2019 condensing agent, were applied to a panel of lung epithelial cell lines, H1299, A549 and Calu-3 and cell internalization levels, trafficking pathways and gene silencing assessed on exposure to pharmacological inhibitors.", {"entities": []}], ["The data reveal striking differences in the internalization behaviour and gene silencing efficiency in the tested cell lines, despite their common lung epithelial origins.", {"entities": []}], ["The model system\u2019s silencing was lower where clathrin internalization pathway predominated in Calu-3, relative to silencing in H1299\u00a0cells where a non-clathrin internalization appears dominant.", {"entities": []}], ["Increased silencing on endosomal disruption was apparent in Calu-3\u00a0cells, but absent when cellular internalization was not predominantly clathrin-mediated in A549\u00a0cells.", {"entities": []}], ["This highlights that identifying cell trafficking pathways before incorporation of functional components to siRNA delivery systems (e.g.", {"entities": []}], ["endosomolytic compounds) is crucial.", {"entities": []}], ["The study hence stresses the importance of selection of appropriate cell culture model, relevant to in\u00a0vivo target, to assess the gene silencing efficiency and decide which functionalities the \u2018stratified siRNA silencing vector\u2019 requires.", {"entities": []}], ["\u2022 Relationship between cell type, uptake path and silencing examined to inform siRNA vector design.", {"entities": []}], ["\u2022 Notable differences observed in cell uptake pathways and silencing despite cells\u2019 common origin.", {"entities": []}], ["\u2022 Addition of endosomolytic functionality shows no effect when non-clathrin pathways dominate.", {"entities": []}], ["\u2022 Cell model important to assess silencing and decide which functionalities siRNA vector requires.", {"entities": []}], ["Relationship between cell type, uptake path and silencing examined to inform siRNA vector design.", {"entities": []}], ["Notable differences observed in cell uptake pathways and silencing despite cells\u2019 common origin.", {"entities": []}], ["Addition of endosomolytic functionality shows no effect when non-clathrin pathways dominate.", {"entities": []}], ["Cell model important to assess silencing and decide which functionalities siRNA vector requires.", {"entities": []}], ["Patients with more severe chronic obstructive pulmonary disease frequently experience exacerbations and it is estimated that up to 50% of these exacerbations are associated with bacterial infections.", {"entities": [[26, 63, "DISEASE"]]}], ["The mainstay treatment for these infection-related exacerbations constitutes the administration of glucocorticoids, alone or in combination with antibiotics.", {"entities": []}], ["A recent line of evidence demonstrates that many hormones including the steroid beclomethasone can also directly affect bacterial growth, virulence, and antibiotic resistance.", {"entities": []}], ["The effect of these regimens on the release of potentially virulent and toxic membrane vesicles (MVs) is at present unclear.", {"entities": []}], ["In this study, we determined the effect of several pharmacological agents on\u00a0MVs release by and bacterial growth of common respiratory pathogens.", {"entities": []}], ["We found that neither the release of MVs nor the bacterial growth was affected by the glucocorticoids budesonide and fluticasone.", {"entities": []}], ["The macrolide antibiotic azithromycin only inhibited the growth of Moraxella catarrhalis but no effects were observed on bacterial MV release at a concentration that is achieved locally in the epithelial lining on administration.", {"entities": []}], ["The macrophage pro-inflammatory response to MVs was significantly reduced after treatment with budesonide and fluticasone but not by azithromycin treatment.", {"entities": []}], ["Our findings suggest that these glucocorticoids may have a positive effect on infection-related inflammation although the bacterial growth and MV release remained unaffected.", {"entities": []}], ["Silica nanoparticles (SNPs) are widely used in many scientific and industrial fields despite the lack of proper evaluation of their potential toxicity.", {"entities": []}], ["This study examined the effects of acute exposure to SNPs, either alone or in conjunction with ovalbumin (OVA), by studying the respiratory systems in exposed mouse models.", {"entities": []}], ["Three types of SNPs were used: spherical SNPs (S-SNPs), mesoporous SNPs (M-SNPs), and PEGylated SNPs (P-SNPs).", {"entities": []}], ["In the acute SNP exposure model performed, 6-week-old BALB/c female mice were intranasally inoculated with SNPs for 3 consecutive days.", {"entities": []}], ["In the OVA/SNPs asthma model, the mice were sensitized two times via the peritoneal route with OVA.", {"entities": [[16, 22, "DISEASE"]]}], ["Additionally, the mice endured OVA with or without SNP challenges intranasally.", {"entities": []}], ["Acute SNP exposure induced significant airway inflammation and airway hyper-responsiveness, particularly in the S-SNP group.", {"entities": []}], ["In OVA/SNPs asthma models, OVA with SNP-treated group showed significant airway inflammation, more than those treated with only OVA and without SNPs.", {"entities": [[12, 18, "DISEASE"]]}], ["In these models, the P-SNP group induced lower levels of inflammation on airways than both the S-SNP or M-SNP groups.", {"entities": []}], ["Interleukin (IL)-5, IL-13, IL-1\u03b2 and interferon-\u03b3 levels correlated with airway inflammation in the tested models, without statistical significance.", {"entities": []}], ["In the mouse models studied, increased airway inflammation was associated with acute SNPs exposure, whether exposed solely to SNPs or SNPs in conjunction with OVA.", {"entities": []}], ["P-SNPs appear to be relatively safer for clinical use than S-SNPs and M-SNPs, as determined by lower observed toxicity and airway system inflammation.", {"entities": []}], ["Mast cell (MC)-derived serine proteases have been implicated in a variety of inflammatory processes.", {"entities": []}], ["We have previously shown that rat peritoneal MC (PMC) express mRNA for protease activated receptor 2 (PAR-2), a G-coupled receptor activated by trypsin-like proteases.", {"entities": []}], ["Recent evidence also suggests that MC-induced inflammation can be mediated through PAR.", {"entities": []}], ["Therefore, we hypothesized that specific PAR-2 agonist peptides (PAR-2ap) induce protease release from PMC.", {"entities": []}], ["Western blot analysis of PMC supernatants revealed that a PAR-2ap, tc-LIGRLO (10 \u03bcM), stimulated the release of rat MC protease (RMCP)-1, RMCP-5 and carboxypeptidase-A.", {"entities": []}], ["The release was evident by 20 min but further increased up to 8 h. To study the biological effects of protease release we tested supernatants from tc-LIGRLO, tc-OLRGIL (inactive control peptide) and antigen-activated PMC for proteolytic activity by seeding with TNF (150 pg/ml), incubating for 8 h at 37\u00b0C, and measuring TNF remaining in the supernatants.", {"entities": [[262, 265, "GENE"], [321, 324, "GENE"], [262, 265, "GENE"], [321, 324, "GENE"]]}], ["Supernatants from tc-LIGRLO-stimulated PMC degraded 44 % of seeded TNF (n = 5).", {"entities": [[67, 70, "GENE"]]}], ["Moreover, this TNF proteolysis was dependent on the concentration of tc-LIGRLO used to stimulate PMC, and was significantly inhibited (94 %) by soybean trypsin inhibitor.", {"entities": [[15, 18, "GENE"]]}], ["Antigen and tc-OLRGIL induced no significant release of such proteolytic activity.", {"entities": []}], ["These data indicate that a PAR-2ap induces the release of proteases from mast cells, which may degrade extracellular cytokines and other substrates thus modulating the inflammatory response.", {"entities": []}], ["Maternal immune activation can induce neuropsychiatric disorders, such as autism and schizophrenia.", {"entities": [[85, 98, "DISEASE"]]}], ["Previous investigations by our group have shown that prenatal treatment of rats on gestation day 9.5 with lipopolysaccharide (LPS; 100 \u03bcg/kg, intraperitoneally), which mimics infections by gram-negative bacteria, induced autism-like behavior in male rats, including impaired communication and socialization and induced repetitive/restricted behavior.", {"entities": []}], ["However, the behavior of female rats was unchanged.", {"entities": []}], ["Little is known about how LPS-induced changes in the pregnant dam subsequently affect the developing fetus and the fetal immune system.", {"entities": []}], ["The present study evaluated the hypothalamic-pituitary-adrenal (HPA) axis activity, the placental tissue and the reproductive performance of pregnant Wistar rats exposed to LPS.", {"entities": []}], ["In the adult offspring, we evaluated the HPA axis and pro-inflammatory cytokine levels with or without a LPS challenge.", {"entities": []}], ["LPS exposure increased maternal serum corticosterone levels, injured placental tissue and led to higher post-implantation loss, resulting in fewer live fetuses.", {"entities": []}], ["The HPA axis was not affected in adult offspring.", {"entities": []}], ["However, prenatal LPS exposure increased IL-1\u03b2 serum levels, revealing that prenatal LPS exposure modified the immune response to a LPS challenge in adulthood.", {"entities": []}], ["Increased IL-1\u03b2 levels have been reported in several autistic patients.", {"entities": []}], ["Together with our previous studies, our model induced autistic-like behavioral and immune disturbances in childhood and adulthood, indicating that it is a robust rat model of autism.", {"entities": []}], ["A novel sandwich ELISA for the quantitative and sensitive determination of IL-13 in human serum and plasma was established.", {"entities": []}], ["The assay employs an incubation step at acidic pH, which was shown to decrease nonspecific binding and interference from IL-13 binding proteins.", {"entities": []}], ["The assay was validated and was shown to be accurate and precise over the entire quantification range (0.59 to 68.4\u2009pg/mL in human EDTA plasma).", {"entities": []}], ["The validated assay was successfully applied to samples from healthy volunteers and patients with atopic seasonal rhinitis.", {"entities": [[114, 122, "DISEASE"]]}], ["The assay is suitable for use in clinical trials to monitor efficacy or pharmacodynamic effects of drug candidates.", {"entities": []}], ["While global momentum supporting mobile health (mHealth) research and development is increasing, it is imperative to assess the potential fit of mHealth programs in local settings.", {"entities": []}], ["We describe the penetration of mobile technologies among Bolivian patients with noncommunicable diseases (NCDs) to inform research on mHealth interventions for the Andean region as well as low- and middle-income countries more generally.", {"entities": []}], ["Five-hundred and fifty-nine NCD patients were identified from outpatient clinics affiliated with four hospitals in the cities of La Paz and El Alto.", {"entities": []}], ["Respondents completed surveys about their use of standard mobile phones and smartphones.", {"entities": []}], ["Respondents also provided information about their sociodemographic characteristics, health status, and access to care.", {"entities": []}], ["We used descriptive statistics and logistic regression to understand the variation in mobile phone use across groups defined by patient characteristics associated with health service access and socioeconomic vulnerability.", {"entities": []}], ["Respondents were on average 52 years of age, 33\u00a0% had at most a sixth grade education, and 30\u00a0% spoke an indigenous language in their home.", {"entities": []}], ["Eighty-six percent owned a mobile phone and 13\u00a0% owned a smartphone.", {"entities": []}], ["Fifty-eight percent of mobile phone users sent or received a text message at least once a week.", {"entities": []}], ["Some mobile phone owners reported connectivity problems, such as lacking mobile signal (9\u00a0%) or credit to make a call (17\u00a0%).", {"entities": []}], ["Younger age, male gender, high health literacy, more years of education, and having fewer previously diagnosed NCDs were positively related to mobile phone ownership.", {"entities": []}], ["Among mobile phone users, respondents with lower education and other indicators of vulnerability were less likely than their counterparts to report frequent usage of texting services.", {"entities": []}], ["Mobile phones have high penetration among NCD patients in La Paz, Bolivia, including among those who are older, less educated, and who have other socioeconomic risk factors.", {"entities": []}], ["Smartphone use is still relatively uncommon, even among patients who are younger and more educated.", {"entities": []}], ["While certain patient characteristics such as age or education impact patients\u2019 use of text messaging, mobile phone-based mHealth interventions are feasible strategies for increasing NCD patients\u2019 access to self-management support between face-to-face clinical encounters.", {"entities": []}], ["The commensal microbiota is in constant interaction with the immune system, teaching immune cells to respond to antigens.", {"entities": []}], ["Studies in mice have demonstrated that manipulation of the intestinal microbiota alters host immune cell homeostasis.", {"entities": []}], ["Additionally, metagenomic-sequencing analysis has revealed alterations in intestinal microbiota in patients suffering from inflammatory bowel disease, asthma, and obesity.", {"entities": [[123, 149, "DISEASE"], [163, 170, "DISEASE"], [151, 157, "DISEASE"]]}], ["Perturbations in the microbiota composition result in a deficient immune response and impaired tolerance to commensal microorganisms.", {"entities": []}], ["Due to altered microbiota composition which is associated to some inflammatory diseases, several strategies, such as the administration of probiotics, diet, and antibiotic usage, have been utilized to prevent or ameliorate chronic inflammatory diseases.", {"entities": []}], ["The purpose of this review is to present and discuss recent evidence showing that the gut microbiota controls immune system function and onset, development, and resolution of some common inflammatory diseases.", {"entities": []}], ["Our present study investigated whether the ventilatory and gas exchange responses show different dynamics in response to sinusoidal change in cycle work rate or walking speed even if the metabolic demand was equivalent in both types of exercise.", {"entities": []}], ["Locomotive parameters (stride length and step frequency), breath-by-breath ventilation ( V\u0307 E ) and gas exchange (CO 2 output ( V\u0307 CO 2 ) and O 2 uptake ( V\u0307 O 2 )) responses were measured in 10 healthy young participants.", {"entities": []}], ["The speed of the treadmill was sinusoidally changed between 3 km\u00b7h V\u0307 E decreased sharply whereas the phase shift of V\u0307 E increased.", {"entities": []}], ["In comparing walking and cycling at the equivalent metabolic demand, the amplitude of V\u0307 E during sinusoidal walking (SW) was significantly greater than that during sinusoidal cycling (SC), and the phase shift became smaller.", {"entities": []}], ["The steeper slope of linear regression for the V\u0307 E amplitude ratio to V\u0307 CO 2 amplitude ratio was observed during SW than SC.", {"entities": []}], ["These findings suggested that the greater amplitude and smaller phase shift of ventilatory dynamics were not equivalent between SW and SC even if the metabolic demand was equivalent between both exercises.", {"entities": []}], ["Such phenomenon would be derived from central command in proportion to locomotor muscle recruitment (feedforward) and muscle afferent feedback.", {"entities": []}], ["Health state utilities measured by the major multi-attribute utility instruments differ.", {"entities": []}], ["Understanding the reasons for this is important for the choice of instrument and for research designed to reconcile these differences.", {"entities": []}], ["This paper investigates these reasons by explaining pairwise differences between utilities derived from six multi-attribute utility instruments in terms of (1) their implicit measurement scales; (2) the structure of their descriptive systems; and (3) \u2018micro-utility effects\u2019, scale-adjusted differences attributable to their utility formula.", {"entities": []}], ["The EQ-5D-5L, SF-6D, HUI 3, 15D and AQoL-8D were administered to 8,019 individuals.", {"entities": []}], ["Utilities and unweighted values were calculated using each instrument.", {"entities": []}], ["Scale effects were determined by the linear relationship between utilities, the effect of the descriptive system by comparison of scale-adjusted values and \u2018micro-utility effects\u2019 by the unexplained difference between utilities and values.", {"entities": []}], ["Overall, 66\u00a0% of the differences between utilities was attributable to the descriptive systems, 30.3\u00a0% to scale effects and 3.7\u00a0% to micro-utility effects.", {"entities": []}], ["Results imply that the revision of utility algorithms will not reconcile differences between instruments.", {"entities": []}], ["The dominating importance of the descriptive system highlights the need for researchers to select the instrument most capable of describing the health states relevant for a study.", {"entities": []}], ["Reconciliation of inconsistent utilities produced by different instruments must focus primarily upon the content of the descriptive system.", {"entities": []}], ["Utility weights primarily determine the measurement scale.", {"entities": []}], ["Other differences, attributable to utility formula, are comparatively unimportant.", {"entities": []}], ["Proteomics changes of brain tissues have been described in different neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.", {"entities": []}], ["However, the brain proteomics of human prion disease remains less understood.", {"entities": [[39, 52, "DISEASE"]]}], ["In the study, the proteomics patterns of cortex and cerebellum of brain tissues of sporadic Creutzfeldt-Jakob disease, fatal familial insomnia, and G114V genetic CJD were analyzed with isobaric tags for relative and absolute quantitation combined with multidimensional liquid chromatography and MS analysis, with the brains from three normal individuals as controls.", {"entities": [[119, 142, "DISEASE"]]}], ["Global protein profiling, significant pathway, and functional categories were analyzed.", {"entities": []}], ["In total, 2287 proteins were identified with quantitative information both in cortex and cerebellum regions.", {"entities": []}], ["Cerebellum tissues appeared to contain more up- and down-regulated proteins (727 proteins) than cortex regions (312 proteins) of Creutzfeldt-Jakob disease, fatal familial insomnia, and G114V genetic CJD.", {"entities": [[156, 179, "DISEASE"]]}], ["Viral myocarditis, Parkinson's disease, Alzheimer's disease, lysosome, oxidative phosphorylation, protein export, and drug metabolism-cytochrome P450 were the most commonly affected pathways of the three kinds of diseases.", {"entities": [[6, 17, "DISEASE"]]}], ["Almost coincident biological functions were identified in the brain tissues of the three diseases.", {"entities": []}], ["In all, data here demonstrate that the brain tissues of Creutzfeldt-Jakob disease, fatal familial insomnia, and G114V genetic CJD have obvious proteomics changes at their terminal stages, which show the similarities not only among human prion diseases but also with other neurodegeneration diseases.", {"entities": [[83, 106, "DISEASE"]]}], ["This is the first study to provide a reference proteome map for human prion diseases and will be helpful for future studies focused on potential biomarkers for the diagnosis and therapy of human prion diseases.", {"entities": []}], ["Traditional herbal cures and remedies have played an important historical role in the treatment of a variety of illnesses and diseases in Northern Ireland for the last three hundred years.", {"entities": []}], ["Recently, these have been reviewed in the publication by Linda Ballard from the Ulster Folk and Transport Museum at Cultra, Co. Down, which details the variety of local plants used and for what purpose.", {"entities": []}], ["From this publication and another related publication, we note the description of several plant species that consistently appear in traditional cures and remedies, particularly used to treat infections and infectious diseases.", {"entities": []}], ["Unfortunately, although these plants have strong associations with the local historical evidence base, there are very limited and mainly no formal publications in the medical/scientific evidence base, examining their scientific background and clinical efficacy.", {"entities": []}], ["The precise mechanisms leading to development of T helper type (Th)2-driven allergic responses are unknown.", {"entities": []}], ["We aimed to determine how IL-4 receptor alpha (IL-4R\u03b1) signaling on CD11c", {"entities": []}], ["Type 1 diabetes mellitus (T1DM) is an autoimmune disease, where destruction of beta-cells causes insulin deficiency.", {"entities": [[7, 24, "DISEASE"]]}], ["The incidence of T1DM has increased in the last decades and cannot entirely be explained by genetic predisposition.", {"entities": []}], ["Several environmental factors are suggested to promote T1DM, like early childhood enteroviral infections and nutritional factors, but the evidence is inconclusive.", {"entities": []}], ["Prenatal and early life exposure to environmental pollutants like phthalates, bisphenol A, perfluorinated compounds, PCBs, dioxins, toxicants, and air pollutants can have negative effects on the developing immune system, resulting in asthma-like symptoms and increased susceptibility to childhood infections.", {"entities": [[234, 240, "DISEASE"]]}], ["In this review the associations between environmental chemical exposure and T1DM development is summarized.", {"entities": []}], ["Although information on environmental chemicals as possible triggers for T1DM is sparse, we conclude that it is plausible that environmental chemicals can contribute to T1DM development via impaired pancreatic beta-cell and immune-cell functions and immunomodulation.", {"entities": []}], ["Several environmental factors and chemicals could act together to trigger T1DM development in genetically susceptible individuals, possibly via hormonal or epigenetic alterations.", {"entities": []}], ["Further observational T1DM cohort studies and animal exposure experiments are encouraged.", {"entities": []}], ["S100A7 is an antimicrobial peptide involved in several inflammatory diseases.", {"entities": [[0, 6, "GENE"]]}], ["The aim of the present study was to explore the expression and regulation of S100A7 in seasonal allergic rhinitis (SAR).", {"entities": [[96, 113, "DISEASE"], [105, 113, "DISEASE"], [77, 83, "GENE"]]}], ["Nasal lavage (NAL) fluid was obtained from healthy controls before and after lipopolysaccharide (LPS) provocation, from SAR patients before and after allergen challenge, and from SAR patients having completed allergen-specific immunotherapy (ASIT).", {"entities": []}], ["Nasal biopsies, nasal epithelial cells and blood were acquired from healthy donors.", {"entities": []}], ["The airway epithelial cell line FaDu was used for in vitro experiments.", {"entities": []}], ["Real-time RT-PCR and immunohistochemistry were used to determine S100A7 expression in nasal tissue and cells.", {"entities": [[65, 71, "GENE"]]}], ["Release of S100A7 in NAL and culture supernatants was measured by ELISA.", {"entities": [[11, 17, "GENE"]]}], ["The function of recombinant S100A7 was explored in epithelial cells, neutrophils and peripheral blood mononuclear cells (PBMC).", {"entities": [[28, 34, "GENE"]]}], ["Nasal administration of LPS induced S100A7 release in healthy non-allergic subjects.", {"entities": [[36, 42, "GENE"]]}], ["The level of S100A7 was lower in NAL from SAR patients than from healthy controls, and it was further reduced in the SAR group 6 h post allergen provocation.", {"entities": [[13, 19, "GENE"]]}], ["In contrast, ASIT patients displayed higher levels after completed treatment.", {"entities": []}], ["S100A7 was expressed in the nasal epithelium and in glands, and it was secreted by cultured epithelial cells.", {"entities": [[0, 6, "GENE"]]}], ["Stimulation with IL-4 and histamine repressed the epithelial S100A7 release.", {"entities": [[61, 67, "GENE"]]}], ["Further, recombinant S100A7 induced activation of neutrophils and PBMC.", {"entities": [[21, 27, "GENE"]]}], ["The present study shows an epithelial expression and excretion of S100A7 in the nose after microbial stimulation.", {"entities": [[66, 72, "GENE"]]}], ["The levels are diminished in rhinitis patients and in the presence of an allergic cytokine milieu, suggesting that the antimicrobial defense is compromised in patients with SAR.", {"entities": [[29, 37, "DISEASE"]]}], ["It has been demonstrated that spider mites such as the two-spotted spider mite ( Tetranychus urticae ) are important allergens for fruit farmers.", {"entities": []}], ["A total of 2,467 adults (795 metropolitan urban, 788 non-metropolitan urban, and 884 rural subjects) were enrolled.", {"entities": []}], ["They responded to the questionnaire, and underwent methacholine bronchial provocation tests as well as skin prick tests to locally common aeroallergens including the two-spotted spider mite.", {"entities": []}], ["The prevalences of asthma and rhinitis as reported on the questionnaire were 7.8% and 16.4% of adults aged 20-35, 9.4% and 24.7% of those 36-50, and 17.7% and 21.7% of those older than 50, respectively.", {"entities": [[30, 38, "DISEASE"], [19, 25, "DISEASE"]]}], ["Among the older group, the two-spotted spider mite was the most common sensitizing allergen, although it was second of that of house dust mites among the other two age groups.", {"entities": []}], ["Sensitization to the two-spotted spider mite was significantly associated with the prevalence of asthma and rhinitis among the younger age group, and associated with the prevalence of rhinitis among the older age group.", {"entities": [[108, 116, "DISEASE"], [184, 192, "DISEASE"], [97, 103, "DISEASE"]]}], ["The two-spotted spider mite might be a common sensitizing allergen in the general population of adults, and sensitization to this mite may play a role in the manifestation of asthma and rhinitis symptoms during adulthood.", {"entities": [[186, 194, "DISEASE"], [175, 181, "DISEASE"]]}], ["In airway epithelium, mucociliary clearance (MCC) velocity depends on the ciliary beat frequency (CBF), and it is affected by mucus viscoelastic properties.", {"entities": [[45, 48, "GENE"]]}], ["Local inflammation induces secretion of cytokines (TNF \u03b1 ) that can alter mucus viscosity; however airway ciliated cells have an autoregulatory mechanism to prevent the collapse of CBF in response to increase in mucus viscosity, mechanism that is associated with an increment in intracellular Ca i ).", {"entities": [[51, 54, "GENE"]]}], ["We studied the effect of TNF \u03b1 on the autoregulatory mechanism that regulates CBF in response to increased viscosity using dextran solutions, in ciliated cells cultured from human pediatric epithelial adenoid tissue.", {"entities": [[25, 28, "GENE"]]}], ["Cultures were treated with TNF \u03b1 , before and after the viscous load was changed.", {"entities": [[27, 30, "GENE"]]}], ["TNF \u03b1 treatment produced a significantly larger decrease in CBF in cultures exposed to dextran.", {"entities": [[0, 3, "GENE"]]}], ["Furthermore, an increment in [Ca i was observed, which was significantly larger after TNF \u03b1 treatment.", {"entities": [[86, 89, "GENE"]]}], ["In conclusion, although TNF \u03b1 has deleterious effects on ciliated cells in response to maintaining CBF after increasing viscous loading, it has a positive effect, since increasing [Ca i may prevent the MCC collapse.", {"entities": [[24, 27, "GENE"], [202, 205, "GENE"]]}], ["These findings suggest that augmented levels of TNF \u03b1 associated with an inflammatory response of the nasopharyngeal epithelium may have dual effects that contribute to maintaining the effectiveness of MCC in the upper airways.", {"entities": [[48, 51, "GENE"], [202, 205, "GENE"]]}], ["Pollutants originating from the destruction of the World Trade Center (WTC) in New York City on 11 September 2001 have been reported to cause adverse respiratory responses in rescue workers and nearby residents.", {"entities": []}], ["We examined whether WTC-derived fine particulate matter [particulate matter with a mass median aerodynamic diameter < 2.5 microm (PM2.5)] has detrimental respiratory effects in mice to contribute to the risk assessment of WTC-derived pollutants.", {"entities": []}], ["Samples of WTC PM2.5 were derived from settled dust collected at several locations around Ground Zero on 12 and 13 September 2001.", {"entities": []}], ["Aspirated samples of WTC PM2.5 induced mild to moderate degrees of pulmonary inflammation 1 day after exposure but only at a relatively high dose (100 microg).", {"entities": []}], ["This response was not as great as that caused by 100 microg PM2.5 derived from residual oil fly ash (ROFA) or Washington, DC, ambient air PM [National Institute of Standards and Technology, Standard Reference Material (SRM) 1649a].", {"entities": [[219, 222, "GENE"]]}], ["However, this same dose of WTC PM2.5 caused airway hyperresponsiveness to methacholine aerosol comparable to that from SRM 1649a and to a greater degree than that from ROFA.", {"entities": [[119, 122, "GENE"]]}], ["Mice exposed to lower doses by aspiration or inhalation exposure did not develop significant inflammation or hyperresponsiveness.", {"entities": []}], ["These results show that exposure to high levels of WTC PM2.5 can promote mechanisms of airflow obstruction in mice.", {"entities": []}], ["Airborne concentrations of WTC PM2.5 that would cause comparable doses in people are high (approximately 425 microg/m3 for 8 hr) but conceivable in the aftermath of the collapse of the towers when rescue and salvage efforts were in effect.", {"entities": [[125, 127, "GENE"]]}], ["We conclude that a high-level exposure to WTC PM2.5 could cause pulmonary inflammation and airway hyperresponsiveness in people.", {"entities": []}], ["The effects of chronic exposures to lower levels of WTC PM2.5, the persistence of any respiratory effects, and the effects of coarser WTC PM are unknown and were not examined in these studies.", {"entities": []}], ["Degree of exposure and respiratory protection, individual differences in sensitivity to WTC PM2.5, and species differences in responses must be considered in assessing the risks of exposure to WTC PM2.5.", {"entities": []}], ["Live attenuated influenza vaccine (LAIV) has demonstrated varying levels of efficacy against seasonal influenza; however, LAIV may be used as a tool to measure interactions between the human microbiome and a live, replicating virus.", {"entities": [[16, 25, "DISEASE"], [102, 111, "DISEASE"]]}], ["To increase our knowledge of this interaction, we measured changes to the nasal microbiome in subjects who received LAIV to determine if associations between influenza-specific IgA production and the nasal microbiome exist after immunization with a live virus vaccine.", {"entities": [[158, 167, "DISEASE"]]}], ["The anterior nares of 47 healthy subjects were swabbed pre- (Day 0) and post- (Days 7 and 28) LAIV administration, and nasal washes were conducted on Days 0 and 28.", {"entities": []}], ["We performed next-generation sequencing on amplified 16s rRNA genes and measured mucosal influenza-specific IgA titers via enzyme-linked immunosorbent assay (ELISA).", {"entities": [[89, 98, "DISEASE"]]}], ["A significant increase in alpha diversity was identified (Observed, CHAO, and ACE) between Days 7 vs 0 (p-values = 0.017, 0.005, 0.005, respectively) and between Days 28 vs 0 (p-values = 0.054, 0.030, 0.050, respectively).", {"entities": []}], ["Several significant associations between the presence of different microbial species, including Lactobacillus helveticus , Prevotella melaninogenica , Streptococcus infantis , Veillonella dispar , and Bacteroides ovatus , and influenza-specific H1 and H3 IgA antibody response were demonstrated.", {"entities": [[226, 235, "DISEASE"]]}], ["These data suggest that LAIV alters the nasal microbiome, allowing several less-abundant OTUs to establish a community niche.", {"entities": []}], ["Additionally, specific alterations in the nasal microbiome are significantly associated with variations in influenza-specific IgA antibody production and could be clinically relevant.", {"entities": [[107, 116, "DISEASE"]]}], ["Increasing clinical epidemiological and experimental evidence indicates that excess of production of reactive oxygen free radicals (ROS) induced by an oxidative stress is involved in the pathogenesis of a number of human airway disorders, as well as equine recurrent airway obstruction.", {"entities": []}], ["Free-radicals modulate the activation of transcription factors, such as nuclear factor-(NF)-\u03baB and activator protein (AP)-1, in several different cells.", {"entities": []}], ["This activation leads to expression of many pro-inflammatory cytokines, including interleukin (IL)-1\u03b2.", {"entities": []}], ["We have hypothesized that equine airway sensitization might induce an oxidative stress and increase the ROS production, which in turn might enhance a production of IL-1\u03b2 and airway hyperresponsiveness.", {"entities": []}], ["We have examined the effect of passive sensitization on IL-1\u03b2 mRNA expression and electrical field stimulation (EFS)-induced contraction in equine isolated bronchi, and the potential interference of reduced-glutathione (GSH), an antioxidant, with these responses.", {"entities": [[112, 115, "GENE"]]}], ["Bronchi passively sensitized with serum from animals suffering from heaves and having high total level of IgE, and control tissues, either pretreated or not with GSH (100 \u03bcM), were used to quantify IL-1\u03b2 mRNA.", {"entities": []}], ["Other tissues were used to study the effect of EFS (3\u201310\u201325 Hz).", {"entities": [[47, 50, "GENE"]]}], ["Mean IL-1\u03b2 mRNA expression was higher in passively sensitized than in control rings.", {"entities": []}], ["GSH significantly ( p < 0.05) reduced the IL-1\u03b2 mRNA expression only in passively sensitized bronchi.", {"entities": []}], ["ELF induced a frequency-dependent contraction in both non-sensitized and passively sensitized tissues, with a significantly greater response always observed in sensitized tissues.", {"entities": []}], ["GSH did not modify the EFS-induced contraction in non-sensitized bronchi, but significantly ( p < 0.05) decreased it in passively sensitized tissues.", {"entities": []}], ["Our data indicate that the passive sensitization of equine bronchi induces inflammation and hyperresponsiveness.", {"entities": []}], ["These effects might be due to an oxidative stress because a pretreatment with GSH decreased the increased IL-1\u03b2 mRNA expression and responsiveness to EFS of passively sensitized bronchi.", {"entities": [[150, 153, "GENE"]]}], ["Despite past improvements in air quality, very large parts of the population in urban areas breathe air that does not meet European standards let alone the health-based World Health Organisation Air Quality Guidelines.", {"entities": []}], ["Over the last 10\u00a0years, there has been a substantial increase in findings that particulate matter (PM) air pollution is not only exerting a greater impact on established health endpoints, but is also associated with a broader number of disease outcomes.", {"entities": []}], ["Data strongly suggest that effects have no threshold within the studied range of ambient concentrations, can occur at levels close to PM 2.5 background concentrations and that they follow a mostly linear concentration\u2013response function.", {"entities": []}], ["Having firmly established this significant public health problem, there has been an enormous effort to identify what it is in ambient PM that affects health and to understand the underlying biological basis of toxicity by identifying mechanistic pathways\u2014information that in turn will inform policy makers how best to legislate for cleaner air.", {"entities": []}], ["Another intervention in moving towards a healthier environment depends upon the achieving the right public attitude and behaviour by the use of optimal air pollution monitoring, forecasting and reporting that exploits increasingly sophisticated information systems.", {"entities": []}], ["Improving air quality is a considerable but not an intractable challenge.", {"entities": []}], ["Translating the correct scientific evidence into bold, realistic and effective policies undisputedly has the potential to reduce air pollution so that it no longer poses a damaging and costly toll on public health.", {"entities": []}], ["Influenza causes considerable morbidity and mortality in China, but its impact on the health-related quality of life (HRQoL) has not been previously measured.", {"entities": [[0, 9, "DISEASE"]]}], ["We conducted a retrospective telephone survey to assess the impact of influenza on the HRQoL among outpatients and inpatients using the EuroQoL EQ-5D-3\u00a0L instrument.", {"entities": [[70, 79, "DISEASE"]]}], ["Participants were individuals with laboratory-confirmed influenza infection registered by the National Influenza-like-illness Surveillance Network in 2013.", {"entities": [[56, 65, "DISEASE"], [103, 112, "DISEASE"]]}], ["We interviewed 839 of 11,098 eligible influenza patients.", {"entities": [[38, 47, "DISEASE"]]}], ["After excluding those who were unable to complete the HRQoL for the registered influenza episode, 778 patients were included in the analysis.", {"entities": [[79, 88, "DISEASE"]]}], ["Both outpatients ( n \u00a0=\u00a0529) and inpatients ( n \u00a0=\u00a0249) most commonly reported problems with pain/discomfort (71.8% of outpatients and 71.9% of inpatients) and anxiety/depression (62.0% of outpatients and 75.1% of inpatients).", {"entities": []}], ["For individual influenza outpatients, the mean health utility was 0.6142 (SD 0.2006), and the average quality adjusted life days (QALD) loss was 1.62 (SD 1.84) days.", {"entities": [[15, 24, "DISEASE"]]}], ["The HRQoL of influenza inpatients was worse (mean health utility 0.5851, SD 0.2197; mean QALD loss 3.51\u00a0days, SD 4.25) than that of outpatients ( p \u00a0<\u00a00.05).", {"entities": [[13, 22, "DISEASE"]]}], ["The presence of underlying medical conditions lowered the HRQoL for both outpatients and inpatients (p\u00a0<\u00a00.05).", {"entities": []}], ["Influenza illness had a substantial impact on HRQoL.", {"entities": [[0, 9, "DISEASE"]]}], ["QALD loss due to an acute influenza episode in younger children was comparable to that due to enterovirus A71-associated hand, foot and mouth disease.", {"entities": [[121, 149, "DISEASE"], [26, 35, "DISEASE"], [136, 149, "DISEASE"]]}], ["Our findings are key inputs into disease burden estimates and cost-effectiveness evaluations of influenza-related interventions in China.", {"entities": [[96, 105, "DISEASE"]]}], ["The online version of this article (10.1186/s12879-017-2801-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["HFE , a major regulator of iron (Fe) homeostasis, has been suggested to be under positive selection in both European and Asian populations.", {"entities": [[0, 3, "GENE"]]}], ["While the genetic variant under selection in Europeans (a non-synonymous mutation, C282Y) has been relatively well-studied, the adaptive variant in Asians and its functional consequences are still unknown.", {"entities": []}], ["Identifying the adaptive HFE variants in Asians will not only elucidate the evolutionary history and the genetic basis of population difference in Fe status, but also assist the future practice of genome-informed dietary recommendation.", {"entities": [[25, 28, "GENE"]]}], ["Using data from the International HapMap Project, we confirmed the signatures of positive selection on HFE in Asian populations and identified a candidate adaptive haplotype that is common in Asians (52.35\u201354.71\u00a0%) but rare in Europeans (5.98\u00a0%) and Africans (4.35\u00a0%).", {"entities": [[103, 106, "GENE"]]}], ["The T allele at tag SNP rs9366637 (C/T) captured 95.8\u00a0% of this Asian-common haplotype.", {"entities": []}], ["A significantly reduced HFE expression was observed in individuals carrying T/T at rs9366637 compared to C/C and C/T, indicating a possible role of gene regulation in adaptation.", {"entities": [[24, 27, "GENE"]]}], ["We recruited 57 women of Asian descent and measured Fe absorption using stable isotopes in those homozygous at rs9366637.", {"entities": []}], ["We observed a 22\u00a0% higher absorption in women homozygous for the Asian-common haplotype (T/T) compared to the control genotype (C/C).", {"entities": []}], ["Additionally, compared with a group of age-matched Caucasian women, Asian women exhibited significantly elevated Fe absorption.", {"entities": []}], ["Our results indicate parallel adaptation of HFE gene in Europeans and Asians with different genetic variants.", {"entities": [[44, 47, "GENE"]]}], ["Moreover, natural selection on HFE may have contributed to elevated Fe absorption in Asians.", {"entities": [[31, 34, "GENE"]]}], ["This study regarding population differences in Fe homeostasis has significant medical impact as high Fe level has been linked to an increased disease risk of metabolic syndromes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12863-015-0223-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Adverse pregnancy outcomes (APOs) can be increased by preconception risk factors and lifestyles.", {"entities": []}], ["We measured the prevalence of preconception risk factors for APOs in a population of Italian women of childbearing age enrolled in a web-based study.", {"entities": []}], ["Participants were enrolled through a web platform ( http://www.mammainforma.it ).", {"entities": []}], ["After enrollment, participants filled in a questionnaire regarding socio-demographic characteristics, clinical data and preconception risk factors for adverse pregnancy outcomes.", {"entities": []}], ["Through logistic regression, we explored how the prevalence of risk factors was affected by age, education level, employment, parity, physician\u2019s recommendation and knowledge of the specific risk factor.", {"entities": []}], ["We enrolled a total of 728 women.", {"entities": []}], ["Sixty-two percent had a University degree, 84% were employed and 77% were planning their first pregnancy.", {"entities": []}], ["Nearly 70% drank alcohol in any quantity; 16% were smokers; 6% was underweight; 21.4% was overweight; 51.6% did not assume folic acid; 22% was susceptible to rubella, 44.5% to hepatitis b and 13.2% to varicella.", {"entities": [[176, 187, "DISEASE"], [176, 185, "DISEASE"], [158, 165, "DISEASE"]]}], ["According to the multivariate analysis, compared to women who already had at least one pregnancy, nulliparous women had a higher BMI [OR 1.60 (CI 1.02;2.48)] and were less likely to be susceptible to rubella [OR 0.33 (CI 0.20;0.58)] and to be consuming alcohol [OR 0.47 (CI 0.31;0.70)] or cigarettes [OR 0.48 (CI 0.26;0.90)].", {"entities": [[200, 207, "DISEASE"]]}], ["Appropriate knowledge was associated with a correct behavior regarding smoking, drinking alcohol and folic acid supplementation.", {"entities": []}], ["This study shows that the prevalence of risk factors for APOs in our population is high.", {"entities": []}], ["Interventions aimed at reducing risk factors for APOs are needed and, to this purpose, a web intervention may represent a feasible tool to integrate tailored information and to inform preconception counseling targeting a specific group of women planning a pregnancy who are engaged on the web.", {"entities": []}], ["Nuts (tree nuts and peanuts) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds: high-quality vegetable protein, fiber, minerals, tocopherols, phytosterols, and phenolic compounds.", {"entities": []}], ["By virtue of their unique composition, nuts are likely to beneficially impact health outcomes.", {"entities": []}], ["Epidemiologic studies have associated nut consumption with a reduced incidence of coronary heart disease and gallstones in both genders and diabetes in women.", {"entities": [[91, 104, "DISEASE"], [82, 104, "DISEASE"]]}], ["Limited evidence also suggests beneficial effects on hypertension, cancer, and inflammation.", {"entities": [[53, 65, "DISEASE"], [67, 73, "DISEASE"]]}], ["Interventional studies consistently show that nut intake has a cholesterol-lowering effect, even in the context of healthy diets, and there is emerging evidence of beneficial effects on oxidative stress, inflammation, and vascular reactivity.", {"entities": []}], ["Blood pressure, visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption.", {"entities": [[53, 61, "DISEASE"]]}], ["Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors.", {"entities": []}], ["Contrary to expectations, epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss.", {"entities": [[134, 141, "DISEASE"]]}], ["Safety concerns are limited to the infrequent occurrence of nut allergy in children.", {"entities": []}], ["In conclusion, nuts are nutrient rich foods with wide-ranging cardiovascular and metabolic benefits, which can be readily incorporated into healthy diets.", {"entities": []}], ["The pathophysiology of atopic dermatitis (AD) is multifactorial and is a complex interrelationship between skin barrier, genetic predisposition, immunologic development, skin microbiome, environmental, nutritional, pharmacological, and psychological factors.", {"entities": [[23, 40, "DISEASE"], [30, 40, "DISEASE"]]}], ["Several microbial modulations of the intestinal microbiome with pre- and/or probiotics have been used in AD management, with different clinical out-come (both positive, as well as null findings).", {"entities": []}], ["This review provides an overview of the clinical evidence from trials in children from 2008 to 2017, aiming to evaluate the effect of dietary interventions with pre- and/or pro-biotics for the treatment of AD.", {"entities": []}], ["By searching the PUBMED/MEDLINE, EMBADE, and COCHRANE databases 14 clinical studies were selected and included within this review.", {"entities": []}], ["Data extraction was independently conducted by two authors.", {"entities": []}], ["The primary outcome was an improvement in the clinical score of AD severity.", {"entities": []}], ["Changes of serum immunological markers and/or gastrointestinal symptoms were explored if available.", {"entities": []}], ["In these studies some dietary interventions with pre- and/or pro-biotics were beneficial compared to control diets in the management of AD in children, next to treatment with emollients, and/or local corticosteroids.", {"entities": []}], ["However, heterogeneity between studies was high, making it clear that focused clinical randomized controlled trials are needed to understand the potential role and underlying mechanism of dietary interventions in children with AD.", {"entities": []}], ["Apolipoprotein E deficiency (ApoE", {"entities": [[29, 33, "GENE"]]}], ["Theophylline is a natural compound present in tea.", {"entities": []}], ["Because of its property to relax smooth muscle it is used in pharmacology for the treatment of airway diseases (ie, chronic obstructive pulmonary disease, asthma).", {"entities": [[116, 153, "DISEASE"], [155, 161, "DISEASE"]]}], ["However, this effect on smooth muscle is dose dependent and it is related to the development of side effects.", {"entities": []}], ["Recently, an increasing body of evidence suggests that theophylline, at low concentrations, also has anti-inflammatory effects related to the activation of histone deacetylases.", {"entities": []}], ["In this study, we evaluated the effects of theophylline alone and in combination with corticosteroids on human bronchial epithelial cells under inflammatory stimuli.", {"entities": []}], ["Theophylline administrated alone was not able to reduce growth-stimulating signaling via extracellular signal-regulated kinases activation and matrix metalloproteases release, whereas it strongly counteracts this biochemical behavior when administered in the presence of corticosteroids.", {"entities": []}], ["These data provide scientific evidence for supporting the rationale for the pharmacological use of theophylline and corticosteroid combined drug.", {"entities": []}], ["Gastrointestinal problems are common during wars, and they have exerted significant adverse effects on the health of service members involved in warfare.", {"entities": [[44, 48, "GENE"]]}], ["The spectrum of digestive diseases has varied during wars of different eras.", {"entities": [[53, 57, "GENE"], [71, 75, "GENE"]]}], ["At the end of the 20th century, new frontiers of military medical research emerged due to the occurrence of high-tech wars such as the Gulf War and the Kosovo War, in which ground combat was no longer the primary method of field operations.", {"entities": [[118, 122, "GENE"]]}], ["The risk to the military personnel who face trauma has been greatly reduced, but disease and non-battle injuries (DNBIs) such as neuropsychological disorders and digestive diseases seemed to be increased.", {"entities": []}], ["Data revealed that gastrointestinal symptoms such as constipation, diarrhea, dyspepsia, and noncardiac chest pain are common among military personnel during modern wars.", {"entities": [[77, 86, "DISEASE"], [53, 65, "DISEASE"], [67, 75, "DISEASE"], [164, 168, "GENE"]]}], ["In addition, a large number of deployed soldiers and veterans who participated in recent wars presented with chronic gastrointestinal complaints, which fulfilled with the Rome III criteria for functional gastrointestinal disorders (FGIDs).", {"entities": [[89, 93, "GENE"]]}], ["It was also noted that many veterans who returned from the Gulf War suffered not only from chronic digestive symptoms but also from neuropsychological dysfunction; however, they also showed symptoms of other systems.", {"entities": []}], ["Presently, this broad range of unexplained symptoms is known as \u201cGulf War syndrome\u201d.", {"entities": [[74, 82, "DISEASE"]]}], ["The mechanism that underlies Gulf War syndrome remains unclear, but many factors have been associated with this syndrome such as war trauma, stress, infections, immune dysfunction, radiological factors, anthrax vaccination and so on.", {"entities": [[38, 46, "DISEASE"], [112, 120, "DISEASE"]]}], ["Some have questioned if the diagnosis of FGIDs can be reached given the complexity of the military situation.", {"entities": []}], ["As a result, further studies are needed to elucidate the pathogenesis of gastrointestinal disease among military personnel.", {"entities": []}], ["Only about one-third of eligible HIV/AIDS patients receive anti-retroviral treatment (ART).", {"entities": []}], ["Decentralizing treatment is crucial to wider and more equitable access, but key obstacles are a shortage of trained healthcare workers (HCW) and challenges integrating HIV/AIDS care with other primary care.", {"entities": []}], ["This report describes the development of a guideline and training program (PALM PLUS) designed to integrate HIV/AIDS care with other primary care in Malawi.", {"entities": []}], ["PALM PLUS was adapted from PALSA PLUS, developed in South Africa, and targets middle-cadre HCWs (clinical officers, nurses, and medical assistants).", {"entities": []}], ["We adapted it to align with Malawi's national treatment protocols, more varied healthcare workforce, and weaker health system infrastructure.", {"entities": []}], ["The international research team included the developers of the PALSA PLUS program, key Malawi-based team members and personnel from national and district level Ministry of Health (MoH), professional associations, and an international non-governmental organization.", {"entities": []}], ["The PALSA PLUS guideline was extensively revised based on Malawi national disease-specific guidelines.", {"entities": []}], ["Advice and input was sought from local clinical experts, including middle-cadre personnel, as well as Malawi MoH personnel and representatives of Malawian professional associations.", {"entities": []}], ["An integrated guideline adapted to Malawian protocols for adults with respiratory conditions, HIV/AIDS, tuberculosis, and other primary care conditions was developed.", {"entities": [[104, 116, "DISEASE"]]}], ["The training program was adapted to Malawi's health system and district-level supervision structure.", {"entities": []}], ["PALM PLUS is currently being piloted in a cluster-randomized trial in health centers in Malawi (ISRCTN47805230).", {"entities": []}], ["The PALM PLUS guideline and training intervention targets primary care middle-cadre HCWs with the objective of improving HCW satisfaction and retention, and the quality of patient care.", {"entities": []}], ["Successful adaptations are feasible, even across health systems as different as those of South Africa and Malawi.", {"entities": []}], ["The skin provides an important first line of defence and immunological barrier to invasive pathogens, but immune responses must also be regulated to maintain barrier function and ensure tolerance of skin surface commensal organisms.", {"entities": []}], ["In schistosomiasis-endemic regions, populations can experience repeated percutaneous exposure to schistosome larvae, however little is known about how repeated exposure to pathogens affects immune regulation in the skin.", {"entities": [[3, 18, "DISEASE"]]}], ["Here, using a murine model of repeated infection with Schistosoma mansoni larvae, we show that the skin infection site becomes rich in regulatory IL-10, whilst in its absence, inflammation, neutrophil recruitment, and local lymphocyte proliferation is increased.", {"entities": []}], ["Whilst CD4 reg ) cells (i.e.", {"entities": [[7, 10, "GENE"]]}], ["FoxP3, Helios, Nrp1, CD223, or CD49b).", {"entities": [[0, 5, "GENE"], [15, 19, "GENE"]]}], ["Nevertheless, these IL-10 The skin is a major barrier protecting the host from pathogen infection, but is also a site for immune regulation.", {"entities": []}], ["Using a murine model of repeated percutaneous exposure to infectious Schistosoma mansoni cercariae, we show that, in the skin, CD4", {"entities": [[127, 130, "GENE"]]}], ["Childhood asthma in the Caribbean is advancing in prevalence and morbidity.", {"entities": [[10, 16, "DISEASE"]]}], ["Though viral respiratory tract infections are reported triggers for exacerbations, information on these infections with asthma is sparse in Caribbean territories.", {"entities": [[120, 126, "DISEASE"]]}], ["We examined the distribution of respiratory viruses and their association with seasons in acute and stable asthmatic children in Trinidad.", {"entities": []}], ["In a cross-sectional study of 70 wheezing children attending the emergency department for nebulisation and 80 stable control subjects (2 to 16 yr of age) in the asthma clinic, nasal specimens were collected during the dry ( n = 38, January to May) and rainy ( n = 112, June to December) seasons.", {"entities": [[161, 167, "DISEASE"]]}], ["A multitarget, sensitive, specific high-throughput Respiratory MultiCode assay tested for respiratory-virus sequences for eight distinct groups: human rhinovirus, respiratory syncytial virus, parainfluenza virus, influenza virus, metapneumovirus, adenovirus, coronavirus, and enterovirus.", {"entities": [[213, 222, "DISEASE"]]}], ["Wheezing children had a higher [\u03c7 p = 0.018] prevalence of respiratory viruses compared with stabilized asthmatics (34.3% (24) versus (vs.) 17.5% (14)).", {"entities": []}], ["Acute asthmatics were thrice as likely to be infected with a respiratory virus (OR = 2.5, 95% CI = 1.2 \u2013 5.3).", {"entities": []}], ["The predominant pathogens detected in acute versus stable asthmatics were the rhinovirus (RV) ( n = 18, 25.7% vs. n = 7, 8.8%; p = 0.005), respiratory syncytial virus B (RSV B) ( n = 2, 2.9% vs. n = 4, 5.0%), and enterovirus ( n = 1, 1.4% vs. n = 2, 2.5%).", {"entities": []}], ["Strong odds for rhinoviral infection were observed among nebulised children compared with stable asthmatics ( p = 0.005, OR = 3.6, 95% CI = 1.4 \u2013 9.3,).", {"entities": []}], ["RV was prevalent throughout the year (Dry, n = 6, 15.8%; Rainy, n = 19, 17.0%) and without seasonal association [\u03c7 p = 0.867].", {"entities": []}], ["However it was the most frequently detected virus [Dry = 6/10, (60.0%); Rainy = 19/28, (67.9%)] in both seasons.", {"entities": []}], ["Emergent wheezing illnesses during childhood can be linked to infection with rhinovirus in Trinidad's tropical environment.", {"entities": []}], ["Viral-induced exacerbations of asthma are independent of seasons in this tropical climate.", {"entities": [[31, 37, "DISEASE"]]}], ["Further clinical and virology investigations are recommended on the role of infections with the rhinovirus in Caribbean childhood wheeze.", {"entities": []}], ["Clinical assessment of asthma often includes a crude assessment of speech, for example whether the patient can speak in full sentences.", {"entities": [[23, 29, "DISEASE"]]}], ["To date, this statement, despite appearing in national asthma guidelines, has not been related to lung function testing in asthma exacerbation.", {"entities": [[55, 61, "DISEASE"], [123, 129, "DISEASE"]]}], ["Seven asthmatics underwent a bronchial challenge and were then recorded reading a standardised text for 1\u2009min.", {"entities": []}], ["The recordings were played to 88 healthcare professionals who were asked to estimate FEV 1 % predicted.", {"entities": [[85, 88, "GENE"]]}], ["Health care professionals' estimations showed moderate correlation to FEV 1 % predicted (rho=0.61 P <0.01).", {"entities": [[70, 73, "GENE"]]}], ["There were no significant differences between professionals grouped by seniority or speciality.", {"entities": []}], ["Speech can intuitively be estimated by health care professionals with moderate accuracy.", {"entities": []}], ["This gives an evidence basis for the assessment in speech in acute asthma and may provide a new avenue for monitoring.", {"entities": [[67, 73, "DISEASE"]]}], ["Asthma and other chronic airway diseases can be effectively treated by inhaler therapy.", {"entities": [[0, 6, "DISEASE"]]}], ["Inhaler therapy depends on appropriate use of the inhaler.", {"entities": []}], ["This study evaluates the knowledge among Dutch children and their parents regarding asthma inhaler therapy and appropriateness of its use.", {"entities": [[84, 90, "DISEASE"]]}], ["Five general practices selected all children aged 0 to 12 years on asthma inhalation medication.", {"entities": [[67, 73, "DISEASE"]]}], ["Children demonstrated inhaler use and were interviewed with their parents.", {"entities": []}], ["46 subjects were enrolled; mean age 5.5 years (SD 3.4) years; 26 (57%) were boys.", {"entities": []}], ["Of the children using one inhaler only, 70% used the inhaler as indicated and of those using more than one inhaler 46%.", {"entities": []}], ["On average 2.6 mistakes were made during demonstration of the technique, and 2 mistakes were reported in the interview.", {"entities": []}], ["In total, 87% of the parents decided when and how the inhaler had to be used.", {"entities": []}], ["Spacer cleaning was performed correctly by 49%; 26% reported a correct way of assessing how many doses were remaining.", {"entities": []}], ["Dutch children make essential mistakes related to inhaler use that are easy to avoid.", {"entities": []}], ["We recommend a better explanation and demonstration of the technique, and recommend involvement of the parents during instruction.", {"entities": []}], ["Recent evidence suggests that endogenous arginase activity potentiates airway responsiveness to methacholine by attenuation of agonist-induced nitric oxide (NO) production, presumably by competition with epithelial constitutive NO synthase for the common substrate, L-arginine.", {"entities": []}], ["Using guinea pig tracheal open-ring preparations, we now investigated the involvement of arginase in the modulation of neuronal nitric oxide synthase (nNOS)-mediated relaxation induced by inhibitory nonadrenergic noncholinergic (iNANC) nerve stimulation.", {"entities": []}], ["Electrical field stimulation (EFS; 150 mA, 4 ms, 4 s, 0.5 \u2013 16 Hz)-induced relaxation was measured in tracheal preparations precontracted to 30% with histamine, in the presence of 1 \u03bcM atropine and 3 \u03bcM indomethacin.", {"entities": [[30, 33, "GENE"]]}], ["The contribution of NO to the EFS-induced relaxation was assessed by the nonselective NOS inhibitor L-NNA (0.1 mM), while the involvement of arginase activity in the regulation of EFS-induced NO production and relaxation was investigated by the effect of the specific arginase inhibitor nor-NOHA (10 \u03bcM).", {"entities": []}], ["Furthermore, the role of substrate availability to nNOS in EFS-induced relaxation was measured in the presence of various concentrations of exogenous L-arginine.", {"entities": []}], ["EFS induced a frequency-dependent relaxation, ranging from 6.6 \u00b1 0.8% at 0.5 Hz to 74.6 \u00b1 1.2% at 16 Hz, which was inhibited with the NOS inhibitor L-NNA by 78.0 \u00b1 10.5% at 0.5 Hz to 26.7 \u00b1 7.7% at 8 Hz (P < 0.01 all).", {"entities": [[0, 3, "GENE"]]}], ["In contrast, the arginase inhibitor nor-NOHA increased EFS-induced relaxation by 3.3 \u00b1 1.2-fold at 0.5 Hz to 1.2 \u00b1 0.1-fold at 4 Hz (P < 0.05 all), which was reversed by L-NNA to the level of control airways in the presence of L-NNA (P < 0.01 all).", {"entities": []}], ["Similar to nor-NOHA, exogenous L-arginine increased EFS-induced airway relaxation (P < 0.05 all).", {"entities": []}], ["The results indicate that endogenous arginase activity attenuates iNANC nerve-mediated airway relaxation by inhibition of NO generation, presumably by limiting L-arginine availability to nNOS.", {"entities": []}], ["Studies suggest childhood exposure to environmental tobacco smoke (ETS) leads to increased incidence of infections of the lower respiratory tract.", {"entities": []}], ["The objective of this study was to determine whether perinatal exposure to ETS increases the incidence, morbidity and severity of respiratory influenza infection and whether a secondary bacterial challenge at the peak of a pre-existing viral infection creates an enhanced host-pathogen susceptibility to an opportunistic infection.", {"entities": [[142, 151, "DISEASE"]]}], ["Timed-pregnant female Balb/c mice were exposed to either ETS for 6 h/day, 7 d/week beginning on gestation day 14 and continuing with the neonates to 6 weeks of age.", {"entities": []}], ["Control animals were exposed to filtered air (FA).", {"entities": []}], ["At the end of exposure, mice were intranasally inoculated with a murine-adapted influenza A.", {"entities": [[80, 89, "DISEASE"]]}], ["One week later, an intranasal inoculation of S. aureus bacteria was administered.", {"entities": []}], ["The respective treatment groups were: bacteria only, virus only or virus+bacteria for both FA and ETS-exposed animals for a total of six treatment groups.", {"entities": []}], ["Animal behavior and body weights were documented daily following infection.", {"entities": []}], ["Mice were necropsied 1-day post-bacterial infection.", {"entities": []}], ["Bronchoalveolar lavage fluid (BALF) cell analysis demonstrated perinatal exposure to ETS, compared to FA, leads to delayed but enhanced clinical symptoms and enhanced total cell influx into the lungs associated with viral infection followed by bacterial challenge.", {"entities": []}], ["Viral infection significantly increases the number of neutrophils entering the lungs following bacterial challenge with either FA or ETS exposure, while the influx of lymphocytes and monocytes is significantly enhanced only by perinatal ETS exposure.", {"entities": []}], ["There is a significant increase in peribronchiolar inflammation following viral infection in pups exposed to ETS compared with pups exposed to FA, but no change is noted in the degree of lung injury between FA and ETS-exposed animals following bacterial challenge.", {"entities": []}], ["The data suggests perinatal exposure to ETS alters the response of neonates to the timing and severity of infection as well as ETS alters the pattern of inflammation and cellular influx into the lungs due to viral and bacterial infection.", {"entities": []}], ["Genome-wide association studies have identified loci at 15q25 ( IREB2 ) and 4q22 ( FAM13A ), associated with lung cancer (LC) and chronic obstructive pulmonary disease (COPD).", {"entities": [[109, 120, "DISEASE"], [130, 167, "DISEASE"], [114, 120, "DISEASE"], [64, 69, "GENE"], [83, 89, "GENE"]]}], ["The aim of our research was to determine the association of IREB2 and FAM13A SNPs with LC and severe/very severe COPD patients.", {"entities": [[60, 65, "GENE"], [70, 76, "GENE"]]}], ["We examined IREB2 variants (rs2568494, rs2656069, rs10851906, rs13180) and FAM13A (rs1903003, rs7671167, rs2869967) among 1.141 participants (468 LC, 149 COPD, 524 smoking controls).", {"entities": [[12, 17, "GENE"], [75, 81, "GENE"]]}], ["The frequency of the minor IREB2 rs2568494 AA genotype, was higher in LC vs controls ( P \u2009=\u20090.0081, OR\u2009=\u20091.682).", {"entities": [[27, 32, "GENE"]]}], ["The FAM13A rs2869967 was associated with COPD (minor CC genotype: P \u2009=\u20090.0007, OR\u2009=\u20092.414).", {"entities": [[4, 10, "GENE"]]}], ["The rs1903003, rs7671167 FAM13A variants confer a protective effect on COPD (both P \u2009<\u20090.002, OR\u2009<\u20090.405).", {"entities": [[25, 31, "GENE"]]}], ["Haplotype-based tests identified an association of the IREB2 AAAT haplotype with LC ( P \u2009=\u20090.0021, OR\u2009=\u20091.513) and FAM13A TTC with COPD ( P \u2009=\u20090.0013, OR\u2009=\u20091.822).", {"entities": [[55, 60, "GENE"], [115, 121, "GENE"]]}], ["Cumulative genetic risk score analyses (CGRS), derived by adding risk alleles, revealed that the risk for COPD increased with the growing number of the FAM13A risk alleles.", {"entities": [[152, 158, "GENE"]]}], ["OR (95% CI) for carriers of \u22655 risk alleles reached 2.998 (1.8 to 4.97) compared to the controls.", {"entities": []}], ["This study confirms that the IREB2 variants contribute to an increased risk of LC, whereas FAM13A predisposes to increased susceptibility to COPD.", {"entities": [[29, 34, "GENE"], [91, 97, "GENE"]]}], ["As part of a citywide effort to increase lead poisoning awareness within the city of Hartford, Connecticut, the Hartford Health Department implemented a multifaceted public health campaign involving several novel elements and partnerships, including the use of municipal sanitation trucks to disseminate lead-poisoning prevention messages throughout the city.", {"entities": []}], ["To evaluate campaign reach and effectiveness, Health Department personnel collected measures of lead-poisoning knowledge, recall of campaign components, and reports of steps taken to prevent lead poisoning from 180 largely ethnic minority parents of preschool-age children.", {"entities": []}], ["Key results were as follows: a) Recall of campaign components ranged from 21.5 to 62.6%, with newspaper advertisements and signs on buses and billboards recalled most often and a video broadcast on public-access television recalled least often.", {"entities": []}], ["b) More than 45% of respondents reported that they took steps to prevent lead poisoning because of at least one of the campaign components, with the newspaper advertisements being the most effective component in terms of prompting lead-poisoning prevention behavior.", {"entities": []}], ["c) Respondents' awareness was particularly low in terms of how medical personnel and procedures can and cannot detect and prevent lead poisoning in children.", {"entities": []}], ["This campaign prompted caregivers to take steps to prevent lead poisoning and may help public health professionals in other communities to develop novel ideas through which to embark on similar initiatives.", {"entities": []}], ["The recommendations for the treatment of moderate persistent asthma in the Global Initiative for Asthma (GINA) guidelines for paediatric asthma are mainly based on scientific evidence extrapolated from studies in adults or on consensus.", {"entities": [[61, 67, "DISEASE"], [97, 103, "DISEASE"], [137, 143, "DISEASE"]]}], ["Furthermore, clinical decision-making would benefit from formal ranking of treatments in terms of effectiveness.", {"entities": []}], ["Our objective is to assess all randomized trial-based evidence specifically pertaining to 5-18 year olds with moderate persistent asthma.", {"entities": [[130, 136, "DISEASE"]]}], ["Rank the different drug treatments of GINA guideline steps 3&4 in terms of effectiveness.", {"entities": []}], ["Systematic review with network meta-analysis.", {"entities": []}], ["After a comprehensive search in Central, Medline, Embase, CINAHL and the WHO search portal two reviewers selected RCTs performed in 4,129 children from 5-18 year old, with moderate persistent asthma comparing any GINA step 3&4 medication options.", {"entities": [[192, 198, "DISEASE"]]}], ["Further quality was assessed according the Cochrane Collaboration\u2019s tool and data-extracted included papers and built a network of the trials.", {"entities": []}], ["Attempt at ranking treatments with formal statistical methods employing direct and indirect (e.g.", {"entities": []}], ["through placebo) connections between all treatments.", {"entities": []}], ["8,175 references were screened; 23 randomized trials (RCT), comparing head-to-head (n=17) or against placebo (n=10), met the inclusion criteria.", {"entities": []}], ["Except for theophylline as add-on therapy in step 4, a closed network allowed all comparisons to be made, either directly or indirectly.", {"entities": []}], ["Huge variation in, and incomplete reporting of, outcome measurements across RCTs precluded assessment of relative efficacies.", {"entities": []}], ["Evidence-based ranking of effectiveness of drug treatments in GINA steps 3&4 is not possible yet.", {"entities": []}], ["Existing initiatives for harmonization of outcome measurements in asthma trials need urgent implementation.", {"entities": [[66, 72, "DISEASE"]]}], ["There has been increased concern over health effects related to potential exposure of building occupants to bioaerosols.", {"entities": []}], ["We report the case of a worker with a respiratory illness related to bioaerosol exposure in a water-damaged building with extensive fungal contamination.", {"entities": []}], ["We performed environmental tests to evaluate potential exposure to fungi, and we used mycotoxin-specific IgG antibody in serologic studies in the attempt to evaluate exposure to mycotoxins.", {"entities": []}], ["Extensive fungal contamination was documented in many areas of the building.", {"entities": []}], ["Penicillium, Aspergillus, and Stachybotrys species were the most predominant fungi found in air sampling.", {"entities": []}], ["Our serologic test was not useful in differentiating workers who were probably occupationally exposed to mycotoxins from those who were not; however, it did yield evidence that individuals may make specific IgG antibodies to macrocyclic tricothecene mycotoxins.", {"entities": []}], ["Further research is needed concerning health effects related to bioaerosol exposures, particularly regarding markers of exposure to specific fungi that may produce mycotoxins.", {"entities": []}], ["In the absence of clinical tools specific for evaluation of mycotoxin-related illness, a systematic clinical approach for evaluating persons with suspected building-related respiratory illness is warranted.", {"entities": []}], ["Autoantibody production is a characteristic of most autoimmune diseases including rheumatoid arthritis (RA).", {"entities": [[82, 102, "DISEASE"], [93, 102, "DISEASE"]]}], ["The role of these autoantibodies in the pathogenesis of RA remains elusive, but they appear in the serum many years before the onset of clinical disease suggesting an early break in B cell tolerance.", {"entities": []}], ["The stage of B cell development at which B cell tolerance is broken in RA remains unknown.", {"entities": []}], ["We previously established in healthy donors that most polyreactive developing B cells are silenced in the bone marrow, and additional autoreactive B cells are removed in the periphery.", {"entities": []}], ["B cell tolerance in untreated active RA patients was analyzed by testing the specificity of recombinant antibodies cloned from single B cells.", {"entities": []}], ["We find that autoreactive B cells fail to be removed in all six RA patients and represent 35\u201352% of the mature naive B cell compartment compared with 20% in healthy donors.", {"entities": []}], ["In some patients, RA B cells express an increased proportion of polyreactive antibodies that can recognize immunoglobulins and cyclic citrullinated peptides, suggesting early defects in central B cell tolerance.", {"entities": []}], ["Thus, RA patients exhibit defective B cell tolerance checkpoints that may favor the development of autoimmunity.", {"entities": []}], ["Although the age range of chronic obstructive pulmonary disease (COPD) patients is broad, few studies have focused on the effects of age on disease characteristics.", {"entities": [[26, 63, "DISEASE"]]}], ["Keio University and affiliated hospitals established an observational COPD cohort.", {"entities": []}], ["Patients were assessed using high resolution computed tomography (CT) to quantify emphysema, health status using the COPD assessment test (CAT) and the St. George\u2019s Respiratory Questionnaire (SGRQ), spirometry, echocardiogram, dual X-ray absorption of bone, biomarkers and comorbid diagnoses.", {"entities": []}], ["We examined the characteristics of COPD patients aged 75 and over compared with patients below 75.", {"entities": []}], ["A total of 443 patients comprising 252 patients aged <75\u00a0years and 191 patients aged \u226575\u00a0years, were enrolled.", {"entities": []}], ["Emphysematous changes on CT and prevalence of possible pulmonary hypertension were greater in late-elderly patients.", {"entities": [[65, 77, "DISEASE"], [55, 77, "DISEASE"]]}], ["The slope of the relationship between CT emphysema densitometry score and forced expiratory volume in 1\u00a0s was significantly less steep in the late-elderly than the younger patients (p\u00a0=\u00a00.002).", {"entities": []}], ["CAT and total SGRQ scores and the frequency of long-term oxygen therapy were significantly higher in the late-elderly with moderate airflow obstruction compared to those of the younger in the same grade, although the opposite was seen in late-elderly patients with very severe airflow obstruction.", {"entities": []}], ["Hypertension, aortic aneurysm, prostatic hypertrophy, anemia, and cataract are more prevalent in late-elderly patients.", {"entities": [[0, 12, "DISEASE"], [66, 74, "DISEASE"], [31, 52, "DISEASE"], [14, 29, "DISEASE"], [54, 60, "DISEASE"]]}], ["Elderly COPD patients show a varied age-related pattern of disease that warrants specific attention in clinical practice above and beyond assessment of airflow limitation.", {"entities": []}], ["Trial registration Clinical trial registered with the University Hospital Medical Information Network (UMIN000003470, April 10, 2010) The online version of this article (doi:10.1186/s13104-015-1810-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Studies of unexplained symptoms observed in chemically sensitive subjects have increased the awareness of the relationship between neurological and immunological diseases due to exposure to volatile organic compounds (VOCs).", {"entities": []}], ["However, there is no direct evidence that links exposure to low doses of VOCs and neurological and immunological dysfunction.", {"entities": []}], ["We review animal model data to clarify the role of VOCs in neuroimmune interactions and discuss our recent studies that show a relationship between chronic exposure of C3H mice to low levels of formaldehyde and the induction of neural and immune dysfunction.", {"entities": []}], ["We also consider the possible mechanisms by which VOC exposure can induce the symptoms presenting in patients with a multiple chemical sensitivity.", {"entities": [[117, 146, "DISEASE"]]}], ["Dendritic cells are professional antigen-presenting cells that play an essential role in the initiation and modulation of T cell responses.", {"entities": []}], ["They have been studied widely for their potential clinical applications, but for clinical use to be successful, alternatives to xenogeneic substances like fetal bovine serum (FBS) in cell culture need to be found.", {"entities": []}], ["Protocols for the generation of dendritic cells ex vivo from monocytes are well established for several species, including horses.", {"entities": []}], ["Currently, the gold standard protocol for generating dendritic cells from monocytes across various species relies upon a combination of GM-CSF and IL-4 added to cell culture medium which is supplemented with FBS.", {"entities": []}], ["The aim of this study was to substitute FBS with heterologous horse serum.", {"entities": []}], ["For this purpose, equine monocyte-derived dendritic cells (eqMoDC) were generated in the presence of horse serum or FBS and analysed for the effect on morphology, phenotype and immunological properties.", {"entities": []}], ["Changes in the expression of phenotypic markers (CD14, CD86, CD206) were assessed during dendritic cell maturation by flow cytometry.", {"entities": [[49, 53, "GENE"], [55, 59, "GENE"]]}], ["To obtain a more complete picture of the eqMoDC differentiation and assess possible differences between FBS- and horse serum-driven cultures, a transcriptomic microarray analysis was performed.", {"entities": []}], ["Lastly, immature eqMoDC were primed with a primary antigen (ovalbumin) or a recall antigen (tetanus toxoid) and, after maturation, were co-cultured with freshly isolated autologous CD5 The microarray analysis demonstrated that eqMoDC generated with horse serum were indistinguishable from those generated with FBS.", {"entities": [[92, 99, "DISEASE"], [181, 184, "GENE"]]}], ["However, eqMoDC incubated with horse serum-supplemented medium exhibited a more characteristic dendritic cell morphology during differentiation from monocytes.", {"entities": []}], ["A significant increase in cell viability was also observed in eqMoDC cultured with horse serum.", {"entities": []}], ["Furthermore, eqMoDC generated in the presence of horse serum were found to be superior in their functional T lymphocyte priming capacity and to elicit significantly less non-specific proliferation.", {"entities": []}], ["EqMoDC generated with horse serum-supplemented medium showed improved morphological characteristics, higher cell viability and exhibited a more robust performance in the functional T cell assays.", {"entities": []}], ["Therefore, horse serum was found to be superior to FBS for generating equine monocyte-derived dendritic cells.", {"entities": []}], ["We investigated bubble oscillation and its induced enhancement of mass transfer in a liquid-liquid extraction process with an acoustically-driven, bubble-based microfluidic device.", {"entities": []}], ["The oscillation of individually trapped bubbles, of known sizes, in microchannels was studied at both a fixed frequency, and over a range of frequencies.", {"entities": []}], ["Resonant frequencies were analytically identified and were found to be in agreement with the experimental observations.", {"entities": []}], ["The acoustic streaming induced by the bubble oscillation was identified as the cause of this enhanced extraction.", {"entities": []}], ["Experiments extracting Rhodanmine B from an aqueous phase (DI water) to an organic phase (1-octanol) were performed to determine the relationship between extraction efficiency and applied acoustic power.", {"entities": []}], ["The enhanced efficiency in mass transport via these acoustic-energy-assisted processes was confirmed by comparisons against a pure diffusion-based process.", {"entities": []}], ["Bisphosphonates impair function of osteoclasts and prevent bone resorption, the mechanism of which has been studied extensively.", {"entities": []}], ["However, the possible effects of bisphosphonates on chondroblast differentiation and calcium deposition by osteoblasts have only been demonstrated recently.", {"entities": []}], ["Moreover, cells from monocytic lineage are capable of stimulating osteoblast proliferation.", {"entities": []}], ["Hence, susceptibility of osteoblasts to various factors requires further investigation.", {"entities": []}], ["A primary culture of bone marrow\u2010derived stromal cells was treated with liposomal clodronate (0.1, 0.5, or 1.0\u00a0mg/ml) or conditioned medium from liposomal clodronate.", {"entities": []}], ["Liposomal clodronate (0.25\u00a0mg) was injected into mouse femur for in\u00a0vivo experiments.", {"entities": []}], ["The effects of liposomal clodronate were examined by alkaline phosphatase staining and/or activity assay, and real\u2010time RT \u2010 PCR was used for studying the effect on osteogenic gene expression.", {"entities": []}], ["Administration of liposomal clodronate to bone marrow\u2010derived mesenchymal stromal cell culture enhanced alkaline phosphatase activity and mRNA levels of Runx2 and Dlx5.", {"entities": [[153, 158, "GENE"], [163, 167, "GENE"]]}], ["In addition, conditioned medium from liposomal clodronate also stimulated osteogenic characteristics similar to those of observed in\u00a0vitro , and the number of exosomes in the conditioned medium was highest when pre\u2010treated with liposomal clodronate.", {"entities": []}], ["Western blot analysis revealed the presence of RANK proteins in exosomes collected from conditioned medium of liposomal clodronate.", {"entities": []}], ["Identical observations were obtained in\u00a0vivo , as liposomal clodronate\u2010injected mouse femur showed increased alkaline phosphatase activity and Runx2 and Dlx5 mRNA expressions, even though the numbers of monocytes and macrophages were reduced.", {"entities": [[143, 148, "GENE"], [153, 157, "GENE"]]}], ["In conclusion, osteoblast differentiation was promoted via soluble RANK \u2010containing exosomes in response to clodronates.", {"entities": []}], ["Most interventions aimed at reducing hospitalizations and emergency department (ED) visits in patients with chronic obstructive pulmonary disease (COPD) have employed resource-intense programs in high-risk individuals.", {"entities": [[108, 145, "DISEASE"]]}], ["Although COPD is a progressive disease, little is known about the effectiveness of proactive interventions aimed at preventing hospitalizations and ED visits in the much larger population of low-risk (no known COPD-related hospitalizations or ED visits in the prior year) patients, some of whom will eventually become high-risk.", {"entities": []}], ["We tested the effect of a simple educational and self-efficacy intervention (n = 2243) versus usual care (n = 2182) on COPD/breathing-related ED visits and hospitalizations in a randomized study of low-risk patients at three Veterans Affairs (VA) medical centers in the upper Midwest.", {"entities": []}], ["Administrative data was used to track VA admissions and ED visits.", {"entities": []}], ["A patient survey was used to determine health-related events outside the VA. Rates of COPD-related VA hospitalizations in the education and usual care group were not significantly different (3.4 versus 3.6 admissions per 100 person-years, respectively; 95% CI of difference \u22121.3 to 1.0, P = 0.77).", {"entities": []}], ["The much higher patient-reported rates of non-VA hospitalizations for breathing-related problems were lower in the education group (14.0 versus 19.0 per 100 person-years; 95% CI \u22128.6 to \u22121.4, P = 0.006).", {"entities": []}], ["Rates of COPD-related VA ED visits were not significantly different (6.8 versus 5.3; 95% CI \u22120.1 to 3.0, P = 0.07), nor were non-VA ED visits (32.4 versus 36.5; 95% CI \u22129.3 to 1.1, P = 0.12).", {"entities": []}], ["All-cause VA admission and ED rates did not differ.", {"entities": []}], ["Mortality rates (6.9 versus 8.3 per 100 person-years, respectively; 95% CI \u22123.0 to 0.4, P = 0.13) did not differ.", {"entities": []}], ["An educational intervention that is practical for large numbers of low-risk patients with COPD may reduce the rate of breathing-related hospitalizations.", {"entities": []}], ["Further research that more closely tracks hospitalizations to non-VA facilities is needed to confirm this finding.", {"entities": []}], ["Epidemiologic studies suggest an association between vitamin D deficiency and atopic diseases, including asthma.", {"entities": [[105, 111, "DISEASE"]]}], ["The objective of this study was to systematically review the benefits and harms of vitamin D supplementation in children with asthma.", {"entities": [[126, 132, "DISEASE"]]}], ["We used standard Cochrane systematic review methodology.", {"entities": []}], ["The search strategy included an electronic search in February 2013 of MEDLINE and EMBASE.", {"entities": []}], ["Two reviewers completed in duplicate and independently study selection, data abstraction, and assessment of risk of bias.", {"entities": []}], ["We pooled the results of trials using a random-effects model.", {"entities": []}], ["We assessed the quality of evidence by outcome using the GRADE methodology.", {"entities": []}], ["Four trials with a total of 149 children met eligibility criteria.", {"entities": []}], ["The trials had major methodological limitations.", {"entities": []}], ["Given the four studies reporting on asthma symptoms used different instruments to measure that outcome, we opted not to conduct a meta-analysis.", {"entities": [[36, 42, "DISEASE"]]}], ["Three of those studies reported improvement in asthma symptoms in the vitamin D supplemented group study, while the fourth reported no effect (very low quality evidence).", {"entities": [[47, 53, "DISEASE"]]}], ["For the lung function outcome, a meta-analysis of two trials assessing post treatment FEV-1 found a mean difference of 0.54 liters per second (95% CI -5.28; 4.19; low quality evidence).", {"entities": []}], ["For the vitamin D level outcome, a meta-analysis of three trials found a mean difference of 6.56 ng/ml (95% CI -0.64; 13.77; very low quality evidence).", {"entities": []}], ["The available very low to low quality evidence does not confirm or rule out beneficial effects of vitamin D supplementation in children with asthma.", {"entities": [[141, 147, "DISEASE"]]}], ["Large-scale, well-designed and executed randomized controlled trials are needed to better understand the effectiveness and safety of vitamin D in children with asthma.", {"entities": [[160, 166, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s13104-014-0961-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Swimming in chlorinated pools involves exposure to disinfection by-products (DBPs) and has been associated with impaired respiratory health.", {"entities": []}], ["We evaluated short-term changes in several respiratory biomarkers to explore mechanisms of potential lung damage related to swimming pool exposure.", {"entities": []}], ["We measured lung function and biomarkers of airway inflammation [fractional exhaled nitric oxide (FeNO), eight cytokines, and vascular endothelial growth factor (VEGF) in exhaled breath condensate], oxidative stress (8-isoprostane in exhaled breath condensate), and lung permeability [surfactant protein D (SP-D) and the Clara cell secretory protein (CC16) in serum] in 48 healthy nonsmoking adults before and after they swam for 40 min in a chlorinated indoor swimming pool.", {"entities": []}], ["We measured trihalomethanes in exhaled breath as a marker of individual exposure to DBPs.", {"entities": []}], ["Energy expenditure during swimming, atopy, and CC16 genotype (rs3741240) were also determined.", {"entities": []}], ["Median serum CC16 levels increased from 6.01 to 6.21 \u03bcg/L (average increase, 3.3%; paired Wilcoxon test p = 0.03), regardless of atopic status and CC16 genotype.", {"entities": []}], ["This increase was explained both by energy expenditure and different markers of DBP exposure in multivariate models.", {"entities": [[80, 83, "GENE"]]}], ["FeNO was unchanged overall but tended to decrease among atopics.", {"entities": []}], ["We found no significant changes in lung function, SP-D, 8-isoprostane, eight cytokines, or VEGF.", {"entities": []}], ["We detected a slight increase in serum CC16, a marker of lung epithelium permeability, in healthy adults after they swam in an indoor chlorinated pool.", {"entities": []}], ["Exercise and DBP exposure explained this association, without involving inflammatory mechanisms.", {"entities": [[13, 16, "GENE"]]}], ["Further research is needed to confirm the results, establish the clinical relevance of short-term serum CC16 changes, and evaluate the long-term health impacts.", {"entities": []}], ["Chronic parasitic infections are associated with active immunomodulation which may include by-stander effects on unrelated antigens.", {"entities": []}], ["It has been suggested that pre-natal exposure to parasitic infections in the mother impacts immunological development in the fetus and hence the offspring\u2019s response to vaccines, and that control of parasitic infection among pregnant women will therefore be beneficial.", {"entities": []}], ["We used new data from the Entebbe Mother and Baby Study, a trial of anthelminthic treatment during pregnancy conducted in Uganda, to further investigate this hypothesis.", {"entities": []}], ["2705 mothers were investigated for parasitic infections and then randomised to albendazole (400mg) versus placebo and praziquantel (40mg/kg) during pregnancy in a factorial design.", {"entities": []}], ["All mothers received sulfadoxine/pyrimethamine for presumptive treatment of malaria.", {"entities": [[76, 83, "DISEASE"]]}], ["Offspring received Expanded Programme on Immunisation vaccines at birth, six, 10 and 14 weeks.", {"entities": []}], ["New data on antibody levels to diphtheria toxin, three pertussis antigens, Haemophilus influenzae type B (HiB) and Hepatitis B, measured at one year (April 2004 \u2013May 2007) from 1379 infants were analysed for this report.", {"entities": [[31, 41, "DISEASE"], [55, 64, "DISEASE"]]}], ["Additional observational analyses relating maternal infections to infant vaccine responses were also conducted.", {"entities": []}], ["Helminth infections were highly prevalent amongst mothers (hookworm 43.1%, Mansonella 20.9%, Schistosoma mansoni 17.3%, Strongyloides 11.7%, Trichuris 8.1%) and 9.4% had malaria at enrolment.", {"entities": [[170, 177, "DISEASE"]]}], ["In the trial analysis we found no overall effect of either anthelminthic intervention on the measured infant vaccine responses.", {"entities": []}], ["In observational analyses, no species was associated with suppressed responses.", {"entities": []}], ["Strongyloidiasis was associated with enhanced responses to pertussis toxin, HiB and Hep B vaccine antigens.", {"entities": [[59, 68, "DISEASE"]]}], ["Our results do not support the hypothesis that routine anthelminthic treatment during pregnancy has a benefit for the infant\u2019s vaccine response, or that maternal helminth infection has a net suppressive effect on the offspring\u2019s response to vaccines.", {"entities": []}], ["ISRCTN.com ISRCTN32849447 Parasitic infections, such as worms and malaria, have potent effects on the human immune system.", {"entities": [[66, 73, "DISEASE"]]}], ["These effects include modification of immune responses in the fetus and infant if a mother has a parasitic infection during pregnancy.", {"entities": []}], ["These immunological changes can influence the way a child responds to the same infection when exposed in later life.", {"entities": []}], ["It has been suggested that the immunological changes might also influence how the child responds to the vaccines given in infancy, and that treating mothers for parasitic infections when they are pregnant might be helpful.", {"entities": []}], ["In this study we compared responses to vaccines between infants of mothers who had, or had not, been treated for worms while they were pregnant.", {"entities": []}], ["We found no overall differences.", {"entities": []}], ["We also compared vaccine responses between groups of mothers with and without parasitic infections.", {"entities": []}], ["We found no evidence that the parasitic infections were associated with reduced responses in the children.", {"entities": []}], ["This means that, although treating worms during pregnancy may have some benefits, improvements in the children\u2019s responses to vaccines are not likely to be among them.", {"entities": []}], ["Accurate representation of study findings is crucial to preserve public trust.", {"entities": []}], ["The language used to describe results could affect perceptions of the efficacy or safety of interventions.", {"entities": []}], ["We sought to compare the adjectives used in clinical trial reports of industry-authored and non-industry-authored research.", {"entities": []}], ["We included studies in PubMed that were randomized trials and had an abstract.", {"entities": []}], ["Studies were classified as \u201cnon-industry-authored\u201d when all authors had academic or governmental affiliations, or as \u201cindustry-authored\u201d when any of the authors had industry affiliations.", {"entities": []}], ["Abstracts were analyzed using a part-of-speech tagger to identify adjectives.", {"entities": []}], ["To reduce the risk of false positives, the analysis was restricted to adjectives considered relevant to \u201ccoloring\u201d (influencing interpretation) of trial results.", {"entities": []}], ["Differences between groups were determined using exact tests, stratifying by journal.", {"entities": []}], ["A total of 306,007 publications met the inclusion criteria.", {"entities": []}], ["We were able to classify 16,789 abstracts; 9,085 were industry-authored research, and 7,704 were non-industry-authored research.", {"entities": []}], ["We found a differential use of adjectives between industry-authored and non-industry-authored reports.", {"entities": []}], ["Adjectives such as \u201cwell tolerated\u201d and \u201cmeaningful\u201d were more commonly used in the title or conclusion of the abstract by industry authors, while adjectives such as \u201cfeasible\u201d were more commonly used by non-industry authors.", {"entities": []}], ["There are differences in the adjectives used when study findings are described in industry-authored reports compared with non-industry-authored reports.", {"entities": []}], ["Authors should avoid overusing adjectives that could be inaccurate or result in misperceptions.", {"entities": []}], ["Editors and peer reviewers should be attentive to the use of adjectives and assess whether the usage is context appropriate.", {"entities": []}], ["A novel tiotropium bromide monodose capsule dry powder inhaler (DPI) formulation and device have been developed.", {"entities": []}], ["The formulation was based on a spray-dried matrix that enhances the aerosolizaton properties, allowing a less active tiotropium metered dose (13\u00a0\u00b5g/capsule) while maintaining the same delivered dose (10\u00a0\u00b5g/actuation).", {"entities": []}], ["This study describes the pharmacokinetic bioequivalence to the reference product.", {"entities": []}], ["This randomized, two-stage, crossover, semi-replicate (three-way) study was performed in healthy volunteers.", {"entities": []}], ["In each study period, subjects received a single dose of two capsules (20\u00a0\u03bcg delivered dose) of the study medication, separated by a 14-day washout period: tiotropium 10\u00a0\u03bcg delivered dose (Laboratorios Liconsa, Spain) and Spiriva HandiHaler C max ), area under the concentration\u2013time curve (AUC) from time zero hours to the last observed concentration at time t (AUC t ), and AUC from time zero hours to 30\u00a0min (AUC 0.5 ).", {"entities": [[243, 246, "GENE"]]}], ["Bioequivalence was accepted if the 90.20\u00a0% confidence interval (CI) for the ratio test/reference of the primary pharmacokinetic parameters lay within the acceptance range of 80\u2013125\u00a0%.", {"entities": []}], ["Safety assessment was a secondary endpoint.", {"entities": []}], ["A total of 30 subjects were randomized and bioequivalence was demonstrated for all primary pharmacokinetic parameters: C max (CI 87.26\u2013106.60\u00a0%), AUC t (CI 101.33\u2013111.64\u00a0%), and AUC 0.5 (CI 97.95\u2013113.49\u00a0%).", {"entities": [[121, 124, "GENE"]]}], ["Both study treatments were well tolerated (four non-serious adverse events [AEs] were reported in four subjects: one AE before any product administration, two AEs after test product administration; and one AE after reference product administration).", {"entities": []}], ["Both products containing tiotropium 10\u00a0\u00b5g delivered-dose DPI were bioequivalent and showed good tolerability and a similar safety profile.", {"entities": []}], ["Researchers and clinicians in environmental health and medicine increasingly show respect for participants and patients by involving them in decision-making.", {"entities": []}], ["In this context, the return of personal results to study participants is becoming ethical best practice, and many participants now expect to see their data.", {"entities": []}], ["However, researchers often lack the time and expertise required for report-back, especially as studies measure greater numbers of analytes, including many without clear health guidelines.", {"entities": []}], ["In this article, our goal is to demonstrate how a prototype digital method, the Digital Exposure Report-Back Interface (DERBI), can reduce practical barriers to high-quality report-back.", {"entities": []}], ["DERBI uses decision rules to automate the production of personalized summaries of notable results and generates graphs of individual results with comparisons to the study group and benchmark populations.", {"entities": []}], ["Reports discuss potential sources of chemical exposure, what is known and unknown about health effects, strategies for exposure reduction, and study-wide findings.", {"entities": []}], ["Researcher tools promote discovery by drawing attention to patterns of high exposure and offer novel ways to increase participant engagement.", {"entities": []}], ["DERBI reports have been field tested in two studies.", {"entities": []}], ["Digital methods like DERBI reduce practical barriers to report-back thus enabling researchers to meet their ethical obligations and participants to get knowledge they can use to make informed choices.", {"entities": []}], ["Please cite this paper as: Martin et\u00a0al.", {"entities": []}], ["(2012) Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children.", {"entities": []}], ["Influenza and Other Respiratory Viruses 6(1), 71\u201377.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Molecular testing for viral pathogens has resulted in increasing detection of multiple viruses in respiratory secretions of ill children.", {"entities": []}], ["The clinical impact of multiple virus infections on clinical presentation and outcome is unclear.", {"entities": []}], ["Objectives\u2002 To compare clinical characteristics and viral load between children with multiple virus versus single virus illnesses.", {"entities": []}], ["Patients/methods\u2002 Eight hundred and ninety\u2010three residual nasal wash samples from children treated for respiratory illness at Children\u2019s Hospital, Seattle, from September 2003 to September 2004 were evaluated by quantitative PCR for respiratory syncytial virus (RSV), human metapneumovirus (hMPV), influenza (Flu), parainfluenza, adenoviruses, and coronaviruses (CoV).", {"entities": [[298, 307, "DISEASE"]]}], ["Illness severity and patient characteristics were abstracted from medical charts.", {"entities": []}], ["Results\u2002 Coinfections were identified in 103 (18%) of 566 virus\u2010positive samples.", {"entities": []}], ["Adenovirus was most commonly detected in coinfections (52%), followed by CoV (50%).", {"entities": []}], ["Illnesses with a single virus had increased risk of oxygen requirement ( P \u2003=\u20030\u00b702), extended hospital stays ( P \u2003=\u20030\u00b7002), and admissions to the inpatient ( P \u2003=\u20030\u00b702) or intensive care units ( P \u2003=\u20030\u00b704).", {"entities": []}], ["For Adv and PIV\u20101, multiple virus illnesses had a significantly lower viral load (log 10 copies/ml) than single virus illnesses (4\u00b72 versus 5\u00b76, P \u2003=\u20030\u00b7007 and 4\u00b72 versus 6\u00b79, P \u2003<\u20030\u00b7001, respectively).", {"entities": []}], ["RSV, Flu\u2010A, PIV\u20103, and hMPV viral loads were consistently high whether or not another virus was detected.", {"entities": []}], ["Conclusions\u2002 Illnesses with multiple virus detections were correlated with less severe disease.", {"entities": []}], ["The relationship between viral load and multiple virus infections was virus specific, and this may serve as a way to differentiate viruses in multiple virus infections.", {"entities": []}], ["Prescribing medicines for older adults in care homes is known to be sub-optimal.", {"entities": []}], ["Whilst trials testing interventions to optimise prescribing in this setting have been published, heterogeneity in outcome reporting has hindered comparison of interventions, thus limiting evidence synthesis.", {"entities": []}], ["The aim of this study was to develop a core outcome set (COS), a list of outcomes which should be measured and reported, as a minimum, for all effectiveness trials involving optimising prescribing in care homes.", {"entities": []}], ["The COS was developed as part of the Care Homes Independent Pharmacist Prescribing Study (CHIPPS).", {"entities": []}], ["A long-list of outcomes was identified through a review of published literature and stakeholder input.", {"entities": []}], ["Outcomes were reviewed and refined prior to entering a two-round online Delphi exercise and then distributed via a web link to the CHIPPS Management Team, a multidisciplinary team including pharmacists, doctors and Patient Public Involvement representatives (amongst others), who comprised the Delphi panel.", {"entities": []}], ["The Delphi panellists ( n \u2009=\u200919) rated the importance of outcomes on a 9-point Likert scale from 1 (not important) to 9 (critically important).", {"entities": []}], ["Consensus for an outcome being included in the COS was defined as \u226570% participants scoring 7\u20139 and <15% scoring 1\u20133.", {"entities": []}], ["Exclusion was defined as \u226570% scoring 1\u20133 and <15% 7\u20139.", {"entities": []}], ["Individual and group scores were fed back to participants alongside the second questionnaire round, which included outcomes for which no consensus had been achieved.", {"entities": []}], ["A long-list of 63 potential outcomes was identified.", {"entities": []}], ["Refinement of this long-list of outcomes resulted in 29 outcomes, which were included in the Delphi questionnaire (round 1).", {"entities": []}], ["Following both rounds of the Delphi exercise, 13 outcomes (organised into seven overarching domains: medication appropriateness, adverse drug events, prescribing errors, falls, quality of life, all-cause mortality and admissions to hospital (and associated costs)) met the criteria for inclusion in the final COS. We have developed a COS for effectiveness trials aimed at optimising prescribing in older adults in care homes using robust methodology.", {"entities": []}], ["Widespread adoption of this COS will facilitate evidence synthesis between trials.", {"entities": []}], ["Future work should focus on evaluating appropriate tools for these key outcomes to further reduce heterogeneity in outcome measurement in this context.", {"entities": []}], ["The gastrointestinal microbiome is a diverse consortium of bacteria, archaea, fungi, protozoa, and viruses that inhabit the gut of all mammals.", {"entities": []}], ["Studies in humans and other mammals have implicated the microbiome in a range of physiologic processes that are vital to host health including energy homeostasis, metabolism, gut epithelial health, immunologic activity, and neurobehavioral development.", {"entities": []}], ["The microbial genome confers metabolic capabilities exceeding those of the host organism alone, making the gut microbiome an active participant in host physiology.", {"entities": []}], ["Recent advances in DNA sequencing technology and computational biology have revolutionized the field of microbiomics, permitting mechanistic evaluation of the relationships between an animal and its microbial symbionts.", {"entities": []}], ["Changes in the gastrointestinal microbiome are associated with diseases in humans and animals including inflammatory bowel disease, asthma, obesity, metabolic syndrome, cardiovascular disease, immune\u2010mediated conditions, and neurodevelopmental conditions such as autism spectrum disorder.", {"entities": [[104, 130, "DISEASE"], [140, 147, "DISEASE"], [159, 167, "DISEASE"], [263, 287, "DISEASE"], [132, 138, "DISEASE"]]}], ["While there remains a paucity of data regarding the intestinal microbiome in small animals, recent studies have helped to characterize its role in host animal health and associated disease states.", {"entities": []}], ["This review is intended to familiarize small animal veterinarians with recent advances in the field of microbiomics and to prime them for a future in which diagnostic tests and therapies will incorporate these developments into clinical practice.", {"entities": []}], ["Increased nicotine metabolism during pregnancy could explain why nicotine replacement therapy (NRT) appears to be less effective on smoking cessation in pregnancy than in non\u2010pregnant smokers, but little is known about nicotine metabolism across pregnancy.", {"entities": []}], ["This study was conducted to determine when changes in nicotine metabolism occur during pregnancy and to describe the magnitude of these changes.", {"entities": []}], ["Longitudinal cohort study of pregnant smokers' nicotine metabolite ratio (NMR).", {"entities": []}], ["101 pregnant smokers recruited from hospital antenatal clinics in Nottingham, UK were asked to provide saliva samples at 8\u201314 weeks (n\u2009=\u200998), 18\u201322 weeks (n\u2009=\u200965), 32\u201336 weeks gestation (n\u2009=\u200947), 4 weeks postpartum (n\u2009=\u200944) and 12 weeks postpartum (n\u2009=\u200947).", {"entities": []}], ["Nicotine metabolite ratio (NMR) was measured using the ratio of cotinine to its primary metabolite trans\u20103'\u2010hydroxycotinine.", {"entities": []}], ["Multi\u2010level modelling was used to detect any overall difference in NMR between time points.", {"entities": []}], ["The 12 week postpartum NMR was compared with the NMRs collected antenatally and 4 weeks postpartum.", {"entities": []}], ["NMR changed over time (p\u2009=\u20090.0006).", {"entities": []}], ["Compared with NMR at 12 weeks postpartum, NMR was significantly higher at 18\u201322 weeks (26% higher, 95% CI 12% to 38%) and 32\u201336 weeks (23% higher, 95% CI 9% to 35%).", {"entities": []}], ["There was no significant difference between the 8\u201014 weeks gestation or 4 weeks postpartum NMR and 12 weeks postpartum.", {"entities": []}], ["Nicotine metabolism appears to be faster during pregnancy; this faster metabolism is apparent from 18 to 22 weeks of pregnancy and appears to fall by 4 weeks after childbirth.", {"entities": []}], ["To examine the risks of bias, risks of random errors, reporting quality, and methodological quality of randomized clinical trials of oral health interventions and the development of these aspects over time.", {"entities": []}], ["We included 540 randomized clinical trials from 64 selected systematic reviews.", {"entities": []}], ["We extracted, in duplicate, details from each of the selected randomized clinical trials with respect to publication and trial characteristics, reporting and methodologic characteristics, and Cochrane risk of bias domains.", {"entities": []}], ["We analyzed data using logistic regression and Chi-square statistics.", {"entities": []}], ["Sequence generation was assessed to be inadequate (at unclear or high risk of bias) in 68% (n = 367) of the trials, while allocation concealment was inadequate in the majority of trials (n = 464; 85.9%).", {"entities": []}], ["Blinding of participants and blinding of the outcome assessment were judged to be inadequate in 28.5% (n = 154) and 40.5% (n = 219) of the trials, respectively.", {"entities": []}], ["A sample size calculation before the initiation of the study was not performed/reported in 79.1% (n = 427) of the trials, while the sample size was assessed as adequate in only 17.6% (n = 95) of the trials.", {"entities": []}], ["Two thirds of the trials were not described as double blinded (n = 358; 66.3%), while the method of blinding was appropriate in 53% (n = 286) of the trials.", {"entities": []}], ["We identified a significant decrease over time (1955\u20132013) in the proportion of trials assessed as having inadequately addressed methodological quality items (P < 0.05) in 30 out of the 40 quality criteria, or as being inadequate (at high or unclear risk of bias) in five domains of the Cochrane risk of bias tool: sequence generation, allocation concealment, incomplete outcome data, other sources of bias, and overall risk of bias.", {"entities": []}], ["The risks of bias, risks of random errors, reporting quality, and methodological quality of randomized clinical trials of oral health interventions have improved over time; however, further efforts that contribute to the development of more stringent methodology and detailed reporting of trials are still needed.", {"entities": []}], ["In Brazil, 72% of all deaths in 2007 were attributable to non-communicable diseases (NCD).", {"entities": []}], ["We used a risk and related factor based index to prioritize NCD prevention programs in the combined 26 capital cities and the federal district (i.e., Brasilia) of Brazil.", {"entities": []}], ["We used 2006\u20132011 data (adults) from census and Brazil's surveillance of 12 NCD risk factors and 74 disease group mortality.", {"entities": []}], ["The risk and related factors were: smoking, physical inactivity, overweight-obesity, low fruits and vegetables intake, binge drinking, insufficient Pap smear screening (women aged 25 to 59\u00a0years), insufficient mammography screening (women aged 50 to 69\u00a0years), insufficient blood pressure screening, insufficient blood glucose screening, diagnosis of hypercholesterolemia, diagnosis of hypertension and diagnosis of diabetes.", {"entities": [[386, 398, "DISEASE"], [76, 83, "DISEASE"]]}], ["We generated six indicators: intervention reduction of the risk factor prevalence, intervention cost per person, prevalence of risk factor, deaths attributable to risk factor, risk factor prevalence trend and ratio of risk factor prevalence between people with and without a high school education.", {"entities": []}], ["We transformed risk and related factor indicators into priority scores to compute a priority health index (PHI).", {"entities": []}], ["We implemented sensitivity analysis of PHI by computing it with slightly altered formulas and altering values of indicators under the assumption of bias in their estimation.", {"entities": []}], ["We ranked risk factors based on PHI values.", {"entities": []}], ["We found one intermediate (i.e., overweight-obesity) and six top risk and related factors priorities for NCD prevention in Brazil's large urban areas: diagnosed hypertension, physical inactivity, blood pressure screening, diagnosed hypercholesterolemia, smoking and binge drinking.", {"entities": [[161, 173, "DISEASE"], [44, 51, "DISEASE"]]}], ["Brazil has already prioritized the six top priorities (i.e., hypertension, physical inactivity, blood pressure screening, hypercholesterolemia, smoking and binge drinking) and one intermediate priority (i.e., overweight-obesity) for NCD prevention identified in this report.", {"entities": [[61, 73, "DISEASE"], [220, 227, "DISEASE"]]}], ["Because effective interventions to reduce disease burden associated with each of the six priority risk factors are available, strategies based on these interventions need to be sustained in order to reduce NCD burden in Brazil.", {"entities": []}], ["PHI can be used to track NCD prevention and health promotion actions at the local and national level in Brazil and in countries with similar public health surveillance systems.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-1787-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The trivalent inactivated influenza vaccine Fluarix\u2122 is licensed in the US for adults and children from 3 years old.", {"entities": [[26, 35, "DISEASE"]]}], ["This randomized observer-blind study (NCT00764790) evaluated Fluarix\u2122 at two doses; 0.25 ml (Flu-25) and 0.5 ml (Flu-50) in children aged 6\u201335 months.", {"entities": []}], ["The primary objective was to demonstrate immunogenic non-inferiority vs. a control vaccine ( Fluzone\u00ae ; 0.25 ml).", {"entities": []}], ["Children received Flu-25 (n = 1107), Flu-50 (n = 1106) or control vaccine (n = 1104) at Day 0 and for un-primed children, also on Day 28.", {"entities": []}], ["Serum hemagglutination-inhibition titers were determined pre-vaccination and at Day 28 (primed) or Day 56 (un-primed).", {"entities": []}], ["Non-inferiority was assessed by post-vaccination geometric mean titer (GMT) ratio, (upper 95% confidence interval [CI] \u2264 1.5) and difference in seroconversion rate (upper 95% CI \u2264 10%).", {"entities": []}], ["Reactogenicity/safety was monitored.", {"entities": []}], ["The immune response to Flu-50 met all regulatory criteria.", {"entities": []}], ["Indicated by adjusted GMT ratios [with 95% CI], the criteria for non-inferiority of Flu-50 vs. control vaccine were reached for the B/Florida strain (1.13 [1.01\u20131.25]) but not for the A/Brisbane/H1N1 (1.74 [1.54\u20131.98]) or A/Uruguay/H3N2 (1.72 [1.57\u20131.89]) strains.", {"entities": []}], ["In children aged 18\u201335 months similar immune responses were observed for Flu-50 and the control vaccine.", {"entities": []}], ["Flu-50 induced a higher response than Flu-25 for all strains.", {"entities": []}], ["Temperature (\u2265 37.5\u00b0C) was reported in 6.2%, 6.4%, and 6.6% of the Flu-25, Flu-50, and control group, respectively.", {"entities": []}], ["Reactogenicity/safety endpoints were within the same range for all vaccines.", {"entities": []}], ["In children aged 6\u201335 months, immune responses with Flu-50 fulfilled regulatory criteria but did not meet the pre-defined criteria for non-inferiority vs. control.", {"entities": []}], ["This appeared to be due to differences in immunogenicity in children aged &lt; 18 months.", {"entities": [[75, 77, "GENE"]]}], ["Patients with chronic obstructive pulmonary disease (COPD) present with a variety of symptoms and pathological consequences.", {"entities": [[14, 51, "DISEASE"]]}], ["Although primarily viewed as a respiratory disease, COPD has both pulmonary and extrapulmonary effects, which have an impact on many aspects of physical, emotional, and mental well-being.", {"entities": []}], ["Traditional assessment of COPD relies heavily on measuring lung function, specifically forced expiratory volume in 1 second (FEV 1 ).", {"entities": [[125, 128, "GENE"]]}], ["However, the evidence suggests that FEV 1 is a relatively poor correlate of symptoms such as breathlessness and the impact of COPD on daily life.", {"entities": [[36, 39, "GENE"]]}], ["Furthermore, many consequences of the disease, including anxiety and depression and the ability to perform daily activities, can only be described and reported reliably by the patient.", {"entities": []}], ["Thus, in order to provide a comprehensive view of the effects of interventions in clinical trials, it is essential that spirometry is accompanied by assessments using patient-reported outcome (PRO) instruments.", {"entities": []}], ["We provide an overview of patient-reported outcome concepts in COPD, such as breathlessness, physical functioning, and health status, and evaluate the tools used for measuring these concepts.", {"entities": []}], ["Particular attention is given to the newly developed instruments emerging in response to recent regulatory guidelines for the development and use of PROs in clinical trials.", {"entities": []}], ["We conclude that although data from the development and validation of these new PRO instruments are emerging, to build the body of evidence that supports the use of a new instrument takes many years.", {"entities": []}], ["Furthermore, new instruments do not necessarily have better discriminative or evaluative properties than older instruments.", {"entities": []}], ["The development of new PRO tools, however, is crucial, not only to ensure that key COPD concepts are being reliably measured but also that the relevant treatment effects are being captured in clinical trials.", {"entities": []}], ["In turn, this will help us to understand better the patient\u2019s experience of the disease.", {"entities": []}], ["Resolvin D1 (RvD1) is a lipid-derived mediator generated during the resolution inflammation.", {"entities": []}], ["While the immunoresolvent effects of Resolvins have been extensively studied in leukocytes, actions of Resolvins on intrinsic kidney cells have received little attention.", {"entities": []}], ["The podocyte plays a central role in glomerular function, and podocyte damage can lead to proteinuria and glomerulosclerosis.", {"entities": [[90, 101, "DISEASE"]]}], ["This study examined whether RvD1 has renoprotective effects upon podocytes.", {"entities": []}], ["We investigated a mouse model of adriamycin (ADR) nephropathy featuring rapid induction of podocyte damage and proteinuria followed by glomerulosclerosis.", {"entities": [[111, 122, "DISEASE"]]}], ["We identified a progressive loss of synaptopodin expression over a 28 day time-course of ADR nephropathy which was associated with increased acetylation of 14-3-3\u03b2 and reduced synaptopodin phosphorylation.", {"entities": []}], ["Groups of mice were given once daily RvD1 treatment (4 ng/g body weight/day) starting either 30 min (early treatment) or 14 days (late treatment) after ADR injection and continued until mice were killed on day 28.", {"entities": []}], ["Early, but not late, RvD1 treatment attenuated ADR-induced proteinuria, glomerulosclerosis and tubulointerstitial fibrosis, modified macrophages from an M1 to M2 phenotype.", {"entities": [[59, 70, "DISEASE"]]}], ["Early RvD1 treatment prevented the down-regulation of synaptopodin expression and changes in 14-3-3\u03b2 acetylation and synaptopodin phosphorylation.", {"entities": []}], ["In a podocyte cell line, RvD1 was shown to prevent rapid TNF-\u03b1-induced down-regulation of synaptopodin expression.", {"entities": []}], ["In transfection studies, TNF-\u03b1-induced a decrease in synaptopodin phosphorylation and an increase in acetylation of 14-3-3\u03b2, resulting in disassociation between 14-3-3\u03b2 and synaptopodin.", {"entities": []}], ["RvD1 prevented TNF-\u03b1 induced post-translational modification of synaptopodin and 14-3-3\u03b2 proteins, and maintained the synaptopodin/14-3-3\u03b2 interaction.", {"entities": []}], ["Furthermore, replacement of lysine K51, or K117+K122 in 14-3-3\u03b2 with glutamine, to mimic lysine acetylation, significantly reduced the interaction between 14-3-3\u03b2 and synaptopodin.", {"entities": []}], ["In conclusion, our studies provide the first evidence that RvD1 can protect against podocyte damage by preventing down-regulation of synaptopodin through inhibition of 14-3-3\u03b2/synaptopodin dissociation.", {"entities": []}], ["RvD1 treatment may have potential application in the treatment of chronic kidney disease.", {"entities": [[74, 88, "DISEASE"]]}], ["Idiopathic intermediate uveitis (IIU) is a potentially sight-threatening inflammatory disorder with well-defined anatomic diagnostic criteria.", {"entities": [[11, 31, "DISEASE"], [24, 31, "DISEASE"]]}], ["It is often associated with multiple sclerosis, and both conditions are linked to HLA-DRB1*15 .", {"entities": [[28, 46, "DISEASE"]]}], ["Previously, we have shown that non-infectious uveitis (NIU) is associated with interleukin 10 ( IL10 ) polymorphisms, IL10-2849A (rs6703630), IL10+434T (rs2222202), and IL10+504G (rs3024490), while a LTA+252AA/TNFA-238GG haplotype (rs909253/rs361525) is protective.", {"entities": [[46, 53, "DISEASE"], [96, 100, "GENE"], [118, 122, "GENE"], [142, 146, "GENE"], [169, 173, "GENE"]]}], ["In this study, we determined whether patients with IIU have a similar genetic profile as patients with NIU or multiple sclerosis.", {"entities": [[110, 128, "DISEASE"]]}], ["Twelve polymorphisms were genotyped, spanning the tumor necrosis factor (TNF) and IL10 genomic regions, in 44 patients with IIU and 92 population controls from the UK and the Republic of Ireland.", {"entities": [[73, 76, "GENE"], [82, 86, "GENE"]]}], ["IIU was strongly associated with the TNFA-308A and TNFA-238A polymorphisms.", {"entities": []}], ["We found the combination of TNFA-308 and -238 loci was more strongly associated with IIU than any other loci across the major histocompatibility complex, including HLA-DRB1 .", {"entities": [[164, 172, "GENE"]]}], ["TNF polymorphisms, associated with increased TNF production, are highly associated with IIU.", {"entities": [[0, 3, "GENE"], [45, 48, "GENE"], [0, 3, "GENE"], [45, 48, "GENE"]]}], ["These results offer the potential to ascribe therapeutic response and risk (i.e., the influence of HLA-DRB1*15 status and TNFR1 polymorphism) to anti-TNF therapy in IIU.", {"entities": []}], ["We previously demonstrated that cyclooxygenase (COX)-1 deficiency results in greater morbidity and inflammation, whereas COX-2 deficiency leads to reduced morbidity, inflammation and mortality in influenza infected mice.", {"entities": [[196, 205, "DISEASE"]]}], ["We investigated the effects of COX-1 and COX-2 inhibitors in influenza A viral infection.", {"entities": [[61, 70, "DISEASE"]]}], ["Mice were given a COX-1 inhibitor (SC-560), a COX-2 inhibitor (celecoxib) or no inhibitor beginning 2 weeks prior to influenza A viral infection (200 PFU) and throughout the course of the experiment.", {"entities": [[117, 126, "DISEASE"]]}], ["Body weight and temperature were measured daily as indicators of morbidity.", {"entities": []}], ["Animals were sacrificed on days 1 and 4 post-infection and bronchoalveolar lavage (BAL) fluid was collected or daily mortality was recorded up to 2 weeks post-infection.", {"entities": []}], ["Treatment with SC-560 significantly increased mortality and was associated with profound hypothermia and greater weight loss compared to celecoxib or control groups.", {"entities": []}], ["On day 4 of infection, BAL fluid cells were modestly elevated in celecoxib treated mice compared to SC-560 or control groups.", {"entities": []}], ["Viral titres were similar between treatment groups.", {"entities": []}], ["Levels of TNF-\u03b1 and G-CSF were significantly attenuated in the SC-560 and celecoxib groups versus control and IL-6 levels were significantly lower in BAL fluid of celecoxib treated mice versus control and versus the SC-560 group.", {"entities": []}], ["The chemokine KC was significantly lower in SC-560 group versus control.", {"entities": []}], ["Treatment with a COX-1 inhibitor during influenza A viral infection is detrimental to the host whereas inhibition of COX-2 does not significantly modulate disease severity.", {"entities": [[40, 49, "DISEASE"]]}], ["COX-1 plays a critical role in controlling the thermoregulatory response to influenza A viral infection in mice.", {"entities": [[76, 85, "DISEASE"]]}], ["Resistive breathing (RB), a hallmark of obstructive airway diseases, is characterized by strenuous contractions of the inspiratory muscles that impose increased mechanical stress on the lung.", {"entities": []}], ["RB is shown to induce pulmonary inflammation in previous healthy animals.", {"entities": []}], ["Tiotropium bromide, an anticholinergic bronchodilator, is also shown to exert anti-inflammatory effects.", {"entities": []}], ["The effect of tiotropium on RB-induced pulmonary inflammation is unknown.", {"entities": []}], ["Adult rats were anesthetized, tracheostomized and breathed spontaneously through a two-way non-rebreathing valve.", {"entities": []}], ["Resistances were connected to the inspiratory and/or expiratory port, to produce inspiratory resistive breathing (IRB) of 40% or 50% P i / P i,max (40% and 50% IRB), expiratory resistive breathing (ERB) of 60% P e / P e,max (60% ERB) or combined resistive breathing (CRB) of both 40% P i / P i,max and 60% P e / P e,max (40%/60% CRB).", {"entities": [[143, 146, "GENE"], [220, 223, "GENE"], [294, 297, "GENE"], [316, 319, "GENE"], [143, 146, "GENE"], [220, 223, "GENE"], [294, 297, "GENE"], [316, 319, "GENE"], [143, 146, "GENE"], [220, 223, "GENE"], [294, 297, "GENE"], [316, 319, "GENE"], [143, 146, "GENE"], [220, 223, "GENE"], [294, 297, "GENE"], [316, 319, "GENE"]]}], ["Tiotropium aerosol was inhaled prior to RB.", {"entities": []}], ["After 6 h of RB, mechanical parameters of the respiratory system were measured and bronchoalveolar lavage (BAL) was performed.", {"entities": []}], ["IL-1\u03b2 and IL-6 protein levels were measured in lung tissue.", {"entities": []}], ["Lung injury was estimated histologically.", {"entities": []}], ["In all, 40% and 50% IRB increased macrophage and neutrophil counts in BAL and raised IL-1\u03b2 and IL-6 lung levels, tissue elasticity, BAL total protein levels and lung injury score.", {"entities": []}], ["Tiotropium attenuated BAL neutrophil number, IL-1\u03b2, IL-6 levels and lung injury score increase at both 40% and 50% IRB.", {"entities": []}], ["The increase in macrophage count and protein in BAL was only reversed at 40% IRB, while tissue elasticity was not affected.", {"entities": []}], ["In all, 60% ERB raised BAL neutrophil count and total protein and reduced macrophage count.", {"entities": []}], ["IL-1\u03b2 and IL-6 levels and lung injury score were increased.", {"entities": []}], ["Tiotropium attenuated these alterations, except for the decrease in macrophage count and the increase in total protein level.", {"entities": []}], ["In all, 40%/60% CRB increased macrophage and neutrophil count in BAL, IL-1\u03b2 and IL-6 levels, tissue elasticity, total protein in BAL and histological injury score.", {"entities": []}], ["Tiotropium attenuated the aforementioned alterations.", {"entities": []}], ["Tiotropium inhalation attenuates RB-induced pulmonary inflammation.", {"entities": []}], ["Genetically modified (GM) foods are evaluated carefully for their ability to induce allergic disease.", {"entities": []}], ["However, few studies have tested the capacity of a GM food to act as an adjuvant, i.e.", {"entities": []}], ["influencing allergic responses to other unrelated allergens at acute onset and in individuals with pre-existing allergy.", {"entities": []}], ["We sought to evaluate the effect of short-term feeding of GM Bacillus thuringiensis ( Bt )-maize (MON810) on the initiation and relapse of allergic asthma in mice.", {"entities": [[139, 154, "DISEASE"], [148, 154, "DISEASE"]]}], ["BALB/c mice were provided a diet containing 33% GM or non-GM maize for up to 34 days either before ovalbumin (OVA)-induced experimental allergic asthma or disease relapse in mice with pre-existing allergy.", {"entities": [[136, 151, "DISEASE"], [145, 151, "DISEASE"]]}], ["We observed that GM-maize feeding did not affect OVA-induced eosinophilic airway and lung inflammation, mucus hypersecretion or OVA-specific antibody production at initiation or relapse of allergic asthma.", {"entities": [[189, 204, "DISEASE"], [198, 204, "DISEASE"]]}], ["There was no adjuvant effect upon GM-maize consumption on the onset or severity of allergic responses in a mouse model of allergic asthma.", {"entities": [[122, 137, "DISEASE"], [131, 137, "DISEASE"]]}], ["Objective : To understand and describe the meaning of medications for patients.", {"entities": []}], ["Methods : A metasynthesis of three different, yet complementary qualitative research studies, was conducted by two researchers.", {"entities": []}], ["The first study was a phenomenological study of patients\u2019 medication experiences that used unstructured interviews.", {"entities": []}], ["The second study was an ethnographic study of pharmaceutical care practice, which included participant observation, in-depth interviews and focus groups with patients of pharmaceutical care.", {"entities": []}], ["The third was a phenomenological study of the chronic illness experience of medically uninsured individuals in the United States and included an explicit aim to understand the medication experience within that context.", {"entities": []}], ["The two researchers who conducted these three qualitative studies that examined the medication experience performed the meta-synthesis.", {"entities": []}], ["The process began with the researchers reviewing the themes of the medication experience for each study.", {"entities": []}], ["The researchers then aggregated the themes to identify the overlapping and similar themes of the medication experience and which themes are sub-themes within another theme versus a unique theme of the medication experience.", {"entities": []}], ["The researchers then used the analytic technique, \u201cfree imaginative variation\u201d to determine the essential, structural themes of the medication experience.", {"entities": []}], ["Results : The meaning of medications for patients was captured as four themes of the medication experience: a meaningful encounter; bodily effects; unremitting nature; and exerting control.", {"entities": []}], ["The medication experience is an individual\u2019s subjective experience of taking a medication in his daily life.", {"entities": []}], ["It begins as an encounter with a medication.", {"entities": []}], ["It is an encounter that is given meaning before it occurs.", {"entities": []}], ["The experience may include positive or negative bodily effects.", {"entities": []}], ["The unremitting nature of a chronic medication often causes an individual to question the need for the medication.", {"entities": []}], ["Subsequently, the individual may exert control by altering the way he takes the medication and often in part because of the gained expertise with the medication in his own body.", {"entities": []}], ["Conclusion : The medication experience is a practice concept that serves to understand patients\u2019 experiences and to understand an individual patient\u2019s medication experience and medication-taking behaviors in order to meet his or her medication-related needs.", {"entities": []}], ["Publication of scientific articles related to khat ( Catha edulis ) in peer-reviewed journals is considered a measure of research productivity.", {"entities": []}], ["The principal objectives of this study were to quantify the research contribution related to khat at the global level, as well as to determine its relative growth rate, collaborative measures taken, productivity at the institutional level, and the most prolific journals publishing on the topic.", {"entities": []}], ["On the basis of title words related to khat, publications were identified for all data in Scopus bibliographic database\u2019s history up to December 31, 2014.", {"entities": []}], ["The research productivity for the top 10 countries was evaluated in relation to the population size and gross domestic product (GDP) in 2013.", {"entities": []}], ["The criteria were met by 651documents published in 51 countries.", {"entities": []}], ["The largest number of articles associated with khat was from the UK (15.2\u00a0%), followed by Yemen (10.3\u00a0%), the USA (9.7\u00a0%) and Ethiopia (9.1\u00a0%).", {"entities": []}], ["Ethiopia, Yemen, and Kenya had the highest productivity of publications after standardization by population size and GDP.", {"entities": []}], ["Furthermore, Yemen achieved the highest number of collaborations, by having researchers from 19 countries.", {"entities": []}], ["Ethiopia followed, having researchers from 16 countries.", {"entities": []}], ["This bibliometric study provides a demonstration for the worldwide research activity regarding khat.", {"entities": []}], ["The number of articles related to khat has increased rapidly over the last 10\u00a0years.", {"entities": []}], ["The present study is a good starting point to evaluate research activity in the field of khat.", {"entities": []}], ["Although the data shows a promising increase in the research activity, the quantity of khat-related research is still too little compared to the massive use of khat in certain countries.", {"entities": []}], ["Trachoma is a blinding disease usually caused by infection with Chlamydia trachomatis (Ct) serovars A, B, and C in the upper tarsal conjunctiva.", {"entities": [[0, 8, "DISEASE"]]}], ["Individuals in endemic regions are repeatedly infected with Ct throughout childhood.", {"entities": []}], ["A proportion of individuals experience prolonged or severe inflammatory episodes that are known to be significant risk factors for ocular scarring in later life.", {"entities": []}], ["Continued scarring often leads to trichiasis and in-turning of the eyelashes, which causes pain and can eventually cause blindness.", {"entities": [[121, 130, "DISEASE"]]}], ["The mechanisms driving the chronic immunopathology in the conjunctiva, which largely progresses in the absence of detectable Ct infection in adults, are likely to be multifactorial.", {"entities": []}], ["Socioeconomic status, education, and behavior have been identified as contributing to the risk of scarring and inflammation.", {"entities": []}], ["We focus on the contribution of host and pathogen genetic variation, bacterial ecology of the conjunctiva, and host epigenetic imprinting including small RNA regulation by both host and pathogen in the development of ocular pathology.", {"entities": []}], ["Each of these factors or processes contributes to pathogenic outcomes in other inflammatory diseases and we outline their potential role in trachoma.", {"entities": [[140, 148, "DISEASE"]]}], ["Alternative strategies are required to control the southern cattle tick, Rhipicephalus microplus , due to evolving resistance to commercially available acaricides.", {"entities": []}], ["This invasive ectoparasite is a vector of economically important diseases of cattle such as bovine babesiosis and anaplasmosis.", {"entities": [[99, 109, "DISEASE"]]}], ["An understanding of the biological intricacies underlying vector-host-pathogen interactions is required to innovate sustainable tick management strategies that can ultimately mitigate the impact of animal and zoonotic tick-borne diseases.", {"entities": []}], ["Tick saliva contains molecules evolved to impair host innate and adaptive immune responses, which facilitates blood feeding and pathogen transmission.", {"entities": []}], ["Antigen presenting cells are central to the development of robust T cell responses including Th1 and Th2 determination.", {"entities": []}], ["In this study we examined changes in co-stimulatory molecule expression and cytokine response of bovine macrophages exposed to salivary gland extracts (SGE) obtained from 2-3 day fed, pathogen-free adult R. microplus .", {"entities": []}], ["Peripheral blood-derived macrophages were treated for 1 hr with 1, 5, or 10 \u03bcg/mL of SGE followed by 1, 6, 24 hr of 1 \u03bcg/mL of lipopolysaccharide (LPS).", {"entities": [[56, 58, "GENE"], [110, 112, "GENE"], [56, 58, "GENE"], [110, 112, "GENE"]]}], ["Real-time PCR and cytokine ELISA were used to measure changes in co-stimulatory molecule expression and cytokine response.", {"entities": []}], ["Changes were observed in co-stimulatory molecule expression of bovine macrophages in response to R .", {"entities": []}], ["microplus SGE exposure.", {"entities": []}], ["After 6 hrs, CD86, but not CD80, was preferentially up-regulated on bovine macrophages when treated with 1 \u03bcg/ml SGE and then LPS, but not SGE alone.", {"entities": [[13, 17, "GENE"], [27, 31, "GENE"]]}], ["At 24 hrs CD80, CD86, and CD69 expression was increased with LPS, but was inhibited by the addition of SGE.", {"entities": [[10, 14, "GENE"], [16, 20, "GENE"], [26, 30, "GENE"]]}], ["SGE also inhibited LPS induced upregulation of TNF\u03b1, IFN\u03b3 and IL-12 cytokines, but did not alter IL-4 or CD40 mRNA expression.", {"entities": [[105, 109, "GENE"]]}], ["Molecules from the salivary glands of adult R. microplus showed bimodal concentration-, and time-dependent effects on differential up-regulation of CD86 in bovine macrophages activated by the TLR4-ligand, LPS.", {"entities": [[148, 152, "GENE"]]}], ["Up regulation of proinflammatory cytokines and IL-12, a Th1 promoting cytokine, were inhibited in a dose-dependent manner.", {"entities": []}], ["The co-stimulatory molecules CD80, as well as the cell activation marker, CD69, were also suppressed in macrophages exposed to SGE.", {"entities": [[29, 33, "GENE"], [74, 78, "GENE"]]}], ["Continued investigation of the immunomodulatory factors will provide the knowledge base to research and develop therapeutic or prophylactic interventions targeting R. microplus -cattle interactions at the blood-feeding interface.", {"entities": []}], ["ADAM8 belongs to a family of transmembrane proteins implicated in cell\u2013cell interactions, proteolysis of membrane proteins, and various aspects of carcinogenesis.", {"entities": [[0, 5, "GENE"]]}], ["In the present study, we aimed to evaluate the expression and function of ADAM8 in pancreatic cancer.", {"entities": [[83, 100, "DISEASE"], [94, 100, "DISEASE"], [74, 79, "GENE"]]}], ["ADAM8 mRNA levels were analysed by quantitative RT-PCR and correlated to patient survival.", {"entities": [[0, 5, "GENE"]]}], ["Immunohistochemistry was performed to localize ADAM8 in pancreatic tis-sues.", {"entities": [[47, 52, "GENE"]]}], ["Silencing of ADAM8 expression was carried out by transfection with specific siRNA oligonucleotides.", {"entities": [[13, 18, "GENE"]]}], ["Cell growth and invasion assays were used to assess the functional consequences of ADAM8 silencing.", {"entities": [[83, 88, "GENE"]]}], ["SELDI-TOF-MS was performed to detect the proteolytic activity of ADAM8 in pancreatic cancer cells.", {"entities": [[74, 91, "DISEASE"], [85, 91, "DISEASE"], [65, 70, "GENE"]]}], ["ADAM8 mRNA was significantly overexpressed in pancreatic ductal adenocarcinoma (PDAC) compared with normal pancreatic tissues (5.3-fold increase; P = 0.0008), and high ADAM8 mRNA and protein expression levels correlated with reduced survival time of PDAC patients ( P = 0.048 and P = 0.065, respectively).", {"entities": [[64, 78, "DISEASE"], [46, 78, "DISEASE"], [0, 5, "GENE"], [168, 173, "GENE"], [0, 5, "GENE"], [168, 173, "GENE"]]}], ["Silencing of ADAM8 expression did not significantly influence pancreatic cancer cell growth but suppressed invasiveness.", {"entities": [[62, 79, "DISEASE"], [73, 79, "DISEASE"], [13, 18, "GENE"]]}], ["In addition, decreased proteolytic activity was measured in cell culture supernatants following silencing of ADAM8.", {"entities": [[109, 114, "GENE"]]}], ["In conclusion, ADAM8 is overexpressed in PDAC, influences cancer cell invasiveness and correlates with reduced survival, suggesting that ADAM8 might be a potential target in pancreatic cancer therapy.", {"entities": [[174, 191, "DISEASE"], [58, 64, "DISEASE"], [185, 191, "DISEASE"], [15, 20, "GENE"], [137, 142, "GENE"], [15, 20, "GENE"], [137, 142, "GENE"]]}], ["Acute respiratory distress syndrome (ARDS) is a life-threatening critical illness, characterised by qualitative and quantitative surfactant compositional changes associated with premature airway collapse, gas-exchange abnormalities and acute hypoxic respiratory failure.", {"entities": [[250, 269, "DISEASE"], [27, 35, "DISEASE"]]}], ["The underlying mechanisms for this dysregulation in surfactant metabolisms are not fully explored.", {"entities": []}], ["Lack of therapeutic benefits from clinical trials, highlight the importance of detailed in-vivo analysis and characterisation of ARDS patients according to patterns of surfactant synthesis and metabolism.", {"entities": []}], ["Ten patients with moderate to severe ARDS were recruited.", {"entities": []}], ["Most (90%) suffered from pneumonia.", {"entities": [[25, 34, "DISEASE"]]}], ["They had an infusion of methyl -D 9 -choline chloride and small volume bronchoalveolar lavage fluid (BALF) was obtained at 0,6,12,24,48,72 and 96\u00a0hours.", {"entities": []}], ["Controls were healthy volunteers, who had BALF at 24 and 48\u00a0hours after methyl -D 9 -choline infusion.", {"entities": []}], ["Compositional analysis and enrichment patterns of stable isotope labelling of surfactant phosphatidylcholine (PC) was determined by electrospray ionisation mass spectrometry.", {"entities": [[110, 112, "GENE"]]}], ["BALF of patients with ARDS consisted of diminished total PC and fractional PC16:0/16:0 concentrations compared to healthy controls.", {"entities": [[57, 59, "GENE"]]}], ["Compositional analysis revealed, reductions in fractional compositions of saturated PC species with elevated levels of longer acyl chain unsaturated PC species.", {"entities": [[84, 86, "GENE"], [149, 151, "GENE"], [84, 86, "GENE"], [149, 151, "GENE"]]}], ["Molecular specificity of newly synthesised PC fraction showed time course variation, with lower PC16:0/16:0 composition at earlier time points, but achieved near equilibrium with endogenous composition at 48\u00a0hours after methyl -D 9 -choline infusion.", {"entities": [[43, 45, "GENE"]]}], ["The enrichment of methyl -D 9 -choline into surfactant total PC is nearly doubled in patients, with considerable variation between individuals.", {"entities": [[61, 63, "GENE"]]}], ["This study demonstrate significant alterations in composition and kinetics of surfactant PC extracted from ARDS patients.", {"entities": [[89, 91, "GENE"]]}], ["This novel approach may facilitate biochemical phenotyping of ARDS patients according to surfactant synthesis and metabolism, enabling individualised treatment approaches for the management of ARDS patients in the future.", {"entities": []}], ["To evaluate the effect size of oral corticosteroid treatment on eosinophilic bronchitis in asthma, through systematic review and meta-analysis.", {"entities": [[91, 97, "DISEASE"], [77, 87, "DISEASE"]]}], ["We systematically reviewed articles in the Medline, Cochrane Controlled Trials Register, EMBASE, and LILACS databases.", {"entities": []}], ["We selected studies meeting the following criteria: comparing at least two groups or time points (prednisone vs. control, prednisone vs. another drug, or pre- vs. post-treatment with prednisone); and evaluating parameters before and after prednisone use, including values for sputum eosinophils, sputum eosinophil cationic protein (ECP), and sputum IL-5-with or without values for post-bronchodilator FEV 1 -with corresponding 95% CIs or with sufficient data for calculation.", {"entities": [[401, 404, "GENE"]]}], ["The independent variables were the use, dose, and duration of prednisone treatment.", {"entities": []}], ["The outcomes evaluated were sputum eosinophils, IL-5, and ECP, as well as post-bronchodilator FEV 1 .", {"entities": [[94, 97, "GENE"]]}], ["The pooled analysis of the pre- vs. post-treatment data revealed a significant mean reduction in sputum eosinophils (\u21938.18%; 95% CI: 7.69-8.67; p < 0.001), sputum IL-5 (\u219383.64 pg/mL; 95% CI: 52.45-114.83; p < 0.001), and sputum ECP (\u2193267.60 \u00b5g/L; 95% CI: 244.57-290.63; p < 0.0001), as well as a significant mean increase in post-bronchodilator FEV 1 (\u21918.09%; 95% CI: 5.35-10.83; p < 0.001).", {"entities": [[345, 348, "GENE"]]}], ["In patients with moderate-to-severe eosinophilic bronchitis, treatment with prednisone caused a significant reduction in sputum eosinophil counts, as well as in the sputum levels of IL-5 and ECP.", {"entities": [[49, 59, "DISEASE"]]}], ["This reduction in the inflammatory response was accompanied by a significant increase in post-bronchodilator FEV 1 .", {"entities": [[109, 112, "GENE"]]}], ["To develop and validate a recombinant vaccine to attenuate inflammation in arthritis by sustained neutralization of the anaphylatoxin C5a.", {"entities": [[75, 84, "DISEASE"]]}], ["We constructed and expressed fusion protein of C5a and maltose binding protein.", {"entities": []}], ["Efficacy of specific C5a neutralization was tested using the fusion protein as vaccine in three different arthritis mouse models: collagen induced arthritis (CIA), chronic relapsing CIA and collagen antibody induced arthritis (CAIA).", {"entities": [[106, 115, "DISEASE"], [147, 156, "DISEASE"], [216, 225, "DISEASE"]]}], ["Levels of anti-C5a antibodies and anti-collagen type II were measured by ELISA.", {"entities": []}], ["C5a neutralization assay was done using a rat basophilic leukemia cell-line transfected with the human C5aR.", {"entities": [[57, 65, "DISEASE"]]}], ["Complement activity was determined using a hemolytic assay and joint morphology was assessed by histology.", {"entities": []}], ["Vaccination of mice with MBP-C5a led to significant reduction of arthritis incidence and severity but not anti-collagen antibody synthesis.", {"entities": [[65, 74, "DISEASE"]]}], ["Histology of the MBP-C5a and control (MBP or PBS) vaccinated mice paws confirmed the vaccination effect.", {"entities": [[17, 20, "GENE"], [38, 41, "GENE"]]}], ["Sera from the vaccinated mice developed C5a-specific neutralizing antibodies, however C5 activation and formation of the membrane attack complex by C5b were not significantly altered.", {"entities": [[86, 88, "GENE"]]}], ["Exploitation of host immune response to generate sustained C5a neutralizing antibodies without significantly compromising C5/C5b activity is a useful strategy for developing an effective vaccine for antibody mediated and C5a dependent inflammatory diseases.", {"entities": []}], ["Further developing of such a therapeutic vaccine would be more optimal and cost effective to attenuate inflammation without affecting host immunity.", {"entities": []}], ["Primary ciliary dyskinesia (PCD) is a chronic respiratory disease for which there is little psycho-social research and no qualitative studies of individuals living with the condition.", {"entities": []}], ["A questionnaire-based survey in 2003 found evidence of stigmatisation in some individuals with PCD.", {"entities": []}], ["Although the questionnaire had face and construct validity, stigmatisation was not cross-validated against interviews.", {"entities": []}], ["The present study had the twin aims of carrying out a qualitative study of the adult patients living with PCD, and using a structured design to validate the questionnaire measure of stigma.", {"entities": []}], ["Interviews were carried out with six pairs of individuals with PCD, matched for sex, situs, and age, one with a high stigma score in 2003 and the other with a low stigma score.", {"entities": []}], ["Depth-qualitative interviews were conducted by one author to explore themes surrounding the psycho-social impact of PCD using a grounded theory analysis.", {"entities": []}], ["The interviewer was blind to the stigma scores of participants, and after the qualitative analysis was completed, the interviewer made an assessment of which member of each pair seemed the more stigmatised, after which the code was broken.", {"entities": []}], ["Interviews revealed a number of themes, including other people's knowledge of PCD, the sharing of knowledge about PCD, the concealment of symptoms of PCD, embarrassment at symptoms, changes of behaviour in response to PCD, mistrust of medical care, in particular in relation to problems in diagnosis, a mistrust of general practitioners who were seen as poorly informed, and the importance of expert care at tertiary referral centres.", {"entities": []}], ["Although stigmatisation as such was rarely mentioned directly by respondents, when the interviewer's judgement on level of stigmatisation was correlated with stigma scores from 2003, it was found that the more stigmatised member had been correctly identified in all six pairs (p = .016).", {"entities": []}], ["Our results suggest that some people with PCD feel isolated through mistrust in medicine, and lack of knowledge surrounding PCD.", {"entities": []}], ["Many responses to PCD can be explained in terms of stigmatisation, and in particular felt stigma.", {"entities": []}], ["The correlation between questionnaire used several years previously, and the interviewer's judgements of stigmatisation suggest that the stigma questionnaire had both predictive validity and long-term stability.", {"entities": []}], ["As in other chronic conditions, stigmatisation occurs only in some individuals with PCD, and the present study explores the basis of stigmatisation, and validate the questionnaire as a measure of difference in stigma.", {"entities": []}], ["Mast cells (MCs) are key effector cells of IgE-Fc\u03b5RI- or MrgprX2-mediated signaling event.", {"entities": []}], ["Shuang-Huang-Lian (SHL), a herbal formula from Chinese Pharmacopoeia, has been clinically used in type I hypersensitivity.", {"entities": []}], ["Our previous study demonstrated that SHL exerted a non-negligible effect on MC stabilization.", {"entities": []}], ["Herein, we sought to elucidate the molecular mechanisms of the prominent anti-allergic ability of SHL.", {"entities": []}], ["MrgprX2- and IgE-Fc\u03b5RI-mediated MC activation in vitro and in vivo models were developed by using compound 48/80 (C48/80) and shrimp tropomyosin (ST), respectively.", {"entities": []}], ["Our data showed that SHL markedly dampened C48/80- or ST-induced MC degranulation in vitro and in vivo .", {"entities": []}], ["Mechanistic study indicated that cytosolic Ca [c] ) level decreased rapidly and sustainably after SHL treatment, and then returned to homeostasis when SHL was withdrawn.", {"entities": []}], ["Moreover, SHL decreases Ca [c] levels mainly through enhancing the mitochondrial Ca [m] ) uptake.", {"entities": []}], ["After genetically silencing or pharmacologic inhibiting mitochondrial calcium uniporter (MCU), the effect of SHL on the Ca [c] level and MC degranulation was significantly weakened.", {"entities": []}], ["Simultaneously, the activation of SHL on Ca [m] uptake was completely lost.", {"entities": []}], ["Collectively, by activating MCU, SHL decreases Ca [c] level to stabilize MCs, thus exerting a remarkable anti-allergic activity, which could have considerable influences on clinical practice and research.", {"entities": []}], ["Secondhand smoke (SHS) causes many deaths.", {"entities": []}], ["Inequalities in SHS have been reported in several countries; however, the evidence in Asian countries is scarce.", {"entities": []}], ["We aimed to investigate the association between socioeconomic status (SES) and SHS at home and the workplace/school among non-smoking Japanese adults.", {"entities": []}], ["Cross-sectional data from the Miyagi Prefectural Health Survey 2014 were analyzed.", {"entities": []}], ["Self-reported questionnaires were randomly distributed to residents \u226520 years of age and 2,443 (92.8%) responded.", {"entities": []}], ["The data of the 1,738 and 1,003 respondents were included to the analyses for SHS in the past month at home and at the workplace/school, respectively.", {"entities": []}], ["Ordered logistic regression models considering possible confounders, including knowledge of the adverse health effects of tobacco, were applied.", {"entities": []}], ["The prevalence of SHS at home and the workplace/school was 19.0% and 39.0%, respectively.", {"entities": []}], ["Compared with \u226513 years of education, odds ratios (ORs) and 95% confidence intervals (CIs) for SHS at home were 1.94 (95% CI, 1.42\u20132.64) for 10\u201312 years and 3.00 (95% CI, 1.95\u20134.60) for \u22649 years; those for SHS at the workplace/school were 1.80 (95% CI, 1.36\u20132.39) and 3.82 (95% CI, 2.29\u20136.36), respectively.", {"entities": []}], ["Knowledge of the adverse health effects of tobacco was significantly associated with lower SHS at home (OR 0.95; 95% CI, 0.91\u20130.98) but it was not associated with SHS at the workplace/school (OR 1.02; 95% CI, 0.98\u20131.06).", {"entities": []}], ["Social inequalities in SHS existed among Japanese non-smoking adults.", {"entities": []}], ["Knowledge about tobacco was negatively associated with SHS at home but not at workplace/school.", {"entities": []}], ["To identify the major infiltrating phagocytes during leptospirosis and examine the killing mechanism used by the host to eliminate Leptospira interrogans .", {"entities": [[53, 66, "DISEASE"]]}], ["Major infiltrating phagocytes in Leptospira -infected C3H/HeJ mice were detected by immunohistochemistry.", {"entities": []}], ["Chemokines and vascular endothelial cell adhesion molecules (VECAMs) of Leptospira -infected mice and leptospirosis patients were detected by microarray and immunohistochemistry.", {"entities": [[102, 115, "DISEASE"]]}], ["Leptospira -phagocytosing and -killing abilities of human or mouse macrophages and neutrophils, and the roles of intracellular ROS, NO and [Ca Leptospira -killing process were evaluated by confocal microscopy and spectrofluorimetry.", {"entities": []}], ["Peripheral blood mononuclear-macrophages rather than neutrophils were the main infiltrating phagocytes in the lungs, liver and kidneys of infected mice.", {"entities": []}], ["Levels of macrophage- but not neutrophil-specific chemokines and VECAMs were significantly increased in the samples from infected mice and patients.", {"entities": []}], ["All macrophages tested had a higher ability than neutrophils to phagocytose and kill leptospires.", {"entities": []}], ["Higher ROS and NO levels and [Ca Mononuclear-macrophages but not neutrophils represent the main infiltrating and anti-leptospiral phagocytes during leptospirosis.", {"entities": [[148, 161, "DISEASE"]]}], ["A lower level of phagosome-lysosome fusion may be responsible for the lower Leptospira -killing ability of human macrophages.", {"entities": []}], ["Hematopoietic cell growth, differentiation, and chemotactic responses require coordinated action between cytokines and chemokines.", {"entities": []}], ["Cytokines promote receptor oligomerization, followed by Janus kinase (JAK) kinase activation, signal transducers and transactivators of transcription (STAT) nuclear translocation, and transcription of cytokine-responsive genes.", {"entities": []}], ["These include genes that encode a family of negative regulators of cytokine signaling, the suppressors of cytokine signaling (SOCS) proteins.", {"entities": []}], ["After binding their specific receptors, chemokines trigger receptor dimerization and activate the JAK/STAT pathway.", {"entities": []}], ["We show that SOCS3 overexpression or up-regulation, stimulated by a cytokine such as growth hormone, impairs the response to CXCL12, measured by Ca i pathways, without interfering with cell surface chemokine receptor expression.", {"entities": [[13, 18, "GENE"], [125, 131, "GENE"]]}], ["The data provide clear evidence for signaling cross-talk between cytokine and chemokine responses in building a functional immune system.", {"entities": []}], ["Pandemic influenza caused significant increases in healthcare utilization across several continents including the use of high-intensity rescue therapies like extracorporeal membrane oxygenation (ECMO) or high-frequency oscillatory ventilation (HFOV).", {"entities": [[9, 18, "DISEASE"]]}], ["The severity of illness observed with pandemic influenza in 2009 strained healthcare resources.", {"entities": [[47, 56, "DISEASE"]]}], ["Because lung injury in ARDS can be influenced by daily management and multiple organ failure, we performed a retrospective cohort study to understand the severity of H1N1 associated ARDS after adjustment for treatment.", {"entities": []}], ["Sixty subjects were identified in our hospital with ARDS from \u201cdirect injury\u201d within 24 hours of ICU admission over a three month period.", {"entities": []}], ["Twenty-three subjects (38.3%) were positive for H1N1 within 72 hours of hospitalization.", {"entities": []}], ["These cases of H1N1-associated ARDS were compared to non-H1N1 associated ARDS patients.", {"entities": []}], ["Subjects with H1N1-associated ARDS were younger and more likely to have a higher body mass index (BMI), present more rapidly and have worse oxygenation.", {"entities": []}], ["Severity of illness (SOFA score) was directly related to worse oxygenation.", {"entities": []}], ["Management was similar between the two groups on the day of admission and subsequent five days with respect to tidal volumes used, fluid balance and transfusion practices.", {"entities": []}], ["There was, however, more frequent use of \u201crescue\u201d therapy like prone ventilation, HFOV or ECMO in H1N1 patients.", {"entities": []}], ["First morning set tidal volumes and BMI were significantly associated with increased severity of lung injury (Lung injury score, LIS) at presentation and over time while prior prescription of statins was protective.", {"entities": []}], ["After assessment of the effect of these co-interventions LIS was significantly higher in H1N1 patients.", {"entities": []}], ["Patients with pandemic influenza-associated ARDS had higher LIS both at presentation and over the course of the first six days of treatment when compared to non-H1N1 associated ARDS controls.", {"entities": [[23, 32, "DISEASE"]]}], ["The difference in LIS persisted over the duration of observation in patients with H1N1 possibly explaining the increased duration of mechanical ventilation.", {"entities": []}], ["Mesenchymal Stem/Stromal Cells (MSCs) define a population of progenitor cells capable of giving rises to at least three mesodermal lineages in vitro, the chondrocytes, osteoblasts and adipocytes.", {"entities": []}], ["The validity of MSCs in vivo has been questioned because their existence, either as a homogeneous progenitor cell population or as a stem cell lineage, has been difficult to prove.", {"entities": []}], ["The wide use of primary MSCs in regenerative and therapeutic applications raises ethical and regulatory concerns in many countries.", {"entities": []}], ["In contrast to hematopoietic stem cells, a parallel concept which carries an embryological emphasis from its outset, MSCs have attracted little interest among developmental biologists and the embryological basis for their existence, or lack thereof, has not been carefully evaluated.", {"entities": []}], ["This article provides a brief, embryological overview of these three mesoderm cell lineages and offers a framework of ontological rationales for the potential existence of MSCs in vivo.", {"entities": []}], ["Emphasis is given to the common somatic lateral plate mesoderm origin of the majority of body\u2019s adipose and skeletal tissues and of the major sources used for MSC derivation clinically.", {"entities": [[159, 162, "GENE"]]}], ["Support for the MSC hypothesis also comes from a large body of molecular and lineage analysis data in vivo.", {"entities": [[16, 19, "GENE"]]}], ["It is concluded that despite the lack of a definitive proof, the MSC concept has a firm embryological basis and that advances in MSC research can be facilitated by achieving a better integration with developmental biology.", {"entities": [[65, 68, "GENE"], [129, 132, "GENE"], [65, 68, "GENE"], [129, 132, "GENE"]]}], ["Although the processes of haemostasis and thrombosis have been studied extensively in the past several decades, much of the effort has been spent characterizing the biological and biochemical aspects of clotting.", {"entities": []}], ["More recently, researchers have discovered that the function and physiology of blood cells and plasma proteins relevant in haematologic processes are mechanically, as well as biologically, regulated.", {"entities": []}], ["This is not entirely surprising considering the extremely dynamic fluidic environment that these blood components exist in.", {"entities": []}], ["Other cells in the body such as fibroblasts and endothelial cells have been found to biologically respond to their physical and mechanical environments, affecting aspects of cellular physiology as diverse as cytoskeletal architecture to gene expression to alterations of vital signalling pathways.", {"entities": []}], ["In the circulation, blood cells and plasma proteins are constantly exposed to forces while they, in turn, also exert forces to regulate clot formation.", {"entities": []}], ["These mechanical factors lead to biochemical and biomechanical changes on the macro- to molecular scale.", {"entities": []}], ["Likewise, biochemical and biomechanical alterations in the microenvironment can ultimately impact the mechanical regulation of clot formation.", {"entities": []}], ["The ways in which these factors all balance each other can be the difference between haemostasis and thrombosis.", {"entities": []}], ["Here, we review how the biomechanics of blood cells intimately interact with the cellular and molecular biology to regulate haemostasis and thrombosis in the context of health and disease from the macro- to molecular scale.", {"entities": []}], ["We will also show how these biomechanical forces in the context of haemostasis and thrombosis have been replicated or measured in vitro .", {"entities": []}], ["Background: Indigenous American communities face disproportionate health burdens and environmental health risks compared with the average North American population.", {"entities": []}], ["These health impacts are issues of both environmental and reproductive justice.", {"entities": []}], ["Objectives: In this commentary, we review five indigenous communities in various stages of environmental health research and discuss the intersection of environmental health and reproductive justice issues in these communities as well as the limitations of legal recourse.", {"entities": []}], ["Discussion: The health disparities impacting life expectancy and reproductive capabilities in indigenous communities are due to a combination of social, economic, and environmental factors.", {"entities": []}], ["The system of federal environmental and Indian law is insufficient to protect indigenous communities from environmental contamination.", {"entities": []}], ["Many communities are interested in developing appropriate research partnerships in order to discern the full impact of environmental contamination and prevent further damage.", {"entities": []}], ["Conclusions: Continued research involving collaborative partnerships among scientific researchers, community members, and health care providers is needed to determine the impacts of this contamination and to develop approaches for remediation and policy interventions.", {"entities": []}], ["The Ginkgo biloba is one of ancient trees that exists from billions of years ago, its leaf and nut are used as herbs and foods in China, while so far its pollen does not have any application except pollination.", {"entities": []}], ["In order to evaluate the antioxidant activity of Ginkgo biloba pollen, and rapidly screen its antioxidative components, the 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging ability, total flavonoid, total phenol, and proanthocyanidin of Ginkgo biloba pollen were determined and compared with those of Ginkgo biloba leaf and nut, and the off-line DPPH-HPLC-PAD and HPLC-ESI-MS Ginkgo biloba pollen.", {"entities": []}], ["The results showed that the DPPH scavenging ability of Ginkgo biloba pollen was much higher than Ginkgo biloba nut, but lower than Ginkgo biloba leaf, while the total content of flavonoid in Ginkgo biloba pollen was approximately 4.37 times higher than in Ginkgo biloba leaf.", {"entities": []}], ["Further studies found that the major flavonol aglycone in Ginkgo biloba pollen was kaempferol, which accounted for 96.71% of the total aglycones (includes quercetin, kaempferol and isorhamnetin), and the main flavonoid components in Ginkgo biloba pollen were flavonoid glycosides.", {"entities": []}], ["Finally, ten antioxidant peaks were screened and identified to be flavonoids (including kaempferol and nine flavonoid glycosides), so flavonoids were likely to be the main antioxidant components in GP, and among them, three novel kaempferol glycosides (peaks 1, 2, and 3) were found in Ginkgo biloba pollen for the first time, which had never been found in Ginkgo biloba .", {"entities": []}], ["Microarrays are a powerful tool that have multiple applications both in clinical and cell biology arenas of common lung diseases.", {"entities": []}], ["To exemplify how this tool can be useful, in this review, we will provide an overview of the application of microarray technology in research relevant to common lung diseases and present some of the future perspectives.", {"entities": []}], ["To compare the proportion of Beijing children who have ever had pneumonia ( %Pneumonia ) to those in other locations, and to estimate by how much national vaccine coverage with Pneumococcal Conjugate Vaccine (PCV) and Haemophilus Influenzae Type b (Hib) could reduce Beijing %Pneumonia .", {"entities": [[64, 73, "DISEASE"], [77, 86, "DISEASE"], [276, 285, "DISEASE"]]}], ["%Pneumonia was obtained for each age group from 1 to 8 years inclusive from 5,876 responses to a cross-sectional questionnaire.", {"entities": [[1, 10, "DISEASE"]]}], ["Literature searches were conducted for world-wide reports of %Pneumonia .", {"entities": [[62, 71, "DISEASE"]]}], ["Previous vaccine trials conducted worldwide were used to estimate the pneumococcal ( S .", {"entities": []}], ["pneumoniae ) and Hib ( H .", {"entities": []}], ["influenzae) burdens and %Pneumonia as well as the potential for PCV and Hib vaccines to reduce Beijing children\u2019s %Pneumonia .", {"entities": [[25, 34, "DISEASE"], [115, 124, "DISEASE"]]}], ["The majority of pneumonia cases occurred by the age of three.", {"entities": [[16, 25, "DISEASE"]]}], ["The cumulative %Pneumonia for 3\u20138 year-old Beijing children, 26.9%, was only slightly higher than the 25.4% for the discrete 3 year-old age group, similar to trends for Tianjin (China) and Texas (USA).", {"entities": [[16, 25, "DISEASE"]]}], ["Beijing\u2019s %Pneumonia is disproportionally high relative to its Gross National Income (GNI) per capita, and markedly higher than %Pneumonia in the US and other high GNI per capita countries.", {"entities": [[11, 20, "DISEASE"], [129, 138, "DISEASE"]]}], ["Chinese diagnostic guidelines recommend chest X-ray confirmation while most other countries discourage it in favor of clinical diagnosis.", {"entities": []}], ["Literature review shows that chest X-ray confirmation returns far fewer pneumonia diagnoses than clinical diagnosis.", {"entities": [[72, 81, "DISEASE"]]}], ["Accordingly, Beijing\u2019s %Pneumonia is likely higher than indicated by raw numbers.", {"entities": [[24, 33, "DISEASE"]]}], ["Vaccine trials suggest that national PCV and Hib vaccination could reduce Beijing\u2019s %Pneumonia from 26.9% to 19.7% and 24.9% respectively.", {"entities": [[85, 94, "DISEASE"]]}], ["National PCV and Hib vaccination programs would substantially reduce Beijing children\u2019s pneumonia incidence.", {"entities": [[88, 97, "DISEASE"]]}], ["G protein-coupled receptor 4 (GPR4), previously proposed as the receptor for sphingosylphosphorylcholine, has recently been identified as the proton-sensing G protein-coupled receptor (GPCR) coupling to multiple intracellular signaling pathways, including the G s protein/cAMP and G 13 protein/Rho.", {"entities": [[30, 34, "GENE"]]}], ["In the present study, we characterized some imidazopyridine compounds as GPR4 modulators that modify GPR4 receptor function.", {"entities": [[73, 77, "GENE"], [101, 105, "GENE"], [73, 77, "GENE"], [101, 105, "GENE"]]}], ["In the cells that express proton-sensing GPCRs, including GPR4, OGR1, TDAG8, and G2A, extracellular acidification stimulates serum responsive element (SRE)-driven transcriptional activity, which has been shown to reflect Rho activity, with different proton sensitivities.", {"entities": [[58, 62, "GENE"]]}], ["Imidazopyridine compounds inhibited the moderately acidic pH-induced SRE activity only in GPR4-expressing cells.", {"entities": []}], ["Acidic pH-stimulated cAMP accumulation, mRNA expression of inflammatory genes, and GPR4 internalization within GPR4-expressing cells were all inhibited by the GPR4 modulator.", {"entities": [[83, 87, "GENE"], [111, 115, "GENE"], [159, 163, "GENE"], [83, 87, "GENE"], [111, 115, "GENE"], [159, 163, "GENE"]]}], ["We further compared the inhibition property of the imidazopyridine compound with psychosine, which has been shown to selectively inhibit actions induced by proton-sensing GPCRs, including GPR4.", {"entities": [[188, 192, "GENE"]]}], ["In the GPR4 mutant, in which certain histidine residues were mutated to phenylalanine, proton sensitivity was significantly shifted to the right, and psychosine failed to further inhibit acidic pH-induced SRE activation.", {"entities": [[7, 11, "GENE"]]}], ["On the other hand, the imidazopyridine compound almost completely inhibited acidic pH-induced action in mutant GPR4.", {"entities": [[111, 115, "GENE"]]}], ["We conclude that some imidazopyridine compounds show specificity to GPR4 as negative allosteric modulators with a different action mode from psychosine, an antagonist susceptible to histidine residues, and are useful for characterizing GPR4-mediated acidic pH-induced biological actions.", {"entities": [[68, 72, "GENE"], [236, 240, "GENE"]]}], ["Methamphetamine is one of the fastest growing illicit drugs worldwide, causing multiple organ damage and excessive natural deaths.", {"entities": []}], ["The authors aimed to identify potential laboratory indices and clinical characteristics associated with natural death through a two-phase study.", {"entities": []}], ["Methamphetamine-dependent patients (n\u200a=\u200a1,254) admitted to a psychiatric center in Taiwan between 1990 and 2007 were linked with a national mortality database for causes of death.", {"entities": []}], ["Forty-eight subjects died of natural causes, and were defined as the case subjects.", {"entities": []}], ["A time-efficient sex- and age-matched nested case-control study derived from the cohort was conducted first to explore the potential factors associated with natural death through a time-consuming standardized review of medical records.", {"entities": []}], ["Then the identified potential factors were evaluated in the whole cohort to validate the findings.", {"entities": []}], ["In phase I, several potential factors associated with natural death were identified, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), comorbid alcohol use disorder, and the prescription of antipsychotic drugs.", {"entities": []}], ["In phase II, these factors were confirmed in the whole cohort using survival analysis.", {"entities": []}], ["For the characteristics at the latest hospital admission, Cox proportional hazards models showed that the adjusted hazard ratios for natural death were 6.75 ( p <0.001) in the group with markedly elevated AST (>80 U/L) and 2.66 ( p <0.05) in the group with mildly elevated AST (40\u201380 U/L), with reference to the control group (<40 U/L).", {"entities": []}], ["As for ALT, the adjusted hazard ratios were 5.41 ( p <0.001), and 1.44 ( p >0.05).", {"entities": []}], ["Comorbid alcohol use disorder was associated with an increased risk of natural death, whereas administration of antipsychotic drugs was not associated with lowered risk.", {"entities": []}], ["This study highlights the necessity of intensive follow-up for those with elevated AST and ALT levels and comorbid alcohol use disorder for preventing excessive natural deaths.", {"entities": []}], ["Protein and mRNA expression are in most cases poorly correlated, which suggests that the posttranscriptional regulatory program of a cell is an important component of gene expression.", {"entities": []}], ["This regulatory network is still poorly understood, including how RNA structure quantitatively contributes to translational control.", {"entities": []}], ["We present here a series of structural and functional experiments that together allow us to derive a quantitative, structure-dependent model of translation that accurately predicts translation efficiency in reporter assays and primary human tissue for a complex and medically important protein, \u03b1-1-antitrypsin.", {"entities": []}], ["Our model demonstrates the importance of accurate, experimentally derived RNA structural models partnered with Kozak sequence information to explain protein expression and suggests a strategy by which \u03b1-1-antitrypsin expression may be increased in diseased individuals.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) affects over 65 million individuals worldwide, where \u03b1-1-antitrypsin deficiency is a major genetic cause of the disease.", {"entities": []}], ["The \u03b1-1-antitrypsin gene, SERPINA1 , expresses an exceptional number of mRNA isoforms generated entirely by alternative splicing in the 5\u2032-untranslated region (5\u2032-UTR).", {"entities": [[26, 34, "GENE"]]}], ["Although all SERPINA1 mRNAs encode exactly the same protein, expression levels of the individual mRNAs vary substantially in different human tissues.", {"entities": [[13, 21, "GENE"]]}], ["We hypothesize that these transcripts behave unequally due to a posttranscriptional regulatory program governed by their distinct 5\u2032-UTRs and that this regulation ultimately determines \u03b1-1-antitrypsin expression.", {"entities": []}], ["Using whole-transcript selective 2\u2032-hydroxyl acylation by primer extension (SHAPE) chemical probing, we show that splicing yields distinct local 5\u2032-UTR secondary structures in SERPINA1 transcripts.", {"entities": [[176, 184, "GENE"]]}], ["Splicing in the 5\u2032-UTR also changes the inclusion of long upstream ORFs (uORFs).", {"entities": []}], ["We demonstrate that disrupting the uORFs results in markedly increased translation efficiencies in luciferase reporter assays.", {"entities": []}], ["These uORF-dependent changes suggest that \u03b1-1-antitrypsin protein expression levels are controlled at the posttranscriptional level.", {"entities": []}], ["A leaky-scanning model of translation based on Kozak translation initiation sequences alone does not adequately explain our quantitative expression data.", {"entities": []}], ["However, when we incorporate the experimentally derived RNA structure data, the model accurately predicts translation efficiencies in reporter assays and improves \u03b1-1-antitrypsin expression prediction in primary human tissues.", {"entities": []}], ["Our results reveal that RNA structure governs a complex posttranscriptional regulatory program of \u03b1-1-antitrypsin expression.", {"entities": []}], ["Crucially, these findings describe a mechanism by which genetic alterations in noncoding gene regions may result in \u03b1-1-antitrypsin deficiency.", {"entities": []}], ["A qualitative review of the epidemiological literature on the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) and health after 2001 is presented.", {"entities": []}], ["In order to compare the exposure of the general population, bystanders and occupational groups, their urinary levels were also reviewed.", {"entities": []}], ["In the general population, 2,4-D exposure is at or near the level of detection (LOD).", {"entities": []}], ["Among individuals with indirect exposure, i.e.", {"entities": []}], ["bystanders, the urinary 2,4-D levels were also very low except in individuals with opportunity for direct contact with the herbicide.", {"entities": []}], ["Occupational exposure, where exposure was highest, was positively correlated with behaviors related to the mixing, loading and applying process and use of personal protection.", {"entities": []}], ["Information from biomonitoring studies increases our understanding of the validity of the exposure estimates used in epidemiology studies.", {"entities": []}], ["The 2,4-D epidemiology literature after 2001 is broad and includes studies of cancer, reproductive toxicity, genotoxicity, and neurotoxicity.", {"entities": [[78, 84, "DISEASE"]]}], ["In general, a few publications have reported statistically significant associations.", {"entities": []}], ["However, most lack precision and the results are not replicated in other independent studies.", {"entities": []}], ["In the context of biomonitoring, the epidemiology data give no convincing or consistent evidence for any chronic adverse effect of 2,4-D in humans.", {"entities": []}], ["Although evidence exists that regulatory T cells (Tregs) can suppress the effector phase of immune responses, it is clear that their major role is in suppressing T cell priming in secondary lymphoid organs.", {"entities": []}], ["Recent experiments using two photon laser microscopy indicate that dendritic cells (DCs) are central to Treg cell function and that the in vivo mechanisms of T cell regulation are more complex than those described in vitro .", {"entities": []}], ["Here we have sought to determine whether and how modulation of Treg numbers modifies the lymph node (LN) microenvironment.", {"entities": []}], ["We found that pro-inflammatory chemokines\u2014CCL2 (MCP-1) and CCL3 (MIP-la)\u2014are secreted in the LN early (24 h) after T cell activation, that this secretion is dependent on antigen-specific DC\u2013T cell interactions, and that it was inversely related to the frequency of Tregs specific for the same antigen.", {"entities": [[59, 63, "GENE"]]}], ["Furthermore, we demonstrate that Tregs modify the chemoattractant properties of antigen-presenting DCs, which, as the frequency of Tregs increases, fail to produce CCL2 and CCL3 and to attract antigen-specific T cells.", {"entities": [[164, 168, "GENE"], [173, 177, "GENE"]]}], ["These results substantiate a major role of Tregs in LN patterning during antigen-specific immune responses.", {"entities": []}], ["Glucocorticoids (GCs) play a key role in the treatment of seasonal allergic rhinitis (SAR).", {"entities": [[67, 84, "DISEASE"], [76, 84, "DISEASE"]]}], ["However, some patients show a low response to GC treatment.", {"entities": [[46, 48, "GENE"]]}], ["We hypothesized that proteins that correlated to discrimination between symptomatic high and low responders (HR and LR) to GC treatment might be regulated by GCs and therefore suitable as biomarkers for GC treatment.", {"entities": [[109, 111, "GENE"], [123, 125, "GENE"], [203, 205, "GENE"], [123, 125, "GENE"], [203, 205, "GENE"]]}], ["We identified 953 nasal fluid proteins in symptomatic HR and LR with a LC MS/MS based-quantitative proteomics analysis and performed multivariate analysis to identify a combination of proteins that best separated symptomatic HR and LR.", {"entities": [[54, 56, "GENE"], [225, 227, "GENE"], [54, 56, "GENE"], [225, 227, "GENE"]]}], ["Pathway analysis showed that those proteins were most enriched in the acute phase response pathway .", {"entities": []}], ["We prioritized candidate biomarkers for GC treatment based on the multivariate and pathway analysis.", {"entities": [[40, 42, "GENE"]]}], ["Next, we tested if those candidate biomarkers differed before and after GC treatment in nasal fluids from 40 patients with SAR using ELISA.", {"entities": [[72, 74, "GENE"]]}], ["Several proteins including ORM (P<0.0001), APOH (P<0.0001), FGA (P<0.01), CTSD (P<0.05) and SERPINB3 (P<0.05) differed significantly before and after GC treatment.", {"entities": [[43, 47, "GENE"], [60, 63, "GENE"], [74, 78, "GENE"], [92, 100, "GENE"], [150, 152, "GENE"]]}], ["Particularly, ORM (P<0.01), FGA (P<0.05) and APOH (P<0.01) that belonged to the acute phase response pathway decreased significantly in HR but not LR before and after GC treatment.", {"entities": [[28, 31, "GENE"], [45, 49, "GENE"], [136, 138, "GENE"], [167, 169, "GENE"]]}], ["We identified several novel biomarkers for GC treatment response in SAR with combined proteomics, multivariate and pathway analysis.", {"entities": [[43, 45, "GENE"]]}], ["The analytical principles may be generally applicable to identify biomarkers in clinical studies of complex diseases.", {"entities": []}], ["The etiology of respiratory allergies (RA) can be partly explained by DNA methylation changes caused by adverse environmental and lifestyle factors experienced early in life.", {"entities": []}], ["Longitudinal, prospective studies can aid in the unravelment of the epigenetic mechanisms involved in the disease development.", {"entities": []}], ["High compliance rates can be expected in these studies when data is collected using non-invasive and convenient procedures.", {"entities": []}], ["Saliva is an attractive biofluid to analyze changes in DNA methylation patterns.", {"entities": []}], ["We investigated in a pilot study the differential methylation in saliva of RA (n = 5) compared to healthy controls (n = 5) using the Illumina Methylation 450K BeadChip platform.", {"entities": []}], ["We evaluated the results against the results obtained in mononuclear blood cells from the same individuals.", {"entities": []}], ["Differences in methylation patterns from saliva and mononuclear blood cells were clearly distinguishable (P Adj <0.001 and |\u0394\u03b2|>0.2), though the methylation status of about 96% of the cg-sites was comparable between peripheral blood mononuclear cells and saliva.", {"entities": []}], ["When comparing RA cases with healthy controls, the number of differentially methylated sites (DMS) in saliva and blood were 485 and 437 (P<0.05 and |\u0394\u03b2|>0.1), respectively, of which 216 were in common.", {"entities": []}], ["The methylation levels of these sites were significantly correlated between blood and saliva.", {"entities": []}], ["The absolute levels of methylation in blood and saliva were confirmed for 3 selected DMS in the PM20D1 , STK32C , and FGFR2 genes using pyrosequencing analysis.", {"entities": [[96, 102, "GENE"], [118, 123, "GENE"]]}], ["The differential methylation could only be confirmed for DMS in PM20D1 and STK32C genes in saliva.", {"entities": [[64, 70, "GENE"]]}], ["We show that saliva can be used for genome-wide methylation analysis and that it is possible to identify DMS when comparing RA cases and healthy controls.", {"entities": []}], ["The results were replicated in blood cells of the same individuals and confirmed by pyrosequencing analysis.", {"entities": []}], ["This study provides proof-of-concept for the applicability of saliva-based whole-genome methylation analysis in the field of respiratory allergy.", {"entities": []}], ["To identify and appraise the quality of studies that primarily assessed the measurement properties of English language versions of multidimensional patient\u2010reported outcome measures ( PROM s) when evaluated with children with neurodisability, and to summarize this evidence.", {"entities": []}], ["MEDLINE , Embase, Psyc INFO , CINAHL , AMED , and the National Health Service Economic Evaluation Database were searched.", {"entities": []}], ["The methodological quality of the papers was assessed using the CO nsensus\u2010based Standards for selection of health Measurement IN struments checklist.", {"entities": []}], ["Evidence of content validity, construct validity, internal consistency, test\u2013retest reliability, proxy reliability, responsiveness, and precision was extracted and judged against standardized reference criteria.", {"entities": []}], ["We identified 48 studies of mostly fair to good methodological quality: 37 papers for seven generic PROM s ( CHIP , CHQ , CQ oL, KIDSCREEN , Peds QL , SLSS , and YQOL ), seven papers for two chronic\u2013generic PROM s ( DISABKIDS and Neuro\u2010 QOL ), and four papers for three preference\u2010based measures ( HUI , EQ \u20105D\u2010Y, and CHSCS \u2010 PS ).", {"entities": []}], ["On the basis of this appraisal, the DISABKIDS appears to have more supportive evidence in samples of children with neurodisability.", {"entities": []}], ["The overall lack of evidence for responsiveness and measurement error is a concern when using these instruments to measure change, or to interpret the findings of studies in which these PROM s have been used to assess change.", {"entities": []}], ["Patient\u2010reported outcome measures evaluated in children with cerebral palsy, epilepsy, attention\u2010deficit\u2010hyperactivity disorder, autism spectrum disorder, and traumatic brain injury.", {"entities": [[61, 75, "DISEASE"], [129, 153, "DISEASE"]]}], ["Variable methodological quality of studies; improved quality in more recent evaluations.", {"entities": []}], ["Evidence lacking for instruments to assess meaningful changes in health.", {"entities": []}], ["Patient\u2010reported outcome measures evaluated in children with cerebral palsy, epilepsy, attention\u2010deficit\u2010hyperactivity disorder, autism spectrum disorder, and traumatic brain injury.", {"entities": [[61, 75, "DISEASE"], [129, 153, "DISEASE"]]}], ["Variable methodological quality of studies; improved quality in more recent evaluations.", {"entities": []}], ["Evidence lacking for instruments to assess meaningful changes in health.", {"entities": []}], ["This article is commented on by Knox on pages 427\u2013428 of this issue.", {"entities": []}], ["We sought to identify cells and cytokines in bronchoalveolar lavage (BAL) fluids that distinguish asthma from healthy control subjects and those that distinguish controlled asthma from uncontrolled asthma.", {"entities": [[98, 104, "DISEASE"], [173, 179, "DISEASE"], [198, 204, "DISEASE"]]}], ["Following informed consent, 36 human subjects were recruited for this study.", {"entities": []}], ["These included 11 healthy control subjects, 15 subjects with controlled asthma with FEV 1 \u226580% predicted and 10 subjects with uncontrolled asthma with FEV 1 <80% predicted.", {"entities": [[72, 78, "DISEASE"], [139, 145, "DISEASE"], [84, 87, "GENE"], [151, 154, "GENE"], [84, 87, "GENE"], [151, 154, "GENE"]]}], ["BAL fluid was obtained from all subjects.", {"entities": []}], ["The numbers of different cell types and the levels of 48 cytokines were measured in these fluids.", {"entities": []}], ["Compared to healthy control subjects, patients with asthma had significantly more percentages of eosinophils and neutrophils, IL-1RA, IL-1\u03b1, IL-1\u03b2, IL-2R\u03b1, IL-5, IL-6, IL-7, IL-8, G-CSF, GRO\u03b1 (CXCL1), MIP-1\u03b2 (CCL4), MIG (CXCL9), RANTES (CCL5) and TRAIL in their BAL fluids.", {"entities": [[52, 58, "DISEASE"], [193, 198, "GENE"], [209, 213, "GENE"], [221, 226, "GENE"], [237, 241, "GENE"]]}], ["The only inflammatory markers that distinguished controlled asthma from uncontrolled asthma were neutrophil percentage and IL-8 levels, and both were inversely correlated with FEV 1 .", {"entities": [[60, 66, "DISEASE"], [85, 91, "DISEASE"], [176, 179, "GENE"]]}], ["We examined whether grouping asthma subjects on the basis of BAL eosinophil % or neutrophil % could identify specific cytokine profiles.", {"entities": [[29, 35, "DISEASE"]]}], ["The only differences between neutrophil-normal asthma (neutrophil\u22642.4%) and neutrophil-high asthma (neutrophils%>2.4%) were a higher BAL fluid IL-8 levels, and a lower FEV 1 in the latter group.", {"entities": [[47, 53, "DISEASE"], [92, 98, "DISEASE"], [168, 171, "GENE"]]}], ["By contrast, compared to eosinophil-normal asthma (eosinophils\u22640.3%), eosinophil-high asthma (eosinophils>0.3%) had higher levels of IL-5, IL-13, IL-16, and PDGF-bb, but same neutrophil percentage, IL-8, and FEV 1 .", {"entities": [[43, 49, "DISEASE"], [86, 92, "DISEASE"], [208, 211, "GENE"]]}], ["Our results identify neutrophils and IL-8 are the only inflammatory components in BAL fluids that distinguish controlled asthma from uncontrolled asthma, and both correlate inversely with FEV 1 .", {"entities": [[121, 127, "DISEASE"], [146, 152, "DISEASE"], [188, 191, "GENE"]]}], ["Thrombin stimulation of human platelets results in the release of a preformed proteinaceous human eosinophil (Eo)-chemotactic activity.", {"entities": []}], ["By the use of different high-performance liquid chromatography techniques, two Eo-chemotactic polypeptides (EoCPs), tentatively termed EoCP-1 and EoCP-2, were purified to homogeneity.", {"entities": []}], ["Upon SDS-PAGE analysis, these chemotaxins showed molecular masses near 8 kD.", {"entities": []}], ["NH2-terminal amino acid sequence analysis revealed identical sequences for both EoCP-1 and EoCP- 2, which are also identical to that of RANTES, a cytokine that structurally belongs to the interleukin 8 superfamily of leukocyte selective attractants, and that is known to be a \"memory-type\" T lymphocyte-selective attractant.", {"entities": []}], ["In the major Eo chemotaxin, EoCP-1, the residues 4 and 5, which in EoCP-2 were found to be serine residues, could not be identified.", {"entities": []}], ["Electrospray mass spectrometry (ESP-MS) of EoCPs revealed for EoCP-2 a molecular mass of 7,862.8 +/- 1.1 daltons, which is 15.8 mass units higher than the calculated value of RANTES, indicating that EoCP-2 is identical to the full-length cytokine, and oxygenation, probably at methionine residue number 64, has taken place.", {"entities": []}], ["Upon ESP-MS, EoCP-1 showed an average molecular mass of 8,355 +/- 10 daltons, suggesting O-glycosylation at these serine residues.", {"entities": []}], ["Both natural forms of RANTES showed strong Eo-chemotactic activity (ED50 = 2 nM) with optimal chemotactic migration at concentrations near 10 nM, however, there were no significant migratory responses with human neutrophils.", {"entities": []}], ["Chemotactic activity of RANTES for human Eos could be confirmed using recombinant material, which has been found to be as active as the natural forms.", {"entities": []}], ["Since RANTES gene expression has been detected in activated T lymphocytes, and recombinant RANTES was shown to be a \"memory\" T lymphocyte-selective attractant, it is now tempting to speculate about an important role of RANTES in clinical situations such as allergene-induced late-phase skin reactions in atopic subjects or asthma, where in affected tissues both memory T cells and Eos are characteristic.", {"entities": [[323, 329, "DISEASE"]]}], ["Doctors and patients hold varying beliefs concerning illness and treatment.", {"entities": []}], ["Patients' and families' explanatory models (EMs) vary according to personality and sociocultural factors.", {"entities": []}], ["In a multi-ethnic society, it is becoming increasingly significant that doctors understand the different beliefs of their patients in order to improve patient/doctor communication as well as patient adherence to treatment.", {"entities": []}], ["Twelve focus groups were formed, consisting of 40 children diagnosed with asthma, as well as 28 mothers of these children.", {"entities": [[74, 80, "DISEASE"]]}], ["These groups included mothers and children of different ethnicities who were living in Amsterdam, the Netherlands.", {"entities": []}], ["In order to understand the beliefs that both mothers and children hold regarding asthma and its treatment, the explanatory models were analysed and compared.", {"entities": [[81, 87, "DISEASE"]]}], ["Study findings show that mothers and children, regardless of ethnicity and age, have their own EMs.", {"entities": []}], ["Overall, there is a great deal of uncertainty related to the causes, consequences, problems, and symptoms of asthma and its treatment.", {"entities": [[109, 115, "DISEASE"]]}], ["It also seems that many concerns and feelings of discomfort are the result of lack of knowledge.", {"entities": []}], ["For instance, the fact that asthma is not seen as a chronic disease requiring daily intake of an inhaled corticosteroid, but rather as an acute phenomenon triggered by various factors, may be very relevant for clinical practice.", {"entities": [[28, 34, "DISEASE"]]}], ["This particular belief might suggest an explanation for non-adherent behaviour.", {"entities": []}], ["A thorough understanding of the mothers' and children's beliefs regarding the illness and its treatment is an important aspect in the management of asthma.", {"entities": [[148, 154, "DISEASE"]]}], ["Gaining an understanding of these beliefs will provide a foundation for a solid clinician-patient/family partnership in asthma care.", {"entities": [[120, 126, "DISEASE"]]}], ["Although ethnic differences were observed, the similarities between the mothers' and children's beliefs in this multi-ethnic population were striking.", {"entities": []}], ["In particular, a common belief is that asthma is considered an acute rather than a chronic condition.", {"entities": [[39, 45, "DISEASE"]]}], ["In addition, there is a lack of knowledge about the course and the self-management of asthma.", {"entities": [[86, 92, "DISEASE"]]}], ["Health care providers should be aware of these commonly held beliefs, and this information could be shared in educational programs.", {"entities": []}], ["Children who are exposed to secondhand smoke (SHS) have an increased risk of a wide range of health problems and illnesses.", {"entities": []}], ["Smoke-free legislation aims to improve indoor air quality and in this way protect the health of people who do not smoke.", {"entities": []}], ["This paper examines trends in SHS exposure at home among children in Germany since the introduction of smoking bans in public places.", {"entities": []}], ["Special focus is placed on the importance of the family of origin\u2019s socioeconomic status (SES) and on parental smoking behaviour.", {"entities": []}], ["The analyses are based on two waves of the \u201cGerman Health Interview and Examination Survey for Children and Adolescents\u201d (KiGGS)\u2014one of which was conducted immediately before the introduction of central smoke-free legislation in the 2003-2006 period, the other approximately 6\u00a0years later from 2009 to 2012.", {"entities": []}], ["A comparison is made between the answers given by the parents of children aged between 0 to 6 (KiGGS baseline study, n \u2009=\u20096680; KiGGS Wave 1, n \u2009=\u20094455).", {"entities": []}], ["Domestic SHS exposure is covered in the parent interviews by asking whether anyone is allowed to smoke at home in the presence of their child.", {"entities": []}], ["Parental smoking behaviour is determined separately for mothers and fathers.", {"entities": []}], ["SES is determined on the basis of the parents\u2019 education, occupational status and income.", {"entities": []}], ["The percentage of 0- to 6-year-old children exposed to SHS in the parental home fell from 23.9 to 6.6\u00a0% in the period from 2003-2006 to 2009-2012.", {"entities": []}], ["At the same time, the percentage of children with at least one parent who smokes decreased from 49.8 to 41.8\u00a0%.", {"entities": []}], ["While relative social inequalities in parental smoking behaviour have tended to increase over time, inequalities in domestic SHS exposure have persisted.", {"entities": []}], ["Children whose parents smoke and children from low-SES families are still most likely to be exposed to tobacco smoke.", {"entities": []}], ["In both study periods and after statistical adjustment for parental smoking behaviour, children with a low SES had a 6.6-fold higher risk for SHS exposure in the parental home than children from high-SES households.", {"entities": []}], ["The results of the KiGGS study show that the proportion of children in Germany who are exposed to SHS at home has declined significantly over the last few years.", {"entities": []}], ["There is much to suggest that the smoke-free legislation that has been introduced in Germany has led to a heightened awareness of the health risks of SHS both in public and in the private sphere, as well as to a denormalization of smoking.", {"entities": []}], ["Children whose parents smoke, and among them particularly children from socially disadvantaged families, should be recognised as key target groups when implementing future tobacco-control measures.", {"entities": []}], ["Gene expression regulators, such as transcription factors (TFs) and microRNAs (miRNAs), have varying regulatory targets based on the tissue and physiological state (context) within which they are expressed.", {"entities": []}], ["While the emergence of regulator-characterizing experiments has inferred the target genes of many regulators across many contexts, methods for transferring regulator target genes across contexts are lacking.", {"entities": []}], ["Further, regulator target gene lists frequently are not curated or have permissive inclusion criteria, impairing their use.", {"entities": []}], ["Here, we present a method called iterative Contextual Transcriptional Activity Inference of Regulators (icTAIR) to resolve these issues.", {"entities": []}], ["icTAIR takes a regulator\u2019s previously-identified target gene list and combines it with gene expression data from a context, quantifying that regulator\u2019s activity for that context.", {"entities": []}], ["It then calculates the correlation between each listed target gene\u2019s expression and the quantitative score of regulatory activity, removes the uncorrelated genes from the list, and iterates the process until it derives a stable list of refined target genes.", {"entities": []}], ["To validate and demonstrate icTAIR\u2019s power, we use it to refine the MSigDB c3 database of TF, miRNA and unclassified motif target gene lists for breast cancer.", {"entities": [[145, 158, "DISEASE"], [152, 158, "DISEASE"], [75, 77, "GENE"], [90, 92, "GENE"]]}], ["We then use its output for survival analysis with clinicopathological multivariable adjustment in 7 independent breast cancer datasets covering 3,430 patients.", {"entities": [[112, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["We uncover many novel prognostic regulators that were obscured prior to refinement, in particular NFY, and offer a detailed look at the composition and relationships among the breast cancer prognostic regulome.", {"entities": [[176, 189, "DISEASE"], [183, 189, "DISEASE"]]}], ["We anticipate icTAIR will be of general use in contextually refining regulator target genes for discoveries across many contexts.", {"entities": []}], ["The icTAIR algorithm can be downloaded from https://github.com/icTAIR .", {"entities": []}], ["Gene expression regulators, such as transcription factors and microRNAs, are critical actors in cellular physiology and pathophysiology and act by modulating the expression levels of sets of target genes.", {"entities": []}], ["Given their significance, numerous experiments have sought to characterize the specific target genes of specific regulators, which in turn has led to regulator target gene list databases.", {"entities": []}], ["Unfortunately, these lists are plagued by poor curation and validation.", {"entities": []}], ["Further, all lists suffer from the fundamental issue that regulator targets vary across tissue type and physiological state, or \u201ccontext\u201d, making them poor for conducting downstream, context-specific analyses.", {"entities": []}], ["To address this issue, here we present a method called icTAIR that contextually-refines regulator target gene lists.", {"entities": []}], ["To demonstrate its value, we use icTAIR to take the largest-available database of regulator target gene lists, refine it for the breast cancer context, and use both the pre-refined and refined lists for downstream survival analyses in over 3,400 tumors.", {"entities": [[129, 142, "DISEASE"], [136, 142, "DISEASE"]]}], ["We find that icTAIR improves the statistical power of the analyses by multiple orders of magnitude.", {"entities": []}], ["This in turn lets us map the relational network of breast cancer regulators and identify regulators with prognostic effects even after clinicopathological adjustment.", {"entities": [[51, 64, "DISEASE"], [58, 64, "DISEASE"]]}], ["We anticipate icTAIR will be broadly useful in regulator studies.", {"entities": []}], ["Aluminum potroom exposure is associated with increased mortality of COPD but the association between potroom exposure and annual decline in lung function is unknown.", {"entities": []}], ["We have measured lung volumes annually using spirometry from 1986 to 1996.", {"entities": []}], ["The objective was to compare annual decline in forced expiratory volume in 1\u2009s (dFEV1) and forced vital capacity (dFVC).", {"entities": []}], ["The number of aluminum potroom workers was 4,546 (81% males) and the number of workers in the reference group was 651 (76% males).", {"entities": []}], ["The number of spirometries in the index group and the references were 24,060 and 2,243, respectively.", {"entities": []}], ["After adjustment for confounders, the difference in dFEV1 and dFVC between the index and reference groups were 13.5 ( P \u2009<\u20090.001) and \u22128.0 ( P \u2009=\u20090.060)\u2009ml/year.", {"entities": []}], ["Aluminum potroom operators have increased annual decline in FEV1 relative to a comparable group with non\u2010exposure to potroom fumes and gases.", {"entities": []}], ["59:322\u2013329, 2016.", {"entities": []}], ["\u00a9 2016 The Authors.", {"entities": []}], ["American Journal of Industrial Medicine Published by Wiley Periodicals, Inc.", {"entities": []}], ["Multiple sclerosis (MS) is thought to be a Th17-mediated dysimmune disease of the central nervous system.", {"entities": []}], ["However, recent publications have questioned the pathogenicity of IL-17 per se and rather suggest the implication of other Th17-related inflammatory mediators.", {"entities": []}], ["Therefore, we studied the expression of GM-CSF, IL-22, IL-24, IL-26 and CD39 in peripheral blood mononuclear cells (PBMCs) from MS patients during relapses, remission and following corticosteroid treatment.", {"entities": []}], ["We performed qPCR to measure mRNA levels from ex vivo or in vitro -stimulated PBMCs.", {"entities": []}], ["Cytokine levels were determined by ELISA.", {"entities": []}], ["We used flow cytometry to assess GM-CSF ex vivo by ivMP.", {"entities": []}], ["Our results contribute to a better characterisation of Th17, Th22 and ThGM-CSF cells in the setting of MS and according to disease activity.", {"entities": []}], ["Asthma is a clinical condition characterized by intermittent respiratory symptoms, nonspecific airway hyperresponsiveness, and reversible airway obstruction.", {"entities": [[0, 6, "DISEASE"]]}], ["Although the pathogenesis of asthma is incompletely understood, it is clear that airway inflammation is a paramount feature of the condition.", {"entities": [[29, 35, "DISEASE"]]}], ["Because inhalation of ozone by normal, healthy subjects causes increased airway responsiveness and inflammation, it is somewhat surprising that most controlled human exposure studies that have involved asthmatic subjects have not shown them to be especially sensitive to ozone.", {"entities": []}], ["The acute decrement in lung function that is the end point traditionally used to define sensitivity to ozone in these studies may be due more to neuromuscular mechanisms limiting deep inspiration than to bronchoconstriction.", {"entities": []}], ["The frequency of asthma attacks following ozone exposures may be a more relevant end point.", {"entities": [[17, 23, "DISEASE"]]}], ["Epidemiologic studies, rather than controlled human exposure studies, are required to determine whether ozone pollution increases the risk of asthma exacerbations.", {"entities": [[142, 148, "DISEASE"]]}], ["Asthma affects approximately 10 million people in the United States and, thus, the answer to this question is of considerable public health importance.", {"entities": [[0, 6, "DISEASE"]]}], ["Both the prevalence and severity of asthma appear to be increasing in many countries.", {"entities": [[36, 42, "DISEASE"]]}], ["Although increased asthma morbidity and mortality are probably of multifactorial etiology, a contributory role of urban air pollution is plausible.", {"entities": [[19, 25, "DISEASE"]]}], ["The epidemiologic database to support an association between asthma and ozone exposure is limited, but the results of several studies suggest such an association.", {"entities": [[61, 67, "DISEASE"]]}], ["Some potential approaches to further investigation of the relationship between asthma and ozone, including those that would link controlled human exposures to population-based studies, are considered.", {"entities": [[79, 85, "DISEASE"]]}], ["Well-documented air pollution episodes throughout recent history have led to deaths among individuals with cardiovascular and respiratory disease.", {"entities": []}], ["Although the components of air pollution that cause the adverse health effects in these individuals are unknown, a small proportion by mass but a large proportion by number of the ambient air particles are ultrafine, i.e., less than 100 nm in diameter.", {"entities": []}], ["This ultrafine component of particulate matter with a mass median aerodynamic diameter less than 10 microm (PM(10) may mediate some of the adverse health effects reported in epidemiologic studies and for which there is toxicologic evidence to support this contention.", {"entities": []}], ["The exact mechanism by which ultrafine particles have adverse effects is unknown, but these particles have recently been shown to enhance calcium influx on contact with macrophages.", {"entities": []}], ["Oxidative stress is also to be anticipated at the huge particle surface; this can be augmented by oxidants generated by recruited inflammatory leukocytes.", {"entities": []}], ["Atheromatous plaques form in the coronary arteries and are major causes of morbidity and death associated epidemiologically with particulate air pollution.", {"entities": []}], ["In populations exposed to air pollution episodes, blood viscosity, fibrinogen, and C-reactive protein (CRP) were higher.", {"entities": [[103, 106, "GENE"]]}], ["More recently, increases in heart rate in response to rising air pollution have been described and are most marked in individuals who have high blood viscosity.", {"entities": []}], ["In our study of elderly individuals, there were significant rises in CRP, an index of inflammation.", {"entities": [[69, 72, "GENE"]]}], ["In this present review, we consider the likely interactions between the ultrafine particles the acute phase response and cardiovascular disease.", {"entities": []}], ["The glycoprotein YKL-40 (CHI3L1) is a secreted chitinase family protein that induces angiogenesis, cell survival, and cell proliferation, and plays roles in tissue remodeling and immune regulation.", {"entities": [[25, 31, "GENE"]]}], ["It is expressed primarily in cells of mesenchymal origin, is overexpressed in numerous aggressive carcinomas and sarcomas, but is rarely expressed in normal ectodermal tissues.", {"entities": []}], ["Bone marrow-derived mesenchymal stem cells (MSCs) can be induced to differentiate into various mesenchymal tissues and trans-differentiate into some non-mesenchymal cell types.", {"entities": []}], ["Since YKL-40 has been used as a mesenchymal marker, we followed YKL-40 expression as undifferentiated MSCs were induced to differentiate into bone, cartilage, and neural phenotypes.", {"entities": []}], ["Undifferentiated MSCs contain significant levels of YKL-40 mRNA but do not synthesize detectable levels of YKL-40 protein.", {"entities": []}], ["MSCs induced to differentiate into chondrocytes and osteocytes soon began to express and secrete YKL-40 protein, as do ex vivo cultured chondrocytes and primary osteocytes.", {"entities": []}], ["In contrast, MSCs induced to trans-differentiate into neurons did not synthesize YKL-40 protein, consistent with the general absence of YKL-40 protein in normal CNS parenchyma.", {"entities": []}], ["However, these trans-differentiated neurons retained significant levels of YKL-40 mRNA, suggesting the mechanisms which prevented YKL-40 translation in undifferentiated MSCs remained in place, and that these trans-differentiated neurons differ in at least this way from neurons derived from neuronal stem cells.", {"entities": []}], ["Utilization of a differentiation protocol containing \u03b2-mercaptoethanol resulted in cells that expressed significant amounts of intracellular YKL-40 protein that was not secreted, which is not seen in normal cells.", {"entities": []}], ["Thus the synthesis of YKL-40 protein is a marker for MSC differentiation into mature mesenchymal phenotypes, and the presence of untranslated YKL-40 mRNA in non-mesenchymal cells derived from MSCs reflects differences between differentiated and trans-differentiated phenotypes.", {"entities": [[53, 56, "GENE"]]}], ["Energy drinks and highly caffeinated drinks comprise some of the fastest growing products of the beverage industry, often targeting teenagers and young adults.", {"entities": []}], ["Cardiac arrhythmias in children related to high caffeine consumption have not been well described in the literature.", {"entities": []}], ["This case series describes the possible association between the consumption of highly caffeinated drinks and the subsequent development of atrial fibrillation in the adolescent population.", {"entities": []}], ["We report the cases of two Caucasian adolescent boys of 14 and 16 years of age at the time of presentation, each without a significant cardiac history, who presented with palpitations or vague chest discomfort or both after a recent history of excessive caffeine consumption.", {"entities": []}], ["Both were found to have atrial fibrillation on electrocardiogram; one patient required digoxin to restore a normal sinus rhythm, and the other self-converted after intravenous fluid administration.", {"entities": []}], ["With the increasing popularity of energy drinks in the pediatric and adolescent population, physicians should be aware of the arrhythmogenic potential associated with highly caffeinated beverage consumption.", {"entities": []}], ["It is important for pediatricians to understand the lack of regulation in the caffeine content and other ingredients of these high-energy beverages and their complications so that parents and children can be educated about the risk of cardiac arrhythmias with excessive energy drink consumption.", {"entities": []}], ["Interleukin (IL)-33 is involved in T helper (Th)2-biased immune responses in mice infected with Schistosom a, but the precise mechanism remains to be elucidated.", {"entities": []}], ["Herein, we investigated the role of IL-33 and its receptor ST2L in hepatic granuloma pathology induced by Schistosoma japonicum infection.", {"entities": []}], ["We found that IL-33 induced the increased production of IL-5 and IL-13 from splenocytes and liver mononuclear cells (MNCs) of infected mice.", {"entities": []}], ["The infected mice developed significantly higher number of ST2L-expressing cells in spleen and liver.", {"entities": []}], ["Most of the ST2L-expressing cells in liver were F4/80 in vitro and ST2L-expressing macrophage displayed MHCII S. japonicum infection.", {"entities": []}], ["These data demonstrate that IL-33 contributes to hepatic granuloma pathology through induction of M2 macrophages during S. japonicum infection.", {"entities": []}], ["One in five children visiting a homeopathic physician suffers from atopic eczema.", {"entities": []}], ["We aimed to examine the long-term effectiveness, safety and costs of homoeopathic vs. conventional treatment in usual medical care of children with atopic eczema.", {"entities": []}], ["In this prospective multi-centre comparative observational non-randomized rater-blinded study, 135 children (48 homoeopathy, 87 conventional) with mild to moderate atopic eczema were included by their respective physicians.", {"entities": []}], ["Depending on the specialisation of the physician, the primary treatment was either standard conventional treatment or individualized homeopathy as delivered in routine medical care.", {"entities": []}], ["The main outcome was the SCORAD (SCORing Atopic Dermatitis) at 36 months by a blinded rater.", {"entities": []}], ["Further outcomes included quality of life, conventional medicine consumption, safety and disease related costs at six, 12 and 36 months after baseline.", {"entities": []}], ["A multilevel ANCOVA was used, with physician as random effect and the following fixed effects: age, gender, baseline value, severity score, social class and parents\u2019 expectation.", {"entities": []}], ["The adjusted mean SCORAD showed no significant differences between the groups at 36 months (13.7 95% CI [7.9\u201319.5] vs. 14.9 [10.4\u201319.4], p\u200a=\u200a0.741).", {"entities": []}], ["The SCORAD response rates at 36 months were similar in both groups (33% response: homoeopathic 63.9% vs. conventional 64.5%, p\u200a=\u200a0.94; 50% response: 52.0% vs. 52.3%, p\u200a=\u200a0.974).", {"entities": []}], ["Total costs were higher in the homoeopathic versus the conventional group (months 31\u201336 200.54 Euro [132.33\u2013268.76] vs. 68.86 Euro [9.13\u2013128.58], p\u200a=\u200a0.005).", {"entities": []}], ["Taking patient preferences into account, while being unable to rule out residual confounding, in this long-term observational study, the effects of homoeopathic treatment were not superior to conventional treatment for children with mild to moderate atopic eczema, but involved higher costs.", {"entities": []}], ["Using a multidimensional assessment of health literacy (the Cancer Message Literacy Test-Listening, the Cancer Message Literacy Test-Reading, and the Lipkus Numeracy Scale), the authors assessed a stratified random sample of 1013 insured adults (40\u201370 years of age).", {"entities": [[60, 66, "DISEASE"], [104, 110, "DISEASE"]]}], ["The authors explored whether low health literacy across all 3 domains ( n = 111) was associated with sets of variables likely to affect engagement in cancer prevention and screening activities: (a) attitudes and behaviors relating to health care encounters and providers, (b) attitudes toward cancer and health, (c) knowledge of cancer screening tests, and (d) attitudes toward health related media and actual media use.", {"entities": [[150, 156, "DISEASE"], [293, 299, "DISEASE"], [329, 335, "DISEASE"]]}], ["Adults with low health literacy were more likely to report avoiding doctor's visits, to have more fatalistic attitudes toward cancer, to be less accurate in identifying the purpose of cancer screening tests, and more likely to avoid information about diseases they did not have.", {"entities": [[126, 132, "DISEASE"], [184, 190, "DISEASE"]]}], ["Compared with other participants, those with lower health literacy were more likely to say that they would seek information about cancer prevention or screening from a health care professional and less likely to turn to the Internet first for such information.", {"entities": [[130, 136, "DISEASE"]]}], ["Those with lower health literacy reported reading on fewer days and using the computer on fewer days than did other participants.", {"entities": []}], ["The authors assessed the association of low health literacy with colorectal cancer screening in an age-appropriate subgroup for which colorectal cancer screening is recommended.", {"entities": [[65, 82, "DISEASE"], [134, 151, "DISEASE"], [76, 82, "DISEASE"], [145, 151, "DISEASE"]]}], ["In these insured subjects receiving care in integrated health care delivery systems, those with low health literacy were less likely to be up to date on screening for colorectal cancer, but the difference was not statistically significant.", {"entities": [[167, 184, "DISEASE"], [178, 184, "DISEASE"]]}], ["Low molecular weight heparin (LMWH) has a structure similar to heparan sulfate, which exerts anti-inflammatory effects via inhibiting elastase (Ela) activity.", {"entities": []}], ["Release of Ela along the glomerular capillary wall may induce glomerular injury and proteinuria.", {"entities": [[84, 95, "DISEASE"]]}], ["The present study aimed to investigate the influence of LMWH on steroid-sensitive nephrotic syndrome (SSNS) and the potential underlying mechanism.", {"entities": [[82, 100, "DISEASE"], [92, 100, "DISEASE"]]}], ["A total of 40 SSNS patients and 20 healthy controls were recruited.", {"entities": []}], ["SSNS patients were treated with LMWH and prednisone simultaneously (LMWH+pred group) or with prednisone alone (pred group).", {"entities": []}], ["Proteinuria, urinary glycosaminoglycans (GAGs), serum Ela and urinary creatinine levels were measured.", {"entities": [[0, 11, "DISEASE"]]}], ["The nephrotic period of SSNS was 15.93\u00b15.78 days.", {"entities": []}], ["The nephrotic period of SSNS in LMWH+pred group was significantly reduced compared with the pred group (14.13\u00b14.56 vs. 18.63\u00b16.49 days; P<0.05).", {"entities": []}], ["At the follow-up of the SSNS patients, there was no statistically significant difference in number of relapses between the LMWH+pred and pred groups.", {"entities": []}], ["Proteinuria (2.51\u00b10.97 g/24 h), urinary GAG levels (4.92\u00b10.87 mg/mmol creatinine) and serum Ela levels (77.64\u00b110.99 ng/l) were significantly greater in the nephrotic period of SSNS compared with the remission period (0.107\u00b10.026 g/24 h, 1.53\u00b10.27 mg/mmol Cr and 41.92\u00b17.81 ng/l, respectively) and the healthy control group (0.098\u00b10.027 g/24 h, 1.40\u00b10.26 mg/mmol creatinine and 38.43\u00b19.83 ng/l, respectively; P<0.05).", {"entities": [[0, 11, "DISEASE"]]}], ["During the remission period, urinary GAG and serum Ela levels in the LMWH+pred group were significantly reduced compared with the pred group (P<0.05), whereas proteinuria did not differ between these groups (P>0.05).", {"entities": [[159, 170, "DISEASE"]]}], ["Positive correlations were revealed between urinary GAG excretion and proteinuria (r=0.877; P<0.05), proteinuria and serum Ela levels (r=0.844; P<0.05) and serum Ela levels and urinary GAG excretion (r=0.881; P<0.05).", {"entities": [[70, 81, "DISEASE"], [101, 112, "DISEASE"]]}], ["The results of the present study indicated that elevated serum Ela levels may induce proteinuria by degrading GAGs in the glomerular basement membrane in children with SSNS.", {"entities": [[85, 96, "DISEASE"]]}], ["LMWH may benefit nephrotic remission of SSNS via inhibiting Ela.", {"entities": []}], ["The majority of investigations of the epidemiology of nontuberculous mycobacteria (NTM) have focused on highly developed nations with a low prevalence of tuberculosis.", {"entities": [[154, 166, "DISEASE"], [83, 86, "GENE"]]}], ["In contrast, the Para state of north Brazil represents an area of high tuberculosis prevalence and increasing NTM incidence.", {"entities": [[71, 83, "DISEASE"], [110, 113, "GENE"]]}], ["Toward the goal of understanding the dynamics of infection by all Mycobacterium species, we report patient characteristics and the identification of NTM strains isolated from sputum samples from patients that were residents of Para, a state in the Amazon region, Northern of Brazil, over the period January 2010 through December 2011 (2 years).", {"entities": [[149, 152, "GENE"]]}], ["The 29 NTM patients comprised 13.5% of positive mycobacterial cultures over the 2-year period.", {"entities": [[7, 10, "GENE"]]}], ["A major risk factor for NTM pulmonary disease was previous tuberculosis (76%).", {"entities": [[59, 71, "DISEASE"], [24, 27, "GENE"]]}], ["Further, the average age of NTM patients (52 years) was significantly higher than that of tuberculosis patients (39 years) and more were female (72.4% vs. 37.4%).", {"entities": [[90, 102, "DISEASE"], [28, 31, "GENE"]]}], ["Unlike other Brazilian states, NTM pulmonary patients in Para were infected with a different spectrum of mycobacteria; primarily the rapidly growing Mycobacterium massiliense and Mycobacterium simiae complex.", {"entities": [[31, 34, "GENE"]]}], ["Nontuberculous mycobacteria (NTM) are environmental organisms that are naturally found in soil, water, dust and other sites.", {"entities": [[29, 32, "GENE"]]}], ["Several case reports and studies on the prevalence of pulmonary NTM disease have been published, nevertheless, the impact and the exact magnitude of NTM infections in countries where tuberculosis (TB) is endemic are not known.", {"entities": [[183, 195, "DISEASE"], [64, 67, "GENE"], [149, 152, "GENE"], [64, 67, "GENE"], [149, 152, "GENE"]]}], ["Here, we report the identification of NTM strains isolated from pulmonary samples from patients with a presumptive diagnosis of pulmonary TB and residents of the State of Para, in the Amazon region, Northern of Brazil.", {"entities": [[38, 41, "GENE"]]}], ["This study documents the occurrence and diversity of species of NTM that cause pulmonary disease in a region representative of those in the world with high infection rates by Mycobacterium tuberculosis .", {"entities": [[189, 201, "DISEASE"], [64, 67, "GENE"]]}], ["Bronchial thermoplasty (BT) is a bronchoscopic procedure that improves asthma control by reducing excess airway smooth muscle.", {"entities": [[71, 77, "DISEASE"]]}], ["Treated patients have been followed out to 5 years to evaluate long-term safety of this procedure.", {"entities": []}], ["Patients enrolled in the Asthma Intervention Research Trial were on inhaled corticosteroids \u2265200 \u03bcg beclomethasone or equivalent + long-acting-beta 2 -agonists and demonstrated worsening of asthma on long-acting-\u03b2 2 -agonist withdrawal.", {"entities": [[25, 31, "DISEASE"], [190, 196, "DISEASE"]]}], ["Following initial evaluation at 1 year, subjects were invited to participate in a 4 year safety study.", {"entities": []}], ["Adverse events (AEs) and spirometry data were used to assess long-term safety out to 5 years post-BT.", {"entities": []}], ["45 of 52 treated and 24 of 49 control group subjects participated in long-term follow-up of 5 years and 3 years respectively.", {"entities": []}], ["The rate of respiratory adverse events (AEs/subject) was stable in years 2 to 5 following BT (1.2, 1.3, 1.2, and 1.1, respectively,).", {"entities": []}], ["There was no increase in hospitalizations or emergency room visits for respiratory symptoms in Years 2, 3, 4, and 5 compared to Year 1.", {"entities": []}], ["The FVC and FEV 1 values showed no deterioration over the 5 year period in the BT group.", {"entities": [[12, 15, "GENE"]]}], ["Similar results were obtained for the Control group.", {"entities": []}], ["The absence of clinical complications (based on AE reporting) and the maintenance of stable lung function (no deterioration of FVC and FEV 1 ) over a 5-year period post-BT in this group of patients with moderate to severe asthma support the long-term safety of the procedure out to 5 years.", {"entities": [[222, 228, "DISEASE"], [135, 138, "GENE"]]}], ["The African lion is in decline across its range, and consumptive utilisation and trade of their body parts and skins has been postulated as a cause for concern.", {"entities": []}], ["We undertook a pan-African questionnaire and literature survey to document informed opinion and evidence for the occurrence of domestic and international trade and consumption in African lion body parts across current and former range states.", {"entities": []}], ["Sixty-five people from 18 countries participated in the online questionnaire survey (run from July 2014 to May 2015), with information provided for 28 countries (including 20 out of 24 countries believed to have extant populations).", {"entities": []}], ["Respondents were experts within their professional spheres, and 77% had \u22656 years relevant experience within lion conservation or allied wildlife matters.", {"entities": []}], ["Their opinions revealed wide sub-regional differences in consumptive use, drivers of trade, and access to lions that impact wild lion populations in different ways.", {"entities": []}], ["Traditional medicine practices (African and Asian) were perceived to be the main uses to which lion body parts and bones are put domestically and traded internationally, and there is reason for concern about persistent imports from former lion range states (mainly in West Africa) for parts for this purpose.", {"entities": []}], ["The domestic, rather than international, trade in lion body parts was perceived to be a bigger threat to wild lion populations.", {"entities": []}], ["Parts such as skin, claws, teeth and bones are thought to be in most demand across the continent.", {"entities": []}], ["The impact of international trade on wild populations was acknowledged to be largely unknown, but occasionally was judged to be \u2018high\u2019, and therefore vigilance is needed to monitor emerging detrimental impacts.", {"entities": []}], ["Seventeen countries were nominated as priorities for immediate monitoring, including: South Africa, Tanzania, Zimbabwe, Mozambique, Zambia, Botswana, Kenya, Nigeria, and Cameroon.", {"entities": []}], ["Reasons for their selection include: prevalence of trophy hunting, \u2018hot spots\u2019 for poaching, active domestic trade in lion body parts, trade in curios for the tourist market, and histories of legal-illegal wildlife trade.", {"entities": []}], ["This survey, and increased incident reports since mid-2015 of lion poisoning and poaching in Mozambique, Zimbabwe and South Africa, and sporadic poaching events in Uganda and Tanzania, are signalling an escalating trend in the trade of lion products that is an increasing threat to some national populations.", {"entities": []}], ["The evidence is sufficient to make more detailed investigation of this trade a conservation priority.", {"entities": []}], ["Evidence supporting the recommendation to include chest radiography in the work-up of all cervical cancer patients is limited.", {"entities": [[99, 105, "DISEASE"], [90, 105, "DISEASE"]]}], ["We investigated the diagnostic value of routine chest radiography in cervical cancer staging.", {"entities": [[78, 84, "DISEASE"], [69, 84, "DISEASE"]]}], ["All consecutive cervical cancer patients who presented at our tertiary referral center in the Netherlands (January 2006 \u2013 September 2013), and for whom \u22656 months follow-up was available, were included.", {"entities": [[25, 31, "DISEASE"], [16, 31, "DISEASE"]]}], ["As part of the staging procedure, patients underwent a routine two-directional digital chest radiograph.", {"entities": []}], ["Findings were compared to a composite reference standard consisting of all imaging studies and histology obtained during the 6 months following radiography.", {"entities": []}], ["Of the 402 women who presented with cervical cancer, 288 (71.6%) underwent chest radiography and had \u22656 months follow-up.", {"entities": [[45, 51, "DISEASE"], [36, 51, "DISEASE"]]}], ["Early clinical stage (I/II) cervical cancer was present in 244/288 (84.7%) women, while 44 (15.3%) presented with advanced disease (stage III/IV).", {"entities": [[37, 43, "DISEASE"], [28, 43, "DISEASE"]]}], ["The chest radiograph of 1 woman \u2013 with advanced pre-radiograph stage (IVA) disease \u2013 showed findings consistent with pulmonary metastases.", {"entities": []}], ["Radiographs of 7 other women \u2013 4 early, 3 advanced stage disease \u2013 were suspicious for pulmonary metastases which was confirmed by additional imaging in only 1 woman (with pre-radiograph advanced stage (IIIB) disease) and excluded in 6 cases, including all women with early stage disease.", {"entities": []}], ["In none of the 288 women were thoracic skeletal metastases identified on imaging or during 6 months follow up.", {"entities": []}], ["Radiography was unremarkable in 76.4% of the study population, and showed findings unrelated to the cervical carcinoma in 21.2%.", {"entities": [[109, 118, "DISEASE"]]}], ["Routine chest radiography was of no value for any of the early stage cervical cancer patients presenting at our tertiary center over a period of 7.7 years.", {"entities": [[78, 84, "DISEASE"], [69, 84, "DISEASE"]]}], ["Loss-of-function mutations in the skin barrier protein filaggrin ( FLG ) are a major risk for atopic dermatitis (AD).", {"entities": [[94, 111, "DISEASE"], [101, 111, "DISEASE"], [67, 70, "GENE"]]}], ["The pathogenic sequence of disturbances in skin barrier function before or during the early development of AD is not fully understood.", {"entities": []}], ["A\u00a0more detailed understanding of these events is needed to develop a clearer picture of disease pathogenesis.", {"entities": []}], ["A\u00a0robust, noninvasive test to identify babies at high risk of AD would be important in planning early intervention and/or prevention studies.", {"entities": []}], ["To ascertain whether a noninvasive measurement of\u00a0skin barrier function at day 2 after birth and at 2 months predicts the development of AD at 1 year.", {"entities": []}], ["Furthermore, to determine whether increases in transepidermal water loss (TEWL) predate the development of clinical AD.", {"entities": []}], ["A total of 1903 infants were enrolled in the Cork Babies After Scope: Evaluating the Longitudinal Impact Using Neurological and Nutritional Endpoints Birth Cohort study from July 2009 to October 2011.", {"entities": []}], ["Measurements of TEWL were made at birth (day 2) and at 2 and 6 months.", {"entities": []}], ["The presence of AD was ascertained at 6 and 12 months, and disease severity was assessed by using the SCORing Atopic Dermatitis clinical tool at 6 months and by using both the SCORing Atopic Dermatitis clinical tool and Nottingham Severity Score at 12 months.", {"entities": [[110, 127, "DISEASE"], [184, 201, "DISEASE"], [117, 127, "DISEASE"], [191, 201, "DISEASE"]]}], ["A\u00a0total of 1300 infants were genotyped for FLG mutations.", {"entities": [[43, 46, "GENE"]]}], ["At 6 months, 18.7% of the children had AD, and at 12 months, 15.53%.", {"entities": []}], ["In a logistic regression model, day 2 upper quartile TEWL measurement was significantly predictive of AD at 12 months (area under the receiver operating characteristic curve, 0.81; P \u00a0< .05).", {"entities": []}], ["Lowest quartile day 2 TEWL was protective against AD at 12 months.", {"entities": []}], ["An upper quartile 2 month TEWL was also strongly predictive of AD at 12 months (area under the receiver operating characteristic curve, 0.84; P \u00a0< .05).", {"entities": []}], ["At both ages, this effect was independent of parental atopy, FLG \u00a0status, or report of an itchy flexural rash at 2 months.", {"entities": [[61, 64, "GENE"]]}], ["Associations were increased when parental atopy status or child FLG mutation status was added into the linear regression model.", {"entities": [[64, 67, "GENE"]]}], ["Impairment of skin barrier function at birth and at 2 months precedes clinical AD.", {"entities": []}], ["In addition to providing important mechanistic insights into disease pathogenesis, these findings have implications for the optimal timing of interventions for the prevention of AD.", {"entities": []}], ["Background.", {"entities": []}], ["Foodstuff traders operating from warehouses (FTFW) are potentially exposed to dangerous rodenticides/pesticides that may have adverse effects on cardiopulmonary function.", {"entities": []}], ["Fifty consenting male foodstuff traders, comprising 15 traders (21\u201363 years) operating outside warehouses and 35 FTFW (20\u201364 years), were randomly recruited at Ogbete Market, Enugu, in a cross-sectional observational study of spirometric and electrocardiographic parameters.", {"entities": []}], ["Seventeen FTFW (21\u201357 years) participated in focus group discussions.", {"entities": []}], ["Qualitative and quantitative data were analysed thematically and with independent t -test and Pearson correlation coefficient at p < 0.05, respectively.", {"entities": []}], ["Most FTFW experienced respiratory symptoms, especially dry cough (97.1%) and wheezing (31.4%) with significant reductions in forced vital capacity (FVC) ( t = \u22122.654; p = 0.011), forced expiratory volume in one second (FEV 1 ) ( t = \u22122.240; p = 0.030), maximum expiratory flow rate (FEF 200\u20131200 ) ( t = \u22121.148; p = \u22120.047), and forced end-expiratory flow (FEF 75\u201385 ) ( t = \u22121.11; p = 0.007).", {"entities": [[219, 222, "GENE"]]}], ["The maximum mid-expiratory flow (FEF 25\u201375 ) was marginally decreased ( p > 0.05) with a significantly prolonged ( p < 0.05) QTc interval.", {"entities": []}], ["Conclusion.", {"entities": []}], ["Allergic response was evident in the FTFW.", {"entities": []}], ["Significant decrease in FVC may negatively impact lung flow rates and explains the marginal decrease in FEF 25\u201375 , which implies a relative limitation in airflow of peripheral/distal airways and elastic recoil of the lungs.", {"entities": []}], ["This is consistent with obstructive pulmonary disease; a significant decrease in FEF 75\u201385 /FEV 1 supports this conclusion.", {"entities": []}], ["Significant decrease in FEF 200\u20131200 indicates abnormalities in the large airways/larynx just as significantly prolonged ventricular repolarization suggests cardiac arrhythmias.", {"entities": []}], ["Picornavirus replication is known to cause extensive remodeling of Golgi and endoplasmic reticulum membranes, and a number of the host proteins involved in the viral replication complex have been identified, including oxysterol binding protein (OSBP) and phosphatidylinositol 4-kinase III beta (PI4KB).", {"entities": [[245, 249, "GENE"], [295, 300, "GENE"]]}], ["Since both OSBP and PI4KB are substrates for protein kinase D (PKD) and PKD is known to be involved in the control of Golgi membrane vesicular and lipid transport, we hypothesized that PKD played a role in viral replication.", {"entities": [[11, 15, "GENE"], [20, 25, "GENE"]]}], ["We present multiple lines of evidence in support of this hypothesis.", {"entities": []}], ["First, infection of HeLa cells with human rhinovirus (HRV) induced the phosphorylation of PKD.", {"entities": []}], ["Second, PKD inhibitors reduced HRV genome replication, protein expression, and titers in a concentration-dependent fashion and also blocked the replication of poliovirus (PV) and foot-and-mouth disease virus (FMDV) in a variety of cells.", {"entities": [[188, 201, "DISEASE"]]}], ["Third, HRV replication was significantly reduced in HeLa cells overexpressing wild-type and mutant forms of PKD1.", {"entities": [[108, 112, "GENE"]]}], ["Fourth, HRV genome replication was reduced in HAP1 cells in which the PKD1 gene was knocked out by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9.", {"entities": [[46, 50, "GENE"], [70, 74, "GENE"]]}], ["Although we have not identified the molecular mechanism through which PKD regulates viral replication, our data suggest that this is not due to enhanced interferon signaling or an inhibition of clathrin-mediated endocytosis, and PKD inhibitors do not need to be present during viral uptake.", {"entities": []}], ["Our data show for the first time that targeting PKD with small molecules can inhibit the replication of HRV, PV, and FMDV, and therefore, PKD may represent a novel antiviral target for drug discovery.", {"entities": []}], ["IMPORTANCE Picornaviruses remain an important family of human and animal pathogens for which we have a very limited arsenal of antiviral agents.", {"entities": []}], ["HRV is the causative agent of the common cold, which in itself is a relatively trivial infection; however, in asthma and chronic obstructive pulmonary disease (COPD) patients, this virus is a major cause of exacerbations resulting in an increased use of medication, worsening symptoms, and, frequently, hospital admission.", {"entities": [[121, 158, "DISEASE"], [34, 45, "DISEASE"], [110, 116, "DISEASE"]]}], ["Thus, HRV represents a substantial health care and economic burden for which there are no approved therapies.", {"entities": []}], ["We sought to identify a novel host target as a potential anti-HRV therapy.", {"entities": []}], ["HRV infection induces the phosphorylation of PKD, and inhibitors of this kinase effectively block HRV replication at an early stage of the viral life cycle.", {"entities": []}], ["Moreover, PKD inhibitors also block PV and FMDV replication.", {"entities": []}], ["This is the first description that PKD may represent a target for antiviral drug discovery.", {"entities": []}], ["Chronic inflammation containing CD8", {"entities": []}], ["We aimed to examine the course of depression during 2-year follow-up in a group clinically depressed older persons.", {"entities": []}], ["Subsequently, we studied which socio-demographic and clinical characteristics predict a depression diagnoses at 2-year follow-up.", {"entities": []}], ["Data were used from the Netherlands Study of Depression in Older persons (NESDO; N\u2009=\u2009510).", {"entities": []}], ["Diagnoses of depression DSM-IV-TR criteria were available from 285 patients at baseline and at 2-year follow-up.", {"entities": []}], ["Severity of the depressive symptoms, as assessed with the Inventory of Depressive Symptoms (IDS), was obtained from 6-monthly postal questionnaires.", {"entities": [[92, 95, "GENE"]]}], ["Information about socio-demographic and clinical variables was obtained from the baseline measurement.", {"entities": []}], ["From the 285 older persons who were clinically depressed at baseline almost half (48.4%) also suffered from a depressive disorder two years later.", {"entities": []}], ["Patients with more severe depressive symptoms, comorbid dysthymia, younger age of onset and more chronic diseases were more likely to be depressed at 2-year follow-up.", {"entities": []}], ["61% of the persons that were depressed at baseline had a chronic course of depressive symptoms during these two years.", {"entities": []}], ["Late-life depression often has a chronic course, even when treated conform current guidelines for older persons.", {"entities": []}], ["Our results suggest that physical comorbidity may be candidate for adjusted and intensified treatment strategies of older depressed patients with chronic and complex pathology.", {"entities": []}], ["Asthma is prone to Th2-mediated chronic airway inflammation.", {"entities": [[0, 6, "DISEASE"]]}], ["Interleukin-27 (IL-27) is a member of the IL-12 family that promotes the differentiation of Th1 cells and inhibits Th2 cells.", {"entities": []}], ["We use human/mouse CD4 We isolated and cultured CD4 In vitro, although IL-27 could inhibit na\u00efve CD4 Preventative administration of IL-27 improved the pathological changes in mouse asthma models via both the STAT1 and GADD45\u03b3/p38 MAPK pathways while therapeutic administration of IL-27 had no significant effect, which may be due to the presence of already differentiated Th2 cells in asthmatic airways that resist IL-27 inhibition.", {"entities": [[181, 187, "DISEASE"], [19, 22, "GENE"], [48, 51, "GENE"], [97, 100, "GENE"], [19, 22, "GENE"], [48, 51, "GENE"], [97, 100, "GENE"], [19, 22, "GENE"], [48, 51, "GENE"], [97, 100, "GENE"], [208, 213, "GENE"]]}], ["The online version of this article (doi:10.1186/s12967-016-1039-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Antimicrobial resistance is a global public health challenge and carbapenem resistance, in particular, is considered an urgent global health threat.", {"entities": []}], ["This study was carried out to give a bibliometric overview of literature on carbapenem resistance.", {"entities": []}], ["In specific, number of publications, top productive countries and institutes, highly cited articles, citation analysis, co-authorships, international collaboration, top active authors, and journals publishing articles on carbapenem resistance were analyzed and discussed.", {"entities": []}], ["Specific keywords pertaining to carbapenem resistance were used in Scopus database.", {"entities": []}], ["Quantitative and qualitative analysis of retrieved data were presented using appropriate bibliometric indicators and visualization maps.", {"entities": []}], ["A total of 2617 journal articles were retrieved.", {"entities": []}], ["The average number of citations per article was of 21.47.", {"entities": []}], ["The growth of publications showed a dramatic increase from 2008 to 2015.", {"entities": []}], ["Approximately 9\u00a0% of retrieved articles on carbapenem resistance were published in Antimicrobial Agents and Chemotherapy journal.", {"entities": []}], ["Retrieved articles were published by 102 different countries.", {"entities": []}], ["The United States of America (USA) contributed most with 437 (16.70\u00a0%) articles followed by China with 257 (9.82\u00a0%) articles.", {"entities": []}], ["When productivity was stratified by population size, Greece ranked first followed by France.", {"entities": []}], ["Greece also ranked first when data were stratified by gross domestic product (GDP).", {"entities": []}], ["Asian countries have lesser international collaboration compared with other countries in the top ten list.", {"entities": []}], ["Five of top ten productive institutes were Europeans (France, the UK, Greece, Italy, and Switzerland) and two were Asians (China and South Korea).", {"entities": []}], ["Other active institutes included an Israeli and a Brazilian institute.", {"entities": []}], ["Four of the top ten cited articles were published in Antimicrobial Agents and Chemotherapy journal and two were published in The Lancet Infectious Diseases .", {"entities": []}], ["There was a dramatic increase in number of publications on carbapenem resistance in the past few years.", {"entities": []}], ["These publications were produced from different world regions including Asia, Europe, Middle East, and Latin America.", {"entities": []}], ["International collaboration needs to be encouraged particularly for researchers in Asia.", {"entities": []}], ["Molecular biology and epidemiology dominated the theme of the top ten cited articles on carbapenem resistance.", {"entities": []}], ["This bibliometric study will hopefully help health policy makers in planning future research and allocating funds pertaining to carbapenem resistance.", {"entities": []}], ["We confirmed that the filaggrin gene mutation c.3321delA is associated with atopic dermatitis in our previous genome wide association study of the Chinese Han population.", {"entities": [[76, 93, "DISEASE"], [83, 93, "DISEASE"]]}], ["c.3321delA is the most common filaggrin gene mutation in Chinese atopic dermatitis patients but is not present in European populations.", {"entities": [[65, 82, "DISEASE"], [72, 82, "DISEASE"]]}], ["To investigate the genetic model for the c.3321delA mutation and to determine the correlation between c.3321delA and atopic dermatitis clinical phenotypes in the Chinese Han population.", {"entities": [[117, 134, "DISEASE"], [124, 134, "DISEASE"]]}], ["The filaggrin gene mutation c.3321delA was sequenced in 1,080 atopic dermatitis patients and 908 controls from the Chinese population.", {"entities": [[62, 79, "DISEASE"], [69, 79, "DISEASE"]]}], ["The \u03c7 Analyses of the genetic model revealed that the additive model best described the c.3321delA mutation ( P \u200a=\u200a3.09E-11, OR\u200a=\u200a3.43, 95%CI\u200a=\u200a2.38\u20134.96).", {"entities": []}], ["Stratified analyses showed that the c.3321delA allele frequency distribution is significantly associated with concomitant skin xerosis ( P \u200a=\u200a1.68E-03, OR\u200a=\u200a2.13,95%CI\u200a=\u200a1.32\u20133.46), palmar hyperlinearity ( P \u200a=\u200a3.64E-17, OR\u200a=\u200a4.0,95%CI\u200a=\u200a2.86\u20135.70), white dermatographism ( P \u200a=\u200a4.25E-03, OR\u200a=\u200a1.82,95%CI\u200a=\u200a1.22\u20132.71), food intolerance ( P \u200a=\u200a1.51E-03, OR\u200a=\u200a1.76,95%CI\u200a=\u200a1.23\u20132.50) and disease severity ( P \u200a=\u200a9.67E-05).", {"entities": []}], ["Our study indicates that the filaggrin gene mutation c.3321delA is associated with clinical phenotypes of atopic dermatitis in the Chinese Han population, which might help us gain a better understanding on the pathogenesis of atopic dermatitis.", {"entities": [[106, 123, "DISEASE"], [226, 243, "DISEASE"], [113, 123, "DISEASE"], [233, 243, "DISEASE"]]}], ["Along with article-based checklists, structured template recording systems have been reported as useful to create more accurate clinical recording, but their contributions to the improvement of the quality of patient care have been controversial.", {"entities": []}], ["An emergency department (ED) must manage many patients in a short time.", {"entities": []}], ["Therefore, such a template might be especially useful, but few ED-based studies have examined such systems.", {"entities": []}], ["A structured template produced according to widely used head injury guidelines was used by ED residents for head injury patients.", {"entities": []}], ["The study was conducted by comparing each 6-month period before and after launching the system.", {"entities": []}], ["The quality of the patient notes and factors recorded in the patient notes to support the head computed tomography (CT) performance were evaluated by medical students blinded to patient information.", {"entities": []}], ["The subject patients were 188 and 177 in respective periods.", {"entities": []}], ["The numbers of patient notes categorized as \u201cCT indication cannot be determined\u201d were significantly lower in the postintervention term (18% \u2192 9.0%), which represents the patient note quality improvement.", {"entities": []}], ["No difference was found in the rates of CT performance or CT skip without clearly recorded CT indication in the patient notes.", {"entities": []}], ["The structured template functioned as a checklist to support residents in writing more appropriately recorded patient notes in the ED head injury patients.", {"entities": []}], ["Such a template customized to each clinical condition can facilitate standardized patient management and can improve patient safety in the ED.", {"entities": []}], ["As patients become increasingly involved in their medical care, physician-patient communication gains importance.", {"entities": []}], ["A previous study showed that physician self-disclosure (SD) of personal information by primary care providers decreased patient rating of the provider communication skills.", {"entities": []}], ["The objective of this study was to explore the incidence and impact of emergency department (ED) provider self-disclosure on patients\u2019 rating of provider communication skills.", {"entities": []}], ["A survey was administered to 520 adult patients or parents of pediatric patients in a large tertiary care ED during the summer of 2014.", {"entities": []}], ["The instrument asked patients whether the provider self-disclosed and subsequently asked patients to rate providers\u2019 communication skills.", {"entities": []}], ["We compared patients\u2019 ratings of communication measurements between encounters where self-disclosure occurred to those where it did not.", {"entities": []}], ["Patients reported provider SD in 18.9% of interactions.", {"entities": []}], ["Provider SD was associated with more positive patient perception of provider communication skills (p<0.05), more positive ratings of provider rapport (p<0.05) and higher satisfaction with provider communication (p<0.05).", {"entities": []}], ["Patients who noted SD scored their providers\u2019 communication skills as \u201cexcellent\u201d (63.4%) compared to patients without self-disclosure (47.1%).", {"entities": []}], ["Patients reported that they would like to hear about their providers\u2019 experiences with a similar chief complaint (64.4% of patients), their providers\u2019 education (49%), family (33%), personal life (21%) or an injury/ailment unlike their own (18%).", {"entities": []}], ["Patients responded that providers self-disclose to make patients comfortable/at ease and to build rapport.", {"entities": []}], ["Provider self-disclosure in the ED is common and is associated with higher ratings of provider communication, rapport, and patient satisfaction.", {"entities": []}], ["Psoriasis is a chronic skin disorder with multifactorial etiology.", {"entities": [[0, 9, "DISEASE"]]}], ["In a recent study, we reported results of a genome-wide scan on 46 French extended families presenting with plaque psoriasis.", {"entities": [[115, 124, "DISEASE"]]}], ["In addition to unambiguous linkage to the major susceptibility locus PSORS1 on Chromosome 6p21, we provided evidence for a susceptibility locus on Chromosome 20p13.", {"entities": []}], ["To follow up this novel psoriasis susceptibility locus we used a family-based association test (FBAT) for an association scan over the 17 Mb candidate region.", {"entities": [[24, 33, "DISEASE"], [138, 140, "GENE"]]}], ["A total of 85 uncorrelated SNP markers located in 65 genes of the region were initially investigated in the same set of large families used for the genome wide search, which consisted of 295 nuclear families.", {"entities": []}], ["When positive association was obtained for a SNP, candidate genes nearby were explored more in detail using a denser set of SNPs.", {"entities": []}], ["Thus, the gene ADAM33 was found to be significantly associated with psoriasis in this family set (The best association was on a 3-SNP haplotype P \u200a=\u200a0.00004, based on 1,000,000 permutations).", {"entities": [[68, 77, "DISEASE"], [15, 21, "GENE"]]}], ["This association was independent of PSORS1 .", {"entities": []}], ["ADAM33 has been previously associated with asthma, which demonstrates that immune system diseases may be controlled by common susceptibility genes with general effects on dermal inflammation and immunity.", {"entities": [[43, 49, "DISEASE"], [0, 6, "GENE"]]}], ["The identification of ADAM33 as a psoriasis susceptibility gene identified by positional cloning in an outbred population should provide insights into the pathogenesis and natural history of this common disease.", {"entities": [[34, 43, "DISEASE"], [22, 28, "GENE"]]}], ["It has been claimed that osteopathic manipulative treatment (OMT) is able to enhance the immune response of individuals.", {"entities": []}], ["In particular, it has been reported that OMT has the capability to increase antibody titers, enhance the efficacy of vaccination, and upregulate the numbers of circulating leukocytes.", {"entities": []}], ["Recently, it has been shown in human patients suffering chronic low back pain, that OMT is able to modify the levels of cytokines such as IL-6 and TNF-\u03b1 in blood upon repeated treatment.", {"entities": []}], ["Further, experimental animal models show that lymphatic pump techniques can induce a transient increase of cytokines in the lymphatic circulation.", {"entities": []}], ["Taking into account all these data, we decided to investigate in healthy individuals the capacity of OMT to induce a rapid modification of the levels of cytokines and leukocytes in circulation.", {"entities": []}], ["Human volunteers were subjected to a mixture of lymphatic and thoracic OMT, and shortly after the levels of several cytokines were evaluated by protein array technology and ELISA multiplex analysis, while the profile and activation status of circulating leukocytes was extensively evaluated by multicolor flow cytometry.", {"entities": []}], ["In addition, the levels of nitric oxide and C-reactive protein (CRP) in plasma were determined.", {"entities": [[64, 67, "GENE"]]}], ["In this study, our results show that OMT was not able to induce a rapid modification in the levels of plasma nitrites or CRP or in the proportion or activation status of central memory, effector memory or na\u00efve CD4 and CD8 T cells.", {"entities": [[121, 124, "GENE"], [211, 214, "GENE"]]}], ["A significant decrease in the proportion of a subpopulation of blood dendritic cells was detected in OMT patients.", {"entities": []}], ["Significant differences were also detected in the levels of immune molecules such as IL-8, MCP-1, MIP-1\u03b1 and most notably, G-CSF.", {"entities": []}], ["Thus, OMT is able to induce a rapid change in the immunological profile of particular circulating cytokines and leukocytes.", {"entities": []}], ["Rhinoviruses may be pathogens contributing to the development of childhood wheezing.", {"entities": []}], ["However, their role in low risk infants without an asthmatic predisposition is unknown.", {"entities": []}], ["Knowing which healthy, low risk children are at increased risk for childhood wheezing after rhinovirus wheezing illness (RV\u2010WI) in infancy, might help in developing prevention and treatment strategies for childhood wheezing.", {"entities": []}], ["The aim of this study was to determine the association of medically attended wheezing at the age of three with RV\u2010WI in the first year of life in low risk children without parental asthma.", {"entities": [[181, 187, "DISEASE"]]}], ["In a low risk, prospective birth cohort study, we followed 181 healthy born children from birth through the third year of life.", {"entities": []}], ["We considered children \u2018low risk\u2019 if neither parent had a doctor's diagnosis of asthma.", {"entities": [[80, 86, "DISEASE"]]}], ["We determined infant RV\u2010WI by parent\u2010reported wheezing (based on daily logs) and simultaneous molecular rhinovirus detection in the first year of life.", {"entities": []}], ["Respiratory function and blood eosinophil count were both measured in the first month of life.", {"entities": []}], ["The primary outcome, third year wheezing, was defined as the use of prescribed inhaled asthma medications together with a doctor's visit for respiratory symptoms in the third year of life.", {"entities": [[87, 93, "DISEASE"]]}], ["We calculated the association of RV\u2010WI with medically attended third year wheezing and other known possible risk factors for wheezing at the age of three.", {"entities": []}], ["Among low risk children, third year wheezing was observed in 7 out of 18 (39%) children with versus 10 out of 163 (6%) children without infant RV\u2010WI (OR 9.7, 95% CI 3.1\u201333.5, P\u2009 <\u20090.0001).", {"entities": []}], ["The association between RV\u2010WI and third year wheezing was unchanged after adjustment for potential confounders such as eosinophilia and atopic eczema.", {"entities": [[119, 131, "DISEASE"]]}], ["RV\u2010WI is a robust and independent risk factor for third year wheezing in low risk children without parental asthma.", {"entities": [[108, 114, "DISEASE"]]}], ["Future research will identify and protect those children at increased risk for RV\u2010WI.", {"entities": []}], ["Multicenter Study on the Prevalence of Perennial Allergic Rhinitis and Allergy-Associated Disorders This study was aimed to determine the prevalence of perennial allergic rhinitis (PAR) using the skin test, radioallergosorbent test (RAST), or multiple allergosorbent test (MAST) and to clarify the clinical aspects of the patients diagnosed as having PAR by the questionnaire survey and rhinologic examination.", {"entities": [[49, 66, "DISEASE"], [162, 179, "DISEASE"], [58, 66, "DISEASE"], [171, 179, "DISEASE"]]}], ["The 71,120 subjects who had visited the 23 otolaryngology clinics at the randomly selected tertiary referral hospitals in Korea between November 1, 1999 and April 30, 2000 were studied.", {"entities": []}], ["PAR was diagnosed when subjects complained of two or more associated symptoms and the skin test, RAST, or MAST using perennial inhalant allergens was positive.", {"entities": []}], ["The questionnaire survey and rhinologic examination were performed in subjects with PAR.", {"entities": []}], ["The prevalence of PAR was 3.93%.", {"entities": []}], ["We could find no significant difference in the prevalence of PAR between the two sexes.", {"entities": []}], ["However, there was a significant difference in the prevalence of PAR between the child and adult groups.", {"entities": []}], ["The chief complaints were, in order of decreasing frequency, nasal obstruction, watery rhinorrhea, and sneezing.", {"entities": []}], ["There was a family history of PAR in 40.2% of the subjects.", {"entities": []}], ["The 39.6% of the subjects had associated allergic diseases, being atopic dermatitis most common.", {"entities": [[66, 83, "DISEASE"], [73, 83, "DISEASE"]]}], ["In conclusion, the prevalence of PAR in tertiary referral hospitals in Korea is 3.93%.", {"entities": []}], ["Many subjects with PAR have family history and appear to be associated with other allergic diseases.", {"entities": []}], ["Severe blunt chest trauma (TxT) induces a strong inflammatory response with posttraumatic immune suppression pointing to an impaired adaptive immune response.", {"entities": []}], ["Since CD11b in vitro .", {"entities": []}], ["Suppressive activity correlated with increased expression of arginase-1 and iNOS.", {"entities": []}], ["MDSCs also prevented antigen-induced T cell expansion in vivo , since staphylococcus enterotoxin B (SEB)-induced proliferation of v\u03b28", {"entities": []}], ["Integrins regulate diverse functions in cancer pathology and in tumor cell development and contribute to important processes such as cell shape, survival, proliferation, transcription, angiogenesis, migration, and invasion.", {"entities": [[40, 46, "DISEASE"]]}], ["A number of snake venom proteins have the ability to interact with integrins.", {"entities": []}], ["Among these are the disintegrins, a family of small, non-enzymatic, and cysteine-rich proteins found in the venom of numerous snake families.", {"entities": []}], ["The venom proteins may have a potential role in terms of novel therapeutic leads for cancer treatment.", {"entities": [[85, 91, "DISEASE"]]}], ["Disintegrin can target specific integrins and as such it is conceivable that they could interfere in important processes involved in carcinogenesis, tumor growth, invasion and migration.", {"entities": []}], ["Herein we present a survey of studies involving the use of snake venom disintegrins for cancer detection and treatment.", {"entities": [[88, 94, "DISEASE"]]}], ["The aim of this review is to highlight the relationship of integrins with cancer and to present examples as to how certain disintegrins can detect and affect biological processes related to cancer.", {"entities": [[74, 80, "DISEASE"], [190, 196, "DISEASE"]]}], ["This in turn will illustrate the great potential of these molecules for cancer research.", {"entities": [[72, 78, "DISEASE"]]}], ["Furthermore, we also outline several new approaches being created to address problems commonly associated with the clinical application of peptide-based drugs such as instability, immunogenicity, and availability.", {"entities": []}], ["The role of race in human genetics and biomedical research is among the most contested issues in science.", {"entities": []}], ["Much debate centers on the relative importance of genetic versus sociocultural factors in explaining racial inequalities in health.", {"entities": []}], ["However, few studies integrate genetic and sociocultural data to test competing explanations directly.", {"entities": []}], ["We draw on ethnographic, epidemiologic, and genetic data collected in southeastern Puerto Rico to isolate two distinct variables for which race is often used as a proxy: genetic ancestry versus social classification.", {"entities": []}], ["We show that color , an aspect of social classification based on the culturally defined meaning of race in Puerto Rico, better predicts blood pressure than does a genetic-based estimate of continental ancestry.", {"entities": []}], ["We also find that incorporating sociocultural variables reveals a new and significant association between a candidate gene polymorphism for hypertension (\u03b1 2C adrenergic receptor deletion) and blood pressure.", {"entities": [[140, 152, "DISEASE"]]}], ["This study addresses the recognized need to measure both genetic and sociocultural factors in research on racial inequalities in health.", {"entities": []}], ["Our preliminary results provide the most direct evidence to date that previously reported associations between genetic ancestry and health may be attributable to sociocultural factors related to race and racism, rather than to functional genetic differences between racially defined groups.", {"entities": []}], ["Our results also imply that including sociocultural variables in future research may improve our ability to detect significant allele-phenotype associations.", {"entities": []}], ["Thus, measuring sociocultural factors related to race may both empower future genetic association studies and help to clarify the biological consequences of social inequalities.", {"entities": []}], ["One of the mechanisms by which adult disease can arise from a fetal origin is by in utero disruption of organogenesis.", {"entities": []}], ["These studies were designed to examine respiratory function changes in aging rats following transient disruption of lung growth at 16 days gestation.", {"entities": []}], ["Fetuses were treated in utero with a replication deficient adenovirus containing the cystic fibrosis conductance transmembrane regulator (CFTR) gene fragment cloned in the anti-sense direction.", {"entities": [[85, 100, "DISEASE"], [138, 142, "GENE"]]}], ["The in utero-treated rats demonstrated abnormal lung function beginning as early as 30 days of age and the pathology progressed as the animals aged.", {"entities": []}], ["The pulmonary function abnormalities included decreased static compliance as well as increased conducting airway resistance, tissue damping, and elastance.", {"entities": []}], ["Pressure volume (PV) curves demonstrated a slower early rise to volume and air trapping at end-expiration.", {"entities": []}], ["The alterations of pulmonary function correlated with lung structural changes determined by morphometric analysis.", {"entities": []}], ["These studies demonstrate how transient disruption of lung organogensis by single gene interference can result in progressive change in lung function and structure.", {"entities": []}], ["They illustrate how an adult onset disease can arise from subtle changes in gene expression during fetal development.", {"entities": []}], ["Hypertensive disorders of pregnancy, including preeclampsia, are major contributors to maternal morbidity.", {"entities": []}], ["The goal of this study was to evaluate the potential of metabolomics to predict preeclampsia and gestational hypertension from urine and serum samples in early pregnancy, and elucidate the metabolic changes related to the diseases.", {"entities": [[109, 121, "DISEASE"]]}], ["Metabolic profiles were obtained by nuclear magnetic resonance spectroscopy of serum and urine samples from 599 women at medium to high risk of preeclampsia (nulliparous or previous preeclampsia/gestational hypertension).", {"entities": [[207, 219, "DISEASE"]]}], ["Preeclampsia developed in 26 (4.3%) and gestational hypertension in 21 (3.5%) women.", {"entities": [[52, 64, "DISEASE"]]}], ["Multivariate analyses of the metabolic profiles were performed to establish prediction models for the hypertensive disorders individually and combined.", {"entities": []}], ["Urinary metabolomic profiles predicted preeclampsia and gestational hypertension at 51.3% and 40% sensitivity, respectively, at 10% false positive rate, with hippurate as the most important metabolite for the prediction.", {"entities": [[68, 80, "DISEASE"]]}], ["Serum metabolomic profiles predicted preeclampsia and gestational hypertension at 15% and 33% sensitivity, respectively, with increased lipid levels and an atherogenic lipid profile as most important for the prediction.", {"entities": [[66, 78, "DISEASE"]]}], ["Combining maternal characteristics with the urinary hippurate/creatinine level improved the prediction rates of preeclampsia in a logistic regression model.", {"entities": []}], ["The study indicates a potential future role of clinical importance for metabolomic analysis of urine in prediction of preeclampsia.", {"entities": []}], ["Mexico is a developing country with one of the highest youth obesity rates worldwide; >34% of children and adolescents between 5 and 19 years of age are overweight or obese.", {"entities": [[61, 68, "DISEASE"]]}], ["The current review seeks to compile, describe, and analyze dietary conditions, physical activity, socioeconomic status, and cultural factors that create and exacerbate an obesogenic environment among Mexican youth.", {"entities": []}], ["A narrative review was performed using PubMed and the Cochrane Library databases, as well as grey literature data from the Mexican government, academics, and statistical reports from nongovernmental organizations, included in electronic formats.", {"entities": []}], ["The recent socioeconomic and nutritional transition has resulted in reduced healthy meal options at public schools, high rates of sedentary lifestyles among adolescents, lack of open spaces and playgrounds, socioeconomic deprivation, false or misunderstood sociocultural traditional beliefs, misconceptions about health, a high percentage of overweight or obese adults, and low rates of maternal breastfeeding.", {"entities": []}], ["Some of the factors identified are exacerbating the obesity problem in this population.", {"entities": [[52, 59, "DISEASE"]]}], ["Current evidence also shows that more policies and health programs are needed for prevention of childhood and adolescent obesity.", {"entities": [[121, 128, "DISEASE"]]}], ["Mexico presents alarming obesity levels, which need to be curtailed and urgently reversed.", {"entities": [[25, 32, "DISEASE"]]}], ["The present narrative review presents an overview of dietary, physical activity, societal and cultural preconceptions that are potentially modifiable obesity-promoting factors in Mexican youth.", {"entities": [[150, 157, "DISEASE"]]}], ["Measures to control these factors need to be implemented in all similar developing countries by governments, policy makers, stakeholders, and health care professionals to tackle obesity in children and young people.", {"entities": [[178, 185, "DISEASE"]]}], ["How can we best support others in difficult times?", {"entities": []}], ["Studies testing the effects of supportive communication revealed mixed findings.", {"entities": []}], ["The current study focuses on the effects of supportive communication following different disclosure styles, and includes outcome measures to assess emotional well-being.", {"entities": []}], ["Hypotheses were tested in a 2 (disclosure style: cognitive reappraisal disclosure vs. emotional disclosure) \u00d73 (support message: cognitive reappraisal response vs. socio-affective response vs. no response) between subjects factorial design.", {"entities": []}], ["Receiving a cognitive reappraisal response, rather than a socio-affective response or no response, decreased emotional distress in the emotional disclosure group.", {"entities": []}], ["Support messages showed no effects in the cognitive reappraisal disclosure group.", {"entities": []}], ["Although socio-affective responses were positively evaluated, cognitive reappraisal responses may be more effective during emotional upheaval because they provide a positive way out of negative emotions.", {"entities": []}], ["Childhood respiratory allergies, which contribute to missed school days and other activity limitations, have increased in recent years, possibly due to environmental factors.", {"entities": []}], ["In this study we examined whether air pollutants are associated with childhood respiratory allergies in the United States.", {"entities": []}], ["For the approximately 70,000 children from the 1999\u20132005 National Health Interview Survey eligible for this study, we assigned between 40,000 and 60,000 ambient pollution monitoring data from the U.S. Environmental Protection Agency, depending on the pollutant.", {"entities": []}], ["We used monitors within 20 miles of the child\u2019s residential block group.", {"entities": []}], ["We used logistic regression models, fit with methods for complex surveys, to examine the associations between the reporting of respiratory allergy or hay fever and annual average exposure to particulate matter \u2264 2.5 \u03bcm in diameter (PM 2.5 ), PM \u2264 10 \u03bcm in diameter, sulfur dioxide, and nitrogen dioxide and summer exposure to ozone, controlling for demographic and geographic factors.", {"entities": []}], ["Increased respiratory allergy/hay fever was associated with increased summer O 3 levels [adjusted odds ratio (AOR) per 10 ppb = 1.20; 95% confidence interval (CI), 1.15\u20131.26] and increased PM 2.5 (AOR per 10 \u03bcg/m These results provide evidence of adverse health for children living in areas with chronic exposure to higher levels of O 3 and PM 2.5 compared with children with lower exposures.", {"entities": []}], ["N6-benzyladenine and kinetin are adenine-type cytokinins that play various roles in many aspects of plant development and stimulate anabolic processes in plant cells.", {"entities": []}], ["The aim of this study was to examine the effect of N6-benzyladenine and kinetin on basic oxidative stress parameters, such as antioxidative enzyme activity, reduced glutathione and thiol group content, and lipid peroxidation.", {"entities": []}], ["The results show a stimulatory effect of kinetin and N6-benzyladenine on antioxidative enzyme activity, as well as reduced glutathione and thiol group content.", {"entities": []}], ["Cytokinins caused a decrease in membrane phospholipid peroxidation and exhibited protective properties against malondialdehyde production.", {"entities": []}], ["The present findings reveal that both N6-benzyladenine and kinetin exhibit multiple and complex actions in fibroblast cells in vitro.", {"entities": []}], ["Both show antioxidant properties and are potentially powerful agents with applications in the prevention and treatment of many diseases connected with oxidative stress in skin, for example, psoriasis.", {"entities": [[190, 199, "DISEASE"]]}], ["Thymic stromal lymphopoietin (TSLP), an IL7-like cytokine produced by bronchial epithelial cells is upregulated in asthma and induces dendritic cell maturation supporting a Th2 response.", {"entities": [[115, 121, "DISEASE"], [30, 34, "GENE"]]}], ["Environmental pollutants, including tobacco smoke and diesel exhaust particles upregulate TSLP suggesting that TSLP may be an interface between environmental pollution and immune responses in asthma.", {"entities": [[192, 198, "DISEASE"], [90, 94, "GENE"], [111, 115, "GENE"], [90, 94, "GENE"], [111, 115, "GENE"]]}], ["Since asthma is prevalent in urban communities, variants in the TSLP gene may be important in asthma susceptibility in these populations.", {"entities": [[6, 12, "DISEASE"], [94, 100, "DISEASE"], [64, 68, "GENE"]]}], ["To determine whether genetic variants in TSLP are associated with asthma in an urban admixed population.", {"entities": [[66, 72, "DISEASE"], [41, 45, "GENE"]]}], ["Ten tag-SNPs in the TSLP gene were analyzed for association with asthma using 387 clinically diagnosed asthmatic cases and 212 healthy controls from an urban admixed population.", {"entities": [[65, 71, "DISEASE"], [20, 24, "GENE"]]}], ["One SNP (rs1898671) showed nominally significant association with asthma (odds ratio (OR)\u200a=\u200a1.50; 95% confidence interval (95% CI): 1.09\u20132.05, p\u200a=\u200a0.01) after adjusting for age, BMI, income, education and population stratification.", {"entities": [[66, 72, "DISEASE"]]}], ["Association results were consistent using two different approaches to adjust for population stratification.", {"entities": []}], ["When stratified by smoking status, the same SNP showed a significantly increased risk associated with asthma in ex-smokers (OR\u200a=\u200a2.00, 95% CI: 1.04\u20133.83, p\u200a=\u200a0.04) but not significant in never-smokers (OR\u200a=\u200a1.34; 95% CI: 0.93\u20131.94, p\u200a=\u200a0.11).", {"entities": [[102, 108, "DISEASE"]]}], ["Haplotype-specific score test indicated that an elevated risk for asthma was associated with a specific haplotype of TSLP involving SNP rs1898671 (OR\u200a=\u200a1.58, 95% CI: 1.10\u20132.27, p\u200a=\u200a0.01).", {"entities": [[66, 72, "DISEASE"], [117, 121, "GENE"]]}], ["Association of this SNP with asthma was confirmed in an independent large population-based cohort consortium study (OR\u200a=\u200a1.15, 95% CI: 1.07\u20131.23, p\u200a=\u200a0.0003) and the results stratified by smoking status were also validated (ex-smokers: OR\u200a=\u200a1.21, 95% CI: 1.08\u20131.34, p\u200a=\u200a0.003; never-smokers: OR\u200a=\u200a1.06, 95% CI: 0.94\u20131.17, p\u200a=\u200a0.33).", {"entities": [[29, 35, "DISEASE"]]}], ["Genetic variants in TSLP may contribute to asthma susceptibility in admixed urban populations with a gene and environment interaction.", {"entities": [[43, 49, "DISEASE"], [20, 24, "GENE"]]}], ["Current rhinometric and flow assessments measure nasal patency and are often poorly correlated with rhinitis symptoms.", {"entities": [[100, 108, "DISEASE"]]}], ["To evaluate magnetic resonance imaging (MRI) as a new method to measure inflammatory changes in nasal and sinus mucosa following nasal allergen challenge.", {"entities": []}], ["A pilot study ( n \u2009=\u20096) determined the optimal technical settings for MRI to measure inflammatory change which were then adopted for the main study.", {"entities": []}], ["This study was a single blind, placebo\u2010controlled, three\u2010way crossover trial in 14 subjects with seasonal allergic rhinitis.", {"entities": [[106, 123, "DISEASE"], [115, 123, "DISEASE"]]}], ["Effects of cetirizine, cetirizine and pseudoephedrine (Cet+PE), or placebo on total nasal symptom scores (TNSS), peak nasal inspiratory flow (PNIF), nasal nitric oxide (nNO), acoustic rhinometry, and MRI end points following nasal intranasal allergen challenge were measured.", {"entities": []}], ["There were significant changes in all parameters after allergen challenge ( P\u2009 <\u20090.01), except for nNO.", {"entities": []}], ["MRI end points were less variable and more consistent than PNIF and acoustic rhinometry in detecting changes after allergen challenge.", {"entities": []}], ["Total nasal airspace volume was the most sensitive and reproducible MRI measurement, with a mean reduction from \u22125.37\u2009cm P\u2009 <\u20090.001), which was maximal 60\u2009min after allergen challenge.", {"entities": []}], ["A change of one in TNSS corresponded to a change in MRI volume of \u22120.57\u2009cm P\u2009 >\u20090.07; comparison of active versus placebo P\u2009 >\u20090.09).", {"entities": []}], ["MRI provides novel insights into the anatomical inflammatory changes post allergen challenge and provides a new method for assessment of nasal patency and objective measurement of inflammatory responses.", {"entities": []}], ["The incidence of co-infection with Treponema pallidum and human immunodeficiency virus (HIV) is increasing in developing and developed countries.", {"entities": []}], ["The neurological complications of both infections occasionally occur simultaneously during a clinical course.", {"entities": []}], ["We herein report the case of an HIV carrier with syphilitic meningomyelitis and subclinical optic neuropathy.", {"entities": [[98, 108, "DISEASE"]]}], ["The patient presumably had latent syphilis and slowly developed longitudinally extensive transverse myelitis (LETM).", {"entities": [[100, 108, "DISEASE"], [34, 42, "DISEASE"], [27, 42, "DISEASE"]]}], ["A cerebrospinal fluid examination confirmed the diagnosis of active neurosyphilis based on an elevated T. pallidum hemagglutination assay index.", {"entities": []}], ["A change in the patient's immune status, possibly due to HIV, might have converted the syphilis from latent to active, leading to LETM of the spinal cord.", {"entities": [[87, 95, "DISEASE"]]}], ["Self- administered questionnaires or interviews and medical records are often used as sources of research data; thus it is essential to evaluate their concordance and reliability.", {"entities": []}], ["The aim of this paper was to assess the concordance between medical and behavioral data obtained from medical records and interview questionnaires in two correctional facilities.", {"entities": []}], ["Medical record and interview data were compared for 679 inmates from one male and one female maximum security prison between April 2010 and February 2013.", {"entities": []}], ["Gender non-stratified and gender-stratified analyses were conducted in SPSS to calculate the prevalence and kappa coefficient scores (\u03ba) for medical (e.g., HIV, diabetes, hypertension) and behavioral (e.g., smoking, drug use, tattoos) conditions.", {"entities": [[171, 183, "DISEASE"]]}], ["Sensitivity/specificity between medical records and interview were calculated in the gender non-stratified data.", {"entities": []}], ["In the gender non-stratified analysis, \u03ba score for HIV, hepatitis C, diabetes, asthma, and history of tattoos had strong or good concordance (0.66-0.89).", {"entities": [[56, 65, "DISEASE"], [79, 85, "DISEASE"]]}], ["Hypertension, renal/kidney disease, cigarette smoking, antibiotic use in the last 6\u00a0months, and cocaine use ever were moderately correlated (0.49-0.57).", {"entities": [[0, 12, "DISEASE"], [20, 34, "DISEASE"]]}], ["Both history of any illicit drug use ever (0.36) and marijuana use ever (0.23) had poor concordance.", {"entities": []}], ["Females had higher \u03ba scores and prevalence rates than males overall.", {"entities": []}], ["Medical conditions were reported more frequently in medical records and behavioral conditions had higher prevalence in interviews.", {"entities": []}], ["Sensitivity for medical conditions in the combined facility data ranged from 50.0% to 86.0% and 48.2% to 85.3% for behavioral conditions whereas specificity ranged from 95.9% to 99.5% for medical conditions and 75.9% to 92.8% for behavioral conditions.", {"entities": []}], ["Levels of agreement between medical records and self-reports varied by type of factor.", {"entities": []}], ["Medical conditions were more frequently reported by chart review and behavioral factors more frequently by self-report.", {"entities": []}], ["Data source used may need to be chosen carefully depending upon the type of information sought.", {"entities": []}], ["The Drug Ontology (DrOn) is an OWL2-based representation of drug products and their ingredients, mechanisms of action, strengths, and dose forms.", {"entities": []}], ["We originally created DrOn for use cases in comparative effectiveness research, primarily to identify historically complete sets of United States National Drug Codes (NDCs) that represent packaged drug products, by the ingredient(s), mechanism(s) of action, and so on contained in those products.", {"entities": []}], ["Although we had designed DrOn from the outset to carefully distinguish those entities that have a therapeutic indication from those entities that have a molecular mechanism of action, we had not previously represented in DrOn any particular therapeutic indication.", {"entities": []}], ["In this work, we add therapeutic indications for three research use cases: resistant hypertension, malaria, and opioid abuse research.", {"entities": [[85, 97, "DISEASE"], [99, 106, "DISEASE"], [112, 124, "DISEASE"]]}], ["We also added mechanisms of action for opioid analgesics and added 108 classes representing drug products in response to a large term request from the Program for Resistance, Immunology, Surveillance and Modeling of Malaria in Uganda (PRISM) project.", {"entities": [[216, 223, "DISEASE"]]}], ["The net result is a new version of DrOn, current to May 2016, that represents three major therapeutic classes of drugs and six new mechanisms of action.", {"entities": []}], ["A therapeutic indication of a drug product is represented as a therapeutic function in DrOn.", {"entities": []}], ["Adverse effects of drug products, as well as other therapeutic uses for which the drug product was not designed are dispositions.", {"entities": []}], ["Our work provides a framework for representing additional therapeutic indications, adverse effects, and uses of drug products beyond their design.", {"entities": []}], ["Our work also validated our past modeling decisions for specific types of mechanisms of action, namely effects mediated via receptor and/or enzyme binding.", {"entities": []}], ["DrOn is available at: http://purl.obolibrary.org/obo/dron.owl .", {"entities": []}], ["A smaller version without NDCs is available at: http://purl.obolibrary.org/obo/dron/dron-lite.owl", {"entities": []}], ["Measure Yourself Medical Outcome Profile (MYMOP) is a patient generated outcome instrument applicable in the evaluation of both allopathic and complementary medicine treatment.", {"entities": []}], ["This study aims to adapt MYMOP into Chinese, and to assess its validity, responsiveness and minimally important change values in a sample of patients using Chinese medicine (CM) services.", {"entities": []}], ["A Chinese version of MYMOP (CMYMOP) is developed by forward-backward-forward translation strategy, expert panel assessment and pilot testing amongst patients.", {"entities": []}], ["272 patients aged 18 or above with subjective symptoms in the past 2 weeks were recruited at a CM clinic, and were invited to complete a set of questionnaire containing CMYMOP and SF-36.", {"entities": []}], ["Follow ups were performed at 2 Criterion validity of CMYMOP was demonstrated by negative correlation between CMYMOP Profile scores and all SF-36 domain and summary scores at baseline.", {"entities": []}], ["For responsiveness between baseline and 4 The findings support the validity and responsiveness of CMYMOP for capturing patient centred clinical changes within 2 weeks in a CM clinical setting.", {"entities": []}], ["Further researches are warranted (1) to estimate Activity item MID, (2) to assess the test-retest reliability of CMYMOP, and (3) to perform further MID evaluation using multiple, item specific anchor questions.", {"entities": []}], ["Schistosomiasis is one of the most important neglected tropical diseases and an effective control is unlikely in the absence of improved sanitation and vaccination.", {"entities": [[0, 15, "DISEASE"]]}], ["A new approach of oral vaccination with alginate coated chitosan nanoparticles appears interesting because their great stability and the ease of target accessibility, besides of chitosan and alginate immunostimulatory properties.", {"entities": []}], ["Here we propose a candidate vaccine based on the combination of chitosan-based nanoparticles containing the antigen SmRho and coated with sodium alginate.", {"entities": []}], ["Our results showed an efficient performance of protein loading of nanoparticles before and after coating with alginate.", {"entities": []}], ["Characterization of the resulting nanoparticles reported a size around 430 nm and a negative zeta potential.", {"entities": []}], ["In vitro release studies of protein showed great stability of coated nanoparticles in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF).", {"entities": []}], ["Further in vivo studies was performed with different formulations of chitosan nanoparticles and it showed that oral immunization was not able to induce high levels of antibodies, otherwise intramuscular immunization induced high levels of both subtypes IgG1 and IgG2a SmRho specific antibodies.", {"entities": []}], ["Mice immunized with nanoparticles associated to CpG showed significant modulation of granuloma reaction.", {"entities": []}], ["Mice from all groups immunized orally with nanoparticles presented significant levels of protection against infection challenge with S. mansoni worms, suggesting an important role of chitosan in inducing a protective immune response.", {"entities": []}], ["Finally, mice immunized with nanoparticles associated with the antigen SmRho plus CpG had 38% of the granuloma area reduced and also presented 48% of protection against of S. mansoni infection.", {"entities": []}], ["Taken together, this results support this new strategy as an efficient delivery system and a potential vaccine against schistosomiasis.", {"entities": [[119, 134, "DISEASE"]]}], ["Schistosomiasis is one of the most important neglected tropical diseases and an effective control is unlikely in the absence of improved sanitation and vaccine.", {"entities": [[0, 15, "DISEASE"]]}], ["The selection of a suitable delivery system and an adjuvant to aid in the stimulation of the appropriate immune response is a critical step in the path to the development and employment of successful anti-schistosome vaccines.", {"entities": []}], ["Here we propose a candidate vaccine based on chitosan nanoparticles associated with the antigen SmRho and coated with alginate, as an alternative strategy to induce protection against S. mansoni infection.", {"entities": []}], ["This vaccination strategy offers many technical advantages, including the possibility of administration by oral route, which makes the vaccine safer than injectable vaccines and facilitates its use mainly in underdeveloped areas.", {"entities": []}], ["Chitosan nanoparticles were prepared and characterized; the results showed that the formulation has features suitable to be delivery orally.", {"entities": []}], ["Immunization studies suggest that the combination of chitosan nanoparticles associated to the antigen SmRho and CpG is an efficient vaccine candidate against schistosomiasis, which was able to modulate the granuloma area, that represents the major pathological response in schistosomiasis and also to induce protection against infection of S. mansoni .", {"entities": [[158, 173, "DISEASE"], [273, 288, "DISEASE"]]}], ["The multiple mechanisms of action for flavocoxid relating to arachidonic acid (AA) formation and metabolism were studied in vitro .", {"entities": []}], ["Flavocoxid titrated into rat peritoneal macrophage cultures inhibited cellular phospholipase A2 (PLA 2 ) (IC 50 = 60\u2009 \u03bc g/mL).", {"entities": []}], ["In in vitro enzyme assays, flavocoxid showed little anti-cyclooxygenase (CO) activity on COX-1/-2 enzymes, but inhibited the COX-1 (IC 50 = 12.3) and COX-2 (IC 50 = 11.3\u2009 \u03bc g/mL) peroxidase (PO) moieties as well as 5-lipoxygenase (5-LOX) (IC 50 = 110\u2009 \u03bc g/mL).", {"entities": []}], ["No detectable 5-LOX inhibition was found for multiple traditional and COX-2 selective NSAIDs.", {"entities": []}], ["Flavocoxid also exhibited strong and varied antioxidant capacities in vitro and decreased nitrite levels (IC 50 = 38\u2009 \u03bc g/mL) in rat peritoneal macrophages.", {"entities": []}], ["Finally, in contrast to celecoxib and ibuprofen, which upregulated the cox -2 gene, flavocoxid strongly decreased expression.", {"entities": []}], ["This work suggests that clinically favourable effects of flavocoxid for management of osteoarthritis (OA) are achieved by simultaneous modification of multiple molecular pathways relating to AA metabolism, oxidative induction of inflammation, and neutralization of reactive oxygen species (ROS).", {"entities": [[86, 100, "DISEASE"]]}], ["Comprehensive proteomic profiling of the human adipocyte secretome identified dipeptidyl peptidase 4 (DPP4) as a novel adipokine.", {"entities": [[102, 106, "GENE"]]}], ["This study assessed the functional implications of the adipokine DPP4 and its association to the metabolic syndrome.", {"entities": [[107, 115, "DISEASE"], [65, 69, "GENE"]]}], ["Human adipocytes and skeletal and smooth muscle cells were used to monitor DPP4 release and assess the effects of soluble DPP4 on insulin signaling.", {"entities": [[75, 79, "GENE"], [122, 126, "GENE"], [75, 79, "GENE"], [122, 126, "GENE"]]}], ["In lean and obese subjects, depot-specific expression of DPP4 and its release from adipose tissue explants were determined and correlated to parameters of the metabolic syndrome.", {"entities": [[169, 177, "DISEASE"], [57, 61, "GENE"]]}], ["Fully differentiated adipocytes exhibit a substantially higher release of DPP4 compared with preadipocytes or macrophages.", {"entities": [[74, 78, "GENE"]]}], ["Direct addition of DPP4 to fat and skeletal and smooth muscle cells impairs insulin signaling.", {"entities": [[19, 23, "GENE"]]}], ["A fivefold higher level of DPP4 protein expression was seen in visceral compared with subcutaneous fat of obese patients, with no regional difference in lean subjects.", {"entities": [[27, 31, "GENE"]]}], ["DPP4 serum concentrations significantly correlated with adipocyte size.", {"entities": [[0, 4, "GENE"]]}], ["By using adipose tissue explants from lean and obese subjects, we observed a twofold increase in DPP4 release that strongly correlated with adipocyte volume and parameters of the metabolic syndrome and was decreased to the lean level after weight reduction.", {"entities": [[189, 197, "DISEASE"], [97, 101, "GENE"]]}], ["DPP4 released from adipose tissue correlated positively with an increasing risk score for the metabolic syndrome.", {"entities": [[104, 112, "DISEASE"], [0, 4, "GENE"]]}], ["DPP4 is a novel adipokine that may impair insulin sensitivity in an autocrine and paracrine fashion.", {"entities": [[0, 4, "GENE"]]}], ["Furthermore, DPP4 release strongly correlates with adipocyte size, potentially representing an important source of DPP4 in obesity.", {"entities": [[123, 130, "DISEASE"], [13, 17, "GENE"], [115, 119, "GENE"], [13, 17, "GENE"], [115, 119, "GENE"]]}], ["Therefore, we suggest that DPP4 may be involved in linking adipose tissue and the metabolic syndrome.", {"entities": [[92, 100, "DISEASE"], [27, 31, "GENE"]]}], ["In this study we compared the diagnostic utility of: (1) neuron-specific enolase (NSE); (2) squamous cell carcinoma antigen (SCC); (3) carcinoembryonic antigen (CEA); and (4) cytokeratin markers (CYFRA 21-1, TPA, TPM, TPS) in patients with small-cell lung cancer (SCLC) (21 cases) and non-small-cell lung cancer (94 cases).", {"entities": [[251, 262, "DISEASE"], [300, 311, "DISEASE"], [106, 115, "DISEASE"], [92, 115, "DISEASE"], [256, 262, "DISEASE"], [305, 311, "DISEASE"]]}], ["For comparison we also studied 66 patients with benign lung diseases and nine with pleural mesothelioma.", {"entities": []}], ["NSE levels in SCLC patients were significantly higher than those in all the other groups studied.", {"entities": []}], ["No significant variations were found among the SCC levels in all groups.", {"entities": []}], ["CEA levels in patients with adenocarcinoma were significantly higher than those in all other groups studied.", {"entities": [[28, 42, "DISEASE"]]}], ["CYFRA 21-1 serum levels significantly increased in patients with squamous cell carcinoma and mesothelioma, while TPA, TPS and TPM increased in patients with lung cancer irrespective of the histological type.", {"entities": [[157, 168, "DISEASE"], [79, 88, "DISEASE"], [65, 88, "DISEASE"], [162, 168, "DISEASE"]]}], ["In patients with SCLC, high levels of all markers except SCC were found when the disease was extensive.", {"entities": []}], ["In patients with non-SCLC, the highest levels of all tumour markers were usually found in those with advanced disease, although CYFRA 21-1 gave a sensitivity of 44% when a specificity of 95% was fixed in stage I non-SCLC patients.", {"entities": []}], ["An analysis of receiver operating characteristic curves revealed that the highest diagnostic accuracies in distinguishing benign from malignant lung diseases were achieved with TPM (81%), CYFRA 21-1 (72%), CEA (78%) or TPA (78%) when using cut-off values of 46 Ul-1, 3.0 micrograms l-1, 2.0 micrograms l-1 and 75 Ul-1 respectively.", {"entities": []}], ["When all patients were considered, the combined evaluation of more than one marker did not significantly improve the results obtained with TPM alone.", {"entities": []}], ["However, taking into consideration the fact that CYFRA 21-1 is the most sensitive index of early lung tumours and that its combined determination with TPM did not worsen the overall sensitivity and specificity of the latter, the combined use of these two markers may be suggested as a useful took for the diagnosis of lung tumours.", {"entities": []}], ["The current study examined the association between temperature change and clinical visits for childhood respiratory tract infections (RTIs) in Guangzhou, China.", {"entities": []}], ["Outpatient records of clinical visits for pediatric RTIs, which occurred from 1 January 2012 to 31 December 2013, were collected from Guangzhou Women and Children\u2019s Hospital.", {"entities": []}], ["Records for meteorological variables during the same period were obtained from the Guangzhou Meteorological Bureau.", {"entities": []}], ["Temperature change was defined as the difference between the mean temperatures on two consecutive days.", {"entities": []}], ["A distributed lag non-linear model (DLNM) was used to examine the impact of temperature change on pediatric outpatient visits for RTIs.", {"entities": []}], ["A large temperature decrease was associated with a significant risk for an RTI, with the effect lasting for ~10 days.", {"entities": []}], ["The maximum effect of a temperature drop (\u22128.8 \u00b0C) was reached at lag 2~3 days.", {"entities": []}], ["Children aged 0\u20132 years, and especially those aged <1 year, were particularly vulnerable to the effects of temperature drop.", {"entities": []}], ["An extreme temperature decrease affected the number of patient visits for both upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs).", {"entities": []}], ["A temperature change between consecutive days, and particularly an extreme temperature decrease, was significantly associated with increased pediatric outpatient visits for RTIs in Guangzhou.", {"entities": []}], ["Many human genes have adapted to the constant threat of exposure to infectious agents; according to the \u201chygiene hypothesis,\u201d lack of exposure to parasites in modern settings results in immune imbalances, augmenting susceptibility to the development of autoimmune and allergic conditions.", {"entities": []}], ["Here, by estimating the number of pathogen species/genera in a specific geographic location (pathogen richness) for 52 human populations and analyzing 91 interleukin (IL)/IL receptor genes (IL genes), we show that helminths have been a major selective force on a subset of these genes.", {"entities": []}], ["A population genetics analysis revealed that five IL genes, including IL7R and IL18RAP , have been a target of balancing selection, a selection process that maintains genetic variability within a population.", {"entities": [[70, 74, "GENE"], [79, 86, "GENE"]]}], ["Previous identification of polymorphisms in some of these loci, and their association with autoimmune conditions, prompted us to investigate the relationship between adaptation and disease.", {"entities": []}], ["By searching for variants in IL genes identified in genome-wide association studies, we verified that six risk alleles for inflammatory bowel (IBD) or celiac disease are significantly correlated with micropathogen richness.", {"entities": [[151, 165, "DISEASE"]]}], ["These data support the hygiene hypothesis for IBD and provide a large set of putative targets for susceptibility to helminth infections.", {"entities": []}], ["Inorganic arsenic (iAs) is an established transplacental agent known to affect fetal development in animal studies.", {"entities": []}], ["However, iAs has not been adequately studied in the general population with respect to iAs exposure during pregnancy and its impact on the health status of newborns.", {"entities": []}], ["The aims of this study were to 1) elucidate the association between arsenic exposure and oxidative/methylated DNA damage in pregnant women, and 2) determine the association with birth outcomes.", {"entities": []}], ["A birth cohort study of 299 pregnant mother-newborn pairs was recruited during 2001\u20132002 in Taiwan.", {"entities": []}], ["We collected maternal urine samples during the 3 p <0.001) and oxidative 8-oxodG (beta \u200a=\u200a0.24, p <0.001) DNA damage biomarkers, and a decreased one-minute (1-min) Apgar score (beta \u200a=\u200a-0.23, p \u200a=\u200a0.041).", {"entities": []}], ["Maternal N p \u200a=\u200a0.042).", {"entities": []}], ["Mutual adjustment for iAs and N p \u200a=\u200a0.036).", {"entities": []}], ["Maternal iAs exposure was associated with both maternal DNA damage and adverse newborn health.", {"entities": []}], ["The identification of \u201cenvironmental justice (EJ) communities\u201d is an increasingly common element in environmental planning, policy, and regulation.", {"entities": []}], ["As a result, the choice of methods to define and identify these communities is a critical and often contentious process.", {"entities": []}], ["This contentiousness is, in turn, a factor of the lack of a commonly accepted method, the concern among many EJ advocates and some regulators that existing frameworks are inadequate, and ultimately, the significant consequences of such designations for both public policy and community residents.", {"entities": []}], ["With the aim of assisting regulators and advocates to more strategically focus their efforts, the authors developed a Cumulative Environmental Vulnerability Assessment (CEVA).", {"entities": []}], ["This CEVA is composed of a Cumulative Environmental Hazard Index and a Social Vulnerability Index, with a Health Index as a reference.", {"entities": []}], ["Applying CEVA produces spatial analysis that identifies the places that are subject to both the highest concentrations of cumulative environmental hazards and the fewest social, economic and political resources to prevent, mitigate, or adapt to these conditions.", {"entities": []}], ["We recommended that these areas receive special consideration in permitting, monitoring, and enforcement actions, as well as investments in public participation, capacity building, and community economic development.", {"entities": []}], ["Plant-derived molecules (PDMs) are known to be a rich source of diverse scaffolds that could serve as a basis for rational drug design.", {"entities": []}], ["Structured compilation of phytochemicals from traditional medicinal plants can facilitate prospection for novel PDMs and their analogs as therapeutic agents.", {"entities": []}], ["Rauvolfia serpentina is an important medicinal plant, endemic to Himalayan mountain ranges of Indian subcontinent,\u00a0reported to be of immense therapeutic value against various diseases.", {"entities": []}], ["We present SerpentinaDB, a structured compilation of 147 R. serpentina PDMs, inclusive of their plant part source, chemical classification, IUPAC, SMILES, physicochemical properties, and 3D chemical structures with associated references.", {"entities": []}], ["It also provides refined search option for identification of analogs of natural molecules\u00a0against ZINC database at user-defined cut-off.", {"entities": []}], ["SerpentinaDB is an exhaustive resource of R. serpentina molecules facilitating prospection for therapeutic molecules from a medicinally important source of natural products.", {"entities": []}], ["It also provides refined search option to explore the neighborhood of chemical space against ZINC database to identify analogs of natural molecules obtained as leads.", {"entities": []}], ["In a previous study, we have demonstrated the utility of this resource by identifying novel aldose reductase inhibitors towards intervention of complications of diabetes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12906-015-0683-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Depression is a common issue in institutionalized elderly people.", {"entities": []}], ["The \u201cAttentively Embracing Story\u201d theory is applied to help individuals transform negative thoughts into positive, and reflect on spiritual healing.", {"entities": []}], ["This study aimed to examine the effectiveness of a \u201cStory-Centred Care Intervention Program\u201d based on the \u201cAttentively Embracing Story\u201d theory in improving depressive symptoms, cognitive function, and heart rate variability in institutionalized elderly people.", {"entities": []}], ["Seventy long-term care residents were recruited from two long-term care facilities and randomized into the story-centred care intervention (n = 35) and control groups (n = 35).", {"entities": []}], ["We excluded five long-term care residents who did not complete the post-test measures and five long-term care residents who had interference events on the outcome measures.", {"entities": []}], ["Finally, sixty long-term care residents (40 women and 20 men; age 84.3\u00b15.98 years) were included in the final analysis.", {"entities": []}], ["Data were collected at four times (pre-intervention and post-intervention, 1 and 3-month follow-up) and analyzed with the generalized estimating equation approach.Instruments, including Geriatric Depression Scale, Short Portable Mind Status Questionnaire, and a CheckMyHeart device to measure heart rate variability, were used in study.", {"entities": []}], ["The degree of improvement in depressive symptoms was significantly higher in the story-centred care intervention group than in the control group after providing the story-centred care intervention program (p < .001) and at 1 and 3-month follow-up (p = .001, p = .006, respectively; GDS-15 score reduced 1.816 at the 3-month follow-up).", {"entities": []}], ["Participants receiving the story-centred care intervention program showed significantly greater improvement than those in the control group in the cognitive function at 1and 3-month follow-up (p = .009, p = .024, respectively; SPMSQ score reduced 0.345 at the 3-month follow-up).", {"entities": []}], ["The heart rate variability parameters (SDNN, RMSSD) did not show a statistically significant increase.", {"entities": []}], ["However an increasing trend in the parameters was observed in the intervention group (SDNN increased 16.235ms at the 3-month follow-up; RMSSD increased 16.424 ms at the 3-month follow-up).", {"entities": []}], ["In conclusions, the story-centred care intervention program was effective on the improvement of depressive symptoms and cognitive status in institutionalized elderly people.", {"entities": []}], ["Immunoglobulin E (IgE) is known to activate mast cells.", {"entities": []}], ["Prior studies have shown that mast cells contribute to diet-induced obesity and diabetes mellitus (DM).", {"entities": [[68, 75, "DISEASE"], [80, 97, "DISEASE"]]}], ["We aimed to determine whether adults with IgE sensitization were at risk of DM.", {"entities": []}], ["We performed assays regarding serum total IgE and allergen-specific IgE levels against the house dust mite, the cockroach, and the dog on 1,528 adults randomly sampled from every age and gender group in various districts.", {"entities": []}], ["The total and three allergen-specific IgE levels were positively correlated with fasting glucose level and insulin resistance.", {"entities": []}], ["Subjects with increased levels of total IgE (>100 kU/L), compared to those without, had an odds ratio (OR) of 1.72 (95% confidence interval [95% CI], 1.17\u20132.54) for DM after adjusting for various covariates.", {"entities": []}], ["Further controlling for previous allergic disease did not attenuate the association between total IgE level and DM.", {"entities": []}], ["Subjects sensitized to the house dust mite (OR 1.63, 95% CI, 1.03\u20132.59) and the cockroach (OR 2.27, 95% CI, 1.40\u20133.66) were also at increased risk of DM.", {"entities": []}], ["We found a strong positive association between IgE sensitization and DM in a general Korean population, suggesting that IgE may be an important independent risk factor for metabolic diseases in Koreans.", {"entities": []}], ["Type VI collagen (COL6), an extracellular matrix protein, is important in maintaining the integrity of lung tissue.", {"entities": []}], ["An increase in COL6 mRNA and protein deposition was found in the lungs of patients with pulmonary fibrosis, a chronic inflammatory condition with a strong association with lung cancer.", {"entities": [[172, 183, "DISEASE"], [88, 106, "DISEASE"], [177, 183, "DISEASE"]]}], ["In the present study, we demonstrated overexpression of COL6 in the lungs of non-small cell lung cancers.", {"entities": []}], ["We hypothesized that excessive COL6 in the lung interstitium may exert stimulatory effects on the adjacent cells.", {"entities": []}], ["In vitro stimulation of monocytes with COL6 resulted in the production of IL-23, which may promote tumor development in an environment of IL-23-mediated lung inflammation, where tissue modeling occurs concurrently with excessive COL6 production.", {"entities": []}], ["In addition, COL6 was capable of stimulating signaling pathways that activate focal adhesion kinase and extracellular signal-regulated kinase 1/2 in lung epithelial cells, which may also facilitate the development of lung neoplasms.", {"entities": []}], ["Taken together, our data suggest the potential role of COL6 in promoting lung neoplasia in diseased lungs where COL6 is overexpressed.", {"entities": []}], ["The quality of mineral water commercialized in Brazil regarding the microbial content was analyzed and the results were compared with the standards established by the current legislation.", {"entities": []}], ["Results demonstrated there was no bacterial contamination, but several types of fungi were found.", {"entities": []}], ["Therefore, bottled mineral water could be considered a possible route for the transmission of filamentous fungi and yeasts.", {"entities": []}], ["Interpretation of gene expression microarray data in the light of external information on both columns and rows (experimental variables and gene annotations) facilitates the extraction of pertinent information hidden in these complex data.", {"entities": []}], ["Biologists classically interpret genes of interest after retrieving functional information from a subset of genes of interest.", {"entities": []}], ["Transcription factors play an important role in orchestrating the regulation of gene expression.", {"entities": []}], ["Their activity can be deduced by examining the presence of putative transcription factors binding sites in the gene promoter regions.", {"entities": []}], ["In this paper we present the multivariate statistical method RLQ which aims to analyze microarray data where additional information is available on both genes and samples.", {"entities": []}], ["As an illustrative example, we applied RLQ methodology to analyze transcription factor activity associated with the time-course effect of steroids on the growth of primary human lung fibroblasts.", {"entities": []}], ["RLQ could successfully predict transcription factor activity, and could integrate various other sources of external information in the main frame of the analysis.", {"entities": []}], ["The approach was validated by means of alternative statistical methods and biological validation.", {"entities": []}], ["RLQ provides an efficient way of extracting and visualizing structures present in a gene expression dataset by directly modeling the link between experimental variables and gene annotations.", {"entities": []}], ["Schistosoma mansoni antigens in the early life alter homologous and heterologous immunity during postnatal infections.", {"entities": []}], ["We evaluate the immunity to parasite antigens and ovalbumin (OA) in adult mice born/suckled by schistosomotic mothers.", {"entities": []}], ["Newborns were divided into: born (BIM), suckled (SIM) or born/suckled (BSIM) in schistosomotic mothers, and animals from noninfected mothers (control).", {"entities": []}], ["When adults, the mice were infected and compared the hepatic granuloma size and cellularity.", {"entities": []}], ["Some animals were OA + adjuvant immunised.", {"entities": []}], ["We evaluated hypersensitivity reactions (HR), antibodies levels (IgG1/IgG2a) anti-soluble egg antigen and anti-soluble worm antigen preparation, and anti-OA, cytokine production, and CD4 g .", {"entities": [[41, 43, "GENE"], [183, 186, "GENE"]]}], ["In BSIM, there was higher production of IL-10 and IFN- g, but lower levels of IL-4 and CD4", {"entities": [[87, 90, "GENE"]]}], ["It was recently reported that dairy cows fed a polyphenol-rich grape seed and grape marc meal extract (GSGME) during the transition period had an increased milk yield, but the underlying reasons remained unclear.", {"entities": []}], ["As polyphenols exert a broad spectrum of metabolic effects, we hypothesized that feeding of GSGME influences metabolic pathways in the liver which could account for the positive effects of GSGME in dairy cows.", {"entities": []}], ["In order to identify these pathways, we performed genome-wide transcript profiling in the liver and lipid profiling in plasma of dairy cows fed GSGME during the transition period at 1\u00a0week postpartum.", {"entities": []}], ["Transcriptomic analysis of the liver revealed 207 differentially expressed transcripts, from which 156 were up- and 51 were down-regulated, between cows fed GSGME and control cows.", {"entities": []}], ["Gene set enrichment analysis of the 155 up-regulated mRNAs showed that the most enriched gene ontology (GO) biological process terms were dealing with cell cycle regulation and the most enriched Kyoto Encyclopedia of Genes and Genomes pathways were p53 signaling and cell cycle.", {"entities": []}], ["Functional analysis of the 43 down-regulated mRNAs revealed that a great part of these genes are involved in endoplasmic reticulum (ER) stress-induced unfolded protein response (UPR) and inflammatory processes.", {"entities": []}], ["Accordingly, protein folding, response to unfolded protein, unfolded protein binding, chemokine activity and heat shock protein binding were identified as one of the most enriched GO biological process and molecular function terms assigned to the down-regulated genes.", {"entities": []}], ["In line with the transcriptomics data the plasma concentrations of the acute phase proteins serum amyloid A (SAA) and haptoglobin were reduced in cows fed GSGME compared to control cows.", {"entities": []}], ["Lipidomic analysis of plasma revealed no differences in the concentrations of individual species of major and minor lipid classes between cows fed GSGME and control cows.", {"entities": []}], ["Analysis of hepatic transcript profile in cows fed GSGME during the transition period at 1\u00a0week postpartum indicates that polyphenol-rich feed components are able to inhibit ER stress-induced UPR and inflammatory processes, both of which are considered to contribute to liver-associated diseases and to impair milk performance in dairy cows, in the liver of dairy cows during early lactation.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-017-3638-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a multicomponent disorder that leads to substantial disability, impaired quality of life, and increased mortality.", {"entities": []}], ["Although the majority of COPD patients are first diagnosed and treated in primary care practices, there is comparatively little information on the management of COPD patients in primary care.", {"entities": []}], ["A web-based pilot survey was conducted to evaluate the primary care physician\u2019s, or general practitioner\u2019s (GP\u2019s), knowledge, understanding, and management of COPD in twelve territories across the Asia-Pacific region, Africa, eastern Europe, and Latin America, using a 10-minute questionnaire comprising 20 questions and translated into the native language of each participating territory.", {"entities": []}], ["The questionnaire was administered to a total of 600 GPs (50 from each territory) involved in the management of COPD patients and all data were collated and analyzed by an independent health care research consultant.", {"entities": []}], ["This survey demonstrated that the GPs\u2019 understanding of COPD was variable across the territories, with large numbers of GPs having very limited knowledge of COPD and its management.", {"entities": []}], ["A consistent finding across all territories was the underutilization of spirometry (median 26%; range 10%\u201348%) and reliance on X-rays (median 14%; range 5%\u201322%) for COPD diagnosis, whereas overuse of blood tests (unspecified) was particularly high in Russia and South Africa.", {"entities": []}], ["Similarly, there was considerable underrecognition of the importance of exacerbation history as an important factor of COPD and its initial management in most territories (median 4%; range 0%\u201322%).", {"entities": []}], ["Management of COPD was well below guideline-recommended levels in most of the regions investigated.", {"entities": []}], ["The findings of this survey suggest there is a need for more ongoing education and information, specifically directed towards GPs outside of Europe and North America, and that global COPD guidelines appear to have limited reach and application in most of the areas studied.", {"entities": []}], ["The early introduction of fish has been reported to reduce the risk of wheezing disorder in early childhood, while broad-spectrum antibiotics in the first week have been associated with an increased risk.", {"entities": []}], ["However, it is uncertain whether the effects remain into school age.", {"entities": []}], ["The aim was to explore these risk factors for doctor-diagnosed asthma at 8 years.", {"entities": [[63, 69, "DISEASE"]]}], ["Data were obtained from a prospective, longitudinal study of a cohort of children born in western Sweden.", {"entities": []}], ["The parents answered questionnaires at 6 months and 1, 4.5 and 8 years of age.", {"entities": []}], ["The response rate at 8 years was 80% of the questionnaires distributed (4051/5044), that is, 71% of the families entering the study (4051/5654).", {"entities": []}], ["At 8 years, 5.7% reported current doctor-diagnosed asthma.", {"entities": [[51, 57, "DISEASE"]]}], ["Of these, 65% had atopic asthma and 35% non-atopic asthma.", {"entities": [[25, 31, "DISEASE"], [51, 57, "DISEASE"]]}], ["In the multivariate analysis, atopic heredity, male gender and own allergic disease during infancy were risk factors for doctor-diagnosed asthma at 8 years.", {"entities": [[138, 144, "DISEASE"]]}], ["In addition, the introduction of fish before the age of 9 months independently reduced the risk (adjusted OR 0.6; 95% CI 0.4\u20130.96), while broad-spectrum antibiotics in the first week independently increased the risk of current asthma at school age (aOR 2.3; 1.2\u20134.2).", {"entities": [[227, 233, "DISEASE"]]}], ["Regarding types of asthma, the effects were significant in atopic asthma but not in non-atopic asthma.", {"entities": [[19, 25, "DISEASE"], [66, 72, "DISEASE"], [95, 101, "DISEASE"]]}], ["The early introduction of fish and neonatal antibiotic treatment influence the risk of asthma into school age.", {"entities": [[87, 93, "DISEASE"]]}], ["The significant effect on atopic asthma is of particular importance, as this phenotype is of major clinical significance.", {"entities": [[33, 39, "DISEASE"]]}], ["Fe 3 O 4 magnetic nanoparticles (MgNPs-Fe 3 O 4 ) are widely used in medical applications, including magnetic resonance imaging, drug delivery, and in hyperthermia.", {"entities": []}], ["However, the same properties that aid their utility in the clinic may potentially induce toxicity.", {"entities": []}], ["Therefore, the purpose of this study was to investigate the cytotoxicity and genotoxicity of MgNPs-Fe 3 O 4 in A549 human lung epithelial cells.", {"entities": []}], ["MgNPs-Fe 3 O 4 caused cell membrane damage, as assessed by the release of lactate dehydrogenase (LDH), only at a high concentration (100 \u03bcg/mL); a lower concentration (10 \u03bcg/mL) increased the production of reactive oxygen species, increased oxidative damage to DNA, and decreased the level of reduced glutathione.", {"entities": []}], ["MgNPs-Fe 3 O 4 caused a dose-dependent increase in the CD44 3 O 4 induced the expression of heme oxygenase-1 at a concentration of 1 \u03bcg/mL, and in a dose-dependent manner.", {"entities": [[55, 59, "GENE"]]}], ["Despite these effects, MgNPs-Fe 3 O 4 had minimal effect on cell viability and elicited only a small increase in the number of cells undergoing apoptosis.", {"entities": []}], ["Together, these data suggest that MgNPs-Fe 3 O 4 exert little or no cytotoxicity until a high exposure level (100 \u03bcg/mL) is reached.", {"entities": []}], ["This dissociation between elevated indices of cell damage and a small effect on cell viability warrants further study.", {"entities": []}], ["T follicular helper (T FH ) cells are the prototypic helper T cell subset specialized to enable B cells to form germinal centers and produce high-affinity antibodies.", {"entities": [[23, 25, "GENE"]]}], ["We found that miRNA expression by T cells was essential for T FH cell differentiation.", {"entities": [[62, 64, "GENE"]]}], ["More specifically, we show that after protein immunization the microRNA cluster miR-17~92 was critical for robust T FH cell differentiation and function in a cell-intrinsic manner that occurred regardless of changes in proliferation.", {"entities": [[116, 118, "GENE"]]}], ["In a viral infection model, miR-17~92 restrained the expression of T FH subset-inappropriate genes, including the direct target RAR-related orphan receptor alpha ( Rora ).", {"entities": [[69, 71, "GENE"], [164, 168, "GENE"]]}], ["Genetically removing one Rora allele partially rescued the inappropriate gene signature in miR-17~92-deficient T FH cells.", {"entities": [[25, 29, "GENE"], [113, 115, "GENE"]]}], ["Our results identify the miR-17~92 cluster as a critical regulator of T cell-dependent antibody responses, T FH cell differentiation and the fidelity of the T FH cell gene expression program.", {"entities": [[109, 111, "GENE"], [159, 161, "GENE"], [109, 111, "GENE"], [159, 161, "GENE"]]}], ["Antinuclear antibodies (ANA) are primarily significant in the diagnosis of systemic connective tissue diseases.", {"entities": []}], ["The relationship between their occurrence in allergic diseases is poorly documented.", {"entities": []}], ["However, the mechanism of allergic and autoimmune diseases has a common thread.", {"entities": []}], ["In both cases, an increased production of IgE antibodies and presence of ANA in selected disease entities is observed.", {"entities": []}], ["Equally important is the activation of basophils secreting proinflammatory factors and affecting the differentiation of TH17 lymphocytes.", {"entities": []}], ["Both autoimmune and allergic diseases have complex multi-pathogenesis and often occur in genetically predisposed individuals.", {"entities": []}], ["The presence of antinuclear antibodies was confirmed in many systemic connective tissue diseases and some allergic diseases.", {"entities": []}], ["Examples include atopic dermatitis, non-allergic asthma, and pollen allergy.", {"entities": [[17, 34, "DISEASE"], [40, 55, "DISEASE"], [49, 55, "DISEASE"], [24, 34, "DISEASE"]]}], ["Co-occurring allergic and autoimmune disorders induce further search for mechanisms involved in the aetiopathogenesis of both groups of diseases.", {"entities": []}], ["Background .", {"entities": []}], ["Multiple chemical sensitivity (MCS) is a chronic condition characterized by an exaggerated response to toxicants.", {"entities": []}], ["We ascertained the prevalence of allergy to metals and toxicological aspects in MCS patients.", {"entities": []}], ["We conducted a retrospective review of medical records of 41 patients with MCS.", {"entities": []}], ["We performed patch testing ( n = 21) for dental series and did lymphocyte transformation test ( n = 18) for metals.", {"entities": []}], ["We measured mercury in samples of blood ( n = 19), urine ( n = 19), saliva ( n = 20), and scalp hair ( n = 17) to investigate the association between mercury levels and cases of MCS.", {"entities": []}], ["The prevalence of metal immune hypersensitivity in a subset of 26 patients was 92.3 percent.", {"entities": []}], ["Elevations of mercury occurred in 81.2 percent (26 of 32).", {"entities": []}], ["The mean (\u00b1SD) in blood concentrations of mercury was 7.6 \u00b1 13.6\u2009 \u03bc g/L; mean in urine was 1.9 \u00b1 2.5\u2009 \u03bc g/L; mean in scalp hair was 2.2 \u00b1 2.5\u2009 \u03bc g/g; mean in saliva was 38.1 \u00b1 52.1\u2009 \u03bc g/L.", {"entities": []}], ["Subgroup analyses showed that elevation of mercury levels in biological matrices were associated with mercury amalgams in patients with MCS (22 patients), compared with controls (8 patients) (odds ratio 11\u2009:\u200995 percent confidence interval 1.5 to 81.6; P = 0.023).", {"entities": []}], ["Conclusions .", {"entities": []}], ["Our data show an increased prevalence of metal allergy and elevation of mercury levels in bioindicators among patients with MCS.", {"entities": []}], ["To determine the course of food allergy in accordance with the level of respiratory tract injury in children of Eastern Siberia.", {"entities": [[27, 39, "DISEASE"]]}], ["We have examined 70 children aged 2\u201316 , who have food sensibilization.", {"entities": []}], ["We divided them into 2 groups: group I (n=32) with diseases of the upper and middle respiratory tract; and group II (n=38) with diseases of the lower respiratory tract.", {"entities": []}], ["Allergological medical history, clinical laboratory examination and immunological examination, including the determination of IgA, IgM, IgG and IgE in blood serum.", {"entities": []}], ["In cases where causal allergens were found, elimination diets were recommended.", {"entities": []}], ["Onset of upper respiratory tract injury in group I was more often registered in children aged 0\u20131; in group II, it was in the 3\u20137 age group.", {"entities": []}], ["Isolated food sensibilization was more often marked in group I as compared to group II.", {"entities": []}], ["Atopic mechanisms of respiratory tract injuries were more often registered in group II children.", {"entities": []}], ["In the course of the elimination diet, we marked positive dynamics in 100% of group I and in 75% of group II The most frequent allergens that cause respiratory forms of food allergy are hen eggs, cow milk, nutritive cereals, vegetables and fruit.", {"entities": [[169, 181, "DISEASE"]]}], ["Indices of a humoral link of immunity in the examined patients were more often registered as normal or their level is increased.", {"entities": []}], ["Timely etiotropic therapy in the majority of cases allows for a stabilization of allergic inflammation.", {"entities": []}], ["With continued increases in smartphone ownership, researchers and clinicians are investigating the use of this technology to enhance the management of chronic illnesses such as bipolar disorder (BD).", {"entities": [[177, 193, "DISEASE"]]}], ["Smartphones can be used to deliver interventions and psychoeducation, supplement treatment, and enhance therapeutic reach in BD, as apps are cost-effective, accessible, anonymous, and convenient.", {"entities": []}], ["While the evidence-based development of BD apps is in its infancy, there has been an explosion of publicly available apps.", {"entities": []}], ["However, the opportunity for mHealth to assist in the self-management of BD is only feasible if apps are of appropriate quality.", {"entities": []}], ["Our aim was to identify the types of apps currently available for BD in the Google Play and iOS stores and to assess their features and the quality of their content.", {"entities": []}], ["A systematic review framework was applied to the search, screening, and assessment of apps.", {"entities": []}], ["We searched the Australian Google Play and iOS stores for English-language apps developed for people with BD.", {"entities": []}], ["The comprehensiveness and quality of information was assessed against core psychoeducation principles and current BD treatment guidelines.", {"entities": []}], ["Management tools were evaluated with reference to the best-practice resources for the specific area.", {"entities": []}], ["General app features, and privacy and security were also assessed.", {"entities": [[8, 11, "GENE"]]}], ["Of the 571 apps identified, 82 were included in the review.", {"entities": []}], ["Of these, 32 apps provided information and the remaining 50 were management tools including screening and assessment (n=10), symptom monitoring (n=35), community support (n=4), and treatment (n=1).", {"entities": []}], ["Not even a quarter of apps (18/82, 22%) addressed privacy and security by providing a privacy policy.", {"entities": []}], ["Overall, apps providing information covered a third (4/11, 36%) of the core psychoeducation principles and even fewer (2/13, 15%) best-practice guidelines.", {"entities": []}], ["Only a third (10/32, 31%) cited their information source.", {"entities": []}], ["Neither comprehensiveness of psychoeducation information ( r =-.11, P =.80) nor adherence to best-practice guidelines ( r =-.02, P =.96) were significantly correlated with average user ratings.", {"entities": []}], ["Symptom monitoring apps generally failed to monitor critical information such as medication (20/35, 57%) and sleep (18/35, 51%), and the majority of self-assessment apps did not use validated screening measures (6/10, 60%).", {"entities": []}], ["In general, the content of currently available apps for BD is not in line with practice guidelines or established self-management principles.", {"entities": []}], ["Apps also fail to provide important information to help users assess their quality, with most lacking source citation and a privacy policy.", {"entities": []}], ["Therefore, both consumers and clinicians should exercise caution with app selection.", {"entities": [[70, 73, "GENE"]]}], ["While mHealth offers great opportunities for the development of quality evidence-based mobile interventions, new frameworks for mobile mental health research are needed to ensure the timely availability of evidence-based apps to the public.", {"entities": []}], ["The Cough Symptom Score (CSS) is a simple, useful tool for measuring cough severity.", {"entities": []}], ["However, there is no standard Korean version of the CSS.", {"entities": []}], ["We developed a Korean version of the CSS and evaluated its clinical utility and validity for assessing chronic cough severity.", {"entities": []}], ["The CSS was adapted for Korean use following a forward-backward translation procedure.", {"entities": []}], ["Patients with chronic cough enrolled from five university hospitals were graded using the CSS and a 100-mm linear visual analog scale (VAS) of cough severity at each visit.", {"entities": []}], ["Patients completed the Leicester Cough Questionnaire (LCQ) upon presentation and completed the LCQ and Global Rating of Change at follow-up visits after 2 to 4 weeks.", {"entities": []}], ["The concurrent validity, repeatability, and responsiveness of the Korean version of the CSS were determined.", {"entities": []}], ["Correlation coefficients between the CSS and LCQ, and between the CSS and VAS, were \u20130.66 and 0.52, respectively.", {"entities": []}], ["There was a weak correlation between the scores for night and day symptoms ( r = 0.24, p = 0.0006).", {"entities": []}], ["The repeatability of the CSS in patients with no change in cough (n = 23) was high (intra-class correlation coefficient, 0.75; 95% confidence interval [CI], 0.51 to 0.88).", {"entities": []}], ["Patients who reported an improvement in cough (n = 30) at follow-up visits had a significant improvement in the CSS (median, \u20132; 95% CI, \u20133 to \u20131; p = 0.0003).", {"entities": []}], ["The Korean version of the CSS correlated well with other tools for accessing cough severity in chronic cough patients.", {"entities": []}], ["Therefore, it could be a reliable method for measuring chronic cough severity.", {"entities": []}], ["Patient: Male, 27 Final Diagnosis: Tracheobronchopathia osteochondroplastica Symptoms: Shortness of breath \u2022 stridor Medication: \u2014 Clinical Procedure: Neck computer tomography \u2022 pulmonary function test \u2022 neck surgical exploration \u2022 tracheostomy placement Specialty: Critical Care Medicine Unusual clinical course Tracheobronchopathia osteochondroplastica is a rare benign and often indolent disease.", {"entities": []}], ["We report the first case of tracheobronchopathia osteochondroplastica (TBO) presenting as acute hypercarbic respiratory failure due to superimposed subglottic submucosal abscess.", {"entities": [[108, 127, "DISEASE"]]}], ["A 27-year-old man presented to the emergency department in respiratory distress that required mechanical ventilation for acute hypercarbic respiratory failure.", {"entities": [[139, 158, "DISEASE"]]}], ["Upon extubation the next day, stridor was elicited with ambulation.", {"entities": []}], ["Spirometry revealed fixed upper airway obstruction.", {"entities": []}], ["Neck imaging showed a 2.8\u00d72.0\u00d74.0 cm partially calcified subglottic mass with cystic and solid component obstructing 75% of the airway.", {"entities": []}], ["Surgical exploration revealed purulent drainage upon elevation of the thyroid isthmus and an anterolateral cricoid wall defect in communication with a subglottic submucosal cavity.", {"entities": []}], ["Microbiology was negative for bacteria or fungi.", {"entities": []}], ["Pathology showed chondro-osseous metaplasia compatible with tracheobronchopathia osteochondroplastica (TBO).", {"entities": []}], ["The patient received a course of antibiotics and prophylactic tracheostomy.", {"entities": []}], ["Since tracheostomy removal 3 days later, the patient remains asymptomatic.", {"entities": []}], ["Tracheobronchopathia osteochondroplastica is a rare disease with usually benign clinical course and incidental diagnosis.", {"entities": []}], ["It may present as acute hypercarbic respiratory failure when subglottic infection is superimposed.", {"entities": [[36, 55, "DISEASE"]]}], ["Allergic asthma is associated with persistent functional and structural changes in the airways and involves many different cell types.", {"entities": [[0, 15, "DISEASE"], [9, 15, "DISEASE"]]}], ["Many proteins involved in allergic asthma have been identified individually, but complete protein profiles (proteome) have not yet been reported.", {"entities": [[26, 41, "DISEASE"], [35, 41, "DISEASE"]]}], ["Here we have used a differential proteome mapping strategy to identify tissue proteins that are differentially expressed in mice with allergic asthma and in normal mice.", {"entities": [[134, 149, "DISEASE"], [143, 149, "DISEASE"]]}], ["Mouse lung tissue proteins were separated using two-dimensional gel electrophoresis over a pH range between 4 and 7, digested, and then analyzed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MS).", {"entities": []}], ["The proteins were identified using automated MS data acquisition.", {"entities": []}], ["The resulting data were searched against a protein database using an internal Mascot search routine.", {"entities": []}], ["This approach identified 15 proteins that were differentially expressed in the lungs of mice with allergic asthma and normal mice.", {"entities": [[98, 113, "DISEASE"], [107, 113, "DISEASE"]]}], ["All 15 proteins were identified by MS, and 9 could be linked to asthma-related symptoms, oxidation, or tissue remodeling.", {"entities": [[64, 70, "DISEASE"]]}], ["Our data suggest that these proteins may prove useful as surrogate biomarkers for quantitatively monitoring disease state progression or response to therapy.", {"entities": []}], ["Intestinal circulatory disturbances, atony, edema and swelling are of great clinical relevance, but the related mechanisms and possible therapeutic options are poorly characterized, in part because of the difficulties to comprehensively analyze these conditions.", {"entities": []}], ["To overcome these limitations we have developed a model of the isolated perfused rat small intestine where all of these symptoms can be studied simultaneously.", {"entities": []}], ["Here we used this model to study the role of eicosanoids, steroids and quinidine in platelet-activating factor (PAF)-induced intestinal disorders.", {"entities": []}], ["A vascular bolus of PAF (0.5 nmol) triggered release of thromboxane and peptidoleukotrienes into the vascular bed (peak concentration 35 nM and 0.8 nM) and reproduced all symptoms of intestinal failure: mesenteric vasoconstriction, translocation of fluid and macromolecules from the vasculature to the lumen and lymphatics, intestinal edema formation, loss of intestinal peristalsis and decreased galactose uptake.", {"entities": []}], ["All effects of PAF were abolished by the PAF-receptor antagonist ABT491 (2.5 \u03bcM).", {"entities": []}], ["The COX and LOX inhibitors ASA and AA861 (500 \u03bcM, 10 \u03bcM) did not exhibit barrier-protective effects and the eicosanoid antagonists SQ29548 and MK571 (10 \u03bcM, each) only moderately attenuated the loss of vascular fluid, the redistribution to the lumen and the transfer of FITC dextran to the lumen.", {"entities": []}], ["The steroid dexamethasone (10 \u03bcM) showed no barrier-protective properties and failed to prevent edema formation.", {"entities": []}], ["Quinidine (100 \u03bcM) inhibited the increase in arterial pressure, stabilized all the intestinal barriers, and reduced lymph production and the transfer of FITC dextran to the lymph.", {"entities": []}], ["While quinidine by itself reduced peristalsis, it also obviated paralysis, preserved intestinal functions and prevented edema formation.", {"entities": []}], ["We conclude that quinidine exerts multiple protective effects against vasoconstriction, edema formation and paralysis in the intestine.", {"entities": []}], ["The therapeutic use of quinidine for intestinal ailments deserves further study.", {"entities": []}], ["Though lung sounds auscultation is important for the diagnosis and monitoring of lung diseases, the spectral characteristics of lung sounds have not been fully understood.", {"entities": []}], ["This study compared the spectral characteristics of lung sounds between the right and left lungs and between healthy male and female subjects using a dual-channel auscultation system.", {"entities": []}], ["Forty-two subjects aged 18\u201322 years without smoking habits and any known pulmonary diseases participated in this study.", {"entities": []}], ["The lung sounds were recorded from seven pairs of auscultation sites on the chest wall simultaneously.", {"entities": []}], ["We found that in four out of seven auscultation pairs, the lung sounds from the left lung had a higher total power (P T ) than those from the right lung.", {"entities": []}], ["The P T of male subjects was higher than that of female ones in most auscultation pairs.", {"entities": []}], ["The ratio of inspiration power to expiration power (R I/E ) of lung sounds from the right lung was greater than that from the left lung at auscultation pairs on the anterior chest wall, while this phenomenon was reversed at auscultation pairs on the posterior chest wall in combined subjects, and similarly in both male and female subjects.", {"entities": []}], ["Though the frequency corresponding to maximum power density of lung sounds (F MPD ) from the left and right lungs was not significantly different, the frequency that equally divided the power spectrum of lung sounds (F 50 ) from the left lung was significantly smaller than that from the right lung at auscultation site on the anterior and lateral chest walls, while it was significantly larger than that of from the right lung at auscultation site on the posterior chest walls.", {"entities": []}], ["In conclusion, significant differences in the P T , F MPD , F 50 , and R I/E between the left and right lungs at some auscultation pairs were observed by using a dual-channel auscultation system in this study.", {"entities": []}], ["Structural differences between the left and the right lungs, between the female and male subjects, and between anterior and posterior lungs might account for the observed differences in the spectral characteristics of lung sounds.", {"entities": []}], ["The dual-channel auscultation system might be useful for future development of digital stethoscopes and power spectral analysis of lung sounds in patients with various kinds of cardiopulmonary diseases.", {"entities": []}], ["The healthy lung maintains a steady state of immune readiness to rapidly respond to injury from invaders.", {"entities": []}], ["Integrins are important for setting the parameters of this resting state, particularly the epithelial-restricted \u03b1V\u03b26 integrin, which is upregulated during injury.", {"entities": []}], ["Once expressed, \u03b1V\u03b26 moderates acute lung injury (ALI) through as yet undefined molecular mechanisms.", {"entities": []}], ["We show that the upregulation of \u03b26 during influenza infection is involved in disease pathogenesis.", {"entities": [[43, 52, "DISEASE"]]}], ["\u03b26-deficient mice (\u03b26 KO) have increased survival during influenza infection likely due to the limited viral spread into the alveolar spaces leading to reduced ALI.", {"entities": [[57, 66, "DISEASE"]]}], ["Although the \u03b26 KO have morphologically normal lungs, they harbor constitutively activated lung CD11b The lung undergoes daily assault by microbes and other inhaled particulates and must maintain the balance between clearance of harmful microorganisms while protecting the delicate lung structure to avoid acute lung injury.", {"entities": []}], ["Not surprisingly, this is a complex process requiring communication between the lung epithelial cells (first site of attack by invaders) and the cells of the intrinsic immune response.", {"entities": []}], ["We demonstrate the \u03b1V\u03b26 integrin is an important player in this interface.", {"entities": []}], ["Loss of \u03b1V\u03b26 during influenza infection, and other respiratory infections, leads to bolstered protection against severe lung disease and improved survival in mice.", {"entities": [[20, 29, "DISEASE"], [120, 132, "DISEASE"]]}], ["Even in the absence of infection, \u03b26 KO animals have a distinct anti-microbial lung microenvironment as evidenced by increased type I IFN activity and activated alveolar macrophages that appear \u201cpoised to defend\u201d.", {"entities": []}], ["These studies explore how the epithelial-specific \u03b1V\u03b26 integrin regulates the lung microenvironment to alter alveolar macrophage activity through a TGF-\u03b2-dependent mechanism, leading to changes in both the homeostatic lung and responses to respiratory infections as a way of balancing microbial clearance with protection of the lung from excessive damage.", {"entities": []}], ["Nutrition and lifestyle are well-defined modulators of chronic diseases.", {"entities": []}], ["Poor dietary habits (such as high intake of processed foods rich in fat and low intake of fruits and vegetables), as well as a sedentary lifestyle clearly contribute to today\u2019s compromised quality of life in the United States.", {"entities": []}], ["It is becoming increasingly clear that nutrition can modulate the toxicity of environmental pollutants.", {"entities": []}], ["Our goal in this commentary is to discuss the recommendation that nutrition should be considered a necessary variable in the study of human disease associated with exposure to environmental pollutants.", {"entities": []}], ["Certain diets can contribute to compromised health by being a source of exposure to environmental toxic pollutants.", {"entities": []}], ["Many of these pollutants are fat soluble, and thus fatty foods often contain higher levels of persistent organics than does vegetable matter.", {"entities": []}], ["Nutrition can dictate the lipid milieu, oxidative stress, and antioxidant status within cells.", {"entities": []}], ["The modulation of these parameters by an individual\u2019s nutritional status may have profound affects on biological processes, and in turn influence the effects of environmental pollutants to cause disease or dysfunction.", {"entities": []}], ["For example, potential adverse health effects associated with exposure to polychlorinated biphenyls may increase as a result of ingestion of certain dietary fats, whereas ingestion of fruits and vegetables, rich in antioxidant and anti-inflammatory nutrients or bioactive compounds, may provide protection.", {"entities": []}], ["We recommend that future directions in environmental health research explore this nutritional paradigm that incorporates a consideration of the relationships between nutrition and lifestyle, exposure to environmental toxicants, and disease.", {"entities": []}], ["Nutritional interventions may provide the most sensible means to develop primary prevention strategies of diseases associated with many environmental toxic insults.", {"entities": []}], ["CLCA2 was reported as a tumor suppressor and disregulated in breast cancer.", {"entities": [[61, 74, "DISEASE"], [68, 74, "DISEASE"], [0, 5, "GENE"]]}], ["However, its function in tumor growth and metastasis in NPC has rarely been reported.", {"entities": []}], ["In this study, we investigated the functional and molecular mechanisms by which CLCA2 influences NPC.", {"entities": [[80, 85, "GENE"]]}], ["CLCA2 expression in human NPC cell lines and tissues was examined via real-time PCR (RT-PCR), Western blot and IHC.", {"entities": [[0, 5, "GENE"]]}], ["The biological roles of CLCA2 in proliferative, migration and invasion of NPC cell lines was evaluated in 5-8F, S18, S26 and SUNE-1 cells.", {"entities": [[24, 29, "GENE"]]}], ["Cell viability, migration and invasion were assessed in vitro by MTS, colony formation and transwell assay, respectively.", {"entities": []}], ["CLCA2 in growth and metastasis of NPC were evaluated in vivo through NPC xenograft tumor growth, lung metastatic mice model and popliteal lymph node (LN) metastasis model.", {"entities": [[0, 5, "GENE"]]}], ["Overexpression of CLCA2 significantly decreased proliferation, migration and invasion of NPC cells.", {"entities": [[18, 23, "GENE"]]}], ["In contrast, knockdown of CLCA2 elicited the opposite effects.", {"entities": [[26, 31, "GENE"]]}], ["CLCA2 overexpression suppressed xenograft tumor growth and lung, popliteal lymph node (LN) metastasis in vivo.", {"entities": [[0, 5, "GENE"]]}], ["CLCA2 inhibited tumor metastasis through suppressing epithelial-Mesenchymal transition (EMT) and in-activating FAK/ERK1/2 signaling pathway in NPC cells.", {"entities": [[0, 5, "GENE"]]}], ["Immunohistochemical staining of 143 NPC samples revealed that CLCA2 expression was an independent, favorable prognostic factor for overall survival and distant metastasis-free survival of patients.", {"entities": [[62, 67, "GENE"]]}], ["In addition, inhibition of FAK and ERK1/2 reversed CLCA2 silencing-induced tumor cell migration.", {"entities": [[51, 56, "GENE"]]}], ["Furthermore, inhibitors against chloride channels suppressed NPC cellular migration which could have been enhanced by the presence of CLCA2.", {"entities": [[134, 139, "GENE"]]}], ["CLCA2 suppress NPC proliferation, migration, invasion and epithelial-mesenchymal transition through inhibiting FAK/ERK signaling.", {"entities": [[0, 5, "GENE"]]}], ["The online version of this article (10.1186/s13046-018-0692-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Computerized decision support decreases the number of computed tomography pulmonary angiograms (CTPA) for pulmonary embolism (PE) ordered in emergency departments, but it is not always well accepted by emergency physicians.", {"entities": [[106, 124, "DISEASE"]]}], ["We studied a department-endorsed, evidence-based clinical protocol that included the PE rule-out criteria (PERC) rule, multi-modal education using principles of knowledge translation (KT), and clinical decision support embedded in our order entry system, to decrease the number of unnecessary CTPA ordered.", {"entities": []}], ["We performed a historically controlled observational before-after study for one year pre- and post-implementation of a departmentally-endorsed protocol.", {"entities": []}], ["We included patients > 18 in whom providers suspected PE and who did not have a contraindication to CTPA.", {"entities": []}], ["Providers entered clinical information into a diagnostic pathway via computerized order entry.", {"entities": []}], ["Prior to protocol implementation, we provided education to ordering providers.", {"entities": []}], ["The primary outcome measure was the number of CTPA ordered per 1,000 visits one year before vs. after implementation.", {"entities": []}], ["CTPA declined from 1,033 scans for 98,028 annual visits (10.53 per 1,000 patient visits (95% CI [9.9\u201311.2]) to 892 scans for 101,172 annual visits (8.81 per 1,000 patient visits (95% CI [8.3\u20139.4]) p<0.001.", {"entities": []}], ["The absolute reduction in PACT ordered was 1.72 per 1,000 visits (a 16% reduction).", {"entities": []}], ["Patient characteristics were similar for both periods.", {"entities": []}], ["Knowledge translation clinical decision support using the PERC rule significantly reduced the number of CTPA ordered.", {"entities": []}], ["Mucopolysaccharidosis type IVA (MPS IVA) or Morquio syndrome is a multisystem disorder caused by galactosamine-6-sulfatase deficiency.", {"entities": [[52, 60, "DISEASE"]]}], ["Skeletal manifestations, including short stature, skeletal dysplasia, cervical instability, and joint destruction, are known to be associated with this condition.", {"entities": []}], ["Due to the severity of these skeletal manifestations, the non-skeletal manifestations are frequently overlooked despite their significant contribution to disease progression and impact on quality of life.", {"entities": []}], ["This review provides detailed information regarding the non-skeletal manifestations and suggests long-term assessment guidelines.", {"entities": []}], ["The visual, auditory, digestive, cardiovascular, and respiratory systems are addressed and overall quality of life as measured by endurance and other functional abilities is discussed.", {"entities": []}], ["Impairments such as corneal clouding, astigmatism, glaucoma, hearing loss, hernias, hepatomegaly, dental abnormalities, cardiac valve thickening and regurgitation, obstructive sleep apnea, tracheomalacia, restrictive and obstructive respiratory compromise, and muscular weakness are discussed.", {"entities": [[51, 59, "DISEASE"], [38, 49, "DISEASE"]]}], ["Increased awareness of these non-skeletal features is needed to improve patient care.", {"entities": []}], ["The online version of this article (doi:10.1007/s10545-012-9459-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This systematic review aimed to evaluate the psychometric properties and clinical utility of all condition specific outcome measures used to assess quality of life (QOL) in school aged children with cerebral palsy (CP).", {"entities": [[199, 213, "DISEASE"], [215, 217, "GENE"]]}], ["Relevant outcome measures were identified by searching 8 electronic databases, supplemented by citation tracking.", {"entities": []}], ["Two independent reviewers completed data extraction and analysis of the measures using a modified version of the CanChild Outcome Measures Rating Form.", {"entities": []}], ["From the 776 papers identified 5 outcome measures met the inclusion criteria: the Care and Comfort Hypertonicity Questionnaire (C&CHQ), the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD), CP QOL-Child, DISABKIDS and PedsQL 3.0 CP Module.", {"entities": [[221, 223, "GENE"], [260, 262, "GENE"], [221, 223, "GENE"], [260, 262, "GENE"]]}], ["There was evidence of construct validity for all five measures.", {"entities": []}], ["Content validity was reported for all measures except PedsQL 3.0.", {"entities": []}], ["The CPCHILD and CP QOL-Child were the only outcome measures to have reported data on concurrent validity.", {"entities": [[16, 18, "GENE"]]}], ["All measures, with the exception of one (C&CHQ) provided evidence of internal reliability.", {"entities": []}], ["The CPCHILD and the CP-QOL-Child had evidence of test-retest reliability and DISABKIDS had evidence of inter-rater reliability.", {"entities": []}], ["There were no published data on the responsiveness of these outcome measures.", {"entities": []}], ["The CPCHILD and the CP QOL-Child demonstrated the strongest psychometric properties and clinical utility.", {"entities": [[20, 22, "GENE"]]}], ["Further work is needed, for all measures, on data for sensitivity to change.", {"entities": []}], ["Clinical pathways (CPWs) are a common component in the quest to improve the quality of health.", {"entities": []}], ["CPWs are used to reduce variation, improve quality of care, and maximize the outcomes for specific groups of patients.", {"entities": []}], ["An ongoing challenge is the operationalization of a definition of CPW in healthcare.", {"entities": []}], ["This may be attributable to both the differences in definition and a lack of conceptualization in the field of clinical pathways.", {"entities": []}], ["This correspondence article describes a process of refinement of an operational definition for CPW research and proposes an operational definition for the future syntheses of CPWs literature.", {"entities": []}], ["Following the approach proposed by Kinsman et al.", {"entities": []}], ["(BMC Medicine 8(1):31, 2010) and Wieland et al.", {"entities": []}], ["(Alternative Therapies in Health and Medicine 17(2):50, 2011), we used a four-stage process to generate a five criteria checklist for the definition of CPWs.", {"entities": []}], ["We refined the operational definition, through consensus, merging two of the checklist\u2019s criteria, leading to a more inclusive criterion for accommodating CPW studies conducted in various healthcare settings.", {"entities": []}], ["The following four criteria for CPW operational definition, derived from the refinement process described above, are (1) the intervention was a structured multidisciplinary plan of care; (2) the intervention was used to translate guidelines or evidence into local structures; (3) the intervention detailed the steps in a course of treatment or care in a plan, pathway, algorithm, guideline, protocol or other \u2018inventory of actions\u2019 (i.e.", {"entities": []}], ["the intervention had time-frames or criteria-based progression); and (4) the intervention aimed to standardize care for a specific population.", {"entities": []}], ["An intervention meeting all four criteria was considered to be a CPW.", {"entities": []}], ["The development of operational definitions for complex interventions is a useful approach to appraise and synthesize evidence for policy development and quality improvement.", {"entities": []}], ["Our previous report revealed that immature dendritic cells (imDCs) with adenovirus-mediated CCR7 overexpression acquired an enhanced migratory ability but also exhibited the lower immune tolerance observed in more mature cells.", {"entities": [[92, 96, "GENE"]]}], ["In the present study, we aimed to investigate whether BTLA overexpression was sufficient to preserve immune tolerance in imDCs with exogenous CCR7 overexpression.", {"entities": [[54, 58, "GENE"], [142, 146, "GENE"]]}], ["Scanning electron microscopy and surface antigens analysis revealed that BTLA overexpression suppressed DC maturation, an effect further potentiated in CCR7 and BTLA cooverexpressing cells.", {"entities": [[73, 77, "GENE"], [161, 165, "GENE"], [152, 156, "GENE"], [73, 77, "GENE"], [161, 165, "GENE"]]}], ["Correspondingly, in vitro chemotaxis assays and mixed lymphocyte reactions demonstrated increased migratory potential and immune tolerance in CCR7 and BTLA coexpressing cells.", {"entities": [[142, 146, "GENE"], [151, 155, "GENE"]]}], ["Furthermore, CCR7 and BTLA cooverexpressed imDCs suppressed IFN- \u03b3 and IL-17 expression and promoted IL-4 and TGF-beta expression of lymphocyte, indicating an increase of T helper 2 (Th2) regulatory T cell (Treg).", {"entities": [[13, 17, "GENE"], [22, 26, "GENE"]]}], ["Thus, these data indicate that CCR7 and BTLA cooverexpression imparts an intermediate immune phenotype in imDCs when compared to that in CCR7- or BTLA-expressing counterparts that show a more immunocompetent or immunotolerant phenotype, respectively.", {"entities": [[31, 35, "GENE"], [137, 141, "GENE"], [40, 44, "GENE"], [146, 150, "GENE"]]}], ["All these results indicated that adenovirus-mediated CCR7 and BTLA overexpression could enhance immune tolerance and migration of imDCs.", {"entities": [[53, 57, "GENE"], [62, 66, "GENE"]]}], ["Our study provides a basis for further studies on imDCs in immune tolerance, with the goal of developing effective cellular immunotherapies for transplant recipients.", {"entities": []}], ["Current advances in the knowledge of asthma pathobiology suggest that anticytokine therapies can be potentially useful for the treatment of this complex and heterogeneous airway disease.", {"entities": [[37, 43, "DISEASE"]]}], ["Recent evidence is accumulating in support of the efficacy of anti-IL-4, anti-IL-5, and anti-IL-13 drugs.", {"entities": []}], ["Therefore, these new developments are now changing the global scenario of antiasthma therapies, especially with regard to more severe disease.", {"entities": []}], ["Current findings referring to variability of individual therapeutic responses highlight that the different asthma subtypes need to be well characterized, in order to implement phenotype-targeted treatments which in the near future will hopefully be mainly based on cytokine-directed biologics.", {"entities": [[107, 113, "DISEASE"]]}], ["Asthma and allergic diseases have increased in the developed countries.", {"entities": [[0, 6, "DISEASE"]]}], ["It is important to determine whether the same trends are occurring in the developing countries in Africa.", {"entities": []}], ["We aimed to determine the time trend in the prevalence of exercise-induced bronchospasm (EIB) and atopic sensitisation over a ten-year period in Ghanaian schoolchildren.", {"entities": []}], ["Two surveys conducted using the same methodology ten years apart (1993 and 2003) among schoolchildren aged 9\u201316 years attending urban rich (UR), urban poor (UP), and rural (R) schools.", {"entities": []}], ["Exercise provocation consisted of free running for six minutes.", {"entities": []}], ["Children were skin tested to mite, cat, and dog allergen.", {"entities": []}], ["1,095 children were exercised in 1993 and 1,848 in 2003; 916 were skin tested in 1993 and 1,861 in 2003.", {"entities": []}], ["The prevalence of EIB increased from 3.1% (95% CI 2.2%\u20134.3%) to 5.2% (4.3%\u20136.3%); absolute percentage increase 2.1% (95% CI 0.6%\u20133.5%, p < 0.01); among UR, UP, and R children EIB had approximately doubled from 4.2%, 1.4%, and 2.2% to 8.3%, 3.0% and 3.9% respectively.", {"entities": []}], ["The prevalence of sensitisation had also doubled from 10.6%, 4.7%, and 4.4% to 20.2%, 10.3%, and 9.9% (UR, UP, and R respectively).", {"entities": []}], ["Mite sensitisation remained unchanged (5.6% versus 6.4%), but sensitisation to cat and dog increased considerably from 0.7% and 0.3% to 4.6% and 3.1%, respectively.", {"entities": []}], ["In the multiple logistic regression analysis, sensitisation (odds ratio [OR] 1.77, 95% CI 1.12\u20132.81), age (OR 0.88, 95% CI 0.79\u20130.98), school (the risk being was significantly lower in UP and R schools: OR 0.40, 95% CI 0.23\u20130.68 and OR 0.54, 95% CI 0.34\u20130.86, respectively) and year of the study (OR 1.73, 95% CI 1.13\u20132.66) remained significant and independent associates of EIB.", {"entities": []}], ["The prevalence of both EIB and sensitisation has approximately doubled over the ten-year period amongst 9- to 16-year-old Ghanaian children irrespective of location, with both EIB and atopy being more common among the UR than the UP and R children.", {"entities": []}], ["The prevalence of both exercise-induced bronchospasm and sensitisation has approximately doubled over the ten-year period amongst 9- to 16-year-old Ghanaian children The proportion of children with asthma is thought to be increasing worldwide, and particularly among children that live in more developed countries.", {"entities": [[198, 204, "DISEASE"]]}], ["However, it is not clear why this is, since many different aspects of lifestyle and the environment have been linked with the onset of asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["In Africa, asthma has typically been thought of as being very uncommon, and indeed in many African dialects there is no word for asthma or the symptoms, such as wheezing, that asthmatic children experience.", {"entities": [[11, 17, "DISEASE"], [129, 135, "DISEASE"]]}], ["However, some research studies have suggested that asthma might be becoming more common in Africa and that this could be linked to ongoing economic and social changes.", {"entities": [[51, 57, "DISEASE"]]}], ["The researchers here wanted to understand whether the trend for childhood asthma to be on the increase worldwide was also the case in Africa.", {"entities": [[74, 80, "DISEASE"]]}], ["Economic growth is bringing about rapid changes in lifestyle in many developing countries, and at the same time the burden of disease is changing.", {"entities": []}], ["In order to make sure that health systems are appropriately resourced, it's important to anticipate future changes in the burden of different diseases.", {"entities": []}], ["This study was based on a comparison between two surveys, carried out ten years apart, of children attending three schools in Ghana's second largest city, Kumasi.", {"entities": []}], ["The surveys were done in 1993 and 2003, and the schools surveyed were a rich city school, a poor city school, and a school in the nearby countryside.", {"entities": []}], ["The same methods were used in the two different surveys.", {"entities": []}], ["Importantly, the researchers used an exercise test as an indicator for asthma, because language differences meant they could not find out whether children were indeed asthmatic.", {"entities": [[71, 77, "DISEASE"]]}], ["In the exercise test, the schoolchildren ran outdoors for six minutes, and the researchers measured how fast the children could breathe out before and after exercise (their \u201cpeak flow\u201d).", {"entities": []}], ["Children whose drop in peak flow was more than 12.5% were classified as having exercise-induced bronchospasm, which is thought to predict asthma.", {"entities": [[138, 144, "DISEASE"]]}], ["The children were also tested for their response to extracts that commonly cause allergic reactions, such as from dust mites and cat and dog hair.", {"entities": []}], ["1,095 children were studied in 1993 and 1,848 in 2003, paralleling the growth of the city, which also meant that by 2003 the rural school had become incorporated into the city.", {"entities": []}], ["Over this period of time, the proportion of children with exercise-induced bronchospasm increased in all three schools; overall this proportion went up from 3.1% to 5.2%.", {"entities": []}], ["Children from the rich city school were most likely to have exercise-induced bronchospasm at either survey date.", {"entities": []}], ["However, children from the poor city school experienced the biggest change over the time period studied, with more than double the proportion of children having exercise-induced bronchospasm in 2003 as compared to 1993.", {"entities": []}], ["The researchers also saw similar trends in children who had allergic reactions to common substances.", {"entities": []}], ["The researchers observed substantial increases in the rate of exercise-induced bronchospasm, and allergic reactions, between the two survey dates.", {"entities": []}], ["This finding suggests that asthma is likely to have become much more common in that time.", {"entities": [[27, 33, "DISEASE"]]}], ["However, exercise-induced bronchospasm is not an exact indicator of asthma so it is not possible to be certain about this.", {"entities": [[68, 74, "DISEASE"]]}], ["These changes are likely to be linked with the adoption of westernized lifestyles, but which precise factors are responsible for the increase is not clear.", {"entities": []}], ["Factors linked to the development of asthma include a lower rate of childhood infections, a lower rate of breast-feeding, environmental pollution, and many others.", {"entities": [[37, 43, "DISEASE"]]}], ["Links between the increase in exercise-induced bronchospasm and any of these factors were not examined in this study.", {"entities": []}], ["However, these results suggest that if the findings here are common to other African cities as well, a greater proportion of African health budgets will need to be devoted to asthma care in the future.", {"entities": [[175, 181, "DISEASE"]]}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0040070 .", {"entities": []}], ["Wikipedia has an entry on asthma (Wikipedia is an internet encyclopedia anyone can edit) The World Health Organization's Ghana minisite has information on this country Patient information from NHS Direct on asthma An accompanying PLoS Medicine Essay by Matthias Wjst and Daniel Boakye discusses research on asthma in Africa", {"entities": [[26, 32, "DISEASE"], [207, 213, "DISEASE"], [307, 313, "DISEASE"], [193, 196, "GENE"]]}], ["Glutathione S transferase ( GST ) polymorphisms have been considered risk factors for the development of glaucoma, including primary open angle glaucoma (POAG) and other types of glaucoma.", {"entities": [[125, 152, "DISEASE"], [105, 113, "DISEASE"], [144, 152, "DISEASE"], [179, 187, "DISEASE"]]}], ["However, the results remain controversial.", {"entities": []}], ["In this study, we have conducted a meta-analysis to assess the association between polymorphisms of GSTM1 , GSTT1 and GSTP1 and glaucoma risk.", {"entities": [[128, 136, "DISEASE"], [100, 105, "GENE"], [108, 113, "GENE"], [118, 123, "GENE"]]}], ["Published literature from PubMed and other databases were retrieved.", {"entities": []}], ["All studies evaluating the association between GSTM1 , GSTT1 and GSTP1 polymorphisms and glaucoma risk were included.", {"entities": [[89, 97, "DISEASE"], [47, 52, "GENE"], [55, 60, "GENE"], [65, 70, "GENE"]]}], ["Pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using random- or fixed-effects model.", {"entities": []}], ["Twelve studies on GSTM1 (1109 cases and 844 controls), ten studies on GSTT1 (709 cases and 664 controls) and four studies on GSTP1 (543 cases and 511 controls) were included.", {"entities": [[18, 23, "GENE"], [70, 75, "GENE"], [125, 130, "GENE"]]}], ["By pooling all the studies, either GSTM1 or GSTT1 null polymorphism was not associated with a POAG risk, and this negative association maintained in Caucasian.", {"entities": [[35, 40, "GENE"], [44, 49, "GENE"]]}], ["The GSTP1 Ile 105 Val polymorphism was significantly correlated with increased POAG risk among Caucasian in a recessive model (Val/Val vs .", {"entities": [[4, 9, "GENE"]]}], ["Ile/Ile+Ile/Val: OR, 1.62, 95%CI: 1.00\u20132.61).", {"entities": []}], ["Interestingly, increased glaucoma risk was associated with the combined GSTM1 and GSTT1 null genotypes (OR, 2.20; 95% CI, 1.47\u20133.31), and with the combined GSTM1 null and GSTP1 Val genotypes (OR, 1.86; 95% CI, 1.15\u20133.01).", {"entities": [[25, 33, "DISEASE"], [72, 77, "GENE"], [156, 161, "GENE"], [82, 87, "GENE"], [72, 77, "GENE"], [156, 161, "GENE"], [171, 176, "GENE"]]}], ["This meta-analysis suggests that combinations of GST polymorphisms are associated with glaucoma risk.", {"entities": [[87, 95, "DISEASE"]]}], ["Given the limited sample size, the associations between single GST polymorphism and glaucoma risk await further investigation.", {"entities": [[84, 92, "DISEASE"]]}], ["In human medicine, bronchoalveolar lavage is the main non-traumatic procedure allowing an insight into the respiratory Dendritic Cells (DC) and Macrophages populations.", {"entities": []}], ["However, it has never been demonstrated in a relevant model that alveolar DC subpopulations were comparable to their interstitial counterparts.", {"entities": []}], ["In a precedent work we observed that respiratory pig DC and Macrophages were more similar to the human ones than to the mouse ones.", {"entities": []}], ["In the present work, thanks to our animal model, we were able to collect the rare bronchoalveolar DC and compare them to their interstitial counterparts.", {"entities": []}], ["We observed that DC presented very similar gene-expression patterns in the alveolar and interstitial compartments, validating the study of human bronchoalveolar DC as surrogate of their interstitium counterparts.", {"entities": []}], ["Recurrent airway obstruction (RAO) is a severe chronic respiratory disease affecting horses worldwide, though mostly in the Northern hemisphere.", {"entities": []}], ["Environmental as well as genetic factors strongly influence the course and prognosis of the disease.", {"entities": []}], ["Research has been focused on characterization of immunologic factors contributing to inflammatory responses, on genetic linkage analysis, and, more recently, on proteomic analysis of airway secretions from affected horses.", {"entities": []}], ["The goal of this study was to investigate the interactions between eight candidate genes previously identified in a genetic linkage study and proteins expressed in bronchoalveolar lavage fluid (BALF) collected from healthy and RAO-affected horses.", {"entities": []}], ["The analysis was carried out with Ingenuity Pathway Analysis The gene with the greatest number of indirect interactions with the set of proteins identified is Interleukin 4 Receptor (IL-4R) , whose protein has also been detected in BALF.", {"entities": []}], ["Interleukin 21 receptor and chemokine (C-C motif) ligand 24 also showed a large number of interactions with the group of detected proteins.", {"entities": []}], ["Protein products of other genes like that of SOCS5 , revealed direct interactions with the IL-4R protein.", {"entities": [[45, 50, "GENE"]]}], ["The interacting proteins NOD2, RPS6KA5 and FOXP3 found in several pathways are reported regulators of the NF\u03baB pathway.", {"entities": [[25, 29, "GENE"], [31, 38, "GENE"], [43, 48, "GENE"]]}], ["The pathways generated with IL-4R highlight possible important intracellular signaling cascades implicating, for instance, NF\u03baB.", {"entities": []}], ["Furthermore, the proposed interaction between SOCS5 and IL-4R could explain how different genes can lead to identical clinical RAO phenotypes, as observed in two Swiss Warmblood half sibling families because these proteins interact upstream of an important cascade where they may act as a functional unit.", {"entities": [[46, 51, "GENE"]]}], ["Chronic obstructive pulmonary disease (COPD) exacerbations have a negative impact on the quality of life of patients and the evolution of the disease.", {"entities": []}], ["We have investigated the prognostic value of several health-related quality of life questionnaires to predict the appearance of a composite event (new ambulatory or emergency exacerbation, hospitalization, or death) over a 1-year follow-up.", {"entities": []}], ["This was a multicenter, prospective, observational study.", {"entities": []}], ["Patients completed four questionnaires after recovering from an exacerbation (COPD Assessment Test [CAT], a Clinical COPD Questionnaire [CCQ], COPD Severity Score [COPDSS], and Airways Questionnaire [AQ20]).", {"entities": []}], ["Patients were followed-up until the appearance of the composite event or for 1 year, whichever came first.", {"entities": []}], ["A total of 497 patients were included in the study.", {"entities": []}], ["The majority of them were men (89.7%), with a mean age of 68.7 (SD 9.2) years, and a forced expiratory volume in 1 second of 47.1% (SD 17.5%).", {"entities": []}], ["A total of 303 (61%) patients experienced a composite event.", {"entities": []}], ["Patients with an event had worse mean scores of all questionnaires at baseline compared to patients without event: CAT=12.5 vs 11.3 ( P =0.028); CCQ=2.2 vs 1.9 ( P =0.013); COPDSS=12.3 vs 10.9 ( P =0.001); AQ20=8.3 vs 7.5 ( P =0.048).", {"entities": []}], ["In the multivariate analysis, only previous history of exacerbations and CAT score \u226513.5 were significant risk factors for the composite event.", {"entities": []}], ["A CAT score \u226513.5 increased the predictive value of previous exacerbations with an area under the receiver operating characteristic curve of 0.864 (95% CI: 0.829\u20130.899; P =0.001).", {"entities": []}], ["The predictive value of previous exacerbations significantly increased only in one of the four trialled questionnaires, namely in the CAT questionnaire.", {"entities": []}], ["However, previous history of exacerbations was the strongest predictor of the composite event.", {"entities": []}], ["COPD exacerbations requiring hospitalization increase morbidity and mortality.", {"entities": []}], ["Although most COPD exacerbations are neutrophilic, approximately 10%\u201325% of exacerbations are eosinophilic.", {"entities": []}], ["We aimed to evaluate mortality and outcomes of eosinophilic and non-eosinophilic COPD exacerbations and identify new biomarkers that predict survival.", {"entities": []}], ["A retrospective observational cohort study was carried out in a tertiary teaching hospital from January 1, 2014 to November 1, 2014.", {"entities": []}], ["All COPD patients hospitalized with exacerbations were enrolled in the study at their initial hospitalization and followed-up for 6 months after discharge.", {"entities": []}], ["Electronic data were collected from the hospital database.", {"entities": []}], ["Subjects\u2019 characteristics, hemogram parameters, CRP levels, neutrophil-to-lymphocyte ratio (NLR), platelet-to-mean platelet volume ratio on admission and discharge, length of hospital stay (days), readmissions, and mortality were recorded.", {"entities": [[48, 51, "GENE"]]}], ["Patients were grouped according to peripheral blood eosinophil (PBE) levels: Group 1, >2% PBE, eosinophilic; Group 2, non-eosinophilic \u22642%.", {"entities": []}], ["Patient survival after hospital discharge was evaluated by Kaplan\u2013Meier survival analysis.", {"entities": []}], ["A total of 1,704 patients hospitalized with COPD exacerbation were included.", {"entities": []}], ["Approximately 20% were classified as eosinophilic.", {"entities": []}], ["Six-month mortality was similar in eosinophilic and non-eosinophilic groups (14.2% and 15.2%, respectively); however, the hospital stay length and readmission rate were longer and higher in the non-eosinophilic group ( P <0.001 and P <0.01, respectively).", {"entities": []}], ["CRP and NLR were significantly higher in the non-eosinophilic group (both P <0.01).", {"entities": [[0, 3, "GENE"]]}], ["The platelet-to-mean platelet volume ratio was not different between the two groups.", {"entities": []}], ["Cox regression analysis showed that survival was negatively influenced by elevated CRP ( P <0.035) and NLR ( P <0.001) in the non-eosinophilic group.", {"entities": [[83, 86, "GENE"]]}], ["Non-eosinophilic patients with COPD exacerbations with high CRP and NLR values had worse outcomes than eosinophilic patients.", {"entities": [[60, 63, "GENE"]]}], ["PBE and NLR can be helpful markers to guide treatment decisions.", {"entities": []}], ["In Japan, all trainee physicians must begin clinical practice in a standardized, mandatory junior residency program, which encompasses the first two years of post-graduate medical training (PGY1 \u2013 PGY2).", {"entities": []}], ["Implemented in 2004 to foster primary care skills, the comprehensive rotation program (CRP) requires junior residents to spend 14 months rotating through a comprehensive array of clinical departments including internal medicine, surgery, anesthesiology, obstetrics-gynecology (OBGYN), pediatrics, psychiatry, and rural medicine.", {"entities": [[87, 90, "GENE"]]}], ["In 2010, Japan\u2019s health ministry relaxed this curricular requirement, allowing training programs to offer a limited rotation program (LRP), in which core departments constitute 10 months of training, with electives geared towards residents\u2019 choice of career specialty comprising the remaining 14 months.", {"entities": [[134, 137, "GENE"]]}], ["The effectiveness of primary care skill acquisition during early training warrants evaluation.", {"entities": []}], ["This study assesses self-reported confidence with clinical competencies, as well as case experience, between residents in CRP versus LRP curricula.", {"entities": [[122, 125, "GENE"], [133, 136, "GENE"]]}], ["A nation-wide cross-sectional study of all PGY2 physicians in Japan was conducted in March 2011.", {"entities": []}], ["Primary outcomes were self-report confidence for 98 clinical competency items, and number of cases experienced for 85 common diseases.", {"entities": []}], ["We compared confidence scores and case experience between residents in CRP and LRP programs, adjusting for parameters relevant to training.", {"entities": [[71, 74, "GENE"], [79, 82, "GENE"]]}], ["Among 7506 PGY2 residents, 5052 replied to the survey (67.3%).", {"entities": []}], ["Of 98 clinical competency items, CRP residents reported higher confidence in 12 items compared to those in an LRP curriculum, 10 of which remained significantly higher after adjustment.", {"entities": [[33, 36, "GENE"], [110, 113, "GENE"]]}], ["CRP trainees reported lower confidence scores in none of the items.", {"entities": [[0, 3, "GENE"]]}], ["Out of 85 diseases, LRP residents reported less experience with 11 diseases.", {"entities": [[20, 23, "GENE"]]}], ["CRP trainees reported lower case experience with one disease, though this did not remain significant on adjusted analysis.", {"entities": [[0, 3, "GENE"]]}], ["Confidence and case experience with OBGYN- and pediatrics-related items were particularly low among LRP trainees.", {"entities": [[100, 103, "GENE"]]}], ["Residents in the specialty-oriented LRP curriculum showed less confidence and less case experience compared to peers training in the broader CRP residency curriculum.", {"entities": [[36, 39, "GENE"], [141, 144, "GENE"]]}], ["In order to foster competence in independent primary care practice, junior residency programs requiring experience in a breadth of core departments should continue to be mandated to ensure adequate primary care skills.", {"entities": []}], ["CP001 is four traditional herbal medicine mixtures with anti-inflammatory properties.", {"entities": []}], ["In this study, we investigated the effect of oral administration of CP001 ethanol extract on the 2,4-dinitrochlorobenzene- (DNCB-) induced AD mouse models.", {"entities": []}], ["For that purpose, we observed the effects of oral administration of CP001 on skin inflammatory cell infiltration, skin mast cells, production of serum IgE, and expression of Th2 cytokine mRNA in the AD skin lesions of DNCB treated BALB/c mice.", {"entities": []}], ["Histological analyses demonstrated that CP001 decreased dermis and epidermis thickening as well as dermal infiltration induced by inflammatory cells.", {"entities": []}], ["In addition, CP001 decreased mast cell infiltration in count as well as dermal infiltration induced by inflammatory cells.", {"entities": []}], ["In the skin lesions, mRNA expression of interleukin- (IL-) 4 and IL-13 was inhibited by CP001.", {"entities": []}], ["CP001 also reduced the production of IgE level in mouse plasma.", {"entities": []}], ["In addition, we investigated the effect of CP001 on the inflammatory allergic reaction using human mast cells (HMC-1).", {"entities": []}], ["In HMC-1, cytokine production and mRNA levels of IL-4, IL-13, IL-6, and IL-8 were suppressed by CP001.", {"entities": []}], ["Taken together, our results showed that oral administration of CP001 exerts beneficial effects in AD symptoms, suggesting that CP001 might be a useful candidate for the treatment of AD.", {"entities": []}], ["Graphene, a monolayer of carbon, is an engineered nanomaterial (ENM) with physical and chemical properties that may offer application advantages over other carbonaceous ENMs, such as carbon nanotubes (CNT).", {"entities": []}], ["The goal of this study was to comparatively assess pulmonary and systemic toxicity of graphite nanoplates, a member of the graphene-based nanomaterial family, with respect to nanoplate size.", {"entities": []}], ["Three sizes of graphite nanoplates [20\u00a0\u03bcm lateral (Gr20), 5\u00a0\u03bcm lateral (Gr5), and <2\u00a0\u03bcm lateral (Gr1)] ranging from 8\u201325\u00a0nm in thickness were characterized for difference in surface area, structure,, zeta potential, and agglomeration in dispersion medium, the vehicle for in vivo studies.", {"entities": []}], ["Mice were exposed by pharyngeal aspiration to these 3 sizes of graphite nanoplates at doses of 4 or 40\u00a0\u03bcg/mouse, or to carbon black (CB) as a carbonaceous control material.", {"entities": []}], ["At 4\u00a0h, 1\u00a0day, 7\u00a0days, 1\u00a0month, and 2\u00a0months post-exposure, bronchoalveolar lavage was performed to collect fluid and cells for analysis of lung injury and inflammation.", {"entities": []}], ["Particle clearance, histopathology and gene expression in lung tissue were evaluated.", {"entities": []}], ["In addition, protein levels and gene expression were measured in blood, heart, aorta and liver to assess systemic responses.", {"entities": []}], ["All Gr samples were found to be similarly composed of two graphite structures and agglomerated to varying degrees in DM in proportion to the lateral dimension.", {"entities": []}], ["Surface area for Gr1 was approximately 7-fold greater than Gr5 and Gr20, but was less reactive reactive per m Pulmonary and systemic toxicity of graphite nanoplates may be dependent on lateral size and/or surface reactivity, with the graphite nanoplates\u2009>\u20095\u00a0\u03bcm laterally inducing greater toxicity which peaked at the early time points post-exposure relative to the 1\u20132\u00a0\u03bcm graphite nanoplate.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-016-0145-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Toxic waste sites contain a broad range of suspected or confirmed human carcinogens, and remain a source of concern to many people, particularly those living in the vicinity of a site.", {"entities": []}], ["Despite years of study, a consensus has not emerged regarding the cancer risk associated with such sites.", {"entities": [[66, 72, "DISEASE"]]}], ["We examined the published, peer-reviewed literature addressing cancer incidence or mortality in the vicinity of toxic waste sites between 1980 and 2006, and catalogued the methods employed by such studies.", {"entities": [[63, 69, "DISEASE"]]}], ["Nineteen studies are described with respect to eight methodological criteria.", {"entities": []}], ["Most were ecological, with minimal utilization of hydrogeological or air pathway modeling.", {"entities": []}], ["Many did not catalogue whether a potable water supply was contaminated, and very few included contaminant measurements at waste sites or in subjects' homes.", {"entities": []}], ["Most studies did not appear to be responses to a recognized cancer mortality cluster.", {"entities": [[60, 66, "DISEASE"]]}], ["Studies were highly variable with respect to handling of competing risk factors and multiple comparisons.", {"entities": []}], ["We conclude that studies to date have generated hypotheses, but have been of limited utility in determining whether populations living near toxic waste sites are at increased cancer risk.", {"entities": [[175, 181, "DISEASE"]]}], ["In the UK, patients normally see their general practitioner first and 86% of the health needs of the population are managed in general practice, with 14% being referred to specialist/hospital care.", {"entities": []}], ["Early diagnosis is the privilege of general practice since general practitioners make most medical diagnoses in the NHS.", {"entities": [[116, 119, "GENE"]]}], ["Their historic aim has been to diagnose as early as possible and if possible before patients are aware of symptoms.", {"entities": []}], ["Over time, diagnoses are being made earlier in the trajectory of chronic diseases and pre-symptomatic diagnoses through tests like cervical screening.", {"entities": []}], ["Earlier diagnosis benefits patients and allows earlier treatment.", {"entities": []}], ["In diabetes, the presence of lower HbA1c levels correlates with fewer complications.", {"entities": []}], ["Methodologically, single practice research means smaller populations but greater ability to track patients and ask clinicians about missing data.", {"entities": []}], ["All diagnoses of type 2 diabetes, wherever made, were tracked until death or transfer out.", {"entities": []}], ["Clinical opportunistic screening has been undervalued and is more cost-effective than population screening.", {"entities": []}], ["It works best in generalist practice.", {"entities": []}], ["Over 19 consecutive years, all 429 patients with type 2 diabetes in one NHS general practice were analysed.", {"entities": [[72, 75, "GENE"]]}], ["The prevalence of type 2 diabetes rose from 1.1% to 3.0% of the registered population.", {"entities": []}], ["Since 2000, 95.9% were diagnosed within the general practice and the majority (70/121\u2009=\u200957.9%) of diagnoses were made before the patients reported any diabetes-related symptom.", {"entities": []}], ["These patients had median HbA1c levels 1.1% lower than patients diagnosed after reporting symptoms, a clinically and statistically significant difference ( P \u2009=\u20090.01).", {"entities": []}], ["Traffic emissions including diesel engine exhaust are associated with increased respiratory and cardiovascular morbidity and mortality.", {"entities": []}], ["Controlled human exposure studies have demonstrated impaired vascular function after inhalation of exhaust generated by a diesel engine under idling conditions.", {"entities": []}], ["To assess the vascular and fibrinolytic effects of exposure to diesel exhaust generated during urban-cycle running conditions that mimic ambient 'real-world' exposures.", {"entities": []}], ["In a randomised double-blind crossover study, eighteen healthy male volunteers were exposed to diesel exhaust (approximately 250 \u03bcg/m Forearm blood flow increased in a dose-dependent manner with both endothelial-dependent (acetylcholine and bradykinin) and endothelial-independent (sodium nitroprusside and verapamil) vasodilators.", {"entities": []}], ["Diesel exhaust exposure attenuated the vasodilatation to acetylcholine (P < 0.001), bradykinin (P < 0.05), sodium nitroprusside (P < 0.05) and verapamil (P < 0.001).", {"entities": []}], ["In addition, the net release of tissue plasminogen activator during bradykinin infusion was impaired following diesel exhaust exposure (P < 0.05).", {"entities": []}], ["Exposure to diesel exhaust generated under transient running conditions, as a relevant model of urban air pollution, impairs vasomotor function and endogenous fibrinolysis in a similar way as exposure to diesel exhaust generated at idling.", {"entities": []}], ["This indicates that adverse vascular effects of diesel exhaust inhalation occur over different running conditions with varying exhaust composition and concentrations as well as physicochemical particle properties.", {"entities": []}], ["Importantly, exposure to diesel exhaust under ETC conditions was also associated with a novel finding of impaired of calcium channel-dependent vasomotor function.", {"entities": []}], ["This implies that certain cardiovascular endpoints seem to be related to general diesel exhaust properties, whereas the novel calcium flux-related effect may be associated with exhaust properties more specific for the ETC condition, for example a higher content of diesel soot particles along with their adsorbed organic compounds.", {"entities": []}], ["Objectives To determine, using longitudinal analyses, if retirement is followed by a change in the risk of incident chronic diseases, depressive symptoms, and fatigue.", {"entities": []}], ["Design Prospective study with repeat measures from 7 years before to 7 years after retirement.", {"entities": []}], ["Setting Large French occupational cohort (the GAZEL study), 1989-2007.", {"entities": []}], ["Participants 11\u2009246 men and 2858 women.", {"entities": []}], ["Main outcome measures Respiratory disease, diabetes, coronary heart disease and stroke, mental fatigue, and physical fatigue, measured annually by self report over the 15 year observation period; depressive symptoms measured at four time points.", {"entities": [[62, 75, "DISEASE"], [53, 75, "DISEASE"]]}], ["Results The average number of repeat measurements per participant was 12.1.", {"entities": []}], ["Repeated measures logistic regression with generalised estimating equations showed that the cumulative prevalence of self reported respiratory disease, diabetes, and coronary heart disease and stroke increased with age, with no break in the trend around retirement.", {"entities": [[175, 188, "DISEASE"], [166, 188, "DISEASE"]]}], ["In contrast, retirement was associated with a substantial decrease in the prevalence of both mental fatigue (odds ratio for fatigue one year after versus one year before retirement 0.19, 95% confidence interval 0.18 to 0.21) and physical fatigue (0.27, 0.26 to 0.30).", {"entities": []}], ["A major decrease was also observed in depressive symptoms (0.60, 0.53 to 0.67).", {"entities": []}], ["The decrease in fatigue around retirement was more pronounced among people with a chronic disease before retirement.", {"entities": []}], ["Conclusions Longitudinal modelling of repeat data showed that retirement did not change the risk of major chronic diseases but was associated with a substantial reduction in mental and physical fatigue and depressive symptoms, particularly among people with chronic diseases.", {"entities": []}], ["The purpose of the present study is to estimate the effects of sheep/goat whey protein dietary supplementation on the redox status of blood and tissues of rats.", {"entities": []}], ["Twelve male Wistar rats were divided into the control group (standard commercial diet) and whey group [standard commercial diet + sheep/goat whey protein (1 g kg b.w/day)] (6 rats/group).", {"entities": []}], ["The animals were maintainted on their respective diet for 28 days.", {"entities": []}], ["At the end of the experimental period, reduced glutathione, catalase activity, total antioxidant capacity, thiobarbituric reactive substances, protein carbonyls and the decomposition rate of H 2 O 2 were measured in blood and tissues of rats.", {"entities": []}], ["According to the results, the rats fed with the sheep/goat whey protein exhibited improved antioxidant status and decreased free radical-induced toxic effects on lipids and proteins.", {"entities": []}], ["Specifically, in blood, GSH and CAT levels were significantly increased while TBARS and protein carbonyl levels were significantly decreased compared to the control group.", {"entities": []}], ["Regarding the effects on tissues, it was observed that GSH levels were significantly increased in small intestine, quadriceps muscle, pancreas and lung tissue compared to the control group.", {"entities": []}], ["The decomposition rate of H 2 O 2 was significantly decreased in liver, brain and quadriceps muscle, but was significantly increased in spleen tissue compared to the control group.", {"entities": []}], ["TBARS levels were significantly decreased in liver, brain, quadriceps muscle, pancreas, lung and spleen tissue compared to the control group.", {"entities": []}], ["Finally, protein carbonyl levels were significantly decreased in brain, small intestine, kidney, pancreas and spleen tissue compared to the control group.", {"entities": []}], ["Thus, the present findings show the beneficial effects of sheep/goat whey protein, a by-product of cheese manufacturing, on the redox status in an in vivo model.", {"entities": []}], ["What matters to people in their everyday experiences of living with asthma is influenced by a diverse range of personal, social, medical and environmental factors.", {"entities": [[68, 74, "DISEASE"]]}], ["Previous reviews of the asthma literature have largely focused on medical aspects of asthma or specific population groups with particular needs.", {"entities": [[24, 30, "DISEASE"], [85, 91, "DISEASE"]]}], ["To identify, describe and synthesize from the available qualitative literature the views and experiences of adults living with asthma.", {"entities": [[127, 133, "DISEASE"]]}], ["We systematically searched for qualitative studies reporting on the personal experience of living with asthma.", {"entities": [[103, 109, "DISEASE"]]}], ["A meta\u2010synthesis approach was used to analyse and interpret the data.", {"entities": []}], ["Key themes relating to personal perspectives on asthma were identified and grouped into overarching concepts.", {"entities": [[48, 54, "DISEASE"]]}], ["We identified 26 studies.", {"entities": []}], ["There was a paucity of literature on the physical burden of asthma symptoms and the role of social support.", {"entities": [[60, 66, "DISEASE"]]}], ["Our synthesis generated a central concept of the \u201cwork\u201d associated with living with asthma: work was of a personal nature, and at times an intensely emotional experience.", {"entities": [[84, 90, "DISEASE"]]}], ["Individuals tailored their behaviour in response to demands of the physical and social environment, including interactions with health\u2010care professionals.", {"entities": []}], ["This is the first systematic review of the qualitative literature reporting on people's own perspectives of living with asthma.", {"entities": [[120, 126, "DISEASE"]]}], ["Our findings draw attention to the nuances and sensitivities surrounding patient experiences of self\u2010management.", {"entities": []}], ["Medical care is a central plank of managing chronic conditions, but our health\u2010care systems are now expected to deliver patient\u2010centred care.", {"entities": []}], ["Considering the broader aspects of asthma management, beyond that of symptoms and treatment, will help to facilitate comprehensive care.", {"entities": [[35, 41, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a chronic, irreversible disease and a leading cause of worldwide morbidity and mortality.", {"entities": []}], ["In Canada, COPD is the fourth leading cause of death.", {"entities": []}], ["This systematic review was undertaken to update healthcare professionals and decision makers regarding the recent clinical, humanistic and economic burden evidence in Canada.", {"entities": []}], ["A systematic literature search was conducted in PubMed, EMBASE, and Cochrane databases to identify original research published January 2000 through December 2012 on the burden of COPD in Canada.", {"entities": []}], ["Each search was conducted using controlled vocabulary and key words, with \u201cCOPD\u201d as the main search concept and limited to Canadian studies, written in English and involving human subjects.", {"entities": []}], ["Selected studies included randomized controlled trials, observational studies and systematic reviews/meta-analyses that reported healthcare resource utilization, quality of life and/or healthcare costs.", {"entities": []}], ["Of the 972 articles identified through the literature searches, 70 studies were included in this review.", {"entities": []}], ["These studies were determined to have an overall good quality based on the quality assessment.", {"entities": []}], ["COPD patients were found to average 0\u20134 annual emergency department visits, 0.3\u20131.5 annual hospital visits, and 0.7\u20135 annual physician visits.", {"entities": []}], ["Self-care management was found to lessen the overall risk of emergency department (ED) visits, hospitalization and unscheduled physician visits.", {"entities": []}], ["Additionally, integrated care decreased the mean number of hospitalizations and telephone support reduced the number of annual physician visits.", {"entities": []}], ["Overall, 60\u201368\u00a0% of COPD patients were found to be inactive and 60\u201372\u00a0% reported activity restriction.", {"entities": []}], ["Pain was found to negatively correlate with physical activity while breathing difficulties resulted in an inability to leave home and reduced the ability to handle activities of daily living.", {"entities": []}], ["Evidence indicated that treating COPD improved patients\u2019 overall quality of life.", {"entities": []}], ["The average total cost per patient ranged between CAN $2444\u20134391 from a patient perspective to CAN $3910\u20136693 from a societal perspective.", {"entities": []}], ["Furthermore, evidence indicated that COPD exacerbations lead to higher costs.", {"entities": []}], ["The clinical, humanistic and economic burden of COPD in Canada is substantial.", {"entities": []}], ["Use of self-care management programs, telephone support, and integrated care may reduce the overall burden to Canadian patients and society.", {"entities": []}], ["Genome-wide scans for positively selected genes (PSGs) in mammals have provided insight into the dynamics of genome evolution, the genetic basis of differences between species, and the functions of individual genes.", {"entities": []}], ["However, previous scans have been limited in power and accuracy owing to small numbers of available genomes.", {"entities": []}], ["Here we present the most comprehensive examination of mammalian PSGs to date, using the six high-coverage genome assemblies now available for eutherian mammals.", {"entities": []}], ["The increased phylogenetic depth of this dataset results in substantially improved statistical power, and permits several new lineage- and clade-specific tests to be applied.", {"entities": []}], ["Of \u223c16,500 human genes with high-confidence orthologs in at least two other species, 400 genes showed significant evidence of positive selection (FDR<0.05), according to a standard likelihood ratio test.", {"entities": []}], ["An additional 144 genes showed evidence of positive selection on particular lineages or clades.", {"entities": []}], ["As in previous studies, the identified PSGs were enriched for roles in defense/immunity, chemosensory perception, and reproduction, but enrichments were also evident for more specific functions, such as complement-mediated immunity and taste perception.", {"entities": []}], ["Several pathways were strongly enriched for PSGs, suggesting possible co-evolution of interacting genes.", {"entities": []}], ["A novel Bayesian analysis of the possible \u201cselection histories\u201d of each gene indicated that most PSGs have switched multiple times between positive selection and nonselection, suggesting that positive selection is often episodic.", {"entities": []}], ["A detailed analysis of Affymetrix exon array data indicated that PSGs are expressed at significantly lower levels, and in a more tissue-specific manner, than non-PSGs.", {"entities": []}], ["Genes that are specifically expressed in the spleen, testes, liver, and breast are significantly enriched for PSGs, but no evidence was found for an enrichment for PSGs among brain-specific genes.", {"entities": []}], ["This study provides additional evidence for widespread positive selection in mammalian evolution and new genome-wide insights into the functional implications of positive selection.", {"entities": []}], ["Populations evolve as mutations arise in individual organisms and, through hereditary transmission, gradually become \u201cfixed\u201d (shared by all individuals) in the population.", {"entities": []}], ["Many mutations have essentially no effect on organismal fitness and can become fixed only by the stochastic process of neutral drift.", {"entities": []}], ["However, some mutations produce a selective advantage that boosts their chances of reaching fixation.", {"entities": []}], ["Genes in which new mutations tend to be beneficial, rather than neutral or deleterious, tend to evolve rapidly and are said to be under positive selection.", {"entities": []}], ["Genes involved in immunity and defense are a well-known example; rapid evolution in these genes presumably occurs because new mutations help organisms to prevail in evolutionary \u201carms races\u201d with pathogens.", {"entities": []}], ["Many mammalian genes show evidence of positive selection, but open questions remain about the overall impact of positive selection in mammals.", {"entities": []}], ["For example, which key differences between species can be attributed to positive selection?", {"entities": []}], ["How have patterns of selection changed across the mammalian phylogeny?", {"entities": []}], ["What are the effects of population size and gene expression patterns on positive selection?", {"entities": []}], ["Here we attempt to shed light on these and other questions in a comprehensive study of \u223c16,500 genes in six mammalian genomes.", {"entities": []}], ["Sceptridium ternatum is an expectorant in traditional Chinese medicine and is prescribed for the treatment of asthma.", {"entities": [[110, 116, "DISEASE"]]}], ["The study aim was to screen Sceptridium ternatum for ingredients with antitussive and antiasthmatic effects and to study their associated mechanisms.", {"entities": []}], ["Cough in mice was induced using ammonia.", {"entities": []}], ["Cough latency and the number of coughs within 3 minutes were determined.", {"entities": []}], ["Airway responsiveness was assessed using ovalbumin as a sensitizer and characteristic asthma indicators were measured.", {"entities": [[86, 92, "DISEASE"]]}], ["Chloroform and ethyl acetate extracts significantly reduced the number of coughs within 3 minutes, tidal volume, and the percentage of eosinophilic granulocytes, lymphocytes and neutrophils.", {"entities": []}], ["All extracts decreased airway responsiveness in asthmatic mice compared with the untreated group.", {"entities": []}], ["Petroleum ether, chloroform and n-butanol extracts lowered the Penh values of asthmatic mice.", {"entities": []}], ["Petroleum ether and ethyl acetate extracts greatly reduced interleukin-4 expression and the interleukin-4/interferon gamma ratio.", {"entities": []}], ["Compared with the model group, all extracts reduced mRNA expression of the cysteinyl leukotriene receptor-1 (CysLT 1 ).", {"entities": []}], ["Chloroform extract and ethyl acetate extract displayed obvious antitussive effects and reduced airway inflammation.", {"entities": []}], ["Thus, these two extracts contain the effective ingredients of Sceptridium ternatum .", {"entities": []}], ["The active mechanism was ascribed to inhibition of mRNA expression of the CysLT 1 receptor in mice with bronchial asthma.", {"entities": [[114, 120, "DISEASE"]]}], ["Extensive research on memory interventions has confirmed their success with older adults, but the individual difference factors that predict successful training outcomes remain relatively unexplored.", {"entities": []}], ["In the current intervention, trainees were identified as active (compliant with training regimens) or inactive using trainer ratings based on attendance, homework completion, and class participation.", {"entities": []}], ["The active group showed significantly greater training-related gains than the inactive group and the control group on most measures.", {"entities": []}], ["Compliance was predicted by health, education, and self-efficacy.", {"entities": []}], ["Specifically, active trainees were more likely to have advanced degrees and somewhat higher self-efficacy, and to have higher vitality and fewer functional limitations than the inactive trainees.", {"entities": []}], ["This research may assist future investigators to target interventions to those who will show the most benefit.", {"entities": []}], ["The aim of our study was to investigate the association of interleukin-17A (IL-17A) polymorphisms with IL-17A serum levels and risk of ischemic stroke (IS) in a Chinese population.", {"entities": []}], ["392 IS patients and 443 controls were included in this study.", {"entities": []}], ["The polymorphisms of IL-17A gene were determined by Snapshot SNP genotyping assay and DNA sequencing.", {"entities": []}], ["Serum IL-17A levels were measured by enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["We found that the G allele, GA and GG genotypes, and GA/GG vs. AA model of rs2275913 polymorphism were associated with increased risk of IS even after adjusted by clinical characters such as age, gender and diabetes (G vs. A: OR=1.27, 95% CI, 1.05\u223c1.54, P =0.014; GA vs. AA: OR=1.72, 95% CI, 1.05\u223c2.81, P =0.032; GG vs. AA: OR=1.99, 95% CI, 1.08\u223c3.67, P =0.028; GA/GG vs. AA: OR=1.78, 95% CI, 1.11\u223c2.86, P =0.017).", {"entities": []}], ["Serum IL-17A levels were increased in IS patients compared with controls ( P <0.01).", {"entities": []}], ["Individuals carrying rs2275913 GA or GG genotype present higher serum IL-17A levels compared with the rs2275913AA genotype in the IS group ( P <0.01).", {"entities": []}], ["In conclusion, this is the first study reporting the rs2275913 polymorphism as a risk factor for IS, which may be partly explained by influencing the levels of IL-17A cytokine.", {"entities": []}], ["Mycobacterium xenopi -infected patients have a high prevalence of pulmonary cavities and nodules.", {"entities": []}], ["However, the clinical course for patients with miliary nodules due to M. xenopi has not yet been reported.", {"entities": []}], ["We encountered a case of miliary nodules with gradually worsening coughing and sputum production in a 44-year-old male who had renal dysfunction due to glomerulosclerosis with a decade-long history of steroid therapy.", {"entities": []}], ["Although we started anti-tuberculosis treatment on clinical suspicion of miliary tuberculosis, cultures of sputum and bronchial lavage were both positive for M. xenopi .", {"entities": [[73, 93, "DISEASE"], [25, 37, "DISEASE"], [81, 93, "DISEASE"]]}], ["The patient was successfully treated with rifampin, ethambutol and clarithromycin, without fibrosis.", {"entities": []}], ["It was unclear whether the miliary pattern was induced by hematogenous or endobronchial spread of the M. xenopi infection.", {"entities": []}], ["Even when clinical and radiological disease manifestations are similar to those of miliary tuberculosis, M. xenopi infection should be considered in the differential diagnosis of miliary nodules.", {"entities": [[83, 103, "DISEASE"], [91, 103, "DISEASE"]]}], ["The scoping review has become an increasingly popular approach for synthesizing research evidence.", {"entities": []}], ["It is a relatively new approach for which a universal study definition or definitive procedure has not been established.", {"entities": []}], ["The purpose of this scoping review was to provide an overview of scoping reviews in the literature.", {"entities": []}], ["A scoping review was conducted using the Arksey and O'Malley framework.", {"entities": []}], ["A search was conducted in four bibliographic databases and the gray literature to identify scoping review studies.", {"entities": []}], ["Review selection and characterization were performed by two independent reviewers using pretested forms.", {"entities": []}], ["The search identified 344 scoping reviews published from 1999 to October 2012.", {"entities": []}], ["The reviews varied in terms of purpose, methodology, and detail of reporting.", {"entities": []}], ["Nearly three-quarter of reviews (74.1%) addressed a health topic.", {"entities": []}], ["Study completion times varied from 2 weeks to 20 months, and 51% utilized a published methodological framework.", {"entities": []}], ["Quality assessment of included studies was infrequently performed (22.38%).", {"entities": []}], ["Scoping reviews are a relatively new but increasingly common approach for mapping broad topics.", {"entities": []}], ["Because of variability in their conduct, there is a need for their methodological standardization to ensure the utility and strength of evidence.", {"entities": []}], ["\u00a9 2014 The Authors.", {"entities": []}], ["Research Synthesis Methods published by John Wiley & Sons, Ltd.", {"entities": []}], ["We conducted imputation to the 1000 Genomes Project of four genome-wide association studies of lung cancer in populations of European ancestry (11,348 cases and 15,861 controls) and genotyped an additional 10,246 cases and 38,295 controls for follow-up.", {"entities": [[95, 106, "DISEASE"], [100, 106, "DISEASE"]]}], ["We identified large-effect genome-wide associations for squamous lung cancer with the rare variants of BRCA2 -K3326X (rs11571833; odds ratio [OR]=2.47, P =4.74\u00d710 CHEK2 -I157T (rs17879961; OR=0.38 P =1.27\u00d710 TP63 ; rs13314271; OR=1.13, P =7.22\u00d710", {"entities": [[65, 76, "DISEASE"], [70, 76, "DISEASE"], [103, 108, "GENE"], [163, 168, "GENE"], [208, 212, "GENE"]]}], ["Interleukin 12 (termed IL-12p70 and commonly designated IL-12) is an important immunoregulatory cytokine that is produced mainly by antigen-presenting cells.", {"entities": []}], ["The expression of IL-12 during infection regulates innate responses and determines the type of adaptive immune responses.", {"entities": []}], ["IL-12 induces interferon-\u03b3 (IFN-\u03b3) production and triggers CD4", {"entities": [[59, 62, "GENE"]]}], ["Chronic exposure to drinking water arsenic is a significant worldwide environmental health concern.", {"entities": []}], ["Exposure to As is associated with an increased risk of lung disease, which may make it a unique toxicant, because lung toxicity is usually associated with inhalation rather than ingestion.", {"entities": [[55, 67, "DISEASE"]]}], ["The goal of this study was to examine mRNA and protein expression changes in the lungs of mice exposed chronically to environmentally relevant concentrations of As in the food or drinking water, specifically examining the hypothesis that As may preferentially affect gene and protein expression related to immune function as part of its mechanism of toxicant action.", {"entities": []}], ["C57BL/6J mice fed a casein-based AIN-76A defined diet were exposed to 10 or 100 ppb As in drinking water or food for 5\u20136 weeks.", {"entities": []}], ["Whole genome transcriptome profiling of animal lungs revealed significant alterations in the expression of many genes with functions in cell adhesion and migration, channels, receptors, differentiation and proliferation, and, most strikingly, aspects of the innate immune response.", {"entities": []}], ["Confirmation of mRNA and protein expression changes in key genes of this response revealed that genes for interleukin 1\u03b2, interleukin 1 receptor, a number of toll-like receptors, and several cytokines and cytokine receptors were significantly altered in the lungs of As-exposed mice.", {"entities": []}], ["These findings indicate that chronic low-dose As exposure at the current U.S. drinking-water standard can elicit effects on the regulation of innate immunity, which may contribute to altered disease risk, particularly in lung.", {"entities": []}], ["Venous thromboembolism (VTE) is a common disease where known genetic risk factors explain only a small portion of the genetic variance.", {"entities": []}], ["Then, the analysis of intermediate phenotypes, such as thrombin generation assay, can be used to identify novel genetic risk factors that contribute to VTE.", {"entities": []}], ["To investigate the genetic basis of distinct quantitative phenotypes of thrombin generation and its relationship to the risk of VTE.", {"entities": []}], ["Lag time, thrombin peak and endogenous thrombin potential (ETP) were measured in the families of the Genetic Analysis of Idiopathic Thrombophilia 2 (GAIT-2) Project.", {"entities": [[132, 145, "DISEASE"]]}], ["This sample consisted of 935 individuals in 35 extended families selected through a proband with idiopathic thrombophilia.", {"entities": [[108, 121, "DISEASE"]]}], ["We performed also genome wide association studies (GWAS) with thrombin generation phenotypes.", {"entities": []}], ["The results showed that 67% of the variation in the risk of VTE is attributable to genetic factors.", {"entities": []}], ["The heritabilities of lag time, thrombin peak and ETP were 49%, 54% and 52%, respectively.", {"entities": []}], ["More importantly, we demonstrated also the existence of positive genetic correlations between thrombin peak or ETP and the risk of VTE.", {"entities": []}], ["Moreover, the major genetic determinant of thrombin generation was the F2 gene.", {"entities": [[71, 73, "GENE"]]}], ["However, other suggestive signals were observed.", {"entities": []}], ["The thrombin generation phenotypes are strongly genetically determined.", {"entities": []}], ["The thrombin peak and ETP are significantly genetically correlated with the risk of VTE.", {"entities": []}], ["In addition, F2 was identified as a major determinant of thrombin generation.", {"entities": [[13, 15, "GENE"]]}], ["We reported suggestive signals that might increase our knowledge to explain the variability of this important phenotype.", {"entities": []}], ["Validation and functional studies are required to confirm GWAS results.", {"entities": []}], ["There is evidence that patients with schizophrenia benefit from standard cognitive behaviour therapy (CBT) only if active techniques are used (\u2018full therapy\u2019).", {"entities": [[37, 50, "DISEASE"]]}], ["By contrast, attending sessions but not proceeding beyond engagement and assessment strategies (\u2018partial therapy\u2019), or simply not attending sessions (\u2018no therapy\u2019), is not associated with better outcomes.", {"entities": []}], ["The factors leading to full therapy are unknown.", {"entities": []}], ["We hypothesized that patients' initial ideas about the nature and extent of their problems would predict use of CBT.", {"entities": []}], ["A match between patients' views of their problems and the principles underlying treatment would lead to better outcomes.", {"entities": []}], ["Ninety-two patients with a recent relapse of psychosis completed the Illness Perception Questionnaire (IPQ) before receiving CBT.", {"entities": []}], ["We examined whether their illness perceptions predicted the take-up of therapy.", {"entities": []}], ["Patients who did not attend sessions believed their problems would not last as long as those who attended them.", {"entities": []}], ["Those who attended sessions but did not proceed to full therapy had a lower sense of control over their problems and a more biological view of their causes.", {"entities": []}], ["Patients who took up full therapy were more likely to attribute the cause of their problems to their personality and state of mind.", {"entities": []}], ["The take-up of therapy was predicted neither by levels of psychiatric symptoms nor by insight.", {"entities": []}], ["People with psychosis who have psychologically orientated views of their problems, including the potential to gain control over them, may be more likely to engage fully and do well with standard CBT for psychosis, irrespective of the severity of their problems.", {"entities": []}], ["Background: New antibacterial compounds are urgently needed; DNA gyrase is a well-validated target.", {"entities": []}], ["Results: Diospyrin and other naphthoquinones inhibit DNA gyrase by binding to a novel site in the B subunit.", {"entities": []}], ["Conclusion: Naphthoquinones are inhibitors of gyrase with a novel mechanism of action.", {"entities": []}], ["Significance: Naphthoquinones have potential as antibacterial compounds against TB.", {"entities": []}], ["Tuberculosis and other bacterial diseases represent a significant threat to human health.", {"entities": [[0, 12, "DISEASE"]]}], ["The DNA topoisomerases are excellent targets for chemotherapy, and DNA gyrase in particular is a well-validated target for antibacterial agents.", {"entities": []}], ["Naphthoquinones ( e.g.", {"entities": []}], ["diospyrin and 7-methyljuglone) have been shown to have therapeutic potential, particularly against Mycobacterium tuberculosis .", {"entities": [[113, 125, "DISEASE"]]}], ["We have found that these compounds are inhibitors of the supercoiling reaction catalyzed by M. tuberculosis gyrase and other gyrases.", {"entities": [[95, 107, "DISEASE"]]}], ["Our evidence strongly suggests that the compounds bind to the N-terminal domain of GyrB, which contains the ATPase active site, but are not competitive inhibitors of the ATPase reaction.", {"entities": []}], ["We propose that naphthoquinones bind to GyrB at a novel site close to the ATPase site.", {"entities": []}], ["This novel mode of action could be exploited to develop new antibacterial agents.", {"entities": []}], ["Most research on long-term sickness absence has focussed on exposure to occupational psychosocial risk factors such as low decision latitude.", {"entities": []}], ["These provide an incomplete explanation as they do not account for other relevant factors.", {"entities": []}], ["Such occupational risk factors may be confounded by social or temperamental risk factors earlier in life.", {"entities": []}], ["We analysed data from the 1958 British Birth Cohort.", {"entities": []}], ["Long-term sickness absence was defined as receipt of Incapacity Benefit/Severe Disablement Allowance at age 42.", {"entities": []}], ["In those in employment aged 33 we examined the effects of psychological distress, musculoskeletal symptoms, and low decision latitude.", {"entities": []}], ["These were then adjusted for IQ, educational attainment, and the presence of early life somatic and neurotic symptoms.", {"entities": []}], ["Low decision latitude predicted subsequent long-term absence, and this association remained, albeit reduced, following adjustment for psychological distress and musculoskeletal symptoms at age 33.", {"entities": []}], ["Low decision latitude was no longer associated with long-term absence when IQ and educational attainment were included.", {"entities": []}], ["Adjusting for early life somatic and neurotic symptoms had little impact.", {"entities": []}], ["A greater understanding of the ways in which occupational risk factors interact with individual vulnerabilities across the life-course is required.", {"entities": []}], ["Self reported low decision latitude might reflect the impact of education and cognitive ability on how threat, and the ability to manage threat, is perceived, rather than being an independent risk factor for long-term sick leave.", {"entities": []}], ["This has implications for policy aimed at reducing long-term sick leave.", {"entities": []}], ["Monocytes are actively recruited at sites of chronic inflammation.", {"entities": []}], ["However, molecular factors involved in this process are not fully elucidated.", {"entities": []}], ["Here, we show that cytokine IL-4 which is implicated in the development of chronic inflammatory disease atopic dermatitis (AD) induces expression of transcription factor FoxQ1 in human monocytes and macrophages.", {"entities": [[104, 121, "DISEASE"], [111, 121, "DISEASE"], [170, 175, "GENE"]]}], ["FoxQ1 mRNA levels were elevated in monocytes of AD patients compared to healthy donors.", {"entities": [[0, 5, "GENE"]]}], ["Overexpression of FoxQ1 in RAW 264.7 monocytic cells facilitated their migration towards MCP-1 and was associated with decreased expression of migration-regulating genes (claudin 11 and plexin C1).", {"entities": [[18, 23, "GENE"]]}], ["Furthermore, FoxQ1 overexpression in RAW cells accelerated TNF\u03b1 secretion after LPS challenge.", {"entities": [[13, 18, "GENE"]]}], ["Overall, our results indicate that FoxQ1 stimulates monocyte motility, increases pro-inflammatory potential, and directs monocyte migration towards MCP-1 that is crucial for monocyte influx into inflammatory sites.", {"entities": [[35, 40, "GENE"]]}], ["This mechanism could contribute to the pathogenesis of chronic inflammatory disorders such as AD.", {"entities": []}], ["To assess the level of knowledge for bronchial asthma of the primary healthcare physicians serving a rural population on the island of Crete, both before and immediately after a one-day educational course.", {"entities": [[47, 53, "DISEASE"]]}], ["Twenty-one primary health care physicians, randomly selected from a list of 14 Health Care Centres on the island of Crete were invited to participate in the study and attended an educational course.", {"entities": []}], ["Nine of the 21 physicians were fully qualified general practitioners, while the remainder were non-specialized (NSs) physicians who had recently graduated from the University of Crete, Medical School.", {"entities": []}], ["A questionnaire of 20 items based on current bronchial asthma clinical guidelines was used.", {"entities": [[55, 61, "DISEASE"]]}], ["Three scores, the mean total, knowledge subscore and attitudes subscore, were calculated for each group of physicians, both before and after the course.", {"entities": []}], ["At baseline mean total score and knowledge and attitudes subscores were higher for non-specialized physicians than for the general practitioners, but the differences were not statistically significant (p > 0.05).", {"entities": []}], ["The knowledge subscore was improved in both groups, however the difference was statistically significant only for the non-specialized physicians (t = 2.628, d.f.", {"entities": []}], ["= 11, p < 0.05).", {"entities": []}], ["The mean total score after the course was significantly higher for the non-specialized physicians in comparison to that of the general practitioners (t=-2.688, d.f.", {"entities": []}], ["= 19, p < 0.05).", {"entities": []}], ["This study adds to the information about the success of continuing medical education, and also demonstrates that the recent graduates in the studied population, could be educated with more positive results than the fully qualified practitioners", {"entities": []}], ["Activation of the group 2 innate lymphoid cell (ILC2) population leads to production of the classical type 2 cytokines, thus promoting type 2 immunity.", {"entities": []}], ["Chemoattractant receptor-homologous molecule expressed on T H 2 cells (CRTH2), a receptor for prostaglandin D 2 (PGD 2 ), is expressed by human ILC2s.", {"entities": [[113, 116, "GENE"]]}], ["However, the function of CRTH2 in these cells is unclear.", {"entities": []}], ["We sought to determine the role of PGD 2 and CRTH2 in human ILC2s and compare it with that of the established ILC2 activators IL-25 and IL-33.", {"entities": [[35, 38, "GENE"]]}], ["The effects of PGD 2 , IL-25, and IL-33 on the cell migration, cytokine production, gene regulation, and receptor expression of ILC2s were measured with chemotaxis, ELISA, Luminex, flow cytometry, quantitative RT-PCR, and QuantiGene assays.", {"entities": [[15, 18, "GENE"]]}], ["The effects of PGD 2 under physiologic conditions were evaluated by using the supernatant from activated mast cells.", {"entities": [[15, 18, "GENE"]]}], ["PGD 2 binding to CRTH2 induced ILC2 migration and production of type 2 cytokines and many other cytokines.", {"entities": [[0, 3, "GENE"]]}], ["ILC2 activation through CRTH2 also upregulated the expression of IL-33 and IL-25 receptor subunits (ST2 and IL-17RA).", {"entities": []}], ["The effects of PGD 2 on ILC2s could be mimicked by the supernatant from activated human mast cells and inhibited by a CRTH2 antagonist.", {"entities": [[15, 18, "GENE"]]}], ["PGD 2 is an important and potent activator of ILC2s through CRTH2 mediating strong proallergic inflammatory responses.", {"entities": [[0, 3, "GENE"]]}], ["Through IgE-mediated mast cell degranulation, these innate cells can also contribute to adaptive type 2 immunity; thus CRTH2 bridges the innate and adaptive pathways in human ILC2s.", {"entities": []}], ["The aim of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of a single 12.5- or 25-mg dose of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, in pediatric (children and adolescents) and adult subjects with type 2 diabetes mellitus (T2DM).", {"entities": [[252, 269, "DISEASE"], [245, 269, "DISEASE"]]}], ["A randomized, open-label, multicenter study was conducted in pediatric and adult subjects.", {"entities": []}], ["Subjects in two pediatric groups (children and adolescents) were randomized 1:1 to receive a single oral dose of alogliptin 12.5 or 25\u00a0mg, respectively; all gender- and race-matched adult subjects received alogliptin 25\u00a0mg.", {"entities": []}], ["Blood and urine samples were collected at prespecified time points for PK/PD analyses.", {"entities": []}], ["A PK/PD model was developed using data from the study for steady-state simulations.", {"entities": []}], ["Safety was also assessed.", {"entities": []}], ["In pediatric subjects receiving the 25-mg dose, the mean alogliptin peak plasma concentrations (C max ) and AUC 0-inf values were 26 and 23% lower, respectively, than in adults receiving the 25-mg dose, but maximum observed DPP-4 inhibition effect (E max ) and AUEC 0\u201324 values were similar to those in adults.", {"entities": [[98, 101, "GENE"], [251, 254, "GENE"], [98, 101, "GENE"], [251, 254, "GENE"]]}], ["In pediatric subjects receiving the 12.5-mg dose, the mean alogliptin C max and AUC 0-inf values were 58 and 54% lower, respectively, than those in adults, hence E max and AUEC 0\u201324 values were also lower by 11 and 17%, respectively.", {"entities": [[72, 75, "GENE"], [164, 167, "GENE"], [72, 75, "GENE"], [164, 167, "GENE"]]}], ["The PK/PD model simulated data were consistent with study results.", {"entities": []}], ["No safety concern was found.", {"entities": []}], ["A 25-mg dose of alogliptin in pediatric subjects achieved alogliptin exposures and DPP-4 inhibition similar to those in adult T2DM patients without safety concerns; therefore, this dose is recommended for a pediatric phase 3 trial.", {"entities": []}], ["The online version of this article (doi:10.1007/s00228-016-2175-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To review, from a primary care physician (PCP) perspective, the use of patient-reported outcome (PRO) instruments for assessment of gastro-oesophageal reflux disease (GERD) symptoms, their impact on health-related quality of life (HRQL) and the effectiveness of therapy.", {"entities": []}], ["While generic and disease-specific PRO instruments have been used in the assessment of GERD, the latter can be considered to be more appropriate as they focus only on problems relevant to the disease in question (and therefore tend to be more responsive to change).", {"entities": []}], ["Such instruments include the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire and the Gastrointestinal Symptom Rating Scale and the Reflux Disease Questionnaire (RDQ).", {"entities": []}], ["Their use indicates that GERD symptoms are troublesome and significantly reduce patients\u2019 HRQL, and that effective treatment of GERD improves HRQL.", {"entities": []}], ["The GERD Impact Scale (GIS) questionnaire, primarily developed for use within primary care, can also help to determine the impact of symptoms on patients\u2019 everyday lives and, in turn, the benefit of appropriately targeted therapy.", {"entities": []}], ["Notably, these PRO instruments were developed from focus groups of GERD patients, and only aspects rated of highest importance are used in the final instruments.", {"entities": []}], ["Consequently, PCPs can feel confident that these questionnaires encompass the most relevant points that they are likely to ask in terms of how symptoms affect patients\u2019 everyday lives.", {"entities": []}], ["Primary care physicians are encouraged to make wider use of PRO instruments within routine practice to improve communication with their GERD patients that, in turn, could lead to improved clinical outcomes and greater patient satisfaction.", {"entities": []}], ["Review Criteria We conducted a review of validated patient-reported outcome (PRO) instruments used in gastro-oesophageal reflux disease (GERD), based on the authors\u2019 expertise in the field and a supplementary MEDLINE search with the terms \u2018health-related quality of life\u2019, \u2018quality of life questionnaire\u2019, \u2018patient-reported outcomes\u2019, \u2018patient satisfaction\u2019 and \u2018gastro-oesophageal reflux disease\u2019.", {"entities": []}], ["We reviewed papers reporting health-related quality of life (HRQL) data in patients with GERD, including the effect of GERD on HRQL, treatment efficacy and HRQL, patient satisfaction and physician-patient agreement, to help primary care physicians to incorporate PRO instruments into their day-to-day management of patients with GERD.", {"entities": []}], ["Message for the Clinic An evidence-based review shows that PRO instruments can accurately assess the nature of GERD symptoms, their impact on HRQL and the efficacy of treatment.", {"entities": []}], ["Primary care physicians are encouraged to make wider use of PRO instruments as part of their management of patients with GERD, given that such questionnaires can facilitate patient communication and help physicians understand and satisfy the therapeutic needs of their patients.", {"entities": []}], ["Among validated PRO instruments, the GERD Impact Scale represents a practical tool that is easy for primary care physicians to incorporate into their everyday practice.", {"entities": []}], ["We conducted a review of validated patient-reported outcome (PRO) instruments used in gastro-oesophageal reflux disease (GERD), based on the authors\u2019 expertise in the field and a supplementary MEDLINE search with the terms \u2018health-related quality of life\u2019, \u2018quality of life questionnaire\u2019, \u2018patient-reported outcomes\u2019, \u2018patient satisfaction\u2019 and \u2018gastro-oesophageal reflux disease\u2019.", {"entities": []}], ["We reviewed papers reporting health-related quality of life (HRQL) data in patients with GERD, including the effect of GERD on HRQL, treatment efficacy and HRQL, patient satisfaction and physician-patient agreement, to help primary care physicians to incorporate PRO instruments into their day-to-day management of patients with GERD.", {"entities": []}], ["An evidence-based review shows that PRO instruments can accurately assess the nature of GERD symptoms, their impact on HRQL and the efficacy of treatment.", {"entities": []}], ["Primary care physicians are encouraged to make wider use of PRO instruments as part of their management of patients with GERD, given that such questionnaires can facilitate patient communication and help physicians understand and satisfy the therapeutic needs of their patients.", {"entities": []}], ["Among validated PRO instruments, the GERD Impact Scale represents a practical tool that is easy for primary care physicians to incorporate into their everyday practice.", {"entities": []}], ["Inborn errors of metabolism (IEMs) are known for their low prevalence and multidisciplinary care mostly founded on expert opinion.", {"entities": []}], ["Clinical pathways are multidisciplinary tools to organise care which provide a clear route to the best care and improve communication.", {"entities": []}], ["In 2010 the Dutch Society for Children and Adults with an Inborn Error of Metabolism (VKS) initiated development of clinical pathways for inborn errors of metabolism.", {"entities": []}], ["In this letter to the editor we describe why it is warranted to develop clinical pathways for IEMs and shortly discuss the process of development for these pathways in the Netherlands.", {"entities": []}], ["Susceptibility to fungal infection is commonly associated with impaired neutrophil responses.", {"entities": []}], ["To study the mechanisms underlying this association, we investigated neutrophil recruitment to the conducting airway wall after Aspergillus fumigatus conidium inhalation in mouse models of drug-induced immunosuppression and antibody-mediated neutrophil depletion (neutropenia) by performing three-dimensional confocal laser-scanning microscopy of whole-mount primary bronchus specimens.", {"entities": [[264, 275, "DISEASE"]]}], ["Actin staining enabled visualization of the epithelial and smooth muscle layers that mark the airway wall.", {"entities": []}], ["Gr-1 A. fumigatus infection were analyzed and compared.", {"entities": []}], ["Our results show that the number of conducting airway wall neutrophils in immunocompetent mice significantly increased upon inflammation, while a dramatic reduction in this number was observed following immunosuppression and neutropenia.", {"entities": [[225, 236, "DISEASE"]]}], ["Interestingly, a slight increase in the infiltration of neutrophils into the airway wall was detected as a result of infection, even in immunosuppressed and neutropenic mice.", {"entities": []}], ["Taken together, these data indicate that neutrophils are present in intact conducting airway walls and the number elevates upon A. fumigatus infection.", {"entities": []}], ["Conducting airway wall neutrophils are affected by both neutropenia and immunosuppression.", {"entities": [[56, 67, "DISEASE"]]}], ["The aim of our study was to evaluate factors affecting cystic fibrosis (CF) patients\u2019 health-related quality of life (HRQoL) and to assess the level of agreement on HRQol between children and their parents.", {"entities": [[55, 70, "DISEASE"]]}], ["Fifty-nine patients (mean age: 14.03\u2009\u00b1\u20094.81\u00a0years) from 5 Hungarian CF centres completed the survey.", {"entities": []}], ["HRQoL was measured using The Cystic Fibrosis Questionnaire-Revised (CFQ-R).", {"entities": [[29, 44, "DISEASE"]]}], ["Parents were asked to fill out a questionnaire about their smoking habits, educational level and history of chronic illness.", {"entities": []}], ["Disease severity was assessed using the physician-reported Shwachman-Kulczycki (SK) score system.", {"entities": []}], ["Spirometry, Body Mass Index (BMI) percentile (pc), hospitalisation and Pseudomonas aeruginosa (PA) infection were examined as physiologic parameters of CF, and the impact of these factors on HRQoL was assessed.", {"entities": [[46, 48, "GENE"]]}], ["A multivariate regression analysis was performed to identify the most important factors affecting HRQoL.", {"entities": []}], ["The level of significance was set to 0.05.", {"entities": []}], ["Passive smoking and parental educational level and chronic diseases status did not have a significant impact on the patients\u2019 HRQoL (p\u2009>\u20090.05).", {"entities": []}], ["Significantly lower SK scores and spirometry values were found in low BMI pc patients (p\u2009<\u20090.001), in hospitalised (p\u2009<\u20090.01) and in PA-infected patients (p\u2009<\u20090.01), than in the adequate-weight, non-hospitalised and PA culture-negative subgroup.", {"entities": [[74, 76, "GENE"]]}], ["Lower CFQ-R scores were detected in hospitalised patients than in non-hospitalised patients in their Physical functioning domain.", {"entities": []}], ["PA-infected patients had HRQoL scores that were significantly worse in the Body image (p\u2009<\u20090.01) and Respiratory symptoms (p\u2009<\u20090.05) domains than the PA culture-negative patients.", {"entities": []}], ["Patients with a low BMI pc (<25 Passive smoking, parental educational level and chronic diseases of parents do not affect the HRQoL of CF patients.", {"entities": [[24, 26, "GENE"]]}], ["In contrast, hospitalisation, PA infection and malnutrition have a significant and negative impact on patients\u2019 HRQoL and the clinical severity of the disease.", {"entities": []}], ["Parents and children were consistent in their scoring of symptoms and behaviours that were observable.", {"entities": []}], ["Many drugs that target G-protein-coupled receptors (GPCRs) induce or inhibit their signal transduction with different strengths, which affect their therapeutic properties.", {"entities": []}], ["However, the mechanism underlying the differences in the signalling levels is still not clear, although several structures of GPCRs complexed with ligands determined by X-ray crystallography are available.", {"entities": []}], ["Here we utilized NMR to monitor the signals from the methionine residue at position 82 in neutral antagonist- and partial agonist-bound states of \u03b2 2 -adrenergic receptor (\u03b2 2 AR), which are correlated with the conformational changes of the transmembrane regions upon activation.", {"entities": []}], ["We show that this residue exists in a conformational equilibrium between the inverse agonist-bound states and the full agonist-bound state, and the population of the latter reflects the signal transduction level in each ligand-bound state.", {"entities": []}], ["These findings provide insights into the multi-level signalling of \u03b2 2 AR and other GPCRs, including the basal activity, and the mechanism of signal transduction mediated by GPCRs.", {"entities": []}], ["Many drugs exist that target the \u03b2-adrenergic receptor, but they have different efficacies.", {"entities": []}], ["Kofuku et al .", {"entities": []}], ["use NMR to show that methionine 82 in the transmembrane domain undergoes conformational changes depending on whether agonists or inverse agonists are bound, explaining the differential drug efficacy.", {"entities": []}], ["There is a substantial burden of chronic lung disease among treated children with human immunodeficiency virus infection in this study from Zimbabwe.", {"entities": [[41, 53, "DISEASE"]]}], ["The radiological findings, coupled with functional test results, indicate that the key pathological lesion is constrictive obliterative bronchiolitis.", {"entities": [[136, 149, "DISEASE"]]}], ["Chronic respiratory symptoms are common among children living with human immunodeficiency virus (HIV).", {"entities": []}], ["We investigated the radiological features of chronic lung disease in children aged 6\u201316 years receiving antiretroviral therapy for \u22656 months in Harare, Zimbabwe.", {"entities": [[53, 65, "DISEASE"]]}], ["Consecutive participants from a HIV clinic underwent clinical assessment and chest radiography.", {"entities": []}], ["Participants with an abnormal chest radiograph (assessed by a clinician) and/or those meeting a clinical case definition for chronic lung disease underwent high-resolution computed tomography (HRCT).", {"entities": [[133, 145, "DISEASE"]]}], ["Radiological studies were scored independently and blindly by 2 thoracic radiologists.", {"entities": []}], ["Relationships between radiological abnormalities and lung function were examined.", {"entities": []}], ["Among 193 participants (46% female; median age, 11.2 years; interquartile range, 9.0\u201312.8 years), the median CD4 cell count was 720/\u00b5L (473\u2013947/\u00b5L), and 79% had a human immunodeficiency virus (HIV) load of <400 copies/mL.", {"entities": [[109, 112, "GENE"]]}], ["The most common chest radiographic finding was ring/tramline opacities (55 of 193 participants; 29%).", {"entities": []}], ["HRCT scans were evaluated in 84 participants (69%); decreased attenuation (present in 43%) was the dominant abnormality seen.", {"entities": []}], ["The extent of decreased attenuation was strongly correlated with both the severity and extent of bronchiectasis ( r s = 0.68 and P < .001 for both).", {"entities": [[97, 111, "DISEASE"]]}], ["The extent of decreased attenuation was also negatively correlated with forced expiratory volume in first second of expiration ( r s = \u20130.52), forced vital capacity ( r s = \u20130.42), and forced expiratory flow, midexpiratory phase ( r s = \u20130.42) ( P < .001 for all).", {"entities": []}], ["The HRCT findings strongly suggest that obliterative bronchiolitis may be the major cause of chronic lung disease in our cohort.", {"entities": [[101, 113, "DISEASE"], [53, 66, "DISEASE"]]}], ["Further studies to understand the pathogenesis and natural history are urgently needed.", {"entities": []}], ["Asthma is a heterogeneous condition and differential effects of pet ownership on non-atopic versus atopic asthma have been reported.", {"entities": [[0, 6, "DISEASE"], [106, 112, "DISEASE"]]}], ["The aim of this study was to investigate whether pet ownership during pregnancy and early childhood was associated with wheezing from birth to age 7 years and with lung function at age 8 years in a UK population-based birth cohort.", {"entities": []}], ["Data from the Avon Longitudinal Study of Parents and Children (ALSPAC) were used to investigate associations of pet ownership at six time-points from pregnancy to age 7 years with concurrent episodes of wheezing, wheezing trajectories (phenotypes) and lung function at age 8 years using logistic regression models adjusted for child\u2019s sex, maternal history of asthma/atopy, maternal smoking during pregnancy, and family adversity.", {"entities": [[360, 366, "DISEASE"]]}], ["4,706 children had complete data on pet ownership and wheezing.", {"entities": []}], ["From birth to age 7 years, cat ownership was associated with an overall 6% lower odds of wheezing (OR=0.94 (0.89-0.99)).", {"entities": []}], ["Rabbit and rodent ownership was associated with 21% (OR=1.21 (1.12-1.31)) and 11% (OR=1.11 (1.02\u20131.21)) higher odds of wheezing, respectively, with strongest effects evident during infancy.", {"entities": []}], ["Rabbit and rodent ownership was positively associated with a \u2018persistent wheeze\u2019 phenotype.", {"entities": []}], ["Pet ownership was not associated with lung function at age 8 years, with the exception of positive associations of rodent and bird ownership with better lung function.", {"entities": []}], ["Cat ownership was associated with reduced risk, and rabbit and rodent ownership with increased risk, of wheezing during childhood.", {"entities": []}], ["The mechanisms behind these differential effects warrant further investigation.", {"entities": []}], ["Millions of Americans live with chronic sinus infection.", {"entities": []}], ["Most infections are caused by either bacteria or fungi.", {"entities": []}], ["Some of these infections can be hard to treat, eluding medical and surgical treatment and persisting for months or even years.", {"entities": []}], ["A recent study in New York found that some patients with a chronic sinus infection had tuberculosis-like organisms (mycobacteria) in their sinuses and that the same organisms were also in the tap water at their homes.", {"entities": [[87, 99, "DISEASE"]]}], ["These mycobacteria can be resistant to commonly used antimicrobial drugs.", {"entities": []}], ["Doctors should check for mycobacteria in patients with treatment-resistant sinus infection.", {"entities": []}], ["Patients who flush their sinuses at home should use sterile saline, not tap water.", {"entities": []}], ["Symptoms of chronic rhinosinusitis (CRS) often persist despite treatment.", {"entities": []}], ["Because nontuberculous mycobacteria (NTM) are resistant to commonly used antimicrobial drugs and are found in drinking water that patients may use for sinus irrigation, we investigated whether some CRS patients were infected with NTM in New York, New York, USA, during 2001\u20132011.", {"entities": [[37, 40, "GENE"], [230, 233, "GENE"], [37, 40, "GENE"], [230, 233, "GENE"]]}], ["Two approaches were chosen: 1) records of NTM-infected CRS patients were reviewed to identify common features of infection and Mycobacterium species; 2) samples from plumbing in households of 8 NTM-infected patients were cultured for NTM presence.", {"entities": [[42, 45, "GENE"], [194, 197, "GENE"], [234, 237, "GENE"]]}], ["In 3 households sampled, M. avium sharing rep -PCR and pulsed field gel electrophoresis fingerprints identified M. avium isolates clonally related to the patients\u2019 isolates.", {"entities": []}], ["We conclude that patients with treatment-resistant CRS may be infected with NTM and should have cultures performed for NTM so appropriate therapy can be instituted.", {"entities": [[76, 79, "GENE"], [119, 122, "GENE"], [76, 79, "GENE"], [119, 122, "GENE"]]}], ["In addition, the results suggest that CRS patients can be infected by NTM in their household plumbing.", {"entities": [[70, 73, "GENE"]]}], ["Elderly persons are more susceptible to RSV-induced pneumonia than young people, but the molecular mechanism underlying this susceptibility is not well understood.", {"entities": [[52, 61, "DISEASE"]]}], ["In this study, we used an aged mouse model of RSV-induced pneumonia to examine how aging alters the lung pathology, modulates antiviral gene expressions, and the production of inflammatory cytokines in response to RSV infection.", {"entities": [[58, 67, "DISEASE"]]}], ["Young (2\u20133 months) and aged (19\u201321 months) mice were intranasally infected with mucogenic or non-mucogenic RSV strains, lung histology was examined, and gene expression was analyzed.", {"entities": []}], ["Upon infection with mucogenic strains of RSV, leukocyte infiltration in the airways was elevated and prolonged in aged mice compared to young mice.", {"entities": []}], ["Minitab factorial analysis identified several antiviral genes that are influenced by age, infection, and a combination of both factors.", {"entities": []}], ["The expression of five antiviral genes, including pro-inflammatory cytokines IL-1\u03b2 and osteopontin (OPN), was altered by both age and infection, while age was associated with the expression of 15 antiviral genes.", {"entities": []}], ["Both kinetics and magnitude of antiviral gene expression were diminished as a result of older age.", {"entities": []}], ["In addition to delays in cytokine signaling and pattern recognition receptor induction, we found TLR7/8 signaling to be impaired in alveolar macrophages in aged mice.", {"entities": []}], ["In vivo , induction of IL-1\u03b2 and OPN were delayed but prolonged in aged mice upon RSV infection compared to young.", {"entities": []}], ["In conclusion, this study demonstrates inherent differences in response to RSV infection in young vs. aged mice, accompanied by delayed antiviral gene induction and cytokine signaling.", {"entities": []}], ["To evaluated the differences in knowledge, adherence, attitudes, and beliefs about medicine in adolescents with inflammatory bowel disease (IBD) attending transition clinics.", {"entities": [[112, 138, "DISEASE"]]}], ["We prospectively enrolled patients from July 2012 to June 2013.", {"entities": []}], ["All adolescents who attended a tertiary-centre-based dedicated IBD transition clinic were invited to participate.", {"entities": []}], ["Adolescent controls were recruited from university-affiliated gastroenterology offices.", {"entities": []}], ["Participants completed questionnaires about their disease and reported adherence to prescribed therapy.", {"entities": []}], ["Beliefs in Medicine Questionnaire was used to evaluate patients\u2019 attitudes and beliefs.", {"entities": []}], ["Beliefs of medication overuse, harm, necessity and concerns were rated on a Likert scale.", {"entities": []}], ["Based on necessity and concern ratings, attitudes were then characterized as accepting, ambivalent, skeptical and indifferent.", {"entities": []}], ["One hundred and twelve adolescents were included and 59 attended transition clinics.", {"entities": []}], ["Self-reported adherence rates were poor, with only 67.4% and 56.8% of patients on any IBD medication were adherent in the transition and control groups, respectively.", {"entities": []}], ["Adolescents in the transition cohort held significantly stronger beliefs that medications were necessary ( P = 0.0035).", {"entities": []}], ["Approximately 20% of adolescents in both cohorts had accepting attitudes toward their prescribed medicine.", {"entities": []}], ["However, compared to the control group, adolescents in the transition cohort were less skeptical of (6.8% vs 20.8%) and more ambivalent (61% vs 34%) (OR = 0.15; 95%CI: 0.03-0.75; P = 0.02) to treatment.", {"entities": []}], ["Attendance at dedicated transition clinics was associated with differences in attitudes in adolescents with IBD.", {"entities": []}], ["Elevated levels of immunoglobulin (Ig) E are associated with bronchial asthma, a disease characterized by eosinophilic inflammation of the airways.", {"entities": [[71, 77, "DISEASE"]]}], ["Activation of antigen-specific T helper (Th) 2 cells in the lung with the subsequent release of interleukin (IL) 4 and IL-5 is believed to play an important role in the pathogenesis of this disease.", {"entities": []}], ["In this study, we have used a non-anaphylactogenic anti-mouse-IgE antibody to investigate the relationship between IgE, airway eosinophil infiltration, and the production of Th2 cytokines.", {"entities": []}], ["Immunization of mice with house dust mite antigen increased serum levels of IgE and IgG.", {"entities": []}], ["Antigen challenge of immunized but not control mice induced an infiltration of eosinophils in the bronchoalveolar lavage associated with the production of IL-4 and IL-5 from lung purified Thy1.2+ cells activated through the CD3-T cell receptor complex.", {"entities": []}], ["Administration of the anti-IgE monoclonal antibody (mAb) 6h before antigen challenge neutralized serum IgE but not IgG and inhibited the recruitment of eosinophils into the lungs and the production of IL-4 and IL-5 but not interferon gamma.", {"entities": []}], ["Studies performed using an anti-CD23 mAb, CD23 deficient and mast cell deficient mice suggest that anti-IgE mAb suppresses eosinophil infiltration and Th2 cytokine production by inhibiting IgE-CD23-facilitated antigen presentation to T cells.", {"entities": []}], ["Our results demonstrate that IgE-dependent mechanisms are important in the induction of a Th2 immune response and the subsequent infiltration of eosinophils into the airways.", {"entities": []}], ["Neutralization of IgE, for example, non- anaphylactogenic anti-IgE mAbs may provide a novel therapeutic approach to the treatment of allergic airway disease.", {"entities": []}], ["The lung is composed of airways and lung parenchyma, and the extracellular matrix ( ECM ) contains the main building blocks of both components.", {"entities": []}], ["The ECM provides physical support and stability to the lung, and as such it has in the past been regarded as an inert structure.", {"entities": []}], ["More recent research has provided novel insights revealing that the ECM is also a bioactive environment that orchestrates the cellular responses in its environs.", {"entities": []}], ["Changes in the ECM in the airway or parenchymal tissues are now recognized in the pathological profiles of many respiratory diseases, including asthma, chronic obstructive pulmonary disease ( COPD ), and idiopathic pulmonary fibrosis ( IPF ).", {"entities": [[152, 189, "DISEASE"], [215, 233, "DISEASE"], [144, 150, "DISEASE"], [204, 233, "DISEASE"]]}], ["Only recently have we begun to investigate whether these ECM changes result from the disease process, or whether they constitute a driving factor that orchestrates the pathological outcomes.", {"entities": []}], ["This review summarizes our current knowledge of the alterations in the ECM in asthma, COPD , and IPF , and the contributions of these alterations to the pathologies.", {"entities": [[78, 84, "DISEASE"]]}], ["Emerging data suggest that alterations in the composition, folding or rigidity of ECM proteins may alter the functional responses of cells within their environs, and in so doing change the pathological outcomes.", {"entities": []}], ["These characteristics highlight potential avenues for targeting lung pathologies in the future.", {"entities": []}], ["This may ultimately contribute to a better understanding of chronic lung diseases, and novel approaches for finding therapeutic solutions.", {"entities": []}], ["\u00a9 2016 The Authors.", {"entities": []}], ["The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.", {"entities": []}], ["Nutrition, bacterial composition of the gastrointestinal tract, and general health status can all influence the metabolic profile of an organism.", {"entities": []}], ["We previously demonstrated that feeding pasteurized transgenic goats\u2019 milk expressing human lysozyme (hLZ) can positively impact intestinal morphology and modulate intestinal microbiota composition in young pigs.", {"entities": []}], ["The objective of this study was to further examine the effect of consuming hLZ-containing milk on young pigs by profiling serum metabolites.", {"entities": []}], ["Pigs were placed into two groups and fed a diet of solid food and either control (non-transgenic) goats\u2019 milk or milk from hLZ-transgenic goats for 6\u00a0weeks.", {"entities": []}], ["Serum samples were collected at the end of the feeding period and global metabolite profiling was performed.", {"entities": []}], ["For a total of 225 metabolites (160 known, 65 unknown) semi-quantitative data was obtained.", {"entities": []}], ["Levels of 18 known and 4 unknown metabolites differed significantly between the two groups with the direction of change in 13 of the 18 known metabolites being almost entirely congruent with improved health status, particularly in terms of the gastrointestinal tract health and immune response, with the effects of the other five being neutral or unknown.", {"entities": []}], ["These results further support our hypothesis that consumption of hLZ-containing milk is beneficial to health.", {"entities": []}], ["Matrix metalloproteinase-9 (MMP-9) expression is upregulated in alveolar macrophages (AM) of HIV1 Methods.", {"entities": []}], ["Cytokine arrays evaluated cytokine protein levels in ELF obtained from 5 groups of individuals: HIV1 CO ), HIV1 CO .", {"entities": []}], ["Increased levels of the Th17 related cytokine IL-23 were found in HIV1 CO and HIV1 CO .", {"entities": []}], ["Infection with HIV1 in vitro induced IL-23 expression in normal AM.", {"entities": []}], ["IL-23 stimulation of AM/lymphocyte cocultures in vitro induced upregulation of MMP-9.", {"entities": []}], ["Lung T lymphocytes express receptor IL-23R and interact with AM in order to upregulate MMP-9.", {"entities": []}], ["Conclusion .", {"entities": []}], ["This mechanism may contribute to the increased tissue destruction in the lungs of HIV1", {"entities": []}], ["In bronchiectasis patients, chronic Pseudomonas aeruginosa (PA) infection has been associated with worse health-related quality of life (HRQL), but little is known about Mycobacterium avium complex lung disease (MACLD) patients in this context.", {"entities": [[3, 17, "DISEASE"], [198, 210, "DISEASE"]]}], ["This study aimed to evaluate HRQL and investigate the impact of chronic PA infection in MACLD patients.", {"entities": []}], ["This cross-sectional study was conducted using the Registry of Prospective Cohort Study including MACLD patients.", {"entities": []}], ["The 36-item Short-Form health survey (SF-36) and St. George\u2019s Respiratory Questionnaire (SGRQ) were administered to assess clinical outcomes.", {"entities": []}], ["Clinical variables included treatment and sputum culture status, pulmonary function tests, cavitary lesions, and modified Reiff scores on high-resolution computed tomography.", {"entities": []}], ["The study included 244 MACLD patients (median age, 68\u00a0years; 196 women), 19 of whom had chronic PA infection.", {"entities": []}], ["Modified Reiff score was higher in patients with chronic infection than in those without ( P \u2009=\u20090.028).", {"entities": []}], ["Regarding SF-36 scores, physical functioning subscale scores were significantly lower in patients with chronic infection ( P \u2009=\u20090.029).", {"entities": []}], ["Additionally, SGRQ symptoms, impact, and total scores were significantly higher in patients with chronic infection.", {"entities": []}], ["During analysis of covariance comparisons, SGRQ symptoms and impact scores were significantly higher for patients with chronic infection ( P \u2009=\u20090.043 and 0.021, respectively).", {"entities": []}], ["MACLD patients with chronic PA infection exhibited significantly higher SGRQ scores, indicating impaired HRQL.", {"entities": []}], ["Chronic PA infection was significantly associated with the severity of bronchiectasis.", {"entities": [[71, 85, "DISEASE"]]}], ["Enterovirus D68 (EV-D68) is an emerging virus known to cause sporadic disease and occasional epidemics of severe lower respiratory tract infection.", {"entities": []}], ["However, the true prevalence of infection with EV-D68 is unknown, due in part to the lack of a rapid and specific nucleic acid amplification test as well as the infrequency with which respiratory samples are analyzed by enterovirus surveillance programs.", {"entities": []}], ["During the 2014 EV-D68 epidemic in the United States, we noted an increased frequency of \u201clow-positive\u201d results for human rhinovirus (HRV) detected in respiratory tract samples using the GenMark Diagnostics eSensor respiratory viral panel, a multiplex PCR assay able to detect 14 known respiratory viruses but not enteroviruses.", {"entities": []}], ["We simultaneously noted markedly increased admissions to our Pediatric Intensive Care Unit for severe lower respiratory tract infections in patients both with and without a history of reactive airway disease.", {"entities": []}], ["Accordingly, we hypothesized that these \u201clow-positive\u201d RVP results were due to EV-D68 rather than rhinovirus infection.", {"entities": []}], ["Sequencing of the picornavirus 5\u2019 untranslated region (5\u2019-UTR) of 49 samples positive for HRV by the GenMark RVP revealed that 33 (67.3%) were in fact EV-D68.", {"entities": []}], ["Notably, the mean intensity of the HRV RVP result was significantly lower in the sequence-identified EV-D68 samples (20.3 nA) compared to HRV (129.7 nA).", {"entities": []}], ["Using a cut-off of 40 nA for the differentiation of EV-D68 from HRV resulted in 94% sensitivity and 88% specificity.", {"entities": []}], ["The robust diagnostic characteristics of our data suggest that the cross-reactivity of EV-D68 and HRV on the GenMark Diagnostics eSensor RVP platform may be an important factor to consider in making accurate molecular diagnosis of EV-D68 at institutions utilizing this system or other molecular respiratory platforms that may also cross-react.", {"entities": []}], ["Air pollution can influence women\u2019s reproductive health, specifically menstrual cycle characteristics, oocyte quality, and risk of miscarriage.", {"entities": []}], ["The aim of the study was to assess whether air pollution can affect the length of the overall menstrual cycle and the length of its phases (follicular and luteal).", {"entities": []}], ["Municipal ecological monitoring data was used to assess the air pollution exposure during the monitored menstrual cycle of each of 133 woman of reproductive age.", {"entities": []}], ["Principal component analyses were used to group pollutants (PM 10 , SO 2 , CO, and NO x ) to represent a source-related mixture.", {"entities": []}], ["PM 10 and SO 2 assessed separately negatively affected the length of the luteal phase after standardization (b = \u22120.02; p = 0.03; b = \u22120.06; p = 0.02, respectively).", {"entities": []}], ["Representing a fossil fuel combustion emission, they were also associated with luteal phase shortening (b = \u22120.32; p = 0.02).", {"entities": []}], ["These pollutants did not affect the follicular phase length and overall cycle length, neither in single- nor in multi-pollutant models.", {"entities": []}], ["CO and NO x assessed either separately or together as a traffic emission were not associated with overall cycle length or the length of cycle phases.", {"entities": []}], ["Luteal phase shortening, a possible manifestation of luteal phase deficiency, can result from fossil fuel combustion.", {"entities": []}], ["This suggests that air pollution may contribute to fertility problems in women.", {"entities": []}], ["Missing data are unavoidable in environmental epidemiologic surveys.", {"entities": []}], ["The aim of this study was to compare methods for handling large amounts of missing values: omission of missing values, single and multiple imputations (through linear regression or partial least squares regression), and a fully Bayesian approach.", {"entities": []}], ["These methods were applied to the PARIS birth cohort, where indoor domestic pollutant measurements were performed in a random sample of babies' dwellings.", {"entities": []}], ["A simulation study was conducted to assess performances of different approaches with a high proportion of missing values (from 50% to 95%).", {"entities": []}], ["Different simulation scenarios were carried out, controlling the true value of the association (odds ratio of 1.0, 1.2, and 1.4), and varying the health outcome prevalence.", {"entities": []}], ["When a large amount of data is missing, omitting these missing data reduced statistical power and inflated standard errors, which affected the significance of the association.", {"entities": []}], ["Single imputation underestimated the variability, and considerably increased risk of type I error.", {"entities": []}], ["All approaches were conservative, except the Bayesian joint model.", {"entities": []}], ["In the case of a common health outcome, the fully Bayesian approach is the most efficient approach (low root mean square error, reasonable type I error, and high statistical power).", {"entities": []}], ["Nevertheless for a less prevalent event, the type I error is increased and the statistical power is reduced.", {"entities": []}], ["The estimated posterior distribution of the OR is useful to refine the conclusion.", {"entities": []}], ["Among the methods handling missing values, no approach is absolutely the best but when usual approaches (e.g.", {"entities": []}], ["single imputation) are not sufficient, joint modelling approach of missing process and health association is more efficient when large amounts of data are missing.", {"entities": []}], ["Levamisole-induced vasculitis is a relatively new entity in people who use cocaine.", {"entities": [[19, 29, "DISEASE"]]}], ["We describe a 44-year-old woman with a history of cocaine use who presented with a complaint of a painful rash of 2-3 month\u2019s duration on her extremities, cheeks, nose, and earlobes.", {"entities": []}], ["She had not experienced fever, weight loss, alopecia, dry eyes, oral ulcers, photosensitivity, or arthralgia.", {"entities": [[44, 52, "DISEASE"]]}], ["Examination revealed tender purpuric eruptions with central necrosis on her nose, cheeks, earlobes, and extremities.", {"entities": []}], ["Laboratory investigations revealed neutropenia, an elevated erythrocyte sedimentation rate (ESR), presence of lupus anticoagulant, low complement component 3 (C3), and presence of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA).", {"entities": [[35, 46, "DISEASE"], [159, 161, "GENE"]]}], ["A urine toxicology screen was positive for cocaine, and gas chromatography\u2013mass spectrometry was positive for levamisole.", {"entities": []}], ["Skin biopsy showed leukocytoclastic vasculitis and small vessel thrombosis.", {"entities": [[36, 46, "DISEASE"]]}], ["Necrotic lesions of the nose led to its self-amputation.", {"entities": []}], ["Large bullae on the lower extremities ruptured, leading to wound infection and extensive necrosis that required multiple surgical debridements.", {"entities": []}], ["When necrosis progressed despite debridement, bilateral above-knee amputation of the legs was performed.", {"entities": []}], ["Once new lesions stopped appearing, the patient was discharged home.", {"entities": []}], ["Two months later, she had a recurrence related to cocaine use.", {"entities": []}], ["To the best of our knowledge, this is only the second reported case of levamisole-induced vasculitis that required above-knee amputation.", {"entities": [[90, 100, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a major public health problem worldwide.", {"entities": []}], ["However, several studies that have assessed the role of traditional Chinese exercise in the management of this disease include broad variations in sample sizes and results.", {"entities": []}], ["Therefore, this meta-analysis was conducted to assess the effects of traditional Chinese exercise on patients with COPD.", {"entities": []}], ["Two investigators independently identified and extracted data from selected articles.", {"entities": []}], ["A computerized search of electronic databases through August 2015 was conducted.", {"entities": []}], ["Mean differences (MDs) and 95% confidence intervals (CIs) were calculated to analyze the combined data.", {"entities": []}], ["The methodological quality was evaluated using the Cochrane risk-of-bias tool.", {"entities": []}], ["Heterogeneity was assessed with the I Ten randomized, controlled trials (RCTs) involving 622 patients met the inclusion criteria.", {"entities": []}], ["There were significant improvements in the 6-minute walking distance test (6 MWD;MWD = 12.10 m; 95% CI, 7.56\u201316.65 m; p<0.001); forced expiratory volume in one second (FEV1% predicted; WMD = 9.02; 95% CI, 6.80\u201311.23; p<0.00001); forced expiratory volume in 1 second/forced vital capacity (FEV(1)/FVC) ratio (Tiffenau Index; WMD = 6.67; 95% CI, 5.09\u20138.24; p<0.00001); and quality of life, as evaluated by the Chronic Respiratory Disease Questionnaire (CRDQ; WMD = 0.85 score; 95% CI, 0.52\u20131.18; p<0.00001).", {"entities": [[289, 292, "GENE"]]}], ["Traditional Chinese exercise could provide an effective alternative method for managing COPD.", {"entities": []}], ["Larger and higher-quality trials are required.", {"entities": []}], ["Youth Risk Behavior Survey (YRBS) data have rarely been analyzed at the subcounty level.", {"entities": []}], ["The purpose of this study was to explore the feasibility of such analysis and its potential to inform local policy and resource allocation.", {"entities": []}], ["We administered the 2009 YRBS to 5,860 students from 46 public middle and high schools in Duval County, Florida.", {"entities": []}], ["In addition to asking core questions, we asked a set of questions customized for local needs, including questions about zip codes.", {"entities": []}], ["These data were used to simulate subcounty areas consistent with areas identified by behavioral, morbidity, mortality, and health disparity surveillance.", {"entities": []}], ["We oversampled Duval County and used weighting procedures that adjusted for subcounty areas.", {"entities": []}], ["Many Duval County health risk behavior rates were higher than those for Florida overall but did not vary significantly within the county.", {"entities": []}], ["Physical activity and violence-related behaviors were exceptions that reflect major health disparities in parts of the county with a high proportion of racial/ethnic minorities.", {"entities": []}], ["This study demonstrated that collecting subcounty data in large metropolitan areas is feasible and that analysis of these data at the local level has implications for policy.", {"entities": []}], ["Some health risk behaviors were common across the county, indicating the need for health promotion and disease prevention programs at the school district level.", {"entities": []}], ["Other health risk behaviors were more prevalent in specific areas of the county and may have been exacerbated by state or local policies such as restrictions on physical education.", {"entities": []}], ["Health disparities remain a challenge throughout the country; reducing them will require more extensive data-driven problem solving at state and local levels.", {"entities": []}], ["The Dead Sea region, the lowest in the world at 410 meters below sea level, is considered a potent climatotherapy center for the treatment of different chronic diseases.", {"entities": []}], ["To assess the prevalence of chronic diseases and the quality of life of residents of the Dead Sea region compared with residents of the Ramat Negev region, which has a similar climate, but is situated 600 meters above sea level.", {"entities": []}], ["An observational study based on a self-administered questionnaire.", {"entities": []}], ["Data were collected from kibbutz (communal settlement) members in both regions.", {"entities": []}], ["Residents of the Dead Sea were the study group and of Ramat Negev were the control group.", {"entities": []}], ["We compared demographic characteristics, the prevalence of different chronic diseases and health-related quality of life (HRQOL) using the SF-36 questionnaire.", {"entities": []}], ["There was a higher prevalence of skin nevi and non-inflammatory rheumatic diseases (NIRD) among Dead Sea residents, but they had significantly higher HRQOL mean scores in general health (68.7 \u00b1 21 vs. 64.4 \u00b1 22, p = 0.023) and vitality (64.7 \u00b1 17.9 vs. 59.6 \u00b1 17.3, p = 0.001), as well as significantly higher summary scores: physical component score (80.7 \u00b1 18.2 vs. 78 \u00b1 18.6, p = 0.042), and mental component score (79 \u00b1 16.4 vs. 77.2 \u00b1 15, p = 0.02).", {"entities": []}], ["These results did not change after adjusting for social-demographic characteristics, health-related habits, and chronic diseases.", {"entities": []}], ["No significant difference between the groups was found in the prevalence of most chronic diseases, except for higher rates of skin nevi and NIRD among Dead Sea residents.", {"entities": []}], ["HRQOL was significantly higher among Dead Sea residents, both healthy or with chronic disease.", {"entities": []}], ["The aim of this study was to determine the molecular mechanisms of physalin F, an effective purified extract of Physalis angulata L. (Solanacae), in renal carcinoma A498 cells.", {"entities": [[149, 164, "DISEASE"], [155, 164, "DISEASE"]]}], ["Physalin F was observed to significantly induce cytotoxicity of three human renal carcinoma A498, ACHN, and UO-31 cells in a concentration-dependent manner; this was especially potent in A498 cells.", {"entities": [[76, 91, "DISEASE"], [82, 91, "DISEASE"]]}], ["The physalin F-induced cell apoptosis of A498 cells was characterized by MTT assay, nuclear DNA fragmentation and chromatin condensation.", {"entities": []}], ["Using flow cytometry analysis, physalin F induced A498 cell apoptosis as demonstrated by the accumulation of the sub-G1 phase in a concentration- and time-dependent manner.", {"entities": []}], ["Moreover, physalin F-mediated accumulation of reactive oxygen species (ROS) caused Bcl-2 family proteins, Bcl-2, and Bcl-xL degradation, which led to disruption of mitochondrial membrane potential and release of cytochrome c from the mitochondria into the cytosol.", {"entities": []}], ["These effects were associated with induction of caspase-3 and caspase-9 activity, which led to poly(ADP-ribose) polymerase cleavage.", {"entities": []}], ["However, the antioxidant N -acetyl- L -cysteine (NAC) and glutathione (GSH) resulted in the inhibition of these events and reversed physalin F-induced cell apoptosis.", {"entities": []}], ["In addition, physalin F suppressed NF-\u03baB activity and nuclear translocation of p65 and p50, which was reversed by NAC and GSH.", {"entities": []}], ["Physalin F induced cell apoptosis through the ROS-mediated mitochondrial pathway and suppressed NF-\u03baB activation in human renal cancer A498 cells.", {"entities": [[128, 134, "DISEASE"]]}], ["Thus, physalin F appears to be a promising anti-cancer agent worthy of further clinical development.", {"entities": [[48, 54, "DISEASE"]]}], ["VEGF dampens the expression of microRNA-1, which drives inflammation in part via increasing the expression of Mpl.", {"entities": [[110, 113, "GENE"]]}], ["Asthma, the prototypic Th2-mediated inflammatory disorder of the lung, is an emergent disease worldwide.", {"entities": [[0, 6, "DISEASE"]]}], ["Vascular endothelial growth factor (VEGF) is a critical regulator of pulmonary Th2 inflammation, but the underlying mechanism and the roles of microRNAs (miRNAs) in this process have not been defined.", {"entities": []}], ["Here we show that lung-specific overexpression of VEGF decreases miR-1 expression in the lung, most prominently in the endothelium, and a similar down-regulation occurs in lung endothelium in Th2 inflammation models.", {"entities": []}], ["Intranasal delivery of miR-1 inhibited inflammatory responses to ovalbumin, house dust mite, and IL-13 overexpression.", {"entities": []}], ["Blocking VEGF inhibited Th2-mediated lung inflammation, and this was restored by antagonizing miR-1.", {"entities": []}], ["Using mRNA arrays, Argonaute pull-down assays, luciferase expression assays, and mutational analysis, we identified Mpl as a direct target of miR-1 and showed that VEGF controls the expression of endothelial Mpl during Th2 inflammation via the regulation of miR-1.", {"entities": [[116, 119, "GENE"], [208, 211, "GENE"], [116, 119, "GENE"], [208, 211, "GENE"]]}], ["In vivo knockdown of Mpl inhibited Th2 inflammation and indirectly inhibited the expression of P-selectin in lung endothelium.", {"entities": [[21, 24, "GENE"]]}], ["These experiments define a novel VEGF\u2013miR-1\u2013Mpl\u2013P-selectin effector pathway in lung Th2 inflammation and herald the utility of miR-1 and Mpl as potential therapeutic targets for asthma.", {"entities": [[178, 184, "DISEASE"], [44, 47, "GENE"], [137, 140, "GENE"]]}], ["We have reported 1-year outcomes and antacid medication use in 100 patients undergoing laparoscopic Nissen fundoplication.", {"entities": []}], ["As a follow-up study, we queried these same patients to determine whether their outcomes endured 4 years after fundoplication.", {"entities": []}], ["One hundred patients undergoing laparoscopic Nissen fundoplication between 1992 and 1997 were asked, at 1 to 2 years and 4 to 6 years postoperatively, to grade their symptoms on a scale of 1 (mild) to 10 (severe).", {"entities": []}], ["Patients were also queried as to the number/cost of antacid medications used before and after fundoplication.", {"entities": []}], ["Significant improvements were noted in symptoms of heartburn, postprandial emesis, gas/bloating, and dysphagia after fundoplication.", {"entities": []}], ["Significant decreases in antacid medication use (97%vs 19%) and monthly costs ($168\u00b1$91 vs $30\u00b1$54) were seen following fundoplication.", {"entities": []}], ["The number of patients on antacid medications and the monthly costs of these medications (37%and $53\u00b1$87, respectively) increased significantly from early to late follow-up, but were still significantly lower than those before surgery.", {"entities": []}], ["Overall, 87%and 90%of patients were pleased with their outcome at early and late follow-up, respectively, and 93%and 92%of patients stated they would consider undergoing fundoplication again if necessary ( P =NS).", {"entities": []}], ["Laparoscopic Nissen fundoplication results in a significant reduction in the symptoms of reflux and the use of antacid medications with a high degree of patient satisfaction.", {"entities": []}], ["Although some patients return to antacid medications at late follow-up, they continue to have few symptoms and are pleased with their outcomes.", {"entities": []}], ["Intensive care is generally regarded as expensive, and as a result beds are limited.", {"entities": []}], ["This has raised serious questions about rationing when there are insufficient beds for all those referred.", {"entities": []}], ["However, the evidence for the cost effectiveness of intensive care is weak and the work that does exist usually assumes that those who are not admitted do not survive, which is not always the case.", {"entities": []}], ["Randomised studies of the effectiveness of intensive care are difficult to justify on ethical grounds; therefore, this observational study examined the cost effectiveness of ICU admission by comparing patients who were accepted into ICU after ICU triage to those who were not accepted, while attempting to adjust such comparison for confounding factors.", {"entities": []}], ["This multi-centre observational cohort study involved 11 hospitals in 7 EU countries and was designed to assess the cost effectiveness of admission to intensive care after ICU triage.", {"entities": []}], ["A total of 7,659 consecutive patients referred to the intensive care unit (ICU) were divided into those accepted for admission and those not accepted.", {"entities": []}], ["The two groups were compared in terms of cost and mortality using multilevel regression models to account for differences across centres, and after adjusting for age, Karnofsky score and indication for ICU admission.", {"entities": []}], ["The analyses were also stratified by categories of Simplified Acute Physiology Score (SAPS) II predicted mortality (< 5%, 5% to 40% and >40%).", {"entities": []}], ["Cost effectiveness was evaluated as cost per life saved and cost per life-year saved.", {"entities": []}], ["Admission to ICU produced a relative reduction in mortality risk, expressed as odds ratio, of 0.70 (0.52 to 0.94) at 28 days.", {"entities": []}], ["When stratified by predicted mortality, the odds ratio was 1.49 (0.79 to 2.81), 0.7 (0.51 to 0.97) and 0.55 (0.37 to 0.83) for <5%, 5% to 40% and >40% predicted mortality, respectively.", {"entities": []}], ["Average cost per life saved for all patients was $103,771 (\u20ac82,358) and cost per life-year saved was $7,065 (\u20ac5,607).", {"entities": []}], ["These figures decreased substantially for patients with predicted mortality higher than 40%, $60,046 (\u20ac47,656) and $4,088 (\u20ac3,244), respectively.", {"entities": []}], ["Results were very similar when considering three-month mortality.", {"entities": []}], ["Sensitivity analyses performed to assess the robustness of the results provided findings similar to the main analyses.", {"entities": []}], ["Not only does ICU appear to produce an improvement in survival, but the cost per life saved falls for patients with greater severity of illness.", {"entities": []}], ["This suggests that intensive care is similarly cost effective to other therapies that are generally regarded as essential.", {"entities": []}], ["PM 2.5 is the main particulate air pollutant whose aerodynamic diameter is less than 2.5 micron.", {"entities": []}], ["The inflammation of various respiratory diseases are associated with PM 2.5 inhalation.", {"entities": []}], ["Pro-inflammatory cytokine IL-1\u03b2 generated from effected cells usually plays a crucial role in many kinds of lung inflammatory reactions.", {"entities": []}], ["The exacerbation of Th immune responses are identified in some PM 2.5 related diseases.", {"entities": []}], ["To elucidate the underlying mechanism of PM 2.5 -induced acute lung inflammation, we exposed Balb/c mice to PM 2.5 intratracheally and established a mice model.", {"entities": []}], ["Acute lung inflammation and increased IL-1\u03b2 expression was observed after PM 2.5 instillation.", {"entities": []}], ["Regulatory factors of IL-1\u03b2 (TLR4/MyD88 signaling pathway and NLRP3 inflammasome) participated in this lung inflammatory response as well.", {"entities": [[62, 67, "GENE"]]}], ["Treatment with compound essential oils (CEOs) substantially attenuated PM 2.5 -induced acute lung inflammation.", {"entities": []}], ["The decreased IL-1\u03b2 and Th immune responses after CEOs treatment were significant.", {"entities": []}], ["PM 2.5 may increase the secretion of IL-1\u03b2 through TLR4/MyD88 and NLRP3 pathway resulting in murine airway inflammation.", {"entities": [[66, 71, "GENE"]]}], ["CEOs could attenuate the lung inflammation by reducing IL-1\u03b2 and Th immune responses in this model.", {"entities": []}], ["This study describes a potentially important mechanism of PM 2.5 -induced acute lung inflammation and that may bring about novel therapies for the inflammatory diseases associated with PM 2.5 inhalation.", {"entities": []}], ["A subset of patients hospitalized with acute heart failure experiences worsening clinical status and requires escalation of therapy.", {"entities": []}], ["Worsening heart failure is an end point in many clinical trials, but little is known about its prevalence in clinical practice and its associated outcomes.", {"entities": []}], ["We analyzed inpatient data from the Acute Decompensated Heart Failure National Registry linked to Medicare claims to examine the prevalence and outcomes of patients with worsening heart failure, defined as the need for escalation of therapy at least 12 hours after hospital presentation.", {"entities": []}], ["We compared patients with worsening heart failure to patients with an uncomplicated hospital course and patients with a complicated presentation.", {"entities": []}], ["Of 63 727 patients hospitalized with acute heart failure, 11% developed worsening heart failure.", {"entities": []}], ["These patients had the highest observed rates of mortality, all\u2010cause readmission, and Medicare payments at 30 days and 1 year after hospitalization ( P < 0.001 for all comparisons).", {"entities": []}], ["The adjusted hazards of 30\u2010day mortality were 2.56 (99% CI, 2.34 to 2.80) compared with an uncomplicated course and 1.29 (99% CI, 1.17 to 1.42) compared with a complicated presentation.", {"entities": []}], ["The adjusted cost ratios for postdischarge Medicare payments at 30 days were 1.35 (99% CI, 1.24 to 1.46) compared with an uncomplicated course and 1.11 (99% CI, 1.02 to 1.22) compared with a complicated presentation.", {"entities": []}], ["In\u2010hospital worsening heart failure was common and was associated with higher rates of mortality, all\u2010cause readmission, and postdischarge Medicare payments.", {"entities": []}], ["Prevention and treatment of in\u2010hospital worsening heart failure represents an important goal for patients hospitalized with acute heart failure.", {"entities": []}], ["The complement components C8\u03b1, C8\u03b2 and C9 have important roles in the innate immune system against invading microorganisms.", {"entities": [[39, 41, "GENE"]]}], ["Partial cDNA sequences of the Pf_C8\u03b1 , Pf_C8\u03b2 and Pf_C9 genes ( Pf : abbreviation of Pelteobagrus fulvidraco ) were cloned from yellow catfish.", {"entities": []}], ["The Pf_C8\u03b1 , Pf_C8\u03b2 and Pf_C9 genes showed the greatest amino acid similarity to C8\u03b1 (54%) and C8\u03b2 (62%) of zebrafish and to C9 (52%) of grass carp, respectively.", {"entities": [[125, 127, "GENE"]]}], ["Ontogenetic expression analyses using real-time quantitative PCR suggested that the three genes may play crucial roles during embryonic and early larval development.", {"entities": []}], ["The mRNA expressions of the three genes were all at the highest levels in liver tissue, and at lower or much lower levels in 16 other tissues, demonstrating that the liver is the primary site for the protein synthesis of Pf_ C8\u03b1, Pf_ C8\u03b2 and Pf_ C9.", {"entities": [[246, 248, "GENE"]]}], ["Injection of Aeromonas hydrophila led to up-regulation of the three genes in the spleen, head kidney, kidney, liver and blood tissues, indicating that the three genes may contribute to the host\u2019s defense against invading pathogenic microbes.", {"entities": []}], ["An increased understanding of the functions of the Pf_C8\u03b1 , Pf_C8\u03b2 and Pf_C9 genes in the innate immunity of yellow catfish will help enhance production of this valuable freshwater species.", {"entities": []}], ["Regeneration of the epithelium of mammalian lungs is essential for restoring normal function following injury, and various cells and mechanisms contribute to this regeneration and repair.", {"entities": []}], ["Club cells, bronchioalveolar stem cells (BASCs), and alveolar type II epithelial cells (ATII) are dominant stem/progenitor cells for maintaining epithelial turnover and repair.", {"entities": []}], ["Epithelial Na", {"entities": []}], ["Atopy is known to play an important role in the asthmatic disease.", {"entities": []}], ["The main objective of this study was to evaluate the frequency of sensitisation to common aeroallergens in a cohort of asthmatics with different inflammatory phenotypes and disease severity.", {"entities": []}], ["We have conducted a retrospective cross\u2010sectional study including 772 asthmatics recruited between 2003 and 2014 in our Asthma Clinic.", {"entities": [[120, 126, "DISEASE"]]}], ["The patients were defined as asthmatics on the basis of respiratory symptoms together with a positive methacholine test (PC20M) < 16 mg/ml and/or a reversibility to short\u2010acting \u03b22\u2010agonists (salbutamol) \u2265 12% and 200 ml.", {"entities": []}], ["Sensitisation to house dust mites, grass and birch pollens, cats, dogs and moulds was assessed by RAST and a specific immunoglobulin E (IgE) > 0.35 kU/l was considered as significant.", {"entities": []}], ["Inflammatory phenotypes were subdivided between pauci\u2010granulocytic ( n = 309) (40%), eosinophilic ( n = 311) (40%), neutrophilic ( N = 134) (17%) and mixed\u2010granulocytic ( N = 18) (3%) asthmatics.", {"entities": []}], ["Severe asthmatics ( n = 118) were defined according to the American Thoracic Society (ATS 2000) criteria and compared with mild\u2010to\u2010moderate asthmatics ( N = 654).", {"entities": []}], ["The eosinophilic phenotype was associated with higher levels of total serum IgE compared with neutrophilic and pauci\u2010granulocytic asthma (p < 0.001 for both).", {"entities": [[130, 136, "DISEASE"]]}], ["Sensitisation rate to dogs and cats was higher in eosinophilic asthmatics (31% and 37%, respectively, p < 0.01 both) compared with neutrophilic (18% and 23% respectively) and pauci\u2010granulocytic asthmatics (20% and 24%, respectively), while sensitisation rate to house dust mites and moulds were rather similar between the groups (ranging from 33% to 40% and from 10% to 16%, respectively).", {"entities": []}], ["Severe asthmatics had slightly increased total serum IgE compared with mild\u2010to\u2010moderate asthmatics (p < 0.05) without any difference in the sensitisation rate to common aeroallergens.", {"entities": []}], ["Eosinophilic asthma exhibits higher total serum IgE and sensitisation rate towards animal dander while clinical severity, though also associated with higher total IgE, did not preferentially relate to any type of common aeroallergens.", {"entities": [[13, 19, "DISEASE"]]}], ["Parkinson\u2019s Disease (PD) is the second most common neurodegenerative disorder of the central nervous system.", {"entities": []}], ["Motor symptoms are the focus of pharmacotherapy, yet non-motor features of the disease (e.g.", {"entities": []}], ["fatigue, mood disturbances, sleep disturbances and symptoms of anxiety) are both common and disabling for the patient.", {"entities": []}], ["The pathophysiological mechanisms behind the non-motor symptoms in PD are yet to be untangled.", {"entities": []}], ["The main objective of this study was to investigate associations between pro-inflammatory substances and non-motor symptoms in patients with PD.", {"entities": []}], ["We measured C-reactive protein, interleukin (IL)-6, soluble IL-2 receptor (sIL-2R) and tumor necrosis factor-\u03b1 (TNF-\u03b1) in blood samples from PD patients (n\u200a=\u200a86) and healthy controls (n\u200a=\u200a40).", {"entities": []}], ["Symptoms of fatigue, depression, anxiety and sleeping difficulties were assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT), the Hospital Anxiety and Depression Scale (HAD), and the Scales for Outcome in PD-Sleep Scale respectively.", {"entities": []}], ["IL-6 was significantly higher in PD patients than in healthy controls.", {"entities": []}], ["Compared to healthy controls, PD patients displayed significantly higher mean scores on HAD and lower scores on FACIT, thus indicating more severe symptoms as measured with these scales.", {"entities": []}], ["Within the PD sample, high levels of both sIL-2R and TNF-\u03b1 were significantly associated with more severe symptoms assessed by means of FACIT and HAD (depression and anxiety subscales).", {"entities": []}], ["SIL-2-R levels were able to significantly predict FACIT and HAD scores after the effects of age, gender, anti-parkinsonian medications, and severity of motor symptoms were controlled for.", {"entities": []}], ["We suggest that non-motor symptoms in PD patients, such as fatigue and depressive symptoms, might be generated via inflammatory mechanisms.", {"entities": []}], ["This knowledge might contribute to the development of novel treatment options in PD, specifically targeting non-motor symptoms.", {"entities": []}], ["The work of care for parents of children with complex special health care needs may be increasing, while excessive work demands may erode the quality of care.", {"entities": []}], ["We sought to summarize knowledge and develop a general conceptual model of the work of care.", {"entities": []}], ["Systematic review of peer-reviewed journal articles that focused on parents of children with special health care needs and addressed factors related to the physical and emotional work of providing care for these children.", {"entities": []}], ["From the large pool of eligible articles, we selected articles in a randomized sequence, using qualitative techniques to identify the conceptual components of the work of care and their relationship to the family system.", {"entities": []}], ["The work of care for a child with special health care needs occurs within a dynamic system that comprises 5 core components: (1) performance of tasks such as monitoring symptoms or administering treatments, (2) the occurrence of various events and the pursuit of valued outcomes regarding the child's physical health, the parent's mental health, or other attributes of the child or family, (3) operating with available resources and within certain constraints (4) over the passage of time , (5) while mentally representing or depicting the ever-changing situation and detecting possible problems and opportunities.", {"entities": []}], ["These components interact, some with simple cause-effect relationships and others with more complex interdependencies.", {"entities": []}], ["The work of care affecting the health of children with special health care needs and their families can best be understood, studied, and managed as a multilevel complex system.", {"entities": []}], ["Reactive airways disease in children is increasing in many countries around the world.", {"entities": []}], ["The clinical diagnosis of asthma or reactive airways disease includes a variable airflow and an increased sensitivity in the airways.", {"entities": [[26, 32, "DISEASE"]]}], ["This condition can develop after an augmented reaction to a specific agent (allergen) and may cause a life-threatening situation within a very short period of exposure.", {"entities": []}], ["It can also develop after a long-term exposure to irritating agents that cause an inflammation in the airways in the absence of an allergen.", {"entities": []}], ["(paragraph) Several environmental agents have been shown to be associated with the increased incidence of childhood asthma.", {"entities": [[116, 122, "DISEASE"]]}], ["They include allergens, cat dander, outdoor as well as indoor air pollution, cooking fumes, and infections.", {"entities": []}], ["There is, however, increasing evidence that mold growth indoors in damp buildings is an important risk factor.", {"entities": []}], ["About 30 investigations from various countries around the world have demonstrated a close relationship between living in damp homes or homes with mold growth, and the extent of adverse respiratory symptoms in children.", {"entities": []}], ["Some studies show a relation between dampness/mold and objective measures of lung function.", {"entities": []}], ["Apart from airways symptoms, some studies demonstrate the presence of general symptoms that include fatigue and headache and symptoms from the central nervous system.", {"entities": []}], ["At excessive exposures, an increased risk for hemorraghic pneumonia and death among infants has been reported.", {"entities": [[58, 67, "DISEASE"]]}], ["(paragraph) The described effects may have important consequences for children in the early years of life.", {"entities": []}], ["A child's immune system is developing from birth to adolescence and requires a natural, physiologic stimulation with antigens as well as inflammatory agents.", {"entities": []}], ["Any disturbances of this normal maturing process will increase the risk for abnormal reactions to inhaled antigens and inflammagenic agents in the environment.", {"entities": []}], ["(paragraph) The knowledge about health risks due to mold exposure is not widespread and health authorities in some countries may not be aware of the serious reactions mold exposure can provoke in some children.", {"entities": []}], ["Individual physicians may have difficulty handling the patients because of the lack of recognition of the relationship between the often complex symptoms and the indoor environment (paragraph) The workshop was organized to develop a basis for risk assessment and formulation of recommendations, particularly for diagnostic purposes and prevention, and to formulate priorities for future research.", {"entities": []}], ["The participants were all active researchers with current experience in child health, molds, and respiratory disease.", {"entities": []}], ["They were engaged in free and intensive discussions on a scientific basis throughout the duration of the 3-day workshop (paragraph) This monograph contains peer-reviewed papers based on individual presentations at the workshop as well as the workshop conclusions.", {"entities": []}], ["They are offered to the public health community, administrators, research agencies, physicians, particularly pediatricians, nurses and health workers as information and encouragement to engage themselves in this health problem of importance for the next generation in our population.", {"entities": []}], ["(paragraph) Acknowledgments: The workshop received financial support from the U.S. Environmental Protection Agency, the National Center for Environmental Assessment at the U.S. EPA, the Vardal Foundation (Sweden), Astra Corp (Sweden), the Committee on Organic Dusts, International Commission on Occupational Health.", {"entities": []}], ["The printing of this document was made possible by a grant from the Center for Indoor Air Research (U.S.).", {"entities": []}], ["Yvonne Peterson, research secretary, provided excellent and invaluable assistance in the organization and publication efforts.", {"entities": []}], ["Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by unexplained persistent fatigue, commonly accompanied by cognitive dysfunction, sleeping disturbances, orthostatic intolerance, fever, lymphadenopathy, and irritable bowel syndrome (IBS).", {"entities": [[235, 259, "DISEASE"], [26, 50, "DISEASE"], [42, 50, "DISEASE"], [251, 259, "DISEASE"], [8, 25, "DISEASE"]]}], ["The extent to which the gastrointestinal microbiome and peripheral inflammation are associated with ME/CFS remains unclear.", {"entities": []}], ["We pursued rigorous clinical characterization, fecal bacterial metagenomics, and plasma immune molecule analyses in 50 ME/CFS patients and 50 healthy controls frequency-matched for age, sex, race/ethnicity, geographic site, and season of sampling.", {"entities": []}], ["Topological analysis revealed associations between IBS co-morbidity, body mass index, fecal bacterial composition, and bacterial metabolic pathways but not plasma immune molecules.", {"entities": []}], ["IBS co-morbidity was the strongest driving factor in the separation of topological networks based on bacterial profiles and metabolic pathways.", {"entities": []}], ["Predictive selection models based on bacterial profiles supported findings from topological analyses indicating that ME/CFS subgroups, defined by IBS status, could be distinguished from control subjects with high predictive accuracy.", {"entities": []}], ["Bacterial taxa predictive of ME/CFS patients with IBS were distinct from taxa associated with ME/CFS patients without IBS.", {"entities": []}], ["Increased abundance of unclassified Alistipes and decreased Faecalibacterium emerged as the top biomarkers of ME/CFS with IBS; while increased unclassified Bacteroides abundance and decreased Bacteroides vulgatus were the top biomarkers of ME/CFS without IBS.", {"entities": []}], ["Despite findings of differences in bacterial taxa and metabolic pathways defining ME/CFS subgroups, decreased metabolic pathways associated with unsaturated fatty acid biosynthesis and increased atrazine degradation pathways were independent of IBS co-morbidity.", {"entities": []}], ["Increased vitamin B6 biosynthesis/salvage and pyrimidine ribonucleoside degradation were the top metabolic pathways in ME/CFS without IBS as well as in the total ME/CFS cohort.", {"entities": []}], ["In ME/CFS subgroups, symptom severity measures including pain, fatigue, and reduced motivation were correlated with the abundance of distinct bacterial taxa and metabolic pathways.", {"entities": []}], ["Independent of IBS, ME/CFS is associated with dysbiosis and distinct bacterial metabolic disturbances that may influence disease severity.", {"entities": []}], ["However, our findings indicate that dysbiotic features that are uniquely ME/CFS-associated may be masked by disturbances arising from the high prevalence of IBS co-morbidity in ME/CFS.", {"entities": []}], ["These insights may enable more accurate diagnosis and lead to insights that inform the development of specific therapeutic strategies in ME/CFS subgroups.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-017-0261-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Parasites are accomplished evaders of host immunity.", {"entities": []}], ["Their evasion strategies have shaped every facet of the immune system, driving diversity within gene families and immune gene polymorphisms within populations.", {"entities": []}], ["New studies published recently in BMC Biology and Journal of Experimental Medicine document parasite-associated immunosuppression in natural populations and suggest that host genetic variants favoring resistance to parasites may be detrimental in the absence of infection.", {"entities": []}], ["Associations between air pollution and a multitude of health effects are now well established.", {"entities": []}], ["Given ubiquitous exposure to some level of air pollution, the attributable health burden can be high, particularly for susceptible populations.", {"entities": []}], ["An international multidisciplinary workshop was convened to discuss evidence of the effectiveness of actions to reduce health impacts of air pollution at both the community and individual level.", {"entities": []}], ["The overall aim was to summarize current knowledge regarding air pollution exposure and health impacts leading to public health recommendations.", {"entities": []}], ["During the workshop, experts reviewed the biological mechanisms of action of air pollution in the initiation and progression of disease, as well as the state of the science regarding community and individual-level interventions.", {"entities": []}], ["The workshop highlighted strategies to reduce individual baseline risk of conditions associated with increased susceptibility to the effects of air pollution and the need to better understand the role of exposure duration in disease progression, reversal, and adaptation.", {"entities": []}], ["We have identified two promising and largely unexplored strategies to address and mitigate air pollution\u2013related health impacts: reducing individual baseline risk of cardiovascular disease and incorporating air pollution\u2013related health impacts into land-use decisions.", {"entities": []}], ["Asthma deaths are a barometer of the quality of asthma care.", {"entities": [[0, 6, "DISEASE"], [48, 54, "DISEASE"]]}], ["The principal care for patients with severe asthma is often a joint partnership between primary and secondary services.", {"entities": [[44, 50, "DISEASE"]]}], ["Communication between the two services determines the effectiveness of treatment.", {"entities": []}], ["Undertaking an audit on asthma in either primary or separately in secondary care is a relatively straightforward process.", {"entities": [[24, 30, "DISEASE"]]}], ["However, when the audit spans both primary and secondary care in a country as large as the United Kingdom which is further sub-divided into the separate healthcare systems of England, Wales, Scotland, and Northern Island, then the audit becomes considerably more challenging.", {"entities": []}], ["The National Review of Asthma Deaths (NRAD) reported in May 2014 was a confidential enquiry tasked with identifying circumstances surrounding asthma deaths across the whole of the UK, in order to ascertain avoidable factors and make recommendations to improve care and reduce future asthma deaths (Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report, 2014, http://www.rcplondon.ac.uk/sites/default/files/why-asthma-still-kills-full-report.pdf ).", {"entities": [[23, 29, "DISEASE"], [142, 148, "DISEASE"], [283, 289, "DISEASE"], [302, 308, "DISEASE"], [345, 351, "DISEASE"], [452, 458, "DISEASE"]]}], ["The idea for NRAD arose from a longstanding East of England confidential enquiry started in 1988 by Dr Brian Harrison and then handed onto me in 2001 until funding for the national review of asthma deaths was secured in 2010.", {"entities": [[191, 197, "DISEASE"]]}], ["Health care spending is overwhelmingly concentrated within a very small proportion of the population, referred to as the high-cost users (HCU).", {"entities": []}], ["To date, research on HCU has been limited in scope, focusing mostly on those characteristics available through administrative databases, which have been largely clinical in nature, or have relied on ecological measures of socio-demographics.", {"entities": []}], ["This study links population health surveys to administrative data, allowing for the investigation of a broad range of individual-level characteristics and provides a more thorough characterization of community-dwelling HCU across demographic, social, behavioral and clinical characteristics.", {"entities": []}], ["We linked three cycles of the Canadian Community Health Survey (CCHS) to medical claim data for the years 2003\u20132008 for Ontario, Canada.", {"entities": []}], ["Participants were ranked according to gradients of cost (Top 1%, Top 2-5%, Top 6-50% and Bottom 50%) and multinomial logistic regression was used to investigate a wide range of factors, including health behaviors and socio-demographics, likely associated with HCU status.", {"entities": []}], ["Using a total sample of 91,223 adults (18 and older), we found that HCU status was strongly associated with being older, having multiple chronic conditions, and reporting poorer self-perceived health.", {"entities": []}], ["Specifically, in the fully-adjusted model, poor self-rated health (vs. good) was associated with a 26-fold increase in odds of becoming a Top 1% HCU (vs. Bottom 50% user) [95% CI: (18.9, 36.9)].", {"entities": []}], ["Further, HCU tended to be of lower socio-economic status, former daily smokers, physically inactive, current non-drinkers, and obese.", {"entities": []}], ["The results of this study have provided valuable insights into the broader characteristics of community-dwelling HCU, including unique demographic and behavioral characteristics.", {"entities": []}], ["Additionally, strong associations with self-reported clinical variables, such as self-rated general and mental health, highlight the importance of the patient perspective for HCU.", {"entities": []}], ["These findings have the potential to inform policies for health care and public health, particularly in light of increasing decision-maker attention in the sustainability of the health care system, improving patient outcomes and, more generally, in order to achieve the common goal of improving population health outcomes.", {"entities": []}], ["Finding eligible studies for meta-analysis and systematic reviews relies on keyword-based searching as the gold standard, despite its inefficiency.", {"entities": []}], ["Searching based on direct citations is not sufficiently comprehensive.", {"entities": []}], ["We propose a novel strategy that ranks articles on their degree of co-citation with one or more \u201cknown\u201d articles before reviewing their eligibility.", {"entities": []}], ["In two independent studies, we aimed to reproduce the results of literature searches for sets of published meta-analyses ( n \u2009=\u200910 and n \u2009=\u200942).", {"entities": []}], ["For each meta-analysis, we extracted co-citations for the randomly selected \u2018known\u2019 articles from the Web of Science database, counted their frequencies and screened all articles with a score above a selection threshold.", {"entities": []}], ["In the second study, we extended the method by retrieving direct citations for all selected articles.", {"entities": []}], ["In the first study, we retrieved 82\u00a0% of the studies included in the meta-analyses while screening only 11\u00a0% as many articles as were screened for the original publications.", {"entities": []}], ["Articles that we missed were published in non-English languages, published before 1975, published very recently, or available only as conference abstracts.", {"entities": []}], ["In the second study, we retrieved 79\u00a0% of included studies while screening half the original number of articles.", {"entities": []}], ["Citation searching appears to be an efficient and reasonably accurate method for finding articles similar to one or more articles of interest for meta-analysis and reviews.", {"entities": []}], ["The online version of this article (doi:10.1186/s12874-015-0077-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Sphingosine kinase 1 (SphK1), a key enzyme responsible for phosphorylating sphingosine into sphingosine-1-phosphate (S1P) has been shown to be expressed in monocytes and monocyte-derived peripheral macrophages.", {"entities": [[22, 27, "GENE"]]}], ["This study demonstrates SphK1 immunoexpression in amoeboid microglial cells (AMC), a nascent monocyte-derived brain macrophage in the corpus callosum of developing rat brain.", {"entities": [[24, 29, "GENE"]]}], ["SphK1 immunofluorescence expression, which appeared to be weak in AMC in normal brain, was markedly induced by lipopolysaccharide (LPS) or hypoxia treatment.", {"entities": [[0, 5, "GENE"]]}], ["Western blot analysis also showed increased expression level of SphK1 in the corpus callosum rich in AMC after LPS treatment.", {"entities": [[64, 69, "GENE"]]}], ["Detection of SphK1 mRNA and its upregulation after LPS treatment was confirmed in primary culture AMC by RT-PCR.", {"entities": [[13, 18, "GENE"]]}], ["Administration of N, N-dimethylsphingosine (DMS), a specific inhibitor of SphK1, effectively reduced upregulated SphK1 immunoexpression in AMC both in vivo and in vitro .", {"entities": [[74, 79, "GENE"], [113, 118, "GENE"], [74, 79, "GENE"], [113, 118, "GENE"]]}], ["This was corroborated by western blot which showed a decrease in SphK1 protein level of callosal tissue with DMS pretreatment.", {"entities": [[65, 70, "GENE"]]}], ["Remarkably, LPS-induced upregulation of the transcription factor NF\u03baB was suppressed by DMS.", {"entities": []}], ["We conclude that SphK1 expression in AMC may be linked to regulation of proinflammatory cytokines via an NF\u03baB signaling pathway.", {"entities": [[17, 22, "GENE"]]}], ["G-protein-coupled receptor (GPCR) ligands function by stabilizing multiple, functionally distinct receptor conformations.", {"entities": []}], ["This property underlies how \u201cbiased agonists\u201d activate specific subsets of a given receptor\u2019s signaling profile.", {"entities": []}], ["However, stabilization of distinct active GPCR conformations to enable structural characterization of mechanisms underlying GPCR activation remains difficult.", {"entities": []}], ["These challenges have accentuated the need for receptor tools that allosterically stabilize and regulate receptor function via unique, previously unappreciated mechanisms.", {"entities": []}], ["Here, utilizing a highly diverse RNA library combined with advanced selection strategies involving state-of-the-art next-generation sequencing and bioinformatics analyses, we identify RNA aptamers that bind a prototypical GPCR, \u03b2 2 -adrenoceptor (\u03b2 2 AR).", {"entities": []}], ["Using biochemical, pharmacological, and biophysical approaches, we demonstrate that these aptamers bind with nanomolar affinity at defined surfaces of the receptor, allosterically stabilizing active, inactive, and ligand-specific receptor conformations.", {"entities": []}], ["The discovery of RNA aptamers as allosteric GPCR modulators significantly expands the diversity of ligands available to study the structural and functional regulation of GPCRs.", {"entities": []}], ["Regular physical activity has established physical and mental health benefits; however, merely one quarter of the U.S. adult population meets national physical activity recommendations.", {"entities": []}], ["In an effort to engage individuals who do not meet these guidelines, researchers have utilized popular emerging technologies, including mobile devices (ie, personal digital assistants [PDAs], mobile phones).", {"entities": []}], ["This study is the first to synthesize current research focused on the use of mobile devices for increasing physical activity.", {"entities": []}], ["To conduct a meta-analysis of research utilizing mobile devices to influence physical activity behavior.", {"entities": []}], ["The aims of this review were to: (1) examine the efficacy of mobile devices in the physical activity setting, (2) explore and discuss implementation of device features across studies, and (3) make recommendations for future intervention development.", {"entities": []}], ["We searched electronic databases (PubMed, PsychINFO, SCOPUS) and identified publications through reference lists and requests to experts in the field of mobile health.", {"entities": []}], ["Studies were included that provided original data and aimed to influence physical activity through dissemination or collection of intervention materials with a mobile device.", {"entities": []}], ["Data were extracted to calculate effect sizes for individual studies, as were study descriptives.", {"entities": []}], ["A random effects meta-analysis was conducted using the Comprehensive Meta-Analysis software suite.", {"entities": []}], ["Study quality was assessed using the quality of execution portion of the Guide to Community Preventative Services data extraction form.", {"entities": []}], ["Four studies were of \u201cgood\u201d quality and seven of \u201cfair\u201d quality.", {"entities": []}], ["In total, 1351 individuals participated in 11 unique studies from which 18 effects were extracted and synthesized, yielding an overall weight mean effect size of g = 0.54 (95% CI = 0.17 to 0.91, P = .01).", {"entities": []}], ["Research utilizing mobile devices is gaining in popularity, and this study suggests that this platform is an effective means for influencing physical activity behavior.", {"entities": []}], ["Our focus must be on the best possible use of these tools to measure and understand behavior.", {"entities": []}], ["Therefore, theoretically grounded behavior change interventions that recognize and act on the potential of smartphone technology could provide investigators with an effective tool for increasing physical activity.", {"entities": []}], ["Control of cytosolic calcium plays a key role in airway myocyte function.", {"entities": []}], ["Changes in intracellular Ca To investigate the roles of the STIM homologues in SOC activation in airway myocytes, specific siRNA sequences were utilised to target and selectively suppress both STIM1 and STIM2.", {"entities": [[193, 198, "GENE"], [203, 208, "GENE"]]}], ["Quantitative real time PCR was employed to assess the efficiency and the specificity of the siRNA mediated knockdown of mRNA.", {"entities": []}], ["Activation of SOC was investigated by both whole cell patch clamp electrophysiology and a fluorescence based calcium assay.", {"entities": []}], ["Transfection of 20 nM siRNA specific for STIM1 or 2 resulted in robust decreases (>70%) of the relevant mRNA.", {"entities": [[41, 46, "GENE"]]}], ["siRNA targeted at STIM1 resulted in a reduction of SOC associated Ca Here we show that STIM1 acts as a key signal for SOC activation following intracellular Ca", {"entities": [[18, 23, "GENE"], [87, 92, "GENE"], [18, 23, "GENE"], [87, 92, "GENE"]]}], ["Background .", {"entities": []}], ["Studies have documented that built environment factors potentially promote or impede leisure time physical activity (LTPA).", {"entities": []}], ["This study explored the relationship between multiple built environment factors and individual characteristics on LTPA.", {"entities": []}], ["Multiple data sources were utilized including individual level data for health behaviors and health status from the Nevada Behavioral Risk Factor Surveillance System (BRFSS) and community level data from different data sources including indicators for recreation facilities, safety, air quality, commute time, urbanization, population density, and land mix level.", {"entities": []}], ["Mixed model logistic regression and geographic information system (GIS) spatial analysis were conducted.", {"entities": []}], ["Among 6,311 respondents, 24.4% reported no LTPA engagement during the past 30 days.", {"entities": []}], ["No engagement in LTPA was significantly associated with (1) individual factors: older age, less education, lower income, being obesity, and low life satisfaction and (2) community factors: more commute time, higher crime rate, urban residence, higher population density, but not for density and distance to recreation facilities, air quality, and land mix.", {"entities": [[127, 134, "DISEASE"]]}], ["Conclusions .", {"entities": []}], ["Multiple data systems including complex population survey and spatial analysis are valuable tools on health and built environment studies.", {"entities": []}], ["Asthmatic inflammation is responsible for vital features of the disease, including bronchial hyperresponsiveness (BHR).", {"entities": []}], ["At present we do not have precise markers for monitoring asthmatic inflammation.", {"entities": []}], ["C-reactive protein (CRP), a marker of systemic inflammation, seemed to be a factor which could also reflect the level of asthmatic inflammation expressed by BHR.", {"entities": [[20, 23, "GENE"]]}], ["Therefore the relationship between CRP concentration and BHR was evaluated.", {"entities": [[35, 38, "GENE"]]}], ["One hundred and two patients entered the study.", {"entities": []}], ["A skin prick test with a broad spectrum of common aeroallergens as well as baseline spirometry and a histamine bronchoprovocation test were performed in each subject.", {"entities": []}], ["Blood samples for high-sensitivity CRP (hsCRP) measurement were taken before the bronchial challenge tests.", {"entities": [[35, 38, "GENE"]]}], ["Serum hsCRP concentrations ranged from 0.20 to 14.5 mg/l (median: 1.2 mg/l, 25\u201375% quartiles: 0.6\u20132.4).", {"entities": []}], ["Positive skin prick tests were found in 26 subjects.", {"entities": []}], ["Bronchial hyperresponsiveness was confirmed in 42 patients (first subgroup), while 60 subjects did not demonstrate BHR (second subgroup).", {"entities": []}], ["Among the patients with BHR, asthma was diagnosed in 33 cases and Corrao syndrome in 9.", {"entities": [[73, 81, "DISEASE"], [29, 35, "DISEASE"]]}], ["In both subgroups, serum hsCRP concentrations had similar levels (median: 1.4 mg/l, 25\u201375% quartiles: 0.8\u20132.4 and median: 0.9 mg/l, 25\u201375% quartiles: 0.5\u20132.8, respectively; p=0.297).", {"entities": []}], ["There was no statistically significant correlation (r= \u22120.163, p=0.302) between serum hsCRP concentration and the level of BHR expressed as the 20% provocative concentration for histamine.", {"entities": []}], ["In addition, hsCRP serum concentration, after adjustment for age, atopy, body mass index, and gender, was not a significant predictor of positive histamine bronchoprovocation test results (p=0.22, OR=0.86, 95% CI).", {"entities": []}], ["Serum hsCRP concentration is not a good marker of BHR, which is mainly dependent on asthmatic inflammation and is measured during bronchial challenge with histamine.", {"entities": []}], ["This finding is important for interpreting and discussing results obtained from epidemiological and population-based studies on relationships between either CRP concentration and BHR or local and systemic inflammation.", {"entities": [[157, 160, "GENE"]]}], ["Despite the widespread induction of miR-146a during the innate immune response little is known regarding its biogenesis, function and mechanism.", {"entities": [[36, 44, "GENE"]]}], ["We have therefore examined the role of miR-146a during the interleukin (IL)-1\u03b2-stimulated IL-6 and IL-8 release and proliferation in primary human airway smooth muscle (HASM) cells.", {"entities": [[39, 47, "GENE"]]}], ["HASM cells were isolated from human lung re-section, cultured to a maximum of 3 - 6 passages and then exposed to IL-1\u03b2.", {"entities": []}], ["miR-146a expression were determined by qRT-PCR, IL-6 and IL-8 release by ELISA and proliferation using bromodeoxyuridine incorporation.", {"entities": [[0, 8, "GENE"]]}], ["The role of NF-\u03baB and the MAP kinase pathways was assessed using pharmacological inhibitors of IKK2 (TPCA-1), JNK (SP600125), p38 MAP kinase (SB203580) and MEK-1/2 (PD98059).", {"entities": []}], ["miR-146a function was determined following transfection of HASM with inhibitors and mimics using Amaxa electroporation.", {"entities": [[0, 8, "GENE"]]}], ["IL-1\u03b2 induced a time-dependent and prolonged 100-fold induction in miR-146a expression, which correlated with release of IL-6 and IL-8.", {"entities": [[67, 75, "GENE"]]}], ["Exposure to IL-1\u03b2 had no effect upon HASM proliferation.", {"entities": []}], ["Pharmacological studies showed that expression of primary miR-146a was regulated at the transcriptional levels by NF-\u03baB whilst post-transcriptional processing to mature miR-146a was regulated by MEK-1/2 and JNK-1/2.", {"entities": [[58, 66, "GENE"], [169, 177, "GENE"], [58, 66, "GENE"], [169, 177, "GENE"]]}], ["Functional studies indicated that IL-1\u03b2-induced miR-146a expression does not negatively regulate IL-6 and IL-8 release or basal proliferation.", {"entities": [[48, 56, "GENE"]]}], ["However, inhibition of IL-1\u03b2-induced IL-6 and IL-8 release was observed at the super-maximal intracellular miR-146a levels obtained by transfection with miR-146a mimics and indicates that studies using miRNA mimics can produce false positive results.", {"entities": [[107, 115, "GENE"], [153, 161, "GENE"], [107, 115, "GENE"], [153, 161, "GENE"]]}], ["Mechanistic studies showed that in the presence of super-maximal levels, the action of miR-146a mimics was mediated at a step following IL-6 and IL-8 mRNA transcription and not through down-regulation of IL-1 receptor associated kinase 1 (IRAK-1) and TNF receptor-associated factor 6 (TRAF6) protein expression, two predicted miR-146a targets involved in IL-1\u03b2 signalling.", {"entities": [[87, 95, "GENE"], [326, 334, "GENE"], [251, 254, "GENE"], [285, 290, "GENE"], [87, 95, "GENE"], [326, 334, "GENE"]]}], ["We have shown that IL-1\u03b2-induced miR-146a expression in HASM and that this was regulated at the transcriptional level by NF-\u03baB and at the post-transcriptional level by the MEK-1/2 and JNK-1/2.", {"entities": [[33, 41, "GENE"]]}], ["Unlike previous reports, studies using miRNA inhibitors showed that miR-146a expression did not regulate IL-6 and IL-8 release or proliferation and suggest miR-146a function and mechanism is cell-type dependent.", {"entities": [[68, 76, "GENE"], [156, 164, "GENE"], [68, 76, "GENE"], [156, 164, "GENE"]]}], ["Paediatric inflammatory bowel disease (PIBD), comprising Crohn\u2019s disease (CD), ulcerative colitis (UC) and inflammatory bowel disease unclassified (IBDU) is a complex and multifactorial condition with increasing incidence.", {"entities": [[11, 37, "DISEASE"], [107, 133, "DISEASE"], [79, 97, "DISEASE"]]}], ["An accurate diagnosis of PIBD is necessary for a prompt and effective treatment.", {"entities": []}], ["This study utilises machine learning (ML) to classify disease using endoscopic and histological data for 287 children diagnosed with PIBD.", {"entities": []}], ["Data were used to develop, train, test and validate a ML model to classify disease subtype.", {"entities": []}], ["Unsupervised models revealed overlap of CD/UC with broad clustering but no clear subtype delineation, whereas hierarchical clustering identified four novel subgroups characterised by differing colonic involvement.", {"entities": []}], ["Three supervised ML models were developed utilising endoscopic data only, histological only and combined endoscopic/histological data yielding classification accuracy of 71.0%, 76.9% and 82.7% respectively.", {"entities": []}], ["The optimal combined model was tested on a statistically independent cohort of 48 PIBD patients from the same clinic, accurately classifying 83.3% of patients.", {"entities": []}], ["This study employs mathematical modelling of endoscopic and histological data to aid diagnostic accuracy.", {"entities": []}], ["While unsupervised modelling categorises patients into four subgroups, supervised approaches confirm the need of both endoscopic and histological evidence for an accurate diagnosis.", {"entities": []}], ["Overall, this paper provides a blueprint for ML use with clinical data.", {"entities": []}], ["Chitinases (EC.3.2.1.14) hydrolyze the \u03b2-1,4-linkages in chitin, an abundant N-acetyl-\u03b2-D-glucosamine polysaccharide that is a structural component of protective biological matrices such as insect exoskeletons and fungal cell walls.", {"entities": []}], ["The glycoside hydrolase 18 (GH18) family of chitinases is an ancient gene family widely expressed in archea, prokaryotes and eukaryotes.", {"entities": []}], ["Mammals are not known to synthesize chitin or metabolize it as a nutrient, yet the human genome encodes eight GH18 family members.", {"entities": []}], ["Some GH18 proteins lack an essential catalytic glutamic acid and are likely to act as lectins rather than as enzymes.", {"entities": []}], ["This study used comparative genomic analysis to address the evolutionary history of the GH18 multiprotein family, from early eukaryotes to mammals, in an effort to understand the forces that shaped the human genome content of chitinase related proteins.", {"entities": []}], ["Gene duplication and loss according to a birth-and-death model of evolution is a feature of the evolutionary history of the GH18 family.", {"entities": []}], ["The current human family likely originated from ancient genes present at the time of the bilaterian expansion (approx.", {"entities": []}], ["The family expanded in the chitinous protostomes C. elegans and D. melanogaster , declined in early deuterostomes as chitin synthesis disappeared, and expanded again in late deuterostomes with a significant increase in gene number after the avian/mammalian split.", {"entities": []}], ["This comprehensive genomic study of animal GH18 proteins reveals three major phylogenetic groups in the family: chitobiases, chitinases/chitolectins, and stabilin-1 interacting chitolectins.", {"entities": []}], ["Only the chitinase/chitolectin group is associated with expansion in late deuterostomes.", {"entities": []}], ["Finding that the human GH18 gene family is closely linked to the human major histocompatibility complex paralogon on chromosome 1, together with the recent association of GH18 chitinase activity with Th2 cell inflammation, suggests that its late expansion could be related to an emerging interface of innate and adaptive immunity during early vertebrate history.", {"entities": []}], ["There is a vast literature reporting that the point prevalence of low back pain (LBP) is high and increasing.", {"entities": [[81, 84, "GENE"]]}], ["It is also known that a large proportion of acute LBP episodes are recurrent within 12 months.", {"entities": [[50, 53, "GENE"]]}], ["However, few studies report the annual trends in the prevalence of recurrent LBP or describe these trends according to age and sex categories.", {"entities": [[77, 80, "GENE"]]}], ["We conducted a retrospective cohort study involving 401 264 adults selected from the administrative database of physician claims for the province of Quebec, Canada.", {"entities": []}], ["These adults, aged 18 years and over, met the criteria of having consulted a physician three times within a 365-day period between 2000 and 2007 for a LBP condition corresponding to ICD-9 codes 721, 722, 724 or 739.", {"entities": [[151, 154, "GENE"]]}], ["All data were analyzed by sex and clustered according to specific age categories.", {"entities": []}], ["We observed a decrease from 1.64% to 1.33% in the annual prevalence between 2000 and 2007 for men.", {"entities": []}], ["This decrease in prevalence was mostly observed between 35 and 59 years of age.", {"entities": []}], ["Older (\u226565 years) women were 1.35 times more at risk to consult a physician for LBP in a recurrent manner than older men.", {"entities": [[80, 83, "GENE"]]}], ["The most frequently reported diagnosis was non-specific LBP between 2000 to 2007.", {"entities": [[56, 59, "GENE"]]}], ["During the same period, sequelae of previous back surgery and spinal stenosis were the categories with the largest increases.", {"entities": [[62, 77, "DISEASE"]]}], ["The annual prevalence of claims-based recurrent LBP progressively decreased between 2000 and 2007 for younger adults (<65 years) while older adults (\u226565 years) showed an increase.", {"entities": [[48, 51, "GENE"]]}], ["Given the aging Canadian population, recurrent low back pain could have an increasing impact on the quality of life of the elderly as well as on the healthcare system.", {"entities": []}], ["Melatonin may have important immunostimulatory actions in allergic diseases, in addition to its well-known antioxidant and cytoprotective effects in several inflammatory conditions.", {"entities": []}], ["The activation of the immune system leads to free radical production associated with decreased melatonin levels and depressed antioxidant enzyme activities in several inflammatory diseases.", {"entities": []}], ["Many skin disorders, including atopic dermatitis, are accompanied by infiltration and activation of mast cells, which release vasoactive and proinflammatory mediators.", {"entities": [[31, 48, "DISEASE"], [38, 48, "DISEASE"]]}], ["Experimental data suggest that melatonin inhibits development of atopic eczema and reduces serum total IgE and IL-4.", {"entities": []}], ["Allergic asthma is a condition characterized by bronchial hyperresponsiveness and the presence of IgE antibodies in response to inhaled allergens; often there is also enhanced total serum IgE levels.", {"entities": [[9, 15, "DISEASE"]]}], ["Melatonin regulates smooth muscle tone and influences the immune response.", {"entities": []}], ["Melatonin may, however, act as a pro-inflammatory agent in asthma leading to bronchial constriction.", {"entities": [[59, 65, "DISEASE"]]}], ["The safety of melatonin as a sleep-inducing agent has been confirmed in asthmatic subjects, but its routine use is not recommended in bronchial asthma.", {"entities": [[144, 150, "DISEASE"]]}], ["This review summarizes what is known about the role of melatonin as an immunomodulatory agent in asthma and atopic eczema.", {"entities": [[97, 103, "DISEASE"]]}], ["Selective IgA deficiency (SIgAD) is the most common type of primary immunoglobulin deficiency.", {"entities": []}], ["Most individuals with SIgAD are asymptomatic.", {"entities": []}], ["However, some patients are associated with allergic and autoimmune disease.", {"entities": []}], ["SIgAD is included in the list of differential diagnoses of eosinophilia.", {"entities": [[59, 71, "DISEASE"]]}], ["We experienced a patient who initially presented with abdominal pain and eosinophilia.", {"entities": [[73, 85, "DISEASE"]]}], ["A >1-year follow-up revealed SIgAD, and we had difficulty differentiating it from Churg-Strauss syndrome (CSS) or hypereosinophilic syndrome (HES).", {"entities": [[96, 104, "DISEASE"], [132, 140, "DISEASE"]]}], ["A 66-year-old Japanese male presented with a history of recurrent abdominal pain.", {"entities": []}], ["A diagnostic work-up revealed eosinophilia, eosinophilic gastritis, eosinophilic pneumonia, and SIgAD over 1 year of clinical observation.", {"entities": [[44, 66, "DISEASE"], [57, 66, "DISEASE"], [81, 90, "DISEASE"], [68, 90, "DISEASE"], [30, 42, "DISEASE"]]}], ["He also suffered from asthma and sinusitis.", {"entities": [[33, 42, "DISEASE"], [22, 28, "DISEASE"]]}], ["Anti-neutrophil cytoplasmic antibody was negative and vasculitis was not detected in the obtained tissue specimens of stomach, lung, nose and skin.", {"entities": [[54, 64, "DISEASE"]]}], ["The patient showed no evidence of drug ingestion, parasitic infections, or malignant neoplasms.", {"entities": []}], ["Although we cannot rule out prevasculitic CSS and idiopathic HES, the whole clinical picture in this patient can be explained most consistently by SIgAD.", {"entities": []}], ["The epidemiology of cough in the elderly population has not been studied comprehensively.", {"entities": []}], ["The present study aimed to investigate the epidemiology of cough in a community elderly population, particularly in relation with their comorbidity.", {"entities": []}], ["A cross-sectional analysis was performed using a baseline dataset from the Korean Longitudinal Study on Health and Aging, a community-based elderly population cohort study.", {"entities": []}], ["Three types of cough (frequent cough, chronic persistent cough, and nocturnal cough) were defined using questionnaires.", {"entities": []}], ["Comorbidity was examined using a structured questionnaire.", {"entities": []}], ["Health-related quality of life was assessed using the Short Form 36 questionnaire.", {"entities": []}], ["The prevalence was 9.3% for frequent cough, 4.6% for chronic persistent cough, and 7.3% for nocturnal cough.", {"entities": []}], ["In multivariate logistic regression analyses, smoking, asthma and allergic rhinitis were found to be risk factors for cough in the elderly.", {"entities": [[66, 83, "DISEASE"], [75, 83, "DISEASE"], [55, 61, "DISEASE"]]}], ["Interestingly, among comorbidities, constipation and uncontrolled diabetes mellitus (HbA1c \u2265 8%) were also found to have positive associations with elderly cough.", {"entities": [[36, 48, "DISEASE"], [66, 83, "DISEASE"]]}], ["In the Short Form 36 scores, chronic persistent cough was independently related to impairment of quality of life, predominantly in the mental component.", {"entities": []}], ["Cough has a high prevalence and is detrimental to quality of life in the elderly.", {"entities": []}], ["Associations with smoking, asthma and rhinitis confirmed previous findings in younger populations.", {"entities": [[38, 46, "DISEASE"], [27, 33, "DISEASE"]]}], ["Previously unrecognised relationships with constipation and uncontrolled diabetes mellitus suggested the multi-faceted nature of cough in the elderly.", {"entities": [[43, 55, "DISEASE"], [73, 90, "DISEASE"]]}], ["The Magpie Trial, a randomised trial comparing magnesium sulphate with placebo for women with pre-eclampsia.", {"entities": [[98, 107, "DISEASE"], [94, 107, "DISEASE"]]}], ["This paper describes methods used for follow up in the UK, and presents additional data collected.", {"entities": []}], ["In the UK 774 women and their 827 children were included; excluded were women discharged without a surviving child and families who opted out.", {"entities": []}], ["General practitioners were sent a questionnaire when the child was around 18 months old.", {"entities": []}], ["When the child was two years, or older, questionnaires asking about the health of the women and children were posted to families.", {"entities": []}], ["A sample of families was offered a home visit, during which the child was assessed using the Bayley Scales of Infant Development.", {"entities": []}], ["Of the women, 12 were lost to follow up and three died.", {"entities": []}], ["Of the children, 12 were lost to follow up, 5 were excluded and 19 died.", {"entities": []}], ["General practitioners returned 688/759 (91%) questionnaires, as did 619/759 (82%) women.", {"entities": []}], ["Responses were largely comparable.", {"entities": []}], ["32 women had serious morbidity potentially related to pre-eclampsia.", {"entities": [[58, 67, "DISEASE"], [54, 67, "DISEASE"]]}], ["30% of children were reported to have been admitted to hospital.", {"entities": []}], ["There were no clear differences between the randomised groups in the child's behaviour, women's fertility or use of health service resources.", {"entities": []}], ["Data presented here provide further reassurance about the longer term safety of magnesium sulphate when used for women with pre-eclampsia.", {"entities": [[128, 137, "DISEASE"], [124, 137, "DISEASE"]]}], ["Postal questionnaires in the UK to assess the longer term health and wellbeing of women and children recruited to trials are feasible, and can achieve a high response rate.", {"entities": []}], ["Responses from families and general practitioners were comparable Trial registration number of the Magpie Trial [ISRCTN86938761]", {"entities": []}], ["Trypanosoma cruzi is the causative agent of the life-threatening Chagas disease, in which increased platelet aggregation related to myocarditis is observed.", {"entities": [[132, 143, "DISEASE"]]}], ["Platelet-activating factor (PAF) is a potent intercellular lipid mediator and second messenger that exerts its activity through a PAF-specific receptor (PAFR).", {"entities": []}], ["Previous data from our group suggested that T. cruzi synthesizes a phospholipid with PAF-like activity.", {"entities": []}], ["The structure of T. cruzi PAF-like molecule, however, remains elusive.", {"entities": []}], ["Here, we have purified and structurally characterized the putative T. cruzi PAF-like molecule by electrospray ionization-tandem mass spectrometry (ESI-MS/MS).", {"entities": []}], ["Our ESI-MS/MS data demonstrated that the T. cruzi PAF-like molecule is actually a lysophosphatidylcholine (LPC), namely sn -1 C18:1(delta 9)-LPC.", {"entities": []}], ["Similar to PAF, the platelet-aggregating activity of C18:1-LPC was abrogated by the PAFR antagonist, WEB 2086.", {"entities": []}], ["Other major LPC species, i.e., C16:0-, C18:0-, and C18:2-LPC, were also characterized in all T. cruzi stages.", {"entities": []}], ["These LPC species, however, failed to induce platelet aggregation.", {"entities": []}], ["Quantification of T. cruzi LPC species by ESI-MS revealed that intracellular amastigote and trypomastigote forms have much higher levels of C18:1-LPC than epimastigote and metacyclic trypomastigote forms.", {"entities": []}], ["C18:1-LPC was also found to be secreted by the parasite in extracellular vesicles (EV) and an EV-free fraction.", {"entities": []}], ["A three-dimensional model of PAFR was constructed and a molecular docking study was performed to predict the interactions between the PAFR model and PAF, and each LPC species.", {"entities": []}], ["Molecular docking data suggested that, contrary to other LPC species analyzed, C18:1-LPC is predicted to interact with the PAFR model in a fashion similar to PAF.", {"entities": []}], ["Taken together, our data indicate that T. cruzi synthesizes a bioactive C18:1-LPC, which aggregates platelets via PAFR.", {"entities": []}], ["We propose that C18:1-LPC might be an important lipid mediator in the progression of Chagas disease and its biosynthesis could eventually be exploited as a potential target for new therapeutic interventions.", {"entities": []}], ["Chagas disease, caused by the parasite Trypanosoma cruzi , was exclusively confined to Latin America but it has recently spread to other regions of the world.", {"entities": []}], ["Chagas disease affects 8\u201310 million people and kills thousands of them every year.", {"entities": []}], ["Lysophosphatidylcholine (LPC) is a major bioactive phospholipid of human plasma low-density lipoproteins (LDL).", {"entities": []}], ["Platelet-activating factor (PAF) is a phospholipid similar to LPC and a potent intercellular mediator.", {"entities": []}], ["Both PAF and LPC have been reported to act on mammalian cells through PAF receptor (PAFR).", {"entities": []}], ["Previous data from our group suggested that T. cruzi produces a phospholipid with PAF activity.", {"entities": []}], ["Here, we describe the structural and functional analysis of different species of LPC from T. cruzi , including a LPC with a fatty acid chain of 18 carbon atoms and one double bond (C18:1-LPC).", {"entities": []}], ["We also show that C18:1-LPC is able to induce rabbit platelet aggregation, which is abrogated by a PAFR antagonist.", {"entities": []}], ["In addition, a three-dimensional model of human PAFR was constructed.", {"entities": []}], ["Contrary to other T. cruzi LPC molecules, C18:1-LPC is predicted to interact with the PAFR model in a fashion similar to PAF.", {"entities": []}], ["Further studies are needed to validate the biosynthesis of T. cruzi C18:1-LPC as a potential drug target in Chagas disease.", {"entities": []}], ["Safe and complete resection represents the first step in the treatment of glioblastomas and is mandatory in increasing the effectiveness of adjuvant therapy to prolong overall survival.", {"entities": []}], ["With gross total resection currently limited in extent to MRI contrast enhancing areas, the extent to which supra-complete resection beyond obvious contrast enhancement could have impact on overall survival remains unclear.", {"entities": []}], ["DiVA (dual intraoperative visualization approach) redefines gross total resection as currently accepted by enabling for the first time supra-complete surgery without compromising patient safety.", {"entities": []}], ["This approach exploits the advantages of two already accepted surgical techniques combining intraoperative MRI with integrated functional neuronavigation and 5-ALA by integrating them into a single surgical approach.", {"entities": []}], ["We investigated whether this technique has impact on overall outcome in GBM patients.", {"entities": []}], ["105 patients with GBM were included.", {"entities": []}], ["We achieved complete resection with intraoperative MRI alone according to current best-practice in glioma surgery in 75 patients.", {"entities": []}], ["30 patients received surgery with supra-complete resection.", {"entities": []}], ["The control arm showed a median life expectancy of 14 months, reflecting current standards-of-care and outcome.", {"entities": []}], ["In contrast, patients receiving supra-complete surgery displayed significant increase in median survival time to 18.5 months with overall survival time correlating directly with extent of supra-complete resection.", {"entities": []}], ["This extension of overall survival did not come at the cost of neurological deterioration.", {"entities": []}], ["We show for the first time that supra-complete glioma surgery leads to significant prolongation of overall survival time in GBM patients.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) outpatients account for a large burden of usual care by respirologists.", {"entities": []}], ["EPOCONSUL is the first national clinical audit conducted in Spain on the medical care for COPD patients delivered in outpatient respiratory clinics.", {"entities": []}], ["We aimed to evaluate the clinical interventions and the degree of adherence to recommendations in outpatients of current COPD clinical practice guidelines.", {"entities": []}], ["This is an observational study with prospective recruitment (May 2014\u2013May 2015) of patients with a COPD diagnosis as seen in outpatient respiratory clinics.", {"entities": []}], ["The information collected was historical in nature as for the clinical data of the last and previous consultations, and the information concerning hospital resources was concurrent.", {"entities": []}], ["A total of 17,893 clinical records of COPD patients in outpatient respiratory clinics from 59 Spanish hospitals were evaluated.", {"entities": []}], ["Of the 5,726 patients selected, 4,508 (78.7%) were eligible.", {"entities": []}], ["Overall, 12.1% of COPD patients did not fulfill a diagnostic spirometry criteria.", {"entities": []}], ["Considerable variability existed in the available resources and work organization of the hospitals, although the majority were university hospitals with respiratory inpatient units.", {"entities": []}], ["There was insufficient implementation of clinical guidelines in preventive and educational matters.", {"entities": []}], ["In contrast, quantitative evaluation of dyspnea grade (81.9%) and exacerbation history (70.9%) were more frequently performed.", {"entities": []}], ["Only 12.4% had COPD severity calculated according to the Body mass index, airflow Obstruction, Dyspnoea and Exercise capacity (BODE) index.", {"entities": []}], ["Phenotype characteristics according to Spanish National Guideline for COPD were determined in 46.3% of the audited patients, and the risk evaluation according to Global initiative for chronic Obstructive Lung Disease was estimated only in 21.9%.", {"entities": []}], ["The EPOCONSUL study reports the current situation of medical care for COPD patients in outpatient clinics in Spain, revealing its variability, strengths, and weaknesses.", {"entities": []}], ["This information has to be accounted for by health managers to define corrective strategies and maximize good clinical practice.", {"entities": []}], ["Among patients with chronic obstructive pulmonary disease (COPD), the frequency and severity of past exacerbations potentiates future events.", {"entities": [[20, 57, "DISEASE"]]}], ["The impact of current therapies on exacerbation frequency and severity in patients with different exacerbation risks is not well known.", {"entities": []}], ["A post hoc analysis of patients at low (\u22641 exacerbation [oral steroids/antibiotics requirement] and no COPD-related hospitalization in the year preceding trial entry) or high (\u22652 exacerbations [oral steroids/antibiotics requirement] or \u22651 COPD-related hospitalization[s] in the year preceding trial entry) exacerbation risk, from the Prevention of Exacerbations with Tiotropium in Chronic Obstructive Pulmonary Disease (POET-COPD Compared with salmeterol, tiotropium significantly increased time to first COPD exacerbation (hazard ratio 0.84; 95% confidence interval [CI] 0.76\u20130.92; p \u00a0=\u00a00.0002) and reduced the number of COPD exacerbations (rate ratio 0.90; 95% CI 0.81\u20130.99; p \u00a0=\u00a00.0383) in patients at high exacerbation risk.", {"entities": [[381, 418, "DISEASE"]]}], ["With treatment, the risk of remaining in the high-risk exacerbator subgroup was statistically lower with tiotropium versus salmeterol (risk ratio [RR] 0.89; 95% CI 0.80\u20131.00; p \u00a0=\u00a00.0478).", {"entities": []}], ["For low-risk patients, time to first COPD exacerbation and number of COPD exacerbations were numerically lower with tiotropium versus salmeterol.", {"entities": []}], ["With treatment, the risk of transitioning from a low to a high exacerbation risk was lower with tiotropium versus salmeterol (RR 0.87; 95% CI 0.71\u20131.07; p \u00a0=\u00a00.1968).", {"entities": []}], ["This analysis confirms the higher efficacy of tiotropium versus salmeterol in prolonging time to first COPD exacerbation and reducing number of exacerbations in patients both at low and high exacerbation risk.", {"entities": []}], ["Boehringer Ingelheim and Pfizer.", {"entities": []}], ["Clinical trial registration number: ClinicalTrials.gov NCT00563381.", {"entities": []}], ["The online version of this article (doi:10.1007/s12325-015-0216-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Ventilator-associated respiratory infection (VARI) is an important cause of morbidity in critically-ill patients.", {"entities": []}], ["Clinical trials performed in heterogeneous populations have suggested there are limited benefits from invasive diagnostic testing to identify patients at risk or to target antimicrobial therapy.", {"entities": []}], ["However, multiple patient subgroups (for example, immunocompromised, antibiotic-treated) have traditionally been excluded from randomization.", {"entities": []}], ["We hypothesized that a prospective surveillance study would better identify patients with suspected VARI (sVARI) at high risk for adverse clinical outcomes, and who might be specifically targeted in future trials.", {"entities": []}], ["We performed a prospective observational study in all patients ventilated for greater than 48\u00a0hours.", {"entities": []}], ["sVARI was identified by surveillance for changes in white blood cell count, temperature, sputum, and/or new chest X-ray infiltrates.", {"entities": []}], ["Indices of disease co-morbidity, as well as mortality, duration of mechanical ventilation, and length of hospital or ICU stay were correlated with sVARI.", {"entities": []}], ["Of 1806 patients admitted to the ICU over 14\u00a0months, 267 were ventilated for greater than 48\u00a0hours, and 77 developed sVARI.", {"entities": []}], ["Incidence of sVARI was associated with iatrogenic immunosuppression or admission for respiratory illness.", {"entities": []}], ["Any sVARI, whether suspected ventilator-associated pneumonia (sVAP) or ventilator-associated tracheobronchitis (sVAT), was associated with increased length of stay and duration of mechanical ventilation.", {"entities": [[51, 60, "DISEASE"]]}], ["Clinical surveillance for sVARI identifies patients at risk for increased morbidity.", {"entities": []}], ["Iatrogenically immunosuppressed patients, a subgroup previously excluded from randomized clinical trials, represent a growing proportion of the critically-ill at risk for sVARI who might be targeted for future investigations on diagnostic or therapeutic modalities.", {"entities": []}], ["Mycoplasma pneumoniae \u00a0synthesizes a novel human surfactant protein A (SP-A)-binding cytotoxin, designated community-acquired respiratory distress syndrome (CARDS) toxin, that exhibits ADP-ribosylating and vacuolating activities in mammalian cells and is directly linked to a range of acute and chronic airway diseases, including asthma.", {"entities": [[147, 155, "DISEASE"], [330, 336, "DISEASE"]]}], ["In our attempt to detect additional CARDS toxin-binding proteins, we subjected the membrane fraction of human A549 airway cells to affinity chromatography using recombinant CARDS toxin as bait.", {"entities": []}], ["A 36-kDa A549 cell membrane protein bound to CARDS toxin and was identified by time of flight (TOF) mass spectroscopy as annexin A2 (AnxA2) and verified by immunoblotting with anti-AnxA2 monoclonal antibody.", {"entities": [[133, 138, "GENE"], [181, 186, "GENE"]]}], ["Dose-dependent binding of CARDS toxin to recombinant AnxA2 reinforced the specificity of the interaction, and further studies revealed that the carboxy terminus of CARDS toxin mediated binding to AnxA2.", {"entities": [[53, 58, "GENE"], [196, 201, "GENE"], [53, 58, "GENE"], [196, 201, "GENE"]]}], ["In addition, pretreatment of viable A549 cells with anti-AnxA2 monoclonal antibody or AnxA2 small interfering RNA (siRNA) reduced toxin binding and internalization.", {"entities": [[57, 62, "GENE"], [86, 91, "GENE"]]}], ["Immunofluorescence analysis of CARDS toxin-treated A549 cells demonstrated the colocalization of CARDS toxin with cell surface-associated AnxA2 upon initial binding and with intracellular AnxA2 following toxin internalization.", {"entities": [[138, 143, "GENE"], [188, 193, "GENE"], [138, 143, "GENE"], [188, 193, "GENE"]]}], ["HepG2 cells, which express low levels of AnxA2, were transfected with a plasmid expressing AnxA2 protein, resulting in enhanced binding of CARDS toxin and increased vacuolization.", {"entities": [[41, 46, "GENE"], [91, 96, "GENE"], [41, 46, "GENE"], [91, 96, "GENE"]]}], ["In addition, NCI-H441 cells, which express both AnxA2 and SP-A, upon AnxA2 siRNA transfection, showed decreased binding and subsequent vacuolization.", {"entities": [[48, 53, "GENE"], [69, 74, "GENE"], [48, 53, "GENE"], [69, 74, "GENE"]]}], ["These results indicate that CARDS toxin recognizes AnxA2 as a functional receptor, leading to CARDS toxin-induced changes in mammalian cells.", {"entities": [[51, 56, "GENE"]]}], ["Host cell susceptibility to bacterial toxins is usually determined by the presence and abundance of appropriate receptors, which provides a molecular basis for toxin target cell specificities.", {"entities": []}], ["To perform its ADP-ribosylating and vacuolating activities, community-acquired respiratory distress syndrome (CARDS) toxin must bind to host cell surfaces via receptor-mediated events in order to be internalized and trafficked effectively.", {"entities": [[100, 108, "DISEASE"]]}], ["Earlier, we reported the binding of CARDS toxin to surfactant protein A (SP-A), and here we show how CARDS toxin uses an alternative receptor to execute its pathogenic properties.", {"entities": []}], ["CARDS toxin binds selectively to annexin A2 (AnxA2), which exists both on the cell surface and intracellularly.", {"entities": [[45, 50, "GENE"]]}], ["Since AnxA2 regulates membrane dynamics at early stages of endocytosis and trafficking, it serves as a distinct receptor for CARDS toxin binding and internalization and enhances CARDS toxin-induced vacuolization in mammalian cells.", {"entities": [[6, 11, "GENE"]]}], ["Recent developments have meant that network theory is making an important contribution to the topological study of biological networks, such as protein-protein interaction (PPI) networks.", {"entities": []}], ["The identification of differentially expressed genes in DNA array experiments is a source of information regarding the molecular pathways involved in disease.", {"entities": []}], ["Thus, considering PPI analysis and gene expression studies together may provide a better understanding of multifactorial neurodegenerative diseases such as Multiple Sclerosis (MS) and Alzheimer disease (AD).", {"entities": []}], ["The aim of this study was to assess whether the parameters of degree and betweenness, two fundamental measures in network theory, are properties that differentiate between implicated (seed-proteins) and non-implicated nodes (neighbors) in MS and AD.", {"entities": []}], ["We used experimentally validated PPI information to obtain the neighbors for each seed group and we studied these parameters in four networks: MS-blood network; MS-brain network; AD-blood network; and AD-brain network.", {"entities": []}], ["Specific features of seed-proteins were revealed, whereby they displayed a lower average degree in both diseases and tissues, and a higher betweenness in AD-brain and MS-blood networks.", {"entities": []}], ["Additionally, the heterogeneity of the processes involved indicate that these findings are not pathway specific but rather that they are spread over different pathways.", {"entities": []}], ["Our findings show differential centrality properties of proteins whose gene expression is impaired in neurodegenerative diseases.", {"entities": []}], ["Epigenetics refers to changes in cell characteristics that occur independently of modifications to the deoxyribonucleic acid (DNA) sequence.", {"entities": []}], ["Alterations mediated by epigenetic mechanisms are important factors in cancer progression.", {"entities": [[71, 77, "DISEASE"]]}], ["Although an exciting prospect, the identification of early epigenetic markers associated with clinical outcome in premalignant and malignant disorders remains elusive.", {"entities": []}], ["We examined alterations in chromatin acetylation in oral lichen planus (OLP) with distinct clinical behavior and compared the alterations to the levels of DNA double-strand breaks (DSBs).", {"entities": [[57, 70, "DISEASE"]]}], ["We analyzed 42 OLP patients, who had different responses to therapy, for acetyl-histone H3 at lys9 (H3K9ac), which is associated with enhanced transcription and nuclear decondensation, and the presence of DSBs, as determined by accumulation of phosphorylated \u03b3H2AX foci.", {"entities": []}], ["Patients with high levels of H3K9ac acetylation failed to respond to therapy or experienced disease recurrence shortly after therapy.", {"entities": []}], ["Similar to H3K9ac, patients who responded poorly to therapy had increased accumulation of DNA DSB, indicating genomic instability.", {"entities": []}], ["These findings suggest that histone modifications occur in OLP, and H3K9ac and \u03b3H2AX histones may serve as epigenetic markers for OLP recurrence.", {"entities": []}], ["We investigated patients with chronic obstructive pulmonary disease (COPD) to analyze patterns and identify determinants of healthcare use, according to the severity of airflow obstruction.", {"entities": [[30, 67, "DISEASE"]]}], ["We used retrospective cohort data from a combination of the 4 Demographic and medical claims data were retrospectively analyzed from the 4 Among 6,663 eligible participants, 897 (13.5%) had airway obstruction.", {"entities": []}], ["Self-reported physician-diagnosed COPD comprised only 3%, and there were 870 undiagnosed COPD patients (97%).", {"entities": []}], ["Self-reported physician-diagnosed asthma made up 3.7%.", {"entities": [[34, 40, "DISEASE"]]}], ["Of the 897 respondents, 244 (27.2%) used COPD-related healthcare services.", {"entities": []}], ["The frequency of healthcare visits increased with increasing severity of airway obstruction.", {"entities": []}], ["After a 3-year follow-up period, 646 (74.2% of those initially undiagnosed) remained undiagnosed and only 224 (25.8%) were diagnosed and treated for COPD.", {"entities": []}], ["Only 27.5% of the 244 participants with airway obstruction who used COPD-related healthcare underwent PFTs during the study period.", {"entities": []}], ["The percentage of prescribed medications associated with COPD increased in accordance with the severity of the COPD.", {"entities": []}], ["Inhaled long-acting anticholinergics were prescribed for 10.9% of patients with moderate airway obstruction and for 52.4% of patients with severe obstruction.", {"entities": []}], ["Inhaled long-acting \u03b2-agonists combined with corticosteroids were prescribed for 50% of patients with severe airway obstruction.", {"entities": []}], ["Conversely, 44.6% of healthcare users were prescribed oral theophylline for COPD treatment, and 21.7% were also prescribed an oral corticosteroid.", {"entities": []}], ["The determinants of COPD-associated healthcare use in respondents with obstructive lung disease were advanced age, severe airflow limitation, presence of comorbidities, and self-reported physician diagnosis of COPD.", {"entities": [[71, 95, "DISEASE"], [83, 95, "DISEASE"]]}], ["This study ascertained marked underdiagnosed COPD.", {"entities": []}], ["Although the percentage of prescribed medication used to treat COPD increased with the severity of the COPD, medications primarily prescribed such as oral theophylline or oral corticosteroids are inappropriate for first-line COPD treatment.", {"entities": []}], ["Immunoglobulin (Ig) E is the principal Ig involved in immediate hypersensitivities and chronic allergic diseases such as asthma.", {"entities": [[121, 127, "DISEASE"]]}], ["Helminths are the most potent infectious agents known for their capacity to stimulate IgE production during the course of infection.", {"entities": []}], ["In rats, the nematode Trichinella spiralis typically elicits a strong parasite-specific IgE response during infection, and this IgE antibody has been shown to be protective against the parasite in passive transfer experiments.", {"entities": []}], ["The study reported here analyzed the fate of 125I- labeled myeloma IgE (1R162) in normal and T. spiralis-infected rats after intravenous injection.", {"entities": [[59, 66, "DISEASE"]]}], ["T. spiralis infection induced a capacity for specific binding to the gut wall of 125I-IgE rather than 125I-IgG1, as well as the transport of IgE, but not IgG1, into the gut lumen.", {"entities": []}], ["Peak intestinal uptake and transport of 125I-IgE occurred during the first and second weeks after injection but was not elevated in the fourth week, that is, after intestinal adult worms had been expelled.", {"entities": []}], ["Neither 125I-IgE uptake in the gut wall nor transport to the lumen could be ascribed to tissue damage or vascular leakage.", {"entities": []}], ["Luminal transport occurred in the small intestine and not the liver, which only transports low molecular weight degraded 125I-IgE.", {"entities": []}], ["Calculations based on the amount of intact IgE in the lumen suggest that, in a 24-h period, up to 20% of injected 125I-IgE can be transported to the gut lumen during the peak transport period, between 6 and 14 d after infection.", {"entities": []}], ["The intestinal IgE binding and transport response can be adoptively transferred with T. spiralis immune CD4+ OX22- (CD45RC-) lymphocytes, which are protective, but not the nonprotective sister population CD4+ OX22+ (CD45RC+) of lymphocytes isolated simultaneously from thoracic duct lymph of infected rats.", {"entities": []}], ["The intravenous infusion of recombinant rat interleukin 4 also elicited significant intestinal uptake of 125I-IgE.", {"entities": []}], ["We also present evidence for the presence of CD23 on rat intraepithelial lymphocytes.", {"entities": []}], ["These data provide evidence for a novel, inducible, intestine-specific IgE uptake and transport mechanism.", {"entities": []}], ["Glycans serve as important regulators of antibody activities and half-lives.", {"entities": []}], ["IgE is the most heavily glycosylated antibody, but in comparison to other antibodies little is known about its glycan structure function relationships.", {"entities": []}], ["We therefore describe the site specific IgE glycosylation from a patient with a novel hyper IgE syndrome linked to mutations in PGM3, which is an enzyme involved in synthesizing UDP-GlcNAc, a sugar donor widely required for glycosylation.", {"entities": [[96, 104, "DISEASE"], [128, 132, "GENE"]]}], ["A two-step method was developed to prepare two IgE samples from less than 1\u00a0mL of serum collected from a patient with PGM3 mutation and a patient with atopic dermatitis as a control subject.", {"entities": [[151, 168, "DISEASE"], [158, 168, "DISEASE"], [118, 122, "GENE"]]}], ["Then, a glycoproteomic strategy was used to study the site-specific glycosylation.", {"entities": []}], ["No glycosylation was found at Asn264, whilst high mannose glycans were only detected at Asn275, tri-antennary glycans were exclusively observed at Asn99 and Asn252, and non-fucosylated complex glycans were detected at Asn99.", {"entities": []}], ["The results showed similar glycosylation profiles between the two IgE samples.", {"entities": []}], ["These observations, together with previous knowledge of IgE glycosylation, imply that IgE glycosylation is similarly regulated among healthy control, allergy and PGM3 related hyper IgE syndrome.", {"entities": [[185, 193, "DISEASE"], [162, 166, "GENE"]]}], ["The online version of this article (doi:10.1007/s10719-015-9638-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Deoxyschizandrin as one of the most important component of Schisandra chinensis (Turcz.)", {"entities": []}], ["Baill plays an immunomodulatory role in a variety of diseases, yet its role in ulcerative colitis remains to be elucidated.", {"entities": [[79, 97, "DISEASE"]]}], ["We aimed to investigate the role of deoxyschizandrin in DSS-induced ulcerative colitis in mice.", {"entities": [[68, 86, "DISEASE"]]}], ["In the present study, an inflammation model of cells was constructed to confirm the anti-inflammatory effect of deoxyschizandrin.", {"entities": []}], ["Then a mouse model with Dextran sulfate sodium sulfate (DSS)-induced ulcerative colitis was constructed, and the effects of deoxyschizandrin on mouse colon inflammation, apoptosis, and CD4 T lymphocyte infiltration in ulcerative colitis were examined.", {"entities": [[69, 87, "DISEASE"], [218, 236, "DISEASE"], [185, 188, "GENE"]]}], ["Deoxyschizandrin could improve the symptoms of ulcerative colitis, determined by hematoxylin-eosin (HE) staining and histopathological scores.", {"entities": [[47, 65, "DISEASE"]]}], ["Moreover, deoxyschizandrin reduced the levels of inflammatory cytokines, suppressed CD4 T cell infiltration, and effectively inhibited apoptosis in the colon of DSS-induced ulcerative colitis mice.", {"entities": [[173, 191, "DISEASE"], [84, 87, "GENE"]]}], ["In summary, deoxyschizandrin can effectively rescue the symptoms of DSS-induced ulcerative colitis in mice by inhibiting inflammation.", {"entities": [[80, 98, "DISEASE"]]}], ["T cell infiltration and apoptosis in the colon, suggesting that deoxyschizandrin could be a potential drug in treating ulcerative colitis.", {"entities": [[119, 137, "DISEASE"]]}], ["This study was undertaken to determine whether there was an association between coarse particles (PM 2.5\u201310 ) levels and frequency of hospital admissions for respiratory diseases (RD) in Kaohsiung, Taiwan.", {"entities": [[180, 182, "GENE"]]}], ["Hospital admissions for RD including chronic obstructive pulmonary disease (COPD), asthma, and pneumonia, and ambient air pollution data levels for Kaohsiung were obtained for the period from 2006 to 2010.", {"entities": [[95, 104, "DISEASE"], [37, 74, "DISEASE"], [83, 89, "DISEASE"], [24, 26, "GENE"]]}], ["The relative risk of hospital admissions for RD was estimated using a case-crossover approach, controlling for weather variables, day of the week, seasonality, and long-term time trends.", {"entities": [[45, 47, "GENE"]]}], ["For the single pollutant model (without adjustment for other pollutants), increased rate of admissions for RD were significantly associated with higher coarse PM levels only on cool days (<25 \u00b0C), with a 10 \u00b5g/m 2.5\u201310 concentrations associated with a 3% (95% CI = 1%\u20135%) rise in COPD admissions, 4% (95% CI = 1%\u20137%) increase in asthma admissions, and 3% (95% CI = 2%\u20134%) rise in pneumonia admissions.", {"entities": [[380, 389, "DISEASE"], [329, 335, "DISEASE"], [107, 109, "GENE"]]}], ["No significant associations were found between coarse particle levels and the number of hospital admissions for RD on warm days.", {"entities": [[112, 114, "GENE"]]}], ["In the two-pollutant models, PM 2.5\u201310 levels remained significantly correlated with higher rate of RD admissions even controlling for sulfur dioxide, nitrogen dioxide, carbon monoxide, or ozone on cool days.", {"entities": [[100, 102, "GENE"]]}], ["This study provides evidence that higher levels of PM 2.5\u201310 enhance the risk of hospital admissions for RD on cool days.", {"entities": [[105, 107, "GENE"]]}], ["While it is generally accepted that Subcutaneous Injection Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT) are both efficacious, there is not yet a significant amount of information regarding their comparative efficacy.", {"entities": []}], ["In this paper, we performed a retrospective chart review and compared treatment results in two groups of patients (both with nasal allergies with or without asthma) that were treated either with SCIT or SLIT.", {"entities": [[157, 163, "DISEASE"]]}], ["Both treatment modalities were found to be of similar efficacy.", {"entities": []}], ["Background and Objective.", {"entities": []}], ["Oxidative stress is intimately associated with many diseases, including chronic obstructive pulmonary disease (COPD).", {"entities": [[72, 109, "DISEASE"]]}], ["Study objectives include a comparison of the oxidative stress, antioxidant status, and lipid profile between COPD patients and controls and evaluation of the effect of spirulina intervention on oxidative stress, antioxidant status, and lipid profile of COPD patients.", {"entities": []}], ["30 patients with COPD and 20 controls with no respiratory problems were selected.", {"entities": []}], ["Global Initiative for Chronic Obstructive Lung Disease criteria were served as the basis of COPD diagnosis.", {"entities": []}], ["The serum content of malondialdehyde (MDA), lipid hydroperoxide, glutathione (GSH), vitamin C, cholesterol, triglyceride (TG), and high density lipoprotein (HDL) was measured.", {"entities": [[122, 124, "GENE"]]}], ["The activity of superoxide dismutase (SOD), catalase (CAT), and glutathione-s-transferase (GST) was also measured.", {"entities": []}], ["Two different doses, (500 \u00d7 2)\u2009mg and (500 \u00d7 4)\u2009mg spirulina, were given to two groups, each of which comprises 15 COPD patients.", {"entities": []}], ["All targeted blood parameters have significant difference ( P = 0.000) between COPD patients and controls except triglyceride (TG).", {"entities": [[127, 129, "GENE"]]}], ["Spirulina intake for 30 and 60 days at (500 \u00d7 2)\u2009mg dose has significantly reduced serum content of MDA, lipid hydroperoxide, and cholesterol ( P = 0.000) while increasing GSH, Vit C level ( P = 0.000), and the activity of SOD ( P = 0.000) and GST ( P = 0.038).", {"entities": [[177, 180, "GENE"]]}], ["At the same time, spirulina intake for 30 and 60 days at (500 \u00d7 4)\u2009mg dose has favorable significant effect ( P = 0.000) on all targeted blood parameters except for HDL ( P = 0.163).", {"entities": []}], ["The relationship between chromosome deletion in wheat and protein expression were investigated using Chinese Spring and fine deletion line 3BS-8.", {"entities": []}], ["Through 2-DE (2-D electrophoresis) analysis, no differentially expressed proteins (DEPs) were found in leaf samples; however, 47 DEPs showed at least two-fold abundance variation ( p < 0.05) in matured wheat grains and 21 spots were identified by tandem MALDI-TOF/TOF-MS.", {"entities": []}], ["Among the identified spots, four were cultivar-specific, including three (spots B15, B16, and B21) in Chinese Spring and one in 3BS-8 (spot B10).", {"entities": []}], ["Among variety-different DEPs between Chinese Spring and 3BS-8, most spots showed a higher express profile in CS; only four spots showed up-regulated expression tendency in 3BS-8.", {"entities": [[109, 111, "GENE"]]}], ["An interesting observation was that more than half of the identified protein spots were involved in storage proteins, of which 11 spots were identified as globulins.", {"entities": []}], ["According to these results, we can presume that the encoded genes of protein spots B15, B16, and B21 were located on the chromosome segment deleted in 3BS-8.", {"entities": []}], ["Epilepsy, a chronic disorder of brain characterised by a predisposition to generate epileptic seizures, has an effect on the psychosocial well-being of sufferers.", {"entities": []}], ["Measuring the quality of life (QOL) of people with epilepsy (PWE) is increasingly recognized as an important component of clinical management.", {"entities": []}], ["QOL measures differ between countries and there is limited information regarding PWE in Malaysia.", {"entities": []}], ["The aim of this study was to determine the health related QOL and its relationship with the presence of seizures in PWE at a Malaysian tertiary referral center.", {"entities": []}], ["A total of 106 adults with epilepsy attending the weekly neurology clinic of Universiti Sains Malaysia Hospital were interviewed in this cross-sectional study.", {"entities": []}], ["The QOL was measured using a validated Malay translated version of the Quality of Life in Epilepsy Scale-31 (QOLIE-31).", {"entities": []}], ["Analysis of covariance was used for data analysis.", {"entities": []}], ["The mean age was 31.8\u00a0years old (standard deviation (SD) 11.0) and 56.6% were females.", {"entities": []}], ["The mean total score of QOLIE-31was 68.9 (SD 15.9).", {"entities": []}], ["The highest subscale score was the medication effects with a mean of 79.4 (SD 28.5) and the lowest was seizure worry with 47.5 (SD 25.0).", {"entities": []}], ["Respondents who had one or more seizures in the past four weeks had significantly lower mean score of QOL [63.4, 95% CI: 59.2, 67.5] than those who had no seizure [mean score 73.5, 95% CI: 69.3, 77.9] after adjusting for age, sex, treatment, duration and age at onset of epilepsy [F test =11.215, p\u2009=\u20090.001, R Worrying about seizure had the major contribution on QOL, while medication effect had the least.", {"entities": []}], ["This study confirms the importance of seizure control for a better QOL in Malaysian patients with epilepsy.", {"entities": []}], ["Oral lichen planus (OLP) is a premalignant mucocutaneous disease in which genetic factors and immune responses play a major role.", {"entities": [[5, 18, "DISEASE"]]}], ["Cytokines play an important role in the pathogenesis and disease progression of OLP.", {"entities": []}], ["The aim of this study was to investigate the impact of gene polymorphisms of T helper cell subtype Th1 and Th2 cytokines, interferon-gamma (IFN-\u03b3), interleukin-6 (IL-6) and transforming growth factor (TGF)-\u03b21 on OLP susceptibility in a Saudi cohort.", {"entities": []}], ["Forty two unrelated patients with OLP and 195 healthy controls were genotyped for IFN-\u03b3 (874A/T), IL-6 (174G/C) and TGF-\u03b21 (509C/T) polymorphisms.", {"entities": []}], ["The frequency of genotype AT of IFN-\u03b3 (874A/T) was significantly higher while genotype AA was lower in OLP patients as compared to controls ( P \u2009<\u20090.05).", {"entities": []}], ["The frequency of T containing genotypes (AT\u2009+\u2009TT) was also higher in OLP patients as compared to that in controls ( P \u2009=\u20090.003).", {"entities": []}], ["The frequencies of allele T was higher while that of allele A lower in patients than the controls however the difference was not statistically significant ( P \u2009=\u20090.07).", {"entities": []}], ["There was no significant difference in the frequencies of alleles and genotypes of IL-6 (174G/C) and TGF-\u03b21 (509C/T) polymorphisms between patient and control groups.", {"entities": []}], ["These results indicated that genotype AT of IFN-\u03b3 (874A/T) polymorphism is associated with OLP risk and genotype AA is protective to OLP.", {"entities": []}], ["On the other hand the polymorphisms IL-6 (174G/C) and TGF-\u03b21 (509C/T) may not be associated with OLP risk in our population.", {"entities": []}], ["It is concluded that IFN-\u03b3 (874A/T) polymorphism is associated with the susceptibility of OLP, however further studies with large sample size involving different ethnic populations should be conducted to strengthen our results.", {"entities": []}], ["New therapeutic agents are warranted in idiopathic membranous nephropathy.", {"entities": []}], ["Synthetic ACTH may be advantageous with reported remission rates up to 85% and few side effects.", {"entities": []}], ["We conducted a prospective open label cohort study from 2008 till 2010 ( NCT00694863 ).", {"entities": []}], ["We prospectively selected patients with idiopathic membranous nephropathy and high risk for progression (defined as \u03b2eta-2-microglobulin (\u03b22m) excretion of >500 ng/min).", {"entities": []}], ["For comparison, we selected matched historical controls treated with cyclophosphamide.", {"entities": []}], ["The prospectively selected patients received intramuscular injections of synthetic ACTH during 9 months (maximal dose 1 mg twice a week).", {"entities": []}], ["The primary endpoints concerned the feasibility and incidence of remissions as a primary event.", {"entities": []}], ["Secondary endpoints included side effects of treatment and the incidence of remissions and relapses at long-term follow-up.", {"entities": []}], ["Twenty patients (15 men) were included (age 54\u00b114 years, serum creatinine 104 \u03bcmol/l [IQR 90\u2013113], urine protein:creatinine ratio 8.7 g/10 mmol creatinine [IQR 4.3\u201311.1]).", {"entities": []}], ["Seventeen patients (85%) completed treatment.", {"entities": []}], ["97% of injections were administered correctly.", {"entities": []}], ["Cumulative remission rate was 55% (complete remission in 4 patients, partial remission 7 patients).", {"entities": []}], ["In a group of historical controls treated with cyclophosphamide and steroids, 19 of 20 patients (95%) developed a remission (complete remission in 13 patients, partial remission in 6 patients) (p<0.01).", {"entities": []}], ["The main limitation of our study is its small size and the use of a historical control group.", {"entities": []}], ["We show that treatment with intramuscular injections of synthetic ACTH is feasible.", {"entities": []}], ["Our data suggest that synthetic ACTH is less effective than cyclophosphamide in inducing a remission in high risk patients with idiopathic membranous nephropathy.", {"entities": []}], ["The use of synthetic ACTH was also associated with many adverse events.", {"entities": []}], ["Therefore, we advise against synthetic ACTH as standard treatment in membranous nephropathy.", {"entities": []}], ["ClinicalTrials.gov NCT00694863", {"entities": []}], ["Scrub typhus is an endemic disease in Asia.", {"entities": [[0, 12, "DISEASE"], [6, 12, "DISEASE"]]}], ["It has been a rural disease, but indigenous urban cases have been observed in Seoul, South Korea.", {"entities": []}], ["Urban scrub typhus may have a significant impact because of the large population.", {"entities": [[6, 18, "DISEASE"], [12, 18, "DISEASE"]]}], ["Indigenous urban scrub typhus was epidemiologically identified in Seoul, the largest metropolitan city in South Korea, using national notifiable disease data from 2010 to 2013.", {"entities": [[17, 29, "DISEASE"], [23, 29, "DISEASE"]]}], ["For detailed analysis of clinical features, patients from one hospital that reported the majority of cases were selected and compared to a historic control group.", {"entities": []}], ["Chigger mites were prospectively collected in the city using a direct chigger mite-collecting trap, and identified using both phenotypic and 18S rDNA sequencing analyses.", {"entities": []}], ["Their infection with Orientia tsutsugamushi was confirmed by sequencing the 56-kDa antigen gene.", {"entities": []}], ["Eighty-eight cases of urban scrub typhus were determined in Seoul.", {"entities": [[28, 40, "DISEASE"], [34, 40, "DISEASE"]]}], ["The possible sites of infection were mountainous areas (56.8%), city parks (20.5%), the vicinity of one\u2019s own residence (17.0%), and riversides (5.7%).", {"entities": []}], ["Eighty-seven chigger mites were collected in Gwanak mountain, one of the suspected infection sites in southern Seoul, and seventy-six (87.4%) of them were identified as Helenicula miyagawai and eight (9.2%) as Leptotrombidium scutellare .", {"entities": []}], ["Pooled DNA extracted from H .", {"entities": []}], ["miyagawai mites yielded O .", {"entities": []}], ["tsutsugamushi Boryong strain.", {"entities": []}], ["Twenty-six patients from one hospital showed low APACHE II score (3.4 \u00b1 2.7), low complication rate (3.8%), and no hypokalemia.", {"entities": [[115, 126, "DISEASE"]]}], ["We identified the presence of indigenous urban scrub typhus in Seoul, and a subgroup of them had mild clinical features.", {"entities": [[47, 59, "DISEASE"], [53, 59, "DISEASE"]]}], ["The chigger mite H .", {"entities": []}], ["miyagawai infected with O .", {"entities": []}], ["tsutsugamushi within the city was found.", {"entities": []}], ["In endemic area, urban scrub typhus needs to be considered as one of the differential febrile diseases and a target for prevention.", {"entities": [[23, 35, "DISEASE"], [29, 35, "DISEASE"]]}], ["Scrub typhus is one of the high burdened infectious diseases in endemic rural areas.", {"entities": [[0, 12, "DISEASE"], [6, 12, "DISEASE"]]}], ["Our study showed that the disease could be endemic in urban areas.", {"entities": []}], ["Indigenous urban scrub typhus may also have significant impact in terms of a disease burden and differential diagnosis.", {"entities": [[17, 29, "DISEASE"], [23, 29, "DISEASE"]]}], ["A low rate of characteristic eschar and skin rash may make the clinical suspicion more troublesome.", {"entities": []}], ["Scrub typhus is the 3 Helenicula miyagawai (87.4%) and Leptotrombidium scutellare (9.2%) were the dominant species.", {"entities": [[0, 12, "DISEASE"], [6, 12, "DISEASE"]]}], ["In addition, O .", {"entities": []}], ["tsutsugamushi -specific gene, tsa56 , was identified in a fraction of the collected H .", {"entities": []}], ["miyagawai .", {"entities": []}], ["The 18S rDNA sequencing of the chigger mites was complementarily helpful for the differentiation of species.", {"entities": []}], ["Our data are from one region, but urban scrub typhus is likely a scenario in endemic areas.", {"entities": [[40, 52, "DISEASE"], [46, 52, "DISEASE"]]}], ["Urban areas should be included as possible locations for scrub typhus.", {"entities": [[57, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["The focal adhesion kinase (FAK) regulates the dynamics of integrin-based cell adhesions important for motility.", {"entities": []}], ["FAK\u2019s activity regulation is involved in stress-sensing and focal-adhesion turnover.", {"entities": []}], ["The effect of FAK on 3D migration and cellular mechanics is unclear.", {"entities": []}], ["We analyzed FAK knock-out mouse embryonic fibroblasts and cells expressing a kinase-dead FAK mutant, R454-FAK, in comparison to FAK wild-type cells.", {"entities": []}], ["FAK knock-out and FAK", {"entities": []}], ["Interleukin 4 (IL-4) is an anti-inflammatory cytokine, which regulates balance between T H 1 and T H 2 immune response, immunoglobulin class switching and humoral immunity.", {"entities": []}], ["Polymorphisms in this gene have been reported to affect the risk of infectious and autoimmune diseases.", {"entities": []}], ["We have analyzed three regulatory IL-4 polymorphisms; -590C>T, -34C>T and 70 bp intron-3 VNTR, in 4216 individuals; including: (1) 430 ethnically matched case-control groups (173 severe malaria, 101 mild malaria and 156 asymptomatic); (2) 3452 individuals from 76 linguistically and geographically distinct endogamous populations of India, and (3) 334 individuals with different ancestry from outside India (84 Brazilian, 104 Syrian, and 146 Vietnamese).", {"entities": [[186, 193, "DISEASE"], [204, 211, "DISEASE"]]}], ["The - 590T, - 34T and intron-3 VNTR R2 alleles were found to be associated with reduced malaria risk (P<0.001 for - 590C>T and - 34C>T, and P\u200a=\u200a0.003 for VNTR).", {"entities": [[88, 95, "DISEASE"]]}], ["These three alleles were in strong LD (r - 590T, - 34T and intron-3 VNTR R2) haplotype appeared to be a susceptibility factor for malaria (P\u200a=\u200a0.009, OR\u200a=\u200a0.552, 95% CI\u200a=\u200a0.356 \u20130.854).", {"entities": [[130, 137, "DISEASE"]]}], ["Allele and genotype frequencies differ significantly between caste, nomadic, tribe and ancestral tribal populations (ATP).", {"entities": []}], ["The distribution of protective haplotype TTR2 was found to be significant (\u03c7 3 \u200a=\u200a182.95, p-value <0.001), which is highest in ATP (40.5%); intermediate in tribes (33%); and lowest in caste (17.8%) and nomadic (21.6%).", {"entities": []}], ["Our study suggests that the IL-4 polymorphisms regulate host susceptibility to malaria and disease progression.", {"entities": [[79, 86, "DISEASE"]]}], ["TTR2 haplotype, which gives protection against malaria, is high among ATPs.", {"entities": [[47, 54, "DISEASE"]]}], ["Since they inhabited in isolation and mainly practice hunter-gatherer lifestyles and exposed to various parasites, IL-4 TTR2 haplotype might be under positive selection.", {"entities": []}], ["A longstanding and widely held assumption is that immigrants suffer from ill health and adaptation problems.", {"entities": []}], ["Yet recent studies show that immigrants report the same or better state of health compared to their native-born counterparts.", {"entities": []}], ["This phenomenon, known as the healthy immigrant effect , has been found in studies of specific health conditions of adults.", {"entities": []}], ["The present study focuses instead on adolescents and extends its examination of the healthy immigrant effect, measuring both health and adaptation.", {"entities": []}], ["Using data from population samples in the Canadian Community Health Survey (2007), foreign-born immigrant adolescents (n\u2009=\u2009920) were compared to non-immigrant adolescents (n\u2009=\u200913,572) for their self-report to questionnaire items for health (general health, mental health, chronic illnesses with psychosomatic symptoms, and psychological illnesses) and adaptation (daily life stress, life satisfaction, and sense of belonging).", {"entities": []}], ["Adolescents\u2019 gender, age, and length of residence were analyzed for the effects.", {"entities": []}], ["Immigrant adolescents were better than non-immigrant peers on the four health measures, and did not differ from non-immigrants on the three adaptation measures despite having less household income and more family members in the household.", {"entities": []}], ["Immigrant girls exhibited more resilient adaptability, while young immigrant boys and older non-immigrant girls displayed some potential vulnerability.", {"entities": []}], ["Length of residence, on the other hand, did not contribute to differences for the health and adaptation of immigrant adolescents.", {"entities": []}], ["The healthy immigrant effect was confirmed in a community population sample of adolescents in Canada.", {"entities": []}], ["Foreign-born immigrant adolescents experience better health, as well as good adaptation equal to their native-born peers.", {"entities": []}], ["These outcomes call for further research on sustaining good health and adaptation of the immigrant population, in particular by providing age-related effective services and prevention strategies.", {"entities": []}], ["Immediate treatment of depression and anxiety may not always be necessary in resilient patients.", {"entities": []}], ["This study aimed to determine remission rates of subthreshold depression and anxiety, incidence rates of major depressive and anxiety disorders, and predictors of these remission and incidence rates in visually impaired older adults after a three-month \u2018watchful waiting\u2019 period.", {"entities": []}], ["A pretest\u2013posttest study in 265 visually impaired older adults (mean age 74\u00a0years), from outpatient low-vision rehabilitation services, with subthreshold depression and/or anxiety was performed as part of a randomised controlled trial on the cost-effectiveness of a stepped-care intervention.", {"entities": []}], ["An ordinal logistic regression analysis was conducted.", {"entities": []}], ["Main outcome measures were: (1) subthreshold depression and anxiety measured with the Centre for Epidemiologic Studies Depression Scale (CES-D) and the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A), and (2) depressive and anxiety disorders measured with the Mini International Neuropsychiatric Interview.", {"entities": []}], ["After a three-month watchful waiting period, depression and anxiety decreased significantly by 3.8 (CES-D) and 1.4 points (HADS-A) ( p \u00a0<\u00a00.001).", {"entities": []}], ["Of all participants, 34\u00a0% recovered from subthreshold depression and/or anxiety and 18\u00a0% developed a depressive and/or anxiety disorder.", {"entities": [[119, 135, "DISEASE"]]}], ["Female gender [odds ratio (OR) 0.49, 95\u00a0% confidence interval (CI) 0.28\u20130.86], more problems with adjustment to vision loss at baseline (OR 1.02, 95\u00a0% CI 1.00\u20131.03), more symptoms of depression and anxiety at baseline (OR 1.06, 95\u00a0% CI 1.02\u20131.10), and a history of major depressive, dysthymic, and/or panic disorder (OR 2.28, 95\u00a0% CI 1.28\u20134.07) were associated with lower odds of remitting from subthreshold depression and/or anxiety and higher odds of developing a disorder after watchful waiting.", {"entities": [[301, 315, "DISEASE"]]}], ["Watchful waiting can be an appropriate step in managing depression and anxiety in visually impaired older adults.", {"entities": []}], ["However, female gender, problems with adjustment to vision loss, higher depression and anxiety symptoms, and a history of a depressive or anxiety disorder confer a disadvantage.", {"entities": [[138, 154, "DISEASE"]]}], ["Screening tools may be used to identify patients with these characteristics, who may benefit more from higher intensity treatment or a shorter period of watchful waiting.", {"entities": []}], ["Vaccination is an important control measure for neosporosis that is caused by a coccidian parasite, Neospora caninum , leading to abortion and reproductive disorders in cattle and serious economic impacts worldwide.", {"entities": []}], ["A D-galactose-binding lectin from Synadenium carinatum latex (ScLL) was recently described by our group with potential immunostimulatory and adjuvant effects in the leishmaniasis model.", {"entities": [[165, 178, "DISEASE"]]}], ["In this study, we evaluated the adjuvant effect of ScLL in immunization of mice against neosporosis .", {"entities": []}], ["First, we investigated in vitro cytokine production by dendritic cells stimulated with Neospora lysate antigen (NLA), ScLL or both.", {"entities": []}], ["Each treatment induced TNF-\u03b1, IL-6, IL-10 and IL-12 production in a dose-dependent manner, with synergistic effect of NLA plus ScLL.", {"entities": []}], ["Next, four groups of C57BL/6 mice were immunized with NLA + ScLL, NLA, ScLL or PBS.", {"entities": []}], ["The kinetics of antibody response showed a predominance of IgG and IgG1 for NLA + ScLL group, whereas IgG2a response was similar between NLA + ScLL and NLA groups.", {"entities": []}], ["Ex vivo cytokine production by mouse spleen cells showed the highest IFN-\u03b3/IL-10 ratio in the presence of NLA stimulation for mice immunized with NLA + ScLL and the lowest for those immunized with ScLL alone.", {"entities": []}], ["After parasite challenge, mice immunized with NLA + ScLL or ScLL alone presented higher survival rates (70-80%) and lower brain parasite burden as compared to PBS group, but with no significant changes in morbidity and inflammation scores.", {"entities": []}], ["In conclusion, ScLL combined with NLA was able to change the cytokine profile induced by the antigen or lectin alone for a Th1-biased immune response, resulting in high protection of mice challenged with the parasite, but with low degree of inflammation.", {"entities": []}], ["Both features may be important to prevent congenital neosporosis, since protection and low inflammatory response are necessary events to guide towards a successful pregnancy.", {"entities": []}], ["We examined gene expression of whole blood cells (WBC) from 11 healthy elderly volunteers participating on a Phase I open label study before and after oral treatment with Lactobacillus rhamnosus GG-ATCC 53103 (LGG)) using RNA-sequencing (RNA-Seq).", {"entities": []}], ["Elderly patients (65\u201380 yrs) completed a clinical assessment for health status and had blood drawn for cellular RNA extraction at study admission (Baseline), after 28 days of daily LGG treatment (Day 28) and at the end of the study (Day 56) after LGG treatment had been suspended for 28 days.", {"entities": []}], ["Treatment compliance was verified by measuring LGG-DNA copy levels detected in host fecal samples.", {"entities": []}], ["Normalized gene expression levels in WBC RNA were analyzed using a paired design built within three analysis platforms (edgeR, DESeq2 and TSPM) commonly used for gene count data analysis.", {"entities": []}], ["From the 25,990 transcripts detected, 95 differentially expressed genes (DEGs) were detected in common by all analysis platforms with a nominal significant difference in gene expression at Day 28 following LGG treatment (FDR<0.1; 77 decreased and 18 increased).", {"entities": []}], ["With a more stringent significance threshold (FDR<0.05), only two genes ( FCER2 and LY86 ), were down-regulated more than 1.5 fold and met the criteria for differential expression across two analysis platforms.", {"entities": [[74, 79, "GENE"], [84, 88, "GENE"]]}], ["The remaining 93 genes were only detected at this threshold level with DESeq2 platform.", {"entities": []}], ["Data analysis for biological interpretation of DEGs with an absolute fold change of 1.5 revealed down-regulation of overlapping genes involved with Cellular movement , Cell to cell signaling interactions , Immune cell trafficking and Inflammatory response .", {"entities": []}], ["These data provide evidence for LGG-induced transcriptional modulation in healthy elderly volunteers because pre-treatment transcription levels were restored at 28 days after LGG treatment was stopped.", {"entities": []}], ["To gain insight into the signaling pathways affected in response to LGG treatment, DEG were mapped using biological pathways and genomic data mining packages to indicate significant biological relevance.", {"entities": []}], ["Trial Registration : ClinicalTrials.gov NCT01274598", {"entities": []}], ["A previous study has documented the reliability and validity of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) in exploring patient satisfaction with medicines for chronic health conditions in routine medical practice, but the minimally important difference (MID) of this tool is as yet unknown.", {"entities": []}], ["The objective of this research was to estimate the MID for the SATMED-Q total score and six constituent domains.", {"entities": []}], ["The sample of patients (456 subjects, mean age 59 years, 53% male) used for testing psychometric properties was also used to assess MID.", {"entities": []}], ["Item #14 of the Treatment Satisfaction Questionnaire for Medication (TSQM) was used as an anchor reference since it directly explores satisfaction with medicine on a 7-point ordinal scale (from extremely satisfied to extremely dissatisfied, with a neutral category).", {"entities": []}], ["Patients were classified into four categories according to responses to this item (extremely satisfied/dissatisfied, very satisfied/dissatisfied, satisfied/dissatisfied, neither satisfied nor dissatisfied (neutral), and calculations were made for the total score and each domain of the SATMED-Q using standardised scores.", {"entities": []}], ["The mean absolute differences in total score (and domains) between the neutral category and the satisfied/dissatisfied category were considered to be the MID.", {"entities": []}], ["Effect sizes (ES) were also computed.", {"entities": []}], ["The MID for the total score was 13.4 (ES = 0.91), while the domain values ranged from 10.3 (medical care domain, ES = 0.43) to 20.6 (impact on daily living, ES = 0.85).", {"entities": []}], ["Mean differences in satisfaction (as measured by the total SATMED-Q score and domain scores) using the levels of satisfaction established by item #14 were significantly different, with F values ranging from 12.2 to 88.8 (p < 0.001 in all cases).", {"entities": []}], ["The SATMED-Q was demonstrated to be responsive to different levels of patient satisfaction with therapy in chronically ill subjects.", {"entities": []}], ["The MID obtained was 13.4 points for the overall normalised scoring scale, and between 10.3 and 20.6 points for domains.", {"entities": []}], ["World Trade Center-particulate matter(WTC-PM) exposure and metabolic-risk are associated with WTC-Lung Injury(WTC-LI).", {"entities": []}], ["The receptor for advanced glycation end-products (RAGE) is most highly expressed in the lung, mediates metabolic risk, and single-nucleotide polymorphisms at the AGER-locus predict forced expiratory volume(FEV).", {"entities": [[206, 209, "GENE"]]}], ["Our objectives were to test the hypotheses that RAGE is a biomarker of WTC-LI in the FDNY-cohort and that loss of RAGE in a murine model would protect against acute PM-induced lung disease.", {"entities": [[176, 188, "DISEASE"]]}], ["We know from previous work that early intense exposure at the time of the WTC collapse was most predictive of WTC-LI therefore we utilized a murine model of intense acute PM-exposure to determine if loss of RAGE is protective and to identify signaling/cytokine intermediates.", {"entities": []}], ["This study builds on a continuing effort to identify serum biomarkers that predict the development of WTC-LI.", {"entities": []}], ["A case-cohort design was used to analyze a focused cohort of male never-smokers with normal pre-9/11 lung function.", {"entities": []}], ["Odds of developing WTC-LI increased by 1.2, 1.8 and 1.0 in firefighters with soluble RAGE (sRAGE)\u226597pg/mL, CRP\u22652.4mg/L, and MMP-9\u2264397ng/mL, respectively, assessed in a multivariate logistic regression model (ROC AUC of 0.72).", {"entities": []}], ["Wild type(WT) and RAGE-deficient(Ager ) mice were exposed to PM or PBS-control by oropharyngeal aspiration.", {"entities": []}], ["Lung function, airway hyperreactivity, bronchoalveolar lavage, histology, transcription factors and plasma/BAL cytokines were quantified.", {"entities": []}], ["WT-PM mice had decreased FEV and compliance, and increased airway resistance and methacholine reactivity after 24-hours.", {"entities": [[25, 28, "GENE"]]}], ["Decreased IFN-\u03b3 and increased LPA were observed in WT-PM mice; similar findings have been reported for firefighters who eventually develop WTC-LI.", {"entities": [[30, 33, "GENE"]]}], ["In the murine model, lack of RAGE was protective from loss of lung function and airway hyperreactivity and was associated with modulation of MAP kinases.", {"entities": []}], ["We conclude that in a multivariate adjusted model increased sRAGE is associated with WTC-LI.", {"entities": []}], ["In our murine model, absence of RAGE mitigated acute deleterious effects of PM and may be a biologically plausible mediator of PM-related lung disease.", {"entities": [[138, 150, "DISEASE"]]}], ["Diagnosis of acute lung allograft rejection is currently based on transbronchial lung biopsies.", {"entities": []}], ["Additional methods to detect acute allograft dysfunction derived from plasma and bronchoalveolar lavage samples might facilitate diagnosis and ultimately improve allograft survival.", {"entities": []}], ["This review article gives an overview of the cell profiles of bronchoalveolar lavage and plasma samples during acute lung allograft rejection.", {"entities": []}], ["The value of these cells and changes within the pattern of differential cytology to support the diagnosis of acute lung allograft rejection is discussed.", {"entities": []}], ["Current findings on the topic are highlighted and trends for future research are identified.", {"entities": []}], ["Cancer from smoking tobacco is considered dependent on mutagens, but significant molecular aspects of smoking\u2010specific, cancer development remain unknown.", {"entities": [[0, 6, "DISEASE"], [120, 126, "DISEASE"]]}], ["We defined sets of coding regions for oncoproteins, tumor suppressor proteins, and cytoskeletal\u2010related proteins that were compared between nonsmokers and smokers, for mutation occurrences, in the lung adenocarcinoma ( LUAD ), head and neck squamous carcinoma ( HNSC ), bladder carcinoma ( BLCA ), and pancreatic adenocarcinoma ( PAAD ) datasets from the cancer genome atlas ( TCGA ).", {"entities": [[202, 216, "DISEASE"], [313, 327, "DISEASE"], [197, 216, "DISEASE"], [250, 259, "DISEASE"], [278, 287, "DISEASE"], [270, 287, "DISEASE"], [355, 361, "DISEASE"]]}], ["We uncovered significant differences in overall mutation rates, and in mutation rates in cytoskeletal protein\u2010related coding regions ( CPCR s, including extracellular matrix protein coding regions), between nonsmokers and smokers in LUAD and HNSC ( P \u00a0<\u00a00.001), raising the question of whether the CPCR mutation differences lead to different clinical courses for nonsmoker and smoker cancers.", {"entities": []}], ["Another important question inspired by these results is, whether high smoker cancer mutation rates would facilitate genotoxicity or neoantigen\u2010based therapies.", {"entities": [[77, 83, "DISEASE"]]}], ["No significant, mutation\u2010based differences were found in the BLCA or PAAD datasets, between nonsmokers and smokers.", {"entities": []}], ["However, a significant difference was uncovered for the average number of overall cancer mutations, in LUAD , for persons who stopped smoking more than 15\u00a0years ago, compared with more recent smokers ( P \u00a0<\u00a00.032).", {"entities": [[82, 88, "DISEASE"]]}], ["Numerous studies have shown that acute particulate air pollution exposure is linked with pulmonary adverse effects, including alterations of pulmonary function, inflammation, and oxidative stress.", {"entities": []}], ["Nootkatone, a constituent of grapefruit, has antioxidant and anti-inflammatory effects.", {"entities": []}], ["However, the effect of nootkatone on lung toxicity has not been reported so far.", {"entities": []}], ["In this study we evaluated the possible protective effects of nootkatone on diesel exhaust particles (DEP)-induced lung toxicity, and the possible mechanisms underlying these effects.", {"entities": []}], ["Mice were intratracheally (i.t.)", {"entities": []}], ["instilled with either DEP (30 \u00b5g/mouse) or saline (control).", {"entities": []}], ["Nootkatone was given to mice by gavage, 1 h before i.t.", {"entities": []}], ["instillation, with either DEP or saline.", {"entities": []}], ["Twenty-four hours following DEP exposure, several physiological and biochemical endpoints were assessed.", {"entities": []}], ["Nootkatone pretreatment significantly prevented the DEP-induced increase in airway resistance in vivo, decreased neutrophil infiltration in bronchoalveolar lavage fluid, and abated macrophage and neutrophil infiltration in the lung interstitium, assessed by histolopathology.", {"entities": []}], ["Moreover, DEP caused a significant increase in lung concentrations of 8-isoprostane and tumor necrosis factor \u03b1, and decreased the reduced glutathione concentration and total nitric oxide activity.", {"entities": []}], ["These actions were all significantly alleviated by nootkatone pretreatment.", {"entities": []}], ["Similarly, nootkatone prevented DEP-induced DNA damage and prevented the proteolytic cleavage of caspase-3.", {"entities": []}], ["Moreover, nootkatone inhibited nuclear factor-kappaB (NF-\u03baB) induced by DEP.", {"entities": []}], ["We conclude that nootkatone prevented the DEP-induced increase in airway resistance, lung inflammation, oxidative stress, and the subsequent DNA damage and apoptosis through a mechanism involving inhibition of NF-\u03baB activation.", {"entities": []}], ["Nootkatone could possibly be considered a beneficial protective agent against air pollution-induced respiratory adverse effects.", {"entities": []}], ["During pregnancy, many women experience sleep problems and anxiety that require treatment.", {"entities": []}], ["The long-term safety for the child of maternal benzodiazepine (BZD) and z-hypnotic use during pregnancy remains controversial.", {"entities": []}], ["We conducted a cohort and a sibling control study using data from the Norwegian Mother and Child Cohort Study.", {"entities": []}], ["Data on use of BZD and z-hypnotics, internalizing and externalizing outcomes, and covariates were collected from mothers at gestational weeks 17 and 30 and when children were 0.5, 1.5, and 3 years of age.", {"entities": []}], ["The total sample consisted of 71,996 children (19,297 siblings) at 1.5 years and 55,081 children (13,779 siblings) at 3 years.", {"entities": []}], ["Short-term use was defined as use in one pregnancy period only.", {"entities": []}], ["Long-term use was defined as use in two or more pregnancy periods.", {"entities": []}], ["Linear full cohort random-effect and sibling-matched fixed-effect regression models were used to compare internalizing and externalizing behavior in children prenatally exposed compared to those unexposed in the full cohort of pregnancies accounting for family clusters, as well as within sibling clusters comparing pregnancies with discordant exposures.", {"entities": []}], ["Propensity score (PS) adjustment included variables on indication for use (sleep problems, symptoms of anxiety and depression) and other potential confounding factors.", {"entities": []}], ["Long-term prenatal exposure to BZD or z-hypnotics was associated with increased internalizing behavior in crude cohort analyses and at age 1.5 years after PS adjustment in sibling-matched fixed-effect models [\u03b2 0.60, 95% confidence interval 0.17\u20130.95].", {"entities": []}], ["Analyses on specific drug groups showed that prenatal exposure to BZD-anxiolytics was associated with increased internalizing problems at both 1.5 years [\u03b2 0.25, 0.01\u20130.49] and 3 years [\u03b2 0.26, 0.002\u20130.52] while exposure to z-hypnotics was not associated with any adverse outcomes after adjustment.", {"entities": []}], ["The findings suggest a moderate association between BZD-anxiolytic exposure and child internalizing problems that is not likely due to stable familial confounding factors.", {"entities": []}], ["We investigated TLR10 expression in human monocytes, THP-1 cells, cultured in hypoxia (3% O 2 ).", {"entities": [[16, 21, "GENE"]]}], ["Levels of both TLR10 mRNA and protein in THP-1 cells cultured in hypoxia were significantly higher than those cultured in normoxia (20% O 2 ).", {"entities": [[15, 20, "GENE"]]}], ["We examined intracellular reactive oxygen species (ROS) content in hypoxic cells, and TLR10 expression in cells treated with hydrogen peroxide (H 2 O 2 ), to determine whether the increase in TLR10 expression observed with hypoxia was due to an increase in intracellular ROS levels.", {"entities": [[86, 91, "GENE"], [192, 197, "GENE"], [86, 91, "GENE"], [192, 197, "GENE"]]}], ["We found that the level of intracellular ROS in cells subject to hypoxia was significantly higher than in normoxia.", {"entities": []}], ["Experiments with ROS synthesis inhibitors revealed that hypoxia induced ROS production is mainly due to NADPH oxidase activity.", {"entities": []}], ["TLR10 mRNA expression was increased by treatment with H 2 O 2 at concentrations ranging from 50 to 250 \u03bcM.", {"entities": [[0, 5, "GENE"]]}], ["We screened the TLR10 promoter and found putative binding sites for transcription factors (TFs), such as NF-\u03baB, NF-AT and AP-1.", {"entities": [[16, 21, "GENE"]]}], ["Next, we examined TF activities using a luciferase reporter assay.", {"entities": [[18, 20, "GENE"]]}], ["Activities of NF-\u03baB, NF-AT and AP-1 in the cells treated with H 2 O 2 were significantly higher than in untreated cells.", {"entities": []}], ["The experiment with TF inhibitors revealed that ROS-induced upregulation of TLR10 expression is mainly due to NF-\u03baB activation.", {"entities": [[20, 22, "GENE"], [76, 81, "GENE"]]}], ["Overall, our results suggest that hypoxia or ROS increase TLR10 expression in human monocytes and the transcriptional activities of NF-\u03baB are involved in this process.", {"entities": [[58, 63, "GENE"]]}], ["Therefore, it is suggested that ROS produced by various exogenous stimuli may play a crucial role in the regulation of expression and function of TLR10 as second messengers.", {"entities": [[146, 151, "GENE"]]}], ["Following restrictions on smoking in vehicles carrying children in several countries, legislation to safeguard minors from second-hand smoke exposure in vehicles is under-consideration or has been implemented across the United Kingdom.", {"entities": []}], ["This article presents the first investigation into social constructions of children, smokers and smoking parents in newsprint media and coverage of debates about protecting children from exposure to second-hand smoke in vehicles.", {"entities": []}], ["Using Scotland as an example, articles on children\u2019s exposure to second-hand smoke published between 1 January 2004 and 16 February 2014 in three Scottish newspapers were identified using Nexis UK.", {"entities": []}], ["In all, 131 articles were thematically coded and analysed.", {"entities": []}], ["Children were portrayed as vulnerable and requiring protection, with few articles highlighting children\u2019s ability to voice concerns about the dangers of smoking.", {"entities": []}], ["Smokers and smoking parents were mainly portrayed in a factual manner, but also frequently as irresponsible and, in some cases, intentionally imposing harm.", {"entities": []}], ["Individual smokers were blamed for their recklessness, with only a small number of articles mentioning the need to assist smokers in quitting.", {"entities": []}], ["Supporters of legislation focused on corresponding discourse, whereas critics directed debates towards established arguments against policy, including individual freedom, privacy and problems of enforcement.", {"entities": []}], ["Focusing on children\u2019s vulnerability to second-hand smoke might have increased support for legislation but risked a side effect of smokers being stigmatised.", {"entities": []}], ["The media and supporters of public health policy are encouraged to consider appropriate approaches to raise awareness of the health harms of second-hand smoke to children while avoiding unintended stigmatisation of those in which they want to encourage behaviour change.", {"entities": []}], ["Published data on influenza in severe acute respiratory infection (SARI) patients are limited.", {"entities": [[18, 27, "DISEASE"]]}], ["We conducted SARI surveillance in central China and estimated hospitalization rates of SARI attributable to influenza by viral type/subtype.", {"entities": [[108, 117, "DISEASE"]]}], ["Surveillance was conducted at four hospitals in Jingzhou, China from 2010 to 2012.", {"entities": []}], ["We enrolled hospitalized patients who had temperature \u226537\u00b73\u00b0C and at least one of: cough, sore throat, tachypnea, difficulty breathing, abnormal breath sounds on auscultation, sputum production, hemoptysis, chest pain, or chest radiograph consistent with pneumonia.", {"entities": [[255, 264, "DISEASE"]]}], ["A nasopharyngeal swab was collected from each case-patient within 24 hours of admission for influenza testing by real-time reverse transcription PCR.", {"entities": [[92, 101, "DISEASE"]]}], ["Of 17 172 SARI patients enrolled, 90% were aged <15 years.", {"entities": []}], ["The median duration of hospitalization was 5 days.", {"entities": []}], ["Of 16 208 (94%) SARI cases tested, 2057 (13%) had confirmed influenza, including 1427 (69%) aged <5 years.", {"entities": [[60, 69, "DISEASE"]]}], ["Multiple peaks of influenza occurred during summer, winter, and spring months.", {"entities": [[18, 27, "DISEASE"]]}], ["Influenza was associated with an estimated 115 and 142 SARI hospitalizations per 100 000 during 2010\u20132011 and 2011\u20132012 [including A(H3N2): 55 and 44 SARI hospitalizations per 100 000; pandemic A(H1N1): 33 SARI hospitalizations per 100 000 during 2010\u20132011; influenza B: 26 and 98 hospitalizations per 100 000], with the highest rate among children aged 6\u201311 months (3603 and 3805 hospitalizations per 100 000 during 2010\u20132011 and 2011\u20132012, respectively).", {"entities": [[0, 9, "DISEASE"], [258, 267, "DISEASE"]]}], ["In central China, influenza A and B caused a substantial number of hospitalizations during multiple periods each year.", {"entities": [[18, 27, "DISEASE"]]}], ["Our findings strongly suggest that young children should be the highest priority group for annual influenza vaccination in China.", {"entities": [[98, 107, "DISEASE"]]}], ["The proinflammatory cytokine, TNF\u03b1, is a crucial mediator of the pathogenesis of several diseases, more so in cases involving the liver wherein it is critical in maintaining liver homeostasis since it is a major determiner of hepatocyte life and death.", {"entities": []}], ["Gene expression profiling serves as an appropriate strategy to unravel the underlying signatures to envisage such varied responses and considering this, gene transcription profiling was examined in control and TNF\u03b1 treated HepG2 cells.", {"entities": []}], ["Microarray experiments between control and TNF\u03b1 treated HepG2 cells indicated that TNF\u03b1 could significantly alter the expression profiling of 140 genes; among those up-regulated, several GO (Gene Ontology) terms related to lipid and fat metabolism were significantly (p<0.01) overrepresented indicating a global preference of fat metabolism within the hepatocyte and those within the down-regulated dataset included genes involved in several aspects of the immune response like immunoglobulin receptor activity and IgE binding thereby indicating a compromise in the immune defense mechanism(s).", {"entities": []}], ["Conserved transcription factor binding sites were identified in identically clustered genes within a common GO term and SREBP-1 and FOXJ2 depicted increased occupation of their respective binding elements in the presence of TNF\u03b1.", {"entities": [[132, 137, "GENE"]]}], ["The interacting network of \u201clipid metabolism, small molecule biochemistry\u201d was derived to be significantly overrepresented that correlated well with the top canonical pathway of \u201cbiosynthesis of steroids\u201d.", {"entities": []}], ["TNF\u03b1 alters the transcriptome profiling within HepG2 cells with an interesting catalog of genes being affected and those involved in lipid and steroid metabolism to be the most favored.", {"entities": []}], ["This study represents a composite analysis of the effects of TNF\u03b1 in HepG2 cells that encompasses the altered transcriptome profiling, the functional analysis of the up- and down- regulated genes and the identification of conserved transcription factor binding sites.", {"entities": []}], ["These could possibly determine TNF\u03b1 mediated alterations mainly the phenotypes of hepatic steatosis and fatty liver associated with several hepatic pathological states.", {"entities": []}], ["We report here a case of strongyloidiasis in a 72-year-old diabetic patient (woman) accompanied by gastrointestinal stromal tumor receiving imatinib therapy, first diagnosed as hypereosinophilic syndrome and treated with steroids for uncontrolled eosinophilia.", {"entities": [[99, 129, "DISEASE"], [195, 203, "DISEASE"], [25, 41, "DISEASE"], [247, 259, "DISEASE"]]}], ["She suffered from lower back pain and intermittent abdominal discomfort with nausea and diagnosed with gastrointestinal stromal tumor.", {"entities": [[103, 133, "DISEASE"]]}], ["After post-operative imatinib treatment eosinophilia persisted, so that steroid therapy was started under an impression of hypereosinophilic syndrome.", {"entities": [[141, 149, "DISEASE"], [40, 52, "DISEASE"]]}], ["In spite of 6 months steroid therapy, eosinophilia persisted.", {"entities": [[38, 50, "DISEASE"]]}], ["Stool examination was performed to rule out intestinal helminth infections.", {"entities": []}], ["Rhabditoid larvae of Strongyloides stercoralis were detected and the patient was diagnosed as strongyloidiasis.", {"entities": [[94, 110, "DISEASE"]]}], ["This diagnosis was confirmed again by PCR.", {"entities": []}], ["The patient was treated with albendazole for 14 days and her abdominal pain and diarrhea improved.", {"entities": [[80, 88, "DISEASE"]]}], ["This case highlights the need for thorough investigation, including molecular approaches, to test for strongyloidiasis before and during steroid therapies.", {"entities": [[102, 118, "DISEASE"]]}], ["Physical activity is important for a healthy lifestyle.", {"entities": []}], ["Although physical activity can delay complications and decrease the burden of the disease, the level of activity of patients with chronic obstructive pulmonary disease (COPD) or type 2 Diabetes Mellitus (DM2) is often far from optimal.", {"entities": [[130, 167, "DISEASE"]]}], ["To stimulate physical activity, a monitoring and feedback tool, consisting of an accelerometer linked to a smart phone and webserver ( It\u2019s LiFe!", {"entities": []}], ["tool), and a counselling protocol for practice nurses in primary care was developed (the Self-management Support Program).", {"entities": []}], ["The main objective of this study is to measure the longitudinal effects of this counselling protocol and the added value of using the tool.", {"entities": []}], ["This three-armed cluster randomised controlled trial with 120 participants with COPD and 120 participants with DM2 (aged 40\u201370), compares the counselling protocol with and without the use of the tool (group 1 and 2) with usual care (group 3).", {"entities": []}], ["Recruitment takes place at GP practices in the southern regions of the Netherlands.", {"entities": []}], ["Randomisation takes place at the practice level.", {"entities": []}], ["The intended sample (three arms of 8 practices) powers the study to detect a 10-minute difference of moderate and intense physical activity per day between groups 1 and 3.", {"entities": []}], ["Participants in the intervention groups have to visit the practice nurse 3\u20134 times for physical activity counselling, in a 4-6-month period.", {"entities": []}], ["Specific activity goals tailored to the individual patient's preferences and needs will be set.", {"entities": []}], ["In addition, participants in group 1 will be instructed to use the tool in daily life.", {"entities": []}], ["The primary outcome, physical activity, will be measured in all groups with a physical activity monitor (PAM).", {"entities": []}], ["Secondary outcomes are quality of life, general - and exercise - self-efficacy, and health status.", {"entities": []}], ["Follow-up will take place after 6 and 9\u00a0months.", {"entities": []}], ["Separately, a process evaluation will be conducted to explore reasons for trial non-participation, and the intervention\u2019s acceptability for participating patients and nurses.", {"entities": []}], ["Results of this study will give insight into the effects of the It\u2019s LiFe!", {"entities": []}], ["monitoring and feedback tool combined with care from a practice nurse for people with COPD or DM2 on physical activity.", {"entities": []}], ["ClinicalTrials.gov: NCT01867970", {"entities": []}], ["Calorie restriction (CR) inhibits inflammation and slows aging in many animal species, but in rodents housed in pathogen-free facilities, CR impairs immunity against certain pathogens.", {"entities": []}], ["However, little is known about the effects of long-term moderate CR on immune function in humans.", {"entities": []}], ["In this multi-center, randomized clinical trial to determine CR's effect on inflammation and cell-mediated immunity, 218 healthy non-obese adults (20-50 y), were assigned 25% CR (n=143) or an ad-libitum (AL) diet (n=75), and outcomes tested at baseline, 12, and 24 months of CR.", {"entities": []}], ["CR induced a 10.4% weight loss over the 2-y period.", {"entities": []}], ["Relative to AL group, CR reduced circulating inflammatory markers, including total WBC and lymphocyte counts, ICAM-1 and leptin.", {"entities": []}], ["Serum CRP and TNF-\u03b1 concentrations were about 40% and 50% lower in CR group, respectively.", {"entities": [[6, 9, "GENE"]]}], ["CR had no effect on the delayed-type hypersensitivity skin response or antibody response to vaccines, nor did it cause difference in clinically significant infections.", {"entities": []}], ["In conclusion, long-term moderate CR without malnutrition induces a significant and persistent inhibition of inflammation without impairing key in vivo indicators of cell-mediated immunity.", {"entities": []}], ["Given the established role of these pro-inflammatory molecules in the pathogenesis of multiple chronic diseases, these CR-induced adaptations suggest a shift toward a healthy phenotype.", {"entities": []}], ["The relative ease of identifying microRNAs and their increasing recognition as important regulators of organogenesis motivate the development of methods to efficiently assess microRNA function during organ morphogenesis.", {"entities": []}], ["In this context, embryonic organ explants provide a reliable and reproducible system that recapitulates some of the important early morphogenetic processes during organ development.", {"entities": []}], ["Here we present a method to target microRNA function in explanted mouse embryonic organs.", {"entities": []}], ["Our method combines the use of peptide-based nanoparticles to transfect specific microRNA inhibitors or activators into embryonic organ explants, with a microRNA pulldown assay that allows direct identification of microRNA targets.", {"entities": []}], ["This method provides effective assessment of microRNA function during organ morphogenesis, allows prioritization of multiple microRNAs in parallel for subsequent genetic approaches, and can be applied to a variety of embryonic organs.", {"entities": []}], ["Patient Activation is defined as the knowledge, skill, and confidence a patient has in managing their health.", {"entities": []}], ["Higher levels of patient activation are associated with better self-management, better health outcomes, and lower healthcare costs.", {"entities": []}], ["Understanding the drivers of patient activation can allow better tailoring of patient support and interventions.", {"entities": []}], ["There are few data on patient activation in UK patients with long-term conditions.", {"entities": []}], ["A prospective cohort design was used.", {"entities": []}], ["Questionnaires were mailed to 12,989 patients over the age of 65\u00a0years with at least one long-term condition in Salford, UK.", {"entities": []}], ["They completed the Patient Activation Measure and self-report measures of: depression, health literacy, social support, health-related quality of life, and impact of multimorbidity.", {"entities": []}], ["We report descriptive data on baseline activation and change over time, and use multivariate regression to model associations with patient activation at baseline and predictors of change in Activation over 6\u00a0months.", {"entities": []}], ["The cohort included 4377 (33.6\u00a0%) older people, of whom 4225 were mailed a further questionnaire at 6\u00a0months; 3390 returned it complete (80.2\u00a0%).", {"entities": []}], ["At baseline, 15\u00a0% self-reported PAM level 1, 16\u00a0% level 2, 45\u00a0% level 3, and 25\u00a0% level 4.", {"entities": []}], ["Across all patients, depression had the strongest association with patient activation.", {"entities": []}], ["Other important factors were: older age, being retired, poor health literacy, health-related quality of life, and social support.", {"entities": []}], ["Total number of self-reported comorbidities and the perceived impact of comorbidities were also important for patients with more than one long-term condition.", {"entities": []}], ["Patient activation scores were reasonably enduring over time ( r \u2009=\u20090.43 between baseline and at six months), although nearly half changed \u2018levels\u2019 of activation over that time.", {"entities": []}], ["Few variables predicted change in activation over 6\u00a0months.", {"entities": []}], ["This is the first large scale assessment of patient activation in the UK.", {"entities": []}], ["Our data may be useful in identifying patients who need support with patient activation, and allow interventions (such as health coaching) to be tailored to better support older patients with long-term conditions who have symptoms of depression, poor social support and impaired health literacy.", {"entities": []}], ["Further analyses of longitudinal studies will be necessary to better understand the causal relationships between patient activation and variables such as depression.", {"entities": []}], ["Many studies have examined the effects of air pollution on daily mortality over the past two decades.", {"entities": []}], ["However, information on the relationship between levels of coarse particles (PM 2.5\u201310 ) and daily mortality is relatively sparse due to the limited availability of monitoring data.", {"entities": []}], ["Furthermore, the results are inconsistent.", {"entities": []}], ["In the current study, the association between coarse particle levels and daily mortality in Taipei, Taiwan\u2019s largest city, which has a subtropical climate, was undertaken for the period 2006\u20132008 using a time-stratified case-crossover analysis.", {"entities": []}], ["For the single pollutant model (without adjustment for other pollutants), PM 2.5\u201310 showed statistically significant association with total mortality both on warm and cool days, with an interquartile range increase associated with a 11% (95% CI = 6%\u201317%) and 4% (95% CI = 1%\u20137%) rise in number of total deaths, respectively.", {"entities": []}], ["In two-pollutant models, PM 2.5\u201310 remained significant effects on total mortality after the inclusion of SO 2 and O 3 both on warm and cool days.", {"entities": []}], ["We observed no significant associations between PM 2.5\u201310 and daily mortality from respiratory diseases both on warm and cool days.", {"entities": []}], ["For daily mortality from circulatory diseases, the effect of PM 2.5\u201310 remained significant when SO 2 or O 3 was added in the regression model both on warm and cool days.", {"entities": []}], ["Future studies of this type in cities with varying climates and cultures are needed.", {"entities": []}], ["Mast cell-associated mediators are generally classified into two groups: the preformed mediators, which are stored in the cells' cytoplasmic granules and are released upon exocytosis, and the newly synthesized mediators, which are not stored but are produced and secreted only after appropriate stimulation of the cell.", {"entities": []}], ["We now report that tumor necrosis factor alpha (TNF-alpha)/cachectin represents a new type of mast cell-associated mediator, in that IgE-dependent mast cell activation results in the rapid release of preformed stores of the cytokine followed by the synthesis and sustained release of large quantities of newly formed TNF-alpha.", {"entities": []}], ["We also demonstrate that challenge with specific antigen induces higher levels of TNF-alpha mRNA at skin sites sensitized with IgE in normal mice or mast cell- reconstituted genetically mast cell-deficient WBB6F1-W/W1' mice than at identically treated sites in WBB6F1-W/W1' mice that are devoid of mast cells.", {"entities": []}], ["These findings identify mast cells as a biologically significant source of TNF-alpha/cachectin during IgE-dependent responses and define a mechanism whereby stimulation of mast cells via the FC epsilon RI can account for both the rapid and sustained release of this cytokine.", {"entities": []}], ["P-21 activated kinases (PAKs) are effectors of Rac1/Cdc42 which coordinate signals from the cell membrane to the nucleus.", {"entities": []}], ["Activation of PAKs drive important signalling pathways including mitogen activated protein kinase, phospoinositide 3-kinase (PI3K/AKT), NF-\u03baB and Wnt/\u03b2-catenin.", {"entities": []}], ["Intestinal PAK1 expression increases with inflammation and malignant transformation, although the biological relevance of PAKs in the development and progression of GI disease is only incompletely understood.", {"entities": [[11, 15, "GENE"]]}], ["This review highlights the importance of altered PAK activation within GI inflammation, emphasises its effect on oncogenic signalling and discusses PAKs as therapeutic targets of chemoprevention.", {"entities": []}], ["To succeed, pregnancies need to initiate immune biases towards T helper 2 (Th2) responses, yet little is known about what establishes this bias.", {"entities": []}], ["Using the Illumina 450 K platform, we explored changes in DNA methylation (DNAm) of Th1, Th2, Th17, and regulatory T cell pathway genes before and during pregnancy.", {"entities": []}], ["Female participants were recruited at birth (1989), and followed through age 18 years and their pregnancy (2011\u20132015).", {"entities": []}], ["Peripheral blood DNAm was measured in 245 girls at 18 years; from among these girls, the DNAm of 54 women was repeatedly measured in the first (weeks 8\u201321, n = 39) and second (weeks 22\u201338, n = 35) halves of pregnancy, respectively.", {"entities": []}], ["M-values (logit-transformed \u03b2-values of DNAm) were analyzed: First, with repeated measurement models, cytosine\u2013phosphate\u2013guanine sites (CpGs) of pathway genes in pregnancy and at age 18 (nonpregnant) were compared for changes ( p \u2264 0.05).", {"entities": []}], ["Second, we tested how many of the 348 pathway-related CpGs changed compared to 10 randomly selected subsets of all other CpGs and compared to 10 randomly selected subsets of other CD4+-related CpGs (348 in each subset).", {"entities": []}], ["Contrasted to the nonpregnant state, 27.7% of Th1-related CpGs changed in the first and 36.1% in the second half of pregnancy.", {"entities": []}], ["Among the Th2 pathway CpGs, proportions of changes were 35.1% (first) and 33.8% (second half).", {"entities": []}], ["The methylation changes suggest involvement of both Th1 and Th2 pathway CpGs in the immune bias during pregnancy.", {"entities": []}], ["Changes in regulatory T cell and Th17 pathways need further exploration.", {"entities": []}], ["Supplemental Digital Content is available in the text Bojungikki-tang, a herbal medicine for strengthening the digestive system, has been widely used in East Asian countries since the Yuan Dynasty in China.", {"entities": []}], ["Moreover, Bojungikki-tang has reportedly exhibited anti-allergy effects in many clinical trials.", {"entities": []}], ["This systematic review will assess the effectiveness and safety of Bojungikki-tang for allergic rhinitis (AR).", {"entities": [[87, 104, "DISEASE"], [96, 104, "DISEASE"]]}], ["Eleven databases, including Asian databases, will be searched for studies conducted through October 2017.", {"entities": []}], ["We will include randomized controlled trials (RCTs) assessing Bojungikki-tang for AR.", {"entities": []}], ["The risk of bias will be evaluated using the Cochrane risk of bias assessment tool, and confidence in the cumulative evidence will be evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) instrument.", {"entities": []}], ["This systematic review will be published in a peer-reviewed journal and will also be disseminated electronically and in print.", {"entities": []}], ["The review will be updated to inform and guide health care practices.", {"entities": []}], ["The protocol for this systematic review has been registered in PROSPERO ( https://www.crd.york.ac.uk/PROSPERO ) under number CRD42017068993.", {"entities": []}], ["Purinergic P2X7 receptor (P2X7R), an ATP-gated cation channel, is unique among all other family members because of its ability to respond to various stimuli and to modulate pro-inflammatory signaling.", {"entities": []}], ["The activation of P2X7R in immune cells is absolutely required for mature interleukin -1beta (IL-1beta) and IL-18 production and release.", {"entities": []}], ["Lung alveoli are lined by the structural alveolar epithelial type I (AEC I) and alveolar epithelial type II cells (AEC II).", {"entities": []}], ["AEC I plays important roles in alveolar barrier protection and fluid homeostasis whereas AEC II synthesizes and secrete surfactant and prevents alveoli from collapse.", {"entities": []}], ["Earlier studies indicated that purinergic P2X7 receptors were specifically expressed in AEC I.", {"entities": []}], ["However, their implication in alveolar functions has not been explored.", {"entities": []}], ["This paper reviews two important signaling pathways of P2X7 receptors in surfactant homeostatsis and Acute Lung Injury (ALI).", {"entities": []}], ["Thus, P2X7R resides at the critical nexus of alveolar pathophysiology.", {"entities": []}], ["Liquorice ingestion often elevates blood pressure, but the detailed haemodynamic alterations are unknown.", {"entities": []}], ["We studied haemodynamic changes induced by liquorice consumption in 20 subjects versus 30 controls with average blood pressures of 120/68 and 116/64 mmHg, respectively.", {"entities": []}], ["Haemodynamic variables were measured in supine position before and after two weeks of liquorice consumption (daily glycyrrhizin dose 290\u2013370 mg) with tonometric recording of radial blood pressure, pulse wave analysis, and whole-body impedance cardiography.", {"entities": []}], ["Thirty age-matched healthy subjects maintaining their normal diet were studied as controls.", {"entities": []}], ["Two weeks of liquorice ingestion elevated peripheral and central systolic and diastolic blood pressure (by 7/4 and 8/4 mmHg, 95% confidence intervals [CI] 2-11/1-8 and 3-13/1-8, respectively, P <0.05), and increased extracellular volume by 0.5 litres ( P <0.05 versus controls).", {"entities": []}], ["Also augmentation index adjusted to heart rate 75/min (from 7% to 11%, 95% CI for change 0.3-7.5, P <0.05) and aortic pulse pressure (by 4 mmHg, 95% CI 1-7, P <0.05) were elevated indicating increased wave reflection from the periphery.", {"entities": []}], ["In contrast, peripheral (\u22123/\u22120.3 mmHg) and central blood pressure (\u22122/\u22120.5 mmHg), aortic pulse pressure (\u22121 mmHg), and augmentation index adjusted to heart rate 75/min (from 9% to 7%) decreased numerically but not statistically significantly without changes in extracellular volume in the control group.", {"entities": []}], ["Heart rate, systemic vascular resistance, cardiac output, and pulse wave velocity did not differ between the groups.", {"entities": []}], ["Two weeks of daily liquorice consumption increased extracellular volume, amplified pressure wave reflection from the periphery, and elevated central systolic and diastolic blood pressure.", {"entities": []}], ["EU Clinical Trials Register EudraCT 2006-002065-39</url> ClinicalTrials.gov NCT01742702", {"entities": []}], ["Although allergen specific immunotherapy (SIT) represents the only immune- modifying and curative option available for patients with allergic rhinitis (AR), the optimal schedule for specific subcutaneous immunotherapy (SCIT) is still unknown.", {"entities": [[133, 150, "DISEASE"], [142, 150, "DISEASE"]]}], ["The objective of this study is to systematically assess the efficacy and safety of cluster SCIT for patients with AR.", {"entities": []}], ["By searching PubMed, EMBASE and the Cochrane clinical trials database from 1980 through May 10th, 2013, we collected and analyzed the randomized controlled trials (RCTs) of cluster SCIT to assess its efficacy and safety.", {"entities": []}], ["Eight trials involving 567 participants were included in this systematic review.", {"entities": []}], ["Our meta-analysis showed that cluster SCIT have similar effect in reduction of both rhinitis symptoms and the requirement for anti-allergic medication compared with conventional SCIT, but when comparing cluster SCIT with placebo, no statistic significance were found in reduction of symptom scores or medication scores.", {"entities": [[84, 92, "DISEASE"]]}], ["Some caution is required in this interpretation as there was significant heterogeneity between studies.", {"entities": []}], ["Data relating to Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in 3 included studies were analyzed, which consistently point to the efficacy of cluster SCIT in improving quality of life compared to placebo.", {"entities": []}], ["To assess the safety of cluster SCIT, meta-analysis showed that no differences existed in the incidence of either local adverse reaction or systemic adverse reaction between the cluster group and control group.", {"entities": []}], ["Based on the current limited evidence, we still could not conclude affirmatively that cluster SCIT was a safe and efficacious option for the treatment of AR patients.", {"entities": []}], ["Further large-scale, well-designed RCTs on this topic are still needed.", {"entities": []}], ["Trials of aspiration thrombectomy (AT) prior to primary percutaneous intervention (PCI) in patients with ST-segment elevation MI (STEMI) have shown apparently inconsistent results and therefore generated uncertainty and controversy.", {"entities": []}], ["To summarize the effects of AT prior to PCI versus conventional PCI in STEMI patients.", {"entities": []}], ["Searches of MEDLINE, EMBASE and CENTRAL to June 2015 and review of reference lists of previous reviews.", {"entities": []}], ["We included randomized controlled trials (RCTs) comparing AT prior to PCI with conventional PCI alone.", {"entities": []}], ["Pairs of reviewers independently screened eligible articles; extracted data; and assessed risk of bias.", {"entities": []}], ["We used the GRADE approach to rate overall certainty of the evidence.", {"entities": []}], ["Among 73 potential articles identified, 20 trials including 21,660 patients were eligible; data were complete for 20,866 patients.", {"entities": []}], ["Moderate-certainty evidence suggested a non statistically significant decrease in overall mortality (risk ratio (RR) 0.89, 95\u00a0% confidence interval, 0.78 to 1.01, risk difference (RD) 4/1,000 over 6\u00a0months), no impact on recurrent MI (RR 0.94, 95\u00a0% CI, 0.79 to 1.12) or major bleeding (RR 1.02, 95\u00a0% CI, 0.78 to 1.35), and an increase in stroke (RR 1.56, 95\u00a0% CI, 1.09 to 2.24, RD 3/1,000 over 6\u00a0months).", {"entities": [[180, 182, "GENE"], [378, 380, "GENE"], [180, 182, "GENE"], [378, 380, "GENE"]]}], ["Moderate certainty evidence suggests aspiration thrombectomy is associated with a possible small decrease in mortality (4 less deaths/1000 over 6\u00a0months) and a small increase in stroke (3 more strokes/1000 over 6\u00a0months).", {"entities": []}], ["Because absolute effects are very small and closely balanced, thrombectomy prior to primary PCI should not be used as a routine strategy.", {"entities": []}], ["A minor but significant fraction of samples subjected to next-generation sequencing methods are either mixed-up or cross-contaminated.", {"entities": []}], ["These events can lead to false or inconclusive results.", {"entities": []}], ["We have therefore developed SASI-Seq; a process whereby a set of uniquely barcoded DNA fragments are added to samples destined for sequencing.", {"entities": []}], ["From the final sequencing data, one can verify that all the reads derive from the original sample(s) and not from contaminants or other samples.", {"entities": []}], ["By adding a mixture of three uniquely barcoded amplicons, of different sizes spanning the range of insert sizes one would normally use for Illumina sequencing, at a spike-in level of approximately 0.1%, we demonstrate that these fragments remain intimately associated with the sample.", {"entities": []}], ["They can be detected following even the tightest size selection regimes or exome enrichment and can report the occurrence of sample mix-ups and cross-contamination.", {"entities": []}], ["As a consequence of this work, we have designed a set of 384 eleven-base Illumina barcode sequences that are at least 5 changes apart from each other, allowing for single-error correction and very low levels of barcode misallocation due to sequencing error.", {"entities": []}], ["SASI-Seq is a simple, inexpensive and flexible tool that enables sample assurance, allows deconvolution of sample mix-ups and reports levels of cross-contamination between samples throughout NGS workflows.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2164-15-110) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Excessive fluid intake can lead to water intoxication, electrolyte abnormalities, exacerbation of heart failure and anatomical changes in the urinary tract that may present diagnostic and therapeutic challenges for patients and physicians.", {"entities": []}], ["Although the development of nonobstructive hydronephrosis is recognized in patients with central and nephrogenic diabetes insipidus, pregnancy or psychiatric polydipsia, it is rarely a diagnostic consideration in healthy individuals with excessive fluid ingestion.", {"entities": [[101, 131, "DISEASE"], [43, 57, "DISEASE"], [113, 131, "DISEASE"]]}], ["We now present what we believe to be the first report of nonobstructive hydronephrosis associated with social polydipsia.", {"entities": [[72, 86, "DISEASE"]]}], ["A 53-year-old African-American woman with moderate back pain was found to have bilateral moderate hydronephrosis and hydroureter by abdominal computed tomography.", {"entities": [[98, 112, "DISEASE"]]}], ["She underwent ureteral stent placement followed by exploratory laparoscopy with lysis of adhesions and a right oophorectomy, without resolution of the nonobstructive hydronephrosis.", {"entities": [[166, 180, "DISEASE"]]}], ["A careful assessment revealed a social habit of consuming approximately 5.5L of fluid daily in an effort to remain hydrated in accordance with public health service announcements.", {"entities": []}], ["It was recommended that the patient reduce her fluid intake.", {"entities": []}], ["A repeat ultrasound after six weeks revealed complete resolution of the bilateral hydronephrosis and hydroureter.", {"entities": [[82, 96, "DISEASE"]]}], ["Recognition of the nonobstructive nature of hydronephrosis caused by polydipsia in healthy individuals is important to prevent unnecessary interventions.", {"entities": [[44, 58, "DISEASE"]]}], ["Coeliac disease might affect school performance due to its effect on cognitive performance and related health consequences that might increase school absenteeism.", {"entities": []}], ["The aim of this study was to investigate whether children with coeliac disease performed differently on completion of ninth grade in school compared with children without coeliac disease.", {"entities": []}], ["Analysis was performed on a population of 445 669 children born in Sweden between 1991 and 1994 of whom 1767 were diagnosed with coeliac disease.", {"entities": []}], ["School performance at ninth grade was the outcome and coeliac disease was the exposure.", {"entities": []}], ["Other covariates included sex, Apgar score at 5\u2009min, small for gestational age, year of birth, family type, parental education and income.", {"entities": []}], ["There was no association between coeliac disease and school performance at ninth grade (adjusted coefficient \u22122.4, 95%\u2009CI 5.1 to 0.4).", {"entities": []}], ["A weak association was established between late coeliac diagnosis and higher grades, but this disappeared after adjusting for parent socioeconomic conditions.", {"entities": []}], ["Being small for gestational age affected performance negatively (adjusted coefficient \u22126.9, 95%\u2009CI 8.0 to 5.7).", {"entities": []}], ["Grade scores were significantly lower in children living with a single parent (adjusted coefficient \u221220.6, 95%\u2009CI 20.9 to 20.2), compared with those with married/cohabiting parents.", {"entities": []}], ["A positive association was found between scores at ninth grade and parental education and income.", {"entities": []}], ["Coeliac disease diagnosis during childhood is not associated with poor school performance at ninth grade.", {"entities": []}], ["The circadian clock regulates metabolic homeostasis and its disruption predisposes to obesity and other metabolic diseases.", {"entities": [[86, 93, "DISEASE"]]}], ["However, the effect of phase shifts on metabolism is not completely understood.", {"entities": []}], ["We examined whether alterations in the circadian rhythm caused by phase shifts induce metabolic changes in crucial genes that would predispose to obesity.", {"entities": [[146, 153, "DISEASE"]]}], ["Three-month-old rats were maintained on a standard diet under lighting conditions with chronic phase shifts consisting of advances, delays or advances plus delays.", {"entities": []}], ["Serum leptin, insulin and glucose levels decreased only in rats subjected to advances.", {"entities": []}], ["The expression of the clock gene Bmal 1 increased in the hypothalamus, white adipose tissue (WAT), brown adipose tissue (BAT) and liver of the advanced group compared to control rats.", {"entities": []}], ["The advanced group showed an increase in hypothalamic AgRP and NPY mRNA, and their lipid metabolism gene profile was altered in liver, WAT and BAT.", {"entities": [[54, 58, "GENE"], [63, 66, "GENE"]]}], ["WAT showed an increase in inflammation and ER stress and brown adipocytes suffered a brown-to-white transformation and decreased UCP-1 expression.", {"entities": []}], ["Our results indicate that chronic phase advances lead to significant changes in neuropeptides, lipid metabolism, inflammation and ER stress gene profile in metabolically relevant tissues such as the hypothalamus, liver, WAT and BAT.", {"entities": []}], ["This highlights a link between alteration of the circadian rhythm and metabolism at the transcriptional level.", {"entities": []}], ["The epidemiology of diseases associated with chemical waste disposal sites has often been delayed for years after the affected community became aware of the exposure.", {"entities": []}], ["Frequently, this has resulted in an aroused neighborhood community that is distrustful of those public agencies and officials responsible for protecting their health.", {"entities": []}], ["It is thus important that positive steps be taken to alleviate the antagonism and to involve the community in an active and constructive role in the epidemiology study.", {"entities": []}], ["This paper presents a case history of such an incident and highlights some of the lessons learned.", {"entities": []}], ["The first steps were to involve and inform the community.", {"entities": []}], ["A citizen and industry advisory committee was formed to participate in the work, publish a newsletter, and conduct regular community meetings.", {"entities": []}], ["The newsletter and the community meetings were used to identify problems and to explain them; to describe uncertainties of a scientific as well as of political or financial nature; to involve community leaders, including those distrustful; to conduct an epidemiologic census and a neighborhood environmental exposure survey.", {"entities": []}], ["The end results were a defusing of the antagonism toward authorities, complete acceptance by the community of the merit of the report, a higher quality of report than might otherwise have been possible, and the freedom to move toward alleviating the problems of the disposal site.", {"entities": []}], ["To inform potential pathophysiological mechanisms of air pollution effects on cardiovascular disease (CVD), we investigated short-term associations between ambient air pollution and a range of cardiovascular events from three national databases in England and Wales.", {"entities": []}], ["Using a time-stratified case-crossover design, over 400\u2005000 myocardial infarction (MI) events from the Myocardial Ischaemia National Audit Project (MINAP) database, over 2 million CVD emergency hospital admissions and over 600\u2005000 CVD deaths were linked with daily mean concentrations of carbon monoxide (CO), nitrogen dioxide (NO 2 ), particulate matter less than 10\u2005\u03bcm in aerodynamic diameter (PM 10 ), particulate matter less than 2.5\u2005\u03bcm in aerodynamic diameter (PM 2.5 ) and sulfur dioxide (SO 2 ), and daily maximum of 8-hourly running mean of O 3 measured at the nearest air pollution monitoring site to the place of residence.", {"entities": [[60, 81, "DISEASE"]]}], ["Pollutant effects were modelled using lags up to 4\u2005days and adjusted for ambient temperature and day of week.", {"entities": []}], ["For mortality, no CVD outcome analysed was clearly associated with any pollutant, except for PM 2.5 with arrhythmias, atrial fibrillation and pulmonary embolism.", {"entities": [[142, 160, "DISEASE"]]}], ["With hospital admissions, only NO 2 was associated with a raised risk: CVD 1.7% (95% CI 0.9 to 2.6), non-MI CVD 2.0% (1.1 to 2.9), arrhythmias 2.9% (0.6 to 5.2), atrial fibrillation 2.8% (0.3 to 5.4) and heart failure 4.4% (2.0 to 6.8) for a 10th\u201390th centile increase.", {"entities": []}], ["With MINAP, only NO 2 was associated with an increased risk of MI, which was specific to non-ST-elevation myocardial infarction (non-STEMIs): 3.6% (95% CI 0.4 to 6.9).", {"entities": [[106, 127, "DISEASE"]]}], ["This study found no clear evidence for pollution effects on STEMIs and stroke, which ultimately represent thrombogenic processes, though it did for pulmonary embolism.", {"entities": [[148, 166, "DISEASE"]]}], ["The strongest associations with air pollution were observed with selected non-MI outcomes.", {"entities": []}], ["This study examines trends in healthcare expenditure in adults with chronic kidney disease (CKD) and other kidney diseases (OKD) in the U.S. from 2002 to 2011.", {"entities": [[76, 90, "DISEASE"]]}], ["One hundred and eighty-seven thousand, three hundred and fourty-one adults aged \u226518 from the Medical Expenditure Panel Survey (MEPS) Household Component were analyzed.", {"entities": []}], ["CKD and OKD were based on ICD-9 or CCC codes.", {"entities": []}], ["A novel two-part model was used to estimate the likelihood of any healthcare use and total expenditures.", {"entities": []}], ["Covariates included individual demographics and comorbidities.", {"entities": []}], ["Approximately 711 adults surveyed from 2002 to 2011 had CKD and 3693 had OKD.", {"entities": []}], ["CKD was more likely among Non-Hispanic Blacks (NHB), Midwest and Western residents while OKD was more likely among Non-Hispanic Whites (NHW), Hispanics, married and Northeast residents.", {"entities": []}], ["Both CKD and OKD were more likely in \u226545\u00a0years, males, widowed/divorced/single, \u2264high school educated, publicly insured, Southern residents, poor and low income individuals.", {"entities": []}], ["All comorbidities were more likely among people with CKD and OKD.", {"entities": []}], ["Unadjusted analysis for mean expenditures for CKD and OKD vs. no kidney disease was $39,873 and $13,247 vs. $5411 for the pooled sample.", {"entities": [[65, 79, "DISEASE"]]}], ["After adjusting for covariates as well as time, individuals with CKD had $17,472 and OKD $5014 higher expenditures, while adjusted mean expenditures increased by $293 to $658 compared to the reference year group.", {"entities": []}], ["Unadjusted yearly expenditures for CKD and OKD in the US population were approximately $24.6 and $48.1 billion, while adjusted expenditures were approximately $10.7 and $18.2 billion respectively.", {"entities": []}], ["CKD and OKD are significant cost-drivers and impose a profound economic burden to the US population.", {"entities": []}], ["A sensitive and highly multiplex method to directly measure RNA sequence abundance without requiring reverse transcription would be of value for a number of biomedical applications, including high throughput small molecule screening, pathogen transcript detection and quantification of short/degraded RNAs.", {"entities": []}], ["R NA A nnealing, S election and L igation (RASL) assays, which are based on RNA template-dependent oligonucleotide probe ligation, have been developed to meet this need, but technical limitations have impeded their adoption.", {"entities": []}], ["Whereas DNA ligase-based RASL assays suffer from extremely low and sequence-dependent ligation efficiencies that compromise assay robustness, Rnl2 can join a fully DNA donor probe to a 3\u2032-diribonucleotide-terminated acceptor probe with high efficiency on an RNA template strand.", {"entities": []}], ["Rnl2-based RASL exhibits sub-femtomolar transcript detection sensitivity, and permits the rational tuning of probe signals for optimal analysis by massively parallel DNA sequencing (RASL-seq).", {"entities": []}], ["A streamlined Rnl2-based RASL-seq protocol was assessed in a small molecule screen using 77 probe sets designed to monitor complex human B cell phenotypes during antibody class switch recombination.", {"entities": []}], ["Our data demonstrate the robustness, cost-efficiency and broad applicability of Rnl2-based RASL assays.", {"entities": []}], ["Neurodevelopmental changes over the lifespan, from childhood through adulthood into old age, have important implications for the onset, presentation, course, and treatment of anxiety disorders.", {"entities": []}], ["This article presents data on anxiety disorders as they appear in older adults, as compared with earlier in life.", {"entities": []}], ["In this article, we focus on aging-related changes in the epidemiology, presentation, and treatment of anxiety disorders.", {"entities": []}], ["Also, this article describes some of the gaps and limitations in our understanding and suggests research directions that may elucidate the mechanisms of anxiety disorder development later in life.", {"entities": [[153, 169, "DISEASE"]]}], ["Finally we describe optimal management of anxiety disorders across the lifespan, in \u201ceight simple steps\u201d for practitioners.", {"entities": []}], ["Neonatal outcomes can be directly and indirectly affected by caesarean delivery (CD).", {"entities": []}], ["Data on CD rates in semi-urban and rural hospitals in resource-limited settings are scarce and yet are needed to better guide the care of women and neonates in these settings.", {"entities": []}], ["we carried out this study to determine the frequency of CD, its indications and the frequency of the various adverse neonatal outcomes (ANO) in the Limbe Regional Hospital (LRH) and the Buea Regional Hospital (BRH), Cameroon.", {"entities": []}], ["We also assessed the relationship between the indication for CD and ANO in the said hospitals.", {"entities": []}], ["This was a hospital-based retrospective and prospective cross-sectional study using descriptive and analytic methods conducted in the LRH and the BRH maternity units within a nine months period in 2015.", {"entities": []}], ["Informed consent was obtainedfrom mothers of the neonates.", {"entities": []}], ["Data analyses were performed using Epi-Info 3.5.4 software.", {"entities": []}], ["We recruited 199 neonates born through CD.", {"entities": []}], ["The prevalence of CD was 13.3% with cephalopelvic disproportion (CPD) being the most frequent (32.2%) indication for CD.", {"entities": [[65, 68, "GENE"]]}], ["There were 52 (26.1%) ANO following CD and respiratory distress was the most common 24 (46.2%) of all ANO.", {"entities": []}], ["Emergency indications for CD were associated with more ANO 49 (34.5%) as compared to elective indications for CD 3 (5.3%) [p-value<0.001].", {"entities": []}], ["We noted a significant association between indications for CD and the various type of ANO, with CPD having the worse prognostic neonatal outcomes 30.8% [p-value=0.02].", {"entities": [[96, 99, "GENE"]]}], ["The prevalence of ANO associated with CD in our hospitals was high with a worrying prognosis.", {"entities": []}], ["While the exact reasons are unknown, the creation of well-equipped neonatal units with trained staff, may contribute to reduce neonatal morbidity and fatalities.", {"entities": []}], ["Furthermore, the association of CPD to worse prognostic neonatal outcomes calls for clinicians, to consider additional management options, such as antibiotic prophylaxis and oxygen therapy to the neonates, prior to CD.", {"entities": [[32, 35, "GENE"]]}], ["Oxidative stress is recognized to be one of predisposing factor in the pathogenesis of COPD.", {"entities": []}], ["The oxidant/antioxidant imbalance is significantly pronounced in patients with COPD exacerbation.", {"entities": []}], ["N-acetylcysteine (NAC) seems to be able to reduce COPD exacerbations by modulating the oxidative stress in addition to its well-known mucolytic activity, but there are discordant findings on the actual anti-oxidant activity of NAC.", {"entities": []}], ["The anti-oxidant effect of NAC and its impact on the inflammatory response have been pharmacologically characterized on a human ex vivo model of COPD exacerbation induced by lipopolysaccharide (LPS).", {"entities": []}], ["NAC prevented the desensitization induced by LPS incubation on the contractile tone in linear concentration-response manner.", {"entities": []}], ["Concentrations of NAC \u22651\u00a0\u03bcM reduced the pro-oxidant response (peroxidase activity, hydrogen peroxide, malondialdehyde, nitric oxide), and improved the anti-oxidant response (total anti-oxidant capacity, glutathione, superoxide dismutase) induced by LPS.", {"entities": []}], ["Lower concentrations of NAC (<1\u00a0\u03bcM) did not modulate the bronchial oxidative imbalance.", {"entities": []}], ["Concentrations of NAC \u2265300\u00a0\u03bcM inhibited the inflammatory response (release of IL-1\u03b2, IL-8, and TNF-\u03b1) of human airways induced by the overnight stimulation with LPS, whereas lower concentrations of NAC (\u22651\u00a0\u03bcM) were sufficient to reduce the release of IL-6 elicited by LPS.", {"entities": []}], ["Both the anti-oxidant effect and the anti-inflammatory effect of NAC were inversely correlated with the release of NKA.", {"entities": []}], ["The findings of this study suggest that NAC may have a role in modulating the detrimental effect induced by LPS in course of COPD exacerbation.", {"entities": []}], ["It may elicit both anti-oxidant and anti-inflammatory effects when administered at high concentrations.", {"entities": []}], ["Contradictory arguments regarding the benefits and harm of insecticides, especially DDT, have caused concerns in different societal circles, threatening to undermine the achievements of the indoor residual spraying (IRS) programme in South Africa.", {"entities": []}], ["These concerns were exacerbated by the screening of a documentary on South African Broadcasting Corporation (SABC) Television with anti-DDT sentiments.", {"entities": []}], ["Consequently, Limpopo Malaria Control Programme (LMCP) Management advocated for an investigation to determine the potential effect of such campaigns on vector-control personnel\u2019s knowledge and perceived effects of insecticides on human health, with a view to improving the educational materials designed for use in training vector-control personnel.", {"entities": [[22, 29, "DISEASE"]]}], ["The study was a cross-sectional descriptive survey using a structured field-piloted questionnaire, administered to 233 randomly selected vector-control personnel.", {"entities": []}], ["Ethical clearance was granted by the University of KwaZulu-Natal.", {"entities": []}], ["Approval for the study was granted by the Department of Health, Limpopo.", {"entities": []}], ["Participation in the study was voluntary and all respondents signed informed consent.", {"entities": []}], ["Descriptive statistics were used to analyse the collected data.", {"entities": []}], ["Most respondents (96.6%) had a positive perception of IRS as a method to control malaria.", {"entities": [[81, 88, "DISEASE"]]}], ["Despite their positive perception, 93.6% viewed IRS insecticides to be potentially harmful to the users.", {"entities": []}], ["DDT was perceived to cause long-term reproductive and respiratory effects, whereas alpha-cypermethrin and deltamethrin were largely associated with skin irritation/itchiness and skin burn.", {"entities": []}], ["Study participants were more worried about DDT\u2019s potential effects on their reproductive system, including poor sexual performance, decline in libido, miscarriage and bearing children with genetic defects.", {"entities": []}], ["However, none reported personal experience of bearing a child with genetic defects or miscarriage.", {"entities": []}], ["Most anti-insecticide messages, especially relating to DDT, emanated from sources external to the LMCP, mainly through radio (62%) and television (33.9%) and about 70% believed such messages.", {"entities": []}], ["While most respondents preferred to work with a moderately itchy deltamethrin, DDT was admittedly the most effective insecticide.", {"entities": []}], ["Vector-control personnel faced health and ethical dilemmas, in that, while they perceived insecticides used for IRS in Limpopo to be potentially harmful to the health of users, as purported through media, they also viewed IRS using insecticides to be effective in controlling malaria.", {"entities": [[276, 283, "DISEASE"]]}], ["The stable lineage commitment of na\u00efve T helper cells to a hybrid Th1/2 phenotype reveals the cell-intrinsic reconciliation of two opposing T cell differentiation programs and provides a self-limiting mechanism to dampen immunopathology.", {"entities": []}], ["Differentiated T helper (Th) cell lineages are thought to emerge from alternative cell fate decisions.", {"entities": []}], ["However, recent studies indicated that differentiated Th cells can adopt mixed phenotypes during secondary immunological challenges.", {"entities": []}], ["Here we show that natural primary immune responses against parasites generate bifunctional Th1 and Th2 hybrid cells that co-express the lineage-specifying transcription factors T-bet and GATA-3 and co-produce Th1 and Th2 cytokines.", {"entities": []}], ["The integration of Th1-promoting interferon (IFN)-\u03b3 and interleukin (IL)-12 signals together with Th2-favoring IL-4 signals commits naive Th cells directly and homogeneously to the hybrid Th1/2 phenotype.", {"entities": []}], ["Specifically, IFN-\u03b3 signals are essential for T-bet in vitro and in vivo by breaking the dominance of IL-4 over IL-12 signals.", {"entities": []}], ["The hybrid Th1/2 phenotype is stably maintained in memory cells in vivo for months.", {"entities": []}], ["It resists reprogramming into classic Th1 or Th2 cells by Th1- or Th2-promoting stimuli, which rather induce quantitative modulations of the combined Th1 and Th2 programs without abolishing either.", {"entities": []}], ["The hybrid phenotype is associated with intermediate manifestations of both Th1 and Th2 cell properties.", {"entities": []}], ["Consistently, hybrid Th1/2 cells support inflammatory type-1 and type-2 immune responses but cause less immunopathology than Th1 and Th2 cells, respectively.", {"entities": []}], ["Thus, we propose the self-limitation of effector T cells based on the stable cell-intrinsic balance of two opposing differentiation programs as a novel concept of how the immune system can prevent excessive inflammation.", {"entities": []}], ["T helper (Th) cells, a subgroup of white blood cells important in the immune system, can differentiate into diverse lineages, for example Th1 and Th2, whose effector mechanisms target different types of pathogens but cause problems if not properly regulated.", {"entities": []}], ["Lineage commitment is driven by cytokine signals that control the expression of distinct lineage-specifying \u201cmaster regulator\u201d transcription factor molecules.", {"entities": []}], ["Lineage commitment is thought to reflect alternative cell-fate decisions because the initiated differentiation programs have self-amplifying and mutually repressive features.", {"entities": []}], ["Here we show that the Th1 and Th2 differentiation programs are more compatible with each other than previously thought.", {"entities": []}], ["Individual naive T cells can simultaneously integrate Th1- and Th2-polarizing signals and develop into hybrid Th1/2 cells that stably co-express both the Th1 master regulator T-bet and the Th2 master regulator GATA-3.", {"entities": []}], ["We find that hybrid Th1/2 cells arise naturally during parasite infections and that the two opposing differentiation programs can stably co-exist in resting memory Th1/2 cells for periods of months.", {"entities": []}], ["Th1- or Th2-polarizing stimuli induced quantitative modulations in the hybrid state but did not extinguish either program.", {"entities": []}], ["The cell-intrinsic antagonism gives the hybrid Th1/2 cells properties that are quantitatively intermediate between those of Th1 and Th2 cells.", {"entities": []}], ["Thus, in typical Th1 and Th2 immune responses, hybrid Th1/2 cells cause less immunopathology than their classic Th1 or Th2 counterparts, demonstrating a cell-intrinsic self-limiting mechanism that can prevent excessive inflammation.", {"entities": []}], ["Parkinson\u2019s disease (PD) is the second most common neurodegenerative disorder affecting the senile population with manifestation of motor disability and cognitive impairment.", {"entities": []}], ["Reactive oxygen species (ROS) is implicated in the progression of oxidative stress-related apoptosis and cell death of the midbrain dopaminergic neurons.", {"entities": []}], ["Its interplay with mitochondrial functionality constitutes an important aspect of neuronal survival in the perspective of PD.", {"entities": []}], ["Edible bird\u2019s nest (EBN) is an animal-derived natural food product made of saliva secreted by swiftlets from the Aerodamus genus.", {"entities": []}], ["It contains bioactive compounds which might confer neuroprotective effects to the neurons.", {"entities": []}], ["Hence this study aims to investigate the neuroprotective effect of EBN extracts in the neurotoxin-induced in vitro PD model.", {"entities": []}], ["EBN was first prepared into pancreatin-digested crude extract and water extract.", {"entities": []}], ["In vitro PD model was generated by exposing SH-SY5Y cells to neurotoxin 6-hydroxydopamine (6-OHDA).", {"entities": []}], ["Cytotoxicity of the extracts on SH-SY5Y cells was tested using MTT assay.", {"entities": []}], ["Then, microscopic morphological and nuclear examination, cell viability test and ROS assay were performed to assess the protective effect of EBN extracts against 6-OHDA-induced cellular injury.", {"entities": []}], ["Apoptotic event was later analysed with Annexin V-propidium iodide flow cytometry.", {"entities": []}], ["To understand whether the mechanism underlying the neuroprotective effect of EBN was mediated via mitochondrial or caspase-dependent pathway, mitochondrial membrane potential (MMP) measurement and caspase-3 quantification were carried out.", {"entities": []}], ["Cytotoxicity results showed that crude EBN extract did not cause SH-SY5Y cell death at concentrations up to 75\u00a0\u03bcg/ml while the maximum non-toxic dose (MNTD) of water extract was double of that of crude extract.", {"entities": []}], ["Morphological observation and nuclear staining suggested that EBN treatment reduced the level of 6-OHDA-induced apoptotic changes in SH-SY5Y cells.", {"entities": []}], ["MTT study further confirmed that cell viability was better improved with crude EBN extract.", {"entities": []}], ["However, water extract exhibited higher efficacy in ameliorating ROS build up, early apoptotic membrane phosphatidylserine externalization as well as inhibition of caspase-3 cleavage.", {"entities": []}], ["None of the EBN treatment had any effect on MMP.", {"entities": []}], ["Current findings suggest that EBN extracts might confer neuroprotective effect against 6-OHDA-induced degeneration of dopaminergic neurons, particularly through inhibition of apoptosis.", {"entities": []}], ["Thus EBN may be a viable nutraceutical option to protect against oxidative stress-related neurodegenerative disorders such as PD.", {"entities": []}], ["The role of B-lymphocytes in chemical-induced asthma is largely unknown.", {"entities": [[46, 52, "DISEASE"]]}], ["Recent work demonstrated that transferring B lymphocytes from toluene diisocyanate (TDI)-sensitized mice into na\u00efve mice, B cell KO mice and SCID mice, triggered an asthma-like response in these mice after a subsequent TDI-challenge.", {"entities": [[165, 171, "DISEASE"]]}], ["We applied two-dimensional difference gel electrophoresis (2D-DIGE) to describe the \u201csensitized signature\u201d of B lymphocytes comparing TDI-sensitized mice with control mice.", {"entities": []}], ["Sixteen proteins were identified that were significantly up- or down-regulated in B lymphocytes of sensitized mice.", {"entities": []}], ["Particularly differences in the expression of cyclophilin A, cofilin 1 and zinc finger containing CCHC domain protein 11 could be correlated to the function of B lymphocytes as initiators of T lymphocyte independent asthma-like responses.", {"entities": [[216, 222, "DISEASE"]]}], ["This study revealed important alterations in the proteome of sensitized B cells in a mouse model of chemical-induced asthma, which will have an important impact on the B cell function.", {"entities": [[117, 123, "DISEASE"]]}], ["Drug adverse events (AEs) are a major health threat to patients seeking medical treatment and a significant barrier in drug discovery and development.", {"entities": []}], ["AEs are now required to be submitted during clinical trials and can be extracted from ClinicalTrials.gov ( https://clinicaltrials.gov/ ), a database of clinical studies around the world.", {"entities": []}], ["By extracting drug and AE information from ClinicalTrials.gov and structuring it into a database, drug-AEs could be established for future drug development and repositioning.", {"entities": []}], ["To our knowledge, current AE databases contain mainly U.S. Food and Drug Administration (FDA)-approved drugs.", {"entities": []}], ["However, our database contains both FDA-approved and experimental compounds extracted from ClinicalTrials.gov .", {"entities": []}], ["Our database contains 8,161 clinical trials of 3,102,675 patients and 713,103 reported AEs.", {"entities": []}], ["We extracted the information from ClinicalTrials.gov using a set of python scripts, and then used regular expressions and a drug dictionary to process and structure relevant information into a relational database.", {"entities": []}], ["We performed data mining and pattern analysis of drug-AEs in our database.", {"entities": []}], ["Our database can serve as a tool to assist researchers to discover drug-AE relationships for developing, repositioning, and repurposing drugs.", {"entities": []}], ["To study the prevalence of tobacco use among teenagers, to evaluate a tobacco prevention programme and to study factors related to participation in the prevention programme.", {"entities": []}], ["Population-based prospective cohort study.", {"entities": []}], ["Within the Obstructive Lung disease in Northern Sweden (OLIN) studies, a cohort study about asthma in schoolchildren started in 2006.", {"entities": [[92, 98, "DISEASE"]]}], ["All children aged 7\u20138\u2005years in three municipalities were invited to a questionnaire survey and 2585 (96%) participated.", {"entities": []}], ["The cohort was followed up at age 11\u201312\u2005years (n=2612, 95% of invited) and 14\u201315\u2005years (n=2345, 88% of invited).", {"entities": []}], ["In 2010, some of the children in the OLIN cohort (n=447) were invited to a local tobacco prevention programme and 224 (50%) chose to participate.", {"entities": []}], ["At the age of 14\u201315\u2005years, the prevalence of daily smoking was 3.5%.", {"entities": []}], ["Factors related to smoking were female sex, having a smoking mother, participation in sports and lower parental socioeconomic status (SES).", {"entities": []}], ["The prevalence of using snus was 3.3% and risk factors were male sex, having a smoking mother, having a snus-using father and non-participation in the prevention programme.", {"entities": []}], ["In the prevention programme, the prevalence of tobacco use was significantly lower among the participants compared with the controls in the cohort.", {"entities": []}], ["Factors related to non-participation were male sex, having a smoking mother, lower parental SES and participation in sports.", {"entities": []}], ["The prevalence of tobacco use was lower among the participants in the tobacco prevention programme compared with the non-participants as well as with the controls in the cohort.", {"entities": []}], ["However, the observed benefit of the intervention may be overestimated as participation was biased by selection.", {"entities": []}], ["In Southeast Asia, Miltenberger antigen subtype III (Mi.III; GP.Mur) is considered one of the most important red blood cell antigens in the field of transfusion medicine.", {"entities": []}], ["Mi.III functions to promote erythrocyte band 3 expression and band 3-related HCO 3 2 metabolism.", {"entities": []}], ["Could Mi.III affect physiologic CO 2 respiration in its carriers?", {"entities": []}], ["Here, we conducted a human trial to study the impacts of Mi.III expression in respiration.", {"entities": []}], ["We recruited 188 healthy, adult subjects for blood typing, band 3 measurements, and respiratory tests before and after exercise.", {"entities": []}], ["The 3-minute step exercise test forced the demand for CO 2 dissipation to rise.", {"entities": []}], ["We found that immediately following exercise, Mi.III\u2009+\u2009subjects exhaled CO 2 at greater rates than Miltenberger-negative subjects.", {"entities": []}], ["Respiration rates were also higher for Mi.III\u2009+\u2009subjects immediately after exercise.", {"entities": []}], ["Blood gas tests further revealed distinct blood CO 2 responses post-exercise between Mi.III and non-Mi.III.", {"entities": []}], ["In contrast, from measurements of heart rates, blood O 2 saturation and lactate, Mi.III phenotype was found to be independent of one\u2019s aerobic and anaerobic capacities.", {"entities": []}], ["Thus, Mi.III expression supported physiologic CO 2 respiration.", {"entities": []}], ["Conceivably, Mi.III\u2009+\u2009people may have advantages in performing physically enduring activities.", {"entities": []}], ["MicroRNAs (miRNAs) have been proved to play crucial roles in tumorigenesis.", {"entities": []}], ["TGF\u03b2 signal pathway abnormality is found in various cancers and correlates with tumor proliferation and metastasis.", {"entities": []}], ["However, the mechanisms underlying the dys-regulation of TGF\u03b2R2 expression in GC have not been investigated yet.", {"entities": [[78, 80, "GENE"]]}], ["In this study, we found that the TGF\u03b2R2 protein was clearly repressed in tumor tissues, while miR-130 expression level was dramatically increased in GC tissues.", {"entities": [[149, 151, "GENE"]]}], ["Firefly luciferase activity assay revealed that miR-130 could directly bind to 3\u2032UTR of TGF\u03b2R2 mRNA.", {"entities": []}], ["Meanwhile, miR-130 mimics lead to the decreased TGF\u03b2R2 protein levels, while miR-130 inhibitors enhanced TGF\u03b2R2 expression in SGC7901 cells.", {"entities": []}], ["Subsequent functional experiments showed that overexpressed miR-130 could promote proliferation and migration of SGC7901 cells.", {"entities": []}], ["And siRNA-mediated TGF\u03b2R2 down-regulation could simulate the effects of miR-130 mimics on phenotypes of SGC7901 cells.", {"entities": []}], ["Furthermore, there existed intense relationship between the expression level of miR-130 and epithelial-mesenchymal markers.", {"entities": []}], ["Our results demonstrated that miR-130 was an oncogene by directly targeting TGF\u03b2R2 in GC.", {"entities": [[86, 88, "GENE"]]}], ["To study the variability of central retinal thickness (CRT), its concordance to the fellow eye, and the implications for designing future clinical trials using spectral-domain optical coherence tomography (SD-OCT).", {"entities": []}], ["Cross-sectional retrospective analysis of European Genetic Database.", {"entities": []}], ["632 eyes of 316 subjects over 60\u2005years of age without macular pathology were examined using SD-OCT.", {"entities": []}], ["Mean CRT was 280.22\u2005\u00b5m and 281.02\u2005\u00b5m for the right and left eyes, respectively.", {"entities": []}], ["There was a strong concordance for all measured values between right and left eyes.", {"entities": []}], ["Men had significantly thicker CRT than women.", {"entities": []}], ["Variation up to 23\u2005\u00b5m difference between both eyes was seen.", {"entities": []}], ["To detect a change of at least 30\u2005\u00b5m in CRT, a sample size of 90 or 176 per group is needed for a single-arm or double-arm study, respectively (\u03b1=0.05, power=0.80, no loss to follow up, assuming SD in future studies=100\u2005\u00b5m).", {"entities": []}], ["Clinical trials using CRT as an endpoint are feasible in terms of sample size needed.", {"entities": []}], ["Th2-driven lung inflammation increases Arginase 1 (Arg1) expression in alternatively-activated macrophages (AAMs).", {"entities": [[51, 55, "GENE"]]}], ["AAMs modulate T cell and wound healing responses and Arg1 might contribute to asthma pathogenesis by inhibiting nitric oxide production, regulating fibrosis, modulating arginine metabolism and restricting T cell proliferation.", {"entities": [[78, 84, "DISEASE"], [53, 57, "GENE"]]}], ["We used mice lacking Arg1 in myeloid cells to investigate the contribution of Arg1 to lung inflammation and pathophysiology.", {"entities": [[21, 25, "GENE"], [78, 82, "GENE"], [21, 25, "GENE"], [78, 82, "GENE"]]}], ["In six model systems encompassing acute and chronic Th2-mediated lung inflammation we observed neither a pathogenic nor protective role for myeloid-expressed Arg1.", {"entities": [[158, 162, "GENE"]]}], ["The number and composition of inflammatory cells in the airways and lungs, mucus secretion, collagen deposition, airway hyper-responsiveness, and T cell cytokine production were not altered if AAMs were deficient in Arg1 or simultaneously in both Arg1 and NOS2.", {"entities": [[216, 220, "GENE"], [247, 251, "GENE"], [216, 220, "GENE"], [247, 251, "GENE"], [256, 260, "GENE"]]}], ["Our results argue that Arg1 is a general feature of alternative activation but only selectively regulates Th2 responses.", {"entities": [[23, 27, "GENE"]]}], ["Therefore, attempts to experimentally or therapeutically inhibit arginase activity in the lung should be examined with caution.", {"entities": []}], ["Supplemental Digital Content is available in the text.", {"entities": []}], ["We present 2 infants with the rare association of long congenital tracheal stenosis, ventricular septal defect, and pulmonary hypertension.", {"entities": [[126, 138, "DISEASE"], [85, 110, "DISEASE"], [66, 83, "DISEASE"], [116, 138, "DISEASE"]]}], ["We describe a step-by-step assessment of the patients and the necessary procedures for a successful concomitant repair of both cardiac and tracheal malformations.", {"entities": []}], ["The use of a helium\u2013oxygen mixture (heliox) for the induction of anesthesia and pre-cardiopulmonary bypass is discussed.", {"entities": []}], ["TRPM7 is a ubiquitous divalent-selective ion channel with its own kinase domain.", {"entities": [[0, 5, "GENE"]]}], ["Recent studies have shown that suppression of TRPM7 protein expression by RNA interference increases resistance to ischemia-induced neuronal cell death in vivo and in vitro , making the channel a potentially attractive pharmacological target for molecular intervention.", {"entities": [[115, 123, "DISEASE"], [46, 51, "GENE"]]}], ["Here, we report the identification of the 5-lipoxygenase inhibitors, NDGA, AA861, and MK886, as potent blockers of the TRPM7 channel.", {"entities": [[119, 124, "GENE"]]}], ["Using a cell-based assay, application of these compounds prevented cell rounding caused by overexpression of TRPM7 in HEK-293 cells, whereas inhibitors of 12-lipoxygenase and 15-lipoxygenase did not prevent the change in cell morphology.", {"entities": [[109, 114, "GENE"]]}], ["Application of the 5-lipoxygenase inhibitors blocked heterologously expressed TRPM7 whole-cell currents without affecting the protein's expression level or its cell surface concentration.", {"entities": [[78, 83, "GENE"]]}], ["All three inhibitors were also effective in blocking the native TRPM7 current in HEK-293 cells.", {"entities": [[64, 69, "GENE"]]}], ["However, two other 5-lipoxygenase specific inhibitors, 5,6-dehydro-arachidonic acid and zileuton, were ineffective in suppressing TRPM7 channel activity.", {"entities": [[130, 135, "GENE"]]}], ["Targeted knockdown of 5-lipoxygenase did not reduce TRPM7 whole-cell currents.", {"entities": [[52, 57, "GENE"]]}], ["In addition, application of 5-hydroperoxyeicosatetraenoic acid (5-HPETE), the product of 5-lipoxygenase, or 5-HPETE's downstream metabolites, leukotriene B4 and leukotriene D4, did not stimulate TRPM7 channel activity.", {"entities": [[195, 200, "GENE"]]}], ["These data suggested that NDGA, AA861, and MK886 reduced the TRPM7 channel activity independent of their effect on 5-lipoxygenase activity.", {"entities": [[61, 66, "GENE"]]}], ["Application of AA861 and NDGA reduced cell death for cells overexpressing TRPM7 cultured in low extracellular divalent cations.", {"entities": [[74, 79, "GENE"]]}], ["Moreover, treatment of HEK-293 cells with AA861 increased cell resistance to apoptotic stimuli to a level similar to that obtained for cells in which TRPM7 was knocked down by RNA interference.", {"entities": [[150, 155, "GENE"]]}], ["In conclusion, NDGA, AA861, and MK886 are potent blockers of the TRPM7 channel capable of attenuating TRPM7's function during cell stress, making them effective tools for the biophysical characterization and suppression of TRPM7 channel conductance in vivo .", {"entities": [[65, 70, "GENE"], [102, 107, "GENE"], [223, 228, "GENE"], [65, 70, "GENE"], [102, 107, "GENE"], [223, 228, "GENE"], [65, 70, "GENE"], [102, 107, "GENE"], [223, 228, "GENE"]]}], ["To elucidate problems with microfungal infestation in indoor environments, a multidisciplinary collaborative pilot study, supported by a grant from the Danish Ministry of Housing and Urban Affairs, was performed on 72 mold-infected building materials from 23 buildings.", {"entities": []}], ["Water leakage through roofs, rising damp, and defective plumbing installations were the main reasons for water damage with subsequent infestation of molds.", {"entities": []}], ["From a score system assessing the bioavailability of the building materials, products most vulnerable to mold attacks were water damaged, aged organic materials containing cellulose, such as wooden materials, jute, wallpaper, and cardboard.", {"entities": []}], ["The microfungal genera most frequently encountered were Penicillium (68%), Aspergillus (56%), Chaetomium (22%), Ulocladium, (21%), Stachybotrys (19%) and Cladosporium (15%).", {"entities": []}], ["Penicillium chrysogenum, Aspergillus versicolor, and Stachybotrys chartarum were the most frequently occurring species.", {"entities": []}], ["Under field conditions, several trichothecenes were detected in each of three commonly used building materials, heavily contaminated with S. chartarum.", {"entities": []}], ["Under experimental conditions, four out of five isolates of S. chartarum produced satratoxin H and G when growing on new and old, very humid gypsum boards.", {"entities": []}], ["A. versicolor produced the carcinogenic mycotoxin sterigmatocystin and 5-methoxysterigmatocystin under the same conditions.", {"entities": []}], ["Inflammation may play a significant role in Keratoconus (KC), but the implication of immunity on this inflammatory response is unknown.", {"entities": []}], ["Therefore, our aim was to determine the expression levels of Toll-like receptors 2 (TLR2) and 4 (TLR4) in monocytes and neutrophils from patients with KC and control subjects for demonstrating the role of innate immunity in KC.", {"entities": [[84, 88, "GENE"], [97, 101, "GENE"]]}], ["We also study the correlation between TLR2/TLR4 expression and serum levels of proinflammatory markers (IL-1\u03b2, IL-6, TNF-\u03b1, MMP-9 and NF-\u03baB).", {"entities": []}], ["Forty patients with bilateral KC (55% males; mean age; 33.1\u2009\u00b1\u200910.9 years) and 20 control subjects (55% males; mean age; 30.4\u2009\u00b1\u20097.6 years) were included in the study.", {"entities": []}], ["Our results showed that mean expression of TLR2 and TLR4 in both neutrophils and monocytes was significantly higher in patients with KC compared to control subjects (all p\u2009<\u20090.0001).", {"entities": [[43, 47, "GENE"], [52, 56, "GENE"]]}], ["Furthermore, KC patients also showed higher serum levels of IL-1B, IL-6, TNF-\u03b1, MMP-9 (all p\u2009<\u20090.0001) and NF-\u03baB (p\u2009=\u20090.036).", {"entities": []}], ["In addition, we found a strong correlation between TLR2 expression in both monocytes and neutrophils (all p\u2009<\u20090.0001), and TLR4 in monocytes (all p\u2009<\u20090.05) with serum levels of IL-1B, IL-6, TNF-\u03b1 and MMP-9.", {"entities": [[51, 55, "GENE"], [123, 127, "GENE"]]}], ["In conclusion, these findings suggest that TLRs may play an important role in the pathophysiology of KC.", {"entities": []}], ["Bacterial cells are surrounded by a polymer known as peptidoglycan (PG), which protects the cell from changes in osmotic pressure and small molecule insults.", {"entities": []}], ["A component of this material, N -acetyl-muramic acid (NAM), serves as a core structural element for innate immune recognition of PG fragments.", {"entities": []}], ["We report the synthesis of modifiable NAM carbohydrate derivatives and the installation of these building blocks into the backbone of Gram-positive and Gram-negative bacterial PG utilizing metabolic cell wall recycling and biosynthetic machineries.", {"entities": []}], ["Whole cells are labelled via click chemistry and visualized using super-resolution microscopy, revealing higher resolution PG structural details and allowing the cell wall biosynthesis, as well as its destruction in immune cells, to be tracked.", {"entities": []}], ["This study will assist in the future identification of mechanisms that the immune system uses to recognize bacteria, glean information about fundamental cell wall architecture and aid in the design of novel antibiotics.", {"entities": []}], ["N -acetyl-muramic acid (NAM) is a core component of the bacterial peptidoglycan (PG) cell wall, and is recognised by the innate immune system.", {"entities": []}], ["Here the authors engineer Gram-negative and Gram-positive bacteria to incorporate a modified NAM into the backbone of PG, which can be labelled with click chemistry for imaging and tracking.", {"entities": []}], ["An analysis of NIH funding in 1996 found that the strongest predictor of funding, disability-adjusted life-years (DALYs), explained only 39% of the variance in funding.", {"entities": []}], ["In 1998, Congress requested that the Institute of Medicine (IOM) evaluate priority-setting criteria for NIH funding; the IOM recommended greater consideration of disease burden.", {"entities": []}], ["We examined whether the association between current burden and funding has changed since that time.", {"entities": []}], ["We analyzed public data on 2006 NIH funding for 29 common conditions.", {"entities": []}], ["Measures of US disease burden in 2004 were obtained from the World Health Organization's Global Burden of Disease study and national databases.", {"entities": []}], ["We assessed the relationship between disease burden and NIH funding dollars in univariate and multivariable log-linear models that evaluated all measures of disease burden.", {"entities": []}], ["Sensitivity analyses examined associations with future US burden, current and future measures of world disease burden, and a newly standardized NIH accounting method.", {"entities": []}], ["In univariate and multivariable analyses, disease-specific NIH funding levels increased with burden of disease measured in DALYs (p\u200a=\u200a0.001), which accounted for 33% of funding level variation.", {"entities": []}], ["No other factor predicted funding in multivariable models.", {"entities": []}], ["Conditions receiving the most funding greater than expected based on disease burden were AIDS ($2474 M), diabetes mellitus ($390 M), and perinatal conditions ($297 M).", {"entities": [[105, 122, "DISEASE"]]}], ["Depression ($719 M), injuries ($691 M), and chronic obstructive pulmonary disease ($613 M) were the most underfunded.", {"entities": [[44, 81, "DISEASE"]]}], ["Results were similar using estimates of future US burden, current and future world disease burden, and alternate NIH accounting methods.", {"entities": []}], ["Current levels of NIH disease-specific research funding correlate modestly with US disease burden, and correlation has not improved in the last decade.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) has substantial economic and human costs; it is expected to be the third leading cause of death worldwide by 2030.", {"entities": []}], ["To minimize these costs high quality guidelines have been developed.", {"entities": []}], ["However, guidelines alone rarely result in meaningful change.", {"entities": []}], ["One method of integrating guidelines into practice is the use of clinical pathways (CPWs).", {"entities": []}], ["CPWs bring available evidence to a range of healthcare professionals by detailing the essential steps in care and adapting guidelines to the local context.", {"entities": []}], ["We are working with local stakeholders to develop CPWs for COPD with the aims of improving care while reducing utilization.", {"entities": []}], ["The CPWs will employ several steps including: standardizing diagnostic training, unifying components of chronic disease care, coordinating education and reconditioning programs, and ensuring care uses best practices.", {"entities": []}], ["Further, we have worked to identify evidence-informed implementation strategies which will be tailored to the local context.", {"entities": []}], ["We will conduct a three-year research project using an interrupted time series (ITS) design in the form of a multiple baseline approach with control groups.", {"entities": []}], ["The CPW will be implemented in two health regions (experimental groups) and two health regions will act as controls (control groups).", {"entities": []}], ["The experimental and control groups will each contain an urban and rural health region.", {"entities": []}], ["Primary outcomes for the study will be quality of care operationalized using hospital readmission rates and emergency department (ED) presentation rates.", {"entities": []}], ["Secondary outcomes will be healthcare utilization and guideline adherence, operationalized using hospital admission rates, hospital length of stay and general practitioner (GP) visits.", {"entities": []}], ["Results will be analyzed using segmented regression analysis.", {"entities": []}], ["Funding has been procured from multiple stakeholders.", {"entities": []}], ["The project has been deemed exempt from ethics review as it is a quality improvement project.", {"entities": []}], ["Intervention implementation is expected to begin in summer of 2017.", {"entities": []}], ["This project is expected to improve quality of care and reduce healthcare utilization.", {"entities": []}], ["In addition it will provide evidence on the effects of CPWs in both urban and rural settings.", {"entities": []}], ["If the CPWs are found effective we will work with all stakeholders to implement similar CPWs in surrounding health regions.", {"entities": []}], ["Clinicaltrials.gov ( NCT03075709 ).", {"entities": []}], ["Registered 8 March 2017.", {"entities": []}], ["As a low-cost and easily operated treatment, the use of professionally applied topical fluoride was approved for preventing dental caries and remineralising early enamel caries or white spot lesions.", {"entities": [[163, 176, "DISEASE"], [124, 137, "DISEASE"]]}], ["It is also used to arrest dentine caries.", {"entities": []}], ["The aim of this study is to investigate the clinical efficacy of professional fluoride therapy in remineralising and arresting caries in children.", {"entities": []}], ["A systematic search of publications from 1948 to 2014 was conducted using four databases: PubMed, Cochrane Library, ISI Web of Science and Embase.", {"entities": []}], ["The key words used were (fluoride) AND (remineralisation OR remineralization OR arresting) AND (children caries OR early childhood caries).", {"entities": []}], ["The title and abstract of initially identified publications were screened.", {"entities": []}], ["Clinical trials about home-use fluorides, laboratory studies, case reports, reviews, non-English articles and irrelevant studies were excluded.", {"entities": []}], ["The full texts of the remaining papers were retrieved.", {"entities": []}], ["Manual screening was conducted on the bibliographies of the remaining papers to identify relevant articles.", {"entities": []}], ["A total of 2177 papers were found, and 17 randomised clinical trials were included in this review.", {"entities": []}], ["Ten studies investigated the remineralising effect on early enamel caries using silicon tetrafluoride, fluoride gel, silver diamine fluoride or sodium fluoride.", {"entities": [[60, 73, "DISEASE"]]}], ["Seven studies reported an arresting effect on dentine caries using silver diamine fluoride or nano-silver fluoride.", {"entities": []}], ["Meta-analysis was performed on four papers using 5\u00a0% sodium fluoride varnish to remineralise early enamel caries, and the overall percentage of remineralised enamel caries was 63.6\u00a0% (95\u00a0% CI: 36.0\u00a0% - 91.2\u00a0%; p\u2009<\u20090.001).", {"entities": [[99, 112, "DISEASE"], [158, 171, "DISEASE"]]}], ["Meta-analysis was also performed on five papers using 38\u00a0% silver diamine fluoride to arrest dentine caries and the overall proportion of arrested dentine caries was 65.9\u00a0% (95\u00a0% CI: 41.2\u00a0% - 90.7\u00a0%; p\u2009<\u20090.001).", {"entities": []}], ["Professionally applied 5\u00a0% sodium fluoride varnish can remineralise early enamel caries and 38\u00a0% silver diamine fluoride is effective in arresting dentine caries.", {"entities": [[74, 87, "DISEASE"]]}], ["Bronchial asthma (BA) is a chronic airway disease characterized by airway hyperresponsiveness and remodeling, which are intimately linked to chronic airway inflammation.", {"entities": [[10, 16, "DISEASE"]]}], ["Reactive oxygen species (ROS) such as hydrogen peroxide are generated by inflammatory cells that are involved in the pathogenesis of BA.", {"entities": []}], ["However, the role of ROS in the management of BA patients is not yet clear.", {"entities": []}], ["We attempted to determine the role of ROS as a biomarker in the clinical setting of BA.", {"entities": []}], ["We enrolled patients with BA from 2013 through 2015 and studied the degrees of asthma control, anti-asthma treatment, pulmonary function test results, fractional exhaled nitric oxide (FeNO), serum reactive oxygen metabolite (ROM) levels, and serum levels of interleukin (IL)-6 and IL-8.", {"entities": [[79, 85, "DISEASE"], [100, 106, "DISEASE"]]}], ["We recruited 110 patients with BA.", {"entities": []}], ["Serum ROM levels correlated with white blood cell (WBC) count (rs = 0.273, p = 0.004), neutrophil count (rs = 0.235, p = 0.014), CRP (rs = 0.403, p < 0.001), and IL-6 (rs = 0.339, p < 0.001).", {"entities": [[129, 132, "GENE"]]}], ["Serum ROM levels and IL-8 and CRP levels negatively correlated with %FEV 1 (rs = -0.240, p = 0.012, rs = -0.362, p < 0.001, rs = -0.197, p = 0.039, respectively).", {"entities": [[30, 33, "GENE"], [69, 72, "GENE"]]}], ["Serum ROM levels were significantly higher in patients who experienced severe exacerbation within 3 months than in patients who did not (339 [302\u2013381] vs. 376 [352\u2013414] CARR U, p < 0.025).", {"entities": []}], ["Receiver-operating characteristics analysis showed that ROM levels correlated significantly with the occurrence of severe exacerbation (area under the curve: 0.699, 95% CI: 0.597\u20130.801, p = 0.025).", {"entities": []}], ["Serum levels of ROM were significantly associated with the degrees of airway obstruction, WBC counts, neutrophil counts, IL-6, and severe exacerbations.", {"entities": []}], ["This biomarker may be useful in predicting severe exacerbations of BA.", {"entities": []}], ["Although the risk of transfusion-transmitted infections today is lower than ever, the supply of safe blood products remains subject to contamination with known and yet to be identified human pathogens.", {"entities": []}], ["Only continuous improvement and implementation of donor selection, sensitive screening tests and effective inactivation procedures can ensure the elimination, or at least reduction, of the risk of acquiring transfusion transmitted infections.", {"entities": []}], ["In addition, ongoing education and up-to-date information regarding infectious agents that are potentially transmitted via blood components is necessary to promote the reporting of adverse events, an important component of transfusion transmitted disease surveillance.", {"entities": []}], ["Thus, the collaboration of all parties involved in transfusion medicine, including national haemovigilance systems, is crucial for protecting a secure blood product supply from known and emerging blood-borne pathogens.", {"entities": []}], ["Dual sensor (DS) for rate adaption was supposed to be more physiological.", {"entities": []}], ["To evaluate its superiority, the DS (accelerometer [ACC] and minute ventilation [MV]) and normal sinus rate response were compared in a self-controlled way during exercise treadmill testing.", {"entities": []}], ["This self-controlled study was performed in atrioventricular block patients with normal sinus function who met the indications of pacemaker implant.", {"entities": []}], ["Twenty-one patients came to the 1-month follow-up visit.", {"entities": []}], ["Patients performed a treadmill test 1-month post implant while programmed in DDDR and sensor passive mode.", {"entities": []}], ["For these patients, sensor response factors were left at default settings (ACC = 8, MV = 3) and sensor indicated rates (SIRs) for DS, ACC and MV sensor were retrieved from the pacemaker memories, along with measured sinus node (SN) rates from the beginning to 1-minute after the end of the treadmill test, and compared among study groups.", {"entities": []}], ["Repeated measures analysis of variance and profile analysis, as well as variance analysis of randomized block designs, were used for statistical analysis.", {"entities": []}], ["Fifteen patients (15/21) were determined to be chronotropically competent.", {"entities": []}], ["The mean differences between DS SIRs and intrinsic sinus rates during treadmill testing were smaller than those for ACC and MV sensor (mean difference between SIR and SN rate: ACC vs. SN, MV vs. SN, DS vs. SN, respectively, 34.84, 17.60, 16.15 beats/min), though no sensors could mimic sinus rates under the default settings for sensor response factor (ACC vs. SN P -adjusted < 0.001; MV vs. SN P -adjusted = 0.002; DS vs. SN P -adjusted = 0.005).", {"entities": []}], ["However, both in the range of 1 P -adjusted = 0.09, 0.90, respectively).", {"entities": []}], ["The DS under default settings provides more physiological rate response during physical activity than the corresponding single sensors (ACC or MV sensor).", {"entities": []}], ["Further study is needed to determine if individual optimization would further improve adaptive performance of the DS.", {"entities": []}], ["New models of primary care are needed to address funding and staffing pressures.", {"entities": []}], ["We addressed the research question \u201cwhat works for whom in what circumstances in relation to the role of community pharmacies in providing lifestyle interventions to support smoking cessation?\u201d This is a realist review conducted according to RAMESES standards.", {"entities": []}], ["We began with a sample of 103 papers included in a quantitative review of community pharmacy intervention trials identified through systematic searching of seven databases.", {"entities": []}], ["We supplemented this with additional papers: studies that had been excluded from the quantitative review but which provided rigorous and relevant additional data for realist theorising; citation chaining (pursuing reference lists and Google Scholar forward tracking of key papers); the \u2018search similar citations\u2019 function on PubMed.", {"entities": []}], ["After mapping what research questions had been addressed by these studies and how, we undertook a realist analysis to identify and refine candidate theories about context-mechanism-outcome configurations.", {"entities": []}], ["Our final sample consisted of 66 papers describing 74 studies (12 systematic reviews, 6 narrative reviews, 18 RCTs, 1 process detail of a RCT, 1 cost-effectiveness study, 12 evaluations of training, 10 surveys, 8 qualitative studies, 2 case studies, 2 business models, 1 development of complex intervention).", {"entities": []}], ["Most studies had been undertaken in the field of pharmacy practice (pharmacists studying what pharmacists do) and demonstrated the success of pharmacist training in improving confidence, knowledge and (in many but not all studies) patient outcomes.", {"entities": []}], ["Whilst a few empirical studies had applied psychological theories to account for behaviour change in pharmacists or people attempting to quit, we found no studies that had either developed or tested specific theoretical models to explore how pharmacists\u2019 behaviour may be affected by organisational context.", {"entities": []}], ["Because of the nature of the empirical data, only a provisional realist analysis was possible, consisting of five mechanisms (pharmacist identity, pharmacist capability, pharmacist motivation and clinician confidence\u00a0and public trust).", {"entities": []}], ["We offer hypotheses about how these mechanisms might play out differently in different contexts to account for the success, failure or partial success of pharmacy-based smoking cessation efforts.", {"entities": []}], ["Smoking cessation support from community pharmacists and their staff has been extensively studied, but few policy-relevant conclusions are possible.", {"entities": []}], ["We recommend that further research should avoid duplicating existing literature on individual behaviour change; seek to study the organisational and system context and how this may shape, enable and constrain pharmacists\u2019 extended role; and develop and test theory.", {"entities": []}], ["This study aims to examine the benefits of wearing a new construction work uniform in real-work settings.", {"entities": []}], ["A field experiment with a randomized assignment of an intervention group to a newly designed uniform and a control group to a commercially available trade uniform was executed.", {"entities": []}], ["A total of 568 sets of physical, physiological, perceptual, and microclimatological data were obtained.", {"entities": []}], ["A linear mixed-effects model (LMM) was built to examine the cause-effect relationship between the Perceptual Strain Index (PeSI) and heat stressors including wet bulb globe temperature (WBGT), estimated workload (relative heart rate), exposure time, trade, workplace, and clothing type.", {"entities": []}], ["An interaction effect between clothing and trade revealed that perceptual strain of workers across four trades was significantly alleviated by 1.6\u20136.3 units in the intervention group.", {"entities": []}], ["Additionally, the results of a questionnaire survey on assessing the subjective sensations on the two uniforms indicated that wearing comfort was improved by 1.6\u20131.8 units when wearing the intervention type.", {"entities": []}], ["This study not only provides convincing evidences on the benefits of wearing the newly designed work uniform in reducing perceptual strain but also heightens the value of the field experiment in heat stress intervention studies.", {"entities": []}], ["Electronic tongue systems are traditionally used to analyse: food products, water samples and taste masking technologies for pharmaceuticals.", {"entities": []}], ["In principle, their applications are almost limitless, as they are able to almost completely reduce the impact of interferents and can be applied to distinguish samples of extreme complexity as for example broths from different stages of fermentation.", {"entities": []}], ["Nevertheless, their applications outside the three principal sample types are, in comparison, rather scarce.", {"entities": []}], ["In this review, we would like to take a closer look on what are real capabilities of electronic tongue systems, what can be achieved using mixed sensor arrays and by introduction of biosensors or molecularly imprinted polymers in the matrix.", {"entities": []}], ["We will discuss future directions both in the sense of applications as well as system development in the ever-growing trend of low cost analysis.", {"entities": []}], ["Normal human breathing exhibits complex variability in both respiratory rhythm and volume.", {"entities": []}], ["Analyzing such nonlinear fluctuations may provide clinically relevant information in patients with complex illnesses such as asthma.", {"entities": [[125, 131, "DISEASE"]]}], ["We compared the cycle-by-cycle fluctuations of inter-breath interval (IBI) and lung volume (LV) among healthy volunteers and patients with various types of asthma.", {"entities": [[156, 162, "DISEASE"]]}], ["Continuous respiratory datasets were collected from forty age-matched men including 10 healthy volunteers, 10 patients with controlled atopic asthma, 10 patients with uncontrolled atopic asthma, and 10 patients with uncontrolled non-atopic asthma during 60 min spontaneous breathing.", {"entities": [[142, 148, "DISEASE"], [187, 193, "DISEASE"], [240, 246, "DISEASE"]]}], ["Complexity of breathing pattern was quantified by calculating detrended fluctuation analysis, largest Lyapunov exponents, sample entropy, and cross-sample entropy.", {"entities": []}], ["The IBI as well as LV fluctuations showed decreased long-range correlation, increased regularity and reduced sensitivity to initial conditions in patients with asthma, particularly in uncontrolled state.", {"entities": [[160, 166, "DISEASE"]]}], ["Our results also showed a strong synchronization between the IBI and LV in patients with uncontrolled asthma.", {"entities": [[102, 108, "DISEASE"]]}], ["Receiver operating characteristic (ROC) curve analysis showed that nonlinear analysis of breathing pattern has a diagnostic value in asthma and can be used in differentiating uncontrolled from controlled and non-atopic from atopic asthma.", {"entities": [[133, 139, "DISEASE"], [231, 237, "DISEASE"]]}], ["We suggest that complexity analysis of breathing dynamics may represent a novel physiologic marker to facilitate diagnosis and management of patients with asthma.", {"entities": [[155, 161, "DISEASE"]]}], ["However, future studies are needed to increase the validity of the study and to improve these novel methods for better patient management.", {"entities": []}], ["Flash nanoprecipitation (FNP) can generate hydrophobic drug nanoparticles in \u223c100 nm with a much higher drug loading (e.g., > 40 wt %) than traditional nanocarriers (e.g., < 20 wt %).", {"entities": []}], ["This paper studies the effects of drug molecules on nanoparticle stability made via FNP and demonstrates that chemically bonding a drug compound (e.g., paclitaxel) with a cleavable hydrophobic moiety of organosilicate (e.g., triethoxysilicate) is able to enhance the particle size stability.", {"entities": []}], ["A nonionic amphiphilic diblock copolymer, poly(lactic- co -glycolic acid)- block -poly(ethylene glycol) (PLGA- b -PEG), is used as a model surfactant to provide steric stabilization.", {"entities": []}], ["The experiments here show that the lower the drug solubility in the aqueous medium, the more stable the particles in terms of Ostwald ripening, which are consistent with the prediction by the LSW theory.", {"entities": []}], ["The initial particle size distribution is sufficiently narrow and of insignificance to Ostwald ripening.", {"entities": []}], ["To correlate the particle stability with hydrophobicity, this study introduces the n -octanol/water partition coefficient (Log P ), a hydrophobicity indication, into the FNP technique.", {"entities": []}], ["A comparison of various drugs and their analogues shows that Log P of a drug is a better hydrophobicity indication than the solubility parameter (\u03b4) and correlates well with the particle stability.", {"entities": []}], ["Empirically, with ACDLog P > \u223c12, nanoparticles have good stability; with \u223c2 < ACDLog P < \u223c9, nanoparticles show fast Ostwald ripening and interparticle recrystallization; with ACDLog P < \u223c2, the drug is very likely difficult to form nanoparticles.", {"entities": []}], ["This rule creates a quick way to predict particle stability for a randomly selected drug structure and helps to enable a fast preclinical drug screen.", {"entities": []}], ["Exposure to environmental stressors during early-life stages can change the rate and timing of various developmental processes.", {"entities": []}], ["Epigenetic marks affecting transcriptional regulation can be altered by such environmental stimuli.", {"entities": []}], ["To assess how stress might affect the methylome and transcriptome in salmon, fish were treated using cold-shock and air-exposure from the eye-stage until start-feeding.", {"entities": []}], ["The fish were either stressed prior to hatching ( E ), post-hatching ( PH ), pre- and post-hatching ( EPH ) or not stressed ( CO ).", {"entities": []}], ["Assessing transcriptional abundances just prior to start feeding, E and PH individuals were found to have modified the expression of thousands of genes, many with important functions in developmental processes.", {"entities": []}], ["The EPH individuals however, showed expression similar to those of CO , suggesting an adaptive response to extended periods of stress.", {"entities": []}], ["The methylome of stressed individuals differed from that of the CO , suggesting the importance of environment in shaping methylation signatures.", {"entities": []}], ["Through integration of methylation with transcription, we identified bases with potential regulatory functions, some 10s of kb away from the targeted genes.", {"entities": []}], ["We then followed fish growth for an additional year.", {"entities": []}], ["Individuals in EPH showed superior growth compared to other treatment groups, highlighting how stress can potentially have long-lasting effects on an organism\u2019s ability to adapt to environmental perturbations.", {"entities": []}], ["The worsening atmospheric pollution increases the necessity of air quality early warning systems (EWSs).", {"entities": []}], ["Despite the fact that a massive amount of investigation about EWS in theory and practicality has been conducted by numerous researchers, studies concerning the quantification of uncertain information and comprehensive evaluation are still lacking, which impedes further development in the area.", {"entities": []}], ["In this paper, firstly a comprehensive warning system is proposed, which consists of two vital indispensable modules, namely effective forecasting and scientific evaluation, respectively.", {"entities": []}], ["For the forecasting module, a novel hybrid model combining the theory of data preprocessing and numerical optimization is first developed to implement effective forecasting for air pollutant concentration.", {"entities": []}], ["Especially, in order to further enhance the accuracy and robustness of the warning system, interval forecasting is implemented to quantify the uncertainties generated by forecasts, which can provide significant risk signals by using point forecasting for decision-makers.", {"entities": []}], ["For the evaluation module, a cloud model, based on probability and fuzzy set theory, is developed to perform comprehensive evaluations of air quality, which can realize the transformation between qualitative concept and quantitative data.", {"entities": []}], ["To verify the effectiveness and efficiency of the warning system, extensive simulations based on air pollutants data from Dalian in China were effectively implemented, which illustrate that the warning system is not only remarkably high-performance, but also widely applicable.", {"entities": []}], ["Few studies addressed trans-regional differences in allergen sensitization between areas within a similar latitudinal range but with distinct geomorphological features.", {"entities": []}], ["We investigated specific IgE (sIgE) positivity to common allergens in populations from two southern China provinces.", {"entities": []}], ["Using a uniformed protocol, serum samples were collected from 2778 subjects with suspected atopy in coastal Guangdong and inland Yunnan.", {"entities": []}], ["The overall prevalence of sIgE positivity were 57.8% (95% CI: 56.0%, 59.6%) from Guangdong vs 60.9% (95% CI: 59.1%, 62.7%) from Yunnan.", {"entities": []}], ["House dust mite (d1) was the most common allergen in both regions.", {"entities": []}], ["Among d1-sensitized subjects, only 35.7% (208/583) in Guangdong and 22.9% (147/642) in Yunnan tested positive for d1 alone.", {"entities": []}], ["Among those poly-sensitized d1-positive subjects, cockroach was the most common co-sensitizing aeroallergen.", {"entities": []}], ["41.9% of the d1-sensitized Guangdong subjects showed high-class sIgE reactivity (\u2265class 4), in contrast to a very low percentage of such reactivity in Yunnan.", {"entities": []}], ["However, 36.3% of d1-sensitized subjects in Yunnan were concomitantly positive for tree pollen mix.", {"entities": []}], ["Surprisingly, Yunnan subjects showed high prevalence of sIgE positivity for crabs and shrimps, either by overall or by age-group analysis, compared with their Guangdong counterparts (both P \u2009<\u20090.05).", {"entities": []}], ["These findings may add to data about local allergies in China and worldwide.", {"entities": []}], ["No previous study has reported a comprehensive assessment of the attainment of cardiometabolic goals in the diabetic population of a European country.", {"entities": []}], ["We examined the achievement of cardiometabolic goals among diabetics in Spain.", {"entities": []}], ["A cross-sectional survey was performed in 2008\u20132010 among 12,077 individuals representative of the Spanish population aged \u226518 years.", {"entities": []}], ["Information on cardiometabolic characteristics was collected at the participants\u2019 homes through structured questionnaires, physical examination, and fasting blood samples.", {"entities": []}], ["Attainment of cardiometabolic goals was evaluated according to the most well-known guidelines.", {"entities": []}], ["A total of 834 individuals had diabetes (fasting serum glucose \u2265126 mg/dl, or glycosylated hemoglobin \u22656.5%,) or were being treated with oral antidiabetic drugs or insulin).", {"entities": []}], ["Among diabetic patients, 661 (79.2%) were aware of their condition.", {"entities": []}], ["Among the aware diabetic patients, only 11.4% had neither general (body mass index <25 kg/m In a European country with universal healthcare coverage, achievement of many cardiometabolic goals, in particular lifestyle, among aware diabetic individuals is poor.", {"entities": []}], ["This suggests a need for improvement in both clinical guidelines' implementation and patients\u2019 adherence.", {"entities": []}], ["Health complaints have been reported to be higher among the industrial area residents when compared with reference community.", {"entities": []}], ["Such reports being only a few, a questionnaire survey was conducted in three different areas (Industrial, Residential, Commercial) of Ahmedabad city of India to determine the pattern of morbidity and to do a comparative analysis of different areas within the city.", {"entities": []}], ["A total of 679 families (243 from commercial, 199 from residential and 237 from industrial area) were included in this study.", {"entities": []}], ["This study revealed that apart from presence of industry in close proximity to residence (99.2%), industrial area residents are having many other disadvantages from the point of view of public health like waste water stagnation (87.4%), problem of cooking smoke (33.2%) and presence of garbage dumps near residence (72.8%).", {"entities": []}], ["Consequently, problems like coughing, wheezing, eye irritation, skin irritation, jaundice, asthma, and dental caries have been observed to be more common in industrial area.", {"entities": [[103, 116, "DISEASE"], [91, 97, "DISEASE"]]}], ["Comparative risk calculated in terms of odds ratio for different such problems have ranged from 1.83 to 6.2 when industrial area was compared with commercial area.", {"entities": []}], ["Similarly on comparison of industrial area with residential area, odds ratio for different problems have ranged from 1.82 to 11.5.", {"entities": []}], ["This study has pointed out the need of separate planning and implementation of specific upliftment programs for addressing the environmental as well as public health issues of industrial localities.", {"entities": []}], ["Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths reported worldwide.", {"entities": [[0, 24, "DISEASE"], [15, 24, "DISEASE"], [61, 67, "DISEASE"]]}], ["The incidence is higher in Asia and Africa, where there is greater endemic prevalence of hepatitis B and C. The devastating outcome of cancer can be minimized only by the use of potent therapeutic agents.", {"entities": [[89, 98, "DISEASE"], [135, 141, "DISEASE"]]}], ["Tridham (TD) has been acknowledged since olden days for its wide spectrum of biological properties and was used by traditional practitioners of Siddha and other indigenous systems of medicine.", {"entities": []}], ["The present study aims at investigating the mechanistic action of TD by assessing the antiproliferative and pro-apoptotic effects on human hepatocellular carcinoma cell line (Huh7).", {"entities": [[139, 163, "DISEASE"], [154, 163, "DISEASE"]]}], ["Cell viability and apoptosis assay using MTT analysis and trypan blue staining, DAPI staining, DNA fragmentation, cell cycle analysis, mitochondrial membrane potential, real-time reverse transcription-polymerase chain reaction, western blotting and immunofluorescence staining were determined in Huh7 cells.", {"entities": []}], ["Viability studies of TD treated Huh7 cells showed an inhibition in cell growth in time and dose dependent manner.", {"entities": []}], ["Chromatin condensation, DNA fragmentation and apoptotic bodies, which are structural changes characteristic of apoptosis, were found following TD treatment of Huh7 cells.", {"entities": []}], ["DAPI staining and agarose gel electrophoresis confirmed the induction of apoptosis by TD.", {"entities": []}], ["Cell cycle analysis of Huh7 cells treated with TD exhibited a marked accumulation of cells in the sub-G1 phase of the cell cycle in a dose dependent manner.", {"entities": []}], ["Immunofluorescent staining for Ki-67 showed a higher level of expression in untreated cells as compared to TD treated cells.", {"entities": []}], ["We observed a significant loss in the mitochondrial membrane potential and the release of cytochrome c into the cytosol in TD treated cells.", {"entities": []}], ["Down regulation of Bcl-2, up regulation of Bax and Bad as well as activation of caspases-3 and 9 were also observed.", {"entities": [[43, 46, "GENE"]]}], ["The p53 gene expression was found to be unaltered in TD treated cells.", {"entities": []}], ["These results suggest that TD induces apoptosis of Huh7 cells through activation of Bax and triggered caspase cascade, independent of p53 function.", {"entities": [[84, 87, "GENE"]]}], ["This study throws light on the mechanistic action of TD in triggering apoptosis in Huh 7 cells.", {"entities": []}], ["Polychlorinated biphenyls (PCBs) are ubiquitous environmental toxicants, for which animal studies demonstrate immunotoxic effects, including thymic atrophy and suppressed immune responses; human investigations of similar end points are sparse.", {"entities": []}], ["The thymus is essential for the differentiation and maturation of T-cell lymphocytes.", {"entities": []}], ["The objective of this study was to examine the association between prenatal PCB exposures and estimated thymus volume in infants from eastern Slovakia, a region where PCBs were produced until 1984.", {"entities": []}], ["Mothers were enrolled at delivery, and maternal blood samples were collected for analysis of 15 PCB congeners, p,p \u2032-DDT [1,1,1-trichloro-2,2\u2032-bis( p -chlorophenyl)ethane], and p,p \u2032-DDE [1,1-dichloro-2,2-bis( p -chlorophenyl)ethylene].", {"entities": []}], ["Each mother was interviewed to obtain information on sociodemographic characteristics, past pregnancies, occupational history, medication history, and living environment.", {"entities": []}], ["Neonatal thymus volume was estimated using ultrasound measurements on the third or fourth day after birth.", {"entities": []}], ["Thymic index was calculated on 982 newborns from mothers with PCB measurements.", {"entities": []}], ["We developed a predictive model of the natural log of the thymic index using multiple linear regression with covariates selected from the bivariate analyses.", {"entities": []}], ["Prenatal PCB exposure was associated with a smaller thymic index at birth [\u03b2= \u221236 (natural log-transformed; nanograms per gram lipids); p = 0.047].", {"entities": []}], ["District of residence and delivery also predicted thymic index.", {"entities": []}], ["Male sex, later gestational age, larger birth weight z -score, and Roma ethnicity were associated with a larger thymic index, whereas respiratory illness was associated with a lower thymic index.", {"entities": []}], ["This study provides the first evidence to date that PCB exposure in neonates is associated with a smaller thymic volume, suggesting possible impaired immunologic development.", {"entities": []}], ["Please cite this paper as: Jules et\u00a0al.", {"entities": []}], ["(2012) Estimating age\u2010specific influenza\u2010related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN.", {"entities": [[31, 40, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(3), e63\u2013e71.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 In April 2009, a pandemic caused by a novel influenza strain, the A(H1N1)pdm09 virus, started.", {"entities": [[56, 65, "DISEASE"]]}], ["Few age\u2010specific estimates of hospitalizations associated with the first year of circulation of the pandemic virus are available.", {"entities": []}], ["Objectives\u2002 To estimate age\u2010specific hospitalization rates associated with laboratory\u2010confirmed A(H1N1)pdm09 virus in Davidson County, TN, from May 2009 to March 2010.", {"entities": []}], ["Patients/methods\u2002 Two separate strategies were applied: capture\u2013recapture and surveillance\u2010sampling methods.", {"entities": []}], ["For the capture\u2013recapture estimates, we linked data collected via two independent prospective population\u2010based surveillance systems: The Influenza Vaccine Effectiveness Network (Flu\u2010VE) tested consenting county patients hospitalized with respiratory symptoms at selected hospitals using real\u2010time reverse transcriptase polymerase chain reaction (rRT\u2010PCR); the Emerging Infections Program identified county patients with positive influenza tests in all area hospitals.", {"entities": [[137, 146, "DISEASE"], [429, 438, "DISEASE"]]}], ["For the surveillance\u2010sampling estimates, we applied the age\u2010specific proportions of influenza\u2010positive patients (from Flu\u2010VE) to the number of acute respiratory illness hospitalizations obtained from the Tennessee Hospital Discharge Data system.", {"entities": [[84, 93, "DISEASE"]]}], ["Results\u2002 With capture\u2013recapture, we estimated 0\u00b789 (95% CI, 0\u00b772\u20131\u00b749), 0\u00b762 (0\u00b742\u20131\u00b711), 1\u00b778 (0\u00b799\u20133\u00b763), and 0\u00b776 (0\u00b750\u20131\u00b776) hospitalizations per 1000 residents aged <5, 5\u201317, 18\u201349, and \u226550\u2003years, respectively.", {"entities": []}], ["Surveillance\u2010sampling estimated rates were 0\u00b778 (0\u00b746\u20131\u00b722), 0\u00b732 (0\u00b714\u20130\u00b769), 0\u00b799 (0\u00b764\u20131\u00b752), and 1\u00b743 (0\u00b780\u20132\u00b748) hospitalizations per 1000 residents aged <5, 5\u201317, 18\u201349, and \u226550\u2003years, respectively.", {"entities": []}], ["In all age\u2010groups combined, we estimated approximately 1 influenza\u2010related hospitalization per 1000 residents.", {"entities": [[57, 66, "DISEASE"]]}], ["Conclusions\u2002 Two independent methods provided consistent results on the burden of pandemic virus in Davidson County and suggested that the overall incidence of A(H1N1)pdm09\u2010associated hospitalization was 1 per 1000 county residents.", {"entities": []}], ["Research evidence is insufficient to change physicians' behaviour.", {"entities": []}], ["In 1996, Pathman developed a four step model: that physicians need to be aware of, agree with, adopt, and adhere to guidelines.", {"entities": []}], ["To review evidence in different settings on the patterns of \u2018leakage\u2019 in the utilisation of clinical guidelines using Pathman's awareness-to-adherence model.", {"entities": []}], ["A systematic review was conducted in June 2010.", {"entities": []}], ["Primary studies were included if they reported on rates of awareness and agreement and adoption and/or adherence.", {"entities": []}], ["11 primary studies were identified, reporting on 29 recommendations.", {"entities": []}], ["Descriptive analyses of patterns and causes of leakage were tabulated and graphed.", {"entities": []}], ["Leakage was progressive across all four steps.", {"entities": []}], ["Median adherence from all recommendations was 34%, suggesting that potential benefits for patients from health research may be lost.", {"entities": []}], ["There was considerable variation across different types of guidelines.", {"entities": []}], ["Recommendations for drug interventions, vaccination and health promotion activities showed high rates of awareness.", {"entities": []}], ["Leakage was most pronounced between adoption and adherence for drug recommendations and between awareness and agreement for medical management recommendations.", {"entities": []}], ["Barriers were reported differentially for all steps of the model.", {"entities": []}], ["Leakage from research publication to guideline utilisation occurs in a wide variety of clinical settings and at all steps of the awareness-to-adherence pathway.", {"entities": []}], ["This review confirms that clinical guidelines are insufficient to implement research and suggests there may be different factors influencing clinicians at each step of this pathway.", {"entities": []}], ["Recommendations to improve guideline adherence need to be tailored to each step.", {"entities": []}], ["Evaluate the effectiveness of collaborative management of hypertension by primary care-pharmacist teams in community-based clinics.", {"entities": [[58, 70, "DISEASE"]]}], ["A 12-month prospective, single-blind, randomized, controlled trial in the Providence Primary Care Research Network of patients with hypertension and uncontrolled blood pressure.", {"entities": [[132, 144, "DISEASE"]]}], ["As compared to usual primary care, intervention consisted of pharmacy practitioners participating in the active management of hypertension in the primary care office according to established collaborative treatment protocols.", {"entities": [[126, 138, "DISEASE"]]}], ["At baseline, there was no significant difference in blood pressure between groups.", {"entities": []}], ["Primary outcome measures were the differences in mean systolic and diastolic blood pressures between arms at study end.", {"entities": []}], ["Secondary measures included blood pressure goal attainment (<140/90\u00a0mmHg), hypertension-related knowledge, medication adherence, home blood pressure monitoring, resource utilization, quality of life, and satisfaction.", {"entities": [[75, 87, "DISEASE"]]}], ["A total of 463 subjects were enrolled (n\u2009=\u2009233 control, n\u2009=\u2009230 intervention).", {"entities": []}], ["Subjects receiving the intervention achieved significantly lower systolic (p\u2009=\u20090.007) and diastolic (p\u2009=\u20090.002) blood pressures compared to control (137/75\u00a0mmHg vs. 143/78\u00a0mmHg).", {"entities": []}], ["In addition, 62% of intervention subjects achieved target blood pressure compared to 44% of control subjects (p\u2009=\u20090.003).", {"entities": []}], ["The intervention group received more total office visits (7.2 vs. 4.9, p\u2009<\u20090.0001), however had fewer physician visits (3.2 vs. 4.7, p\u2009<\u20090.0001) compared to control.", {"entities": []}], ["Intervention subjects were prescribed more antihypertensive medications (2.7 vs. 2.4, p\u2009=\u20090.02), but did not take more antihypertensive pills per day (2.4 vs. 2.5, p\u2009=\u20090.87).", {"entities": []}], ["There were minimal differences between groups in hypertension-related knowledge, medication adherence, quality of life, or satisfaction.", {"entities": [[49, 61, "DISEASE"]]}], ["Patients randomized to collaborative primary care-pharmacist hypertension management achieved significantly better blood pressure control compared to usual care with no difference in quality of life or satisfaction.", {"entities": [[61, 73, "DISEASE"]]}], ["Influenza severity increases and vaccine effectiveness decreases with age.", {"entities": [[0, 9, "DISEASE"]]}], ["High-dose influenza vaccine (HD) with quadruple the antigen of standard-dose (SD) vaccine is more efficacious in community-dwelling persons 65\u00a0years and older.", {"entities": [[10, 19, "DISEASE"]]}], ["We evaluated the feasibility of recruiting and randomizing Medicare certified nursing homes (NHs) for a pragmatic cluster-randomized trial comparing HD vs. SD (NCT1720277).", {"entities": [[93, 96, "GENE"]]}], ["Residents were long-stay and at least 65\u00a0years old.", {"entities": []}], ["NH leadership agreed to standard of care random assignment with HD (Fluzone\u00ae High-Dose) or SD (Fluzone\u00ae) influenza vaccine for their facility for the 2012\u20132013 influenza season.", {"entities": [[105, 114, "DISEASE"], [160, 169, "DISEASE"]]}], ["We used Minimum Data Set (MDS) 3.0 and Vital Status records for pre-specified clinical outcomes: 1) all-cause hospitalization, 2) NH mortality, and 3) functional decline.", {"entities": []}], ["Intent-to-treat analyses were performed at the resident-level using Cox proportional hazards, multivariable Poisson, and logistic regression models accounting for clustering by facility.", {"entities": []}], ["We randomized 39 NHs (19 SD and 20 HD), coordinated vaccine delivery, implemented web-based data collection, and accessed MDS data, demonstrating feasibility.", {"entities": [[17, 20, "GENE"]]}], ["There were 2,957 eligible residents (SD 1496; HD 1461); characteristics were similar between groups.", {"entities": []}], ["A total of 301 (20.1%) of SD and 197 (13.5%) of HD allocated residents were ever hospitalized, (adjusted relative risk 0.680; 95% CI: 0.537, 0.862; p = 0.001).", {"entities": []}], ["NH mortality was 274 (18.3%) SD vs. 249 (17.1%) HD, adjusted relative risk 0.834; 95% CI: 0.678, 1.027; p = 0.087).", {"entities": []}], ["There were no differences in decline in functional status (13.4\u00a0vs. 13.8%, adjusted relative risk 0.994; 95% CI: 0.774,1.278; p = 0.965).", {"entities": []}], ["We demonstrate that a pragmatic large-scale trial is feasible in a NH setting.", {"entities": []}], ["Exposure to toxic metals during the prenatal period carries the potential for adverse developmental effects to the fetus, yet such exposure remains largely unmonitored in the United States.", {"entities": []}], ["The aim of this study was to assess maternal exposure to four toxic metals (arsenic (As), cadmium (Cd), mercury (Hg), and lead (Pb)) in a cohort of pregnant women in North Carolina.", {"entities": []}], ["We analyzed blood samples submitted to the North Carolina Department of Health and Human Services for blood typing to assess toxic metal levels in pregnant women (n\u200a=\u200a211) across six North Carolina counties.", {"entities": []}], ["Whole blood metal concentrations were measured by inductively coupled plasma mass spectrometry.", {"entities": []}], ["The association between maternal characteristics, including county of residence, age, and race, and metal exposure was analyzed using multiple linear regression analysis.", {"entities": []}], ["A large fraction of the blood samples showed detectable levels for each of the four metals.", {"entities": []}], ["Specifically, As (65.7%), Cd (57.3%), Hg (63.8%), and Pb (100%) were detected in blood samples.", {"entities": []}], ["Moreover, compared with adult females participating in the Fourth National Report on Human Exposure to Environmental Chemicals and guidelines for pregnant women, some women in the sample population exceeded benchmark levels of Cd, Hg, and Pb.", {"entities": []}], ["Evidence from this pilot study indicates that pregnant women in North Carolina are exposed to As, Cd, Hg, and Pb and suggests that factors related to maternal county of residence and race may impact maternal exposure levels.", {"entities": []}], ["As increased levels of one or more of these metals in utero have been associated with detrimental developmental and reproductive outcomes, further study is clearly warranted to establish the impacts to newborns.", {"entities": []}], ["The inhaled corticosteroid fluticasone furoate (FF) in combination with the long-acting \u03b2 2 agonist vilanterol (VI) is in development for asthma and chronic obstructive pulmonary disease.", {"entities": [[149, 186, "DISEASE"], [138, 144, "DISEASE"]]}], ["To assess the safety and tolerability of FF/VI over 52\u2005weeks in patients with asthma.", {"entities": [[78, 84, "DISEASE"]]}], ["Patients (aged \u226512\u2005years; on inhaled corticosteroid) were randomised (2:2:1) to FF/VI 100/25\u2005\u00b5g or FF/VI 200/25\u2005\u00b5g once daily in the evening, or fluticasone propionate (FP) 500\u2005\u00b5g twice daily.", {"entities": []}], ["Safety evaluations included adverse events (AEs), non-fasting glucose, potassium, 24-h urinary cortisol excretion, ophthalmic assessments, heart rate and pulse rate.", {"entities": []}], ["On-treatment AEs were similar across groups (FF/VI 66\u201369%; 73% FP).", {"entities": []}], ["Oral candidiasis/oropharyngeal candidiasis was more common with FF/VI (6\u20137%) than FP (3%).", {"entities": [[5, 16, "DISEASE"], [31, 42, "DISEASE"]]}], ["Twelve serious AEs were reported; one (worsening hepatitis B on FP) was considered drug related.", {"entities": [[49, 58, "DISEASE"]]}], ["Statistically significant cortisol suppression was seen with FP compared with both FF/VI groups at Weeks 12 and 28 (ratios [95% CI] to FP ranged from 1.43 [1.11 to 1.84] to 1.67 [1.34 to 2.08]; p\u22640.006), but not at Week 52 (ratios to FP were 1.05 [0.83 to 1.33] for FF/VI 100/25\u2005\u00b5g and 1.09 [0.87 to 1.38] for FF/VI 200/25\u2005\u00b5g).", {"entities": []}], ["No clinically important changes in non-fasting glucose, potassium, QT interval corrected using Fridericia's formula (QTc[F]) or ophthalmic assessments were reported.", {"entities": []}], ["Pulse rate (10\u2005min post dose [T max ], Week 52) was significantly increased with FF/VI versus FP (3.4\u2005bpm, 95% CI 1.3 to 5.6; p=0.002 [FF/VI 100/25\u2005\u00b5g]; 3.4\u2005bpm, 95% CI 1.2 to 5.6; p=0.003 [FF/VI 200/25\u2005\u00b5g]).", {"entities": [[32, 35, "GENE"]]}], ["Mean heart rate (24-h Holter monitoring) decreased from screening values in all groups (0.2\u20131.1\u2005bpm FF/VI vs 5\u2005bpm FP; Week 52).", {"entities": []}], ["FF/VI (100/25\u2005\u00b5g or 200/25\u2005\u00b5g) administered once daily over 52\u2005weeks was well tolerated by patients aged \u226512\u2005years with asthma.", {"entities": [[120, 126, "DISEASE"]]}], ["The overall safety profile of FF/VI did not reveal any findings of significant clinical concern.", {"entities": []}], ["NCT01018186", {"entities": []}], ["The genetic component was suggested to contribute to the development of chronic obstructive pulmonary disease (COPD), a major and growing public health burden.", {"entities": [[72, 109, "DISEASE"]]}], ["The present review aims to characterize the evidence that gene polymorphisms contribute to the aetiology of COPD and related traits, and explore the potential relationship between certain gene polymorphisms and COPD susceptibility, severity, lung function, phenotypes, or drug effects, even though limited results from related studies lacked consistency.", {"entities": []}], ["Most of these studies were association studies, rather than confirmatory studies.", {"entities": []}], ["More large-sized and strictly controlled studies are needed to prove the relationship between gene polymorphisms and the reviewed traits.", {"entities": []}], ["More importantly, prospective confirmatory studies beyond initial association studies will be necessary to evaluate true relationships between gene polymorphisms and COPD and help individualized treatment for patients with COPD.", {"entities": []}], ["Electronic cigarettes (ECs) have been rapidly gaining ground on conventional cigarettes due to their efficiency in ceasing or reducing tobacco consumption, competitive prices, and the perception of them being a much less harmful smoking alternative.", {"entities": []}], ["Direct confirmation that long-term EC use leads to reductions in smoking-related diseases is not available and it will take a few decades before the tobacco harm reduction potential of this products is firmly established.", {"entities": []}], ["Nonetheless, it is feasible to detect early changes in airway function and respiratory symptoms in smokers switching to e-vapor.", {"entities": []}], ["Acute investigations do not appear to support negative respiratory health outcomes in EC users and initial findings from long-term studies are supportive of a beneficial effect of EC use in relation to respiratory outcomes.", {"entities": []}], ["The emerging evidence that EC use can reverse harm from tobacco smoking should be taken into consideration by regulatory authorities seeking to adopt proportional measures for the e-vapor category.", {"entities": []}], ["Experimental human pneumococcal carriage (EHPC) is scientifically important because nasopharyngeal carriage of Streptococcus pneumoniae is both the major source of transmission and the prerequisite of invasive disease.", {"entities": []}], ["A model of carriage will allow accurate determination of the immunological correlates of protection, the immunizing effect of carriage and the effect of host pressure on the pathogen in the nasopharyngeal niche.", {"entities": []}], ["Further, methods of carriage detection useful in epidemiologic studies, including vaccine studies, can be compared.", {"entities": []}], ["We aim to develop an EHPC platform that is a safe and useful reproducible method that could be used to down-select candidate novel pneumococcal vaccines with prevention of carriage as a surrogate of vaccine induced immunity.", {"entities": []}], ["It will work towards testing of candidate vaccines and descriptions of the mechanisms underlying EHPC and vaccine protection from carriage We inoculate with S. pneumoniae suspended in 100 \u03bcl of saline.", {"entities": []}], ["Safety is a major factor in the development of the EHPC model and is achieved through intensive volunteer screening and monitoring.", {"entities": []}], ["A safety committee consisting of clinicians and scientists that are independent from the study provides objective feedback on a weekly basis.", {"entities": []}], ["The bacterial inoculum is standardized and requires that no animal products are inoculated into volunteers (vegetable-based media and saline).", {"entities": []}], ["The doses required for colonization (10 Our current protocol has been safe in over 100 volunteers at a range of doses using two different bacterial serotypes S. pneumoniae 6B and 23F is currently being conducted to determine the optimal inoculation dose for 50% carriage.", {"entities": []}], ["A predicted 50% rate of carriage will allow the EHPC model to have high sensitivity for vaccine efficacy with small study numbers.", {"entities": []}], ["Pattern recognition receptors (PRRs), including Toll-like receptor 3 (TLR3), are involved in arthritic responses; however, whether interleukin-33 (IL-33) is involved in TLR3-mediated cartilage degeneration is unknown.", {"entities": [[70, 74, "GENE"], [169, 173, "GENE"]]}], ["Here, we found that IL-33 was abundantly increased in chondrocytes of osteoarthritis, especially the chondrocytes of weight-bearing cartilage.", {"entities": [[70, 84, "DISEASE"]]}], ["Furthermore, double-stranded RNA (dsRNA) released from damaged articular chondrocytes induced by mechanical stretching upregulated IL-33 expression to a greater degree than IL-1 \u03b2 and tumor necrosis factor- \u03b1 .", {"entities": []}], ["dsRNA induced IL-33 expression via the TLR3-p38 mitogen-activated protein kinase-nuclear factor- \u03ba B (NF- \u03ba B) pathway.", {"entities": []}], ["In addition, formation of the p65 and peroxisome proliferator-activated receptor -\u03b3 transcriptional complex was required for dsRNA-induced IL-33 expression.", {"entities": []}], ["IL-33, in turn, acted on chondrocytes to induce matrix metalloproteinase-1/13 and inhibit type II collagen expression.", {"entities": []}], ["These findings reveal that dsRNA released from damaged articular chondrocytes promotes cartilage degeneration via the TLR3-IL-33 pathway.", {"entities": []}], ["The last few years have witnessed a rapid increase in our knowledge of the retinoid-related orphan receptors ROR\u03b1, -\u03b2, and -\u03b3 (NR1F1-3), their mechanism of action, physiological functions, and their potential role in several pathologies.", {"entities": []}], ["The characterization of ROR-deficient mice and gene expression profiling in particular have provided great insights into the critical functions of RORs in the regulation of a variety of physiological processes.", {"entities": []}], ["These studies revealed that ROR\u03b1 plays a critical role in the development of the cerebellum, that both ROR\u03b1 and ROR\u03b2 are required for the maturation of photoreceptors in the retina, and that ROR\u03b3 is essential for the development of several secondary lymphoid tissues, including lymph nodes.", {"entities": []}], ["RORs have been further implicated in the regulation of various metabolic pathways, energy homeostasis, and thymopoiesis.", {"entities": []}], ["Recent studies identified a critical role for ROR\u03b3 in lineage specification of uncommitted CD4", {"entities": [[91, 94, "GENE"]]}], ["Chronic rhinosinusitis is a disease with high prevalence, significant impact on health-related quality of life (HRQoL) and it is associated with substantial healthcare and productivity costs.", {"entities": []}], ["We face an urgent need to improve the level of disease control and achieve higher patient satisfaction and disease prevention.", {"entities": []}], ["Precision medicine is increasingly recognized as the way forward in optimal patient care.", {"entities": []}], ["The combination of personalized care, prevention of disease, prediction of success of treatment, and participation of the patient in the elaboration of the treatment plan is expected to guarantee the best possible therapeutic approach for individuals suffering from a chronic disabling condition.", {"entities": []}], ["This is a narrative review on the current state of endotypes, biomarkers, and targeted treatments in chronic inflammatory conditions of the nose and paranasal sinuses.", {"entities": []}], ["Different phenotypes of rhinitis and chronic rhinosinusitis (CRS) have been described based on symptom severity and duration, atopy status, level of control, comorbidities, and presence or absence of nasal polyps in CRS.", {"entities": [[24, 32, "DISEASE"]]}], ["The underlying pathophysiological mechanisms are diverse, with different endotypes being recognized.", {"entities": []}], ["Novel emerging therapies are targeting specific pathophysiological pathways or endotypes.", {"entities": []}], ["This endotype-driven treatment approach requires careful selection of the patient population who might benefit from a specific treatment.", {"entities": []}], ["This review provides a comprehensive overview of the current state of endotypes, biomarkers and targeted treatments in chronic inflammatory conditions of the nose and paranasal sinuses.", {"entities": []}], ["Background: World Trade Center (WTC) rescue and recovery workers were exposed to a complex mix of pollutants and carcinogens.", {"entities": []}], ["Objective: The purpose of this investigation was to evaluate cancer incidence in responders during the first 7 years after 11 September 2001.", {"entities": [[61, 67, "DISEASE"]]}], ["Methods: Cancers among 20,984 consented participants in the WTC Health Program were identified through linkage to state tumor registries in New York, New Jersey, Connecticut, and Pennsylvania.", {"entities": []}], ["Standardized incidence ratios (SIRs) were calculated to compare cancers diagnosed in responders to predicted numbers for the general population.", {"entities": []}], ["Multivariate regression models were used to estimate associations with degree of exposure.", {"entities": []}], ["Results: A total of 575 cancers were diagnosed in 552 individuals.", {"entities": []}], ["Increases above registry-based expectations were noted for all cancer sites combined (SIR = 1.15; 95% CI: 1.06, 1.25), thyroid cancer (SIR = 2.39; 95% CI: 1.70, 3.27), prostate cancer (SIR = 1.21; 95% CI: 1.01, 1.44), combined hematopoietic and lymphoid cancers (SIR = 1.36; 95% CI: 1.07, 1.71), and soft tissue cancers (SIR = 2.26; 95% CI: 1.13, 4.05).", {"entities": [[119, 133, "DISEASE"], [63, 69, "DISEASE"], [127, 133, "DISEASE"], [177, 183, "DISEASE"], [168, 183, "DISEASE"]]}], ["When restricted to 302 cancers diagnosed \u2265 6 months after enrollment, the SIR for all cancers decreased to 1.06 (95% CI: 0.94, 1.18), but thyroid and prostate cancer diagnoses remained greater than expected.", {"entities": [[159, 165, "DISEASE"], [150, 165, "DISEASE"]]}], ["All cancers combined were increased in very highly exposed responders and among those exposed to significant amounts of dust, compared with responders who reported lower levels of exposure.", {"entities": []}], ["Conclusion: Estimates should be interpreted with caution given the short follow-up and long latency period for most cancers, the intensive medical surveillance of this cohort, and the small numbers of cancers at specific sites.", {"entities": []}], ["However, our findings highlight the need for continued follow-up and surveillance of WTC responders.", {"entities": []}], ["Multiorgan dysfunction syndrome contributes to adverse outcomes in advanced heart failure (AdHF) patients after mechanical circulatory support (MCS) implantation and is associated with aberrant leukocyte activity.", {"entities": [[23, 31, "DISEASE"]]}], ["We tested the hypothesis that preoperative peripheral blood mononuclear cell (PBMC) gene expression profiles (GEP) can predict early postoperative improvement or non-improvement in patients undergoing MCS implantation.", {"entities": []}], ["We believe this information may be useful in developing prognostic biomarkers.", {"entities": []}], ["We conducted a study with 29 patients undergoing MCS-surgery in a tertiary academic medical center from 2012 to 2014.", {"entities": []}], ["PBMC samples were collected one day before surgery (day -1).", {"entities": []}], ["Clinical data was collected on day -1 and day 8 postoperatively.", {"entities": []}], ["Patients were classified by Sequential Organ Failure Assessment score and Model of End-stage Liver Disease Except INR score (measured eight days after surgery): Group I = improving (both scores improved from day -1 to day 8, n = 17) and Group II = not improving (either one or both scores did not improve from day -1 to day 8, n = 12).", {"entities": []}], ["RNA-sequencing was performed on purified mRNA and analyzed using Next Generation Sequencing Strand.", {"entities": []}], ["Differentially expressed genes (DEGs) were identified by Mann-Whitney test with Benjamini-Hochberg correction.", {"entities": []}], ["Preoperative DEGs were used to construct a support vector machine algorithm to predict Group I vs. Group II membership.", {"entities": []}], ["Out of 28 MCS-surgery patients alive 8 days postoperatively, one-year survival was 88% in Group I and 27% in Group II.", {"entities": []}], ["We identified 28 preoperative DEGs between Group I and II, with an average 93% prediction accuracy.", {"entities": []}], ["Out of 105 DEGs identified preoperatively between year 1 survivors and non-survivors, 12 genes overlapped with the 28 predictive genes.", {"entities": []}], ["In AdHF patients following MCS implantation, preoperative PBMC-GEP predicts early changes in organ function scores and correlates with long-term outcomes.", {"entities": []}], ["Therefore, gene expression lends itself to outcome prediction and warrants further studies in larger longitudinal cohorts.", {"entities": []}], ["Recent identifications of associations between novel variants in inflammation-related genes and several common diseases emphasize the need for systematic evaluations of these genes in disease susceptibility.", {"entities": []}], ["Considering that many genes are involved in the complex inflammation responses and many genetic variants in these genes have the potential to alter the functions and expression of these genes, we assembled a list of key inflammation-related genes to facilitate the identification of genetic associations of diseases with an inflammation-related etiology.", {"entities": []}], ["We first reviewed various phases of inflammation responses, including the development of immune cells, sensing of danger, influx of cells to sites of insult, activation and functional responses of immune and non-immune cells, and resolution of the immune response.", {"entities": []}], ["Assisted by the Ingenuity Pathway Analysis, we then identified 17 functional sub-pathways that are involved in one or multiple phases.", {"entities": []}], ["This organization would greatly increase the chance of detecting gene-gene interactions by hierarchical clustering of genes with their functional closeness in a pathway.", {"entities": []}], ["Finally, as an example application, we have developed tagging single nucleotide polymorphism (tSNP) arrays for populations of European and African descent to capture all the common variants of these key inflammation-related genes.", {"entities": []}], ["Assays of these tSNPs have been designed and assembled into two Affymetrix ParAllele customized chips, one each for European (12,011 SNPs) and African (21,542 SNPs) populations.", {"entities": []}], ["These tSNPs have greater coverage for these inflammation-related genes compared to the existing genome-wide arrays, particularly in the African population.", {"entities": []}], ["These tSNP arrays can facilitate systematic evaluation of inflammation pathways in disease susceptibility.", {"entities": []}], ["For additional applications, other genotyping platforms could also be employed.", {"entities": []}], ["For existing genome-wide association data, this list of key inflammation-related genes and associated subpathways can facilitate comprehensive inflammation pathway- focused association analyses.", {"entities": []}], ["Small airway narrowing is an important pathology which impacts lung function in chronic obstructive pulmonary disease (COPD).", {"entities": [[80, 117, "DISEASE"]]}], ["The accumulation of fibroblasts and myofibroblasts contribute to inflammation, remodeling and fibrosis by production and release of mediators such as cytokines, profibrotic factors and extracellular matrix proteins.", {"entities": []}], ["This study investigated the effects of the phosphodiesterase 4 inhibitor roflumilast, combined with the long acting \u03b2 2 adrenergic agonist indacaterol, both approved therapeutics for COPD, on fibroblast functions that contribute to inflammation and airway fibrosis.", {"entities": []}], ["The effects of roflumilast and indacaterol treatment were characterized on transforming growth factor \u03b21 (TGF\u03b21)-treated normal human lung fibroblasts (NHLF).", {"entities": []}], ["NHLF were evaluated for expression of the profibrotic mediators endothelin-1 (ET-1) and connective tissue growth factor (CTGF), expression of the myofibroblast marker alpha smooth muscle actin, and fibronectin (FN) secretion.", {"entities": [[121, 125, "GENE"]]}], ["Tumor necrosis factor-\u03b1 (TNF-\u03b1) was used to induce secretion of chemokine C-X-C motif ligand 10 (CXCL10), chemokine C-C motif ligand 5 (CCL5) and granulocyte macrophage colony-stimulating factor (GM-CSF) from NHLF and drug inhibition was assessed.", {"entities": [[97, 103, "GENE"], [136, 140, "GENE"]]}], ["Evaluation of roflumilast (1-10 \u03bcM) showed no significant inhibition alone on TGF\u03b21-induced ET-1 and CTGF mRNA transcripts, ET-1 and FN protein production, alpha smooth muscle expression, or TNF-\u03b1-induced secretion of CXCL10, CCL5 and GM-CSF.", {"entities": [[101, 105, "GENE"], [218, 224, "GENE"], [226, 230, "GENE"]]}], ["A concentration-dependent inhibition of ET-1 and CTGF was shown with indacaterol treatment, and a submaximal concentration was chosen for combination studies.", {"entities": [[49, 53, "GENE"]]}], ["When indacaterol (0.1 nM) was added to roflumilast, significant inhibition was seen on all inflammatory and fibrotic mediators evaluated, which was superior to the inhibition seen with either drug alone.", {"entities": []}], ["Roflumilast plus indacaterol combination treatment resulted in significantly elevated phosphorylation of the transcription factor cAMP response element-binding protein (CREB), an effect that was protein kinase A-dependent.", {"entities": []}], ["Inhibition of protein kinase A was also found to reverse the inhibition of indacaterol and roflumilast on CTGF.", {"entities": [[106, 110, "GENE"]]}], ["These results demonstrate that addition of roflumilast to a LABA inhibits primary fibroblast/myofibroblast function and therapeutically this may impact lung fibroblast proinflammatory and profibrotic mediator release which contributes to small airway remodeling and airway obstruction in COPD.", {"entities": []}], ["We investigated the associations between traditional and environmentally preferable cleaning product exposure and dermal, respiratory, and musculoskeletal symptoms in a population of custodians.", {"entities": []}], ["We analyzed associations between symptoms and exposure to traditional and environmentally preferable cleaning product exposure among 329 custodians.", {"entities": []}], ["We observed increased odds of dermal ( P\u2009 <\u20090.01), upper ( P\u2009 =\u20090.01) and lower respiratory ( P\u2009 =\u20090.01), and upper extremity ( P\u2009 <\u20090.01), back ( P\u2009 <\u20090.01), and lower extremity ( P\u2009 =\u20090.01) musculoskeletal symptoms associated with increased typical traditional cleaning product exposure.", {"entities": []}], ["We observed significant trends for increased odds of dermal ( P\u2009 =\u20090.03) and back ( P\u2009 =\u20090.04) and lower ( P\u2009 =\u20090.02) extremity musculoskeletal symptoms associated with increased typical environmentally preferable cleaning product exposure.", {"entities": []}], ["Fewer positive associations and reduced odds of health symptoms associated with environmentally preferable cleaning product exposure suggest that these products may represent a safer alternative to traditional cleaning products.", {"entities": []}], ["58:988\u2013995, 2015.", {"entities": []}], ["\u00a9 2015 The Authors.", {"entities": []}], ["American Journal of Industrial Medicine Published by Wiley Periodicals, Inc.", {"entities": []}], ["Soft tissue injuries commonly present to the emergency department (ED), often with acute pain.", {"entities": []}], ["They cause significant suffering and morbidity if not adequately treated.", {"entities": []}], ["Paracetamol and ibuprofen are commonly used analgesics, but it remains unknown if either one or the combination of both is superior for pain control.", {"entities": []}], ["To investigate the analgesic effect of paracetamol, ibuprofen and the combination of both in the treatment of soft tissue injury in an ED, and the side effect profile of these drugs.", {"entities": []}], ["Double-blind, double dummy, placebo-controlled randomised controlled trial.", {"entities": []}], ["782 adult patients presenting with soft tissue injury without obvious fractures attending the ED of a university hospital in the New Territories of Hong Kong were recruited.", {"entities": []}], ["Patients were randomised using a random number table into three parallel arms of paracetamol only, ibuprofen only and a combination of paracetamol and ibuprofen in a 1:1:1 ratio.", {"entities": []}], ["The primary outcome measure was pain score at rest and on activity in the first 2 hours and first 3 days.", {"entities": []}], ["Data was analysed on an intention to treat basis.", {"entities": []}], ["There was no statistically significant difference in pain score in the initial two hours between the three groups, and no clinically significant difference in pain score in the first three days.", {"entities": []}], ["There was no difference in analgesic effects or side effects observed using oral paracetamol, ibuprofen or a combination of both in patients with mild to moderate pain after soft tissue injuries attending the ED.", {"entities": []}], ["The study is registered with ClinicalTrials.gov (no.", {"entities": []}], ["NCT00528658 ).", {"entities": []}], ["Congenital heart disease (CHD) is one of the most prevalent birth defects.", {"entities": [[11, 24, "DISEASE"]]}], ["Housing renovations are a newly recognized source of indoor environmental pollution that is detrimental to health.", {"entities": []}], ["A growing body of research suggests that maternal occupational exposure to renovation materials may be associated with an increased risk of giving birth to fetuses with CHD.", {"entities": []}], ["However, the effect of indoor housing renovation exposure on CHD occurrence has not been reported.", {"entities": []}], ["A multi-hospital case\u2013control study was designed to investigate the association between maternal periconceptional housing renovation exposure and the risk of CHD for offspring.", {"entities": []}], ["In total, 346 cases and 408 controls were enrolled in this study from four hospitals in China.", {"entities": []}], ["Exposure information was based on a questionnaire given to women during pregnancy.", {"entities": []}], ["The association between housing renovation exposure and CHD occurrence was assessed by estimating odds ratios (OR) with logistic regression models adjusted for potential confounders.", {"entities": []}], ["The risk for CHD in offspring was significantly associated with maternal exposure to housing renovations (AOR: 1.89, 95% CI: 1.29-2.77).", {"entities": []}], ["There were similar risks for cardiac defects with or without extra-cardiac malformation (AOR of 2.65 and 1.76, respectively).", {"entities": []}], ["Maternal housing renovation exposure may increase the fetus\u2019 risk of suffering from conotruncal defect or anomalous venous return.", {"entities": []}], ["There were significant risks for cardiac defects if the pregnant woman moved into a new house within one month after decoration at either 3\u00a0months before pregnancy (AOR: 2.38, 95% CI: 1.03 to 5.48) or during first trimester (AOR: 4.00, 95% CI: 1.62 to 9.86).", {"entities": []}], ["Maternal exposure to housing renovations may have an increased risk of giving birth to fetuses with some selected types of CHD.", {"entities": []}], ["This relationship was stronger for women who moved into a newly decorated house.", {"entities": []}], ["However, considering the limited number of subjects and the problem of multiple exposures, more research is needed to clarify the effects seen here.", {"entities": []}], ["It has been suggested that children that are exposed to a stressful environment at home have an increased susceptibility for air pollution-related asthma.", {"entities": [[147, 153, "DISEASE"]]}], ["The aim here was to investigate the association between air pollution exposure and asthma, and effect modification by mental health and by socio-economic status (as markers of a stressful environment).", {"entities": [[83, 89, "DISEASE"]]}], ["All individuals under 18 years of age in four Swedish counties during 2007 to 2010 (1.2 million people) were included.", {"entities": []}], ["The outcome was defined as dispensing at least two asthma medications during follow up.", {"entities": [[51, 57, "DISEASE"]]}], ["We linked data on NO 2 from an empirical land use regression to data from national registers on outcome and potential confounders.", {"entities": []}], ["Data was analyzed with logistic regression.", {"entities": []}], ["There was an odds ratio (OR) of 1.02 (95% Confidence Interval (CI: 1.01\u20131.03) for asthma associated with a 10 \u00b5g\u00b7m 2 .", {"entities": [[82, 88, "DISEASE"]]}], ["The association only seemed to be present in areas where NO 2 was higher than 15 \u00b5g\u00b7m", {"entities": []}], ["Metabolic activation of the innate immune system governed by interleukin (IL)-1\u03b2 contributes to \u03b2-cell failure in type 2 diabetes.", {"entities": []}], ["Gevokizumab is a novel, human-engineered monoclonal anti\u2013IL-1\u03b2 antibody.", {"entities": []}], ["We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.", {"entities": []}], ["In a placebo-controlled, dose-escalation study, a total of 98 patients were randomly assigned to placebo (17 subjects) or gevokizumab (81 subjects) at increasing doses and dosing schedules.", {"entities": []}], ["The primary objective of the study was to evaluate the safety profile of gevokizumab in type 2 diabetes.", {"entities": []}], ["The secondary objectives were to assess pharmacokinetics for different dose levels, routes of administration, and regimens and to assess biological activity.", {"entities": []}], ["The study drug was well tolerated with no serious adverse events.", {"entities": []}], ["There was one hypoglycemic event whereupon concomitant insulin treatment had to be reduced.", {"entities": []}], ["Clearance of gevokizumab was consistent with that for a human IgG 2 , with a half-life of 22 days.", {"entities": []}], ["In the combined intermediate-dose group (single doses of 0.03 and 0.1 mg/kg), the mean placebo-corrected decrease in glycated hemoglobin was 0.11, 0.44, and 0.85% after 1, 2 ( P = 0.017), and 3 ( P = 0.049) months, respectively, along with enhanced C-peptide secretion, increased insulin sensitivity, and a reduction in C-reactive protein and spontaneous and inducible cytokines.", {"entities": []}], ["This novel IL-1\u03b2\u2013neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes.", {"entities": []}], ["This therapeutic agent may be able to be used on a once-every-month or longer schedule.", {"entities": []}], ["Oxidative stress is a normal phenomenon in the body.", {"entities": []}], ["Under normal conditions, the physiologically important intracellular levels of reactive oxygen species (ROS) are maintained at low levels by various enzyme systems participating in the in vivo redox homeostasis.", {"entities": []}], ["Therefore, oxidative stress can also be viewed as an imbalance between the prooxidants and antioxidants in the body.", {"entities": []}], ["For the last two decades, oxidative stress has been one of the most burning topics among the biological researchers all over the world.", {"entities": []}], ["Several reasons can be assigned to justify its importance: knowledge about reactive oxygen and nitrogen species production and metabolism; identification of biomarkers for oxidative damage; evidence relating manifestation of chronic and some acute health problems to oxidative stress; identification of various dietary antioxidants present in plant foods as bioactive molecules; and so on.", {"entities": []}], ["This review discusses the importance of oxidative stress in the body growth and development as well as proteomic and genomic evidences of its relationship with disease development, incidence of malignancies and autoimmune disorders, increased susceptibility to bacterial, viral, and parasitic diseases, and an interplay with prooxidants and antioxidants for maintaining a sound health, which would be helpful in enhancing the knowledge of any biochemist, pathophysiologist, or medical personnel regarding this important issue.", {"entities": []}], ["Worldwide, paracetamol is administered as a remedy for complaints that occur after vaccination.", {"entities": []}], ["Recently published results indicate that paracetamol inhibits the vaccination response in infants when given prior to vaccination.", {"entities": []}], ["The goal of this study was to establish whether paracetamol exerts similar effects in young adults.", {"entities": []}], ["In addition, the effect of timing of paracetamol intake was investigated.", {"entities": []}], ["In two randomized, controlled, open-label studies 496 healthy young adults were randomly assigned to three groups.", {"entities": []}], ["The study groups received paracetamol for 24 hours starting at the time of (prophylactic use) - or 6 hours after (therapeutic use) the primary (0 month) and first booster (1 month) hepatitis B vaccination.", {"entities": [[181, 190, "DISEASE"]]}], ["The control group received no paracetamol.", {"entities": []}], ["None of the participants used paracetamol around the second booster (6 months) vaccination.", {"entities": []}], ["Anti-HBs levels were measured prior to and one month after the second booster vaccination on ADVIA Centaur XP.", {"entities": []}], ["One month after the second booster vaccination, the anti-HBs level in the prophylactic paracetamol group was significantly lower (p\u200a=\u200a0.048) than the level in the control group (4257 mIU/mL vs. 5768 mIU/mL).", {"entities": []}], ["The anti-HBs level in the therapeutic paracetamol group (4958 mIU/mL) was not different (p\u200a=\u200a0.34) from the level in the control group.", {"entities": []}], ["Only prophylactic paracetamol treatment, and not therapeutic treatment, during vaccination has a negative influence on the antibody concentration after hepatitis B vaccination in adults.", {"entities": [[152, 161, "DISEASE"]]}], ["These findings prompt to consider therapeutic instead of prophylactic treatment to ensure maximal vaccination efficacy and retain the possibility to treat pain and fever after vaccination.", {"entities": []}], ["Controlled-Trials.com ISRCTN03576945", {"entities": []}], ["Dendritic cells (DC) are potential tools for therapeutic applications and several strategies to generate tolerogenic DCs are under investigation.", {"entities": []}], ["When activated by cytokines and microbial products, DCs express mediators that modulate immune responses.", {"entities": []}], ["In this regard, the metabolites generated by the activities of inducible nitric oxide synthase (iNOS) and arginase in DCs seem to play important roles.", {"entities": []}], ["Here, we evaluated the effects of adoptive transfer of DCs generated in vitro from bone marrow precursors (BMDC) modulated with L-NAME (N\u03c9-nitro-L-arginine methyl ester) and NOHA (NG-Hydroxy-L-arginine), inhibitors of iNOS and arginase, respectively, upon the immune response of the wild type (BALB/c) and OVA-TCR transgenic (DO11.10) mice.", {"entities": []}], ["The modulation with L-NAME increased CD86 expression in BMDC, whereas treatment with NOHA increased both CD80 and CD86 expression.", {"entities": [[37, 41, "GENE"], [114, 118, "GENE"], [105, 109, "GENE"], [37, 41, "GENE"], [114, 118, "GENE"]]}], ["Adoptive transfer of either L-NAME- or NOHA-modulated BMDCs to BALB/c mice reduced the plasma levels of ovalbumin-specific antibody as well as proliferation and cytokine secretion in cultures of spleen cells in comparison adoptive transfer of non-modulated DCs.", {"entities": []}], ["Conversely, transfer of both modulated and non-modulated BMDCs had no effect on immune response of DO11.10 mice.", {"entities": []}], ["Together, these results show that the treatment with iNOS and Arg inhibitors leads to increased expression of co-stimulatory molecules in DCs, and provides evidences that L-arginine metabolism may be an important therapeutic target for modulating immune responses in inflammatory disorders.", {"entities": []}], ["The expression modulation of the immunosuppressive non-classical Human leukocyte antigen-G (HLA-G) molecule and its soluble isoforms is an immune evasion strategy being deployed by cytomegalovirus (CMV).", {"entities": [[92, 97, "GENE"]]}], ["The +3142 C>G single nucleotide polymorphism (SNP) located within the 3\u2032 untranslated region (3\u2032UTR) is of crucial importance for the regulation of HLA-G expression.", {"entities": [[148, 153, "GENE"]]}], ["Therefore, we analyzed the influence of the +3142 C>G HLA-G SNP on the occurrence of CMV infection in a cohort of 178 living-donor kidney recipients and their 178 corresponding donors.", {"entities": [[54, 59, "GENE"]]}], ["In addition, soluble HLA-G (sHLA-G) levels were quantified before and after transplantation.", {"entities": [[21, 26, "GENE"]]}], ["The presence of the HLA-G +3142 CC genotype in recipients, but not donors of our cohort as along with elevated sHLA-G levels (\u22656.1 ng/mL) were associated with higher susceptibility to CMV infection after transplantation.", {"entities": [[20, 25, "GENE"]]}], ["Our results provided evidence that (i) HLA-G is implicated in the establishment of CMV after living-donor kidney transplantation and (ii) recipient HLA-G +3142 CC genotype and sHLA-G concentration levels could represent important predictive risk markers for CMV infection.", {"entities": [[39, 44, "GENE"], [148, 153, "GENE"], [39, 44, "GENE"], [148, 153, "GENE"]]}], ["The role of cytokines in relation to clinical manifestations, disease severity, and outcome of children with H1N1 virus infection remains thus far unclear.", {"entities": []}], ["The aim of this study was to evaluate interleukin IL-1 \u03b2 and IL-6 plasma expressions and their association with clinical findings, disease severity, and outcome of children with H1N1 infection.", {"entities": []}], ["We prospectively evaluated 15 children with H1N1 virus infection and 15 controls with lower respiratory tract infections (LRTI).", {"entities": []}], ["Interleukin plasma levels were measured using immunoenzymatic assays.", {"entities": []}], ["Significantly higher levels of IL-1 \u03b2 and IL-6 were detected in all patients with H1N1 virus infection compared to controls.", {"entities": []}], ["It is noteworthy to mention that in H1N1 patients with more severe clinical manifestations of disease IL-1 \u03b2 and IL-6 expressions were significantly upregulated compared to H1N1 patients with mild clinical manifestations.", {"entities": []}], ["In particular, IL-6 was significantly correlated with specific clinical findings, such as severity of respiratory compromise and fever.", {"entities": []}], ["No correlation was found between interleukin expression and final outcome.", {"entities": []}], ["In conclusion, H1N1 virus infection induces an early and significant upregulation of both interleukins IL1 \u03b2 and IL-6 plasma expressions.", {"entities": []}], ["The upregulation of these cytokines is likely to play a proinflammatory role in H1N1 virus infection and may contribute to airway inflammation and bronchial hyperreactivity in these patients.", {"entities": []}], ["Chronic sputum is a troublesome symptom in many respiratory diseases.", {"entities": []}], ["The prevalence of chronic sputum varies from 1.2% to 13% according to the country.", {"entities": []}], ["The purpose of this study was to estimate the prevalence of chronic sputum and to find its associated factors in a general Korean population.", {"entities": []}], ["We analyzed the data of the Korea National Health and Nutrition Examination Survey 2010 and 2011.", {"entities": []}], ["A total number of 6,783 subjects aged 40 yr or more were enrolled in this study with 3,002 men and 3,781 women.", {"entities": []}], ["As a result, the prevalence of chronic sputum was 6.3% (n=430).", {"entities": []}], ["Significant risk factors for chronic sputum by multivariate analysis were: age (\u226570 yr) (odds ratio [OR], 1.954; 95% confidence interval [CI], 1.308-2.917), current smoking (OR, 4.496; 95% CI, 3.001-6.734), chronic obstructive pulmonary disease (COPD) (OR, 1.483; 95% CI, 1.090-2.018), and tuberculosis (OR, 1.959; 95% CI, 1.307-2.938).", {"entities": [[207, 244, "DISEASE"], [290, 302, "DISEASE"]]}], ["In conclusion, the prevalence of chronic sputum in Korea was in the intermediate range compared with other countries.", {"entities": []}], ["Smoking is a preventable risk factor identified in this study, and major respiratory diseases, such as COPD and tuberculosis, should be considered in subjects with chronic sputum.", {"entities": [[112, 124, "DISEASE"]]}], ["Unmet health care needs are determined as the difference between the services judged necessary and the services actually received, and stem from barriers related to accessibility, availability and acceptability.", {"entities": []}], ["This study aims to examine the prevalence of unmet needs and to identify the socioeconomic and health status factors that are associated with unmet needs.", {"entities": []}], ["A cross-sectional study was conducted in Greece in 2010 and involved data from 1,000 consenting subjects (>18 years old).", {"entities": []}], ["Multiple binary logistic regression analysis was applied to investigate the predictors of unmet needs and to determine the relation between the socio-demographic characteristics and the accessibility, availability and acceptability barriers.", {"entities": []}], ["Ninety nine participants (9.9%) reported unmet health needs during the 12 months prior to the research.", {"entities": []}], ["The most frequently self-reported reasons were cost and lack of time.", {"entities": []}], ["Youth, parenthood, physician consultations, and poor mental health increased the likelihood of unmet needs.", {"entities": []}], ["Women were less likely to report accessibility and availability than acceptability barriers.", {"entities": []}], ["Educational differences were evident and individuals with primary and secondary education were associated with significantly more accessibility and availability barriers compared with those with tertiary education.", {"entities": []}], ["Unmet health needs pose a significant challenge to the health care system, especially given the difficult current financial situation in Greece.", {"entities": []}], ["It is believed that unmet health needs will continue to increase, which will widen inequalities in health and health care access.", {"entities": []}], ["The prevalence of asthma among Shanghai children has increased over time.", {"entities": [[18, 24, "DISEASE"]]}], ["This increase might be associated with changes in environmental exposures.", {"entities": []}], ["Investigation of the time-trend of asthma and current prevalences is essential to understanding the causes.", {"entities": [[35, 41, "DISEASE"]]}], ["To estimate the current prevalences of asthma, allergies and other respiratory symptoms among Shanghai preschool children, and to investigate the time-trend of childhood asthma prevalence of from 1990 to 2011.", {"entities": [[39, 45, "DISEASE"], [170, 176, "DISEASE"]]}], ["From April 2011 to April 2012, the CCHH (China, Children, Homes, Health) cross-sectional study was conducted in Shanghai.", {"entities": []}], ["Questionnaires were distributed to 17,898 parents or guardians of preschool children from 72 kindergartens in 5 districts.", {"entities": []}], ["Previous similar studies were also summarized by a systematic literature review.", {"entities": []}], ["From a total of 14,884 questionnaires for 3\u20137 year old children, prevalences of the following diseases and symptoms were calculated: asthma 10.2%, wheeze (ever) 28.1%, pneumonia (ever) 33.5%, otitis media 11.0%, rhinitis (ever) 54.1%, hay fever 12.2%, eczema (ever) 22.7%, and food allergy 15.7%.", {"entities": [[192, 204, "DISEASE"], [168, 177, "DISEASE"], [212, 220, "DISEASE"], [277, 289, "DISEASE"], [133, 139, "DISEASE"]]}], ["Urban children had higher prevalences of most symptoms than suburban children.", {"entities": []}], ["The prevalence of asthma has increased significantly, almost five-fold, from 2.1% in 1990 to 10.2% in the present study.", {"entities": [[18, 24, "DISEASE"]]}], ["The prevalence of asthma in boys was higher than in girls in the present study and in all reviewed studies.", {"entities": [[18, 24, "DISEASE"]]}], ["Asthma, allergy and airway symptoms are common among preschool children in Shanghai.", {"entities": [[0, 6, "DISEASE"]]}], ["The prevalence of childhood asthma in Shanghai has increased rapidly from 1990 to 2011.", {"entities": [[28, 34, "DISEASE"]]}], ["Studies show that B\u2010cells, in addition to producing antibodies and antigen\u2010presentation, are able to produce cytokines as well.", {"entities": []}], ["These include regulatory cytokines such as IL\u201010 by regulatory B\u2010cells.", {"entities": []}], ["Furthermore, a rare regulatory subset of B\u2010cells have the potential to express FasL, which is a death\u2010inducing ligand.", {"entities": []}], ["This subset of B\u2010cells have a positive role during autoimmune disease, but has not yet been studied during tuberculosis.", {"entities": [[107, 119, "DISEASE"]]}], ["These FasL\u2010expressing B\u2010cells are induced by bacterial LPS and CpG, thus we hypothesized that this phenotype might be induced during tuberculosis as well.", {"entities": [[133, 145, "DISEASE"]]}], ["B\u2010cells from participants with TB (at diagnosis and during treatment) and controls were collected, and analyzed by means of real\u2010time PCR and flow cytometry.", {"entities": []}], ["In addition to this, BAL was collected from TB participants as well and analyzed by means of MAGPix (multi\u2010cytokine) technology.", {"entities": []}], ["Gene expression analysis show that FASL transcript levels increase by the end of treatment.", {"entities": []}], ["Similarly, phenotypic analysis show that there is a higher frequency of FasL\u2010expressing B\u2010cells by the end of treatment.", {"entities": []}], ["Collectively, these results indicate that these FasL\u2010expressing B\u2010cells are being induced during anti\u2010TB treatment, and thus may play a positive role.", {"entities": []}], ["Further studies are required to elucidate this.", {"entities": []}], ["Despite increasing clinical use, there is limited data regarding regadenoson in stress perfusion cardiovascular magnetic resonance (CMR).", {"entities": []}], ["In particular, given its long half-life the optimal stress protocol remains unclear.", {"entities": []}], ["Although Myocardial Perfusion Reserve (MPR) may provide additive prognostic information, current techniques for its measurement are cumbersome and challenging for routine clinical practice.", {"entities": []}], ["The aims of this study were: 1) To determine the feasibility of MPR quantification during regadenoson stress CMR by measurement of Coronary Sinus (CS) flow; and 2) to investigate the role of aminophylline reversal during regadenoson stress-CMR.", {"entities": [[147, 149, "GENE"]]}], ["117 consecutive patients with possible myocardial ischemia were prospectively enrolled.", {"entities": [[50, 58, "DISEASE"]]}], ["Perfusion imaging was performed at 1\u00a0minute and 15\u00a0minutes after administration of 0.4\u00a0mg regadenoson.", {"entities": []}], ["A subgroup of 41 patients was given aminophylline (100\u00a0mg) after stress images were acquired.", {"entities": []}], ["CS flow was measured using phase-contrast imaging at baseline (pre CS flow), and immediately after the stress (peak CS flow) and rest (post CS flow) perfusion images.", {"entities": [[0, 2, "GENE"], [67, 69, "GENE"], [116, 118, "GENE"], [140, 142, "GENE"], [0, 2, "GENE"], [67, 69, "GENE"], [116, 118, "GENE"], [140, 142, "GENE"], [0, 2, "GENE"], [67, 69, "GENE"], [116, 118, "GENE"], [140, 142, "GENE"], [0, 2, "GENE"], [67, 69, "GENE"], [116, 118, "GENE"], [140, 142, "GENE"]]}], ["CS flow measurements were obtained in 92% of patients with no adverse events.", {"entities": [[0, 2, "GENE"]]}], ["MPR was significantly underestimated when calculated as peak CS flow/post CS flow as compared to peak CS flow/pre CS flow (2.43\u2009\u00b1\u20090.20 vs. 3.28\u2009\u00b1\u20090.32, p\u2009=\u20090.03).", {"entities": [[61, 63, "GENE"], [74, 76, "GENE"], [102, 104, "GENE"], [114, 116, "GENE"], [61, 63, "GENE"], [74, 76, "GENE"], [102, 104, "GENE"], [114, 116, "GENE"], [61, 63, "GENE"], [74, 76, "GENE"], [102, 104, "GENE"], [114, 116, "GENE"], [61, 63, "GENE"], [74, 76, "GENE"], [102, 104, "GENE"], [114, 116, "GENE"]]}], ["This difference was abolished when aminophylline was administered (3.35\u2009\u00b1\u20090.44 vs. 3.30\u2009\u00b1\u20090.52, p\u2009=\u20090.95).", {"entities": []}], ["Impaired MPR (peak CS flow/pre CS flow <2) was associated with advanced age, diabetes, current smoking and higher Framingham risk score.", {"entities": [[19, 21, "GENE"], [31, 33, "GENE"], [19, 21, "GENE"], [31, 33, "GENE"]]}], ["Regadenoson stress CMR with MPR measurement from CS flow can be successfully performed in most patients.", {"entities": [[49, 51, "GENE"]]}], ["This measurement of MPR appears practical to perform in the clinical setting.", {"entities": []}], ["Residual hyperemia is still present even 15\u00a0minutes after regadenoson administration, at the time of resting-perfusion acquisition, and is completely reversed by aminophylline.", {"entities": []}], ["Our findings suggest routine aminophylline administration may be required when performing stress CMR with regadenoson.", {"entities": []}], ["Intercountry comparability between studies on medication use in pregnancy is difficult due to dissimilarities in study design and methodology.", {"entities": []}], ["This study aimed to examine patterns and factors associated with medications use in pregnancy from a multinational perspective, with emphasis on type of medication utilised and indication for use.", {"entities": []}], ["Cross-sectional, web-based study performed within the period from 1 October 2011 to 29 February 2012.", {"entities": []}], ["Uniform collection of drug utilisation data was performed via an anonymous online questionnaire.", {"entities": []}], ["Multinational study in Europe (Western, Northern and Eastern), North and South America and Australia.", {"entities": []}], ["Pregnant women and new mothers with children less than 1\u2005year of age.", {"entities": []}], ["Prevalence of and factors associated with medication use for acute/short-term illnesses, chronic/long-term disorders and over-the-counter (OTC) medication use.", {"entities": [[139, 142, "GENE"]]}], ["The study population included 9459 women, of which 81.2% reported use of at least one medication (prescribed or OTC) during pregnancy.", {"entities": [[112, 115, "GENE"]]}], ["Overall, OTC medication use occurred in 66.9% of the pregnancies, whereas 68.4% and 17% of women reported use of at least one medication for treatment of acute/short-term illnesses and chronic/long-term disorders, respectively.", {"entities": [[9, 12, "GENE"]]}], ["The extent of self-reported medicated illnesses and types of medication used by indication varied across regions, especially in relation to urinary tract infections, depression or OTC nasal sprays.", {"entities": [[180, 183, "GENE"]]}], ["Women with higher age or lower educational level, housewives or women with an unplanned pregnancy were those most often reporting use of medication for chronic/long-term disorders.", {"entities": []}], ["Immigrant women in Western (adjusted OR (aOR): 0.55, 95% CI 0.34 to 0.87) and Northern Europe (aOR: 0.50, 95% CI 0.31 to 0.83) were less likely to report use of medication for chronic/long-term disorders during pregnancy than non-immigrants.", {"entities": []}], ["In this study, the majority of women in Europe, North America, South America and Australia used at least one medication during pregnancy.", {"entities": []}], ["There was a substantial inter-region variability in the types of medication used.", {"entities": []}], ["Chronic kidney disease progression has been linked to pro-inflammatory cytokines and markers of inflammation.", {"entities": [[8, 22, "DISEASE"]]}], ["These markers are also elevated in end-stage renal disease (ESRD), which constitutes a serious public health problem.", {"entities": []}], ["To investigate whether single nucleotide polymorphisms (SNPs) located in genes related to immune and inflammatory processes, could be associated with ESRD development.", {"entities": []}], ["A retrospective case-control study was carried out on 276 patients with ESRD and 288 control subjects.", {"entities": []}], ["Forty-eight SNPs were genotyped via SNPlex platform.", {"entities": []}], ["Logistic regression was used to assess the relationship between each sigle polymorphism and the development of ESRD.", {"entities": []}], ["Four polymorphisms showed association with ESRD: rs1801275 in the interleukin 4 receptor ( IL4R ) gene (OR: 0.66 (95%CI\u2009=\u20090.46-0.95); p \u2009=\u20090.025; overdominant model), rs4586 in chemokine (C-C motif) ligand 2 ( CCL2 ) gene (OR: 0.70 (95%CI\u2009=\u20090.54-0.90); p \u2009=\u20090.005; additive model), rs301640 located in an intergenic binding site for signal transducer and activator of transcription 4 (STAT4) (OR: 1.82 (95%CI\u2009=\u20091.17-2.83); p \u2009=\u20090.006; additive model) and rs7830 in the nitric oxide synthase 3 ( NOS3) gene (OR: 1.31 (95%CI\u2009=\u20091.01-1.71); p \u2009=\u20090.043; additive model).", {"entities": [[91, 95, "GENE"], [210, 214, "GENE"], [385, 390, "GENE"], [495, 499, "GENE"]]}], ["After adjusting for multiple testing, results lost significance.", {"entities": []}], ["Our preliminary data suggest that four genetic polymorphisms located in genes related to inflammation and immune processes could help to predict the risk of developing ESRD.", {"entities": []}], ["Non-invasive in vivo imaging strategies are of high demand for longitudinal monitoring of inflammation during disease progression.", {"entities": []}], ["In this study we present an imaging approach using near infrared fluorescence (NIRF) imaging in combination with a polyanionic macromolecular conjugate as a dedicated probe, known to target L- and P-selectin and C3/C5 complement factors.", {"entities": []}], ["We investigated the suitability of dendritic polyglycerol sulfates (dPGS), conjugated with a hydrophilic version of the indocyanine green label with 6 sulfonate groups (6S-ICG) to monitor sites of inflammation using an experimental mouse model of allergic asthma.", {"entities": [[247, 262, "DISEASE"], [256, 262, "DISEASE"]]}], ["Accumulation of the NIRF-conjugated dPGS (dPGS-NIRF) in the inflamed lungs was analyzed in and ex vivo in comparison with the free NIRF dye using optical imaging.", {"entities": []}], ["Commercially available smart probes activated by matrix metalloproteinase's (MMP) and cathepsins were used as a comparative control.", {"entities": []}], ["The fluorescence intensity ratio between lung areas of asthmatic and healthy mice was four times higher for the dPGS in comparison to the free dye in vivo at four hrs post intravenous administration.", {"entities": []}], ["No significant difference in fluorescence intensity between healthy and asthmatic mice was observed 24 hrs post injection for dPGS-NIRF.", {"entities": []}], ["At this time point ex-vivo scans of asthmatic mice confirmed that the fluorescence within the lungs was reduced to approximately 30% of the intensity observed at 4 hrs post injection.", {"entities": []}], ["Compared with smart-probes resulting in a high fluorescence level at 24 hrs post injection optical imaging with dPGS-NIRF conjugates is characterized by fast uptake of the probe at inflammatory sites and represents a novel approach to monitor lung inflammation as demonstrated in mice with allergic asthma.", {"entities": [[290, 305, "DISEASE"], [299, 305, "DISEASE"]]}], ["Sleep disturbance is common in children with neurodevelopmental disorders, with high rates identified in children with Smith-Magenis syndrome (SMS), Angelman syndrome (AS), autism spectrum disorder (ASD) and tuberous sclerosis complex (TSC).", {"entities": [[133, 141, "DISEASE"], [158, 166, "DISEASE"], [173, 197, "DISEASE"], [208, 226, "DISEASE"], [143, 146, "GENE"]]}], ["Phenotypic sleep profiles for these groups may implicate different pathways to sleep disturbance.", {"entities": []}], ["At present, cross-group comparisons that might elucidate putative phenotypic sleep characteristics are limited by measurement differences between studies.", {"entities": []}], ["In this study, a standardised questionnaire was administered across groups affording comparison of the prevalence and profile of sleep disturbance between groups and contrast to chronologically age-matched typically developing (TD) peers.", {"entities": []}], ["The modified version of Simonds and Parraga\u2019s sleep questionnaire, adapted for use in children with intellectual disabilities, was employed to assess sleep disturbance profiles in children aged 2\u201315\u00a0years with SMS ( n \u2009=\u200926), AS ( n \u2009=\u200970), ASD ( n \u2009=\u200930), TSC ( n \u2009=\u200920) and a TD contrast group ( n \u2009=\u200947).", {"entities": [[210, 213, "GENE"]]}], ["Associations between sleep disturbance and age, obesity, health conditions and overactivity/impulsivity were explored for each neurodevelopmental disorder group.", {"entities": [[48, 55, "DISEASE"]]}], ["Children with SMS displayed severe night waking (81%) and early morning waking (73%).", {"entities": [[14, 17, "GENE"]]}], ["In contrast, children with ASD experienced difficulties with sleep onset (30%) and sleep maintenance (43%).", {"entities": []}], ["Fewer children with ASD (43%) and AS (46%) experienced severe night waking compared to children with SMS (both p \u2009<\u2009.01).", {"entities": [[101, 104, "GENE"]]}], ["Higher sleep-disordered breathing scores were identified for children with SMS ( p \u2009<\u2009.001) and AS ( p \u2009<\u2009.001) compared to the TD group.", {"entities": [[75, 78, "GENE"]]}], ["Sleep disturbance in children with AS and TSC was associated with poorer health.", {"entities": []}], ["Children experiencing symptoms indicative of gastro-oesophageal reflux had significantly higher sleep-disordered breathing scores in the AS, SMS and ASD groups (all p \u2009<\u2009.01).", {"entities": [[141, 144, "GENE"]]}], ["A number of associations between overactivity, impulsivity, gastro-oesophageal reflux, age and sleep disturbance were found for certain groups.", {"entities": []}], ["These data reveal syndrome-specific profiles of sleep disturbance.", {"entities": [[18, 26, "DISEASE"]]}], ["The divergent associations between sleep parameters and person characteristics, specifically symptoms of gastro-oesophageal reflux, overactivity and impulsivity and age, implicate aetiology-specific mechanisms underpinning sleep disturbance.", {"entities": []}], ["The differences in prevalence, severity and mechanisms implicated in sleep disturbance between groups support a syndrome-sensitive approach to assessment and treatment of sleep disturbance in children with neurodevelopmental disorders.", {"entities": [[112, 120, "DISEASE"]]}], ["The online version of this article (10.1186/s11689-018-9226-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Despite numerous studies of geographic variation in healthcare cost and utilization at the local, regional, and state levels across the U.S., a comprehensive characterization of geographic variation in outcomes has not been published.", {"entities": []}], ["Our objective was to quantify variation in US health outcomes in an all-payer population before and after risk-adjustment.", {"entities": []}], ["We used information from 16 independent data sources, including 22 million all-payer inpatient admissions from the Healthcare Cost and Utilization Project (which covers regions where 50% of the U.S. population lives) to analyze 24 inpatient mortality, inpatient safety, and prevention outcomes.", {"entities": []}], ["We compared outcome variation at state, hospital referral region, hospital service area, county, and hospital levels.", {"entities": []}], ["Risk-adjusted outcomes were calculated after adjusting for population factors, co-morbidities, and health system factors.", {"entities": []}], ["Even after risk-adjustment, there exists large geographical variation in outcomes.", {"entities": []}], ["The variation in healthcare outcomes exceeds the well publicized variation in US healthcare costs.", {"entities": []}], ["On average, we observed a 2.1-fold difference in risk-adjusted mortality outcomes between top- and bottom-decile hospitals.", {"entities": []}], ["For example, we observed a 2.3-fold difference for risk-adjusted acute myocardial infarction inpatient mortality.", {"entities": [[71, 92, "DISEASE"], [65, 92, "DISEASE"]]}], ["On average a 10.2-fold difference in risk-adjusted patient safety outcomes exists between top and bottom-decile hospitals, including an 18.3-fold difference for risk-adjusted Central Venous Catheter Bloodstream Infection rates.", {"entities": []}], ["A 3.0-fold difference in prevention outcomes exists between top- and bottom-decile counties on average; including a 2.2-fold difference for risk-adjusted congestive heart failure admission rates.", {"entities": [[154, 178, "DISEASE"]]}], ["The population, co-morbidity, and health system factors accounted for a range of R The amount of variability in health outcomes in the U.S. is large even after accounting for differences in population, co-morbidities, and health system factors.", {"entities": []}], ["These findings suggest that: 1) additional examination of regional and local variation in risk-adjusted outcomes should be a priority; 2) assumptions of uniform hospital quality that underpin rationale for policy choices (such as narrow insurance networks or antitrust enforcement) should be challenged; and 3) there exists substantial opportunity for outcomes improvement in the US healthcare system.", {"entities": []}], ["Human exposure to brevetoxins produced by the red tide organism, Karenia brevis , is an increasing public health concern.", {"entities": []}], ["Using in vitro exposure of rat liver cells to brevetoxin B (PbTx-2), the primary toxin product of K. brevis , we previously showed that it formed C 27,28 -epoxy brevetoxin metabolites capable of covalently binding to nucleic acids, a common initiation step for carcinogenesis.", {"entities": []}], ["This study was undertaken to evaluate nucleic acid adduction in lung following in vitro and in vivo brevetoxin exposures.", {"entities": []}], ["To clarify reactions of brevetoxin epoxide with DNA, we analyzed reaction products of PbTx-6 (a C 27,28 epoxide metabolite of brevetoxin B) with nucleosides.", {"entities": []}], ["We also analyzed adducts from nucleic acid hydrolysates of isolated rat lung cells treated with PbTx-2 or PbTx-6 in vitro and lung tissue from rats after intratracheal exposure to PbTx-2 or PbTx-6 at 45 \u03bcg toxin/kg body weight.", {"entities": []}], ["Our results indicate that PbTx-2 forms DNA adducts with cytidine after treatment of isolated lung cells, and forms DNA adducts with adenosine and guanosine after intratracheal exposure.", {"entities": []}], ["These results are consistent with metabolic activation of highly reactive brevetoxin intermediates that bind to nucleic acid.", {"entities": []}], ["These findings provide a basis for monitoring exposure and assessing the hazard associated with depurination of brevetoxin\u2013nucleotide adducts in lung tissue.", {"entities": []}], ["Over the past decade, the Dutch government has pursued a research-based approach to tackle socioeconomic inequalities in health.", {"entities": []}], ["We report on the most recent phase in this approach: the development of a strategy to reduce health inequalities in the Netherlands by an independent committee.", {"entities": []}], ["In addition, we will reflect on the way the report of this committee has influenced health policy and practice.", {"entities": []}], ["A 6-year research and development program was conducted which covered a number of different policy options and consisted of 12 intervention studies.", {"entities": []}], ["The study results were discussed with experts and policy makers.", {"entities": []}], ["A government advisory committee developed a comprehensive strategy that intends to reduce socioeconomic inequalities in disability-free life expectancy by 25% in 2020.", {"entities": []}], ["The strategy covers 4 different entry-points for reducing socioeconomic inequalities in health, contains 26 specific recommendations, and includes 11 quantitative policy targets.", {"entities": []}], ["Further research and development efforts are also recommended.", {"entities": []}], ["Although the Dutch approach has been influenced by similar efforts in other European countries, particularly the United Kingdom and Sweden, it is unique in terms of its emphasis on building a systematic evidence-base for interventions and policies to reduce health inequalities.", {"entities": []}], ["Both researchers and policy-makers were involved in the process, and there are clear indications that some of the recommendations are being adopted by health policy-makers and health care practice, although more so at the local than at the national level.", {"entities": []}], ["Panallergens comprise various protein families of plant as well as animal origin and are responsible for wide IgE cross\u2010reactivity between related and unrelated allergenic sources.", {"entities": []}], ["Such cross\u2010reactivities include reactions between various pollen sources, pollen and plant\u2010derived foods as well as invertebrate\u2010derived inhalants and foodstuff.", {"entities": []}], ["Here, we provide an overview on the most clinically relevant panallergens from plants (profilins, polcalcins, non\u2010specific lipid transfer proteins, pathogenesis\u2010related protein family 10 members) and on the prominent animal\u2010derived panallergen family, tropomyosins.", {"entities": []}], ["In addition, we explore the role of panallergens in the sensitization process and progress of the allergic disease.", {"entities": []}], ["Emphasis is given on epidemiological aspects of panallergen sensitization and clinical manifestations.", {"entities": []}], ["Finally, the issues related to diagnosis and therapy of patients sensitized to panallergens are outlined, and the use of panallergens as predictors for cross\u2010reactive allergy and as biomarkers for disease severity is discussed.", {"entities": []}], ["Studies have explored ozone\u2019s connection to asthma and total respiratory emergency department visits (EDVs) but have neglected other specific respiratory diagnoses despite hypotheses relating ozone to respiratory infections and allergic responses.", {"entities": [[44, 50, "DISEASE"]]}], ["We examined relationships between ozone and EDVs for respiratory visits, including specifically acute respiratory infections (ARI), asthma, pneumonia, chronic obstructive pulmonary disease (COPD), and upper respiratory tract inflammation (URTI).", {"entities": [[140, 149, "DISEASE"], [151, 188, "DISEASE"], [132, 138, "DISEASE"]]}], ["We conducted a multi-site time-stratified case-crossover study of ozone exposures for approximately 3.7 million respiratory EDVs from 2005 through 2008 among California residents living within 20 km of an ozone monitor.", {"entities": []}], ["Conditional logistic regression was used to estimate associations by climate zone.", {"entities": []}], ["Random effects meta-analysis was then applied to estimate pooled excess risks (ER).", {"entities": []}], ["Effect modification by season, distance from the monitor and individual demographic characteristics (i.e., age, race/ethnicity, sex, and payment method), and confounding by other gaseous air pollutants were also investigated.", {"entities": []}], ["Meta-regression was utilized to explore how climate zone\u2013level meteorological, demographic, and regional differences influenced estimates.", {"entities": []}], ["We observed ozone-associated increases in all respiratory, asthma, and ARI visits, which were slightly larger in the warm season [asthma ER per 10-ppb increase in mean of same and previous 3 days ozone exposure (lag03) = 2.7%, 95% CI: 1.5, 3.9; ARI ERlag03 = 1.4%, 95% CI: 0.8, 1.9].", {"entities": [[59, 65, "DISEASE"], [130, 136, "DISEASE"]]}], ["EDVs for pneumonia, COPD, and URTI were also significantly associated with ozone exposure over the whole year, but typically more consistently so during the warm season.", {"entities": [[9, 18, "DISEASE"]]}], ["Short-term ozone exposures among California residents living near an ozone monitor were positively associated with EDVs for asthma, ARI, pneumonia, COPD, and URTI from 2005 through 2008.", {"entities": [[137, 146, "DISEASE"], [124, 130, "DISEASE"]]}], ["Those associations were typically larger and more consistent during the warm season.", {"entities": []}], ["Our findings suggest that these outcomes should be considered when evaluating the potential health benefits of reducing ozone concentrations.", {"entities": []}], ["Malig BJ, Pearson DL, Chang YB, Broadwin R, Basu R, Green RS, Ostro B.", {"entities": []}], ["A time-stratified case-crossover study of ambient ozone exposure and emergency department visits for specific respiratory diagnoses in California (2005\u20132008).", {"entities": []}], ["Environ Health Perspect 124:745\u2013753; http://dx.doi.org/10.1289/ehp.1409495", {"entities": []}], ["YKL\u201040, encoded by the chitinase 3\u2010like 1 ( CHI3L1 ) gene, is a chitinase\u2010like protein involved in innate immune function hypothesized to play a role in the progression of atherosclerosis that may have differential roles in myocardial infarction (MI), as compared to stroke.", {"entities": [[172, 187, "DISEASE"], [224, 245, "DISEASE"], [44, 50, "GENE"]]}], ["In a nested case\u2010control study conducted within a prospective cohort of 23 294 initially healthy women of European ancestry, we (1) measured plasma concentration of YKL\u201040 among 359 participants who subsequently developed cardiovascular events and among 359 age\u2010, smoking\u2010, and hormone replacement therapy\u2013matched participants who remained free of disease during 17 years of follow\u2010up, (2) compared effects of YKL\u201040 on vascular risk to that associated with 3 alternative inflammatory biomarkers (high\u2010sensitivity C\u2010reactive protein) ([hsCRP], soluble intracellular adhesion molecule 1, and fibrinogen), and (3) evaluated the role of 41 single\u2010nucleotide polymorphisms (SNPs) in the chitinase 3\u2010like 1 gene ( CHI3L1 ) as determinants of YKL\u201040 levels and incident vascular events.", {"entities": [[709, 715, "GENE"]]}], ["YKL\u201040 levels were higher in women with hypertension, diabetes, and obesity and correlated modestly with high\u2010density lipoprotein cholesterol, triglycerides, and hsCRP, but not with low\u2010density lipoprotein cholesterol.", {"entities": [[40, 52, "DISEASE"], [68, 75, "DISEASE"]]}], ["Baseline YKL\u201040 level was significantly associated with incident thromboembolic stroke with a magnitude of effect (a 40% per quartile increase in odds ratio [OR], P =0.019) comparable to that of hsCRP (a 52% per quartile increase in OR, P =0.006).", {"entities": []}], ["By contrast, no significant association was observed between YKL\u201040 and incident MI.", {"entities": []}], ["Genetic variation in CHI3L1 was strongly associated with YKL\u201040 levels; however, in this sample set, we did not observe a statistically significant association between genotype and future vascular events.", {"entities": [[21, 27, "GENE"]]}], ["Among initially healthy U.S. women, plasma levels of the proinflammatory chitenase\u2010like protein, YKL\u201040, were influenced by environmental as well as genetic factors and predicted incident thromboembolic stroke, but not MI, a differential effect consistent with limited previous data.", {"entities": []}], ["Peritoneal cells from thioglycollate-stimulated mice were allowed to adhere to coverglasses for 2 h to give a dense monolayer of adherent cells greater than 95% of which were macrophages.", {"entities": []}], ["After incubation with the tetra-acetoxymethyl ester of quin2, coverglasses were rinsed with Ca2+-free saline, oriented at a 45 degree angle in square cuvettes containing a magnetically driven stir bar, and analyzed for changes in quin2 fluorescence in a spectrofluorimeter.", {"entities": []}], ["Such fluorescence, taken as an indication of intracellular calcium ion concentration ([Ca2+]i), increased as exogenous calcium ion concentration ([Ca2+]o) was raised to 1 mM.", {"entities": []}], ["At [Ca2+]o approximately equal to 10 microM, [Ca2+]i = 72 +/- 14 nM (n = 26); at [Ca2+]o = 1 mM, [Ca2+]i = 140-220 nM, levels not increased by N, N, N', N'-tetrakis (2-pyridylmethyl) ethylenediamine, a membrane-permeant chelator of heavy metals than can quench quin2.", {"entities": []}], ["Addition of mouse alpha + beta fibroblast interferon, lipopolysaccharide, thrombin, collagen, vasopressin, ADP, compound 48/80, or U46619 did not change [Ca2+]i.", {"entities": []}], ["However, addition of platelet activating factor (PAF) (2-20 ng/ml) raised [Ca2+]i by 480 nM within 1 min if [Ca2+]o = 1 mM.", {"entities": []}], ["In the presence of 5 mM EGTA, PAF raised [Ca2+]i by 25 nM.", {"entities": []}], ["This suggests that PAF causes influx of exogenous Ca2+, as well as releasing some Ca2+ from intracellular stores.", {"entities": []}], ["Consistent with these results, when PAF was added to 1 mM Ca2+ in the presence of 100 microM Cd2+ or Mn2+ to block Ca2+ influx, [Ca2+]i increased by only intermediate amounts; at the times of such dampened peak response, [Ca2+]i could be raised within 1 min to normal PAF-stimulated levels by chelation of the exogenous heavy metals with diethylenetriaminepentaacetic acid.", {"entities": []}], ["Normal PAF responses were observed in the presence of indomethacin.", {"entities": []}], ["The lowest dose of PAF observed to raise [Ca2+]i was 0.1 ng/ml.", {"entities": []}], ["Response of [Ca2+]i to 2-20 ng/ml PAF was transient, and second applications had no effect.", {"entities": []}], ["The PAF response also was seen in cell suspensions.", {"entities": []}], ["These results suggest that an increase in [Ca2+]i may be an early event in PAF activation of macrophages.", {"entities": []}], ["Internally displaced persons (IDPs) are among the most vulnerable people in the world today.", {"entities": []}], ["Previous research highlights that conflict-induced forced displacement can cause problems with mental health and wellbeing.", {"entities": []}], ["This study aimed to contribute to this body of knowledge by investigating the mental health, quality of life, and life satisfaction among IDPs living in Nakuru, Kenya.", {"entities": []}], ["A questionnaire that included the General Health Questionnaire-12, Satisfaction with Life Scale, and a modified version of the WHO Quality of Life-BREF tool was used for data collection.", {"entities": []}], ["The questionnaire also included an open-ended question inviting qualitative responses about their experience as an IDP.", {"entities": []}], ["The questionnaire was distributed through a three-stage sampling approach across four refugee camps from four regions of the Nakuru County in Kenya.", {"entities": []}], ["One hundred IDPs participated in this study.", {"entities": []}], ["All participants scored substantially higher than the applied GHQ-12 threshold for caseness (mean GHQ-12 score\u2009=\u200928.7, SD\u2009=\u20093.6).", {"entities": []}], ["Quality of life and life satisfaction scores were also very poor (M\u2009=\u200910.24, SD\u2009=\u20091.9; M\u2009=\u20096.82, SD\u2009=\u20091.5 respectively).", {"entities": []}], ["The qualitative results reflected these findings with statements reflecting suicidal thoughts, unhappiness with the government, lack of support, and fear for themselves and their children.", {"entities": []}], ["Significantly higher GHQ-12 scores were found among older IDPs (rho\u2009=\u2009.202, sig\u2009=\u2009.046), widowers compared to married IDPs (mean difference\u2009=\u2009\u22122.41, SE\u2009=\u2009.885, sig\u2009=\u2009.027), while lower scores were found among IDPs who reported having friends as a source of support (U\u2009=\u2009834, sig\u2009=\u2009.045), while quality of life scores were higher among IDPs who reported receiving governmental support (U\u2009=\u2009248, sig\u2009=\u2009.018).", {"entities": []}], ["The findings revealed poor levels of mental health, quality of life and life satisfaction.", {"entities": []}], ["Older, widowed IDPs and those who did not perceive support from friends or the government were found to be at the highest risk of poor health and wellbeing.", {"entities": []}], ["Indoor risk factors for physician-diagnosed asthma and wheezing in the past 12 months without previous asthma diagnosis were assessed in a survey of parents of 5-9-year-old Seattle primary school students.", {"entities": [[44, 50, "DISEASE"], [103, 109, "DISEASE"]]}], ["Among the 925 respondents, 106 (11%) reported a physician diagnosis of asthma, 66 (7%) had wheezing without diagnosis, and 753 (82%) were asymptomatic.", {"entities": [[71, 77, "DISEASE"]]}], ["After adjusting for age, sex, gender, ethnicity, medical history, socioeconomic status (SES) and parental asthma status, an increased risk of physician diagnosis of asthma was associated with household water damage, the presence of one or more household tobacco smokers, and at least occasional environmental tobacco smoke (ETS) exposure.", {"entities": [[106, 112, "DISEASE"], [165, 171, "DISEASE"]]}], ["Similarly, an increased risk of wheezing in the past 12 months among children without diagnosed asthma was associated with household water damage, presence of one or more household tobacco smokers, and occasional or more frequent ETS exposure.", {"entities": [[96, 102, "DISEASE"]]}], ["No increased risk of either condition was associated with gas, wood, or kerosene stove use, household mold, basement water, or wall/window dampness.", {"entities": []}], ["Similarities in the indoor risk factors patterns between diagnosed asthma and wheezing without diagnosis suggested a similar etiology of these two conditions.", {"entities": [[67, 73, "DISEASE"]]}], ["The slightly higher association between ETS and asthma may indicate that parents of diagnosed asthmatics were more conscious of ETS, and were more likely to prohibit household smoking by resident smokers.", {"entities": [[48, 54, "DISEASE"]]}], ["Future research is needed to quantify which aspects of household water damage are related to respiratory illness.", {"entities": []}], ["High risk medications are commonly prescribed to older US patients.", {"entities": []}], ["Currently, less is known about high risk medication prescribing in other Western Countries, including the UK.", {"entities": []}], ["We measured trends and correlates of high risk medication prescribing in a subset of the older UK population (community/institutionalized) to inform harm minimization efforts.", {"entities": []}], ["Three cross-sectional samples from primary care electronic clinical records (UK Clinical Practice Research Datalink, CPRD) in fiscal years 2003/04, 2007/08 and 2011/12 were taken.", {"entities": []}], ["This yielded a sample of 13,900 people aged 65\u00a0years or over from 504 UK general practices.", {"entities": []}], ["High risk medications were defined by 2012 Beers Criteria adapted for the UK.", {"entities": []}], ["Using descriptive statistical methods and regression modelling, prevalence of \u2018any\u2019 (drugs prescribed at least once per year) and \u2018long-term\u2019 (drugs prescribed all quarters of year) high risk medication prescribing and correlates were determined.", {"entities": []}], ["While polypharmacy rates have risen sharply, high risk medication prevalence has remained stable across a decade.", {"entities": []}], ["A third of older (65+) people are exposed to high risk medications, but only half of the total prevalence was long-term (any\u2009=\u200938.4\u00a0% [95\u00a0% CI: 36.3, 40.5]; long-term\u2009=\u200917.4\u00a0% [15.9, 19.9] in 2011/12).", {"entities": []}], ["Long-term but not any high risk medication exposure was associated with older ages (85\u00a0years or over).", {"entities": []}], ["Women and people with higher polypharmacy burden were at greater risk of exposure; lower socio-economic status was not associated.", {"entities": []}], ["Ten drugs/drug classes accounted for most of high risk medication prescribing in 2011/12.", {"entities": []}], ["High risk medication prescribing has not increased over time against a background of increasing polypharmacy in the UK.", {"entities": []}], ["Half of patients receiving high risk medications do so for less than a year.", {"entities": []}], ["Reducing or optimising the use of a limited number of drugs could dramatically reduce high risk medications in older people.", {"entities": []}], ["Further research is needed to investigate why the oldest old and women are at greater risk.", {"entities": []}], ["Interventions to reduce high risk medications may need to target shorter and long-term use separately.", {"entities": []}], ["The online version of this article (doi:10.1186/s12877-015-0143-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Genome-wide association studies identified single nucleotide polymorphisms (SNPs) in the nicotinic acetylcholine receptors (nAChRs) cluster as a risk factor for nicotine dependency and COPD.", {"entities": []}], ["We investigated whether SNPs in the nAChR cluster are associated with smoking habits and lung function decline, and if these potential associations are independent of each other.", {"entities": []}], ["The SNPs rs569207, rs1051730 and rs8034191 in the nAChR cluster were analyzed in the Vlagtwedde-Vlaardingen cohort (n\u200a=\u200a1,390) that was followed for 25 years.", {"entities": []}], ["We used GEE and LME models to analyze the associations of the SNPs with quitting or restarting smoking and with the annual FEV 1 decline respectively.", {"entities": [[123, 126, "GENE"]]}], ["Individuals homozygote (CC) for rs569207 were more likely to quit smoking (OR (95%CI)\u200a=\u200a1.58 (1.05\u20132.38)) compared to wild-type (TT) individuals.", {"entities": []}], ["Individuals homozygote (TT) for rs1051730 were less likely to quit smoking (0.64 (0.42; 0.97)) compared to wild-type (CC) individuals.", {"entities": []}], ["None of the SNPs was significantly associated with the annual FEV 1 decline in smokers and ex-smokers.", {"entities": [[62, 65, "GENE"]]}], ["We show that SNPs in the nAChR region are associated with smoking habits such as quitting smoking, but have no significant effect on the annual FEV 1 decline in smokers and ex-smokers, suggesting a potential role of these SNPs in COPD development via smoking habits rather than via direct effects on lung function.", {"entities": [[144, 147, "GENE"]]}], ["Asthma represents an area of significant unmet medical need, with few new drugs making it to the clinic in the past 50\u2005years.", {"entities": [[0, 6, "DISEASE"]]}], ["Much asthma research is currently carried out in non-human models.", {"entities": [[5, 11, "DISEASE"]]}], ["However, as asthma is a uniquely human condition, it is difficult to translate findings from these models to efficacious therapies.", {"entities": [[12, 18, "DISEASE"]]}], ["Based on the results of a survey of the UK asthma research community carried out jointly between the NC3Rs, Asthma UK, the UK Respiratory Research Collaborative and the Human Tissue Authority, we propose that more emphasis be placed on the use of human tissue studies to provide more relevant models that better translate to the clinic and which reduce the reliance of the asthma community on less predictive animal models.", {"entities": [[43, 49, "DISEASE"], [108, 114, "DISEASE"], [373, 379, "DISEASE"]]}], ["Objective To evaluate the efficacy of oral anti-inflammatory or antibiotic treatment compared with placebo in the resolution of cough in patients with uncomplicated acute bronchitis and discoloured sputum.", {"entities": [[171, 181, "DISEASE"]]}], ["Design Multicentre, parallel, single blinded placebo controlled, randomised clinical trial.", {"entities": []}], ["Setting Nine primary care centres in Spain.", {"entities": []}], ["Participants Adults aged 18 to 70 presenting symptoms associated with respiratory tract infection of less than one week\u2019s duration, with cough as the predominant symptom, the presence of discoloured sputum, and at least one other symptom of lower respiratory tract infection (dyspnoea, wheezing, chest discomfort, or chest pain).", {"entities": []}], ["Interventions Patients were randomised to receive either ibuprofen 600 mg three times daily, amoxicillin-clavulanic acid 500 mg/125 mg three times daily, or placebo three times daily for 10 days.", {"entities": []}], ["The duration of symptoms was measured with a diary card.", {"entities": []}], ["Main outcome measure Number of days with frequent cough after the randomisation visit.", {"entities": []}], ["Results 416 participants were randomised (136 to ibuprofen, 137 to antibiotic, and 143 to placebo) and 390 returned their symptom diaries fully completed.", {"entities": []}], ["The median number of days with frequent cough was slightly lower among patients assigned to ibuprofen (9 days, 95% confidence interval 8 to 10 days) compared with those receiving amoxicillin-clavulanic acid (11 days, 10 to 12 days) or placebo (11 days, 8 to 14 days), albeit without statistically significant differences.", {"entities": []}], ["Neither amoxicillin-clavulanic acid nor ibuprofen increased the probability of cough resolution (hazard ratio 1.03, 95% confidence interval 0.78 to 1.35 and 1.23, 0.93 to 1.61, respectively) compared with placebo.", {"entities": []}], ["Adverse events were observed in 27 patients, and were more common in the antibiotic arm (12%) than ibuprofen or placebo arms (5% and 3%, respectively; P<0.01).", {"entities": []}], ["Conclusion No significant differences were observed in the number of days with cough between patients with uncomplicated acute bronchitis and discoloured sputum treated with ibuprofen, amoxicillin-clavulanic acid, or placebo.", {"entities": [[127, 137, "DISEASE"]]}], ["Trial registration Current Controlled Trials ISRCTN07852892.", {"entities": []}], ["Breast and cervical cancer are the most common cancers affecting women.", {"entities": [[20, 26, "DISEASE"], [11, 26, "DISEASE"]]}], ["The symptom distresses experienced by cancer survivors are critical factors influencing their quality of life (QOL).", {"entities": [[38, 44, "DISEASE"]]}], ["This study investigated the QOL of breast and cervical cancer survivors, their physical, psychological and social conditions.", {"entities": [[55, 61, "DISEASE"], [46, 61, "DISEASE"]]}], ["The participants were older than 20\u00a0years, had been diagnosed with breast or cervical cancer for more than 2\u00a0years, and had completed their cancer treatment.", {"entities": [[86, 92, "DISEASE"], [140, 146, "DISEASE"], [77, 92, "DISEASE"]]}], ["The survey incorporated the QOL questionnaires developed by the European Organization of Research and Treatment for Cancer and a self-designed questionnaire.", {"entities": [[116, 122, "DISEASE"]]}], ["The mean age at diagnosis was 48.89\u2009\u00b1\u20098.53\u00a0years for the breast cancer survivors and 49.00\u2009\u00b1\u200910.30\u00a0years for the cervical cancer survivors.", {"entities": [[57, 70, "DISEASE"], [64, 70, "DISEASE"], [122, 128, "DISEASE"], [113, 128, "DISEASE"]]}], ["The corresponding QOL scores were 75.33\u2009\u00b1\u200920.25 and 75.56\u2009\u00b1\u200917.93.", {"entities": []}], ["The factors influencing QOL of breast cancer survivors were household income, number of comorbidities, stage of cancer, type of cancer treatment and duration of illness, whereas the factor related to QOL of cervical cancer survivors was only household income.", {"entities": [[31, 44, "DISEASE"], [38, 44, "DISEASE"], [112, 118, "DISEASE"], [128, 134, "DISEASE"], [216, 222, "DISEASE"], [207, 222, "DISEASE"]]}], ["The QOL of the two groups was similar.", {"entities": []}], ["Healthcare providers should demonstrate greater concern toward breast and cervical cancer survivors.", {"entities": [[83, 89, "DISEASE"], [74, 89, "DISEASE"]]}], ["Antidepressant prescribing continues to rise.", {"entities": []}], ["Increased long-term prescribing and higher doses are contributing to current growth; however, patient factors associated with the use of higher doses remain unknown.", {"entities": []}], ["This study\u2019s aim was to investigate patient factors associated with selective serotonin re-uptake inhibitor (SSRI) prescribed daily dose for depression treatment in general practice.", {"entities": []}], ["A stratified sample of low to high prescribing practices were selected.", {"entities": []}], ["Routine individual patient-level data were extracted one practice at a time: September 2009 to January 2011.", {"entities": []}], ["Patients included were \u226518\u00a0years, and prescribed an SSRI for depression.", {"entities": []}], ["Logistic regression analysis was undertaken to assess individual predictor variables on SSRI daily dose by standard therapeutic dose versus higher dose, as SSRIs demonstrate flat dose response curves for depression treatment.", {"entities": []}], ["Predictor variables included: age, gender, deprivation, co-morbidity, smoking status, being prescribed the same SSRI for \u22652\u00a0years, and patients\u2019 general practice.", {"entities": []}], ["For a subgroup of patients a second sub-group analysis included long-term benzodiazepine and/or z-hypnotic (B&Z) as a predictor variable.", {"entities": []}], ["Inter-practice SSRI prescribing varied significantly; practice point prevalence ranged from 2.5% (94/3697) to 11.9% (359/3007) of the practice population \u226518\u00a0years old; median 7.3% (250/3421) (\u03c7 Higher SSRI doses for depression were associated with practice attended and being prescribed the same antidepressant for \u22652\u00a0years.", {"entities": []}], ["As long-term antidepressant use increases, the use of higher doses may further contribute to prescribing growth.", {"entities": []}], ["The online version of this article (doi:10.1186/s12875-014-0210-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a major clinical challenge mostly due to cigarette smoke (CS) exposure.", {"entities": [[106, 108, "GENE"]]}], ["Invariant natural killer T ( i NKT) cells are potent immunoregulatory cells that have a crucial role in inflammation.", {"entities": []}], ["In the current study, we investigate the role of i NKT cells in COPD pathogenesis.", {"entities": []}], ["The frequency of activated NKT cells was found to be increased in peripheral blood of COPD patients relative to controls.", {"entities": []}], ["In mice chronically exposed to CS, activated i NKT cells accumulated in the lungs and strongly contributed to the pathogenesis.", {"entities": [[31, 33, "GENE"]]}], ["The detrimental role of i NKT cells was confirmed in an acute model of oxidative stress, an effect that depended on interleukin (IL)-17.", {"entities": []}], ["CS extracts directly activated mouse and human dendritic cells (DC) and airway epithelial cells (AECs) to trigger interferon\u03b3 and/or IL-17 production by i NKT cells, an effect ablated by the anti-oxidant N-acetylcystein.", {"entities": [[0, 2, "GENE"]]}], ["In mice, this treatment abrogates i NKT-cell accumulation in the lung and abolished the development of COPD.", {"entities": []}], ["Together, activation of i NKT cells by oxidative stress in DC and AECs participates in the development of experimental COPD, a finding that might be exploited at a therapeutic level.", {"entities": []}], ["Veterans of the U.S. armed forces tend to be older and have more chronic health problems than the general adult population, which may place them at greater risk of complications from influenza.", {"entities": [[183, 192, "DISEASE"]]}], ["Despite Centers for Disease Control and Prevention (CDC) recommendations, seasonal influenza vaccination rates for the general adult population remain well below the national goal of 80%.", {"entities": [[83, 92, "DISEASE"]]}], ["Achieving this goal would be facilitated by a clearer understanding of which factors influence vaccination.", {"entities": []}], ["Using the 2010 U.S. National Health Interview Survey (NHIS), this study estimates models of two types of vaccinations (H1N1 and seasonal flu), assesses if the correlates differ for these vaccinations, and analyses the distribution of the correlates by veteran status.", {"entities": []}], ["Veterans, women, non-Hispanic whites, non-smokers, those at high risk, educated, with health insurance, and who use clinics as a usual source of care were more likely to receive both types of vaccinations.", {"entities": []}], ["Those who were older, married, and with higher income were more likely to get vaccinated for seasonal flu, but not for H1N1.", {"entities": []}], ["Age and number of children living in the household were found to have different effects for H1N1 compared to seasonal flu.", {"entities": []}], ["Veterans are more likely to get vaccinated for seasonal influenza and H1N1 compared to the general population.", {"entities": [[56, 65, "DISEASE"]]}], ["This might be due to Veterans having better access to care or Veterans participating in better health care practices.", {"entities": []}], ["Future studies should examine potential differences in flu vaccination use among Veterans using Veterans Affairs (VA) health care system vs. non-VA users.", {"entities": []}], ["To pilot enhanced safety surveillance of seasonal influenza vaccine meeting the European Medicines Agency (EMA) requirement to rapidly detect a significant increase in the frequency or severity of adverse events of interest (AEIs), which may indicate risk from the new season\u2019s vaccine.", {"entities": [[50, 59, "DISEASE"]]}], ["A prospective passive enhanced safety surveillance combining data collection from adverse drug reaction (ADR) cards with automated collection of pseudonymised routinely collected electronic health record (EHR) data.", {"entities": []}], ["This study builds on a feasibility study carried out at the start of the 2015/2016 influenza season.", {"entities": [[83, 92, "DISEASE"]]}], ["We will report influenza vaccine exposure and any AEIs reported via ADR card or recorded directly into the EHR, from the commencement of influenza vaccination and ends as specified by EMA (30 November 2016).", {"entities": [[15, 24, "DISEASE"], [137, 146, "DISEASE"]]}], ["Ten volunteer English general practices, primarily using the GSK influenza vaccines.", {"entities": [[65, 74, "DISEASE"]]}], ["They had selected this vaccine in advance of the study.", {"entities": []}], ["People who receive a seasonal influenza vaccine, in each age group defined in EMA interim guidance: 6\u2009months to 5 years, 6\u201312 years, 13\u201317 years, 18\u201365 years and >65 years.", {"entities": [[30, 39, "DISEASE"]]}], ["The primary outcome measure is the rate of AEIs occurring within 7 days postvaccination, using passive surveillance of general practitioner (GP) EHR systems enhanced by a card-based ADR reporting system.", {"entities": []}], ["Extracted data will be presented overall by brand (Fluarix Tetra vs others), by age strata and risk groups.", {"entities": []}], ["The secondary outcome measure is the vaccine uptake among the subjects registered in the enrolled general practices.", {"entities": []}], ["Ethical approval was granted by the Proportionate Review Sub-committee of the North East\u2014Newcastle & North Tyneside 2 on 5 August 2016.", {"entities": []}], ["The study received approval from the Health Research Authority on 1 September 2016.", {"entities": []}], ["We will produce an interim analysis within 8 weeks, and an end-of-study report, which will be submitted to peer-reviewed journals.", {"entities": []}], ["Previous studies on schizophrenia have detected elevated cytokines in both brain and blood, suggesting neuroinflammation may contribute to the pathophysiology in some cases.", {"entities": [[20, 33, "DISEASE"]]}], ["We aimed to determine the extent to which elevated peripheral cytokine messenger RNA (mRNA) expression: (1) characterizes a subgroup of people with schizophrenia and (2) shows a relationship to cognition, brain volume and/or symptoms.", {"entities": [[148, 161, "DISEASE"]]}], ["Forty-three outpatients with schizophrenia or schizoaffective disorder and matched healthy controls were assessed for peripheral cytokine mRNAs (interleukin (IL)-1\u03b2, IL-2, IL-6, IL-8 and IL-18), intelligence quotient, memory and verbal fluency, symptom severity and cortical brain volumes integral to language (that is, Broca's and Wernicke's areas).", {"entities": [[29, 42, "DISEASE"], [46, 70, "DISEASE"]]}], ["IL-1\u03b2 mRNA levels were 28% increased in schizophrenia compared with controls (t(82)=2.64, P <0.01).", {"entities": [[40, 53, "DISEASE"]]}], ["Using a two-step clustering procedure, we identified a subgroup of people displaying relatively elevated cytokine mRNA levels (17/43 people with schizophrenia and 9/42 controls).", {"entities": [[145, 158, "DISEASE"]]}], ["Individuals with schizophrenia in the elevated cytokine subgroup performed significantly worse than the low-cytokine subgroup on verbal fluency (F(1,40)=15.7, P <0.001).", {"entities": [[17, 30, "DISEASE"]]}], ["There was a 17% volume reduction of the left pars opercularis (POp) (Broca's area) in patients with elevated cytokines compared with patients with lower cytokines (F(1,29)=9.41, P =0.005).", {"entities": []}], ["Negative linear relationships between IL-1\u03b2 mRNA levels and both verbal fluency and left POp volume were found in schizophrenia.", {"entities": [[114, 127, "DISEASE"]]}], ["This study is among the first to link blood biomarkers of inflammation with both cognitive deficits and brain volume reductions in people with schizophrenia, supporting that those with elevated cytokines represent a neurobiologically meaningful subgroup.", {"entities": [[143, 156, "DISEASE"]]}], ["These findings raise the possibility that targeted anti-inflammatory treatments may ameliorate cognitive and brain morphological abnormalities in some people with schizophrenia.", {"entities": [[163, 176, "DISEASE"]]}], ["In Ethiopia, most deaths take place at home and routine certification of cause of death by physicians is lacking.", {"entities": []}], ["As a result, reliable cause of death (CoD) data are often not available.", {"entities": []}], ["Recently, a computerized method for interpretation of verbal autopsy (VA) data, called InterVA, has been developed and used.", {"entities": []}], ["It calculates the probability of a set of CoD given the presence of circumstances, signs, and symptoms reported during VA interviews.", {"entities": []}], ["We applied the InterVA model to describe CoD in a rural population of Ethiopia.", {"entities": []}], ["VA data for 436/599 (72.7%) deaths that occurred during 2010\u20132011 were included.", {"entities": []}], ["InterVA-4 was used to interpret the VA data into probable cause of death.", {"entities": []}], ["Cause-specific mortality fraction was used to describe frequency of occurrence of death from specific causes.", {"entities": []}], ["InterVA-4 was able to give likely cause(s) of death for 401/436 of the cases (92.0%).", {"entities": []}], ["Overall, 35.0% of the total deaths were attributed to communicable diseases, and 30.7% to chronic non-communicable diseases.", {"entities": []}], ["Tuberculosis (12.5%) and acute respiratory tract infections (10.4%) were the most frequent causes followed by neoplasms (9.6%) and diseases of circulatory system (7.2%).", {"entities": []}], ["InterVA-4 can produce plausible estimates of the major public health problems that can guide public health interventions.", {"entities": []}], ["We encourage further validation studies, in local settings, so that InterVA can be integrated into national health surveys.", {"entities": []}], ["We evaluated how well physicians' global estimates of disease severity correspond to more specific physician-rated disease variables as well as patients' self-rated health and other patient variables.", {"entities": []}], ["We analyzed baseline data from 1662 primary care patients with chronic cardiac or pulmonary disease who were enrolled in a longitudinal study of health-related quality of life (HRQoL).", {"entities": []}], ["Each patient's primary physician rated overall disease severity, estimated the two-year risk of hospitalization and mortality, and reported the use of disease-specific medications, tests, and subspecialty referrals.", {"entities": []}], ["Patient variables included sociodemographic characteristics, psychosocial factors, self-rated health, and both generic and disease-specific HRQoL.", {"entities": []}], ["Physicians rated 40% of their patients \"about average\", 30% \"worse\", and 30% \"better\" than the typical patient seen with the specific target disorder.", {"entities": []}], ["The physician's global estimate of disease severity was strongly associated ( P < 0.001) with each of the five more specific elements of physician-rated disease severity, but only marginally associated with patient self-rated health.", {"entities": []}], ["Multivariable regression identified a set of patient variables that explained 16.4% of the variance in physician-rated disease severity.", {"entities": []}], ["Physicians' global ratings may provide disease severity and prognostic information unique from and complementary to patient self-rated health and HRQoL measures.", {"entities": []}], ["The elements influencing physician-rated disease severity and its predictive validity for clinical outcomes warrant prospective investigation.", {"entities": []}], ["Although evidence-based and effective treatments are available for people with depression, a substantial number does not seek or receive help.", {"entities": []}], ["Therefore, it is important to gain a better understanding of the reasons why people do or do not seek help.", {"entities": []}], ["This study examined what predisposing and need factors are associated with help-seeking among people with major depression.", {"entities": []}], ["A cross-sectional study was conducted in 102 subjects with major depression.", {"entities": []}], ["Respondents were recruited from the general population in collaboration with three Municipal Health Services (GGD) across different regions in the Netherlands.", {"entities": []}], ["Inclusion criteria were: being aged 18\u00a0years or older, a high score on a screening instrument for depression (K10\u2009>\u200920), and a diagnosis of major depression established through the Composite International Diagnostic Interview (CIDI 2.1).", {"entities": []}], ["Of the total sample, 65\u00a0% ( n\u2009= \u200966) had received help in the past six months.", {"entities": []}], ["Results showed that respondents with a longer duration of symptoms and those with lower personal stigma were more likely to seek help.", {"entities": []}], ["Other determinants were not significantly related to help-seeking.", {"entities": []}], ["Longer duration of symptoms was found to be an important determinant of help-seeking among people with depression.", {"entities": []}], ["It is concerning that stigma was related to less help-seeking.", {"entities": []}], ["Knowledge and understanding of depression should be promoted in society, hopefully leading to reduced stigma and increased help-seeking.", {"entities": []}], ["Type-1 interferons (IFNs) are pleiotropic cytokines that signal through the type-1 IFN receptor (IFNAR1).", {"entities": [[97, 103, "GENE"]]}], ["Recent literature has implicated the type-1 IFNs in disorders of the CNS.", {"entities": []}], ["In this study, we have investigated the role of type-1 IFNs in neuroinflammation following traumatic brain injury (TBI).", {"entities": []}], ["Using a controlled cortical impact model, TBI was induced in 8- to 10-week-old male C57BL/6J WT and IFNAR1", {"entities": [[100, 106, "GENE"]]}], ["Data-driven discovery in complex neurological disorders has potential to extract meaningful syndromic knowledge from large, heterogeneous data sets to enhance potential for precision medicine.", {"entities": []}], ["Here we describe the application of topological data analysis (TDA) for data-driven discovery in preclinical traumatic brain injury (TBI) and spinal cord injury (SCI) data sets mined from the Visualized Syndromic Information and Outcomes for Neurotrauma-SCI (VISION-SCI) repository.", {"entities": []}], ["Through direct visualization of inter-related histopathological, functional and health outcomes, TDA detected novel patterns across the syndromic network, uncovering interactions between SCI and co-occurring TBI, as well as detrimental drug effects in unpublished multicentre preclinical drug trial data in SCI.", {"entities": []}], ["TDA also revealed that perioperative hypertension predicted long-term recovery better than any tested drug after thoracic SCI in rats.", {"entities": [[37, 49, "DISEASE"]]}], ["TDA-based data-driven discovery has great potential application for decision-support for basic research and clinical problems such as outcome assessment, neurocritical care, treatment planning and rapid, precision-diagnosis.", {"entities": []}], ["Data-driven discovery in complex neurological disorders has potential to extract meaningful knowledge from large, heterogeneous datasets.", {"entities": []}], ["Here the authors apply topological data analysis to assess therapeutic effects in preclinical traumatic brain injury and spinal cord injury research studies.", {"entities": []}], ["Triple therapy using salmeterol/fluticasone propionate (FP) and tiotropium bromide is commonly used to treat chronic obstructive pulmonary disease (COPD), but sparse efficacy data exist in COPD patients with fewer symptoms and with a lower dose of inhaled corticosteroid in Japanese patients.", {"entities": [[109, 146, "DISEASE"]]}], ["The effects of of salmeterol/fluticasone propionate 50/250 \u03bcg (SFC250) twice daily plus tiotropium 18 \u03bcg (TIO) once daily and individual treatments on lung function were compared.", {"entities": []}], ["Fifty three Japanese COPD patients participated in this randomized, double-blind, double-dummy, Williams square design crossover study.", {"entities": []}], ["Lung function was assessed by plethysmography and spirometry.", {"entities": []}], ["The primary endpoint of postdose specific airway conductance area under the curve (AUC 0\u20134h ) on day 28 was significantly higher following SFC250 + TIO (0.854) compared with TIO (0.737, 15.8%) and SFC250 (0.663, 28.8%) alone.", {"entities": []}], ["SFC250 + TIO significantly improved trough forced expiratory volume in 1 second from baseline versus TIO (0.161 L, P <0.001) and SFC250 (0.103 L, P =0.008).", {"entities": []}], ["SFC250 + TIO significantly improved residual volume compared with TIO ( P <0.001) and SFC250 ( P =0.003) on day 28.", {"entities": []}], ["Nonsignificant improvements were seen in trough inspiratory capacity, total lung capacity, and thoracic gas volume.", {"entities": []}], ["There was no mean change seen in rescue medication.", {"entities": []}], ["Triple therapy using SFC250 + TIO was well tolerated and gave a greater improvement in bronchodilation compared with TIO and SFC250 alone in Japanese patients with COPD.", {"entities": []}], ["There was improvement in few symptoms, but no mean change was seen in patient-reported outcomes measured by rescue medication use.", {"entities": []}], ["Transcatheter aortic valve implantation ( TAVI ) is indicated for patients with aortic stenosis who are intermediate\u2010high surgical risk.", {"entities": []}], ["Although all\u2010cause mortality rates after TAVI are established, survival attributable to the procedure is unclear because of competing causes of mortality.", {"entities": []}], ["The aim was to report relative survival ( RS ) after TAVI , which accounts for background mortality risks in a matched general population.", {"entities": []}], ["National cohort data (n=6420) from the 2007 to 2014 UK TAVI registry were matched by age, sex, and year to mortality rates for England and Wales (population, 57.9\u00a0million).", {"entities": []}], ["The Ederer II method related observed patient survival to that expected from the matched general population.", {"entities": []}], ["We modelled RS using a flexible parametric approach that modelled the log cumulative hazard using restricted cubic splines.", {"entities": []}], ["RS of the TAVI cohort was 95.4%, 90.2%, and 83.8% at 30 days, 1\u00a0year, and 3\u00a0years, respectively.", {"entities": []}], ["By 1\u2010year follow\u2010up, mortality hazards in the >85 years age group were not significantly different from those of the matched general population; by 3\u00a0years, survival rates were comparable.", {"entities": []}], ["The flexible parametric RS model indicated that increasing age was associated with significantly lower excess hazards after the procedure; for example, by 2 years, a 5\u2010year increase in age was associated with 20% lower excess mortality over the general population.", {"entities": []}], ["RS after TAVI was high, and survival rates in those aged >85 years approximated those of a matched general population within 3\u00a0years.", {"entities": []}], ["High rates of RS indicate that patients selected for TAVI tolerate the risks of the procedure well.", {"entities": []}], ["Tryptase, a major secretory product of human mast cells has been implicated as a key mediator of allergic inflammation.", {"entities": []}], ["Genetic variation in the tryptases is extensive, and \u03b1-tryptase, an allelic variant of the more extensively studied \u03b2-tryptase, is absent in substantial numbers of the general population.", {"entities": []}], ["The degree to which \u03b1-tryptase expression may be associated with asthma has not been studied.", {"entities": [[65, 71, "DISEASE"]]}], ["We have investigated the \u03b1-tryptase gene copy number variation and its potential associations with phenotypes of asthma.", {"entities": [[113, 119, "DISEASE"]]}], ["Caucasian families ( n \u00a0=\u00a0341) with at least two asthmatic siblings ( n \u00a0=\u00a01350) were genotyped for the \u03b1-tryptase alleles, using high-resolution melting assays.", {"entities": []}], ["Standards for the possible \u03b1-/\u03b2-tryptase ratios were constructed by cloning \u03b1-and \u03b2-tryptase PCR products to generate artificial templates.", {"entities": []}], ["Association analysis of asthma affection status and related phenotypes [total and allergen-specific serum IgE, bronchial hyperresponsiveness to methacholine, forced expiratory volume in 1s (FEV 1 ) and atopy and asthma severity scores] was undertaken using family-based association tests (FBAT).", {"entities": [[24, 30, "DISEASE"], [212, 218, "DISEASE"], [190, 193, "GENE"]]}], ["Four consistent melting patterns for the \u03b1-tryptase genotype were identified with alleles carrying null, one or two copies of the \u03b1-tryptase allele.", {"entities": []}], ["Possessing one copy of \u03b1-tryptase was significantly associated with lower serum levels of total and dust mite-specific IgE levels and higher FEV 1 measurements, while two copies were related to higher serum concentrations of total and dust mite-specific IgE and greater atopy severity scores.", {"entities": [[141, 144, "GENE"]]}], ["Associations of \u03b1-tryptase copy number with serum IgE levels, atopy scores and bronchial function may reflect roles for tryptases in regulating IgE production and other processes in asthma.", {"entities": [[182, 188, "DISEASE"]]}], ["Pulmonary function is compromised in most smokers.", {"entities": []}], ["Yet it is unknown whether exercise training improves pulmonary function and aerobic capacity in cigarette and hookah smokers and whether these smokers respond in a similar way as do non-smokers.", {"entities": []}], ["To evaluate the effects of an interval exercise training program on pulmonary function and aerobic capacity in cigarette and hookah smokers.", {"entities": []}], ["Twelve cigarette smokers, 10 hookah smokers, and 11 non-smokers participated in our exercise program.", {"entities": []}], ["All subjects performed 30 min of interval exercise (2 min of work followed by 1 min of rest) three times a week for 12 weeks at an intensity estimated at 70% of the subject's maximum aerobic capacity ( V .", {"entities": []}], ["Pulmonary function was measured using spirometry, and maximum aerobic capacity was assessed by maximal exercise testing on a treadmill before the beginning and at the end of the exercise training program.", {"entities": []}], ["As expected, prior to the exercise intervention, the cigarette and hookah smokers had significantly lower pulmonary function than the non-smokers.", {"entities": []}], ["The 12-week exercise training program did not significantly affect lung function as assessed by spirometry in the non-smoker group.", {"entities": []}], ["However, it significantly increased both forced expiratory volume in 1 second and peak expiratory flow (PEF) in the cigarette smoker group, and PEF in the hookah smoker group.", {"entities": []}], ["Our training program had its most notable impact on the cardiopulmonary system of smokers.", {"entities": []}], ["In the non-smoker and cigarette smoker groups, the training program significantly improved V .", {"entities": []}], ["O 2 max (4.4 and 4.7%, respectively), v V .", {"entities": [[4, 7, "GENE"]]}], ["O 2 max (6.7 and 5.6%, respectively), and the recovery index (7.9 and 10.5%, respectively).", {"entities": [[4, 7, "GENE"]]}], ["After 12 weeks of interval training program, the increase of V .", {"entities": []}], ["O 2 max and the decrease of recovery index and resting heart rate in the smoking subjects indicated better exercise tolerance.", {"entities": [[4, 7, "GENE"]]}], ["Although the intermittent training program altered pulmonary function only partially, both aerobic capacity and life quality were improved.", {"entities": []}], ["Intermittent training should be advised in the clinical setting for subjects with adverse health behaviors.", {"entities": []}], ["The structures of the lipooligosaccharides from Brucella melitensis mutants affected in the WbkD and ManB core proteins have been fully characterized using NMR spectroscopy.", {"entities": []}], ["The results revealed that disruption of wbkD gives rise to a rough lipopolysaccharide (R-LPS) with a complete core structure (\u03b2- d -Glc p -(1\u21924)-\u03b1-Kdo p -(2\u21924)[\u03b2- d -Glc p N-(1\u21926)-\u03b2- d -Glc p N-(1\u21924)[\u03b2- d -Glc p N-(1\u21926)]-\u03b2- d -Glc p N-(1\u21923)-\u03b1- d -Man p -(1\u21925)]-\u03b1-Kdo p -(2\u21926)-\u03b2- d -Glc p N3N4 P -(1\u21926)-\u03b1- d -Glc p N3N1 P ), in addition to components lacking one of the terminal \u03b2- d -Glc p N and/or the \u03b2- d -Glc p residues (48 and 17%, respectively).", {"entities": []}], ["These structures were identical to those of the R-LPS from B. melitensis EP, a strain simultaneously expressing both smooth and R-LPS, also studied herein.", {"entities": []}], ["In contrast, disruption of manB core gives rise to a deep-rough pentasaccharide core (\u03b2- d -Glc p -(1\u21924)-\u03b1-Kdo p -(2\u21924)-\u03b1-Kdo p -(2\u21926)-\u03b2- d -Glc p N3N4 P -(1\u21926)-\u03b1- d -Glc p N3N1 P ) as the major component (63%), as well as a minor tetrasaccharide component lacking the terminal \u03b2- d -Glc p residue (37%).", {"entities": []}], ["These results are in agreement with the predicted functions of the WbkD (glycosyltransferase involved in the biosynthesis of the O-antigen) and ManB core proteins (phosphomannomutase involved in the biosynthesis of a mannosyl precursor needed for the biosynthesis of the core and O-antigen).", {"entities": []}], ["We also report that deletion of B. melitensis wadC removes the core oligosaccharide branch not linked to the O-antigen causing an increase in overall negative charge of the remaining LPS inner section.", {"entities": []}], ["This is in agreement with the mannosyltransferase role predicted for WadC and the lack of Glc p N residues in the defective core oligosaccharide.", {"entities": []}], ["Despite carrying the O-antigen essential in B. melitensis virulence, the core deficiency in the wadC mutant structure resulted in a more efficient detection by innate immunity and attenuation, proving the role of the \u03b2- d -Glc p N-(1\u21926)-\u03b2- d -Glc p N-(1\u21924)[\u03b2- d -Glc p N-(1\u21926)]-\u03b2- d -Glc p N-(1\u21923)-\u03b1- d -Man p -(1\u21925) structure in virulence.", {"entities": []}], ["Antimicrobial resistance (AMR) is a substantial threat to public health.", {"entities": []}], ["Safe and effective alternatives are required to reduce unnecessary antibiotic prescribing.", {"entities": []}], ["Andrographis Paniculata ( A .", {"entities": []}], ["Paniculata , Chu\u0101n X\u012bn Li\u00e1n) has traditionally been used in Indian and Chinese herbal medicine for cough, cold and influenza, suggesting a role in respiratory tract infections (RTIs).", {"entities": [[115, 124, "DISEASE"]]}], ["This systematic review aimed to evaluate the clinical effectiveness and safety of A .", {"entities": []}], ["Paniculata for symptoms of acute RTIs (ARTIs).", {"entities": []}], ["English and Chinese databases were searched from their inception to March 2016 for randomised controlled trials (RCTs) evaluating oral A .", {"entities": []}], ["Paniculata without language barriers (Protocol ID: CRD42016035679).", {"entities": []}], ["The primary outcomes were improvement in ARTI symptoms and adverse events (AEs).", {"entities": []}], ["A random effects model was used to pool the mean differences and risk ratio with 95% CI reported.", {"entities": []}], ["Methodological quality was evaluated using the Cochrane risk of bias tool; two reviewers independently screened eligibility and extracted data.", {"entities": []}], ["Thirty-three RCTs (7175 patients) were included.", {"entities": []}], ["Most trials evaluated A .", {"entities": []}], ["Paniculata (as a monotherapy and as a herbal mixture) provided commercially but seldom reported manufacturing or quality control details.", {"entities": []}], ["Paniculata improved cough (n = 596, standardised mean difference SMD: -0.39, 95% confidence interval CI [-0.67, -0.10]) and sore throat (n = 314, SMD: -1.13, 95% CI [-1.37, -0.89]) when compared with placebo.", {"entities": []}], ["Paniculata (alone or plus usual care) has a statistically significant effect in improving overall symptoms of ARTIs when compared to placebo, usual care, and other herbal therapies.", {"entities": []}], ["Evidence also suggested that A .", {"entities": []}], ["Paniculata (alone or plus usual care) shortened the duration of cough, sore throat and sick leave/time to resolution when compared versus usual care.", {"entities": []}], ["No major AEs were reported and minor AEs were mainly gastrointestinal.", {"entities": []}], ["The methodological quality of included trials was overall poor.", {"entities": []}], ["Paniculata appears beneficial and safe for relieving ARTI symptoms and shortening time to symptom resolution.", {"entities": []}], ["However, these findings should be interpreted cautiously owing to poor study quality and heterogeneity.", {"entities": []}], ["Well-designed trials evaluating the effectiveness and potential to reduce antibiotic use of A .", {"entities": []}], ["Paniculata are warranted.", {"entities": []}], ["To date, conventional and/or novel histamine receptors (HRs) have not been investigated in mouse skeletal myogenesis.", {"entities": []}], ["Therefore, the present study aimed to investigate the HR-subtypes in skeletal myogenesis.", {"entities": []}], ["The myogenesis of C2C12 skeletal myoblasts was evaluated using desmin, myogenin and myosin heavy chain (Myh) as early, intermediate and late differentiation markers, respectively.", {"entities": []}], ["Reverse transcription-quantitative polymerase chain reaction and immunostaining were performed and the messenger RNA (mRNA) expression levels of the HR-subtypes and markers were determined.", {"entities": []}], ["H 1 R mRNA was found to be highly expressed in myoblasts at day 0; however, the expression levels were reduced as differentiation progressed.", {"entities": []}], ["By contrast, H 2 R mRNA expression remained constant, while H 3 R mRNA expression increased by 28-, 103- and 198-fold at days 2, 4 and 6 compared with the baseline level (day 0), respectively.", {"entities": []}], ["In addition, Myh expression increased by 7,718-, 94,487- and 286,288-fold on days 2, 4 and 6 compared with the baseline expression level (day 0).", {"entities": []}], ["Weak positive staining of the cells for H 3 R protein was observed on day 2, whereas highly positive staining was observed on days 4 and 6.", {"entities": []}], ["HR expression during myogenesis was, in part, regulated by the stage of differentiation.", {"entities": [[0, 2, "GENE"]]}], ["These results along with previous findings indicated possible involvement of H 1 R in the regulation of progenitor cell mitogenesis and of H 2 R in the relaxation of acetylcholine-stimulated contraction of muscle cells, following the activation of professional histamine-producing cells, including mast cells.", {"entities": []}], ["By contrast, H 3 R may participate in the regulation of specialized myocyte functions, potentially by maintaining the relaxed state under the influence of constitutive H 3 R activity and low histamine concentrations, locally produced/released by non-professional histamine-producing cells.", {"entities": []}], ["Fungal allergy is considered as serious health problem worldwide and is increasing at an alarming rate in the industrialized areas.", {"entities": []}], ["Rhizopus oyzae is a ubiquitously present airborne pathogenic mold and an important source of inhalant allergens for the atopic population of India.", {"entities": []}], ["Here, we report the biochemical and immunological features of its 44 kDa sero-reactive aspartic protease allergen, which is given the official designation \u2018Rhi o 1\u2019.", {"entities": []}], ["The natural Rhi o 1 was purified by sequential column chromatography and its amino acid sequence was determined by mass spectrometry and N-terminal sequencing.", {"entities": []}], ["Based on its amino acid sequence, the cDNA sequence was identified, cloned and expressed to produce recombinant Rhi o 1.", {"entities": []}], ["The allergenic activity of rRhi o 1 was assessed by means of its IgE reactivity and histamine release ability.", {"entities": []}], ["The biochemical property of Rhi o 1 was studied by enzyme assay.", {"entities": []}], ["IgE-inhibition experiments were performed to identify its cross-reactivity with the German cockroach aspartic protease allergen Bla g 2.", {"entities": []}], ["For precise characterization of the cross-reactive epitope, we used anti-Bla g 2 monoclonal antibodies for their antigenic specificity towards Rhi o 1.", {"entities": []}], ["A homology based model of Rhi o 1 was built and mapping of the cross-reactive conformational epitope was done using certain in silico structural studies.", {"entities": []}], ["The purified natural nRhi o 1 was identified as an endopeptidase.", {"entities": []}], ["The full length allergen cDNA was expressed and purified as recombinant rRhi o 1.", {"entities": []}], ["Purified rRhi o 1 displayed complete allergenicity similar to the native nRhi o 1.", {"entities": []}], ["It was recognized by the serum IgE of the selected mold allergy patients and efficiently induced histamine release from the sensitized PBMC cells.", {"entities": []}], ["This allergen was identified as an active aspartic protease functional in low pH.", {"entities": []}], ["The Rhi o 1 showed cross reactivity with the cockroach allergen Bla g 2, as it can inhibit IgE binding to rBla g 2 up to certain level.", {"entities": []}], ["The rBla g 2 was also found to cross-stimulate histamine release from the effector cells sensitized with anti-Rhi o 1 serum IgE.", {"entities": []}], ["This cross-reactivity was found to be mediated by a common mAb4C3 recognizable conformational epitope.", {"entities": []}], ["Bioinformatic studies revealed high degree of structural resemblances between the 4C3 binding sites of both the allergens.", {"entities": []}], ["The present study reports for the first time anew fungal aspartic protease allergen designated as Rhi o 1, which triggers IgE-mediated sensitization leading to various allergic diseases.", {"entities": []}], ["Here we have characterized the recombinant Rhi o 1 and its immunological features including cross-reactive epitope information that will facilitate the component-resolved diagnosis of mold allergy.", {"entities": []}], ["Interindividual variability in anatomical and physiological properties results in significant differences in drug pharmacokinetics.", {"entities": []}], ["The consideration of such pharmacokinetic variability supports optimal drug efficacy and safety for each single individual, e.g.", {"entities": []}], ["by identification of individual-specific dosings.", {"entities": []}], ["One clear objective in clinical drug development is therefore a thorough characterization of the physiological sources of interindividual variability.", {"entities": []}], ["In this work, we present a Bayesian population physiologically-based pharmacokinetic (PBPK) approach for the mechanistically and physiologically realistic identification of interindividual variability.", {"entities": []}], ["The consideration of a generic and highly detailed mechanistic PBPK model structure enables the integration of large amounts of prior physiological knowledge, which is then updated with new experimental data in a Bayesian framework.", {"entities": []}], ["A covariate model integrates known relationships of physiological parameters to age, gender and body height.", {"entities": []}], ["We further provide a framework for estimation of the a posteriori parameter dependency structure at the population level.", {"entities": []}], ["The approach is demonstrated considering a cohort of healthy individuals and theophylline as an application example.", {"entities": []}], ["The variability and co-variability of physiological parameters are specified within the population; respectively.", {"entities": []}], ["Significant correlations are identified between population parameters and are applied for individual- and population-specific visual predictive checks of the pharmacokinetic behavior, which leads to improved results compared to present population approaches.", {"entities": []}], ["In the future, the integration of a generic PBPK model into an hierarchical approach allows for extrapolations to other populations or drugs, while the Bayesian paradigm allows for an iterative application of the approach and thereby a continuous updating of physiological knowledge with new data.", {"entities": []}], ["This will facilitate decision making e.g.", {"entities": []}], ["from preclinical to clinical development or extrapolation of PK behavior from healthy to clinically significant populations.", {"entities": []}], ["It is difficult to experimentally infect volunteers with RV strains to which the subject demonstrates serological immunity.", {"entities": []}], ["However, in RV challenges, viral clearance begins before de novo adaptive immune responses would develop.", {"entities": []}], ["We speculated that adaptive immunity to RV reflects heterologous immunity by effector memory cells.", {"entities": []}], ["DCs were generated from monocytes using GM-CSF and IL-4 and RV39 loading accomplished with a dose of \u223c350 TCID 50 /10 Maturation of DC by RV was confirmed as upregulation of MHC Class II (83.3\u00b15.0% to 87.8\u00b14.1%), CD80 (39.4\u00b17.2% to 47.6\u00b17.7%) and CD86 (78.4\u00b14.7% to 84.1\u00b13.4%).", {"entities": [[213, 217, "GENE"], [247, 251, "GENE"]]}], ["Both CD4 and CD8 memory T cells were recognized in the circulation of healthy subjects.", {"entities": [[5, 8, "GENE"]]}], ["RV drives DC maturation and results in their ability to present RV antigens to both T helper and cytotoxic lymphocytes.", {"entities": []}], ["Both CD4 and CD8 cells capable of recognizing RV-associated antigens are present in the circulation of healthy subjects where they are presumably involved in immune surveillance and explain the rapid recruitment of an adaptive immune response during RV infection.", {"entities": [[5, 8, "GENE"]]}], ["School belongingness has gained currency among educators and school health professionals as an important determinant of adolescent health.", {"entities": []}], ["The current cross-sectional study presents the 15 most significant personal and contextual factors that collectively explain 66.4% (two-thirds) of the variability in 12-year old students\u2019 perceptions of belongingness in primary school.", {"entities": []}], ["The study is part of a larger longitudinal study investigating the factors associated with student adjustment in the transition from primary to secondary school.", {"entities": []}], ["The study found that girls and students with disabilities had higher school belongingness scores than boys, and their typically developing counterparts respectively; and explained 2.5% of the variability in school belongingness.", {"entities": []}], ["The majority (47.1% out of 66.4%) of the variability in school belongingness was explained by student personal factors, such as social acceptance, physical appearance competence, coping skills, and social affiliation motivation; followed by parental expectations (3% out of 66.4%), and school-based factors (13.9% out of 66.4%) such as, classroom involvement, task-goal structure, autonomy provision, cultural pluralism, and absence of bullying.", {"entities": []}], ["Each of the identified contributors of primary school belongingness can be shaped through interventions, system changes, or policy reforms.", {"entities": []}], ["\u2022 Clinical measures greatly increase the predictive power of primary care cost models.", {"entities": []}], ["\u2022 Counts of diseases perform better than complex multimorbidity measures.", {"entities": []}], ["\u2022 Capitation for given patient types varies strongly with the morbidity measure.", {"entities": []}], ["\u2022 Gains from patient selection are substantial with all morbidity measures.", {"entities": []}], ["\u2022 Pro poor horizontal inequity is smaller the better fitting the cost model.", {"entities": []}], ["Clinical measures greatly increase the predictive power of primary care cost models.", {"entities": []}], ["Counts of diseases perform better than complex multimorbidity measures.", {"entities": []}], ["Capitation for given patient types varies strongly with the morbidity measure.", {"entities": []}], ["Gains from patient selection are substantial with all morbidity measures.", {"entities": []}], ["Pro poor horizontal inequity is smaller the better fitting the cost model.", {"entities": []}], ["Models of the determinants of individuals\u2019 primary care costs can be used to set capitation payments to providers and to test for horizontal equity.", {"entities": []}], ["We compare the ability of eight measures of patient morbidity and multimorbidity to predict future primary care costs and examine capitation payments based on them.", {"entities": []}], ["The measures were derived from four morbidity descriptive systems: 17 chronic diseases in the Quality and Outcomes Framework (QOF); 17 chronic diseases in the Charlson scheme; 114 Expanded Diagnosis Clusters (EDCs); and 68 Adjusted Clinical Groups (ACGs).", {"entities": []}], ["These were applied to patient records of 86,100 individuals in 174 English practices.", {"entities": []}], ["For a given disease description system, counts of diseases and sets of disease dummy variables had similar explanatory power.", {"entities": []}], ["The EDC measures performed best followed by the QOF and ACG measures.", {"entities": []}], ["The Charlson measures had the worst performance but still improved markedly on models containing only age, gender, deprivation and practice effects.", {"entities": []}], ["Comparisons of predictive power for different morbidity measures were similar for linear and exponential models, but the relative predictive power of the models varied with the morbidity measure.", {"entities": []}], ["Capitation payments for an individual patient vary considerably with the different morbidity measures included in the cost model.", {"entities": []}], ["Even for the best fitting model large differences between expected cost and capitation for some types of patient suggest incentives for patient selection.", {"entities": []}], ["Models with any of the morbidity measures show higher cost for more deprived patients but the positive effect of deprivation on cost was smaller in better fitting models.", {"entities": []}], ["Na\u00efve CD4 T (NCD4T) cells post-activation undergo programming for inducible production of cytokines leading to generation of memory cells with various functions.", {"entities": [[6, 9, "GENE"]]}], ["Based on cytokine based polarization of NCD4T cells in vitro, programming for either \u2018Th1\u2019 (interferon-gamma [IFNg]) or \u2018Th2\u2019 (interleukin [IL]-4/5/13) cytokines is thought to occur via mutually exclusive expression and functioning of T-bet or GATA-3 transcription factors (TFs).", {"entities": [[110, 114, "GENE"]]}], ["However, we show that a high proportion of mouse and human memory-phenotype CD4 T (MCD4T) cells generated in vivo which expressed either Th1 or Th2 cytokines commonly co-expressed T-bet and GATA-3.", {"entities": [[76, 79, "GENE"]]}], ["While T-bet levels did not differ between IFNg-expressing and IL-4/5/13-expressing MCD4T cells, GATA-3 levels were higher in the latter.", {"entities": []}], ["These observations were also confirmed in MCD4T cells from FVB/NJ or aged C57BL/6 or IFNg-deficient mice.", {"entities": []}], ["While MCD4T cells from these strains showed greater Th2 commitment than those from young C57BL/6 mice, pattern of co-expression of TF was similar.", {"entities": [[131, 133, "GENE"]]}], ["Effector T cells generated in vivo following immunization also showed TF co-expression in Th1 or Th2 cytokine producing cells.", {"entities": [[70, 72, "GENE"]]}], ["We speculated that the difference in TF expression pattern of MCD4T cells generated in vivo and those generated in cytokine polarized cultures in vitro could be due to relative absence of polarizing conditions during activation in vivo.", {"entities": [[37, 39, "GENE"]]}], ["We tested this by NCD4T cell activation in non-polarizing conditions in vitro.", {"entities": []}], ["Anti-CD3 and anti-CD28-mediated priming of polyclonal NCD4T cells in vitro without polarizing milieu generated cells that expressed either IFNg or IL-4/5/13 but not both, yet both IFNg- and IL-4/5/13-expressing cells showed upregulation of both TFs.", {"entities": [[139, 143, "GENE"], [180, 184, "GENE"]]}], ["We also tested monoclonal T cell populations activated in non-polarizing conditions.", {"entities": []}], ["TCR-transgenic NCD4T cells primed in vitro by cognate peptide in non-polarizing conditions which expressed either IFNg or IL-4/5/13 also showed a high proportion of cells co-expressing TFs, and their cytokine commitment varied depending on genetic background or priming conditions, without altering pattern of TF co-expression.", {"entities": [[114, 118, "GENE"], [310, 312, "GENE"]]}], ["Thus, the model of mutually antagonistic differentiation programs driven by mutually exclusively expressed T-bet or GATA-3 does not completely explain natural CD4 T cell priming outcomes.", {"entities": [[159, 162, "GENE"]]}], ["Non-steroidal anti-inflammatory (NSAID) medications are a common cause of reported adverse drug side-effects.", {"entities": []}], ["This study describes the prevalence of non-steroidal anti-inflammatory (NSAID) use (other than low-dose aspirin) and the presence of co-existing relative contraindications to NSAID use and chronic conditions in a representative population sample.", {"entities": []}], ["Data were analysed from 3,206 adults attending first follow-up of the North West Adelaide Health Study (NWAHS) in 2004 - 2006, a longitudinal representative population study.", {"entities": []}], ["Medications were brought into study clinic visits by participants.", {"entities": []}], ["Clinical assessment included measured blood pressure, kidney function, serum cholesterol, blood glucose.", {"entities": []}], ["Questionnaires assessed demographics, lifestyle risk factors, physician-diagnosed chronic conditions.", {"entities": []}], ["Data were weighted to census measures by region, age group, gender, and probability of selection in the household, to provide population representative estimates.", {"entities": []}], ["Pearson's Chi-square tests determined significant differences in proportions.", {"entities": []}], ["Multiple logistic regression was used to examine associations of socio-demographic characteristics with use of NSAIDs.", {"entities": []}], ["Of 3,175 participants, 357 (11.2%), and 16% of those aged > 55 years, reported using either non-specific NSAIDs or COX-2 inhibitors, other than low-dose aspirin.", {"entities": []}], ["Among people using NSAIDs, 60.8% had hypertension, 30.8% had Stage 3 or higher chronic kidney disease, 17.2% had a history of cardiovascular disease (CVD) and 20.7% had a > 15% 10-year CVD risk.", {"entities": [[37, 49, "DISEASE"], [87, 101, "DISEASE"]]}], ["The prevalence of NSAID use among people with hypertension was 16%, with kidney disease 15.9%, and a history of CVD 20.0%.", {"entities": [[46, 58, "DISEASE"], [73, 87, "DISEASE"]]}], ["Among people taking diuretics, 24.1% were also taking NSAIDs, and of those taking medications for gastro-esophageal reflux, 24.7% were on NSAIDs.", {"entities": []}], ["Prescription-only COX-2 inhibitors, but not other NSAIDs, were used more by people > 75 years than by 35-54 year olds (OR 3.7, 95% CI 2.0, 6.7), and also were more commonly used by people with hypertension, cardiac and kidney disease.", {"entities": [[193, 205, "DISEASE"], [219, 233, "DISEASE"]]}], ["There is a high prevalence of current NSAID use among groups at-risk for significant drug-related adverse events or who have major chronic conditions that are relative contraindications to NSAID use.", {"entities": []}], ["Assessment of absolute risks regarding cardiovascular and kidney disease need to take into account use of medications such as NSAIDs.", {"entities": [[58, 72, "DISEASE"]]}], ["The potential to make a substantial impact on chronic disease burden via improved use of NSAIDs is considerable.", {"entities": []}], ["Ectonucleotidases CD39 and CD73, specific nucleotide metabolizing enzymes located on the surface of the host, can convert a pro-inflammatory environment driven by a danger molecule extracellular-ATP to an adenosine-mediated anti-inflammatory milieu.", {"entities": []}], ["Accordingly, CD39/CD73 signaling has been strongly implicated in modulating the intensity, duration, and composition of purinergic danger signals delivered to host.", {"entities": []}], ["Recent studies have eluted potential roles for CD39 and CD73 in selective triggering of a variety of host immune cells and molecules in the presence of pathogenic microorganisms or microbial virulence molecules.", {"entities": []}], ["Growing evidence also suggests that CD39 and CD73 present complimentary, but likely differential, actions against pathogens to shape the course and severity of microbial infection as well as the associated immune response.", {"entities": []}], ["Similarly, adenosine receptors A 2A and A 2B have been proposed to be major immunomodulators of adenosine signaling during chronic inflammatory conditions induced by opportunistic pathogens, such as oral colonizer Porphyromonas gingivalis.", {"entities": []}], ["Therefore, we here review the recent studies that demonstrate how complex network of molecules in the extracellular adenosine signaling machinery and their interactions can reshape immune responses and may also be targeted by opportunistic pathogens to establish successful colonization in human mucosal tissues and modulate the host immune response.", {"entities": []}], ["Ca i ), typically provoked by activation of G q \u2010protein coupled receptors (G q PCR).", {"entities": []}], ["G q PCR activation initiates depletion of plasmalemmal phosphatidylinositol 4,5\u2010bisphosphate (PIP 2 ).", {"entities": []}], ["Here, we determined whether PIP 2 acts as a signalling lipid for CaCCs coded by the TMEM16A and TMEM16B genes.", {"entities": []}], ["Patch\u2010clamp electrophysiology, in conjunction with genetically encoded systems to control cellular PIP 2 content, was used to define the mechanism of action of PIP 2 on TMEM16A and TMEM16B channels.", {"entities": []}], ["A water\u2010soluble PIP 2 analogue (diC8\u2010PIP 2 ) activated TMEM16A channels by up to fivefold and inhibited TMEM16B by ~0.2\u2010fold.", {"entities": []}], ["The effects of diC8\u2010PIP 2 on TMEM16A currents were especially pronounced at low [Ca i .", {"entities": []}], ["In contrast, diC8\u2010PIP 2 modulation of TMEM16B channels did not vary over a broad [Ca i range but was only detectable at highly depolarized membrane potentials.", {"entities": []}], ["Modulation of TMEM16A and TMEM16B currents was due to changes in channel gating, while single channel conductance was unaltered.", {"entities": []}], ["Co\u2010expression of TMEM16A or TMEM16B with a Danio rerio voltage\u2010sensitive phosphatase (DrVSP), which degrades PIP 2 , led to reduction and enhancement of TMEM16A and TMEM16B currents respectively.", {"entities": []}], ["These effects were abolished by an inactivating mutation in DrVSP and antagonized by simultaneous co\u2010expression of a phosphatidylinositol\u20104\u2010phosphate 5\u2010kinase that catalyses PIP 2 formation.", {"entities": []}], ["PIP 2 acts as a modifier of TMEM16A and TMEM16B channel gating.", {"entities": []}], ["Drugs interacting with PIP 2 signalling may affect TMEM16A and TMEM16B channel gating and have potential uses in basic science and implications for therapy.", {"entities": []}], ["Polymorphisms in glutathione S-transferase (GST) genes may influence response to oxidative stress and modify prostate cancer (PCA) susceptibility.", {"entities": [[118, 124, "DISEASE"], [109, 124, "DISEASE"]]}], ["These enzymes generally detoxify endogenous and exogenous agents, but also participate in the activation and inactivation of oxidative metabolites that may contribute to PCA development.", {"entities": []}], ["Genetic variations within selected GST genes may influence PCA risk following exposure to carcinogen compounds found in cigarette smoke and decreased the ability to detoxify them.", {"entities": []}], ["Thus, we evaluated the effects of polymorphic GSTs ( M1 , T1 , and P1 ) alone and combined with cigarette smoking on PCA susceptibility.", {"entities": []}], ["In order to evaluate the effects of GST polymorphisms in relation to PCA risk, we used TaqMan allelic discrimination assays along with a multi-faceted statistical strategy involving conventional and advanced statistical methodologies (e.g., Multifactor Dimensionality Reduction and Interaction Graphs).", {"entities": []}], ["Genetic profiles collected from 873 men of African-descent (208 cases and 665 controls) were utilized to systematically evaluate the single and joint modifying effects of GSTM1 and GSTT1 gene deletions, GSTP1 105 Val and cigarette smoking on PCA risk.", {"entities": [[171, 176, "GENE"], [181, 186, "GENE"], [203, 208, "GENE"]]}], ["We observed a moderately significant association between risk among men possessing at least one variant GSTP1 105 Val allele (OR = 1.56; 95%CI = 0.95-2.58; p = 0.049), which was confirmed by MDR permutation testing (p = 0.001).", {"entities": [[104, 109, "GENE"]]}], ["We did not observe any significant single gene effects among GSTM1 (OR = 1.08; 95%CI = 0.65-1.82; p = 0.718) and GSTT1 (OR = 1.15; 95%CI = 0.66-2.02; p = 0.622) on PCA risk among all subjects.", {"entities": [[61, 66, "GENE"], [113, 118, "GENE"]]}], ["Although the GSTM1 - GSTP1 pairwise combination was selected as the best two factor LR and MDR models (p = 0.01), assessment of the hierarchical entropy graph suggested that the observed synergistic effect was primarily driven by the GSTP1 Val marker.", {"entities": [[13, 18, "GENE"], [21, 26, "GENE"], [234, 239, "GENE"], [21, 26, "GENE"], [234, 239, "GENE"]]}], ["Notably, the GSTM1 - GSTP1 axis did not provide additional information gain when compared to either loci alone based on a hierarchical entropy algorithm and graph.", {"entities": [[13, 18, "GENE"], [21, 26, "GENE"]]}], ["Smoking status did not significantly modify the relationship between the GST SNPs and PCA.", {"entities": []}], ["A moderately significant association was observed between PCA risk and men possessing at least one variant GSTP1 105 Val allele (p = 0.049) among men of African descent.", {"entities": [[107, 112, "GENE"]]}], ["We also observed a 2.1-fold increase in PCA risk associated with men possessing the GSTP1 (Val/Val) and GSTM1 (*1/*1 + *1/*0) alleles.", {"entities": [[84, 89, "GENE"], [104, 109, "GENE"]]}], ["MDR analysis validated these findings; detecting GSTP1 105 Val (p = 0.001) as the best single factor for predicting PCA risk.", {"entities": [[49, 54, "GENE"]]}], ["Our findings emphasize the importance of utilizing a combination of traditional and advanced statistical tools to identify and validate single gene and multi-locus interactions in relation to cancer susceptibility.", {"entities": [[192, 198, "DISEASE"]]}], ["Bacteria and fungi are believed to influence mucosal inflammation in chronic rhinosinusitis (CRS).", {"entities": []}], ["However their presence and relationship to disease is debated.", {"entities": []}], ["This study used multiple detection methods to compare microbial diversity and microbial abundance in healthy and diseased sinonasal mucosa.", {"entities": []}], ["The utility of contemporary detection methods is also examined.", {"entities": []}], ["Sinonasal mucosa was analyzed from 38 CRS and 6 controls.", {"entities": []}], ["Bacterial and fungal analysis was performed using conventional culture, molecular diagnostics (polymerase chain reaction coupled with electrospray ionization time-of-flight mass spectrometry) and fluorescence in situ hybridization .", {"entities": []}], ["Microbes were detected in all samples, including controls, and were often polymicrobial.", {"entities": []}], ["33 different bacterial species were detected in CRS, 5 in control patients, with frequent recovery of anaerobes.", {"entities": []}], ["Staphylococcus aureus and Propionibacterium acnes were the most common organisms in CRS and controls, respectively.", {"entities": []}], ["Using a model organism, FISH had a sensitivity of 78%, and a specificity of 93%.", {"entities": []}], ["Many species were detected in both CRS and controls however, microbial abundance was associated with disease manifestation.", {"entities": []}], ["This study highlights some cornerstones of microbial variations in healthy and diseased paranasal sinuses.", {"entities": []}], ["Whilst the healthy sinus is clearly not sterile, it appears prevalence and abundance of organisms is critical in determining disease.", {"entities": []}], ["Evidence from high-sensitivity techniques, limits the role of fungi in CRS to a small group of patients.", {"entities": []}], ["Comparison with molecular analysis suggests that the detection threshold of FISH and culture is related to organism abundance and, furthermore, culture tends to select for rapidly growing organisms.", {"entities": []}], ["This study reports the concentrations of Polycyclic Aromatic Hydrocarbons (PAHs) in human blood sera samples ( n = 650) obtained at autopsy from individuals who died of drug abuse, alcohol toxicity, homicide, suicide and other unknown causes.", {"entities": []}], ["The analyzed samples from decedents revealed the presence of PAHs of which B(a)P was the most predominant one, followed by benzo(b)fluoranthene and benzo(k)fluoranthene.", {"entities": []}], ["The other PAHs detected sporadically and measured were benzo(g,h,i)perylene, acenaphthene, anthracene, phenanthrene, and fluoranthene The mean concentrations of PAHs were greater in the twenties to fifties age groups compared to others.", {"entities": []}], ["The PAH residue levels detected were high in African Americans compared to Caucasians, Asians, and Hispanics.", {"entities": []}], ["It appears that environmental exposure, dietary intake and in some cases occupational exposure may have contributed to the PAH body burden.", {"entities": []}], ["While the PAH residue concentrations measured fall within the range of those reported for healthy adults elsewhere, in isolated cases, the concentrations detected were high, calling the need for a reduction in PAH emissions and human biomonitoring studies for purposes of risk assessment.", {"entities": []}], ["The association between impaired lung function and cardiovascular disease (CVD) risk factors has been shown in adults.", {"entities": []}], ["However, there is little evidence of such an association in young adults, particularly from South America, where the burden of CVD and chronic obstructive pulmonary disease (COPD) is as high as that observed in more developed countries.", {"entities": [[135, 172, "DISEASE"]]}], ["We therefore investigated the relation between CVD risk factors including metabolic syndrome (MS), and lung function status in young adults from Chile.", {"entities": [[84, 92, "DISEASE"]]}], ["970 subjects from a sample of 998 adults born between 1974 and 1978 in Limache, Chile, were studied.", {"entities": []}], ["A Spanish translation of the European Community Respiratory Health Survey (ECRHS) questionnaire was used.", {"entities": []}], ["Forced expiratory volume in 1 second (FEV 1 ) and forced vital capacity (FVC) were measured.", {"entities": [[38, 41, "GENE"]]}], ["Weight, height, waist circumference (WC), blood pressure, Homeostatic model assessment (HOMA-IR), triglycerides, high density lipoprotein (HDL), glycaemia, and metabolic syndrome (MS) were also assessed.", {"entities": [[170, 178, "DISEASE"]]}], ["The prevalence of MS was 11.8%.", {"entities": []}], ["A lower FEV 1 and lower FVC were associated with having MS (\u03b2-coefficient -0.13; 95% Confidence Interval [CI] -0.21 to -0.05, and \u03b2-coefficient -0.18; 95% CI -0.27 to -0.09, respectively).", {"entities": [[8, 11, "GENE"]]}], ["Both spirometric measures were also negatively associated with having an elevated HOMA-IR (\u03b2-coefficient for FEV 1 -0.08; 95% CI -0.13 to -0.03, and \u03b2-coefficient for FVC -0.11; 95% CI -0.17 to -0.05).", {"entities": [[109, 112, "GENE"]]}], ["In males only, a lower FEV 1 and FVC were associated with having elevated triglycerides (\u03b2-coefficient highest vs. lowest tertile -0.13, 95% CI -0.24 to -0.03, and \u03b2-coefficient -0.13, 95% CI -0.25 to -0.01, respectively).", {"entities": [[23, 26, "GENE"]]}], ["In women, a higher FEV 1 and FVC were statistically significantly related to having higher levels of HDL.", {"entities": [[19, 22, "GENE"]]}], ["Ventilatory function was unrelated to hypertension or WC in this population.", {"entities": [[38, 50, "DISEASE"]]}], ["In this population-based study of young adults, a poorer ventilatory function was associated with many CVD risk factors.", {"entities": []}], ["Endeavours to understand better causality issues of such associations are warranted.", {"entities": []}], ["Background: Evidence on the short-term effects of fine and coarse particles on morbidity in Europe is scarce and inconsistent.", {"entities": []}], ["Objectives: We aimed to estimate the association between daily concentrations of fine and coarse particles with hospitalizations for cardiovascular and respiratory conditions in eight Southern European cities, within the MED-PARTICLES project.", {"entities": []}], ["Methods: City-specific Poisson models were fitted to estimate associations of daily concentrations of particulate matter with aerodynamic diameter \u2264 2.5 \u03bcm (PM 2.5 ), \u2264 10 \u03bcm (PM 10 ), and their difference (PM 2.5\u201310 ) with daily counts of emergency hospitalizations for cardiovascular and respiratory diseases.", {"entities": []}], ["We derived pooled estimates from random-effects meta-analysis and evaluated the robustness of results to co-pollutant exposure adjustment and model specification.", {"entities": []}], ["Pooled concentration\u2013response curves were estimated using a meta-smoothing approach.", {"entities": []}], ["Results: We found significant associations between all PM fractions and cardiovascular admissions.", {"entities": []}], ["Increases of 10 \u03bcg/m 2.5 , 6.3 \u03bcg/m 2.5\u201310 , and 14.4 \u03bcg/m 10 (lag 0\u20131 days) were associated with increases in cardiovascular admissions of 0.51% (95% CI: 0.12, 0.90%), 0.46% (95% CI: 0.10, 0.82%), and 0.53% (95% CI: 0.06, 1.00%), respectively.", {"entities": []}], ["Stronger associations were estimated for respiratory hospitalizations, ranging from 1.15% (95% CI: 0.21, 2.11%) for PM 10 to 1.36% (95% CI: 0.23, 2.49) for PM 2.5 (lag 0\u20135 days).", {"entities": []}], ["Conclusions: PM 2.5 and PM 2.5\u201310 were positively associated with cardiovascular and respiratory admissions in eight Mediterranean cities.", {"entities": []}], ["Information on the short-term effects of different PM fractions on morbidity in Southern Europe will be useful to inform European policies on air quality standards.", {"entities": []}], ["Citation: Stafoggia M, Samoli E, Alessandrini E, Cadum E, Ostro B, Berti G, Faustini A, Jacquemin B, Linares C, Pascal M, Randi G, Ranzi A, Stivanello E, Forastiere F, the MED-PARTICLES Study Group.", {"entities": []}], ["Short-term associations between fine and coarse particulate matter and hospitalizations in Southern Europe: results from the MED-PARTICLES project.", {"entities": []}], ["Environ Health Perspect 121:1026\u20131033; http://dx.doi.org/10.1289/ehp.1206151", {"entities": []}], ["Meta-analyses have been suggested to be the highest form of evidence available to clinicians to guide clinical practice in critical care.", {"entities": []}], ["The purpose of this study was to systematically evaluate the quality of meta-analyses that address topics pertinent to critical care.", {"entities": []}], ["To identify potentially eligible meta-analyses for inclusion, a systematic search of Medline, EMBASE and the Cochrane Database of Systematic Reviews was undertaken, using broad search terms relevant to intensive care, including: intensive care, critical care, shock, resuscitation, inotropes and mechanical ventilation.", {"entities": []}], ["Predetermined inclusion criteria were applied to each identified meta-analysis independently by two authors.", {"entities": []}], ["To assess report quality, the included meta-analyses were assessed using the component and overall scores from the Overview Quality Assessment Questionnaire (OQAQ).", {"entities": []}], ["The quality of reports published before and after the publication of the QUOROM statement was compared.", {"entities": []}], ["A total of 139 reports of meta-analyses were included (kappa = 0.93).", {"entities": []}], ["The overall quality of reports of meta-analyses was found to be poor, with an estimated mean overall OQAQ score of 3.3 (95% CI; 3.0\u20133.6).", {"entities": []}], ["Only 43 (30.9%) were scored as having minimal or minor flaws (>5).", {"entities": []}], ["We noted problems with the reporting of key characteristics of meta-analyses, such as performing a thorough literature search, avoidance of bias in the inclusion of studies and appropriately referring to the validity of the included studies.", {"entities": []}], ["After the release of the QUOROM statement, however, an improvement in the overall quality of published meta-analyses was noted.", {"entities": []}], ["The overall quality of the reports of meta-analyses available to critical care physicians is poor.", {"entities": []}], ["Physicians should critically evaluate these studies prior to considering applying the results of these studies in their clinical practice.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide.", {"entities": []}], ["Low-grade systemic inflammation is considered a hallmark of COPD that potentially links COPD to increased rate of systemic manifestations of the disease.", {"entities": []}], ["Obesity with/without the metabolic syndrome and cachexia represent two poles of metabolic abnormalities that may relate to systemic inflammation.", {"entities": [[0, 7, "DISEASE"], [35, 43, "DISEASE"]]}], ["On one hand systemic inflammatory syndrome likely reflects inflammation in the lungs, i.e.", {"entities": [[34, 42, "DISEASE"]]}], ["results from lung-to plasma spillover of inflammatory mediators.", {"entities": []}], ["On the other hand, obesity-related hypoxia results in local inflammatory response within adipose tissue per se , and may contribute to elevations in circulatory mediators by spillover from the adipose tissue to the systemic compartment.", {"entities": [[19, 26, "DISEASE"]]}], ["The extent to which systemic hypoxia contributes to the adipose tissue inflammation remains unknown.", {"entities": []}], ["We assume that in patients with COPD and concurrent obesity at least three factors play a role in the systemic inflammatory syndrome: the severity of pulmonary impairment, the degree of obesity-related adipose tissue hypoxia, and the severity of systemic hypoxia due to reduced pulmonary functions.", {"entities": [[52, 59, "DISEASE"], [186, 193, "DISEASE"], [124, 132, "DISEASE"]]}], ["The present review summarizes the epidemiological and clinical evidence linking COPD to obesity, the role of adipose tissue as an endocrine organ, and the role of hypoxia in adipose tissue inflammation.", {"entities": [[88, 95, "DISEASE"]]}], ["More than half of the general population does not attend screening for cardiovascular diseases (CVD) hence they are unaware of their risks.", {"entities": []}], ["The objective of this study was to explore the views and experiences of the public in deciding to undergo health checks for CVD prevention.", {"entities": []}], ["This was a qualitative study utilising the constructivist grounded theory approach.", {"entities": []}], ["A total of 31 individuals aged 30 years and above from the community were sampled purposively.", {"entities": []}], ["Eight interviews and six focus groups were involved, using a semi-structured topic guide.", {"entities": []}], ["A conceptual framework was developed to explain the public\u2019s decision-making process on health check participation for CVD prevention.", {"entities": []}], ["The intention to participate in health checks was influenced by the interplay between perceived relevance and the individual\u2019s readiness to face the outcome of health checks.", {"entities": []}], ["Health checks were deemed relevant if people perceived themselves to be at risk of CVD and there was an advantage in knowing their cardiovascular status.", {"entities": []}], ["People were ready to face the outcome of health checks if they wanted to know the results and were prepared to deal with the subsequent management.", {"entities": []}], ["The decision to participate in health checks was also influenced by external factors such as the views of significant others, and the accessibility and availability of resources including time and finances.", {"entities": []}], ["The intention to screen for CVD is motivated by two internal factors: the perceived relevance of the disease and readiness to face screening outcomes.", {"entities": []}], ["Strategies targeting the internal decision-making process may prove to be key in improving the uptake of screening.", {"entities": []}], ["Acute pancreatitis is potentially fatal but treatment options are limited as disease pathogenesis is poorly understood.", {"entities": [[6, 18, "DISEASE"], [0, 18, "DISEASE"]]}], ["IL-33, a novel IL-1 cytokine family member, plays a role in various inflammatory conditions but its role in acute pancreatitis is not well understood.", {"entities": [[114, 126, "DISEASE"], [108, 126, "DISEASE"]]}], ["Specifically, whether pancreatic acinar cells produce IL-33 when stressed or respond to IL-33 stimulation, and whether IL-33 exacerbates acute pancreatic inflammation is unknown.", {"entities": []}], ["In duct ligation-induced acute pancreatitis in mice and rats, we found that (a) IL-33 concentration was increased in the pancreas; (b) mast cells, which secrete and also respond to IL-33, showed degranulation in the pancreas and lung; (c) plasma histamine and pancreatic substance P concentrations were increased; and (d) pancreatic and pulmonary proinflammatory cytokine concentrations were increased.", {"entities": [[31, 43, "DISEASE"], [25, 43, "DISEASE"]]}], ["In isolated mouse pancreatic acinar cells, TNF-\u03b1 stimulation increased IL-33 release while IL-33 stimulation increased proinflammatory cytokine release, both involving the ERK MAP kinase pathway; the flavonoid luteolin inhibited IL-33-stimulated IL-6 and CCL2/MCP-1 release.", {"entities": []}], ["In mice without duct ligation, exogenous IL-33 administration induced pancreatic inflammation without mast cell degranulation or jejunal inflammation; pancreatic changes included multifocal edema and perivascular infiltration by neutrophils and some macrophages.", {"entities": []}], ["ERK MAP kinase (but not p38 or JNK) and NF-kB subunit p65 were activated in the pancreas of mice receiving exogenous IL-33, and acinar cells isolated from the pancreas of these mice showed increased spontaneous cytokine release (IL-6, CXCL2/MIP-2\u03b1).", {"entities": []}], ["Also, IL-33 activated ERK in human pancreatic tissue.", {"entities": []}], ["As exogenous IL-33 does not induce jejunal inflammation in the same mice in which it induces pancreatic inflammation, we have discovered a potential role for an IL-33/acinar cell axis in the recruitment of neutrophils and macrophages and the exacerbation of acute pancreatic inflammation.", {"entities": []}], ["IL-33 is induced in acute pancreatitis, activates acinar cell proinflammatory pathways and exacerbates acute pancreatic inflammation.", {"entities": [[26, 38, "DISEASE"], [20, 38, "DISEASE"]]}], ["Although the effect of bisphenol A on various health outcomes has been extensively examined, few studies have investigated its effect on asthma.", {"entities": [[137, 143, "DISEASE"]]}], ["We hypothesized that exposure to bisphenol A in school-age children was associated with wheezing and asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["Participants included 127 children aged 7\u20138 years without a previous asthma diagnosis in an elementary school in Seoul, Korea.", {"entities": [[69, 75, "DISEASE"]]}], ["Three surveys were conducted, each 2 years apart.", {"entities": []}], ["Bisphenol A concentration was measured at the baseline survey, and PC 20 , which is defined as the methacholine concentration that induces a decrease in FEV 1 of 20% from baseline, was measured at every survey.", {"entities": [[67, 69, "GENE"], [153, 156, "GENE"]]}], ["Associations between bisphenol A concentration at 7\u20138 years of age and wheezing, asthma, and PC 20 at ages up to 11\u201312 years were examined using generalized estimating equations, a marginal Cox regression model, and a linear mixed model.", {"entities": [[81, 87, "DISEASE"], [93, 95, "GENE"]]}], ["The log-transformed creatinine-adjusted urinary bisphenol A concentration at 7\u20138 years was positively associated with wheezing (odds ratio, 2.48; 95% confidence interval, 1.15\u20135.31; P \u200a=\u200a.02) and asthma (hazard ratio, 2.13; 95% confidence interval, 1.51\u20133.00; P <.001) at ages up to 11\u201312 years.", {"entities": [[196, 202, "DISEASE"]]}], ["Bisphenol A was also negatively associated with PC 20 (\u00df\u200a=\u200a\u22122.33; P \u200a=\u200a.02).", {"entities": [[48, 50, "GENE"]]}], ["When stratified by sex, the association between bisphenol A and asthma remained significant only in girls (hazard ratio, 2.45; 95% confidence interval, 2.18\u20132.76; P <.001).", {"entities": [[64, 70, "DISEASE"]]}], ["Increased urinary bisphenol A concentrations at 7\u20138 years old were positively associated with wheezing and asthma and negatively associated with PC 20 at ages up to 11\u201312 years.", {"entities": [[107, 113, "DISEASE"], [145, 147, "GENE"]]}], ["22q13 deletion syndrome, also known as Phelan-McDermid syndrome, is a neurodevelopmental disorder characterized by intellectual disability, hypotonia, delayed or absent speech, and autistic features.", {"entities": [[115, 138, "DISEASE"], [15, 23, "DISEASE"], [55, 63, "DISEASE"]]}], ["SHANK3 has been identified as the critical gene in the neurological and behavioral aspects of this syndrome.", {"entities": [[99, 107, "DISEASE"], [0, 6, "GENE"]]}], ["The phenotype of SHANK3 deficiency has been described primarily from case studies, with limited evaluation of behavioral and cognitive deficits.", {"entities": [[17, 23, "GENE"]]}], ["The present study used a prospective design and inter-disciplinary clinical evaluations to assess patients with SHANK3 deficiency, with the goal of providing a comprehensive picture of the medical and behavioral profile of the syndrome.", {"entities": [[227, 235, "DISEASE"], [112, 118, "GENE"]]}], ["A serially ascertained sample of patients with SHANK3 deficiency (n = 32) was evaluated by a team of child psychiatrists, neurologists, clinical geneticists, molecular geneticists and psychologists.", {"entities": [[47, 53, "GENE"]]}], ["Patients were evaluated for autism spectrum disorder using the Autism Diagnostic Interview-Revised and the Autism Diagnostic Observation Schedule-G. Thirty participants with 22q13.3 deletions ranging in size from 101 kb to 8.45 Mb and two participants with de novo SHANK3 mutations were included.", {"entities": [[28, 52, "DISEASE"], [228, 230, "GENE"], [265, 271, "GENE"]]}], ["The sample was characterized by high rates of autism spectrum disorder: 27 (84%) met criteria for autism spectrum disorder and 24 (75%) for autistic disorder.", {"entities": [[140, 157, "DISEASE"], [46, 70, "DISEASE"], [98, 122, "DISEASE"]]}], ["Most patients (77%) exhibited severe to profound intellectual disability and only five (19%) used some words spontaneously to communicate.", {"entities": [[49, 72, "DISEASE"]]}], ["Dysmorphic features, hypotonia, gait disturbance, recurring upper respiratory tract infections, gastroesophageal reflux and seizures were also common.", {"entities": []}], ["Analysis of genotype-phenotype correlations indicated that larger deletions were associated with increased levels of dysmorphic features, medical comorbidities and social communication impairments related to autism.", {"entities": []}], ["Analyses of individuals with small deletions or point mutations identified features related to SHANK3 haploinsufficiency, including ASD, seizures and abnormal EEG, hypotonia, sleep disturbances, abnormal brain MRI, gastroesophageal reflux, and certain dysmorphic features.", {"entities": [[95, 101, "GENE"]]}], ["This study supports findings from previous research on the severity of intellectual, motor, and speech impairments seen in SHANK3 deficiency, and highlights the prominence of autism spectrum disorder in the syndrome.", {"entities": [[207, 215, "DISEASE"], [175, 199, "DISEASE"], [123, 129, "GENE"]]}], ["Limitations of existing evaluation tools are discussed, along with the need for natural history studies to inform clinical monitoring and treatment development in SHANK3 deficiency.", {"entities": [[163, 169, "GENE"]]}], ["Convincing evidence has emerged demonstrating that impairment of mitochondrial function is critically important in regulating alveolar epithelial cell (AEC) programmed cell death (apoptosis) that may contribute to aging-related lung diseases, such as idiopathic pulmonary fibrosis (IPF) and asbestosis (pulmonary fibrosis following asbestos exposure).", {"entities": [[291, 301, "DISEASE"], [262, 280, "DISEASE"], [303, 321, "DISEASE"], [251, 280, "DISEASE"]]}], ["The mammalian mitochondrial DNA (mtDNA) encodes for 13 proteins, including several essential for oxidative phosphorylation.", {"entities": []}], ["We review the evidence implicating that oxidative stress-induced mtDNA damage promotes AEC apoptosis and pulmonary fibrosis.", {"entities": [[105, 123, "DISEASE"]]}], ["We focus on the emerging role for AEC mtDNA damage repair by 8-oxoguanine DNA glycosylase (OGG1) and mitochondrial aconitase (ACO-2) in maintaining mtDNA integrity which is important in preventing AEC apoptosis and asbestos-induced pulmonary fibrosis in a murine model.", {"entities": [[232, 250, "DISEASE"], [91, 95, "GENE"]]}], ["We then review recent studies linking the sirtuin (SIRT) family members, especially SIRT3, to mitochondrial integrity and mtDNA damage repair and aging.", {"entities": [[84, 89, "GENE"]]}], ["We present a conceptual model of how SIRTs modulate reactive oxygen species (ROS)-driven mitochondrial metabolism that may be important for their tumor suppressor function.", {"entities": []}], ["The emerging insights into the pathobiology underlying AEC mtDNA damage and apoptosis is suggesting novel therapeutic targets that may prove useful for the management of age-related diseases, including pulmonary fibrosis and lung cancer.", {"entities": [[225, 236, "DISEASE"], [202, 220, "DISEASE"], [230, 236, "DISEASE"]]}], ["To quantify the extent of squamous metaplasia in bronchial biopsies and relate it to the presence of chronic obstructive pulmonary disease (COPD), a smoking-related pathology.", {"entities": [[101, 138, "DISEASE"]]}], ["Bronchial biopsies (n = 15 in each group) from smokers with COPD GOLD stage1 and GOLD stage2, smokers without COPD and healthy non-smokers were stained immunohistochemically with a panel of antibodies that facilitated the identification of pseudostratified epithelium and distinction of squamous metaplasia and squamous epithelium from tangentially cut epithelium.", {"entities": []}], ["The percentage length of each of these epithelial phenotypes was measured as a percent of total epithelial length using computerised image analysis.", {"entities": []}], ["Sections were also stained for carcinoembryonic antigen and p53, early markers of carcinogenesis, and Ki67, and the percentage epithelial expression measured.", {"entities": []}], ["The extent of squamous metaplasia was significantly increased in both COPD1 and COPD2 compared to healthy smokers and healthy non-smokers.", {"entities": []}], ["The amount of fully differentiated squamous epithelium was also increased in COPD1 and COPD2 compared to healthy non-smokers, as was the expression of carcinoembryonic antigen.", {"entities": []}], ["These features correlated with one other.", {"entities": []}], ["In subjects with COPD there is a loss of pseudostratified epithelium accompanied by an increase in squamous metaplasia with transition into a fully squamous epithelium and expression of early markers of carcinogenesis.", {"entities": []}], ["Malaria causes about half a million deaths annually, with Plasmodium falciparum being responsible for 90% of all the cases.", {"entities": [[0, 7, "DISEASE"]]}], ["Recent reports on artemisinin resistance in Southeast Asia warrant urgent discovery of novel drugs for the treatment of malaria.", {"entities": [[120, 127, "DISEASE"]]}], ["However, most bioactive compounds fail to progress to treatments due to safety concerns.", {"entities": []}], ["Drug repositioning offers an alternative strategy where drugs that have already been approved as safe for other diseases could be used to treat malaria.", {"entities": [[144, 151, "DISEASE"]]}], ["This study screened approved drugs for antimalarial activity using an in silico chemogenomics approach prior to in vitro verification.", {"entities": []}], ["All the P .", {"entities": []}], ["falciparum proteins sequences available in NCBI RefSeq were mined and used to perform a similarity search against DrugBank, TTD and STITCH databases to identify similar putative drug targets.", {"entities": []}], ["Druggability indices of the potential P .", {"entities": []}], ["falciparum drug targets were obtained from TDR targets database.", {"entities": []}], ["Functional amino acid residues of the drug targets were determined using ConSurf server which was used to fine tune the similarity search.", {"entities": []}], ["This study predicted 133 approved drugs that could target 34 P .", {"entities": []}], ["falciparum proteins.", {"entities": []}], ["A literature search done at PubMed and Google Scholar showed 105 out of the 133 drugs to have been previously tested against malaria, with most showing activity.", {"entities": [[125, 132, "DISEASE"]]}], ["For further validation, drug susceptibility assays using SYBR Green I method were done on a representative group of 10 predicted drugs, eight of which did show activity against P .", {"entities": []}], ["falciparum 3D7 clone.", {"entities": []}], ["Seven had IC 50 values ranging from 1 \u03bcM to 50 \u03bcM.", {"entities": []}], ["This study also suggests drug-target association and hence possible mechanisms of action of drugs that did show antiplasmodial activity.", {"entities": []}], ["The study results validate the use of proteome-wide target similarity approach in identifying approved drugs with activity against P .", {"entities": []}], ["falciparum and could be adapted for other pathogens.", {"entities": []}], ["Polypharmacy of respiratory medications is commonly observed in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[78, 115, "DISEASE"]]}], ["The aims of this study were to investigate determinants of polypharmacy and to study the consistency of actual respiratory drug use with current Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in pulmonary rehabilitation candidates with COPD.", {"entities": []}], ["Data were extracted from the records of all patients with a diagnosis of COPD referred for pulmonary rehabilitation to CIRO+ between 2005 and 2009.", {"entities": []}], ["Use of respiratory medications, self-reported COPD exacerbations, lung function, blood gases, exercise capacity, Medical Research Council (MRC) dyspnea grade, and St George\u2019s Respiratory Questionnaire (SGRQ) were recorded as part of assessment of health status.", {"entities": []}], ["In total, 1859 COPD patients of mean age (\u00b1 standard deviation) 64.3 \u00b1 9.7 years and with a forced expiratory volume in one second (FEV 1 ) of 44.7% \u00b1 18.2% were included.", {"entities": [[132, 135, "GENE"]]}], ["On average, patients used 3.5 \u00b1 1.5 respiratory medications; this number increased with increasing GOLD stage, MRC score, and SGRQ scores.", {"entities": []}], ["FEV 1 (% predicted), SGRQ, and number of recent exacerbations were independent determinants of polypharmacy.", {"entities": [[0, 3, "GENE"]]}], ["Use of long-acting bronchodilators and inhaled corticosteroids was substantial and comparable in all GOLD stages.", {"entities": []}], ["Use of corticosteroids was not restricted to patients with frequent exacerbations.", {"entities": []}], ["Polypharmacy of respiratory medications is common in COPD patients with persistent symptoms.", {"entities": []}], ["In addition to severity of disease, health status is an independent predictor of polypharmacy.", {"entities": []}], ["Actual drug use in COPD patients referred for pulmonary rehabilitation is partially inconsistent with current GOLD guidelines.", {"entities": []}], ["Bisphenol A (BPA) is an endocrine disrupting chemical used in a wide range of consumer products including photoactive dyes used in thermal paper.", {"entities": []}], ["Recent studies have shown that dermal absorption of BPA can occur when handling these papers.", {"entities": []}], ["Yet, regulatory agencies have largely dismissed thermal paper as a major source of BPA exposure.", {"entities": []}], ["Exposure estimates provided by agencies such as the European Food Safety Authority (EFSA) are based on assumptions about how humans interact with this material, stating that \u2018typical\u2019 exposures for adults involve only one handling per day for short periods of time (<1 minute), with limited exposure surfaces (three fingertips).", {"entities": []}], ["The objective of this study was to determine how individuals handle thermal paper in one common setting: a cafeteria providing short-order meals.", {"entities": []}], ["We observed thermal paper handling in a college-aged population (n = 698 subjects) at the University of Massachusetts\u2019 dining facility.", {"entities": []}], ["We find that in this setting, individuals handle receipts for an average of 11.5 min, that >30% of individuals hold thermal paper with more than three fingertips, and >60% allow the paper to touch their palm.", {"entities": []}], ["Only 11% of the participants we observed were consistent with the EFSA model for time of contact and dermal surface area.", {"entities": []}], ["Mathematical modeling based on handling times we measured and previously published transfer coefficients, concentrations of BPA in paper, and absorption factors indicate the most conservative estimated intake from handling thermal paper in this population is 51.1 ng/kg/day, similar to EFSA\u2019s estimates of 59 ng/kg/day from dermal exposures.", {"entities": []}], ["Less conservative estimates, using published data on concentrations in thermal paper and transfer rates to skin, indicate that exposures are likely significantly higher.", {"entities": []}], ["Based on our observational data, we propose that the current models for estimating dermal BPA exposures are not consistent with normal human behavior and should be reevaluated.", {"entities": []}], ["Individuals living with diabetes mellitus are at an increased risk of developing foot ulcers and cardiovascular complications or a neuropathy that may result in amputations.", {"entities": [[131, 141, "DISEASE"], [24, 41, "DISEASE"]]}], ["These complications have been shown to be already present in about 10% of diabetic patients at the time of diagnosis.", {"entities": []}], ["This study was carried out to determine the level of awareness and attitude to foot care among adult diabetic patients attending a university health centre (i.e.", {"entities": []}], ["a primary care centre) and to emphasise the ever-present need for health education and promotion and early complication detection (especially of foot problems) among diabetic patients.", {"entities": []}], ["A descriptive cross-sectional, clinic-based study was carried out at the University of Ibadan Health Centre (Jaja Clinic).", {"entities": []}], ["The study population consisted of consenting adult diabetic patients.", {"entities": []}], ["Data were collected by the self-administration of structured questionnaires to eligible subjects and were analysed using the SPSS v.15software.", {"entities": []}], ["Appropriate statistics were employed to analyse the collected data.", {"entities": []}], ["A total of 137 patients participated in the study and ranged in age from 37 to 75 years, with the mean \u00b1 SD age being 58.2 \u00b1 9.2 years.", {"entities": []}], ["Of the participants, 98 (71.5%) were men and 39 (28.5%) were women; all of the participants were married.", {"entities": []}], ["The duration of illness ranged from 1 year to 20 years, with the median duration of illness being 3 \u00b1 1.7 years.", {"entities": []}], ["One hundred and twenty-six (92%) patients had never received any education on foot care from their healthcare providers, while 11 (8%) had received some form of foot care education.", {"entities": []}], ["Among those who had never received any foot care education, 92 (73%) had been diabetic for 1\u20135 years, while the remaining 34 (27%) had been diabetic for 6 \u2013 20 years.", {"entities": []}], ["Of the foot care measures that were known, 35 (25.5%) patients knew to wash their feet daily and dry in between the toes thoroughly, 31 (22.6%) knew not to go outdoors barefooted, 27 (19.7%) checked their feet daily, 27 (19.7%) checked inside their shoes daily, 8 (5.8%) consciously made an effort to avoid injuries to their feet and 4 (2.9%) clipped their toenails with care.", {"entities": []}], ["The results of this study showed that awareness of foot care measures is very poor among known diabetic patients and this is largely due to a lack of education of the patients by their health care providers.", {"entities": []}], ["A long\u2010standing challenge in community\u2010based participatory research ( CBPR ) has been to anchor practice and evaluation in a relevant and comprehensive theoretical framework of community change.", {"entities": []}], ["This study describes the development of a multidimensional conceptual framework that builds on social movement theories to identify key components of CBPR processes.", {"entities": []}], ["Framework synthesis was used as a general literature search and analysis strategy.", {"entities": []}], ["An initial conceptual framework was developed from the theoretical literature on social movement.", {"entities": []}], ["A literature search performed to identify illustrative CBPR projects yielded 635 potentially relevant documents, from which eight projects (corresponding to 58 publications) were retained after record and full\u2010text screening.", {"entities": []}], ["Framework synthesis was used to code and organize data from these projects, ultimately providing a refined framework.", {"entities": []}], ["The final conceptual framework maps key concepts of CBPR mobilization processes, such as the pivotal role of the partnership; resources and opportunities as necessary components feeding the partnership's development; the importance of framing processes; and a tight alignment between the cause (partnership's goal), the collective action strategy, and the system changes targeted.", {"entities": []}], ["The revised framework provides a context\u2010specific model to generate a new, innovative understanding of CBPR mobilization processes, drawing on existing theoretical foundations.", {"entities": []}], ["Based on framework synthesis, we propose a conceptual framework to understand CBPR processes.", {"entities": []}], ["Drawing on social movement theories, this framework emphasizes: \u2013 The central and catalytic role of the partnership in the mobilization process; \u2013 Framing processes, i.e., construction of shared interpretation of the partnership's goal and action; \u2013 Resources and opportunities as necessary components feeding the partnership's development.", {"entities": []}], ["Our framework provides innovative insights for the implementation and evaluation of CBPR.", {"entities": []}], ["Based on framework synthesis, we propose a conceptual framework to understand CBPR processes.", {"entities": []}], ["Drawing on social movement theories, this framework emphasizes: \u2013 The central and catalytic role of the partnership in the mobilization process; \u2013 Framing processes, i.e., construction of shared interpretation of the partnership's goal and action; \u2013 Resources and opportunities as necessary components feeding the partnership's development.", {"entities": []}], ["The central and catalytic role of the partnership in the mobilization process; Framing processes, i.e., construction of shared interpretation of the partnership's goal and action; Resources and opportunities as necessary components feeding the partnership's development.", {"entities": []}], ["Our framework provides innovative insights for the implementation and evaluation of CBPR.", {"entities": []}], ["Although the anti-inflammatory role of the A 2a receptor is well established, controversy remains with regard to the therapeutic value for A 2a agonists in treatment of inflammatory lung diseases, also as a result of unwanted A 2a -mediated cardiovascular effects.", {"entities": []}], ["In this paper, we describe the discovery and characterization of a new, potent and selective A 2a agonist (compound 2) with prolonged lung retention and limited systemic exposure following local administration.", {"entities": []}], ["To support the lead optimization chemistry program with compound selection and profiling, multiple in vitro and in vivo assays were used, characterizing compound properties, pharmacodynamics (PD), and drug concentrations.", {"entities": []}], ["Particularly, pharmacokinetic-PD modeling was applied to quantify the effects on the cardiovascular system, and an investigative toxicology study in rats was performed to explore potential myocardial toxicities.", {"entities": []}], ["Compound 2, in comparison to a reference A 2a agonist, UK-432,097, demonstrated higher solubility, lower lipophilicity, lower plasma protein binding, high rat lung retention (28% remaining after 24\u00a0h), and was efficacious in a lung inflammatory rat model following intratracheal dosing.", {"entities": []}], ["Despite these properties, compound 2 did not provide a sufficient therapeutic index, that is, separation of local anti-inflammatory efficacy in the lung from systemic side effects in the cardiovascular system.", {"entities": []}], ["The plasma concentration that resulted in induction of hypotension (half maximal effective concentration; EC 50 0.5\u00a0nmol/L) correlated to the in vitro A 2a potency (rIC 50 0.6\u00a0nmol/L).", {"entities": []}], ["Histopathological lesions in the heart were observed at a dose level which is threefold above the efficacious dose level in the inflammatory rat lung model.", {"entities": []}], ["In conclusion, compound 2 is a highly potent and selective A 2a agonist with significant lung retention after intratracheal administration.", {"entities": []}], ["Despite its local anti-inflammatory efficacy in rat lung, small margins to the cardiovascular effects suggested limited therapeutic value of this compound for treatment of inflammatory lung disease by the inhaled route.", {"entities": [[185, 197, "DISEASE"]]}], ["Alveolar macrophages (AMs) constitute the first line of defence in the lung of all species, playing a crucial role in the regulation of immune responses to inhaled pathogens.", {"entities": []}], ["A detailed understanding of the function and phenotype of AMs is a necessary pre-requisite to both elucidating their role in preventing opportunistic bacterial colonisation of the lower respiratory tract and developing appropriate preventative strategies.", {"entities": []}], ["The purpose of the study was to characterise this important innate immune cell at the tissue level by making functional and phenotypic comparisons with peritoneal macrophages (PMs).", {"entities": []}], ["We hypothesised that the tissue of origin determines a unique phenotype of AMs, which may constitute an appropriate therapeutic target for certain equine respiratory diseases.", {"entities": []}], ["Macrophages isolated from the lung and the peritoneal cavity of 9 horses were stimulated with various toll like receptor (TLR) ligands and the production of nitrite, tumour necrosis factor alpha (TNF\u03b1), interleukin (IL) 10 and indoleamine 2,3-dioxygenase (IDO) were measured by the Griess reaction and enzyme linked immunosorbent assay (ELISA) and/or quantitative polymerase chain reaction, respectively.", {"entities": []}], ["Cells were also compared on the basis of phagocytic-capacity and the expression of several cell surface markers.", {"entities": []}], ["AMs, but not PMs, demonstrated increased TNF\u03b1 release following stimulation with LPS, polyinosinic polycytidylic acid (Poly IC) and heat-killed Salmonella typhinurium and increased TNF\u03b1 and IDO mRNA expression when stimulated with LPS.", {"entities": []}], ["AMs showed high expression of the specific macrophage markers cluster of differentiation (CD) 14, CD163 and TLR4, whereas PMs showed high expression of TLR4 only.", {"entities": [[98, 103, "GENE"], [108, 112, "GENE"], [152, 156, "GENE"], [108, 112, "GENE"], [152, 156, "GENE"]]}], ["AMs, but not PMs, demonstrated efficient phagocytic activity.", {"entities": []}], ["Our results demonstrate that AMs are more active than PMs when stimulated with various pro-inflammatory ligands, thus supporting the importance of the local microenvironment in the activation status of the macrophage.", {"entities": []}], ["This information provides a valuable knowledge base on which to improve our understanding of the role of macrophages and their microenvironment in equine innate immunity.", {"entities": []}], ["Little research has focused on whether there are individual differences among children in their sensitivity to sweet taste and, if so, the biological correlates of such differences.", {"entities": []}], ["Our goal was to understand how variations in children\u2019s sucrose detection thresholds relate to their age and gender, taste genotype, body composition, and dietary intake of added sugars.", {"entities": []}], ["Sucrose detection thresholds in 7- to 14-year-old children were tested individually using a validated, two-alternative, forced-choice, paired-comparison tracking method.", {"entities": []}], ["Five genetic variants of taste genes were assayed: TAS1R3 and GNAT3 (sweet genes; one variant each) and the bitter receptor gene TAS2R38 (three variants).", {"entities": [[51, 57, "GENE"], [62, 67, "GENE"], [129, 136, "GENE"]]}], ["All children were measured for body weight and height.", {"entities": []}], ["A subset of these children were measured for the percentage of body fat and waist circumference and provided added sugar intake by 24-hour dietary recall.", {"entities": []}], ["Sucrose thresholds ranged from 0.23 to 153.8 mM with most of the children completing the threshold task (216/235; 92%).", {"entities": []}], ["Some children were biologically related (i.e., siblings), and for the genetic analysis, one sibling from each family was studied.", {"entities": []}], ["Variants in the bitter but not the sweet genes were related to sucrose threshold and sugar intake; children with two bitter-sensitive alleles could detect sucrose at lower concentrations ( F (2,165) = 4.55, p = .01; rs1726866) and reported eating more added sugar (% kcal; F (2, 62) = 3.64, p = .03) than did children with less sensitive alleles.", {"entities": []}], ["Age, gender, and indices of obesity also were related to child-to-child differences in sucrose threshold; girls were more sensitive than boys ( t (214) = 2.0, p = .05), older children were more sensitive than younger children ( r (214) = \u2212.16, p = .02), and fatter ( r (84) = \u2212.22, p = .05) or more centrally obese children ( r (84) = \u2212.26, p = .02) were more sensitive relative to others.", {"entities": [[28, 35, "DISEASE"]]}], ["Inborn differences in bitter sensitivity may affect childhood dietary sugar intake with long-term health consequences.", {"entities": []}], ["There may be a more complex interplay between the developing bitter and sweet taste systems than previously understood.", {"entities": []}], ["Complementary and alternative medicine (CAM) is commonly used by children, but estimates of that use vary widely partly due to the range of questionnaires used to assess CAM use.", {"entities": []}], ["However, no studies have attempted to appraise measurement properties of these questionnaires.", {"entities": []}], ["The aim of this systematic review was to critically appraise and summarize measurement properties of questionnaires of CAM use in pediatrics.", {"entities": []}], ["A search strategy was implemented in major electronic databases in March 2011 and conference websites, scientific journals and experts were consulted.", {"entities": []}], ["Studies were included if they mentioned a questionnaire assessing the prevalence of CAM use in pediatrics.", {"entities": []}], ["Members of the team independently rated the methodological quality of the studies (using the COSMIN checklist) and measurement properties of the questionnaires (using the Terwee and Cohen criteria).", {"entities": []}], ["A total of 96 CAM questionnaires were found in 104 publications.", {"entities": []}], ["The COSMIN checklist showed that no studies reported adequate methodological quality.", {"entities": []}], ["The Terwee criteria showed that all included CAM questionnaires had indeterminate measurement properties.", {"entities": []}], ["According to the Cohen score, none were considered to be a well-established assessment, two approached the level of a well-established assessment, seven were promising assessments and the remainder (n\u200a=\u200a87) did not reach the score\u2019s minimum standards.", {"entities": []}], ["None of the identified CAM questionnaires have been thoroughly validated.", {"entities": []}], ["This systematic review highlights the need for proper validation of CAM questionnaires in pediatrics, which may in turn lead to improved research and knowledge translation about CAM in clinical practice.", {"entities": []}], ["Subtle changes in the intracellular reduction\u2013oxidation (redox) state can modulate nuclear factor-\u03baB (NF-\u03baB) activity.", {"entities": []}], ["Thioredoxin-1 (Trx) is a small, ubiquitous, redox-active thiol (-SH) protein that, with thioredoxin reductase-1 (TrxR), modifies the redox status of NF-\u03baB pathway components.", {"entities": []}], ["PMX464 is a novel thiol-reactive quinol thought to inhibit the Trx/TrxR system.", {"entities": []}], ["The aim of this work was to investigate whether PMX464 inhibited NF-\u03baB-mediated proinflammatory activation of human type II alveolar epithelial cells (A549).", {"entities": []}], ["Intercellular adhesion molecule-1 (ICAM-1), granulocyte-macrophage colony-stimulating factor (GM-CSF) and CXCL8, NF-\u03baB DNA binding, nuclear translocation of NF-\u03baB p65 subunit, I\u03baB\u03b1 degradation, I\u03baB phosphorylation and I\u03baB kinase (IKK) activity were assessed in A549 cells stimulated with IL-1\u03b2 with or without PMX464 pretreatment.", {"entities": []}], ["Effects of PMX464 on ICAM-1 expression in human lung microvascular endothelial cells (HLMVEC) were also investigated.", {"entities": []}], ["For comparison, selected measurements (ICAM-1 and I\u03baB-\u03b1 phospho-I\u03baB-\u03b1) were made on A549 cells after RNA interference-mediated silencing (siRNA) of Trx.", {"entities": []}], ["PMX464 reduced ICAM-1, GM-CSF and CXCL8 expression in IL-1\u03b2-stimulated A549 cells and ICAM-1 in HLMVEC.", {"entities": []}], ["PMX464 inhibited IL-1\u03b2-induced NF-\u03baB DNA binding, nuclear translocation of NF-\u03baB p65 subunit and factors involved in NF-\u03baB activation; specifically, I\u03baB\u03b1 degradation, I\u03baB phosphorylation and I\u03baB kinase (IKK) activity in A549.", {"entities": []}], ["By contrast, Trx siRNA did not alter ICAM-1 expression or I\u03baB\u03b1 degradation/phosphorylation in IL-1\u03b2-stimulated A549 cells.", {"entities": []}], ["PMX464 inhibits a proinflammatory response in A549 cells targeting the NF\u03baB pathway above IKK.", {"entities": []}], ["The lack of effect with Trx siRNA suggests that PMX464 acts on thiol proteins, in addition to Trx, to elicit anti-inflammatory responses in lung epithelial cells.", {"entities": []}], ["An ethnopharmacological survey was carried out to collect information on the use of seven medicinal plants in rural areas in the nearby regions of Bamako, Mali.", {"entities": []}], ["The plants were Opilia celtidifolia , Anthocleista djalonensis , Erythrina senegalensis , Heliotropium indicum , Trichilia emetica , Piliostigma thonningii and Cochlospermum tinctorium About 50 medical indications were reported for the use of these plants in traditional medicine.", {"entities": []}], ["The most frequent ailments reported were malaria, abdominal pain and dermatitis.", {"entities": [[41, 48, "DISEASE"], [69, 79, "DISEASE"]]}], ["The highest number of usages was reported for the treatment of malaria (22%).", {"entities": [[63, 70, "DISEASE"]]}], ["The majority of the remedies were prepared from freshly collected plant material from the wild and from a single species only.", {"entities": []}], ["They were mainly taken orally, but some applications were prepared with a mixture of plants or ingredients such as honey, sugar, salt, ginger and pepper.", {"entities": []}], ["Decoction of the leaves was the main form of preparation (65%) and leaf powder was mostly used for the preparation of infusions (13%).", {"entities": []}], ["The part of the plants most frequently used was the leaves.", {"entities": []}], ["There was a high degree of informant consensus for the species and their medicinal indications between the healers interviewed.", {"entities": []}], ["The results of this study showed that people are still dependent on medicinal plants in these rural areas of Mali.", {"entities": []}], ["The aim of this review was to evaluate and summarize the available scientific information on penehyclidine hydrochloride (PHC) for the treatment of chronic obstructive pulmonary disease (COPD) as a result of its ability to attenuate Toll-like receptors.", {"entities": [[148, 185, "DISEASE"]]}], ["Penehyclidine hydrochloride is an anticholinergic drug manufactured in China, with both antimuscarinic and antinicotinic activity.", {"entities": []}], ["PHC is used widely in the clinic as a reversal agent in cases of organic phosphorus poisoning and soman poisoning, but also may also have an important role as a bronchodilator in the treatment of obstructive airway disease, including asthma and, in particular, COPD.", {"entities": [[234, 240, "DISEASE"]]}], ["Our bibliographic sources included the CAPLUS, MEDLINE, REGISTRY, CASREACT, CHEMLIST, CHEMCATS, and CNKI databases, updated to September 2012.", {"entities": []}], ["In order to assess the data in detail, we used the search terms \u201cpenehyclidine hydrochloride,\u201d \u201cCOPD,\u201d \u201cmuscarinic receptor,\u201d and \u201ctoll-like receptors.\u201d Papers were restricted to those published in the English and Chinese languages, and to \u201cpaper\u201d and \u201creview\u201d as the document type.", {"entities": []}], ["Patents were also reviewed.", {"entities": []}], ["Our survey mainly yielded the results of research on PHC and the mechanisms of COPD.", {"entities": []}], ["COPD is a preventable and treatable disease with some significant extrapulmonary manifestations that may contribute to its severity in some patients.", {"entities": []}], ["Recently, it has been shown that muscarinic receptors may interact with Toll-like receptors.", {"entities": []}], ["Basic and clinical studies of the relationship between the mechanism of action and the effects of PHC in the respiratory tract have been studied by a number of laboratories and institutions.", {"entities": []}], ["The main advantages of PHC are that it has few M 2 receptor-associated cardiovascular side effects and attenuates Toll-like receptors.", {"entities": []}], ["PHC may be a promising candidate agent in the treatment of COPD in the future because of its ability to attenuate Toll-like receptors.", {"entities": []}], ["This review should be of help to those intending to research this topic further.", {"entities": []}], ["Platinum-based chemotherapy toxicity is always one of the serious problems from which lung cancer patients suffer.", {"entities": [[86, 97, "DISEASE"], [91, 97, "DISEASE"]]}], ["The genetic polymorphism of WISP1 was revealed to be associated with susceptibility and platinum-based chemotherapy response in our previous studies.", {"entities": [[28, 33, "GENE"]]}], ["In this study, we aimed to investigate the relationship of WISP1 genetic polymorphisms with platinum-based chemotherapy toxicity in lung cancer patients.", {"entities": [[132, 143, "DISEASE"], [137, 143, "DISEASE"], [59, 64, "GENE"]]}], ["A total of 412 lung cancer patients were enrolled in this study, and 28 polymorphisms of the WISP1 gene were genotyped by SequenomMassARRAY.", {"entities": [[15, 26, "DISEASE"], [20, 26, "DISEASE"], [93, 98, "GENE"]]}], ["We found that WISP1 polymorphisms (rs2929965, rs2929969, rs2929970, rs2929973 and rs754958) were related to the overall chemotherapy toxicity of lung cancer in subgroup analyses.", {"entities": [[145, 156, "DISEASE"], [150, 156, "DISEASE"], [14, 19, "GENE"]]}], ["Rs16904853, rs2929970, rs2977549 and rs2977551 ( p = 0.021, 0.028, 0.024, 0.048, respectively) polymorphisms were significantly associated with hematologic toxicity.", {"entities": []}], ["Rs2929946, rs2929970, rs2977519, rs2977536, rs3739262 and rs754958 ( p = 0.031, 0.046, 0.029, 0.016, 0.042, 0.035, respectively) polymorphisms were significantly associated with the gastrointestinal toxicity of lung cancer.", {"entities": [[211, 222, "DISEASE"], [216, 222, "DISEASE"]]}], ["Genotypes of WISP1 may be novel and useful biomarkers for predicting platinum-based chemotherapy toxicity in lung cancer patients.", {"entities": [[109, 120, "DISEASE"], [114, 120, "DISEASE"], [13, 18, "GENE"]]}], ["The International Agency for Research on Cancer (IARC) and Japan Society for Occupational Health (JSOH) classified wood dust as a human carcinogen.", {"entities": []}], ["Former studies have suggested that sanding with a portable sander is one of the processes that are liable to cause highest exposure to wood dust.", {"entities": []}], ["However, the wood dust by sanding operation has not been investigated sufficiently.", {"entities": []}], ["In this study, the generation rate and the particle size distribution of the wood dust produced by handheld sanding operation were observed by laboratory experiments.", {"entities": []}], ["Beech and cypress were taken as typical hard and soft wood specimen respectively, and sanded with a portable sander.", {"entities": []}], ["Three grades of sand paper (coarse, medium, fine) were attached to the sander in turn to be tested.", {"entities": []}], ["The quantity of the wood dust produced by the sander was measured by weighing the specimen before and after the sanding and then the generation rate of the dust was calculated.", {"entities": []}], ["Soft wood generated more dust than hard wood due to the difference in abrasion durability.", {"entities": []}], ["A coarse sand paper produced more dust than a fine sand paper.", {"entities": []}], ["The particles of less than 1 \u03bcm diameter were scarcely observed in the wood dust.", {"entities": []}], ["When the specimens were sanded with a fine sand paper, the mass median aerodynamic diameters of beech dust and cypress dust were 9.0 \u03bcm and 9.8 \u03bcm, respectively.", {"entities": []}], ["Respirable wood dust is able to be controlled by general ventilation with more than 0.7-4.2 m", {"entities": []}], ["There are few studies in Brazil that address baseline prevalence of MRSA colonization and associated risk factors at hospital admission, or the incidence of nosocomial colonization.", {"entities": []}], ["We report a prospective study in a tertiary-care, university-affiliated hospital to implement a new MRSA control policy at the institution.", {"entities": []}], ["A cohort of randomly selected patients admitted to emergency and clinical wards at our hospital was followed until discharge.", {"entities": []}], ["Nasal swabs were taken for identification of MRSA-colonized patients and detection of SCC mecA in positive cultures, at admission and weekly thereafter.", {"entities": []}], ["Multivariate analysis using a log-binomial analysis was used to identify risk factors for colonization.", {"entities": []}], ["After screening 297 adult patients and 176 pediatric patients, the prevalence of MRSA at admission was 6.1% (95%CI, 3.6% to 9.4%), in the adult population and 2.3% (95%CI, 0.6% to 5.7%), for children.", {"entities": []}], ["From multivariate analysis, the risk factors associated with colonization in adults were: age above 60 years ( P = 0.019) and hospitalization in the previous year ( P = 0.022).", {"entities": []}], ["Incidence analysis was performed in 276 MRSA-negative patients (175 adults and 101 children).", {"entities": []}], ["Acquisition rate was 5.5/1,000 patient-days for adults (95%CI, 3.4 to 8.5/1,000 patients-days), and 1.1/1,000 patient-days for children (95%CI, 0.1 to 4.0/1,000 patients-days).", {"entities": []}], ["The identification of MRSA carriers is a step towards establishing a control policy for MRSA, and helps to identify measures needed to reduce colonization pressure and to decrease the high acquisition rate in hospitalized patients.", {"entities": []}], ["The New York City (NYC) subway is the main mode of transport for over 5 million passengers on an average weekday.", {"entities": []}], ["Therefore, airborne pollutants in the subway stations could have a significant impact on commuters and subway workers.", {"entities": []}], ["This study looked at black carbon (BC) and particulate matter (PM 2.5 ) concentrations in selected subway stations in Manhattan.", {"entities": []}], ["BC and PM 2.5 levels were measured in real time using a Micro-Aethalometer and a PDR-1500 DataRAM, respectively.", {"entities": []}], ["Simultaneous samples were also collected on quartz filters for organic and elemental carbon (OC/EC) analysis and on Teflon filters for gravimetric and trace element analysis.", {"entities": []}], ["In the underground subway stations, mean real time BC concentrations ranged from 5 to 23 \u03bcg/m 2.5 levels ranged from 35 to 200 \u03bcg/m 2.5 concentrations were below 3 and 10 \u03bcg/m", {"entities": []}], ["Genome-wide association studies (GWAS) have provided a large set of genetic loci influencing the risk for many common diseases.", {"entities": []}], ["Association studies typically analyze one specific trait in single populations in an isolated fashion without taking into account the potential phenotypic and genetic correlation between traits.", {"entities": []}], ["However, GWA data can be efficiently used to identify overlapping loci with analogous or contrasting effects on different diseases.", {"entities": []}], ["Here, we describe a new approach to systematically prioritize and interpret available GWA data.", {"entities": []}], ["We focus on the analysis of joint and disjoint genetic determinants across diseases.", {"entities": []}], ["Using network analysis, we show that variant-based approaches are superior to locus-based analyses.", {"entities": []}], ["In addition, we provide a prioritization of disease loci based on network properties and discuss the roles of hub loci across several diseases.", {"entities": []}], ["We demonstrate that, in general, agonistic associations appear to reflect current disease classifications, and present the potential use of effect sizes in refining and revising these agonistic signals.", {"entities": []}], ["We further identify potential branching points in disease etiologies based on antagonistic variants and describe plausible small-scale models of the underlying molecular switches.", {"entities": []}], ["The observation that a surprisingly high fraction (>15%) of the SNPs considered in our study are associated both agonistically and antagonistically with related as well as unrelated disorders indicates that the molecular mechanisms influencing causes and progress of human diseases are in part interrelated.", {"entities": []}], ["Genetic overlaps between two diseases also suggest the importance of the affected entities in the specific pathogenic pathways and should be investigated further.", {"entities": []}], ["We hypothesized that CIH may affect the upper airway immune system and aimed to verify whether CIH can induce airway inflammation in a murine obstructive sleep apnea (OSA) model.", {"entities": []}], ["C57BL6 male mice were exposed to intermittent hypoxia (CIH group; 5\u2009~\u200921% FiO 2 , 120\u2009sec cycles, 12\u2009h/d, n = 6) or room air (Sham group, n = 6) for up to 4 weeks in identical chambers.", {"entities": []}], ["Nasal and lung tissues and lavage fluid were collected and analyzed by multiplex assay.", {"entities": []}], ["Lung lavage fluid was also utilized for FACS analysis to determine eosinophil count.", {"entities": []}], ["We determined the protein level of 24 different cytokines, chemokines, and inflammatory mediators.", {"entities": []}], ["Among various cytokines, levels of IL-1 \u03b1 , IL-1 \u03b2 , IL-4, IL-6, and IL-13 were significantly elevated in nose or lung tissue from the CIH group.", {"entities": []}], ["In addition, MCP-1 and periostin were elevated in nose and lung tissue and lavage fluid from the CIH group.", {"entities": []}], ["CIH for 4 weeks altered the levels of inflammatory mediators in both the nose and lungs of mouse model.", {"entities": []}], ["We suggest that the airway immune system may be deteriorated by CIH and allergic inflammation in the upper or lower airway could be worsened by sleep apnea.", {"entities": []}], ["Tissue remodeling is believed to cause recalcitrant chronic rhinosinusitis (CRS).", {"entities": []}], ["Epithelial-mesenchymal transition (EMT) is a novel clinical therapeutic target in many chronic airway diseases related with tissue remodeling.", {"entities": []}], ["The aim of this study was to investigate the effect of trichostatin A (TSA) on transforming growth factor (TGF)-\u03b21-induced EMT in airway epithelium and nasal tissue.", {"entities": []}], ["A549 cells, primary nasal epithelial cells (PNECs), or inferior nasal turbinate organ culture were exposed to TSA prior to stimulation with TGF-\u03b21.", {"entities": []}], ["Expression levels of E-cadherin, vimentin, fibronectin, \u03b1-smooth muscle actin (SMA), histone deacetylase 2 (HDAC2), and HDAC4 were determined by western blotting and/or immunofluorescent staining.", {"entities": [[108, 113, "GENE"], [120, 125, "GENE"]]}], ["Hyperacetylation of histone H2 and H4 by TSA was measured by western blotting.", {"entities": []}], ["After siHDAC transfection, the effects of HDAC2 and HDAC4 silencing on expression of E-cadherin, vimentin, fibronectin, \u03b1-SMA, HDAC2, and HDAC4 in TGF-\u03b21-induced A549 were determined by RT-PCR and/or western blotting.", {"entities": [[42, 47, "GENE"], [127, 132, "GENE"], [52, 57, "GENE"], [138, 143, "GENE"], [42, 47, "GENE"], [127, 132, "GENE"], [52, 57, "GENE"], [138, 143, "GENE"]]}], ["We assessed the change in migration capacity of A549 cells by using cell migration assay and transwell invasion assay.", {"entities": []}], ["TGF-\u03b21 altered mRNA and protein expression levels of EMT markers including E-cadherin, vimentin, fibronectin, \u03b1-SMA, slug, and snail in A549 cells.", {"entities": []}], ["Inhibition and silencing of HDAC2 and HDAC4 by TSA and siRNA enhanced TGF-\u03b21-induced EMT in A549 cells.", {"entities": [[28, 33, "GENE"], [38, 43, "GENE"]]}], ["TSA blocked the effect of TGF-\u03b21 on the migratory ability of A549 cells.", {"entities": []}], ["In experiments using PNECs and inferior turbinate organ cultures, TSA suppressed expression of EMT markers induced by TGF-\u03b21.", {"entities": []}], ["We showed that EMT is induced by TGF-\u03b21 in airway epithelial cells and nasal tissue via activation of HDAC2 and HDAC4, and that inhibition of HDAC2 and HDAC4 by TSA reduces TGF-\u03b21-induced EMT.", {"entities": [[102, 107, "GENE"], [142, 147, "GENE"], [112, 117, "GENE"], [152, 157, "GENE"], [102, 107, "GENE"], [142, 147, "GENE"], [112, 117, "GENE"], [152, 157, "GENE"]]}], ["This observation indicates that histone deacetylase inhibitors such as TSA could be potential candidates for treatment of recalcitrant CRS related with tissue remodeling.", {"entities": []}], ["Virtually all agricultural communities worldwide are exposed to agricultural pesticides.", {"entities": []}], ["Yet, the health consequences of such exposure are poorly understood, and the scientific literature remains ambiguous.", {"entities": []}], ["Using individual birth and demographic characteristics for over 500\u2009000 birth observations between 1997\u20132011 in the agriculturally dominated San Joaquin Valley, California, we statistically investigate if residential agricultural pesticide exposure during gestation, by trimester, and by toxicity influences birth weight, gestational length, or birth abnormalities.", {"entities": []}], ["Overall, our analysis indicates that agricultural pesticide exposure increases adverse birth outcomes by 5\u20139%, but only among the population exposed to very high quantities of pesticides (e.g., top 5th percentile, i.e., ~4200\u2009kg applied over gestation).", {"entities": []}], ["Thus, policies and interventions targeting the extreme right tail of the pesticide distribution near human habitation could largely eliminate the adverse birth outcomes associated with agricultural pesticide exposure documented in this study.", {"entities": []}], ["The health consequences of exposure to pesticides are uncertain and subject to much debate.", {"entities": []}], ["Here, the effect of exposure during pregnancy is investigated in an agriculturally dominated residential area, showing that an increase in adverse birth outcomes is observed with very high levels of pesticide exposure.", {"entities": []}], ["To identify factors that hinder discussions regarding chronic obstructive pulmonary disease (COPD) between primary care physicians (PCPs) and their patients in Sweden.", {"entities": [[54, 91, "DISEASE"]]}], ["Primary health care centres (PHCCs) in Stockholm, Sweden.", {"entities": []}], ["A total of 59 PCPs.", {"entities": []}], ["Semi-structured individual and focus-group interviews between 2012 and 2014.", {"entities": []}], ["Data were analysed inspired by grounded theory methods (GTM).", {"entities": []}], ["Time-pressured patient\u2013doctor consultations lead to deprioritization of COPD.", {"entities": []}], ["During unscheduled visits, deprioritization resulted from focusing only on acute health concerns, while during routine care visits, COPD was deprioritized in multi-morbid patients.", {"entities": []}], ["The reasons PCPs gave for deprioritizing COPD are: \u201cNot becoming aware of COPD\u201d, \u201cNot becoming concerned due to clinical features\u201d, \u201cInsufficient local routines for COPD care\u201d, \u201cNegative personal attitudes and views about COPD\u201d, \u201cManaging diagnoses one at a time\u201d, and \u201cPerceiving a patient\u2019s motivation as low\u2019\u2019.", {"entities": []}], ["De-prioritization of COPD was discovered during PCP consultations and several factors were identified associated with time constraints and multi-morbidity.", {"entities": []}], ["A holistic consultation approach is suggested, plus extended consultation time for multi-morbid patients, and better documentation and local routines.", {"entities": []}], ["Key points Under-diagnosis and insufficient management of chronic obstructive pulmonary disease (COPD) are common in primary health care.", {"entities": [[58, 95, "DISEASE"]]}], ["A patient\u2013doctor consultation offers a key opportunity to identify and provide COPD care.", {"entities": []}], ["Time pressure, due to either high number of patients or multi-morbidity, leads to omission or deprioritization of COPD during consultation.", {"entities": []}], ["Deprioritization occurs due to lack of awareness, concern, and local routines, negative personal views, non-holistic consultation approach, and low patient motivation.", {"entities": []}], ["Better local routines, extended consultation time, and a holistic approach are needed when managing multi-morbid patients with COPD.", {"entities": []}], ["Under-diagnosis and insufficient management of chronic obstructive pulmonary disease (COPD) are common in primary health care.", {"entities": [[47, 84, "DISEASE"]]}], ["A patient\u2013doctor consultation offers a key opportunity to identify and provide COPD care.", {"entities": []}], ["Time pressure, due to either high number of patients or multi-morbidity, leads to omission or deprioritization of COPD during consultation.", {"entities": []}], ["Deprioritization occurs due to lack of awareness, concern, and local routines, negative personal views, non-holistic consultation approach, and low patient motivation.", {"entities": []}], ["Better local routines, extended consultation time, and a holistic approach are needed when managing multi-morbid patients with COPD.", {"entities": []}], ["Time pressure, due to either high number of patients or multi-morbidity, leads to omission or deprioritization of COPD during consultation.", {"entities": []}], ["Deprioritization occurs due to lack of awareness, concern, and local routines, negative personal views, non-holistic consultation approach, and low patient motivation.", {"entities": []}], ["Better local routines, extended consultation time, and a holistic approach are needed when managing multi-morbid patients with COPD.", {"entities": []}], ["To compare frequencies of complications among HIV-infected and-uninfected women undergoing common gynecological surgical procedures in inpatient settings.", {"entities": []}], ["We used 1994\u20132007 data from the Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project, a nationally representative sample of inpatient hospitalizations.", {"entities": []}], ["Our analysis included discharge records of women aged \u226515 undergoing hysterectomy, oophorectomy, salpingectomy for ectopic pregnancy, bilateral tubal sterilization, or dilation and curettage.", {"entities": []}], ["Associations between HIV infection status and surgical complications were evaluated in multivariable logistic regression models, adjusting for key covariates.", {"entities": []}], ["For each surgery, HIV infection was associated with experiencing \u22651 complication.", {"entities": []}], ["Adjusted ORs ranged from 2.0 (95% confidence interval (CI): 1.7, 2.2) for hysterectomy with oophorectomy to 3.1 (95% CI: 2.4, 4.0) for bilateral tubal sterilization with no comorbidity present.", {"entities": []}], ["HIV infection was positively associated with extended length of stay and infectious complications of all of the surgeries examined.", {"entities": []}], ["For some surgeries, it was positively associated with transfusion and anemia due to acute blood loss.", {"entities": [[70, 76, "DISEASE"]]}], ["Among HIV-infected women, the odds of infectious and other complications did not decrease between 1994\u20132000 and 2001\u20132007.", {"entities": []}], ["Conclusion.", {"entities": []}], ["HIV infection was associated with elevated frequencies of complications of gynecologic surgeries in the US, even in the era of HAART.", {"entities": []}], ["In real life, outcomes in wet age related macular degeneration (W-AMD) continue to fall behind the results from randomized controlled trials.", {"entities": [[30, 62, "DISEASE"], [42, 62, "DISEASE"]]}], ["The aim of this trial was to assess if outcomes can be improved by an intervention in healthcare organization following recommendations of the Chronic Care Model (CCM).", {"entities": []}], ["Multi-centered randomized controlled clinical trial.", {"entities": []}], ["The multifaceted intervention consisted in reorganization of care (delivery by trained chronic care coaches, using reminder systems, performing structured follow-up, empowering patients in self-monitoring and giving decision-support).", {"entities": []}], ["In the control usual care was continued.", {"entities": []}], ["Main outcome measures were changes in ETDRS visual acuity, optical coherence tomography (OCT) macular retinal thickness and quality of life (NEI VFQ-25 questionnaire).", {"entities": []}], ["169 consecutive patients in Swiss ophthalmology centers were included.", {"entities": []}], ["Mean ETDRS baseline visual acuity of eyes with W-AMD was 57.8 (\u00b1 18.7).", {"entities": []}], ["After 12 months, the between-group difference in mean change of ETDRS visual acuity was -4.8 (95%CI: -10.8 to +1.2, p = 0.15); difference in mean change of OCT was +14.0 (95% CI -39.6 to 67.6, p = 0.60); difference in mean change of NEI VFQ-25 composite score mean change was +2.1(95%CI: -1.3 to +5.5, p = 0.19).", {"entities": []}], ["The intervention aiming at improving chronic care was not associated with favorable outcomes within 12 months.", {"entities": []}], ["Other approaches need to be tested to close the evidence-performance gap in W-AMD.", {"entities": []}], ["Controlled-Trials.com ISRCTN32507927", {"entities": []}], ["Myeloid and plasmacytoid dendritic cells (mDCs, pDC) are crucial to the immune system, detecting microorganisms and linking the innate and adaptive immunity.", {"entities": [[48, 51, "GENE"]]}], ["pDC are present in small quantities in tissues that are in contact with the external environment; mainly the skin, the inner lining of the nose, lungs, stomach and intestines.", {"entities": [[0, 3, "GENE"]]}], ["They produce large amounts of IFN-\u03b1 after stimulation and are pivotal for the induction of antiviral responses.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) patients are known to be more susceptible to viral infections.", {"entities": []}], ["We have demonstrated that exposure of mDC to cigarette smoke extract (CSE) leads to the release of chemokines, however, not much is known about the role of pDC in COPD.", {"entities": [[156, 159, "GENE"]]}], ["In this study, we addressed several key questions with respect to the mechanism of action of CSE on human pDC in an in vitro model.", {"entities": [[106, 109, "GENE"]]}], ["Human pDCs were isolated from normal healthy volunteers and subjected to fresh CSE and the levels of IL-8, TNF-\u03b1, IP-10, IL-6, IL-1, IL-12 and IL-10 and IFN-\u03b1 were studied by both ELISA and real time PCR methods.", {"entities": []}], ["We observed that CSE augmented the production of IL-8 and suppressed the release of TNF-\u03b1, IL-6 and IFN-\u03b1.", {"entities": []}], ["Moreover, CSE suppressed PI3K/Akt signalling in pDC.", {"entities": [[48, 51, "GENE"]]}], ["In conclusion, our data indicate that CSE has both the potential to diminish anti-viral immunity by downregulating the release of IFN-\u03b1 and other pro-inflammatory cytokines while, at the same time, augmenting the pathogenesis of COPD via an IL-8 induced recruitment of neutrophils.", {"entities": []}], ["Iodine is an effective, simple, and cost-efficient means of water disinfection for people who vacation, travel, or work in areas where municipal water treatment is not reliable.", {"entities": []}], ["However, there is considerable controversy about the maximum safe iodine dose and duration of use when iodine is ingested in excess of the recommended daily dietary amount.", {"entities": []}], ["The major health effect of concern with excess iodine ingestion is thyroid disorders, primarily hypothyroidism with or without iodine-induced goiter.", {"entities": [[142, 148, "DISEASE"], [96, 110, "DISEASE"]]}], ["A review of the human trials on the safety of iodine ingestion indicates that neither the maximum recommended dietary dose (2 mg/day) nor the maximum recommended duration of use (3 weeks) has a firm basis.", {"entities": []}], ["Rather than a clear threshold response level or a linear and temporal dose-response relationship between iodine intake and thyroid function, there appears to be marked individual sensitivity, often resulting from unmasking of underlying thyroid disease.", {"entities": []}], ["The use of iodine for water disinfection requires a risk-benefit decision based on iodine's benefit as a disinfectant and the changes it induces in thyroid physiology.", {"entities": []}], ["By using appropriate disinfection techniques and monitoring thyroid function, most people can use iodine for water treatment over a prolonged period of time.", {"entities": []}], ["B7-H3 is a new member of the B7 ligand family and regulates T-cell responses in various conditions.", {"entities": []}], ["However, the role of B7-H3 in tumour immunity is largely unknown.", {"entities": []}], ["The purpose of this study was to evaluate the clinical significance of B7-H3 expression in human pancreatic cancer and the therapeutic potential for cancer immunotherapy.", {"entities": [[97, 114, "DISEASE"], [108, 114, "DISEASE"], [149, 155, "DISEASE"]]}], ["We investigated B7-H3 expression in 59 patients with pancreatic cancer by immunohistochemistry and real-time PCR.", {"entities": [[53, 70, "DISEASE"], [64, 70, "DISEASE"]]}], ["Furthermore, we examined the anti-tumour effect of B7-H3-blocking monoclonal antibody in vivo in a murine pancreatic cancer model.", {"entities": [[106, 123, "DISEASE"], [117, 123, "DISEASE"]]}], ["Tumour-related B7-H3 expression was abundant in most human pancreatic cancer tissues and was significantly higher compared with that in non-cancer tissue or normal pancreas.", {"entities": [[59, 76, "DISEASE"], [70, 76, "DISEASE"], [140, 146, "DISEASE"]]}], ["Moreover, its expression was significantly more intense in cases with lymph node metastasis and advanced pathological stage.", {"entities": []}], ["B7-H3 blockade promoted CD8 Our data show for the first time that B7-H3 may have a critical role in pancreatic cancer and provide the rationale for developing a novel cancer immunotherapy against this fatal disease.", {"entities": [[100, 117, "DISEASE"], [111, 117, "DISEASE"], [167, 173, "DISEASE"]]}], ["Despite wide recognition that children with disability often have poor oral health, few high quality, controlled results are available.", {"entities": []}], ["Twenty-four objective and subjective criteria covering feeding, autonomy, access to dental care, oral hygiene, oral disease, general health and behavior were evaluated in a observational cross-sectional study of 2,487 children with disability (DC group), 4,772 adolescents with disability (DA group) and 1,641 children without disability (NDC group).", {"entities": []}], ["Five algorithms ranked the subjects according to clinical criteria in three original oral health indices: the Clinical Oral Health Index (COHI), indicating the level of oral health problems, the Clinical Oral Care Needs Index (COCNI) giving dental care need levels, and the Clinical Oral Prevention Index (COPI) determining possible needs in terms of dental education initiatives.", {"entities": []}], ["DC-group children presented poorer oral health and had greater needs in both treatment and preventive oral health actions than NDC-group children (OR\u200a=\u200a3.97, 95% CI\u200a=\u200a3.25\u20134.86 for COHI; OR\u200a=\u200a2.01, 95% CI\u200a=\u200a1.77\u20132.28 for COCNI; OR\u200a=\u200a5.25, 95% CI\u200a=\u200a4.55\u20136.02 for COPI).", {"entities": []}], ["These conditions were worse again in the DA group comparing to the DC group (OR\u200a=\u200a3.52, 95% CI\u200a=\u200a2.7\u20134.6 for COHI; OR\u200a=\u200a1.52, 95% CI\u200a=\u200a1.38\u20131.69 for COCNI; OR\u200a=\u200a1.53, 95% CI\u200a=\u200a1.39\u20131.69 for COPI).", {"entities": []}], ["Clinical indices generated by algorithmic association of various clinical indicators allow sensitive clinical measurement, and in this study demonstrated inequalities in oral health for children with disabilities schooling in institutions.", {"entities": []}], ["Questions need now to be addressed as to the measures that could be taken to compensate for this situation.", {"entities": []}], ["The use of pacifiers is commonplace in Australia and has been shown to be negatively associated with breastfeeding duration.", {"entities": []}], ["In order to influence behaviour related to the use of pacifiers it is important to understand the reasons for their use.", {"entities": []}], ["The primary aim of this observational study was to investigate who (if anyone) advises first-time mothers to give a pacifier and the reasons for which they first give (or try to give) a pacifier to their infant.", {"entities": []}], ["Additionally, this study investigated the predictors of pacifier use and the relationship between pacifier use and breastfeeding duration.", {"entities": []}], ["In total, 670 Australian first-time mothers recruited as part of the NOURISH trial completed a questionnaire regarding infant feeding and pacifier use.", {"entities": []}], ["Pacifiers were introduced by 79% of mothers, of whom 28.7% were advised to use a pacifier by their mother/mother-in-law with a further 22.7% being advised by a midwife.", {"entities": []}], ["The majority of mothers used a pacifier in order to soothe their infant (78.3%), to help put them to sleep (57.4%) and to keep them comforted and quiet (40.4%).", {"entities": []}], ["Pacifiers given to infants before four weeks (adjHR 3.67; 95%CI 2.14-6.28) and used most days (adjHR 3.28; 95%CI 1.92-5.61) were significantly associated with shorter duration of breastfeeding.", {"entities": []}], ["This study identifies an opportunity for educating new mothers and their support network, particularly their infant's grandmothers, with regards to potential risks associated with the early and frequent use of a pacifier, and alternative methods for soothing their infant, in order to reduce the use of pacifiers and their potentially negative effect on breastfeeding duration.", {"entities": []}], ["Background .", {"entities": []}], ["Chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C) are common functional lower gastrointestinal disorders that impair patients' quality of life.", {"entities": [[67, 91, "DISEASE"], [19, 31, "DISEASE"], [42, 54, "DISEASE"], [83, 91, "DISEASE"], [33, 36, "GENE"]]}], ["In a national survey, we aimed to evaluate (1) Canadian physician practice patterns in the utilization of therapeutic agents listed in the new ACG and AGA guidelines; (2) physicians satisfaction with these agents for their CIC and IBS-C patients; and (3) the usefulness of these new guidelines in their clinical practice.", {"entities": [[223, 226, "GENE"]]}], ["A 9-item questionnaire was sent to 350 Canadian specialists to evaluate their clinical practice for the management of CIC and IBS-C.", {"entities": [[118, 121, "GENE"]]}], ["The response rate to the survey was 16% ( n = 55).", {"entities": []}], ["Almost all (96%) respondents followed a standard, stepwise approach for management while they believed that only 24% of referring physicians followed the same approach.", {"entities": []}], ["Respondents found guanylyl cyclase C (GCC) agonist most satisfying when treating their patients.", {"entities": []}], ["Among the 69% of respondents who were aware of published guidelines, only 50% found them helpful in prioritizing treatment choices and 69% of respondents indicated that a treatment algorithm, applicable to Canadian practice, would be valuable.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Based on this needs assessment, a treatment algorithm was developed to provide clinical guidance in the management of IBS-C and CIC in Canada.", {"entities": [[128, 131, "GENE"]]}], ["The health system of a country needs to be adjusted to patterns of morbidity and mortality to mitigate the income-erosion consequences of prolonged ill-health and premature death of adults.", {"entities": []}], ["Population-based data on mortality by cause are a key to modifying the health system.", {"entities": []}], ["However, these data are scarce, particularly for rural populations in developing countries.", {"entities": []}], ["The objectives of this study were to determine the burdens of health due to major causes of death obtained from verbal autopsy of adults and the elderly and their healthcare-seeking patterns before death in a well-defined rural population.", {"entities": []}], ["There were 2,397 deaths\u2014613 were among adults aged 15-59 years and 1,784 among the elderly aged 60", {"entities": []}], ["Elevated mitogen-activated protein kinase p38 (p38 MAPK) signaling has been implicated in various experimental and human glomerulopathies, and its inhibition has proven beneficial in animal models of these diseases.", {"entities": []}], ["p38 MAPK signaling is partially mediated through MK2 and MK3, two phylogenetically related protein kinases that are its direct substrates.", {"entities": []}], ["The current study was designed to determine the specific roles of MK2 and MK3 in a mouse model of acute proliferative glomerulonephritis, using mice with disrupted MK2 and/or MK3 genes.", {"entities": [[118, 136, "DISEASE"], [98, 136, "DISEASE"], [104, 136, "DISEASE"]]}], ["We found that the absence of MK3 alone worsened the disease course and increased mortality slightly compared to wild-type mice, whereas the absence of MK2 alone exhibited no significant effect.", {"entities": []}], ["However, in an MK3-free background, the disease course depended on the presence of MK2 in a gene dosage-dependent manner, with double knock-out mice being most susceptible to disease induction.", {"entities": []}], ["Histological and renal functional analyses confirmed kidney damage following disease induction.", {"entities": []}], ["Because the renal stress response plays a crucial role in kidney physiology and disease, we analyzed the stress response pattern in this disease model.", {"entities": []}], ["We found that renal cortices of diseased mice exhibited a pronounced and specific pattern of expression and/or phosphorylation of stress proteins and other indicators of the stress response (HSPB1, HSPB6, HSPB8, CHOP, eIF2\u03b1), partially in a MK2/MK3 genotype-specific manner, and without induction of a general stress response.", {"entities": [[191, 196, "GENE"], [198, 203, "GENE"], [205, 210, "GENE"]]}], ["Similarly, the expression and activation patterns of other protein kinases downstream of p38 MAPK (MNK1, MSK1) depended partially on the MK2/MK3 genotype in this disease model.", {"entities": []}], ["In conclusion, MK2 and MK3 together play crucial roles in the regulation of the renal stress response and in the development of glomerulonephritis, which can potentially be exploited to develop novel therapeutic approaches to treat glomerular disease.", {"entities": [[128, 146, "DISEASE"]]}], ["Improvement in quality of life (QOL) has become a focus for the management of incurable chronic diseases, including chronic obstructive pulmonary disease (COPD).", {"entities": [[116, 153, "DISEASE"]]}], ["This study investigates factors influencing the QOL of patients with COPD in India.", {"entities": []}], ["Seventy-three consecutive COPD patients visiting an outpatient pulmonary clinic underwent health-related QOL (HRQOL) assessment using the World Health Organization\u2019s QOL abbreviated questionnaire and St George\u2019s Respiratory Questionnaire (SGRQ).", {"entities": []}], ["Symptom severity and grade of dyspnea were estimated by the Chronic Lung Disease Severity Index (CLD) and Medical Research Council assessments, and patient demographic data were collected.", {"entities": [[68, 80, "DISEASE"]]}], ["Spirometry and 6-minute walk tests were performed to assess lung function and functional status.", {"entities": []}], ["Patients with COPD showed significantly reduced HRQOL when measured by the World Health Organization\u2019s QOL abbreviated questionnaire and the SGRQ.", {"entities": []}], ["CLD estimate for severity of lung disease ( P < 0.001), Medical Research Council assessment for dyspnea ( P < 0.01), and duration of illness ( P < 0.05) showed close correlation with HRQOL.", {"entities": [[29, 41, "DISEASE"]]}], ["Worsening forced expiratory volume in 1 second and 6-minute walk test results closely correlated with poorer HRQOL ( P < 0.01).", {"entities": []}], ["No association between QOL and age, quantum of smoking, education, comorbid illnesses, or occupational exposure was found.", {"entities": []}], ["This study showed that Indian patients with COPD had reduced HRQOL.", {"entities": []}], ["Longer disease duration, patient perception of disease severity, and worsening dyspnea impacted negatively on HRQOL.", {"entities": []}], ["This study investigates the importance of alcohol as a migraine trigger factor, the prevalence of alcohol consumers and the mechanism of headache provocation.", {"entities": [[55, 63, "DISEASE"]]}], ["A MEDLINE search from 1988 to October 2007 was performed for \u201cheadache and alcohol\u201d, \u201cheadache and wine\u201d, \u201cmigraine and alcohol\u201d and \u201cmigraine and wine\u201d.", {"entities": [[107, 115, "DISEASE"], [134, 142, "DISEASE"]]}], ["In retrospective studies, about one-third of the migraine patients reported alcohol as a migraine trigger, at least occasionally, but only 10% of the migraine patients reported alcohol as a migraine trigger frequently.", {"entities": [[49, 57, "DISEASE"], [89, 97, "DISEASE"], [150, 158, "DISEASE"], [190, 198, "DISEASE"]]}], ["Regional differences were reported, perhaps depending in part on alcohol habits.", {"entities": []}], ["No differences were found between migraine and tension headache and different genders.", {"entities": [[34, 42, "DISEASE"]]}], ["However, prospective studies limit considerably the importance of alcohol as a trigger.", {"entities": []}], ["Recent studies show that migraine patients consume less alcohol than controls.", {"entities": [[25, 33, "DISEASE"]]}], ["Red wine was reported to be the principal trigger of migraine, but other studies show that white wine or other drinks are more involved.", {"entities": [[53, 61, "DISEASE"]]}], ["Then, the discussion based on the different composition of the various alcoholic beverages, in order to discover the content of alcoholic drinks responsible for migraine attack, reflects this uncertainty.", {"entities": [[161, 169, "DISEASE"]]}], ["Biogenic amines, sulphites, flavonoid phenols, 5-hydroxytryptamine mechanisms and vasodilating effects are discussed.", {"entities": []}], ["The fact that few headache patients cannot tolerate some alcoholic drinks does not justify the consideration that alcohol is a major trigger and the suggestion of abstinence.", {"entities": []}], ["In fact, low doses of alcohol can have a beneficial effect on patients such as migraineurs, who were reported to have an increased risk of cardiovascular disease.", {"entities": []}], ["Respiratory syncytial virus (RSV) is one of the most frequently observed pathogens during infancy and childhood.", {"entities": []}], ["However, the corresponding pathogenesis has not been determined to date.", {"entities": []}], ["We previously demonstrated that IFN-\u03b3 plays an important role in RSV pathogenesis, and SARM-TRIF-signaling pathway could regulate the production of IFN-\u03b3.", {"entities": []}], ["This study is to investigate whether T cells or innate immune cells are the predominant producers of IFN-\u03b3, and further to explore other culprits in addition to IFN-\u03b3 in the condition of RSV infection.", {"entities": []}], ["Normal BALB/c mice and nude mice deficient in T cells were infected intranasally with RSV.", {"entities": []}], ["Leukocytes in bronchoalveolar lavage fluid were counted, lung histopathology was examined, and airway hyperresponsiveness (AHR) was measured by whole-body plethysmography.", {"entities": [[123, 126, "GENE"]]}], ["IFN-\u03b3 and MMP-12 were detected by ELISA.", {"entities": []}], ["MMP408, a selective MMP-12 inhibitor, was given intragastrically.", {"entities": []}], ["Resveratrol, IFN-\u03b3 neutralizing antibody and recombinant murine IFN-\u03b3 were administered intraperitoneally.", {"entities": []}], ["SARM and TRIF protein were semi-quantified by Western blot.", {"entities": []}], ["siRNA was used to knock-down SARM expression.", {"entities": []}], ["RSV induced significant airway inflammation and AHR in both mice; IFN-\u03b3 was significantly increased in BALB/c mice but not in nude mice.", {"entities": [[48, 51, "GENE"]]}], ["MMP-12 was dramatically increased in both mice but earlier in nude mice.", {"entities": []}], ["When MMP-12 was inhibited by MMP408, RSV-induced respiratory symptoms were alleviated.", {"entities": []}], ["SARM was significantly suppressed while TRIF was significantly enhanced in both mice strains.", {"entities": []}], ["Following resveratrol administration in nude mice, 1) SARM inhibition was prevented, 2) TRIF and MMP-12 were correspondingly down-regulated and 3) airway disorders were subsequently alleviated.", {"entities": []}], ["Moreover, when SARM was efficiently knocked down using siRNA, TRIF and MMP-12 were markedly enhanced, and the anti-RSV effects of resveratrol were remarkably abrogated.", {"entities": []}], ["MMP-12 was significantly increased in the IFN-\u03b3 neutralizing antibody-treated BALB/c mice but reduced in the recombinant murine IFN-\u03b3-treated nude mice.", {"entities": []}], ["MMP-12 can result in at least part of the airway inflammation and AHR independent of IFN-\u03b3.", {"entities": [[66, 69, "GENE"]]}], ["And SARM-TRIF- signaling pathway is involved in regulating the overproduction of MMP-12.", {"entities": []}], ["To the best of our knowledge, this study is the first that has examined the effects of SARM on MMP-12 and further highlights the potential to target SARM-TRIF-MMP-12 cascades to treat RSV infection.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0176-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objective To independently evaluate the impact of the second phase of the Health Foundation\u2019s Safer Patients Initiative (SPI2) on a range of patient safety measures.", {"entities": []}], ["Design A controlled before and after design.", {"entities": []}], ["Five substudies: survey of staff attitudes; review of case notes from high risk (respiratory) patients in medical wards; review of case notes from surgical patients; indirect evaluation of hand hygiene by measuring hospital use of handwashing materials; measurement of outcomes (adverse events, mortality among high risk patients admitted to medical wards, patients\u2019 satisfaction, mortality in intensive care, rates of hospital acquired infection).", {"entities": []}], ["Setting NHS hospitals in England.", {"entities": [[8, 11, "GENE"]]}], ["Participants Nine hospitals participating in SPI2 and nine matched control hospitals.", {"entities": []}], ["Intervention The SPI2 intervention was similar to the SPI1, with somewhat modified goals, a slightly longer intervention period, and a smaller budget per hospital.", {"entities": [[54, 58, "GENE"]]}], ["Results One of the scores (organisational climate) showed a significant (P=0.009) difference in rate of change over time, which favoured the control hospitals, though the difference was only 0.07 points on a five point scale.", {"entities": []}], ["Results of the explicit case note reviews of high risk medical patients showed that certain practices improved over time in both control and SPI2 hospitals (and none deteriorated), but there were no significant differences between control and SPI2 hospitals.", {"entities": []}], ["Monitoring of vital signs improved across control and SPI2 sites.", {"entities": []}], ["This temporal effect was significant for monitoring the respiratory rate at both the six hour (adjusted odds ratio 2.1, 99% confidence interval 1.0 to 4.3; P=0.010) and 12 hour (2.4, 1.1 to 5.0; P=0.002) periods after admission.", {"entities": []}], ["There was no significant effect of SPI for any of the measures of vital signs.", {"entities": []}], ["Use of a recommended system for scoring the severity of pneumonia improved from 1.9% (1/52) to 21.4% (12/56) of control and from 2.0% (1/50) to 41.7% (25/60) of SPI2 patients.", {"entities": [[56, 65, "DISEASE"]]}], ["This temporal change was significant (7.3, 1.4 to 37.7; P=0.002), but the difference in difference was not significant (2.1, 0.4 to 11.1; P=0.236).", {"entities": []}], ["There were no notable or significant changes in the pattern of prescribing errors, either over time or between control and SPI2 hospitals.", {"entities": []}], ["Two items of medical history taking (exercise tolerance and occupation) showed significant improvement over time, across both control and SPI2 hospitals, but no additional SPI2 effect.", {"entities": []}], ["The holistic review showed no significant changes in error rates either over time or between control and SPI2 hospitals.", {"entities": []}], ["The explicit case note review of perioperative care showed that adherence rates for two of the four perioperative standards targeted by SPI2 were already good at baseline, exceeding 94% for antibiotic prophylaxis and 98% for deep vein thrombosis prophylaxis.", {"entities": []}], ["Intraoperative monitoring of temperature improved over time in both groups, but this was not significant (1.8, 0.4 to 7.6; P=0.279), and there were no additional effects of SPI2.", {"entities": []}], ["A dramatic rise in consumption of soap and alcohol hand rub was similar in control and SPI2 hospitals (P=0.760 and P=0.889, respectively), as was the corresponding decrease in rates of Clostridium difficile and meticillin resistant Staphylococcus aureus infection (P=0.652 and P=0.693, respectively).", {"entities": []}], ["Mortality rates of medical patients included in the case note reviews in control hospitals increased from 17.3% (42/243) to 21.4% (24/112), while in SPI2 hospitals they fell from 10.3% (24/233) to 6.1% (7/114) (P=0.043).", {"entities": []}], ["Fewer than 8% of deaths were classed as avoidable; changes in proportions could not explain the divergence of overall death rates between control and SPI2 hospitals.", {"entities": []}], ["There was no significant difference in the rate of change in mortality in intensive care.", {"entities": []}], ["Patients\u2019 satisfaction improved in both control and SPI2 hospitals on all dimensions, but again there were no significant changes between the two groups of hospitals.", {"entities": []}], ["Conclusions Many aspects of care are already good or improving across the NHS in England, suggesting considerable improvements in quality across the board.", {"entities": [[74, 77, "GENE"]]}], ["These improvements are probably due to contemporaneous policy activities relating to patient safety, including those with features similar to the SPI, and the emergence of professional consensus on some clinical processes.", {"entities": []}], ["This phenomenon might have attenuated the incremental effect of the SPI, making it difficult to detect.", {"entities": []}], ["Alternatively, the full impact of the SPI might be observable only in the longer term.", {"entities": []}], ["The conclusion of this study could have been different if concurrent controls had not been used.", {"entities": []}], ["This analysis investigated the relationships between healthcare expenditures in the last 6\u2005months of life and use of general practitioner (GP) services in the preceding 12-month period among older residents of New South Wales, Australia.", {"entities": []}], ["Questionnaire data (2006\u20132009) for more than 260\u2005000 people aged 45\u2005years and over were linked to individual hospital and death records and cost data.", {"entities": []}], ["For 14\u2005819 participants who died during follow-up, generalised linear mixed models were used to explore the relationships between costs of hospital, emergency department (ED) and Medicare-funded outpatient and pharmaceutical services in the last 6\u2005months of life, and quintile of GP use in the 18\u20137\u2005months before death.", {"entities": []}], ["Analyses were adjusted for age at death, sex, educational level, language, private health insurance, household income, self-reported health status, functional limitation, psychological distress, number of comorbidities and geographic clustering.", {"entities": []}], ["Almost 85% of decedents had at least one hospitalisation in the last 6\u2005months, and the mean (median) of total cost for each person in this period was $A20\u2005453 (14\u2005835).", {"entities": []}], ["There was no significant difference in the hospital cost, including cost for preventable hospitalisations in the last 6\u2005months of life, across quintiles of GP use in the 18\u20137\u2005months before death.", {"entities": []}], ["Participants in the lowest quintile of GP use incurred more ED costs, but ED costs were similar across the other quintiles of GP use.", {"entities": []}], ["Costs for Medicare-funded outpatient services and pharmaceuticals increased steeply according to quintile of GP use.", {"entities": []}], ["In the Australian setting, there was no association between use of GP services in the 18\u20137\u2005months before death and hospital costs in the last 6\u2005months, but there was significant association with higher costs for outpatient services and pharmaceuticals.", {"entities": []}], ["However, there was some indication that limited GP access might be associated with increased ED use at end of life.", {"entities": []}], ["Respiratory syncytial virus (RSV) is the leading respiratory viral pathogen in young children worldwide.", {"entities": []}], ["RSV disease is associated with acute airway obstruction (AO), long-term airway hyperresponsiveness (AHR), and chronic lung inflammation.", {"entities": [[100, 103, "GENE"]]}], ["Using two different mouse strains, this study was designed to determine whether RSV disease patterns are host-dependent.", {"entities": []}], ["C57BL/6 and BALB/c mice were inoculated with RSV and followed for 77 days.", {"entities": []}], ["RSV loads were measured by plaque assay and polymerase chain reaction (PCR) in bronchoalveolar lavage (BAL) and whole lung samples; cytokines were measured in BAL samples.", {"entities": []}], ["Lung inflammation was evaluated with a histopathologic score (HPS), and AO and AHR were determined by plethysmography.", {"entities": [[79, 82, "GENE"]]}], ["Viral load dynamics, histopathologic score (HPS), cytokine concentrations, AO and long-term AHR were similar in both strains of RSV-infected mice, although RSV-infected C57BL/6 mice developed significantly greater AO compared with RSV-infected BALB/c mice on day 5.", {"entities": [[92, 95, "GENE"]]}], ["PCR detected RSV RNA in BAL samples of RSV infected mice until day 42, and in whole lung samples through day 77.", {"entities": []}], ["BAL concentrations of cytokines TNF-\u03b1, IFN-\u03b3, and chemokines MIG, RANTES and MIP-1\u03b1 were significantly elevated in both strains of RSV-infected mice compared with their respective controls.", {"entities": []}], ["Viral load measured by PCR significantly correlated with disease severity on days 14 and 21.", {"entities": []}], ["RSV-induced acute and chronic airway disease is independent of genetic background.", {"entities": []}], ["Household air pollution (HAP) contributes to the global burden of disease.", {"entities": []}], ["Our primary purpose was to determine whether HAP exposure was associated with reduced lung function and respiratory and non-respiratory symptoms in Belizean adults and children.", {"entities": []}], ["Our secondary purpose was to investigate whether lifestyle (physical activity (PA) and fruit and vegetable consumption (FV)) is associated with reported symptoms.", {"entities": []}], ["Belizean adults ( n = 67, 19 Male) and children ( n = 23, 6 Male) from San Ignacio Belize and surrounding areas participated in this cross-sectional study.", {"entities": []}], ["Data collection took place at free walk-in clinics.", {"entities": []}], ["Investigators performed initial screenings and administered questionnaires on (1) sources of HAP exposure; (2) reported respiratory and non-respiratory symptoms and (3) validated lifestyle questionnaires.", {"entities": []}], ["Participants then performed pulmonary function tests (PFTs) and exhaled breath carbon monoxide (CO).", {"entities": []}], ["There were no significant associations between HAP exposure and pulmonary function in adults.", {"entities": []}], ["Increased exhaled CO was associated with a significantly lower forced expiratory volume in 1-s divided by forced vital capacity (FEV 1 /FVC) in children.", {"entities": [[129, 132, "GENE"]]}], ["Exposed adults experienced headaches, burning eyes, wheezing and phlegm production more frequently than unexposed adults.", {"entities": []}], ["Adults who met PA guidelines were less likely to experience tightness and pressure in the chest compared to those not meeting guidelines.", {"entities": []}], ["In conclusion, adults exposed to HAP experienced greater respiratory and non-respiratory symptoms, which may be attenuated by lifestyle modifications.", {"entities": []}], ["Mast cell-derived mediators mediate several of the pathological features of asthma.", {"entities": [[76, 82, "DISEASE"]]}], ["Microbial infections induce asthma exacerbations in which the contribution of mast cells remains incomprehensible.", {"entities": [[28, 34, "DISEASE"]]}], ["In this study we have investigated the characteristic expression pattern of Toll-like receptors (TLRs) 1\u20139 and the effect of TLR ligand treatment on IgE-receptor mediated mast cell reactivity.", {"entities": []}], ["For the studies we employed in vitro differentiated connective tissue like mast cells (CTLMC) and mucosal like mast cells (MLMC) from mice.", {"entities": []}], ["Both phenotypes were treated for 24 h or 96 h with ligands for TLR1/2, TLR2/6, TLR3 and TLR4, before activation with IgE and antigen.", {"entities": [[79, 83, "GENE"], [88, 92, "GENE"]]}], ["Prolonged exposure (96 h) with TLR-ligands promoted mast cell reactivity following IgE-receptor activation.", {"entities": []}], ["TLR4 activation with LPS generated the most pronounced effect, with an enhanced degranulation and secretion of leukotrienes, cytokines and chemokines, in both CTLMC and MLMC.", {"entities": [[0, 4, "GENE"]]}], ["The effect of LPS was mediated through a Myd88-dependent pathway and the increased effect involved JNK-dependent pathway.", {"entities": []}], ["We find that prolonged exposure of mast cells to pathogens/TLR-ligands modulates their effector responses by priming them for increased release of several inflammatory mediators when subsequently activated by IgE-receptors.", {"entities": []}], ["These data suggest that infections might exaggerate the severity of allergic reactions such as in asthma, by enhancing mediator release from mast cells.", {"entities": [[98, 104, "DISEASE"]]}], ["Our earlier genome-wide expression study revealed up-regulation of a tryptophan-catabolizing enzyme, indoleamine 2,3-dioxygenase (IDO1), in patients with scrub typhus.", {"entities": [[154, 166, "DISEASE"], [160, 166, "DISEASE"], [130, 134, "GENE"]]}], ["This gene has been previously reported to have anti-microbial activity in a variety of infectious diseases; therefore, we aimed to prove whether it is also involved in host defense against Orientia tsutsugamushi (OT) infection.", {"entities": []}], ["Using LC-MS, we observed an increased ratio of serum L-kynurenine to serum L-tryptophan in patients with scrub typhus, which suggests an active catalytic function of this enzyme upon the illness.", {"entities": [[105, 117, "DISEASE"], [111, 117, "DISEASE"]]}], ["To evaluate the effect of IDO1 activation on OT infection, a human macrophage-like cell line THP-1 was used as a study model.", {"entities": [[26, 30, "GENE"]]}], ["Although transcription of IDO1 was induced by OT infection, its functional activity was not significantly enhanced unless the cells were pretreated with IFN-\u03b3, a potent inducer of IDO1.", {"entities": [[26, 30, "GENE"], [180, 184, "GENE"], [26, 30, "GENE"], [180, 184, "GENE"]]}], ["When the degree of infection was evaluated by quantitative real-time PCR, the relative number of OT 47 kDa gene per host genes, or infection index, was markedly reduced by IFN-\u03b3 treatment as compared to the untreated cultures at five days post-infection.", {"entities": []}], ["Inhibition of IDO1 activity in IFN-\u03b3 treated cultures by 1-methyl-L-tryptophan, a competitive inhibitor of IDO1, resulted in partial restoration of infection index; while excessive supplementation of L-tryptophan in IFN-\u03b3 treated cultures raised the index to an even higher level than that of the untreated ones.", {"entities": [[14, 18, "GENE"], [107, 111, "GENE"], [14, 18, "GENE"], [107, 111, "GENE"]]}], ["Altogether, these data implied that IDO1 was partly involved in restriction of OT growth caused by IFN-\u03b3 through deprivation of tryptophan.", {"entities": [[36, 40, "GENE"]]}], ["Activation of IDO1 appeared to be a defensive mechanism downstream of IFN-\u03b3 that limited intracellular expansion of OT via tryptophan depletion.", {"entities": [[14, 18, "GENE"]]}], ["Our work provided not only the first link of in vivo activation of IDO1 and IFN-\u03b3-mediated protection against OT infection but also highlighted the promise of this multifaceted gene in scrub typhus research.", {"entities": [[185, 197, "DISEASE"], [191, 197, "DISEASE"], [67, 71, "GENE"]]}], ["Scrub typhus is a potentially life-threatening infectious disease that is a major cause of acute undifferentiated fever in Asia-Pacific region.", {"entities": [[0, 12, "DISEASE"], [6, 12, "DISEASE"]]}], ["It is caused by Orientia tsutsugamushi (OT), an obligatory intracellular gram-negative bacterium in family rickettsiaceae.", {"entities": []}], ["Earlier studies have shown that IFN-\u03b3 is essential in protection against OT infection in animals and cell-based models, but molecular mechanisms underlying such phenomenon remain largely unclear.", {"entities": []}], ["In the present study, we are the first to demonstrate that activation of IDO1, a key enzyme in tryptophan-degrading pathway, is a mechanism downstream to IFN-\u03b3 in control of OT infection.", {"entities": [[73, 77, "GENE"]]}], ["IDO1 was found active in patients with acute scrub typhus.", {"entities": [[45, 57, "DISEASE"], [51, 57, "DISEASE"], [0, 4, "GENE"]]}], ["Subsequent in vitro experiments suggested that IDO1 restrains OT growth via deprivation of tryptophan, an important material for proliferation of OT, rather than via production of its downstream anti-microbial metabolites.", {"entities": [[47, 51, "GENE"]]}], ["Since IDO1 is a multifaceted gene that also plays a part in several processes of the immune system, including induction of tolerogenic responses; other possible consequences of IDO1 activation deserve further investigation in a more complex experimental model as well as in naturally infected human before subsequent clinical implication of this basic knowledge can be ultimately applied.", {"entities": [[6, 10, "GENE"], [177, 181, "GENE"], [6, 10, "GENE"], [177, 181, "GENE"]]}], ["The Clean Air Act, as amended in 1977, requires periodic review and revision of all national ambient air quality standards (NAAQS) to insure that they are based on the latest scientific information.", {"entities": []}], ["This article presents an overview of how EPA currently reviews and establishes NAAQS.", {"entities": []}], ["The role of scientific information and expertise in the process is illustrated by a review of several key issues faced in the development of the proposed revisions to the carbon monoxide NAAQS.", {"entities": []}], ["Finally, a risk analysis framework being developed within EPA's Office of Air Quality Planning and Standards for possible future use in NAAQS reviews is described.", {"entities": []}], ["The principal objective of the risk analysis framework is to provide more formal treatment of uncertainties in the scientific data base.", {"entities": []}], ["Rates of Potentially Preventable Hospitalizations (PPH) are used to evaluate access of territorially delimited populations to high quality ambulatory care.", {"entities": []}], ["A common geographic pattern of several PPH would reflect the performance of healthcare providers.", {"entities": []}], ["This study is aimed at modeling jointly the geographical variation in six chronic PPH conditions in one Spanish Autonomous Community for describing common and discrepant patterns, and to assess the relative weight of the common pattern on each condition.", {"entities": []}], ["Data on the 39,970 PPH hospital admissions for diabetes short term complications, chronic obstructive pulmonary disease (COPD), congestive heart failure, dehydration, angina admission and adult asthma, between 2007 and 2009 were extracted from the Hospital Discharge Administrative Databases and assigned to one of the 240 Basic Health Zones.", {"entities": [[128, 152, "DISEASE"], [82, 119, "DISEASE"], [194, 200, "DISEASE"]]}], ["Rates and Standardized Hospitalization Ratios per geographic unit were estimated.", {"entities": []}], ["The spatial analysis was carried out jointly for PPH conditions using Shared Component Models (SCM).", {"entities": []}], ["The component shared by the six PPH conditions explained about the 36% of the variability of each PPH condition, ranging from the 25.9 for dehydration to 58.7 for COPD.", {"entities": []}], ["The geographical pattern found in the latent common component identifies territorial clusters with particularly high risk.", {"entities": []}], ["The specific risk pattern that each isolated PPH does not share with the common pattern for all six conditions show many non-significant areas for most PPH, but with some exceptions.", {"entities": []}], ["The geographical distribution of the risk of the PPH conditions is captured in a 36% by a unique latent pattern.", {"entities": []}], ["The SCM modeling may be useful to evaluate healthcare system performance.", {"entities": []}], ["The hygiene hypothesis suggests that helminth infections prevent a range of autoimmune diseases.", {"entities": []}], ["To investigate the effects of S. japonicum infection on collagen-induced arthritis (CIA), male DBA/1 mice were challenged with unisexual or bisexual S. japonicum cercariae two weeks prior to bovine type II collagen (CII) immunization or at the onset of CIA.", {"entities": [[73, 82, "DISEASE"]]}], ["S. japonicum infection prior to CII immunization significantly reduced the severity of CIA.", {"entities": []}], ["ELISA (enzyme linked immunosorbent assay) showed that the levels of anti-CII IgG and IgG2a were reduced in prior schistosome-infected mice, while anti-CII IgG1 was elevated.", {"entities": []}], ["Splenocyte proliferation against both polyclonal and antigen-specific stimuli was reduced by prior schistosome infection as measured by tritiated thymidine incorporation ( \u03b3 , TNF- \u03b1 , IL-1 \u03b2 and IL-6) and Th1 cells, together with up-regulation of the anti-inflammatory cytokine IL-10 and Th2 cells.", {"entities": []}], ["Interestingly, the expansion of Treg cells and the reduction of Th17 cells were only observed in bisexually infected mice.", {"entities": []}], ["In addition, prior schistosome infection notably reduced the expression of pro-inflammatory cytokines and receptor activator of NF-\u03baB ligand (RANKL) in the inflamed joint.", {"entities": []}], ["However, the disease was exacerbated at one week after infection when established CIA mice were challenged with bisexual cercariae.", {"entities": []}], ["Our data provide direct evidence that the Th2 response evoked by prior S. japonicum infection can suppress the Th1 response and pro-inflammatory mediator and that bisexual infection with egg-laying up-regulates the Treg response and down-regulates the Th17 response, resulting in an amelioration of autoimmune arthritis.", {"entities": [[310, 319, "DISEASE"]]}], ["The beneficial effects might depend on the establishment of a Th2-dominant response rather than the presence of the eggs.", {"entities": []}], ["Our results suggest that anti-inflammatory molecules from the parasite could treat autoimmune diseases.", {"entities": []}], ["The publication of the first tick sialome (salivary gland transcriptome) heralded a new era of research of tick protease inhibitors, which represent important constituents of the proteins secreted via tick saliva into the host.", {"entities": []}], ["Three major groups of protease inhibitors are secreted into saliva: Kunitz inhibitors, serpins, and cystatins.", {"entities": []}], ["Kunitz inhibitors are anti-hemostatic agents and tens of proteins with one or more Kunitz domains are known to block host coagulation and/or platelet aggregation.", {"entities": []}], ["Serpins and cystatins are also anti-hemostatic effectors, but intriguingly, from the translational perspective, also act as pluripotent modulators of the host immune system.", {"entities": []}], ["Here we focus especially on this latter aspect of protease inhibition by ticks and describe the current knowledge and data on secreted salivary serpins and cystatins and their role in tick-host-pathogen interaction triad.", {"entities": []}], ["We also discuss the potential therapeutic use of tick protease inhibitors.", {"entities": []}], ["Malaria worldwide annual reported cases range between 250 and 500 million and nearly half a million deaths are reported every year.", {"entities": [[0, 7, "DISEASE"]]}], ["Colombia has a vast expanse of territory with environmental and social conditions conducive to malaria transmission, which is the reason why it has second place in Latin America for the number of cases of malaria.", {"entities": [[95, 102, "DISEASE"], [205, 212, "DISEASE"]]}], ["This is a retrospective, paired, case\u2013control study that compares patients with severe malaria and malaria patients without mention of complication.", {"entities": [[87, 94, "DISEASE"], [99, 106, "DISEASE"]]}], ["Medical records of patients with confirmed malaria diagnosis were reviewed.", {"entities": [[43, 50, "DISEASE"]]}], ["The objective of this study was to identify factors associated with complicated malaria in three municipalities of Colombia during the period 2009\u20132013.", {"entities": [[80, 87, "DISEASE"]]}], ["A total sample of 180 medical records was collected, 60 corresponding to cases and 120 to controls following a 1:2 ratio.", {"entities": []}], ["From the total sample, 88.33\u00a0% (159) of subjects were originally from Tumaco, 7.78\u00a0%, most of the patients of the study (104) were diagnosed and treated in 2013.", {"entities": []}], ["Among the laboratory findings, the platelet count was found to have statistically significant differences between cases and controls; this was also true for total bilirubin value and transaminases.", {"entities": []}], ["The most prevalent severity finding was clinical jaundice, followed by elevated bilirubin (25\u00a0%) and elevated transaminases (44.4\u00a0%).", {"entities": []}], ["Thrombocytopenia was found in 11/44 cases (20\u00a0%) and only five of 60 patients (8.3\u00a0%) presented severe anaemia.", {"entities": []}], ["The multivariate analysis showed that a platelet count\u00a0<100,000 and clinical jaundice not associated with organ failure, were the two variables associated with severe malaria in the patients described.", {"entities": [[167, 174, "DISEASE"]]}], ["Most of the cases studied, despite meeting criteria of severity, were shown not to be as morbid or severe as in other countries.", {"entities": []}], ["Clinical jaundice and thrombocytopaenia are associated with severe malaria, and they can be used by general practitioners or primary care physicians to promptly identify patients who may have severe malaria.", {"entities": [[67, 74, "DISEASE"], [199, 206, "DISEASE"]]}], ["The study was undertaken to investigate the interrelation of toll-like receptor (TLR) and interleukin (IL)-17 in the salivary glands of patients with primary Sjogren's syndrome (pSS) and to determine the role of TLR and IL-17 in the pathophysiology of pSS.", {"entities": [[168, 176, "DISEASE"]]}], ["The expressions of various TLRs, IL-17 and the cytokines involved in Th17 cell differentiation including IL-6, IL-23, tumor necrosis factor-alpha (TNF-\u03b1) and IL-1\u03b2 were examined by immunohistochemistry in salivary glands of pSS patients.", {"entities": []}], ["The IL-17 producing CD4+ T cells (Th17 cells) were examined by flow cytometry and confocal staining in peripheral mononuclear blood cells (PMBCs) and salivary glands of pSS patients.", {"entities": []}], ["After PBMCs were treated with TLR specific ligands, the induction of IL-17 and IL-23 was determined using real-time PCR and ELISA.", {"entities": []}], ["The signaling pathway that mediates the TLR2 stimulated production of IL-17 and IL-23 was investigated by using treatment with specific signaling inhibitors.", {"entities": [[40, 44, "GENE"]]}], ["We showed that TLR2, TLR4, TLR6, IL-17 and the cytokines associated with Th17 cells were highly expressed in salivary glands of pSS patients but not in controls.", {"entities": [[15, 19, "GENE"], [21, 25, "GENE"], [27, 31, "GENE"]]}], ["The expressions of TLR2, TLR4 and TLR6 were observed in the infiltrating mononuclear cells and ductal epithelial cells, whereas IL-17 was mainly observed in infiltrating CD4+ T cells.", {"entities": [[19, 23, "GENE"], [25, 29, "GENE"], [34, 38, "GENE"]]}], ["The number of IL-17 producing CD4+ T cells was significantly higher in pSS patients both in PBMCs and minor salivary glands.", {"entities": []}], ["The stimulation of TLR2, TLR4 and TLR6 additively induced the production of IL-17 and IL-23 from the PBMCs of pSS patients especially in the presence of TLR2 stimulation.", {"entities": [[19, 23, "GENE"], [153, 157, "GENE"], [25, 29, "GENE"], [34, 38, "GENE"], [19, 23, "GENE"], [153, 157, "GENE"]]}], ["IL-6, signal transducer and activator of transcription 3 (STAT3) and nuclear factor-kappaB (NF-kB) pathways were implicated in the TLR2 stimulated IL-17 and IL-23.", {"entities": [[58, 63, "GENE"], [131, 135, "GENE"]]}], ["Our data demonstrate that TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in pSS.", {"entities": [[26, 30, "GENE"], [88, 93, "GENE"]]}], ["Therefore, therapeutic strategies that target TLR/IL-17 pathway might be strong candidates for treatment modalities of pSS.", {"entities": []}], ["Patients with asthma\u2013chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) and cardiovascular diseases (CVDs) share common risk factors.", {"entities": [[21, 58, "DISEASE"], [74, 82, "DISEASE"], [14, 20, "DISEASE"]]}], ["However, the association between ACOS and the incidence of CVDs has not been reported.", {"entities": []}], ["This study investigated the relationship between CVDs and ACOS in the general population.", {"entities": []}], ["Data were obtained from Taiwan\u2019s National Health Insurance Research Database for the period 2000 to 2010.", {"entities": []}], ["The ACOS cohort comprised patients (n=5814) who had received a diagnosis of asthma and COPD.", {"entities": [[76, 82, "DISEASE"]]}], ["The non-ACOS cohort comprised patients who had not received a diagnosis of asthma or COPD and were matched to the ACOS cohort (2:1) by age, sex and index date (n=11\u2009625).", {"entities": [[75, 81, "DISEASE"]]}], ["The cumulative incidence of CVDs\u2014coronary artery disease (CAD), cardiac dysrhythmia (CD) and heart failure (HF)\u2014was calculated.", {"entities": []}], ["Cox proportional regression analysis was employed to examine the relationship between ACOS and CVDs.", {"entities": []}], ["After adjustment for multiple confounding factors\u2014age, sex, comorbidities and medications\u2014patients with ACOS were associated with a significantly higher risk of CVDs; the adjusted HRs (aHRs; 95% CI) for CAD, CD and HF were 1.62 (1.50 to 1.76), 1.44 (1.30 to 1.61) and 1.94 (1.73 to 2.19), respectively, whereas those of beta-blockers treatment for CAD, CD and HF were 1.19 (0.92 to 1.53), 0.90 (0.56 to 1.45) and 0.82 (0.49 to 1.38).", {"entities": []}], ["The aHR of atenolol treatment for CD was 1.72 (1.01 to 2.93).", {"entities": [[4, 7, "GENE"]]}], ["The aHRs (95% CIs) of ACOS without acute exacerbation of COPD (AE-COPD) for CAD, CD and HF were 1.85 (1.70 to 2.01), 1.57 (1.40 to 1.77) and 2.07 (1.82 to 2.35), respectively.", {"entities": []}], ["ACOS was associated with higher CVD risk, even without the presence of previous comorbidities or AE-COPD.", {"entities": []}], ["No significant differences in CVD events were observed in the ACOS cohort using beta-blockers, except for those using atenolol for treating CD.", {"entities": []}], ["SOCS1 and -3 proteins are released by alveolar macrophages into exosomes and microparticles, respectively, which are then taken up by alveolar epithelial cells, resulting in inhibition of STAT signaling.", {"entities": [[0, 5, "GENE"]]}], ["This process was dampened by exposure to cigarette smoke and may thus be important in suppressing airway inflammation.", {"entities": []}], ["JAK-STAT signaling mediates the actions of numerous cytokines and growth factors, and its endogenous brake is the family of SOCS proteins.", {"entities": []}], ["Consistent with their intracellular roles, SOCS proteins have never been identified in the extracellular space.", {"entities": []}], ["Here we report that alveolar macrophages can secrete SOCS1 and -3 in exosomes and microparticles, respectively, for uptake by alveolar epithelial cells and subsequent inhibition of STAT activation.", {"entities": [[53, 58, "GENE"]]}], ["Secretion is tunable and occurs both in vitro and in vivo.", {"entities": []}], ["SOCS secretion into lung lining fluid was diminished by cigarette smoking in humans and mice.", {"entities": []}], ["Secretion and transcellular delivery of vesicular SOCS proteins thus represent a new model for the control of inflammatory signaling, which is subject to dysregulation during states of inflammation.", {"entities": []}], ["Plasmodium falciparum malaria episodes may vary considerably in their severity and clinical manifestations.", {"entities": [[22, 29, "DISEASE"]]}], ["There is good evidence that host genetic factors contribute to this variability.", {"entities": []}], ["To date, most genetic studies aiming at the identification of these genes have used a case/control study design for severe malaria, exploring specific candidate genes.", {"entities": [[123, 130, "DISEASE"]]}], ["Here, we performed a family-based genetic study of falciparum malaria related phenotypes in two independent longitudinal survey cohorts, as a first step towards the identification of genes and mechanisms involved in the outcome of infection.", {"entities": [[62, 69, "DISEASE"]]}], ["We studied two Senegalese villages, Dielmo and Ndiop that differ in ethnicity, malaria transmission and endemicity.", {"entities": [[79, 86, "DISEASE"]]}], ["We performed genome-scan linkage analysis of several malaria-related phenotypes both during clinical attacks and asymptomatic infection.", {"entities": [[53, 60, "DISEASE"]]}], ["We show evidence for a strong genetic contribution to both the number of clinical falciparum malaria attacks and the asymptomatic parasite density.", {"entities": [[93, 100, "DISEASE"]]}], ["The asymptomatic parasite density showed linkage to chromosome 5q31 (LOD\u200a=\u200a2.26, empirical p \u200a=\u200a0.0014, Dielmo), confirming previous findings in other studies.", {"entities": []}], ["Suggestive linkage values were also obtained at three additional chromosome regions: the number of clinical malaria attacks on chromosome 5p15 (LOD\u200a=\u200a2.57, empirical p \u200a=\u200a0.001, Dielmo) and 13q13 (LOD\u200a=\u200a2.37, empirical p \u200a=\u200a0.0014 Dielmo), and the maximum parasite density during asymptomatic infection on chromosome 12q21 (LOD\u200a=\u200a3.1, empirical p <10", {"entities": [[108, 115, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease, and bacterial infection plays a role in its pathogenesis.", {"entities": []}], ["Bacteria secrete nanometer-sized extracellular vesicles (EVs), which may induce more immune dysfunction and inflammation than the bacteria themselves.", {"entities": []}], ["We hypothesized that the microbiome of lung EVs might have distinct characteristics depending on the presence of COPD and smoking status.", {"entities": []}], ["We analyzed and compared the microbiomes of 13 nonsmokers with normal spirometry, 13 smokers with normal spirometry (healthy smokers) and 13 patients with COPD by using 16S ribosomal RNA gene sequencing of surgical lung tissue and lung EVs.", {"entities": []}], ["Subjects were matched for age and sex in all groups and for smoking levels in the COPD and healthy smoker groups.", {"entities": []}], ["Each group included 12 men and 1 woman with the same mean age of 65.5 years.", {"entities": []}], ["In all groups, EVs consistently showed more operational taxonomic units (OTUs) than lung tissue.", {"entities": []}], ["In the healthy smoker and COPD groups, EVs had a higher Shannon index and a lower Simpson index than lung tissue and this trend was more prominent in the COPD group.", {"entities": []}], ["Principal component analysis (PCA) showed clusters based on sample type rather than participants' clinical characteristics.", {"entities": []}], ["Stenotrophomonas , Propionibacterium and Alicyclobacillus were the most commonly found genera.", {"entities": []}], ["Firmicutes were highly present in the EVs of the COPD group compared with other samples or groups.", {"entities": []}], ["Our analysis of the lung microbiome revealed that the bacterial communities present in the EVs and in the COPD group possessed distinct characteristics with differences in the OTUs, diversity indexes and PCA clustering.", {"entities": []}], ["Multiple hypersensitivities ( MHS ) have been described in humans, cats, and dogs, but not horses.", {"entities": []}], ["Horses suffering from recurrent airway obstruction ( RAO ), insect bite hypersensitivity ( IBH ), or urticaria ( URT ) will have an increased risk of also being affected by another one of these hypersensitivities.", {"entities": [[101, 110, "DISEASE"]]}], ["This predisposition for MHS also will be associated with decreased shedding of strongylid eggs in feces and with a single nucleotide polymorphism ( SNP BIEC2\u2010224511 ), previously shown to be associated with RAO .", {"entities": []}], ["The first population (P1) included 119 randomly sampled horses representative of the Swiss sporthorse population; the replication population (P2) included 210 RAO \u2010affected Warmblood horses and 264 RAO \u2010unaffected controls.", {"entities": []}], ["All horses were Warmbloods, 14\u00a0years or older.", {"entities": []}], ["Associations between disease phenotypes ( RAO , IBH , URT , MHS ) fecal egg counts, the SNP BIEC2\u2010224511 as well as management and environmental factors were investigated.", {"entities": []}], ["In P1, RAO \u2010affected horses had a 13.1 times higher odds ratio ( OR ) of also suffering from IBH ( P \u00a0=\u00a0.004).", {"entities": []}], ["In P2, the respective OR was 7.4 ( P \u00a0=\u00a0.002) and IBH \u2010affected horses also showed a 7.1 times increased OR of concomitantly suffering from URT ( P \u00a0<\u00a0.001).", {"entities": []}], ["IBH , URT , and MHS phenotypes were significantly associated with the absence of nematode eggs in the feces.", {"entities": []}], ["This is the first report of MHS in horses.", {"entities": []}], ["Specifically, an increased risk for IBH should be expected in RAO \u2010affected horses.", {"entities": []}], ["The genetic diversity and population genetic structure of 252 accessions from 21 Prunus sibirica L. populations were investigated using 10 ISSR, SSR, and SRAP markers.", {"entities": []}], ["The results suggest that the entire population has a relatively high level of genetic diversity, with populations HR and MY showing very high diversity.", {"entities": [[114, 116, "GENE"]]}], ["A low level of inter-population genetic differentiation and a high level of intra-population genetic differentiation was found, which is supported by a moderate level of gene flow, and largely attributable to the cross-pollination and self-incompatibility reproductive system.", {"entities": []}], ["A STRUCTURE (model-based program) analysis revealed that the 21 populations can be divided into two main groups, mainly based on geographic differences and genetic exchanges.", {"entities": []}], ["The entire wild Siberia apricot population in China could be divided into two subgroups, including 107 accessions in subgroup (SG) 1 and 147 accessions in SG 2.", {"entities": []}], ["A Mantel test revealed a significant positive correlation between genetic and geographic distance matrices, and there was a very significant positive correlation among three marker datasets.", {"entities": []}], ["Overall, we recommend a combination of conservation measures, with ex situ and in situ conservation that includes the construction of a core germplasm repository and the implement of in situ conservation for populations HR, MY, and ZY.", {"entities": [[220, 222, "GENE"]]}], ["Pulmonary aspergilloma usually results from the ingrowth of colonized Aspergillus from a damaged bronchial tree, a pulmonary cyst, or from the cavities of patients with underlying lung diseases.", {"entities": [[0, 22, "DISEASE"]]}], ["In the present study, we analyzed the clinical features, diagnostic methods, and managements of 36 patients with pulmonary aspergilloma.", {"entities": [[113, 135, "DISEASE"]]}], ["Thirty-six patients were diagnosed as having pulmonary aspergilloma at Chung-Ang University Hospital between February 1988 and February 2000.", {"entities": [[45, 67, "DISEASE"]]}], ["Their medical records were reviewed retrospectively.", {"entities": []}], ["The age of patients (median\u00b1SD) was 53.3\u00b111.8 years, the male to female ratio was 2.36:1, and the most frequent symptom was hemoptysis, which occurred in 24 patients (65%).", {"entities": []}], ["The most common underlying disease was pulmonary tuberculosis (81%), and the upper lobes of both lungs were the most frequently involved sites.", {"entities": [[49, 61, "DISEASE"], [39, 61, "DISEASE"]]}], ["Nine patients received a chest CT in the prone position and seven of these showed a movable fungus ball.", {"entities": []}], ["Eleven patients were positive for the precipitin antibody to A. fumigatus.", {"entities": []}], ["Twenty patients underwent surgical resection, and post-operative complications were reported in seven cases.", {"entities": []}], ["The post-operative mortality was 5.6% (2/36).", {"entities": []}], ["Pulmonary aspergilloma usually develops in the patients with underlying lung diseases.", {"entities": [[0, 22, "DISEASE"]]}], ["Resectional lung surgery is considered the mainstay of therapy for pulmonary aspergilloma.", {"entities": [[67, 89, "DISEASE"]]}], ["However, this operation is associated with significant complications and death in some cases.", {"entities": []}], ["Therefore, it is necessary to develop reasonable criteria for selection of candidates for such surgery.", {"entities": []}], ["RSV is a common illness among young children that causes significant morbidity and health care costs.", {"entities": []}], ["Routinely collected health administrative data can be used to track disease incidence, explore risk factors and conduct health services research.", {"entities": []}], ["Due to potential for misclassification bias, the accuracy of data-elements should be validated prior to use.", {"entities": []}], ["The objectives of this study were to validate an algorithm to accurately identify pediatric cases of hospitalized respiratory syncytial virus (RSV) from within Ontario\u2019s health administrative data, estimate annual incidence of hospitalization due to RSV and report the prevalence of major risk factors within hospitalized patients.", {"entities": []}], ["A retrospective chart review was performed to establish a reference-standard cohort of children from the Ottawa region admitted to the Children\u2019s Hospital of Eastern Ontario (CHEO) for RSV-related disease in 2010 and 2011.", {"entities": []}], ["Chart review data was linked to Ontario\u2019s administrative data and used to evaluate the diagnostic accuracy of algorithms of RSV-related ICD-10 codes within provincial hospitalization and emergency department databases.", {"entities": []}], ["Age- and sex-standardized incidence was calculated over time, with trends in incidence assessed using Poisson regression.", {"entities": []}], ["From a total of 1411 admissions, chart review identified 327 children hospitalized for laboratory confirmed RSV-related disease.", {"entities": []}], ["Following linkage to administrative data and restriction to first admissions, there were 289 RSV patients in the reference-standard cohort.", {"entities": []}], ["The best algorithm, based on hospitalization data, resulted in sensitivity 97.9% (95%CI: 95.5\u201399.2%), specificity 99.6% (95%CI: 98.2\u201399.8%), PPV 96.9% (95%CI: 94.2\u201398.6%), NPV 99.4% (95%CI: 99.4\u201399.9%).", {"entities": []}], ["Incidence of hospitalized RSV in Ontario from 2005\u20132012 was 10.2 per 1000 children under 1 year and 4.8 per 1000 children aged 1 to 3 years.", {"entities": []}], ["During the surveillance period, there was no identifiable increasing or decreasing linear trend in the incidence of hospitalized RSV, hospital length of stay and PICU admission rates.", {"entities": []}], ["Among the Ontario RSV cohort, 16.3% had one or more major risk factors, with a decreasing trend observed over time.", {"entities": []}], ["Children hospitalized for RSV-related disease can be accurately identified within population-based health administrative data.", {"entities": []}], ["RSV is a major public health concern and incidence has not changed over time, suggesting a lack of progress in prevention.", {"entities": []}], ["In a recent study of 198 Swedish children with persistent allergic symptoms and 202 controls without such symptoms, we reported associations between the symptoms and the concentrations of n -butyl benzyl phthalate (BBzP) and di(2-ethylhexyl) phthalate (DEHP) in dust taken from the childrens\u2019 bedrooms.", {"entities": []}], ["In the present study we examined associations between the concentrations of different phthalate esters in the dust from these bedrooms and various characteristics of the home.", {"entities": []}], ["The study focused on BBzP and DEHP because these were the phthalates associated with health complaints.", {"entities": []}], ["Associations have been examined using parametric and nonparametric tests as well as multiple logistic regression.", {"entities": []}], ["For both BBzP and DEHP, we found associations between their dust concentrations and the amount of polyvinyl chloride (PVC) used as flooring and wall material in the home.", {"entities": []}], ["Furthermore, high concentrations of BBzP (above median) were associated with self-reported water leakage in the home, and high concentrations of DEHP were associated with buildings constructed before 1960.", {"entities": []}], ["Other associations, as well as absence of associations, are reported.", {"entities": []}], ["Both BBzP and DEHP were found in buildings with neither PVC flooring nor wall covering, consistent with the numerous additional plasticized materials that are anticipated to be present in a typical home.", {"entities": []}], ["The building characteristics examined in this study cannot serve as complete proxies for these quite varied sources.", {"entities": []}], ["However, the associations reported here can help identify homes where phthalate concentrations are likely to be elevated and can aid in developing mitigation strategies.", {"entities": []}], ["Health status has been demonstrated to vary by neighbourhood socioeconomic status (SES).", {"entities": []}], ["However, neighbourhood effects may vary between countries.", {"entities": []}], ["In this study, neighbourhood variations in health outcomes are compared across four socially contrasting neighbourhoods in Glasgow, Scotland and Hamilton, Ontario Canada.", {"entities": []}], ["Data came from the 2001 wave of the West of Scotland Twenty-07 Longitudinal Study and a 2000/2001 cross-sectional survey conducted in Hamilton.", {"entities": []}], ["The results of the comparison point to important variations in the relationship between neighbourhood SES and health.", {"entities": []}], ["While both cities display a socioeconomic gradient with respect to various measures of health and health behaviours, for some outcome measures the high SES neighbourhoods in Glasgow display distributions similar to those found in the low SES neighbourhoods in Hamilton.", {"entities": []}], ["Our results suggest that a low SES neighbourhood in one country may not mean the same for health as a low SES neighbourhood in another country.", {"entities": []}], ["As such, country context may explain the distribution of health status and health behaviours among socially contrasting neighbourhoods, and neighbourhood variations in health may be context specific.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is characterized by the complex interaction of cells involved in chronic inflammation and fibrosis.", {"entities": [[11, 29, "DISEASE"]]}], ["Global gene expression of a homogenous cell population will identify novel candidate genes.", {"entities": []}], ["Gene expression of fibroblasts derived from lung tissues (8 IPF and 4 controls) was profiled, and ontology and functional pathway were analyzed in the genes exhibiting >2 absolute fold changes with p -values\u2009<\u20090.05.", {"entities": []}], ["CCL8 mRNA and protein levels were quantified using real-time PCR and ELISA.", {"entities": [[0, 4, "GENE"]]}], ["CCL8 localization was evaluated by immunofluorescence staining.", {"entities": [[0, 4, "GENE"]]}], ["One hundred seventy eight genes differentially expressed and 15 genes exhibited >10-fold change.", {"entities": []}], ["Among them, 13 were novel in relation with IPF.", {"entities": []}], ["CCL8 expression was 22.8-fold higher in IPF fibroblasts.", {"entities": [[0, 4, "GENE"]]}], ["The levels of CCL8 mRNA and protein were 3 and 9-fold higher in 14 IPF fibroblasts than those in 10 control fibroblasts by real-time PCR and ELISA ( p \u2009=\u20090.022 and p \u2009=\u20090.026, respectively).", {"entities": [[14, 18, "GENE"]]}], ["The CCL8 concentrations in BAL fluid was significantly higher in 86 patients with IPF than those in 41 controls, and other interstitial lung diseases including non-specific interstitial pneumonia ( n \u2009=\u200922), hypersensitivity pneumonitis ( n \u2009=\u200920) and sarcoidosis ( n \u2009=\u200919) ( p \u2009<\u20090.005, respectively).", {"entities": [[186, 195, "DISEASE"], [252, 263, "DISEASE"], [4, 8, "GENE"]]}], ["Cut-off values of 2.29 pg/mL and 0.43 pg/mL possessed 80.2 and 70.7% accuracy for the discrimination of IPF from NC and the other lung diseases, respectively.", {"entities": []}], ["IPF subjects with CCL8 levels >28.61 pg/mL showed shorter survival compared to those with lower levels ( p \u2009=\u20090.012).", {"entities": [[18, 22, "GENE"]]}], ["CCL8 was expressed by \u03b1-SMA-positive cells in the interstitium of IPF.", {"entities": [[0, 4, "GENE"]]}], ["Transcriptome analysis identified several novel IPF-related genes.", {"entities": []}], ["Among them, CCL8 is a candidate molecule for the differential diagnosis and prediction of survival.", {"entities": [[12, 16, "GENE"]]}], ["The online version of this article (doi:10.1186/s12931-016-0493-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Transcatheter aortic valve implantation has become an option for high-surgical-risk patients with aortic valve disease.", {"entities": [[98, 118, "DISEASE"]]}], ["To evaluate the in-hospital and one-year follow-up outcomes of transcatheter aortic valve implantation.", {"entities": []}], ["Prospective cohort study of transcatheter aortic valve implantation cases from July 2009 to February 2015.", {"entities": []}], ["Analysis of clinical and procedural variables, correlating them with in-hospital and one-year mortality.", {"entities": []}], ["A total of 136 patients with a mean age of 83 years (80-87) underwent heart valve implantation; of these, 49% were women, 131 (96.3%) had aortic stenosis, one (0.7%) had aortic regurgitation and four (2.9%) had prosthetic valve dysfunction.", {"entities": []}], ["NYHA functional class was III or IV in 129 cases (94.8%).", {"entities": []}], ["The baseline orifice area was 0.67 \u00b1 0.17 cm Transcatheter aortic valve implantation was performed with a high success rate and low mortality.", {"entities": []}], ["Blood transfusion was associated with higher in-hospital and one-year mortality.", {"entities": []}], ["Peak C-reactive protein was associated with one-year mortality.", {"entities": []}], ["The elusive but ubiquitous multifactor interactions represent a stumbling block that urgently needs to be removed in searching for determinants involved in human complex diseases.", {"entities": []}], ["The dimensionality reduction approaches are a promising tool for this task.", {"entities": []}], ["Many complex diseases exhibit composite syndromes required to be measured in a cluster of clinical traits with varying correlations and/or are inherently longitudinal in nature (changing over time and measured dynamically at multiple time points).", {"entities": []}], ["A multivariate approach for detecting interactions is thus greatly needed on the purposes of handling a multifaceted phenotype and longitudinal data, as well as improving statistical power for multiple significance testing via a two-stage testing procedure that involves a multivariate analysis for grouped phenotypes followed by univariate analysis for the phenotypes in the significant group(s).", {"entities": []}], ["In this article, we propose a multivariate extension of generalized multifactor dimensionality reduction (GMDR) based on multivariate generalized linear, multivariate quasi-likelihood and generalized estimating equations models.", {"entities": []}], ["Simulations and real data analysis for the cohort from the Study of Addiction: Genetics and Environment are performed to investigate the properties and performance of the proposed method, as compared with the univariate method.", {"entities": []}], ["The results suggest that the proposed multivariate GMDR substantially boosts statistical power.", {"entities": []}], ["Malignant Mesothelioma is a rare primary neoplasm affecting the serosal membranes.", {"entities": []}], ["During its relative short course, this malignant neoplasm can give local and, rarely, distant haematogenous metastases in different organs.", {"entities": []}], ["The reported metastatic sites include liver, lung, heart, brain, thyroid, adrenals, kidneys, pancreas, bone, soft tissue, skin and lymph nodes.", {"entities": []}], ["We report a sixty one year-old man with a history of malignant pleural epithelioid mesothelioma treated with six cycles of Pemetrexed and Carboplatin completed 03/11/04 followed by radiotherapy to the drain site 250 Kv/TD20Gy/5F completed 13/12/2004.", {"entities": []}], ["Then he developed multiple facial skin lesions 4 years later.", {"entities": []}], ["These lesions were proved to be metastatic malignant sarcomatoid mesothelioma.", {"entities": [[53, 77, "DISEASE"]]}], ["Mesothelioma metastases should be suspected in any known Mesothelioma patient with newly developed skin lesion.", {"entities": []}], ["Exposure to environmental tobacco smoke (ETS) has been shown to increase allergic sensitization and reactivity and there has been some suggestion that the influence of ETS on the allergic response is dissimilar in males and females.", {"entities": []}], ["It is to be determined whether gender differences exist in the IgE response to ovalbumin (OVA) sensitization following ETS exposure from the neonatal period through adulthood.", {"entities": []}], ["To address this thesis, we examined gender differences in OVA sensitization of BALB/c mice housed from birth through adulthood under smoking and nonsmoking conditions.", {"entities": []}], ["At 6 weeks of age (day 0) all mice were injected i.p.", {"entities": []}], ["with OVA in aluminum hydroxide adjuvant followed by three 20 min exposures to 1% aerosolized OVA between day 14 and 80.", {"entities": []}], ["There were significantly ( p <0.05) more total and OVA specific IgE and IgG1 in the serum of females compared to males.", {"entities": []}], ["Moreover, these sex responses, along with eosinophilia, were further enhanced in mice exposed to ETS.", {"entities": [[42, 54, "DISEASE"]]}], ["There were also significantly more IgE positive cells in the lungs of female, but not male, mice exposed to ETS compared with ambient air ( p <0.05).", {"entities": []}], ["There was also an elevation of Th2 cytokines (IL4, IL5, IL10, and IL13) after re-stimulation of lung homogenates following ETS exposure.", {"entities": [[46, 49, "GENE"], [51, 54, "GENE"], [56, 60, "GENE"], [66, 70, "GENE"]]}], ["These data demonstrate that female animals are significantly more susceptible than males to the influence of ETS on the allergic response.", {"entities": []}], ["Several controlled clinical studies have evaluated the potential of the infection biomarker procalcitonin (PCT) to improve the diagnostic work-up of patients with bacterial infections and its influence on decisions regarding antibiotic therapy.", {"entities": []}], ["Most research has focused on lower respiratory tract infections and critically ill sepsis patients.", {"entities": []}], ["A clinical utility for PCT has also been found for patients with urinary tract infections, postoperative infections, meningitis, and patients with acute heart failure with possible superinfection (i.e., pneumonia).", {"entities": [[203, 212, "DISEASE"], [117, 127, "DISEASE"]]}], ["In these indications, PCT levels measured on hospital admission were found to substantially reduce the initiation of antibiotic treatment in low-risk situations (i.e., bronchitis, chronic obstructive pulmonary disease exacerbation).", {"entities": [[180, 217, "DISEASE"], [168, 178, "DISEASE"]]}], ["For more severe infections (i.e., pneumonia, sepsis), antibiotic stewardship by monitoring of PCT kinetics resulted in shorter antibiotic treatment durations with early cessation of therapy.", {"entities": [[34, 43, "DISEASE"]]}], ["Importantly, these strategies appear to be safe without increasing the risk for mortality, recurrent infections, or treatment failures.", {"entities": []}], ["PCT kinetics also proved to have prognostic value correlating with disease severity (i.e., pancreatitis, abdominal infection) and resolution of illness (i.e., sepsis).", {"entities": [[91, 103, "DISEASE"]]}], ["Although promising findings have been published in these different types of infections, there are a number of limitations regarding PCT, including suboptimal sensitivity and/or specificity, which makes a careful interpretation of PCT in the clinical context mandatory.", {"entities": []}], ["This narrative review aims to update clinicians on the strengths and limitations of PCT for patient management, focusing on research conducted within the last 4\u00a0years.", {"entities": []}], ["OM-85 (Broncho-Vaxom\u00ae, Broncho-Munal\u00ae, Ommunal\u00ae, Paxoral\u00ae, Vaxoral\u00ae), a product made of the water soluble fractions of 21 inactivated bacterial strain patterns responsible for respiratory tract infections, is used for the prevention of recurrent upper respiratory tract infections and acute exacerbations in chronic obstructive pulmonary disease patients.", {"entities": [[308, 345, "DISEASE"]]}], ["OM-85 is able to potentiate both innate and adaptive immune responses.", {"entities": []}], ["However, the molecular mechanisms responsible for OM-85 activation are still largely unknown.", {"entities": []}], ["Purpose of this study was to investigate the impact of OM-85 stimulation on human dendritic cell functions.", {"entities": []}], ["We show that OM-85 selectively induced NF-kB and MAPK activation in human DC with no detectable action on the interferon regulatory factor (IRF) pathway.", {"entities": []}], ["As a consequence, chemokines (i.e.", {"entities": []}], ["CXCL8, CXCL6, CCL3, CCL20, CCL22) and B-cell activating cytokines (i.e.", {"entities": [[7, 12, "GENE"], [14, 18, "GENE"], [20, 25, "GENE"], [27, 32, "GENE"]]}], ["IL-6, BAFF and IL-10) were strongly upregulated.", {"entities": []}], ["OM-85 also synergized with the action of classical pro-inflammatory stimuli used at suboptimal concentrations.", {"entities": []}], ["Peripheral blood mononuclear cells from patients with COPD, a pathological condition often associated with altered PRR expression pattern, fully retained the capability to respond to OM-85.", {"entities": []}], ["These results provide new insights on the molecular mechanisms of OM-85 activation of the immune response and strengthen the rational for its use in clinical settings.", {"entities": []}], ["Social networking sites (SNSs) have the potential to increase the reach and efficiency of essential public health services, such as surveillance, research, and communication.", {"entities": []}], ["The objective of this study was to conduct a systematic literature review to identify the use of SNSs for public health research and practice and to identify existing knowledge gaps.", {"entities": []}], ["We performed a systematic literature review of articles related to public health and SNSs using PubMed, EMBASE, and CINAHL to search for peer-reviewed publications describing the use of SNSs for public health research and practice.", {"entities": []}], ["We also conducted manual searches of relevant publications.", {"entities": []}], ["Each publication was independently reviewed by 2 researchers for inclusion and extracted relevant study data.", {"entities": []}], ["A total of 73 articles met our inclusion criteria.", {"entities": []}], ["Most articles (n=50) were published in the final 2 years covered by our search.", {"entities": []}], ["In all, 58 articles were in the domain of public health research and 15 were in public health practice.", {"entities": []}], ["Only 1 study was conducted in a low-income country.", {"entities": []}], ["Most articles (63/73, 86%) described observational studies involving users or usages of SNSs; only 5 studies involved randomized controlled trials.", {"entities": []}], ["A large proportion (43/73, 59%) of the identified studies included populations considered hard to reach, such as young individuals, adolescents, and individuals at risk of sexually transmitted diseases or alcohol and substance abuse.", {"entities": [[217, 232, "DISEASE"]]}], ["Few articles (2/73, 3%) described using the multidirectional communication potential of SNSs to engage study populations.", {"entities": []}], ["The number of publications about public health uses for SNSs has been steadily increasing in the past 5 years.", {"entities": []}], ["With few exceptions, the literature largely consists of observational studies describing users and usages of SNSs regarding topics of public health interest.", {"entities": []}], ["More studies that fully exploit the communication tools embedded in SNSs and study their potential to produce significant effects in the overall population\u2019s health are needed.", {"entities": []}], ["Antidepressants are among the most commonly prescribed drugs in primary care in England and their use is increasing.", {"entities": []}], ["This is largely due to longer durations of treatment of depression.", {"entities": []}], ["Observational studies have shown some differences in adverse outcomes associated with different antidepressant drugs but relatively little is known about their relative safety particularly with long term use.", {"entities": []}], ["The primary aim of this study is to determine the relative and absolute risks of pre-defined adverse events comparing different classes of antidepressant drugs in adults aged under 65 years and diagnosed with depression.", {"entities": []}], ["The study will identify a cohort of patients with a first recorded diagnosis of depression between 1/1/2000 and 31/07/2011, and made between the ages of 20 to 64 years using a large primary care database (QResearch).", {"entities": []}], ["Patients will be followed up until 1/08/2012.", {"entities": []}], ["Details of all prescriptions for antidepressants in patients in the cohort will be extracted, including the date of each prescription, the type of antidepressant drug, the dose and total quantity prescribed.", {"entities": []}], ["Prospectively recorded data will be used to ascertain information on adverse outcomes that occurred during follow-up and after entry into the cohort.", {"entities": []}], ["These are: all-cause mortality, suicide, attempted suicide/self-harm, sudden death, antidepressant overdose/poisoning, myocardial infarction, stroke/transient ischaemic attack, cardiac arrhythmia, epilepsy/seizures, upper gastrointestinal bleeding, falls, fractures, adverse drug reactions and motor vehicle crashes.", {"entities": [[119, 140, "DISEASE"]]}], ["Cox proportional hazard models will be used to estimate the association of the outcomes with class of antidepressant drug adjusting for potential confounding variables.", {"entities": []}], ["The analyses will also examine associations by duration and dose and with the most frequently prescribed individual antidepressant drugs.", {"entities": []}], ["Self-controlled case series analyses will be used to estimate the relative incidence of the outcomes of interest for defined time periods of antidepressant use.", {"entities": []}], ["The results of this study will help to establish the relative safety and balance of risks for different antidepressant drugs in people aged under 65.", {"entities": []}], ["One of the most consistent biological findings in autism is the elevated blood serotonin levels.", {"entities": []}], ["Immune abnormalities, including autoimmunity with production of brain specific auto-antibodies, are also commonly observed in this disorder.", {"entities": []}], ["Hyperserotonemia may be one of the contributing factors to autoimmunity in some patients with autism through the reduction of T-helper (Th) 1-type cytokines.", {"entities": []}], ["We are the first to investigate the possible role of hyperserotonemia in the induction of autoimmunity, as indicated by serum anti-myelin-basic protein (anti-MBP) auto-antibodies, in autism.", {"entities": []}], ["Serum levels of serotonin and anti-MBP auto-antibodies were measured, by ELISA, in 50 autistic patients, aged between 5 and 12 years, and 30 healthy-matched children.", {"entities": []}], ["Autistic children had significantly higher serum levels of serotonin and anti-MBP auto-antibodies than healthy children (P < 0.001 and P < 0.001, respectively).", {"entities": []}], ["Increased serum levels of serotonin and anti-MBP auto-antibodies were found in 92% and 80%, respectively of autistic patients.", {"entities": []}], ["Patients with severe autism had significantly higher serum serotonin levels than children with mild to moderate autism (P < 0.001).", {"entities": []}], ["Serum serotonin levels had no significant correlations with serum levels of anti-MBP auto-antibodies in autistic patients (P = 0.39).", {"entities": []}], ["Hyperserotonemia may not be one of the contributing factors to the increased frequency of serum anti-MBP auto-antibodies in some autistic children.", {"entities": []}], ["These data should be treated with caution until further investigations are performed.", {"entities": []}], ["However, inclusion of serum serotonin levels as a correlate may be useful in other future immune studies in autism to help unravel the long-standing mystery of hyperserotonemia and its possible role in the pathophysiology of this disorder.", {"entities": []}], ["Little is known about the relationship between socioeconomic status (SES) and cardiovascular disease (CVD) among Indigenous Australians, or whether any such relationship is similar to that in non-Indigenous Australians.", {"entities": []}], ["Weighted data on self-reported CVD and several SES measures were analyzed for 5,417 Indigenous and 15,432 non-Indigenous adults aged 18-64 years from two nationally representative surveys conducted in parallel by the Australian Bureau of Statistics in 2004-05.", {"entities": []}], ["After adjusting for age and sex, self-reported CVD prevalence was generally higher among those of lower SES in both the Indigenous and non-Indigenous populations.", {"entities": []}], ["The relative odds of self-reported CVD were generally similar in the two populations.", {"entities": []}], ["For example, the relative odds of self-reported CVD for those who did not complete Year 10 (versus those who did) was 1.4 (95% confidence interval [CI]: 1.1-1.8) among Indigenous people and 1.3 (95% CI: 1.2-1.5) among non-Indigenous people.", {"entities": []}], ["However, Indigenous people generally had higher self-reported CVD levels than non-Indigenous people of the same age and SES group.", {"entities": []}], ["Although smoking history varied by SES, smoking did not explain the observed relationships between SES and self-reported CVD.", {"entities": []}], ["Socioeconomic disparities in self-reported CVD among Indigenous Australians appear similar in relative terms to those seen in non-Indigenous Australians, but absolute differences remain.", {"entities": []}], ["As with other population groups, the socioeconomic heterogeneity of the Indigenous population must be considered in developing and implementing programs to promote health and prevent illness.", {"entities": []}], ["In addition, factors that operate across the SES spectrum, such as racism, stress, dispossession, and grief, must also be addressed to reduce the burden of CVD.", {"entities": []}], ["Depression is the most common and disabling mental illness in the globe.", {"entities": []}], ["It accounts for about 6.5% of the burden of diseases in Ethiopia.", {"entities": []}], ["Regardless of its severity and relapse rate, there are no synthesized evidences about its prevalence and potential risk factors in Ethiopia.", {"entities": []}], ["The aim of this review was thus to synthesize scientific information about the prevalence and potential risk factors of depression in Ethiopia.", {"entities": []}], ["Out of 37 papers, 31 were collected from PubMed, Medline and Google Scholar electronic databases, and the remaining six from Addis Ababa University, Department of Psychiatry.", {"entities": []}], ["But, 13 articles were removed after reading the titles; five after reading the abstracts and two after reading the manuscripts and five of them were duplicates.", {"entities": []}], ["Finally, 12 papers were reviewed and the pooled prevalence was also computed.", {"entities": []}], ["The pooled prevalence of depression for the five studies, which had used Composite International Diagnostic Interview (CIDI), was 6.8% (95%, CI: 6.4\u20137.3); but, it increased to 11% (95% CI: 10.4\u201311.5) when three other studies that had used other screening tools were included.", {"entities": []}], ["Demographic variables such as sex, age, marital status, violence, migration and substance use were associated with depression, but not with economic factors.", {"entities": []}], ["More attention should be given to socio-demographic risk factors and intimate partner violence, since they are potential risk factors of depression.", {"entities": []}], ["The prevalence of depression in Ethiopia was also found comparable to that of some high-income countries.", {"entities": []}], ["The widespread availability of powerful tools in commercial geographic information system (GIS) software has made address geocoding a widely employed technique in spatial epidemiologic studies.", {"entities": []}], ["The objective of this study was to determine the effect of the positional error in geocoding on the analysis of exposure to traffic-related air pollution of children at school locations.", {"entities": []}], ["For a case study of Orange County, Florida, we determined the positional error of geocoding of school locations through comparisons with a parcel database and digital orthophotography.", {"entities": []}], ["We used four different geocoding techniques for comparison to establish the repeatability of geocoding, and an analysis of proximity to major roads to determine bias and error in environmental exposure assessment.", {"entities": []}], ["Results indicate that the positional error in geocoding of schools is very substantial: We found that the 95% root mean square error was 196 m using street centerlines, 306 m using TIGER roads, and 210 and 235 m for two commercial geocoding firms.", {"entities": []}], ["We found bias and error in proximity analysis to major roads to be unacceptably large at distances of < 500 m. Bias and error are introduced by lack of positional accuracy and lack of repeatability of geocoding of school locations.", {"entities": []}], ["These results suggest that typical geocoding is insufficient for fine-scale analysis of school locations and more accurate alternatives need to be considered.", {"entities": []}], ["Limited health literacy (HL) contributes to poor health outcomes and disparities, and direct measurement is often time-intensive.", {"entities": []}], ["Self-reported HL questions have not been validated among Spanish-speaking and diverse English-speaking populations.", {"entities": []}], ["To evaluate three self-reported questions: This was a validation study nested within a trial of diabetes self-management support in the San Francisco Department of Public Health.", {"entities": []}], ["English and Spanish-speaking adults with type 2 diabetes receiving primary care.", {"entities": []}], ["Using the Test of Functional Health Literacy in Adults (s-TOFHLA) in English and Spanish as the reference, we classified HL as inadequate, marginal, or adequate.", {"entities": []}], ["We calculated the C-index and test characteristics of the three questions and summative scale compared to the s-TOFHLA and assessed variations in performance by language, race/ethnicity, age, and education.", {"entities": []}], ["Of 296 participants, 48% were Spanish-speaking; 9% were White, non-Hispanic; 47% had inadequate HL and 12% had marginal HL.", {"entities": []}], ["Overall, 57% reported being confident with forms \u201csomewhat\u201d or less.", {"entities": []}], ["The \u201cconfident with forms\u201d question performed best for detecting inadequate (C-index = 0.82, (0.77-0.87)) and inadequate plus marginal HL (C index = 0.81, (0.76-0.86); p\u2009<\u20090.01 for differences from other questions), and performed comparably to the summative scale.", {"entities": []}], ["The \u201cconfident with forms\u201d question and scale also performed best across language, race/ethnicity, educational attainment, and age.", {"entities": []}], ["A single self-reported HL question about confidence with forms and a summative scale of three questions discriminated between Spanish and English speakers with adequate HL and those with inadequate and/or inadequate plus marginal HL.", {"entities": []}], ["The \u201cconfident with forms\u201d question or the summative scale may be useful for estimating HL in clinical research involving Spanish-speaking and English-speaking, chronically-ill, diverse populations.", {"entities": []}], ["The online version of this article (doi:10.1007/s11606-010-1552-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Wnt pathway mediates differentiation of epithelial tissues; depending on the tissue types, Wnt can either drive or inhibit the differentiation process.", {"entities": []}], ["We hypothesized that key genes in the Wnt pathway are suppressed in the human airway epithelium under the stress of cigarette smoking, a stress associated with dysregulation of the epithelial differentiated state.", {"entities": []}], ["Microarrays were used to assess the expression of Wnt-related genes in the small airway epithelium (SAE) obtained via bronchoscopy and brushing of healthy nonsmokers, healthy smokers, and smokers with COPD.", {"entities": []}], ["Thirty-three of 56 known Wnt-related genes were expressed in the SAE.", {"entities": []}], ["Wnt pathway downstream mediators \u03b2-catenin and the transcription factor 7-like 1 were down-regulated in healthy smokers and smokers with COPD, as were many Wnt target genes.", {"entities": []}], ["Among the extracellular regulators that suppress the Wnt pathway, secreted frizzled-related protein 2 (SFRP2), was up-regulated 4.3-fold in healthy smokers and 4.9-fold in COPD smokers, an observation confirmed by TaqMan Real-time PCR, Western analysis and immunohistochemistry.", {"entities": [[103, 108, "GENE"]]}], ["Finally, cigarette smoke extract mediated up-regulation of SFRP2 and down-regulation of Wnt target genes in airway epithelial cells in vitro .", {"entities": [[59, 64, "GENE"]]}], ["Smoking down-regulates the Wnt pathway in the human airway epithelium.", {"entities": []}], ["In the context that Wnt pathway plays an important role in differentiation of epithelial tissues, the down-regulation of Wnt pathway may contribute to the dysregulation of airway epithelium differentiation observed in smoking-related airway disorders.", {"entities": []}], ["The space-filling fractal network in the human lung creates a remarkable distribution system for gas exchange.", {"entities": []}], ["Landmark studies have illuminated how the fractal network guarantees minimum energy dissipation, slows air down with minimum hardware, maximizes the gas- exchange surface area, and creates respiratory flexibility between rest and exercise.", {"entities": []}], ["In this paper, we investigate how the fractal architecture affects oxygen transport and exchange under varying physiological conditions, with respect to performance metrics not previously studied.", {"entities": []}], ["We present a renormalization treatment of the diffusion-reaction equation which describes how oxygen concentrations drop in the airways as oxygen crosses the alveolar membrane system.", {"entities": []}], ["The treatment predicts oxygen currents across the lung at different levels of exercise which agree with measured values within a few percent.", {"entities": []}], ["The results exhibit wide-ranging adaptation to changing process parameters, including maximum oxygen uptake rate at minimum alveolar membrane permeability, the ability to rapidly switch from a low oxygen uptake rate at rest to high rates at exercise, and the ability to maintain a constant oxygen uptake rate in the event of a change in permeability or surface area.", {"entities": []}], ["We show that alternative, less than space-filling architectures perform sub-optimally and that optimal performance of the space-filling architecture results from a competition between underexploration and overexploration of the surface by oxygen molecules.", {"entities": []}], ["The possibility of predicting oxygen currents in the human lung under varying conditions may give new understanding of the lung's operation, new therapeutic interventions, and new designs for non-biological transport systems.", {"entities": []}], ["We introduce such a computation which requires only a pocket calculator and agrees with measured currents within a few percent.", {"entities": []}], ["It treats the network of airways as a fractal surface and exhibits wide-ranging adaptation to changing process parameters, including tolerance to changes in membrane permeability, near-invariance of trans-membrane oxygen pressure at rest and exercise, and transformation of 180,000 gas exchangers into 1,500,000 exchangers from rest to exercise.", {"entities": []}], ["We show that alternative architectures perform sub-optimally and that the observed performance results from a competition between underexploration and overexploration of the surface by oxygen molecules.", {"entities": []}], ["To investigate the conjunctival and nasal flora and the antibiotic susceptibility profiles of isolates from patients undergoing cataract surgery.", {"entities": [[128, 136, "DISEASE"]]}], ["Observational and cross-sectional study.", {"entities": []}], ["A single-centre study in Taiwan.", {"entities": []}], ["128 consecutive patients precataract surgery.", {"entities": []}], ["Conjunctival and nasal cultures were prospectively obtained from 128 patients on the day of cataract surgery before instillation of ophthalmic solutions in our hospital.", {"entities": [[92, 100, "DISEASE"]]}], ["Isolates and antibiotic susceptibility profiles were identified through standard microbiological techniques.", {"entities": []}], ["Participants were asked to complete a questionnaire on healthcare-associated factors.", {"entities": []}], ["The positive culture rate from conjunctiva was 26.6%, yielding 84 isolates.", {"entities": []}], ["Coagulase-negative Staphylococci were the most commonly isolated organisms (45.2%), and 35% of staphylococcal isolates were methicillin-resistant.", {"entities": []}], ["Among staphylococcal isolates, all were susceptible to vancomycin, and 75%\u201382.5% were susceptible to fluoroquinolones.", {"entities": []}], ["Methicillin-resistant isolates were significantly less susceptible than their methicillin-sensitive counterparts to tobramycin, the most commonly used prophylactic antibiotic in our hospital (28.6% vs 69.2%; p=0.005).", {"entities": []}], ["The positive culture rate from nares for S taphylococcus aureus was 21.9%, and six isolates were methicillin-resistant.", {"entities": []}], ["No subjects had S. aureus colonisation on conjunctiva and nares simultaneously.", {"entities": []}], ["There were no associated risk factors for colonisation of methicillin-resistant Staphylococci.", {"entities": []}], ["The most common conjunctival bacterial isolate of patients undergoing cataract surgery was coagulase-negative Staphylococci in Taiwan.", {"entities": [[70, 78, "DISEASE"]]}], ["Because of predominant antibiotic preferences and selective antibiotic pressures, Staphylococci were more susceptible to fluoroquinolones but less to tobramycin than in other reports.", {"entities": []}], ["Additionally, methicillin-resistant Staphylococci exhibited co-resistance to tobramycin but not to fluoroquinolones.", {"entities": []}], ["This paper discusses the principles of study design and related methodologic issues in environmental epidemiology.", {"entities": []}], ["Emphasis is given to studies aimed at evaluating causal hypotheses regarding exposures to suspected health hazards.", {"entities": []}], ["Following background sections on the quantitative objectives and methods of population-based research, we present the major types of observational designs used in environmental epidemiology: first, the three basic designs involving the individual as the unit of analysis (i.e., cohort, cross-sectional, and case-control studies) and a brief discussion of genetic studies for assessing gene-environment interactions; second, various ecologic designs involving the group or region as the unit of analysis.", {"entities": []}], ["Ecologic designs are given special emphasis in this paper because of our lack of resources or inability to accurately measure environmental exposures in large numbers of individuals.", {"entities": []}], ["The paper concludes with a section highlighting current design issues in environmental epidemiology and several recommendations for future work.", {"entities": []}], ["Non-tuberculous mycobacteria (NTM) are ubiquitous in the environment and they infect mainly persons with underlying pulmonary diseases but also previously healthy elderly women.", {"entities": [[30, 33, "GENE"]]}], ["Defects in host resistance that lead to pulmonary infections by NTM are relatively unknown.", {"entities": [[64, 67, "GENE"]]}], ["A few genetic defects have been associated with both pulmonary and disseminated mycobacterial infections.", {"entities": []}], ["Rare disseminated NTM infections have been associated with genetic defects in T-cell mediated immunity and in cytokine signaling in families.", {"entities": [[18, 21, "GENE"]]}], ["We investigated whether there was an association between NTM infections and deficiencies of complement components C4A or C4B that are encoded by major histocompatibility complex (MHC).", {"entities": [[57, 60, "GENE"], [114, 117, "GENE"], [121, 124, "GENE"]]}], ["50 adult patients with a positive NTM culture with symptoms and findings of a NTM disease were recruited.", {"entities": [[34, 37, "GENE"], [78, 81, "GENE"], [34, 37, "GENE"], [78, 81, "GENE"]]}], ["Patients' clinical history was collected and symptoms and clinical findings were categorized according to 2007 diagnostic criteria of The American Thoracic Society (ATS).", {"entities": []}], ["To investigate the deficiencies of complement, C4A and C4B gene copy numbers and phenotype frequencies of the C4 allotypes were analyzed.", {"entities": [[47, 50, "GENE"], [55, 58, "GENE"]]}], ["Unselected, healthy, 149 Finnish adults were used as controls.", {"entities": []}], ["NTM patients had more often C4 deficiencies ( C4A or C4B ) than controls (36/50 [72%] vs 83/149 [56%], OR\u200a=\u200a2.05, 95%CI\u200a=\u200a1.019\u20134.105, p\u200a=\u200a0.042).", {"entities": [[0, 3, "GENE"], [46, 49, "GENE"], [53, 56, "GENE"]]}], ["C4 deficiencies for female NTM patients were more common than for controls (29/36 [81%] vs 55/100 [55%], OR\u200a=\u200a3.39, 95% CI\u200a=\u200a1.358\u20138.460, p\u200a=\u200a0.007).", {"entities": [[27, 30, "GENE"]]}], ["C4 deficiences seemed not to be related to any specific underlying disease or C4 phenotype.", {"entities": []}], ["C4 deficiency may be a risk factor for NTM infection in especially elderly female patients.", {"entities": [[39, 42, "GENE"]]}], ["To evaluate the efficacy and safety of topical isopropyl unoprostone (IU) in treating macular atrophy in age-related macular degeneration (AMD) patients.", {"entities": [[117, 137, "DISEASE"]]}], ["Fifty-two AMD patients with macular atrophy were included and randomly assigned (1:1) to the treatment (topical 0.15% IU) or placebo group.", {"entities": []}], ["Subjects used study eye drops 3 times a day for 54 weeks.", {"entities": []}], ["The macular atrophy was documented on fundus autofluorescence photographs and measured using RegionFinder.", {"entities": []}], ["The enlargement rate of macular atrophy and the changes in visual acuity were examined statistically between baseline and 54 weeks.", {"entities": []}], ["Forty-eight subjects were included in the analyses because 4 subjects withdrew from the study.", {"entities": []}], ["The differences between the IU and placebo groups in mean and median area of macular atrophy were not statistically significant at baseline.", {"entities": []}], ["The baseline median lesion size of macular atrophy was 2.33\u200amm P \u200a=\u200a0.51).", {"entities": []}], ["The intergroup difference in the enlargement ratio of macular atrophy (21\u200a\u00b1\u200a15% in the IU group and 111\u200a\u00b1\u200a96% in the placebo group) was statistically significant ( P \u200a<\u200a0.001).", {"entities": []}], ["Additionally, visual acuity tended to improve over baseline in the IU group.", {"entities": []}], ["No serious adverse events were observed.", {"entities": []}], ["Topical IU therapy is safe and effective for treating macular atrophy in AMD patients.", {"entities": []}], ["Results of epidemiological studies are greatly influenced by the chosen methodology.", {"entities": []}], ["The study aims to investigate how two frequently used questionnaires (Qs), with partly different layout, influence the prevalence of respiratory symptoms.", {"entities": []}], ["A booklet containing two Qs, the Global Allergy and Asthma European Network Q and the Obstructive Lung Disease in Northern Sweden Q, was mailed to 30 000 subjects aged 16\u201375 years in West Sweden; 62% responded.", {"entities": []}], ["Sixteen questions were included in the analysis: seven identical between the Qs, four different in set-up and five with the same layout but different wording.", {"entities": []}], ["Comparisons were made using differences in proportions, observed agreement and Kappa statistics.", {"entities": []}], ["Identical questions yielded similar prevalences with high observed agreement and kappa values.", {"entities": []}], ["Questions with different set-up or differences in wording resulted in significantly different prevalences with lower observed agreement and kappa values.", {"entities": []}], ["In general, the use of follow-up questions, excluding subjects answering no to the initial question, resulted in 2.9\u20136.7% units lower prevalence.", {"entities": []}], ["The question set-up has great influences on epidemiological results, and specifically questions that are set up to be excluded based on a previous no answer leads to lower prevalence compared with detached questions.", {"entities": []}], ["Therefore, Q layout and exact wording of questions has to be carefully considered when comparing studies.", {"entities": []}], ["Please cite this paper as: Ekerljung L, R\u00f6nmark E, L\u00f6tvall J, Wennergren G, Tor\u00e9n K and Lundb\u00e4ck B. Questionnaire layout and wording influence prevalence and risk estimates of respiratory symptoms in a population cohort.", {"entities": []}], ["Clin Respir J 2013; 7: 53\u201363.", {"entities": []}], ["Severe infection with respiratory syncytial virus (RSV) during infancy is strongly associated with the development of asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["To identify genetic variation that contributes to asthma following severe RSV bronchiolitis during infancy, we sequenced the coding exons of 131 asthma candidate genes in 182 European and African American children with severe RSV bronchiolitis in infancy using anonymous pools for variant discovery, and then directly genotyped a set of 190 nonsynonymous variants.", {"entities": [[50, 56, "DISEASE"], [145, 151, "DISEASE"], [78, 91, "DISEASE"], [230, 243, "DISEASE"]]}], ["Association testing was performed for physician-diagnosed asthma before the 7 20 ) at age 6 years.", {"entities": [[58, 64, "DISEASE"]]}], ["We identified four rare nonsynonymous variants that were significantly associated with asthma following severe RSV bronchiolitis, including single variants in ADRB2 , FLG and NCAM1 in European Americans (p = 4.6x10 NOS1 in African Americans (p = 2.3x10 ADRB2 (rs1800888), which was also nominally associated with asthma (p = 0.027) and active asthma (p = 0.013) among European Americans with severe RSV bronchiolitis without including the ESP.", {"entities": [[87, 93, "DISEASE"], [313, 319, "DISEASE"], [343, 349, "DISEASE"], [115, 128, "DISEASE"], [403, 416, "DISEASE"], [159, 164, "GENE"], [253, 258, "GENE"], [167, 170, "GENE"], [175, 180, "GENE"], [215, 219, "GENE"], [159, 164, "GENE"], [253, 258, "GENE"]]}], ["Our results suggest that rare nonsynonymous variants contribute to the development of asthma following severe RSV bronchiolitis in infancy, notably in ADRB2 .", {"entities": [[86, 92, "DISEASE"], [114, 127, "DISEASE"], [151, 156, "GENE"]]}], ["Additional studies are required to explore the role of rare variants in the etiology of asthma and asthma-related traits following severe RSV bronchiolitis.", {"entities": [[88, 94, "DISEASE"], [99, 105, "DISEASE"], [142, 155, "DISEASE"]]}], ["Background: The present study aimed to investigate the prevalence and associated socio-demographic factors of passive smoking among women in Jilin Province, China.", {"entities": []}], ["Methods: A cross-sectional study was conducted in 2012, using a self-reported questionnaire interview.", {"entities": []}], ["A representative sample of 9788 non-smoking women aged 18\u201379 years was collected in Jilin Province of China by a multistage stratified random cluster sampling design.", {"entities": []}], ["Descriptive data analysis and 95% confidence intervals (CI) of prevalence/frequency were conducted.", {"entities": []}], ["Multivariable logistic regressions were used to examine the associated socio-demographic factors of passive smoking.", {"entities": []}], ["Results: The overall prevalence of passive smoking among non-smoking women in Jilin Province was 60.6% (95% CI: 59.3\u201361.8), 58.3% (95% CI: 56.7\u201359.9) from urban areas, and 63.4% (95% CI: 61.6\u201365.3) from rural areas.", {"entities": []}], ["Twenty-six percent (95% CI: 24.9\u201327.1) of the non-smoking women reported daily passive smoking, of which 42.9% (95% CI: 41.6\u201344.1) reported passive smoking at home, and 5.1% (95% CI: 4.5\u20135.7) reported passive smoking in restaurants.", {"entities": []}], ["Women in urban areas were less likely to be passive smokers than those in rural ones (OR-Odds Ratio: 0.825, 95% CI: 0.729\u20130.935), elderly women were less likely to be passive smokers than younger women (55\u201364 years OR: 0.481, 95% CI: 0.342\u20130.674; 65\u201379 years OR: 0.351, 95% CI: 0.241\u20130.511).", {"entities": []}], ["Seperated/divorced women were less likely to be passive smokers (OR: 0.701, 95% CI: 0.500\u20130.982), and widowed women (OR: 0.564, 95%CI: 0.440\u20130.722), as the married were the reference group.", {"entities": []}], ["Retired women second-hand smoked due to environmental causes significantly less than manual workers (OR: 0.810, 95% CI: 0.708\u20130.928).", {"entities": []}], ["Women with a monthly family income of more than 5000 RMB were less likely to be passive smokers than those with an income less than 500 RMB (OR: 0.615, 95% CI: 0.432\u20130.876).", {"entities": []}], ["Conclusions: The prevalence of passive smoking is lower than that reported in 2010 Global Adult Tobacco Survey (GATS) China, but passive smoking is still prevalent and has been an acute public health problem among non-smoking women in Jilin Province, China.", {"entities": []}], ["Our findings suggest an urgent need for tobacco control and the efforts of public health should be both comprehensive and focus on high-risk populations in Jilin Province, China.", {"entities": []}], ["A common human gut bacterium, Bacteroides fragilis , produces a sphingolipid ligand for the conserved host receptor CD1d and can modulate natural killer T cell activity.", {"entities": [[116, 120, "GENE"]]}], ["While the human gut microbiota are suspected to produce diffusible small molecules that modulate host signaling pathways, few of these molecules have been identified.", {"entities": []}], ["Species of Bacteroides and their relatives, which often comprise >50% of the gut community, are unusual among bacteria in that their membrane is rich in sphingolipids, a class of signaling molecules that play a key role in inducing apoptosis and modulating the host immune response.", {"entities": []}], ["Although known for more than three decades, the full repertoire of Bacteroides sphingolipids has not been defined.", {"entities": []}], ["Here, we use a combination of genetics and chemistry to identify the sphingolipids produced by Bacteroides fragilis NCTC 9343.", {"entities": []}], ["We constructed a deletion mutant of BF2461, a putative serine palmitoyltransferase whose yeast homolog catalyzes the committed step in sphingolipid biosynthesis.", {"entities": []}], ["We show that the \u03942461 mutant is sphingolipid deficient, enabling us to purify and solve the structures of three alkaline-stable lipids present in the wild-type strain but absent from the mutant.", {"entities": []}], ["The first compound was the known sphingolipid ceramide phosphorylethanolamine, and the second was its corresponding dihydroceramide base.", {"entities": []}], ["Unexpectedly, the third compound was the glycosphingolipid \u03b1-galactosylceramide (\u03b1-GalCer Bf ), which is structurally related to a sponge-derived sphingolipid (\u03b1-GalCer, KRN7000) that is the prototypical agonist of CD1d-restricted natural killer T (iNKT) cells.", {"entities": []}], ["We demonstrate that \u03b1-GalCer Bf has similar immunological properties to KRN7000: it binds to CD1d and activates both mouse and human iNKT cells both in vitro and in vivo .", {"entities": [[93, 97, "GENE"]]}], ["Thus, our study reveals BF2461 as the first known member of the Bacteroides sphingolipid pathway, and it indicates that the committed steps of the Bacteroides and eukaryotic sphingolipid pathways are identical.", {"entities": []}], ["Moreover, our data suggest that some Bacteroides sphingolipids might influence host immune homeostasis.", {"entities": []}], ["While human gut bacteria are thought to produce diffusible molecules that influence host biology, few of these molecules have been identified.", {"entities": []}], ["Species of Bacteroides , a Gram-negative bacterial genus whose members often comprise >50% of the gut community, are unusual in that they produce sphingolipids, signaling molecules that play a key role in modulating the host immune response.", {"entities": []}], ["Sphingolipid production is ubiquitous among eukaryotes but present in only a few bacterial genera.", {"entities": []}], ["We set out to construct a Bacteroides strain that is incapable of producing sphingolipids, knocking out a gene predicted to encode the first enzymatic step in the Bacteroides sphingolipid biosynthetic pathway.", {"entities": []}], ["The resulting mutant is indeed deficient in sphingolipid production, and we purified and solved the structures of three sphingolipids that are present in the wild-type strain but absent in the mutant.", {"entities": []}], ["To our surprise, one of these molecules is a close chemical relative of a sponge sphingolipid that is the prototypical ligand for a host receptor that controls the activity of natural killer T cells.", {"entities": []}], ["Like the sponge sphingolipid, the Bacteroides sphingolipid can modulate natural killer T cell activity, suggesting a novel mechanism by which Bacteroides in the gut might influence the host immune response.", {"entities": []}], ["The cyanobacterium species Microcystis aeruginosa produces microcystin and an array of diverse metabolites believed responsible for their toxicity and/or immunogenicity.", {"entities": []}], ["Previously, chronic rhinitis patients were demonstrated to elicit a specific IgE response to nontoxic strains of M. aeruginosa by skin-prick testing, indicating that cyanobacteria allergenicity resides in a non-toxin\u2013producing component of the organism.", {"entities": [[20, 28, "DISEASE"], [12, 28, "DISEASE"]]}], ["We sought to identify and characterize M. aeruginosa peptide(s) responsible for allergic sensitization in susceptible individuals, and we investigated the functional interactions between cyanobacterial toxins and their coexpressed immunogenic peptides.", {"entities": []}], ["Sera from patients and extracts from M. aeruginosa toxic [MC(+)] and nontoxic [MC(\u2013)] strains were used to test IgE-specific reactivity by direct and indirect ELISAs; 2D gel electrophoresis, followed by immunoblots and mass spectrometry (MS), was performed to identify the relevant sensitizing peptides.", {"entities": []}], ["Cytotoxicity and mediator release assays were performed using the MC(+) and MC(\u2013) lysates.", {"entities": []}], ["We found specific IgE to be increased more in response to the MC(\u2013) strain than the MC(+) strain.", {"entities": []}], ["This response was inhibited by preincubation of MC(\u2013) lysate with increasing concentrations of microcystin.", {"entities": []}], ["MS revealed that phycocyanin and the core-membrane linker peptide are the responsible allergens, and MC(\u2013) extracts containing these proteins induced \u03b2-hexosaminidase release in rat basophil leukemia cells.", {"entities": [[191, 199, "DISEASE"]]}], ["Phycobiliprotein complexes in M. aeruginosa have been identified as the relevant sensitizing proteins.", {"entities": []}], ["Our finding that allergenicity is inhibited in a dose-dependent manner by microcystin toxin suggests that further investigation is warranted to understand the interplay between immunogenicity and toxicity of cyanobacteria under diverse environmental conditions.", {"entities": []}], ["Geh EN, Ghosh D, McKell M, de la Cruz AA, Stelma G, Bernstein JA.", {"entities": []}], ["Identification of Microcystis aeruginosa peptides responsible for allergic sensitization and characterization of functional interactions between cyanobacterial toxins and immunogenic peptides.", {"entities": []}], ["Environ Health Perspect 123:1159\u20131166;\u2002 http://dx.doi.org/10.1289/ehp.1409065", {"entities": []}], ["Supplemental Digital Content is available in the text The aim of the study was to comprehensively examine the efficacy and safety of noninvasive ventilation used at the pulmonary infection control (PIC) window for acute respiratory failure (ARF) in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).", {"entities": [[220, 239, "DISEASE"], [286, 323, "DISEASE"]]}], ["Seven electronic databases and relevant resources were searched to identify randomized controlled trials (RCTs) comparing patients using noninvasive ventilation at PIC window with those continuing receiving invasive ventilation.", {"entities": []}], ["Retrieved citations were screened, risk of bias was assessed, and data were extracted by 2 independent review authors.", {"entities": []}], ["Overall effect sizes were synthesized by using meta-analyses.", {"entities": []}], ["Quality of evidence was rated by using Grading of Recommendations, Assessment, Development and Evaluation approach.", {"entities": []}], ["A total of 17 trials involving 959 participants were included for this review.", {"entities": []}], ["Compared with continuous invasive ventilation, noninvasive ventilation used at PIC window significantly reduced mortality, ventilator-associated pneumonia, weaning failures, reintubations, duration of invasive ventilation, total duration of mechanical ventilation, length of stay (LOS) in intensive care unit, and LOS in hospital as well as hospital costs.", {"entities": [[145, 154, "DISEASE"]]}], ["Of these, mortality significantly decreased (risk ratio = 0.27, 95% confidence interval: 0.17\u20130.42, P \u200a<\u200a0.001) without significant heterogeneity (I P = 0.99).", {"entities": []}], ["Quality of evidence regarding the 9 outcomes across the included studies was rated from moderate to low.", {"entities": []}], ["Use of noninvasive ventilation at PIC window showed beneficial effects across identified trials for ARF in AECOPD patients.", {"entities": []}], ["Considering the absence of high quality of available evidence and the uncertainty of long-term effect of this intervention, a weak recommendation for clinical practice was generated, and further well-designed and adequately powered RCTs are required to validate this conclusion.", {"entities": []}], ["Background .", {"entities": []}], ["Large-scale surveys of complementary traditional Chinese medicine (TCM) use in pediatric cancer patients are lacking.", {"entities": [[89, 95, "DISEASE"]]}], ["The aim of our study was to investigate the use of TCM in pediatric cancer patients.", {"entities": [[68, 74, "DISEASE"]]}], ["We analyzed cancer patients younger than 18 years (n = 12\u2009965) who were registered in the National Health Insurance Research Database in Taiwan between 2001 and 2011.", {"entities": [[12, 18, "DISEASE"]]}], ["Patients were categorized into TCM or non\u2013TCM users based on their use of TCM.", {"entities": []}], ["In Taiwan, 8086 (62.4%) children with cancer sought TCM treatment at some point.", {"entities": [[38, 44, "DISEASE"]]}], ["Children in older age groups, including school-aged children and adolescents, were more likely to use TCM.", {"entities": []}], ["There was no significant difference in the distributions of gender and urbanization.", {"entities": []}], ["The 3 most common diseases for which TCM users visited the clinic were neoplasm (33.2%), respiratory system disease (32.9%), and infectious disease (8.86%).", {"entities": [[89, 115, "DISEASE"]]}], ["The most commonly utilized TCM therapy was Chinese herbal remedies.", {"entities": []}], ["Patients who had comorbid conditions such as allergic rhinitis, dyspepsia, disorders of menstruation, and disease of the musculoskeletal system and connective tissue tended to visit TCM clinics.", {"entities": [[45, 62, "DISEASE"], [64, 73, "DISEASE"], [54, 62, "DISEASE"]]}], ["Conclusions .", {"entities": []}], ["Adjunctive TCM use is not low in Taiwanese children with cancer.", {"entities": [[57, 63, "DISEASE"]]}], ["Further studies to investigate the efficacy and safety of TCM in children with cancer are warranted.", {"entities": [[79, 85, "DISEASE"]]}], ["In preterm infants, the need for intubation and mechanical ventilation is associated with ventilator-induced lung injuries and subsequent bronchopulmonary dysplasia.", {"entities": []}], ["The aim of the present review was to improve the understanding of the mechanisms of injury that involve cytokine-mediated inflammation to contribute to the development of new preventive strategies.", {"entities": []}], ["Relevant articles were retrieved from the PubMed database using the search terms \"ventilator-induced lung injury preterm\", \"continuous positive airway pressure\", \"preterm\", and \"bronchopulmonary dysplasia\".", {"entities": []}], ["The resulting data and other relevant information were divided into several topics to ensure a thorough, critical view of ventilation-induced lung injury and its consequences in preterm infants.", {"entities": []}], ["The role of pro-inflammatory cytokines (particularly interleukins 6 and 8 and tumor necrosis factor alpha) as mediators of lung injury was assessed.", {"entities": []}], ["Evidence from studies conducted with animals and human newborns is described.", {"entities": []}], ["This evidence shows that brief periods of mechanical ventilation is sufficient to induce the release of pro-inflammatory cytokines.", {"entities": []}], ["Other forms of mechanical and non-invasive ventilation were also analyzed as protective alternatives to conventional mechanical ventilation.", {"entities": []}], ["It was concluded that non-invasive ventilation, intubation followed by early surfactant administration and quick extubation for nasal continuous positive airway pressure, and strategies that regulate tidal volume and avoid volutrauma (such as volume guarantee ventilation) protect against ventilator-induced lung injury in preterm infants.", {"entities": []}], ["Satellite measurements have distinct advantages over conventional ground measurements because they can collect the information repeatedly and automatically.", {"entities": []}], ["Since 1970 globally and 1985 in China, the availability of remote sensing (RS) techniques has steadily grown and they are becoming increasingly important to improve our understanding of human health.", {"entities": []}], ["This paper gives the first detailed overview on the developments of RS applications for disease control in China.", {"entities": []}], ["The problems, challenges and future directions are also discussed with an aim of guiding prospective studies.", {"entities": []}], ["Chronic otitis media with effusion (COME) is a prevalent upper airway infection resulting in hearing loss.", {"entities": [[8, 20, "DISEASE"]]}], ["The aim of this research was to determine risk factors for COME in preschool children.", {"entities": []}], ["A case\u2013control design was conducted in Auckland, New Zealand from May 2011 until November 2013.", {"entities": []}], ["The cases were children aged 3 and 4\u00a0years referred for tympanostomy tube placement due to a diagnosis of COME ( n \u2009=\u2009178).", {"entities": []}], ["The controls were a random sample of healthy children aged 3 and 4\u00a0years from primary care practices ( n \u2009=\u2009209).", {"entities": []}], ["The children\u2019s guardians completed an interviewer-administered questionnaire that covered topics including socio-demographic information, pregnancy and birth, infant feeding practices, home environment, and respiratory health.", {"entities": []}], ["In addition, skin prick tests for atopy were performed.", {"entities": []}], ["Odds ratios (OR) estimating the risk of COME independently associated with the exposures were calculated using a logistic regression model.", {"entities": []}], ["Children with COME frequently had nasal obstruction (OR: 4.38 [95% CI: 2.37\u20138.28]), always snored (OR: 3.64 [95% CI: 1.51\u20139.15]) or often snored (OR: 2.45 [95% CI: 1.04\u20135.96]), spent more hours per week in daycare (OR per hour/week: 1.03 [95% CI: 1.00\u20131.05]), had frequent colds (OR: 2.67 [95% CI: 1.59\u20134.53]), had siblings who had undergone tympanostomy tube placement (OR: 2.68 [95% CI: 1.22\u20136.02]), underwent long labour (OR: 2.59 [95% CI: 1.03\u20136.79]), and had early introduction of cow\u2019s milk (OR: 1.76 [95% CI: 1.05\u20132.97]).", {"entities": []}], ["Asian ethnicity (OR: 0.20 [95% CI: 0.07\u20130.53]) and having older siblings (OR: 0.54 [95% CI: 0.31\u20130.93]) were inversely associated with COME.", {"entities": []}], ["COME in preschool children was associated with pathogen exposure, respiratory infection, and nasal obstruction.", {"entities": []}], ["Strategies to prevent pathogen transmission warrant investigation.", {"entities": []}], ["The novel findings of long labour and early cow\u2019s milk introduction require replication in future studies.", {"entities": []}], ["Positive attitude toward evidence-based practice (EBP) principles in healthcare education may be one of the first steps for motivating a healthcare professional student to later apply EBP principles in clinical decision-making.", {"entities": [[50, 53, "GENE"], [184, 187, "GENE"], [50, 53, "GENE"], [184, 187, "GENE"]]}], ["The objectives for this project were to pilot an international web-based survey of chiropractic students and to describe student attitudes, behaviors, and knowledge about EBP principles.", {"entities": [[171, 174, "GENE"]]}], ["We used SurveyMonkey\u2122 to develop our survey based on an existing questionnaire used to measure basic knowledge, skills and beliefs about EBP among allied healthcare professionals and CAM practitioners.", {"entities": [[137, 140, "GENE"]]}], ["We invited 26 chiropractic educational institutions teaching in English and accredited by official organizations to participate.", {"entities": []}], ["Academic officials and registrars at participating institutions forwarded an invitation email and two reminders to students between July and September 2010.", {"entities": []}], ["The invitation contained a link to the 38-item web-based questionnaire.", {"entities": []}], ["Descriptive statistics were performed for analysis.", {"entities": []}], ["Fourteen institutions from Australia, Canada, US, Denmark and New Zealand participated.", {"entities": []}], ["Among an estimated 7,142 student recipients of invitation letters, 674 participated in the survey for an estimated response rate of 9.4%.", {"entities": []}], ["Most respondents reported having access to medical/healthcare literature through the internet, but only 11% read literature every week and 21% did not read literature at all.", {"entities": []}], ["Respondents generally agreed that the use of research evidence in chiropractic was important.", {"entities": []}], ["Although 76% of respondents found it easy to understand research evidence and 81% had some level of confidence assessing the general worth of research articles, 71% felt they needed more training in EBP to be able to apply evidence in chiropractic care.", {"entities": [[199, 202, "GENE"]]}], ["Respondents without previous training in research methods had lower confidence in assessing published papers.", {"entities": []}], ["While more than 60% marked the correct answer for two knowledge items, the mean number of correct answers to the five knowledge questions was 1.3 (SD 0.9).", {"entities": []}], ["Although it is feasible to conduct an international web survey of chiropractic students, significant stakeholder participation is important to improve response rates.", {"entities": []}], ["Students had relatively positive attitudes toward EBP.", {"entities": [[50, 53, "GENE"]]}], ["However, participants felt they needed more training in EBP and based on the knowledge questions they may need further training about basic research concepts.", {"entities": [[56, 59, "GENE"]]}], ["The role of soluble factors in the suppression of allergic airway inflammation by adipose-derived stem cells (ASCs) remains to be elucidated.", {"entities": []}], ["Moreover, the major soluble factors responsible for the immunomodulatory effects of ASCs in allergic airway diseases have not been well documented.", {"entities": []}], ["We evaluated the effects of ASCs on allergic inflammation in asthmatic mice treated with a prostaglandin E2 (PGE2) inhibitor or transforming growth factor-\u03b2 (TGF-\u03b2) neutralizing antibodies.", {"entities": []}], ["Asthmatic mice were injected intraperitoneally with a PGE2 inhibitor or TGF-\u03b2 neutralizing antibodies at approximately the same time as ASCs injection and were compared with non-treated controls.", {"entities": []}], ["In asthmatic mice, ASCs significantly reduced airway hyperresponsiveness, the number of total inflammatory cells and eosinophils in the bronchoalveolar lavage fluid (BALF), eosinophilic inflammation, goblet cell hyperplasia, and serum total and allergen-specific IgE and IgG1.", {"entities": []}], ["ASCs significantly inhibited Th2 cytokines, such as interleukin (IL)-4, IL-5, and IL-13, and enhanced the Th1 cytokine (Interferon-\u03b3) and regulatory cytokines (IL-10 and TGF-\u03b2) in the BALF and lung draining lymph nodes (LLNs).", {"entities": []}], ["ASCs engraftment caused significant increases in the regulatory T cell (Treg) and IL-10 ASCs are capable of secreting PGE2 and TGF-\u03b2, which may play a role in inducing Treg expansion.", {"entities": []}], ["Furthermore, treatment with a PGE2 inhibitor or TGF-\u03b2 neutralizing antibodies eliminated the beneficial effect of ASCs treatment in asthmatic mice, suggesting that PGE2 and TGF-\u03b2 are the major soluble factors responsible for suppressing allergic airway inflammation.", {"entities": []}], ["The inhalation of normal or hypertonic saline during sputum induction (SI) may act as an indirect bronchoconstrictive stimulus leading to dyspnea and lung function deterioration.", {"entities": []}], ["Our aim was to assess dyspnea and adverse events in COPD patients who undergo SI following a safety protocol.", {"entities": []}], ["Sputum was induced by normal and hypertonic (4.5%) saline solution in 65 patients with COPD of varying severity.", {"entities": []}], ["In order to minimize saline-induced bronchoconstriction a protocol based on the European Respiratory Society sputum induction Task group report was followed.", {"entities": []}], ["Dyspnea change was scored using the Borg scale and lung function was assessed by spirometry and oximetry.", {"entities": []}], ["Borg score changes [median(IQR) 1.5(0\u20132)] were observed during SI in 40 subjects; 16 patients required temporary discontinuation of the procedure due to dyspnea-general discomfort and 2 did not complete the session due to dyspnea-wheezing.", {"entities": []}], ["The change in Borg dyspnea score was significantly correlated with oxygen saturation and heart rate changes and with discontinuation of the procedure due to undesired symptoms.", {"entities": []}], ["19 subjects presented an hyperresponsive reaction (decline>20% from baseline FEV 1 ).", {"entities": [[77, 80, "GENE"]]}], ["No significant correlation between Borg changes and FEV 1 decline was found.", {"entities": [[52, 55, "GENE"]]}], ["Patients with advanced COPD presented significantly greater Borg and oxygen saturation changes than patients with less severe disease (p = 0.02 and p = 0.001, respectively).", {"entities": []}], ["Baseline FEV 1 , oxygen saturation and 6MWT demonstrated significant diagnostic values in distinguishing subjects who develop an adverse physiologic reaction during the procedure.", {"entities": [[9, 12, "GENE"]]}], ["COPD patients undergoing SI following a safety protocol do not experience major adverse events.", {"entities": []}], ["Dyspnea and oxygen desaturation is more likely to occur in patients with disease in advanced stages, leading to short discontinuation or less frequently to termination of the procedure.", {"entities": []}], ["Baseline FEV 1 , oxygen saturation and 6MWT may have a prognostic value for the development of these adverse events and might be useful to be evaluated in advance.", {"entities": [[9, 12, "GENE"]]}], ["Cancer chemotherapy is still hampered by clinical failures due to multi-drug resistance (MDR) of tumor cells.", {"entities": [[0, 6, "DISEASE"]]}], ["In the present study, we have investigated the cytotoxicity of 20 methanol extracts from 10 medicinal plants against the sensitive leukemia CCRF-CEM cells.", {"entities": [[131, 139, "DISEASE"]]}], ["The most cytotoxic extracts were then further tested on a panel of 8 human cancer cell lines, including various MDR phenotypes.", {"entities": [[75, 81, "DISEASE"]]}], ["The cytotoxicity of the 20 methanol extracts from 10 Cameroonian medicinal plants was determined using a resazurin reduction assay.", {"entities": []}], ["Meanwhile, flow cytometry was used to measure cell cycle, apoptosis, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS).", {"entities": []}], ["In the preliminary assay using CCRF-CEM cells, 12 extracts from five plants displayed IC 50 values below 80\u00a0\u03bcg/mL, namely Albizia adianthifolia, Alchornea cordifolia, Alchornea laxiflora, Pennisetum purpureum, and Spathodea campanulata .", {"entities": []}], ["the four best extracts were from two plants: Albizia adianthifolia roots (AAR) and bark (AAB) as well as Alchornea cordifolia leaves (ACL) and bark (ACB) had respective IC 50 values of 0.98\u00a0\u03bcg/mL, 1.45\u00a0\u03bcg/mL, 8.02\u00a0\u03bcg/mL and 12.57\u00a0\u03bcg/mL in CCRF-CEM cells.", {"entities": []}], ["They were further tested in 8 other cell lines as well as in normal AML12 hepatocytes.", {"entities": []}], ["IC 50 values ranging from 2.71\u00a0\u03bcg/mL (towards glioblastoma U87MG.\u0394 EGFR cells) to 10.30\u00a0\u03bcg/mL (towards breast adenocarcinoma MDA-MB-231- BCRP cells) for AAB, from 3.43\u00a0\u03bcg/mL (towards U87MG cells) to 10.77\u00a0\u03bcg/mL (towards colon carcinoma HCT116 ( p53 Some of the tested plants namely Albizia adianthifolia, Alchornea cordifolia, Alchornea laxiflora, Pennisetum purpureum, Spathodea campanulata represent a potential source of novel anticancer drugs.", {"entities": [[110, 124, "DISEASE"], [46, 58, "DISEASE"], [103, 124, "DISEASE"], [226, 235, "DISEASE"], [220, 235, "DISEASE"], [67, 71, "GENE"]]}], ["Especially, Albizia adianthifolia and Alchornea cordifolia revealed considerable cytotoxic activities that could be exploited to develop phytomedicines to fight cancers including MDR phenotypes.", {"entities": []}], ["Growing urbanisation and population requiring enhanced electricity generation as well as the increasing numbers of fossil fuel in Thailand pose important challenges to air quality management which impacts on the health of the population.", {"entities": []}], ["Mortality attributed to ambient air pollution is one of the sustainable development goals (SDGs).", {"entities": []}], ["We estimated the spatial pattern of mortality burden attributable to selected ambient air pollution in 2009 based on the empirical evidence in Thailand.", {"entities": []}], ["We estimated the burden of disease attributable to ambient air pollution based on the comparative risk assessment (CRA) framework developed by the World Health Organization (WHO) and the Global Burden of Disease study (GBD).", {"entities": []}], ["We integrated geographical information systems (GIS)-based exposure assessments into spatial interpolation models to estimate ambient air pollutant concentrations, the population distribution of exposure and the concentration-response (CR) relationship to quantify ambient air pollution exposure and associated mortality.", {"entities": []}], ["We obtained air quality data from the Pollution Control Department (PCD) of Thailand surface air pollution monitoring network sources and estimated the CR relationship between relative risk (RR) and concentration of air pollutants from the epidemiological literature.", {"entities": []}], ["We estimated 650\u201338,410 ambient air pollution-related fatalities and 160\u20135,982 fatalities that could have been avoided with a 20 reduction in ambient air pollutant concentrations.", {"entities": []}], ["The summation of population-attributable fraction (PAF) of the disease burden for all-causes mortality in adults due to NO 2 and PM 2.5 were the highest among all air pollutants at 10% and 7.5%, respectively.", {"entities": []}], ["The PAF summation of PM 2.5 for lung cancer and cardiovascular disease were 16.8% and 14.6% respectively and the PAF summations of mortality attributable to PM 10 was 3.4% for all-causes mortality, 1.7% for respiratory and 3.8% for cardiovascular mortality, while the PAF summation of mortality attributable to NO 2 was 7.8% for respiratory mortality in Thailand.", {"entities": [[32, 43, "DISEASE"], [37, 43, "DISEASE"]]}], ["Mortality due to ambient air pollution in Thailand varies across the country.", {"entities": []}], ["Geographical distribution estimates can identify high exposure areas for planners and policy-makers.", {"entities": []}], ["Our results suggest that the benefits of a 20% reduction in ambient air pollution concentration could prevent up to 25% of avoidable fatalities each year in all-causes, respiratory and cardiovascular categories.", {"entities": []}], ["Furthermore, our findings can provide guidelines for future epidemiological investigations and policy decisions to achieve the SDGs.", {"entities": []}], ["The CDH1 gene plays an important role during carcinogenesis and craniofacial morphogenesis.", {"entities": [[4, 8, "GENE"]]}], ["Germline mutations in this gene have been described in families presenting syndromic diffuse gastric cancer and orofacial clefts.", {"entities": [[101, 107, "DISEASE"]]}], ["The aim of this study was to evaluate the association between nucleotide variants of CDH1 and the risk of non-syndromic cleft lip with or without cleft palate (NSCL/P).", {"entities": [[120, 129, "DISEASE"], [146, 158, "DISEASE"], [85, 89, "GENE"]]}], ["Six single nucleotide polymorphisms (SNPs) of the CDH1 gene (rs16260, rs9929218, rs7186053, rs4783573, rs16958383, and rs1801552) were genotyped using the TaqMan SNP genotyping assays in 250 patients with NSCL/P and 540 controls from the Polish population.", {"entities": [[50, 54, "GENE"]]}], ["Comparison between patient and control groups showed that the CDH1 rs1801552 variant, under the assumption of recessive model, was associated with a two-fold decrease in the risk of NSCL/P (OR TT vs CT\u00a0+\u00a0CC \u00a0=\u00a00.481, 95\u00a0% CI 0.281\u20130.824, p \u00a0=\u00a00.007).", {"entities": [[62, 66, "GENE"]]}], ["This association remained statistically significant even after the multiple testing correction.", {"entities": []}], ["No significant associations with NSCL/P risk were found for the other five tested SNPs.", {"entities": []}], ["We found a strong association between the cancer predisposing gene CDH1 and the risk of NSCL/P in the Polish population.", {"entities": [[42, 48, "DISEASE"], [67, 71, "GENE"]]}], ["This result, together with previous observations of co-occurrence of orofacial clefts and a variety of cancer types, suggests the need for replication studies testing rs1801552 in NSCL/P cohorts with a known cancer history.", {"entities": [[103, 109, "DISEASE"], [208, 214, "DISEASE"]]}], ["Background: There is an increased prevalence of diabetes.", {"entities": []}], ["Doctors in training, irrespective of specialty, will have patients with diabetes under their care.", {"entities": []}], ["Aim: To determine levels of confidence of doctors in training in the management of diabetes and establish their training needs in this area of clinical practice Design: A national online survey of trainee doctors in the UK using a pre-validated questionnaire.", {"entities": []}], ["Methods: A four-point confidence rating scale was used to rate confidence in the management of diabetes and comparators.", {"entities": []}], ["A six-point scale was used to quantify how often trainees would contribute to the management of patients with diabetes and trainees were asked about their training in managing diabetes.", {"entities": []}], ["Results: A total of 2149 doctors completed the survey.", {"entities": []}], ["The percentage \u2018fully confident\u2019 in diagnosing diabetes was 27%, diagnosing and managing hypoglycaemia 55%, diagnosing and managing diabetic ketoacidosis 43%, managing intravenous (IV) insulin 27%, prescribing IV fluids for patients with diabetes 39% and altering diabetes therapy prior to surgery/other procedure 18%.", {"entities": [[132, 153, "DISEASE"]]}], ["In comparison, 66% and 65% were \u2018fully confident\u2019 in the management of angina and asthma, respectively ( P \u2009<\u20090.05).", {"entities": [[82, 88, "DISEASE"]]}], ["Forty-one percent would take the initiative to optimize glycaemic control for patients under their care >80% of the time.", {"entities": []}], ["Respectively, 19% and 35% of respondents reported that their undergraduate and postgraduate training had prepared them adequately to optimize treatment of diabetes.", {"entities": []}], ["The majority (>70%) wanted further training in managing all aspects of diabetes care.", {"entities": []}], ["Conclusions: Trainee doctors in the UK lack confidence in the management of diabetes, are unlikely to take the initiative to optimize glycaemic control and report a need for further training.", {"entities": []}], ["Annotation of a set of genes is often accomplished through comparison to a library of labelled gene sets such as biological processes or canonical pathways.", {"entities": []}], ["However, this approach might fail if the employed libraries are not up to date with the latest research, don't capture relevant biological themes or are curated at a different level of granularity than is required to appropriately analyze the input gene set.", {"entities": []}], ["At the same time, the vast biomedical literature offers an unstructured repository of the latest research findings that can be tapped to provide thematic sub-groupings for any input gene set.", {"entities": []}], ["Our proposed method relies on a gene-specific text corpus and extracts commonalities between documents in an unsupervised manner using a topic model approach.", {"entities": []}], ["We automatically determine the number of topics summarizing the corpus and calculate a gene relevancy score for each topic allowing us to eliminate non-specific topics.", {"entities": []}], ["As a result we obtain a set of literature topics in which each topic is associated with a subset of the input genes providing directly interpretable keywords and corresponding documents for literature research.", {"entities": []}], ["We validate our method based on labelled gene sets from the KEGG metabolic pathway collection and the genetic association database (GAD) and show that the approach is able to detect topics consistent with the labelled annotation.", {"entities": []}], ["Furthermore, we discuss the results on three different types of experimentally derived gene sets, (1) differentially expressed genes from a cardiac hypertrophy experiment in mice, (2) altered transcript abundance in human pancreatic beta cells, and (3) genes implicated by GWA studies to be associated with metabolite levels in a healthy population.", {"entities": []}], ["In all three cases, we are able to replicate findings from the original papers in a quick and semi-automated manner.", {"entities": []}], ["Our approach provides a novel way of automatically generating meaningful annotations for gene sets that are directly tied to relevant articles in the literature.", {"entities": []}], ["Extending a general topic model method, the approach introduced here establishes a workflow for the interpretation of gene sets generated from diverse experimental scenarios that can complement the classical approach of comparison to reference gene sets.", {"entities": []}], ["Quilizumab, a humanized IgG1 monoclonal antibody, targets the M1-prime segment of membrane-expressed IgE, leading to depletion of IgE-switched and memory B cells.", {"entities": []}], ["In patients with mild asthma, quilizumab reduced serum IgE and attenuated the early and late asthmatic reaction following whole lung allergen challenge.", {"entities": [[22, 28, "DISEASE"]]}], ["This study evaluated the efficacy and safety of quilizumab in adults with allergic asthma, inadequately controlled despite high-dose inhaled corticosteroids (ICS) and a second controller.", {"entities": [[74, 89, "DISEASE"], [83, 89, "DISEASE"]]}], ["Five hundred seventy-eight patients were randomized to monthly or quarterly dosing regimens of subcutaneous quilizumab or placebo for 36\u00a0weeks, with a 48-week safety follow-up.", {"entities": []}], ["Quilizumab was evaluated for effects on the rate of asthma exacerbations, lung function, patient symptoms, serum IgE, and pharmacokinetics.", {"entities": [[52, 58, "DISEASE"]]}], ["Exploratory analyses were conducted on biomarker subgroups (periostin, blood eosinophils, serum IgE, and exhaled nitric oxide).", {"entities": []}], ["Quilizumab was well tolerated and reduced serum total and allergen-specific IgE by 30\u201340\u00a0%, but had no impact on asthma exacerbations, lung function, or patient-reported symptom measures.", {"entities": [[113, 119, "DISEASE"]]}], ["At Week 36, the 300\u00a0mg monthly quilizumab group showed a 19.6\u00a0% reduction ( p\u2009= \u20090.38) in the asthma exacerbation rate relative to placebo, but this was neither statistically nor clinically significant.", {"entities": [[94, 100, "DISEASE"]]}], ["Biomarker subgroups did not reveal meaningful efficacy benefits following quilizumab treatment.", {"entities": []}], ["Quilizumab had an acceptable safety profile and reduced serum IgE.", {"entities": []}], ["However, targeting the IgE pathway via depletion of IgE-switched and memory B cells was not sufficient for a clinically meaningful benefit for adults with allergic asthma uncontrolled by standard therapy.", {"entities": [[155, 170, "DISEASE"], [164, 170, "DISEASE"]]}], ["ClinicalTrials.gov NCT01582503 The online version of this article (doi:10.1186/s12931-016-0347-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Diabetes confers an increased risk for cardiovascular effects of airborne particles.", {"entities": []}], ["We hypothesized that inhalation of elemental carbon ultrafine particles (UFP) would activate blood platelets and vascular endothelium in people with type 2 diabetes.", {"entities": []}], ["In a randomized, double-blind, crossover trial, 19 subjects with type 2 diabetes inhaled filtered air or 50 \u03bcg/m Compared with air, particle exposure increased platelet expression of CD40 ligand (CD40L) and the number of platelet-leukocyte conjugates 3.5 hr after exposure.", {"entities": [[183, 187, "GENE"], [255, 257, "GENE"]]}], ["Soluble CD40L decreased with UFP exposure.", {"entities": []}], ["Plasma von Willebrand factor increased immediately after exposure.", {"entities": []}], ["There were no effects of particles on plasma tissue factor, coagulation factors VII or IX, or D-dimer.", {"entities": []}], ["Inhalation of elemental carbon UFP for 2-hr transiently activated platelets, and possibly the vascular endothelium, in people with type 2 diabetes.", {"entities": []}], ["Why and when the immune system skews to Th2 mediated allergic immune responses is still poorly characterized.", {"entities": []}], ["With two homologous lipocalins, the major respiratory dog allergen Can f 1 and the human endogenous, non-allergenic Lipocalin-1, we investigated their impact on human monocyte-derived dendritic cells (DC).", {"entities": []}], ["The two lipocalins had differential effects on DC according to their allergenic potential.", {"entities": []}], ["Compared to Lipocalin-1, Can f 1 persistently induced lower levels of the Th1 skewing maturation marker expression, tryptophan breakdown and interleukin (IL)-12 production in DC.", {"entities": []}], ["As a consequence, T cells stimulated by DC treated with Can f 1 produced more of the Th2 signature cytokine IL-13 and lower levels of the Th1 signature cytokine interferon-\u03b3 than T cells stimulated by Lipocalin-1 treated DC.", {"entities": []}], ["These data were partially verified by a second pair of homologous lipocalins, the cat allergen Fel d 4 and its putative human homologue major urinary protein.", {"entities": []}], ["Our data indicate that the crosstalk of DC with lipocalins alone has the potential to direct the type of immune response to these particular antigens.", {"entities": []}], ["A global gene expression analysis further supported these results and indicated significant differences in intracellular trafficking, sorting and antigen presentation pathways when comparing Can f 1 and Lipocalin-1 stimulated DC.", {"entities": []}], ["With this study we contribute to a better understanding of the induction phase of a Th2 immune response.", {"entities": []}], ["Computational prediction and in vivo protein coupling experiments identify candidate plant G-protein coupled receptors in Arabidopsis , rice and poplar.", {"entities": []}], ["The classic paradigm of heterotrimeric G-protein signaling describes a heptahelical, membrane-spanning G-protein coupled receptor that physically interacts with an intracellular G\u03b1 subunit of the G-protein heterotrimer to transduce signals.", {"entities": []}], ["G-protein coupled receptors comprise the largest protein superfamily in metazoa and are physiologically important as they sense highly diverse stimuli and play key roles in human disease.", {"entities": []}], ["The heterotrimeric G-protein signaling mechanism is conserved across metazoa, and also readily identifiable in plants, but the low sequence conservation of G-protein coupled receptors hampers the identification of novel ones.", {"entities": []}], ["Using diverse computational methods, we performed whole-proteome analyses of the three dominant model plant species, the herbaceous dicot Arabidopsis thaliana (mouse-eared cress), the monocot Oryza sativa (rice), and the woody dicot Populus trichocarpa (poplar), to identify plant protein sequences most likely to be GPCRs.", {"entities": []}], ["Our stringent bioinformatic pipeline allowed the high confidence identification of candidate G-protein coupled receptors within the Arabidopsis , Oryza , and Populus proteomes.", {"entities": []}], ["We extended these computational results through actual wet-bench experiments where we tested over half of our highest ranking Arabidopsis candidate G-protein coupled receptors for the ability to physically couple with GPA1, the sole G\u03b1 in Arabidopsis .", {"entities": []}], ["We found that seven out of eight tested candidate G-protein coupled receptors do in fact interact with GPA1.", {"entities": []}], ["We show through G-protein coupled receptor classification and molecular evolutionary analyses that both individual G-protein coupled receptor candidates and candidate G-protein coupled receptor families are conserved across plant species and that, in some cases, this conservation extends to metazoans.", {"entities": []}], ["Our computational and wet-bench results provide the first step toward understanding the diversity, conservation, and functional roles of plant candidate G-protein coupled receptors.", {"entities": []}], ["Peanuts are one of the most relevant foods implicated in IgE-mediated adverse reactions in pediatric population.", {"entities": []}], ["This study aimed to evaluate the pattern of sensitization towards five peanut allergenic components (rAra h 1, 2, 3, 8 and 9) in a population of Italian children and adolescents with specific IgE (sIgE) to peanut.", {"entities": [[101, 105, "GENE"]]}], ["rAra h 9 was the main allergen implicated in peanut sensitization (58%), followed by rAra h 8 (35%), rAra h 2 (27%), rAra h 3 (23%) and rAra h 1 (12.5%).", {"entities": [[0, 4, "GENE"], [85, 89, "GENE"], [101, 105, "GENE"], [117, 121, "GENE"], [136, 140, "GENE"], [0, 4, "GENE"], [85, 89, "GENE"], [101, 105, "GENE"], [117, 121, "GENE"], [136, 140, "GENE"], [0, 4, "GENE"], [85, 89, "GENE"], [101, 105, "GENE"], [117, 121, "GENE"], [136, 140, "GENE"], [0, 4, "GENE"], [85, 89, "GENE"], [101, 105, "GENE"], [117, 121, "GENE"], [136, 140, "GENE"], [0, 4, "GENE"], [85, 89, "GENE"], [101, 105, "GENE"], [117, 121, "GENE"], [136, 140, "GENE"]]}], ["rAra h 1, 2, and 3 were the main allergenic components in young children: 8/13 (62%) between 2 and 5 years, 8/23 (35%) between 6 and 11 years, and 3/12 (25%) between 1 and 16 years.", {"entities": [[0, 4, "GENE"]]}], ["No differences were found among the levels of sIgE towards rAra h 1, 2, 3, and 9 in the three groups; in contrast, the levels of sIgE against rAra h 8 showed an increasing trend according to age.", {"entities": [[59, 63, "GENE"], [142, 146, "GENE"], [59, 63, "GENE"], [142, 146, "GENE"]]}], ["In conclusion rAra h 1, 2, and 3 were the prevalent sensitizing allergens during the first years of life in Italian patients with sIgE to peanuts (\u201cgenuine\u201d allergy); in contrast rAra h 9 and 8 were mainly involved in school-age children and adolescents with pollen allergy (\u201csecondary\u201d sensitization).", {"entities": [[14, 18, "GENE"], [179, 183, "GENE"], [14, 18, "GENE"], [179, 183, "GENE"]]}], ["To study whether presenilin 1 ( PSEN1 ), apolipoprotein E ( APOE ), and kinesin light chain 1 ( KLC1 ) genotypes are associated with the risk of developing age-related cortical cataracts in the Han Chinese population.", {"entities": [[32, 37, "GENE"], [60, 64, "GENE"]]}], ["We collected and analyzed the blood samples of 227 cortical cataract patients and 263 controls.", {"entities": [[60, 68, "DISEASE"]]}], ["Genotyping was performed by direct sequencing after PCR amplification, and allele frequencies were tested for the Hardy\u2013Weinberg equilibrium.", {"entities": []}], ["The G allele and GG genotype of KLC1 rs8702 were significantly over-represented among cataract patients, as compared to healthy controls (allele P[\u03c72]=0.001 and genotype P[\u03c72]=0.008, respectively) and are associated with an odds ratio for cataract development of 1.54 (95% confidence interval of 1.19\u20132.01).", {"entities": [[86, 94, "DISEASE"], [239, 247, "DISEASE"]]}], ["More specifically, carrying the rs8702 C allele was associated with a decreased cortical cataract risk among individuals devoid of the APOE4 allele (OR=0.55; P[\u03c72]=0.003), whereas it has no significant effect among APOE4 carriers (OR=0.57; P[\u03c72]=0.36).", {"entities": [[89, 97, "DISEASE"]]}], ["The KLC1 and APOE genes may be novel susceptibility genes for age-related cataracts.", {"entities": [[13, 17, "GENE"]]}], ["The T-helper (Th)1/Th2 dichotomy dominated the field of immune regulation until interleukin (IL)-17-expressing T cells (Th17) were proposed to be a third lineage of helper T cells, the key players in the pathogenesis of autoimmune disorders.", {"entities": []}], ["Autoimmunity to brain tissue may play a pathogenic role in autism.", {"entities": []}], ["IL-17A is a pro-inflammatory cytokine that has been shown to play an important role in various autoimmune neuroinflammatory diseases.", {"entities": []}], ["The aim of this study was to measure serum levels of IL-17A in relation to the degree of the severity of autism.", {"entities": []}], ["Serum IL-17A levels were measured by ELISA in 45 children with autism and 40 matched healthy controls.", {"entities": []}], ["Children with autism had significantly higher serum IL-17A levels than healthy controls ( P <0.001), with increased serum levels of IL-17A found in 48.9% of the autism group.", {"entities": []}], ["Patients with severe autism had significantly higher serum IL-17A levels than those with mild to moderate autism ( P \u2009=\u20090.01), and raised serum IL-17A levels were significantly more common in children with severe autism (67.9%) than in those with mild to moderate autism (17.6%), P \u2009=\u20090.001.", {"entities": []}], ["Serum IL-17A levels were raised in the group with autism, and the levels correlated significantly with the severity of autism.", {"entities": []}], ["This is the first study to measure levels of IL-17A in relation to the severity of autism, to our knowledge.", {"entities": []}], ["Further research, with a larger subject population, is warranted to determine whether the increase of serum IL-17A levels plasma has a pathogenic role in autism, and whether anti- IL-17A therapy could be useful", {"entities": []}], ["We characterized the prevalence of cockroach allergen exposure in a nationally representative sample of U.S. homes and assessed risk factors for elevated concentrations.", {"entities": []}], ["We used data from the National Survey of Lead and Allergens in Housing, a population-based cross-sectional survey.", {"entities": []}], ["Participants were residents of 831 U.S. homes in the survey.", {"entities": []}], ["We analyzed allergen, questionnaire, and observational data of 831 U.S. homes.", {"entities": []}], ["Cockroach allergen (Bla g 1) concentrations exceed 2.0 U/g, a level associated with allergic sensitization, in 11% of U.S. living room floors and 13% of kitchen floors.", {"entities": []}], ["Concentrations exceed 8.0 U/g, a level associated with asthma morbidity, in 3% of living room floors and 10% of kitchen floors.", {"entities": [[55, 61, "DISEASE"]]}], ["Elevated concentrations were observed in high-rise apartments, urban settings, pre-1940 constructions, and households with incomes < $20,000.", {"entities": []}], ["Odds of having concentrations > 8.0 U/g were greatest when roach problems were reported or observed and increased with the number of cockroaches observed and with indications of recent cockroach activity.", {"entities": []}], ["Household cockroach allergen exposure is characterized in a nationally representative context.", {"entities": []}], ["The allergen is prevalent in many settings, at levels that may contribute to allergic sensitization and asthma morbidity.", {"entities": [[104, 110, "DISEASE"]]}], ["Likelihood of exposure can be assessed by consideration of demographic and household determinants.", {"entities": []}], ["Change in the prevalence of asthma-like symptoms in populations of ageing adults is likely to be influenced by smoking, asthma treatment and atopy.", {"entities": [[28, 34, "DISEASE"], [120, 126, "DISEASE"]]}], ["The European Community Respiratory Health Survey collected information on prevalent asthma-like symptoms from representative samples of adults aged 20\u201344 years (29 centres in 13 European countries and Australia) at baseline and 10 and 20 years later (n=7844).", {"entities": [[84, 90, "DISEASE"]]}], ["Net changes in symptom prevalence were determined using generalised estimating equations (accounting for non-response through inverse probability weighting), followed by meta-analysis of centre level estimates.", {"entities": []}], ["Over 20 years the prevalence of \u2018wheeze\u2019 and \u2018wheeze in the absence of a cold\u2019 decreased (\u22122.4%, 95%\u2009CI \u22123.5 to \u22121.3%; \u22121.5%, 95%\u2009CI \u22122.4 to \u22120.6%, respectively) but the prevalence of asthma attacks, use of asthma medication and hay fever/nasal allergies increased (0.6%, 95%\u2009CI 0.1 to 1.11; 3.6%, 95%\u2009CI 3.0 to 4.2; 2.7%, 95%\u2009CI 1.7 to 3.7).", {"entities": [[184, 190, "DISEASE"], [207, 213, "DISEASE"]]}], ["Changes were similar in the first 10 years compared with the second 10 years, except for hay fever/nasal allergies (increase seen in the first 10 years only).", {"entities": []}], ["Decreases in these wheeze-related symptoms were largely seen in the group who gave up smoking, and were seen in those who reported hay fever/nasal allergies at baseline.", {"entities": []}], ["European adults born between 1946 and 1970 have, over the last 20 years, experienced less wheeze, although they were more likely to report asthma attacks, use of asthma medication and hay fever.", {"entities": [[139, 145, "DISEASE"], [162, 168, "DISEASE"]]}], ["Decrease in wheeze is largely attributable to smoking cessation, rather than improved treatment of asthma.", {"entities": [[99, 105, "DISEASE"]]}], ["It may also be influenced by reductions in atopy with ageing.", {"entities": []}], ["The purpose of this project was to expand the Rochester Epidemiology Project (REP) medical records linkage infrastructure to include data from oral healthcare providers.", {"entities": []}], ["The goal of this linkage is to facilitate research studies examining the role of oral health in overall health and quality of life.", {"entities": []}], ["Eight dental practices joined the REP between 2011 and 2015.", {"entities": []}], ["The REP study team has linked oral healthcare information with medical record information from local healthcare providers for 31\u2005750 participants who have resided in Olmsted County, Minnesota.", {"entities": []}], ["Overall, 17\u2005718 (56%) participants are women, 14\u2005318 (45%) are 40\u2005years of age or older and 26\u2005090 (82%) are white.", {"entities": []}], ["A first study using this new information was recently completed.", {"entities": []}], ["This resource was used to determine whether the 2007 guidelines from the American Heart Association affected prescription rates of antibiotics to patients with moderate-risk cardiac conditions prior to dental procedures.", {"entities": []}], ["The REP infrastructure was used to identify a series of patients diagnosed with moderate-risk cardiac conditions by the local healthcare providers (n=1351), and to abstract antibiotic prescriptions from dental records both pre-2007 and post-2007.", {"entities": []}], ["Antibiotic prescriptions prior to dental procedures declined from 62% to 7% following the change in guidelines.", {"entities": []}], ["Dental data from participating practitioners will be updated on an annual basis, and new dental data will be linked to patient medical records.", {"entities": []}], ["In addition, we will continue to invite new dental practices to participate in the REP.", {"entities": []}], ["Finally, we will continue to use this research infrastructure to investigate associations between oral and medical health, and will present findings at conferences and in the scientific literature.", {"entities": []}], ["Cystic fibrosis (CF) is caused by mutations in CF transmembrane conductance regulator (CFTR).", {"entities": [[0, 15, "DISEASE"], [87, 91, "GENE"]]}], ["The most frequent mutation (F508del-CFTR) results in altered proteostasis, that is, in the misfolding and intracellular degradation of the protein.", {"entities": []}], ["The F508del-CFTR proteostasis machinery and its homeostatic regulation are well studied, while the question whether \u2018classical\u2019 signalling pathways and phosphorylation cascades might control proteostasis remains barely explored.", {"entities": []}], ["Here, we have unravelled signalling cascades acting selectively on the F508del-CFTR folding-trafficking defects by analysing the mechanisms of action of F508del-CFTR proteostasis regulator drugs through an approach based on transcriptional profiling followed by deconvolution of their gene signatures.", {"entities": []}], ["Targeting multiple components of these signalling pathways resulted in potent and specific correction of F508del-CFTR proteostasis and in synergy with pharmacochaperones.", {"entities": []}], ["These results provide new insights into the physiology of cellular proteostasis and a rational basis for developing effective pharmacological correctors of the F508del-CFTR defect.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.10365.001 Cystic fibrosis is a genetic disease that commonly affects people of European descent.", {"entities": [[47, 62, "DISEASE"], [68, 83, "DISEASE"]]}], ["The condition is caused by mutations in the gene encoding a protein called \u201ccystic fibrosis transmembrane conductance regulator\u201d (or CFTR for short).", {"entities": [[76, 91, "DISEASE"], [133, 137, "GENE"]]}], ["CFTR forms a channel in the membrane of cells in the lungs that help transport salt across the membrane.", {"entities": [[0, 4, "GENE"]]}], ["Mutated versions of the protein are not as efficient at transporting salts, and eventually this damages the lung tissue.", {"entities": []}], ["As the damage progresses, individuals become very vulnerable to bacterial infections that further damage the lungs and may eventually lead to death.", {"entities": []}], ["One of the reasons CFTR mutations are harmful is that they cause the protein to fold up incorrectly and remain trapped inside the cell.", {"entities": [[19, 23, "GENE"]]}], ["Cells have quality control systems that recognize and destroy poorly folded proteins, and so only a few of the mutated CFTR proteins ever make it to the membrane to move salts.", {"entities": [[119, 123, "GENE"]]}], ["New therapies have been developed that improve folding of the protein and/or help the CFTR proteins that make it to the membrane work better.", {"entities": [[86, 90, "GENE"]]}], ["But more and better treatment options are needed.", {"entities": []}], ["Hegde, Parashuraman et al.", {"entities": []}], ["have now tested drugs that control how proteins fold and move to the membrane to see how they affect gene expression in cells with the most common cystic fibrosis-causing mutation.", {"entities": [[147, 162, "DISEASE"]]}], ["These drugs are known to improve the activity of the CFTR mutant, but do so too weakly to be of clinical interest.", {"entities": [[53, 57, "GENE"]]}], ["The experiments revealed that the expression of a few hundred genes was changed in response the drugs.", {"entities": []}], ["Many of these genes were involved in major signalling pathways that control how CFTR is folded and trafficked within cells.", {"entities": [[80, 84, "GENE"]]}], ["Next, Hegde, Parashuraman et al.", {"entities": []}], ["tested drugs that inhibit these signalling pathways to see if they improve salt handling in the mutated cells.", {"entities": []}], ["The experiments demonstrated that these inhibitor drugs efficiently block the breakdown of misfolded CFTR, or boost the likelihood of CFTR making it to the membrane, helping improve salt trafficking in the cells.", {"entities": [[101, 105, "GENE"], [134, 138, "GENE"], [101, 105, "GENE"], [134, 138, "GENE"]]}], ["The inhibitors produced even better results when used in combination with a known CFTR-protecting drug.", {"entities": []}], ["The results suggest that identifying and targeting signalling pathways involved in the folding, trafficking, and breakdown of CFTR may prove a promising way to treat cystic fibrosis.", {"entities": [[166, 181, "DISEASE"], [126, 130, "GENE"]]}], ["DOI: http://dx.doi.org/10.7554/eLife.10365.002", {"entities": []}], ["Patients and policy makers advocate that drug treatments should be individualised.", {"entities": []}], ["However, the term is used in a variety of ways.", {"entities": []}], ["We set out to identify the range of related terminology and concepts in the general field of individualisation, map out the relationships between these concepts and explore how patients\u2019 perspectives are considered.", {"entities": []}], ["We consulted members of an established patient and public involvement group about their experience of medicine taking for long-term conditions and their ideas about individualisation.", {"entities": []}], ["We then conducted a scoping review of the literature to explore how terms surrounding individualisation of drug treatment are used and defined in the literature, and to explore the extent to which patients\u2019 perspectives are represented, with a view to informing future recommendations as to how individualisation can be operationalised.", {"entities": []}], ["We identified relevant literature using a range of search strategies.", {"entities": []}], ["Two researchers independently extracted definitions of terms using a template.", {"entities": []}], ["Inductive and deductive methods were used to explore the data.", {"entities": []}], ["Definitions were categorised according to the following themes: medical management; pharmacogenetics, the patient's perspective; interactions between the healthcare provider and patient and management of long-term conditions.", {"entities": []}], ["Within the literature reviewed, the involvement of patients in the ongoing management of drug treatment was largely absent.", {"entities": []}], ["We propose the use of a new term \u2018mutually agreed tailoring\u2019 (MAT).", {"entities": []}], ["This describes the ongoing pharmacological management of conditions that incorporates patients\u2019 specific needs, experiences and existing strategies for using their medications, and the professionals\u2019 clinical judgement.", {"entities": []}], ["This usually includes patients monitoring their symptoms and, with the support of the professional, making appropriate product, dose or timing adjustments as necessary.", {"entities": []}], ["Our previous work suggests that many patients and doctors are successfully practising MAT, so we suggest that a formal description may facilitate wider utilisation of strategies that will improve patient outcomes.", {"entities": []}], ["Idiopathic phrenic nerve palsy is a rare cause of exertional dyspnea.", {"entities": []}], ["We present a case of a patient presenting with worsening dyspnea of an unknown etiology found to be related to bilateral phrenic nerve palsy.", {"entities": []}], ["Forty-two-year-old man presented to our emergency department with exertional dyspnea, orthopnea, and a left lower lobe consolidation treated initially as bronchitis by his primary physician as an outpatient, then subsequently as pneumonia at another institution, with no improvement in symptomatology.", {"entities": [[229, 238, "DISEASE"], [154, 164, "DISEASE"]]}], ["After admission to our hospital, CT chest demonstrated only supradiaphragmatic atelectatic changes.", {"entities": []}], ["Echocardiography was normal.", {"entities": []}], ["Bronchoscopy was contemplated however the patient could not lie flat.", {"entities": []}], ["A fluoroscopic sniff test demonstrated diaphragmatic dysfunction and pulmonary function tests revealed restrictive pulmonary disease with evidence of neuromuscular etiology.", {"entities": []}], ["Nerve conduction studies confirmed bilateral phrenic neuropathy.", {"entities": [[53, 63, "DISEASE"]]}], ["He was referred to a specialized neuromuscular disease center where subsequent workup did not demonstrate any specific etiology.", {"entities": [[33, 54, "DISEASE"]]}], ["A sleep study confirmed sleep disordered breathing suggestive of diaphragmatic paralysis and he was discharged on bi-level positive pressure ventilation.", {"entities": []}], ["This is a unique case of exertional dyspnea and orthopnea from diaphragmatic paresis caused by bilateral phrenic nerve palsy where the initial workup for pulmonary and cardiovascular etiologies was essentially unremarkable.", {"entities": []}], ["Shortness of breath and orthopnea caused by phrenic neuropathy is a rare condition, yet has a variety of etiologies.", {"entities": [[52, 62, "DISEASE"]]}], ["Our case suggests a template to the diagnostic approach, management, and follow up of bilateral phrenic nerve palsy.", {"entities": []}], ["To investigate the feasibility and the cardiorespiratory effects of using positive expiratory airway pressure, a physiotherapeutic tool, in comparison with a T-tube, to wean patients from mechanical ventilation.", {"entities": []}], ["A prospective, randomized, cross-over study.", {"entities": []}], ["Two intensive care units.", {"entities": []}], ["We evaluated forty patients who met weaning criteria and had been mechanically-ventilated for more than 48 hours, mean age 59 years, including 23 males.", {"entities": []}], ["All patients were submitted to the T-tube and Expiratory Positive Airway Pressure devices, at 7 cm H 2 O, during a 30-minute period.", {"entities": []}], ["Cardiorespiratory variables including work of breathing, respiratory rate (rr), peripheral oxygen saturation (SpO 2 ), heart rate (hr), systolic, diastolic and mean arterial pressures (SAP, DAP, MAP) were measured in the first and thirtieth minutes.", {"entities": [[131, 133, "GENE"]]}], ["The condition was analyzed as an entire sample set (n=40) and was also divided into subconditions: chronic obstructive pulmonary disease (n=14) and non-chronic obstructive pulmonary disease (non- chronic obstructive pulmonary disease) (n=26) categories.", {"entities": [[99, 136, "DISEASE"], [152, 189, "DISEASE"], [196, 233, "DISEASE"]]}], ["Comparisons were made using a t-test and Analysis of Variance.", {"entities": []}], ["The level of significance was p < 0.05.", {"entities": []}], ["Our data showed an increase in work of breathing in the first and thirtieth minutes in the EPAP condition (0.86\u00b1 0.43 and 1.02\u00b11.3) as compared with the T-tube condition (0.25\u00b10.26 and 0.26\u00b10.35) (p<0.05), verified by the flow-sensor monitor (values in J/L).", {"entities": []}], ["No statistical differences were observed when comparing the Expiratory Positive Airway Pressure and T-tube conditions with regard to cardiorespiratory measurements.", {"entities": []}], ["The same result was observed for both chronic obstructive pulmonary disease and non- chronic obstructive pulmonary disease subconditions.", {"entities": [[38, 75, "DISEASE"], [85, 122, "DISEASE"]]}], ["Our study demonstrated that, in weaning patients from mechanical ventilation, the use of a fixed level of Expiratory Positive Airway Pressure caused an increase in work of breathing that was not accompanied by any other significant cardiorespiratory changes.", {"entities": []}], ["Therefore, we have to be cautious when using Expiratory Positive Airway Pressure as a physiotherapeutic tool during weaning from mechanical ventilation.", {"entities": []}], ["Pollen is the most common aeroallergen to cause conjunctivitis.", {"entities": [[48, 62, "DISEASE"]]}], ["In this study, we established a short ragweed (SRW)-induced mouse model of allergic conjunctivitis (AC) and aimed to explore the potential role of miR-146a and its downstream molecules in the development of ocular allergic inflammation.", {"entities": [[75, 98, "DISEASE"], [84, 98, "DISEASE"], [147, 155, "GENE"]]}], ["The mouse model of challenge pollen was used for in vivo study.", {"entities": []}], ["The culture model of primary human limbal epithelium (HLE) exposed to lipopolysaccharide (LPS) was performed for in vitro research.", {"entities": []}], ["The numbers of eosinophils and total inflammatory cells were examined using Giemsa staining.", {"entities": []}], ["The expression of mRNA and miR-146a was determined by quantitative RT-PCR, and protein production was evaluated by Western blotting.", {"entities": [[27, 35, "GENE"]]}], ["In vivo of mice, pollen challenge induced conjunctiva inflammatory response indicated by increased number of eosinophils and total inflammatory cells.", {"entities": []}], ["Interestingly, pollen significantly attenuated miR-146a expression while it enhanced expression of thymic stromal lymphopoietin (TSLP) and its downstream molecules, including TSLP receptor (TSLPR)/ OX40 ligand (OX40L)/CD11C.", {"entities": [[47, 55, "GENE"], [129, 133, "GENE"], [175, 179, "GENE"], [129, 133, "GENE"], [175, 179, "GENE"]]}], ["In vitro of HCE, downregulation effect of miR-146a expression induced by LPS was reversed by Bay treatment, an inhibitor for nuclear factor kappa B (NF-\u03baB), and LPS-induced cell inflammation is mediated by miR-146a-TSLP/TSLPR/OX40L/CD11C signaling pathway.", {"entities": [[42, 50, "GENE"], [206, 214, "GENE"]]}], ["This was further demonstrated by overexpression of miR-146a in mouse abrogated pollen-triggered conjunctiva inflammatory reaction as well as pollen-induced activity of TSLP/TSLPR/OX40L/CD11C signaling.", {"entities": [[51, 59, "GENE"]]}], ["Down-regulation of miR-146a expression induces allergic conjunctivitis in mice by increasing TSLP level.", {"entities": [[47, 70, "DISEASE"], [56, 70, "DISEASE"], [19, 27, "GENE"], [93, 97, "GENE"]]}], ["Historically, bifidobacteria were the dominant intestinal bacteria in breastfed infants.", {"entities": []}], ["Still abundant in infants in developing nations, levels of intestinal bifidobacteria are low among infants in developed nations.", {"entities": []}], ["Recent studies have described an intimate relationship between human milk and a specific subspecies of Bifidobacterium, B. longum subsp.", {"entities": []}], ["infantis ( B. infantis ), yet supplementation of breastfed, healthy, term infants with this organism, has not been reported.", {"entities": []}], ["The IMPRINT Study, a Phase I clinical trial, was initiated to determine the safety and tolerability of supplementing breastfed infants with B. infantis (EVC001).", {"entities": []}], ["Eighty mother-infant dyads were enrolled in either lactation support plus B. infantis supplementation (BiLS) or lactation support alone (LS).", {"entities": []}], ["Starting with Day 7 postnatal, BiLS infants were fed 1.8\u20132.8\u00a0\u00d7\u00a010 B. infantis EVC001 daily in breast milk for 21\u00a0days.", {"entities": []}], ["Mothers collected fecal samples, filled out health questionnaires, and kept daily logs about their infants\u2019 feeding and gastrointestinal symptoms from birth until Day 61 postnatal.", {"entities": []}], ["Safety and tolerability were determined from maternal reports.", {"entities": []}], ["There were no differences in the mean gestational age at birth, weight 1 and 2\u00a0months postnatal, and breast milk intake between groups.", {"entities": []}], ["The mean Log 10 change in fecal Bifidobacterium from Day 6 to Day 28 was higher ( p \u00a0=\u00a00.0002) for BiLS (6.6\u00a0\u00b1\u00a02.8 SD) than for LS infants (3.5\u00a0\u00b1\u00a03.5 SD).", {"entities": []}], ["Daily stool number was higher ( p \u00a0<\u00a00.005) for LS and lower ( p \u00a0<\u00a00.05) for BiLS infants during supplementation than at Baseline.", {"entities": []}], ["During supplementation, watery stools decreased and soft stools increased by 36% over baseline in BiLS infants (p \u00a0<\u00a00.05) with no significant changes in stool consistency for the LS infants.", {"entities": []}], ["None of the safety and tolerability endpoints, including flatulence, bloody stool, body temperature, ratings of gastrointestinal symptoms, use of antibiotics or gas-relieving medications, infant colic, jaundice, number of illnesses, sick doctor visits, or diagnoses of eczema were different for the groups at any point.", {"entities": []}], ["The B. infantis EVC001 supplement was safely consumed and well-tolerated.", {"entities": []}], ["Stools were fewer and better formed in infants in the BiLS group compared with LS group.", {"entities": []}], ["Adverse events were those expected in healthy infants and not different between groups.", {"entities": []}], ["ClinicalTrials.gov NCT02457338 .", {"entities": []}], ["Registered May 27, 2015.", {"entities": []}], ["The online version of this article (doi:10.1186/s12887-017-0886-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Printed educational materials (PEMs) are commonly used simple interventions that can be used alone or with other interventions to disseminate clinical evidence.", {"entities": []}], ["They have been shown to have a small effect on health professional behaviour.", {"entities": []}], ["However, we do not know whether they are effective in primary care.", {"entities": []}], ["We investigated whether PEMs improve primary care physician (PCP) knowledge, behaviour, and patient outcomes.", {"entities": []}], ["We conducted a systematic review of PEMs developed for PCPs.", {"entities": []}], ["Electronic databases were searched for randomized controlled trials, quasi randomized controlled trials, controlled before and after studies, and interrupted time series.", {"entities": []}], ["We combined studies using meta-analyses when possible.", {"entities": []}], ["Statistical heterogeneity was examined, and meta-analysis was performed using a random effects model when significant statistical heterogeneity was present and a fixed effects model otherwise.", {"entities": []}], ["The template for intervention description and replication (TIDieR) checklist was used to assess the quality of intervention description.", {"entities": []}], ["Our search identified 12,439 studies and 40 studies met our inclusion criteria.", {"entities": []}], ["We combined outcomes from 26 studies in eight meta-analyses.", {"entities": []}], ["No significant effect was found on clinically important patient outcomes, physician behaviour, or physician cognition when PEMs were compared to usual care.", {"entities": []}], ["In the 14 studies that could not be included in the meta-analyses, 14 of 71 outcomes were significantly improved following receipt of PEMs compared to usual care.", {"entities": []}], ["Most studies lacked details needed to replicate the intervention.", {"entities": []}], ["PEMs were not effective at improving patient outcomes, knowledge, or behaviour of PCPs.", {"entities": []}], ["Further trials should explore ways to optimize the intervention and provide detailed information on the design of the materials.", {"entities": []}], ["PROSPERO, CRD42013004356 The online version of this article (doi:10.1186/s13012-015-0347-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Despite experiencing a disproportionate burden of acute and chronic health issues, many homeless people face barriers to primary health care.", {"entities": []}], ["Most studies on health care access among homeless populations have been conducted in the United States, and relatively few are available from countries such as Canada that have a system of universal health insurance.", {"entities": []}], ["We investigated access to primary health care among a representative sample of homeless adults in Toronto, Canada.", {"entities": []}], ["Homeless adults were recruited from shelter and meal programs in downtown Toronto between November 2006 and February 2007.", {"entities": []}], ["Cross-sectional data were collected on demographic characteristics, health status, health determinants and access to health care.", {"entities": []}], ["We used multivariable logistic regression analysis to investigate the association between having a family doctor as the usual source of health care (an indicator of access to primary care) and health status, proof of health insurance, and substance use after adjustment for demographic characteristics.", {"entities": []}], ["Of the 366 participants included in our study, 156 (43%) reported having a family doctor.", {"entities": []}], ["After adjustment for potential confounders and covariates, we found that the odds of having a family doctor significantly decreased with every additional year spent homeless in the participant\u2019s lifetime (adjusted odds ratio [OR]\u00a00.91, 95% confidence interval [CI]\u00a00.86\u20130.97).", {"entities": []}], ["Having a family doctor was significantly associated with being lesbian, gay, bisexual or transgendered (adjusted OR\u00a02.70, 95% CI\u00a01.04\u20137.00), having a health card (proof of health insurance coverage in the province of Ontario) (adjusted OR\u00a02.80, 95% CI\u00a01.61\u20134.89) and having a chronic medical condition (adjusted OR\u00a01.91, 95% CI\u00a01.03\u20133.53).", {"entities": []}], ["Less than half of the homeless people in Toronto who participated in our study reported having a family doctor.", {"entities": []}], ["Not having a family doctor was associated with key indicators of health care access and health status, including increasing duration of homelessness, lack of proof of health insurance coverage and having a chronic medical condition.", {"entities": []}], ["Increased efforts are needed to address the barriers to appropriate health care and good health that persist in this population despite the provision of health insurance.", {"entities": []}], ["Adverse reactions to iodinated and gadolinium contrast media are an important clinical issue.", {"entities": []}], ["Although some guidelines have proposed oral steroid premedication protocols to prevent adverse reactions, some patients may have reactions to contrast media in spite of premedication (breakthrough reaction; BTR).", {"entities": []}], ["The purpose of this study was to assess the frequency, type and severity of BTR when following an oral steroid premedication protocol.", {"entities": []}], ["All iodinated and gadolinium contrast-enhanced radiologic examinations between August 2011 and February 2013 for which the premedication protocol was applied in our institution were assessed for BTRs.", {"entities": []}], ["The protocol was applied to a total of 252 examinations (153 patients, ages 15\u201387 years; 63 males, 90 females).", {"entities": []}], ["Of these, 152 were for prior acute adverse reactions to contrast media, 85 were for a history of bronchial asthma, and 15 were for other reasons.", {"entities": [[107, 113, "DISEASE"]]}], ["There were 198 contrast enhanced CTs and 54 contrast enhanced MRIs.", {"entities": []}], ["There were nine BTR (4.5%) for iodinated contrast media, and only one BTR (1.9%) for gadolinium contrast media: eight were mild and one was moderate.", {"entities": []}], ["No patient who had a mild index reaction (IR) had a severe BTR.", {"entities": []}], ["Incidence of BTRs when following the premedication protocol was low.", {"entities": []}], ["This study by no means proves the efficacy of premedication, but provides some support for following a premedication protocol to improve safety of contrast-enhanced examinations when prior adverse reactions are mild, or when there is a history of asthma.", {"entities": [[247, 253, "DISEASE"]]}], ["Epidemiologic findings are inconsistent concerning the associations between C-reactive protein (CRP), interleukin 6 (IL-6) and lung cancer risk.", {"entities": [[127, 138, "DISEASE"], [132, 138, "DISEASE"], [96, 99, "GENE"]]}], ["We conducted a meta-analysis of epidemiologic studies to examine these associations.", {"entities": []}], ["A systematic literature search up to October 2011 was performed in MEDLINE and EMBASE.", {"entities": []}], ["Study-specific risk estimates were pooled using a random-effects model.", {"entities": []}], ["The 10 studies on CRP involved a total of 1918 lung cancer cases.", {"entities": [[47, 58, "DISEASE"], [52, 58, "DISEASE"], [18, 21, "GENE"]]}], ["The pooled RR of lung cancer for one unit change in natural logarithm (ln) CRP was 1.28 (95% CI 1.17\u20131.41).", {"entities": [[17, 28, "DISEASE"], [22, 28, "DISEASE"], [75, 78, "GENE"]]}], ["There was no statistically significant heterogeneity among studies ( P \u200a=\u200a0.116; I CRP was associated with increased risk of lung cancer, especially among men.", {"entities": [[125, 136, "DISEASE"], [130, 136, "DISEASE"], [83, 86, "GENE"]]}], ["There was no significant association between IL-6 and lung cancer risk.", {"entities": [[54, 65, "DISEASE"], [59, 65, "DISEASE"]]}], ["Poor self-rated health (SRH) has been connected to immunological changes, and pregnancy complications have been suggested in the etiology of autoimmune diseases including inflammatory bowel disease (IBD).", {"entities": [[171, 197, "DISEASE"]]}], ["We evaluated the impact of self-rated pre-pregnancy health and pregnancy course, hyperemesis, gestational hypertension, and preeclampsia on risk of IBD.", {"entities": [[106, 118, "DISEASE"]]}], ["Information was collected by questionnaires from The Danish National Birth Cohort (enrolment 1996\u20132002) at 16 Risk of IBD increased with decreasing level of self-rated pre-pregnancy health (p\u200a=\u200a0.002) and was elevated in women with poor self-rated pregnancy course (HR, 1.61, 95% CI 1.22\u20132.12).", {"entities": [[266, 268, "GENE"]]}], ["Associations persisted for more than 5 years postpartum.", {"entities": []}], ["Hyperemesis and preeclampsia were not significantly associated with risk of IBD.", {"entities": []}], ["This is the first prospective observational study to suggest that poor self-rated health \u2013 in general and in relation to pregnancy \u2013 is associated with increased risk of IBD even in the long term though results needs further confirmation.", {"entities": []}], ["Symptoms of specific pregnancy complications were, on the other hand, not significantly associated with risk of IBD.", {"entities": []}], ["Cancer and healthy cells have distinct distributions of molecular properties and thus respond differently to drugs.", {"entities": [[0, 6, "DISEASE"]]}], ["Cancer drugs ideally kill cancer cells while limiting harm to healthy cells.", {"entities": [[0, 6, "DISEASE"], [26, 32, "DISEASE"]]}], ["However, the inherent variance among cells in both cancer and healthy cell populations increases the difficulty of selective drug action.", {"entities": [[51, 57, "DISEASE"]]}], ["Here we formalize a classification framework based on the idea that an ideal cancer drug should maximally discriminate between cancer and healthy cells.", {"entities": [[77, 83, "DISEASE"], [127, 133, "DISEASE"]]}], ["More specifically, this discrimination should be performed on the basis of measurable cell markers.", {"entities": []}], ["We divide the problem into three parts which we explore with examples.", {"entities": []}], ["First, molecular markers should discriminate cancer cells from healthy cells at the single-cell level.", {"entities": [[45, 51, "DISEASE"]]}], ["Second, the effects of drugs should be statistically predicted by these molecular markers.", {"entities": []}], ["Third, drugs should be optimized for classification performance.", {"entities": []}], ["We find that expression levels of a handful of genes suffice to discriminate well between individual cells in cancer and healthy tissue.", {"entities": [[110, 116, "DISEASE"]]}], ["We also find that gene expression predicts the efficacy of some cancer drugs, suggesting that these cancer drugs act as suboptimal classifiers using gene profiles.", {"entities": [[64, 70, "DISEASE"], [100, 106, "DISEASE"]]}], ["Finally, we formulate a framework that defines an optimal drug, and predicts drug cocktails that may target cancer more accurately than the individual drugs alone.", {"entities": [[108, 114, "DISEASE"]]}], ["Conceptualizing cancer drugs as solving a discrimination problem in the high-dimensional space of molecular markers promises to inform the design of new cancer drugs and drug cocktails.", {"entities": [[16, 22, "DISEASE"], [153, 159, "DISEASE"]]}], ["Although anaphylaxis caused by jellyfish stings is common in coastal areas, an allergic shock caused by cooked jellyfish ingestion has never been reported in China.", {"entities": []}], ["In this paper, we report a case of allergic shock being caused by ingestion of cooked salt-preserved jellyfish shortly after being stung by a live jellyfish.", {"entities": []}], ["A 26-year-old Chinese man presented with dizziness, pruritus, dyspnea, hypotension, and tachycardia after eating cooked salted jellyfish.", {"entities": []}], ["The patient had been stung twice by jellyfish half a year ago.", {"entities": []}], ["Allergic shock caused by ingestion of cooked jellyfish.", {"entities": []}], ["The patient was treated with phenergan (25\u200amg, intramuscular injection), 250 mL normal saline (NS) and 10\u200amg dexamethasone (intravenous drip), 500 mL NS and 0.4\u200ag cimetidine (intravenous drip), and 500 mL NS for rapid fluid infusion (intravenous drip).", {"entities": []}], ["After the treatment, the main clinical symptoms of the patient improved quickly.", {"entities": []}], ["Five days later, the patient's urticaria had dissipated.", {"entities": [[31, 40, "DISEASE"]]}], ["A history of jellyfish contact or sting might be an important allergic factor for individuals who consume any kind of jellyfish.", {"entities": []}], ["Smoking is an important health threat in Turkey.", {"entities": []}], ["This study aimed to determine the frequency of and main factors associated with smoking in persons of 15 years and over, and the frequency of passive smoking in homes in the South-east Anatolian Project (SEAP) Region in Turkey.", {"entities": []}], ["A cross sectional design was employed.", {"entities": []}], ["The sample waschosen by the State Institute of Statistics using a stratified cluster probability sampling method.", {"entities": []}], ["1126 houses representing the SEAP Region were visited.", {"entities": []}], ["Questionnaires about tobacco smoking and related factors were applied to 2166 women and 1906 men (of 15 years old and above) in their homes.", {"entities": []}], ["Face-to-face interview methods were employed.", {"entities": []}], ["Participants were classified as current, ex, and non-smokers.", {"entities": []}], ["The presence of a regular daily smoker in a house was used as an indication of passive smoking.", {"entities": []}], ["The chi-square andlogistic regressionanalysis methods were used for the statistical analysis.", {"entities": []}], ["The prevalence of smoking, in those of 15 years and over, was 11.8% in women and 49.7% in men.", {"entities": []}], ["The prevalence of current smokers was higher in urban (34.5 %) than in rural (22.8 %) regions.", {"entities": []}], ["The mean of total cigarette consumption was 6.5 packs/year in women and 17.9 packs/year in men.", {"entities": []}], ["There was at least one current smoker in 70.1% of the houses.", {"entities": []}], ["Smoking is a serious problem in the South-eastern Anatolian Region.", {"entities": []}], ["Male gender, middle age, a high level of education and urban residency were most strongly associated with smoking.", {"entities": []}], ["Across the developing world, countries are increasingly adopting the integrated community case management of childhood illnesses (iCCM) strategy in efforts to reduce child mortality.", {"entities": []}], ["This intervention\u2019s effectiveness is dependent on community adoption and changes in care-seeking practices.", {"entities": []}], ["We assessed the implementation process of a theory-driven community dialogue (CD) intervention specifically designed to strengthen the support and uptake of the newly introduced iCCM services and related behaviours in three African countries.", {"entities": []}], ["A qualitative process evaluation methodology was chosen and used secondary project data and primary data collected in two districts of each of the three countries, in purposefully sampled communities.", {"entities": []}], ["The final data set included 67 focus group discussions and 57 key informant interviews, totalling 642 respondents, including caregivers, CD facilitators community leaders, and trainers.", {"entities": []}], ["Thematic analysis of the data followed the \u2018Framework Approach\u2019 utilising both a deduction and induction process.", {"entities": []}], ["Results show that CDs contribute to triggering community uptake of and support for iCCM services through filling health information gaps and building cooperation within communities.", {"entities": []}], ["We found it to be an effective approach for addressing social norms around child care practices.", {"entities": []}], ["This approach was embraced by communities for its flexibility and value in planning individual and collective change.", {"entities": []}], ["Regular CDs can contribute to the formation of new habits, particularly in relation to seeking timely care in case of child sickness.", {"entities": []}], ["This study also confirms the value of process evaluation to unwrap the mechanisms of community mobilisation approaches in context and provides key insights for improving the CD approach.", {"entities": []}], ["The online version of this article (doi:10.1186/s41043-017-0106-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Multimorbidity is a growing concern worldwide, with approximately 1 in 4 adults affected.", {"entities": []}], ["Most of the evidence on multimorbidity, its prevalence and effects, comes from high income countries.", {"entities": []}], ["Not much is known about multimorbidity in low income countries, particularly in sub-Saharan Africa.", {"entities": []}], ["The aim of this study was to determine the prevalence of multimorbidity and examine its association with various social determinants of health in South Africa.", {"entities": []}], ["The data used in this study are taken from the South Africa National Income Dynamic Survey (SA-NIDS) of 2008.", {"entities": []}], ["Multimorbidity was defined as the coexistence of two or more chronic diseases in an individual.", {"entities": []}], ["Multinomial logistic regression models were constructed to analyse the relationship between multimorbidity and several indicators including socioeconomic status, area of residence and obesity.", {"entities": [[184, 191, "DISEASE"]]}], ["The prevalence of multimorbidity in South Africa was 4% in the adult population.", {"entities": []}], ["Over 70% of adults with multimorbidity were females.", {"entities": []}], ["Factors associated with multimorbidity were social assistance (Odds ratio (OR) 2.35; Confidence Interval (CI) 1.59-3.49), residence (0.65; 0.46-0.93), smoking (0.61; 0.38-0.96); obesity (2.33; 1.60-3.39), depression (1.07; 1.02-1.11) and health facility visits (5.14; 3.75-7.05).", {"entities": [[178, 185, "DISEASE"]]}], ["Additionally, income was strongly positively associated with multimorbidity.", {"entities": []}], ["The findings are similar to observations made in studies conducted in developed countries.", {"entities": []}], ["The findings point to a potential difference in the factors associated with single chronic disease and multimorbidity.", {"entities": []}], ["Income was consistently significantly associated with multimorbidity, but not single chronic diseases.", {"entities": []}], ["This should be investigated further in future research on the factors affecting multimorbidity.", {"entities": []}], ["Diesel exhaust and its particles (DEP) have been under scrutiny for health effects in humans.", {"entities": []}], ["In the development of these effects inflammation is regarded as a key process.", {"entities": []}], ["Overall, in vitro studies report similar DEP-induced changes in markers of inflammation, including cytokines and chemokines, as studies in vivo .", {"entities": []}], ["In vitro studies suggest that soluble extracts of DEP have the greatest impact on the expression and release of proinflammatory markers.", {"entities": []}], ["Main DEP mediators of effects have still not been identified and are difficult to find, as fuel and engine technology developments lead to continuously altered characteristics of emissions.", {"entities": []}], ["Involved mechanisms remain somewhat unclear.", {"entities": []}], ["DEP extracts appear to comprise components that are able to activate various membrane and cytosolic receptors.", {"entities": []}], ["Through interactions with receptors, ion channels, and phosphorylation enzymes, molecules in the particle extract will trigger various cell signaling pathways that may lead to the release of inflammatory markers directly or indirectly by causing cell death.", {"entities": []}], ["In vitro studies represent a fast and convenient system which may have implications for technology development.", {"entities": []}], ["Furthermore, knowledge regarding how particles elicit their effects may contribute to understanding of DEP-induced health effects in vivo , with possible implications for identifying susceptible groups of people and effect biomarkers.", {"entities": []}], ["This study aimed to investigate the relationship between bladder trabeculation, urinary function, and the stage of pelvic organ prolapse (POP).", {"entities": []}], ["The medical records of 104 patients with POP who underwent cystoscopies and urodynamic studies were reviewed retrospectively.", {"entities": []}], ["Age, incidence of detrusor instability, stage and site of POP, and the parameters of urodynamic studies of patients with and without bladder trabeculation were compared.", {"entities": []}], ["The difference in the incidence of bladder trabeculation was estimated between patients with and without a suspected bladder outlet obstruction.", {"entities": []}], ["There were significant differences in the patients' age, stage of POP, and maximal voiding velocity.", {"entities": []}], ["Patients with a suspected bladder outlet obstruction had a significantly higher incidence of bladder trabeculation.", {"entities": []}], ["In addition, patients with advanced stages of POP were also found to have a higher incidence of bladder trabeculation.", {"entities": []}], ["Tuberculosis (TB) is the second most common cause of death from infectious diseases.", {"entities": []}], ["About 90% of those infected are asymptomatic\u2014the so-called latent TB infections (LTBI), with a 10% lifetime chance of progressing to active TB.", {"entities": []}], ["To further understand the molecular pathogenesis of TB, several molecular studies have attempted to compare the expression profiles between healthy controls and active TB or LTBI patients.", {"entities": []}], ["However, the results vary due to diverse genetic backgrounds and study designs and the inherent complexity of the disease process.", {"entities": []}], ["Thus, developing a sensitive and efficient method for the detection of LTBI is both crucial and challenging.", {"entities": []}], ["For the present study, we performed a systematic analysis of the gene and microRNA profiles of healthy individuals versus those affected with TB or LTBI.", {"entities": []}], ["Combined with a series of in silico analysis utilizing publicly available microRNA knowledge bases and published literature data, we have uncovered several microRNA-gene interactions that specifically target both the blood and lungs.", {"entities": []}], ["Some of these molecular interactions are novel and may serve as potential biomarkers of TB and LTBI, facilitating the development for a more sensitive, efficient, and cost-effective diagnostic assay for TB and LTBI for the Taiwanese population.", {"entities": []}], ["Genetic factors are known to contribute to COPD susceptibility and these factors are not fully understood.", {"entities": []}], ["Conflicting results have been reported for many genetic studies of candidate genes based on their role in the disease.", {"entities": []}], ["Genome-wide association studies in combination with expression profiling have identified a number of new candidates including IREB2 .", {"entities": [[126, 131, "GENE"]]}], ["A meta-analysis has implicated transforming growth factor beta-1 ( TGFbeta1 ) as a contributor to disease susceptibility.", {"entities": []}], ["We have examined previously reported associations in both genes in a collection of 1017 white COPD patients and 912 non-diseased smoking controls.", {"entities": []}], ["Genotype information was obtained for seven SNPs in the IREB2 gene, and for four SNPs in the TGFbeta1 gene.", {"entities": [[56, 61, "GENE"]]}], ["Allele and genotype frequencies were compared between COPD cases and controls, and odds ratios were calculated.", {"entities": []}], ["The analysis was adjusted for age, sex, smoking and centre, including interactions of age, sex and smoking with centre.", {"entities": []}], ["Our data replicate the association of IREB2 SNPs in association with COPD for SNP rs2568494, rs2656069 and rs12593229 with respective adjusted p-values of 0.0018, 0.0039 and 0.0053.", {"entities": [[38, 43, "GENE"]]}], ["No significant associations were identified for TGFbeta1 .", {"entities": []}], ["These studies have therefore confirmed that the IREB2 locus is a contributor to COPD susceptibility and suggests a new pathway in COPD pathogenesis invoking iron homeostasis.", {"entities": [[48, 53, "GENE"]]}], ["To investigate the impact of exacerbations in health-related quality of life (HRQL) of patients with COPD and to compare the effect of treatment of COPD exacerbations with moxifloxacin (400 mg/day for 5 days) and amoxicillin/clavulanate (500/125 mg 3 times a day for 10 days) on HRQL.", {"entities": []}], ["229 outpatients with stable COPD (mean age 68.2 years; mean FEV 1 % predicted 49.3%) participated in a prospective, observational study of 2 years\u2019 duration.", {"entities": [[60, 63, "GENE"]]}], ["The St George\u2019s Respiratory Questionnaire (SGRQ) was completed at baseline and every 6 months thereafter.", {"entities": []}], ["COPD exacerbations (mean 2.7 episodes/patient) occurred in 136 patients (124 patients received the study medications [amoxicillin/clavulanate 54, moxifloxacin 70]).", {"entities": []}], ["Differences between baseline and the final visit were higher for moxifloxacin compared with amoxicillin/clavulanate for total SGRQ score (\u22122.60 [13.1] vs 4.21 [16.2], P = 0.05) and \u201cSymptoms\u201d subscale (\u22125.64 [16.7] vs 8.27 [21], P = 0.02).", {"entities": []}], ["The same findings were observed in patients with two or more exacerbations.", {"entities": []}], ["In COPD outpatients, treatment of exacerbations with moxifloxacin had a more favorable long-term effect on quality of life than amoxicillin/clavulanate.", {"entities": []}], ["Interleukin-33 (IL-33) is associated with multiple diseases, including asthma, rheumatoid arthritis, tissue injuries and infections.", {"entities": [[79, 99, "DISEASE"], [90, 99, "DISEASE"], [71, 77, "DISEASE"]]}], ["Although IL-33 has been indicated to be involved in Staphylococcus aureus ( S. aureus ) wound infection, little is known about how IL-33 is regulated as a mechanism to increase host defense against skin bacterial infections.", {"entities": []}], ["To explore the underlying intricate mechanism we first evaluated the expression of IL-33 in skin from S. aureus -infected human patients.", {"entities": []}], ["Compared to normal controls, IL-33 was abundantly increased in skin of S. aureus -infected patients.", {"entities": []}], ["We next developed a S. aureus cutaneous infection mouse model and found that IL-33 was significantly increased in dermal macrophages of infected mouse skin.", {"entities": []}], ["The expression of IL-33 by macrophages was induced by staphylococcal peptidoglycan (PGN) and lipoteichoic acid (LTA) via activation of toll-like receptor 2(TLR2) \u2013mitogen-activated protein kinase (MAPK)-AKT-signal transducer and activator of transcription 3(STAT3) signaling pathway as PGN and LTA failed to induce IL-33 in Tlr2 -deficient peritoneal macrophages, and MAPK,AKT, STAT3 inhibitors significantly decreased PGN- or LTA-induced IL-33.", {"entities": [[112, 115, "GENE"], [294, 297, "GENE"], [427, 430, "GENE"], [156, 160, "GENE"], [324, 328, "GENE"], [258, 263, "GENE"], [378, 383, "GENE"], [112, 115, "GENE"], [294, 297, "GENE"], [427, 430, "GENE"], [156, 160, "GENE"], [324, 328, "GENE"], [258, 263, "GENE"], [378, 383, "GENE"]]}], ["IL-33, in turn, acted on macrophages to induce microbicidal nitric oxygen (NO) release.", {"entities": []}], ["This induction was dependent on inducible nitric oxide synthase (iNOS) activation, as treatment of macrophages with an inhibitor of iNOS, aminoguanidine, significantly decreased IL-33-induced NO release.", {"entities": []}], ["Moreover, aminoguanidine significantly blocked the capacity of IL-33 to inhibit the growth of S. aureus , and IL-33 silencing in macrophages significantly increased the survival of S. aureus in macrophages.", {"entities": []}], ["Furthermore, the administration of IL-33-neutralizing antibody into mouse skin decreased iNOS production but increased the survival of S. aureus in skin.", {"entities": []}], ["These findings reveal that IL-33 can promote antimicrobial capacity of dermal macrophages, thus enhancing antimicrobial defense against skin bacterial infections.", {"entities": []}], ["Interleukin-33 (IL-33) is associated with multiple diseases, including asthma, rheumatoid arthritis, tissue injuries and infections.", {"entities": [[79, 99, "DISEASE"], [90, 99, "DISEASE"], [71, 77, "DISEASE"]]}], ["Although IL-33 has been indicated to be involved in wound infections, little is known about how IL-33 is regulated as a mechanism to increase host defense against skin bacterial infections.", {"entities": []}], ["Here we have shown that Staphylococcus aureus ( S. aureus ) cutaneous infection increases IL-33 expression in dermal macrophages in the skin.", {"entities": []}], ["The expression of IL-33 by macrophages is induced by staphylococcal peptidoglycan (PGN) and lipoteichoic acid (LTA) via activation of toll-like receptor 2(TLR2) \u2013mitogen-activated protein kinase (MAPK)-AKT-signal transducer and activator of transcription 3(STAT3) signaling pathway.", {"entities": [[111, 114, "GENE"], [155, 159, "GENE"], [257, 262, "GENE"]]}], ["IL-33 in turn acts on macrophages to inhibit the growth of S. aureus by binding to its receptor ST2 followed by activation of the AKT-\u03b2-catenin pathway, thus inducing and activating inducible nitric oxygen synthase (iNOS) to release microbiocidal nitric oxygen (NO).", {"entities": []}], ["These findings reveal that IL-33 can promote antimicrobial capacity of dermal macrophages, thus enhancing antimicrobial defense against skin bacterial infections.", {"entities": []}], ["Asthma is associated with airway hyperresponsiveness and enhanced T-cell number/activity on one hand and increased levels of exhaled nitric oxide (NO) with expression of inducible NO synthase (iNOS) on the other hand.", {"entities": [[0, 6, "DISEASE"]]}], ["These findings are in paradox, as NO also relaxes airway smooth muscle and has immunosuppressive properties.", {"entities": []}], ["The exact role of the endothelial NOS (eNOS) isoform in asthma is still unknown.", {"entities": [[56, 62, "DISEASE"]]}], ["We hypothezised that a delicate regulation in the production of NO and its bioactive forms by eNOS might be the key to the pathogenesis of asthma.", {"entities": [[139, 145, "DISEASE"]]}], ["The contribution of eNOS on the development of asthmatic features was examined.", {"entities": []}], ["We used transgenic mice that overexpress eNOS and measured characteristic features of allergic asthma after sensitisation and challenge of these mice with the allergen ovalbumin.", {"entities": [[86, 101, "DISEASE"], [95, 101, "DISEASE"]]}], ["eNOS overexpression resulted in both increased eNOS activity and NO production in the lungs.", {"entities": []}], ["Isolated thoracic lymph nodes cells from eNOS overexpressing mice that have been sensitized and challenged with ovalbumin produced significantly less of the cytokines IFN-\u03b3, IL-5 and IL-10.", {"entities": []}], ["No difference in serum IgE levels could be found.", {"entities": []}], ["Further, there was a 50% reduction in the number of lymphocytes and eosinophils in the lung lavage fluid of these animals.", {"entities": []}], ["Finally, airway hyperresponsiveness to methacholine was abolished in eNOS overexpressing mice.", {"entities": []}], ["These findings demonstrate that eNOS overexpression attenuates both airway inflammation and airway hyperresponsiveness in a model of allergic asthma.", {"entities": [[133, 148, "DISEASE"], [142, 148, "DISEASE"]]}], ["We suggest that a delicate balance in the production of bioactive forms of NO derived from eNOS might be essential in the pathophysiology of asthma.", {"entities": [[141, 147, "DISEASE"]]}], ["Environmental estrogens are exogenous estrogen-mimicking compounds that can interfere with endogenous endocrine systems.", {"entities": []}], ["Several of these endocrine disruptors have been shown to alter normal development and influence tumorigenesis in experimental models.", {"entities": []}], ["N-butyl benzyl phthalate (BBP), a widely used plasticizer, is a well-known endocrine disruptor.", {"entities": []}], ["The aim of this study was to elucidate the effect of prenatal exposure to BBP on the morphology, proliferative index, and genomic signature of the rat mammary gland at different ages.", {"entities": []}], ["In utero exposure was performed by gavage of pregnant Sprague Dawley CD rats with 120mg or 500mg BBP/kg/day from day 10 post-conception to delivery.", {"entities": []}], ["Female litters were euthanized at 21, 35, 50 and 100 days.", {"entities": []}], ["The morphology and proliferative index of the mammary gland were studied from whole mount preparations and BrdU incorporation, respectively.", {"entities": []}], ["Gene expression profile was assessed by microarrays.", {"entities": []}], ["Several genes found differentially expressed and related to different functional categories were further validated by real time RT-PCR.", {"entities": []}], ["Prenatal exposure of BBP induced delayed vaginal opening and changes in the post-natal mammary gland long after the end of the treatment, mainly by 35 days of age.", {"entities": []}], ["Exposure to the high dose resulted in modifications in architecture and proliferative index of the mammary gland, mostly affecting the undifferentiated terminal end buds.", {"entities": []}], ["Moreover, the expression profiles of this gland in the exposed rats were modified in a dose-dependent fashion.", {"entities": []}], ["Analysis of functional categories showed that modified genes were related to immune function, cell signaling, proliferation and differentiation, or metabolism.", {"entities": []}], ["Our data suggest that in utero exposure to BBP induced a delayed pubertal onset and modified morphology of the mammary gland.", {"entities": []}], ["These alterations were accompanied by modifications in gene expression previously associated with an increased susceptibility to carcinogenesis.", {"entities": []}], ["Neuropilin-1 surface expression discriminates between nT reg cells with stable expression and Nrp1 low iT reg cells showing inducible expression under inflammatory conditions.", {"entities": [[94, 98, "GENE"]]}], ["Foxp3 activity is essential for the normal function of the immune system.", {"entities": [[0, 5, "GENE"]]}], ["Two types of regulatory T (T reg) cells express Foxp3, thymus-generated natural T reg (nT reg) cells, and peripherally generated adaptive T reg (iT reg) cells.", {"entities": [[48, 53, "GENE"]]}], ["These cell types have complementary functions.", {"entities": []}], ["Until now, it has not been possible to distinguish iT reg from nT reg cells in vivo based solely on surface markers.", {"entities": []}], ["We report here that Neuropilin 1 (Nrp1) is expressed at high levels by most nT reg cells; in contrast, mucosa-generated iT reg and other noninflammatory iT reg cells express low levels of Nrp1.", {"entities": [[34, 38, "GENE"], [188, 192, "GENE"], [34, 38, "GENE"], [188, 192, "GENE"]]}], ["We found that Nrp1 expression is under the control of TGF-\u03b2.", {"entities": [[14, 18, "GENE"]]}], ["By tracing nT reg and iT reg cells, we could establish that some tumors have a very large proportion of infiltrating iT reg cells.", {"entities": []}], ["iT reg cells obtained from highly inflammatory environments, such as the spinal cords of mice with spontaneous autoimmune encephalomyelitis (EAE) and the lungs of mice with chronic asthma, express Nrp1.", {"entities": [[181, 187, "DISEASE"], [122, 139, "DISEASE"], [197, 201, "GENE"]]}], ["In the same animals, iT reg cells in secondary lymphoid organs remain Nrp1", {"entities": [[70, 74, "GENE"]]}], ["The Korean list of occupational skin diseases was amended in July 2013.", {"entities": []}], ["The past list was constructed according to the causative agent and the target organ, and the items of that list had not been reviewed for a long period.", {"entities": []}], ["The revised list was reconstructed to include diseases classified by the International Classification of Diseases (10th version).", {"entities": []}], ["Therefore, the items of compensable occupational skin diseases in the amended list in Korea comprise contact dermatitis; chemical burns; Stevens-Johnson syndrome; tar-related skin diseases; infectious skin diseases; skin injury-induced cellulitis; and skin conditions resulting from physical factors such as heat, cold, sun exposure, and ionized radiation.", {"entities": [[236, 246, "DISEASE"], [101, 119, "DISEASE"], [153, 161, "DISEASE"], [109, 119, "DISEASE"]]}], ["This list will be more practical and convenient for physicians and workers because it follows a disease-based approach.", {"entities": []}], ["The revised list is in accordance with the International Labor Organization list and is refined according to Korean worker's compensation and the actual occurrence of occupational skin diseases.", {"entities": []}], ["However, this revised list does not perfectly reflect the actual status of skin diseases because of the few cases of occupational skin diseases, incomplete statistics of skin diseases, and insufficient scientific evidence.", {"entities": []}], ["Thus, the list of occupational diseases should be modified periodically on the basis of recent evidence and statistics.", {"entities": []}], ["Current techniques for monitoring patients for apnoea suffer from significant limitations.", {"entities": []}], ["These include insufficient availability to meet diagnostic needs, cost, accuracy of results in the presence of artefacts and difficulty of use in unsupervised conditions.", {"entities": []}], ["We created and clinically tested a novel miniature medical device that targets overcoming these limitations.", {"entities": []}], ["We studied 20 healthy control participants and 10 patients who had been referred for sleep apnoea diagnosis.", {"entities": []}], ["The performances of the new system and also of the Food and Drug Administration (FDA) approved SOMNO clinical system, conventionally used for sleep apnoea diagnosis were evaluated under the same conditions.", {"entities": []}], ["Both systems were tested during a normal night of sleep in controls and patients.", {"entities": []}], ["Their performances were quantified in terms of detection of apnoea and hypopnoea in individual 10\u2005s epochs, which were compared with scoring of signals by a blinded clinician.", {"entities": []}], ["For spontaneous apnoeas during natural sleep and considering the clinician scorer as the gold standard, the new wearable apnoea detection device had 88.6% sensitivity and 99.6% specificity.", {"entities": []}], ["In comparison the SOMNO system had 14.3% sensitivity and 99.3% specificity.", {"entities": []}], ["The novel device had been specifically designed to detect apnoea, but if apnoea and hypopnoea during sleep were both considered in the assessment, the sensitivity and specificity were 77.1% and 99.7%, respectively, versus 54% and 98.5%, respectively, for the SOMNO.", {"entities": []}], ["The performance of the novel device compares very well to the scoring by an experienced clinician even in the presence of breathing artefacts, in this small pilot study.", {"entities": []}], ["This can potentially make it a real solution for apnoea home monitoring.", {"entities": []}], ["To examine the effects of neuroprotectin D1 (NPD1), a stereospecific derivative of docosahexaenoic acid, on choroidal neovascularization (CNV) in a laser-induced mouse model.", {"entities": []}], ["Specifically, this was assessed by clinically grading laser-induced lesions, measuring leakage area, and volumetrically quantifying vascular endothelial cell proliferation.", {"entities": []}], ["C57Bl/6 mice were treated with vehicle control or NPD1, and choroidal neovascularization was induced by laser rupture of Bruch's membrane; treatment was administered throughout the first week of recovery.", {"entities": []}], ["One and two weeks after CNV induction, fundus fluorescein angiography was performed.", {"entities": []}], ["Angiograms were clinically graded to assess leakage severity, while leakage area was measured by image analysis of angiograms.", {"entities": []}], ["Proliferation of vascular endothelial cells was evaluated volumetrically by three-dimensional laser confocal immunofluorescent microscopy of cytoskeletal, nuclear, and endothelial cell markers.", {"entities": []}], ["At seven days after CNV induction, NPD1-treated mice had 60% fewer clinically relevant lesions than controls, dropping to 80% fewer by 14 days.", {"entities": []}], ["NPD1 mice exhibited 25% smaller leakage area than controls at 7 days and 44% smaller area at 14 days.", {"entities": []}], ["Volumetric immunofluorescence revealed 46% less vascular endothelial cell volume in 7-day NPD1-treated mice than in 7-day controls, and by 14 days NPD1 treatment was 68% lower than controls.", {"entities": []}], ["Furthermore, comparison of 7- and 14-day volumes of NPD1-treated mice revealed a 50% reduction at 14 days.", {"entities": []}], ["NPD1 significantly inhibits choroidal neovascularization.", {"entities": []}], ["There are at least two possible mechanisms that could explain the neuroprotective action of NPD1.", {"entities": []}], ["Ultimately, nuclear factor-\u03baB could be inhibited with a reduction in cyclooxygenase-2 (COX-2) to reduce vascular endothelial growth factor (VEGF) expression, and/or activation of the resolution phase of the inflammatory response/survival pathways could be upregulated.", {"entities": []}], ["Moreover, NPD1 continues to be effective after treatment is concluded, suggesting sustained protection and highlighting the potential applicability of this lipid mediator in preventing or ameliorating endothelial cell growth in pathoangiogenesis.", {"entities": []}], ["Thousands of disease-associated SNPs (daSNPs) are located in intergenic regions (IGR), making it difficult to understand their association with disease phenotypes.", {"entities": []}], ["Recent analysis found that non-coding daSNPs were frequently located in or approximate to regulatory elements, inspiring us to try to explain the disease phenotypes of IGR daSNPs through nearby regulatory sequences.", {"entities": []}], ["Hence, after locating the nearest distal regulatory element (DRE) to a given IGR daSNP, we applied a computational method named INTREPID to predict the target genes regulated by the DRE, and then investigated their functional relevance to the IGR daSNP's disease phenotypes.", {"entities": []}], ["36.8% of all IGR daSNP-disease phenotype associations investigated were possibly explainable through the predicted target genes, which were enriched with, were functionally relevant to, or consisted of the corresponding disease genes.", {"entities": []}], ["This proportion could be further increased to 60.5% if the LD SNPs of daSNPs were also considered.", {"entities": []}], ["Furthermore, the predicted SNP-target gene pairs were enriched with known eQTL/mQTL SNP-gene relationships.", {"entities": []}], ["Overall, it's likely that IGR daSNPs may contribute to disease phenotypes by interfering with the regulatory function of their nearby DREs and causing abnormal expression of disease genes.", {"entities": []}], ["Kenneth Coburn and colleagues report findings from a randomized trial evaluating the effects of a complex nursing intervention on mortality risk among older individuals diagnosed with chronic health conditions.", {"entities": []}], ["Improving the health of chronically ill older adults is a major challenge facing modern health care systems.", {"entities": []}], ["A community-based nursing intervention developed by Health Quality Partners (HQP) was one of 15 different models of care coordination tested in randomized controlled trials within the Medicare Coordinated Care Demonstration (MCCD), a national US study.", {"entities": []}], ["Evaluation of the HQP program began in 2002.", {"entities": []}], ["The study reported here was designed to evaluate the survival impact of the HQP program versus usual care up to five years post-enrollment.", {"entities": []}], ["HQP enrolled 1,736 adults aged 65 and over, with one or more eligible chronic conditions (coronary artery disease, heart failure, diabetes, asthma, hypertension, or hyperlipidemia) during the first six years of the study.", {"entities": [[148, 160, "DISEASE"], [140, 146, "DISEASE"]]}], ["The intervention group ( n \u200a=\u200a873) was offered a comprehensive, integrated, and tightly managed system of care coordination, disease management, and preventive services provided by community-based nurse care managers working collaboratively with primary care providers.", {"entities": []}], ["The control group (n\u200a=\u200a863) received usual care.", {"entities": []}], ["Overall, a 25% lower relative risk of death (hazard ratio [HR] 0.75 [95% CI 0.57\u20131.00], p \u200a=\u200a0.047) was observed among intervention participants with 86 (9.9%) deaths in the intervention group and 111 (12.9%) deaths in the control group during a mean follow-up of 4.2 years.", {"entities": [[59, 61, "GENE"]]}], ["When covariates for sex, age group, primary diagnosis, perceived health, number of medications taken, hospital stays in the past 6 months, and tobacco use were included, the adjusted HR was 0.73 (95% CI 0.55\u20130.98, p \u200a=\u200a0.033).", {"entities": [[183, 185, "GENE"]]}], ["Subgroup analyses did not demonstrate statistically significant interaction effects for any subgroup.", {"entities": []}], ["No suspected program-related adverse events were identified.", {"entities": []}], ["The HQP model of community-based nurse care management appeared to reduce all-cause mortality in chronically ill older adults.", {"entities": []}], ["Limitations of the study are that few low-income and non-white individuals were enrolled and implementation was in a single geographic region of the US.", {"entities": []}], ["Additional research to confirm these findings and determine the model's scalability and generalizability is warranted.", {"entities": []}], ["ClinicalTrials.gov NCT01071967 Please see later in the article for the Editors' Summary In almost every country in the world, the proportion of people aged over 60 years is growing faster than any other age group because of increased life expectancy.", {"entities": []}], ["This demographic change has several implications for public health, especially as older age is a risk factor for many chronic diseases\u2014diseases of long duration and generally slow progression.", {"entities": []}], ["Chronic diseases, such as heart disease, stroke, cancer, chronic respiratory diseases, and diabetes, are by far the leading cause of death in the world, representing almost two-thirds of all deaths.", {"entities": [[26, 39, "DISEASE"], [49, 55, "DISEASE"]]}], ["Therefore in most countries, the challenge of managing increasingly ageing populations who have chronic illnesses demands an urgent response and countries such as the United States are actively researching possible solutions.", {"entities": []}], ["Some studies suggest that innovations in chronic disease management that are led by nurses may help address the epidemic of chronic diseases by increasing the quality and reducing the cost of care.", {"entities": []}], ["However, to date, reports of the evaluation of such interventions lack rigor and do not provide evidence of improved long-term health outcomes or reduced health care costs.", {"entities": []}], ["So in this study, the researchers used the gold standard of research, a randomized controlled trial, to examine the impact of a community-based nurse care management model for older adults with chronic illnesses in the United States as part of a series of studies supported by the Centers for Medicare and Medicaid Services.", {"entities": []}], ["The researchers recruited eligible patients aged 65 years and over with heart failure, coronary heart disease, asthma, diabetes, hypertension, and/or hyperlipidemia who received traditional Medicare\u2014a fee for service insurance scheme in which beneficiaries can choose to receive their care from any Medicare provider\u2014from participating primary care practices in Pennsylvania.", {"entities": [[129, 141, "DISEASE"], [96, 109, "DISEASE"], [87, 109, "DISEASE"], [111, 117, "DISEASE"]]}], ["The researchers then categorized patients according to their risk on the basis of several factors including the number of chronic diseases each individual had before randomizing patients to receive usual care or the nurse-led intervention.", {"entities": []}], ["The intervention included an individualized plan comprising education, symptom monitoring, medication, counseling for adherence, help identifying, arranging, and monitoring community health and social service referrals in addition to group interventions such as weight loss maintenance and exercise classes.", {"entities": []}], ["The researchers checked whether any participating patients had died by using the online Social Security Death Master File.", {"entities": []}], ["Then the researchers used a statistical model to calculate the risk of death in both groups.", {"entities": []}], ["Of the 1,736 patients the researchers recruited into the trial, 873 were randomized to receive the intervention and 863 were in the control group (usual care).", {"entities": []}], ["The researchers found that 86 (9.9%) participants in the intervention group and 111 (12.9%) participants in the control group died during the study period, representing a 25% lower relative risk of death among the intervention group.", {"entities": []}], ["However, when the researchers considered other factors, such as sex, age group, primary diagnosis, perceived health, number of medications taken, hospital stays in the past 6 months, and tobacco use in their statistical model, this risk was slightly altered\u20140.73 risk of death in the intervention group.", {"entities": []}], ["These findings suggest that that community-based nurse care management is associated with a reduction in all-cause mortality among older adults with chronic illnesses who are beneficiaries of the fee for service Medicare scheme in the United States.", {"entities": []}], ["These findings also support the important role of nurses in improving health outcomes in this group of patients and show the feasibility of implementing this program in collaboration with primary care practices.", {"entities": []}], ["Future research is needed to test the adaptability, scalability, and generalizability of this model of care.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001265 .", {"entities": []}], ["This study is further discussed in a PLoS Medicine Perspective by Arlene Bierman Information about the Centers for Medicare and Medicaid Services is available The World Health Organization provides statistics on the prevalence of both chronic illness and ageing Heath Quality Partners provide information about the study", {"entities": []}], ["Background: The fractional concentration of nitric oxide in exhaled air (Fe NO ) potentially detects airway inflammation related to air pollution exposure.", {"entities": []}], ["Existing studies have not yet provided conclusive evidence on the association of Fe NO with traffic-related pollution (TRP).", {"entities": []}], ["Objectives: We evaluated the association of Fe NO with residential TRP exposure in a large cohort of children.", {"entities": []}], ["Methods: We related Fe NO measured on 2,143 children (ages 7\u201311 years) who participated in the Southern California Children\u2019s Health Study (CHS) to five classes of metrics of residential TRP: distances to freeways and major roads; length of all and local roads within circular buffers around the home; traffic densities within buffers; annual average line source dispersion modeled nitrogen oxides (NO x ) from freeways and nonfreeway roads; and predicted annual average nitrogen oxide, nitrogen dioxide, and NO x from a model based on intracommunity sampling in the CHS.", {"entities": []}], ["Results: In children with asthma, length of roads was positively associated with Fe NO , with stronger associations in smaller buffers [46.7%; 95% confidence interval (CI), 14.3\u201388.4], 12.4% (95% CI, \u20138.8 to 38.4), and 4.1% (95% CI, \u201314.6 to 26.8) higher Fe NO for 100-, 300-, and 1,000-m increases in the length of all roads in 50-, 100-, and 200-m buffers, respectively.", {"entities": [[26, 32, "DISEASE"]]}], ["Other TRP metrics were not significantly associated with Fe NO , even though the study design was powered to detect exposures explaining as little as 0.4% of the variation in natural log-transformed Fe NO ( R Conclusion: Length of road was the only indicator of residential TRP exposure associated with airway inflammation in children with asthma, as measured by Fe NO .", {"entities": [[340, 346, "DISEASE"]]}], ["Complementary and alternative medicine (CAM) has been practiced in India for thousands of years.", {"entities": []}], ["The aim of this study was to determine the extent of use, perception and attitude of doctors and patients utilizing the same healthcare facility.", {"entities": []}], ["This study was conducted among 200 doctors working at a tertiary care teaching Hospital, India and 403 patients attending the same, to determine the extent of usage, attitude and perception toward CAM.", {"entities": []}], ["The use of CAM was more among doctors (58%) when compared with the patients (28%).", {"entities": []}], ["Among doctors, those who had utilized CAM themselves, recommended CAM as a therapy to their patients (52%) and enquired about its use from patients (37%) to a greater extent.", {"entities": []}], ["CAM was used concomitantly with allopathic medicine by 60% patients.", {"entities": []}], ["Very few patients (7%) were asked by their doctors about CAM use, and only 19% patients voluntarily informed their doctors about the CAM they were using.", {"entities": []}], ["Most patients who used CAM felt it to be more effective, safer, less costly and easily available in comparison to allopathic medicines.", {"entities": []}], ["CAM is used commonly by both doctors and patients.", {"entities": []}], ["There is a lack of communication between doctors and patients regarding CAM, which may be improved by sensitization of doctors and inclusion of CAM in the medical curriculum", {"entities": []}], ["IL-10 is a regulatory cytokine that plays a major role in the homeostasis of the gut and this is illustrated by the fact that IL-10 \u03b3 was higher in the colon.", {"entities": []}], ["Colitis progression culminates with the reduction of CD4", {"entities": [[53, 56, "GENE"]]}], ["Endothelial permeability is involved in injury, inflammation, diabetes and cancer.", {"entities": [[75, 81, "DISEASE"]]}], ["It is partly regulated by the thrombin-, histamine-, and VEGF-mediated myosin-light-chain (MLC) activation pathways.", {"entities": []}], ["While these pathways have been investigated, questions such as temporal effects and the dynamics of multi-mediator regulation remain to be fully studied.", {"entities": []}], ["Mathematical modeling of these pathways facilitates such studies.", {"entities": []}], ["Based on the published ordinary differential equation models of the pathway components, we developed an integrated model of thrombin-, histamine-, and VEGF-mediated MLC activation pathways.", {"entities": []}], ["Our model was validated against experimental data for calcium release and thrombin-, histamine-, and VEGF-mediated MLC activation.", {"entities": []}], ["The simulated effects of PAR-1, Rho GTPase, ROCK, VEGF and VEGFR2 over-expression on MLC activation, and the collective modulation by thrombin and histamine are consistent with experimental findings.", {"entities": []}], ["Our model was used to predict enhanced MLC activation by CPI-17 over-expression and by synergistic action of thrombin and VEGF at low mediator levels.", {"entities": []}], ["These may have impact in endothelial permeability and metastasis in cancer patients with blood coagulation.", {"entities": [[68, 74, "DISEASE"]]}], ["Our model was validated against a number of experimental findings and the observed synergistic effects of low concentrations of thrombin and histamine in mediating the activation of MLC.", {"entities": []}], ["It can be used to predict the effects of altered pathway components, collective actions of multiple mediators and the potential impact to various diseases.", {"entities": []}], ["Similar to the published models of other pathways, our model can potentially be used to identify important disease genes through sensitivity analysis of signalling components.", {"entities": []}], ["The behavior of Japanese cedar ( Cryptomeria japonica ) and Japanese cypress ( Chamaecyparis obtusa ) pollens in an urban area was examined through the measurements of the dispersion characteristics at the various sampling locations in both outdoor and indoor environments.", {"entities": []}], ["Airborne pollens were counted continuously for three months during the Japanese cedar pollen and Japanese cypress seasons in 2005 and 2006 by the use of Durham\u2019s pollen trap method in and around Tokyo, Japan.", {"entities": []}], ["The dispersion of pollens at the rooftop of Kyoritsu Women\u2019s University was observed to be at extremely high levels in 2005 compared with previously reported results during the past two decades.", {"entities": []}], ["As for Japanese cedar pollen, the maximum level was observed as 440 counts cm", {"entities": []}], ["The aim of this study was to explore potential immunoregulatory mechanisms underlying the suppressive effect on atherosclerosis of QiShenYiQi pill (QSYQ).", {"entities": [[112, 127, "DISEASE"]]}], ["Male ApoE QSYQ exerted an anti-atherosclerosis effect by promoting regulatory T cells in atherosclerotic lesion, inhibiting T helper 17 cells in plaque and spleen and accelerating liver cholesterol excretion.", {"entities": [[31, 46, "DISEASE"], [5, 9, "GENE"]]}], ["A relatively small percentage of patients with chronic medical conditions account for a much larger percentage of inpatient costs.", {"entities": []}], ["There is some evidence that case-management can improve health and quality-of-life and reduce the number of times these patients are readmitted.", {"entities": []}], ["To assess whether a statistical algorithm, based on routine inpatient data, can be used to identify patients at risk of readmission and who would therefore benefit from case-management.", {"entities": []}], ["Queensland database study of public-hospital patients, who had at least one emergency admission for a chronic medical condition (e.g., congestive heart failure, chronic obstructive pulmonary disease, diabetes or dementia) during 2005/2006.", {"entities": [[135, 159, "DISEASE"], [212, 220, "DISEASE"], [161, 198, "DISEASE"]]}], ["Multivariate logistic regression was used to develop an algorithm to predict readmission within 12 months.", {"entities": []}], ["The performance of the algorithm was tested against recorded readmissions using sensitivity, specificity, and Likelihood Ratios (positive and negative).", {"entities": []}], ["Several factors were identified that predicted readmission (i.e., age, co-morbidities, economic disadvantage, number of previous admissions).", {"entities": []}], ["The discriminatory power of the model was modest as determined by area under the receiver operating characteristic (ROC) curve (c = 0.65).", {"entities": []}], ["At a risk score threshold of 50, the algorithm identified only 44.7% (95% CI: 42.5%, 46.9%) of patients admitted with a reference condition who had an admission in the next 12 months; 37.5% (95% CI: 35.0%, 40.0%) of patients were flagged incorrectly (they did not have a subsequent admission).", {"entities": []}], ["A statistical algorithm based on Queensland hospital inpatient data, performed only moderately in identifying patients at risk of readmission.", {"entities": []}], ["The main problem is that there are too many false negatives, which means that many patients who might benefit would not be offered case-management.", {"entities": []}], ["Small interfering RNA (siRNA)-based therapies have great promise in the treatment of a number of prevalent pulmonary disorders including lung cancer, asthma and cystic fibrosis.", {"entities": [[137, 148, "DISEASE"], [161, 176, "DISEASE"], [150, 156, "DISEASE"], [142, 148, "DISEASE"]]}], ["However, progress in this area has been hindered due to the lack of carriers that can efficiently deliver siRNA to lung epithelial cells, and also due to challenges in developing oral inhalation (OI) formulations for the regional administration of siRNA and their carriers to the lungs.", {"entities": []}], ["In this work we report the ability of generation four, amine-terminated poly(amidoamine) (PAMAM) dendrimer (G4NH2)\u2013siRNA complexes (dendriplexes) to silence the enhanced green fluorescent protein (eGFP) gene on A549 lung alveolar epithelial cells stably expressing eGFP.", {"entities": []}], ["We also report the formulation of the dendriplexes and their aerosol characteristics in propellant-based portable OI devices.", {"entities": []}], ["The size and gene silencing ability of the dendriplexes was seen not to be a strong function of the N/P ratio.", {"entities": []}], ["Silencing efficiencies of up to 40% are reported.", {"entities": []}], ["Stable dispersions of the dendriplexes encapsulated in mannitol and also in a biodegradable and water-soluble co-oligomer were prepared in hydrofluoroalkane (HFA)-based pressurized metered-dose inhalers (pMDIs).", {"entities": []}], ["Their aerosol characteristics were very favorable, and conducive to deep lung deposition, with respirable fractions of up to 77%.", {"entities": []}], ["Importantly, siRNA formulated as dendriplexes in pMDIs was shown to keep its integrity after the particle preparation processes, and also after long-term exposures to HFA.", {"entities": []}], ["The relevance of this study stems from the fact that this is the first work to report the formulation of inhalable siRNA with aerosol properties suitable to deep lung deposition using pMDIs devices that are the least expensive and most widely used portable inhalers.", {"entities": []}], ["This study is relevant because, also for the first time, it shows that siRNA\u2013G4NH2 dendriplexes can efficiently target lung alveolar epithelial A549 cells and silence genes even after siRNA has been exposed to the propellant environment.", {"entities": []}], ["Traditional ecological knowledge among indigenous communities plays an important role in retaining cultural identity and achieving sustainable natural resource management.", {"entities": []}], ["Hundreds of millions of people mostly in developing countries derive a substantial part of their subsistence and income from plant resources.", {"entities": []}], ["The aim of this study was to assess useful plant species diversity, plant use categories and local knowledge of both wild and cultivated useful species in the Eastern Cape province, South Africa.", {"entities": []}], ["The study was conducted in six villages in the Eastern Cape province, South Africa between June 2014 and March 2017.", {"entities": []}], ["Data on socio-economic characteristics of the participants, useful plants harvested from the wild, managed in home gardens were documented by means of questionnaires, observation and guided field walks with 138 participants.", {"entities": []}], ["A total of 125 plant species belonging to 54 genera were recorded from the study area.", {"entities": []}], ["More than half of the species (59.2%) are from 13 families, Apiaceae, Apocynaceae, Araliaceae, Asparagaceae, Asphodelaceae, Asteraceae, Fabaceae, Lamiaceae, Malvaceae, Myrtaceae, Poaceae, Rosaceae and Solanaceae.", {"entities": []}], ["More than a third of the useful plants (37.6%) documented in this study are exotic to South Africa.", {"entities": []}], ["About three quarters of the documented species (74.4%) were collected from the wild, while 20.8% were cultivated and 4.8% were spontaneous.", {"entities": []}], ["Majority of the species (62.4%) were used as herbal medicines, followed by food plants (30.4%), ethnoveterinary medicine (18.4%), construction timber and thatching (11.2%).", {"entities": []}], ["Other minor plant use categories (1\u20135%) included firewood, browse, live fence, ornamentals, brooms and crafts.", {"entities": []}], ["This study demonstrated that local people in the Eastern Cape province harbour important information on local vegetation that provides people with food, fuel and medicines, as well as materials for construction and the manufacturing of crafts and many other products.", {"entities": []}], ["This study also demonstrated the dynamism of traditional ecological knowledge, practices and beliefs of local people demonstrated by the incorporation of exotic plants in their diets and indigenous pharmacopoeia.", {"entities": []}], ["Reliable data on the distribution of causes of death (COD) in a population are fundamental to good public health practice.", {"entities": []}], ["In the absence of comprehensive medical certification of deaths, the only feasible way to collect essential mortality data is verbal autopsy (VA).", {"entities": []}], ["The Tariff Method was developed by the Population Health Metrics Research Consortium (PHMRC) to ascertain COD from VA information.", {"entities": []}], ["Given its potential for improving information about COD, there is interest in refining the method.", {"entities": []}], ["We describe the further development of the Tariff Method.", {"entities": []}], ["This study uses data from the PHMRC and the National Health and Medical Research Council (NHMRC) of Australia studies.", {"entities": []}], ["Gold standard clinical diagnostic criteria for hospital deaths were specified for a target cause list.", {"entities": []}], ["VAs were collected from families using the PHMRC verbal autopsy instrument including health care experience (HCE).", {"entities": []}], ["The original Tariff Method (Tariff 1.0) was trained using the validated PHMRC database for which VAs had been collected for deaths with hospital records fulfilling the gold standard criteria (validated VAs).", {"entities": []}], ["In this study, the performance of Tariff 1.0 was tested using VAs from household surveys (community VAs) collected for the PHMRC and NHMRC studies.", {"entities": []}], ["We then corrected the model to account for the previous observed biases of the model, and Tariff 2.0 was developed.", {"entities": []}], ["The performance of Tariff 2.0 was measured at individual and population levels using the validated PHMRC database.", {"entities": []}], ["For median chance-corrected concordance (CCC) and mean cause-specific mortality fraction (CSMF) accuracy, and for each of three modules with and without HCE, Tariff 2.0 performs significantly better than the Tariff 1.0, especially in children and neonates.", {"entities": []}], ["Improvement in CSMF accuracy with HCE was 2.5\u00a0%, 7.4\u00a0%, and 14.9\u00a0% for adults, children, and neonates, respectively, and for median CCC with HCE it was 6.0\u00a0%, 13.5\u00a0%, and 21.2\u00a0%, respectively.", {"entities": []}], ["Similar levels of improvement are seen in analyses without HCE.", {"entities": []}], ["Tariff 2.0 addresses the main shortcomings of the application of the Tariff Method to analyze data from VAs in community settings.", {"entities": []}], ["It provides an estimation of COD from VAs with better performance at the individual and population level than the previous version of this method, and it is publicly available for use.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-015-0527-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Increases in alcohol related mortality and morbidity have been reported among older people in England over the last decade.", {"entities": []}], ["There is, however, evidence that drinking is protective for some health conditions.", {"entities": []}], ["The validity of this evidence has been questioned due to residual confounding and selection bias.", {"entities": []}], ["The aim of this study is to clarify which drinking profiles and other demographic characteristics are associated with poor self-rated health among a community-based sample of older adults in England.", {"entities": []}], ["The study also examines whether drinking designated as being \u201cincreasing-risk\u201d or \u201chigher-risk\u201d is associated with poorer self-rated health.", {"entities": []}], ["This study used data from Wave 0, Wave 1 and Wave 5 of the English Longitudinal Study of Ageing [ELSA].", {"entities": []}], ["Logistic regression analysis, was used to examine the association between drinking profiles (based on quantity and frequency of drinking) and self-rated health, adjusting for gender, age, wealth, social class, education, household composition, smoking and body mass index [BMI].", {"entities": []}], ["Twenty percent of the sample reported drinking above the recommended level at wave 0.", {"entities": []}], ["Rates of poor self-rated health were highest among those who had stopped drinking, followed by those who never drank.", {"entities": []}], ["The rates of poor self-rated health among non-drinkers were significantly higher than the rates of poor self-rated health for any of the groups who reported alcohol consumption.", {"entities": []}], ["In the adjusted logistic regression models there were no drinking profiles associated with significantly higher rates of poor self-rated health relative to occasional drinkers.", {"entities": []}], ["Among those who drank alcohol, there was no evidence that any pattern of current alcohol consumption was associated with poor self-rated health, even after adjustment for a wide range of variables.", {"entities": []}], ["The results associated with the stopped drinking profile indicate improvement in self-rated health can be associated with changes in drinking behaviour.", {"entities": []}], ["Although several limitations of the study are noted, policy makers may wish to consider how these findings should be translated into drinking guidelines for older adults.", {"entities": []}], ["Up to 65% of newly diagnosed breast cancer patients had not been screened correctly before diagnosis resulting in increased stage of cancer at presentation.", {"entities": [[29, 42, "DISEASE"], [36, 42, "DISEASE"], [133, 139, "DISEASE"]]}], ["This study assessed whether their primary relatives are, in turn, assessed appropriately.", {"entities": []}], ["An ethically approved prospective study involving 274 primary relatives of women diagnosed with breast cancer, between 2009\u20132012, at a symptomatic breast unit in Ireland.", {"entities": [[96, 109, "DISEASE"], [103, 109, "DISEASE"]]}], ["Telephone interview established: demographics, menstrual history, family history verification, breast screening history.", {"entities": []}], ["Personal risk level was calculated and whether current screening met screening guidelines.", {"entities": []}], ["Participants were enrolled into appropriate screening programs if currently not in one and results analyzed.", {"entities": []}], ["Two hundred and fifteen of the 280 (76.8%) newly diagnosed patients responded giving details of their 274 primary relatives; this made up the study cohort.", {"entities": []}], ["Mean age 50\u00a0\u00b1\u00a010 (35\u201375).", {"entities": []}], ["Thirty two percent were low risk, 64% moderate and 4% high.", {"entities": []}], ["190/274 (69%) were being screened appropriately.", {"entities": []}], ["Seventy five relatives were then assessed with: mammography in 55, Mg and US in 16.", {"entities": []}], ["Four underwent a biopsy and to date none had cancer.", {"entities": [[45, 51, "DISEASE"]]}], ["Surveillance was: annual screening in 48%; national screening program and General Practitioner ( GP ) in 33%; GP only in over 65s in 13%; 6% await further assessment at specialist genetics clinics where their surveillance will be decided.", {"entities": []}], ["This study has identified an opportunity to improve the delivery of appropriate screening to higher risk primary relatives of patients with breast cancer.", {"entities": [[140, 153, "DISEASE"], [147, 153, "DISEASE"]]}], ["This necessitates an integrated national approach involving providers of primary care, patients and screening breast programs.", {"entities": []}], ["( R )-stereospecific amine transaminases ( R -ATAs) are important biocatalysts for the production of ( R )-amine compounds in a strict stereospecific manner.", {"entities": []}], ["An improved R -ATA, ATA-117-Rd11, was successfully engineered for the manufacture of sitagliptin, a widely used therapeutic agent for type-2 diabetes.", {"entities": []}], ["The effects of the individual mutations, however, have not yet been demonstrated due to the lack of experimentally determined structural information.", {"entities": []}], ["Here we describe three crystal structures of the first isolated R -ATA, its G136F mutant and engineered ATA-117-Rd11, which indicated that the mutation introduced into the 136", {"entities": []}], ["Deficient production of anti-viral interferons (IFNs) may be involved in causing viral-induced asthma exacerbations.", {"entities": [[95, 101, "DISEASE"]]}], ["Hence, drugs inducing lung IFN production would be warranted.", {"entities": []}], ["Azithromycin may reduce asthma exacerbations but its modus operandi is unknown.", {"entities": [[24, 30, "DISEASE"]]}], ["Here, we investigated if azithromycin induces IFN\u03b2 expression in vitro in rhinovirus-infected bronchial epithelial cells from asthmatic donors and in vivo in our allergic inflammation-based mouse model of viral stimulus-induced asthma exacerbations.", {"entities": [[228, 234, "DISEASE"]]}], ["Azithromycin dose-dependently augmented viral-induced IFN\u03b2 expression in asthmatic, but not in healthy bronchial epithelial cells.", {"entities": []}], ["The effect negatively correlated with viral load.", {"entities": []}], ["Knockdown of MDA5 and RIG-I by siRNA showed involvement of MDA5 but not RIG-I in azithromycin's IFN-inducing effects in vitro .", {"entities": []}], ["In vivo azithromycin induced IFN\u03b2 protein, restoring a reduced lung IFN response exclusively in allergic exacerbating mice.", {"entities": []}], ["This was associated with induction of interferon-stimulated genes and MDA5, but not RIG-I.", {"entities": []}], ["We suggest that clinically relevant concentrations of azithromycin produce MDA5-dependent, anti-viral, IFN-inducing effects in bronchial epithelium distinctly from asthmatic donors.", {"entities": []}], ["Similarly, azithromycin induced MDA5-associated IFN in virally stimulated lungs in vivo exclusively in allergic mice.", {"entities": []}], ["Effects of azithromycin and MDA5-active drugs on viral-induced exacerbations deserve further research.", {"entities": []}], ["Calcium mobilization can regulate a wide range of essential functions of respiratory epithelium, including ion transport, ciliary beat frequency, and secretion of mucus, all of which are modified in cystic fibrosis (CF).", {"entities": [[199, 214, "DISEASE"]]}], ["SERCA2, an important controller of calcium signaling, is deficient in CF epithelium.", {"entities": []}], ["We conducted this study to determine whether SERCA2 deficiency can modulate airway epithelial responses to environmental oxidants such as ozone.", {"entities": []}], ["This could contribute to the pathogenesis of pulmonary exacerbations, which are important and frequent clinical events in CF.", {"entities": []}], ["To address this, we used air-liquid interface (ALI) cultures of non-CF and CF cell lines, as well as differentiated cultures of cells derived from non-CF and CF patients.", {"entities": []}], ["We found that ozone exposure caused enhanced membrane damage, mitochondrial dysfunction and apoptotic cell death in CF airway epithelial cell lines relative to non-CF.", {"entities": []}], ["Ozone exposure caused increased proinflammatory cytokine production in CF airway epithelial cell lines.", {"entities": []}], ["Elevated proinflammatory cytokine production also was observed in shRNA-mediated SERCA2 knockdown cells.", {"entities": []}], ["Overexpression of SERCA2 reversed ozone-induced proinflammatory cytokine production.", {"entities": []}], ["Ozone-induced proinflammatory cytokine production was NF-\u03baB- dependent.", {"entities": []}], ["In a stable NF-\u03baB reporter cell line, SERCA2 inhibition and knockdown both upregulated cytomix-induced NF-\u03baB activity, indicating importance of SERCA2 in modulating NF-\u03baB activity.", {"entities": []}], ["In this system, increased NF-\u03baB activity was also accompanied by increased IL-8 production.", {"entities": []}], ["Ozone also induced NF-\u03baB activity and IL-8 release, an effect that was greater in SERCA2-silenced NF-\u03baB-reporter cells.", {"entities": []}], ["SERCA2 overexpression reversed cytomix-induced increased IL-8 release and total nuclear p65 in CFTR-deficient (16HBE-AS) cells.", {"entities": []}], ["These studies suggest that SERCA2 is an important regulator of the proinflammatory response of airway epithelial cells and could be a potential therapeutic target.", {"entities": []}], ["Innate lymphoid cells (ILCs) are a recently discovered family of innate immune cells belonging to the lymphoid lineage, yet lacking antigen-specific receptors.", {"entities": []}], ["ILCs were first identified in the intestinal tract, where they contribute to epithelial barrier integrity and host responses to commensal microbes.", {"entities": []}], ["Teunissen et al.", {"entities": []}], ["in the current issue and Villanova et al .", {"entities": []}], ["(JID, 134, 984-99) now suggest an important role for type 3 ILCs (ILC3s) in the skin, particularly in psoriasis.", {"entities": [[102, 111, "DISEASE"]]}], ["Both groups found an increased frequency of IL-22- and/or IL-17A-producing ILCs in psoriatic skin and blood.", {"entities": []}], ["These cells are activated in response to IL-1\u03b2 and IL-23, correlate with disease severity, and are decreased following anti-TNF\u03b1 treatment.", {"entities": []}], ["The presence of a novel ILC population in psoriatic skin, one that responds to biologic therapeutics, suggests that dysregulation of ILCs is a contributing factor to psoriasis pathogenesis.", {"entities": [[166, 175, "DISEASE"]]}], ["As traditional lifestyle and diets change with social and economic development, disadvantaged communities in low- and middle-income countries increasingly face a double burden of communicable and non-communicable diseases.", {"entities": []}], ["We studied the relationship between physical fitness and infections with soil-transmitted helminths (STHs), intestinal protozoa and Helicobacter pylori among schoolchildren in Port Elizabeth, South Africa.", {"entities": []}], ["We conducted a cross-sectional survey among 1009 children, aged 9 to 12\u00a0years, from eight primary schools in socioeconomically disadvantaged neighbourhoods of Port Elizabeth.", {"entities": []}], ["Physical fitness was determined using field-deployable tests of the Eurofit fitness test battery.", {"entities": []}], ["Stool samples were analysed with the Kato-Katz thick smear technique to diagnose STHs and with rapid diagnostic tests (RDTs) to detect intestinal protozoa and H. pylori infections.", {"entities": []}], ["Haemoglobin (Hb) levels were assessed and anthropometric indicators determined.", {"entities": []}], ["Complete data were available for 934 children (92\u00a0%).", {"entities": []}], ["In two schools, high STH prevalences were found ( Ascaris lumbricoides 60 and 72\u00a0%; Trichuris trichiura 65\u00a0% each).", {"entities": []}], ["For boys and girls co-infected with A. lumbricoides and T. trichiura ( n \u2009=\u2009155) the maximal oxygen uptake (VO 2 max) was estimated to be 50.1 and 47.2\u00a0ml\u00a0kg n \u2009=\u2009278), respectively.", {"entities": [[113, 116, "GENE"]]}], ["On average, children without helminth infections had greater body mass ( P \u2009=\u20090.011), height ( P \u2009=\u20090.009) and a higher body mass index ( P \u2009=\u20090.024) and were less often stunted ( P \u2009=\u20090.006), but not significantly less wasted compared to their peers with a single or dual species infection.", {"entities": []}], ["Among 9-year-old boys, a negative correlation between helminth infections and VO 2 max, grip strength and standing broad jump distance was observed ( P \u2009=\u20090.038).", {"entities": [[83, 86, "GENE"]]}], ["The overall mean Hb level was 122.2\u00a0g\u00a0l Intestinal parasite infections appear to have a small but significant negative effect on the physical fitness of infected children, as expressed by their maximal oxygen uptake.", {"entities": []}], ["We observed a clear impact on anthropometric indicators.", {"entities": []}], ["The online version of this article (doi:10.1186/s13071-016-1761-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Clinical workplaces offer postgraduate trainees a wealth of opportunities to learn from experience.", {"entities": []}], ["To promote deliberate and meaningful learning self-regulated learning skills are foundational.", {"entities": []}], ["We explored trainees\u2019 learning activities related to patient encounters to better understand what aspects of self-regulated learning contribute to trainees\u2019 development, and to explore supervisor\u2019s role herein.", {"entities": []}], ["We conducted a qualitative non-participant observational study in seven general practices.", {"entities": []}], ["During two days we observed trainee\u2019s patient encounters, daily debriefing sessions and educational meetings between trainee and supervisor and interviewed them separately afterwards.", {"entities": []}], ["Data collection and analysis were iterative and inspired by a phenomenological approach.", {"entities": []}], ["To organise data we used networks, time-ordered matrices and codebooks.", {"entities": []}], ["Self-regulated learning supported trainees to increasingly perform independently.", {"entities": []}], ["They engaged in self-regulated learning before, during and after encounters.", {"entities": []}], ["Trainees\u2019 activities depended on the type of medical problem presented and on patient, trainee and supervisor characteristics.", {"entities": []}], ["Trainees used their sense of confidence to decide if they could manage the encounter alone or if they should consult their supervisor.", {"entities": []}], ["They deliberately used feedback on their performance and engaged in reflection.", {"entities": []}], ["Supervisors appeared vital in trainees\u2019 learning by reassuring trainees, discussing experience, knowledge and professional issues, identifying possible unawareness of incompetence, assessing performance and securing patient safety.", {"entities": []}], ["Self-confidence, reflection and feedback, and support from the supervisor are important aspects of self-regulated learning in practice.", {"entities": []}], ["The results reflect how self-regulated learning and self-entrustment promote trainees\u2019 increased participation in the workplace.", {"entities": []}], ["Securing organized moments of interaction with supervisors is beneficial to trainees\u2019 self-regulated learning.", {"entities": []}], ["The goal was to elucidate predictors of decreased free water clearance (DFWC) in very low birth weight (VLBW) infants.", {"entities": []}], ["We hypothesized that DFWC and fluid retention are linked to the severity of pulmonary problems and prolonged respiratory support, especially to nCPAP treatment.", {"entities": []}], ["The investigation was carried out at Tampere University Hospital between 2001 and 2006.", {"entities": []}], ["The study population comprised 74 VLBW infants born at 29.21 (24.57\u201334.14) weeks of gestation.", {"entities": []}], ["Median birth weight was 1175 (575\u20131490) grams.", {"entities": []}], ["We measured plasma and urine osmolality and 24-hour urine volume to calculate free water clearance (FWC) for each infant.", {"entities": []}], ["If FWC was less than 30 ml/kg/day the infant was classified as having DFWC.", {"entities": []}], ["There were 38 (51.4%) infants with DFWC in the study population.", {"entities": []}], ["The median duration of the observed DFT period was 14 (4\u201344) days.", {"entities": []}], ["The gestational age at birth was lower for DFWC infants compared to infants with normal FWC (NFWC), 28.29 (24.57\u201332.86) vs. 30.00 (25.57\u201334.14) weeks (p\u200a=\u200a0.001).", {"entities": []}], ["DFWC infants also needed longer ventilator treatment, 2 (0\u201323) vs. 0.50 (0\u201323) days (p\u200a=\u200a0.046), nCPAP treatment 30 (0\u2013100) vs. 3 (0\u201341) days (p<0.0001) and longer oxygen supplementation 47 (0\u2013163) vs. 22 (0\u201374) days (p\u200a=\u200a0.011) than NFWC infants.", {"entities": []}], ["All values presented here are medians with ranges.", {"entities": []}], ["DFWC appears to be frequently connected with exacerbation and prolongation of pulmonary problems in VLBW infants.", {"entities": []}], ["Cautious fluid administration seems to be indicated in VLBW infants with prolonged respiratory problems and DFWC.", {"entities": []}], ["The evidence that asthma is increasing in prevalence is becoming increasingly compelling.", {"entities": [[18, 24, "DISEASE"]]}], ["This trend has been demonstrated not only in the United States, but also in the United Kingdom, New Zealand, Australia, and several other Western countries.", {"entities": []}], ["In the United States, the increase is largest in the group under 18 years of age.", {"entities": []}], ["There is mounting evidence that certain environmental air pollutants are involved in exacerbating asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["This is based primarily on epidemiologic studies and more recent clinical studies.", {"entities": []}], ["The U.S. Clean Air Act of 1970 provides special consideration to the class of outdoor air pollutants referred to as criteria pollutants, including O3, sulfur dioxide (SO2), particulate matter (PM), NOx, CO, and Pb.", {"entities": []}], ["Standards for these pollutants are set by the U.S. Environmental Protection Agency with particular concern for populations at risk.", {"entities": []}], ["Current evidence suggests that asthmatics are more sensitive to the effects of O3, SO2, PM, and NO2, and are therefore at risk.", {"entities": []}], ["High SO2 and particulate concentrations have been associated with short-term increases in morbidity and mortality in the general population during dramatic air pollution episodes in the past.", {"entities": []}], ["Controlled exposure studies have clearly shown that asthmatics are sensitive to low levels of SO2.", {"entities": []}], ["Exercising asthmatics exposed to SO2 develop bronchoconstriction within minutes, even at levels of 0.25 ppm.", {"entities": []}], ["Responses are modified by air temperature, humidity, and exercise level.", {"entities": []}], ["Recent epidemiologic studies have suggested that exposure to PM is strongly associated with morbidity and mortality in the general population and that hospital admissions for bronchitis and asthma were associated with PM10 levels.", {"entities": [[190, 196, "DISEASE"], [175, 185, "DISEASE"]]}], ["In controlled clinical studies, asthmatics appear to be no more reactive to aerosols than healthy subjects.", {"entities": []}], ["Consequently, it is difficult to attribute the increased mortality observed in epidemiologic studies to specific effects demonstrated in controlled human studies.", {"entities": []}], ["Epidemiologic studies of hospital admissions for asthma have implicated O3 as contributing to the exacerbation of asthma; however, most study designs could not separate the O3 effects from the concomitant effects of acid aerosols and SO2.", {"entities": [[49, 55, "DISEASE"], [114, 120, "DISEASE"]]}], ["Controlled human clinical studies have suggested that asthmatics have similar changes in spirometry and airway reactivity in response to O3 exposure compared to healthy adults.", {"entities": []}], ["However, a possible role of O3 in worsening atopic asthma has recently been suggested in studies combining allergen challenge following exposure to O3.", {"entities": [[51, 57, "DISEASE"]]}], ["Attempts at identification of factors that predispose asthmatics to responsiveness to NO2 has produced inconsistent results and requires further investigation.", {"entities": []}], ["In summary, asthmatics have been shown to be a sensitive subpopulation relative to several of the criteria pollutants.", {"entities": []}], ["Further research linking epidemiologic, clinical, and toxicologic approaches is required to better understand and characterize the risk of exposing asthmatics to these pollutants.", {"entities": []}], ["The aim of this initial study was to evaluate the clinical and radiological effectiveness of radioembolization (RE) using Overall, we included 13 patients with 20 therapy sessions.", {"entities": []}], ["Clinical and radiological responses were assessed at 6 weeks after therapy, and then every 3 months.", {"entities": []}], ["The objective radiological response was classified according to Response Evaluation Criteria in Solid Tumors (RECIST) v.1.0 by sequential MRI.", {"entities": []}], ["Adverse events were evaluated using NCI CTCAE v.4.03.", {"entities": []}], ["There were 4 patients with hepatocellular carcinoma (HCC), 6 with metastatic colorectal cancer (mCRC), 2 with neuroendocrine carcinoma (NEC), and 1 patient with ovarian carcinoma.", {"entities": [[110, 134, "DISEASE"], [27, 51, "DISEASE"], [77, 94, "DISEASE"], [42, 51, "DISEASE"], [125, 134, "DISEASE"], [169, 178, "DISEASE"], [161, 178, "DISEASE"], [88, 94, "DISEASE"]]}], ["Mean administered activity of The results of this preliminary study indicate that RE using", {"entities": []}], ["Brown Adipose Tissue (BAT) is associated with higher energy expenditure and lower adiposity in adults.", {"entities": []}], ["However, the relationship between BAT composition and adiposity in early life is unknown.", {"entities": []}], ["The objective of this study was to test the hypothesis that brown fat composition at birth is prospectively associated with adiposity gain during the first six months of postnatal life.", {"entities": []}], ["N=35 healthy infants were followed prospectively from intrauterine life and birth through 6 months age.", {"entities": []}], ["Dixon MRI scans were conducted during the neonatal period to characterize supraclavicular BAT composition.", {"entities": []}], ["Dual-energy X-ray absorptiometry to assess total body composition was performed within the first month of life and at 6 months age.", {"entities": []}], ["After adjusting for potential confounding factors, a more brown-like composition (smaller fat fraction) of the supraclavicular BAT depot was associated with a smaller increase in percent body fat over the first six months of postnatal life.", {"entities": []}], ["A more brown-like BAT composition at birth appears to be protective against excess adiposity gain in early life.", {"entities": []}], ["Newborn BAT tissue may constitute a target for prevention strategies against the subsequent development of obesity.", {"entities": [[107, 114, "DISEASE"]]}], ["The Fip1-like1 (FIP1L1)\u2013platelet-derived growth factor receptor alpha (PDGFRA) (F/P) oncogene can cause chronic eosinophilic leukemia (CEL), but requires IL-5 cytokine participation.", {"entities": [[125, 133, "DISEASE"], [16, 22, "GENE"], [71, 77, "GENE"], [135, 138, "GENE"]]}], ["In this study, we investigate the mechanism of F/P in collaboration with IL-5 in CEL.", {"entities": [[81, 84, "GENE"]]}], ["The results showed that Lyn, a key effector in the IL-5-motivated eosinophil production, is extensively activated in F/P-positive CEL cells.", {"entities": [[24, 27, "GENE"], [130, 133, "GENE"]]}], ["Lyn can associate and phosphorylate IL-5 receptor \u03b1 (IL-5RA) in F/P-positive cells.", {"entities": [[0, 3, "GENE"]]}], ["Moreover, the activation of Lyn and IL-5R kinase were strengthened when the cells were stimulated by IL-5.", {"entities": [[28, 31, "GENE"]]}], ["Lyn inhibition in F/P-positive CEL cells attenuated cellular proliferation, induced apoptosis, and blocked cell migration and major basic protein (MBP) release.", {"entities": [[0, 3, "GENE"], [31, 34, "GENE"], [147, 150, "GENE"]]}], ["We identified the FIP1L1-PDGFRA/JAK2/Lyn/Akt complex in the F/P-expressing cells which can be disrupted by dual inhibition of JAK2 and Lyn, repressing cell proliferation in both EOL-1(F/P-positive human eosinophilic cell line) and imatinib-resistance (IR) cells.", {"entities": [[32, 36, "GENE"], [126, 130, "GENE"], [37, 40, "GENE"], [135, 138, "GENE"]]}], ["Altogether, our data demonstrate that Lyn is a vital downstream kinase activated by F/P converged with IL-5 signals in CEL cells.", {"entities": [[38, 41, "GENE"], [119, 122, "GENE"]]}], ["Lyn activate and expand IL-5RA intracellular signaling through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex, provoking eosinophils proliferation and exaggerated activation manifested as CEL.", {"entities": [[0, 3, "GENE"], [82, 85, "GENE"], [184, 187, "GENE"]]}], ["Parkinson\u2019s disease (PD) is associated with an increased risk of fragility fracture.", {"entities": []}], ["FRAX and Qfracture are risk calculators that estimate the 10-year risk of hip and major fractures and guide definitive investigation for osteoporosis using dual X-ray absorptiometry (DEXA) imaging.", {"entities": [[137, 149, "DISEASE"]]}], ["It is unclear which PD patients should be considered for fracture risk assessment and whether FRAX or Qfracture should be used.", {"entities": []}], ["Seventy-seven patients with PD were recruited in the movement disorders clinic.", {"entities": []}], ["Data were collected on PD-related characteristics and fracture risk scores were calculated.", {"entities": []}], ["Patients with previous osteoporotic fractures had a higher incidence of falls ( p \u00a0=\u00a00.0026) and use of bilateral walking aids ( p \u00a0=\u00a00.0187) in addition to longer disease duration ( p \u00a0=\u00a00.0037).", {"entities": []}], ["Selecting patients with falls in combination with either disease duration >5\u00a0years, bilateral walking aids, or previous osteoporotic fracture distinguished patients with and without previous osteoporotic fracture with specificity 67.7\u00a0% (95\u00a0% CI 55.0\u201378.8) and sensitivity 100.0\u00a0% (95\u00a0% CI 73.5\u2013100.0).", {"entities": []}], ["Qfracture calculated significantly higher fracture risk scores than FRAX for hip ( p \u00a0<\u00a00.0001) and major ( p \u00a0=\u00a00.0008) fracture in PD patients.", {"entities": []}], ["Receiver operating characteristic curves demonstrated that FRAX outperformed Qfracture with an area under the curve of 0.84 (95\u00a0% CI 0.70\u20130.97, p \u00a0=\u00a00.0004) for FRAX and 0.68 (95\u00a0% CI 52\u201386, p \u00a0=\u00a00.0476) for Qfracture major fracture risk calculators.", {"entities": []}], ["We suggest that falls in combination with either a disease duration longer than 5\u00a0years or bilateral walking aids or previous osteoporotic fracture should be used as red flags in PD patients to prompt clinicians to perform a FRAX fracture risk assessment in the neurology clinic.", {"entities": []}], ["Chronic exposure to arsenic is associated with neoplastic, cardiovascular, endocrine, neuro-developmental disorders and can have an adverse effect on women\u2019s reproductive health outcomes.", {"entities": []}], ["This study examined the relationship between arsenic skin lesions (a hallmark sign of chronic arsenic poisoning) and age of natural menopause (final menopausal period) in populations with high levels of arsenic exposure in Bangladesh.", {"entities": []}], ["We compared menopausal age in two groups of women \u2013 with and without arsenic skin lesions; and presence of arsenic skin lesions was used as an indicator for chronic arsenic exposure.", {"entities": []}], ["In a cross-sectional study, a total of 210 participants were randomly identified from two ongoing studies\u2014 participants with arsenic skin lesions were identified from an ongoing clinical trial and participants with no arsenic skin lesions were identified from an ongoing cohort study.", {"entities": []}], ["Mean age of menopause between these two groups were calculated and compared.", {"entities": []}], ["Multivariable linear regression was used to estimate the relationship between the status of the arsenic skin lesions and age of natural menopause in women.", {"entities": []}], ["Women with arsenic skin lesions were 1.5\u00a0years younger (p <0.001) at the time of menopause compared to those without arsenic skin lesions.", {"entities": []}], ["After adjusting with contraceptive use, body mass index, urinary arsenic level and family history of premature menopause, the difference between the groups\u2019 age at menopause was 2.1\u00a0years earlier (p <0.001) for respondents with arsenic skin lesions.", {"entities": [[101, 120, "DISEASE"]]}], ["The study showed a statistically significant association between chronic exposure to arsenic and age at menopause.", {"entities": []}], ["Heavily exposed women experienced menopause two years earlier than those with lower or no exposure.", {"entities": []}], ["In spite of the frequency of chronic urticaria, there are no epidemiological studies on its prevalence in Argentina.", {"entities": [[37, 46, "DISEASE"]]}], ["The objective of this study was to define the prevalence and epidemiological characteristics of chronic urticaria patients in Buenos Aires.", {"entities": [[104, 113, "DISEASE"]]}], ["The population studied were the members of the Italian Hospital Medical Care Program, a prepaid health maintenance organization located in the urban areas around the Autonomous City of Buenos Aires, Argentina.", {"entities": []}], ["All patients with diagnosis of chronic urticaria members of the Italian Hospital Medical Care Program, and with at least 12 months of follow up were included in the study.", {"entities": [[39, 48, "DISEASE"]]}], ["All medical records obtained between January 1st, 2012 and December 31, 2014 were analyzed.", {"entities": []}], ["The prevalence ratio for chronic urticaria per 100,000 population with 95% CI for December 31, 2014 was calculated.", {"entities": [[33, 42, "DISEASE"]]}], ["The prevalence rate for the entire population and then discriminated for adults and pediatric patients (less than 18 years old at diagnosis) was assessed.", {"entities": []}], ["158,926 members were analyzed.", {"entities": []}], ["A total of 463 cases of chronic urticaria were identified on prevalence date (68 in pediatrics, 395 in adults), yielding a crude point prevalence ratio of 0.29% (CI 95% 0.26-0.31%).", {"entities": [[32, 41, "DISEASE"]]}], ["The observed prevalence of chronic urticaria in the adult population was 0.34 % (95% CI 0.31-0.38%), while in pediatrics it was 0.15 % (95% CI 0.11-0.20%).", {"entities": [[35, 44, "DISEASE"]]}], ["the main weakness is that the results were obtained from an HMO and therefore the possibility of selection bias.", {"entities": []}], ["chronic urticaria is a global condition.", {"entities": [[8, 17, "DISEASE"]]}], ["Its prevalence in Buenos Aires is comparable with other countries.", {"entities": []}], ["History has shown that without explicit and enforced guidelines, even well-intentioned researchers can fail to adequately examine the ethical pros and cons of study design choices.", {"entities": []}], ["One area in which consensus does not yet exist is the use of placebo groups in vitamin supplementation studies.", {"entities": []}], ["As a prime example, we focus on vitamin D research.", {"entities": []}], ["We aim to provide an overview of the ethical issues in placebo-controlled studies and guide future discussion about the ethical use of placebo groups.", {"entities": []}], ["Research in the field of vitamin D shows variation in how placebo groups are used.", {"entities": []}], ["We outline four types of control groups in use: active-control, placebo-control with restrictions on supplementation, placebo-control without supplementation restrictions, and placebo-control with rescue repletion therapy.", {"entities": []}], ["The first two types highlight discrete ethical issues: active-control trials limit the ability to detect a difference; placebo-control trials that restrict supplementation potentially place subjects at risk of undue harm.", {"entities": []}], ["The final two, placebo-control without supplementation restrictions or with rescue repletion therapy, offer potential solutions to these ethical challenges.", {"entities": []}], ["Building on this, guidelines should be established and enforced on the use of placebo in supplementation studies.", {"entities": []}], ["Furthermore, the field of vitamin D research has the potential to set an example worthy of emulation.", {"entities": []}], ["Autism Spectrum Disorder (ASD) is a severe, lifelong neurodevelopmental disorder with early onset that places a heavy burden on affected individuals and their families.", {"entities": []}], ["Due to the need for highly specialized health, educational and vocational services, ASD is a cost-intensive disorder, and strain on health care systems increases with increasing age of the affected individual.", {"entities": []}], ["The ASD-Net will study Germany\u2019s largest cohort of patients with ASD over the lifespan.", {"entities": []}], ["By combining methodological expertise from all levels of clinical research, the ASD-Net will follow a translational approach necessary to identify neurobiological pathways of different phenotypes and their appropriate identification and treatment.", {"entities": []}], ["The work of the ASD-Net will be organized into three clusters concentrating on diagnostics, therapy and health economics.", {"entities": []}], ["In the diagnostic cluster, data from a large, well-characterized sample ( N \u00a0=\u00a02568) will be analyzed to improve the efficiency of diagnostic procedures.", {"entities": []}], ["Pattern classification methods (machine learning) will be used to identify algorithms for screening purposes.", {"entities": []}], ["In a second step, the developed algorithm will be tested in an independent sample.", {"entities": []}], ["In the therapy cluster, we will unravel how an ASD-specific social skills training with concomitant oxytocin administration can modulate behavior through neurobiological pathways.", {"entities": []}], ["For the first time, we will characterize long-term effects of a social skills training combined with oxytocin treatment on behavioral and neurobiological phenotypes.", {"entities": []}], ["Also acute effects of oxytocin will be investigated to delineate general and specific effects of additional oxytocin treatment in order to develop biologically plausible models for symptoms and successful therapeutic interventions in ASD.", {"entities": []}], ["Finally, in the health economics cluster, we will assess service utilization and ASD-related costs in order to identify potential needs and cost savings specifically tailored to Germany.", {"entities": []}], ["The ASD-Net has been established as part of the German Research Network for Mental Disorders, funded by the BMBF (German Federal Ministry of Education and Research).", {"entities": []}], ["The highly integrated structure of the ASD-Net guarantees sustained collaboration of clinicians and researchers to alleviate individual distress, harm, and social disability of patients with ASD and reduce costs to the German health care system.", {"entities": []}], ["Both clinical trials of the ASD-Net are registered in the German Clinical Trials Register: DRKS00008952 (registered on August 4, 2015) and DRKS00010053 (registered on April 8, 2016).", {"entities": []}], ["The traditional Chinese theory of acupuncture emphasizes that the intensity of acupuncture must reach a threshold to generate de qi (a specific and compound sensation during the acupuncture), which is necessary to achieve the best therapeutic effect.", {"entities": []}], ["However, the notion that de qi must be achieved for maximum benefit has not been confirmed by modern scientific evidence.", {"entities": []}], ["This study aims to compare the efficacy of acupuncture with either strong (intended to elicit de qi ) or weak stimulation among patients with allergic rhinitis.", {"entities": [[142, 159, "DISEASE"], [151, 159, "DISEASE"]]}], ["This study compares real versus sham acupuncture in 140 patients with a history of persistent allergic rhinitis (PER) or intermittent allergic rhinitis (IAR) and with a positive skin prick test (SPT).", {"entities": [[94, 111, "DISEASE"], [134, 151, "DISEASE"], [103, 111, "DISEASE"], [143, 151, "DISEASE"]]}], ["The trial will be conducted in the Teaching Hospital of Chengdu University of Traditional Chinese Medicine (China).", {"entities": []}], ["In the study, patients will be randomly assigned into two groups by computer-generated randomization and assessed prior to treatment.", {"entities": []}], ["They will then receive 12 sessions of treatments for 4 consecutive weeks and have a follow-up phase lasting 12 weeks.", {"entities": []}], ["The main outcome measures include the primary and secondary indicators.", {"entities": []}], ["Primary indicators are subjective symptoms scores as evaluated by visual analogue scales (VAS), rhinoconjunctivitis quality of life questionnaires (RQLQ), and the Modified Massachusetts General Hospital acupuncture sensation scale, Chinese version (C-MMASS).", {"entities": []}], ["The secondary indicators are the results of laboratory examinations, such as serum allergen-specific immunoglobulin E (sIgE) nasal inflammatory cells counts (mast cells, eosinophils, and T cells), and nitric oxide concentration in nasal excretion.", {"entities": []}], ["The use of anti-allergic medication will also be recorded as one of the secondary indicators.", {"entities": []}], ["Furthermore, adverse events will be recorded and analyzed.", {"entities": []}], ["Intention-to-treat analysis (ITT) and per-protocol (PP) analysis will be performed to test and verify the results in this trial.", {"entities": []}], ["The results of this trial will demonstrate the efficacy of using acupuncture to treat allergic rhinitis and verify whether the effectiveness of acupuncture is related to the needle sensation de qi .", {"entities": [[86, 103, "DISEASE"], [95, 103, "DISEASE"]]}], ["Chinese Clinical Trial Registry: ChiCTR-TRC-13003594 (registered on 16 August 2013, and the first patient was randomized on 27 September 2013).", {"entities": []}], ["The online version of this article (doi:10.1186/1745-6215-15-301) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We conducted a national level assessment of the quality of clinical care practice in the Ukrainian healthcare system for two important causes of death and chronic disease conditions.", {"entities": []}], ["We tested two hypotheses: a) quality of care is predicted by physician and facility characteristics and b) health status is predicted by quality of care.", {"entities": []}], ["During 2009\u20132010 in Ukraine, we collected nationally-representative data from clinical facilities, physicians, Clinical Performance and Value (CPV\u00ae) vignettes, patient surveys from the facilities, and from the general population.", {"entities": []}], ["Each physician completed a written CPV\u00ae vignette\u2014a simulated case scenario of a typical patient visit\u2014for each of two clinical cases, congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD).", {"entities": [[134, 158, "DISEASE"], [169, 206, "DISEASE"]]}], ["CPV\u00ae vignette scores, calculated as a percentage of all care criteria completed by the physician, were used as the measure of clinical quality of care.", {"entities": []}], ["Self-reported health measures were collected from exit and household survey respondents.", {"entities": []}], ["Regression models were developed to test the two study hypotheses.", {"entities": []}], ["136 hospitals and 125 polyclinics were surveyed; 1,044 physicians were interviewed and completed CPV\u00ae vignettes.", {"entities": []}], ["On average physicians scored 47.4% on the vignettes.", {"entities": []}], ["Younger, female physicians provide a higher quality of care\u2014as well as those that have had recent continuing medical education (CME) in chronic disease or health behaviors.", {"entities": []}], ["Higher quality was associated with better health outcomes.", {"entities": []}], ["As low- and middle-income countries around the world are challenged by non-communicable diseases, higher quality of care provided to these populations may result in better outcomes, such as improved health status and life expectancy, and overcome regional shortfalls.", {"entities": []}], ["Policy efforts that serially evaluate quality may improve chronic disease care.", {"entities": []}], ["The role of neutrophil elastase (NE) is poorly understood in bronchiectasis because of the lack of preclinical data and so most of the assumptions made about NE inhibitor potential benefit is based on data from CF .", {"entities": [[61, 75, "DISEASE"]]}], ["In this context, NE seems to be a predictor of long-term clinical outcomes and a possible target of treatment.", {"entities": []}], ["In order to better evaluate the role of NE in bronchiectasis, a systematic search of scientific evidence was performed.", {"entities": [[46, 60, "DISEASE"]]}], ["Two investigators independently performed the search on PubMed and included studies published up to May 15, 2017 according to predefined criteria.", {"entities": []}], ["A final pool of 31 studies was included in the systematic review, with a total of 2679 patients.", {"entities": []}], ["For each paper data of interest were extracted and reported in table.", {"entities": []}], ["In this review sputum NE has proved useful as an inflammatory marker both in stable state bronchiectasis and during exacerbations and local or systemic antibiotic treatment.", {"entities": [[90, 104, "DISEASE"]]}], ["NE has also been associated with risk of exacerbation, time to next exacerbation and all-cause mortality.", {"entities": []}], ["This study reviews also the role of NE as a specific target of treatment in bronchiectasis.", {"entities": [[76, 90, "DISEASE"]]}], ["Inhibition of NE is at a very early stage and future interventional studies should evaluate safety and efficacy for new molecules and formulations.", {"entities": []}], ["The prevalence and severity of latex allergy has increased dramatically in the last 15 years due to exposure to natural rubber products.", {"entities": []}], ["Although historically this health risk has been elevated in hospital personnel and patients, a recent survey has indicated a significant potential risk for the general population.", {"entities": []}], ["To obtain a wide-spread source for latex exposure, we have considered tire debris.", {"entities": []}], ["We have searched for the presence of latex allergens in passenger car and truck tire tread, in debris deposited from the atmosphere near a freeway, and in airborne particulate matter samples representative of the entire year 1993 at two sites in the Los Angeles basin (California).", {"entities": []}], ["After extraction of the samples with phosphate buffered saline, a modified-ELISA inhibition assay was used to measure relative allergen potency and Western blot analyses were used to identify latex allergens.", {"entities": []}], ["The inhibition studies with the human IgE latex assay revealed inhibition by the tire tread source samples and ambient freeway dust, as well as by control latex sap and latex glove extracts.", {"entities": []}], ["Levels of extractable latex allergen per unit of protein extracted were about two orders of magnitude lower for tire tread as compared to latex gloves.", {"entities": []}], ["Western blot analyses using binding of human IgE from latex-sensitive patients showed a band at 34-36 kDa in all tire and ambient samples.", {"entities": []}], ["Long Beach and Los Angeles, California, air samples showed four additional bands between 50 and 135 kDa.", {"entities": []}], ["Alternative Western blot analyses using rabbit IgG raised against latex proteins showed a broad band at 30-50 kDa in all samples, with additional bands in the urban air samples similar to the IgE results.", {"entities": []}], ["A latex cross-reactive material was identified in mountain cedar.", {"entities": []}], ["In conclusion, the latex allergens or latex cross-reactive material present in sedimented and airborne particulate material, derived from tire debris, and generated by heavy urban vehicle traffic could be important factors in producing latex allergy and asthma symptoms associated with air pollution particles.", {"entities": [[254, 260, "DISEASE"]]}], ["Neutrophils, complement system and skin collectively represent the main elements of the innate immune system, the first line of defense of the host against many common microorganisms.", {"entities": []}], ["Bacterial pathogens have evolved strategies to counteract all these defense activities.", {"entities": []}], ["Specifically, Staphylococcus aureus , a major human pathogen, secretes a variety of immune evasion molecules including proteases, which cleave components of the innate immune system or disrupt the integrity of extracellular matrix and intercellular connections of tissues.", {"entities": []}], ["Additionally, S. aureus secretes proteins that can activate host zymogens which, in turn, target specific defense components.", {"entities": []}], ["Secreted proteins can also inhibit the anti-bacterial function of neutrophils or complement system proteases, potentiating S. aureus chances of survival.", {"entities": []}], ["Here, we review the current understanding of these proteases and modulators of host proteases in the functioning of innate immunity and describe the importance of these mechanisms in the pathology of staphylococcal diseases.", {"entities": []}], ["The World Health Organization recommends that human growth should be monitored with the use of international standards.", {"entities": []}], ["However, in obstetric practice, we continue to monitor fetal growth using numerous local charts or equations that are based on different populations for each body structure.", {"entities": []}], ["Consistent with World Health Organization recommendations, the INTERGROWTH-21 The purpose of this study was to determine whether the babies in the INTERGROWTH-21 In the Infant Follow-up Study of the INTERGROWTH-21 There were 3711 eligible singleton live births; 3042 children (82%) were evaluated at 2 years of age.", {"entities": []}], ["There were no substantive differences between the included group and the lost-to-follow up group.", {"entities": []}], ["Infant mortality rate was 3 per 1000; neonatal mortality rate was 1.6 per 1000.", {"entities": []}], ["At the 2-year visit, the children included in the INTERGROWTH-21 The cohort enrolled in the INTERGROWTH-21", {"entities": []}], ["Chronic lung disease is a major worldwide health concern but better tools are required to understand the underlying pathologies.", {"entities": [[8, 20, "DISEASE"]]}], ["Ventilation/perfusion (V/Q) single photon emission computed tomography (SPECT) with per-voxel analysis allows for non-invasive measurement of regional lung function.", {"entities": []}], ["A clinically adapted V/Q methodology was used in healthy mice to investigate V/Q relationships.", {"entities": []}], ["Twelve week-old mice were imaged to describe normal lung function while 36 week-old mice were imaged to determine how age affects V/Q.", {"entities": []}], ["Mice were ventilated with Technegas\u2122 and injected with", {"entities": []}], ["Evidence suggests that arsenic in drinking water causes non-malignant lung disease, but nearly all data concern exposed adults.", {"entities": [[70, 82, "DISEASE"]]}], ["The desert city of Antofagasta (population 257,976) in northern Chile had high concentrations of arsenic in drinking water (>800\u00a0\u03bcg/l) from 1958 until 1970, when a new treatment plant was installed.", {"entities": []}], ["This scenario, with its large population, distinct period of high exposure, and accurate data on past exposure, is virtually unprecedented in environmental epidemiology.", {"entities": []}], ["We conducted a pilot study on early-life arsenic exposure and long-term lung function.", {"entities": []}], ["We present these preliminary findings because of the magnitude of the effects observed.", {"entities": []}], ["We recruited a convenience sample consisting primarily of nursing school employees in Antofagasta and Arica, a city with low drinking water arsenic.", {"entities": []}], ["Lung function and respiratory symptoms in 32 adults exposed to >800\u00a0\u03bcg/l arsenic before age 10 were compared to 65 adults without high early-life exposure.", {"entities": []}], ["Early-life arsenic exposure was associated with 11.5% lower forced expiratory volume in 1\u00a0s (FEV 1 ) ( P \u00a0=\u00a00.04), 12.2% lower forced vital capacity (FVC) ( P \u00a0=\u00a00.04), and increased breathlessness (prevalence odds ratio\u00a0=\u00a05.94, 95% confidence interval 1.36\u201326.0).", {"entities": [[93, 96, "GENE"]]}], ["Exposure\u2013response relationships between early-life arsenic concentration and adult FEV 1 and FVC were also identified ( P trend\u00a0=\u00a00.03).", {"entities": [[83, 86, "GENE"]]}], ["Early-life exposure to arsenic in drinking water may have irreversible respiratory effects of a magnitude similar to smoking throughout adulthood.", {"entities": []}], ["Given the small study size and non-random recruitment methods, further research is needed to confirm these findings.", {"entities": []}], ["In chronic obstructive pulmonary disease (COPD), the problem of poor patient participation in studies of self-management (SM) and pulmonary rehabilitation (PR) programmes (together referred to as COPD support programmes) is established.", {"entities": [[3, 40, "DISEASE"]]}], ["Understanding this problem beyond the previously reported socio-demographics and clinical factors is critical.", {"entities": []}], ["The aim of this study was to explore factors that explain patient participation in studies of COPD support programmes.", {"entities": []}], ["Thematic \u2018framework\u2019 synthesis was conducted on literature published from 1984 to 1 February 2015.", {"entities": []}], ["Emergent themes and subthemes were mapped onto the adapted \u2018attitude\u2013social influence\u2013external barriers\u2019 and the \u2018self-regulation\u2019 models to produce analytical themes.", {"entities": []}], ["Ten out of 12 studies were included: PR ( n =9) and SM ( n =1).", {"entities": []}], ["Three descriptive themes with 38 subthemes were mapped onto the models' constructs, and it generated four analytical themes: \u2018attitude\u2019, \u2018social influences\u2019 and \u2018illness\u2019 and \u2018intervention representations\u2019.", {"entities": []}], ["The following factors influenced (1) attendance\u2014helping oneself through health improvements, perceived control of worsening condition, perceived benefits and positive past experience of the programme, as well as perceived positive influence of professionals; (2) non-attendance\u2014perceived negative effects and negative past experience of the programme, perceived physical/practical concerns related to attendance, perceived severity of condition/symptoms and perceived negative influence of professionals/friends; (3) dropout\u2014no health improvements perceived after attending a few sessions of the programme, perceived severity of the condition and perceived physical/practical concerns related to attendance.", {"entities": []}], ["Psychosocial factors including perceived practical/physical concerns related to attendance influenced patients\u2019 participation in COPD support programmes.", {"entities": []}], ["Addressing the negative beliefs/perceptions via behaviour change interventions may help improve participation in COPD support programmes and, ultimately, patient outcomes.", {"entities": []}], ["The aim of this study was to formulate stable film-coated montelukast sodium (MS) tablets using Opadry MS core tablets were manufactured using a direct compression method.", {"entities": []}], ["Opadry yellow 20A82938 aqueous coating dispersion was used as the film-coating material.", {"entities": []}], ["Dissolution of the film-coated tablets was tested in 900 mL of 0.5% sodium lauryl sulfate solution and the bioequivalence of the tablets was tested by comparing them with a reference formulation \u2013 Singulair The efficiency of the film coating was determined by subjecting the coated tablets to gastric pH and drug release was analyzed using high-performance liquid chromatography.", {"entities": []}], ["The coated tablets had no obvious defects.", {"entities": []}], ["MS release met the study criterion of not less than 80% dissolved after 30 minutes in 0.5% sodium lauryl sulfate solution.", {"entities": []}], ["Statistical comparison of the main pharmacokinetic parameters clearly indicated no significant difference between test and reference in any of the calculated pharmacokinetic parameters.", {"entities": []}], ["Level A correlation between in vitro drug release and in vivo absorption was found to be satisfactory.", {"entities": []}], ["These findings suggest that aqueous film coating with Opadry yellow 20A82938 is an easy, reproducible, and economical approach for preparing stable MS film-coated tablets without affecting the drug-release characteristics.", {"entities": []}], ["Acute airway infections, including bronchiolitis, are common causes of early childhood hospitalization.", {"entities": [[35, 48, "DISEASE"]]}], ["The development of later asthma may be related to early airway infections in young children.", {"entities": [[25, 31, "DISEASE"]]}], ["This study is to investigate the relationship between hospitalized airway infections (HAI) in young children (< 3 years old) and later childhood asthma.", {"entities": [[145, 151, "DISEASE"]]}], ["Hospitalized children (< 3 years old) with bronchiolitis or other acute airway infections (other HAI group) from 1997-2000 were retrieved from the National Health Insurance Research Database of Taiwan, and compared to age- and gender-matched subjects with regards to asthma until 10 years of age; and potential comorbidities and medical care conditions.", {"entities": [[267, 273, "DISEASE"], [43, 56, "DISEASE"]]}], ["In total, 3,264 children (1,981 with bronchiolitis; 1,283 with other HAIs) were compared to 18,527 controls.", {"entities": [[37, 50, "DISEASE"]]}], ["The incidence of childhood asthma was higher in the study (16.2%) than the control (11.7%) group, and most cases were diagnosed between 3-5 years old.", {"entities": [[27, 33, "DISEASE"]]}], ["The hazard ratios were 1.583 (95% CI: 1.414-1.772) and 1.226 (95% CI: 1.053-1.428) for the bronchiolitis and other HAI subgroups, respectively, compared to the control group, and 1.228 (95% CI: 1.075-1.542) in the bronchiolitis subgroup compared to the other HAIs subgroup.", {"entities": [[91, 104, "DISEASE"], [214, 227, "DISEASE"]]}], ["A significantly higher odds ratio (1.973, 95% CI: 1.193-3.263) for the children with congenital heart disease (CHD) in the bronchiolitis subgroup was found at an age of 3-5 years compared to the control group.", {"entities": [[96, 109, "DISEASE"], [123, 136, "DISEASE"]]}], ["Young children (< 3 years old) hospitalized due to acute HAIs are at a higher risk of developing childhood asthma at age 3 to 10 years.", {"entities": [[107, 113, "DISEASE"]]}], ["The parents of children with HAIs at age 0 to 2 years should be informed for the higher risk of developing childhood asthma, especially in children with CHD and bronchiolitis.", {"entities": [[117, 123, "DISEASE"], [161, 174, "DISEASE"]]}], ["Home telemonitoring figures among the various solutions that could help attenuate some of the problems associated with aging populations, rates of chronic illness, and shortages of health professionals.", {"entities": []}], ["The primary aim of this study was to further our understanding of the clinical effects associated with home telemonitoring programs in the context of chronic diseases.", {"entities": []}], ["We conducted a systematic review which covered studies published between January 1966 and December 2008.", {"entities": []}], ["MEDLINE, The Cochrane Library, and the INAHTA (International Network of Agencies for Health Technology Assessment) database were consulted.", {"entities": []}], ["Our inclusion criteria consisted of: (1) English language publications in peer-reviewed journals or conference proceedings and (2) studies involving patients with diabetes, asthma, heart failure, or hypertension, and presenting results on the clinical effects of home telemonitoring.", {"entities": [[199, 211, "DISEASE"], [173, 179, "DISEASE"]]}], ["In all, 62 empirical studies were analyzed.", {"entities": []}], ["The results from studies involving patients with diabetes indicated a trend toward patients with home telemonitoring achieving better glycemic control.", {"entities": []}], ["In most trials in which patients with asthma were enrolled, results showed significant improvements in patients\u2019 peak expiratory flows, significant reductions in the symptoms associated with this illness, and improvements in perceived quality of life.", {"entities": [[38, 44, "DISEASE"]]}], ["Virtually all studies involving patients with hypertension demonstrated the ability of home telemonitoring to reduce systolic and/or diastolic blood pressure.", {"entities": [[46, 58, "DISEASE"]]}], ["Lastly, due to the equivocal nature of current findings of home telemonitoring involving patients with heart failure, larger trials are still needed to confirm the clinical effects of this technology for these patients.", {"entities": []}], ["Although home telemonitoring appears to be a promising approach to patient management, designers of future studies should consider ways to make this technology more effective as well as controlling possible mediating variables.", {"entities": []}], ["Introduction .", {"entities": []}], ["This study investigated views of mothers from disadvantaged urban and regional areas (i.e., beyond major capital cities) as potential end users of child active play and screen time behaviour change interventions, with a focus on text messaging and web-based delivery platforms.", {"entities": []}], ["Thirty-two mothers (22 urban; 10 regional) were interviewed.", {"entities": []}], ["Purpose-designed questions covered topics regarding mothers' preferences for accessing and receiving information related to parenting and child active play and screen time.", {"entities": []}], ["Data from transcribed interviews were analysed to identify responses and key themes.", {"entities": []}], ["Mothers reported frequently accessing parenting- and child-related information online.", {"entities": []}], ["Regional mothers reported seeking information by talking with other people less frequently than urban mothers and seemed to have a stronger preference for receiving information online.", {"entities": []}], ["There were few differences between responses from low and high educated mothers.", {"entities": []}], ["The majority of mothers reported that they would be happy to receive text messages containing information about active play and screen time and that they would find a dedicated website with this information useful.", {"entities": []}], ["Conclusions .", {"entities": []}], ["Mothers in this study held favourable views on the potential of receiving information via new communication technologies.", {"entities": []}], ["Future interventions targeting socioeconomically disadvantaged mothers may benefit from delivering intervention messages via these technologies.", {"entities": []}], ["Glucocorticoids (GCs) selectively trigger cell death in the multiple myeloma cell line MM1S which express NR3C1/Glucocorticoid Receptor (GR) protein, but fail to kill MM1R cells which lack GR protein.", {"entities": [[69, 76, "DISEASE"], [60, 76, "DISEASE"]]}], ["Given recent demonstrations of altered microRNA profiles in a diverse range of haematological malignancies and drug resistance, we characterized GC inducible mRNA and microRNA transcription profiles in GC sensitive MM1S as compared to GC resistant MM1R cells.", {"entities": [[145, 147, "GENE"], [202, 204, "GENE"], [235, 237, "GENE"], [145, 147, "GENE"], [202, 204, "GENE"], [235, 237, "GENE"], [145, 147, "GENE"], [202, 204, "GENE"], [235, 237, "GENE"]]}], ["Transcriptome analysis revealed that GCs regulate expression of multiple genes involved in cell cycle control, cell organization, cell death and immunological disease in MM1S cells, which remain unaffected in MM1R cells.", {"entities": []}], ["With respect to microRNAs, mir-150-5p was identified as the most time persistent GC regulated microRNA, out of 5 QPCR validated microRNAs (mir-26b, mir-125a-5p, mir-146-5p, mir-150-5p, and mir-184), which are GC inducible in MM1S but not in MM1R cells.", {"entities": [[81, 83, "GENE"], [209, 211, "GENE"], [139, 146, "GENE"], [148, 159, "GENE"], [189, 196, "GENE"], [81, 83, "GENE"], [209, 211, "GENE"]]}], ["Functional studies further revealed that ectopic transfection of a synthetic mir-150-5p mimics GR dependent gene expression changes involved in cell death and cell proliferation pathways.", {"entities": []}], ["Remarkably, despite the gene expression changes observed, overexpression of mir-150-5p in absence of GCs did not trigger significant cytotoxicity in MM1S or MM1R cells.", {"entities": []}], ["This suggests the requirement of additional steps in GC induced cell death, which can not be mimicked by mir-150-5p overexpression alone.", {"entities": [[53, 55, "GENE"]]}], ["Interestingly, a combination of mir-150-5p transfection with low doses GC in MM1S cells was found to sensitize therapy response, whereas opposite effects could be observed with a mir-150-5p specific antagomir.", {"entities": [[71, 73, "GENE"]]}], ["Although mir-150-5p overexpression did not substantially change GR expression levels, it was found that mir-150-5p evokes GR specific effects through indirect mRNA regulation of GR interacting transcription factors and hormone receptors, GR chaperones, as well as various effectors of unfolded protein stress and chemokine signalling.", {"entities": []}], ["Altogether GC-inducible mir-150-5p adds another level of regulation to GC specific therapeutic responses in multiple myeloma.", {"entities": [[117, 124, "DISEASE"], [108, 124, "DISEASE"], [11, 13, "GENE"], [71, 73, "GENE"]]}], ["Access to information is critical to a patient\u2019s valid exercise of autonomy.", {"entities": []}], ["One increasingly important source of medical information is the Internet.", {"entities": []}], ["Individuals often turn to drug company (\u201cpharma\u201d) websites to look for drug information.", {"entities": []}], ["The objective of this study was to determine whether there is information on pharma websites that is embargoed: Is there information that is hidden from the patient unless she attests to being a health care provider?", {"entities": []}], ["We discuss the implications of our findings for health care ethics.", {"entities": []}], ["We reviewed a convenience sample of 40 pharma websites for \u201cprofessionals-only\u201d areas and determined whether access to those areas was restricted, requiring attestation that the user is a health care professional in the United States.", {"entities": []}], ["Of the 40 websites reviewed, 38 had information that was labeled for health care professionals-only.", {"entities": []}], ["Of these, 24 required the user to certify their status as a health care provider before they were able to access this \u201chidden\u201d information.", {"entities": []}], ["Many pharma websites include information in a \u201cprofessionals-only\u201d section.", {"entities": []}], ["Of these, the majority require attestation that the user is a health care professional before they can access the information.", {"entities": []}], ["This leaves patients with two bad choices: (1) not accessing the information or (2) lying about being a health care professional.", {"entities": []}], ["Both of these outcomes are unacceptable.", {"entities": []}], ["In the first instance, the patient\u2019s access to information is limited, potentially impairing their health and their ability to make reasonable and well-informed decisions.", {"entities": []}], ["In the second instance, they may be induced to lie in a medical setting.", {"entities": []}], ["\u201cTeaching\u201d patients to lie may have adverse consequences for the provider-patient relationship.", {"entities": []}], ["Atopic dermatitis (AD) is a common chronic inflammatory skin disorder where epidermal barrier dysfunction is a major factor in the pathogenesis.", {"entities": [[7, 17, "DISEASE"]]}], ["The identification of AD susceptibility genes related to barrier dysfunction is therefore of importance.", {"entities": []}], ["The epidermal transglutaminases ( TGM1, TGM3 and TGM5) encodes essential cross-linking enzymes in the epidermis.", {"entities": [[34, 38, "GENE"], [40, 44, "GENE"], [49, 53, "GENE"]]}], ["To determine whether genetic variability in the epidermal transglutaminases contributes to AD susceptibility.", {"entities": []}], ["Forty-seven single nucleotide polymorphisms (SNPs) in the TGM1, TGM3 and TGM5 gene region were tested for genetic association with AD, independently and in relation to FLG genotype, using a pedigree disequilibrium test (PDT) in a Swedish material consisting of 1753 individuals from 539 families.", {"entities": [[58, 62, "GENE"], [64, 68, "GENE"], [73, 77, "GENE"], [168, 171, "GENE"]]}], ["In addition, a German case-control material, consisting of 533 AD cases and 1996 controls, was used for in silico analysis of the epidermal TGM regions.", {"entities": []}], ["Gene expression of the TGM1, TGM3 and TGM5 gene was investigated by relative quantification with Real Time PCR (qRT-PCR).", {"entities": [[23, 27, "GENE"], [29, 33, "GENE"], [38, 42, "GENE"]]}], ["Immunohistochemical (IHC) analysis was performed to detect TG1, TG3 and TG5 protein expression in the skin of patients and healthy controls.", {"entities": []}], ["PDT analysis identified a significant association between the TGM1 SNP rs941505 and AD with allergen-specific IgE in the Swedish AD family material.", {"entities": [[62, 66, "GENE"]]}], ["However, the association was not replicated in the German case-control material.", {"entities": []}], ["No significant association was detected for analyzed SNPs in relation to FLG genotype.", {"entities": [[73, 76, "GENE"]]}], ["TG1, TG3 and TG5 protein expression was detected in AD skin and a significantly increased TGM3 mRNA expression was observed in lesional skin by qRT-PCR.", {"entities": [[90, 94, "GENE"]]}], ["Although TGM1 and TGM3 may be differentially expressed in AD skin, the results from the genetic analysis suggest that genetic variation in the epidermal transglutaminases is not an important factor in AD susceptibility.", {"entities": [[9, 13, "GENE"], [18, 22, "GENE"]]}], ["The (pro)renin receptor [(P)RR] has been recognized as a multifunctional receptor.", {"entities": []}], ["The purpose of this study was to assess the association between plasma soluble (P)RR [s(P)RR] concentration in human cord blood (i.e., neonatal blood at birth) and small for gestational age (SGA) birth.", {"entities": []}], ["Participants were women with a singleton pregnancy who delivered at the National Center for Child Health and Development between January 2010 and December 2011.", {"entities": []}], ["Inclusion criteria were availability of maternal pre-pregnancy and paternal body mass index, and the absence of structural anomalies in neonates.", {"entities": []}], ["s(P)RR concentration in cord blood was measured in 621 neonates.", {"entities": []}], ["The 621 pairs of mothers and neonates were categorized into four groups based on quartiles of s(P)RR concentrations in cord blood.", {"entities": []}], ["SGA was defined as a birth weight below the 10 Among 621 neonates, 55 (8.9%) were diagnosed as SGA (SGA group) and 566 (91.1%) were not (non-SGA group).", {"entities": []}], ["Average s(P)RR concentration in cord blood was 66.1\u00b112.6 ng/ml (mean\u00b1standard deviation).", {"entities": []}], ["There were 155 pairs in the first plasma s(P)RR concentration quartile (Q1: <58.2 ng/ml), 153 pairs in the second quartile (Q2: 58.2\u201365.1 ng/ml), 157 pairs in the third quartile (Q3: 65.1\u201373.1 ng/ml) and 156 pairs in the fourth quartile (Q4: >73.1 ng/ml).", {"entities": []}], ["The distribution of SGA births was 18 (11.6%) in Q1, 14 (9.2%) in Q2, 16 (10.2%) in Q3 and 7 (4.5%) in Q4, respectively.", {"entities": []}], ["The odds ratio of SGA births was 0.24 (95% confidence interval: 0.08\u20130.71) for the fourth quartile compared to the first quartile in multivariate models.", {"entities": []}], ["The P -value for trend was also significant ( P \u200a=\u200a0.020).", {"entities": []}], ["High s(P)RR concentration is associated with a lower SGA birth likelihood.", {"entities": []}], ["This study investigated patient perceptions, experiences and management of COPD throughout the SLS COPD study.", {"entities": []}], ["Follow-up interviews were conducted with 400 patients who completed SLS COPD; a mixed-methods approach was used to collect quantitative and qualitative information.", {"entities": []}], ["Structured interviews using closed-ended questions were conducted with 360 patients, detailing aspects of background/lifestyle information and COPD.", {"entities": []}], ["Extended interviews containing open-ended questions on perceptions of COPD and quality of life (QoL) in addition to the closed-ended questions were completed by 40 further patients.", {"entities": []}], ["Participants also completed the Adherence Starts with Knowledge-12 (ASK-12) and the COPD and Asthma Sleep Impact Scale (CASIS) questionnaire.", {"entities": []}], ["Quantitative data were analysed descriptively; qualitative data were analysed using qualitative description.", {"entities": []}], ["The participants ( n \u2009=\u2009400) were reasonably representative of the SLS COPD population; mean age was 66.2 years.", {"entities": []}], ["Breathlessness was the most commonly recalled symptom of/associated with COPD (88.5% of patients) and was the symptom that changed the most (improved, 26.8%/worsened, 20.9%) throughout the study.", {"entities": []}], ["Participants\u2019 daily functioning and activities were most affected by symptoms of/associated with COPD, followed by relationships and psychological issues.", {"entities": []}], ["66.5% of participants experienced exacerbations, 60.5% of whom reported self-management as their first treatment strategy (taking antibiotics, resting and/or corticosteroids).", {"entities": []}], ["Qualitative analysis revealed COPD symptoms, breathlessness in particular, to have a significant impact on mobility and in turn QoL.", {"entities": []}], ["In conclusion, breathlessness was cited in these interviews as the COPD symptom with the greatest impact on participants\u2019 daily functioning, activities and self-care.", {"entities": []}], ["The findings provided significant additional knowledge to the SLS COPD study findings.", {"entities": []}], ["Interviews with patients undergoing a clinical trial for chronic lung disease highlights the impact of breathlessness on quality of life.", {"entities": [[65, 77, "DISEASE"]]}], ["Henrik Svedsater at GlaxoSmithKline in the UK, and co-workers, wanted to dig deeper into patient perceptions of COPD during the Salford Lung Study in Chronic Obstructive Pulmonary Disease (SLS COPD) clinical trial, which trialed an alternative self-administered inhaler treatment.", {"entities": []}], ["To this end, Svedsater\u2019s team administered questionnaires and interviewed 400 patients involved in SLS COPD, to examine disease impacts on their quality of life.", {"entities": []}], ["The patients cited breathlessness as having the greatest bearing on daily life, particularly on their ability to carry out physical tasks and continue a self-care regime.", {"entities": []}], ["Investigations of disease impact should be incorporated into future clinical trials, particularly to assess how improving lung function affects patient perceptions and quality of life.", {"entities": []}], ["The rate of elective surgeries varies dramatically by geography in the United States.", {"entities": []}], ["For many of these surgeries, there is not clear evidence of their relative merits over alternate treatment choices and there are significant tradeoffs in short- and long-term risks and benefits of selecting one treatment option over another.", {"entities": []}], ["Conditions and symptoms for which there is this lack of a single clear evidence-based treatment choice present great opportunities for patient and provider collaboration on decision making; back pain and joint osteoarthritis are two such ailments.", {"entities": [[210, 224, "DISEASE"]]}], ["A number of decision aids are in active use to encourage this shared decision-making process.", {"entities": []}], ["Decision aids have been assessed in formal studies that demonstrate increases in patient knowledge, increases in patient-provider engagement, and reduction in surgery rates.", {"entities": []}], ["These studies have not widely demonstrated the added benefit of health coaching in support of shared decision making nor have they commonly provided strong evidence of cost reductions.", {"entities": []}], ["In order to add to this evidence base, we undertook a comparative study testing the relative impact on health utilization and costs of active outreach through interactive voice response technology to encourage health coaching in support of shared decision making in comparison to mailed outreach or no outreach.", {"entities": []}], ["This study focused on individuals with back pain or joint pain.", {"entities": []}], ["We conducted four waves of stratified randomized comparisons for individuals with risk for back, hip, or knee surgery who did not have claims-based evidence of one or more of five chronic conditions and were eligible for population care management services within three large regional health plans in the United States.", {"entities": []}], ["An interactive voice response (IVR) form of outreach that included the capability for individuals to directly connect with health coaches telephonically, known as AutoDialog\u00ae, was compared to a control (mailed outreach or natural levels of inbound calling depending on the study wave).", {"entities": []}], ["In total, the study include 24,167 adults with commercial and Medicare Advantage private coverage at three health plans and at risk for lumbar back surgery, hip repair/replacement, or knee repair/replacement.", {"entities": []}], ["Interactive voice response outreach led to 10.7 (P-value\u2009<\u2009.0001) times as many inbound calls within 30 days as the control.", {"entities": []}], ["Over 180 days, the IVR group (\u201cintervention\u201d) had 67 percent (P-value\u2009<\u2009.0001) more health coach communications and agreed to be sent 3.2 (P-value\u2009<\u2009.0001) time as many DVD- and/or booklet-based decision aids.", {"entities": []}], ["Targeted surgeries were reduced by 6.7 percent (P-value\u2009=\u2009.6039).", {"entities": []}], ["Overall costs were lower by 4.9 percent (P-value\u2009=\u2009.055).", {"entities": []}], ["Costs that were not related to maternity, cancer, trauma and substance abuse (\u201cactionable costs\u201d) were reduced by 6.5 percent (P-value\u2009=\u2009.0286).", {"entities": [[61, 76, "DISEASE"], [42, 48, "DISEASE"]]}], ["IVR with a transfer-to-health coach-option significantly increased levels of health coaching compared to mailed or no outreach and lead to significantly reduced actionable medical costs.", {"entities": []}], ["Providing high levels of health coaching to individuals with these types of risks appears to have produced important levels of actionable medical cost reductions.", {"entities": []}], ["We believe this impact resulted from more informed and engaged health care decision making.", {"entities": []}], ["The duration of bronchoscopy examinations varies considerably depending on the diagnostic and therapeutic procedures used.", {"entities": []}], ["It can last more than 20 minutes if a complex diagnostic work-up is included.", {"entities": []}], ["With wide access to videobronchoscopy, the whole procedure can be recorded as a video sequence.", {"entities": []}], ["Common practice relies on an active attitude of the bronchoscopist who initiates the recording process and usually chooses to archive only selected views and sequences.", {"entities": []}], ["However, it may be important to record the full bronchoscopy procedure as documentation when liability issues are at stake.", {"entities": []}], ["Furthermore, an automatic recording of the whole procedure enables the bronchoscopist to focus solely on the performed procedures.", {"entities": []}], ["Video recordings registered during bronchoscopies include a considerable number of frames of poor quality due to blurry or unfocused images.", {"entities": []}], ["It seems that such frames are unavoidable due to the relatively tight endobronchial space, rapid movements of the respiratory tract due to breathing or coughing, and secretions which occur commonly in the bronchi, especially in patients suffering from pulmonary disorders.", {"entities": []}], ["The use of recorded bronchoscopy video sequences for diagnostic, reference and educational purposes could be considerably extended with efficient, flexible summarization algorithms.", {"entities": []}], ["Thus, the authors developed a prototype system to create shortcuts (called summaries or abstracts) of bronchoscopy video recordings.", {"entities": []}], ["Such a system, based on models described in previously published papers, employs image analysis methods to exclude frames or sequences of limited diagnostic or education value.", {"entities": []}], ["The algorithm for the selection or exclusion of specific frames or shots from video sequences recorded during bronchoscopy procedures is based on several criteria, including automatic detection of \"non-informative\", frames showing the branching of the airways and frames including pathological lesions.", {"entities": []}], ["The paper focuses on the challenge of generating summaries of bronchoscopy video recordings.", {"entities": []}], ["Most smokers start young.", {"entities": []}], ["Initiation of cigarette smoking at an earlier age leads to more life-years for tobacco use, makes quitting harder, and increases the risk of serious health consequences.", {"entities": []}], ["Despite these challenges, research focusing on smoking behavior among adolescent boys in Taiwan is rare.", {"entities": []}], ["Although the Taiwanese government enacted the Tobacco Hazards Prevention Act in 2009, aimed at prevention and reducing the rate of smoking, the percentage of high school students who smoke has continued to increase.", {"entities": []}], ["In 2006, 7.5% of adolescent boys engaged in smoking.", {"entities": []}], ["By 2012 the rate had increased to 24.6%.", {"entities": []}], ["This paper explores the experiences that contribute to adolescent Taiwanese boys making the decision to smoke.", {"entities": []}], ["A phenomenological approach to inquiry was used as the philosophical foundations for this study with twelve adolescent boys who engaged in smoking behaviors.", {"entities": []}], ["Data was gathered through two face-to-face semi-structured interviews and a focus group.", {"entities": []}], ["Data analysis was performed using Colaizzi\u2019s analysis method.", {"entities": []}], ["Findings indicated that decisions to begin smoking were motivated by curiosity and as a means of establishing friendships while decisions to continue smoking were linked to the addictive nature of smoking and as a means of coping with stress and passing the time.", {"entities": []}], ["The findings can be used to inform the prevention of tobacco use and to reduce the high smoking rates among adolescent boys.", {"entities": []}], ["Honey bees ( Apis mellifera ) play a critical role in global food production as pollinators of numerous crops.", {"entities": []}], ["Recently, honey bee populations in the United States, Canada, and Europe have suffered an unexplained increase in annual losses due to a phenomenon known as Colony Collapse Disorder (CCD).", {"entities": []}], ["Epidemiological analysis of CCD is confounded by a relative dearth of bee pathogen field studies.", {"entities": []}], ["To identify what constitutes an abnormal pathophysiological condition in a honey bee colony, it is critical to have characterized the spectrum of exogenous infectious agents in healthy hives over time.", {"entities": []}], ["We conducted a prospective study of a large scale migratory bee keeping operation using high-frequency sampling paired with comprehensive molecular detection methods, including a custom microarray, qPCR, and ultra deep sequencing.", {"entities": []}], ["We established seasonal incidence and abundance of known viruses, Nosema sp.", {"entities": []}], [", Crithidia mellificae , and bacteria.", {"entities": []}], ["Ultra deep sequence analysis further identified four novel RNA viruses, two of which were the most abundant observed components of the honey bee microbiome (\u223c10 Nosema occurred in the summer, whereas levels of the trypanosomatid Crithidia mellificae and Lake Sinai virus 2, a novel virus, peaked in January.", {"entities": []}], ["Sulfur mustard is a vesicant chemical warfare agent, which has been used during Iraq-Iran-war.", {"entities": []}], ["Many veterans and civilians still suffer from long-term complications of sulfur mustard exposure, especially in their lung.", {"entities": []}], ["Although the lung lesions of these patients are similar to Chronic Obstructive Pulmonary Disease (COPD), there are some differences due to different etiology and clinical care.", {"entities": []}], ["Less is known on the molecular mechanism of sulfur mustard patients and specific treatment options.", {"entities": []}], ["microRNAs are master regulators of many biological pathways and proofed to be stable surrogate markers in body fluids.", {"entities": []}], ["Based on that microRNA expression for serum samples of sulfur mustard patients were examined, to establish specific microRNA patterns as a basis for diagnostic use and insight into affected molecular pathways.", {"entities": []}], ["Patients were categorized based on their long-term complications into three groups and microRNA serum levels were measured.", {"entities": []}], ["The differentially regulated microRNAs and their corresponding gene targets were identified.", {"entities": []}], ["Cell cycle arrest, ageing and TGF-beta signaling pathways showed up to be the most deregulated pathways.", {"entities": []}], ["The candidate microRNA miR-143-3p could be validated on all individual patients.", {"entities": []}], ["In a ROC analysis miR-143-3p turned out to be a suitable diagnostic biomarker in the mild and severe categories of patients.", {"entities": []}], ["Further microRNAs which might own a link to the biology of the sulfur mustard patients are miR-365a-3p, miR-200a-3p, miR-663a.", {"entities": []}], ["miR-148a-3p, which showed up only in a validation study, might be linked to the airway complications of the sulfur mustard patients.", {"entities": []}], ["All the other candidate microRNAs do not directly link to COPD phenotype or lung complications.", {"entities": []}], ["In summary the microRNA screening study characterizes several molecular differences in-between the clinical categories of the sulfur mustard exposure groups and established some useful microRNA biomarkers.", {"entities": []}], ["qPCR raw data is available via the Gene Expression Omnibus https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110797 .", {"entities": []}], ["Evidence shows that effective self-management behaviors have the potential to improve health outcomes, quality of life, self-efficacy and reduce morbidity, emergency visits and costs of care.", {"entities": []}], ["A better understanding of self-management interventions (i.e.", {"entities": []}], ["programs that help with managing symptoms, treatment, physical and psychological consequences) is needed to achieve a positive impact on health because most children with a disability now live well into adulthood.", {"entities": []}], ["A systematic review of self-management interventions for school age youth with physical disabilities was undertaken to assess their effectiveness.", {"entities": []}], ["Comprehensive electronic searches using international web-based reference libraries were conducted for peer-reviewed and gray literature published between 1980 and January 2012.", {"entities": []}], ["Eligible studies examined the effectiveness of self-management interventions for children and youth between 6 and 18 years of age with congenital or acquired physical disabilities.", {"entities": []}], ["Studies needed to include a comparison group (e.g.", {"entities": []}], ["single group pre/post-test design) and at least one quantifiable health-related outcome.", {"entities": []}], ["Of the 2184 studies identified, six met the inclusion criteria; two involved youth with spina bifida and four with juvenile arthritis.", {"entities": [[124, 133, "DISEASE"], [88, 100, "DISEASE"]]}], ["The majority of the interventions ran several sessions for at least 3 months by a trained interventionist or clinician, had one-to-one sessions and meetings, homework activities and parental involvement.", {"entities": []}], ["Although outcomes varied between the studies, all of the interventions reported at least one significant improvement in either overall self-management skills or a specific health behavior.", {"entities": []}], ["While self-management interventions have the potential to improve health behaviors, there were relatively few rigorously designed studies identified.", {"entities": []}], ["More studies are needed to document the outcomes of self-management interventions, especially their most effective characteristics for children and youth with physical disabilities.", {"entities": []}], ["There is some evidence to suggest that self-management interventions for children and youth with spina bifida and arthritis can improve self-management behaviors and health outcomes.", {"entities": [[114, 123, "DISEASE"], [97, 109, "DISEASE"]]}], ["Parents\u2019 involvement should be considered in encouraging self-management behaviors at different stages of their child\u2019s development.", {"entities": []}], ["Much work is needed to explore the longer term implications of self-management interventions for youth with physical disabilities as well as the impact on health care utilization.", {"entities": []}], ["Introduction.", {"entities": []}], ["Varicella, a vaccine preventable disease (VPD) is one of the most common communicable diseases in Romania.", {"entities": []}], ["The objectives of our study were to describe the epidemiological evolution of varicella in Romania between 2004 and 2013 and the clinical characteristics of the cases admitted to NIID between 2011 and 2013.", {"entities": []}], ["Materials and methods.", {"entities": []}], ["An epidemiological retrospective study was conducted by using the information reported quarterly by general practitioners and hospitals at the national level.", {"entities": []}], ["There is no system for the surveillance of severe cases in Romania, so, to describe the clinical characteristics of varicella cases, a second retrospective study was developed, in which the patients hospitalized in the NIID, within the period 2011-2013, were included.", {"entities": []}], ["Questionnaires were completed by using data from the clinical observation forms.", {"entities": []}], ["Collected information included demographic, clinical and laboratory data, complications, date of onset and admission, length of stay, admission and discharge diagnosis.", {"entities": []}], ["Data were processed and analyzed by using Microsoft Excel program.", {"entities": []}], ["A total of 504,844 cases were reported of at the national level between 2004 and 2013, with a mean incidence of 238.2/ 100,000 inhabitants.", {"entities": []}], ["The most affected age group was 5-9 years old (incidence 1362.7/ 100,000 inhabitants).", {"entities": []}], ["The study conducted in NIID, registered 353 patients hospitalized with varicella between 2011 and 2013.", {"entities": []}], ["Most of the hospitalized cases (88.8%) were under 10 years old and many (72.6 %) attended a community.", {"entities": []}], ["The majority of cases had rash (98.6%) and fever (79.9%).", {"entities": []}], ["The main complications were pneumonia (46.2%), bacterial infection (16.1%) and encephalitis (2.5%).", {"entities": [[28, 37, "DISEASE"], [79, 91, "DISEASE"]]}], ["Discussions.", {"entities": []}], ["Varicella is a very common disease in Romania, which may develop complications.", {"entities": []}], ["A specific surveillance system should be introduced in order to provide accurate epidemiological, clinical and laboratory information to assess whether varicella is a public health problem in Romania and if the introduction of vaccination in NIP is recommended.", {"entities": []}], ["However, given the large number of current cases in Romania, a solution may be a sentinel surveillance system type.", {"entities": []}], ["Airway hyperresponsiveness in asthma may not be a problem of too much airway smooth muscle strength.", {"entities": [[30, 36, "DISEASE"]]}], ["Rather, it may be a problem of too little of the factors that oppose muscle shortening.", {"entities": []}], ["The weight of available evidence seems to support the idea that loss of the dilating response to a deep inspiration may play a central role in this process, and that the locus of the response is within the airway smooth muscle cell.", {"entities": []}], ["Bridge dynamics and plastic reorganization of the smooth muscle cytoskeleton are the focus of this commentary; how these factors interact and details about underlying mechanisms remain unclear.", {"entities": []}], ["To estimate the incidence and relative risk of a hospitalization or emergency visit for noninfectious liver injury in users of eight oral antimicrobials\u2014amoxicillin, amoxicillin-clavulanic acid, clarithromycin, cefuroxime, doxycycline, levofloxacin, moxifloxacin, telithromycin\u2014compared with nonusers of these antimicrobials.", {"entities": []}], ["Retrospective, observational cohort study with a nested case-control analysis.", {"entities": []}], ["HealthCore Integrated Research Database.", {"entities": []}], ["Adults with continuous health plan enrollment for at least 6\u00a0months before study entry who had a new dispensing of a study antimicrobial between July 1, 2001, and March 31, 2009.", {"entities": []}], ["Cases had diagnoses indicating noninfectious liver injury during follow-up.", {"entities": []}], ["To control for potentially confounding risk factors, 10 controls at risk for liver injury during follow-up were matched to each case by age, sex, and event date (liver injury date of the case), and analyses were adjusted for medical history, concomitant drugs, and health care service use.", {"entities": []}], ["Two physician reviewers (blind to exposure) validated the cases.", {"entities": []}], ["Among 1.3 million antimicrobial users, we identified 607 cases of liver injury, including 82 cases of severe hepatocellular injury and 11 cases of liver failure.", {"entities": []}], ["Liver injury incidence in nonusers of study antimicrobials was 35/100,000 person-years (95% confidence interval [CI] 29\u201342/100,000 person-years).", {"entities": []}], ["For valid cases, the adjusted relative risk among current users of multiple antimicrobials was 3.2 (95% CI 1.6\u20136.7).", {"entities": []}], ["Levofloxacin had the highest relative risk for current single use (3.2, 95% CI 1.8\u20135.8).", {"entities": []}], ["Relative risks were also elevated for amoxicillin-clavulanic acid (2.5, 95% CI 1.3\u20135.0), doxycycline (2.5, 95% CI 1.2\u20135.2), moxifloxacin (2.3, 95% CI 1.1\u20134.7), and amoxicillin (2.3, 95% CI 1.1\u20134.7).", {"entities": []}], ["The results support a comparatively high adjusted relative risk of liver injury among patients exposed concurrently to multiple antimicrobials and modest elevations in the risk for several antimicrobials used alone; however, we found little evidence of any strong effect of commonly used antimicrobials on the risk of liver injury.", {"entities": []}], ["Vitronectin, a multifunctional glycoprotein, is involved in coagulation, inhibition of the formation of the membrane attack complex (MAC), cell adhesion and migration, wound healing, and tissue remodeling.", {"entities": []}], ["The primary cellular source of vitronectin is hepatocytes; it is not known whether resident cells of airways produce vitronectin, even though the glycoprotein has been found in exhaled breath condensate and bronchoalveolar lavage from healthy subjects and patients with interstitial lung disease.", {"entities": [[270, 295, "DISEASE"], [283, 295, "DISEASE"]]}], ["It is also not known whether vitronectin expression is altered in subjects with asthma and COPD.", {"entities": [[80, 86, "DISEASE"]]}], ["In this study, bronchial tissue from 7 asthmatic, 10 COPD and 14 control subjects was obtained at autopsy and analyzed by immunohistochemistry to determine the percent area of submucosal glands occupied by vitronectin.", {"entities": []}], ["In a separate set of experiments, quantitative colocalization analysis was performed on tracheobronchial tissue sections obtained from donor lungs (6 asthmatics, 4 COPD and 7 controls).", {"entities": []}], ["Vitronectin RNA and protein expressions in bronchial surface epithelium were examined in 12 subjects who undertook diagnostic bronchoscopy.", {"entities": []}], ["Vitronectin was found in the tracheobronchial epithelium from asthmatic, COPD, and control subjects, although its expression was significantly lower in the asthmatic group.", {"entities": []}], ["Colocalization analysis of 3D confocal images indicates that vitronectin is expressed in the glandular serous epithelial cells and in respiratory surface epithelial cells other than goblet cells.", {"entities": []}], ["Expression of the 65-kDa vitronectin isoform was lower in bronchial surface epithelium from the diseased subjects.", {"entities": []}], ["The cause for the decreased vitronectin expression in asthma is not clear, however, the reduced concentration of vitronectin in the epithelial/submucosal layer of airways may be linked to airway remodeling.", {"entities": [[54, 60, "DISEASE"]]}], ["Th2 immunity is a primary host defence against metazoan pathogens and two of the important cytokines involved in this immune response in mammals are IL-4 and IL-13.", {"entities": []}], ["Recently the origin and evolution of Th2 immune responses have been investigated in fish where a molecule with relatedness to both IL-4 and IL-13 is present, termed IL-4/13.", {"entities": []}], ["Different IL-4/13 paralogues (IL-4/13\u2009A and IL-4/13B) exist in teleost fish.", {"entities": []}], ["In this paper, we have focused on the IL-4/13 isoforms found in the European sea bass ( Dicentrarchus labrax L.).", {"entities": []}], ["Two tandem duplicated but divergent IL-4/13\u2009A isoforms and one IL-4/13B are present, a unique situation compared to other teleosts.", {"entities": []}], ["These genes were studied in terms of their in vitro and in vivo transcript levels after different treatments and their biological activities after production of the recombinant isoforms.", {"entities": []}], ["The results show that the presence of these three paralogues is associated with different activities, both in terms of their expression profiles and the ability of the proteins to modulate the expression of immune genes in head kidney leukocytes.", {"entities": []}], ["It is clear that the initiation and control of type-2 responses in seabass is complex due to the presence of multiple IL-4/13 isoforms with overlapping but distinct activities.", {"entities": []}], ["While the relationship between electronic cigarette use and smoking has often been studied, the association between electronic cigarette use and socioeconomic factors has received less attention.", {"entities": []}], ["This is a study protocol aiming to describe the relationship between the consumption of psychoactive products (in particular: smoking) or some socioeconomic factors and the evolution of the use of electronic cigarette in primary healthcare over 1\u2005year.", {"entities": []}], ["Electronic cigarette, Tobacco, Alcohol and Cannabis ( e -TAC) is a prospective multisite cohort study, including 473 patients at baseline and carrying out in general practices in the Aquitaine area (France).", {"entities": []}], ["The volunteer patients participated in the study regardless of their initial reason for consultation.", {"entities": []}], ["They filled out a self-administered questionnaire at baseline and will also do so after 12\u2005months by phone, email or letter.", {"entities": []}], ["The study will focus on the factors that explain the experimentation with or the current use of the electronic cigarette, as well as factors associated with their evolutions over time using multivariate logistic regression modelling or Cox regression modelling.", {"entities": []}], ["This study received ethical approval from the University of Bordeaux Committee for the protection of persons.", {"entities": []}], ["It was also approved by the National Commission for Data Processing and Freedoms.", {"entities": []}], ["Findings will be submitted for publication in peer-reviewed journals and we will disseminate them by presentations at national or international conferences.", {"entities": []}], ["RCB: 2015-A00778-41; Pre-results.", {"entities": []}], ["Dietary patterns better reflect eating habits as opposed to single dietary components.", {"entities": []}], ["However, the use of dietary pattern analysis in nutritional epidemiology has been hampered by the complexity of interpreting and presenting multidimensional dietary data.", {"entities": []}], ["This study extracts and visualizes dietary patterns from self-reported dietary data collected in mid-pregnancy (25 A total of seven dietary patterns were extracted by principal component analysis, characterized and visualized by color-coded spider plots, and referred to as: Vegetables/Prudent, Alcohol, Western, Nordic, Seafood, Candy and Rice/Pasta/Poultry.", {"entities": []}], ["A consistent dose-response association with preterm birth was only observed for Western diet with an odds ratio of 1.30 (95% CI: 1.13, 1.49) comparing the highest to the lowest quintile.", {"entities": []}], ["This association was primarily driven by induced preterm deliveries (odds ratio\u200a=\u200a1.66, 95% CI: 1.30, 2.11, comparing the highest to the lowest quintile) while the corresponding odds ratio for spontaneous preterm deliveries was more modest (odds ratio\u200a=\u200a1.18, 95% CI: 0.99, 1.39).", {"entities": []}], ["All based on adjusted analyses.", {"entities": []}], ["In conclusion, this study presented a simple and novel framework for visualizing correlation structures between overall consumption of foods group and their relation to nutrient intake and maternal characteristics.", {"entities": []}], ["Our results suggest that Western-type diet, high in meat and fats and low in fruits and vegetables, is associated with increased odds of induced preterm birth.", {"entities": []}], ["One of the major debates in implementation research turns around fidelity and adaptation.", {"entities": []}], ["Fidelity is the degree to which an intervention is implemented as intended by its developers.", {"entities": []}], ["It is meant to ensure that the intervention maintains its intended effects.", {"entities": []}], ["Adaptation is the process of implementers or users bringing changes to the original design of an intervention.", {"entities": []}], ["Depending on the nature of the modifications brought, adaptation could either be potentially positive or could carry the risk of threatening the theoretical basis of the intervention, resulting in a negative effect on expected outcomes.", {"entities": []}], ["Adaptive interventions are those for which adaptation is allowed or even encouraged.", {"entities": []}], ["Classical fidelity dimensions and conceptual frameworks do not address the issue of how to adapt an intervention while still maintaining its effectiveness.", {"entities": []}], ["We support the idea that fidelity and adaptation co-exist and that adaptations can impact either positively or negatively on the intervention\u2019s effectiveness.", {"entities": []}], ["For adaptive interventions, research should answer the question how an adequate fidelity-adaptation balance can be reached.", {"entities": []}], ["One way to address this issue is by looking systematically at the aspects of an intervention that are being adapted.", {"entities": []}], ["We conducted fidelity research on the implementation of an empowerment strategy for dengue prevention in Cuba.", {"entities": []}], ["In view of the adaptive nature of the strategy, we anticipated that the classical fidelity dimensions would be of limited use for assessing adaptations.", {"entities": []}], ["The typology we used in the assessment\u2014implemented, not-implemented, modified, or added components of the strategy\u2014also had limitations.", {"entities": []}], ["It did not allow us to answer the question which of the modifications introduced in the strategy contributed to or distracted from outcomes.", {"entities": []}], ["We confronted our empirical research with existing literature on fidelity, and as a result, considered that the framework for implementation fidelity proposed by Carroll et al.", {"entities": []}], ["in 2007 could potentially meet our concerns.", {"entities": []}], ["We propose modifications to the framework to assess both fidelity and adaptation.", {"entities": []}], ["The modified Carroll et al.\u2019s framework we propose may permit a comprehensive assessment of the implementation fidelity-adaptation balance required when implementing adaptive interventions, but more empirical research is needed to validate it.", {"entities": []}], ["To evaluate the clinical significance of autoantibodies to three major epithelial cytokeratins (CK) - CK8, CK18, and CK19 - we compared 66 patients with toluene diisocyanate (TDI)-induced asthma (group I) with three control groups: 169 asymptomatic exposed subjects (group II), 64 patients with allergic asthma (group III), and 123 unexposed healthy subjects (group IV).", {"entities": [[295, 310, "DISEASE"], [188, 194, "DISEASE"], [304, 310, "DISEASE"]]}], ["Serum IgG, specific for human recombinant CKs, were measured by ELISA (enzyme linked immunosorbent assay), and ELISA inhibition tests were performed.", {"entities": []}], ["The existence of these antibodies was confirmed by IgG immunoblot analysis.", {"entities": []}], ["Anti-TDI-HSA (human serum albumin) IgE and IgG antibodies were measured by ELISA in the same set of the patients.", {"entities": []}], ["The prevalence of CK8, CK18, and CK19 auotantibodies in group I was significantly higher than in the other three groups.", {"entities": []}], ["Results of the ELISA inhibition test showed significant inhibition with the addition of three CKs in a dose-dependent manner.", {"entities": []}], ["No significant association was found between CK autoantibodies and the prevalence of anti-TDI-HSA IgG and IgE antibodies.", {"entities": []}], ["These results suggest that autoantibodies to CK18 and CK19 can be used as serologic markers for identifying patients with TDI-induced asthma among exposed workers.", {"entities": [[134, 140, "DISEASE"]]}], ["We have analysed a family with nine congenital neutropenia patients in four generations, several of which we have studied in a long-term follow-up of over 25\u00a0years.", {"entities": [[47, 58, "DISEASE"]]}], ["The patients were mild to severe neutropenic and suffered from various recurrent bacterial infections.", {"entities": []}], ["Mutations in the genes ELANE , CSF3R and GFI1 have been reported in patients with autosomal dominant congenital neutropenias.", {"entities": [[23, 28, "GENE"], [31, 36, "GENE"], [41, 45, "GENE"]]}], ["Using a small-scale linkage analysis with markers around the ELANE , CSF3R , CSF3 and GFI1 genes, we were able to determine that the disease segregated with markers around the ELANE gene.", {"entities": [[61, 66, "GENE"], [176, 181, "GENE"], [69, 74, "GENE"], [77, 81, "GENE"], [86, 90, "GENE"], [61, 66, "GENE"], [176, 181, "GENE"]]}], ["We identified a novel mutation in the ELANE gene in all of the affected family members that was not present in any of the healthy family members.", {"entities": [[38, 43, "GENE"]]}], ["The mutation leads to an A28S missense mutation in the mature protein.", {"entities": []}], ["None of these patients developed leukaemia.", {"entities": []}], ["This is the first truly multigenerational family with mutations in ELANE as unambiguous cause of severe congenital neutropenia SCN.", {"entities": [[115, 126, "DISEASE"], [97, 126, "DISEASE"], [67, 72, "GENE"]]}], ["Melioidosis is a life threatening infectious disease caused by the gram-negative bacillus Burkholderia pseudomallei predominantly found in southeast Asia and northern Australia.", {"entities": [[0, 11, "DISEASE"]]}], ["Studying the host transcription profiles in response to infection is crucial for understanding disease pathogenesis and correlates of disease severity, which may help improve therapeutic intervention and survival.", {"entities": []}], ["The aim of this study was to analyze gene expression levels of human host factors in melioidosis patients and establish useful correlation with disease biomarkers, compared to healthy individuals and patients with sepsis caused by other pathogens.", {"entities": [[85, 96, "DISEASE"]]}], ["The study population consisted of 30 melioidosis cases, 10 healthy controls and 10 sepsis cases caused by other pathogens.", {"entities": [[37, 48, "DISEASE"]]}], ["Total RNA was extracted from peripheral blood mononuclear cells (PBMC\u2019s) of study subjects.", {"entities": []}], ["Gene expression profiles of 25 gene targets including 19 immune response genes and 6 epigenetic factors were analyzed by real time quantitative polymerase chain reaction (RT-qPCR).", {"entities": []}], ["Inflammatory response genes; TLR4, late onset inflammatory mediator HMGB1, genes associated with antigen presentation; MICB, PSMB2, PSMB8, PSME2, epigenetic regulators; DNMT3B, HDAC1, HDAC2 were significantly down regulated, whereas the anti-inflammatory gene; IL4 was up regulated in melioidosis patients compared to sepsis cases caused by other pathogens.", {"entities": [[285, 296, "DISEASE"], [29, 33, "GENE"], [68, 73, "GENE"], [119, 123, "GENE"], [125, 130, "GENE"], [132, 137, "GENE"], [139, 144, "GENE"], [169, 175, "GENE"], [177, 182, "GENE"], [184, 189, "GENE"], [261, 264, "GENE"]]}], ["Septicaemic melioidosis cases showed significant down regulation of IL8 compared to sepsis cases caused by other pathogens.", {"entities": [[12, 23, "DISEASE"], [68, 71, "GENE"]]}], ["HMGB1, MICB, PSMB8, PSMB2, PSME2, HDAC1, HDAC2 and DNMT3B showed consistent down regulation of gene expression in melioidosis patients compared to other sepsis infection, irrespective of comorbidities such as diabetes, duration of clinical symptoms and antibiotic treatment.", {"entities": [[114, 125, "DISEASE"], [0, 5, "GENE"], [7, 11, "GENE"], [13, 18, "GENE"], [20, 25, "GENE"], [27, 32, "GENE"], [34, 39, "GENE"], [41, 46, "GENE"], [51, 57, "GENE"]]}], ["Specific immune response genes and epigenetic regulators are differentially expressed among melioidosis patients and patients with sepsis caused by other pathogens.", {"entities": [[92, 103, "DISEASE"]]}], ["Therefore, these genes may serve as biomarkers for disease diagnosis to distinguish melioidosis from cases of sepsis due to other infections and therapeutic intervention for melioidosis.", {"entities": [[84, 95, "DISEASE"], [174, 185, "DISEASE"]]}], ["Melioidosis is a life threatening infectious disease caused by a soil-associated gram-negative bacterium, B .", {"entities": [[0, 11, "DISEASE"]]}], ["pseudomallei .", {"entities": []}], ["Melioidosis is endemic in southeast Asia and northern Australia; however, the global distribution of B .", {"entities": [[0, 11, "DISEASE"]]}], ["pseudomallei and the disease burden of melioidosis is still poorly understood.", {"entities": [[39, 50, "DISEASE"]]}], ["Melioidosis is severely under-reported in several tropical countries in which it is probably endemic and warrants a public health response.", {"entities": [[0, 11, "DISEASE"]]}], ["A recent research article predicts the global melioidosis burden to be 165 million cases with a predicted 73 million cases from the high risk zone of south Asia.", {"entities": [[46, 57, "DISEASE"]]}], ["Melioidosis is difficult to treat as B .", {"entities": [[0, 11, "DISEASE"]]}], ["pseudomallei is resistant to many antibiotics and requires a long course of treatment.", {"entities": []}], ["Mortality rate remains high in endemic areas with reoccurrence being common.", {"entities": []}], ["Therefore, it is imperative to diagnose the disease at an early stage and provide vital clinical care to reduce the mortality rate.", {"entities": []}], ["With limitations in treatment and lack of a vaccine, it is crucial to study the immune response mechanisms to this infection to get a better understanding of disease pathogenesis and susceptibility.", {"entities": []}], ["Therefore, this study aimed to analyze the gene expression levels of important immune response genes and epigenetic modifiers to establish useful correlation for diagnostic and therapeutic purposes.", {"entities": []}], ["It has been argued that placebos may not have important clinical impacts in general.", {"entities": []}], ["However, there is increasing evidence of a publication bias among trials published in journals.", {"entities": []}], ["Therefore, we explored the potential for publication bias in randomized trials with active treatment, placebo, and no-treatment groups.", {"entities": []}], ["Three-armed randomized trials of acupuncture, acupoint stimulation, and transcutaneous electrical stimulation were obtained from electronic databases.", {"entities": []}], ["Effect sizes between treatment and placebo groups were calculated for treatment effect, and effect sizes between placebo and no-treatment groups were calculated for placebo effect.", {"entities": []}], ["All data were then analyzed for publication bias.", {"entities": []}], ["For the treatment effect, small trials with fewer than 100 patients per arm showed more benefits than large trials with at least 100 patients per arm in acupuncture and acupoint stimulation.", {"entities": []}], ["For the placebo effect, no differences were found between large and small trials.", {"entities": []}], ["Further analyses showed that the treatment effect in acupuncture and acupoint stimulation may be subject to publication bias because study design and any known factors of heterogeneity were not associated with the small study effects.", {"entities": []}], ["In the simulation, the magnitude of the placebo effect was smaller than that calculated after considering publication bias.", {"entities": []}], ["Randomized three-armed trials, which are necessary for estimating the placebo effect, may be subject to publication bias.", {"entities": []}], ["If the magnitude of the placebo effect is assessed in an intervention, the potential for publication bias should be investigated using data related to the treatment effect.", {"entities": []}], ["Major shoulder surgery often results in severe post-operative pain and a variety of interventions have been developed in an attempt to address this.", {"entities": []}], ["The continuous slow infusion of a local anaesthetic directly into the operative site has recently gained popularity but it is expensive and as yet there is little conclusive evidence that it provides additional benefits over other methods of post-operative pain management.", {"entities": []}], ["This will be a randomised, placebo-controlled trial involving 158 participants.", {"entities": []}], ["Following diagnostic arthroscopy, all participants will undergo arthroscopic subacromial decompression with or without rotator cuff repair, all operations performed by a single surgeon.", {"entities": []}], ["Participants, the surgeon, nurses caring for the patients and outcome assessors will be blinded to treatment allocation.", {"entities": []}], ["All participants will receive a pre-incision bolus injection of 20 mls of ropivacaine 1% into the shoulder and an intra-operative intravenous bolus of parecoxib 40 mg.", {"entities": []}], ["Using concealed allocation participants will be randomly assigned to active treatment (local anaesthetic ropivacaine 0.75%) or placebo (normal saline) administered continuously into the subacromial space by an elastomeric pump at 5 mls per hour post-operatively.", {"entities": []}], ["Patient controlled opioid analgesia and oral analgesics will be available for breakthrough pain.", {"entities": []}], ["Outcome assessment will be at 15, 30 and 60 minutes, 2, 4, 8, 12, 18 and 24 hours, and 2 or 4 months for decompression or decompression plus repair respectively.", {"entities": []}], ["The primary end point will be average pain at rest over the first 12-hour post-operative period on a verbal analogue pain score.", {"entities": []}], ["Secondary end points will be average pain at rest over the second 12-hour post-operative period, maximal pain at rest over the first and second 12-hour periods, amount of rescue medication used, length of inpatient stay and incidence of post-operative adhesive capsulitis.", {"entities": []}], ["The results of this trial will contribute to evidence-based recommendations for the effectiveness of pain management modalities following arthroscopic rotator cuff surgery.", {"entities": []}], ["If the local anaesthetic pain-buster provides no additional benefits over placebo then valuable resources can be put to better use in other ways.", {"entities": []}], ["Australian Clinical Trials Register Number ACTR12606000195550", {"entities": []}], ["To investigate the prevalence and features of ocular allergy (OA) and comorbidities among school children in Shanghai, China.", {"entities": []}], ["This was a population-based cross-sectional study.", {"entities": []}], ["Each participant completed an ISAAC-based questionnaire.", {"entities": []}], ["The prevalence of OA symptoms, allergic rhinitis (AR) asthma, atopic dermatitis (AD), and sensitization to mites, pollen, and food was analyzed.", {"entities": [[31, 48, "DISEASE"], [62, 79, "DISEASE"], [40, 48, "DISEASE"], [54, 60, "DISEASE"], [69, 79, "DISEASE"]]}], ["A total of 724 and 942 completed questionnaires from the 7\u20139-year-old (young group) and the 12\u201314-year-old (teen group) groups were analyzed, respectively.", {"entities": []}], ["The overall prevalence of OA symptoms was 28%.", {"entities": []}], ["However, more young students (10.6%) reported mild to severe daily life interference caused by OA than the teens (5.7%).", {"entities": []}], ["The young group had higher prevalence of diagnosed allergic conjunctivitis (10.2%).", {"entities": [[51, 74, "DISEASE"], [60, 74, "DISEASE"]]}], ["The overall prevalence of AR symptom, diagnosed asthma, and diagnosed AD was 40.4%, 11.6%, and 16.7%, respectively.", {"entities": [[48, 54, "DISEASE"]]}], ["Young children had higher prevalence of diagnosed AR and AD than the teens.", {"entities": []}], ["There were gender associated differences in the prevalence of AR and asthma among young children, but not among the teens.", {"entities": [[69, 75, "DISEASE"]]}], ["The comorbidities associated with OA was also analyzed.", {"entities": []}], ["Sensitization to mites, food, and pollen was associated with higher prevalence of allergic conditions.", {"entities": []}], ["OA together with other allergic conditions affected a significant number of children in Shanghai.", {"entities": []}], ["Hip fracture is a common injury among the elderly.", {"entities": []}], ["Although patients who receive hip fracture surgery carry the best functional recovery compared to other treatment modalities, the presence of postoperative pulmonary complications, such as atelectasis, pneumonia, and pulmonary thromboembolism, may contribute to increased length of hospital stay, perioperative morbidity, and mortality.", {"entities": [[202, 211, "DISEASE"]]}], ["This review aims to provide evidence-based recommendations for preoperative assessment and perioperative strategies to reduce the risk of pulmonary complications after hip fracture surgery.", {"entities": []}], ["Clinical assessment and basic laboratory results are sufficient to stratify the risk of postoperative pulmonary complications.", {"entities": []}], ["Well-documented risk factors for pulmonary complications include advanced age, poor general health status, current infections, pre-existing cardiopulmonary diseases, hypoalbuminemia, and impaired renal function.", {"entities": []}], ["Apart from optimizing the patient's medical conditions, interventions such as lung expansion maneuvers and thromboprophylaxis have been proven to be effective in reducing the risk of pulmonary complications after hip fracture surgery.", {"entities": []}], ["The nature of the association of depression and anxiety with risk for acute myocardial infarction (AMI) remains unclear.", {"entities": [[76, 97, "DISEASE"], [70, 97, "DISEASE"]]}], ["We aimed to study the prospective association of single and recurrent self-reported symptoms of anxiety and depression with a risk of AMI in a large Norwegian population based cohort.", {"entities": []}], ["In the second wave of the Nord-Tr\u00f8ndelag Health Study (HUNT2, 1995\u201397) baseline data on anxiety and depression symptoms, sociodemographic variables, health status including cardiovascular risk factors and common chronic disorders were registered for 57\u00a0953 adult men and women free of cardiovascular disease.", {"entities": []}], ["The cohort was followed up during a mean (SD) 11.4 (2.9) years for a first AMI from baseline through 2008.", {"entities": []}], ["A total of 2111 incident AMIs occurred, either identified at hospitals or by the National Cause of Death Registry.", {"entities": []}], ["The multi-adjusted hazard ratios were 1.31 (95% CI 1.03\u20131.66) for symptoms of depression and 1.25 (CI 0.99\u20131.57) for anxiety.", {"entities": []}], ["Two episodes of mixed symptoms of anxiety and depression (MSAD), reported 10 years apart, increased the risk for AMI by 52% (11\u2013108%).", {"entities": []}], ["After exclusion of the first 5 years of follow-up, the association of depression symptoms with AMI risk was attenuated.", {"entities": []}], ["Relative risk for AMI with anxiety symptoms and MSAD weakened when participants with chronic disorders were excluded.", {"entities": []}], ["Self-reported symptoms of depression and anxiety, especially if recurrent, were moderately associated with the risk of incident AMI.", {"entities": []}], ["We had some indications that these associations might partly reflect reverse causation or confounding from common chronic diseases.", {"entities": []}], ["The multiple organ dysfunction syndrome (MODS), though newly described, has manifested itself in intensive care unit (ICU) patients for several decades.", {"entities": [[31, 39, "DISEASE"]]}], ["As the name implies, it is a syndrome in which more than one organ system fails.", {"entities": [[29, 37, "DISEASE"]]}], ["Failure of these multiple organ systems may or may not be related to the initial injury or disease process for which the patient was admitted to the ICU.", {"entities": []}], ["MODS is the leading cause of morbidity and mortality in current ICU practice.", {"entities": []}], ["While the pathophysiology of MODS is not completely known, much evidence indicates that, during the initial injury which precipitates ICU admission, a chain of events is initiated which results in activation of several endogenous metabolic pathways.", {"entities": []}], ["These pathways release compounds which, in and of themselves, are usually cytoprotective.", {"entities": []}], ["However, an over exuberant activation of these endogenous systems results in an inflammatory response which can lead to development of failure in distant organs.", {"entities": []}], ["As these organs fail, they activate and propagate the systemic inflammatory response.", {"entities": []}], ["No therapy has proven entirely efficacious at modulating this inflammatory response and the incidence and severity of MODS.", {"entities": []}], ["In current ICU practice, treatment is focused on prevention and treating individual organ dysfunction as it develops.", {"entities": []}], ["With increased understanding of the pathophysiology of MODS therapy will come newer modalities which inhibit or interfere with the propagation of the endogenous systemic inflammatory response.", {"entities": []}], ["These newer therapies hold great promise and already some are undergoing clinical investigation.", {"entities": []}], ["Trials evaluating the effects of interventions usually provide little insight into the factors responsible for (lack of) changes in desired outcomes.", {"entities": []}], ["A process evaluation alongside a trial can shed light on the mechanisms responsible for the outcomes of a trial.", {"entities": []}], ["The aim of this study was to investigate exposure to and experiences with a computerized decision support system (CDSS) intervention, in order to gain insight into the intervention\u2019s impact and to provide suggestions for improvement.", {"entities": []}], ["A process evaluation was conducted as part of a large-scale cluster-randomized controlled trial investigating the effects of the CDSS NHGDoc on quality of care.", {"entities": []}], ["Data on exposure to and experiences with the intervention were collected during the trial period among participants in both the intervention and control group - whenever applicable - by means of the NHGDoc server and an electronic questionnaire.", {"entities": []}], ["Multiple data were analyzed using descriptive statistics.", {"entities": []}], ["Ninety-nine percent ( n \u2009=\u2009229) of the included practices generated data for the NHGDoc server and 50\u00a0% ( n \u2009=\u2009116) responded to the questionnaire: both general practitioners (GPs; n \u2009=\u2009112; 49\u00a0%) and practice nurses (PNs; n \u2009=\u200952; 37\u00a0%) participated.", {"entities": []}], ["The actual exposure to the NHGDoc system and specific heart failure module was limited with 52\u00a0% of the GPs and 42\u00a0% of the PNs reporting to either never or rarely use the system.", {"entities": []}], ["Overall, users had a positive attitude towards CDSSs.", {"entities": []}], ["The most perceived barriers to using NHGDoc were a lack of learning capacity of the system, the additional time and work it requires to use the CDSS, irrelevant alerts, too high intensity of alerts and insufficient knowledge regarding the system.", {"entities": []}], ["Several types of barriers may have negatively affected the impact of the intervention.", {"entities": []}], ["Although users are generally positive about CDSSs, a large share of them is insufficiently aware of the functions of NHGDoc and, finds the decision support not always useful or relevant and difficult to integrate into daily practice.", {"entities": []}], ["In designing CDSS interventions we suggest to more intensely involve the end-users and increase the system\u2019s flexibility and learning capacity.", {"entities": []}], ["To improve implementation a proper introduction of a CDSS among its target group including adequate training is advocated.", {"entities": []}], ["Clinical trials NCT01773057 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12875-015-0364-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cough syrups are widely used in the developing world, but safety of their use in infants and children less than two years has not been well documented.", {"entities": []}], ["Some syrups contain multiple combinations of such drugs as promethazine, diphenhydramine and ephedrine; which are individually now contraindicated in children less than two years.", {"entities": []}], ["Despite this, the syrups are available as over the counter drugs and may be dispensed to mothers who are unaware of the potentially hazardous effects to their infants.", {"entities": []}], ["A descriptive cross-sectional study was used to investigate suitability of cough syrups sold within Eldoret municipality for use in children less than two years of age based on their formulations and available literature.", {"entities": []}], ["Two semi-structured questionnaires were administered to pharmacy attendants and mothers attending sick child clinic at a referral hospital to establish whether cough syrups containing more than one active ingredient of compounds, now contraindicated in children are administered to infants, and awareness of potential serious adverse effects.", {"entities": []}], ["Data from labeled contents of cough syrups from retail pharmacies was recorded and corroborated with information from literature to determine those deemed to contain the ingredients.", {"entities": []}], ["The second questionnaire was administered to mothers with children less than two years to ascertain whether they had used the identified syrups.", {"entities": []}], ["A total of 260 mothers and 55 pharmacy attendants were interviewed.", {"entities": []}], ["There was widespread use of the syrups in children, including infants, with 192 (74%) of the respondents having used identified syrups and over 90% of these on children less than 2 years including those less than three months.146 (76%) mothers had administered the syrup at double the recommended dose.", {"entities": []}], ["The regulatory authorities should make concerted efforts to discourage use of cough syrups containing ingredients that pose adverse events to infants, including campaigns to educate pharmacy workers and mothers.", {"entities": []}], ["Airway remodeling and dysfunction are characteristic features of asthma thought to be caused by aberrant production of Th2 cytokines.", {"entities": [[65, 71, "DISEASE"]]}], ["Histamine H 4 receptor (H 4 R) perturbation has previously been shown to modify acute inflammation and Th2 cytokine production in a murine model of asthma.", {"entities": [[148, 154, "DISEASE"]]}], ["We examined the ability of H 4 R antagonists to therapeutically modify the effects of Th2 cytokine production such as goblet cell hyperplasia (GCH), and collagen deposition in a sub-chronic model of asthma.", {"entities": [[199, 205, "DISEASE"]]}], ["In addition, effects on Th2 mediated lung dysfunction were also determined.", {"entities": []}], ["Mice were sensitized to ovalbumin (OVA) followed by repeated airway challenge with OVA.", {"entities": []}], ["After inflammation was established mice were dosed with the H 4 R antagonist, JNJ 7777120, or anti-IL-13 antibody for comparison.", {"entities": []}], ["Airway hyperreactivity (AHR) was measured, lungs lavaged and tissues collected for analysis.", {"entities": [[24, 27, "GENE"]]}], ["Therapeutic H 4 R antagonism inhibited T cell infiltration in to the lung and decreased Th2 cytokines IL-13 and IL-5.", {"entities": []}], ["IL-13 dependent remodeling parameters such as GCH and lung collagen were reduced.", {"entities": []}], ["Intervention with H 4 R antagonist also improved measures of central and peripheral airway dysfunction.", {"entities": []}], ["These data demonstrate that therapeutic H 4 R antagonism can significantly ameliorate allergen induced, Th2 cytokine driven pathologies such as lung remodeling and airway dysfunction.", {"entities": []}], ["The ability of H 4 R antagonists to affect these key manifestations of asthma suggests their potential as novel human therapeutics.", {"entities": [[71, 77, "DISEASE"]]}], ["The availability of increasing volumes of multi-omics profiles across many cancers promises to improve our understanding of the regulatory mechanisms underlying cancer.", {"entities": [[161, 167, "DISEASE"]]}], ["The main challenge is to integrate these multiple levels of omics profiles and especially to analyze them across many cancers.", {"entities": []}], ["Here we present AMARETTO, an algorithm that addresses both challenges in three steps.", {"entities": []}], ["First, AMARETTO identifies potential cancer driver genes through integration of copy number, DNA methylation and gene expression data.", {"entities": [[37, 43, "DISEASE"]]}], ["Then AMARETTO connects these driver genes with co-expressed target genes that they control, defined as regulatory modules.", {"entities": []}], ["Thirdly, we connect AMARETTO modules identified from different cancer sites into a pancancer network to identify cancer driver genes.", {"entities": [[63, 69, "DISEASE"], [113, 119, "DISEASE"]]}], ["Here we applied AMARETTO in a pancancer study comprising eleven cancer sites and confirmed that AMARETTO captures hallmarks of cancer.", {"entities": [[64, 70, "DISEASE"], [127, 133, "DISEASE"]]}], ["We also demonstrated that AMARETTO enables the identification of novel pancancer driver genes.", {"entities": []}], ["In particular, our analysis led to the identification of pancancer driver genes of smoking-induced cancers and \u2018antiviral\u2019 interferon-modulated innate immune response.", {"entities": []}], ["AMARETTO is available as an R package at https://bitbucket.org/gevaertlab/pancanceramaretto \u2022 We present an algorithm for pancancer identification of cancer driver genes based on multi-omics data fusion \u2022 GPX2 is a novel driver gene in smoking induced cancers and validated using knockdown of GPX2 in the A549 cell line.", {"entities": [[150, 156, "DISEASE"], [205, 209, "GENE"], [293, 297, "GENE"], [205, 209, "GENE"], [293, 297, "GENE"]]}], ["\u2022 OAS2 is a novel driver gene defining cancers with an antiviral signature and infiltration of tumor-associated macrophages We present an algorithm for pancancer identification of cancer driver genes based on multi-omics data fusion GPX2 is a novel driver gene in smoking induced cancers and validated using knockdown of GPX2 in the A549 cell line.", {"entities": [[180, 186, "DISEASE"], [2, 6, "GENE"], [233, 237, "GENE"], [321, 325, "GENE"], [233, 237, "GENE"], [321, 325, "GENE"]]}], ["OAS2 is a novel driver gene defining cancers with an antiviral signature and infiltration of tumor-associated macrophages We present an algorithm that combines multiple sources of molecular data to identify novel genes that are involved in cancer development.", {"entities": [[240, 246, "DISEASE"], [0, 4, "GENE"]]}], ["We applied this algorithm on multiple cancers in a combined fashion and identified a network of pancancer driver genes.", {"entities": []}], ["We highlighted two genes in detail GPX2 and OAS2.", {"entities": [[35, 39, "GENE"], [44, 48, "GENE"]]}], ["We showed that GPX2 is an important cancer gene in smoking induced cancers, and validated our predictions using experimental data where GPX2 was inactivated in a lung cancer cell line.", {"entities": [[162, 173, "DISEASE"], [36, 42, "DISEASE"], [167, 173, "DISEASE"], [15, 19, "GENE"], [136, 140, "GENE"], [15, 19, "GENE"], [136, 140, "GENE"]]}], ["Similarly we showed that OAS2 is an important cancer driver gene in cancers that show an antiviral signature.", {"entities": [[46, 52, "DISEASE"], [25, 29, "GENE"]]}], ["Detrimental effects of environmental tobacco smoke (ETS) exposure on child health are well documented.", {"entities": []}], ["Because young children's primary exposure to ETS occurs in homes and automobiles, voluntary smoking restrictions can substantially reduce exposure.", {"entities": []}], ["We assessed the prevalence of home and automobile smoking bans among U.S.- and Mexico-born Hispanics in the southwestern United States, and examined the influence of mother's country of birth and smoking practices on voluntary smoking bans and on child ETS exposure.", {"entities": []}], ["U.S.- and Mexico-born Hispanic mothers of children aged 2 through 12 years were systematically sampled from health clinics in Albuquerque, New Mexico.", {"entities": []}], ["In-person interviews were conducted with 269 mothers (75.4% response rate) to obtain information on main study outcomes (complete versus no/partial home and automobile smoking bans; child room and automobile ETS exposure) and risk factors (mother's country of birth, maternal and household smoking behaviors).", {"entities": []}], ["Data were analyzed with chi square tests and logistic regression models.", {"entities": []}], ["Three-fourths (74\u201377%) of U.S.-born and 90\u201395% of Mexico-born mothers reported complete automobile and home smoking bans.", {"entities": []}], ["In multivariate analyses, mother's U.S nativity, mother's current smoking, and presence of other adult smokers in the home were associated with significantly increased odds of not having a complete home or automobile smoking ban.", {"entities": []}], ["Mother's smoking was associated with child ETS exposure both indoors (odds ratio [OR] = 3.31) and in automobiles (OR = 2.97).", {"entities": []}], ["Children of U.S.-born mothers had increased odds of exposure to ETS indoors (OR = 3.24; 95% confidence interval [CI]: 1.37\u20137.69), but not in automobiles.", {"entities": []}], ["Having complete smoking bans was associated with substantially reduced odds of child ETS exposure both indoors (OR = 0.10; 95% CI: 0.04\u20130.27) and in automobiles (OR = 0.14; 95% CI: 0.05\u20130.36).", {"entities": []}], ["This study of Hispanic mothers in the southwestern U.S. indicates that there are substantial differences between U.S.- and Mexico-born mothers in the prevalence of home and automobile smoking bans, and resulting child ETS exposure.", {"entities": []}], ["Tobacco interventions to increase smoke-free environments for U.S. Hispanic children should focus on both home and automobile smoking practices, especially among U.S.-born mothers, and utilize strategies that impact smoking practices of all household members.", {"entities": []}], ["The role of leukotriene (LT) B 4 , a potent inflammatory mediator, in atopic asthmatic and atopic nonasthmatic children is largely unknown.", {"entities": [[25, 27, "GENE"]]}], ["The lack of a gold standard technique for measuring LTB 4 in exhaled breath condensate (EBC) has hampered its quantitative assessment in this biological fluid.", {"entities": [[52, 55, "GENE"]]}], ["We sought to measure LTB 4 in EBC in atopic asthmatic children and atopic nonasthmatic children.", {"entities": [[21, 24, "GENE"]]}], ["Exhaled nitric oxide (NO) was measured as an independent marker of airway inflammation.", {"entities": []}], ["Fifteen healthy children, 20 atopic nonasthmatic children, 25 steroid-na\u00efve atopic asthmatic children, and 22 atopic asthmatic children receiving inhaled corticosteroids were studied.", {"entities": []}], ["The study design was of cross-sectional type.", {"entities": []}], ["Exhaled LTB 4 concentrations were measured using liquid chromatography/mass spectrometry-mass spectrometry (LC/MS/MS) with a triple quadrupole mass spectrometer.", {"entities": [[8, 11, "GENE"]]}], ["Exhaled NO was measured by chemiluminescence with a single breath on-line method.", {"entities": []}], ["LTB 4 values were expressed as the total amount (in pg) of eicosanoid expired in the 15-minute breath test.", {"entities": [[0, 3, "GENE"]]}], ["Kruskal-Wallis test was used to compare groups.", {"entities": []}], ["Compared with healthy children [87.5 (82.5\u2013102.5) pg, median and interquartile range], exhaled LTB 4 was increased in steroid-na\u00efve atopic asthmatic [255.1 (175.0\u2013314.7) pg, p < 0.001], but not in atopic nonasthmatic children [96.5 (87.3\u2013102.5) pg, p = 0.59)].", {"entities": [[95, 98, "GENE"]]}], ["Asthmatic children who were receiving inhaled corticosteroids had lower concentrations of exhaled LTB 4 than steroid-na\u00efve asthmatics [125.0 (25.0\u2013245.0) pg vs 255.1 (175.0\u2013314.7) pg, p < 0.01, respectively].", {"entities": [[98, 101, "GENE"]]}], ["Exhaled NO was higher in atopic nonasthmatic children [16.2 (13.5\u201322.4) ppb, p < 0.05] and, to a greater extent, in atopic steroid-na\u00efve asthmatic children [37.0 (31.7\u201357.6) ppb, p < 0.001] than in healthy children [8.3 (6.1\u20139.9) ppb].", {"entities": []}], ["Compared with steroid-na\u00efve asthmatic children, exhaled NO levels were reduced in asthmatic children who were receiving inhaled corticosteroids [15.9 (11.5\u201331.7) ppb, p < 0.01].", {"entities": []}], ["In contrast to exhaled NO concentrations, exhaled LTB 4 values are selectively elevated in steroid-na\u00efve atopic asthmatic children, but not in atopic nonasthmatic children.", {"entities": [[50, 53, "GENE"]]}], ["Although placebo control studies are warranted, inhaled corticosteroids seem to reduce exhaled LTB 4 in asthmatic children.", {"entities": [[95, 98, "GENE"]]}], ["LC/MS/MS analysis of exhaled LTB 4 might provide a non-invasive, sensitive, and quantitative method for airway inflammation assessment in asthmatic children.", {"entities": [[29, 32, "GENE"]]}], ["The lysin LysGH15, derived from the staphylococcal phage GH15, exhibits a wide lytic spectrum and highly efficient lytic activity against methicillin-resistant Staphylococcus aureus (MRSA).", {"entities": []}], ["Here, we found that LysGH15 did not induce resistance in MRSA or methicillin-sensitive S. aureus (MSSA) strains after repeated treatment.", {"entities": []}], ["Although LysGH15 triggered the generation of LysGH15-specific antibodies in mice, these antibodies did not block lytic activity in vitro (nor the binding capacity of LysGH15).", {"entities": []}], ["More importantly, when the antibody titre was highest in mice immunized with LysGH15, a single intravenous injection of LysGH15 was sufficient to protect mice against lethal infection with MRSA.", {"entities": []}], ["These results indicated that LysGH15-specific antibodies did not affect the killing efficiency of LysGH15 against MRSA in vitro or in vivo .", {"entities": []}], ["LysGH15 also reduced pro-inflammatory cytokines in mice with lethal infections.", {"entities": []}], ["Furthermore, a high-dose LysGH15 injection did not cause significant adverse effects or pathological changes in the main organs of treated animals.", {"entities": []}], ["These results provide further evidence for the administration of LysGH15 as an alternative strategy for the treatment of infections caused by MRSA.", {"entities": []}], ["Chronic migraine (CM) and episodic migraine (EM) are part of the spectrum of migraine disorders, but they are distinct clinical entities.", {"entities": [[8, 16, "DISEASE"], [35, 43, "DISEASE"], [77, 85, "DISEASE"]]}], ["Population-based studies have shown that those with CM demonstrate higher individual and societal burden because they are significantly more disabled than those with EM and have greater impaired quality of life both inside and outside the home.", {"entities": []}], ["Proper diagnosis of both conditions requires clearly defined clinical criteria.", {"entities": []}], ["Diagnosis enables the initiation of appropriate treatments and risk-factor modification, which ultimately improve functional status and quality of life for persons with migraine.", {"entities": [[169, 177, "DISEASE"]]}], ["Recognizing that both disorders are on the spectrum of migraine, this review serves as a guide to define the disease state of CM as distinct from EM in terms of clinical, epidemiological, sociodemographic, and comorbidity profiles.", {"entities": [[55, 63, "DISEASE"]]}], ["Asthma is a waxing and waning disease that leads to structural changes in the airways, such as subepithelial fibrosis, increased mass of airway smooth muscle and epithelial metaplasia.", {"entities": [[0, 6, "DISEASE"]]}], ["Such a remodeling of the airways futher amplifies asthma symptoms, but its etiology is unknown.", {"entities": [[50, 56, "DISEASE"]]}], ["Transforming growth factor \u03b21 is a pleiotropic cytokine involved in many fibrotic, oncologic and immunologic diseases and is believed to play an essential role in airway remodeling that occurs in asthmatic patients.", {"entities": []}], ["Since it is secreted in an inactive form, the overall activity of this cytokine is not exclusively determined by its level of expression, but also by extensive and complex post-translational mechanisms, which are all importanin modulating the magnitude of the TGF\u03b21 response.", {"entities": []}], ["Even if TGF\u03b21 upregulation in asthma is considered as a dogma by certain investigators in the field, the overall picture of the published litterature is not that clear and the cellular origin of this cytokine in the airways of asthmatics is still a contemporaneous debate.", {"entities": [[30, 36, "DISEASE"]]}], ["On the other hand, it is becoming clear that TGF\u03b21 signaling is increased in the lungs of asthmatics, which testifies the increased activity of this cytokine in asthma pathogenesis.", {"entities": [[161, 167, "DISEASE"]]}], ["The current work is an impartial and exhaustive compilation of the reported papers regarding the expression of TGF\u03b21 in human asthmatics.", {"entities": []}], ["For the sake of comparison, several studies performed in animal models of the disease are also included.", {"entities": []}], ["Inconsistencies observed in human studies are discussed and conclusions as well as trends from the current state of the litterature on the matter are proposed.", {"entities": []}], ["Finally, the different points of regulation that can affect the amplitude of the TGF\u03b21 response are briefly revised and the possibility that TGF\u03b21 is disregulated at another level in asthma, rather than simply in its expression, is highlighted.", {"entities": [[183, 189, "DISEASE"]]}], ["Non-communicable diseases (NCDs) pose a formidable health and development challenge for low- and middle-income countries (LMICs).", {"entities": []}], ["However, translating this challenge into resource allocation is seriously constrained by a lack of country specific evidence on NCD financing and its distributional implications.", {"entities": []}], ["This study estimated expenditures associated with NCDs in Mongolia and their distributions across socioeconomic groups, focusing especially on private out-of-pocket (OOP) spending on the major NCDs.", {"entities": []}], ["Secondary data analysis of multiple data sources on NCD related health service use and expenditures including detailed administrative data, World Health Organization STEPwise approach to Surveillance (STEPs) survey for Mongolia, and household surveys.", {"entities": []}], ["Sample-weighted estimates of OOP expenditures for NCDs were constructed using STEPs data.", {"entities": []}], ["OOP payments per discharge and per outpatient visit were estimated by condition and type of service provider, and survey data on utilization, after adjusting for utilization in administrative records.", {"entities": []}], ["NCDs in Mongolia accounted for more than one-third of total health expenditures in 2013.", {"entities": []}], ["A significant fraction of this expenditure was borne by households in the form of OOP spending.", {"entities": []}], ["CVD-related health spending is the major driver of NCD-spending in Mongolia, accounting for about 24.2% of total health expenditure.", {"entities": []}], ["OOP health payments, largely driven by outpatient diagnostics and drugs, were incurred disproportionately by the better-off, seeking more specialist services and better quality private care.", {"entities": []}], ["A high share of OOP spending for NCDs in Mongolia, which ostensibly enjoys universal health coverage, provides a cautionary tale for LMICs in a similar situation.", {"entities": []}], ["Improvement in the quality of services at the primary care level and rural health care facilities, where the poor mainly attend, is desirable together with an effective exemption policy for user fees at higher level hospitals.", {"entities": []}], ["Recent research has reported that patients receiving bolus (frequent large doses to achieve iron repletion) versus maintenance dosing of iron have an increased short-term risk of infection, but a similar risk of cardiovascular events.", {"entities": []}], ["We sought to determine whether these findings could be replicated using the same methods and a different data source.", {"entities": []}], ["Clinical data from 6,605 patients of a small U.S. dialysis provider merged with Medicare claims data were examined.", {"entities": []}], ["Iron dosing patterns (bolus, maintenance, no iron) were identified during 1-month exposure periods and cardiovascular and infection-related outcomes were assessed during 3-month follow-up periods.", {"entities": []}], ["The effects of bolus versus maintenance dosing were assessed using Cox proportional hazards regression analyses to estimate hazard ratios and semiparametric additive risk models to estimate hazard rate differences, controlling for demographic and clinical characteristics, laboratory values and medications, and comorbidities.", {"entities": []}], ["48,050 exposure/follow-up periods were examined.", {"entities": []}], ["13.9 percent of the exposure periods were bolus dosing, 49.3 percent were maintenance dosing, and the remainder were no iron use.", {"entities": []}], ["All of the adjusted hazard ratios were >1.00 for the infection-related outcomes, suggesting that bolus dosing increases the risk of these events.", {"entities": []}], ["The effects were greatest for hospitalized for infection of any major organ system (hazard ratio 1.13 (1.03, 1.24)) and use of intravenous antibiotics (hazard ratio 1.08 (1.02, 1.15).", {"entities": []}], ["When examining the subgroup of individuals with catheters, the hazard ratios for the infection-related outcomes were generally greater than in the overall sample.", {"entities": []}], ["There was little association between type of dosing practice and cardiovascular outcomes.", {"entities": []}], ["Results of this study provide further evidence of the association between bolus dosing and increased infection risk, particularly in the subgroup of patients with a catheter, and of the lack of an association between dosing practices and cardiovascular outcomes.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2369-15-154) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Soluble ST2, a member of the of the Toll/IL-1 superfamily, is a novel biomarker with exceptional predictive value in heart failure and myocardial infarction- related mortality as well as in acute dyspneic states.", {"entities": [[135, 156, "DISEASE"]]}], ["Soluble ST2 is considered a decoy receptor of IL 33 that blocks the protective effects of the cytokine in atherosclerosis and cardiac remodeling.", {"entities": [[106, 121, "DISEASE"]]}], ["In the present study we investigated the differences in the levels of soluble ST2, BNP and hs-CRP between healthy controls and patients with type 2 diabetes with and without left ventricular diastolic dysfunction.", {"entities": []}], ["A secondary aim was to investigate correlations between sST2 and other biomarkers of type 2 diabetes, such as HbA1c.", {"entities": []}], ["158 volunteers were recruited and underwent a complete Doppler-echocardiographic evaluation of both systolic & diastolic cardiac function.", {"entities": []}], ["All subjects with ejection fraction < 50% were excluded.", {"entities": []}], ["The study population was divided in 4 groups as follows: A: 42 healthy controls, B: 18 subjects without diabetes with LVDD, C: 48 patients with type 2 diabetes without LVDD & D: 50 patients with type 2 diabetes & LVDD.", {"entities": []}], ["ELISA technique was performed to measure sST2 levels.", {"entities": []}], ["Statistical analysis was performed with Kruskal-Wallis & Mann-Whitney test (continuous variables), chi squared & Fischer exact test (discrete variables), Spearman coefficient (univariate analysis) and step-wise backward method (multivariate analysis).", {"entities": []}], ["Patients with type 2 diabetes with (p < 0.001) or without LVDD (p = 0.007) had higher serum ST2 levels compared to healthy controls, state found also for hs-CRP levels but not for the corresponding BNP levels (p = 0.213 & p = 0.207 respectively).", {"entities": []}], ["Patients with type 2 diabetes & LVDD had higher serum ST2 in relation to diabetic patients without LVDD (p = 0.001).", {"entities": []}], ["In multivariate analysis HbA1c positively and independently correlated with sST2 levels in both groups of patients with type 2 diabetes.", {"entities": []}], ["Patients with type 2 diabetes exhibit higher sST2 levels compared to healthy controls.", {"entities": []}], ["The presence of LVDD in patients with type 2 diabetes is associated with even higher sST2 levels.", {"entities": []}], ["A significant correlation between glycemic control and sST2 levels was also revealed.", {"entities": []}], ["Measuring the impact of online health campaigns is challenging.", {"entities": []}], ["Ad click-through rates are traditionally used to measure campaign reach, but few Internet users ever click on ads.", {"entities": []}], ["Alternatively, self-reported exposure to digital ads would be prone to recall bias.", {"entities": []}], ["Furthermore, there may be latency effects whereby people do not click on ads when exposed but visit the promoted website or conduct campaign-related searches later.", {"entities": []}], ["Online panels that unobtrusively collect panelists\u2019 Web behavior data and link ad exposure to website visits and searches can more reliably assess the impact of digital ad exposure.", {"entities": []}], ["From March to June 2012, the Centers for Disease Control and Prevention aired the national Tips From Former Smokers (Tips 2012) media campaign designed to encourage current smokers to quit.", {"entities": []}], ["Advertisements ran across media channels, and the digital ads directed users to the Tips 2012 campaign website.", {"entities": []}], ["Our aim was to examine whether exposure to Tips 2012 digital ads influenced information-seeking behaviors online.", {"entities": []}], ["ComScore mined its panelists\u2019 Web behavior data for unique codes that would indicate exposure to Tips 2012 ads, regardless of whether panelists clicked the ad or not.", {"entities": []}], ["A total of 15,319 US adults were identified as having been exposed to a Tips 2012 campaign ad.", {"entities": []}], ["An equal number of unexposed adults (N=15,319) were identified and matched on demographics and Internet use behavior to the exposed group.", {"entities": []}], ["Panelists\u2019 Web behavior data were mined for up to 4 weeks after initial Tips 2012 ad exposure to determine whether they visited the Tips 2012 campaign website or other cessation-related websites (eg, nicotine replacement therapy site) or conducted searches for campaign-related topics (eg, quit smoking).", {"entities": []}], ["The proportion of exposed adults visiting the Tips 2012 sites increased from 0.4% in Week 1 to 0.9% 4 weeks after ad exposure, and these rates were significantly higher than in the unexposed group (0.1% in Week 1 to 0.4% in Week 4, P <.001) across all weeks examined.", {"entities": []}], ["The proportion of exposed panelists visiting other cessation websites increased from 0.2% in Week 1 to 0.3% 4 weeks after initial ad exposure, and these rates were significantly higher than in the unexposed group (0.0% in Week 1 to 0.2% in Week 4, P =.001 to P =.019) across all weeks examined.", {"entities": []}], ["There were no significant differences in searches for campaign-related topics between the exposed and unexposed group during most of the weeks examined.", {"entities": []}], ["These results suggest that online ad exposure is associated with confirmed visits to the Tips 2012 campaign sites and visits to other cessation websites and that these information-seeking behaviors occur up to several weeks after ad exposure.", {"entities": []}], ["Web behavior data from online panels are useful for examining exposure and behavioral responses to digital campaign ads.", {"entities": []}], ["Sleep disordered breathing in children is associated with increased blood flow velocity and sympathetic overactivity.", {"entities": []}], ["Sympathetic overactivity results in peripheral vasoconstriction and reduced systemic vascular compliance, which increases blood flow velocity during systole.", {"entities": []}], ["Augmented blood flow velocity is recognized to promote vascular remodeling.", {"entities": []}], ["Importantly, increased vascular sympathetic nerve fiber density and innervation in early life plays a key role in the development of early\u2010onset hypertension in animal models.", {"entities": [[145, 157, "DISEASE"]]}], ["Examination of sympathetic nerve fiber density of the tonsillar arteries in children undergoing adenotonsillectomy for Sleep disordered breathing will address this question in humans.", {"entities": []}], ["Thirteen children scheduled for adenotonsillectomy to treat sleep disordered breathing underwent pupillometry, polysomnography, flow\u2010mediated dilation, resting brachial artery blood flow velocity (velocity time integral), and platelet aggregation.", {"entities": []}], ["The dorsal lingual artery (tonsil) was stained and immunofluorescence techniques used to determine sympathetic nerve fiber density.", {"entities": []}], ["Sympathetic nerve fiber density was correlated with increased resting velocity time integral ( r =0.63; P <0.05) and a lower Neuronal Pupillary Index ( r =\u22120.71, P <0.01), as well as a slower mean pupillary constriction velocity (mean, r =\u22120.64; P <0.05).", {"entities": []}], ["A faster resting velocity time integral was associated with a slower peak pupillary constriction velocity ( r =\u22120.77; P <0.01) and higher platelet aggregation to collagen antigen ( r =0.64; P <0.05).", {"entities": []}], ["Slower mean and peak pupillary constriction velocity were associated with higher platelet aggregation scores ( P <0.05; P <0.01, respectively).", {"entities": []}], ["These results indicate that sympathetic activity is associated with change in both the function and structure of systemic vasculature in children with sleep disordered breathing.", {"entities": []}], ["The discoveries made over the past few years have modified the current immunological paradigm.", {"entities": []}], ["It turns out that innate immunity cells can mount some kind of immunological memory, similar to that observed in the acquired immunity and corresponding to the defense mechanisms of lower organisms, which increases their resistance to reinfection.", {"entities": []}], ["This phenomenon is termed trained innate immunity.", {"entities": []}], ["It is based on epigenetic changes in innate immune cells (monocytes/macrophages, NK cells) after their stimulation with various infectious or non-infectious agents.", {"entities": []}], ["Many infectious stimuli, including bacterial or fungal cells and their components (LPS, \u03b2-glucan, chitin) as well as viruses or even parasites are considered potent inducers of innate immune memory.", {"entities": []}], ["Epigenetic cell reprogramming occurring at the heart of the phenomenon may provide a useful basis for designing novel prophylactic and therapeutic strategies to prevent and protect against multiple diseases.", {"entities": []}], ["In this article, we present the current state of art on trained innate immunity occurring as a result of infectious agent induction.", {"entities": []}], ["Additionally, we discuss the mechanisms of cell reprogramming and the implications for immune response stimulation/manipulation.", {"entities": []}], ["Patient-reported outcomes are measured in many epidemiologic studies using self- or interviewer-administered questionnaires.", {"entities": []}], ["While in some studies differences between these administration formats were observed, other studies did not show statistically significant differences important to patients.", {"entities": []}], ["Since the evidence about the effect of administration format is inconsistent and mainly available from cross-sectional studies our aim was to assess the effects of different administration formats on repeated measurements of patient-reported outcomes in participants with AIDS enrolled in the Longitudinal Study of Ocular Complications of AIDS.", {"entities": []}], ["We included participants enrolled in the Longitudinal Study of Ocular Complications in AIDS (LSOCA) who completed the Medical Outcome Study [MOS] -HIV questionnaire, the EuroQol, the Feeling Thermometer and the Visual Function Questionnaire (VFQ) 25 every six months thereafter using self- or interviewer-administration.", {"entities": []}], ["A large print questionnaire was available for participants with visual impairment.", {"entities": []}], ["Considering all measurements over time and adjusting for patient and study site characteristics we used linear models to compare HRQL scores (all scores from 0-100) between administration formats.", {"entities": []}], ["We defined adjusted differences of \u22650.2 standard deviations [SD]) to be quantitatively meaningful.", {"entities": []}], ["We included 2,261 participants (80.6% males) with a median of 43.1 years of age at enrolment who provided data on 23,420 study visits.", {"entities": []}], ["The self-administered MOS-HIV, Feeling Thermometer and EuroQol were used in 70% of all visits and the VFQ-25 in 80%.", {"entities": []}], ["For eight domains of the MOS-HIV differences between the interviewer- and self- administered format were < 0.1 SD.", {"entities": []}], ["Differences in scores were highest for the social and role function domains but the adjusted differences were still < 0.2 SD.", {"entities": []}], ["There was no quantitatively meaningful difference between administration formats for EuroQol, Feeling Thermometer and VFQ-25 domain scores.", {"entities": []}], ["For ocular pain (VFQ-25), we found a statistically significant difference of 3.5 (95% CI 0.2, 6.8), which did, however, not exceed 0.2 SD.", {"entities": []}], ["For all instruments scores were similar for the large and standard print formats with all adjusted differences < 0.2 SD.", {"entities": []}], ["Our large study provides evidence that administration formats do not have a meaningful effect on repeated measurements of patient-reported outcomes.", {"entities": []}], ["As a consequence, longitudinal studies may not need to consider the effect of different administration formats in their analyses.", {"entities": []}], ["Background: Vitamin D is associated with many health conditions, but optimal blood concentrations are still uncertain.", {"entities": []}], ["Objectives: We examined the prospective relation between serum 25-hydroxyvitamin D [25(OH)D] concentrations [which comprised 25(OH)D 3 and 25(OH)D 2 ] and subsequent mortality by the cause and incident diseases in a prospective population study.", {"entities": []}], ["Design: Serum vitamin D concentrations were measured in 14,641 men and women aged 42\u201382 y in 1997\u20132000 who were living in Norfolk, United Kingdom, and were followed up to 2012.", {"entities": []}], ["Participants were categorized into 5 groups according to baseline serum concentrations of total 25(OH)D <30, 30 to <50, 50 to <70, 70 to <90, and \u226590 nmol/L.", {"entities": []}], ["Results: The mean serum total 25(OH)D was 56.6 nmol/L, which consisted predominantly of 25(OH)D 3 (mean: 56.2 nmol/L; 99% of total).", {"entities": []}], ["The age-, sex-, and month-adjusted HRs (95% CIs) for all-cause mortality (2776 deaths) for men and women by increasing vitamin D category were 1, 0.84 (0.74, 0.94), 0.72 (0.63, 0.81), 0.71 (0.62, 0.82), and 0.66 (0.55, 0.79) ( P -trend < 0.0001).", {"entities": []}], ["When analyzed as a continuous variable and with additional adjustment for body mass index, smoking, social class, education, physical activity, alcohol intake, plasma vitamin C, history of cardiovascular disease, diabetes, or cancer, HRs for a 20-nmol/L increase in 25(OH)D were 0.92 (0.88, 0.96) ( P < 0.001) for total mortality, 0.96 (0.93, 0.99) ( P = 0.014) (4469 events) for cardiovascular disease, 0.89 (0.85, 0.93) ( P < 0.0001) (2132 events) for respiratory disease, 0.89 (0.81, 0.98) ( P = 0.012) (563 events) for fractures, and 1.02 (0.99, 1.06) ( P = 0.21) (3121 events) for incident total cancers.", {"entities": [[226, 232, "DISEASE"]]}], ["Conclusions: Plasma 25(OH)D concentrations predict subsequent lower 13-y total mortality and incident cardiovascular disease, respiratory disease, and fractures but not total incident cancers.", {"entities": []}], ["For mortality, lowest risks were in subjects with concentrations >90 nmol/L, and there was no evidence of increased mortality at high concentrations, suggesting that a moderate increase in population mean concentrations may have potential health benefit, but <1% of the population had concentrations >120 nmol/L.", {"entities": []}], ["A carefully structured Tobacco Harm Reduction (THR) initiative, with e-cigarettes as a prominent THR modality, added to current tobacco control programming, is the most feasible policy option likely to substantially reduce tobacco-attributable illness and death in the United States over the next 20 years.", {"entities": []}], ["E-cigarettes and related vapor products are the most promising harm reduction modalities because of their acceptability to smokers.", {"entities": []}], ["There are about 46 million smokers in the United States, and an estimated 480,000 deaths per year attributed to cigarette smoking.", {"entities": []}], ["These numbers have been essentially stable since 2004.", {"entities": []}], ["Currently recommended pharmaceutical smoking cessation protocols fail in about 90% of smokers who use them as directed, even under the best of study conditions, when results are measured at six to twelve months.", {"entities": []}], ["E-cigarettes have not been attractive to non-smoking teens or adults.", {"entities": []}], ["Limited numbers non-smokers have experimented with them, but hardly any have continued their use.", {"entities": []}], ["The vast majority of e-cigarette use is by current smokers using them to cut down or quit cigarettes.", {"entities": []}], ["E-cigarettes, even when used in no-smoking areas, pose no discernable risk to bystanders.", {"entities": []}], ["Finally, addition of a THR component to current tobacco control programming will likely reduce costs by reducing the need for counseling and drugs.", {"entities": []}], ["The placental glucocorticoid receptor (GR) is central to glucocorticoid signalling and for mediating steroid effects on pathways associated with fetal growth and lung maturation but the GR has not been examined in the guinea pig placenta even though this animal is regularly used as a model of preterm birth and excess glucocorticoid exposure.", {"entities": []}], ["Guinea pig dams received subcutaneous injections of either vehicle or betamethasone at 24 and 12 hours prior to preterm or term caesarean-section delivery.", {"entities": []}], ["At delivery pup and organ weights were recorded.", {"entities": []}], ["Placentae were dissected, weighed and analysed using Western blot to examine GR isoform expression in nuclear and cytoplasmic extracts.", {"entities": []}], ["A comparative examination of the guinea pig GR gene identified it is capable of producing seven of the eight translational GR isoforms which include GR\u03b1-A, C1, C2, C3, D1, D2, and D3.", {"entities": [[160, 162, "GENE"], [164, 166, "GENE"]]}], ["GR\u03b1-B is not produced in the Guinea Pig.", {"entities": []}], ["Total GR antibody identified 10 specific bands from term (n = 29) and preterm pregnancies (n = 27).", {"entities": []}], ["Known isoforms included GR\u03b3, GR\u03b1 A, GR\u03b2, GRP, GRA and GR\u03b1 D1-3.", {"entities": [[41, 44, "GENE"]]}], ["There were sex and gestational age differences in placental GR isoform expression.", {"entities": []}], ["Placental GR\u03b1 A was detected in the cytoplasm of all groups but was significantly increased in the cytoplasm and nucleus of preterm males and females exposed to betamethasone and untreated term males (KW-ANOVA, P = 0.0001, P = 0.001).", {"entities": []}], ["Cytoplasmic expression of GR\u03b2 was increased in female preterm placentae and preterm and term male placentae exposed to betamethasone (P = 0.01).", {"entities": []}], ["Nuclear expression of GR\u03b2 was increased in all placentae exposed to betamethasone (P = 0.0001).", {"entities": []}], ["GR\u03b1 D2 and GR\u03b1 D3 were increased in male preterm placentae when exposed to betamethasone (P = 0.01, P = 0.02).", {"entities": []}], ["The current data suggests the sex-specific placental response to maternal betamethasone may be dependent on the expression of a combination of GR isoforms.", {"entities": []}], ["Cells express several antioxidant enzymes to scavenge reactive oxygen species (ROS) responsible for oxidative damages and various human diseases.", {"entities": []}], ["Therefore, antioxidant enzymes are considered biomedicine candidates.", {"entities": []}], ["Among them, extracellular superoxide dismutase (SOD3) had showed prominent efficacy against asthma and inflammation.", {"entities": [[92, 98, "DISEASE"], [48, 52, "GENE"]]}], ["Despite its advantages as a biomedicine, the difficulty in obtaining large quantity of active recombinant human SOD3 (rhSOD3) has limited its clinical applications.", {"entities": [[112, 116, "GENE"]]}], ["We found that a significant fraction of overexpressed rhSOD3 was composed of the inactive apo-enzyme and its potency against inflammation depended on the rate of metal incorporation.", {"entities": []}], ["Also, purified rhSOD3 was unstable and lost its activity very quickly.", {"entities": []}], ["Here, we suggest an ideal preparative method to express, purify, and store highly active rhSOD3.", {"entities": []}], ["The enzymatic activity of rhSOD3 was maximized by incorporating metal ions into rhSOD3 after purification.", {"entities": []}], ["Also, albumin or polyethylene glycol prevented rapid inactivation or degradation of rhSOD3 during preparative procedures and long-term storage.", {"entities": []}], ["[BMB Reports 2015; 48(2): 91-96]", {"entities": []}], ["The clinical characteristics of children diagnosed with Rett syndrome are well described.", {"entities": [[61, 69, "DISEASE"]]}], ["Survival and how these characteristics persist or change in adulthood are less well documented.", {"entities": []}], ["This study aimed to describe overall survival and adult health in those with Rett syndrome.", {"entities": [[82, 90, "DISEASE"]]}], ["Using the Kaplan-Meier method, we estimated survival of individuals registered with the Australian Rett syndrome Database (ARSD) who had been followed for up to 20 years (n\u2009=\u2009396).", {"entities": [[104, 112, "DISEASE"], [123, 127, "GENE"]]}], ["We then conducted logistic and linear regression analyses investigating epilepsy, musculoskeletal, gastrointestinal, autonomic dysfunction and behaviour of individuals aged 18 years and over using cross sectional cohorts from the ARSD (n\u2009=\u2009150) and the international database InterRett (n\u2009=\u2009273).", {"entities": [[230, 234, "GENE"]]}], ["The likelihood of survival was 77.6% at 20 years, 71.5% at 25 years and 59.8% at 37 years.", {"entities": []}], ["The median age of the combined cross-sectional cohort was 25 years (range 18 to 54 years), the majority (71%) were living in their parental home and the remainder being cared for in group homes or other institutions.", {"entities": []}], ["Just over half walked either independently (18%) or with assistance (43%).", {"entities": []}], ["The majority (86%) had scoliosis with 40% of those having undergone corrective surgery.", {"entities": []}], ["Almost two-thirds (64%) of the women were taking anti-epileptic medications at the time of data collection.", {"entities": []}], ["Constipation was highly prevalent (83%) and many experienced bloating (53%).", {"entities": []}], ["Biliary dyskinesia, inflammation or infection of the gallbladder was reported for 20 women (5%) and of those 13 had undergone gallbladder surgery.", {"entities": []}], ["Sleep disturbance was relatively common (63%), and adverse mood events and anxiety were slightly more prevalent in those aged 26-30 years in comparison to the younger and older age groups.", {"entities": []}], ["Other frequently reported medical conditions included urinary tract infections, pneumonia and other respiratory conditions.", {"entities": [[80, 89, "DISEASE"]]}], ["Survival in Rett syndrome has now been estimated with the most accurate follow up to date.", {"entities": [[17, 25, "DISEASE"]]}], ["During adulthood, continuation of multidisciplinary services and programs is necessary to optimise health and wellbeing.", {"entities": []}], ["In the early stages of development of the cellular slime mold Dictyostelium discoideum , chemotaxis toward cAMP plays a pivotal role in organizing discrete cells into a multicellular structure.", {"entities": []}], ["In this process, a series of signaling molecules, such as G-protein-coupled cell surface receptors for cAMP, phosphatidylinositol metabolites, and cyclic nucleotides, function as the signal transducers for controlling dynamics of cytoskeleton.", {"entities": []}], ["Differentiation-inducing factor-1 and -2 (DIF-1 and DIF-2) were originally identified as the factors (chlorinated alkylphenones) that induce Dictyostelium stalk cell differentiation, but it remained unknown whether the DIFs had any other physiologic functions.", {"entities": [[52, 57, "GENE"]]}], ["To further elucidate the functions of DIFs, in the present study we investigated their effects on chemotaxis under various conditions.", {"entities": []}], ["Quite interestingly, in shallow cAMP gradients, DIF-1 suppressed chemotaxis whereas DIF-2 promoted it greatly.", {"entities": [[84, 89, "GENE"]]}], ["Analyses with various mutants revealed that DIF-1 may inhibit chemotaxis, at least in part, via GbpB (a phosphodiesterase) and a decrease in the intracellular cGMP concentration ([cGMP] i ).", {"entities": []}], ["DIF-2, by contrast, may enhance chemotaxis, at least in part, via RegA (another phosphodiesterase) and an increase in [cGMP] i .", {"entities": [[0, 5, "GENE"]]}], ["Using null mutants for DimA and DimB, the transcription factors that are required for DIF-dependent prestalk differentiation, we also showed that the mechanisms for the modulation of chemotaxis by DIFs differ from those for the induction of cell differentiation by DIFs, at least in part.", {"entities": []}], ["Our findings indicate that DIF-1 and DIF-2 function as negative and positive modulators for Dictyostelium chemotaxis, respectively.", {"entities": [[37, 42, "GENE"]]}], ["To our knowledge, this is the first report in any organism of physiologic modulators (small molecules) for chemotaxis having differentiation-inducing activity.", {"entities": []}], ["To systematically study the chemical constituents in Magnolia officinalis var.", {"entities": []}], ["biloba fruits, nine phenylethanoid glycosides were isolated by solvent extraction, silica gel, and preparative high-performance liquid chromatography (HPLC).", {"entities": []}], ["Their structures were elucidated by 1D and 2D NMR analyses, including COSY, HMQC and HMBC correlations, and HPLC analysis of sugar residue.", {"entities": []}], ["Nine phenylethanoid glycosides, namely, magnoloside I a ( 1 ), magnoloside I c ( 2 ), crassifolioside ( 3 ), magnoloside I b ( 4 ), magnoloside III a ( 5 ), magnoloside IV a ( 6 ), magnoloside II a ( 7 ), magnoloside II b ( 8 ) and magnoloside V a ( 9 ), were first isolated from the n -butanol fraction of Magnolia officinalis var.", {"entities": []}], ["biloba fruits alcohol extract.", {"entities": []}], ["Free radical scavenging activities of the nine phenylethanoid glycosides were assessed using the DPPH, ABTS, and superoxide anion radical scavenging assays.", {"entities": []}], ["Simultaneously, protective effects of all compounds against free radical-induced oxidative damage were evaluated by two different kinds of mitochondrial damage model.", {"entities": []}], ["The protective effects were assessed by mitochondrial swelling, the formations of malondialdehyde (MDA) and lipid hydroperoxide (LOOH), the activities of catalase (CAT), glutathione reductase (GR) and superoxide dismutase (SOD).", {"entities": []}], ["All phenylethanoid glycosides showed significant protective effects.", {"entities": []}], ["The objective of this study is to investigate the effect of the ultrasound-microbubble technique in nuclear factor kappa B (NF-\u03baB) decoy oligodeoxynucleotide (ODN) transfection in the gingival tissue in mice.", {"entities": []}], ["The 6-FAM-labeled scrambled decoy ODN with microbubbles was applied to the periodontal tissue in 8-week-old male C57BL/6J mice by ultrasound radiation at low (LUM-Sc) and high (HUM-Sc) intensities to optimize the transfection condition of the ultrasound-microbubble method.", {"entities": []}], ["Histological inspections were performed two hours after transfection to compare the expression with that in the sham-operated group without ultrasound radiation (A-Sc).", {"entities": []}], ["Then, an NF-\u03baB decoy was transfected into the periodontal tissue using the high-intensity ultrasound-microbubble (HUM-NF) technique to examine the anti-inflammatory effects of the decoy ODN.", {"entities": []}], ["Western blot analysis was performed to investigate the expression of interleukin(IL)-1\u03b2, IL-6 and intercellular adhesion molecule-1 (ICAM-1) in the gingival tissues in the HUM-Sc, the HUM-NF and control groups.", {"entities": []}], ["The fluorescence microscopy results showed that the fluorescent intensity in the periodontal tissues in the LUM-Sc and HUM-Sc groups was significantly higher than that in the A-Sc and the control groups.", {"entities": []}], ["The fluorescent intensity in the HUM-Sc group, especially in the gingival connective tissue, was the highest of all groups.", {"entities": []}], ["Western blot analysis indicated that the protein expression levels of IL-1\u03b2, IL-6 and ICAM-1 in the HUM-NF group were significantly lower than those in the HUM-Sc and the control groups.", {"entities": []}], ["These findings suggest that the high-intensity ultrasound-microbubble technique is an effective tool for decoy transfection into the periodontal tissue.", {"entities": []}], ["Aspergillus fumigatus is an inhaled fungal pathogen of human lungs, the developmental growth of which is reliant upon Ca A .", {"entities": []}], ["fumigatus uses intracellular Ca A .", {"entities": []}], ["fumigatus strains derived from the clinical isolate CEA10, and a non-homologous recombination mutant \u0394akuB c ) in response to extracellular stimuli were measured.", {"entities": []}], ["The response to extracellular challenges (hypo- and hyper-osmotic shock, mechanical perturbation, high extracellular Ca c responses to extracellular stimuli were found to be dose- and age-dependent.", {"entities": []}], ["Moreover, Ca", {"entities": []}], ["Factors affecting the design of an epidemiologic study assessing possible health effects from chemical waste disposal sites are reviewed.", {"entities": []}], ["Such epidemiologic studies will most likely be prompted either by a known release of chemicals into the environment around the site, or by an unusual disease cluster in a population near the site.", {"entities": []}], ["In the latter situation, a method for evaluating the health effects is needed, and one possible approach is discussed.", {"entities": []}], ["In the former situation, it may not be obvious what health outcomes are relevant.", {"entities": []}], ["Reported associations between health effects and chemicals in humans were reviewed.", {"entities": []}], ["Studies from the occupational and environmental literature were classified by chemical and target organ affected and presented in tabular form.", {"entities": []}], ["No attempt was made to critically evaluate the quality of evidence for each health effect, although bibliographic documentation was provided where possible.", {"entities": []}], ["Episodes of chemical contamination of food, drinking water and other media were also reviewed and presented in a separate table.", {"entities": []}], ["The organ sites likely to be affected by toxic chemicals from waste disposal sites depend heavily on the route of exposure and the dose that is received.", {"entities": []}], ["Ingestion is the most frequently reported route of exposure in episodes of environmental contamination.", {"entities": []}], ["These have affected the hepatic, renal, hematopoietic, reproductive, and central nervous systems.", {"entities": []}], ["The type and severity of effects were dose-dependent.", {"entities": []}], ["Direct skin contact is important in the occupational environment where dermal and central nervous system effects have been reported but seems less likely as a route of exposure for populations around waste disposal sites.", {"entities": []}], ["Inhalation, unless at relative high concentrations or as a result of fire, is unlikely to be important, although hematopoietic, reproductive, and central nervous system effects have been reported in occupational studies.", {"entities": []}], ["Critically ill patients with chronic obstructive respiratory diseases (CORD) who require intensive care unit (ICU) admission are at particular risk for invasive bronchial-pulmonary aspergillosis (IBPA).", {"entities": [[181, 194, "DISEASE"]]}], ["The purpose of this study is to investigate clinical features for rapid recognition of IBPA in critically ill patients with CORD.", {"entities": []}], ["We included 55 consecutive CORD patients in a respiratory ICU in a prospective, single-center, cohort study.", {"entities": []}], ["In this study, IBPA combined two entities: ATB and IPA.", {"entities": []}], ["Thirteen of 55 patients were diagnosed with IBPA.", {"entities": []}], ["Before ICU admission, three variables were independent predictors of IBPA with statistical significance: more than three kinds of antibiotics used before the ICU admission, accumulated doses of corticosteroids (>350 mg) received before the ICU admission, and APACHE II scores >18 (OR, 1.208; P = 0.022; OR, 8.661; P = 0.038; and OR, 19.488; P = 0.008, respectively).", {"entities": []}], ["After ICU admission, more IBPA patients had a high fever (>38.5\u00b0C) (46.2% versus 11.9%; P = 0.021), wheeze without exertion (84.6% versus 50.0%; P = 0.027), dry rales (84.6% versus 40.4%; P = 0.005), higher white blood cell counts (21 \u00d7 10 P = 0.012), lower mean arterial pressures (77.9 mm Hg versus 90.5 mm Hg; P = 0.019), and serum creatinine clearances (36.2 ml/min versus 68.8 ml/min; P < 0.001), and liver-function and coagulation abnormalities.", {"entities": []}], ["Bronchospasm, sputum ropiness, and plaque formation were more common for IBPA patients during bronchoscopy (66.7% versus 14.3%; P = 0.082; 18% versus 0; P = 0.169; and 73% versus 13%; P = 0.003, respectively).", {"entities": []}], ["More IBPA patients had nodules and patchiness on chest radiograph on day 1 of admission, which rapidly progressed to consolidation on day 7.", {"entities": []}], ["IBPA mortality was higher than that of non-IBPA patients (69.2% versus 16.7%; P = 0.001).", {"entities": []}], ["IBPA may be suspected in critically ill CORD patients with respiratory failure and clinical and bronchoscopic manifestations of severe infection, bronchospasm, and rapid progression of radiologic lesions that are irresponsive to steroids and antibiotics.", {"entities": [[59, 78, "DISEASE"]]}], ["To avoid misdiagnosis and establish the microbiologic etiology, early bronchoscopy and tight radiologic follow-up should be performed.", {"entities": []}], ["There is an increasing interest toward the use of legumes in food industry, mainly due to the quality of their protein fraction.", {"entities": []}], ["Many legumes are cultivated and consumed around the world, but few data is available regarding the chemical or technological characteristics, and especially on their suitability to be fermented.", {"entities": []}], ["Nevertheless, sourdough fermentation with selected lactic acid bacteria has been recognized as the most efficient tool to improve some nutritional and functional properties.", {"entities": []}], ["This study investigated the presence of lunasin-like polypeptides in nineteen traditional Italian legumes, exploiting the potential of the fermentation with selected lactic acid bacteria to increase the native concentration.", {"entities": []}], ["An integrated approach based on chemical, immunological and ex vivo (human adenocarcinoma Caco-2 cell cultures) analyses was used to show the physiological potential of the lunasin-like polypeptides.", {"entities": [[75, 89, "DISEASE"]]}], ["Italian legume varieties, belonging to Phaseulus vulgaris , Cicer arietinum , Lathyrus sativus , Lens culinaris and Pisum sativum species, were milled and flours were chemically characterized and subjected to sourdough fermentation with selected Lactobacillus plantarum C48 and Lactobacillus brevis AM7, expressing different peptidase activities.", {"entities": []}], ["Extracts from legume doughs (unfermented) and sourdoughs were subjected to western blot analysis, using an anti-lunasin primary antibody.", {"entities": []}], ["Despite the absence of lunasin, different immunoreactive polypeptide bands were found.", {"entities": []}], ["The number and the intensity of lunasin-like polypeptides increased during sourdough fermentation, as the consequence of the proteolysis of the native proteins carried out by the selected lactic acid bacteria.", {"entities": []}], ["A marked inhibitory effect on the proliferation of human adenocarcinoma Caco-2 cells was observed using extracts from legume sourdoughs.", {"entities": [[57, 71, "DISEASE"]]}], ["In particular, sourdoughs from Fagiolo di Lamon, Cece dell\u2019Alta Valle di Misa, and Pisello riccio di Sannicola flours were the most active, showing a decrease of Caco-2 cells viability up to 70\u00a0%.", {"entities": []}], ["The over-expression of Caco-2 filaggrin and involucrin genes was also induced.", {"entities": []}], ["Nine lunasin-like polypeptides, having similarity to lunasin, were identified.", {"entities": []}], ["The features of the sourdough fermented legume flours suggested the use for the manufacture of novel functional foods and/or pharmaceuticals preparations.", {"entities": []}], ["Scabies, caused by the mite Sarcoptes scabiei , is an allergic skin disease that affects millions of people and other mammals worldwide.", {"entities": [[0, 7, "DISEASE"], [63, 75, "DISEASE"]]}], ["This highly contagious parasitic disease is among the top 50 epidemic disease and is regarded as a neglected tropical disease.", {"entities": []}], ["Diagnosis of scabies is difficult in the early stage, and the pathogenesis of scabies is not currently clear.", {"entities": [[13, 20, "DISEASE"], [78, 85, "DISEASE"]]}], ["Here, we expressed, identified and located the chitinase-like protein of S. scabiei (SsCLP), and evaluated its potential as an early-stage diagnostic antigen for rabbit scabies.", {"entities": [[169, 176, "DISEASE"]]}], ["Indirect ELISA using recombinant SsCLP (rSsCLP) exhibited diagnostic sensitivity of 94.4% (17/18) and specificity of 86.7% (26/30).", {"entities": []}], ["Early diagnostic test after artificial infection of rabbits with S. scabiei for 1 week showed a positive detection rate of 96.7% (29/30).", {"entities": []}], ["Immunolocalization assays showed that fluorescence signals were localized on the surface of mites and, in infected rabbits, were observed in keratinized skin and embedded mites.", {"entities": []}], ["Intradermal skin tests of rabbits by injecting rSsCLP showed a wheal, flare and erythema reaction.", {"entities": []}], ["These results suggest that S. scabiei chitinase-like protein is conducive to host invasion, participates in inducing the allergic response of the host, and is an effective antigen for the diagnosis of S. scabiei .", {"entities": []}], ["The National Health and Nutrition Examination Survey (NHANES) is a population survey implemented by the Centers for Disease Control and Prevention (CDC) to monitor the health of the United States whose data is publicly available in hundreds of files.", {"entities": []}], ["This Data Descriptor describes a single unified and universally accessible data file, merging across 255 separate files and stitching data across 4 surveys, encompassing 41,474 individuals and 1,191 variables.", {"entities": []}], ["The variables consist of phenotype and environmental exposure information on each individual, specifically (1) demographic information, physical exam results (e.g., height, body mass index), laboratory results (e.g., cholesterol, glucose, and environmental exposures), and (4) questionnaire items.", {"entities": []}], ["Second, the data descriptor describes a dictionary to enable analysts find variables by category and human-readable description.", {"entities": []}], ["The datasets are available on DataDryad and a hands-on analytics tutorial is available on GitHub.", {"entities": []}], ["Through a new big data platform, BD2K Patient Centered Information Commons ( http://pic-sure.org ), we provide a new way to browse the dataset via a web browser ( https://nhanes.hms.harvard.edu ) and provide application programming interface for programmatic access.", {"entities": []}], ["We conducted a population-based cohort study to estimate trends in prevalence, incidence, and mortality of concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[149, 186, "DISEASE"], [138, 144, "DISEASE"]]}], ["Two validated health administrative case definitions were used to identify asthma and COPD among all individuals aged 35 years and older living in Ontario, Canada.", {"entities": [[75, 81, "DISEASE"]]}], ["Annual asthma, COPD, and concurrent asthma and COPD prevalence, incidence, and mortality, standardized for age and sex, were estimated, and compared from 2002 to 2012, using generalized linear models.", {"entities": [[7, 13, "DISEASE"], [36, 42, "DISEASE"]]}], ["Standardized prevalence of concurrent asthma and COPD increased by 10.5%, from 2.9% in 2002 to 3.2% in 2012 overall, but more prominently in women compared to men.", {"entities": [[38, 44, "DISEASE"]]}], ["Overall, standardized incidence decreased by16%, from 2.5 to 2.1 per 1000 individuals, but increased significantly in young adults.", {"entities": []}], ["All-cause mortality among patients with concurrent asthma and COPD decreased by 11.2%, from 2.6% to 2.2%.", {"entities": [[51, 57, "DISEASE"]]}], ["Being diagnosed with both diseases was significantly associated with higher all-cause mortality compared to asthma (OR = 1.56, 95% CI: 1.50\u20131.58), but not compared to COPD (OR = 0.97, 0.96\u20130.98), except in young adults aged 35 to 49 years where people with asthma and COPD had higher mortality (OR = 1.21, 1.15\u20131.27).", {"entities": [[108, 114, "DISEASE"], [257, 263, "DISEASE"]]}], ["In a large North American population, the burden of concurrent physician-diagnosed asthma and COPD is increasing, particularly in women and young adults.", {"entities": [[83, 89, "DISEASE"]]}], ["As new disease-modifying therapies emerge a better knowledge of the risk of comorbid disease in multiple sclerosis (MS) is needed.", {"entities": [[96, 114, "DISEASE"]]}], ["To estimate the incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in MS. We systematically reviewed the world literature by searching PUBMED, EMBASE, SCOPUS, the Web of Knowledge, and reference lists of retrieved articles.", {"entities": []}], ["For selected articles, one reviewer abstracted data using a standardized form.", {"entities": []}], ["The abstraction was verified by a second reviewer.", {"entities": []}], ["The quality of all selected studies was assessed.", {"entities": []}], ["For population-based studies we quantitatively assessed studies using the I Study designs were heterogeneous with respect to populations, case definitions, and methods of ascertainment.", {"entities": []}], ["Incidence of the studied comorbidities was rarely reported.", {"entities": []}], ["Irritable bowel syndrome and chronic lung disease had a prevalence of more than 10% in the MS population.", {"entities": [[0, 24, "DISEASE"], [16, 24, "DISEASE"], [37, 49, "DISEASE"]]}], ["Irritable bowel syndrome, fibromyalgia, cataracts and glaucoma were more common than expected in the MS population.", {"entities": [[0, 24, "DISEASE"], [54, 62, "DISEASE"], [16, 24, "DISEASE"], [26, 38, "DISEASE"]]}], ["Although they have been the subject of less study than other comorbidities, irritable bowel syndrome, arthritis, and chronic lung disease are common in the MS population and occur more often than expected when compared to the general population.", {"entities": [[76, 100, "DISEASE"], [92, 100, "DISEASE"], [102, 111, "DISEASE"], [125, 137, "DISEASE"]]}], ["The National Urban Air Toxics Research Center (NUATRC) hosted its first scientific workshop in 1994 that focused on possible relationships between air toxics and asthma.", {"entities": [[162, 168, "DISEASE"]]}], ["From that meeting came recommendations for future research including a need for more complete individual personal exposure assessments so that determinations of personal exposures to pollutants could be made.", {"entities": []}], ["In the spring of 2001, NUATRC held a second such workshop to review progress made in this area during the intervening 7 years.", {"entities": []}], ["Peer-reviewed articles from the workshop are published in this issue of (italic)Environmental Health Perspectives Supplements(/italic).", {"entities": []}], ["As in 1994, academic, government, and industry scientists participated.", {"entities": []}], ["Dave Guinnup of the Environmental Protection Agency discussed the nature of air toxics, their definition, and the basis for federal regulation.", {"entities": []}], ["George Leikauf from the University of Cincinnati reviewed the 1994 workshop and subsequent research in this field.", {"entities": []}], ["Current research funded by NUATRC that is addressing individual personal exposure was presented by Clifford Weisel (Environmental and Occupational Health Sciences Institute, University of Medicine and Dentistry of New Jersey), Patrick Kinney (Columbia University) and Candis Claiborn (Washington State University).", {"entities": []}], ["David Corry from Baylor College of Medicine highlighted new insights into asthma pathogenesis while Stephen Redd from the Centers for Disease Control presented an overview of asthma epidemiology as well as the societal costs of the disease.", {"entities": [[74, 80, "DISEASE"], [175, 181, "DISEASE"]]}], ["Mary White (Agency for Toxic Substances and Disease Registry) discussed recent epidemiologic investigations by public health agencies into community concerns about asthma and hazardous air pollutants.", {"entities": [[164, 170, "DISEASE"]]}], ["David Peden (University of North Carolina) reviewed scientific studies into the links between asthma and air toxics as well as criteria air pollutants.", {"entities": [[94, 100, "DISEASE"]]}], ["In a session on occupational asthma, Lee Petsonk (National Institute for Occupational Safety and Health) discussed risk factors for work-related asthma, whereas Ralph Delfino (University of California, Irvine) addressed limitations of extrapolating from occupational asthma to asthma in the general population.", {"entities": [[29, 35, "DISEASE"], [145, 151, "DISEASE"], [267, 273, "DISEASE"], [277, 283, "DISEASE"]]}], ["These presentations were followed by panel discussions focusing on future research programs, both for NUATRC and similar research institutions.", {"entities": []}], ["Recommendations for future research included improved assessments of personal exposure to air toxics as well as research focused on specific hazardous air pollutants.", {"entities": []}], ["The latter recommendation was based on medical literature that suggests certain pollutants from the list of 188 air toxics are most likely to adversely affect respiratory health.", {"entities": []}], ["Tobacco and alcohol use and related morbidity and mortality are critical public health problems.", {"entities": []}], ["Results of several, but not all, studies suggest that lesbians and gay men are at elevated risk for smoking tobacco and alcohol misuse.", {"entities": []}], ["Data from random sample general health surveys of adult members of a large Northern California Health Plan conducted in 1999 and 2002 were analyzed using gender-based multivariate logistic regression models to assess whether lesbians (n = 210) and gay men (n = 331) aged 20\u201365 were more likely than similarly aged heterosexual women (n = 12,188) and men (n = 9342) to be smokers and heavy drinkers.", {"entities": []}], ["After adjusting for age, race/ethnicity, education, and survey year, lesbians were significantly more likely than heterosexual women to be heavy drinkers (OR 2.14, 95% CI 1.08, 4.23) and current smokers (OR 1.60, 95% CI 1.02, 2.51).", {"entities": []}], ["Among men, gays were significantly more likely than heterosexuals to be current smokers (OR 2.40, 95% CI 1.75, 3.30), with borderline significant increased risk for heavy drinking (OR 1.54, 95% CI 0.96, 2.45).", {"entities": []}], ["Lesbians and gay men may be at increased risk for morbidity and mortality due to higher levels of cigarette and alcohol use.", {"entities": []}], ["More population-based research is needed to understand the nature of substance use in these communities so that appropriate interventions can be developed.", {"entities": []}], ["Anaphylaxis is a severe allergic reaction that is rapid in onset and may cause death.", {"entities": []}], ["Since it is unpredictable and potentially fatal, prompt recognition and treatment are vital to maximize a positive outcome.", {"entities": []}], ["The occurrence of anaphylaxis is increasing across all ages in the United States, with increased risk of worse outcome in teenagers/young adults and in those with comorbid conditions such as asthma.", {"entities": [[191, 197, "DISEASE"]]}], ["Gaps in the assessment of patient-specific risk factors, identification and prevention of triggers, recognition of signs/symptoms, and pharmacologic treatment of anaphylaxis have been identified at the physician and caregiver/patient level.", {"entities": []}], ["A PubMed literature search (January 2000\u2013December 2011) was conducted to identify publications on childhood anaphylaxis using the following terms: food allergy, food allergens, food hypersensitivity, epinephrine, epinephrine auto-injectors, anaphylactic triggers, and anaphylaxis.", {"entities": [[147, 159, "DISEASE"]]}], ["This review will critically appraise these key issues and highlight strategies that might result in improved management of anaphylaxis in children.", {"entities": []}], ["Approximately 2 billion people currently suffer from intestinal helminth infections, which are typically chronic in nature and result in growth retardation, vitamin A deficiency, anemia and poor cognitive function.", {"entities": [[179, 185, "DISEASE"]]}], ["Such chronicity results from co-evolution between helminths and their mammalian hosts; however, the molecular mechanisms by which these organisms avert immune rejection are not clear.", {"entities": []}], ["We have found that the natural murine helminth, Heligmosomoides polygyrus bakeri (Hp) elicits the secretion of IL-1\u03b2 in vivo and in vitro and that this cytokine is critical for shaping a mucosal environment suited to helminth chronicity.", {"entities": [[82, 84, "GENE"]]}], ["Indeed in mice deficient for IL-1\u03b2 (IL-1\u03b2 Parasitic soil-transmitted helminths (STH) live, feed and mate within the intestine of their mammalian hosts.", {"entities": []}], ["Infection is caused by ingestion of eggs and larvae or by active penetration of the skin by larvae from contaminated soil in poverty stricken areas lacking adequate sanitation.", {"entities": []}], ["Infection with soil-transmitted helminths results in a wide range of symptoms including intestinal complications (diarrhea, abdominal pain), anemia, general malaise and nutritional deficiencies that negatively impact on working and learning capacities and impair physical growth.", {"entities": [[114, 122, "DISEASE"], [141, 147, "DISEASE"]]}], ["The host typically raises a strong type 2 immune response against the invading helminth; however, the majority of helminthes have developed the capacity to escape effective immunity and can remain chronically within the intestine for years.", {"entities": []}], ["We explored the mechanisms responsible for helminth chronicity using a murine model of Heligmosomoides polygyrus bakeri (Hp) infection.", {"entities": [[121, 123, "GENE"]]}], ["We found that Hp is able to induce IL-1\u03b2 secretion in the intestine and that this cytokine acts to suppress the production of the innate cytokines IL-25 and IL-33.", {"entities": [[14, 16, "GENE"]]}], ["Furthermore, we show that parasite rejection requires IL-25 indicating that suboptimal production of this cytokine in the presence of IL-1\u03b2 is responsible for the ability of IL-1\u03b2 to promote parasite chronicity.", {"entities": []}], ["Our study provides new insights into the mechanisms used by helminths to establish chronic infections, and reveals a novel role for IL-1\u03b2 in protective immunity.", {"entities": []}], ["MicroRNAs (miRNAs) are endogenous non-coding RNAs that contain approximately 22 nucleotides.", {"entities": []}], ["They serve as key regulators in various biological processes and their dysregulation is implicated in many diseases including cancer and autoimmune disorders.", {"entities": [[126, 132, "DISEASE"]]}], ["It has been well established that the maturation of miRNAs occurs in the cytoplasm and miRNAs exert post-transcriptional gene silencing (PTGS) via RNA-induced silencing complex (RISC) pathway in the cytoplasm.", {"entities": []}], ["However, numerous studies reaffirm the existence of mature miRNA in the nucleus, and nucleus-cytoplasm transport mechanism has also been illustrated.", {"entities": []}], ["Moreover, active regulatory functions of nuclear miRNAs were found including PTGS, transcriptional gene silencing (TGS), and transcriptional gene activation (TGA), in which miRNAs bind nascent RNA transcripts, gene promoter regions or enhancer regions and exert further effects via epigenetic pathways.", {"entities": []}], ["Based on existing interaction rules, some miRNA binding sites prediction software tools are developed, which are evaluated in this article.", {"entities": []}], ["In addition, we attempt to explore and review the nuclear functions of miRNA in immunity, tumorigenesis and invasiveness of tumor.", {"entities": []}], ["As a non-canonical aspect of miRNA action, nuclear miRNAs supplement miRNA regulatory networks and could be applied in miRNA based therapies.", {"entities": []}], ["Evaluation of a spoon-fed amino acid\u2212based formula (AAF) with a yogurt-type texture compared to the reference oral liquid formula (Neocate).", {"entities": []}], ["Phase III/IV, prospective, randomized (1:1), open-label, multicenter study in infants/young children (6\u201336 months) with severe cow's milk protein allergy (CMA) who had consumed AAF for \u22651 month before the study.", {"entities": []}], ["Patients received reference+test formula (Neocate with a yogurt-type texture for spoon-feeding: group 1) or reference formula (group 2) for 28 days.", {"entities": []}], ["The study formulae were integrated into the patients\u2019 usual daily diet.", {"entities": []}], ["Efficacy on Day 0, 14, and 28 was assessed primarily in terms of symptoms associated with CMA.", {"entities": []}], ["The evolution of symptoms, amount of formula consumed, nutritional and energy intake, anthropometric data, and tolerability were also assessed.", {"entities": []}], ["The incidence of CMA symptoms was similar in each group ( P \u200a>\u200a0.05) on day 0, 14, and 28.", {"entities": []}], ["For specific symptoms, there was little change from day 0 and no significant difference between groups for incidence on day 0 or evolution at day 14 or 28.", {"entities": []}], ["There was no difference in formula consumption (day 0\u2013day 28) between groups ( P \u200a=\u200a0.90), but nutritional value was generally higher for group 1 and calcium intake was statistically higher for group 1 ( P \u200a<\u200a0.05).", {"entities": []}], ["Weight-for-height, weight-for age, and body mass index-for-age z scores were higher for group 1 than group 2 ( P \u200a<\u200a0.05).", {"entities": []}], ["Both formulae were well tolerated.", {"entities": []}], ["There was no difference in efficacy, formula consumption, and tolerability between the new spoon-fed yogurt-type AAF formula and the reference formula, whereas significantly higher calcium intake was achieved with the new formula.", {"entities": []}], ["Transcription factor forkhead box protein 3 (Foxp3) specifically characterizes the thymically derived naturally occurring regulatory T cells (Tregs).", {"entities": [[45, 50, "GENE"]]}], ["Limited evidence indicates that it is also expressed, albeit to a lesser extent, in tissues other than thymus and spleen, while, very recently, it was shown that Foxp3 is expressed by pancreatic carcinoma.", {"entities": [[184, 204, "DISEASE"], [195, 204, "DISEASE"], [162, 167, "GENE"]]}], ["This study was scheduled to investigate whether expression of Foxp3 transcripts and mature protein occurs constitutively in various tumor types.", {"entities": [[62, 67, "GENE"]]}], ["Twenty five tumor cell lines of different tissue origins (lung cancer, colon cancer, breast cancer, melanoma, erythroid leukemia, acute T-cell leukemia) were studied.", {"entities": [[58, 69, "DISEASE"], [85, 98, "DISEASE"], [71, 83, "DISEASE"], [120, 128, "DISEASE"], [143, 151, "DISEASE"], [100, 108, "DISEASE"], [63, 69, "DISEASE"], [77, 83, "DISEASE"], [92, 98, "DISEASE"]]}], ["Detection of Foxp3 mRNA was performed using both conventional RT-PCR and quantitative real-time PCR while protein expression was assessed by immunocytochemistry and flow cytometry, using different antibody clones.", {"entities": [[13, 18, "GENE"]]}], ["Foxp3 mRNA as well as Foxp3 protein was detected in all tumor cell lines, albeit in variable levels, not related to the tissue of origin.", {"entities": [[0, 5, "GENE"], [22, 27, "GENE"], [0, 5, "GENE"], [22, 27, "GENE"]]}], ["This expression correlated with the expression levels of IL-10 and TGFb1.", {"entities": [[67, 72, "GENE"]]}], ["We offer evidence that Foxp3 expression, characterizes tumor cells of various tissue origins.", {"entities": [[23, 28, "GENE"]]}], ["The biological significance of these findings warrants further investigation in the context of tumor immune escape, and especially under the light of current anti-cancer efforts interfering with Foxp3 expression.", {"entities": [[163, 169, "DISEASE"], [195, 200, "GENE"]]}], ["Asthma is a common illness, especially among children.", {"entities": [[0, 6, "DISEASE"]]}], ["Exercise-induced asthma is an important consideration, both as a factor, limiting physical activity of patients, and also as an indicator of poor long term control.", {"entities": [[17, 23, "DISEASE"]]}], ["We investigated pre-Valence of exercise-induced asthma in a group of asthmatic children living in southern Iran.", {"entities": [[48, 54, "DISEASE"]]}], ["We conducted treadmill exercise challenge test in 40 young asthmatic patients aged 6 to 18.", {"entities": []}], ["After 8 minutes exercise to achieve 80% of maximum heart rate predicted for age, patients were examined and spirometry values recorded at frequent intervals.", {"entities": []}], ["We defined exercise-induced asthma as 10% or more decline in Forced Expiratory Volume in one second (FEV1) within 30 minutes after exercise challenge.", {"entities": [[28, 34, "DISEASE"]]}], ["Of 40 patients evaluated, 22 patients (55% of total) met our criteria for exercise-induced asthma.", {"entities": [[91, 97, "DISEASE"]]}], ["Most positive responses (7 of 22, 31.8%) occurred at about 10 minutes after exercise.", {"entities": []}], ["Cough was the most consistent sign (18 of 22 patients, 81%).", {"entities": []}], ["In 2 patients (9%), FEV 1 decline did not accompany any symptom or sign.", {"entities": [[20, 23, "GENE"]]}], ["We concluded that Exercise- induced asthma occurs in a relatively smaller subset of southern Iranian asthmatic children.", {"entities": [[36, 42, "DISEASE"]]}], ["Also treadmill exercise challenge performed by a trained staff, following standard protocol and using enough monitoring and precautions is safe and diagnostic in children and adolescents.", {"entities": []}], ["In 2009, the Tobacco Hazards Prevention Act (Taiwan) was amended to more effectively restrict smoking in indoor public places and workplaces in Taiwan.", {"entities": []}], ["However, the lack of prohibitions for smoking in private homes may place family members at increased risk for exposure to environmental tobacco smoke (ETS).", {"entities": []}], ["The aim of our study was to determine the factors associated with parental smoking in the presence of children at home.", {"entities": []}], ["In 2010, we performed a cross-sectional study of factors associated with parental smoking in the presence of children at home in Taiwan using self-administered questionnaires.", {"entities": []}], ["Quota sampling was used to select five primary schools from four different regions of Taiwan.", {"entities": []}], ["Parents were surveyed to identify parental smokers and 307 parental smokers were selected for participation in our study.", {"entities": []}], ["Questionnaire data regarding parental smoking in the presence of children at home and related interactions among family members were analyzed.", {"entities": []}], ["Hierarchical logistic regression was used to determine the best-fit model for examining the relationships among the variables related to parental smoking in the presence of children at home.", {"entities": []}], ["Two-thirds of parents who smoked reported smoking in the presence of their children.", {"entities": []}], ["The results of the hierarchical logistic regression analysis identified the smokers\u2019 compliance with their family\u2019s antismoking responses, mutual agreement with smoking bans, daily smoking, smoking more than 20 cigarettes per day, the education level of the parental smoker, and the annual family income as determinants of smoking in the presence of children at home.", {"entities": []}], ["Households with smoking parents should be targeted for interventions to encourage the adoption and enforcement of home smoking bans.", {"entities": []}], ["Educational interventions that promote smoke-free homes for children and provide support to help parents stop smoking are critical factors in reducing the frequency of children\u2019s ETS exposure in the home.", {"entities": []}], ["A cat was evaluated for an acute\u2010onset of right pelvic limb paresis.", {"entities": []}], ["Thoracic radiographs revealed normal cardiac size and tortuous pulmonary arteries.", {"entities": []}], ["Abdominal ultrasound identified a heartworm (HW) extending from the caudal abdominal aorta into the right external iliac artery and right femoral artery.", {"entities": []}], ["The cat was HW\u2010antigen positive.", {"entities": []}], ["Echocardiography revealed a HW within the right branch of the main pulmonary artery and evidence of pulmonary hypertension.", {"entities": [[110, 122, "DISEASE"], [100, 122, "DISEASE"]]}], ["An agitated\u2010saline contrast echocardiogram revealed a small right to left intracardiac shunt at the level of the atria.", {"entities": []}], ["Surgical removal of the HW was performed with no substantial postoperative complications.", {"entities": []}], ["There was return of blood flow and improved motor function to the limb.", {"entities": []}], ["The cat remains mildly paretic on the affected limb with no other clinical signs.", {"entities": []}], ["Macrophages play diverse roles in tissue homeostasis and immunity, and canonically activated macrophages are critically associated with acute inflammatory responses.", {"entities": []}], ["It is known that activated macrophages undergo cell death after transient activation in some settings, and the viability of macrophages impacts on inflammatory status.", {"entities": []}], ["Here we report that TGF\u03b2- activated kinase (TAK1) activators, TAK1-binding protein 1 (TAB1) and TAK1-binding protein 2 (TAB2), are critical molecules in the regulation of activated macrophage survival.", {"entities": [[86, 90, "GENE"], [120, 124, "GENE"]]}], ["While deletion of Tak1 induced cell death in bone marrow derived macrophages even without activation, Tab1 or Tab2 deletion alone did not profoundly affect survival of na\u00efve macrophages.", {"entities": [[102, 106, "GENE"], [110, 114, "GENE"]]}], ["However, in lipopolysaccharide (LPS)-activated macrophages, even single deletion of Tab1 or Tab2 resulted in macrophage death with both necrotic and apoptotic features.", {"entities": [[84, 88, "GENE"], [92, 96, "GENE"]]}], ["We show that TAB1 and TAB2 were redundantly involved in LPS-induced TAK1 activation in macrophages.", {"entities": [[13, 17, "GENE"], [22, 26, "GENE"]]}], ["These results demonstrate that TAK1 activity is the key to activated macrophage survival.", {"entities": []}], ["Finally, in an in vivo setting, Tab1 deficiency impaired increase of peritoneal macrophages upon LPS challenge, suggesting that TAK1 complex regulation of macrophages may participate in in vivo macrophage homeostasis.", {"entities": [[32, 36, "GENE"]]}], ["Our results demonstrate that TAB1 and TAB2 are required for activated macrophages, making TAB1 and TAB2 effective targets to control inflammation by modulating macrophage survival.", {"entities": [[29, 33, "GENE"], [90, 94, "GENE"], [38, 42, "GENE"], [99, 103, "GENE"], [29, 33, "GENE"], [90, 94, "GENE"], [38, 42, "GENE"], [99, 103, "GENE"]]}], ["Many Western drugs can give rise to serious side effects due to their ability to bind to acetylcholine receptors in the brain.", {"entities": []}], ["This aggravates when they are combined, which is known as anticholinergic accumulation (AA).", {"entities": []}], ["Some bioactives in Traditional Chinese Medicine (TCM) are known to block acetylcholine receptors and thus potentially cause AA.", {"entities": []}], ["The AA of TCM was screened by quantifying the displacement of [", {"entities": []}], ["Different monocytic subsets are important in inflammation and tissue remodelling, but although heart failure (HF) is associated with local and systemic inflammation, their roles in HF are yet unknown.", {"entities": []}], ["We recruited 59 chronic systolic HF patients (aged 58 \u00b1 13 years, 45 males and 14 females) and 29 age-matched controls with no pervious heart disease.", {"entities": [[136, 149, "DISEASE"]]}], ["Compared to the controls, we found no change in the distribution of the CD14 P < 0.001), and the nonclassical CD14 P < 0.001) in HF patients and was inversely associated with severe HF ( P = 0.015), as assessed by increased end-diastolic dimension (EDD).", {"entities": [[72, 76, "GENE"], [110, 114, "GENE"], [72, 76, "GENE"], [110, 114, "GENE"]]}], ["Compared to the control group, serum TNF \u03b1 , IL-1 \u03b2 , IL-10, and IL-13 levels were significantly elevated in the HF patients.", {"entities": [[37, 40, "GENE"]]}], ["Specifically, IL-13 levels were positively correlated to the CD1CD14 r = 0.277, P = 0.017), and intracellular staining of IL-13 demonstrated that some of these monocytes produce the cytokine in HF patients, but not in the controls.", {"entities": []}], ["We suggest that the inverse association between EDD values and the expansion of CD14", {"entities": [[80, 84, "GENE"]]}], ["Epidemiological studies suggest an association between obesity and asthma in adults and children.", {"entities": [[55, 62, "DISEASE"], [67, 73, "DISEASE"]]}], ["Asthma diagnosis criteria are different among studies.", {"entities": [[0, 6, "DISEASE"]]}], ["The aim of this study was to test the influence of asthma definition on the asthma-obesity relationship.", {"entities": [[83, 90, "DISEASE"], [51, 57, "DISEASE"], [76, 82, "DISEASE"]]}], ["In a cross-sectional analysis of 1922 men and women, subjects completed a translated questionnaire from the European Community Respiratory Health Survey and underwent spirometry and a bronchial challenge test.", {"entities": []}], ["Weight, height and waist circumference were measured.", {"entities": []}], ["Multiple logistic regression analysis was carried out to assess the association of variables related to obesity and asthma.", {"entities": [[104, 111, "DISEASE"], [116, 122, "DISEASE"]]}], ["Asthma was defined either by the presence of symptoms with bronchial hyperresponsiveness (BHR) or by a self-report of a physician-made diagnosis.", {"entities": [[0, 6, "DISEASE"]]}], ["The following variables were separately tested for associations with asthma: socioeconomic characteristics, schooling, physical activity, smoking status, anthropometry and spirometry.", {"entities": [[69, 75, "DISEASE"]]}], ["No association was detected between asthma confirmed by BHR and obesity indicators, odds ratio (OR) = 1.08 (95% confidence interval: 0.69 - 1.68) for obesity assessed by body mass index \u2265 30 kg/m Our findings indicate that the relationship between asthma and obesity in epidemiological studies depends on the definition adopted.", {"entities": [[64, 71, "DISEASE"], [150, 157, "DISEASE"], [259, 266, "DISEASE"], [36, 42, "DISEASE"], [248, 254, "DISEASE"]]}], ["Certain components of asthma, for instance, symptoms may be more prone to the obesity influence than other ones, like bronchial hyperresponsiveness.", {"entities": [[78, 85, "DISEASE"], [22, 28, "DISEASE"]]}], ["Deficient type I interferon-\u03b2 and type III interferon-\u03bb induction by rhinoviruses has previously been reported in mild/moderate atopic asthmatic adults.", {"entities": []}], ["No studies have yet investigated if this occurs in severe therapy resistant asthma (STRA).", {"entities": [[76, 82, "DISEASE"]]}], ["Here, we show that compared with non-allergic healthy control children, bronchial epithelial cells cultured ex vivo from severe therapy resistant atopic asthmatic children have profoundly impaired interferon-\u03b2 and interferon-\u03bb mRNA and protein in response to rhinovirus (RV) and polyIC stimulation.", {"entities": []}], ["Severe treatment resistant asthmatics also exhibited increased virus load, which negatively correlated with interferon mRNA levels.", {"entities": []}], ["Furthermore, uninfected cells from severe therapy resistant asthmatic children showed lower levels of Toll-like receptor-3 mRNA and reduced retinoic acid inducible gene and melanoma differentiation-associated gene 5 mRNA after RV stimulation.", {"entities": [[173, 181, "DISEASE"]]}], ["These data expand on the original work, suggesting that the innate anti-viral response to RVs is impaired in asthmatic tissues and demonstrate that this is a feature of STRA.", {"entities": []}], ["Increased bronchial responsiveness is characteristic of asthma.", {"entities": [[56, 62, "DISEASE"]]}], ["Gas cooking, which is a major indoor source of the highly oxidant nitrogen dioxide, has been associated with respiratory symptoms and reduced lung function.", {"entities": []}], ["However, little is known about the effect of gas cooking on bronchial responsiveness and on how this relationship may be modified by variants in the genes GSTM1 , GSTT1 and GSTP1 , which influence antioxidant defences.", {"entities": [[155, 160, "GENE"], [163, 168, "GENE"], [173, 178, "GENE"]]}], ["The study was performed in subjects with forced expiratory volume in one second at least 70% of predicted who took part in the multicentre European Community Respiratory Health Survey, had bronchial responsiveness assessed by methacholine challenge and had been genotyped for GSTM1 , GSTT1 and GSTP1 -rs1695.", {"entities": [[276, 281, "GENE"], [284, 289, "GENE"], [294, 299, "GENE"]]}], ["Information on the use of gas for cooking was obtained from interviewer-led questionnaires.", {"entities": []}], ["Effect modification by genotype on the association between the use of gas for cooking and bronchial responsiveness was assessed within each participating country, and estimates combined using meta-analysis.", {"entities": []}], ["Overall, gas cooking, as compared with cooking with electricity, was not associated with bronchial responsiveness (\u03b2=\u22120.08, 95% CI \u22120.40 to 0.25, p=0.648).", {"entities": []}], ["However, GSTM1 significantly modified this effect (\u03b2 for interaction=\u22120.75, 95% CI \u22121.16 to \u22120.33, p=4\u00d710 GSTM1 null subjects showing more responsiveness if they cooked with gas.", {"entities": [[9, 14, "GENE"], [106, 111, "GENE"], [9, 14, "GENE"], [106, 111, "GENE"]]}], ["No effect modification by GSTT1 or GSTP1 -rs1695 genotypes was observed.", {"entities": [[26, 31, "GENE"], [35, 40, "GENE"]]}], ["Increased bronchial responsiveness was associated with gas cooking among subjects with the GSTM1 null genotype.", {"entities": [[91, 96, "GENE"]]}], ["This may reflect the oxidant effects on the bronchi of exposure to nitrogen dioxide.", {"entities": []}], ["Understanding the signals that regulate eosinophil survival and death is critical to developing new treatments for asthma, atopy, and gastrointestinal disease.", {"entities": [[115, 121, "DISEASE"]]}], ["Previous studies suggest that TNF-\u03b1 stimulation protects eosinophils from apoptosis, and this TNF-\u03b1-mediated protection is mediated by the upregulation of an unknown protein by NF-\u03baB.", {"entities": []}], ["Here, we show for the first time that eosinophils express the caspase 8-inhibitory protein c-FLIP, and c-FLIP expression is upregulated upon TNF-\u03b1 stimulation.", {"entities": []}], ["Considering that c-FLIP expression is regulated by NF-\u03baB, we hypothesized that c-FLIP might serve as the \u201cmolecular switch\u201d that converts TNFRI activation to a pro-survival signal in eosinophils.", {"entities": []}], ["Indeed, we found that one c-FLIP isoform, c-FLIP L , is required for mouse eosinophil survival in the presence of TNF-\u03b1 both in vitro and in vivo .", {"entities": []}], ["Importantly, our results suggest c-FLIP as a potential therapeutic target for the treatment of eosinophil-mediated disease.", {"entities": []}], ["Because illicit drugs are now widely consumed, every doctor needs to know their acute medical consequences and complications.", {"entities": []}], ["Here, we review the problems associated with the different drugs from a systems-based viewpoint.", {"entities": []}], ["Apart from the respiratory depressant effect of opioids, crack cocaine is the most common cause of respiratory complications, mainly linked with its mode of use, with airway burns, pneumothorax, pneumomediastinum, and lung syndromes being well-recognised sequelae.", {"entities": [[181, 193, "DISEASE"]]}], ["Because of its marked cardiovascular effects, cocaine is also a major cause of coronary syndromes and myocardial infarction.", {"entities": [[102, 123, "DISEASE"]]}], ["Amphetamines may produce similar effects less commonly.", {"entities": []}], ["Hyperthermia may occur with cocaine toxicity or with 3,4-methylenedioxymethamphetamine (MDMA) due to exertion or from serotonin syndrome.", {"entities": [[128, 136, "DISEASE"]]}], ["Cerebral haemorrhage may result from the use of amphetamines or cocaine.", {"entities": []}], ["Hallucinations may follow consumption of LSD, amphetamines, or cocaine.", {"entities": []}], ["MDMA is a major cause of acute severe hyponatraemia and also has been linked with hepatic syndromes.", {"entities": []}], ["Collapse, convulsions, or coma may be caused in different circumstances by opioids, MDMA, or gamma hydroxybutyrate and may be aggravated by other sedatives, especially alcohol and benzodiazepines.", {"entities": []}], ["Recognition of these acute complications is urgent, and treatment must be based on an understanding of the likely underlying problem as well as on basic principles of supportive care.", {"entities": []}], ["The impact of maternal ingestion of peanut during pregnancy and lactation on an offspring\u2019s risk for peanut allergy is under debate.", {"entities": []}], ["To investigate the influence of maternal dietary peanut exposure and breast milk on an offspring\u2019s allergy risk.", {"entities": []}], ["Preconceptionally peanut-exposed C3H/HeJ females were either fed or not fed peanut during pregnancy and lactation.", {"entities": []}], ["The offsprings\u2019 responses to peanut sensitization or oral tolerance induction by feeding antigen prior to immunization were assessed.", {"entities": []}], ["We also assessed the impact of immune murine milk on tolerance induction pre- or post-weaning.", {"entities": []}], ["For antigen uptake studies, mice were gavaged with fluorescent peanut in the presence or absence of immune murine milk; Peyer\u2019s patches were harvested for immunostaining.", {"entities": []}], ["Preconceptional peanut exposure resulted in the production of varying levels of maternal antibodies in serum (and breast milk), which were transferred to the offspring.", {"entities": []}], ["Despite this, maternal peanut exposure either preconceptionally or during pregnancy and lactation, when compared to no maternal exposure, had no impact on peanut allergy.", {"entities": []}], ["When offspring were fed peanut directly, dose-dependent tolerance induction, unaltered by maternal feeding of peanut, was seen.", {"entities": []}], ["Although peanut uptake into the gut-associated lymphoid tissues was enhanced by immune milk as compared to na\u00efve milk, tolerance induction was not affected by the co-administration of immune milk either pre- or post-weaning.", {"entities": []}], ["Maternal peanut exposure during pregnancy and lactation has no impact on the development of peanut allergy in the offspring.", {"entities": []}], ["Tolerance to peanut can be induced early, even pre-weaning, by giving moderate amounts of peanut directly to the infant, and this is neither enhanced nor impaired by concurrent exposure to immune milk.", {"entities": []}], ["Cytokine-based diagnostic assays are increasingly used in research and clinical practice.", {"entities": []}], ["Assays developed for adults such as the interferon-gamma release assay for tuberculosis show inferior performance in children.", {"entities": [[75, 87, "DISEASE"]]}], ["Limited evidence suggests that release of cytokines is influenced by age but normal ranges of cytokines in children are lacking.", {"entities": []}], ["Whole blood of healthy children (0\u201312 years) undergoing elective/diagnostic procedures was stimulated with SEB, PHA, Candida albicans for 24\u2009hours or left unstimulated.", {"entities": []}], ["Concentrations of eight cytokines\u00a0were measured by multiplex bead-based immunoassays and associations with age and other factors quantified by regression analysis.", {"entities": []}], ["271 children (median age 5.2 years) were included.", {"entities": []}], ["In unstimulated samples IL-1ra, IP-10 and TNF-\u03b1 concentrations decreased by up to \u221260% with age.", {"entities": []}], ["Following antigen stimulation, an age-associated increase (ranging from +90% to +500%) was observed for all cytokines except IL-1ra (significant for IL-4, IFN-\u03b3 and TNF-\u03b1).", {"entities": []}], ["Inter-individual variability in cytokine concentrations was large with a coefficient of variation ranging from 42% to 1412%.", {"entities": []}], ["Despite inter-individual variation age was identified as a strong influencing factor of cytokine concentrations.", {"entities": []}], ["Age-specific normal values need to be considered for cytokine-based diagnostic purposes.", {"entities": []}], ["These results are relevant for development of novel cytokine-based diagnostic assays and for optimal dosing of therapeutic agents targeting cytokines.", {"entities": []}], ["Prevalence and risk factors for respiratory symptoms and airway obstruction in HIV-infected subjects in the era of highly active antiretroviral therapy (HAART) are unknown.", {"entities": []}], ["We evaluated respiratory symptoms and measured airway obstruction to identify the impact of HAART and other risk factors on respiratory symptoms and pulmonary function.", {"entities": []}], ["Two hundred thirty-four HIV-infected adults without acute respiratory symptoms were recruited from an HIV clinic.", {"entities": []}], ["All subjects were interviewed and performed spirometry.", {"entities": []}], ["Multivariate linear and logistic regressions were performed to determine predictors of respiratory symptoms, forced expiratory volume in one second (FEV 1 ) percent predicted, and FEV 1 /forced vital capacity (FEV 1 /FVC).", {"entities": [[149, 152, "GENE"], [180, 183, "GENE"], [210, 213, "GENE"], [149, 152, "GENE"], [180, 183, "GENE"], [210, 213, "GENE"], [149, 152, "GENE"], [180, 183, "GENE"], [210, 213, "GENE"]]}], ["Thirty-one percent of subjects reported at least one respiratory symptom.", {"entities": []}], ["Smoking status (current or former versus never) (odds ratio [OR]\u200a=\u200a2.7, 95% confidence interval [CI]\u200a=\u200a1.41\u20135.22, p\u200a=\u200a0.003), higher log plasma HIV viral levels (OR\u200a=\u200a1.12, 95%CI\u200a=\u200a1.02\u20131.24, p\u200a=\u200a0.02), and lower FEV 1 /FVC (OR\u200a=\u200a1.06 for every 0.01 decrease in FEV 1 /FVC, 95%CI\u200a=\u200a1.02\u20131.14, p\u200a=\u200a0.001) were independent predictors of respiratory symptoms.", {"entities": [[213, 216, "GENE"], [262, 265, "GENE"], [213, 216, "GENE"], [262, 265, "GENE"]]}], ["Age (p\u200a=\u200a0.04), pack-year smoking history (p<0.001), previous bacterial pneumonia (p\u200a=\u200a0.007), and HAART use (p\u200a=\u200a0.04) were independent predictors of decreased FEV 1 /FVC.", {"entities": [[72, 81, "DISEASE"], [62, 81, "DISEASE"], [161, 164, "GENE"]]}], ["Respiratory symptoms remain common in HIV-infected subjects, especially in those with a smoking history.", {"entities": []}], ["Subjects who were older, had a greater pack-year history of smoking, or previous bacterial pneumonia had lower FEV 1 /FVC ratios.", {"entities": [[91, 100, "DISEASE"], [81, 100, "DISEASE"], [111, 114, "GENE"]]}], ["Interestingly, use of HAART was independently associated with a decreased FEV 1 /FVC, possibly secondary to an immune response to subclinical infections, increased autoimmunity, or other factors associated with HAART use.", {"entities": [[74, 77, "GENE"]]}], ["To ascertain characteristics of pandemic (H1N1) 2009 virus infection, we reviewed medical records for all suspected or confirmed cases reported in Abu Dhabi during May 2009\u2013March 2010.", {"entities": []}], ["Overall case-fatality rate was 1.4/100,000 population.", {"entities": []}], ["Most patients who died had \u22651 risk factor, and female decedents were considerably younger than male decedents.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) have increased mortality following myocardial infarction (MI) compared with patients without COPD.", {"entities": [[14, 51, "DISEASE"], [94, 115, "DISEASE"]]}], ["We investigated the extent to which differences in recognition and management after MI could explain the mortality difference.", {"entities": []}], ["300\u2005161 patients with a first MI between 2003 and 2013 were identified in the UK Myocardial Ischaemia National Audit Project database.", {"entities": []}], ["Logistic regression was used to compare mortality in hospital and at 180\u2005days postdischarge between patients with and without COPD.", {"entities": []}], ["Variables relating to inhospital factors (delay in diagnosis, use of reperfusion and time to reperfusion/use of angiography) and use of secondary prevention were sequentially added to models.", {"entities": []}], ["Mortality was higher for patients with COPD both inhospital (4.6% vs 3.2%) and at 180\u2005days (12.8% vs 7.7%).", {"entities": []}], ["After adjusting for inhospital factors, the effect of COPD on inhospital mortality after MI was reduced for both ST-elevation myocardial infarctions (STEMIs) and non-STEMIs (STEMIs OR 1.24 (95% CI 1.10 to 1.41) to 1.13 (95% CI 0.99 to 1.29); non-STEMIs OR 1.34 (95% CI 1.24 to 1.45) to 1.16 (95% CI 1.07 to 1.26)).", {"entities": []}], ["Adjusting for inhospital factors reduced the effect of COPD on mortality after non-STEMI at 180\u2005days (OR 1.56 (95% CI 1.47 to 1.65) to 1.37 (95% CI 1.31 to 1.44)).", {"entities": []}], ["Adjusting for use of secondary prevention also reduced the effect of COPD on mortality at 180\u2005days for STEMIs and non-STEMIs (STEMIs OR 1.45 (95% CI 1.31 to 1.61) to 1.25 (95% CI 1.11 to 1.41); non-STEMIs OR 1.37 (95% CI 1.31 to 1.44) to 1.26 (95% CI 1.17 to 1.35).", {"entities": []}], ["Delayed diagnosis, timing and use of reperfusion of a STEMI, use of angiography after a non-STEMI and use of secondary prevention medicines are all potential explanations for the mortality gap after MI in people with COPD.", {"entities": []}], ["Asthma is a complex and heterogeneous chronic inflammatory disorder that is associated with mucous cell metaplasia and mucus hypersecretion.", {"entities": [[0, 6, "DISEASE"]]}], ["Functional genomic analysis indicates that mucous cell metaplasia and mucus hypersecretion depend on members of the calcium-activated chloride channel (CLCA) gene family.", {"entities": []}], ["It has been reported that the inhibition of CLCAs could relieve the symptoms of asthma.", {"entities": [[80, 86, "DISEASE"]]}], ["Thus, the mCLCA3 antibody may be a promising strategy to treat allergic diseases such as asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["We constructed asthmatic mouse models of OVA-induced chronic airway inflammatory disorder to study the function of the mCLCA3 antibody.", {"entities": []}], ["Airway inflammation was measured by HE staining; goblet cell hyperplasia and mucus hypersecretion were detected by PAS staining; muc5ac, IL-13, IFN-\u03b3 levels in bronchoalveolar lavage fluid (BALF) were examined by ELISA; Goblet cell apoptosis was measured by TUNEL assay and alcian blue staining; mCLCA3, Bcl-2 and Bax expression were detected by RT-PCR, Western blotting and immunohistochemical analysis.", {"entities": [[314, 317, "GENE"]]}], ["In our study, mice treated with mCLCA3 antibody developed fewer pathological changes compared with control mice and asthmatic mice, including a remarkable reduction in airway inflammation, the number of goblet cells and mCLCA3 expression in lung tissue.", {"entities": []}], ["The levels of muc5ac and IL-13 were significantly reduced in BALF.", {"entities": []}], ["We also found that the rate of goblet cell apoptosis was increased after treatment with mCLCA3 antibody, which was accompanied by an increase in Bax levels and a decrease in Bcl-2 expression in goblet cells.", {"entities": [[145, 148, "GENE"]]}], ["Taken together, our results indicate that mCLCA3 antibody may have the potential as an effective pharmacotherapy for asthma.", {"entities": [[117, 123, "DISEASE"]]}], ["Certain industries were overrepresented among employed adults with this disease.", {"entities": []}], ["In response to pandemic (H1N1) 2009, data were collected on work status and industry of employment of 3,365 adults hospitalized with laboratory-confirmed influenza during the 2009\u201310 influenza season in the United States.", {"entities": [[154, 163, "DISEASE"], [183, 192, "DISEASE"]]}], ["The proportion of workers hospitalized for influenza was lower than their proportion in the general population, reflecting underlying protective characteristics of workers compared with nonworkers.", {"entities": [[43, 52, "DISEASE"]]}], ["The most commonly represented sectors were transportation and warehousing; administrative and support and waste management and remediation services; health care; and accommodation and food service.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) related to wood smoke exposure is characterized by important inflammation of the central and peripheral airways without significant emphysema.", {"entities": []}], ["The objective of this study is to describe the bronchial hyperresponsiveness (BHR) level in women with COPD related to wood smoke exposure and to compare it with the BHR in women with COPD related to tobacco smoking.", {"entities": []}], ["Two groups of women with stable COPD were studied: (1) wood smoke exposed (WS-COPD); and (2) tobacco smoke exposed (TS-COPD).", {"entities": []}], ["A methacholine challenge test (MCT) was performed in all patients according to American Thoracic Society criteria.", {"entities": []}], ["BHR levels were compared using the methacholine concentration, which caused a 20% fall in the FEV 1 (PC 20 ).", {"entities": [[94, 97, "GENE"], [101, 103, "GENE"]]}], ["Thirty-one patients, 19 with WS-COPD and 12 with TS-COPD, were included.", {"entities": []}], ["There were no significant differences between the groups in baseline FVC, FEV 1 , IC, FEF 25\u201375 , and FEF 25\u201375 /FVC.", {"entities": [[74, 77, "GENE"]]}], ["All 31 patients had a positive MCT (PC 20 < 16 mg/mL) and the fall in the FEV 1 and IC was similar in both groups.", {"entities": [[36, 38, "GENE"], [74, 77, "GENE"]]}], ["The severity of BHR was significantly higher in the WS-COPD patients (PC 20 : 0.39 mg/mL) than in the TS-COPD patients (PC 20 : 1.24 mg/mL) ( P = 0.028).", {"entities": [[70, 72, "GENE"], [120, 122, "GENE"], [70, 72, "GENE"], [120, 122, "GENE"]]}], ["The presence of cough, phlegm, and dyspnea during the test were similar in both groups.", {"entities": []}], ["We found moderate to severe BHR in women with WS-COPD, which was more severe than in the TS-COPD women with similar age and airflow obstruction.", {"entities": []}], ["This paper suggests that the structural and inflammatory changes induced by the chronic exposure to wood smoke, described in other studies, can explain the differences with TS-COPD patients.", {"entities": []}], ["Future studies may clarify our understanding of the impact of BHR on COPD physiopathology, phenotypes, and treatment strategies.", {"entities": []}], ["Inflammation is an important component of various cancers and its inflammatory cells and mediators have been shown to have prognostic potential.", {"entities": []}], ["Tumor-infiltrating mast cells can promote tumor growth and angiogenesis, but the mechanism of mast cell activation is unclear.", {"entities": []}], ["In earlier studies, we demonstrated that immunoglobulin free light chains (FLC) can trigger mast cells in an antigen-specific manner.", {"entities": []}], ["Increased expression of FLC was observed within stroma of various human cancers including those of breast, colon, lung, pancreas, kidney and skin, and FLC expression co-localized with areas of mast cell infiltration.", {"entities": []}], ["In a large cohort of breast cancer patients, FLC expression was shown associated with basal-like cancers with an aggressive phenotype.", {"entities": [[21, 34, "DISEASE"], [28, 34, "DISEASE"]]}], ["Moreover, lambda FLC was found expressed in areas of inflammatory infiltration and its expression was significantly associated with poor clinical outcome.", {"entities": []}], ["Functional importance of FLCs was shown in a murine B16F10 melanoma model, where inhibition of FLC-mediated mast cell activation strongly reduced tumor growth.", {"entities": [[59, 67, "DISEASE"]]}], ["Collectively, this study identifies FLCs as a ligand in the pro-tumorigenic activation of mast cells.", {"entities": []}], ["Blocking this pathway may open new avenues for the inhibition of tumor growth, while immunohistochemical staining of FLC may be helpful in the diagnosis and prognosis of cancer.", {"entities": [[170, 176, "DISEASE"]]}], ["Horse eosinophils purified to greater than 98% generated slow reacting substance (SRS) when incubated with the calcium ionophore A23187.", {"entities": []}], ["On a per cell basis, eosinophils generated four to five times the SRS produced by similarly treated horse neutrophils.", {"entities": []}], ["Eosinophil SRS production was inhibited by 5,8,11,14-eicosatetraynoic acid and augmented by indomethacin and arachidonic acid, suggesting that it was a product(s) of the lipoxygenase pathway of arachidonic acid metabolism.", {"entities": []}], ["Compounds with SRS activity were purified by high-pressure liquid chromatography (HPLC) and identified by ultraviolet spectra, spectral shift on treatment with lipoxygenase, incorporation of [14C]arachidonic acid, gas chromatography-mass spectrometry, and comparison of retention times on HPLC to authentic standards.", {"entities": []}], ["The eosinophil products characterized were 5-(S), 12-(R)-dihydroxy-6-cis-8, 10-trans-14-cis-eicosatetraenoic acid (leukotriene B4) and its 5-(S), 12-(R)-6-trans and 5-(S), 12-(S)-6-trans isomers, 5-(S)-hydroxy-6-(R)-S- glutathionyl-7,9-trans-11, 14-cis-eicosatetraenoic acid (leukotriene C4) and its 11-trans isomer, and 5-(S)-hydroxy-6-(R)-S-cysteinylglycine- 7,9-trans-11,14-cis-eicosatetraenoic acid (leukotriene D4).", {"entities": []}], ["Supplemental Digital Content is available in the text Long noncoding RNA (lncRNA) plays roles in many diseases including asthma.", {"entities": [[121, 127, "DISEASE"]]}], ["Several lncRNAs function in the early differentiation of T-helper cells.", {"entities": []}], ["lncRNA controls gene transcription, protein expression, and epigenetic regulation.", {"entities": []}], ["Of the 4 asthma phenotypes, eosinophilic asthma (EA) is the most common.", {"entities": [[9, 15, "DISEASE"], [41, 47, "DISEASE"]]}], ["However, the lncRNAs associated with eosinophilic asthma have yet to be identified.", {"entities": [[50, 56, "DISEASE"]]}], ["We designed a study to identify the circulating lncRNA signature in EA samples.", {"entities": []}], ["We tested whether significant differences in lncRNA expression were observed between blood samples from patients with EA and healthy individuals (control).", {"entities": []}], ["Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed for the lncRNA\u2013mRNA (messenger RNA) co-expression network.", {"entities": []}], ["lncRNA expression was measured using quantitative real-time PCR (polymerase chain reaction).", {"entities": []}], ["A total of 41 dysregulated lncRNAs and 762 dysregulated mRNAs (difference \u2265 2-fold) were found in EA compared to control samples.", {"entities": []}], ["GO terms and KEGG pathway annotation data revealed that several lncRNAs are significantly associated with EA.", {"entities": []}], ["KEGG pathway annotation indicated that the pathways most enriched in EA were measles, T cell receptor signaling pathway, peroxisome proliferator activated-receptors (PPAR) signaling pathway, Fc gamma R-mediated phagocytosis, NF (nuclear factor) kappa B signaling pathway, chemokine signaling pathway, and primary immunodeficiency.", {"entities": [[77, 84, "DISEASE"]]}], ["Using qRT-PCR, lncRNA was confirmed to differ significantly between EA and control samples.", {"entities": []}], ["The results presented here show that several lncRNAs may take part in the immune regulation of EA.", {"entities": []}], ["Whether these lncRNAs can be used as biomarkers needs further study.", {"entities": []}], ["Sarcoidosis is a systemic disease characterized by the formation of immune granulomas in various organs, mainly the lungs and the lymphatic system.", {"entities": [[0, 11, "DISEASE"]]}], ["Exaggerated granulomatous reaction might be triggered in response to unidentified antigens in individuals with genetic susceptibility.", {"entities": []}], ["The present study aimed to determine the genetic variants implicated in a familial case of sarcoidosis.", {"entities": [[91, 102, "DISEASE"]]}], ["Sarcoidosis presentation and history, NOD2 profile, NF-\u03baB and cytokine production in blood monocytes/macrophages were evaluated in individuals from a family with late appearance of sarcoidosis.", {"entities": [[0, 11, "DISEASE"], [181, 192, "DISEASE"], [38, 42, "GENE"]]}], ["In the present study, we report a case of familial sarcoidosis with typical thoracic sarcoidosis and carrying the NOD2 2722G\u2009>\u2009C variant.", {"entities": [[51, 62, "DISEASE"], [85, 96, "DISEASE"], [114, 118, "GENE"]]}], ["This variant is associated with the presence of three additional SNPs for the IL17RA , KALRN and EPHA2 genes, which discriminate patients expressing the disease from others.", {"entities": [[78, 84, "GENE"], [87, 92, "GENE"], [97, 102, "GENE"]]}], ["Despite a decrease in NF-\u03baB activity, IL-8 and TNF-A mRNA levels were increased at baseline and in stimulated conditions.", {"entities": []}], ["Combination of polymorphisms in the NOD2 , IL17RA , EPHA2 and KALRN genes could play a significant role in the development of sarcoidosis by maintaining a chronic pro-inflammatory status in macrophages.", {"entities": [[126, 137, "DISEASE"], [36, 40, "GENE"], [43, 49, "GENE"], [52, 57, "GENE"], [62, 67, "GENE"]]}], ["The online version of this article (10.1186/s12931-018-0748-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Sepsis is a complex syndrome that develops when the initial, appropriate host response to an infection becomes amplified, and is then dysregulated.", {"entities": [[20, 28, "DISEASE"]]}], ["Among other factors, the innate immune system is of central importance to the early containment of infection.", {"entities": []}], ["Death from infection is strongly heritable in human populations.", {"entities": []}], ["Hence, genetic variations that disrupt innate immune sensing of infectious organisms could explain the ability of the immune system to respond to infection, the diversity of the clinical presentation of sepsis, the response to current medical treatment, and the genetic predisposition to infection in each individual patient.", {"entities": []}], ["Such genetic variations may identify patients at high risk for the development of sepsis and organ dysfunction during severe infections.", {"entities": []}], ["Single base variations, known as single nucleotide polymorphisms (SNPs), are the most commonly used variants.", {"entities": []}], ["There has been great interest in exploring SNP in those genes involved in the inflammatory cascade resulting from the systemic inflammatory response to micro organisms.", {"entities": []}], ["The rationale for studying gene SNPs in critical illnesses seeks to identify potential markers of susceptibility, severity, and clinical outcome; seeks to identify potential markers for responders and non-responders in clinical trials, and seeks to identify targets for therapeutic intervention.", {"entities": []}], ["In this review, we focus on the current state of association studies of those genes governing the powerful bacterial infection-induced inflammation and provide guidelines for future studies describing disease associations with genetic variations based on current recommendations.", {"entities": []}], ["We envision a time in the near future when genotyping will be include in the standard evaluation of critically ill patients and will help to prioritize a therapeutic option.", {"entities": []}], ["Understanding the role of comorbidity in recovery following injury is an important challenge given the increasing prevalence of multimorbidity (2 or more comorbidities) in many countries.", {"entities": []}], ["The Prospective Outcomes of Injury Study recruited 2856 injured 18\u201364 year olds that had registered for entitlements with New Zealand\u2019s universal no-fault injury insurer.", {"entities": []}], ["Recovery, or lack of, in this longitudinal cohort was measured using the World Health Organization Disability Assessment Schedule at 3, 12 and 24 months post-injury.", {"entities": []}], ["Twenty-one pre-existing chronic conditions were used to identify comorbidity.", {"entities": []}], ["To investigate whether rates of recovery differed by pre-injury comorbidity, the interaction between time and comorbidity was modelled using Generalised Estimating Equations.", {"entities": []}], ["Of 1,862 participants with complete data, the distribution reporting none, one comorbidity, or multimorbidity pre-injury was 51%, 27%, and 21% respectively.", {"entities": []}], ["Longitudinal analysis estimated no difference (log odds per year 0.05, 95% Confidence Interval -0.17 to 0.27) between the rate of change of disability for those with one pre-injury comorbidity compared to those with none.", {"entities": []}], ["Those with pre-injury multimorbidity had significantly slower reduction in disability over time than those with no pre-injury comorbidity (log odds per year 0.27, 95% Confidence Interval 0.05 to 0.48).", {"entities": []}], ["In a working age cohort, the rate of recovery in the 24 months following injury was similar for those with none or one pre-existing comorbidity and significantly slower for those with multimorbidity.", {"entities": []}], ["It is important that further research explores mechanisms driving this, and that researchers and health providers identify and implement better supports for injured people with multimorbidity.", {"entities": []}], ["The final meeting of the EXPOsOMICS project \u201cFinal Policy Workshop and Stakeholder Consultation\u201d took place 28\u201329 March 2017 to present the main results of the project and discuss their implications both for future research and for regulatory and policy activities.", {"entities": []}], ["This paper summarizes presentations and discussions at the meeting related with the main results and advances in exposome research achieved through the EXPOsOMICS project; on other parallel research initiatives on the study of the exposome in Europe and in the United States and their complementarity to EXPOsOMICS; lessons learned from these early studies on the exposome and how they may shape the future of research on environmental exposure assessment; and finally the broader implications of exposome research for risk assessment and policy development on environmental exposures.", {"entities": []}], ["The main results of EXPOsOMICS in relation to studies of the external exposome and internal exposome in relation to both air pollution and water contaminants were presented as well as new technologies for environmental health research (adductomics) and advances in statistical methods.", {"entities": []}], ["Although exposome research strengthens the scientific basis for policy development, there is a need in terms of showing added value for public health to: improve communication of research results to non-scientific audiences; target research to the broader landscape of societal challenges; and draw applicable conclusions.", {"entities": []}], ["Priorities for future work include the development and standardization of methodologies and technologies for assessing the external and internal exposome, improved data sharing and integration, and the demonstration of the added value of exposome science over conventional approaches in answering priority policy questions.", {"entities": []}], ["Small airway remodeling is an important cause of the airflow limitation in chronic obstructive pulmonary disease (COPD).", {"entities": [[75, 112, "DISEASE"]]}], ["A large population of patients with COPD also have pulmonary hypertension.", {"entities": [[61, 73, "DISEASE"], [51, 73, "DISEASE"]]}], ["Kr\u00fcppel-like factor 5 (KLF5) is a zinc-finger transcription factor that contributes to tissue remodeling in cardiovascular diseases.", {"entities": [[23, 27, "GENE"]]}], ["Here, we evaluate the possible involvement of KLF5 in the remodeling of small airways and pulmonary vessels in COPD.", {"entities": [[46, 50, "GENE"]]}], ["Lung tissues were obtained from 23 control never-smokers, 17 control ex-smokers and 24 ex-smokers with COPD.", {"entities": []}], ["The expression of KLF5 in the lung tissues was investigated by immunohistochemistry.", {"entities": [[18, 22, "GENE"]]}], ["We investigated whether oxidative/nitrosative stress, which is a major cause of the pathogenesis in COPD, could augment the production of KLF5.", {"entities": [[138, 142, "GENE"]]}], ["We examined the role of KLF5 in the stress-mediated tissue remodeling responses.", {"entities": [[24, 28, "GENE"]]}], ["We also investigated the susceptibility of KLF5 expression to nitrosative stress using bronchial fibroblasts isolated from the lung tissues.", {"entities": [[43, 47, "GENE"]]}], ["The expression of KLF5 was up-regulated in the small airways and pulmonary vessels of the COPD patients and it was mainly expressed in bronchial fibroblasts and cells of the pulmonary vessels.", {"entities": [[18, 22, "GENE"]]}], ["The extent of the KLF5 expression in the small airway of the COPD group had a significant correlation with the severity of the airflow limitation.", {"entities": [[18, 22, "GENE"]]}], ["Oxidative/nitrosative stress augmented the production of KLF5 in lung fibroblasts as well as the translocation of KLF5 into the nuclei.", {"entities": [[57, 61, "GENE"], [114, 118, "GENE"], [57, 61, "GENE"], [114, 118, "GENE"]]}], ["Silencing of KLF5 suppressed the stress-augmented differentiation into myofibroblasts, the release of collagens and metalloproteinases.", {"entities": [[13, 17, "GENE"]]}], ["Bronchial fibroblasts from the patients with COPD highly expressed KLF5 compared to those from the control subjects under basal condition and were more susceptible to the induction of KLF5 expression by nitrosative stress compared to those from the control subjects.", {"entities": [[67, 71, "GENE"], [184, 188, "GENE"], [67, 71, "GENE"], [184, 188, "GENE"]]}], ["We provide the first evidence that the expression of KLF5 is up-regulated in small airways and pulmonary vessels of patients with COPD and may be involved in the tissue remodeling of COPD.", {"entities": [[53, 57, "GENE"]]}], ["A morbidity and mortality study took place, focused on Milos Island, where perlite and bentonite mining sites are located.", {"entities": []}], ["Official data concerning number and cause of deaths, regarding specific respiratory diseases and the total of respiratory diseases, for both Milos Island and the Cyclades Prefecture were used.", {"entities": []}], ["Standardized Mortality Ratios (SMRs) were computed, adjusted specifically for age, gender and calendar year.", {"entities": []}], ["Tests of linear trend were performed.", {"entities": []}], ["By means of a predefined questionnaire, the morbidity rates of specific respiratory diseases in Milos, were compared to those of the municipality of Oinofita, an industrial region.", {"entities": []}], ["Chi-square analysis was used and the confounding factors of age, gender and smoking were taken into account, by estimating binary logistic regression models.", {"entities": []}], ["The SMRs for Pneumonia and Chronic Obstructive Pulmonary Disease (COPD) were found elevated for both genders, although they did not reach statistical significance.", {"entities": [[13, 22, "DISEASE"]]}], ["For the total of respiratory diseases, a statistically significant SMR was identified regarding the decade 1989\u20131998.", {"entities": []}], ["The morbidity study revealed elevated and statistically significant Odds Ratios (ORs), associated with allergic rhinitis, pneumonia, COPD and bronchiectasis.", {"entities": [[103, 120, "DISEASE"], [122, 131, "DISEASE"], [112, 120, "DISEASE"], [142, 156, "DISEASE"]]}], ["An elevated OR was also identified for asthma.", {"entities": [[39, 45, "DISEASE"]]}], ["After controlling for age, gender and smoking, the ORs were statistically significant and towards the same direction.", {"entities": []}], ["Chromosome instability syndromes are a group of inherited conditions associated with chromosomal instability and breakage, often leading to immunodeficiency, growth retardation and increased risk of malignancy.", {"entities": []}], ["We performed exome sequencing on a girl with a suspected chromosome instability syndrome that manifested as growth retardation, microcephaly, developmental delay, dysmorphic features, poikiloderma, immune deficiency with pancytopenia, and myelodysplasia.", {"entities": [[221, 233, "DISEASE"], [80, 88, "DISEASE"], [128, 140, "DISEASE"]]}], ["She was homozygous for a previously reported splice variant, c.4444\u2009+\u20093A\u2009>\u2009G in the POLE1 gene, which encodes the catalytic subunit of DNA polymerase E. This is the second family with POLE1 -deficency, with the affected individual demonstrating a more severe phenotype than previously described.", {"entities": []}], ["The online version of this article (doi:10.1186/s12881-015-0177-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Interleukin-33 (IL-33) is an IL-1 family cytokine that signals via its receptor T1/ST2, and is a key regulator of inflammation, notably the type-2 response implicated in allergic asthma.", {"entities": [[170, 185, "DISEASE"], [179, 185, "DISEASE"]]}], ["Critical to our understanding of the role of IL-33 is the identification of the cellular sources of IL-33.", {"entities": []}], ["Although progress has been made in this area, the development of a robust live cell reporter of expression would allow the localisation of IL-33 during ongoing immune responses.", {"entities": []}], ["We have generated a fluorescent reporter mouse line, Il33 , to define the expression profile of IL-33 in vivo and demonstrate its temporal and spatial expression during experimental allergic asthma responses.", {"entities": [[182, 197, "DISEASE"], [191, 197, "DISEASE"], [53, 57, "GENE"]]}], ["We found that type-2 pneumocytes constitute the major source of IL-33 upon allergic lung inflammation following exposure to OVA, fungal extract or ragweed pollen.", {"entities": []}], ["Using Il33 mice (IL-33-deficient), we establish a role for IL-33 early in the initiation of type-2 responses and the induction of nuocytes (ILC2).", {"entities": [[6, 10, "GENE"]]}], ["We also demonstrate a potential mechanism of action by which IL-33 rapidly initiates type-2 immune responses.", {"entities": []}], ["Il33 mice have enabled new insights into the initiation of type-2 responses and will provide an important tool for further dissection of this important inflammatory pathway in vivo.", {"entities": [[0, 4, "GENE"]]}], ["A re-examination of former concepts is required to meet today\u2019s medical challenges in allergic rhinitis.", {"entities": [[86, 103, "DISEASE"], [95, 103, "DISEASE"]]}], ["Previously, neutrophils have been treated as a relatively homogenous cell population found in the nose both when the patient is suffering at the height of the allergic season as well as when the patient report no symptoms.", {"entities": []}], ["However, new data indicates that neutrophils can be divided into different subsets with diverse roles in inflammation.", {"entities": []}], ["We showed increased levels of neutrophils in peripheral blood, nasal biopsies and nasal lavage fluid (NAL) from allergic patients during the pollen season compared to healthy controls.", {"entities": []}], ["A closer examination revealed that the activated subset of neutrophils, CD16 in vitro experiments revealed that activated neutrophils exhibit a T cell priming capacity and an ability to enhance eosinophil migration.", {"entities": []}], ["Activated neutrophils may thus contribute to allergic inflammation seen in allergic rhinitis by priming T cells and attracting eosinophils.", {"entities": [[75, 92, "DISEASE"], [84, 92, "DISEASE"]]}], ["Arthroscopic shoulder surgery (ASS) is a low mortality and morbidity procedure, but anesthetic complications are reported.", {"entities": []}], ["There have been no reports of combined chest wall swelling and pneumothorax after ASS.", {"entities": [[63, 75, "DISEASE"]]}], ["The patient's right lung was severely collapsed and the mediastinum was deviated after ASS.", {"entities": []}], ["Pneumothorax on right chest.", {"entities": [[0, 12, "DISEASE"]]}], ["A chest tube was inserted and oxygen therapy was performed.", {"entities": []}], ["The patient was discharged uneventfully.", {"entities": []}], ["Elective ASS has low mortality and morbidity rates, but we should be more concerned over the complications after ASS.", {"entities": []}], ["Background: Few studies have investigated effects of air pollution on the incidence of cerebrovascular events.", {"entities": []}], ["Objectives: We assessed the association between long-term exposure to multiple air pollutants and the incidence of stroke in European cohorts.", {"entities": []}], ["Methods: Data from 11 cohorts were collected, and occurrence of a first stroke was evaluated.", {"entities": []}], ["Individual air pollution exposures were predicted from land-use regression models developed within the European Study of Cohorts for Air Pollution Effects (ESCAPE).", {"entities": []}], ["The exposures were: PM 2.5 [particulate matter (PM) \u2264 2.5 \u03bcm in diameter], coarse PM (PM between 2.5 and 10 \u03bcm), PM 10 (PM \u2264 10 \u03bcm), PM 2.5 absorbance, nitrogen oxides, and two traffic indicators.", {"entities": []}], ["Cohort-specific analyses were conducted using Cox proportional hazards models.", {"entities": []}], ["Random-effects meta-analysis was used for pooled effect estimation.", {"entities": []}], ["Results: A total of 99,446 study participants were included, 3,086 of whom developed stroke.", {"entities": []}], ["A 5-\u03bcg/m 2.5 exposure was associated with 19% increased risk of incident stroke [hazard ratio (HR) = 1.19, 95% CI: 0.88, 1.62].", {"entities": [[95, 97, "GENE"]]}], ["Similar findings were obtained for PM 10 .", {"entities": []}], ["The results were robust to adjustment for an extensive list of cardiovascular risk factors and noise coexposure.", {"entities": []}], ["The association with PM 2.5 was apparent among those \u2265 60 years of age (HR = 1.40, 95% CI: 1.05, 1.87), among never-smokers (HR = 1.74, 95% CI: 1.06, 2.88), and among participants with PM 2.5 exposure < 25 \u03bcg/m Conclusions: We found suggestive evidence of an association between fine particles and incidence of cerebrovascular events in Europe, even at lower concentrations than set by the current air quality limit value.", {"entities": [[72, 74, "GENE"], [125, 127, "GENE"], [72, 74, "GENE"], [125, 127, "GENE"]]}], ["Citation: Stafoggia M, Cesaroni G, Peters A, Andersen ZJ, Badaloni C, Beelen R, Caracciolo B, Cyrys J, de Faire U, de Hoogh K, Eriksen KT, Fratiglioni L, Galassi C, Gigante B, Havulinna AS, Hennig F, Hilding A, Hoek G, Hoffmann B, Houthuijs D, Korek M, Lanki T, Leander K, Magnusson PK, Meisinger C, Migliore E, Overvad K, \u00d6stenson CG, Pedersen NL, Pekkanen J, Penell J, Pershagen G, Pundt N, Pyko A, Raaschou-Nielsen O, Ranzi A, Ricceri F, Sacerdote C, Swart WJ, Turunen AW, Vineis P, Weimar C, Weinmayr G, Wolf K, Brunekreef B, Forastiere F. 2014.", {"entities": []}], ["Long-term exposure to ambient air pollution and incidence of cerebrovascular events: results from 11 European cohorts within the ESCAPE project.", {"entities": []}], ["Environ Health Perspect 122:919\u2013925;\u2002 http://dx.doi.org/10.1289/ehp.1307301", {"entities": []}], ["Shared decision-making (SDM) is poorly implemented in routine care, despite being promoted by health policies.", {"entities": []}], ["No reviews have solely focused on an in-depth synthesis of the literature around organizational- and system-level characteristics (i.e., characteristics of healthcare organizations and of healthcare systems) that may affect SDM implementation.", {"entities": []}], ["A synthesis would allow exploration of interventions to address these characteristics.", {"entities": []}], ["The study aim was to compile a comprehensive overview of organizational- and system-level characteristics that are likely to influence the implementation of SDM, and to describe strategies to address those characteristics described in the literature.", {"entities": []}], ["We conducted a scoping review using the Arksey and O\u2019Malley framework.", {"entities": []}], ["The search strategy included an electronic search and a secondary search including gray literature.", {"entities": []}], ["We included publications reporting on projects that promoted implementation of SDM or other decision support interventions in routine healthcare.", {"entities": []}], ["We screened titles and abstracts, and assessed full texts for eligibility.", {"entities": []}], ["We used qualitative thematic analysis to identify organizational- and system-level characteristics.", {"entities": []}], ["After screening 7745 records and assessing 354 full texts for eligibility, 48 publications on 32 distinct implementation projects were included.", {"entities": []}], ["Most projects ( N \u00a0=\u200922) were conducted in the USA.", {"entities": []}], ["Several organizational-level characteristics were described as influencing the implementation of SDM, including organizational leadership, culture, resources, and priorities, as well as teams and workflows.", {"entities": []}], ["Described system-level characteristics included policies, clinical guidelines, incentives, culture, education, and licensing.", {"entities": []}], ["We identified potential strategies to influence the described characteristics, e.g., examples how to facilitate distribution of decision aids in a healthcare institution.", {"entities": []}], ["Although infrequently studied, organizational- and system-level characteristics appear to play a role in the failure to implement SDM in routine care.", {"entities": []}], ["A wide range of characteristics described as supporting and inhibiting implementation were identified.", {"entities": []}], ["Future studies should assess the impact of these characteristics on SDM implementation more thoroughly, quantify likely interactions, and assess how characteristics might operate across types of systems and areas of healthcare.", {"entities": []}], ["Organizations that wish to support the adoption of SDM should carefully consider the role of organizational- and system-level characteristics.", {"entities": []}], ["Implementation and organizational theory could provide useful guidance for how to address facilitators and barriers to change.", {"entities": []}], ["The online version of this article (10.1186/s13012-018-0731-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Children may be more susceptible to exposures to environmental toxins than adults and may be more vulnerable to their effects.", {"entities": []}], ["Because of this, the health care community and those responsible for children need to be alert to possible environmental factors in identifying and responding to the health problems of children.", {"entities": []}], ["Their focus should be on the causes of the health problem, emphasizing environmental sources, and not on simply treating the symptoms.", {"entities": []}], ["The availability of a draft sequence for the human genome will revolutionise research into airway disease.", {"entities": []}], ["This review deals with two of the most important areas impinging on the treatment of patients: pharmacogenetics and pharmacogenomics.", {"entities": []}], ["Considerable inter-individual variation exists at the DNA level in targets for medication, and variability in response to treatment may, in part, be determined by this genetic variation.", {"entities": []}], ["Increased knowledge about the human genome might also permit the identification of novel therapeutic targets by expression profiling at the RNA (genomics) or protein (proteomics) level.", {"entities": []}], ["This review describes recent advances in pharmacogenetics and pharmacogenomics with regard to airway disease.", {"entities": []}], ["The aim of the present study was to determine whether a diagnosis of diabetes mellitus (DM) in a primary setting is associated with an increased risk of subsequent depression.", {"entities": [[69, 86, "DISEASE"]]}], ["A retrospective cohort design was used based on the Registration Network Family Practice (RNH) database.", {"entities": []}], ["Patients diagnosed with diabetes mellitus at or after the age of 40 and who were diagnosed between 01-01-1980 and 01-01-2007 ( N \u00a0=\u00a06,140), were compared with age-matched controls from a reference group ( N \u00a0=\u00a018,416) without a history of diabetes.", {"entities": [[24, 41, "DISEASE"]]}], ["Both groups were followed for an emerging first diagnosis of depression (and/or depressive feelings) until January 1, 2008.", {"entities": []}], ["2.0% of the people diagnosed with diabetes mellitus developed a depressive disorder, compared to 1.6% of the reference group.", {"entities": [[34, 51, "DISEASE"]]}], ["After statistical correction for confounding factors diabetes mellitus was associated with an increased risk of developing subsequent depression (HR 1.26; 95% CI: 1.12\u20131.42) and/or depressive feelings (HR 1.33; 95% CI: 1.18\u20131.46).", {"entities": [[53, 70, "DISEASE"], [146, 148, "GENE"], [202, 204, "GENE"], [146, 148, "GENE"], [202, 204, "GENE"]]}], ["After statistical adjustment practice identification code, age and depression preceding diabetes, were significantly related to a diagnosis of depression.", {"entities": []}], ["Patients with diabetes mellitus are more likely to develop subsequent depression than persons without a history of diabetes.", {"entities": [[14, 31, "DISEASE"]]}], ["Results from this large longitudinal study based on a general practice population indicate that this association is weaker than previously found in cross-sectional research using self-report surveys.", {"entities": []}], ["Several explanations for this dissimilarity are discussed.", {"entities": []}], ["Everts et al.", {"entities": []}], ["use Batf3 Heligmosomoides polygyrus , whereas liver fibrosis was exacerbated with Schistosoma mansoni infection.", {"entities": [[4, 9, "GENE"]]}], ["Mechanistically, steady-state IL-12 production by migratory CD103 CD8\u03b1 Batf3 Batf3 Heligmosomoides polygyrus into an infection that was rapidly controlled.", {"entities": [[71, 76, "GENE"], [77, 82, "GENE"], [71, 76, "GENE"], [77, 82, "GENE"]]}], ["However, liver fibrosis, an IL-13\u2013mediated pathological consequence of wound healing in chronic schistosomiasis, was exacerbated in Batf3 Schistosoma mansoni .", {"entities": [[96, 111, "DISEASE"], [132, 137, "GENE"]]}], ["Mechanistically, steady-state production of IL-12 by migratory CD103", {"entities": []}], ["Chronic necrotizing pulmonary aspergillosis (CNPA) is an unusual form of pulmonary aspergillosis arising in the setting of mildly immune compromised state or altered local defense system.", {"entities": [[30, 43, "DISEASE"], [83, 96, "DISEASE"]]}], ["CNPA rarely shows histological findings mimicking bronchocentric granulomatosis (BCG), which is characterized by peribronchiolar granulomatous destruction.", {"entities": []}], ["We describe a case representing CNPA with elements of BCG.", {"entities": []}], ["A-64 year-old woman was admitted because of atypical pneumonia with multi-focal variable sized consolidations and cavitary lesions on high-resolution computed tomography (HRCT).", {"entities": [[53, 62, "DISEASE"]]}], ["The open lung biopsy specimen showed large areas of necrotizing pneumonia with some scattered aspergillus hyphae within the lung parenchyma.", {"entities": [[64, 73, "DISEASE"]]}], ["Some terminal bronchioles were found to be destroyed and were replaced by peribronchiolar granulomatous inflammation.", {"entities": []}], ["There was no evidence of angioinvasion by aspergillus or aspergillous emboli.", {"entities": []}], ["Despite vigorous antifungal agent and steroid treatment, she died of acute airway obstruction by bronchial casts on the thirty-fourth hospital day.", {"entities": []}], ["Reports regarding gender-related differences in COPD expression have provided conflicting results.", {"entities": []}], ["In the French Initiatives BPCO real-world cohort, which contained 688 patients (146 women) when data were extracted, women were matched with men (1:3 ratio: n\u2009=\u2009107:275) on age (5-year intervals) and FEV 1 (5% predicted intervals) and comparisons were performed using univariate logistic regressions.", {"entities": [[200, 203, "GENE"]]}], ["For a given age and level of airflow obstruction, women with COPD had higher BOD scores due to more pronounced dyspnea and lower BMI, suggesting worse prognosis, and were more likely to exhibit anxiety, suggesting the need for specific assessment and care.", {"entities": []}], ["Under the label of the German Mouse Clinic (GMC), a concept has been developed and implemented that allows the better understanding of human diseases on the pathophysiological and molecular level.", {"entities": []}], ["This includes better understanding of the crosstalk between different organs, pleiotropy of genes, and the systemic impact of envirotypes and drugs.", {"entities": []}], ["In the GMC, experts from various fields of mouse genetics and physiology, in close collaboration with clinicians, work side by side under one roof.", {"entities": []}], ["The GMC is an open-access platform for the scientific community by providing phenotypic analysis in bilateral collaborations (\u201cbottom-up projects\u201d) and as a partner and driver in international large-scale biology projects (\u201ctop-down projects\u201d).", {"entities": []}], ["Furthermore, technology development is a major topic in the GMC.", {"entities": []}], ["Innovative techniques for primary and secondary screens are developed and implemented into the phenotyping pipelines (e.g., detection of volatile organic compounds, VOCs).", {"entities": []}], ["Since emerging in Saint Martin in 2013, chikungunya virus (CHIKV), an alphavirus transmitted by the Aedes aegypti mosquito, has infected approximately two million individuals in the Americas, with over 500,000 reported cases in the Dominican Republic (DR).", {"entities": [[40, 51, "DISEASE"]]}], ["CHIKV-infected patients typically present with a febrile syndrome including polyarthritis/polyarthralgia, and a macropapular rash, similar to those infected with dengue and Zika viruses, and malaria.", {"entities": [[57, 65, "DISEASE"], [191, 198, "DISEASE"]]}], ["Nevertheless, many Dominican cases are unconfirmed due to the unavailability and high cost of laboratory testing and the absence of specific treatment for CHIKV infection.", {"entities": []}], ["To obtain a more accurate representation of chikungunya fever (CHIKF) clinical signs and symptoms, and confirm the viral lineage responsible for the DR CHIKV outbreak, we tested 194 serum samples for CHIKV RNA and IgM antibodies from patients seen in a hospital in La Romana, DR using quantitative RT-PCR and IgM capture ELISA, and performed retrospective chart reviews.", {"entities": [[44, 55, "DISEASE"]]}], ["RNA and antibodies were detected in 49% and 24.7% of participants, respectively.", {"entities": []}], ["Sequencing revealed that the CHIKV strain responsible for the La Romana outbreak belonged to the Asian/American lineage and grouped phylogenetically with recent Mexican and Trinidadian isolates.", {"entities": []}], ["Our study shows that, while CHIKV-infected individuals were infrequently diagnosed with CHIKF, uninfected patients were never falsely diagnosed with CHIKF.", {"entities": []}], ["Participants testing positive for CHIKV RNA were more likely to present with arthralgia, although it was reported in just 20.0% of CHIKF+ individuals.", {"entities": []}], ["High percentages of respiratory (19.6%) signs and symptoms, especially among children, were noted, though it was not possible to determine whether individuals infected with CHIKV were co-infected with other pathogens.", {"entities": []}], ["These results suggest that CHIKV may have been underdiagnosed during this outbreak, and that CHIKF should be included in differential diagnoses of diverse undifferentiated febrile syndromes in the Americas.", {"entities": []}], ["Chikungunya virus (CHIKV) is known for its ability to cause explosive outbreaks of flu-like illness followed by severe joint pain and swelling, which can persist for months to several years.", {"entities": [[0, 11, "DISEASE"]]}], ["We tested patient serum of both suspected and unsuspected chikungunya fever (CHIKF) cases collected at an emergency clinic in La Romana, Dominican Republic for markers of current or recent CHIKV infection, and showed through next generation sequencing that the causative CHIKV strain is closely related to other isolates from the Americas.", {"entities": [[58, 69, "DISEASE"]]}], ["After matching clinical outcomes with diagnostic data, we found that relatively few CHIKF patients presented with the joint symptoms typically associated with CHIKV infection in the past, which likely contributed to a notable frequency of CHIKF misdiagnosis.", {"entities": []}], ["Other deviations from Old World CHIKF outbreaks were also discovered, including shifts in affected age groups and in the frequency of respiratory signs and symptoms.", {"entities": []}], ["These data are particularly important for improving future surveillance endeavors, as well as the diagnosis and treatment of CHIKF in the Americas.", {"entities": []}], ["Population-based estimates of HIV prevalence, rates of new HIV diagnoses, and mortality rates among persons with HIV who have entered care are needed to optimize health service delivery and to improve the health outcomes of these individuals.", {"entities": []}], ["However, these data have been lacking for Ontario.", {"entities": []}], ["Using a validated case-finding algorithm and linked administrative health care databases, we conducted a population-based study to determine the prevalence of HIV and rates of new HIV diagnoses among adults aged 18 years or older in Ontario between fiscal year 1996/1997 and fiscal year 2009/2010, as well as all-cause mortality rates among persons with HIV over the same period.", {"entities": []}], ["Between 1996/1997 and 2009/2010, the number of adults living with HIV increased by 98.6% (from 7608 to 15 107), and the age- and sex-standardized prevalence of HIV increased by 52.8% (from 92.8 to 141.8 per 100 000 population; p < 0.001).", {"entities": []}], ["Women and individuals 50 years of age or older accounted for increasing proportions of persons with HIV, rising from 12.8% to 19.7% ( p < 0.001) and from 10.4% to 29.9% ( p < 0.001), respectively, over the study period.", {"entities": []}], ["During the study period, age- and sex-standardized rates of new HIV diagnoses decreased by 32.5% (from 12.3 to 8.3 per 100 000 population; p < 0.001) and mortality rates among adults with HIV decreased by 71.9% (from 5.7 to 1.6 per 100 adults with HIV; p < 0.001).", {"entities": []}], ["The prevalence of HIV infection in Ontario increased considerably between 1996/1997 and 2009/2010, with a greater relative burden falling on women and individuals aged 50 years of age or older.", {"entities": []}], ["These trends may be due to the decreased rate of new diagnoses among younger men.", {"entities": []}], ["All-cause mortality rates declined among persons with HIV who entered care.", {"entities": []}], ["Dietary vitamin E affects the susceptibility of mice and rats to ozone and nitrogen dioxide, suggesting a free radical mechanism of toxicity.", {"entities": []}], ["Conventional peroxidation does not completely explain the effects of alterations of lung fatty acid composition on both nitrogen dioxide and ozone toxicity.", {"entities": []}], ["A new scheme is proposed based on the cyclization of beta, gamma-allylic peroxyl free radicals to monocyclic and bicyclic peroxides to explain the relationship between diet and toxicity.", {"entities": []}], ["Similar results are likely with other toxicants producing peroxidation as a mechanism of toxicity.", {"entities": []}], ["Such cyclic peroxides may mimic or interfere with the prostaglandin system.", {"entities": []}], ["Several chronic diseases may be exacerbated through such a subtle toxic mechanism.", {"entities": []}], ["The level of vitamin E needed for protection against peroxidation toxicity may be much greater than the present U. S. dietary intake.", {"entities": []}], ["Fungi is a well-known model used to study drug metabolism and its production in in vitro condition.", {"entities": []}], ["We aim to screen the most efficient strain of Cunninghamella sp.", {"entities": []}], ["among C. elegans , C. echinulata and C. blakesleeana for bromhexine metabolites production.", {"entities": []}], ["We characterized the metabolites produced using various analytical tools and compared them with mammalian metabolites in Rat liver microsomes (RLM).", {"entities": []}], ["The metabolites were collected by two-stage fermentation of bromhexine with different strains of Cunninghamella sp.", {"entities": []}], ["followed by extraction.", {"entities": []}], ["Analysis was done by thin layer chromatography, high performance thin layer chromatography, Fourier transform infrared spectroscopy, high performance liquid chromatography and Liquid chromatography\u2013mass spectrometry.", {"entities": []}], ["The role of Cytochrome P3A4 (CYP3A4) enzymes in bromhexine metabolism was studied.", {"entities": [[29, 35, "GENE"]]}], ["Fungal incubates were spiked with reference standard \u2013 clarithromycin to confirm the role of CYP3A4 enzyme in bromhexine metabolism.", {"entities": [[93, 99, "GENE"]]}], ["Three metabolites appeared at 4.7, 5.5 and 6.4\u00a0min retention time in HPLC.", {"entities": []}], ["Metabolites produced by C. elegans and RLM were concluded to be similar based on their retention time, peak area and peak response of 30.05%, 21.06%, 1.34%, and 47.66% of three metabolites and bromhexine in HPLC.", {"entities": []}], ["The role of CYP3A4 enzyme in metabolism of bromhexine and the presence of these enzymes in Cunninghamella species was confirmed due to absence of peaks at 4.7, 5.4 and 6.7\u00a0min when RLM were incubated with a CYP3A4 enzyme inhibitor \u2013 clarithromycin.", {"entities": [[12, 18, "GENE"], [207, 213, "GENE"], [12, 18, "GENE"], [207, 213, "GENE"]]}], ["Cigarette smoking is the most commonly encountered and readily identifiable risk factor for COPD.", {"entities": []}], ["However, it is not clear which quantitative factors related to smoking influence the prognosis of COPD patients.", {"entities": []}], ["A total of 204 patients with a long-term history of smoking were enrolled into this study and followed up for 5 years.", {"entities": []}], ["Patients were divided into \u201cdeath\u201d or \u201csurvival\u201d groups based on follow-up results and \u201cquitting-smoking\u201d or \u201ccontinuing-smoking\u201d groups based on whether they gave up smoking.", {"entities": []}], ["Patients in the death group had a longer smoking time, lower prevalence of quitting smoking, later onset of COPD symptoms, older age at quitting smoking, lower forced expiratory volume in one second (FEV 1 ) % predicted, and lower ratio of FEV 1 /forced vital capacity.", {"entities": [[200, 203, "GENE"], [240, 243, "GENE"], [200, 203, "GENE"], [240, 243, "GENE"]]}], ["Age, age at quitting smoking, and FEV 1 % predicted were independently associated with mortality from COPD.", {"entities": [[34, 37, "GENE"]]}], ["Compared to the continuing-smoking group, the quitting-smoking group had a lower mortality rate, longer course of COPD, earlier onset of COPD symptoms, and lower residual volume percent predicted.", {"entities": []}], ["During the 5-year follow-up, 113 deaths were recorded (quitting-smoking group: n=92; 40 deaths; continuing-smoking group: n=112; 73 deaths).", {"entities": []}], ["The mortality risk remained significantly higher in the continuing-smoking group than the quitting-smoking group (log-rank test, 13.59; P =0.0002).", {"entities": []}], ["Smoking time may be related to the mortality rate from COPD.", {"entities": []}], ["Smoking cessation has the greatest capacity to influence the natural history of COPD.", {"entities": []}], ["Epidemiological studies have suggested an association between maternal vitamin D dietary intake during pregnancy and risk of asthma and allergy in the offspring.", {"entities": [[125, 131, "DISEASE"]]}], ["However, prospective clinical studies on vitamin D measured in cord blood and development of clinical end-points are sparse.", {"entities": []}], ["To investigate the interdependence of cord blood 25-hydroxyvitamin D (25(OH)-Vitamin D) level and investigator-diagnosed asthma- and allergy-related conditions during preschool-age.", {"entities": [[121, 127, "DISEASE"]]}], ["Cord blood 25(OH)-Vitamin D level was measured in 257 children from the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC 2000 ) at-risk mother-child cohort.", {"entities": [[106, 112, "DISEASE"]]}], ["Troublesome lung symptoms (TROLS), asthma, respiratory infections, allergic rhinitis, and eczema, at age 0\u20137 yrs were diagnosed exclusively by the COPSAC pediatricians strictly adhering to predefined algorithms.", {"entities": [[67, 84, "DISEASE"], [76, 84, "DISEASE"], [35, 41, "DISEASE"]]}], ["Objective assessments of lung function and sensitization were performed repeatedly from birth.", {"entities": []}], ["After adjusting for season of birth, deficient cord blood 25(OH)-Vitamin D level (<50 nmol/L) was associated with a 2.7-fold increased risk of recurrent TROLS (HR\u200a=\u200a2.65; 95% CI\u200a=\u200a1.02\u20136.86), but showed no association with respiratory infections or asthma.", {"entities": [[249, 255, "DISEASE"], [160, 162, "GENE"]]}], ["We saw no association between cord blood 25(OH)-Vitamin D level and lung function, sensitization, rhinitis or eczema.", {"entities": [[98, 106, "DISEASE"]]}], ["The effects were unaffected from adjusting for multiple lifestyle factors.", {"entities": []}], ["Cord blood 25(OH)-Vitamin D deficiency associated with increased risk of recurrent TROLS till age 7 years.", {"entities": []}], ["Randomized controlled trials of vitamin D supplementation during pregnancy are needed to prove causality.", {"entities": []}], ["Historically, pharmaceutical aerosols have been employed for the treatment of obstructive airway diseases, such as asthma and chronic obstructive pulmonary disease, but in the past decades their use has been expanded to treat lung infections associated with cystic fibrosis and other respiratory diseases.", {"entities": [[126, 163, "DISEASE"], [258, 273, "DISEASE"], [115, 121, "DISEASE"]]}], ["Tuberculosis (TB) is acquired after inhalation of aerosol droplets containing the bacilli from the cough of infected individuals.", {"entities": []}], ["Even though TB affects other organs, the lungs are the primary site of infection, which makes the pulmonary route an ideal alternative route to administer vaccines or drug treatments.", {"entities": []}], ["Optimization of formulations and delivery systems for anti-TB vaccines and drugs, as well as the proper selection of the animal model to evaluate those is of paramount importance if novel vaccines or drug treatments are to be successful.", {"entities": []}], ["Pharmaceutical aerosols for patient use are generated from metered dose inhalers, nebulizers, and dry powder inhalers (DPIs).", {"entities": []}], ["In addition to the advantages of providing more efficient delivery of the drug, low cost, and portability, pharmaceutical dry powder aerosols are more stable than inhalable liquid dosage forms and do not require refrigeration.", {"entities": []}], ["Methods to manufacture dry powders in respirable sizes include micronization, spray drying, and other proprietary technologies.", {"entities": []}], ["Inhalable dry powders are characterized in terms of their drug content, particle size, and dispersibility to ensure deposition in the appropriate lung region and effective aerosolization from the device.", {"entities": []}], ["These methods will be illustrated as they were applied for the manufacture and characterization of powders containing anti-tubercular agents and vaccines for pulmonary administration.", {"entities": []}], ["The influence of formulation, selection of animal model, method of aerosol generation, and administration on the efficacy demonstrated in a given study will be illustrated by the evaluation of pharmaceutical aerosols of anti-TB drugs and vaccines in guinea pigs by our group.", {"entities": []}], ["Airborne fungi play an important role in causing allergy and infections in susceptible people.", {"entities": []}], ["Identification of these fungi, based on morphological characteristics, is time-consuming, expertise-demanding, and could be inaccurate.", {"entities": []}], ["We developed an oligonucleotide array that could accurately identify 21 important airborne fungi (13 genera) that may cause adverse health problems.", {"entities": []}], ["The method consisted of PCR amplification of the internal transcribed spacer (ITS) regions, hybridization of the PCR products to a panel of oligonucleotide probes immobilized on a nylon membrane, and detection of the hybridization signals with alkaline phosphatase-conjugated antibodies.", {"entities": []}], ["A collection of 72 target and 66 nontarget reference strains were analyzed by the array.", {"entities": []}], ["Both the sensitivity and specificity of the array were 100%, and the detection limit was 10 pg of genomic DNA per assay.", {"entities": []}], ["Furthermore, 70 fungal isolates recovered from air samples were identified by the array and the identification results were confirmed by sequencing of the ITS and D1/D2 domain of the large-subunit RNA gene.", {"entities": []}], ["The sensitivity and specificity of the array for identification of the air isolates was 100% (26/26) and 97.7% (43/44), respectively.", {"entities": []}], ["Identification of airborne fungi by the array was cheap and accurate.", {"entities": []}], ["The current array may contribute to decipher the relationship between airborne fungi and adverse health effect.", {"entities": []}], ["Objectives \u00a0To evaluate the risk of all cause mortality associated with initiating compared with not initiating benzodiazepines in adults, and to address potential treatment barriers and confounding related to the use of a non-active comparator group.", {"entities": []}], ["Design \u00a0Retrospective cohort study.", {"entities": []}], ["Setting \u00a0Large de-identified US commercial healthcare database (Optum Clinformatics Datamart).", {"entities": []}], ["Participants \u00a01:1 high dimensional propensity score matched cohort of benzodiazepine initiators, and randomly selected benzodiazepine non-initiators with a medical visit within 14 days of the start of benzodiazepine treatment (n=1\u2009252\u2009988), between July 2004 and December 2013.", {"entities": []}], ["To address treatment barriers and confounding, patients were required to have filled one or more prescriptions for any medication in the 90 days and 91-180 days before the index date (ie, the date of starting benzodiazepine treatment for initiators and the date of the selected medical visit for benzodiazepine non-initiators) and the high dimensional propensity score was estimated on the basis of more than 300 covariates.", {"entities": []}], ["Main outcome measure \u00a0All cause mortality, determined by linkage with the Social Security Administration Death Master File.", {"entities": []}], ["Results \u00a0Over a six month follow-up period, 5061 and 4691 deaths occurred among high dimensional propensity score matched benzodiazepine initiators versus non-initiators (9.3 v 9.4 events per 1000 person years; hazard ratio 1.00, 95% confidence interval 0.96 to 1.04).", {"entities": []}], ["A 4% (95% confidence interval 1% to 8%) to 9% (2% to 7%) increase in mortality risk was observed associated with the start of benzodiazepine treatment for follow-ups of 12 and 48 months and in subgroups of younger patients and patients initiating short acting agents.", {"entities": []}], ["In secondary analyses comparing 1:1 high dimensional propensity score matched patients initiating benzodiazepines with an active comparator, ie, patients starting treatment with selective serotonin reuptake inhibitor antidepressants, benzodiazepine use was associated with a 9% (95% confidence interval 3% to 16%) increased risk.", {"entities": []}], ["Conclusions \u00a0This large population based cohort study suggests either no increase or at most a minor increase in risk of all cause mortality associated with benzodiazepine initiation.", {"entities": []}], ["If a detrimental effect exists, it is likely to be much smaller than previously stated and to have uncertain clinical relevance.", {"entities": []}], ["Residual confounding likely explains at least part of the small increase in mortality risk observed in selected analyses.", {"entities": []}], ["The aim of this study was to investigate whether or not surgical biopsy of sinus tissue in chronic sinusitis, not responsive to treatment, would detect E .", {"entities": [[99, 108, "DISEASE"]]}], ["We intended to evaluate E .", {"entities": []}], ["coli virulence genes, therefore dispute the causal role of such an unusual microorganism in chronic sinusitis, as well as consider effective pathogen-targeted therapy.", {"entities": [[100, 109, "DISEASE"]]}], ["Patients with E .", {"entities": []}], ["coli isolated by intra-operative puncture biopsy were included in the study.", {"entities": []}], ["Genetic analysis of E .", {"entities": []}], ["coli isolates, including phylogenetic grouping and virulence factor characteristics, were done by multiplex PCR.", {"entities": []}], ["We identified 26 patients with chronic sinusitis, in which 26 E .", {"entities": [[39, 48, "DISEASE"]]}], ["coli isolates were cultured.", {"entities": []}], ["coli isolates belonged mainly to pathogenic phylogenetic group B2, and carried multiple virulence genes.", {"entities": []}], ["Three genes in particular were present in all (100%) of examined isolates, they were (1) marker agn43 gene for forming biofilm, (2) type 1 fimbriae ( fimG/H gene) and (3) yersiniabactin receptor ( fyuA ).", {"entities": []}], ["Furthermore, a pseudo-phylogenetic tree of virulence genes distribution revealed possible cooperation between agn43 , fimG/H , and fyu A in the coding of biofilm formation.", {"entities": []}], ["Intra-operative-biopsy and culture-based therapy, targeting the isolated E .", {"entities": []}], ["coli , coincided with long-term resolution of symptoms.", {"entities": []}], ["This is the first report demonstrating an association between a highly pathogenic E .", {"entities": []}], ["coli , chronic sinus infection, and resolution of symptoms upon E .", {"entities": []}], ["coli targeted therapy, a significant finding due to the fact that E .", {"entities": []}], ["coli has not been considered to be a commensal organism of the oropharynx or sinuses.", {"entities": []}], ["We postulate that the simultaneous presence of three genes, each coding biofilm formation, may in part account for the chronicity of E .", {"entities": []}], ["coli sinusitis.", {"entities": [[5, 14, "DISEASE"]]}], ["Exercise during the inactive period can entrain locomotor activity and peripheral circadian clock rhythm in mice; however, mechanisms underlying this entrainment are yet to be elucidated.", {"entities": []}], ["Here, we showed that the bioluminescence rhythm of peripheral clocks in PER2::LUC mice was strongly entrained by forced treadmill and forced wheel-running exercise rather than by voluntary wheel-running exercise at middle time during the inactivity period.", {"entities": [[72, 76, "GENE"]]}], ["Exercise-induced entrainment was accompanied by increased levels of serum corticosterone and norepinephrine in peripheral tissues, similar to the physical stress-induced response.", {"entities": []}], ["Adrenalectomy with norepinephrine receptor blockers completely blocked the treadmill exercise-induced entrainment.", {"entities": []}], ["The entrainment of the peripheral clock by exercise is independent of the suprachiasmatic nucleus clock, the main oscillator in mammals.", {"entities": []}], ["The present results suggest that the response of forced exercise, but not voluntary exercise, may be similar to that of stress, and possesses the entrainment ability of peripheral clocks through the activation of the adrenal gland and the sympathetic nervous system.", {"entities": []}], ["The role of FOXP3 We followed 65 newborn Swedish children from farming and non-farming families from birth to 3\u00a0years of age and investigated the relation between CD4 The proportions of FOXP3 Multivariate discriminant analysis revealed that children who were sensitized at 18 or 36\u00a0months of age had higher proportions of FOXP3 Our results indicate that high proportions of FOXP3", {"entities": [[12, 17, "GENE"], [186, 191, "GENE"], [322, 327, "GENE"], [374, 379, "GENE"], [163, 166, "GENE"], [12, 17, "GENE"], [186, 191, "GENE"], [322, 327, "GENE"], [374, 379, "GENE"], [12, 17, "GENE"], [186, 191, "GENE"], [322, 327, "GENE"], [374, 379, "GENE"], [12, 17, "GENE"], [186, 191, "GENE"], [322, 327, "GENE"], [374, 379, "GENE"]]}], ["Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) commonly coexist in smokers, and the presence of COPD increases the risk of developing LC.", {"entities": [[0, 11, "DISEASE"], [21, 58, "DISEASE"], [5, 11, "DISEASE"]]}], ["Cigarette smoke causes oxidative stress and an inflammatory response in lung cells, which in turn may be involved in COPD and lung cancer development.", {"entities": [[126, 137, "DISEASE"], [131, 137, "DISEASE"]]}], ["The aim of this study was to identify differential proteomic profiles related to oxidative stress response that were potentially involved in these two pathological entities.", {"entities": []}], ["Protein content was assessed in the bronchoalveolar lavage (BAL) of 60 patients classified in four groups: COPD, COPD and LC, LC, and control (neither COPD nor LC).", {"entities": []}], ["Proteins were separated into spots by two dimensional polyacrylamide gel electrophoresis (2D-PAGE) and examined by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF/TOF).", {"entities": []}], ["A total of 16 oxidative stress regulatory proteins were differentially expressed in BAL samples from LC and/or COPD patients as compared with the control group.", {"entities": []}], ["A distinct proteomic reactive oxygen species (ROS) protein signature emerged that characterized lung cancer and COPD.", {"entities": [[96, 107, "DISEASE"], [101, 107, "DISEASE"]]}], ["In conclusion, our findings highlight the role of the oxidative stress response proteins in the pathogenic pathways of both diseases, and provide new candidate biomarkers and predictive tools for LC and COPD diagnosis.", {"entities": []}], ["This paper describes a single site, open-label Phase I clinical trial evaluating the safety, tolerability and immunogenicity in healthy volunteers of a herpes simplex polynucleotide vaccine that has previously been shown to enhance immunogenicity and protect against lethal herpes simplex virus type 2 (HSV-2) challenge in mice.", {"entities": [[152, 166, "DISEASE"], [274, 288, "DISEASE"]]}], ["Five escalating doses of the vaccine, COR-1, were given by intradermal injection to HSV-1 and 2 seronegative healthy individuals.", {"entities": []}], ["COR-1 was found to be safe and well-tolerated; the only vaccine-related adverse events were mild.", {"entities": []}], ["While vaccine-induced antibody responses were not detectable, cell-mediated immune responses to HSV-specific peptide groups were identified in 19 of the 20 subjects who completed the study, and local inflammation at the immunisation site was observed.", {"entities": []}], ["This study indicates COR-1 has potential to be used as a therapeutic vaccine for HSV-2 infection.", {"entities": []}], ["We aimed to explore whether country of residence or specific country characteristics are associated with work outcomes in rheumatoid arthritis (RA).", {"entities": [[122, 142, "DISEASE"], [133, 142, "DISEASE"]]}], ["Data from the 17 countries participating in the Comorbidities in RA (COMORA) study were used.", {"entities": []}], ["Work outcomes were measured by the Work Productivity and Activity Impairment Questionnaire, addressing employment (yes/no), absenteeism (percentage of time; 3 categories) and presenteeism (percentage of at-work productivity restrictions; 4 categories).", {"entities": []}], ["Contribution of country of residence, gross domestic product (GDP), Human Development Index (HDI), unemployment rate, social protection expenditures (SPE) or world region to work outcomes was investigated in adjusted (ordered) logistic regressions.", {"entities": []}], ["The patients (n\u2009=\u20092395) were younger than 60\u00a0years; mean age 48 (SD 9.2) years, 1972 (84%) female and 1065 (45%) employed.", {"entities": []}], ["Large country differences were found.", {"entities": []}], ["Taking the country with the best work outcome as reference, Moroccan patients had the lowest odds of being employed (OR 0.2 (95% CI 0.1; 0.3) vs. Germany) and highest odds of absenteeism (OR 13.2 (3.6; 48.3) vs. Japan).", {"entities": []}], ["Patients in Taiwan had the highest odds of presenteeism (OR 13.0 (5.5; 30.9) vs. Venezuela).", {"entities": []}], ["All country indices except SPE were associated with work outcomes.", {"entities": []}], ["For example, patients in low-GDP countries had lower odds of employment (OR 0.6 (0.5; 0.8)), higher odds of absenteeism (OR 2.8 (2.0; 4.1)), but lower odds of presenteeism (OR 0.5 (0.4; 0.7)) compared to higher-GDP countries.", {"entities": []}], ["Substantial differences in work outcomes among patients with RA were observed between countries.", {"entities": []}], ["Lower economic wealth and human development of countries were associated with worse employment and higher absenteeism, but lower presenteeism.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-017-1421-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Women comprise a large percentage of the workforce in industrial countries.", {"entities": []}], ["In Europe and many other places in the world, women of reproductive age comprise a significant proportion of the workforce at the workplaces, and the rules and regulations require employers to evaluate and minimize health risks to pregnant women.", {"entities": []}], ["In U.K, 70%, and in the United States 59% of women are employed.", {"entities": []}], ["In Iran, 13% of women are employed, which comes down to less than 5% at Sistan& Baluchestan Province.", {"entities": []}], ["Various studies have reported contradictory results about the effects of maternal employment tasks such as standing, repetitive bending, climbing stairs, and lifting heavy objects during pregnancy on fetal growth, preterm birth and other obstetric complications.", {"entities": []}], ["Given the growing number of working women, and potential complications for mothers, the present study has conducted to investigate the relationship between maternal employment status and pregnancy outcomes in Zahedan city, Iran.", {"entities": []}], ["This cross-sectional study was based on survey conducted on 227 women (121 housewives, and 106 employed women) attending health centers in 2014.", {"entities": []}], ["Using purposive convenient sampling method, eligible pregnant mothers (with no chronic diseases, singleton pregnancy, gravida 1-3, and no addiction) were selected as study subjects.", {"entities": []}], ["Data were collected and recorded through a researcher-made questionnaire and also from mothers\u2019 medical records, including personal details, prenatal and labor complications, and infant\u2019s details.", {"entities": []}], ["Collected data were fed into the SPSS version 21(IBM Corp, USA).", {"entities": []}], ["Frequency of placental abruption was greater among housewives (P=0.02), and a significant relationship was found between employment status and lifting heavy objects, which was more frequent among housewives (P=0.01).", {"entities": [[13, 32, "DISEASE"]]}], ["Lifting heavy objects during pregnancy was only significantly related to reduced amniotic fluid (P=0.001) and low birth weight (P=0.01).", {"entities": []}], ["Frequency of preterm labor was higher among housewives compared to employed women, but not significantly.", {"entities": []}], ["Type of delivery was significantly related to employment, and employed mothers had more cesarean deliveries (P=0.0001).", {"entities": []}], ["The results suggest more frequent lifting of heavy objects by housewives than by employed mothers, leading to increased complications such as reduced amniotic fluid, placental abruption, and low birth weight.", {"entities": [[166, 185, "DISEASE"]]}], ["Perhaps due to higher education levels, frequency of cesarean section and preterm labor was higher among employed mothers.", {"entities": []}], ["However, employment alone does not predict pregnancy outcomes.", {"entities": []}], ["Abuse of opioid analgesics has become a public health issue.", {"entities": []}], ["Some opioid abusers use intravenous administration to increase the magnitude of positive reinforcing effects.", {"entities": []}], ["Intravenous co-administration of oxycodone with naloxone, an opioid antagonist, may reduce these rewarding effects and discourage abuse.", {"entities": []}], ["A 2:1 oxycodone:naloxone (OXN) tablet formulation has been studied in the USA for the management of moderate-to-severe chronic pain.", {"entities": []}], ["Intravenous administration of a 2:1 oxycodone:naloxone solution (sOXN) reflects the oxycodone:naloxone ratio found in laboratory studies of OXN following tampering for intravenous administration.", {"entities": []}], ["The objective of this study was to characterize abuse-deterrent properties of sOXN.", {"entities": []}], ["This single-center, double-blind, randomized, placebo-controlled, active-controlled, crossover study enrolled nondependent recreational opioid users with experience using multiple (two or more) routes of administration.", {"entities": []}], ["Following demonstration that subjects could discern between placebo and oxycodone, 24 eligible male and female subjects were randomized to receive intravenous injections of 0.07\u00a0mg/kg oxycodone (OXY), 0.07\u00a0mg/kg oxycodone and 0.035\u00a0mg/kg naloxone solution (sOXN), or matching placebo over three visits.", {"entities": []}], ["Pharmacokinetics, pharmacodynamics, safety, and tolerability were assessed at scheduled times up to 8\u00a0h post-dose.", {"entities": []}], ["Parameters were computed and statistically compared among treatments.", {"entities": []}], ["Pharmacokinetics were similar between OXY and sOXN.", {"entities": []}], ["Subjects reported significantly fewer rewarding effects with sOXN compared with OXY; differences between sOXN and placebo were generally not significant.", {"entities": []}], ["sOXN was well tolerated.", {"entities": []}], ["Significant reductions in drug liking and other subjective effects following administration of sOXN compared with OXY indicate that naloxone concentrations were sufficient to antagonize the effects of oxycodone when abused by the intravenous route of administration in opioid-experienced drug users.", {"entities": []}], ["Evidence-based medicine, the Institute of Medicine (IOM) and the German Institute for Quality and Efficiency in Health Care (IQWiG), support the inclusion of patients' preferences in health care decisions.", {"entities": []}], ["In fact there are not many trials which include an assessment of patient's preferences.", {"entities": []}], ["The aim of this study is to demonstrate that preferences of physicians and of patients can be assessed and that this information may be helpful for medical decision making.", {"entities": []}], ["One of the established methods for assessment of preferences is the conjoint analysis.", {"entities": []}], ["Conjoint analysis, in combination with a computer assisted telephone interview (CATI), was used to collect data from 827 diabetes patients and 60 physicians, which describe the preferences expressed as levels of four factors in the management and outcome of the disease.", {"entities": []}], ["The first factor described the main treatment effect (reduction of elevated Hb A1c , improved well-being, absence of side effects, and no limitations of daily life).", {"entities": []}], ["The second factor described the effect on the body weight (gain, no change, reduction).", {"entities": []}], ["The third factor analyzed the mode of application (linked to meals or flexible application).", {"entities": []}], ["The fourth factor addressed the type of product (original brand or generic product).", {"entities": []}], ["Utility values were scaled and normalized in a way that the sum of utility points across all levels is equal to the number of attributes (factors) times 100.", {"entities": []}], ["The preference weights confirm that the reduction of body weight is at least as important for patients - especially obese patients - and physicians as the reduction of an elevated Hb A1c .", {"entities": []}], ["Original products were preferred by patients while general practitioners preferred generic products.", {"entities": []}], ["Using the example of diabetes, the difference between patients' and physicians' preferences can be assessed.", {"entities": []}], ["The use of a conjoint analysis in combination with CATI seems to be an effective approach for generation of data which are needed for policy and medical decision making in health care.", {"entities": []}], ["The influence of an anti-allergic agent, suplatast tosilate (IPD-1151T; (+/-)-[2-[4-(3-ethoxy-2-hydroxypropoxy)phenyl-carbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate) on allergic bronchoconstriction induced by allergen and methacholine (MCh) were examined in mice.", {"entities": []}], ["BALB/c mice were sensitized by intraperitoneal injection of dinitrophenylated-keyhole limpet hemocyanin (DNP-KLH) mixed with A1(OH)3 (DNP-KLH).", {"entities": []}], ["IPD-1151T was administered orally once a day for either 5 or 14 days in doses of 10, 30 or 100 mg/kg.", {"entities": []}], ["Bronchoconstriction was measured 24h after the final drug administration.", {"entities": []}], ["IPD-1151T inhibited both antigen- and MCh-mediated bronchoconstriction in actively sensitized mice.", {"entities": []}], ["The inhibition induced was closely related to the dose and frequency of oral administration of the agent.", {"entities": []}], ["We also examined the effect of IPD-1151T on IgE production in response to DNP-KLH immunization.", {"entities": []}], ["IPD-1151T inhibited dose-dependently both total and specific IgE concentrations in serum prepared from mice 15 days after immunization.", {"entities": []}], ["These results strongly indicate that IPD-1151T inhibits IgE production in vivo and results in attenuating effect on bronchoconstriction.", {"entities": []}], ["Multiple micronutrient supplementation for pregnant women reduces low birth weight and has been recommended in low- and middle-income countries (LMICs) to improve child survival, growth and health.", {"entities": []}], ["We aimed to review the evidence from long-term follow-up studies of multiple micronutrient supplementation beginning in the later first or second trimester.", {"entities": []}], ["We searched systematically for follow-up reports from all trials in a 2015 Cochrane review of multiple micronutrient supplementation in pregnancy.", {"entities": []}], ["The intervention comprised three or more micronutrients and the comparison group received iron (60\u00a0mg) and folic acid (400\u00a0\u03bcg), where possible.", {"entities": []}], ["Median gestation of commencement varied from 9 to 23\u00a0weeks.", {"entities": []}], ["Primary outcomes were offspring mortality, height, weight and head circumference, presented as unadjusted differences in means or proportions (intervention minus control).", {"entities": []}], ["Secondary outcomes included other anthropometry, body composition, blood pressure, and cognitive and lung function.", {"entities": []}], ["We found 20 follow-up reports from nine trials (including 88,057 women recruited), six of which used the UNIMMAP supplement designed to provide recommended daily allowances.", {"entities": []}], ["The age of follow-up ranged from 0 to 9\u00a0years.", {"entities": []}], ["Data for mortality estimates were available from all trials.", {"entities": []}], ["Meta-analysis showed no difference in mortality (risk difference \u20130.05 per 1000 livebirths; 95\u00a0% CI, \u20135.25 to 5.15).", {"entities": []}], ["Six trials investigated anthropometry and found no difference at follow-up in weight-for-age z score (0.02; 95\u00a0% CI, \u20130.03 to 0.07), height-for-age z score (0.01; 95\u00a0% CI, \u20130.04 to 0.06), or head circumference (0.11\u00a0cm; 95\u00a0% CI, \u20130.03 to 0.26).", {"entities": []}], ["No differences were seen in body composition, blood pressure, or respiratory outcomes.", {"entities": []}], ["No consistent differences were seen in cognitive function scores.", {"entities": []}], ["There is currently no evidence that, compared with iron and folic acid supplementation, routine maternal antenatal multiple micronutrient supplementation improves childhood survival, growth, body composition, blood pressure, respiratory or cognitive outcomes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-016-0633-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In Belgium and the Netherlands, up to 40% of the children on dialysis are children with immigrant parents of non-Western European origin (non-Western).", {"entities": []}], ["Concerns exist regarding whether these non-Western patients receive the same quality of care as children with parents of Western European origin (Western).", {"entities": []}], ["We compared initial dialysis, post-initial treatment, and outcomes between non-Western and Western patients on dialysis.", {"entities": []}], ["All children <19\u00a0years old on chronic dialysis in the Netherlands and Belgium between September 2007 and May 2011 were included in the study.", {"entities": []}], ["Non-Western patients were defined as children of whom one or both parents were born in non-Western countries.", {"entities": []}], ["Seventy-nine of the 179 included patients (44%) were non-Western children.", {"entities": []}], ["Compared to Western patients, non-Western patients more often were treated with hemodialysis (HD) instead of peritoneal dialysis (PD) as first dialysis mode (52 vs. 37%, p \u2009=\u20090.046).", {"entities": []}], ["Before renal transplantation, non-Western patients were on dialysis for a median (range) of 30 (5\u201399) months, vs. 15 (0\u201366) months in Western patients ( p \u2009=\u20090.007).", {"entities": []}], ["Renal osteodystrophy was diagnosed in 34% of non-Western vs. 18% of Western patients ( p \u2009=\u20090.028).", {"entities": []}], ["The incidence rate ratio [95% confidence interval] for acute peritonitis was 2.44 [1.43-4.17] ( p \u2009=\u20090.032) for non-Western compared to Western patients.", {"entities": [[61, 72, "DISEASE"]]}], ["There are important disparities between children on chronic dialysis with parents from Western European origin and those from non-Western European origin in the choice of modality, duration, and outcomes of dialysis therapy.", {"entities": []}], ["In several human malignancies, the expression of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is associated with aggressive characteristics and poor overall survival.", {"entities": [[66, 72, "DISEASE"]]}], ["RCAS1 alters the tumor microenvironment by inducing peripheral lymphocyte apoptosis and angiogenesis, while reducing the vimentin-positive cell population.", {"entities": []}], ["Although proteolytic processing, referred to as \u201cectodomain shedding,\u201d is pivotal for induction of apoptosis by RCAS1, the proteases involved in RCAS1-dependent shedding remain unclear.", {"entities": []}], ["Here we investigated proteases involved in RCAS1 shedding and the association between tumor protease expression and serum RCAS1 concentration in uterine cancer patients.", {"entities": [[145, 159, "DISEASE"], [153, 159, "DISEASE"]]}], ["A disintegrin and metalloproteinase (ADAM) 9 was shown to be involved in the ectodomain shedding of RCAS1.", {"entities": []}], ["Given the significant correlation between tumor ADAM9 expression and serum RCAS1 concentration in both cervical and endometrial cancer as well as the role for ADAM9 in RCAS1 shedding, further exploration of the regulatory mechanisms by which ADAM9 converts membrane-anchored RCAS1 into its soluble form should aid the development of novel RCAS1-targeting therapeutic strategies to treat human malignancies.", {"entities": [[116, 134, "DISEASE"], [128, 134, "DISEASE"], [48, 53, "GENE"], [159, 164, "GENE"], [242, 247, "GENE"], [48, 53, "GENE"], [159, 164, "GENE"], [242, 247, "GENE"], [48, 53, "GENE"], [159, 164, "GENE"], [242, 247, "GENE"]]}], ["This paper represents the first ethnobotanical study in Chail valley of district Swat-Pakistan and provides significant information on medicinal plants use among the tribal people of the area.", {"entities": []}], ["The aim of this study was to document the medicinal uses of local plants and to develop an ethnobotanical inventory of the species diversity.", {"entities": []}], ["In present study, semi-structured interviews with 142 inhabitants (age range between 31\u201375 years) were conducted.", {"entities": []}], ["Ethnobotanical data was analyzed using relative frequency of citation (RFC) to determine the well-known and most useful species in the area.", {"entities": []}], ["Current research work reports total of 50 plant species belonging to 48 genera of 35 families from Chail valley.", {"entities": []}], ["Origanum vulgare , Geranium wallichianum and Skimmia laureola have the highest values of relative frequency of citation (RFC) and are widely known by the inhabitants of the valley.", {"entities": []}], ["The majority of the documented plants were herbs (58%) followed by shrubs (28%), trees (12%) and then climbers (2%).", {"entities": []}], ["The part of the plant most frequently used was the leaves (33%) followed by roots (17%), fruits (14%), whole plant (12%), rhizomes (9%), stems (6%), barks (5%) and seeds (4%).", {"entities": []}], ["Decoction was the most common preparation method use in herbal recipes.", {"entities": []}], ["The most frequently treated diseases in the valley were urinary disorders, skin infections, digestive disorders, asthma, jaundice, angina, chronic dysentery and diarrhea.", {"entities": [[161, 169, "DISEASE"], [113, 119, "DISEASE"], [147, 156, "DISEASE"]]}], ["This study contributes an ethnobotanical inventory of medicinal plants with their frequency of citations together with the part used, disease treated and methods of application among the tribal communities of Chail valley.", {"entities": []}], ["The present survey has documented from this valley considerable indigenous knowledge about the local medicinal plants for treating number of common diseases that is ready to be further investigated for biological, pharmacological and toxicological screening.", {"entities": []}], ["This study also provides some socio-economic aspects which are associated to the local tribal communities.", {"entities": []}], ["This review is an abridged version of a Cochrane Review previously published in the Cochrane Database of Systematic Reviews 2010, Issue 4, Art.", {"entities": []}], [": MR000013 DOI: 10.1002/14651858.MR000013.pub5 (see www.thecochranelibrary.com for information).", {"entities": []}], ["Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and Cochrane Database of Systematic Reviews should be consulted for the most recent version of the review.", {"entities": []}], ["To identify interventions designed to improve recruitment to randomised controlled trials, and to quantify their effect on trial participation.", {"entities": []}], ["Systematic review.", {"entities": []}], ["The Cochrane Methodology Review Group Specialised Register in the Cochrane Library, MEDLINE, EMBASE, ERIC, Science Citation Index, Social Sciences Citation Index, C2-SPECTR, the National Research Register and PubMed.", {"entities": []}], ["Most searches were undertaken up to 2010; no language restrictions were applied.", {"entities": []}], ["Randomised and quasi-randomised controlled trials, including those recruiting to hypothetical studies.", {"entities": []}], ["Studies on retention strategies, examining ways to increase questionnaire response or evaluating the use of incentives for clinicians were excluded.", {"entities": []}], ["The study population included any potential trial participant (eg, patient, clinician and member of the public), or individual or group of individuals responsible for trial recruitment (eg, clinicians, researchers and recruitment sites).", {"entities": []}], ["Two authors independently screened identified studies for eligibility.", {"entities": []}], ["45 trials with over 43\u2005000 participants were included.", {"entities": []}], ["Some interventions were effective in increasing recruitment: telephone reminders to non-respondents (risk ratio (RR) 1.66, 95% CI 1.03 to 2.46; two studies, 1058 participants), use of opt-out rather than opt-in procedures for contacting potential participants (RR 1.39, 95% CI 1.06 to 1.84; one study, 152 participants) and open designs where participants know which treatment they are receiving in the trial (RR 1.22, 95% CI 1.09 to 1.36; two studies, 4833 participants).", {"entities": []}], ["However, the effect of many other strategies is less clear, including the use of video to provide trial information and interventions aimed at recruiters.", {"entities": []}], ["There are promising strategies for increasing recruitment to trials, but some methods, such as open-trial designs and opt-out strategies, must be considered carefully as their use may also present methodological or ethical challenges.", {"entities": []}], ["Questions remain as to the applicability of results originating from hypothetical trials, including those relating to the use of monetary incentives, and there is a clear knowledge gap with regard to effective strategies aimed at recruiters.", {"entities": []}], ["Human B lymphocytes can produce leukotriene B 4 but the biological function of the 5-lipoxygenase (5-LO) pathway in B cells is unclear.", {"entities": []}], ["In order to better understand and define the role of 5-LO in B cells, we investigated the expression of 5-LO mRNA and protein in subsets of B cells from human tonsils and different types of B cell lymphoma.", {"entities": [[197, 205, "DISEASE"]]}], ["Based on RT-PCR and western blot/immunohistochemical staining, with a polyclonal antibody raised against 5-LO, high expression of 5-LO was found in mantle zone B cells from tonsils.", {"entities": []}], ["By contrast, only a weak expression of 5-LO was detected in germinal centre cells and no expression in plasma cells from tonsils.", {"entities": []}], ["This pattern of 5-LO expression was preserved in malignant lymphoma with high expression in mantle B cell lymphoma (MCL) and weak or no expression in follicular lymphoma.", {"entities": [[59, 67, "DISEASE"], [106, 114, "DISEASE"], [161, 169, "DISEASE"]]}], ["Primary leukemized MCL, so called B-prolymphocytic leukaemia cells, and MCL cell lines also expressed 5-LO and readily produced LTB 4 after activation.", {"entities": [[128, 131, "GENE"]]}], ["The present report demonstrates the expression of 5-LO mainly in normal and malignant mantle zone B cells while the expression is low or absent in germinal centre B cells and plasma cells, indicating a role of the 5-LO pathway in B cells before the cells finally differentiate to plasma cells.", {"entities": []}], ["Although administrative health care databases have long been used to evaluate adverse drug effects, responses to drug safety signals have been slow and uncoordinated.", {"entities": []}], ["We describe the establishment of the Canadian Network for Observational Drug Effect Studies (CNODES), a collaborating centre of the Drug Safety and Effectiveness Network (DSEN).", {"entities": []}], ["CNODES is a distributed network of investigators and linked databases in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec and Nova Scotia.", {"entities": []}], ["Principles of operation are as follows: (1) research questions are prioritized by the coordinating office of DSEN; (2) the linked data stay within the provinces; (3)\u2009for each question, a study team formulates a detailed protocol enabling consistent analyses in each province; (4) analyses are \u201cblind\u201d to results obtained elsewhere; (5) protocol deviations are permitted for technical reasons only; (6)\u2009analyses using multivariable methods are lodged centrally with a methods team, which is responsible for combining the results to provide a summary estimate of effect.", {"entities": []}], ["These procedures are designed to achieve high internal validity of risk estimates and to eliminate the possibility of selective reporting of analyses or outcomes.", {"entities": []}], ["The value of a coordinated multi-provincial approach is illustrated by projects studying acute renal injury with high-potency statins, community-acquired pneumonia with proton pump inhibitors, and hyperglycemic emergencies with antipsychotic drugs.", {"entities": [[154, 163, "DISEASE"]]}], ["CNODES is an academically based distributed network of Canadian researchers and data centres with a commitment to rapid and sophisticated analysis of emerging drug safety signals in study populations totalling over 40 million.", {"entities": []}], ["Honokiol, a small-molecular weight natural product, has previously been reported to activate apoptosis and inhibit gastric tumorigenesis.", {"entities": []}], ["Whether honokiol inhibits the angiogenesis and metastasis of gastric cancer cells remains unknown.", {"entities": [[69, 75, "DISEASE"]]}], ["We tested the effects of honokiol on angiogenic activity and peritoneal dissemination using in vivo, ex vivo and in vitro assay systems.", {"entities": []}], ["The signaling responses in human gastric cancer cells, human umbilical vascular endothelial cells (HUVECs), and isolated tumors were detected and analyzed.", {"entities": [[41, 47, "DISEASE"]]}], ["In a xenograft gastric tumor mouse model, honokiol significantly inhibited the peritoneal dissemination detected by PET/CT technique.", {"entities": []}], ["Honokiol also effectively attenuated the angiogenesis detected by chick chorioallantoic membrane assay, mouse matrigel plug assay, rat aortic ring endothelial cell sprouting assay, and endothelial cell tube formation assay.", {"entities": []}], ["Furthermore, honokiol effectively enhanced signal transducer and activator of transcription (STAT-3) dephosphorylation and inhibited STAT-3 DNA binding activity in human gastric cancer cells and HUVECs, which was correlated with the up-regulation of the activity and protein expression of Src homology 2 (SH2)-containing tyrosine phosphatase-1 (SHP-1).", {"entities": [[178, 184, "DISEASE"], [289, 292, "GENE"]]}], ["Calpain-II inhibitor and siRNA transfection significantly reversed the honokiol-induced SHP-1 activity.", {"entities": []}], ["The decreased STAT-3 phosphorylation and increased SHP-1 expression were also shown in isolated peritoneal metastatic tumors.", {"entities": []}], ["Honokiol was also capable of inhibiting VEGF generation, which could be reversed by SHP-1 siRNA transfection.", {"entities": []}], ["Honokiol increases expression and activity of SPH-1 that further deactivates STAT3 pathway.", {"entities": [[77, 82, "GENE"]]}], ["These findings also suggest that honokiol is a novel and potent inhibitor of angiogenesis and peritoneal dissemination of gastric cancer cells, providing support for the application potential of honokiol in gastric cancer therapy.", {"entities": [[130, 136, "DISEASE"], [215, 221, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a complex chronic inflammatory disease of the respiratory system affecting primarily distal respiratory pathways and lung parenchyma.", {"entities": []}], ["This study was aimed at investigating the association of COPD with IREB2 , CHRNA5 , CHRNA3 , FAM13A and hedgehog interacting protein ( HHIP ) genes in a Tatar population from Russia.", {"entities": [[67, 72, "GENE"], [75, 81, "GENE"], [84, 90, "GENE"], [93, 99, "GENE"], [135, 139, "GENE"]]}], ["Six single nucleotide polymorphisms (SNPs) (rs13180, rs16969968, rs1051730, rs6495309, rs7671167, rs13118928) were genotyped by the real-time polymerase chain reaction in this study (511 COPD patients and 508 controls).", {"entities": []}], ["Logistic regression was used to detect the association of SNPs and haplotypes of linked loci in different models.", {"entities": []}], ["Linear regression analyses were performed to estimate the relationship between SNPs and lung function parameters and pack-years.", {"entities": []}], ["The rs13180 ( IREB2 ), rs16969968 ( CHRNA5 ) and rs1051730 ( CHRNA3 ) were significantly associated with COPD in additive model [ P adj =0.00001, odds ratio (OR)=0.64; P adj =0.0001, OR=1.41 and P adj =0.0001, OR=1.47].", {"entities": [[14, 19, "GENE"], [36, 42, "GENE"], [61, 67, "GENE"]]}], ["The C-G haplotype by rs13180 and rs1051730 was a protective factor for COPD in our population ( P adj =0.0005, OR=0.61).", {"entities": []}], ["These results were confirmed only in smokers.", {"entities": []}], ["The rs16969968 and rs1051730 were associated with decrease of forced expiratory volume in 1 sec % predicted ( P adj =0.005 and P adj =0.0019).", {"entities": []}], ["Our study showed the association of rs13180, rs16969968 and rs1051730 with COPD and lung function in Tatar population from Russia.", {"entities": []}], ["Further studies need to be done in other ethnic populations.", {"entities": []}], ["Tests of pulmonary mechanical function provide information about the state of the lungs, both airways and parenchyma.", {"entities": []}], ["This information can be extracted from measurements made in experimental animals, especially the combined determination of pulmonary resistance and dynamic compliance.", {"entities": []}], ["This report discusses the rationale upon which effects of an intervention on the lung periphery can be distinguished from those on more central airways.", {"entities": []}], ["Further, practical considerations involved in making these measurements are discussed.", {"entities": []}], ["The incidence of allergic disorders and asthma continuously increased over the past decades, consuming a considerable proportion of the health care budget.", {"entities": [[40, 46, "DISEASE"]]}], ["Allergen-specific subcutaneous immunotherapy represents the only intervention treating the underlying causes of type I allergies, but still suffers from unwanted side effects and low compliance.", {"entities": []}], ["There is an urgent need for novel approaches improving safety and efficacy of this therapy.", {"entities": []}], ["In the present study we investigated carbohydrate-mediated targeting of allergens to dermal antigen-presenting cells and its influence on immunogenicity and allergenicity.", {"entities": []}], ["Mannan, high (40\u00a0kDa) and low (6\u00a0kDa) molecular weight dextran, and maltodextrin were covalently attached to ovalbumin and papain via mild carbohydrate oxidation resulting in neoglycocomplexes of various sizes.", {"entities": []}], ["In particular, mannan-conjugates were efficiently taken up by dendritic cells in vivo leading to elevated humoral immune responses against the protein moiety and a shift from IgE to IgG.", {"entities": []}], ["Beyond providing an adjuvant effect, papain glycocomplexes also proved to mask B-cell epitopes, thus rendering the allergen derivative hypoallergenic.", {"entities": []}], ["The present data demonstrate that carbohydrate-modified allergens combine targeting of antigen presenting cells with hypoallergenicity, offering the potential for low dose allergen-specific immunotherapy while concomitantly reducing the risk of side effects.", {"entities": []}], ["Children who reside in agricultural settings are potentially exposed to higher levels of organophosphate (OP) pesticides, endotoxin, and allergens than their urban counterparts.", {"entities": []}], ["Endotoxin and allergens stimulate maturation of the immune response in early childhood, but little is known about the effect of exposures to OPs or to the three combined.", {"entities": []}], ["In this study, we investigated the relationships between these exposures and T-helper 1 (Th1) and T-helper 2 (Th2) cytokines, biomarkers of allergic asthma, in the subjects of CHAMA-COS (Center for the Health Assessment of Mothers and Children of Salinas), a longitudinal birth cohort in Salinas Valley, California.", {"entities": [[140, 155, "DISEASE"], [149, 155, "DISEASE"]]}], ["Exposures were ascertained by interviewer-administered questionnaires and by home visits, and clinical diagnoses were abstracted from medical records.", {"entities": []}], ["Blood samples were collected at 12 and 24 months of age and analyzed for Th1/Th2 status by flow cytometric detection of intracellular interferon-\u03b3/interleukin-4 cytokine expression.", {"entities": []}], ["Mean Th2 levels were significantly higher in children with doctor-diagnosed asthma and children with wheezing at 2 years of age.", {"entities": [[76, 82, "DISEASE"]]}], ["In a multiple linear regression model, exclusive breast-feeding at 1 month and pet ownership were associated with 35.3% ( p < 0.01) and 34.5% ( p = 0.01) increases in Th1, respectively.", {"entities": []}], ["Maternal agricultural work and presence of gas stove in the home were associated with a 25.9% increase ( p = 0.04) and 46.5% increase ( p < 0.01) in Th2, respectively.", {"entities": []}], ["Asthma and wheeze outcomes in children at 24 months of age are associated with elevated Th2 status in children at an early age.", {"entities": [[0, 6, "DISEASE"]]}], ["Our data further suggest that early exposures to an agricultural environment, breast-feeding, pets, and gas stoves affect the development of children\u2019s Th1/Th2 immune response.", {"entities": []}], ["Renin angiotensin system (RAS) is a key hormonal system which regulates the cardiovascular function and is implicated in several autoimmune diseases.", {"entities": []}], ["With the discovery of the angiotensin-converting enzyme 2 (ACE2), a protective axis of RAS namely ACE2/Ang-(1\u20137)/Mas that counteracts the deleterious ACE/AngII/AT1R axis has been established.", {"entities": [[59, 63, "GENE"], [98, 102, "GENE"]]}], ["This axis is emerging as a novel target to attenuate ocular inflammation.", {"entities": []}], ["However, the underlying molecular mechanisms remain unclear.", {"entities": []}], ["We investigated the hypothesis that enhancing the activity of the protective axis of RAS by subretinal delivery of an AAV8 (Y733F)-ACE2 vector would protect against the ocular inflammation in experimental autoimmune uveitis (EAU) mice through regulating the local immune responses.", {"entities": [[216, 223, "DISEASE"]]}], ["Our studies demonstrated that increased ACE2 expression exerts protective effects on inflammation in EAU mouse by modulating ocular immune responses, including the differentiation of Th1/Th17 cells and the polarization of M1/M2 macrophages; whereas the systemic immune responses appeared not affected.", {"entities": [[40, 44, "GENE"]]}], ["These effects were mediated by activating the Ang-(1\u20137)/Mas and inhibiting the MAPK, NF-\u03baB and STAT3 signaling pathways.", {"entities": [[95, 100, "GENE"]]}], ["This proof-of-concept study suggests that activation of ocular ACE2/Ang-(1\u20137)/Mas axis with AAV gene transfer modulates local immune responses and may be a promising, long-lasting therapeutic strategy for refractory and recurrent uveitis, as well as other inflammatory eye diseases.", {"entities": [[230, 237, "DISEASE"]]}], ["C-reactive protein (CRP) is a biomarker of inflammation and a sensitive predictor of stroke, and high homocysteine (Hcy) is also associated with stroke.", {"entities": [[20, 23, "GENE"]]}], ["However, the roles of CRP and Hcy in the pathogenesis, progression and prognosis of branch atheromatous disease (BAD) and lipohyalinotic degeneration (LD) are largely unknown.", {"entities": [[22, 25, "GENE"]]}], ["We sought to determine the relation between them in Chinese patients.", {"entities": []}], ["According to the lesion presences shown by diffusion-weighted imaging (DWI), we retrospectively recruited a cohort of 308 patients with a diagnosis of BAD and LD from a total of 1458 consecutive patients with acute ischemic stroke.", {"entities": []}], ["Progression was defined as worsening by > or \u200a=\u200a1-point in the NIHSS for motor function within the first 5 days.", {"entities": []}], ["Good outcome was deemed as Modified Rankin Scale (mRS) \u2264 2 and poor outcome was mRS > 2 recorded at one month after onset.", {"entities": []}], ["This study comprised a total of 179 patients with BAD and 129 patients with LD.", {"entities": []}], ["Subjects in patients with LD significantly had an elevated Hcy (p\u200a=\u200a0.030), a lower NIHSS score on admission (p<0.001) and mRS score at one month after ictus (p<0.001) than those in patients with BAD.", {"entities": []}], ["Elevated Hcy (P\u200a=\u200a0.004) and increased CRP (P\u200a=\u200a0.025) were associated with progression in patients with BAD, and CRP (p\u200a=\u200a0.006) and diabetes mellitus (p\u200a=\u200a0.011) were found to be associated with poor outcome in patients with BAD.", {"entities": [[134, 151, "DISEASE"], [39, 42, "GENE"], [114, 117, "GENE"], [39, 42, "GENE"], [114, 117, "GENE"]]}], ["However, no association was observed in patients with LD on progression and prognosis.", {"entities": []}], ["After multivariate logistic regression analysis, elevated Hcy (p\u200a=\u200a0.002) remained the only independent predictor for the progression, and increased CRP (p\u200a=\u200a0.027) and smoking (p\u200a=\u200a0.012) became the independent predictors for the poor outcome in patients with BAD.", {"entities": [[149, 152, "GENE"]]}], ["In patients with BAD, elevated Hcy and increased CRP may independently predict progression and prognosis, respectively.", {"entities": [[49, 52, "GENE"]]}], ["In the United States, childhood asthma morbidity and prevalence rates are the highest in less affluent urban minority communities.", {"entities": [[32, 38, "DISEASE"]]}], ["More than 80% of childhood asthmatics are allergic to one or more inhalant allergens.", {"entities": []}], ["We evaluated whether socioeconomic status was associated with a differential in the levels and types of indoor home allergens.", {"entities": []}], ["Dust samples for an ELISA allergen assay were collected from the homes of 499 families as part of a metropolitan Boston, Massachusetts, longitudinal birth cohort study of home allergens and asthma in children with a parental history of asthma or allergy.", {"entities": [[190, 196, "DISEASE"], [236, 242, "DISEASE"]]}], ["The proportion of homes with maximum home allergen levels in the highest category was 42% for dust mite allergen (> or = 10 microg/g Der p 1 or Der f 1), 13% for cockroach allergen (> or = 2 U/g Bla g 1 or Bla g 2), 26% for cat allergen (> or = 8 microg/g Fel d 1), and 20% for dog allergen (> or = 10 microg/g Can f 1).", {"entities": []}], ["Homes in the high-poverty area (> 20% of the population below the poverty level) were more likely to have high cockroach allergen levels than homes in the low-poverty area [51 vs. 3%; OR, 33; 95% confidence interval (CI), 12-90], but less likely to have high levels of dust mite allergen (16 vs. 53%; OR, 0.2; CI, 0.1-0.4).", {"entities": []}], ["Lower family income, less maternal education, and race/ethnicity (black or Hispanic vs. white) were also associated with a lower risk of high dust mite levels and a greater risk of high cockroach allergen levels.", {"entities": []}], ["Within a single U.S. metropolitan area we found marked between-community differences in the types of allergens present in the home, but not necessarily in the overall burden of allergen exposure.", {"entities": []}], ["Respiratory support following postoperative extubation is of major importance to prevent hypoxemia and subsequent respiratory failure and reintubation.", {"entities": [[114, 133, "DISEASE"]]}], ["High-flow nasal cannula oxygen (HFNC) delivers a flow-dependent positive airway pressure and improves oxygenation by increasing end-expiratory lung volume.", {"entities": []}], ["Whether application of HFNC may have therapeutic advantages over conventional oxygen therapy for respiratory support in the early postextubation surgical period remains to be established.", {"entities": []}], ["The Optiflow for prevention of post-extubation hypoxemia after abdominal surgery (OPERA) trial is an investigator-initiated multicenter randomized controlled two-arm trial with assessor-blinded outcome assessment, randomizing 220 patients with intermediate to high risk of pulmonary complications after abdominal surgery to receive HFNC or conventional oxygen therapy following extubation, stratified by the presence of epidural analgesia and center.", {"entities": []}], ["The primary outcome measure is the percentage of patients with postoperative hypoxemia one hour after tracheal extubation.", {"entities": []}], ["Secondary outcome measures are postoperative pulmonary complications, need for noninvasive ventilation and intubation for respiratory failure.", {"entities": [[122, 141, "DISEASE"]]}], ["The OPERA trial is the first randomized controlled study powered to investigate whether early application of HFNC following extubation after abdominal surgery prevents against postoperative hypoxemia and pulmonary complications.", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT01887015.", {"entities": []}], ["To investigate the prevalence of the adherence to the medications of the Specialized Component of Pharmaceutical Services and its association with regular access in users of these medications in the municipality of S\u00e3o Leopoldo, State of Rio Grande do Sul, Brazil.", {"entities": []}], ["This is a cross-sectional study with adults aged 20 years and over, who are users of medications of the Specialized Component of Pharmaceutical Services.", {"entities": []}], ["Sampling was carried out consecutively for users who accessed the service of the Specialized Component of Pharmaceutical Services during the period from December 2014 to March 2015.", {"entities": []}], ["Adherence was measured by the Brief Medication Questionnaire, and adherents were defined as those who did not present barriers to adherence in the three domains.", {"entities": []}], ["Regular access was defined as getting all medications in the last three months, regardless of how it was obtained (paying or for free).", {"entities": []}], ["Data analysis was performed using Poisson regression with robust variance.", {"entities": []}], ["We interviewed 414 subjects, being them mostly women (60.9%), with mean age of 55 years (SD = 13), and using a single medication of the Specialized Component of Pharmaceutical Services (68.1%).", {"entities": []}], ["The prevalence of adherence to the medications used in the last seven days was 28.3% and the prevalence of free regular access was 46.1%, and 25.7% did not have access to all treatment.", {"entities": []}], ["After adjusting for the number of medications in the Specialized Component of Pharmaceutical Services and the number of medications of continuous use, users who had free regular access in the last three months were 60% more likely to show adherence.", {"entities": []}], ["For individuals with paid regular access, no association was found between access and adherence.", {"entities": []}], ["The regularity in the free access to the medications of the Specialized Component of Pharmaceutical Services has an impact on the behavior of users, contributing to their commitment to treatment and self-care.", {"entities": []}], ["The Specialized Component of Pharmaceutical Services needs programming in order to avoid irregular access, which suggests a significant limitation of the drug policies in Brazil.", {"entities": []}], ["To investigate the association between Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) and mortality, with the use of glucocorticoids in HIV-infected individuals.", {"entities": [[102, 110, "DISEASE"], [48, 55, "DISEASE"]]}], ["Case\u2013control study.", {"entities": []}], ["We reviewed the medical records of 145 individuals with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.", {"entities": [[80, 87, "DISEASE"]]}], ["The association of different variables with KS-IRIS and Kaposi's sarcoma-related mortality was explored by univariate and multivariate analyses.", {"entities": [[65, 72, "DISEASE"]]}], ["The main exposure of interest was the use of glucocorticoids.", {"entities": []}], ["We also compared the time to KS-IRIS and the time to death of individuals treated with glucocorticoids vs. those nontreated with glucocorticoids, and the time to death of individuals with KS-IRIS vs. those without KS-IRIS by hazards regression.", {"entities": []}], ["Sixty of 145 individuals received glucocorticoids (41.4%) for the management or suspicion of Pneumocystis jirovecii pneumonia.", {"entities": [[116, 125, "DISEASE"]]}], ["Fifty individuals had KS-IRIS (37%).", {"entities": []}], ["The use of glucocorticoids was more frequent in individuals with KS-IRIS than in those without KS-IRIS (54.9 vs. 36.47%, P \u200a = \u200a0.047).", {"entities": []}], ["Kaposi's sarcoma-related mortality occurred in 17 cases (11.7%), and glucocorticoid use was more frequent in this group (76.47 vs. 36.7%, P \u200a=\u200a0.003).", {"entities": [[9, 16, "DISEASE"]]}], ["Glucocorticoid use was a risk factor for mortality (adjusted odds ratio\u200a=\u200a4.719, 95% confidence interval\u200a=\u200a1.383\u201316.103, P \u200a=\u200a0.0132), and was associated with shorter periods to KS-IRIS ( P \u200a=\u200a0.03) and death ( P \u200a = \u200a0.0073).", {"entities": []}], ["KS-IRIS was a risk factor for mortality ( P \u200a = \u200a0.049).", {"entities": []}], ["In HIV-infected individuals, the use of glucocorticoids is a risk factor for KS-IRIS and Kaposi's sarcoma-associated mortality.", {"entities": [[98, 105, "DISEASE"]]}], ["In addition, KS-IRIS is a risk factor for mortality.", {"entities": []}], ["Therefore, glucocorticoid administration in this population requires careful consideration based on individualized risk\u2013benefit analysis.", {"entities": []}], ["Phosphoinositide specific phospholipase C\u03b3 (PLC\u03b3) activates diacylglycerol (DAG)/protein kinase C (PKC) and inositol 1,4,5-trisphosphate (IP3)/Ca", {"entities": []}], ["Human leukocyte antigen-G (HLA-G) is a low polymorphic nonclassical HLA-I molecule restrictively expressed and with suppressive functions.", {"entities": [[27, 32, "GENE"]]}], ["HLA-G gene products are quite complex, with seven HLA-G isoforms, four membrane bound, and other three soluble isoforms that can suffer different posttranslational modifications or even complex formations.", {"entities": [[0, 5, "GENE"], [50, 55, "GENE"], [0, 5, "GENE"], [50, 55, "GENE"]]}], ["In addition, HLA-G has been described included in exosomes.", {"entities": [[13, 18, "GENE"]]}], ["In this review we will focus on HLA-G biochemistry with special emphasis to the mechanisms that regulate its expression and how the protein modifications affect the quantification in biological fluids.", {"entities": [[32, 37, "GENE"]]}], ["Human rhinoviruses ( HRV s) are a major trigger of asthma exacerbations, with the bronchial epithelium being the major site of HRV infection and replication.", {"entities": [[51, 57, "DISEASE"]]}], ["Mast cells ( MC s) play a key role in asthma where their numbers are increased in the bronchial epithelium with increasing disease severity.", {"entities": [[38, 44, "DISEASE"]]}], ["In view of the emerging role of MC s in innate immunity and increased localization to the asthmatic bronchial epithelium, we investigated whether HRV infection of MC s generated innate immune responses which were protective against infection.", {"entities": []}], ["The LAD 2 MC line or primary human cord blood\u2010derived MC s ( CBMC s) were infected with HRV or UV \u2010irradiated HRV at increasing multiplicities of infection ( MOI ) without or with IFN \u2010\u03b2 or IFN \u2010\u03bb.", {"entities": []}], ["After 24 h, innate immune responses were assessed by RT \u2010 qPCR and IFN protein release by ELISA .", {"entities": []}], ["Viral replication was determined by RT \u2010 qPCR and virion release by TCID 50 assay.", {"entities": []}], ["HRV infection of LAD 2 MC s induced expression of IFN \u2010\u03b2, IFN \u2010\u03bb and IFN \u2010stimulated genes.", {"entities": []}], ["However, LAD 2 MC s were permissive for HRV replication and release of infectious HRV particles.", {"entities": []}], ["Similar findings were observed with CBMC s. Neutralization of the type I IFN receptor had minimal effects on viral shedding, suggesting that endogenous type I IFN signalling offered limited protection against HRV .", {"entities": []}], ["However, augmentation of these responses by exogenous IFN \u2010\u03b2, but not IFN \u2010\u03bb, protected MC s against HRV infection.", {"entities": []}], ["MC s are permissive for the replication and release of HRV , which is prevented by exogenous IFN \u2010\u03b2 treatment.", {"entities": []}], ["Taken together, these findings suggest a novel mechanism whereby MC s may contribute to HRV \u2010induced asthma exacerbations.", {"entities": [[101, 107, "DISEASE"]]}], ["Bronchiolitis is common in the first two years of life and is the most frequent cause of hospitalization in this age group.", {"entities": [[0, 13, "DISEASE"]]}], ["No previous studies have used an episode-of-care analysis to describe the frequency, duration, and predictors of bronchiolitis episodes of care during the first two years.", {"entities": [[113, 126, "DISEASE"]]}], ["We conducted a retrospective cohort study of 123,264 infants \u226532\u2009weeks gestation born at 6 Northern California Kaiser Permanente hospitals between 1996 and 2002.", {"entities": []}], ["We used electronic medical records to concatenate hospital, emergency department and outpatient health care encounters for bronchiolitis into discrete episodes of care.", {"entities": [[123, 136, "DISEASE"]]}], ["We used descriptive statistics to report frequency and duration of bronchiolitis episodes and used logistic regression to assess the effect of gestational age and other clinical and demographic predictors on the outcome of bronchiolitis episodes.", {"entities": [[67, 80, "DISEASE"], [223, 236, "DISEASE"]]}], ["Among all infants, the rate of bronchiolitis episodes was 162 per 1000 children during the first 2\u2009years of life; approximately 40% required >1\u2009day of medical attention with a mean duration of 7.0\u2009\u00b1\u20095.9\u2009days.", {"entities": [[31, 44, "DISEASE"]]}], ["Prematurity was associated with increased risk of bronchiolitis episodes and longer duration.", {"entities": [[50, 63, "DISEASE"]]}], ["Bronchiolitis episodes rates per 1000 infants were 246 for 32\u201333\u2009weeks gestational age, 204 for 34\u201336\u2009weeks, and 148\u2013178 for >36\u2009weeks.", {"entities": [[0, 13, "DISEASE"]]}], ["Male gender, African-American and Hispanic race/ethnicity, and parental history of asthma were associated with an increased risk of having a bronchiolitis episode and/or longer duration.", {"entities": [[83, 89, "DISEASE"], [141, 154, "DISEASE"]]}], ["Bronchiolitis episodes of care are frequent during the first two years of life and the duration ranges from 1 to 27\u2009days.", {"entities": [[0, 13, "DISEASE"]]}], ["Prematurity was associated with more frequent and longer duration of bronchiolitis episodes of care, which may reflect illness severity and/or perceived vulnerability.", {"entities": [[69, 82, "DISEASE"]]}], ["Studies link area features such as neighbourhood socioeconomic deprivation to poor health outcomes.", {"entities": []}], ["However, there is a paucity of research based on representative data investigating the effects of area-level health services on mortality.", {"entities": []}], ["This study examines the extent to which municipal health services account for municipal variation in all-cause and cardiovascular disease (CVD) mortality.", {"entities": []}], ["We hypothesise that unfavourable municipal features (eg, fewer available places for rehabilitation) are associated with higher risk of mortality after accounting for patients\u2019 characteristics.", {"entities": []}], ["Population data from Norwegian national/municipal registrars are analysed using multilevel logistic regression in this prospective cohort study.", {"entities": []}], ["The analytic sample (9412 patients aged 18+ from 336 municipalities) constitutes 87.7% of the nationwide population of Norwegian adults who were hospitalised for acute myocardial infarction (AMI) in 2009 and discharged alive.", {"entities": [[168, 189, "DISEASE"], [162, 189, "DISEASE"]]}], ["All-cause and CVD mortality occurring within 365\u2005days after the first day of hospitalisation for AMI.", {"entities": []}], ["There was a small but significant variation at the municipal level in all-cause mortality (0.5%; intraclass correlation coefficient=0.005) but not CVD mortality.", {"entities": []}], ["There were no significant fixed effects of municipal health services on mortality in bivariate models.", {"entities": []}], ["Patients\u2019 characteristics (eg, gender, comorbidities) fully accounted for the observed municipal variation in mortality.", {"entities": []}], ["Being male versus female (OR=1.21, 95% CI 1.02 to 1.43), or having been previously diagnosed with dementia versus not (OR=2.06, 95% CI 1.53 to 2.77) were also linked to higher odds of death.", {"entities": [[98, 106, "DISEASE"]]}], ["Municipal variation in all-cause mortality for Norwegian patients with AMI appears to be driven not by differences across municipalities in health service levels, but by differences across municipalities in the composition of patients.", {"entities": []}], ["Focusing on chronic disease prevention and treatment, and tackling personal and structural risk factors embedded within patients\u2019 sociodemographic characteristics, may be especially beneficial for longevity.", {"entities": []}], ["Supplemental Digital Content is available in the text Little is known about hospital readmission for patients with diabetes in China.", {"entities": []}], ["We aimed to assess the temporal pattern, risk factors, and variations of all-cause readmission among hospitalized patients with diabetes in Tianjin, China, from 2008 to 2013.", {"entities": []}], ["The Tianjin Basic Medical Insurance Register System database was used to identify discharged patients with diabetes from 2008 to 2013.", {"entities": []}], ["The influential factors and trends of rehospitalization were analyzed for 30-, 60- and 90-day predicted readmission rates.", {"entities": []}], ["The Blinder\u2013Oaxaca decomposition was used to explain the readmission variations between 2008 and 2013.", {"entities": []}], ["The long stay-time at the index hospitalization is a shared risk factor for readmission at 30, 60, and 90 days each year.", {"entities": []}], ["The 90-day predicted readmission rates were the highest for each year (all P \u200a<\u200a.001).", {"entities": []}], ["The adjusted readmission rates generally decreased by year (all P \u200a<\u200a.001), except for at the 90-day interval, which decreased in 2010 and slightly increased in 2013 (from 7.47% in 2012 to 7.65% in 2013).", {"entities": []}], ["If the patients had been readmitted to the hospital in 2013 and the only changes that had occurred since 2008 were observable characteristics, then the readmission rates would have decreased by 0.84%, 0.27%, and 0.18% at 30, 60, and 90 days, respectively.", {"entities": []}], ["The potential policy changes decreased the readmission rates at 1.35%, 2.01%, and 1.04% for the 3 intervals, respectively.", {"entities": []}], ["Identifying targeted factors for the decrease in readmission rates may help to control readmission, particularly for long-interval patients.", {"entities": []}], ["A hallmark of the newly published GLI (Global Lungs Initiative) spirometric reference values is their \"all-age\" (3-95yr) predictive power, accomplished by incorporating non-linear age dependencies into modelling parameters.", {"entities": []}], ["This modelling strategy is especially promising for the age range of puberty; however, the performance of GLI-values for adolescents is currently unknown.", {"entities": []}], ["We calculated GLI-based z-scores for children/adolescents without apparent respiratory diseases from two different German studies, LUNOKID (N = 1943, 4\u201319 years) and GINIplus (N = 1042, 15 years) and determined the goodness of fit for specific age groups.", {"entities": []}], ["We defined fit sufficient if the absolute mean of z-scores was <0.5.", {"entities": []}], ["For children (<10yr) the mean GLI-based z-scores for FEV 1 and FVC reached a good fit with mean z-scores for FEV 1 between -0.11 and 0.01 and mean z-scores for FVC between 0.01 and 0.16, but larger deviations were observed in adolescents, especially boys (mean z-score -0.58 for FEV 1 and -0.57 for FVC in GINIplus).", {"entities": [[53, 56, "GENE"], [109, 112, "GENE"], [279, 282, "GENE"], [53, 56, "GENE"], [109, 112, "GENE"], [279, 282, "GENE"], [53, 56, "GENE"], [109, 112, "GENE"], [279, 282, "GENE"]]}], ["The fit for FEV 1 /FVC was sufficient.", {"entities": [[12, 15, "GENE"]]}], ["GLI reference values provided reasonable estimates for the individuals enrolled in our studies, which span the age range of lung growth and development.", {"entities": []}], ["However, we found that GLI-predictions overestimated lung volumes, especially those for German adolescent boys, which may, left unrecognised, lead to erroneous diagnosis of lung disease.", {"entities": [[173, 185, "DISEASE"]]}], ["Caution should be taken when applying these reference values to epidemiologic studies.", {"entities": []}], ["Objectives \u00a0To assess the overall effect of vitamin D supplementation on risk of acute respiratory tract infection, and to identify factors modifying this effect.", {"entities": []}], ["Design \u00a0Systematic review and meta-analysis of individual participant data (IPD) from randomised controlled trials.", {"entities": []}], ["Data sources \u00a0Medline, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, ClinicalTrials.gov, and the International Standard Randomised Controlled Trials Number registry from inception to December 2015.", {"entities": []}], ["Eligibility criteria for study selection \u00a0Randomised, double blind, placebo controlled trials of supplementation with vitamin D 3 or vitamin D 2 of any duration were eligible for inclusion if they had been approved by a research ethics committee and if data on incidence of acute respiratory tract infection were collected prospectively and prespecified as an efficacy outcome.", {"entities": []}], ["Results \u00a025 eligible randomised controlled trials (total 11\u2009321 participants, aged 0 to 95 years) were identified.", {"entities": []}], ["IPD were obtained for 10\u2009933 (96.6%) participants.", {"entities": []}], ["Vitamin D supplementation reduced the risk of acute respiratory tract infection among all participants (adjusted odds ratio 0.88, 95% confidence interval 0.81 to 0.96; P for heterogeneity <0.001).", {"entities": []}], ["In subgroup analysis, protective effects were seen in those receiving daily or weekly vitamin D without additional bolus doses (adjusted odds ratio 0.81, 0.72 to 0.91) but not in those receiving one or more bolus doses (adjusted odds ratio 0.97, 0.86 to 1.10; P for interaction=0.05).", {"entities": []}], ["Among those receiving daily or weekly vitamin D, protective effects were stronger in those with baseline 25-hydroxyvitamin D levels <25 nmol/L (adjusted odds ratio 0.30, 0.17 to 0.53) than in those with baseline 25-hydroxyvitamin D levels \u226525 nmol/L (adjusted odds ratio 0.75, 0.60 to 0.95; P for interaction=0.006).", {"entities": []}], ["Vitamin D did not influence the proportion of participants experiencing at least one serious adverse event (adjusted odds ratio 0.98, 0.80 to 1.20, P=0.83).", {"entities": []}], ["The body of evidence contributing to these analyses was assessed as being of high quality.", {"entities": []}], ["Conclusions \u00a0Vitamin D supplementation was safe and it protected against acute respiratory tract infection overall.", {"entities": []}], ["Patients who were very vitamin D deficient and those not receiving bolus doses experienced the most benefit.", {"entities": []}], ["Systematic review registration \u00a0PROSPERO CRD42014013953.", {"entities": []}], ["Gastric cancer is common cancer.", {"entities": [[8, 14, "DISEASE"], [25, 31, "DISEASE"]]}], ["Discovering novel genetic biomarkers might help to identify high-risk individuals.", {"entities": []}], ["Copy number variation (CNV) has recently been shown to influence risk for several cancers.", {"entities": []}], ["The aim of the present study was sought to test the association between copy number at a variant region and GC.", {"entities": [[108, 110, "GENE"]]}], ["A total of 110 gastric cancer patients and 325 healthy volunteers were enrolled in this study.", {"entities": [[23, 29, "DISEASE"]]}], ["We searched for a CNV and found a CNV (Variation 7468) containing part of the APC gene, the SRP19 gene and the REEP5 gene.", {"entities": [[78, 81, "GENE"], [92, 97, "GENE"], [111, 116, "GENE"]]}], ["We chose four probes targeting at APC-intron8 , APC-exon9 , SRP19 and REEP5 to interrogate this CNV.", {"entities": [[60, 65, "GENE"], [70, 75, "GENE"]]}], ["Specific Taqman probes labeled by different reporter fluorophores were used in a real-time PCR platform to obtain copy number.", {"entities": []}], ["Both the original non-integer data and transformed integer data on copy number were used for analyses.", {"entities": []}], ["Gastric caner patients had a lower non-integer copy number than controls for the APC-exon9 probe (Adjusted p\u200a=\u200a0.026) and SRP19 probe (Adjusted p\u200a=\u200a0.002).", {"entities": [[122, 127, "GENE"]]}], ["The analysis of integer copy number yielded a similar pattern although less significant (Adjusted p\u200a=\u200a0.07 for APC-exon9 probe and Adjusted p\u200a=\u200a0.02 for SRP19 probe).", {"entities": [[153, 158, "GENE"]]}], ["Losses of a CNV at 5q22, especially in the DNA region surrounding APC-exon 9 , may be associated with a higher risk of gastric cancer.", {"entities": [[127, 133, "DISEASE"]]}], ["Very few studies have evaluated the association between a child's lifestyle factors and their parent's ability to recognise the overweight status of their offspring.", {"entities": []}], ["The aim of this study was to analyze the factors associated with a parent's ability to recognise their own offspring's overweight status.", {"entities": []}], ["125 overweight children out of all 1,278 school beginners in Northern Finland were enrolled.", {"entities": []}], ["Weight and height were measured in health care clinics.", {"entities": []}], ["Overweight status was defined by BMI according to internationally accepted criteria.", {"entities": []}], ["A questionnaire to be filled in by parents was delivered by the school nurses.", {"entities": []}], ["The parents were asked to evaluate their offspring's weight status.", {"entities": []}], ["The child's eating habits and physical activity patterns were also enquired about.", {"entities": []}], ["Factor groups of food and physical activity habits were formed by factor analysis.", {"entities": []}], ["Binary logistic regression was performed using all variables associated with recognition of overweight status in univariate analyses.", {"entities": []}], ["The significant risk factors in the final model are reported using odds ratios (ORs) and their 95% confidence intervals (CIs).", {"entities": []}], ["Fifty-seven percent (69/120) of the parents of the overweight children considered their child as normal weight.", {"entities": []}], ["Child's BMI was positively associated with parental recognition of overweight (OR 3.59, CI 1.8 to 7.0).", {"entities": []}], ["Overweight boys were less likely to be recognised than overweight girls (OR 0.14, CI 0.033 to 0.58).", {"entities": []}], ["Child's healthy diet (OR 0.22, CI 0.091 to 0.54) and high physical activity (OR 0.29, CI 0.11 to 0.79) were inversely related to parental recognition of overweight status.", {"entities": []}], ["Child's healthy eating habits and physical activity are inversely related to parental recognition of their offspring's overweight.", {"entities": []}], ["These should be taken into account when planning prevention and treatment strategies for childhood obesity.", {"entities": [[99, 106, "DISEASE"]]}], ["The World Health Organization recommends community case management of malaria and pneumonia for reduction of under-five mortality in developing countries.", {"entities": [[82, 91, "DISEASE"], [70, 77, "DISEASE"]]}], ["Caregivers\u2019 perception and understanding of the illness influences the care a sick child receives.", {"entities": []}], ["Studies in Ghana and elsewhere have routinely shown adequate recognition of malaria by caregivers.", {"entities": [[76, 83, "DISEASE"]]}], ["Similarly, evidence from Asia and some African countries have shown adequate knowledge on pneumonia.", {"entities": [[90, 99, "DISEASE"]]}], ["However, in Ghana, little has been documented about community awareness, knowledge, perceptions and management of childhood pneumonia particularly in the Dangme West district.", {"entities": [[124, 133, "DISEASE"]]}], ["Therefore this formative study was conducted to determine community perceptions of pneumonia for the purpose of informing the design and implementation of context specific health communication strategies to promote early and appropriate care seeking behaviour for childhood pneumonia.", {"entities": [[83, 92, "DISEASE"], [274, 283, "DISEASE"]]}], ["A mixed method approach was adopted.", {"entities": []}], ["Data were obtained from structured interviews ( N \u2009=\u2009501) and eight focus group discussions made up of 56 caregivers of under-fives and eight community Key Informants.", {"entities": []}], ["Descriptive and inference statistics were used for the quantitative data and grounded theory to guide the analysis of the qualitative data.", {"entities": []}], ["Two-thirds of the respondents had never heard the name pneumonia.", {"entities": [[55, 64, "DISEASE"]]}], ["Most respondents did not know about the signs and symptoms of pneumonia.", {"entities": [[62, 71, "DISEASE"]]}], ["For the few who have heard about pneumonia, causes were largely attributed to coming into contact with cold temperature in various forms.", {"entities": [[33, 42, "DISEASE"]]}], ["Management practices mostly were self-treatment with home remedies and allopathic care.", {"entities": []}], ["The low awareness and inadequate recognition of pneumonia implies that affected children may not receive prompt and appropriate treatment as their caregivers may misdiagnose the illness.", {"entities": [[48, 57, "DISEASE"]]}], ["Adequate measures need to be taken to create the needed awareness to improve care seeking behaviour.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-016-3513-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This paper is to investigate the effects of Centella asiatica on HepG2 (human hepatocellular liver carcinoma cell line).", {"entities": [[99, 108, "DISEASE"], [93, 108, "DISEASE"]]}], ["Centella asiatica is native to the Southeast Asia that is used as a traditional medicine.", {"entities": []}], ["This study aims to determine the chemopreventive effects of the Centella asiatica juice on human HepG2 cell line.", {"entities": []}], ["Different methods including flow cytometry, comet assay and reverse transcription-polymerase chain reaction (RT-PCR) were used to show the effects of juice exposure on the level of DNA damage and the reduction of cancerous cells.", {"entities": []}], ["MTT assay is a colorimetric method applied to measure the toxic effects of juice on cells.", {"entities": []}], ["The Centella asiatica juice was not toxic to normal cells.", {"entities": []}], ["It showed cytotoxic effects on tumor cells in a dose dependent manner.", {"entities": []}], ["Apoptosis in cells was started after being exposed for 72\u00a0hr of dose dependent.", {"entities": [[58, 60, "GENE"]]}], ["It was found that the higher percentage of apoptotic cell death and DNA damage was at the concentration above 0.1%.", {"entities": []}], ["In addition, the juice exposure caused the reduction of c-myc gene expression and the enhancement of c-fos and c-erbB2 gene expressions in tumor cells.", {"entities": []}], ["It was concluded that the Centella asiatica juice reduced liver tumor cells.", {"entities": []}], ["Thus, it has the potential to be used as a chemopreventive agent to prevent and treat liver cancer.", {"entities": [[86, 98, "DISEASE"], [92, 98, "DISEASE"]]}], ["Toll like receptors (TLR) play the central role in the recognition of pathogen associated molecular patterns (PAMPs).", {"entities": []}], ["Mutations in the TLR1, TLR2 and TLR4 genes may change the ability to recognize PAMPs and cause altered responsiveness to the bacterial pathogens.", {"entities": [[17, 21, "GENE"], [23, 27, "GENE"], [32, 36, "GENE"]]}], ["The study presents association between TLR gene mutations and increased susceptibility to Mycobacterium avium subsp.", {"entities": []}], ["paratuberculosis (MAP) infection.", {"entities": []}], ["Novel mutations in TLR genes (TLR1- Ser150Gly and Val220Met; TLR2 \u2013 Phe670Leu) were statistically correlated with the hindrance in recognition of MAP legends.", {"entities": [[61, 65, "GENE"]]}], ["This correlation was confirmed subsequently by measuring the expression levels of cytokines (IL-4, IL-8, IL-10, IL-12 and IFN-\u03b3) in the mutant and wild type moDCs (mocyte derived dendritic cells) after challenge with MAP cell lysate or LPS.", {"entities": []}], ["Further in silico analysis of the TLR1 and TLR4 ectodomains (ECD) revealed the polymorphic nature of the central ECD and irregularities in the central LRR (leucine rich repeat) motifs.", {"entities": [[34, 38, "GENE"], [43, 47, "GENE"], [61, 64, "GENE"], [113, 116, "GENE"], [61, 64, "GENE"], [113, 116, "GENE"]]}], ["The most critical positions that may alter the pathogen recognition ability of TLR were: the 9", {"entities": []}], ["Angiogenesis is involved in the inflammation and proliferation stages of wound healing, to bring inflammatory cells to the wound and provide a microvascular network to maintain new tissue formation.", {"entities": []}], ["An excess of inflammation, however, leads to prolonged wound healing and scar formation, often resulting in unfavourable outcomes such as amputation.", {"entities": []}], ["CC-chemokines play key roles in the promotion of inflammation and inflammatory-driven angiogenesis.", {"entities": []}], ["Therefore, inhibition of the CC-chemokine class may improve wound healing.", {"entities": []}], ["We aimed to determine if the broad-spectrum CC-chemokine inhibitor \u201c35K\u201d could accelerate wound healing in vivo in mice.", {"entities": []}], ["In a murine wound healing model, 35K protein or phosphate buffered saline (PBS, control) were added topically daily to wounds.", {"entities": []}], ["Cohorts of mice were assessed in the early stages (four days post-wounding) and in the later stages of wound repair (10 and 21 days post-wounding).", {"entities": []}], ["Topical application of the 35K protein inhibited CC-chemokine expression (CCL5, CCL2) in wounds and caused enhanced blood flow recovery and wound closure in early-mid stage wounds.", {"entities": [[74, 78, "GENE"], [80, 84, "GENE"]]}], ["In addition, 35K promoted neovascularisation in the early stages of wound repair.", {"entities": []}], ["Furthermore, 35K treated wounds had significantly lower expression of the p65 subunit of NF-\u03baB, a key inflammatory transcription factor, and augmented wound expression of the pro-angiogenic and pro-repair cytokine TGF-\u03b2.", {"entities": []}], ["These findings show that broad-spectrum CC-chemokine inhibition may be beneficial for the promotion of wound healing.", {"entities": []}], ["The Behavioral Risk Factor Surveillance System (BRFSS) monitors multiple health indicators related to 4 domains: risky behaviors, health conditions, health care access, and use of preventive services.", {"entities": []}], ["When evaluating the effect of these indicators on health-related quality of life (HRQOL), conventional analytical methods focus only on individual risks and thus are not ideally suited for analyzing complex relationships among many health indicators.", {"entities": []}], ["The objectives of this study were to 1) summarize and group multiple related health indicators within a health domain by using latent class modeling and 2) analyze how 24 health indicators in 4 health domains were associated with 2 HRQOL outcomes to identify Rhode Island adult populations at highest risk for poor HRQOL.", {"entities": []}], ["The 2008 Rhode Island BRFSS, a population-based, random-digit\u2013dialed telephone survey, collected responses from 4,786 adults aged 18 years or older.", {"entities": []}], ["We used latent class modeling to assign 24 health indicators to high-, intermediate-, and low-risk groups within 4 domains.", {"entities": []}], ["The effects of all risks on HRQOL were then assessed with logistic regression modeling.", {"entities": []}], ["The latent class model with 3 classes fitted the 4 domains best.", {"entities": []}], ["Respondents with more health conditions and limited health care access were more likely to have frequent physical distress.", {"entities": []}], ["Those with more health conditions, risky behaviors, and limited health care access were more likely to have frequent mental distress.", {"entities": []}], ["Use of preventive health services did not affect risk for frequent physical or mental distress.", {"entities": []}], ["The latent class modeling approach can be applied to identifying high-risk subpopulations in Rhode Island for which interventions may have the most substantial effect on HRQOL.", {"entities": []}], ["Mesenchymal stem cells (MSCs) are multipotent stem cells with capacity to differentiate into several mesenchymal lineages.", {"entities": []}], ["This quality makes MSCs good candidates for use in cell therapy.", {"entities": []}], ["MSCs can be isolated from a variety of tissues including bone marrow and adipose tissue, which are the most common sources of these cells.", {"entities": []}], ["However, MSCs can also be isolated from peripheral blood.", {"entities": []}], ["Sheep has been proposed as an ideal model for biomedical studies including those of orthopaedics and transmissible spongiform encephalopathies (TSEs).", {"entities": []}], ["The aim of this work was to advance these studies by investigating the possibility of MSC isolation from ovine peripheral blood (oPB-MSCs) and by subsequently characterizing there in vitro properties.", {"entities": [[86, 89, "GENE"]]}], ["Plastic-adherent fibroblast-like cells were obtained from the mononuclear fraction of blood samples.", {"entities": []}], ["These cells were analysed for their proliferative and differentiation potential into adipocytes, osteoblasts and chondrocytes, as well as for the gene expression of cell surface markers.", {"entities": []}], ["The isolated cells expressed transcripts for markers CD29 , CD73 and CD90 , but failed to express the haematopoietic marker CD45 and expressed only low levels of CD105 .", {"entities": []}], ["The expression of CD34 was variable.", {"entities": [[18, 22, "GENE"]]}], ["The differentiation potential of this cell population was evaluated using specific differentiation media.", {"entities": []}], ["Although the ability of the cultures derived from different animals to differentiate into adipocytes, osteoblasts and chondrocytes was heterogeneous, we confirmed this feature using specific staining and analysing the gene expression of differentiation markers.", {"entities": []}], ["Finally, we tested the ability of oPB-MSCs to transdifferentiate into neuronal-like cells.", {"entities": []}], ["Morphological changes were observed after 24-hour culture in neurogenic media, and the transcript levels of the neurogenic markers increased during the prolonged induction period.", {"entities": []}], ["Moreover, oPB-MSCs expressed the cellular prion protein gene ( PRNP ), which was up-regulated during neurogenesis.", {"entities": [[63, 67, "GENE"]]}], ["This study describes for the first time the isolation and characterization of oPB-MSCs.", {"entities": []}], ["Albeit some variability was observed between animals, these cells retained their capacity to differentiate into mesenchymal lineages and to transdifferentiate into neuron-like cells in vitro .", {"entities": []}], ["Therefore, oPB-MSCs could serve as a valuable tool for biomedical research in fields including orthopaedics or prion diseases.", {"entities": []}], ["Pulmonary dysfunction is a known complication after cardiac surgery using cardiopulmonary bypass, ranging from subclinical functional changes to prolonged postoperative ventilation, acute lung injury, and acute respiratory distress syndrome.", {"entities": [[232, 240, "DISEASE"]]}], ["Whether human pulmonary arterial function is compromised is unknown.", {"entities": []}], ["The aim of the present study was to compare the structure and function of isolated and cannulated human pulmonary arteries obtained from lung biopsies after the chest was opened (pre\u2013cardiopulmonary bypass) to those obtained at the end of cardiopulmonary bypass (post\u2013cardiopulmonary bypass) from patients undergoing coronary artery bypass graft surgery.", {"entities": []}], ["Pre\u2010 and post\u2013cardiopulmonary bypass lung biopsies were received from 12 patients undergoing elective surgery.", {"entities": []}], ["Intralobular small arteries were dissected, cannulated, pressurized, and imaged using confocal microscopy.", {"entities": []}], ["Functionally, the thromboxane mimetic U46619 produced concentration\u2010dependent vasoconstriction in 100% and 75% of pre\u2010 and post\u2013cardiopulmonary bypass arteries, respectively.", {"entities": []}], ["The endothelium\u2010dependent agonist bradykinin stimulated vasodilation in 45% and 33% of arteries pre\u2010 and post\u2013cardiopulmonary bypass, respectively.", {"entities": []}], ["Structurally, in most arteries smooth muscle cells aligned circumferentially; live cell viability revealed that although 100% of smooth muscle and 90% of endothelial cells from pre\u2013cardiopulmonary bypass biopsies had intact membranes and were considered viable, only 60% and 58%, respectively, were viable from post\u2013cardiopulmonary bypass biopsies.", {"entities": []}], ["We successfully investigated isolated pulmonary artery structure and function in fresh lung biopsies from patients undergoing heart surgery.", {"entities": []}], ["Pulmonary artery contractile tone and endothelium\u2010dependent dilation were significantly reduced in post\u2013cardiopulmonary bypass biopsies.", {"entities": []}], ["The decreased functional responses were associated with reduced cell viability.", {"entities": []}], ["URL : http://www.isrctn.com/ISRCTN34428459 .", {"entities": []}], ["Unique identifier: ISRCTN 34428459.", {"entities": []}], ["Maternal smoking is a risk factor for pediatric lung disease, including asthma.", {"entities": [[72, 78, "DISEASE"], [48, 60, "DISEASE"]]}], ["Animal models suggest that maternal smoking causes defective alveolarization in the offspring.", {"entities": []}], ["Retinoic acid signaling modulates both lung development and postnatal immune function.", {"entities": []}], ["Thus, abnormalities in this pathway could mediate maternal smoking effects.", {"entities": []}], ["We tested whether maternal smoking disrupts retinoic acid pathway expression and functioning in a murine model.", {"entities": []}], ["Female C57Bl/6 mice with/without mainstream cigarette smoke exposure (3 research cigarettes a day, 5\u2009days a week) were mated to nonsmoking males.", {"entities": []}], ["Cigarette smoke exposure continued throughout the pregnancy and after parturition.", {"entities": []}], ["Lung tissue from the offspring was examined by mean linear intercept analysis and by quantitative PCR.", {"entities": []}], ["Cell culture experiments using the type II cell-like cell line, A549, tested whether lipid-soluble cigarette smoke components affected binding and activation of retinoic acid response elements in vitro .", {"entities": []}], ["Compared to tobacco-na\u00efve mice, juvenile mice with tobacco toxin exposure had significantly (P\u2009<\u20090.05) increased mean linear intercepts, consistent with an alveolarization defect.", {"entities": []}], ["Tobacco toxin exposure significantly (P\u2009<\u20090.05) decreased mRNA and protein expression of retinoic acid signaling pathway elements, including retinoic acid receptor alpha and retinoic acid receptor beta, with the greatest number of changes observed between postnatal days 3\u20135.", {"entities": []}], ["Lipid-soluble cigarette smoke components significantly (P\u2009<\u20090.05) decreased retinoic acid-induced binding and activation of the retinoic acid receptor response element in A549 cells.", {"entities": []}], ["A murine model of maternal cigarette smoking causes abnormal alveolarization in association with altered retinoic acid pathway element expression in the offspring.", {"entities": []}], ["An in vitro cell culture model shows that lipid-soluble components of cigarette smoke decrease retinoic acid response element activation.", {"entities": []}], ["It is feasible that disruption of retinoic acid signaling contributes to the pediatric lung dysfunction caused by maternal smoking.", {"entities": []}], ["Background : Seafood processing workers have an increased risk of developing occupational asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["This has not been studied among Norwegian crab processing workers, nor has the respiratory health of exposed workers been compared to a control group.", {"entities": []}], ["Objectives : Assessing the impact of working in the crab processing industry on workers\u2019 respiratory health.", {"entities": []}], ["Design : A cross-sectional study of the respiratory health in two types of crab processing workers compared to a control group.", {"entities": []}], ["Methods : The study included 148 king crab ( Paralithodes c amtschaticus ) workers, 70 edible crab ( Cancer pagurus ) workers and 215 controls.", {"entities": []}], ["Workers answered a questionnaire and performed spirometry measurements.", {"entities": []}], ["\u03c7 Results : Self-reported respiratory symptoms were higher among crab processing workers compared to controls, and higher among king crab workers compared to edible crab workers.", {"entities": []}], ["There was no significant difference between crab processing workers and controls in lung function measurements.", {"entities": []}], ["Self-reported doctor-diagnosed asthma prevalence was highest in the control group.", {"entities": [[31, 37, "DISEASE"]]}], ["Conclusions : Increased respiratory symptoms reported by crab processing workers were not reflected in impaired lung function values or asthma diagnose.", {"entities": [[136, 142, "DISEASE"]]}], ["We suggest a healthy worker effect among crab processing workers in Norway.", {"entities": []}], ["We previously conducted a study to assess whether household exposures to tap water increased an individual\u2019s internal dose of trihalomethanes (THMs).", {"entities": []}], ["Increases in blood THM levels among subjects who showered or bathed were variable, with increased levels tending to cluster in two groups.", {"entities": []}], ["Our goal was to assess the importance of personal characteristics, previous exposures, genetic polymorphisms, and environmental exposures in determining THM concentrations in blood after showering.", {"entities": []}], ["One hundred study participants completed a health symptom questionnaire, a 48-hr food and water consumption diary, and took a 10-min shower in a controlled setting.", {"entities": []}], ["We examined THM levels in blood samples collected at baseline and 10 and 30 min after the shower.", {"entities": []}], ["We assessed the significance of personal characteristics, previous exposures to THMs, and specific gene polymorphisms in predicting postshower blood THM concentrations.", {"entities": []}], ["We did not observe the clustering of blood THM concentrations observed in our earlier study.", {"entities": []}], ["We found that environmental THM concentrations were important predictors of blood THM concentrations immediately after showering.", {"entities": []}], ["For example, the chloroform concentration in the shower stall air was the most important predictor of blood chloroform levels 10 min after the shower ( p < 0.001).", {"entities": []}], ["Personal characteristics, previous exposures to THMs, and specific polymorphisms in CYP2D6 and GSTT1 genes were significant predictors of both baseline and postshowering blood THM concentrations as well as of changes in THM concentrations associated with showering.", {"entities": [[84, 90, "GENE"], [95, 100, "GENE"]]}], ["The inclusion of information about individual physiologic characteristics and environmental measurements would be valuable in future studies to assess human health effects from exposures to THMs in tap water.", {"entities": []}], ["The aims of the work were to improve our knowledge of the role of H 4 R in melanoma proliferation and assess in vivo the therapeutic efficacy of histamine, clozapine and JNJ28610244, an H 4 R agonist, in a preclinical metastatic model of melanoma.", {"entities": [[75, 83, "DISEASE"], [238, 246, "DISEASE"]]}], ["Additionally, we aimed to investigate the combinatorial effect of histamine and gamma radiation on the radiobiological response of melanoma cells.", {"entities": [[131, 139, "DISEASE"]]}], ["Results indicate that 1205Lu metastatic melanoma cells express H 4 R and that histamine inhibits proliferation, in part through the stimulation of the H 4 R, and induces cell senescence and melanogenesis.", {"entities": [[40, 48, "DISEASE"]]}], ["Daily treatment with H 4 R agonists (1 mg/kg, sc ) exhibited a significant in vivo antitumor effect and importantly, compounds reduced metastatic potential, particularly in the group treated with JNJ28610244, the H 4 R agonist with higher specificity.", {"entities": []}], ["H 4 R is expressed in benign and malignant lesions of melanocytic lineage, highlighting the potential clinical use of histamine and H 4 R agonists.", {"entities": []}], ["In addition, histamine increased radiosensitivity of melanoma cells in vitro and in vivo .", {"entities": [[53, 61, "DISEASE"]]}], ["We conclude that stimulation of H 4 R by specific ligands may represent a novel therapeutic strategy in those tumors that express this receptor.", {"entities": []}], ["Furthermore, through increasing radiation-induced response, histamine could improve cancer radiotherapy for the treatment of melanoma.", {"entities": [[125, 133, "DISEASE"], [84, 90, "DISEASE"]]}], ["Obesity is a central health issue due to its epidemic prevalence and its association with type 2 diabetes and other comorbidities.", {"entities": [[0, 7, "DISEASE"]]}], ["Obesity is not just being overweight.", {"entities": [[0, 7, "DISEASE"]]}], ["It is a metabolic disorder due to the accumulation of excess dietary calories into visceral fat and the release of high concentrations of free fatty acids into various organs.", {"entities": []}], ["It represents a state of chronic oxidative stress and low-grade inflammation whose intermediary molecules may include leptin, adiponectin and cytokines.", {"entities": []}], ["It may progress to hyperglycemia, leading to type 2 diabetes.", {"entities": [[19, 32, "DISEASE"]]}], ["Whether or not dietary antioxidant supplements are useful in the management of obesity and type 2 diabetes is discussed in this review.", {"entities": [[79, 86, "DISEASE"]]}], ["Only the benefits for obesity and diabetes are examined here.", {"entities": [[22, 29, "DISEASE"]]}], ["Other health benefits of antioxidants are not considered.", {"entities": []}], ["There are difficulties in comparing studies in this field because they differ in the time frame, participants' ethnicity, administration of antioxidant supplements, and even in how obesity was measured.", {"entities": [[181, 188, "DISEASE"]]}], ["However, the literature presents reasonable evidence for marginal benefits of supplementation with zinc, lipoic acid, carnitine, cinnamon, green tea, and possibly vitamin C plus E, although the evidence is much weaker for omega-3 polyunsaturated fatty acids, coenzyme Q10, green coffee, resveratrol, or lycopene.", {"entities": []}], ["Overall, antioxidant supplements are not a panacea to compensate for a fast-food and video-game way of living, but antioxidant-rich foods are recommended as part of the lifestyle.", {"entities": []}], ["Such antioxidant foods are commonly available.", {"entities": []}], ["The evaluation of smoke-free legislation (SFL) in the UK examined the impacts on exposure to second-hand smoke, workers\u2019 attitudes and changes in respiratory health.", {"entities": []}], ["Studies that investigate changes in the health of groups of people often use self-reported symptoms.", {"entities": []}], ["Due to the subjective nature it is of interest to determine whether workers\u2019 attitudes towards the change in their working conditions may be linked to the change in health they report.", {"entities": []}], ["Bar workers were recruited before the introduction of the SFL in Scotland and England with the aim of investigating their changes to health, attitudes and exposure as a result of the SFL.", {"entities": []}], ["They were asked about their attitudes towards SFL and the presence of respiratory and sensory symptoms both before SFL and one year later.", {"entities": []}], ["Here we examine the possibility of a relationship between initial attitudes and changes in reported symptoms, through the use of regression analyses.", {"entities": []}], ["There was no difference in the initial attitudes towards SFL between those working in Scotland and England.", {"entities": []}], ["Bar workers who were educated to a higher level tended to be more positive towards SFL.", {"entities": []}], ["Attitude towards SFL was not found to be related to change in reported symptoms for bar workers in England (Respiratory, p\u2009=\u20090.755; Sensory, p\u2009=\u20090.910).", {"entities": []}], ["In Scotland there was suggestion of a relationship with reporting of respiratory symptoms (p\u2009=\u20090.042), where those who were initially more negative to SFL experienced a greater improvement in self-reported health.", {"entities": []}], ["There was no evidence that workers who were more positive towards SFL reported greater improvements in respiratory and sensory symptoms.", {"entities": []}], ["This may not be the case in all interventions and we recommend examining subjects\u2019 attitudes towards the proposed intervention when evaluating possible health benefits using self-reported methods.", {"entities": []}], ["Immune-complexes play an important role in the inflammatory diseases of the lung.", {"entities": []}], ["Neutrophil activation mediates immune-complex (IC) deposition-induced acute lung injury (ALI).", {"entities": []}], ["Components of gamma amino butyric acid (GABA) signaling, including GABA B receptor 2 (GABA B R2), GAD65/67 and the GABA transporter, are present in the lungs and in the neutrophils.", {"entities": []}], ["However, the role of pulmonary GABA B R activation in the context of neutrophil-mediated ALI has not been determined.", {"entities": []}], ["Thus, the objective of the current study was to determine whether administration of a GABA B R agonist, baclofen would ameliorate or exacerbate ALI.", {"entities": []}], ["We hypothesized that baclofen would regulate IC-induced ALI by preserving pulmonary GABA B R expression.", {"entities": []}], ["Rats were subjected to sham injury or IC-induced ALI and two hours later rats were treated intratracheally with saline or 1 mg/kg baclofen for 2 additional hours and sacrificed.", {"entities": []}], ["ALI was assessed by vascular leakage, histology, TUNEL, and lung caspase-3 cleavage.", {"entities": []}], ["ALI increased total protein, tumor necrosis factor \u03b1 (TNF-\u03b1 and interleukin-1 receptor associated protein (IL-1R AcP), in the bronchoalveolar lavage fluid (BALF).", {"entities": []}], ["Moreover, ALI decreased lung GABA B R2 expression, increased phospho-p38 MAPK, promoted I\u03baB degradation and increased neutrophil influx in the lung.", {"entities": []}], ["Administration of baclofen, after initiation of ALI, restored GABA B R expression, which was inhibited in the presence of a GABA B R antagonist, CGP52432.", {"entities": []}], ["Baclofen administration activated pulmonary phospho-ERK and inhibited p38 MAPK phosphorylation and I\u03baB degradation.", {"entities": []}], ["Additionally, baclofen significantly inhibited pro-inflammatory TNF-\u03b1 and IL-1\u03b2AcP release and promoted BAL neutrophil apoptosis.", {"entities": []}], ["Protective effects of baclofen treatment on ALI were possibly mediated by inhibition of TNF-\u03b1- and IL-1\u03b2-mediated inflammatory signaling.", {"entities": []}], ["Interestingly, GABA B R2 expression was regulated in the type II pneumocytes in lung tissue sections from lung injured patients, further suggesting a physiological role for GABA B R2 in the repair process of lung damage.", {"entities": []}], ["GABA B R2 agonists may play a potential therapeutic role in ALI.", {"entities": []}], ["This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro.", {"entities": []}], ["In a complex architecture of nested, zonated lobules, the liver consists of approximately 80\u00a0% hepatocytes and 20\u00a0% non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage.", {"entities": []}], ["Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4\u03b1, FXR, LXR, SHP, VDR and PPAR) and signaling pathways.", {"entities": [[135, 138, "GENE"]]}], ["When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g.", {"entities": []}], ["HNF-4\u03b1), resulting in up- and downregulation of hundreds of genes.", {"entities": []}], ["An understanding of these changes is crucial for a correct interpretation of in vitro data.", {"entities": []}], ["The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver.", {"entities": []}], ["Also discussed is how closely hepatoma, stem cell and iPS cell\u2013derived hepatocyte-like-cells resemble real hepatocytes.", {"entities": []}], ["Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity.", {"entities": []}], ["One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation.", {"entities": []}], ["Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun.", {"entities": []}], ["The online version of this article (doi:10.1007/s00204-013-1078-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Volumetric three-dimensional displays offer spatially accurate representations of images with a 360\u00b0 view, but have been difficult to implement due to complex fabrication requirements.", {"entities": []}], ["Herein, a chemically enabled volumetric 3D digital light photoactivatable dye display (3D Light PAD) is reported.", {"entities": []}], ["The operating principle relies on photoactivatable dyes that become reversibly fluorescent upon illumination with ultraviolet light.", {"entities": []}], ["Proper tuning of kinetics and emission wavelengths enables the generation of a spatial pattern of fluorescent emission at the intersection of two structured light beams.", {"entities": []}], ["A first-generation 3D Light PAD was fabricated using the photoactivatable dye N -phenyl spirolactam rhodamine B, a commercial picoprojector, an ultraviolet projector and a custom quartz imaging chamber.", {"entities": []}], ["The system displays a minimum voxel size of 0.68\u2009mm Despite living in a three-dimensional world, almost all information in our society is conveyed in a two-dimensional format.", {"entities": []}], ["Here, the authors provide a technique for the generation of spatially accurate and high-resolution three-dimensional images using fluorescent photoswitch chemistry.", {"entities": []}], ["For the first time, a pale amorphous coumarin derivative, 5-methoxyl aesculetin (MOA), was isolated from the dried bark of Fraxinus rhynchophylla Hance (Oleaceae).", {"entities": []}], ["MOA modulates cytokine expression in lipopolysaccharide (LPS)-treated RAW 264.7 macrophages, but the precise mechanisms are still not fully understood.", {"entities": []}], ["We determined the effects of MOA on the production of inflammatory mediators and pro-inflammatory cytokines in the LPS-induced inflammatory responses of RAW 264.7 macrophages.", {"entities": []}], ["MOA significantly inhibited the LPS-induced production of nitric oxide (NO), prostaglandin E 2 (PGE 2 ), tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-6, and interleukin-1\u03b2.", {"entities": []}], ["It also effectively attenuated inducible nitric oxide (NO) synthase, cyclooxygenase-2, and TNF-\u03b1 mRNA expression and significantly decreased the levels of intracellular reactive oxygen species.", {"entities": []}], ["It inhibited phosphorylation of the extracellular signal-regulated kinase (ERK1/2), thus blocking nuclear translocation of activation protein (AP)-1.", {"entities": []}], ["In a molecular docking study, MOA was shown to target the binding site of ERK via the formation of three hydrogen bonds with two residues of the kinase, which is sufficient for the inhibition of ERK.", {"entities": []}], ["These results suggest that the anti-inflammatory effects of MOA in RAW 264.7 macrophages derive from its ability to block both the activation of mitogen-activated protein kinases (MAPKs) and one of their downstream transcription factors, activator protein-1 (AP-1).", {"entities": []}], ["Our observations support the need for further research into MOA as a promising therapeutic agent in inflammatory diseases.", {"entities": []}], ["Severe hyperkalemia, with potassium (K An observational cohort study was performed at 2 medical centers.", {"entities": []}], ["A total of 923 consecutive Korean patients were analyzed.", {"entities": []}], ["All were 19 years of age or older and were hospitalized with severe hyperkalemia between August 2007 and July 2010; the diagnosis of severe hyperkalemia was made either at the time of admission to the hospital or during the period of hospitalization.", {"entities": []}], ["Demographic and baseline clinical characteristics at the time of hyperkalemia diagnosis were assessed, and clinical outcomes such as in-hospital mortality were reviewed, using the institutions' electronic medical record systems.", {"entities": []}], ["Chronic kidney disease (CKD) was the most common underlying medical condition, and the most common precipitating factor of hyperkalemia was metabolic acidosis.", {"entities": [[8, 22, "DISEASE"], [140, 158, "DISEASE"]]}], ["Emergent admission was indicated in 68.6% of patients, 36.7% had electrocardiogram findings typical of hyperkalemia, 24.5% had multi-organ failure (MOF) at the time of hyperkalemia diagnosis, and 20.3% were diagnosed with severe hyperkalemia at the time of cardiac arrest.", {"entities": []}], ["The in-hospital mortality rate was 30.7%; the rate was strongly correlated with the difference between serum K Severe hyperkalemia occurs in various medical conditions; the precipitating factors are similarly diverse.", {"entities": []}], ["The mortality rate is especially high in patients with severe underlying disease, coexisting medical conditions, and those with normal baseline renal function.", {"entities": []}], ["Proponents of personalized medicine predict that genetic information will provide pivotal perspectives for the prevention and management of complex disorders.", {"entities": []}], ["Personalized medicine differs from traditional Western medicine, in that it focuses on more complex disorders that require mechanistic disease modeling and outcome simulation by integrating genomic risk, environmental stressors, and biomarkers as indicators of disease state.", {"entities": []}], ["This information could be useful to guide targeted therapy and prevent pathologic outcomes.", {"entities": []}], ["However, gaps exist in the process of linking the pieces together; currently, genetic data are seldom used to assist physicians in clinical decision making.", {"entities": []}], ["With rapid growth in genetic data and the requirements for new paradigms for complex disorders comes the need to train professionals to understand and manage the impact of genetic information on patients within these clinical settings.", {"entities": []}], ["Here we describe the challenges, controversies, and opportunities for genetics and genetic counselors in managing complex disorders and discuss the rationale for modifications in genetic counselor training and function.", {"entities": []}], ["We conclude that a major paradigm shift is underway and a compelling functional, ethical, and financial argument can be made for employing properly trained genetic counselors to be strategically positioned within the health-care industries that are responsible for managing complex disorders.", {"entities": []}], ["Obesity is a major risk factor for asthma and it influences airway smooth muscle function and responsiveness.", {"entities": [[0, 7, "DISEASE"], [35, 41, "DISEASE"]]}], ["Adiponectin is inversely associated with obesity and its action is mediated through at least 2 cell membrane receptors (AdipoR1 and AdipoR2).", {"entities": [[41, 48, "DISEASE"], [120, 127, "GENE"], [132, 139, "GENE"]]}], ["Leptin is positively associated with obesity.", {"entities": [[37, 44, "DISEASE"]]}], ["We investigated whether human airway smooth muscle (ASM) cells express adiponectin receptors and whether adiponectin and leptin regulate human ASM cell proliferation and vascular endothelial growth factor (VEGF) release.", {"entities": []}], ["Human ASM cells were growth-arrested in serum-deprived medium for 48 hours and then stimulated with PDGF, adiponectin and leptin.", {"entities": []}], ["After 48 hours of stimulation, proliferation was determined using a cell proliferation ELISA kit.", {"entities": []}], ["Human AdipoR1 and -R2 mRNA expressions were determined by RT-PCR using human-specific AdipoR1 and -R2 primers.", {"entities": [[6, 13, "GENE"], [86, 93, "GENE"], [6, 13, "GENE"], [86, 93, "GENE"]]}], ["Concentrations of VEGF, monocyte chemotactic protein (MCP)-1 and macrophage inflammatory protein (MIP)-1\u03b1 in cell culture supernatant were determined by ELISA.", {"entities": [[98, 101, "GENE"]]}], ["Both AdipoR1 and AdipoR2 mRNA were expressed in the cultured human ASM cells.", {"entities": [[5, 12, "GENE"], [17, 24, "GENE"]]}], ["However, adiponectin did not suppress PDGF-enhanced ASM cell proliferation, nor did leptin promote ASM cell proliferation.", {"entities": []}], ["Leptin promoted VEGF release by human ASM cells, while adiponectin did not influence VEGF release.", {"entities": []}], ["Neither leptin nor adiponectin influenced MCP-1 secretion from human ASM cells.", {"entities": []}], ["Adiponectin and MIP-1\u03b1 were not secreted by human ASM cells.", {"entities": []}], ["Human ASM cells expressed adiponectin receptors.", {"entities": []}], ["However, adiponectin did not regulate human ASM cell proliferation or VEGF release, while leptin stimulated VEGF release by human ASM cells.", {"entities": []}], ["Pseudomonas aeruginosa exotoxin A (PEA) causes severe hepatotoxicity in experimental animals and is useful in investigations of immune-mediated liver injury.", {"entities": []}], ["However, strain differences in the sensitivity to PEA-induced hepatotoxicity in rats remains be elucidated.", {"entities": []}], ["In this study, we determined the severity of PEA-induced hepatotoxicity in six genetically different rat strains.", {"entities": []}], ["Male LE (Long Evans), Wistar, F344, WKY, BN/SsN and LEW rats were administered a single intravenous injection of PEA (20 \u03bcg/kg).", {"entities": []}], ["Significantly elevated serum ALT and AST levels, massive necrosis and hemorrhage, and numerous TUNEL-positive hepatocytes were observed in BN/SsN rats.", {"entities": []}], ["In contrast, low levels of ALT and AST as well as mild changes in liver histopathology were observed in Wistar and F344 rats.", {"entities": []}], ["Moderate levels of hepatic injuries were observed in LE, WKY, and LEW rats.", {"entities": []}], ["Pro-inflammatory cytokines including TNF-\u03b1, IL-2 and IL-6 serum levels were markedly increased in BN/SsN rats compared to Wistar and F344 rats.", {"entities": []}], ["However, the hepatic levels of low density lipoprotein receptor-related protein (LRP), which functions as the PEA receptor, were not significantly different in each strain.", {"entities": [[81, 84, "GENE"]]}], ["Taken together, we suggest that BN/SsN is the most sensitive rat strain, whereas Wistar and F344 were the most resistant rat strains to PEA-induced liver damage.", {"entities": []}], ["The different genetic background of rat strains plays an important role in the susceptibility to PEA-induced epatotoxicity that may depend on immune-regulation but not LRP receptor levels.", {"entities": [[168, 171, "GENE"]]}], ["Objective \u00a0To determine the association between use of sulphonylureas and risk of hypoglycaemia in relation to renal function and sulphonylurea metabolic group compared with use of metformin.", {"entities": []}], ["Design \u00a0Population based cohort study using routinely collected data from general practices in England.", {"entities": []}], ["Setting \u00a0Clinical Practice Research Datalink (CPRD) database, 2004-12.", {"entities": []}], ["Participants \u00a0120\u2009803 new users of a non-insulin antidiabetic agent with at least one prescription and aged 18 years or more.", {"entities": []}], ["The first prescription defined start of follow-up.", {"entities": []}], ["Patients were followed until the end of data collection, a record for hypoglycaemia, or a blood glucose level of less than 3.0 mmol/L.", {"entities": []}], ["Main outcome measures \u00a0Associations between sulphonylurea dose, renal impairment, type of sulphonylurea used, and risk of hypoglycaemia, were determined using Cox proportional hazard models.", {"entities": []}], ["Adjustments were made for age, sex, lifestyle, comorbidity, and drug use.", {"entities": []}], ["Results \u00a0The risk of hypoglycaemia in current users of sulphonylureas only was significantly increased compared with current users of metformin only (adjusted hazard ratio 2.50, 95% confidence interval 2.23 to 2.82).", {"entities": []}], ["The higher risk in current users of sulphonylureas only was further increased in patients with an estimated glomerular filtration rate of less than 30 mL/min/1.73 m Conclusions \u00a0Sulphonylurea treatment in patients with a renal function of less than 30 mL/min/1.73 m", {"entities": []}], ["Prison is an extremely stressful environment and prisoners have an increasing risk of suffering from alexithymia .", {"entities": [[101, 112, "DISEASE"]]}], ["Therefore, this study aims to investigate the prevalence and associated factors of alexithymia among prisoners in China.", {"entities": [[83, 94, "DISEASE"]]}], ["A cross-sectional study was conducted in five main jails of the district of Zhejiang province in China, and a total of 1705 adult prisoners ultimately took part in the study.", {"entities": []}], ["Toronto Alexithymia Scale, Childhood Trauma Questionnaire, Beck Depression Inventory, Beck Anxiety Inventory, Beck Hopelessness Scale and several short demographic questions were applied.", {"entities": [[8, 19, "DISEASE"]]}], ["Over 30% of prisoners were classified as alexithymics and as high as 96.2% of prisoners suffered from at least one traumatic experience in their childhood, meanwhile, 81.5%, 53.4% and 85.8% were found to be positive for depression, anxiety and hopelessness symptoms respectively.", {"entities": []}], ["Education, childhood trauma, negative emotional symptoms including depression, anxiety and hopelessness of the respondents, were negatively or positively associated with alexithymia among prisoners.", {"entities": [[170, 181, "DISEASE"]]}], ["The results indicated that high prevalence of alexithymia among prisoners is linked with their level of education, experience of childhood trauma and symptoms of negative emotions.", {"entities": [[46, 57, "DISEASE"]]}], ["Accordingly, the findings in our study can be used for prevention and intervention of alexithymia among prisoners.", {"entities": [[86, 97, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12888-017-1443-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Individuals with COPD have systemic inflammation that can be assessed by measuring C-reactive protein (CRP).", {"entities": [[103, 106, "GENE"]]}], ["In this paper we evaluated whether CRP is related to COPD, lung function and rate of lung function decline.", {"entities": [[35, 38, "GENE"]]}], ["We included 1237 randomly selected subjects (mean age 42, range 28\u201356 years) from three centers in the European Community Respiratory Health Survey: Reykjavik, Uppsala and Tartu.", {"entities": []}], ["CRP was measured at the end of the follow-up (mean 8.3 years) and the values were divided into 4 quartiles.", {"entities": [[0, 3, "GENE"]]}], ["Fifty-three non-asthmatic subjects fulfilled spirometric criteria for COPD (FEV 1 /FVC < 70%).", {"entities": [[76, 79, "GENE"]]}], ["COPD occurred more often in the 4th CRP quartile (OR (95% CI) 3.21 (1.13\u20139.08)) after adjustment for age, gender, body weight and smoking.", {"entities": [[36, 39, "GENE"]]}], ["High CRP levels were related to lower FEV 1 values in both men (\u2212437 (\u2212596, \u2212279) mL) and women (\u2212144 (\u2212243, \u221244) mL).", {"entities": [[5, 8, "GENE"], [38, 41, "GENE"]]}], ["The negative association between CRP and FEV 1 was significantly larger in men than women (p = 0.04).", {"entities": [[33, 36, "GENE"], [41, 44, "GENE"]]}], ["The decline in FEV 1 was larger (16 (5, 27) mL) in men with high CRP levels whereas no significant association between CRP and FEV 1 decline was found in women.", {"entities": [[15, 18, "GENE"], [127, 130, "GENE"], [65, 68, "GENE"], [119, 122, "GENE"], [65, 68, "GENE"], [119, 122, "GENE"], [15, 18, "GENE"], [127, 130, "GENE"]]}], ["Higher CRP values are significantly associated with COPD and lower lung function in men and women.", {"entities": [[7, 10, "GENE"]]}], ["In men higher CRP values are related to a larger decline in FEV 1 .", {"entities": [[14, 17, "GENE"], [60, 63, "GENE"]]}], ["Immune checkpoints have come to the forefront of cancer therapies as a powerful and promising strategy to stimulate antitumor T cell activity.", {"entities": [[49, 55, "DISEASE"]]}], ["Results from recent preclinical and clinical studies demonstrate how checkpoint inhibition can be utilized to prevent tumor immune evasion and both local and systemic immune suppression.", {"entities": []}], ["This review encompasses the key immune checkpoints that have been found to play a role in tumorigenesis and, more specifically, gliomagenesis.", {"entities": []}], ["The review will provide an overview of the existing preclinical and clinical data, antitumor efficacy, and clinical applications for each checkpoint with respect to GBM, as well as a summary of combination therapies with chemotherapy and radiation.", {"entities": []}], ["Erythroderma in infants is a rare condition of varied etiology.", {"entities": []}], ["Psoriasis is now emerging as the most common cause of erythroderma in infants.", {"entities": [[0, 9, "DISEASE"]]}], ["Early diagnosis of the etiological cause much depends upon the histological confirmation, which is essential for an early and appropriate treatment.", {"entities": []}], ["It was aimed to study the histological findings in psoriatic erythroderma in infants.", {"entities": []}], ["A total of 8 infants up to 1 year of age presenting with erythroderma, clinically suspected to be of psoriatic etiology attending private clinic were included.", {"entities": []}], ["After detailed history taking and astute clinical exam, all of them were biopsied.", {"entities": []}], ["In case 6, with a positive family history of psoriasis and asthma in parents, biopsy was taken from two sites.", {"entities": [[45, 54, "DISEASE"], [59, 65, "DISEASE"]]}], ["The histological findings of all nine biopsies were studied and analyzed.", {"entities": []}], ["Histology of all eight children showed psoriasi form pattern with acanthosis (AC) and dilated papillary capillaries (PC).", {"entities": [[117, 119, "GENE"]]}], ["Spongiform (SF) pattern was seen in the second biopsy (6b) of child with features of both psoriasis and atopy.", {"entities": [[90, 99, "DISEASE"]]}], ["SF pustule of Kogoj or Munro's abscess was not seen in any of them.", {"entities": []}], ["Regular AC and PC dilatation were the consistent histological findings observed in infants with erythrodermic psoriasis.", {"entities": [[110, 119, "DISEASE"], [15, 17, "GENE"]]}], ["These were the early findings observed in younger infants.", {"entities": []}], ["Co-existence of psoriasis with atopic dermatitis may indicate a common pathogenic mechanism or an immunogenetic spin-off.", {"entities": [[16, 25, "DISEASE"], [31, 48, "DISEASE"], [38, 48, "DISEASE"]]}], ["In 2008, the prevalence of paediatric asthma in Zambia was unknown and the national treatment guideline was outdated.", {"entities": [[38, 44, "DISEASE"]]}], ["We created an international partnership between Zambian clinicians, the Zambian Government and a pharmaceutical company to address shortcomings in asthma treatment.", {"entities": [[147, 153, "DISEASE"]]}], ["We did two studies, one to estimate prevalence in the capital of Lusaka and one to assess attitudes and practices of patients.", {"entities": []}], ["Based on the information obtained, we educated health workers and the public.", {"entities": []}], ["The information from the studies was also used to modernize government policy for paediatric asthma management.", {"entities": [[93, 99, "DISEASE"]]}], ["The health-care system in Zambia is primarily focused on acute care delivery with a focus on infectious diseases.", {"entities": []}], ["Comprehensive services for noncommunicable diseases are lacking.", {"entities": []}], ["Asthma management relies on treatment of acute exacerbations instead of disease control.", {"entities": [[0, 6, "DISEASE"]]}], ["Seven percent of children surveyed had asthma (255/3911).", {"entities": [[39, 45, "DISEASE"]]}], ["Of the 120 patients interviewed, most (82/120, 68%) used oral short-acting \u03b2 2 -agonists for symptom control; almost half (59/120, 49%) did not think the symptoms were preventable and 43% (52/120) thought inhalers were addictive.", {"entities": []}], ["These misconceptions informed broad-based educational programmes.", {"entities": []}], ["We used a train-the-trainer model to educate health-care workers and ran public awareness campaigns.", {"entities": []}], ["Access to inhalers was increased and the Zambian standard treatment guideline for paediatric asthma was revised to include steroid inhalers as a control treatment.", {"entities": [[93, 99, "DISEASE"]]}], ["Joint activities were required to change paediatric asthma care in Zambia.", {"entities": [[52, 58, "DISEASE"]]}], ["Success will depend on local sustainability, and it may be necessary to shift resources to mirror the disease burden.", {"entities": []}], ["To identify the prevalence of feeding difficulties in preschoolers, its association with epidemiological factors and previous eating habits, and repercussion on nutritional status.", {"entities": []}], ["Cross-sectional study with a questionnaire given to the mothers of 301 children aged 2-6 years enrolled in public and private kindergartens in Natal, Northeast Brazil, conducted in 2014-2015.", {"entities": []}], ["Feeding difficulty was assessed according to Kerzner\u2019s criteria, resulting in the profiles \u201chighly selective intake\u201d, \u201cactive child with small appetite\u201d, \u201cfear of feeding\u201d, and \u201cchild with psychological disorder or neglected\u201d.", {"entities": []}], ["Association with the following independent variables was analyzed by logistic regression: breastfeeding time, age of cows\u2019 milk and complementary feeding introduction, age range, family income, type of school, mothers\u2019 profile (responsive or nonresponsive), and body mass index (BMI).", {"entities": []}], ["Feeding difficulty was found in 37.2% of cases, with predominance of \u201chighly selective intake\u201d (25.4%).", {"entities": []}], ["It was not associated with infancy feeding practices, family income or type of school.", {"entities": []}], ["There were no differences between the BMI Z score means for the groups with and without feeding difficulty (1.0\u00b11.5 SD and 1.1\u00b11.4 SD, respectively).", {"entities": []}], ["The five-to-six age range had more occurrences (OR 1.8; 95%CI 1.1-2.9).", {"entities": []}], ["Children of responsive mothers were less likely to have feeding difficulties (OR 0.4; 95%CI 0.2-0.8).", {"entities": []}], ["Feeding difficulties were very frequent.", {"entities": []}], ["Nutritional status was not impacted by it, and infancy eating habits were not associated with it.", {"entities": []}], ["Responsive mothers\u2019 profile is a protective factor against eating difficulties and reinforces the importance of behavioral factors and mother-child interaction.", {"entities": []}], ["Measurement of NO and/or its metabolites in the various body compartments has transformed our understanding of biology.", {"entities": []}], ["The inability of the current NO measurement methods to account for naturally occurring and experimental NO isotopes, however, has prevented the scientific community from fully understating NO metabolism in vivo.", {"entities": []}], ["Here we present a mid-IR Faraday rotation spectrometer (FRS) for detection of NO isotopes.", {"entities": []}], ["The instrument utilizes a novel dual modulation/demodulation (DM) FRS method which exhibits noise performance at only 2 times the fundamental quantum shot-noise level and provides the record sensitivity in its class.", {"entities": []}], ["This is achieved with a system that is fully autonomous, robust, transportable, and does not require cryogenic cooling.", {"entities": []}], ["The DM-FRS enables continuous monitoring of nitric oxide isotopes with the detection limits of 3.72\u2005ppbv/Hz", {"entities": []}], ["Cytokines play a very important role in nearly all aspects of inflammation and immunity.", {"entities": []}], ["The term 'interleukin' (IL) has been used to describe a group of cytokines with complex immunomodulatory functions -- including cell proliferation, maturation, migration and adhesion.", {"entities": []}], ["These cytokines also play an important role in immune cell differentiation and activation.", {"entities": []}], ["Determining the exact function of a particular cytokine is complicated by the influence of the producing cell type, the responding cell type and the phase of the immune response.", {"entities": []}], ["ILs can also have pro- and anti-inflammatory effects, further complicating their characterisation.", {"entities": []}], ["These molecules are under constant pressure to evolve due to continual competition between the host's immune system and infecting organisms; as such, ILs have undergone significant evolution.", {"entities": []}], ["This has resulted in little amino acid conservation between orthologous proteins, which further complicates the gene family organisation.", {"entities": []}], ["Within the literature there are a number of overlapping nomenclature and classification systems derived from biological function, receptor-binding properties and originating cell type.", {"entities": []}], ["Determining evolutionary relationships between ILs therefore can be confusing.", {"entities": []}], ["More recently, crystallographic data and the identification of common structural motifs have led to a more accurate classification system.", {"entities": []}], ["To date, the known ILs can be divided into four major groups based on distinguishing structural features.", {"entities": []}], ["These groups include the genes encoding the IL1-like cytokines, the class I helical cytokines (IL4-like, \u03b3 -chain and IL6/12-like), the class II helical cytokines (IL10-like and IL28-like) and the IL17-like cytokines.", {"entities": []}], ["In addition, there are a number of ILs that do not fit into any of the above groups, due either to their unique structural features or lack of structural information.", {"entities": []}], ["This suggests that the gene family organisation may be subject to further change in the near future.", {"entities": []}], ["In rheumatoid arthritis-associated interstitial lung disease (RA-ILD), occurring in 10\u00a0% of patients with patients with RA, usual interstitial pattern (UIP) has shown to associate with poor prognosis but more detailed data about the course of the disease in different subtypes is limited.", {"entities": [[3, 23, "DISEASE"], [35, 60, "DISEASE"], [14, 23, "DISEASE"], [48, 60, "DISEASE"]]}], ["Our aim was to compare the disease course of patients with RA-ILD categorized into either UIP or other types of ILDs.", {"entities": []}], ["Clinical and radiological information of 59 patients with RA-ILD were re-assessed and re-classified into UIP or non-UIP groups, followed by a between-group comparison of demographic data, lung function, survival, cause of death and comorbidities.", {"entities": []}], ["The majority of patients ( n \u2009=\u200935/59.3\u00a0%) showed a radiological UIP-like pattern in high resolution computed tomography.", {"entities": []}], ["The median survival was 92\u00a0months (95\u00a0% CI 62.8\u2013121.2) in the UIP-group and 137\u00a0months (95\u00a0% CI 31.0\u2013243.0) in the non-UIP-group ( p \u2009=\u20090.417).", {"entities": []}], ["Differences in course of disease were found in the number of hospitalizations for respiratory reasons (mean 1.9\u2009\u00b1\u20092.6 in UIP vs. 0.5\u2009\u00b1\u20090.9 in non-UIP group, p \u2009=\u20090.004), the use of oxygen therapy (8/22.9\u00a0% UIP patients vs. 0 non-UIP patients, p \u2009=\u20090.016), number of deaths (23/65.7\u00a0% vs. 10/41.7\u00a0%, p \u2009=\u20090.046) and decline in diffusion capacity (56\u2009\u00b1\u200920.6 vs. 69\u2009\u00b1\u200920.2, p \u2009=\u20090.021).", {"entities": []}], ["Dyspnea and inspiratory crackles were detected more often in the UIP group.", {"entities": []}], ["RA-ILD was the most common primary cause of death (39.4\u00a0% of cases).", {"entities": []}], ["Hypertension, coronary artery disease, chronic obstructive pulmonary disease, heart insufficiency, diabetes and asthma were common comorbidities.", {"entities": [[39, 76, "DISEASE"], [112, 118, "DISEASE"]]}], ["ILD preceded RA diagnosis in 13.6\u00a0% of patients.", {"entities": []}], ["The course of the disease in RA-UIP patients is different from the other RA-ILD subtypes.", {"entities": []}], ["Several comorbidities associated commonly with RA-ILD, although ILD was the predominant primary cause of death.", {"entities": []}], ["Mast cell localization within the airway smooth muscle (ASM)-bundle plays an important role in the development of airway hyper-responsiveness (AHR).", {"entities": [[143, 146, "GENE"]]}], ["Genomewide association studies implicate the \u2018alarmin\u2019 IL-33 in asthma, but its role in mast cell\u2013ASM interactions is unknown.", {"entities": [[64, 70, "DISEASE"]]}], ["We examined the expression and functional role of IL-33 in bronchial biopsies of patients with and without asthma, ex vivo ASM, mast cells, cocultured cells and in a mouse model system.", {"entities": [[107, 113, "DISEASE"]]}], ["IL-33 protein expression was assessed in human bronchial tissue from 9 healthy controls, and 18 mild-to-moderate and 12 severe asthmatic patients by immunohistochemistry.", {"entities": []}], ["IL-33 and ST2 mRNA and protein expression in human-derived ASM, epithelial and mast cells were assessed by qPCR, immunofluorescence and/or flow cytometry and ELISA.", {"entities": []}], ["Functional assays were used to assess calcium signalling, wound repair, proliferation, apoptosis and contraction.", {"entities": []}], ["AHR and inflammation were assessed in a mouse model.", {"entities": [[0, 3, "GENE"]]}], ["Bronchial epithelium and ASM expressed IL-33 with the latter in asthma correlating with AHR.", {"entities": [[64, 70, "DISEASE"], [88, 91, "GENE"]]}], ["ASM and mast cells expressed intracellular IL-33 and ST2.", {"entities": []}], ["IL-33 stimulated mast cell IL-13 and histamine secretion independent of Fc\u03b5R1 cross-linking and directly promoted ASM wound repair.", {"entities": []}], ["Coculture of mast cells with ASM activated by IL-33 increased agonist-induced ASM contraction, and in vivo IL-33 induced AHR in a mouse cytokine installation model; both effects were IL-13 dependent.", {"entities": [[121, 124, "GENE"]]}], ["IL-33 directly promotes mast cell activation and ASM wound repair but indirectly promotes ASM contraction via upregulation of mast cell-derived IL-13.", {"entities": []}], ["This suggests that IL-33 may present an important target to modulate mast cell\u2013ASM crosstalk in asthma.", {"entities": [[96, 102, "DISEASE"]]}], ["Curcumin exhibits antioxidant properties potentially beneficial for human health; however, its use in clinical applications is limited by its poor solubility and relative instability.", {"entities": []}], ["Nanoparticles exhibit interesting features for the efficient distribution and delivery of curcumin into cells, and could also increase curcumin stability in biological systems.", {"entities": []}], ["There is a paucity of information regarding the evolution of the antioxidant properties of nanoparticle-encapsulated curcumin.", {"entities": []}], ["We described a simple method of curcumin encapsulation in poly-lactic-co-glycolic acid (PLGA) nanoparticles without the use of detergent.", {"entities": []}], ["We assessed, in epithelial cells and in an acellular model, the evolution of direct antioxidant and antinitrosant properties of free versus PLGA-encapsulated curcumin after storage under different conditions (light vs darkness, 4\u00b0C vs 25\u00b0C vs 37\u00b0C).", {"entities": []}], ["In epithelial cells, endocytosis and efflux pump inhibitors showed that the increased antioxidant activity of PLGA-encapsulated curcumin relied on bypassing the efflux pump system.", {"entities": []}], ["Acellular assays showed that the antioxidant effect of curcumin was greater when loaded in PLGA nanoparticles.", {"entities": []}], ["Furthermore, we observed that light decreased, though heat restored, antioxidant activity of PLGA-encapsulated curcumin, probably by modulating the accessibility of curcumin to reactive oxygen species, an observation supported by results from quenching experiments.", {"entities": []}], ["Moreover, we demonstrated a direct antinitrosant activity of curcumin, enhanced by PLGA encapsulation, which was increased by light exposure.", {"entities": []}], ["These results suggest that the antioxidant and antinitrosant activities of encapsulated curcumin are light sensitive and that nanoparticle modifications over time and with temperature may facilitate curcumin contact with reactive oxygen species.", {"entities": []}], ["These results highlight the importance of understanding effects of nanoparticle maturation on an encapsulated drug\u2019s activity.", {"entities": []}], ["We compared the adverse effects of two types of real ambient particles; i.e., total suspended particles from an electrostatic precipitator of a steel mill and fine air particles from an urban ambient particulate matter of 2.5 \u00b5m, on mucociliary clearance.", {"entities": []}], ["Mucociliary function was quantified by mucociliary transport, ciliary beating frequency and the amount of acid and neutral mucous in epithelial cells through morphometry of frog palate preparations.", {"entities": []}], ["The palates were immersed in one of the following solutions: total suspended particles (0.1 mg/mL), particulate matter 2.5 \u00b5m 0.1 mg/mL (PM0.1) or 3.0 mg/mL (PM3.0) and amphibian Ringer's solution (control).", {"entities": []}], ["Particle chemical compositions were determined by X-ray fluorescence and gas chromatography/mass spectrometry.", {"entities": []}], ["Exposure to total suspended particles and PM3.0 decreased mucociliary transport.", {"entities": []}], ["Ciliary beating frequency was diminished by total suspended particles at all times during exposure, while particulate matter of 2.5 \u00b5m did not elicit changes.", {"entities": []}], ["Particulate matter of 2.5 \u00b5m reduced epithelial mucous and epithelium thickness, while total suspended particles behaved similarly to the control group.", {"entities": []}], ["Total suspended particles exhibited a predominance of Fe and no organic compounds, while the particulate matter 2.5 \u00b5m contained predominant amounts of S, Fe, Si and, to a lesser extent, Cu, Ni, V, Zn and organic compounds.", {"entities": []}], ["Our results showed that different compositions of particles induced different airway epithelial responses, emphasizing that knowledge of their individual characteristics may help to establish policies aimed at controlling air pollution.", {"entities": []}], ["The quorum sensing (QS) circuit plays a role in the precise regulation of genes controlling virulence factors and biofilm formation in Pseudomonas aeruginosa .", {"entities": []}], ["QS-controlled biofilm formation by Pseudomonas aeruginosa in clinical settings has remained controversial due to emerging drug resistance; therefore, screening diverse compounds for anti-biofilm or anti-QS activities is important.", {"entities": []}], ["This study demonstrates the ability of sub-minimum inhibitory concentrations (sub-MICs) of baicalin, an active natural compound extracted from the traditional Chinese medicinal Scutellaria baicalensis , to inhibit the formation of Pseudomonas aeruginosa biofilms and enhance the bactericidal effects of various conventional antibiotics in vitro .", {"entities": []}], ["In addition, baicalin exerted dose-dependent inhibitory effects on virulence phenotypes (LasA protease, LasB elastase, pyocyanin, rhamnolipid, motilities and exotoxin A) regulated by QS in Pseudomonas aeruginosa .", {"entities": []}], ["Moreover, the expression levels of QS-regulatory genes, including lasI , lasR , rhlI , rhlR , pqsR and pqsA , were repressed after sub-MIC baicalin treatment, resulting in significant decreases in the QS signaling molecules 3-oxo-C12-HSL and C4-HSL, confirming the ability of baicalin-mediated QS inhibition to alter gene and protein expression.", {"entities": []}], ["In vivo experiments indicated that baicalin treatment reduces Pseudomonas aeruginosa pathogenicity in Caenorhabditis elegans .", {"entities": []}], ["Greater worm survival in the baicalin-treated group manifested as an increase in the LT 50 from 24 to 96 h. In a mouse peritoneal implant infection model, baicalin treatment enhanced the clearance of Pseudomonas aeruginosa from the implants of mice infected with Pseudomonas aeruginosa compared with the control group.", {"entities": [[85, 87, "GENE"]]}], ["Moreover, the combination of baicalin and antibiotics significantly reduced the numbers of colony-forming units in the implants to a significantly greater degree than antibiotic treatment alone.", {"entities": []}], ["Pathological and histological analyses revealed mitigation of the inflammatory response and reduced cell infiltration in the peritoneal tissue surrounding the implants after baicalin treatment.", {"entities": []}], ["Measurement of the cytokine levels in the peritoneal lavage fluid of mice in the baicalin treatment group revealed a decrease in IL-4, an increase in interferon \u03b3 (IFN-\u03b3), and a reversed IFN-\u03b3/IL-4 ratio compared with the control group, indicating that baicalin treatment activated the Th1-induced immune response to expedite bacterial load clearance.", {"entities": []}], ["Based on these results, baicalin might be a potent QS inhibitor and anti-biofilm agent for combating Pseudomonas aeruginosa biofilm-related infections.", {"entities": []}], ["We address the problem of observing periodic changes in the behaviour of a large population, by analysing the daily contents of newspapers published in the United States and United Kingdom from 1836 to 1922.", {"entities": []}], ["This is done by analysing the daily time series of the relative frequency of the 25K most frequent words for each country, resulting in the study of 50K time series for 31,755 days.", {"entities": []}], ["Behaviours that are found to be strongly periodic include seasonal activities, such as hunting and harvesting.", {"entities": []}], ["A strong connection with natural cycles is found, with a pronounced presence of fruits, vegetables, flowers and game.", {"entities": []}], ["Periodicities dictated by religious or civil calendars are also detected and show a different wave-form than those provoked by weather.", {"entities": []}], ["States that can be revealed include the presence of infectious disease, with clear annual peaks for fever, pneumonia and diarrhoea.", {"entities": [[107, 116, "DISEASE"]]}], ["Overall, 2% of the words are found to be strongly periodic, and the period most frequently found is 365 days.", {"entities": []}], ["Comparisons between UK and US, and between modern and historical news, reveal how the fundamental cycles of life are shaped by the seasons, but also how this effect has been reduced in modern times.", {"entities": []}], ["The achievement of universal health coverage (UHC) in emerging economies is a high priority within the global community.", {"entities": []}], ["This timely study uses standardized national population data collected from adults aged 50 and older in China, Ghana, India, Mexico, the Russian Federation, and South Africa.", {"entities": []}], ["The objective is to describe health care utilization and measure association between inpatient and outpatient service use and patient characteristics in these six low- and middle-income countries.", {"entities": []}], ["Secondary analysis of data from the World Health Organization\u2019s Study on global AGEing and adult health Wave 1 was undertaken.", {"entities": []}], ["Country samples are compared by socio-demographic characteristics, type of health care, and reasons for use.", {"entities": []}], ["Logistic regressions describe association between socio-demographic and health factors and inpatient and outpatient service use.", {"entities": []}], ["In the pooled multi-country sample of over 26,000 adults aged 50-plus, who reported getting health care the last time it was needed, almost 80% of men and women received inpatient or outpatient care, or both.", {"entities": []}], ["Roughly 30% of men and women in the Russian Federation used inpatient services in the previous 3 years and 90% of men and women in India used outpatient services in the past year.", {"entities": []}], ["In China, public hospitals were the most frequently used service type for 52% of men and 51% of women.", {"entities": []}], ["Multivariable regression showed that, compared with men, women were less likely to use inpatient services and more likely to use outpatient services.", {"entities": []}], ["Respondents with two or more chronic conditions were almost three times as likely to use inpatient services and twice as likely to use outpatient services compared with respondents with no reported chronic conditions.", {"entities": []}], ["This study provides a basis for further investigation of country-specific responses to UHC.", {"entities": []}], ["There is limited evidence that the use of nitrates in acute decompensated heart failure early after presentation to a hospital can improve clinical outcomes.", {"entities": []}], ["We aimed to determine whether early nitrate exposure is associated with improved survival in a large retrospective cohort study.", {"entities": []}], ["We examined 11\u00a0078 acute decompensated heart failure patients who presented to emergency departments in Ontario, Canada, between 2004 and 2007, in the Enhanced Feedback For Effective Cardiac Treatment and the Emergency Heart failure Mortality Risk Grade studies.", {"entities": []}], ["In propensity\u2010matched analyses, we examined the effect of nitrate administration in the acute emergency department setting for its impact on death at 7, 30, and 365\u00a0days.", {"entities": []}], ["In propensity\u2010matched analyses, we found no difference in survival between those who received nitrates in the emergency department and the non\u2010nitrate comparator group.", {"entities": []}], ["Hazard ratios for mortality were 0.76 (95% CI ; 0.51, 1.12) over 7\u00a0days, 0.97 (95% CI ; 0.77, 1.21) over 30\u00a0days, and 0.91 (95% CI ; 0.82, 1.02) over 1\u00a0year of follow\u2010up.", {"entities": []}], ["There was no significant difference in survival or hospital length of stay between nitrate and non\u2010nitrate controls in extended follow\u2010up.", {"entities": []}], ["There was also no significant effect of nitrates in subgroups stratified by presence of chest pain, troponin elevation, chronic nitrate use, and known coronary artery disease.", {"entities": []}], ["In acute decompensated heart failure, use of nitrates acutely in the emergency department setting was not associated with improvement in short\u2010term or near\u2010term survival.", {"entities": []}], ["Our study does not support generalized use of nitrates when the primary goal of therapy is to reduce mortality.", {"entities": []}], ["Malignant carcinoid tumours, islet cell tumours and medullary carcinomas of the thyroid are tumours with similar clinical features.", {"entities": []}], ["In patients with unresectable or metastatic tumours leukocyte interferon (IFN) and recombinant human (rh) IFN have demonstrated efficacy.", {"entities": []}], ["Twenty-four evaluable patients with progressive tumours were treated with 2.5 megaunits rh IFN alpha-2b, administered once daily subcutaneously, for a median duration of 7 months (range 0.5-37+).", {"entities": []}], ["Two carcinoid patients demonstrated a response in tumour size, 80% showed stable disease (SD).", {"entities": []}], ["Sixty percent of the carcinoid patients with elevated urinary 5-hydroxyindoleacetic (5-HIAA) levels reached a biochemical partial response of the urinary 5-HIAA levels (median duration 13.5 months).", {"entities": []}], ["In the patients with an islet cell or medullary tumour and an elevated tumour marker, the marker did not further increase.", {"entities": []}], ["Of the 12 carcinoid patients evaluable for a symptomatic response, ten (83%) experienced a relieve of symptoms.", {"entities": []}], ["IFN alpha-2b dose reduction or discontinuation due to toxicity was necessary in three and ten patients, respectively.", {"entities": []}], ["No neutralising IFN alpha-2b antibodies developed despite prolonged treatment.", {"entities": []}], ["In conclusion, IFN alpha-2b had a beneficial effect in patients with progressive tumours, while long-term IFN alpha-2b treatment did not augment neutralising antibodies.", {"entities": []}], ["In view of the IFN alpha-2b-related toxicity, administration of IFN alpha-2b on alternating days may be preferable.", {"entities": []}], ["The general practitioner in Norway is expected to ensure equity and effectiveness through fair rationing.", {"entities": []}], ["At the same time, due to recent reforms of the Norwegian health care sector, both the role of economic incentives and patient autonomy have been strengthened.", {"entities": []}], ["Studies indicate that modern general practitioners, both in Norway and in other countries are uncomfortable with the gatekeeper role, but there is little knowledge about how general practitioners experience rationing in practice.", {"entities": []}], ["Through focus group interviews with Norwegian general practitioners, we explore physicians' attitudes toward factors of influence on medical decision making and how rationing dilemmas are experienced in everyday practice.", {"entities": []}], ["Four major concerns appeared in the group discussions: The obligation to ration health care, professional autonomy, patient autonomy, and competition.", {"entities": []}], ["A central finding was that the physicians find rationing difficult because saying no in face to face relations often is felt uncomfortable and in conflict with other important objectives for the general practitioner.", {"entities": []}], ["It is important to understand the association between using economic incentives in the management of health care, increasing patient autonomy, and the willingness among physicians to contribute to efficient, fair and legitimate resource allocation.", {"entities": []}], ["Intratracheal transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) attenuates the hyperoxia-induced neonatal lung injury.", {"entities": []}], ["The aim of this study was to optimize the timing of MSCs transplantation.", {"entities": []}], ["Newborn Sprague-Dawley rats were randomly exposed to hyperoxia (90% for 2 weeks and 60% for 1 week) or normoxia after birth for 21 days.", {"entities": []}], ["Human UCB-derived MSCs (5\u00d710 indicative of oxidative stress, and increased inflammatory markers such as tumor necrosis factor-\u03b1, interleukin (IL) -1\u03b1, IL-1\u03b2, IL-6, and transforming growth factor-\u03b2 measured by ELISA, and tissue inhibitor of metalloproteinase-1, CXCL7, RANTES, L-selectin and soluble intercellular adhesion molecule-1 measured by protein array were consistently more attenuated in both HT3 and HT3+10 than in HT10.", {"entities": []}], ["Hyperoxia-induced decrease in hepatocyte growth factor and vascular endothelial growth factor was significantly up-regulated in both HT3 and HT3+10, but not in HT10.", {"entities": []}], ["In summary, intratracheal transplantation of human UCB derived MSCs time-dependently attenuated hyperoxia-induced lung injury in neonatal rats, showing significant protection only in the early but not in the late phase of inflammation.", {"entities": []}], ["There were no synergies with combined early+late MSCs transplantation.", {"entities": []}], ["Breathlessness \u2018crises\u2019 in people with chronic respiratory conditions are a common precipitant for emergency department (ED) presentations, many of which might be avoided through improved self-management and support.", {"entities": []}], ["This study sought insights from people with experience of ED \u2018near misses\u2019 where they considered going to the ED but successfully self-managed instead.", {"entities": []}], ["A qualitative approach was used with a phenomenological orientation.", {"entities": []}], ["Participants were eligible if they reported breathlessness on most days from a diagnosed respiratory condition and experience of \u22651\u2009ED near miss.", {"entities": []}], ["Recruitment was through respiratory support groups and pulmonary rehabilitation clinics.", {"entities": []}], ["Semistructured interviews were conducted with each participant via telephone or face-to-face.", {"entities": []}], ["Questions focused on ED-related decision-making, information finding, breathlessness management and support.", {"entities": []}], ["This analysis used an integrative approach and independent coding by two researchers.", {"entities": []}], ["Lazarus and Cohen\u2019s Transactional Model of Stress and Coping informed interpretive themes.", {"entities": []}], ["Interviews were conducted with 20 participants, 15 of whom had chronic obstructive pulmonary disease.", {"entities": [[63, 100, "DISEASE"]]}], ["Nineteen interviews were conducted via telephone.", {"entities": []}], ["Analysis identified important factors in avoiding ED presentation to include perceived control over breathlessness, self-efficacy in coping with a crisis and desire not to be hospitalised.", {"entities": []}], ["Effective coping strategies included: taking a project management approach that involved goal setting, monitoring and risk management; managing the affective dimension of breathlessness separately from the sensory perceptual and building three-way partnerships with primary care and respiratory services.", {"entities": []}], ["In addition to teaching non-pharmacological and pharmacological management of breathlessness, interventions should aim to develop patients\u2019 generic self-management skills.", {"entities": []}], ["Interventions to improve self-efficacy should ensure this is substantiated by transfer of skills and support, including knowledge about when ED presentation is necessary.", {"entities": []}], ["Complementary initiatives are needed to improve coordinated, person-centred care.", {"entities": []}], ["Future research should seek ways to break the cyclical relationship between affective and sensory-perceptual dimensions of breathlessness.", {"entities": []}], ["Single nucleotide polymorphisms in the promoter region of interleukin-18 ( IL-18 ), an inflammatory cytokine, have been linked to susceptibility to many diseases, including cancer and immune dysfunction.", {"entities": [[173, 179, "DISEASE"]]}], ["Here, we explored the potential association between the IL-18 -607C/A (rs1946518) promoter region polymorphism and susceptibility to ischemic stroke (IS).", {"entities": []}], ["This locus was amplified from peripheral blood samples of 386 IS patients (cases) and 364 healthy individuals (controls) by the polymerase chain reaction with sequence-specific primers.", {"entities": []}], ["Significant differences were observed by the \u03c7 IL-18 -607C/A (rs1946518) promoter polymorphism is associated with IS susceptibility, and the C allele may confer increased IS risk.", {"entities": []}], ["Suboptimal maternal health conditions (such as obesity, underweight, depression and stress) and health behaviours (such as smoking, alcohol consumption and unhealthy nutrition) during pregnancy have been associated with negative pregnancy outcomes.", {"entities": [[47, 54, "DISEASE"]]}], ["Our first aim was to give an overview of the self-reported health status and health behaviours of pregnant women under midwife-led primary care in the Netherlands.", {"entities": []}], ["Our second aim was to identify potential differences in these health status indicators and behaviours according to educational level (as a proxy for socio-economic status) and ethnicity (as a proxy for immigration status).", {"entities": []}], ["Our cross-sectional study (data obtained from the DELIVER multicentre prospective cohort study conducted from September 2009 to March 2011) was based on questionnaires about maternal health and prenatal care, which were completed by 6711 pregnant women.", {"entities": []}], ["The relationships of education and ethnicity with 13 health status indicators and 10 health behaviours during pregnancy were examined using multilevel multiple logistic regression analyses, adjusted for age, parity, number of weeks pregnant and either education or ethnicity.", {"entities": []}], ["Lower educated women were especially more likely to smoke (Odds Ratio (OR) 11.3; 95\u00a0% confidence interval (CI) 7.6\u2013 16.8); have passive smoking exposure (OR 6.9; 95 % CI 4.4\u201311.0); have low health control beliefs (OR 10.4; 95 % CI 8.5\u201312.8); not attend antenatal classes (OR 4.5; 95 % CI 3.5\u20135.8) and not take folic acid supplementation (OR 3.4; 95 % CI 2.7\u20134.4).", {"entities": []}], ["They were also somewhat more likely to skip breakfast daily, be obese, underweight and depressed or anxious.", {"entities": []}], ["Non-western women were especially more likely not to take folic acid supplementation (OR 4.5; 95 % CI 3.5\u20135.7); have low health control beliefs (OR 4.1; 95 % CI 3.1\u20135.2) and not to attend antenatal classes (OR 3.3; 95 % CI 2.0\u20135.4).", {"entities": []}], ["They were also somewhat more likely to have nausea, back pains and passive smoking exposure.", {"entities": []}], ["Substantial socio-demographic inequalities persist with respect to many health-related issues in medically low risk pregnancies in the Netherlands.", {"entities": []}], ["Improved strategies are needed to address the specific needs of socio-demographic groups at higher risk and the structures underlying social inequalities in pregnant women.", {"entities": []}], ["This pilot study evaluated the potential effect of household environmental factors such as income, maternal characteristics, and indoor air pollution on children\u2019s respiratory status in an Eastern Indonesian community.", {"entities": []}], ["Household data were collected from cross-sectional ( n = 461 participants) and preliminary childhood case-control surveys (pneumonia cases = 31 diagnosed within three months at a local health clinic; controls = 30).", {"entities": [[123, 132, "DISEASE"]]}], ["Particulate matter (PM 2.5 and PM 10 ) was measured in living rooms, kitchens, children\u2019s bedrooms, and outside areas in close proximity once during the case-control household interviews (55 homes) and once per hour from 6 a.m. to midnight in 11 homes.", {"entities": []}], ["The household survey showed that children were 1.98 times ( p = 0.02) more likely to have coughing symptoms indicating respiratory infection, if mothers were not the primary caregivers.", {"entities": []}], ["More children exhibited coughing if they were not exclusively breastfed (OR = 2.18; p = 0.06) or there was a possibility that their mothers were exposed to environmental tobacco smoke during pregnancy (OR = 2.05; p = 0.08).", {"entities": []}], ["This study suggests that household incomes and mother\u2019s education have an indirect effect on childhood pneumonia and respiratory illness.", {"entities": [[103, 112, "DISEASE"]]}], ["The concentrations of PM 2.5 and PM 10 ranged from 0.5 to 35.7 \u00b5g/m p < 0.01).", {"entities": []}], ["The study also suggests that ambient air may dilute indoor pollution, but also introduces pollution into the home from the community environment.", {"entities": []}], ["Effective intervention programs need to be developed that consider multiple direct and indirect risk factors to protect children.", {"entities": []}], ["Airway epithelial injury is the hallmark of various respiratory diseases, but its mechanisms remain poorly understood.", {"entities": []}], ["While 13-S-hydroxyoctadecadienoic acid (13-S-HODE) is produced in high concentration during mitochondrial degradation in reticulocytes little is known about its role in asthma pathogenesis.", {"entities": [[169, 175, "DISEASE"]]}], ["Here, we show that extracellular 13-S-HODE induces mitochondrial dysfunction and airway epithelial apoptosis.", {"entities": []}], ["This is associated with features of severe airway obstruction, lung remodeling, increase in epithelial stress related proinflammatory cytokines and drastic airway neutrophilia in mouse.", {"entities": []}], ["Further, 13-S-HODE induced features are attenuated by inhibiting Transient Receptor Potential Cation Channel, Vanilloid-type 1 (TRPV1) both in mouse model and human bronchial epithelial cells.", {"entities": [[128, 133, "GENE"]]}], ["These findings are relevant to human asthma, as 13-S-HODE levels are increased in human asthmatic airways.", {"entities": [[37, 43, "DISEASE"]]}], ["Blocking of 13-S-HODE activity or disruption of TRPV1 activity attenuated airway injury and asthma mimicking features in murine allergic airway inflammation.", {"entities": [[92, 98, "DISEASE"], [48, 53, "GENE"]]}], ["These findings indicate that 13-S-HODE induces mitochondrial dysfunction and airway epithelial injury.", {"entities": []}], ["Alveolar macrophages play a central role in the pathogenesis of chronic obstructive pulmonary disease (COPD).", {"entities": [[64, 101, "DISEASE"]]}], ["Monocytes are recruited from blood during inflammation and then mature into alveolar macrophages.", {"entities": []}], ["The aim of this study was to investigate the effect of cigarette smoke (CS) at different times in lung macrophages and monocytes from blood and bone marrow in mice.", {"entities": [[72, 74, "GENE"]]}], ["Male mice (C57BL/6, n = 45) were divided into groups: control, CS 5 days, CS 14 days and CS 30 days.", {"entities": [[63, 65, "GENE"], [74, 76, "GENE"], [89, 91, "GENE"], [63, 65, "GENE"], [74, 76, "GENE"], [89, 91, "GENE"], [63, 65, "GENE"], [74, 76, "GENE"], [89, 91, "GENE"]]}], ["Five days\u2019 CS exposure induced a pronounced influx of neutrophils and macrophages in the lung associated with increased levels of keratinocyte chemoattractant (KC), tumor necrosis factor-\u03b1 (TNF-\u03b1), nitric oxide (NO) and matrix metalloproteinase (MMP)-12.", {"entities": [[11, 13, "GENE"]]}], ["After 14 days of CS exposure, neutrophil recruitment and cytokine production were greatly reduced.", {"entities": [[17, 19, "GENE"]]}], ["Moreover, chronic CS exposure led to increased recruitment of macrophages (with high expression of CD206), transforming growth factor-\u03b2 (TGF-\u03b2) production as well as no detection of TNF-\u03b1, interleukin (IL)-6 and KC.", {"entities": [[18, 20, "GENE"]]}], ["CS can also change the monocyte phenotype in the blood and bone marrow, with an increase in Ly6C", {"entities": [[0, 2, "GENE"]]}], ["The incidence of hypothermia is difficult to evaluate, and the data concerning the morbidity and mortality rates do not seem to fully represent the problem.", {"entities": []}], ["The aim of the study was to estimate the actual prevalence of accidental hypothermia in Poland, as well as the methods of diagnosis and management procedures used in emergency rooms (ERs).", {"entities": []}], ["A specially designed questionnaire, consisting of 14 questions, was mailed to all the 223 emergency rooms (ER) in Poland.", {"entities": []}], ["The questions concerned the incidence, methods of diagnosis and risk factors, as well as the rewarming methods used and available measurement instruments.", {"entities": []}], ["The analysis involved data from 42 ERs providing emergency healthcare for the population of 5 305 000.", {"entities": []}], ["The prevalence of accidental hypothermia may have been 5.05 cases per 100.000 residents per year.", {"entities": []}], ["Among the 268 cases listed 25% were diagnosed with codes T68, T69 or X31, and in 75% hypothermia was neither included nor assigned a code in the final diagnosis.", {"entities": []}], ["The most frequent cause of hypothermia was exposure to cold air alongside ethanol abuse (68%).", {"entities": []}], ["Peripheral temperature was measured in 57%, core temperature measurement was taken in 29% of the patients.", {"entities": []}], ["Peripheral temperature was measured most often at the axilla, while core temperature measurement was predominantly taken rectally.", {"entities": []}], ["Mild hypothermia was diagnosed in 75.5% of the patients, moderate (32-28\u00b0C) in 16.5%, while severe hypothermia (less than 28\u00b0C) in 8% of the cases.", {"entities": []}], ["Cardiopulmonary resuscitation was carried out in 7.5% of the patients.", {"entities": []}], ["The treatment involved mainly warmed intravenous fluids (83.5%) and active external rewarming measures (70%).", {"entities": []}], ["In no case was extracorporeal rewarming put to use.", {"entities": []}], ["The actual incidence of accidental hypothermia in Polish emergency departments may exceed up to four times the official data.", {"entities": []}], ["Core temperature is taken only in one third of the patients, the treatment of hypothermic patients is rarely conducted in intensive care wards and extracorporeal rewarming techniques are not used.", {"entities": []}], ["It may be expected that personnel education and the development of management procedures will brighten the prognosis and increase the survival rate in accidental hypothermia.", {"entities": []}], ["Vertebral compression fractures (VCF) are common in COPD patients, with osteoporosis being the main cause.", {"entities": [[72, 84, "DISEASE"]]}], ["The clinical impact of VCF derives mostly from both pain and chest deformity, which may lead to ventilatory and physical activity limitations.", {"entities": []}], ["Surprisingly, the consequences of VCF on the quality outcomes of hospital care are poorly known.", {"entities": []}], ["To assess these indicators in patients hospitalized due to a COPD exacerbation (ECOPD) who also have VCF.", {"entities": []}], ["Clinical characteristics and quality care indicators were assessed in two one-year periods, one retrospective (exploratory) and one prospective (validation), in all consecutive patients hospitalized for ECOPD.", {"entities": []}], ["Diagnosis of VCF was based on the reduction of >20% height of the vertebral body evaluated in standard lateral chest X-ray (three independent observers).", {"entities": []}], ["From the 248 patients admitted during the exploratory phase, a third had at least one VCF.", {"entities": []}], ["Underdiagnosis rate was 97.6%, and patients with VCF had more admissions (normalized for survival), longer hospital stays, and higher mortality than patients without (4 [25th\u201375th percentiles, 2\u20138] vs 3 [1\u20136] admissions, P <0.01; 12 [6\u201330] vs 9 [6\u201318] days, P <0.05; and 50 vs 32.1% deaths, P <0.01, respectively).", {"entities": []}], ["The risk of dying in the two following years was also higher in VCF patients (odds ratio: 2.11 [1.2\u20133.6], P <0.01).", {"entities": []}], ["The validation cohort consisted of 250 patients who showed very similar results.", {"entities": []}], ["The logistic regression analysis indicated that both VCF and age were factors independently associated with mortality.", {"entities": []}], ["Although VCF is frequently underdiagnosed in patients hospitalized for ECOPD, it is strongly associated with a worse prognosis and quality care outcomes.", {"entities": []}], ["Early hospital arrival and rapid intervention for acute myocardial infarction is essential for a successful outcome.", {"entities": [[56, 77, "DISEASE"], [50, 77, "DISEASE"]]}], ["Several studies have been unable to identify explanatory factors that slowed decision time.", {"entities": []}], ["The present study examines whether personality, psychosocial factors, and coping strategies might explain differences in time delay from onset of symptoms of acute myocardial infarction to arrival at a hospital emergency room.", {"entities": [[164, 185, "DISEASE"], [158, 185, "DISEASE"]]}], ["Questionnaires on coping strategies, personality dimensions, and depression were completed by 323 patients ages 26 to 70 who had suffered an acute myocardial infarction.", {"entities": [[147, 168, "DISEASE"], [141, 168, "DISEASE"]]}], ["Tests measuring stress adaptation were completed by 180 of them.", {"entities": []}], ["The patients were then categorised into three groups, based on time from onset of symptoms until arrival at hospital, and compared using logistic regression analysis and general linear models.", {"entities": []}], ["No correlation could be established between personality factors (i.e., extraversion, neuroticism, openness, agreeableness, conscientiousness) or depressive symptoms and time between onset of symptoms and arrival at hospital.", {"entities": []}], ["Nor was there any significant relationship between self-reported patient coping strategies and time delay.", {"entities": []}], ["We found no significant relationship between personality factors, coping strategies, or depression and time delays in seeking hospital after an acute myocardial infraction.", {"entities": []}], ["The immune response to viral infection is ideally rapid and specific, resulting in viral clearance and establishment of immune memory.", {"entities": []}], ["Some viruses such as HIV can evade such responses leading to chronic infection, while others like Influenza A can elicit a severe inflammatory response with immune-related complications including death.", {"entities": [[98, 107, "DISEASE"]]}], ["Cytokines play a major role in shaping the appropriate outcomes to infection.", {"entities": []}], ["While Interleukin-7 (IL-7) has a critical role in T and B cell development, treatment with IL-7 has recently been shown to aid the adaptive T cell response in clearance of chronic viral infection.", {"entities": []}], ["In contrast, the IL-7-related cytokine thymic stromal lymphopoietin (TSLP) has a limited role in lymphocyte development but is important in the immune response to parasitic worms and allergens.", {"entities": [[69, 73, "GENE"]]}], ["The role for these cytokines in the immune response to an acute viral infection is unclear.", {"entities": []}], ["IL-7 and TSLP share IL-7R\u03b1 as part of their heterodimeric receptors with the gamma common chain (\u03b3c) and TSLPR, respectively.", {"entities": [[9, 13, "GENE"]]}], ["We investigated the role of IL-7 and TSLP in the primary immune response to influenza A infection using hypomorphic IL-7R\u03b1 (IL-7R\u03b1", {"entities": [[76, 85, "DISEASE"], [37, 41, "GENE"]]}], ["Worldwide, HIV-related mortality among adolescents living with HIV (ALHIV) increased by 50% from 2005 to 2012 and is attributed in part to a lack of support for adolescent retention to care and adherence to antiretroviral therapy (ART).", {"entities": []}], ["This vulnerability reinforces the need to better understand incomplete ART adherence among ALHIV, particularly in sub-Saharan Africa, where the majority of the world's 2.1 million ALHIV reside.", {"entities": []}], ["From December 2011 to February 2012, we conducted in-depth interviews with 32 ALHIV (aged 15 to 18) and 23 of their adult caregivers in the Copperbelt Province of Zambia.", {"entities": []}], ["Interviews were transcribed and translated.", {"entities": []}], ["An iterative qualitative process was used to code and analyze the data and main themes were summarized regarding the barriers to and facilitators of ART adherence.", {"entities": []}], ["More than a quarter of ALHIV reported missing a day or more of ART (ranging from one day to six months).", {"entities": []}], ["Barriers to ART adherence included fear of disclosure and anticipated stigma.", {"entities": []}], ["Few youth were willing to take their drugs outside of the home, which led to missed doses of ART.", {"entities": []}], ["Similarly, families tended to manage HIV within the home only.", {"entities": []}], ["As a result, although caregivers and families were often the greatest source of emotional and instrumental support, they coped with HIV in isolation of other potential support from their communities, schools or churches.", {"entities": []}], ["Factors that supported ART adherence included attending clinic-sponsored youth groups, wanting to maintain one's health and using phone and clock alarms.", {"entities": []}], ["Involvement of adult caregivers in HIV management varied greatly and was often based on the age and health status of the youth.", {"entities": []}], ["Some caregivers struggled with letting the adolescents assume responsibility for their medication, and ALHIV had few self-management skills and tools to help them regularly take ART.", {"entities": []}], ["These data highlight the importance of families and home environments in supporting adherence to ART among ALHIV.", {"entities": []}], ["Skill-building and family-based interventions to prepare ALHIV and their adult caregivers for HIV self-management and HIV status disclosure by youth are of paramount importance.", {"entities": []}], ["Future research and programmes also need to address the fears adolescents and families have regarding HIV-related stigma that shape young peoples\u2019 adherence behaviours.", {"entities": []}], ["To perform an assessment of the available literature on manual hyperinflation as a respiratory physical therapy technique used in pediatric patients, with the main outcome of achieving airway clearance.", {"entities": []}], ["We reviewed articles included in the Lilacs (Latin American and Caribbean Literature on Health Sciences/Literatura Latino Americana e do Caribe em Ci\u00eancias da Sa\u00fade), Cochrane Library, Medline (via Virtual Health Library and PubMed), SciELO (Scientific Electronic Library), and PEDro (Physiotherapy Evidence Database) databases from 2002 to 2013 using the following search terms: \"physiotherapy (techniques)\", \"respiratory therapy\", \"intensive care\", and \"airway clearance\".", {"entities": []}], ["The selected studies were classified according to the level of evidence and grades of recommendation (method of the Oxford Centre for Evidence-Based Medicine) by two examiners, while a third examiner repeated the search and analysis and checked the classification of the articles.", {"entities": []}], ["Three articles were included for analysis, comprising 250 children (aged 0 to 16 years).", {"entities": []}], ["The main diagnoses were acute respiratory failure, recovery following heart congenital disease and upper abdominal surgery, bone marrow transplantation, asthma, tracheal reconstruction, brain injury, airway injury, and heterogeneous lung diseases.", {"entities": [[30, 49, "DISEASE"], [153, 159, "DISEASE"]]}], ["The studies were classified as having a level of evidence 2C and grade of recommendation C. Manual hyperinflation appeared useful for airway clearance in the investigated population, although the evidence available in the literature remains insufficient.", {"entities": []}], ["Therefore, controlled randomized studies are needed to establish the safety and efficacy of manual hyperinflation in pediatric patients.", {"entities": []}], ["However, manual hyperinflation must be performed by trained physical therapists only.", {"entities": []}], ["In many fields of medicine there is a growing interest in characterizing diseases at molecular level with a view to developing an individually tailored therapeutic approach.", {"entities": []}], ["Metabolomics is a novel area that promises to contribute significantly to the characterization of various disease phenotypes and to the identification of personal metabolic features that can predict response to therapies.", {"entities": []}], ["Based on analytical platforms such as mass spectrometry or NMR-based spectroscopy, the metabolomic approach enables a comprehensive overview of the metabolites, leading to the characterization of the metabolic fingerprint of a given sample.", {"entities": []}], ["These metabolic fingerprints can then be used to distinguish between different disease phenotypes and to predict a drug's effectiveness and/or toxicity.", {"entities": []}], ["Several studies published in the last few years applied the metabolomic approach in the field of pediatric medicine.", {"entities": []}], ["Being a highly informative technique that can be used on samples collected non-invasively (e.g.", {"entities": []}], ["urine or exhaled breath condensate), metabolomics has appeal for the study of pediatric diseases.", {"entities": []}], ["Here we present and discuss the pediatric clinical studies that have taken the metabolomic approach.", {"entities": []}], ["This is the first detailed study of the relation between cesarean birth and child cognitive development.", {"entities": []}], ["We measure differences in child cognitive performance at 4 to 9 years of age between cesarean-born and vaginally-born children (n\u2009=\u20093,666) participating in the Longitudinal Study of Australian Children (LSAC).", {"entities": []}], ["LSAC is a nationally representative birth cohort surveyed biennially.", {"entities": []}], ["Using multivariate regression, we control for a large range of confounders related to perinatal risk factors and the socio-economic advantage associated with cesarean-born children.", {"entities": []}], ["Across several measures, we find that cesarean-born children perform significantly below vaginally-born children, by up to a tenth of a standard deviation in national numeracy test scores at age 8\u20139.", {"entities": []}], ["Estimates from a low-risk sub-sample and lower-bound analysis suggest that the relation is not spuriously related to unobserved confounding.", {"entities": []}], ["Lower rates of breastfeeding and adverse child and maternal health outcomes that are associated with cesarean birth are found to explain less than a third of the cognitive gap, which points to the importance of other mechanisms such as disturbed gut microbiota.", {"entities": []}], ["The findings underline the need for a precautionary approach in responding to requests for a planned cesarean when there are no apparent elevated risks from vaginal birth.", {"entities": []}], ["Hospital stay represents the opportunity for a change of therapy, about which patients may not know indications, contraindications, and mode of administration, which may lead to dosing errors, drug interactions, side effects, etc.", {"entities": []}], ["It is therefore vital to communicate appropriate information to the discharged\u00a0patient with a new prescription drug.", {"entities": []}], ["The purpose of the study was to evaluate: 1) how communication about new chronic therapies is managed at hospital discharge and what kind of information is provided to patients; 2) to what extent patients are aware and confident in the management of these medications; 3) whether the way communication is provided affects patients\u2019 awareness and self-confidence in the management of these therapies.", {"entities": []}], ["Participants were adult patients who were prescribed at least one new chronic medication at hospital discharge.", {"entities": []}], ["A telephone interview after hospital discharge was performed to assess whether or not hospital healthcare personnel had given information about prescribed therapies and which aspects of therapies had been object of information.", {"entities": []}], ["Five hundred thirty patients were interviewed.", {"entities": []}], ["67.7% reported having received counseling by the hospital physician, while 32.3% by discharge form.", {"entities": []}], ["Basic information on treatment was provided to the great majority of patients, whereas only few patients reported to have been informed about eventual side effects and related behavior in case of side effects.", {"entities": []}], ["Several aspects of patients\u2019 knowledge and self-confidence on long term medications prescribed at hospital discharge need to be improved and the way communication is provided has a crucial role in the empowerment of patients in the management of these medications.", {"entities": []}], ["To assess whether spirometry done in hospital during an admission for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is clinically useful for long-term management.", {"entities": [[95, 132, "DISEASE"]]}], ["Patients admitted to hospital with a clinical diagnosis of AECOPD had spirometry post-bronchodilator at discharge and approximately 4 weeks later.", {"entities": []}], ["Spirometry was achieved in less than half of those considered to have AECOPD.", {"entities": []}], ["Of 49 patients who had spirometry on both occasions, 41 met the GOLD criteria for COPD at discharge and 39 of these met the criteria at 1 month.", {"entities": []}], ["For the 41, spirometry was not statistically different between discharge and 1 month but often crossed arbitrary boundaries for classification of severity based on FEV 1 .", {"entities": [[164, 167, "GENE"]]}], ["The eight who did not meet GOLD criteria at discharge were either misclassified due to comorbidities that reduce FVC, or they did not have COPD as a cause of their hospital admission.", {"entities": []}], ["Spirometry done in hospital at the time of AECOP is useful in patients with a high pre-test probability of moderate-to-severe COPD.", {"entities": []}], ["Small changes in spirometry at 1 month could place them up or down one grade of severity.", {"entities": []}], ["Spirometry at discharge may be useful to detect those who warrant further investigation.", {"entities": []}], ["Glucocorticoid (GC) resistance is a major barrier in COPD treatment.", {"entities": [[16, 18, "GENE"]]}], ["We have shown increased expression of the drug efflux pump, Pgp1 in cytotoxic/pro-inflammatory lymphocytes in COPD.", {"entities": []}], ["Loss of lymphocyte co-stimulatory molecule CD28 (lymphocyte senescence) was associated with a further increase in their pro-inflammatory/cytotoxic potential and resistance to GC.", {"entities": [[43, 47, "GENE"], [175, 177, "GENE"]]}], ["We hypothesized that lymphocyte senescence and increased Pgp1 are also associated with down-regulation of the GC receptor (GCR).", {"entities": [[110, 112, "GENE"]]}], ["Blood was collected from 10 COPD and 10 healthy aged-matched controls.", {"entities": []}], ["Flow cytometry was applied to assess intracellular pro-inflammatory cytokines, CD28, Pgp1, GCR, steroid binding and relative cytoplasm/nuclear GCR by CD28+ and CD28null T, NKT-like cells.", {"entities": [[79, 83, "GENE"], [150, 154, "GENE"]]}], ["GCR localization was confirmed by fluorescent microscopy.", {"entities": []}], ["COPD was associated with increased numbers of CD28nullCD8+ T and NKT-like cells.", {"entities": []}], ["Loss of CD28 was associated with an increased percentage of T and NKT-like cells producing IFN\u03b3 or TNF\u03b1 and associated with a loss of GCR and Dex-Fluor staining but unchanged Pgp1.", {"entities": [[8, 12, "GENE"]]}], ["There was a significant loss of GCR in CD8\u2009+\u2009CD28null compared with CD8\u2009+\u2009CD28+ T and NKT-like cells from both COPD and controls (eg, mean \u00b1 SEM 8\u2009\u00b1\u20093% GCR + CD8\u2009+\u2009CD28null T-cells vs 49\u2009\u00b1\u20095% GCR\u2009+\u2009CD8\u2009+\u2009CD28+ T-cells in COPD).", {"entities": []}], ["There was a significant negative correlation between GCR expression and IFN\u03b3 and TNF\u03b1 production by T and NKT-like cells(eg, COPD: T-cell IFN\u03b3 R\u2009=\u2009\u2212.615; ) and with FEV1 in COPD (R\u2009=\u2009\u2212.777).", {"entities": []}], ["COPD is associated with loss of GCR in senescent CD28null and NKT-like cells suggesting alternative treatment options to GC are required to inhibit these pro-inflammatory/cytotoxic cells.", {"entities": [[121, 123, "GENE"]]}], ["Beta-blockers are frequently withheld in patients with cardiovascular disease who also have chronic obstructive pulmonary disease (COPD) because of concerns that they might provoke bronchospasm and cause deterioration in health status.", {"entities": [[92, 129, "DISEASE"]]}], ["Although beta1-selective beta-blockers are associated with reduced mortality in COPD patients, their effects on health status are unknown.", {"entities": []}], ["The aim of this study was to investigate the relationship between beta-blockers and health-related quality of life (HRQOL) in patients with peripheral arterial disease and COPD.", {"entities": []}], ["Of the original cohort of 3371 vascular surgery patients, 1310 had COPD of whom 469 survived during long-term follow-up.", {"entities": []}], ["These COPD patients were sent the Short Form-36 (SF-36) health-related quality of life questionnaire, which was completed and returned by 326 (70%) patients.", {"entities": []}], ["No significant differences in any of the SF-36 domains were observed between COPD patients who did and did not use beta-blockers (p > 0.05 for all).", {"entities": []}], ["Furthermore, beta-blockers were not associated with any impairment in HRQOL among patients with COPD.", {"entities": []}], ["Beta-blockers had no material impact on the HRQOL of patients with peripheral arterial disease who also had COPD.", {"entities": []}], ["This suggests that beta-blockers can, in most circumstances, be administered to patients with COPD without impairment in HRQOL.", {"entities": []}], ["Some forms of pharmacotherapy are shown to increase the risk of community-acquired pneumonia (CAP).", {"entities": [[83, 92, "DISEASE"]]}], ["The purpose of this study is to investigate whether pharmacotherapy with proton pump inhibitors (PPI), inhaled corticosteroids, and atypical antipsychotics was associated with the increased risk for CAP in hospitalized older adults with the adjustment of known risk factors (such as smoking status and serum albumin levels).", {"entities": []}], ["A retrospective case-control study of adults aged 65 years or older at a rural community hospital during 2004 and 2006 was conducted.", {"entities": []}], ["Cases (N = 194) were those with radiographic evidence of pneumonia on admission.", {"entities": [[57, 66, "DISEASE"]]}], ["The controls were patients without the discharge diagnosis of pneumonia or acute exacerbation of chronic obstructive pulmonary disease (COPD) (N = 952).", {"entities": [[62, 71, "DISEASE"], [97, 134, "DISEASE"]]}], ["Patients with gastric tube feeding, ventilator support, requiring hemodialysis, metastatic diseases or active lung cancers were excluded.", {"entities": []}], ["Multiple logistic regression analysis revealed that the current use of inhaled corticosteroids (adjusted odds ratio [AOR] = 2.89, 95% confidence interval [CI] = 1.56-5.35) and atypical antipsychotics (AOR = 2.26, 95% CI = 1.23-4.15) was an independent risk factor for CAP after adjusting for confounders, including age, serum albumin levels, sex, smoking status, a history of congestive heart failure, coronary artery disease, and COPD, the current use of PPI, \u03b22 agonist and anticholinergic bronchodilators, antibiotic(s), iron supplement, narcotics, and non-steroidal anti-inflammatory drugs.", {"entities": [[376, 400, "DISEASE"]]}], ["The crude OR and the AOR of PPI use for CAP was 1.41 [95% CI = 1.03 - 1.93] and 1.18 [95% CI = 0.80 - 1.74] after adjusting for the above confounders, respectively.", {"entities": []}], ["Lower serum albumin levels independently increased the risk of CAP 1.89- fold by decreasing a gram per deciliter (AOR = 2.89, 95% CI = 2.01 - 4.16).", {"entities": []}], ["Our study reaffirmed that the use of inhaled corticosteroids and atypical antipsychotics was both associated with an increased risk for CAP in hospitalized older adults of a rural community.", {"entities": []}], ["No association was found between current PPI use and the risk for CAP in this patient population of our study.", {"entities": []}], ["In recent years, electronic nose (e-nose) systems have become a focus method for diagnosing pulmonary diseases such as lung cancer.", {"entities": [[119, 130, "DISEASE"], [124, 130, "DISEASE"]]}], ["However, principles and patterns of sensor responses in traditional e-nose systems are relatively homogeneous.", {"entities": []}], ["Less study has been focused on type-different sensor arrays.", {"entities": []}], ["In this paper, we designed a miniature e-nose system using 14 gas sensors of four types and its subsequent analysis of 52 breath samples.", {"entities": []}], ["To investigate the performance of this system in identifying and distinguishing lung cancer from other respiratory diseases and healthy controls, five feature extraction algorithms and two classifiers were adopted.", {"entities": [[80, 91, "DISEASE"], [85, 91, "DISEASE"]]}], ["Lastly, the influence of type-different sensors on the identification ability of e-nose systems was analyzed.", {"entities": []}], ["Results indicate that when using the LDA fuzzy 5 -NN classification method, the sensitivity, specificity and accuracy of discriminating lung cancer patients from healthy controls with e-nose systems are 91.58%, 91.72% and 91.59%, respectively.", {"entities": [[136, 147, "DISEASE"], [141, 147, "DISEASE"]]}], ["Our findings also suggest that type-different sensors could significantly increase the diagnostic accuracy of e-nose systems.", {"entities": []}], ["These results showed e-nose system proposed in this study was potentially practicable in lung cancer screening with a favorable performance.", {"entities": [[89, 100, "DISEASE"], [94, 100, "DISEASE"]]}], ["In addition, it is important for type-different sensors to be considered when developing e-nose systems.", {"entities": []}], ["Using the COPD Diagnostic Questionnaire (CDQ) as a selection tool for spirometry could potentially improve the efficiency and accuracy of chronic obstructive pulmonary disease (COPD) diagnosis in at-risk patients.", {"entities": [[138, 175, "DISEASE"]]}], ["To identify an optimal single cut point for the CDQ that divides primary care patients into low or high likelihood of COPD, with the latter group undergoing spirometry.", {"entities": []}], ["Former or current smokers aged 40\u201385 years with no prior COPD diagnosis were invited to a case-finding appointment with the practice nurse at various general practices in Sydney, Australia.", {"entities": []}], ["The CDQ was collected and pre- and post-bronchodilator spirometry was performed.", {"entities": []}], ["Cases with complete CDQ data and spirometry meeting quality standards were analysed (1,054 out of 1,631 patients).", {"entities": []}], ["CDQ cut points were selected from a receiver operating characteristic (ROC) curve.", {"entities": []}], ["The area under the ROC curve was 0.713.", {"entities": []}], ["A cut point of 19.5 had the optimal combination of sensitivity (63%) and specificity (70%) with two-thirds below this cut point.", {"entities": []}], ["A cut point of 14.5 corresponded to a sensitivity of 91%, specificity of 35% and negative predictive value of 96%, and 31% of patients below this cut point.", {"entities": []}], ["The CDQ can be used to select patients at risk of COPD for spirometry using one cut point.", {"entities": []}], ["We consider two possible cut points.", {"entities": []}], ["The 19.5 cut point excludes a higher proportion of patients from undergoing spirometry with the trade-off of more false negatives.", {"entities": []}], ["The 14.5 cut point has a high sensitivity and negative predictive value, includes more potential COPD cases but has a higher rate of false positives.", {"entities": []}], ["The current reference test for the detection of respiratory abnormalities in asbestos-exposed workers is spirometry.", {"entities": []}], ["However, spirometry has several shortcomings that greatly affect the efficacy of current asbestos control programs.", {"entities": []}], ["The forced oscillation technique (FOT) represents the current state-of-the-art technique in the assessment of lung function.", {"entities": []}], ["This method provides a detailed analysis of respiratory resistance and reactance at different oscillatory frequencies during tidal breathing.", {"entities": []}], ["Here, we evaluate the FOT as an alternative method to standard spirometry for the early detection and quantification of respiratory abnormalities in asbestos-exposed workers.", {"entities": []}], ["Seventy-two subjects were analyzed.", {"entities": []}], ["The control group was composed of 33 subjects with a normal spirometric exam who had no history of smoking or pulmonary disease.", {"entities": []}], ["Thirty-nine subjects exposed to asbestos were also studied, including 32 volunteers in radiological category 0/0 and 7 volunteers with radiological categories of 0/1 or 1/1.", {"entities": []}], ["FOT data were interpreted using classical parameters as well as integer (InOr) and fractional-order (FrOr) modeling.", {"entities": []}], ["The diagnostic accuracy was evaluated by investigating the area under the receiver operating characteristic curve (AUC).", {"entities": []}], ["Exposed workers presented increased obstruction (resistance p<0.001) and a reduced compliance (p<0.001), with a predominance of obstructive changes.", {"entities": []}], ["The FOT parameter changes were correlated with the standard pulmonary function analysis methods (R = -0.52, p<0.001).", {"entities": []}], ["Early respiratory abnormalities were identified with a high diagnostic accuracy (AUC = 0.987) using parameters obtained from the FrOr modeling.", {"entities": []}], ["This accuracy was significantly better than those obtained with classical (p<0.001) and InOr (p<0.001) model parameters.", {"entities": []}], ["The FOT improved our knowledge about the biomechanical abnormalities in workers exposed to asbestos.", {"entities": []}], ["Additionally, a high diagnostic accuracy in the diagnosis of early respiratory abnormalities in asbestos-exposed workers was obtained.", {"entities": []}], ["This makes the FOT particularly useful as a screening tool in the context of asbestos control and elimination.", {"entities": []}], ["Moreover, it can facilitate epidemiological research and the longitudinal follow-up of asbestos exposure and asbestos-related diseases.", {"entities": []}], ["Methyl methacrylate (MMA) is a respiratory irritant and dermal sensitizer that has been associated with occupational asthma in a small number of case reports.", {"entities": [[117, 123, "DISEASE"]]}], ["Those reports have raised concern that it might be a respiratory sensitizer.", {"entities": []}], ["To better understand that possibility, we reviewed the in silico, in chemico, in vitro, and in vivo toxicology literature, and also epidemiologic and occupational medicine reports related to the respiratory effects of MMA.", {"entities": []}], ["Numerous in silico and in chemico studies indicate that MMA is unlikely to be a respiratory sensitizer.", {"entities": []}], ["The few in vitro studies suggest that MMA has generally weak effects.", {"entities": []}], ["In vivo studies have documented contact skin sensitization, nonspecific cytotoxicity, and weakly positive responses on local lymph node assay; guinea pig and mouse inhalation sensitization tests have not been performed.", {"entities": []}], ["Cohort and cross-sectional worker studies reported irritation of eyes, nose, and upper respiratory tract associated with short-term peaks exposures, but little evidence for respiratory sensitization or asthma.", {"entities": [[202, 208, "DISEASE"]]}], ["Nineteen case reports described asthma, laryngitis, or hypersensitivity pneumonitis in MMA-exposed workers; however, exposures were either not well described or involved mixtures containing more reactive respiratory sensitizers and irritants.The weight of evidence, both experimental and observational, argues that MMA is not a respiratory sensitizer.", {"entities": [[40, 50, "DISEASE"], [32, 38, "DISEASE"]]}], ["The epithelial sodium channel (ENaC) mediates passive sodium transport across the apical membranes of sodium absorbing epithelia, like the distal nephron, the intestine, and the lung airways.", {"entities": []}], ["Additionally, the channel has been involved in the transduction of mechanical stimuli, such as hydrostatic pressure, membrane stretch, and shear stress from fluid flow.", {"entities": []}], ["Thus, in vascular endothelium, it participates in the control of the vascular tone via its activity both as a sodium channel and as a shear stress transducer.", {"entities": []}], ["Rather recently, ENaC has been shown to participate in the processes of wound healing, a role that may also involve its activities as sodium transporter and as mechanotransducer.", {"entities": []}], ["Its presence as the sole channel mediating sodium transport in many tissues and the diversity of its functions probably underlie the complexity of its regulation.", {"entities": []}], ["This brief review describes some aspects of ENaC regulation, comments on evidence about ENaC participation in wound healing, and suggests possible regulatory mechanisms involved in this participation.", {"entities": []}], ["Cigarette smoke exposure in utero and during early postnatal development increases the incidence of asthma and airway hyperresponsiveness (AHR) later in life, suggesting that a possible critical period of developmental sensitivity exists in the prenatal and early postnatal periods.", {"entities": [[100, 106, "DISEASE"], [139, 142, "GENE"]]}], ["We investigated mechanisms of susceptibility during critical developmental periods to sidestream smoke (SS) exposure and evaluated the possible effects of SS on neural responses.", {"entities": []}], ["We exposed three different age groups of mice to either SS or filtered air (FA) for 10 consecutive days beginning on gestation day (GD) 7 by maternal exposure or beginning on postnatal day (PND) 2 or PND21 by direct inhalation.", {"entities": []}], ["Lung function, airway substance P (SP) innervation, and nerve growth factor (NGF) levels in broncho alveolar lavage fluid were measured after a single SS exposure on PND59.", {"entities": [[77, 80, "GENE"]]}], ["Methacholine (MCh) dose response for lung resistance (R L ) was significantly elevated, and dynamic pulmonary compliance (C dyn ) was significantly decreased, in the GD7 and PND2 SS exposure groups compared with the FA groups after SS exposure on PND59.", {"entities": []}], ["At the same time points, the percent area of SP nerve fibers in tracheal smooth muscle and the levels of NGF were significantly elevated.", {"entities": [[105, 108, "GENE"]]}], ["MCh dose\u2013response curves for R L and C dyn , SP nerve fiber density, and the level of NGF were not significantly changed in the PND21 exposure group after SS exposure on PND59.", {"entities": [[86, 89, "GENE"]]}], ["These results suggest that a critical period of susceptibility to SS exposure exists in the prenatal and early postnatal period of development in mice that results in increased SP innervation, increased NGF levels in the airway, and enhanced MCh AHR later in life.", {"entities": [[203, 206, "GENE"], [246, 249, "GENE"]]}], ["This investigation offers insights into system-wide pathological processes induced in response to cigarette smoke exposure by determining its influences at the gene expression level.", {"entities": []}], ["We obtained genome-wide quantitative transcriptional profiles from 1,240 individuals from the San Antonio Family Heart Study, including 297 current smokers.", {"entities": []}], ["Using lymphocyte samples, we identified 20,413 transcripts with significantly detectable expression levels, including both known and predicted genes.", {"entities": []}], ["Correlation between smoking and gene expression levels was determined using a regression model that allows for residual genetic effects.", {"entities": []}], ["With a conservative false-discovery rate of 5% we identified 323 unique genes (342 transcripts) whose expression levels were significantly correlated with smoking behavior.", {"entities": []}], ["These genes showed significant over-representation within a range of functional categories that correspond well with known smoking-related pathologies, including immune response, cell death, cancer, natural killer cell signaling and xenobiotic metabolism.", {"entities": [[191, 197, "DISEASE"]]}], ["Our results indicate that not only individual genes but entire networks of gene interaction are influenced by cigarette smoking.", {"entities": []}], ["This is the largest in vivo transcriptomic epidemiological study of smoking to date and reveals the significant and comprehensive influence of cigarette smoke, as an environmental variable, on the expression of genes.", {"entities": []}], ["The central importance of this manuscript is to provide a summary of the relationships between gene expression and smoking in this exceptionally large cross-sectional data set.", {"entities": []}], ["The aim of this study was to compare the effectiveness of a femoral nerve block and a periarticular infiltration in the management of early post-operative pain after total knee arthroplasty (TKA).", {"entities": []}], ["A pragmatic, single centre, two arm parallel group, patient blinded, randomised controlled trial was undertaken.", {"entities": []}], ["All patients due for TKA were eligible.", {"entities": []}], ["Exclusion criteria included contraindications to the medications involved in the study and patients with a neurological abnormality of the lower limb.", {"entities": []}], ["Patients received either a femoral nerve block with 75 mg of 0.25% levobupivacaine hydrochloride around the nerve, or periarticular infiltration with 150 mg of 0.25% levobupivacaine hydrochloride, 10 mg morphine sulphate, 30 mg ketorolac trometamol and 0.25 mg of adrenaline all diluted with 0.9% saline to make a volume of 150 ml.", {"entities": []}], ["A total of 264 patients were recruited and data from 230 (88%) were available for the primary analysis.", {"entities": []}], ["Intention-to-treat analysis of the primary outcome measure of a visual analogue score for pain on the first post-operative day, prior to physiotherapy, was similar in both groups.", {"entities": []}], ["The mean difference was -0.7 (95% confidence interval (CI) -5.9 to 4.5; p = 0.834).", {"entities": []}], ["The periarticular group used less morphine in the first post-operative day compared with the femoral nerve block group (74%, 95% CI 55 to 99).", {"entities": []}], ["The femoral nerve block group reported 39 adverse events, of which 27 were serious, in 31 patients and the periarticular group reported 51 adverse events, of which 38 were serious, in 42 patients up to six weeks post-operatively.", {"entities": []}], ["None of the adverse events were directly attributed to either of the interventions under investigation.", {"entities": []}], ["Periarticular infiltration is a viable and safe alternative to femoral nerve block for the early post-operative relief of pain following TKA.", {"entities": []}], ["Cite this article: Bone Joint J 2017;99-B:904\u201311.", {"entities": []}], ["We have previously shown that transforming growth factor-beta (TGF-beta) impairs glucocorticoid (GC) function in pulmonary epithelial cell-lines.", {"entities": [[97, 99, "GENE"]]}], ["However, the signalling cascade leading to this impairment is unknown.", {"entities": []}], ["In the present study, we provide the first evidence that TGF-beta impairs GC action in differentiated primary air-liquid interface (ALI) human bronchial epithelial cells (HBECs).", {"entities": [[74, 76, "GENE"]]}], ["Using the BEAS-2B bronchial epithelial cell line, we also present a systematic examination of the known pathways activated by TGF-beta, in order to ascertain the molecular mechanism through which TGF-beta impairs epithelial GC action.", {"entities": [[224, 226, "GENE"]]}], ["GC transactivation was measured using a Glucocorticoid Response Element (GRE)\u2013Secreted embryonic alkaline phosphatase (SEAP) reporter and measuring GC-inducible gene expression by qRT-PCR.", {"entities": [[0, 2, "GENE"], [148, 150, "GENE"]]}], ["GC transrepression was measured by examining GC regulation of pro-inflammatory mediators.", {"entities": [[0, 2, "GENE"], [45, 47, "GENE"], [0, 2, "GENE"], [45, 47, "GENE"]]}], ["TGF-beta signalling pathways were investigated using siRNA and small molecule kinase inhibitors.", {"entities": []}], ["GR\u03b1 level, phosphorylation and sub-cellular localisation were determined by western blotting, immunocytochemistry and localisation of GR\u03b1\u2013Yellow Fluorescent Protein (YFP).", {"entities": []}], ["Data are presented as the mean\u2009\u00b1\u2009SEM for n independent experiments in cell lines, or for experiments on primary HBEC cells from n individual donors.", {"entities": []}], ["All data were statistically analysed using GraphPad Prism 5.0 (Graphpad, San Diego, CA).", {"entities": []}], ["In most cases, two-way analyses of variance (ANOVA) with Bonferroni post-hoc tests were used to analyse the data.", {"entities": []}], ["In all cases, P <0.05 was considered to be statistically significant.", {"entities": []}], ["TGF-beta impaired Glucocorticoid Response Element (GRE) activation and the GC induction of several anti-inflammatory genes, but did not broadly impair the regulation of pro-inflammatory gene expression in A549 and BEAS-2B cell lines.", {"entities": [[75, 77, "GENE"]]}], ["TGF-beta-impairment of GC transactivation was also observed in differentiated primary HBECs.", {"entities": [[23, 25, "GENE"]]}], ["The TGF-beta receptor (ALK5) inhibitor SB431541 fully prevented the GC transactivation impairment in the BEAS-2B cell line.", {"entities": [[68, 70, "GENE"]]}], ["However, neither inhibitors of the known downstream non-canonical signalling pathways, nor knocking down Smad4 by siRNA prevented the TGF-beta impairment of GC activity.", {"entities": [[105, 110, "GENE"], [157, 159, "GENE"]]}], ["Our results indicate that TGF-beta profoundly impairs GC transactivation in bronchial epithelial cells through activating ALK5, but not through known non-canonical pathways, nor through Smad4-dependent signalling, suggesting that TGF-beta may impair GC action through a novel non-canonical signalling mechanism.", {"entities": [[54, 56, "GENE"], [250, 252, "GENE"], [54, 56, "GENE"], [250, 252, "GENE"]]}], ["Assessment of airway inflammation in the clinical course of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) may advance our understanding of the pathogenesis and treatment.", {"entities": [[83, 120, "DISEASE"]]}], ["To assess airway inflammation in patients during the course of AECOPD by serial analyses of their exhaled breath condensates (EBC).", {"entities": []}], ["Twenty-six patients with AECOPD (22 males, mean[SD] percentage predicted forced expiratory volume in one second (FEV 1 ) 44.8 [14.3]), 11 with stable COPD, and 14 age and sex-matched healthy controls were studied.", {"entities": [[113, 116, "GENE"]]}], ["Patients with AECOPD were treated with systemic steroid and antibiotic for 7 days.", {"entities": []}], ["EBC was collected from each patient with AECOPD on Day 5, 14, 30, and 60 post-hospitalization using EcoScreen (VIASYS Healthcare, USA) during tidal breathing over 10 minutes.", {"entities": []}], ["Concentrations of tumor necrosis factor-\u03b1 (TNF-\u03b1), leukotriene B4 (LTB4), and interleukin-8 (IL-8) were measured by enzyme-linked immunosorbent assay.", {"entities": []}], ["The median (IQR) of TNF-\u03b1 level on Day 5 was 5.08 (3.80\u20136.32) pg/ml, which was lower than on Day 14 (5.84 [4.91\u20139.14] pg/ml, p = 0.017), Day 30 (6.14 [3.82\u20137.67] pg/ml, p = 0.045), and Day 60 (5.60 [4.53\u20138.80] pg/ml, p = 0.009).", {"entities": []}], ["On Day 60, subjects receiving inhaled corticosteroid (ICS) had a lower level of TNF-\u03b1 than those who were not (4.82 [4.06\u20135.65] vs 7.66 [5.48\u201310.9] pg/ml, p = 0.02).", {"entities": []}], ["EBC LTB4 level did not change significantly during recovery from AECOPD whereas IL-8 was mostly undetectable.", {"entities": []}], ["EBC TNF-\u03b1 level was low in patients receiving systemic steroid and antibiotic therapy for AECOPD.", {"entities": []}], ["These findings suggest a potential role for serial EBC TNF-\u03b1 for non-invasive monitoring of disease activity.", {"entities": []}], ["Oxysterol like 27-hydroxycholesterol (27OHChol) has been reported to induce differentiation of monocytic cells into a mature dendritic cell phenotype.", {"entities": []}], ["We examined whether dexamethasone (Dx) affects 27OHChol-induced differentiation using THP-1 cells.", {"entities": []}], ["Treatment of monocytic cells with Dx resulted in almost complete inhibition of transcription and surface expression of CD80, CD83, and CD88 induced by 27OHChol.", {"entities": [[119, 123, "GENE"], [125, 129, "GENE"]]}], ["Elevated surface levels of MHC class I and II molecules induced by 27OHChol were reduced to basal levels by treatment with Dx.", {"entities": []}], ["A decreased endocytosis ability caused by 27OHChol was recovered by Dx.", {"entities": []}], ["We also examined effects of Dx on expression of CD molecules involved in atherosclerosis.", {"entities": [[73, 88, "DISEASE"]]}], ["Increased levels of surface protein and transcription of CD105, CD137, and CD166 by treatment with 27OHChol were significantly inhibited by cotreatment with Dx.", {"entities": []}], ["These results indicate that Dx inhibits 27OHChol-induced differentiation of monocytic cells into a mature dendritic cell phenotype and expression of CD molecules whose levels are associated with atherosclerosis.", {"entities": [[195, 210, "DISEASE"]]}], ["In addition, we examined phosphorylation of AKT induced by 27OHChol and effect of Dx, where cotreatment with Dx inhibited the phosphorylation of AKT.", {"entities": []}], ["The current study reports that Dx regulates oxysterol-mediated dendritic cell differentiation of monocytic cells.", {"entities": []}], ["Supplemental Digital Content is available in the text Hereditary angioedema (HAE) with deficiency of C1 inhibitor (C1-INH) is an autosomal-dominant disease characterized by recurrent episodes of potentially life-threatening angioedema.", {"entities": [[65, 75, "DISEASE"], [224, 234, "DISEASE"]]}], ["The objective is to study the incidence of HAE among patients who visit the emergency department.", {"entities": []}], ["This was a 3-year prospective observational screening study involving 13 urban tertiary emergency centers in Osaka prefecture, Japan.", {"entities": []}], ["Patients were included if they met the following criteria: unexplained edema of the body, upper airway obstruction accompanied by edema, anaphylaxis, acute abdomen with intestinal edema (including ileus and acute pancreatitis), or asthma attack.", {"entities": [[197, 202, "DISEASE"], [213, 225, "DISEASE"], [207, 225, "DISEASE"], [231, 237, "DISEASE"]]}], ["C1-INH activity and C4 level were measured at the time of emergency department admission during the period between July 2011 and June 2014.", {"entities": []}], ["This study comprised 66 patients with a median age of 54.0 (IQR: 37.5\u201368.3) years.", {"entities": []}], ["Three patients were newly diagnosed as having HAE, and 1 patient had already been diagnosed as having HAE.", {"entities": []}], ["C1-INH activity levels of the patients with HAE were below the detection limit (<25%), whereas those of non-HAE patients (n = 62) were 106% (IQR: 85.5%\u2013127.0%) (normal range, 70%\u2013130%).", {"entities": []}], ["The median level of C4 was significantly lower in the patients with HAE compared with those without HAE (1.2 [IQR: 1\u20133] mg/dL vs 22 [IQR: 16.5\u201329.5] mg/dL, P \u200a<\u200a0.01) (normal range, 17\u201345\u200amg/dL).", {"entities": []}], ["Three patients with undiagnosed HAE were diagnosed as having HAE in the emergency department during the 3-year period.", {"entities": []}], ["If patients have signs and symptoms suspicious of HAE, the levels of C1-INH activity and C4 should be measured.", {"entities": []}], ["In a previous study, exhaled carbon monoxide (eCO) has been assessed in healthy non-smokers with a photo acoustic spectrometer Br\u00fcel&Kj\u00e6r 1312.", {"entities": []}], ["Unexpectedly, values were higher than those reported in literature, which were mostly obtained with electrochemical analysers.", {"entities": []}], ["This study was aimed to compare eCO values obtained with Br\u00fcel&Kj\u00e6r 1312 and PiCO\u2009+\u2009Smokerlyzer, a largely utilized electrochemical analyser.", {"entities": []}], ["Thirty-four healthy subjects, 15 non-smokers and 19 smokers, underwent eCO assessment with Br\u00fcel&Kj\u00e6r 1312 and PiCO\u2009+\u2009Smokerlyzer during a prolonged expiration (15\u00a0seconds).", {"entities": []}], ["Br\u00fcel&Kj\u00e6r 1312 assessed CO concentration 7 and 12\u00a0seconds after the beginning of expiration and displayed the mean value.", {"entities": []}], ["PiCO\u2009+\u2009Smokerlyzer was utilized according to the manufacturer\u2019s recommendations.", {"entities": []}], ["In vitro, the two devices were tested with standard concentrations of CO in nitrogen (5, 9.9, 20, and 50\u00a0ppm), and the time needed by PiCO\u2009+\u2009Smokerlyzer readings to stabilize was assessed at different gas flows.", {"entities": []}], ["Both Br\u00fcel&Kj\u00e6r 1312 and PiCO\u2009+\u2009Smokerlyzer presented very good internal consistency.", {"entities": []}], ["The values provided were strictly correlated, but at low test concentrations, the Br\u00fcel&Kj\u00e6r 1312 readings were greater than the PiCO\u2009+\u2009Smokerlyzer, and vice versa.", {"entities": []}], ["PiCO\u2009+\u2009Smokerlyzer overestimated the CO standard concentrations at 5 and 9.9\u00a0ppm by 20%, while Br\u00fcel&Kj\u00e6r 1312 measures were correct.", {"entities": []}], ["PiCO\u2009+\u2009Smokerlyzer readings stabilized in 12\u00a0seconds during in vitro tests and in 15\u00a0seconds during in vivo measurements, suggesting that the values displayed corresponded to the initial phase of expiration.", {"entities": []}], ["Differences between Br\u00fcel&Kj\u00e6r 1312 and PiCO\u2009+\u2009Smokerlyzer may be explained because Br\u00fcel&Kj\u00e6r 1312 measured CO levels in the middle and at the end of expiration while PiCO\u2009+\u2009Smokerlyzer assessed them in the initial part of expiration.", {"entities": []}], ["To determine whether COPD severity correlates with sputum cell counts, atopy, and asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["This was a cross-sectional study involving 37 patients with COPD and 22 healthy subjects with normal lung function (controls).", {"entities": []}], ["Sputum cell counts were determined by microscopy after centrifugation of samples.", {"entities": []}], ["Skin prick tests were performed, and serum cytokines were determined by ELISA.", {"entities": []}], ["Patients were stratified by bronchodilator response: a non-reversible airflow limitation ( non RAL) group comprised 24 patients showing no significant post-bronchodilator change in FEV 1 ; and a partially reversible airflow limitation ( partial RAL) group comprised 13 patients showing FEV 1 reversibility (post-bronchodilator FEV 1 increase \u2265 12%).", {"entities": [[181, 184, "GENE"], [286, 289, "GENE"], [327, 330, "GENE"], [181, 184, "GENE"], [286, 289, "GENE"], [327, 330, "GENE"], [181, 184, "GENE"], [286, 289, "GENE"], [327, 330, "GENE"]]}], ["The proportion of eosinophils in sputum was higher in the partial RAL group than in the non RAL group (p < 0.01), and there was an inverse correlation between the proportion of eosinophils and FEV 1 (p < 0.05).", {"entities": [[193, 196, "GENE"]]}], ["However, none of the patients had a history of asthma and skin prick test results did not differ between the two groups.", {"entities": [[47, 53, "DISEASE"]]}], ["In the patient sputum samples, neutrophils predominated.", {"entities": []}], ["Serum levels of TNF, IL-6, IL-8, and RANTES (CCL5) were higher in patients than in controls (p < 0.001) but did not differ between the two patient groups.", {"entities": [[16, 19, "GENE"], [45, 49, "GENE"]]}], ["COPD patients with partial FEV 1 reversibility appear to have higher sputum eosinophil counts and greater airway hyperresponsiveness than do those with no FEV 1 reversibility.", {"entities": [[27, 30, "GENE"], [155, 158, "GENE"], [27, 30, "GENE"], [155, 158, "GENE"]]}], ["However, we found that COPD severity did not correlate with atopy or with the cytokine profile.", {"entities": []}], ["Lambda-cyhalothrin (LTC) is a synthetic pyrethroid insecticide for agricultural and public health applications.", {"entities": []}], ["This study was to determine the pathological alterations of LTC in lungs, which has not previously been studied, and the ameliorating effects of plant extracts (ginseng and garlic) on the development of asthma in albino rats.", {"entities": [[203, 209, "DISEASE"]]}], ["Four groups (gps) of albino rats, (n\u2009=\u200920, average body weight\u2009=\u2009200 gm with an age of 4\u00a0months), were formed.", {"entities": []}], ["Gp 1 was kept as control.", {"entities": []}], ["Gp 2 was injected intraperitoneally (i.p.)", {"entities": []}], ["with LTC at a dose of 1/6 LD50 that is 9.34\u00a0mg/kg body weight (w.t.)", {"entities": []}], ["daily for 21\u00a0days (d).", {"entities": []}], ["Gp 3 & 4 were injected (i.p.)", {"entities": []}], ["with ginseng at the dose of 200\u00a0mg/kg b.wt and garlic (Allium sativum L.) at the dose of 100\u00a0mg/kg b.wt., respectively, one hour before being given LTC at a dose of 1/6 LD50 (9.34\u00a0mg/kg b.wt.)", {"entities": []}], ["Each groups were divided into two sacrificed, at 15 and 21 d p.i.", {"entities": []}], ["Blood and lung samples were collected for hematological and histopathological examinations.", {"entities": []}], ["Hematological findings showed that the animals in gps 2 and 3, which were treated for 21\u00a0days, showed a significant difference in RBC counts (P\u2009>\u2009.001), Hb (P\u2009>\u2009.007), PCV% (P\u2009>\u2009.004), (P\u2009>\u2009.008) in comparison with the control group.", {"entities": []}], ["Signs of cough and nasal discharge were seen in gp 2, which became mild in gp 4.", {"entities": []}], ["Grossly, the lungs showed congestion and consolidation in gp 2.", {"entities": []}], ["Histopathologically, macroabscesses and interstitial alveolitis were seen in gp 2, which led to obstruction in the lumen of the bronchioles at 21 d p.i.", {"entities": []}], ["Meanwhile, thickening in the interalveolar septa with mononuclear cells was seen in gps.", {"entities": []}], ["3 and 4 at 21d p.i.", {"entities": []}], ["The study shows 3 gps of rats injected with LHC alone or combined with garlic and ginseng extract, each group were divided into two sacrificed (15 and 21 d p.i.).", {"entities": []}], ["Lambda cyhalothrin causes bronchial obstruction in the lungs of the rats (15 and 21 d p.i), which decreased into mild to moderate interstitial inflammation in the rats given garlic and ginseng, respectively.", {"entities": []}], ["Measuring range of motion (ROM) in the shoulder joint is important for the diagnosis and monitoring of change over time.", {"entities": []}], ["To what degree passive ROM can be trusted as a reliable outcome measure was examined as part of an on-going randomized controlled trial for patients with shoulder capsulitis.", {"entities": []}], ["The aim of this study was to examine intertester reliability of passive ROM in the shoulder joint over a period of eight weeks in patients with adhesive capsulitis stage II.", {"entities": []}], ["Fifty patients with a clinical diagnosis of adhesive shoulder capsulitis were examined by two independent testers.", {"entities": []}], ["A predefined protocol was used for measuring passive range of motion with an inclinometer, a plurimeter, in both affected and non-affected shoulders three times; at the start of the study and after 4 and 8\u00a0weeks.", {"entities": []}], ["Very good to excellent intertester agreements were found for most parameters for the affected arm at all three test points.", {"entities": []}], ["The intraclass correlation coefficient (ICC 2.1) values ranged from 0.76 to 0.98, i.e.", {"entities": []}], ["from very reliable to excellent.", {"entities": []}], ["The measurement error was in general small for the affected arm (5\u00b0\u20137\u00b0).", {"entities": []}], ["ICCs were slightly lower for the non-affected arm at 8\u00a0weeks, but with acceptable measurement errors.", {"entities": []}], ["Intertester reliability between two testers was very good at three visits over a time period of eight weeks using a plurimeter to measure passive range of motion in patients with adhesive shoulder capsulitis.", {"entities": []}], ["This method can reliably determine passive range of motion in this patient population and be a reliable outcome measure.", {"entities": []}], ["As emphasized by international recommendations and largely confirmed by clinical experience, long-acting bronchodilators play a central role in the maintenance treatment of chronic obstructive pulmonary disease (COPD) due to their proven efficacy in reducing airflow obstruction and improving symptoms.", {"entities": [[173, 210, "DISEASE"]]}], ["There are some important aspects to define with regard to inhalation therapy for COPD, particularly those concerning the selection criteria and the optimal use of long-acting bronchodilators.", {"entities": []}], ["First of all, it needs to be determined in which patients and clinical situations monotherapy with one bronchodilator, such as a long-acting muscarinic antagonist (LAMA), should be considered adequate, and in which cases the use of combination therapies, such as the \u201cdouble bronchodilation\u201d with a LAMA and a long-acting \u03b22-agonist (LABA), should be preferred.", {"entities": []}], ["Another critical issue concerns the effect of the frequency of daily administration of inhaled agents on the control of symptoms during the 24 h. COPD symptoms are known to exhibit considerable circadian variability with worsening in the early morning, and a significant proportion of patients have disease-related sleep disorders which can adversely affect their quality of life.", {"entities": []}], ["The worsening of symptoms in the early morning may be due, at least in part, to a reduction in airway caliber caused by an increased \u201ccholinergic tone\u201d at night.", {"entities": []}], ["As such, the coverage of nighttime and early morning symptoms is a reasonable therapeutic goal, which can be achieved by many patients using LAMAs such as aclidinium bromide twice daily (BID).", {"entities": []}], ["Therapeutic adherence is known to be a multifactorial phenomenon that is frequently affected by other aspects than dosing frequency, including the technical features and ease of use of the inhalers.", {"entities": []}], ["To this end, it should be mentioned that certain new-generation inhalers such as Genuair\u00ae have been associated in clinical trials with higher patient preference.", {"entities": []}], ["In this work, in addition to presenting an overview of the main evidence on the efficacy of COPD treatment with the LAMA aclidinium bromide BID, we suggest some selection criteria for the monotherapy with one long-acting bronchodilator or the combination therapy with LAMA and LABA in COPD patients, with particular reference to specific clinical scenarios.", {"entities": []}], ["Respiratory tract infections (RTIs) are a heavy burden on society.", {"entities": []}], ["However, due to the complex etiology of RTIs, the clinical diagnosis, treatment, and prevention of these infections remain challenging, especially in developing countries.", {"entities": []}], ["To determine the epidemiological and clinical characteristics of 18 respiratory pathogens, we analyzed 12,502 patients with acute respiratory infections (ARIs) by performing polymerase chain reaction (PCR) on patient pharyngeal swabs.", {"entities": []}], ["Samples positive for at least 1 pathogen were obtained from 48.42% of the total patients.", {"entities": []}], ["Of these pathogen-positive patients, 17.99% were infected with more than 1 pathogen.", {"entities": []}], ["Of the 18 pathogens analyzed, four were detected with a positive detection rate (PDR) > 5%: influenza A virus (IAV) > respiratory syncytial virus (RSV) > Mycoplasma pneumoniae (MP) > human coronavirus (HCoV).", {"entities": [[92, 101, "DISEASE"]]}], ["The pathogens with the 4 highest co-infection rates (CIRs) were as follows: HCoV > human bocavirus (HBoV) > enterovirus (EV) > parainfluenza virus (PIV).", {"entities": []}], ["The overall positive detection rate (PDR) varied significantly according to patient age, the season and year of detection, and the disease subgroup, but not according to patient sex.", {"entities": []}], ["The individual PDRs of the pathogens followed 3 types of distributions for patient sex, 4 types of distributions for patient age, 4 types of seasonal distributions, 2 types of seasonal epidemic trends, 4 types of yearly epidemic trends, and different susceptibility distributions in the disease subgroups.", {"entities": []}], ["Additionally, the overall CIR showed significantly different distributions according to patient sex, patient age, and the disease subgroup, whereas the CIRs of individual pathogens suggested significant preference characteristics.", {"entities": []}], ["IAV remains the most common pathogen among the pathogens analyzed.", {"entities": []}], ["More effort should be directed toward the prevention and control of pathogens that show a trend of increasing incidence such as HCoV, human adenovirus (ADV), and RSV.", {"entities": []}], ["Although clinically distinguishing specific pathogens responsible for RTIs is difficult, the epidemiological and clinical characteristics of the various RTI-causing agents could provide clues for clinicians, thereby informing decisions regarding prevention and medication and guiding appropriate public health strategies.", {"entities": []}], ["Mast cell (MC) mediators, among them prostaglandin D 2 (PGD 2 ) and 9\u03b1,11\u03b2-PGF 2 , PGD 2 \u2019s metabolite, play a key role in allergic reactions, including bee venom anaphylaxis (BVA).", {"entities": [[56, 59, "GENE"], [83, 86, "GENE"], [56, 59, "GENE"], [83, 86, "GENE"]]}], ["Assessment of these mediators has never been performed in BVA.", {"entities": []}], ["The aim of the study was to assess the activation of MC during in vivo provocation with bee venom (BV) and to measure PGD 2 and 9\u03b1,11\u03b2-PGF 2 in the course of an allergen challenge.", {"entities": [[118, 121, "GENE"]]}], ["The second aim was to determine if assessment of these mediators could be useful for predicting adverse events during venom immunotherapy (VIT).", {"entities": [[139, 142, "GENE"]]}], ["In 16 BV-VIT patients and 12 healthy subjects, levels of PGD 2 and 9\u03b1,11\u03b2-PGF 2 were assessed during BV provocation by means of the skin chamber method.", {"entities": [[57, 60, "GENE"]]}], ["Chamber fluids, collected at 5 and 15\u00a0min, were analyzed for both mediators by gas chromatography mass spectrometry negative ion chemical ionization.", {"entities": []}], ["BVA in comparison to non-allergic patients had a significantly higher ratio of 9\u03b1,11\u03b2-PGF 2 in allergen-challenged chambers to 9\u03b1,11\u03b2-PGF 2 in allergen-free chambers after 15\u00a0min of provocation ( p \u00a0=\u00a00.039).", {"entities": []}], ["Allergen challenge resulted in a significant increase of 9\u03b1,11\u03b2-PGF 2 levels between 5 and 15\u00a0min after provocation only in BVA patients ( p \u00a0<\u00a00.05).", {"entities": []}], ["Analysis of log-transformed PGD2 levels showed significant difference between changes in PGD 2 concentration between BVA and healthy subjects.", {"entities": [[89, 92, "GENE"]]}], ["No study patient developed adverse reactions during.", {"entities": []}], ["9\u03b1,11\u03b2-PGF 2 is actively generated during the early allergic response to BV.", {"entities": []}], ["Skin chamber seems to be a promising, non-invasive and safe model of in vivo allergen provocation in BV-allergic patients.", {"entities": []}], ["High or low levels of both mediators do not predict occurrence of adverse events during VIT.", {"entities": [[88, 91, "GENE"]]}], ["Allergic bronchopulmonary aspergillosis (ABPA) in asthma is a severe, life-affecting disease that potentially affects over 4.8 million people globally.", {"entities": [[26, 39, "DISEASE"], [50, 56, "DISEASE"]]}], ["In the UK, ABPA is predominantly caused by the fungus Aspergillus fumigatus .", {"entities": []}], ["Phagocytosis is important in clearance of this fungus, and Early Endosome Antigen 1 ( EEA1 ) has been demonstrated to be involved in phagocytosis of fungi.", {"entities": [[86, 90, "GENE"]]}], ["We sought to investigate the role of EEA1 mutations and phagocytosis in ABPA.", {"entities": [[37, 41, "GENE"]]}], ["We used exome sequencing to identify variants in EEA1 associated with ABPA.", {"entities": [[49, 53, "GENE"]]}], ["We then cultured monocyte-derived macrophages (MDMs) from 17 ABPA subjects with A .", {"entities": []}], ["fumigatus conidia, and analyzed phagocytosis and phagolysosome acidification in relation to the presence of these variants.", {"entities": []}], ["We found that variants in EEA1 were associated with ABPA and with the rate of phagocytosis of A .", {"entities": [[26, 30, "GENE"]]}], ["fumigatus conidia and the acidification of phagolysosomes.", {"entities": []}], ["MDMs from ABPA subjects carrying the disease associated genotype showed increased acidification and phagocytosis compared to those from ABPA subjects carrying the non-associated genotypes or healthy controls.The identification of ABPA-associated variants in EEA that have functional effects on MDM phagocytosis and phagolysosome acidification of A .", {"entities": []}], ["fumigatus conidia revolutionizes our understanding of susceptibility to this disease, which may in future benefit patients by earlier identification or improved treatments.", {"entities": []}], ["We suggest that the increased phagocytosis and acidification observed demonstrates an over-active MDM profile in these patients, resulting in an exaggerated cellular response to the presence of A .", {"entities": []}], ["fumigatus in the airways.", {"entities": []}], ["Complex traits are determined by the combined effects of many loci and are affected by gene networks or biological pathways.", {"entities": []}], ["Systems biology approaches have an important role in the identification of candidate genes related to complex diseases or traits at the system level.", {"entities": []}], ["The present study systemically analyzed genes associated with bovine marbling score and identified their relationships.", {"entities": []}], ["The candidate nodes were obtained using MedScan text-mining tools and linked by protein-protein interaction (PPI) from the Human Protein Reference Database (HPRD).", {"entities": []}], ["To determine key node of marbling, the degree and betweenness centrality (BC) were used.", {"entities": []}], ["The hub nodes and biological pathways of our network are consistent with the previous reports about marbling traits, and also suggest unknown candidate genes associated with intramuscular fat.", {"entities": []}], ["Five nodes were identified as hub genes, which was consistent with the network analysis using quantitative reverse-transcription PCR (qRT-PCR).", {"entities": []}], ["Key nodes of the PPI network have positive roles (PPAR\u03b3, C/EBP\u03b1, and RUNX1T1) and negative roles (RXRA, CAMK2A) in the development of intramuscular fat by several adipogenesis-related pathways.", {"entities": [[69, 76, "GENE"], [98, 102, "GENE"], [104, 110, "GENE"]]}], ["This study provides genetic information for identifying candidate genes for the marbling trait in bovine.", {"entities": []}], ["Although hyperlipidemia is common in COPD, its relationship to comorbidities, risk factors and lung function in COPD has not been studied in detail.", {"entities": []}], ["Using the baseline data of the COSYCONET cohort we addressed this question.", {"entities": []}], ["Data from 1746 COPD patients (GOLD stage 1\u20134; mean age 64.6 y, mean FEV1%pred 57%) were evaluated, focusing on the comorbidities hyperlipidemia, diabetes and cardiovascular complex (CVC; including arterial hypertension, cardiac failure, ischemic heart disease).", {"entities": [[206, 218, "DISEASE"], [237, 259, "DISEASE"], [246, 259, "DISEASE"]]}], ["Risk factors comprised age, gender, BMI, and packyears of smoking.", {"entities": []}], ["The results of linear and logistic regression analyses were implemented into a path analysis model describing the multiple relationships between parameters.", {"entities": []}], ["Hyperlipidemia (prevalence 42.9%) was associated with lower intrathoracic gas volume (ITGV) and higher forced expiratory volume in 1 second (FEV 1 ) when adjusting for its multiple relationships to risk factors and other comorbidities.", {"entities": [[141, 144, "GENE"]]}], ["These findings were robust in various statistical analyses.", {"entities": []}], ["The associations between comorbidities and risk factors were in accordance with previous findings, thereby underlining the validity of our data.", {"entities": []}], ["In conclusion, hyperlipidemia was associated with less hyperinflation and airway obstruction in patients with COPD.", {"entities": []}], ["This surprising result might be due to different COPD phenotypes in these patients or related to effects of medication.", {"entities": []}], ["Genome-wide association studies (GWAS) analyze the genetic component of a phenotype or the etiology of a disease.", {"entities": []}], ["Despite the success of many GWAS, little progress has been made in uncovering the underlying mechanisms for many diseases.", {"entities": []}], ["The use of metabolomics as a readout of molecular phenotypes has enabled the discovery of previously undetected associations between diseases and signaling and metabolic pathways.", {"entities": []}], ["In addition, combining GWAS and metabolomic information allows the simultaneous analysis of the genetic and environmental impacts on homeostasis.", {"entities": []}], ["Most success has been seen in metabolic diseases such as diabetes, obesity and dyslipidemia.", {"entities": [[67, 74, "DISEASE"]]}], ["Recently, associations between loci such as FADS1 , ELOVL2 or SLC16A9 and lipid concentrations have been explained by GWAS with metabolomics.", {"entities": [[44, 49, "GENE"], [52, 58, "GENE"], [62, 69, "GENE"]]}], ["Combining GWAS with metabolomics (mGWAS) provides the robust and quantitative information required for the development of specific diagnostics and targeted drugs.", {"entities": []}], ["This review discusses the limitations of GWAS and presents examples of how metabolomics can overcome these limitations with the focus on metabolic diseases.", {"entities": []}], ["Human mast cells (hMCs) derived in vitro from cord blood mononuclear cells exhibit stem cell factor (SCF)-dependent comitogenic responses to T helper cell type 2 (Th2) cytokines.", {"entities": []}], ["As cysteinyl leukotriene (cys-LT) biosynthesis is a characteristic of immunoglobulin (Ig)E-activated mucosal hMCs, we speculated that Th2 cytokines might regulate eicosanoid generation by hMCs.", {"entities": []}], ["After passive sensitization for 5 d with IgE in the presence of SCF, anti-IgE\u2013stimulated hMCs elaborated minimal cys-LT (0.1 \u00b1 0.1 ng/10 2 (16.2 \u00b1 10.3 ng/10 2 (by 2.5-fold).", {"entities": []}], ["Although priming with IL-3 or IL-5 alone for 5 d with SCF minimally enhanced anti-IgE\u2013mediated cys-LT generation, these cytokines induced further six- and fourfold increases, respectively, in IgE-dependent cys-LT generation when provided with IL-4 and SCF; this occurred without changes in PGD 2 generation or histamine exocytosis relative to hMCs primed with IL-4 alone.", {"entities": [[290, 293, "GENE"]]}], ["None of these cytokines, either alone or in combination, substantially altered the levels of cytosolic phospholipase A 2 (cPLA 2 ), 5-lipoxygenase (5-LO), or 5-LO activating protein (FLAP) protein expression by hMCs.", {"entities": []}], ["In contrast, IL-4 priming dramatically induced the steady-state expression of leukotriene C 4 synthase (LTC 4 S) mRNA within 6 h, and increased the expression of LTC 4 S protein and functional activity in a dose- and time-dependent manner, with plateaus at 10 ng/ml and 5 d, respectively.", {"entities": []}], ["Priming by either IL-3 or IL-5, with or without IL-4, supported the localization of 5-LO to the nucleus of hMCs.", {"entities": []}], ["Thus, different Th2-derived cytokines target distinct steps in the 5-LO/LTC 4 S biosynthetic pathway (induction of LTC 4 S expression and nuclear import of 5-LO, respectively), each of which is necessary for a full integrated functional response to IgE-dependent activation, thus modulating the effector phenotype of mature hMCs.", {"entities": []}], ["Type 2 diabetes is a progressive chronic illness that will affect more than 500 million people worldwide by 2030.", {"entities": []}], ["It is a significant cause of morbidity and mortality.", {"entities": []}], ["Finding the right care management for diabetes patients is necessary to effectively address the growing population of affected individuals and escalating costs.", {"entities": []}], ["Patient education is one option for improving patient self-management.", {"entities": []}], ["However, there are large discrepancies in the outcomes of such programs and long-term data are lacking.", {"entities": []}], ["We assessed the short and long-term outcomes of diabetes patient education using the health education impact questionnaire (HeiQ).", {"entities": []}], ["We conducted a observational cohort study of 83 type 2 diabetes patients participating in patient education programs in Denmark.", {"entities": []}], ["The seven-scale HeiQ was completed by telephone interview at baseline and 2\u00a0weeks (76 participants, 93%) and 12\u00a0months (66, 80%) after the patient education ended.", {"entities": []}], ["Changes over time were assessed using mean values and standard deviation at each time point and Cohen effect sizes.", {"entities": []}], ["Patients reported improvements 2\u00a0weeks after the program ended in 4 of 7 constructs: skills and technique acquisition (ES\u00a0=\u00a00.59), self-monitoring and insight (ES\u00a0=\u00a00.52), constructive attitudes and approaches (ES\u00a0=\u00a00.43) and social integration and support (ES\u00a0=\u00a00.27).", {"entities": []}], ["After 12\u00a0months, patients reported improvements in 3 of 7 constructs: skills and technique acquisition (ES\u00a0=\u00a00.66), constructive attitudes and approaches (ES\u00a0=\u00a00.43), and emotional wellbeing (ES\u00a0=\u00a00.44).", {"entities": []}], ["Skills and technique showed the largest short- and long-term effect size.", {"entities": []}], ["No significant changes were found in health-related activity or positive and active engagement in life over time.", {"entities": []}], ["After 12\u00a0months, diabetes patients who participated in patient education demonstrated increased self-management skills, improved acceptance of their chronic illness and decreased negative emotional response to their disease.", {"entities": []}], ["Applying HeiQ as an outcome measure yielded new knowledge as to what patients with diabetes can obtain by participating in a patient education.", {"entities": []}], ["Interleukin 27 (IL-27) has pleiotropic properties that can either limit or enhance immune responses.", {"entities": []}], ["Recent studies revealed that single nucleotide polymorphisms (SNPs) of the IL-27 promoter region modulate the development of infectious diseases and individual's susceptibility to therapeutic response.", {"entities": []}], ["Little is known about the relationship between IL-27 single nucleotide polymorphisms and therapy response in patients infected by hepatitis C virus (HCV).", {"entities": [[130, 139, "DISEASE"]]}], ["In this study we have investigated the potential role of SNPs in the promoter region of IL27 p28 gene (alleles rs153109 ) on the outcome of HCV infected patients.", {"entities": [[88, 92, "GENE"]]}], ["rs153109 , corresponding to position c.-964A>G of the IL-27 locus, was amplified from genomic DNA extracted from 15 patients with chronic hepatitis C stratified by sustained viral response (SVR), relapser and non-responder, after treatment with peginterferon-\u03b1 (PegIFN- \u03b1) combined with ribavirin (RBV).", {"entities": [[138, 147, "DISEASE"]]}], ["Amplification products were studied by direct sequencing.", {"entities": []}], ["This method has been applied in a preliminary study on patients with chronic hepatitis C to provide information for a standardized assay useful to genotyping of rs153109 SNPs of IL-27p28.", {"entities": [[77, 86, "DISEASE"]]}], ["The genotype distribution of the c.-964 A>G polymorphism was more present in patients who did not achieve a SVR.", {"entities": []}], ["By contrast, the genotype G/G was absent in non-responder and relapser patients.", {"entities": []}], ["Moreover, the analysis of allelic distribution of rs153109 highlighted a predominance of allele A in all genotypes in spite of allele G. Our work provides preliminary information for a standardized method potentially useful for genotyping rs153109 , and suggests its utility as a candidate approach to evaluate IL-27 p28 polymorphisms as additional clinical predictors of response to therapies in HCV infected patients.", {"entities": []}], ["After publication of this article (Scand J Trauma Resusc Emerg Med 23:40, 2015), it came to light that an earlier version had been published in error.", {"entities": []}], ["This erratum contains the correct version of the article, which incorporates revisions made in response to reviewer comments.", {"entities": []}], ["Additionally, one of the authors was inadvertently omitted from the author list.", {"entities": []}], ["This author, Justin Yan, has been included in the corrected author list above.", {"entities": []}], ["Transcutaneous CO 2 (PtCO 2 ) is a continuous and non-invasive measure recommended by scientific societies in the management of respiratory distress.", {"entities": []}], ["The objective of this study was to evaluate the correlation between PtCO 2 and arterial partial pressure of CO 2 (PaCO 2 ) by arterial blood gas analysis in emergency patients with dyspnoea, and to determine the factors that interfere with this correlation.", {"entities": []}], ["From January to June 2014, all adult patients admitted to the RR with dyspnoea during business hours were included in the study if arterial blood gas measurements were indicated.", {"entities": []}], ["A sensor measuring the PtCO 2 was attached to the ear lobe of the patient before the gas analysis.", {"entities": []}], ["Anamnesis, clinical and laboratory parameters were identified.", {"entities": []}], ["Ninety patients with dyspnoea were included (104 pairs of measurements).", {"entities": []}], ["The median (IQR) age was 79 years (69 \u2013 85).", {"entities": []}], ["The correlation between PtCO 2 and PaCO 2 was R p <.001) but became lower for values of PaCO 2 above 60 mm Hg.", {"entities": []}], ["The mean bias (\u00b1 SD) between the two methods of measurement (Bland-Altman analysis) was \u22121.4 mm Hg (\u00b1 7.7) with limits of agreement from \u221216.4 to 13.7 mm Hg.", {"entities": []}], ["In univariate analysis, PaO 2 interfered with this correlation.", {"entities": []}], ["After multivariate analysis, temperature (OR = 3.01; 95 % CIs [1.16, 7.80]) and PaO 2 (OR = 1.22; 95 % CIs [1.02, 1.47]) significantly interfered with this correlation.", {"entities": []}], ["There is a significant correlation between PaCO 2 and PtCO 2 values for patients admitted to the emergency department for acute respiratory failure.", {"entities": [[128, 147, "DISEASE"]]}], ["One limiting factor to routine use of PtCO 2 measurements in the emergency department is the presence of hyperthermia.", {"entities": []}], ["Animals have been used in research and teaching for a long time.", {"entities": []}], ["However, clear ethical guidelines and pertinent legislation were instated only in the past few decades, even in developed countries with Judeo\u2010Christian ethical roots.", {"entities": []}], ["We compactly cover the basics of animal research ethics, ethical reviewing and compliance guidelines for animal experimentation across the developed world, \u201cour\u201d fundamentals of institutional animal research ethics teaching, and emerging alternatives to animal research.", {"entities": []}], ["This treatise was meticulously constructed for scientists interested/involved in animal research.", {"entities": []}], ["Herein, we discuss key animal ethics principles \u2013 Replacement/Reduction/Refinement.", {"entities": []}], ["Despite similar undergirding principles across developed countries, ethical reviewing and compliance guidelines for animal experimentation vary.", {"entities": []}], ["The chronology and evolution of mandatory institutional ethical reviewing of animal experimentation (in its pioneering nations) are summarised.", {"entities": []}], ["This is followed by a concise rendition of the fundamentals of teaching animal research ethics in institutions.", {"entities": []}], ["With the advent of newer methodologies in human cell\u2010culturing, novel/emerging methods aim to minimise, if not avoid the usage of animals in experimentation.", {"entities": []}], ["Relevant to this, we discuss key extant/emerging alternatives to animal use in research; including organs on chips, human\u2010derived three\u2010dimensional tissue models, human blood derivates, microdosing, and computer modelling of various hues.", {"entities": []}], ["The mechanism by which social relationships influence health can be interpreted as a social network regulating one\u2019s health behaviors.", {"entities": []}], ["Based on the hypothesis that relatives, friends, or neighbors are sources of social support and may monitor one\u2019s health behaviors, researchers have gotten significant and consistent results that a social network can regulate health behaviors.", {"entities": []}], ["However, few empirical studies have been conducted to examine the role of informal care in the regulation of health behaviors, especially for elderly individuals with chronic diseases that can be controlled by healthy behaviors.", {"entities": []}], ["This paper researched the effects of informal care on health behaviors\u2014smoking control, dietetic regulation, weight control, and maintenance of exercise\u2014among elderly patients with chronic diseases in China who are facing the challenge of aging.", {"entities": []}], ["We used the propensity score matching method to control the impacts of a very rich set of family and individual characteristics.", {"entities": []}], ["The 2011\u20132012 national baseline data of the China Health and Retirement Longitudinal Study (CHARLS) was used.", {"entities": []}], ["Our findings showed that informal care could significantly help improve the health behaviors of elderly people.", {"entities": []}], ["Informal care could improve the compliance of smoking control and dietetic regulation significantly.", {"entities": []}], ["Elderly people with informal care smoked less and consumed more meals per day.", {"entities": []}], ["For weight control, informal care helped decrease the possibility of weight gain of elderly people, but its impacts were not significant for BMI and weight loss.", {"entities": []}], ["Last, for the elders, informal care could only help increase the probability of walking exercise; however, there was no significant result for moderate exercise.", {"entities": []}], ["Findings from this study highlight the importance of informal care among elderly people.", {"entities": []}], ["Our results appeal to policy makers who aim to control chronic diseases that they should take informal care into account and provide appropriate policies to meet the demand of informal care for elderly people.", {"entities": []}], ["The online version of this article (10.1186/s41043-017-0117-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Time in the therapeutic range ( TTR ) is associated with the effectiveness and safety of vitamin K antagonist ( VKA ) therapy.", {"entities": [[32, 35, "GENE"]]}], ["To optimize prescribing of VKA , we aimed to develop and validate a prediction model for TTR in older adults taking VKA for nonvalvular atrial fibrillation and venous thromboembolism.", {"entities": [[89, 92, "GENE"]]}], ["The study cohort comprised patients aged \u226565 years who were taking VKA for atrial fibrillation or venous thromboembolism and who were identified in the 2 US electronic health record databases linked with Medicare claims data from 2007 through 2014.", {"entities": []}], ["With the predictors identified from a systematic review and clinical knowledge, we built a prediction model for TTR , using one electronic health record system as the training set and the other as the validation set.", {"entities": [[112, 115, "GENE"]]}], ["We compared the performance of the new models to that of a published prediction score for TTR , SAM e\u2010 TT 2 R 2 .", {"entities": [[90, 93, "GENE"]]}], ["Based on 1663 patients in the training set and 1181 in the validation set, our optimized score included 42 variables and the simplified model included 7 variables, abbreviated as PROSPER (Pneumonia, Renal dysfunction, Oozing blood [prior bleeding], Staying in hospital \u22657\u00a0days, Pain medication use, no Enhanced [structured] anticoagulation services, Rx for antibiotics).", {"entities": []}], ["The PROSPER score outperformed SAM e\u2010 TT 2 R 2 when predicting both TTR \u226570% (area under the receiver operating characteristic curve 0.67 versus 0.55) and the thromboembolic and bleeding outcomes (area under the receiver operating characteristic curve 0.62 versus 0.52).", {"entities": [[68, 71, "GENE"]]}], ["Our geriatric TTR score can be used as a clinical decision aid to select appropriate candidates to receive VKA therapy and as a research tool to address confounding and treatment effect heterogeneity by anticoagulation quality.", {"entities": [[14, 17, "GENE"]]}], ["Cell therapy holds the most promising for acute and chronic deleterious respiratory diseases.", {"entities": []}], ["However, the safety and tolerance for lung disorders are controversy.", {"entities": []}], ["We undertook a systematic review and meta-analyses of all 23 clinical studies of cell therapy.", {"entities": []}], ["The outcomes were odds ratio (OR), risk difference (RD), Peto OR, relative risk, and mean difference of serious adverse events.", {"entities": [[52, 54, "GENE"]]}], ["342 systemic infusions and 57 bronchial instillations (204 recipients) of cells were analyzed for acute respiratory distress syndrome (ARDS), bronchopulmonary dysplasia, pulmonary arterial hypertension, silicosis, sarcoidosis, extensively drug-resistant tuberculosis, chronic obstructive pulmonary diseases (COPD), and idiopathic pulmonary fibrosis.", {"entities": [[189, 201, "DISEASE"], [254, 266, "DISEASE"], [125, 133, "DISEASE"], [214, 225, "DISEASE"], [203, 212, "DISEASE"], [330, 348, "DISEASE"], [319, 348, "DISEASE"]]}], ["The frequency of death in adults from any causes was 71 and 177 per 1,000 for cell therapy and controls, respectively, with an OR of 0.31 (95% CI: 0.03, 3.76) and RD of -0.22 (95% CI: -0.53, 0.09).", {"entities": [[163, 165, "GENE"]]}], ["No significant difference was found for ARDS and COPD.", {"entities": []}], ["The frequency of deaths and non-fatal serious adverse events of 17 open studies were similar to those of randomized controlled trials.", {"entities": []}], ["Moreover, serious adverse events of allogenic cells were greater than autologous preparations, as shown by frequency, OR and RD.", {"entities": [[125, 127, "GENE"]]}], ["We conclude that either infusion or instillation of mesenchymal stem stromal or progenitor cells are well tolerated without serious adverse events causally related to cell treatment.", {"entities": []}], ["Cell therapy has not been associated with significant changes in spirometry, immune function, cardiovascular activity, and the quality of life.", {"entities": []}], ["Pneumonia remains one of the leading causes of death in both adults and children worldwide.", {"entities": [[0, 9, "DISEASE"]]}], ["Despite the adoption of a wide variety of therapeutics, the mortality from community-acquired pneumonia has remained relatively constant.", {"entities": [[94, 103, "DISEASE"]]}], ["Although viral and fungal acute airway infections can result in pneumonia, bacteria are the most common cause of community-acquired pneumonia, with Streptococcus pneumoniae isolated in nearly 50% of cases.", {"entities": [[64, 73, "DISEASE"], [132, 141, "DISEASE"]]}], ["Pneumolysin is a cholesterol-dependent cytolysin or pore-forming toxin produced by Streptococcus pneumonia and has been shown to play a critical role in bacterial pathogenesis.", {"entities": [[97, 106, "DISEASE"]]}], ["Airway epithelium is the initial site of many bacterial contacts and its barrier and mucosal immunity functions are central to infectious lung diseases.", {"entities": []}], ["In our studies, we have shown that the prior exposure to statins confers significant resistance of airway epithelial cells to the cytotoxicity of pneumolysin.", {"entities": []}], ["We decided to take this study one step further, assessing changes in both the transcriptome and lipidome of human airway epithelial cells exposed to toxin, statin or both.", {"entities": []}], ["Our current work provides the first global view in human airway epithelial cells of both the transcriptome and the lipid interactions that result in cellular protection from pneumolysin.", {"entities": []}], ["The mechanism of assembly of the extracellular matrix protein fibronectin (FN) into elastic, insoluble fibrils is still poorly understood.", {"entities": []}], ["FN fibrillogenesis requires cell-generated forces, which expose cryptic FN-FN binding sites buried in FN Type III domains.", {"entities": []}], ["The number and location of cryptic binding sites have been debated, but experimental evidence suggests multiple domains may contain FN-FN binding sites.", {"entities": []}], ["The requirement of cell-dependent forces to generate FN fibrils restricts investigation of the mechanism of assembly.", {"entities": []}], ["To address this, we use a recently developed biophysical model of fibrillogenesis to test competing hypotheses for the location and number of cryptic FN-FN binding sites and quantify the effect of these molecular alterations on assembled FN fibril properties.", {"entities": []}], ["Simulations predict that a single FN-FN binding site facilitates either negligible fibrillogenesis or produces FN fibrils that are neither robust nor physiological.", {"entities": []}], ["However, inclusion of multiple FN-FN binding sites predicts robust fibrillogenesis, which minimally depends on individual domain properties.", {"entities": []}], ["Multiple FN-FN binding site models predict a heterogeneous fibril population that contains two distinct phenotypes with unique viscoelastic properties, which we speculate may play a key role in generating heterogeneous mechanical signaling in the extracellular matrix of developing and regenerating tissues.", {"entities": []}], ["Limited study on the use of complementary alternative medicine (CAM) among patients with diabetes mellitus (DM), particularly in primary -care settings.", {"entities": [[89, 106, "DISEASE"]]}], ["This study seeks to understand the prevalence, types, expenditures, attitudes, beliefs, and perceptions of CAM use among patients with DM visiting outpatient primary care clinics.", {"entities": []}], ["This is a descriptive, cross-sectional study of 240 diabetic patients.", {"entities": []}], ["CAM is defined as a group of diverse medical and healthcare systems, practices, and products that are not generally considered part of conventional Western medicine.", {"entities": []}], ["Data analysis was done using SPSS v. 19 and multiple logistic regressions were used to identify predictors of CAM use.", {"entities": []}], ["The prevalence of CAM use was 62.5 percent.", {"entities": []}], ["Female were 1.8 times more likely than male in using CAM.", {"entities": []}], ["Malays (75%) were the most frequent users, followed Indians (18%) and Chinese (6%).", {"entities": []}], ["Biological therapy (50.0%) were the most widely used, followed by manipulative-body based systems (9.2%), energy system (8.8%), alternative medicine systems (4.6%) and mind-body system (1.7%).", {"entities": []}], ["In biological therapy, a total of 30.4 percent, 24.2 percent, 13.3 percent, and 7.9 percent of diabetic patients consumed bitter gourd ( Momordica Charantia ), followed by Misai Kucing ( Orthosiphon Stamineus Benth ), garlic ( Allium Sativum ), and Sabah snake grass ( Clinacanthus Nutans Lindau ) respectively.", {"entities": []}], ["The mean of the expenditure on CAM usage was RM 52.8 \u00b1 101.9 (US $16.9 \u00b1 32.5) per month.", {"entities": []}], ["According to multiple logistic regression analyses, being Muslim (OR 5.258, 95 percent CI 2.952-9.368) had significant positive association with CAM use.", {"entities": []}], ["The prevalence of CAM use was high among diabetics.", {"entities": []}], ["Islam faith is predictor for CAM use among Type 2 DM patients.", {"entities": []}], ["The most-common herbs used were bitter gourd ( Momordica Charantia ) and Misai Kucing ( Orthosiphon Stamineus, Benth ).", {"entities": []}], ["Further studies on the anti-glycemic activity of the isolated compound may be needed in the future.", {"entities": []}], ["This study explored the relationship between the fractional exhaled nitric oxide (FeNO) level and the efficacy of inhaled corticosteroid (ICS) in asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) patients with different disease severity.", {"entities": [[153, 190, "DISEASE"], [206, 214, "DISEASE"], [146, 152, "DISEASE"]]}], ["A total of 127 ACOS patients with ACOS (case group) and 131 healthy people (control group) were enrolled in this study.", {"entities": []}], ["Based on the severity of COPD, the ACOS patients were divided into: mild ACOS; moderate ACOS; severe ACOS; and extremely severe ACOS groups.", {"entities": []}], ["We compared FeNO levels, pulmonary function parameters including percentage of forced expiratory volume in 1 second (FEV1) to predicted value (FEV1%pred), ratio of FEV1 to forced vital capacity (FEV1/FVC), inspiratory capacity to total lung capacity (IC/TLC) and residual volume to total lung capacity (RV/TLC), arterial blood gas parameters, including PH, arterial partial pressure of oxygen (PaO 2 ) and arterial partial pressure of carbon dioxide (PaCO 2 ), total serum immunoglobulin E (IgE), induced sputum eosinophil (EOS), plasma surfactant protein A (SP-A), plasma soluble receptor for advanced glycation end products (sRAGE), sputum myeloperoxidase (MPO), sputum neutrophil gelatinase-associated lipocalin (NGAL) and Asthma Control Test (ACT) scores, and COPD Assessment Test (CAT) scores.", {"entities": [[726, 732, "DISEASE"], [659, 662, "GENE"]]}], ["Compared with pre-treatment parameters, the FeNO levels, RV/TLC, PaCO 2 , total serum IgE, induced sputum EOS, plasma SP-A, sputum MPO, sputum NGAL, and CAT scores were significantly decreased after 6 months of ICS treatment, while FEV1%pred, FEV1/FVC, IC/TLC, PH, PaO 2, plasma sRAGE, and ACT scores were significantly increased in ACOS patients with different disease severity after 6 months of ICS treatment.", {"entities": [[131, 134, "GENE"]]}], ["This finding suggests that the FeNO level may accurately predict the efficacy of ICS in the treatment of ACOS patients.", {"entities": []}], ["We have previously demonstrated that chronic obstructive pulmonary disease (COPD) patients who do not have Siglec\u201014 are less prone to exacerbation of the disease.", {"entities": [[37, 74, "DISEASE"]]}], ["Siglec\u201014 is a myeloid cell protein that recognizes bacteria and triggers inflammatory responses.", {"entities": []}], ["Therefore, soluble mediators secreted by myeloid cells responding to Siglec\u201014 engagement could be involved in the pathogenesis of exacerbation and could potentially be utilized as biomarkers of exacerbation.", {"entities": []}], ["To find out, we sought genes specifically induced in Siglec\u201014 Haemophilus influenzae to select genes that were specifically induced in Siglec\u201014 n = 39) collected during exacerbation and stable disease states.", {"entities": []}], ["Those gene products that increased during exacerbation were further tested using an independent set ( n = 32) of paired patient sera.", {"entities": []}], ["Serum concentration of interleukin\u201027 (IL\u201027) was elevated during exacerbation (discovery set: P = 0.0472; verification set: P = 0.0428; combined: P = 0.0104; one\u2010sided Wilcoxon matched\u2010pairs signed\u2010rank test), particularly in exacerbations accompanied with sputum purulence and in exacerbations lasting more than a week.", {"entities": []}], ["We concluded that IL\u201027 might be mechanistically involved in the exacerbation of COPD and could potentially serve as a systemic biomarker of exacerbation.", {"entities": []}], ["e12069 Chronic obstructive pulmonary disease (COPD) patients who do not have Siglec\u201014 (a myeloid cell protein that triggers inflammatory responses) are less prone to exacerbation of the disease.", {"entities": [[7, 44, "DISEASE"]]}], ["We tested whether soluble mediators secreted by myeloid cells responding to Siglec\u201014 engagement could be utilized as biomarkers of exacerbation, and found serum concentration of interleukin\u201027 (IL\u201027) was elevated during exacerbation, particularly in exacerbations accompanied with sputum purulence.", {"entities": []}], ["We concluded that IL\u201027 might be mechanistically involved in the exacerbation of COPD and could potentially serve as a systemic biomarker of exacerbation.", {"entities": []}], ["Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are often linked to respiratory infections.", {"entities": [[23, 60, "DISEASE"]]}], ["However, it is unknown if COPD patients who experience frequent exacerbations have impaired humoral immunity.", {"entities": []}], ["The aim of this study was to determine if antibodies specific for common respiratory pathogens are associated with AECOPD.", {"entities": []}], ["Plasma was obtained from COPD patients when clinically stable.", {"entities": []}], ["AECOPD requiring hospitalisation were recorded.", {"entities": []}], ["IgG 1 antibodies to H. Influenzae outer membrane protein 6 (P6), pneumococcal surface protein C (PspC) and the VP1 viral capsid protein of rhinovirus were measured.", {"entities": []}], ["COPD patients who had an AECOPD (n\u2009=\u200932) had significantly lower anti-VP1 IgG 1 antibody levels when stable compared to COPD patients who did not have an AECOPD (n\u2009=\u200928, p\u2009=\u20090.024).", {"entities": []}], ["Furthermore, the number of hospitalisations was inversely proportional to anti-VP1 antibody levels (r\u2009=\u2009\u22120.331, p\u2009=\u20090.011).", {"entities": []}], ["In contrast, antibodies specific for P6 and PspC were present at similar concentrations between groups.", {"entities": []}], ["Plasma IL-21, a cytokine important for B-cell development and antibody synthesis, was also lower in COPD patients who had an AECOPD, than in stable COPD patients (p\u2009=\u20090.046).", {"entities": []}], ["Deficient humoral immunity specific for rhinoviruses is associated with AECOPD requiring hospitalisation, and may partly explain why some COPD patients have an increased exacerbation risk following respiratory viral infections.", {"entities": []}], ["Critically ill ICU patients commonly develop severe muscle wasting and impaired muscle function, leading to delayed recovery, with subsequent increased morbidity and financial costs, and decreased quality of life for survivors.", {"entities": []}], ["Critical illness myopathy (CIM) is a frequently observed neuromuscular disorder in ICU patients.", {"entities": [[17, 25, "DISEASE"]]}], ["Sepsis, systemic corticosteroid hormone treatment and post-synaptic neuromuscular blockade have been forwarded as the dominating triggering factors.", {"entities": []}], ["Recent experimental results from our group using a unique experimental rat ICU model show that the mechanical silencing associated with CIM is the primary triggering factor.", {"entities": []}], ["This study aims to unravel the mechanisms underlying CIM, and to evaluate the effects of a specific intervention aiming at reducing mechanical silencing in sedated and mechanically ventilated ICU patients.", {"entities": []}], ["Muscle gene/protein expression, post-translational modifications (PTMs), muscle membrane excitability, muscle mass measurements, and contractile properties at the single muscle fiber level were explored in seven deeply sedated and mechanically ventilated ICU patients (not exposed to systemic corticosteroid hormone treatment, post-synaptic neuromuscular blockade or sepsis) subjected to unilateral passive mechanical loading for 10 hours per day (2.5 hours, four times) for 9 \u00b1 1 days.", {"entities": [[66, 70, "GENE"]]}], ["These patients developed a phenotype considered pathognomonic of CIM; that is, severe muscle wasting and a preferential myosin loss ( P < 0.001).", {"entities": []}], ["In addition, myosin PTMs specific to the ICU condition were observed in parallel with an increased sarcolemmal expression and cytoplasmic translocation of neuronal nitric oxide synthase.", {"entities": [[20, 24, "GENE"]]}], ["Passive mechanical loading for 9 \u00b1 1 days resulted in a 35% higher specific force ( P < 0.001) compared with the unloaded leg, although it was not sufficient to prevent the loss of muscle mass.", {"entities": []}], ["Mechanical silencing is suggested to be a primary mechanism underlying CIM; that is, triggering the myosin loss, muscle wasting and myosin PTMs.", {"entities": [[139, 143, "GENE"]]}], ["The higher neuronal nitric oxide synthase expression found in the ICU patients and its cytoplasmic translocation are forwarded as a probable mechanism underlying these modifications.", {"entities": []}], ["The positive effect of passive loading on muscle fiber function strongly supports the importance of early physical therapy and mobilization in deeply sedated and mechanically ventilated ICU patients.", {"entities": []}], ["Drug provocation test (DPT) is the controlled administration of a drug to diagnose immune- or non-immune-mediated drug hypersensitivity and the last step for accurate recognition of drug hypersensitivity reactions when the previous diagnostic evaluations are negative or unavailable.", {"entities": [[23, 26, "GENE"]]}], ["A DPT is performed only if other conventional tests fail to yield conclusive results.", {"entities": [[2, 5, "GENE"]]}], ["In each clinical presentation, \u201cto provoke or not to provoke\u201d a patient should be decided after careful assessment of the risk\u2013benefit ratio.", {"entities": []}], ["Well-defined benefits of DPT include confirmative exclusion of diagnoses of drug hypersensitivity and provision of safe alternatives.", {"entities": [[25, 28, "GENE"]]}], ["However, disadvantages such as safety, difficulty in interpretations of results, lack of objective biomarkers, risks of resensitization, efficiency in daily practice, and lack of standardized protocols, are poorly debated.", {"entities": []}], ["This review summarizes the current published research concerning DPT, with particular emphasis on the advantages and disadvantages of DPT in an evidence-based manner.", {"entities": [[65, 68, "GENE"], [134, 137, "GENE"], [65, 68, "GENE"], [134, 137, "GENE"]]}], ["In the United States, there is a largely hidden burden of diseases caused by a group of chronic and debilitating parasitic, bacterial, and congenital infections known as the neglected infections of poverty.", {"entities": []}], ["Like their neglected tropical disease counterparts in developing countries, the neglected infections of poverty in the US disproportionately affect impoverished and under-represented minority populations.", {"entities": []}], ["The major neglected infections include the helminth infections, toxocariasis, strongyloidiasis, ascariasis, and cysticercosis; the intestinal protozoan infection trichomoniasis; some zoonotic bacterial infections, including leptospirosis; the vector-borne infections Chagas disease, leishmaniasis, trench fever, and dengue fever; and the congenital infections cytomegalovirus (CMV), toxoplasmosis, and syphilis.", {"entities": [[298, 310, "DISEASE"], [383, 396, "DISEASE"], [162, 176, "DISEASE"], [283, 296, "DISEASE"], [112, 125, "DISEASE"], [402, 410, "DISEASE"], [64, 76, "DISEASE"], [224, 237, "DISEASE"], [78, 94, "DISEASE"], [96, 106, "DISEASE"]]}], ["These diseases occur predominantly in people of color living in the Mississippi Delta and elsewhere in the American South, in disadvantaged urban areas, and in the US\u2013Mexico borderlands, as well as in certain immigrant populations and disadvantaged white populations living in Appalachia.", {"entities": []}], ["Preliminary disease burden estimates of the neglected infections of poverty indicate that tens of thousands, or in some cases, hundreds of thousands of poor Americans harbor these chronic infections, which represent some of the greatest health disparities in the United States.", {"entities": []}], ["Specific policy recommendations include active surveillance (including newborn screening) to ascertain accurate population-based estimates of disease burden; epidemiological studies to determine the extent of autochthonous transmission of Chagas disease and other infections; mass or targeted treatments; vector control; and research and development for new control tools including improved diagnostics and accelerated development of a vaccine to prevent congenital CMV infection and congenital toxoplasmosis.", {"entities": [[495, 508, "DISEASE"], [484, 508, "DISEASE"]]}], ["Both viral and bacterial infections can be associated with wheezing episodes in children; however, information regarding combined infections with both viral and bacterial pathogens in full\u00a0term neonates is limited.", {"entities": []}], ["We sought to investigate the effects of viral\u2013bacterial codetection on pneumonia severity and recurrent wheezing.", {"entities": [[71, 80, "DISEASE"]]}], ["A retrospective cohort study was conducted on neonates admitted to our hospital with pneumonia from 2009 to 2015.", {"entities": [[85, 94, "DISEASE"]]}], ["Of 606 total cases, 341 were diagnosed with RSV only, and 265 were diagnosed with both RSV and a potential bacterial pathogen.", {"entities": []}], ["The leading four species of bacteria codetected with RSV were Escherichia coli , Klebsiella pneumoniae , Staphylococcus aureus and Enterobacter cloacae .", {"entities": []}], ["Neonates with RSV and a potential bacterial pathogen were significantly more likely to have worse symptoms, higher C-reactive protein values and more abnormal chest x-ray manifestations with Bonferroni correction for multiple comparisons ( P < 0.01).", {"entities": []}], ["On Cox regression analysis, an increased risk of recurrent wheezing was found for neonates positive for RSV\u2013 Staphylococcus aureus and RSV\u2013 Klebsiella pneumoniae .", {"entities": []}], ["Our findings indicate that the combination of bacteria and RSV in the neonatal airway is associated with more serious clinical characteristics.", {"entities": []}], ["The presence of RSV and Staphylococcus aureus or Klebsiella pneumoniae may provide predictive markers for wheeze.", {"entities": []}], ["A new optical-fiber-based airborne particle counter is reported.", {"entities": []}], ["Unlike traditional light-scatter-based techniques, the particle is detected through the drop in optical fiber coupling efficiency as the particle disrupts the electromagnetic mode of the optical beam.", {"entities": []}], ["The system is simple, substantially smaller than traditional systems, and does not require high power laser input.", {"entities": []}], ["This makes it attractive for wearable air quality monitors where size is a premium.", {"entities": []}], ["There is close agreement between theoretical model and experimental results for solid and liquid particles in the 1 to 10 \u00b5m range.", {"entities": []}], ["An extrafine formulation of the long-acting muscarinic antagonist glycopyrronium bromide (GB) is in development for chronic obstructive pulmonary disease (COPD), in combination with beclometasone dipropionate and formoterol fumarate \u2013 a \u201cfixed triple\u201d.", {"entities": [[116, 153, "DISEASE"]]}], ["This two-part study was randomized, double blind, placebo controlled in patients with moderate-to-severe COPD: Part 1: single-dose escalation, GB 12.5, 25, 50, 100 or 200 \u03bcg versus placebo; Part 2: repeat-dose (7-day), four-period crossover, GB 12.5, 25 or 50 \u03bcg twice daily (BID) versus placebo, with an open-label extension in which all patients received tiotropium 18 \u03bcg once daily.", {"entities": []}], ["On the morning of Day 8 in all five periods, patients also received formoterol 12 \u03bcg.", {"entities": []}], ["In study Part 1, 27 patients were recruited.", {"entities": []}], ["All GB doses significantly increased from baseline forced expiratory volume in 1 second (FEV 1 ) area under the curve (AUC 0\u201312h ) and peak FEV 1 , with a trend toward greater efficacy with higher GB dose.", {"entities": [[89, 92, "GENE"], [140, 143, "GENE"], [89, 92, "GENE"], [140, 143, "GENE"]]}], ["All adverse events were mild\u2013moderate in severity, with a lower incidence with GB than placebo and no evidence of a dose\u2013response relationship.", {"entities": []}], ["In study Part 2, of 38 patients recruited, 34 completed the study.", {"entities": []}], ["Adjusted mean differences from placebo in 12 h trough FEV 1 on Day 7 (primary) were 115, 142 and 136 mL for GB 12.5, 25 and 50 \u03bcg BID, respectively (all P <0.001).", {"entities": [[54, 57, "GENE"]]}], ["GB 25 and 50 \u03bcg BID were superior ( P <0.05) to GB 12.5 \u03bcg BID for pre-dose morning FEV 1 on Day 8.", {"entities": [[84, 87, "GENE"]]}], ["For this endpoint, GB 25 and 50 \u03bcg BID were also superior to tiotropium.", {"entities": []}], ["Compared with Day 7, addition of formoterol significantly increased Day 8 FEV 1 peak and AUC 0\u201312h with all GB doses and placebo (all P <0.001).", {"entities": [[74, 77, "GENE"]]}], ["All adverse events were mild\u2013moderate in severity and there was no indication of a dose-related relationship.", {"entities": []}], ["This study provides initial evidence on bronchodilation, safety and pharmacokinetics of extrafine GB BID.", {"entities": []}], ["Overall, the results suggest that GB 25 \u03bcg BID is the optimal dose in patients with COPD.", {"entities": []}], ["We aimed to investigate a potential association between B-lines and weaning failure.", {"entities": []}], ["Fifty-seven subjects eligible for ventilation liberation were enrolled.", {"entities": []}], ["Patients with tracheostomy were excluded.", {"entities": []}], ["Lung ultrasound assessments of six thoracic zones were performed immediately before and at the exnd of the spontaneous breathing trial.", {"entities": []}], ["B-predominance was defined as any profile with anterior bilateral B-pattern.", {"entities": []}], ["Patients were followed up to 48 hours after extubation.", {"entities": []}], ["Thirty-eight individuals were successfully extubated; 11 failed the spontaneous breathing trial and 8 needed reintubation within 48 hours of extubation.", {"entities": []}], ["At the beginning of the T-piece trial, B-pattern or consolidation was already found at the lower and posterior lung regions in more than half of the individuals and remained non-aerated at the end of the trial.", {"entities": []}], ["A trend toward loss of lung aeration during spontaneous breathing trials was observed only in the spontaneous breathing trial-failure group (p = 0.07), and there was higher B-predominance at the end of the trial (p = 0.01).", {"entities": []}], ["A loss of lung aeration during the spontaneous breathing trial in non-dependent lung zones was demonstrated in subjects who failed to wean.", {"entities": []}], ["Smokers have increased susceptibility and altered innate host defense responses to influenza virus infection.", {"entities": [[83, 92, "DISEASE"]]}], ["Broccoli sprouts are a source of the Nrf2 activating agentsulforaphane, and short term ingestion of broccoli sprout homogenates (BSH) has been shown to reduce nasal inflammatory responses to oxidant pollutants.", {"entities": []}], ["Assess the effects of BSH on nasal cytokines, virus replication, and Nrf2 -dependent enzyme expression in smokers and nonsmokers.", {"entities": []}], ["We conducted a randomized, double-blind, placebo-controlled trial comparing the effects of BSH on serially sampled nasal lavage fluid (NLF) cytokines, viral sequence quantity, and Nrf2 -dependent enzyme expression in NLF cells and biopsied epithelium.", {"entities": []}], ["Healthy young adult smokers and nonsmokers ingested BSH or placebo (alfalfa sprout homogenate) for 4 days, designated Days -1, 0, 1, 2.", {"entities": []}], ["On Day 0 they received standard vaccine dose of live attenuated influenza virus (LAIV) intranasally.", {"entities": [[64, 73, "DISEASE"]]}], ["Nasal lavage fluids and nasal biopsies were collected serially to assess response to LAIV.", {"entities": []}], ["In area under curve analyses, post-LAIV IL-6 responses (P\u200a=\u200a0.03) and influenza sequences (P\u200a=\u200a0.01) were significantly reduced in NLF from BSH-treated smokers, whileNAD(P)H: quinoneoxidoreductasein NLF cells was significantly increased.", {"entities": [[70, 79, "DISEASE"]]}], ["In nonsmokers, a similar trend for reduction in virus quantity with BSH did not reach statistical significance.", {"entities": []}], ["In smokers, short term ingestion of broccoli sprout homogenates appears to significantly reduce some virus-induced markers of inflammation, as well as reducing virus quantity.", {"entities": []}], ["Nutritional antioxidant interventions have promise as a safe, low-cost strategy for reducing influenza risk among smokers and other at risk populations.", {"entities": [[93, 102, "DISEASE"]]}], ["ClinicalTrials.gov NCT01269723", {"entities": []}], ["Patterns of illness in American children have changed dramatically in this century.", {"entities": []}], ["The ancient infectious diseases have largely been controlled.", {"entities": []}], ["The major diseases confronting children now are chronic and disabling conditions termed the \"new pediatric morbidity\"--asthma mortality has doubled; leukemia and brain cancer have increased in incidence; neurodevelopmental dysfunction is widespread; hypospadias incidence has doubled.", {"entities": [[250, 261, "DISEASE"], [149, 157, "DISEASE"], [162, 174, "DISEASE"], [119, 125, "DISEASE"], [168, 174, "DISEASE"]]}], ["Chemical toxicants in the environment as well as poverty, racism, and inequitable access to medical care are factors known and suspected to contribute to causation of these pediatric diseases.", {"entities": []}], ["Children are at risk of exposure to over 15,000 high-production-volume synthetic chemicals, nearly all of them developed in the past 50 years.", {"entities": []}], ["These chemicals are used widely in consumer products and are dispersed in the environment.", {"entities": []}], ["More than half are untested for toxicity.", {"entities": []}], ["Children appear uniquely vulnerable to chemical toxicants because of their disproportionately heavy exposures and their inherent biological susceptibility.", {"entities": []}], ["To prevent disease of environmental origin in America's children, the Children's Environmental Health Network (CEHN) calls for a comprehensive, national, child-centered agenda.", {"entities": []}], ["This agenda must recognize children's vulnerabilities to environmental toxicants.", {"entities": []}], ["It must encompass a) a new prevention-oriented research focus; b) a new child-centered paradigm for health risk assessment and policy formulation; and c) a campaign to educate the public, health professionals, and policy makers that environmental disease is caused by preventable exposures and is therefore avoidable.", {"entities": []}], ["To anchor the agenda, CEHN calls for long-term, stable investment and for creation of a national network of pediatric environmental health research and prevention centers.", {"entities": []}], ["Discogenic lower back pain (DLBP) is the most common type of chronic lower back pain (LBP), accounting for 39% of cases, compared to 30% of cases due to disc herniation, and even lower prevalence rates for other causes, such as zygapophysial joint pain.", {"entities": [[86, 89, "GENE"]]}], ["Only a small proportion (approximately 20%) of LBP cases can be attributed with reasonable certainty to a pathologic or anatomical entity.", {"entities": [[47, 50, "GENE"]]}], ["Thus, diagnosing the cause of LBP represents the biggest challenge for doctors in this field.", {"entities": [[30, 33, "GENE"]]}], ["In this review, we summarize the process of obtaining a clinical diagnosis of DLBP and discuss the potential for serum-based diagnosis in the near future.", {"entities": []}], ["The use of serum biomarkers to diagnose DLBP is likely to increase the ease of diagnosis as well as produce more accurate and reproducible results.", {"entities": []}], ["The present study protocol describes the evaluation of a comprehensive integrated care model implemented at two hospital sites at the University Hospital of North Norway (UNN).", {"entities": []}], ["The PAtient Centred Team (PACT) model includes proactive, patient-centred interdisciplinary teams that aim to improve the continuum and quality of care of frail elderly patients and reduce health care costs.", {"entities": []}], ["The main objectives of the evaluation are to analyse the effectiveness and cost effectiveness of using patient-centred teams as part of routine service provision for this patient group.", {"entities": []}], ["The evaluation will analyse the effect on patient health and functional status, patient experiences and hospital utilisation, and it will conduct an economic evaluation.", {"entities": []}], ["This paper describes the PACT model and the rationale for and design of the planned effectiveness and cost-effectiveness study.", {"entities": []}], ["This is a prospective, non-randomised matched control before-and-after intervention study.", {"entities": []}], ["Patients in the intervention group will be recruited from the hospital sites that have implemented the PACT model.", {"entities": []}], ["The controls will be recruited from two hospitals without the model.", {"entities": []}], ["The control patients and the index patients will be matched according to sex, age and number of long-term conditions.", {"entities": []}], ["The study aims to include 600 patients in each group, which will provide sufficient power to detect a clinical change in the primary outcome.", {"entities": []}], ["The primary outcome is the physical dimension of the Short Form Health Survey (SF-36).", {"entities": []}], ["Secondary outcomes are the Patient Generated Index (PGI), the Patient Activation Measure (PAM), the Patient Assessment of Chronic Illness Care (PACIC), hospitalisation and length of stay.", {"entities": []}], ["The cost-effectiveness study takes a health provider perspective and calculates the cost per quality-adjusted life-years (QALYs) gained.", {"entities": []}], ["The data will be collected at baseline, 6 and 12\u00a0months.", {"entities": []}], ["The data will be analysed using techniques and models that recognise the lack of randomisation and the correlation of cost and effect data.", {"entities": []}], ["The study results will provide knowledge about whether the integrated care model implemented at UNN improves the quality of care for the frail elderly with multiple conditions.", {"entities": []}], ["The study will establish whether the PAC.", {"entities": []}], ["T model improves health and functional status and is cost effective compared to the usual care for this patient group.", {"entities": []}], ["ClinicalTrials.gov: NCT02541474", {"entities": []}], ["Macrolides including azithromycin ( AZM ) can improve clinical symptoms in asthma regardless of infection status.", {"entities": [[75, 81, "DISEASE"]]}], ["The mechanisms underlying these beneficial effects are yet to be elucidated.", {"entities": []}], ["The aim of this study was to determine the effect of AZM on the airway epithelial barrier both in an in\u00a0vitro model and in patients with asthma.", {"entities": [[137, 143, "DISEASE"]]}], ["Primary human bronchial epithelial cells ( HBEC ) were grown at air liquid interface ( ALI ) and challenged using lipopolysaccharides from Pseudomonas aeruginosa .", {"entities": []}], ["AZM was added at various stages and barrier integrity assessed using transepithelial electrical resistance ( TEER ) and permeability to FITC \u2010dextran.", {"entities": []}], ["MMP \u20109 levels were measured using ELISA .", {"entities": []}], ["AZM enhanced barrier integrity ( TEER / FITC \u2010dextran), increased thickness, suppressed mucin production, and MMP \u20109 release during the formation of a normal epithelial barrier in\u00a0vitro.", {"entities": []}], ["MMP \u20109 levels inversely correlated with TEER .", {"entities": []}], ["AZM also enhanced maintenance of the barrier and facilitated repair post\u2010 LPS challenge.", {"entities": []}], ["To provide translation of our findings, 10 patients with moderate\u2010severe asthma were recruited and received 250\u00a0mg AZM o.d for 6\u00a0weeks.", {"entities": [[73, 79, "DISEASE"]]}], ["Bronchial biopsies taken pre\u2010 and post\u2010 AZM treatment did not show evidence of increased epithelial barrier thickness or decreased mucin production.", {"entities": []}], ["Similarly, bronchial wash samples did not show reduced MMP \u20109 levels.", {"entities": []}], ["Overall, our data show that AZM can significantly improve the development of a normal bronchial epithelial barrier in\u00a0vitro, mimicking reepithelization postinjury.", {"entities": []}], ["AZM also suppressed MMP \u20109 release which correlated with barrier integrity, suggesting a putative mechanism.", {"entities": []}], ["However, these effects were not observed in biopsy samples from asthma patients treated with AZM , possibly due to small sample size.", {"entities": [[64, 70, "DISEASE"]]}], ["With increasing diabetes prevalence worldwide, an impending diabetes \u201cpandemic\u201d has been reported.", {"entities": []}], ["However, definitions of incident cases and the population at risk remain varied and ambiguous.", {"entities": []}], ["This study analyzed trends in mortality and screening that contribute to diabetes prevalence and incidence, distinguishing between new incident cases and newly detected cases.", {"entities": []}], ["In an integrated provider-and-payer-system covering 53% of Israel\u2019s population, a composite diabetes case-finding algorithm was built using diagnoses, lab tests, and antidiabetic medication purchases from the organization\u2019s electronic medical record database.", {"entities": []}], ["Data were extracted on adult members aged 26+ each year from January 1, 2004 through December 31, 2012.", {"entities": []}], ["Rates of diabetes prevalence, incidence, screening, and mortality were reported, with incidence rates evaluated among the total, \u201cpreviously-screened,\u201d and \u201cpreviously-unscreened\u201d at-risk populations.", {"entities": []}], ["There were 343,554 diabetes cases in 2012 (14.4%) out of 2,379,712 members aged 26+.", {"entities": []}], ["A consistent but decelerating upward trend in diabetes prevalence was observed from 2004\u20132012.", {"entities": []}], ["Annual mortality rates among diabetics decreased from 13.8/1000 to 10.7/1000 (p\u2009=\u20090.0002).", {"entities": []}], ["Total population incidence rates declined from 13.3/1000 in 2006 to 10.8/1000 in 2012 (p\u2009<\u20090.0001), with similar incidence trends (13.2/1000 to 10.2/1000; p\u2009=\u20090.0007) among previously-screened at-risk members, and a rise in testing rates from 53.0% to 66.7% (p\u2009=\u20090.0004).", {"entities": []}], ["The previously-unscreened group decreased 28.6%, and the incidence rates within this group remained stable.", {"entities": []}], ["The increase in diabetes prevalence is decelerating despite declining mortality and increasing testing rates.", {"entities": []}], ["A decline in previously-screened incident cases and a shrinking pool of previously-unscreened members suggests that diabetes trends in Israel are moving toward equilibrium, rather than a growing epidemic.", {"entities": []}], ["The online version of this article (doi:10.1186/s12963-014-0032-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To examine key factors influencing chronic kidney disease (CKD) patients\u2019 total expenditure and offer recommendations on how to reduce total cost of CKD care without compromising quality.", {"entities": [[43, 57, "DISEASE"]]}], ["Using the 2002\u20132011 Medical Expenditure Panel Survey (MEPS) data, our cross-sectional study analyzed 197 patient records\u201479 patients with one record and 59 with two entries per patient (138 unique patients).", {"entities": []}], ["We used three patient groups, based on international statistical classification of diseases version 9 code for condition (ICD9CODX) classification, to focus inference from the analysis: (a) non-dialysis dependent CKD, (b) dialysis and (c) transplant.", {"entities": []}], ["Covariate information included region, demographic, co-morbid conditions and types of services.", {"entities": []}], ["We used descriptive methods and multivariate generalized linear models to understand the impact of cost drivers.", {"entities": []}], ["We compared actual and predicted CKD cost of care data using a hold-out sample of nine, randomly selected patients to validate the models.", {"entities": []}], ["Total costs were significantly affected by treatment type, with dialysis being significantly higher than non-dialysis and transplant groups.", {"entities": []}], ["Costs were highest in the West region of the U.S. Average costs for patients with public insurance were significantly higher than patients with private insurance ( p \u2009<\u2009.0743), and likewise, for patients with co-morbid conditions over those without co-morbid conditions ( p \u2009<\u2009.001).", {"entities": []}], ["Managing CKD patients both before and after the onset of dialysis treatment and managing co-morbid conditions in individuals with CKD are potential sources of substantial cost savings in the care of CKD patients.", {"entities": []}], ["Comparing total costs pre and post the United States Affordable Care Act could provide invaluable insights into managing the cost-quality tradeoff in CKD care.", {"entities": []}], ["Fetuses, infants, and juveniles (preadults) should not be considered simply \"small adults\" when it comes to toxicological risk.", {"entities": []}], ["We present specific examples of developmental toxicants that are more toxic to children than to adults, focusing on effects on the immune and respiratory systems.", {"entities": []}], ["We describe differences in both the pharmacokinetics of the developing immune and respiratory systems as well as changes in target organ sensitivities to toxicants.", {"entities": []}], ["Differential windows of vulnerability during development are identified in the context of available animal models.", {"entities": []}], ["We provide specific approaches to directly investigate differential windows of vulnerability.", {"entities": []}], ["These approaches are based on fundamental developmental biology and the existence of discrete developmental processes within the immune and respiratory systems.", {"entities": []}], ["The processes are likely to influence differential developmental susceptibility to toxicants, resulting in lifelong toxicological changes.", {"entities": []}], ["We also provide a template for comparative research.", {"entities": []}], ["Finally, we discuss the application of these data to risk assessment.", {"entities": []}], ["Emergency department (ED) utilization has dramatically increased in developed countries over the last twenty years.", {"entities": []}], ["Because it has been associated with adverse outcomes, increased costs, and an overload on the hospital organization, several policies have tried to curb this growing trend.", {"entities": []}], ["The aim of this study is to systematically review the effectiveness of organizational interventions designed to reduce ED utilization.", {"entities": []}], ["We conducted electronic searches using free text and Medical Subject Headings on PubMed and The Cochrane Library to identify studies of ED visits, re-visits and mortality.", {"entities": []}], ["We performed complementary searches of grey literature, manual searches and direct contacts with experts.", {"entities": []}], ["We included studies that investigated the effectiveness of interventions designed to reduce ED visits and the following study designs: time series, cross-sectional, repeated cross-sectional, longitudinal, quasi-experimental studies, and randomized trial.", {"entities": []}], ["We excluded studies on specific conditions, children and with no relevant outcomes (ED visits, re-visits or adverse events).", {"entities": []}], ["From 2,348 potentially useful references, 48 satisfied the inclusion criteria.", {"entities": []}], ["We classified the interventions in mutually exclusive categories: 1) Interventions addressing the supply and accessibility of services: 25 studies examined efforts to increase primary care physicians, centers, or hours of service; 2) Interventions addressing the demand for services: 6 studies examined educational interventions and 17 examined barrier interventions (gatekeeping or cost).", {"entities": []}], ["The evidence suggests that interventions aimed at increasing primary care accessibility and ED cost-sharing are effective in reducing ED use.", {"entities": []}], ["However, the rest of the interventions aimed at decreasing ED utilization showed contradictory results.", {"entities": []}], ["Changes in health care policies require rigorous evaluation before being implemented since these can have a high impact on individual health and use of health care resources.", {"entities": []}], ["Systematic review registration: http://www.crd.york.ac.uk/PROSPERO .", {"entities": []}], ["Identifier: CRD420111253", {"entities": []}], ["Patients suffering from chronic inflammatory diseases have an increased mortality risk resulting from cardiovascular disorders due to enhanced atherosclerotic and thrombotic events.", {"entities": []}], ["Until now, it is not completely understood in which way an abnormal expression of pro-inflammatory mediators contributes to this elevated cardiovascular risk, but there is a need for new drugs that on the one hand suppress the expression of pro-inflammatory mediators and on the other hand inhibit arterial platelet adhesion.", {"entities": []}], ["Thus, we analyzed the anti-inflammatory and anti-thrombotic capacity of the fungal metabolite Galiellalactone in atherosclerosis-prone apolipoprotein E-deficient mice.", {"entities": [[113, 128, "DISEASE"]]}], ["Treatment of the mice with Galiellalactone lowered the inflammatory expression profile and improved blood clotting times, as well as platelet adhesion to the injured common carotid artery.", {"entities": []}], ["The results indicate that administration of Galiellalactone is able to reduce the extent of inflammation and arterial platelet adhesion in this mouse model.", {"entities": []}], ["Primary extraintestinal complications caused by Yersinia enterocolitica are extremely rare, especially in the form of skin and soft-tissue manifestations, and little is known about their clinical characteristics and treatments.", {"entities": []}], ["We presented our case and reviewed past cases of primary skin and soft-tissue infections caused by Y enterocolitica .", {"entities": []}], ["We report a case of primary cellulitis and cutaneous abscess caused by Y enterocolitica in an immunocompetent 70-year-old woman with keratodermia tylodes palmaris progressiva.", {"entities": [[28, 38, "DISEASE"]]}], ["She presented to an outpatient clinic with redness, swelling, and pain of the left ring finger and left upper arm without fever or gastrointestinal symptoms 3 days before admission.", {"entities": []}], ["One day later, ulceration of the skin with exposed bone of the proximal interphalangeal joint of the left ring finger developed, and cefditoren pivoxil was described.", {"entities": []}], ["However, she was admitted to our hospital due to deterioration of symptoms involving the left finger and upper arm.", {"entities": []}], ["Cefazolin was initiated on admission, then changed to sulbactam/ampicillin and vancomycin with debridement of the left ring finger and drainage of the left upper arm abscess.", {"entities": []}], ["Wound culture grew Y enterocolitica serotype O:8 and methicillin-sensitive Staphylococcus aureus .", {"entities": []}], ["Blood cultures were negative and osteomyelitis was ruled out.", {"entities": [[33, 46, "DISEASE"]]}], ["Vancomycin was switched to ciprofloxacin, then skin and soft-tissue manifestations showed clear improvement within a few days.", {"entities": []}], ["The patient received 14 days of ciprofloxacin and oral amoxicillin/clavulanate and has since shown no recurrence.", {"entities": []}], ["We reviewed 12 cases of primary skin and soft-tissue infections caused by Y enterocolitica from the literature.", {"entities": []}], ["In several past cases, portal entry involved failure of the skin barrier on distal body parts.", {"entities": []}], ["Thereafter, infection might have spread to the regional lymph nodes from the ruptured skin.", {"entities": []}], ["Y enterocolitica is typically resistant to aminopenicillins and narrow-spectrum cephalosporins.", {"entities": []}], ["In most cases, these inefficient antibiotic agents were initially prescribed, but patient conditions rapidly improved after implementing appropriate therapy and drainage.", {"entities": []}], ["In addition, primary skin and soft-tissue infections occurred even in patients lacking risk factors.", {"entities": []}], ["Physicians should consider the rare differential diagnosis of Y enterocolitica infection when seeing patients with deteriorating skin lesions under standard treatment, even if the patient is immunocompetent.", {"entities": []}], ["An emergency triage, assessment and treatment plus admission care (ETAT+) intervention was implemented in Rwandan district hospitals to improve hospital care for severely ill infants and children.", {"entities": []}], ["Many interventions are rarely implemented with perfect fidelity under real-world conditions.", {"entities": []}], ["Thus, evaluations of the real-world experiences of implementing ETAT+ are important in terms of identifying potential barriers to successful implementation.", {"entities": []}], ["This study explored the perspectives of Rwandan healthcare workers (HCWs) on the relevance of ETAT+ and documented potential barriers to its successful implementation.", {"entities": []}], ["HCWs enrolled in the ETAT+ training were asked, immediately after the training, their perspective regarding (i) relevance of the ETAT+ training to Rwandan district hospitals; (ii) if attending the training would bring about change in their work; and (iii) challenges that they encountered during the training, as well as those they anticipated to hamper their ability to translate the knowledge and skills learned in the ETAT+ training into practice in order to improve care for severely ill infants and children in their hospitals.", {"entities": []}], ["They wrote their perspectives in French, Kinyarwanda, or English and sometimes a mixture of all these languages that are official in the post-genocide Rwanda.", {"entities": []}], ["Their notes were translated to (if not already in) English and transcribed, and transcripts were analyzed using thematic content analysis.", {"entities": []}], ["One hundred seventy-one HCWs were included in our analysis.", {"entities": []}], ["Nearly all these HCWs stated that the training was highly relevant to the district hospitals and that it aligned with their work expectation.", {"entities": []}], ["However, some midwives believed that the \u201cneonatal resuscitation and feeding\u201d components of the training were more relevant to them than other components.", {"entities": []}], ["Many HCWs anticipated to change practice by initiating a triage system in their hospital and by using job aids including guidelines for prescription and feeding.", {"entities": []}], ["Most of the challenges stemmed from the mode of the ETAT+ training delivery (e.g., language barriers, intense training schedule); while others were more related to uptake of guidelines in the district hospitals (e.g., staff turnover, reluctance to change, limited resources, conflicting protocols).", {"entities": []}], ["This study highlights potential challenges to successful implementation of the ETAT+ clinical practice guidelines in order to improve quality of hospital care in Rwandan district hospitals.", {"entities": []}], ["Understanding these challenges, especially from HCWs perspective, can guide efforts to improve uptake of clinical practice guidelines including ETAT+ in Rwanda.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-017-2193-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Diet-induced obesity is a lifestyle-associated medical condition that increases the risk of developing cardiovascular disease, type 2 diabetes and certain types of cancer.", {"entities": [[13, 20, "DISEASE"], [164, 170, "DISEASE"]]}], ["Here we report the design of a closed-loop genetic circuit that constantly monitors blood fatty acid levels in the setting of diet-associated hyperlipidemia and coordinates reversible and adjustable expression of the clinically licensed appetite-suppressing peptide hormone pramlintide.", {"entities": []}], ["Grafting of the peroxisome proliferator-activated receptor-\u03b1 onto the phloretin-responsive repressor TtgR produces a synthetic intracellular lipid-sensing receptor (LSR) that reversibly induces chimeric TtgR-specific promoters in a fatty acid-adjustable manner.", {"entities": [[165, 168, "GENE"]]}], ["Mice with diet-induced obesity in which microencapsulated cells engineered for LSR-driven expression of pramlintide are implanted show significant reduction in food consumption, blood lipid levels and body weight when put on a high-fat diet.", {"entities": [[23, 30, "DISEASE"]]}], ["Therapeutic designer circuits that monitor levels of pathologic metabolites and link these with the tailored expression of protein pharmaceuticals may provide new opportunities for the treatment of metabolic disorders.", {"entities": []}], ["Designer gene circuits allow the controlled expression of proteins in response to specific stimuli.", {"entities": []}], ["Here, R\u00f6ssger et al.", {"entities": []}], ["use synthetic biology approaches to create a fatty-acid biosensor that controls the production of a satiety hormone and use it to control diet-induced obesity in mice.", {"entities": [[151, 158, "DISEASE"]]}], ["Myocardial involvement in AAV patients might be silent, presenting with no or nonspecific symptoms, normal ECG, and preserved left-ventricular ejection fraction (LV-EF).", {"entities": []}], ["Since up to 50% of deaths in these patients may be due to myocardial involvement, a reliable diagnostic tool is warranted.", {"entities": []}], ["In contrast to LGE-CMR, which has its strengths in detecting focal inflammatory or fibrotic processes, recent mapping techniques are able to detect even subtle, diffuse inflammatory or fibrotic processes.", {"entities": []}], ["Our study sought to investigate ANCA (antineutrophil cytoplasmic antibody) associated vasculitides (AAV) patients for myocardial involvement by a cardiovascular magnetic resonance (CMR) protocol, including late gadolinium enhancement (LGE) and mapping sequences.", {"entities": []}], ["Thirty seven AAV patients were prospectively enrolled and underwent CMR imaging.", {"entities": []}], ["Twenty healthy volunteers served as controls.", {"entities": []}], ["Mean LV-EF was 64%; LGE prevalence of the AAV patients was 43%.", {"entities": []}], ["AAV patients had higher median native T1 (988 vs. 952\u00a0ms, p \u2009<\u20090.001), lower post-contrast T1 (488 vs. 524\u00a0ms, p \u2009=\u20090.03), expanded extracellular volume (ECV) (27.5 vs. 24.5%, p \u2009<\u20090.001), and higher T2 (53 vs. 49\u00a0ms, p \u2009<\u20090.001) compared to controls, with most parameters independent of the LGE status.", {"entities": []}], ["Native T1 and T2 in AAV patients showed the highest prevalence of abnormally increased values beyond the 95% percentile of controls.", {"entities": []}], ["AAV patients demonstrated increased T1, ECV, and T2 values, with native T1 and T2 showing the highest prevalence of values beyond the 95% percentile of normal.", {"entities": []}], ["Since these findings seem to be independent of LGE, mapping techniques may provide complementary information to LGE-CMR in the assessment of myocardial involvement in patients with AAV.", {"entities": []}], ["The online version of this article (doi:10.1186/s12968-016-0315-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This trial consisted of a 24\u2010week multicentre, randomized, double\u2010blind, double\u2010dummy, active\u2010controlled study and a 52\u2010week open label extension study to assess the efficacy and safety of evogliptin, a novel dipeptidyl peptidase\u20104 inhibitor, compared to sitagliptin in patients with type 2 diabetes who have inadequate glycaemic control with metformin alone.", {"entities": []}], ["Adult patients with type 2 diabetes mellitus ( N \u2009=\u2009222) with HbA1c 6.5% to 11% who were receiving stable doses of metformin (\u22651000\u2009mg/d) were randomized 1:1 to add\u2010on evogliptin 5\u2009mg ( N \u2009=\u2009112) or sitagliptin 100\u2009mg ( N \u2009=\u2009110) once daily for 24\u2009weeks.", {"entities": [[27, 44, "DISEASE"], [20, 44, "DISEASE"]]}], ["The primary efficacy analysis consisted of a comparison of the change from baseline HbA1c at week 24.", {"entities": []}], ["Non\u2010inferiority was concluded if the upper limit of the 2\u2010sided 95% confidence interval for the HbA1c difference between treatments was <0.35%.", {"entities": []}], ["Mean changes in HbA1c following addition of evogliptin or sitagliptin were \u22120.59% and \u22120.65%, respectively.", {"entities": []}], ["The between\u2010group difference was 0.06% (2\u2010sided 95% confidence interval, \u22120.10 to 0.22), demonstrating non\u2010inferiority.", {"entities": []}], ["After the 52\u2010week treatment, evogliptin caused a persistently decreased level of HbA1c (\u22120.44%\u2009\u00b1\u20090.65%, P \u2009<\u2009.0001).", {"entities": []}], ["In general, both treatments were well tolerated, with incidences and types of adverse events comparable between the two groups.", {"entities": []}], ["Hypoglycaemic events, mostly mild, were reported in 0.9% of patients treated with evogliptin and in 2.8% of patients treated with sitagliptin for 24\u2009weeks.", {"entities": []}], ["Evogliptin 5\u2009mg added to metformin therapy effectively improved glycaemic control and was non\u2010inferior to sitagliptin and well tolerated in patients with type 2 diabetes mellitus that was inadequately controlled by metformin alone.", {"entities": [[161, 178, "DISEASE"], [154, 178, "DISEASE"]]}], ["Evidence is limited regarding the comorbidity burden of patients with cluster headache (CH).", {"entities": []}], ["We aimed to characterize comorbid conditions in a cohort of CH patients diagnosed by headache experts, using electronic health record information from the Partners Research Patient Data Registry (RPDR).", {"entities": []}], ["We identified and reviewed the charts of unique patients diagnosed by headache specialists over an 11-year period, and a set of matched controls.", {"entities": []}], ["Patients were categorized as having Definite, Unconfirmed or no CH.", {"entities": []}], ["We calculated the prevalence of and tested for statistically significant differences of selected comorbid conditions in these populations.", {"entities": []}], ["An RPDR query identified 170 patients with a free text or ICD diagnosis of cluster headache.", {"entities": []}], ["15 records belonging to Partners employees were excluded.", {"entities": []}], ["75 patients met diagnostic criteria for CH (Definite CH).", {"entities": []}], ["22 had headaches with some features of CH but the diagnosis was uncertain (Unconfirmed CH).", {"entities": []}], ["In 58 the diagnosis was determined to be inaccurate due to data entry errors.", {"entities": []}], ["Patients with Definite CH had an average age of 43.4\u00a0years; 80% were male.", {"entities": []}], ["The average time from CH onset to diagnosis was 12.7\u00a0years (range 1\u201351).", {"entities": []}], ["The average number of yearly emergency department and outpatient visits for the group of Definite CH patients was 4.5 and 25.4, respectively, compared with 1.1 and 6.9 in controls.", {"entities": []}], ["Of the 55 examined conditions, four were statistically significantly less common in patients with definite CH compared with controls (diabetes, musculoskeletal/orthopaedic problems, \u201cother gastrointestinal diagnoses\u201d and skin conditions) and four were statistically significantly more common (smoking, depression, dental disorders and deviated septum).", {"entities": []}], ["In this large population-based study, we identified a surprisingly small number of patients who met strict diagnostic criteria for CH.", {"entities": []}], ["In these patients, however, we identified a distinct pattern of selected comorbidities.", {"entities": []}], ["The pattern is somewhat but not entirely consistent with that of the \u201cclassic\u201d CH patient depicted in the medical literature.", {"entities": []}], ["CH patients are frequently diagnosed with sinus or dental problems.", {"entities": []}], ["Many experience substantial delay in receiving a diagnosis.", {"entities": []}], ["These things may in part explain the high frequency of medical visits in this population.", {"entities": []}], ["It is difficult to distinguish conditions that are genuinely comorbid with CH from those that reflect misdiagnoses or medical scrutiny of patients in frequent contact with the healthcare system.", {"entities": []}], ["A hospitalist-run acute medical unit (AMU) opened at a tertiary care hospital on August 2015 for the first time in Korea.", {"entities": []}], ["Patients visiting the emergency department (ED) with acute medical problems are admitted to the AMU.", {"entities": []}], ["They stay in that unit for less than 72 hours and are discharged or transferred to specialty wards if longer treatment is necessary.", {"entities": []}], ["We reviewed 19,450 medical admissions through the ED from January 2014 to September 2016.", {"entities": []}], ["The median length of stay (LOS) significantly decreased from 10.0 days (interquartile range [IQR], 5.5\u201316.7) to 9.1 days (IQR, 5.1\u201315.0) ( P < 0.001) after the establishment of the AMU.", {"entities": []}], ["The median waiting time in the ED significantly shortened by 40% ( P < 0.001).", {"entities": []}], ["Future studies on the impact of AMU on in-patient morbidity, mortality, re-admission rate, and patient or staff satisfaction are necessary.", {"entities": []}], ["This study investigated the prevalence of schizophrenia (ICD-10\u00a0F 20) and of other non-affective psychosis (NAP, ICD-10\u00a0F 21 - F 29) in Sweden.", {"entities": [[42, 55, "DISEASE"]]}], ["It further assessed health care use, comorbidity and medication for these patient groups.", {"entities": []}], ["Most studies either have a study population of patients with strictly defined schizophrenia or a psychosis population of which strict schizophrenia cases form a smaller set.", {"entities": [[78, 91, "DISEASE"], [134, 147, "DISEASE"]]}], ["The present study permits comparison of the two mutually exclusive patient groups using data at the individual level in the diagnosis of non-affective psychosis, use of health care, medical treatment and comorbidity by diagnosis or medical treatment.", {"entities": []}], ["In 2012, data were extracted from a regional registry containing patient-level data on consultations, hospitalisations, diagnoses and dispensed drugs for the total population in the region of Stockholm (2.1 million inhabitants).", {"entities": []}], ["The size of the total psychosis population was 18,769, of which 7284 had a diagnosis of schizophrenia.", {"entities": [[88, 101, "DISEASE"]]}], ["Crude prevalence rates and risk rates with 95% confidence intervals were calculated.", {"entities": []}], ["In 2012, the prevalence of schizophrenia and NAP was 3.5/1000 and 5.5/1000, respectively.", {"entities": [[27, 40, "DISEASE"]]}], ["Schizophrenia was most common among patients aged 50\u201359\u00a0years and NAP most common among patients aged 40\u201349\u00a0years.", {"entities": [[0, 13, "DISEASE"]]}], ["Schizophrenia patients used psychiatric health care more often than the NAP patients but less overall inpatient care (78.6 vs. 60.0%).", {"entities": [[0, 13, "DISEASE"]]}], ["The most prevalent comorbidities were substance abuse/dependence (7.9% in the schizophrenia group vs. 11.7% in the NAP group), hypertension (7.9 vs. 9.7%) and diabetes (6.9 vs. 4.8%).", {"entities": [[127, 139, "DISEASE"], [38, 53, "DISEASE"], [78, 91, "DISEASE"]]}], ["The parenteral form of long-acting injectable antipsychotics was more often dispensed to patients with schizophrenia (10 vs. 2%).", {"entities": [[103, 116, "DISEASE"]]}], ["This study, analysing all diagnoses recorded in a large health region, confirmed prevalence rates found in previous studies.", {"entities": []}], ["Schizophrenia patients use more psychiatric and less overall inpatient health care than NAP patients.", {"entities": [[0, 13, "DISEASE"]]}], ["Differences between the two patient groups in comorbidity and drug treatment were found.", {"entities": []}], ["The registered rates of a substance abuse/dependence diagnosis were the most common comorbidity observed among the patients investigated.", {"entities": [[26, 41, "DISEASE"]]}], ["The observed differences between the schizophrenia and the NAP patients in health care consumption, comorbidity and drug treatment are relevant and warrant further studies.", {"entities": [[37, 50, "DISEASE"]]}], ["The biological activity of the edible basidiomycete Antrodia cinnamomea (AC) has been studied extensively.", {"entities": []}], ["Many effects, such as anti-cancer, anti-inflammatory, and antioxidant activities, have been reported from either crude extracts or compounds isolated from AC.", {"entities": [[27, 33, "DISEASE"]]}], ["However, research addressing the function of AC in enhancing immunity is rare.", {"entities": []}], ["The aim of the present study is to investigate the active components and the mechanism involved in the immunostimulatory effect of AC.", {"entities": []}], ["We found that polysaccharides (PS) in the water extract of AC played a major role in dendritic cell (DC) activation, which is a critical leukocyte in initiating immune responses.", {"entities": []}], ["We further size purified and identified that the high-molecular weight PS fraction (greater than 100 kDa) exhibited the activating effect.", {"entities": []}], ["The AC high-molecular weight PSs (AC hmwPSs) promoted pro-inflammatory cytokine production by DCs and the maturation of DCs.", {"entities": []}], ["In addition, DC-induced antigen-specific T cell activation and Th1 differentiation were increased by AC hmwPSs.", {"entities": []}], ["In studying the molecular mechanism, we confirmed the activation of the MAPK and NF-\u03baB pathways in DCs after AC hmwPSs treatment.", {"entities": []}], ["Furthermore, we demonstrated that TLR2 and TLR4 are required for the stimulatory activity of AC hmwPSs on DCs.", {"entities": [[34, 38, "GENE"], [43, 47, "GENE"]]}], ["In a mouse tumor model, we demonstrated that AC hmwPSs enhanced the anti-tumor efficacy of the HER-2/neu DNA vaccine by facilitating specific Th1 responses.", {"entities": []}], ["Thus, we conclude that hmwPSs are the major components of AC that stimulate DCs via the TLR2/TLR4 and NF-\u03baB/MAPK signaling pathways.", {"entities": []}], ["The AC hmwPSs have potential to be applied as adjuvants.", {"entities": []}], ["Macrophage migration inhibitory factor (MIF) plays an important regulatory role in sepsis.", {"entities": [[40, 43, "GENE"]]}], ["In the promoter region a C/G single nucleotide polymorphism (SNP) at position -173 (rs755622) and a CATT 5-8 microsatellite at position -794 are related to modified promoter activity.", {"entities": []}], ["The purpose of the study was to analyze their association with the incidence and outcome of severe sepsis.", {"entities": []}], ["Genotype distributions and allele frequencies in 169 patients with severe sepsis, 94 healthy blood donors and 183 postoperative patients without signs of infection or inflammation were analyzed by real time PCR and Sequence analysis.", {"entities": []}], ["All included individuals were Caucasians.", {"entities": []}], ["Genotype distribution and allele frequencies of severe sepsis patients were comparable to both control groups.", {"entities": []}], ["However, the genotype and allele frequencies of both polymorphisms were associated significantly with the outcome of severe sepsis.", {"entities": []}], ["The highest risk of dying from severe sepsis was detectable in patients carrying a haplotype with the alleles -173 C and CATT 7 (p = 0.0005, fisher exact test, RR = 1,806, CI: 1.337 to 2.439).", {"entities": []}], ["The haplotype with the combination of the -173 C allele and the -794 CATT 7 allele may not serve as a marker for susceptibility to sepsis, but may help identify septic patients at risk of dying.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) occurs typically in current or former smokers, but only a minority of people with smoking history develops the disease.", {"entities": []}], ["Besides environmental factors, genetics is an important risk factor for COPD.", {"entities": []}], ["However, the relationship between genetics, environment and phenotypes is not well understood.", {"entities": []}], ["Sample sizes for genome-wide expression studies based on lung tissue have been small due to the invasive nature of sample collection.", {"entities": []}], ["Increasing evidence for the systemic nature of the disease makes blood a good alternative source to study the disease, but there have also been few large-scale blood genomic studies in COPD.", {"entities": []}], ["Due to the complexity and heterogeneity of COPD, examining groups of interacting genes may have more relevance than identifying individual genes.", {"entities": []}], ["Therefore, we used Weighted Gene Co-expression Network Analysis to find groups of genes (modules) that are highly connected.", {"entities": []}], ["However, module definitions may vary between individual data sets.", {"entities": []}], ["To alleviate this problem, we used a consensus module definition based on two cohorts, COPDGene and ECLIPSE.", {"entities": []}], ["We studied the relationship between the consensus modules and COPD phenotypes airflow obstruction and emphysema.", {"entities": []}], ["We also used these consensus module definitions on an independent cohort (TESRA) and performed a meta analysis involving all data sets.", {"entities": []}], ["We found several modules that are associated with COPD phenotypes, are enriched in functional categories and are overrepresented for cell-type specific genes.", {"entities": []}], ["Of the 14 consensus modules, three were strongly associated with airflow obstruction (meta p \u2264 0.0002), and two had some association with emphysema (meta p \u2264 0.06); some associations were stronger in the case-control cohorts, and others in the cases-only subcohorts.", {"entities": []}], ["Gene Ontology terms that were overrepresented included \u201cimmune response\u201d and \u201cdefense response.\u201d The cell types whose type-specific genes were overrepresented in modules ( p < 0.05) included natural killer cells, dendritic cells, and neutrophils.", {"entities": []}], ["Together, this is the largest investigation of gene blood expression in COPD with 469 cases in COPDGene, ECLIPSE and TESRA combined, with 6267 genes common to all data sets.", {"entities": []}], ["Additional, we have 42 and 83 controls in COPDGene and ECLIPSE, respectively.", {"entities": []}], ["During the deep reactive ion etching process, the sidewalls of a silicon mold feature rough wavy structures, which can be transferred onto a polydimethylsiloxane (PDMS) microchannel through the soft lithography technique.", {"entities": []}], ["In this article, we utilized the wavy structures of PDMS microchannel sidewalls to initiate and cavitate bubbles in the presence of acoustic waves.", {"entities": []}], ["Through bubble cavitation, this acoustofluidic approach demonstrates fast, effective mixing in microfluidics.", {"entities": []}], ["We characterized its performance by using viscous fluids such as poly(ethylene glycol) (PEG).", {"entities": []}], ["When two PEG solutions with a resultant viscosity 54.9 times higher than that of water were used, the mixing efficiency was found to be 0.92, indicating excellent, homogeneous mixing.", {"entities": []}], ["The acoustofluidic micromixer presented here has the advantages of simple fabrication, easy integration, and capability to mix high-viscosity fluids (Reynolds number: \u223c0.01) in less than 100 ms.", {"entities": []}], ["Type 2 diabetic mellitus (T2DM) is a disease with high prevalence and a major cause for death worldwide.", {"entities": []}], ["Diabetic retinopathy (DR) is one of the major manifestation of diabetes.", {"entities": []}], ["Aldehyde dehydrogenease 2 (ALDH2) detoxifies aldehyde produced during ethanol metabolism and oxidative stress.", {"entities": [[27, 32, "GENE"]]}], ["It has been found that the polymorphism in ALDH2 rs671 is probably associated with the risk of T2DM and DR.", {"entities": [[43, 48, "GENE"]]}], ["However, a lot of inconsistency and controversy still exists.", {"entities": []}], ["In order to get a more precise and comprehensive estimation for the association between ALDH2 polymorphism with the risk of T2DM and DR, we conducted the present meta-analysis.", {"entities": [[88, 93, "GENE"]]}], ["A comprehensive literature search was conducted using databases, such as Pubmed, Embase, Cochrane Central Register of Controlled Trials, Chinese National Knowledge Infrastructure, and Chinese Biomedical Literature Database, for all related studies.", {"entities": []}], ["The included studies met the inclusion criteria, such as being case-control studies about the association of ALDH2 polymorphism and T2DM or DR susceptibility, with sufficient data for the present analysis.", {"entities": [[109, 114, "GENE"]]}], ["Eight studies with 2374 cases and 6694 controls were involved in the present meta-analysis.", {"entities": []}], ["The results indicated a significant lower risk of T2DM for *1/*1 genotype in homozygous models (*1/*1 vs. *2/*2, OR = 0.31, 95% CI = 0.11\u20130.89, p = 0.03) and in the dominant model (*1/*1 vs. *2/*2 + *1/*2, OR = 0.61, 95% CI = 0.37\u20131.00, p = 0.05).", {"entities": []}], ["Subgroup analysis by ethnicity found a significant lower risk of T2DM in Chinese in all genotype models.", {"entities": []}], ["No significant relation was found between ALDH2 rs671 and DR.", {"entities": [[42, 47, "GENE"]]}], ["In conclusion, the current meta-analysis indicated that ALDH2 rs671 was significantly related with T2DM.", {"entities": [[56, 61, "GENE"]]}], ["The ALDH2 rs671 might be able to be used as a predictor for the risk of T2DM.", {"entities": [[4, 9, "GENE"]]}], ["However, due to the existence of heterogeneity and publication bias in the involved studies, our results should be interpreted with caution.", {"entities": []}], ["The neonatal Fc receptor (FcRn), also known as the Brambell receptor and encoded by Fcgrt , is a MHC class I like molecule that functions to protect IgG and albumin from catabolism, mediates transport of IgG across epithelial cells, and is involved in antigen presentation by professional antigen presenting cells.", {"entities": [[84, 89, "GENE"]]}], ["Its function is evident in early life in the transport of IgG from mother to fetus and neonate for passive immunity and later in the development of adaptive immunity and other functions throughout life.", {"entities": []}], ["The unique ability of this receptor to prolong the half-life of IgG and albumin has guided engineering of novel therapeutics.", {"entities": []}], ["Here, we aim to summarize the basic understanding of FcRn biology, its functions in various organs, and the therapeutic design of antibody- and albumin-based therapeutics in light of their interactions with FcRn.", {"entities": []}], ["Stress induces chemical changes in the central nervous system which alters the biochemistry and physiology of the digestive tract.", {"entities": []}], ["The present study determines arachidonic acid oxidation and damage in the colon following stress.", {"entities": []}], ["Ten rats were stressed by the cold-restraint method; ten were controls.", {"entities": []}], ["Stress induced 0.5 \u00b1 0.7 (S.D.)", {"entities": []}], ["mucosal erosions whereas controls had none.", {"entities": []}], ["Subepithelial hemorrhage and erosions occurred only in the proximal two-thirds of the colon.", {"entities": []}], ["Prostaglandin E 2 synthesis was increased after stress compared to the control (381 \u00b1 130 vs. 1610 \u00b1 372 ng/g/min).", {"entities": []}], ["Leukotriene C 4 synthesis also increased after stress (4217 \u00b1 994 vs. 11300 \u00b1 1662 ng/g/min).", {"entities": []}], ["Synthesis of prostaglandin E 2 increased (r = 0.9381) with leukotriene C 4 .", {"entities": []}], ["The response of the colon to stress is less severe than that in the stomach and may be related to regional regulation of prostaglandin and leukotriene synthesis.", {"entities": []}], ["Chronic obstructive pulmonary disease is a common condition and a major cause of mortality.", {"entities": []}], ["COPD is characterized by irreversible airflow obstruction.", {"entities": []}], ["The physiological abnormalities observed in COPD are due to a combination of emphysema and obliteration of the small airways in association with airway inflammation.", {"entities": []}], ["The predominant cells involved in this inflammatory response are CD8+ lymphocytes, neutrophils, and macrophages.", {"entities": []}], ["Although eosinophilic airway inflammation is usually considered a feature of asthma, it has been demonstrated in large and small airway tissue samples and in 20%\u201340% of induced sputum samples from patients with stable COPD.", {"entities": [[77, 83, "DISEASE"]]}], ["This airway eosinophilia is increased in exacerbations.", {"entities": [[12, 24, "DISEASE"]]}], ["Thus, modifying eosinophilic inflammation may be a potential therapeutic target in COPD.", {"entities": []}], ["Eosinophilic airway inflammation is resistant to inhaled corticosteroid therapy, but does respond to systemic corticosteroid therapy, and the degree of response is related to the intensity of the eosinophilic inflammation.", {"entities": []}], ["In COPD, targeting treatment to normalize the sputum eosinophilia reduced the number of hospital admissions.", {"entities": [[53, 65, "DISEASE"]]}], ["Whether controlling eosinophilic inflammation in COPD patients with an airway eosinophilia will modify disease progression and possibly alter mortality is unknown, but warrants further investigation.", {"entities": [[78, 90, "DISEASE"]]}], ["Previous research suggests that children born prematurely or with a low birth weight are more vulnerable to the mental health effects of ambient neighbourhood noise; predominantly road and rail noise, at home.", {"entities": []}], ["This study used data from the Road Traffic and Aircraft Noise Exposure and Children's Cognition and Health (RANCH) study to see if this finding extends to aircraft and road traffic noise at school.", {"entities": []}], ["Children and their parents from schools around three European airports were selected to represent a range of aircraft and road traffic noise exposure levels.", {"entities": []}], ["Birth weight and gestation period were merged to create a dichotomous variable assessing 'early biological risk'.", {"entities": []}], ["Mental health was assessed using the Strengths and Difficulties Questionnaire (SDQ).", {"entities": []}], ["Complete data were available for 1900 primary school children.", {"entities": []}], ["Children who were 'at risk' (i.e.", {"entities": []}], ["low birth weight or premature birth) were rated as having more conduct problems and emotional symptoms and poorer overall mental health than children not at risk.", {"entities": []}], ["However, there was no interaction between aircraft or road traffic noise exposure at school and early biological risk.", {"entities": []}], ["Data from the RANCH study suggests that children with early biological risk are not more vulnerable to the effects of aircraft or road traffic noise at school on mental health than children without this risk; however they are more likely to have mental ill-health.", {"entities": []}], ["We studied the effects of growth hormone (GH), insulin-like growth factor I (IGF-I), IGF-II, and insulin on human immunoglobulin E (IgE) and IgG4 production.", {"entities": []}], ["GH and IGF-I induced IgE and IgG4 production by normal donors' mononuclear cells (MNC) depleted of sIgE+ and sIgG4+ B cells without affecting IgM, IgG1, IgG2, IgG3, IgA1, or IgA2 production, whereas IGF-II and insulin failed to do so.", {"entities": []}], ["GH-induced IgE and IgG4 production was specific, and was not mediated by IGF-I, interleukin 4 (IL-4), or IL-13, since it was blocked by anti-GH antibody (Ab), but not by anti-IGF-I Ab, anti-IL-4 Ab, or anti-IL-13 Ab.", {"entities": []}], ["Conversely, IGF-I-induced IgE and IgG4 production was blocked by anti-IGF-I Ab, but not by anti-GH Ab, anti-IL-4 Ab, or anti-IL-13 Ab.", {"entities": []}], ["Moreover, interferon alpha (IFN-alpha) or IFN-gamma, which counteracted IL-4-and IL-13-induced IgE and IgG4 production, had no effect on induction by GH or IGF-I.", {"entities": []}], ["In contrast to MNC, GH or IGF-I failed to induce IgE and IgG4 production by purified sIgE-, sIgG4- B cells.", {"entities": []}], ["However, in the presence of anti-CD40 monoclonal antibody (mAb), GH or IGF-I induced IgE and IgG4 production by these cells.", {"entities": []}], ["Purified sIgE+, but not sIgE-, B cells from atopic patients spontaneously produced IgE.", {"entities": []}], ["GH or IGF-I with anti-CD40 mAb failed to enhance IgE production by sIgE+ B cells, whereas they induced IgE production by sIgE- B cells.", {"entities": []}], ["Similarly, whereas GH or IGF-I with anti-CD40 mAb failed to enhance IgG4 production by sIgG4+ B cells from atopic patients, they induced IgG4 production by sIgG4- B cells.", {"entities": []}], ["Again, neither IgE nor IgG4 induction was blocked by anti-IL-4 Ab or anti-IL-13 Ab.", {"entities": []}], ["These results indicate that GH and IGF-I induce IgE and IgG4 production by class switching in an IL-4- and IL-13-independent mechanism.", {"entities": []}], ["Human CD1d-restricted, invariant natural killer T cells (iNKT) are a unique class of T lymphocytes that recognise glycolipid antigens such as \u03b1-galactosylceramide (\u03b1GalCer) and upon T cell receptor (TCR) activation produce both Th1 and Th2 cytokines.", {"entities": []}], ["iNKT cells expand when cultured in-vitro with \u03b1GalCer and interleukin 2 (IL-2) in a CD1d-restricted manner.", {"entities": []}], ["However, the expansion ratio of human iNKT cells varies between individuals and this has implications for attempts to manipulate this pathway therapeutically.", {"entities": []}], ["We have studied a panel of twenty five healthy human donors to assess the variability in their in-vitro iNKT cell expansion responses to stimulation with CD1d ligands and investigated some of the factors that may influence this phenomenon.", {"entities": [[154, 158, "GENE"]]}], ["Although all donors had comparable numbers of circulating iNKT cells their growth rates in-vitro over 14 days in response to a range of CD1d ligands and IL-2 were highly donor-dependent.", {"entities": [[136, 140, "GENE"]]}], ["Two reproducible donor response patterns of iNKT expansion were seen which we have called 'strong' or 'poor' iNKT responders.", {"entities": []}], ["Donor response phenotype did not correlate with age, gender, frequency of circulating iNKT, or with the CD1d ligand utilised.", {"entities": [[104, 108, "GENE"]]}], ["Addition of exogenous recombinant human interleukin 4 (IL-4) to 'poor' responder donor cultures significantly increased their iNKT proliferative capacity, but not to levels equivalent to that of 'strong' responder donors.", {"entities": []}], ["However in 'strong' responder donors, addition of IL-4 to their cultures did not significantly alter the frequency of iNKT cells in the expanded CD3 (i) in-vitro expansion of human iNKT cells in response to CD1d ligand activation is highly donor variable, (ii) two reproducible patterns of donor iNKT expansion were observed, which could be classified into 'strong' and 'poor' responder phenotypes, (iii) donor iNKT response phenotypes did not correlate with age, gender, frequency of circulating iNKT cells, or with the CD1d ligand utilised, (iv) addition of IL-4 to 'poor' but not 'strong' responder donor cultures significantly increased their in-vitro iNKT cell expansion to \u03b1GalCer.", {"entities": [[207, 211, "GENE"], [521, 525, "GENE"], [207, 211, "GENE"], [521, 525, "GENE"]]}], ["Carbohydrate deficient transferrin (CDT) is the most specific serum biomarker of heavy alcohol consumption, defined as \u2265\u2009350\u2013420 g alcohol/week.", {"entities": []}], ["Despite introduction of a standardized reference measurement technique, widespread use of CDT remains limited due to low sensitivity.", {"entities": []}], ["The aim of this study was to determine the factors that affect diagnostic sensitivity in patients with sustained heavy alcohol intake.", {"entities": []}], ["Patients with a self-reported history of sustained heavy alcohol consumption were recruited from the hepatology outpatient department or medical wards.", {"entities": []}], ["Each patient was interviewed with a validated structured questionnaire of alcohol consumption and CDT analysis using the standardized reference measurement technique with high performance liquid chromatography was performed on serum collected at time of interview.", {"entities": []}], ["52 patients were recruited: 19 from the hepatology outpatient department and 33 from general medical wards.", {"entities": []}], ["Median alcohol intake was 1013 (range 366\u20135880) g/week over the preceding two week period.", {"entities": []}], ["26 patients had a diagnostic CDT based on a threshold value of %CDT >\u20091.7 indicating heavy alcohol consumption, yielding a sensitivity of 50%.", {"entities": []}], ["Overweight/obesity (defined as body mass index (BMI) \u2265\u200925\u00a0kg/m CDT has limited sensitivity as a biomarker of heavy alcohol consumption.", {"entities": [[11, 18, "DISEASE"]]}], ["Caution should be applied when ordering and interpreting %CDT results, particularly in women, patients with cirrhosis and those with an elevated BMI.", {"entities": []}], ["This report aimed to describe the outcomes of the patients with severe H1N1 associated acute respiratory distress syndrome who were treated with extracorporeal membrane oxygenation therapy.", {"entities": [[114, 122, "DISEASE"]]}], ["This retrospective review analyzed a single-center cohort of adult patients with H1N1-related acute respiratory distress syndrome who were managed with veno-venous extracorporeal membrane oxygenation during the winter of 2013/2014.", {"entities": [[121, 129, "DISEASE"]]}], ["A total of 10 patients received veno-venous extracorporeal membrane oxygenation for H1N1 influenza between January 2013 and March 2014.", {"entities": [[89, 98, "DISEASE"]]}], ["Seven patients were transferred to our center for extracorporeal membrane oxygenation consideration (all within 72 hours of initiating mechanical ventilation).", {"entities": []}], ["The median patient age was forty years, and 30% were female.", {"entities": []}], ["The median arterial oxygen partial pressure to fraction of inspired oxygen ratio was 62.5, and the median RESP score was 6.", {"entities": []}], ["Three patients received inhaled nitric oxide, and four patients were proned as rescue therapy before extracorporeal membrane oxygenation was initiated.", {"entities": []}], ["The median duration of mechanical ventilation was twenty-two days (range, 14 - 32).", {"entities": []}], ["The median length of stay in the intensive care unit was twenty-seven days (range, 14 - 39).", {"entities": []}], ["The median hospital length of stay was 29.1 days (range, 16.0 - 46.9).", {"entities": []}], ["Minor bleeding complications occurred in 6 of 10 patients.", {"entities": []}], ["Eight of the ten patients survived to hospital discharge.", {"entities": []}], ["The survivors were relatively young and discharged with good functional status (i.e., enhancing quality-adjusted life-years-saved).", {"entities": []}], ["Our experience shows that even a relatively new extracorporeal membrane oxygenation program can play an important role in that capacity and provide excellent outcomes for the sickest patients.", {"entities": []}], ["Increased leucine-rich \u03b12-glycoprotein-1 (LRG1) has been observed in plasma of individuals with various diseases.", {"entities": [[42, 46, "GENE"]]}], ["However, the role of LRG1 in allergic airway disease has not been investigated.", {"entities": [[21, 25, "GENE"]]}], ["To explore the involvement of LRG1 in allergy and its cell origins.", {"entities": [[30, 34, "GENE"]]}], ["The expression levels of LRG1 and its receptor transforming growth factor-beta receptor II (TGFBR2) in patients with allergic rhinitis (AR) and asthma (AS) were examined by flow cytometry, and enzyme-linked immunosorbent assay (ELISA).", {"entities": [[117, 134, "DISEASE"], [126, 134, "DISEASE"], [144, 150, "DISEASE"], [25, 29, "GENE"], [92, 98, "GENE"]]}], ["LRG1 and soluble TGFBR2 expression in plasma of patients with AR and AS were markedly lower than that of healthy control (HC) subjects.", {"entities": [[0, 4, "GENE"], [17, 23, "GENE"]]}], ["Large proportions of CD123\u00a0+\u00a0HLA-DR\u2212, CD16+, CD4+, CD8+, CD14+, and CD19+ cells expressed LRG1, although the percentages of LRG1+ cells in these cell populations were lower in AR and AS patients.", {"entities": [[90, 94, "GENE"], [124, 128, "GENE"]]}], ["Up to 89.8 and 15.5\u00a0% of dispersed mast cells expressed LRG1 and TGFBR2.", {"entities": [[56, 60, "GENE"], [65, 71, "GENE"]]}], ["Moreover, allergen extract exposure significantly reduced LRG1 and TGFBR2 expression in the plasma and leukocytes of patients with AR and AS.", {"entities": [[58, 62, "GENE"], [67, 73, "GENE"]]}], ["Reduced LRG1 and TGFBR2 levels in patients with allergic airway disorders are likely caused by inhibitory actions of allergens in LRG1 producing cells.", {"entities": [[8, 12, "GENE"], [130, 134, "GENE"], [17, 23, "GENE"], [8, 12, "GENE"], [130, 134, "GENE"]]}], ["Thus, LRG1 may be a key regulatory factor of allergic responses.", {"entities": [[6, 10, "GENE"]]}], ["Timely reperfusion after ST\u2010elevation myocardial infarction ( STEMI ) improves survival.", {"entities": [[38, 59, "DISEASE"]]}], ["Guidelines recommend primary percutaneous coronary intervention ( PPCI ) within 90\u00a0minutes of arrival at a PCI \u2010capable hospital.", {"entities": []}], ["The alternative is fibrinolysis within 30\u00a0minutes for those in those for whom timely transfer to a PCI \u2010capable hospital is not feasible.", {"entities": []}], ["We identified STEMI patients receiving reperfusion therapy at 229 hospitals participating in the Get With the Guidelines\u2014Coronary Artery Disease ( GWTG \u2010 CAD ) database (January 1, 2003 through December 31, 2008).", {"entities": []}], ["Temporal trends in the use of fibrinolysis and PPCI , its timeliness, and in\u2010hospital mortality outcomes were assessed.", {"entities": []}], ["We also assessed predictors of fibrinolysis versus PPCI and compliance with performance measures.", {"entities": []}], ["Defect\u2010free care was defined as 100% compliance with all performance measures.", {"entities": []}], ["We identified 29\u00a0190 STEMI patients, of whom 2441 (8.4%) received fibrinolysis; 38.2% of these patients achieved door\u2010to\u2010needle times \u226430\u00a0minutes.", {"entities": []}], ["Median door\u2010to\u2010needle times increased from 36 to 60\u00a0minutes ( P =0.005) over the study period.", {"entities": []}], ["Among PPCI patients, median door\u2010to\u2010balloon times decreased from 94 to 64\u00a0minutes ( P <0.0001) over the same period.", {"entities": []}], ["In\u2010hospital mortality was higher with fibrinolysis than with PPCI (4.6% vs 3.3%, P =0.001) and did not change significantly over time.", {"entities": []}], ["Patients receiving fibrinolysis were less likely to receive defect\u2010free care compared with their PPCI counterparts.", {"entities": []}], ["Use of fibrinolysis for STEMI has decreased over time with concomitant worsening of door\u2010to\u2010needle times.", {"entities": []}], ["Over the same time period, use of PPCI increased with improvement in door\u2010to\u2010balloon times.", {"entities": []}], ["In\u2010hospital mortality was higher with fibrinolysis than with PPCI .", {"entities": []}], ["As reperfusion for STEMI continues to shift from fibrinolysis to PPCI , it will be critical to ensure that door\u2010to\u2010needle times and outcomes do not worsen.", {"entities": []}], ["Sickle cell disease (SCD) is an autosomal recessive hemoglobinopathy that causes significant morbidity and mortality related to chronic hemolytic anemia, vaso-occlusion, and resultant end-organ damage.", {"entities": [[52, 68, "DISEASE"], [136, 152, "DISEASE"], [146, 152, "DISEASE"], [21, 24, "GENE"]]}], ["Tobacco smoke exposure (TSE) through secondhand smoke exposure in people with SCD of all ages and through primary smoking in adolescents and adults is associated with significantly increased morbidity, with increased rates of emergency department visits and hospitalizations for painful vaso-occlusive crises and acute chest syndrome (ACS).", {"entities": [[313, 333, "DISEASE"], [325, 333, "DISEASE"], [78, 81, "GENE"]]}], ["Secondhand smoke is also associated with pulmonary function abnormalities in children with SCD who are already at risk for pulmonary function abnormalities on the basis of SCD.", {"entities": [[91, 94, "GENE"], [172, 175, "GENE"], [91, 94, "GENE"], [172, 175, "GENE"]]}], ["TSE is emerging as one of the few modifiable risk factors of SCD.", {"entities": [[61, 64, "GENE"]]}], ["This review discusses the current state of the evidence with respect to TSE and SCD morbidity, discusses potential mechanisms, and highlights current gaps in the evidence and future research directions.", {"entities": [[80, 83, "GENE"]]}], ["Background: It is unclear whether maternal supplementation with small-quantity lipid-based nutrient supplements (SQ-LNSs; 118 kcal/d) affects maternal weight.", {"entities": []}], ["Objective: We compared several secondary anthropometric measures between 3 groups of women in the iLiNS (International Lipid-based Nutrient Supplements)-DYAD trial in Ghana.", {"entities": []}], ["Methods: Women ( n = 1320; <20 wk of gestation) were randomly assigned to receive 60 mg Fe + 400 \u03bcg folic acid/d (IFA), 18 vitamins and minerals/d [multiple micronutrients (MMNs)], or 20 g SQ-LNSs with 22 micronutrients/d (LNS) during pregnancy and a placebo (200 mg Ca/d), MMNs, or SQ-LNSs, respectively, for 6 mo postpartum.", {"entities": []}], ["Weight, midupper arm circumference (MUAC), and triceps skinfold (TSF) thickness at 36 wk of gestation and 6 mo postpartum were analyzed, as were changes from estimated prepregnancy values.", {"entities": []}], ["We assessed the adequacy of estimated gestational weight gain (GWG) by using Institute of Medicine (IOM) and International Fetal and Newborn Growth Standards for the 21st Century (INTERGROWTH-21st) guidelines.", {"entities": []}], ["Results: The estimated prepregnancy prevalence of overweight or obesity was 38.5%.", {"entities": [[64, 71, "DISEASE"]]}], ["By 36 wk of gestation, women ( n = 1015) had a mean \u00b1 SD weight gain of 7.4 \u00b1 3.7 kg and changes of \u22121.0 \u00b1 1.7 cm in MUAC and \u22122.8 \u00b1 4.1 mm in TSF thickness.", {"entities": []}], ["The LNS group had a lower prevalence of inadequate GWG on the basis of IOM guidelines (57.4%) than the MMN (67.2%) but not the IFA (63.1%) groups ( P = 0.030), whereas the prevalence of adequate (26.9% overall) and excessive (10.4% overall) GWG did not differ by group.", {"entities": []}], ["The percentages of normal-weight women (in kg/m n = 754) whose GWG was less than the third centile of the INTERGROWTH-21st standards were 23.0%, 28.7%, and 28.5% for the LNS, MMN, and IFA groups, respectively ( P = 0.36).", {"entities": []}], ["At 6 mo postpartum, the prevalence of overweight or obesity was 45.3%, and the risk of becoming overweight or obese did not differ by group.", {"entities": [[52, 59, "DISEASE"]]}], ["Conclusion: SQ-LNS supplementation is one potential strategy to address the high prevalence of inadequate GWG in women in settings similar to Ghana, without increasing the risk of excessive GWG.", {"entities": []}], ["This trial was registered at clinicaltrials.gov as NCT00970866.", {"entities": []}], ["Persistent airway inflammation, mucus production, and airway hyperreactivity are the major contributors to the frequency and severity of asthma.", {"entities": [[137, 143, "DISEASE"]]}], ["Why lung inflammation persists in asthmatics remains unclear.", {"entities": []}], ["It has been proposed that Fas-mediated apoptosis of inflammatory cells is a fundamental mechanism involved in the resolution of eosinophilic airway inflammation.", {"entities": []}], ["Because infiltrating eosinophils are highly sensitive to Fas-mediated apoptosis, it has been presumed that direct ligation of Fas on eosinophils is involved.", {"entities": [[57, 60, "GENE"], [126, 129, "GENE"]]}], ["Here, we utilize adoptive transfers of T cells to demonstrate that the delayed resolution of eosinophilia in Fas-deficient mice is a downstream effect of Fas deficiency on T cells, not eosinophils.", {"entities": [[93, 105, "DISEASE"], [109, 112, "GENE"], [154, 157, "GENE"]]}], ["Interestingly, the mice that received Fas-deficient T cells, but not the controls, developed a persistent phase of inflammation that failed to resolve even 6 wk after the last challenge.", {"entities": []}], ["This persistent phase correlated with decreased interferon (IFN)\u03b3 production by Fas-deficient T cells and could be reproduced with adoptive transfer of IFN\u03b3-deficient T cells.", {"entities": []}], ["These data demonstrate that Fas deficiency on T cells is sufficient for the development of long-term allergic airway disease in mice and implies that deregulation of death receptors such as Fas on human T cells could be an important factor in the development and/or chronic nature of asthma.", {"entities": [[284, 290, "DISEASE"], [28, 31, "GENE"], [190, 193, "GENE"], [28, 31, "GENE"], [190, 193, "GENE"]]}], ["Background: Pneumonia is the most common complication of varicella-zoster infection in adults and has potentially devastating effects when complicating pregnancy.", {"entities": [[12, 21, "DISEASE"]]}], ["Due to the significant morbidity and mortality associated with this complication during pregnancy and the small number of reported cases in the literature, we present this report to help educate physicians who care for pregnant women.", {"entities": []}], ["Cases: Seven patients are presented in this report.", {"entities": []}], ["These patients presented at various stages in pregnancy, from 17 to 31 weeks of gestation.", {"entities": []}], ["Three of the patients had unremarkable hospital courses.", {"entities": []}], ["Three of the patients had hospital stays over 21 days in duration.", {"entities": []}], ["One patient died from complications of varicella pneumonia after 31 days of hospitalization.", {"entities": [[49, 58, "DISEASE"]]}], ["The obstetric outcomes of the 7 patients described include 1 non-viable delivery at 20 weeks gestation, 3 term deliveries, 2 preterm deliveries, and 1 patient who has not yet delivered.", {"entities": []}], ["All of the patients presented were treated with intravenous acyclovir therapy.", {"entities": []}], ["Of the patients described, 3 required intubation and ventilatory support.", {"entities": []}], ["Other complications encountered include disseminated intravascular coagulation (DIC), adult respiratory distress syndrome (ARDS), metabolic encephalopathy, pneumothorax, superimposed bacterial pneumonia, and sepsis.", {"entities": [[193, 202, "DISEASE"], [113, 121, "DISEASE"], [86, 121, "DISEASE"], [183, 202, "DISEASE"], [156, 168, "DISEASE"], [40, 78, "DISEASE"]]}], ["Conclusion: The course and treatment of varicella pneumonia complicating pregnancy are discussed.", {"entities": [[50, 59, "DISEASE"]]}], ["Current recommendations regarding the use of varicella-zoster immune globulin (VZIG) are also reviewed.", {"entities": []}], ["Over recent years increased emphasis has been given to performance monitoring of NHS hospitals, including overall number of hospital readmissions, which however are often sub-optimally adjusted for case-mix.", {"entities": [[81, 84, "GENE"]]}], ["We therefore conducted a study to examine the effect of various patient and disease factors on the risk of emergency medical readmission.", {"entities": []}], ["The study setting was a District General Hospital in Greater Manchester and the study period was 4.5-years.", {"entities": []}], ["All index emergency medical admission during the study period leading to a live discharge were included in the study (n = 20,209).", {"entities": []}], ["A multivariable proportional hazards modelling was used, based on Hospital Episodes Statistics data, to examine the influence of various baseline factors on readmission risk.", {"entities": []}], ["Deprivation status was measured with the Townsend deprivation index score.", {"entities": []}], ["Hazard ratios (HR) and associated 95% confidence intervals (CI) of unplanned emergency medical admission by sex, age group, admission method, diagnostic group, number of coded co-morbidities, length of stay and patient's deprivation status quartile, were calculated.", {"entities": [[15, 17, "GENE"]]}], ["Significant independent predictors of readmission risk at 12 months were male sex (HR 1.13, CI: 1.07\u20131.2), age (age >75 (HR 1.57, CI 1.45\u20131.7), number of coded co-morbidities (HR for >4 coded co-morbidities: 1.49 CI: 1.26\u20131.76), admission via GP referral (HR 0.93, CI 0.88\u20130.99) and primary diagnosis of heart failure (HR 1.33, CI: 1.16\u20131.53) and chronic obstructive pulmonary disease/asthma (HR 1.34, CI: 1.21\u20131.48).", {"entities": [[347, 384, "DISEASE"], [385, 391, "DISEASE"], [83, 85, "GENE"], [121, 123, "GENE"], [176, 178, "GENE"], [256, 258, "GENE"], [319, 321, "GENE"], [393, 395, "GENE"], [83, 85, "GENE"], [121, 123, "GENE"], [176, 178, "GENE"], [256, 258, "GENE"], [319, 321, "GENE"], [393, 395, "GENE"], [83, 85, "GENE"], [121, 123, "GENE"], [176, 178, "GENE"], [256, 258, "GENE"], [319, 321, "GENE"], [393, 395, "GENE"], [83, 85, "GENE"], [121, 123, "GENE"], [176, 178, "GENE"], [256, 258, "GENE"], [319, 321, "GENE"], [393, 395, "GENE"], [83, 85, "GENE"], [121, 123, "GENE"], [176, 178, "GENE"], [256, 258, "GENE"], [319, 321, "GENE"], [393, 395, "GENE"], [83, 85, "GENE"], [121, 123, "GENE"], [176, 178, "GENE"], [256, 258, "GENE"], [319, 321, "GENE"], [393, 395, "GENE"]]}], ["Higher level of deprivation was also significantly and independently associated and with increased emergency medical readmission risk at three (HR for the most deprived quartile 1.21, CI: 1.08\u20131.35), six (HR 1.21, CI: 1.1\u20131.33) and twelve months (HR 1.25, CI: 1.16\u20131.36).", {"entities": [[144, 146, "GENE"], [205, 207, "GENE"], [247, 249, "GENE"], [144, 146, "GENE"], [205, 207, "GENE"], [247, 249, "GENE"], [144, 146, "GENE"], [205, 207, "GENE"], [247, 249, "GENE"]]}], ["There is a potential for improving health and reducing demand for emergency medical admissions with more effective management of patients with heart failure and chronic obstructive airways disease/asthma.", {"entities": [[197, 203, "DISEASE"]]}], ["There is also a potential for improving health and reducing demand if reasons for increased readmission risk in more deprived patients are understood.", {"entities": []}], ["The potential influence of deprivation status on readmission risk should be acknowledged, and NHS performance indicators adjustment for deprivation case-mix would be prudent.", {"entities": [[94, 97, "GENE"]]}], ["Lung transplantation is a well-established treatment for patients with advanced lung disease.", {"entities": [[80, 92, "DISEASE"]]}], ["The evaluation of a candidate for transplantation is a complex task and involves a multidisciplinary team that follows the patient beyond the postoperative period.", {"entities": []}], ["Currently, the mean time on the waiting list for lung transplantation in the state of S\u00e3o Paulo, Brazil, is approximately 18 months.", {"entities": []}], ["For Brazil as a whole, data from the Brazilian Organ Transplant Association show that, in 2014, there were 67 lung transplants and 204 patients on the waiting list for lung transplantation.", {"entities": []}], ["Lung transplantation is most often indicated in cases of COPD, cystic fibrosis, interstitial lung disease, non-cystic fibrosis bronchiectasis, and pulmonary hypertension.", {"entities": [[157, 169, "DISEASE"], [127, 141, "DISEASE"], [80, 105, "DISEASE"], [63, 78, "DISEASE"], [111, 126, "DISEASE"], [147, 169, "DISEASE"], [93, 105, "DISEASE"]]}], ["This comprehensive review aimed to address the major aspects of lung transplantation: indications, contraindications, evaluation of transplant candidates, evaluation of donor candidates, management of transplant recipients, and major complications.", {"entities": []}], ["To that end, we based our research on the International Society for Heart and Lung Transplantation guidelines and on the protocols used by our Lung Transplant Group in the city of S\u00e3o Paulo, Brazil.", {"entities": []}], ["O transplante pulmonar \u00e9 uma terapia bem estabelecida para pacientes com doen\u00e7a pulmonar avan\u00e7ada.A avalia\u00e7\u00e3o do candidato para o transplante \u00e9 uma tarefa complexa e envolve uma equipe multidisciplinar que acompanha o paciente para al\u00e9m do per\u00edodo p\u00f3s-operat\u00f3rio.O tempo m\u00e9dio atual em lista de espera para transplante pulmonar \u00e9 de aproximadamente 18 meses no estado de S\u00e3o Paulo.", {"entities": []}], ["Em 2014, dados da Associa\u00e7\u00e3o Brasileira de Transplante de \u00d3rg\u00e3os mostram que 67 transplantes pulmonares foram realizados no Brasil e que 204 pacientes estavam na lista de espera para transplante pulmonar.O transplante pulmonar \u00e9 principalmente indicado no tratamento de DPOC, fibrose c\u00edstica, doen\u00e7a intersticial pulmonar, bronquiectasia n\u00e3o fibroc\u00edstica e hipertens\u00e3o pulmonar.Esta revis\u00e3o abrangente teve como objetivos abordar os aspectos principais relacionados ao transplante pulmonar: indica\u00e7\u00f5es, contraindica\u00e7\u00f5es, avalia\u00e7\u00e3o do candidato ao transplante, avalia\u00e7\u00e3o do candidato doador, gest\u00e3o do paciente transplantado e complica\u00e7\u00f5es maiores.", {"entities": []}], ["Para atingirmos tais objetivos, utilizamos como base as diretrizes da Sociedade Internacional de Transplante de Cora\u00e7\u00e3o e Pulm\u00e3o e nos protocolos de nosso Grupo de Transplante Pulmonar localizado na cidade de S\u00e3o Paulo.", {"entities": []}], ["Tobacco use disorder (TUD), defined as the use of tobacco to the detriment of a person\u2019s health or social functioning, is associated with various disorders.", {"entities": []}], ["We hypothesized that mutual variation in genes may partly explain this link.", {"entities": []}], ["The aims of this study were to make a non-exhaustive inventory of the disorders using (partially) the same genetic pathways as TUD, and to describe the genetic similarities between TUD and the selected disorders.", {"entities": []}], ["We developed a 3 stage approach: (i) selection of genes influencing TUD using Gene2Mesh and Ingenuity Pathway Analysis (IPA), (ii) selection of disorders associated with the selected genes using IPA and (iii) genetic similarities between disorders associated with TUD using Jaccard distance and cluster analyses.", {"entities": []}], ["Fourteen disorders and thirty-two genes met our inclusion criteria.", {"entities": []}], ["The Jaccard distance between pairs of disorders ranged from 0.00 (e.g.", {"entities": []}], ["oesophageal cancer and malignant hypertension) to 0.45 (e.g.", {"entities": [[23, 45, "DISEASE"], [33, 45, "DISEASE"], [12, 18, "DISEASE"]]}], ["bladder cancer and addiction).", {"entities": [[8, 14, "DISEASE"]]}], ["A lower number in the Jaccard distance indicates a higher similarity between the two disorders.", {"entities": []}], ["Two main clusters of genetically similar disorders were observed, one including coexisting disorders (e.g.", {"entities": []}], ["addiction and alcoholism) and the other one with the side-effects of smoking (e.g.", {"entities": []}], ["gastric cancer and malignant hypertension).", {"entities": [[19, 41, "DISEASE"], [29, 41, "DISEASE"], [8, 14, "DISEASE"]]}], ["This exploratory study partly explains the potential genetic components linking TUD to other disorders.", {"entities": []}], ["Two principle clusters of disorders were observed (i) coexisting disorders of TUD and (ii) side-effects of TUD disorders.", {"entities": []}], ["A further deepening of this observation in a real life study should allow strengthening this hypothesis.", {"entities": []}], ["Despite the urgent need for evidence to guide the end-of-life (EOL) care for patients with chronic kidney disease (CKD), we have limited knowledge of the costs and intensity of EOL care in this population.", {"entities": [[99, 113, "DISEASE"]]}], ["The present study examined patterns and predictors for EOL care intensity among elderly patients with CKD.", {"entities": []}], ["We conducted a retrospective nationwide cohort study utilizing the Taiwan National Health Insurance (NHI) Research Database.", {"entities": []}], ["A total of 65,124 CKD patients aged\u2009\u2265\u200960\u00a0years, who died in hospitals or shortly after discharge between 2002 and 2012 were analyzed.", {"entities": []}], ["The primary outcomes were inpatient expenses and use of surgical interventions in the last 30\u00a0days of life.", {"entities": []}], ["Utilization of intensive care unit (ICU), mechanical ventilation, resuscitation, and dialysis was also examined in a sub-sample of 2072 patients with detailed prescription data.", {"entities": []}], ["Multivariate log-linear and logistic regression analyses were performed to assess patient-, physician-, and facility-specific predictors and the potential impact of a 2009 payment policy to reimburse hospice care for non-cancer patients.", {"entities": [[221, 227, "DISEASE"]]}], ["During the last 30\u00a0days of life, average inpatients costs for elderly CKD patients were approximately US$10,260, with 40.9% receiving surgical interventions, 40.2% experiencing ICU admission, 45.3% undergoing mechanical ventilation, 14.7% receiving resuscitation and 42.0% receiving dialysis.", {"entities": []}], ["Significant variability was observed in the inpatient costs and use of intensive services.", {"entities": []}], ["Costs were lower among individuals with the following characteristics: advanced age; high income; high Charlson Comorbidity Index scores; treatment by older physicians, nephrologists, and family medicine physicians; and treatment at local hospitals.", {"entities": []}], ["Similar findings were obtained for the use of surgical interventions and other intensive services.", {"entities": []}], ["A declining trend was detected in the costs of EOL care, use of surgical interventions and resuscitation between 2009 and 2012, which is consistent with the impact of a 2009 NHI payment policy to reimburse non-cancer hospice care.", {"entities": [[210, 216, "DISEASE"]]}], ["Overall EOL costs and rates of intensive service use among older patients with CKD were high, with significant variability across various patient and provider characteristics.", {"entities": []}], ["Several opportunities exist for providers and policy makers to reduce costs and enhance the value of EOL care for this population.", {"entities": []}], ["The essential fatty acid eicosapentaenoic acid (EPA) present in fish oils displays beneficial effects in a range of human disorders associated with inflammation including cardiovascular disease.", {"entities": []}], ["Resolvin E1 (RvE1), a new bioactive oxygenated product of EPA, was identified in human plasma and prepared by total organic synthesis.", {"entities": []}], ["Results of bioaction and physical matching studies indicate that the complete structure of RvE1 is 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-EPA.", {"entities": []}], ["At nanomolar levels, RvE1 dramatically reduced dermal inflammation, peritonitis, dendritic cell (DC) migration, and interleukin (IL) 12 production.", {"entities": [[68, 79, "DISEASE"]]}], ["We screened receptors and identified one, denoted earlier as ChemR23, that mediates RvE1 signal to attenuate nuclear factor\u2013\u03baB.", {"entities": []}], ["Specific binding of RvE1 to this receptor was confirmed using synthetic [", {"entities": []}], ["In many healthcare systems, people with severe joint disease wait months to years for joint replacement surgery.", {"entities": []}], ["There are little empirical data on the health consequences of this delay and it is unclear whether people with substantial morbidity at entry to the waiting list continue to deteriorate further while awaiting surgery.", {"entities": []}], ["This study investigated changes in Health-Related Quality of Life (HRQoL), health status and psychological distress among people waiting for total hip (THR) and knee replacement (TKR) surgery at a major metropolitan Australian public hospital.", {"entities": []}], ["134 patients completed questionnaires including the Assessment of Quality of Life (AQoL) instrument, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Kessler Psychological Distress Scale after entering an orthopaedic waiting list (baseline) and before surgery (preadmission).", {"entities": []}], ["To quantify potential decline in wellbeing, we calculated the proportion of people experiencing clinically important deterioration using published guidelines and compared HRQoL and psychological distress outcomes with population norms.", {"entities": []}], ["Most participants (69%) waited \u22656 months for surgery (median 286 days, IQR 169-375 days).", {"entities": []}], ["Despite poor physical and psychological wellbeing at baseline, there was an overall deterioration in HRQoL during the waiting period (mean AQoL change -0.04, 95%CI -0.08 to -0.01), with 53% of participants experiencing decline in HRQoL (\u22650.04 AQoL units).", {"entities": []}], ["HRQoL prior to surgery remained substantially lower than Australian population norms (mean sample AQoL 0.37, 95%CI 0.33 to 0.42 vs mean population AQoL 0.83, 95%CI 0.82 to 0.84).", {"entities": []}], ["Twenty-five per cent of participants showed decline in health status (\u22659.6 WOMAC units) over the waiting period and prevalence of high psychological distress remained high at preadmission (RR 3.5, 95%CI 2.8 to 4.5).", {"entities": []}], ["Most participants considered their pain (84%), fatigue (76%), quality of life (73%) and confidence in managing their health (55%) had worsened while waiting for surgery.", {"entities": []}], ["Despite substantial initial morbidity, over half of the participants awaiting joint replacement experienced deterioration in HRQoL during the waiting period.", {"entities": []}], ["These data provide much-needed evidence to guide health professionals and policymakers in the design of care pathways and resource allocation for people who require joint replacement surgery.", {"entities": []}], ["Physician prescribing is the most frequent medical intervention with a highest impact on healthcare costs and outcomes.", {"entities": []}], ["Therefore improving and promoting rational drug use is a great interest.", {"entities": []}], ["We aimed to assess the effectiveness and cost-effectiveness of two forms of conducting prescribing audit and feedback interventions and a printed educational material intervention in improving physician prescribing.", {"entities": []}], ["A four-arm randomized trial with economic evaluation will be conducted in Tehran.", {"entities": []}], ["Three interventions (routine feedback, revised feedback, and printed educational material) and a no intervention control arm will be compared.", {"entities": []}], ["Physicians working in outpatient practices are randomly allocated to one of the four arms using stratified randomized sampling.", {"entities": []}], ["The interventions are developed based on a review of literature, physician interviews, current experiences in Iran and with theoretical insights from the Theory of Planned Behavior.", {"entities": []}], ["Effects of the interventions on improving antibiotics and corticosteroids prescribing will be assessed in regression analyses.", {"entities": []}], ["Cost data will be assessed from a health care provider\u2019s perspective and incremental cost-effectiveness ratios will be calculated.", {"entities": []}], ["This study will determine the effectiveness and cost-effectiveness of three interventions and allow us to determine the most effective interventions in improving prescribing pattern.", {"entities": []}], ["If the interventions are cost-effective, they will likely be applied nationwide.", {"entities": []}], ["Iranian Registry of Clinical Trials Registration Number: IRCT201106086740N1Pharmaceutical Sciences Research Center of TUMS Ethics Committee Registration Number: 90-02-27-07", {"entities": []}], ["Common polymorphisms of microRNA gene MIR146A were reported as associated with different autoimmune diseases, include systemic lupus erythematosus, psoriatic arthritis, asthma and ankylosing spondylitis.", {"entities": [[191, 202, "DISEASE"], [127, 146, "DISEASE"], [158, 167, "DISEASE"], [148, 167, "DISEASE"], [169, 175, "DISEASE"], [118, 146, "DISEASE"], [180, 202, "DISEASE"]]}], ["In this study we investigated MIR146A SNPs in Chinese people with ankylosing spondylitis.", {"entities": [[77, 88, "DISEASE"], [66, 88, "DISEASE"]]}], ["Three common SNPs: rs2910164, rs2431697 and rs57095329 were selected and genotyped in 611 patients and 617 controls.", {"entities": []}], ["We found no association between these SNPs and ankylosing spondylitis in our samples.", {"entities": [[58, 69, "DISEASE"], [47, 69, "DISEASE"]]}], ["Acidosis in the skin triggers activation of pain pathways and behaviors indicative of pain in vertebrates.", {"entities": []}], ["The exception is the naked mole-rat, the only known vertebrate to show physiological and behavioral insensitivity to acid pain in the skin.", {"entities": []}], ["The goal of the present study was to determine behavioral and physiological responses of this species to airborne acidic fumes, which would be expected to affect the trigeminal pain pathway in other species.", {"entities": []}], ["Behaviorally, naked mole-rats did not avoid fumes from moderately high concentrations of acetic acid (10 and 20%), and c Fos labeling showed no increase in activity in the trigeminal nuclei and nucleus tractus solitarius.", {"entities": [[121, 124, "GENE"]]}], ["In contrast, these concentrations triggered behavioral aversion and increased Fos activity in other laboratory rodents.", {"entities": [[78, 81, "GENE"]]}], ["For a very high concentration of acetic acid (50%), naked mole-rats showed significant avoidance behavior and increased Fos labeling in the nucleus tractus solitarius caudal region, which receives vagal chemosensory information.", {"entities": [[120, 123, "GENE"]]}], ["However, there was no increase in trigeminal labeling, and in fact, activity significantly decreased .", {"entities": []}], ["This pattern is opposite of that associated with another irritant, ammonia fumes, which elicited an increase in trigeminal but not nucleus tractus solitarius Fos labeling, and no behavioral avoidance.", {"entities": [[158, 161, "GENE"]]}], ["Behavioral avoidance of acidic fumes, but no increased labeling in the trigeminal pain nucleus is consistent with the notion of adaptations to blunt acid pain, which would be advantageous for naked mole-rats as they normally live under chronically high levels of acidosis-inducing CO 2 .", {"entities": []}], ["Replicating smallpox vaccines can cause severe complications in individuals with atopic dermatitis (AD).", {"entities": [[12, 20, "DISEASE"], [81, 98, "DISEASE"], [88, 98, "DISEASE"]]}], ["Prior studies evaluating Modified Vaccinia Ankara virus (MVA), a non-replicating vaccine in humans, showed a favorable safety and immunogenicity profile in healthy volunteers.", {"entities": [[34, 42, "DISEASE"]]}], ["This Phase II study compared the safety and immunogenicity of MVA enrolling groups of 350 subjects with AD (SCORAD \u2264 30) and 282 healthy subjects.", {"entities": []}], ["Subjects were vaccinated twice with MVA, each dose given subcutaneously 4 weeks apart.", {"entities": []}], ["Adverse events, cardiac parameters, and the development of vaccinia virus humoral immune responses were monitored.", {"entities": [[59, 67, "DISEASE"]]}], ["The overall safety of the vaccine was similar in both groups.", {"entities": []}], ["Adverse events affecting skin were experienced significantly more often in subjects with AD, but the majority of these events were mild to moderate in intensity.", {"entities": []}], ["Seroconversion rates and geometric mean titers for total and neutralizing vaccinia-specific antibodies in the AD group were non-inferior compared to the healthy subjects.", {"entities": [[74, 82, "DISEASE"]]}], ["The size of the study population limited the detection of serious adverse events occurring at a frequency less than 1%.", {"entities": []}], ["MVA has a favorable safety profile and the ability to elicit vaccinia-specific immune responses in subjects with AD.", {"entities": [[61, 69, "DISEASE"]]}], ["ClinicalTrials.gov NCT00316602", {"entities": []}], ["Analysis of patterns of variation of time-series, termed variability analysis, represents a rapidly evolving discipline with increasing applications in different fields of science.", {"entities": []}], ["In medicine and in particular critical care, efforts have focussed on evaluating the clinical utility of variability.", {"entities": []}], ["However, the growth and complexity of techniques applicable to this field have made interpretation and understanding of variability more challenging.", {"entities": []}], ["Our objective is to provide an updated review of variability analysis techniques suitable for clinical applications.", {"entities": []}], ["We review more than 70 variability techniques, providing for each technique a brief description of the underlying theory and assumptions, together with a summary of clinical applications.", {"entities": []}], ["We propose a revised classification for the domains of variability techniques, which include statistical, geometric, energetic, informational, and invariant.", {"entities": []}], ["We discuss the process of calculation, often necessitating a mathematical transform of the time-series.", {"entities": []}], ["Our aims are to summarize a broad literature, promote a shared vocabulary that would improve the exchange of ideas, and the analyses of the results between different studies.", {"entities": []}], ["We conclude with challenges for the evolving science of variability analysis.", {"entities": []}], ["Heat stroke is associated with prolonged exposures to high air temperatures that usually occur in the summer months of July and August in Tokyo, Japan.", {"entities": []}], ["Also during July and August, residents of Tokyo are often exposed simultaneously to high concentrations of air pollutants.", {"entities": []}], ["To assess the impacts of these combined exposures, daily numbers of heat stroke emergency transport cases/million residents for Tokyo were stratified by gender and three groups: 0-14, 15-64; and > 65 years of age, for the months of July and August in 1980-1995.", {"entities": []}], ["A regression model was constructed using daily maximum temperature (Tmax) and daily average concentrations of NO2 and O3 as model covariates.", {"entities": []}], ["Classification indices were added to make it possible to compare the expected number of heat stroke cases by age and gender.", {"entities": []}], ["Lag times of 1-4 days in Tmax and air quality covariates and terms to account for interactions between pairs of model covariates were also included as additional risk factors.", {"entities": []}], ["Generalized linear models (GLMs), assuming a Poisson error structure for heat stroke emergency transport cases, were used to determine which covariates were significant risk factors for heat stroke for the three age groups of males and females.", {"entities": []}], ["Same-day Tmax and concentrations of NO2 were the most significant risk factors for heat stroke in all age groups of males and females.", {"entities": []}], ["The number of heat stroke emergency transport cases/million residents was greater in males than in females in the same age groups.", {"entities": []}], ["The smallest number of heat stroke emergency transport cases/million residents occurred for females 0-14 years of age and the greatest number of heat stroke emergency transport cases/million residents occurred for males > 65 years of age.", {"entities": []}], ["The Ia antigens, usually expressed primarily on B lymphocytes, are found on a small percentage of normal peripheral blood T cells (average 2.6% by fluorescence and 10.8% by rosette assay).", {"entities": []}], ["Elevated levels up to 40% by both assays were observed in a high proportion of patients with rheumatoid arthritis.", {"entities": [[93, 113, "DISEASE"], [104, 113, "DISEASE"]]}], ["Increases also were found in patients with systemic lupus erythematosus and various types of infections.", {"entities": [[52, 71, "DISEASE"], [43, 71, "DISEASE"]]}], ["The increases were evident with a specific heteroantiserum, a hybridoma reagent, and DR specific alloantisera.", {"entities": []}], ["Normal levels were present in multiple sclerosis and an assortment of metabolic and other disorders.", {"entities": [[30, 48, "DISEASE"]]}], ["A rise in similarly positive T cells occurred in normal individuals after immunization with tetanus toxoid or PPD.", {"entities": [[92, 99, "DISEASE"]]}], ["The cells primarily involved in all of these instances were small lymphocytes, which stained relatively weakly with the fluorescent reagents and were readily distinguishable from T-cell blasts.", {"entities": []}], ["They were found to be enriched in isolated T gamma fractions but were also found in other T cells.", {"entities": []}], ["The accumulated evidence indicated that these cells represent an expansion of one or more subsets of T cells found in normal individuals, and that their level in the peripheral blood may serve as an index of immunological stimulation.", {"entities": []}], ["Respiratory viral infections (RVIs) are the most common causes of respiratory infections.", {"entities": []}], ["The prevalence of respiratory viruses in adults is underestimated.", {"entities": []}], ["Meteorological variations and air pollution are likely to play a role in these infections.", {"entities": []}], ["The objectives of this study were to determine the number of emergency visits for influenza-like illness (ILI) and severe acute respiratory infection (SARI) and to evaluate the association between ILI/SARI, RVI prevalence, and meteorological factors/air pollution, in the city of Porto Alegre, Brazil, from November 2008 to October 2010.", {"entities": [[82, 91, "DISEASE"]]}], ["Eleven thousand nine hundred and fifty-three hospitalizations (adults and children) for respiratory symptoms were correlated with meteorological parameters and air pollutants.", {"entities": []}], ["In a subset of adults, nasopharyngeal aspirates were collected and analyzed through IFI test.", {"entities": []}], ["The data were analyzed using time-series analysis.", {"entities": []}], ["Influenza-like illness and SARI were diagnosed in 3698 (30\u00b79%) and 2063 (17\u00b77%) patients, respectively.", {"entities": [[0, 9, "DISEASE"]]}], ["Thirty-seven (9\u00b70%) samples were positive by IFI and 93 of 410 (22\u00b77%) were IFI and/or PCR positive.", {"entities": []}], ["In a multivariate logistic regression model, IFI positivity was statistically associated with absolute humidity, use of air conditioning, and presence of mold in home.", {"entities": []}], ["Sunshine duration was significantly associated with the frequency of ILI cases.", {"entities": []}], ["For SARI cases, the variables mean temperature, sunshine duration, relative humidity, and mean concentration of pollutants were singnificant.", {"entities": []}], ["At least 22% of infections in adult patients admitted to ER with respiratory complaints were caused by RVI.", {"entities": []}], ["The correlations among meteorological variables, air pollution, ILI/SARI cases, and respiratory viruses demonstrated the relevance of climate factors as significant underlying contributors to the prevalence of RVI.", {"entities": []}], ["Unmethylated CpG-oligodeoxynucleotides (ODNs) are generally thought of as potent adjuvants with considerable therapeutic potential to enhance immune responses against microbes and tumors.", {"entities": []}], ["Surprisingly, certain so-called stimulatory CpG-ODNs strongly inhibited the effector phase of inflammatory arthritis in the K/BxN serum transfer system, either preventively or therapeutically.", {"entities": [[107, 116, "DISEASE"]]}], ["Also unexpected was that the inhibitory influence did not depend on the adaptive immune system cells mobilized in an immunostimulatory context.", {"entities": []}], ["Instead, they relied on cells of the innate immune system, specifically on cross talk between CD8\u03b1", {"entities": []}], ["Longitudinal studies analyzing the correlations between disease-specific and generic health status questionnaires at different time points in patients with advanced COPD are lacking.", {"entities": []}], ["The aim of this study was to determine whether and to what extent a disease-specific health status questionnaire (Saint George\u2019s Respiratory Questionnaire, SGRQ) correlates with generic health status questionnaires (EuroQol-5-Dimensions, EQ-5D; Assessment of Quality of Life instrument, AQoL; Medical Outcomes Study 36-Item Short-Form Health Survey, SF-36) at four different time points in patients with advanced COPD; and to determine the correlation between the changes in these questionnaires during one-year follow-up.", {"entities": []}], ["Demographic and clinical characteristics were assessed in 105 outpatients with advanced COPD at baseline.", {"entities": []}], ["Disease-specific health status (SGRQ) and generic health status (EQ-5D, AQoL, SF-36) were assessed at baseline, four, eight, and 12 months.", {"entities": []}], ["Correlations were determined between SGRQ and EQ-5D, AQoL, and SF-36 scores and changes in these scores.", {"entities": []}], ["Agreement in direction of change was assessed.", {"entities": []}], ["Eighty-four patients (80%) completed one-year follow-up and were included for analysis.", {"entities": []}], ["SGRQ total score and EQ-5D index score, AQoL total score and SF-36 Physical Component Summary measure (SF-36 PCS) score were moderately to strongly correlated.", {"entities": []}], ["The correlation of the changes between the SGRQ total score and EQ-5D index score, AQoL total score, SF-36 PCS, and SF-36 Mental Component Summary measure (SF-36 MCS) score were weak or absent.", {"entities": []}], ["The direction of changes in SGRQ total scores agreed slightly with the direction of changes in EQ-5D index score, AQoL total score, and SF-36 PCS score.", {"entities": []}], ["At four, eight and 12 months after baseline, SGRQ total scores and EQ-5D index scores, AQoL total scores and SF-36 PCS scores were moderately to strongly correlated, while SGRQ total scores were weakly correlated with SF-36 MCS scores.", {"entities": []}], ["The correlations between changes over time were weak or even absent.", {"entities": []}], ["Disease-specific health status questionnaires and generic health status questionnaires should be used together to gain complete insight in health status and changes in health status over time in patients with advanced COPD.", {"entities": []}], ["Although airway management with neuromuscular blockade (NMB) alone is discouraged in the emergency department (ED), our previous study demonstrated that many patients were intubated using NMBs alone without sedatives.", {"entities": [[56, 59, "GENE"]]}], ["To refute this practice, we sought to compare the intubation success and adverse event rates between NMBs only and rapid sequence intubation (RSI).", {"entities": []}], ["This is a secondary analysis of the data from a prospective observational study of ED patients in 13 hospitals who underwent emergency airway management from April 2010 to August 2012.", {"entities": []}], ["The primary outcome was intubation success rate on first attempt.", {"entities": []}], ["The secondary outcomes were the intubation success rate in\u00a0\u22642 attempts and the intubation-related adverse event rate.", {"entities": []}], ["We compared these outcomes between intubation attempts using NMB alone and RSI.", {"entities": [[61, 64, "GENE"]]}], ["We fit multivariable logistic regression models adjusting for potential confounders (age, sex, weight, primary indication for intubation, and training level of intubators).", {"entities": []}], ["Overall, 852 patients were eligible for this analysis, with 114 (13%) intubated with NMB alone and 738 (87%) with RSI.", {"entities": [[85, 88, "GENE"]]}], ["Between the NMB-alone and RSI groups, no significant differences were observed in the success rate on the first attempt (70 vs. 73%; P\u00a0=\u00a00.48) or in\u00a0\u22642 attempts (89 vs. 91%; P\u00a0=\u00a00.46), or in the adverse event rate (11 vs. 12%; P\u00a0=\u00a00.58).", {"entities": []}], ["Similarly, after adjusting for confounders, no significant differences were observed in any of these outcomes (all P\u00a0>\u00a00.05).", {"entities": []}], ["In this analysis of data from a large multicenter study of ED patients, we found no superior effectiveness of intubation with NMB alone when compared to RSI.", {"entities": [[126, 129, "GENE"]]}], ["Our data lend significant support to the concept that intubation with NMB alone should be avoided in the ED.", {"entities": [[70, 73, "GENE"]]}], ["Damage-associated molecular patterns (DAMPs) include endogenous intracellular molecules released by activated or necrotic cells and extracellular matrix (ECM) molecules that are upregulated upon injury or degraded following tissue damage.", {"entities": []}], ["DAMPs are vital danger signals that alert our immune system to tissue damage upon both infectious and sterile insult.", {"entities": []}], ["DAMP activation of Toll-like receptors (TLRs) induces inflammatory gene expression to mediate tissue repair.", {"entities": []}], ["However, DAMPs have also been implicated in diseases where excessive inflammation plays a key role in pathogenesis, including rheumatoid arthritis (RA), cancer, and atherosclerosis.", {"entities": [[165, 180, "DISEASE"], [126, 146, "DISEASE"], [137, 146, "DISEASE"], [153, 159, "DISEASE"]]}], ["TLR activation by DAMPs may initiate positive feedback loops where increasing tissue damage perpetuates pro-inflammatory responses leading to chronic inflammation.", {"entities": []}], ["Here we explore the current knowledge about distinct signalling cascades resulting from self TLR activation.", {"entities": []}], ["We also discuss the involvement of endogenous TLR activators in disease and highlight how specifically targeting DAMPs may yield therapies that do not globally suppress the immune system.", {"entities": []}], ["Road tunnels are increasingly important components of urban infrastructure.", {"entities": []}], ["However, knowledge of their health impact on surrounding communities is limited.", {"entities": []}], ["Our objective was to estimate the short-term respiratory health effects of exposure to emissions from a road tunnel ventilation stack.", {"entities": []}], ["We conducted a randomised cross-over cohort study in 36 volunteers who underwent three exposure scenarios in 2006 before the road tunnel opened, and in 2007 (n=27) and 2008 (n=20) after the tunnel opened.", {"entities": []}], ["Exposure downwind of the stack was compared to upwind of the stack and to a distant heavily trafficked location adjacent to a main road.", {"entities": []}], ["Spirometry, exhaled nitric oxide (eNO) and symptom scores were measured repeatedly during each 2\u2005h exposure session.", {"entities": []}], ["Downwind locations were associated with increased reports of \u2018dry nose\u2019 (score difference 0.36; 95% CI 0.09 to 0.63) compared with the control location (2006 vs 2007/2008), but not with impaired lung function, increased airway inflammation or other symptoms.", {"entities": []}], ["The heavily trafficked location was associated with significantly increased eNO (ratio=1.09; 95% CI 1.04 to 1.14), eye (score difference 0.05; 95% CI 0.01 to 0.10) and chest (score difference 0.21; 95% CI 0.09 to 0.33) symptoms compared to the stack locations.", {"entities": []}], ["There was no consistent evidence of adverse respiratory effects from short-term exposures downwind of the tunnel ventilation stack, except for dry nose symptoms.", {"entities": []}], ["However, the findings of increased airway inflammation and symptoms in subjects after only 2\u2005h exposure at the heavily trafficked location, are suggestive of detrimental effects of short-term exposures to traffic-related air pollution.", {"entities": []}], ["Cumulating evidence has revealed the effectiveness of acupuncture therapy in relieving pain via immunoregulation.", {"entities": []}], ["However, its underlying mechanism remains unknown.", {"entities": []}], ["The present study was designed to determine the changes of immunogenic responses at different time-points of electroacupuncture (EA) interventions in neuropathic pain rats.", {"entities": []}], ["The neuropathic pain model was established by ligature of the left sciatic nerve to induce chronic constriction injury (CCI).", {"entities": []}], ["EA was applied at Zusanli (ST36) and Yanglingquan (GB34) for the EA groups.", {"entities": []}], ["The thermal pain threshold was detected with an algesia-detector.", {"entities": []}], ["The subgroups of plasma and splenic lymphocytes were determined via fluorescence-activated cell sorting.", {"entities": []}], ["Specific inflammatory cytokines were assayed using an ELISA-based bead multiplex assay.", {"entities": []}], ["The activities of splenic natural killer (NK) cells and cytotoxic T lymphocytes were detected by methyl thiazolyl tetrazolium colorimetric method.", {"entities": []}], ["For confirming the involvement of NK cell in EA-analgesia, anti-asialo-ganglio-N-tetraosylceramide (anti-asialo-GM1) antibody was given to CCI rats before EA.", {"entities": []}], ["Following CCI, the thermal pain threshold of the affected hind footpad was significantly decreased, and increased from the 3 Repeated EA interventions have a time-dependent cumulative analgesic effect in neuropathic pain rats, which is closely associated with its regulatory effects on NK cells, splenic IL-2, \u03b2-EP, and plasma IL-2, IL-1\u03b2, IFN-\u03b3 and TGF-\u03b2 levels.", {"entities": []}], ["Anthropogenic climate changes and stratospheric ozone depletion affect human health in various ways.", {"entities": []}], ["Current mainstream epidemiologic research methods do not appear well adapted to analyze these health impacts, which involve complex systems influenced by human interventions or simpler processes that will take place in the future.", {"entities": []}], ["This paper discusses a different paradigm for studying the health impacts of global environmental changes and focuses on the development of integrated ecoepidemiologic models using three examples--the effect of climate change on vector-borne diseases, the effect of climate change on thermal-related mortality, and the effects of increasing ultraviolet levels because of ozone depletion on the rates of skin cancer.", {"entities": [[403, 414, "DISEASE"], [408, 414, "DISEASE"]]}], ["Vaccination is generally considered to be the most effective method of preventing infectious diseases.", {"entities": []}], ["All vaccinations work by presenting a foreign antigen to the immune system in order to evoke an immune response.", {"entities": []}], ["The active agent of a vaccine may be intact but inactivated (\u2018attenuated\u2019) forms of the causative pathogens (bacteria or viruses), or purified components of the pathogen that have been found to be highly immunogenic.", {"entities": []}], ["The increased understanding of antigen recognition at molecular level has resulted in the development of rationally designed peptide vaccines.", {"entities": []}], ["The concept of peptide vaccines is based on identification and chemical synthesis of B-cell and T-cell epitopes which are immunodominant and can induce specific immune responses.", {"entities": []}], ["The accelerating growth of bioinformatics techniques and applications along with the substantial amount of experimental data has given rise to a new field, called immunoinformatics.", {"entities": []}], ["Immunoinformatics is a branch of bioinformatics dealing with in silico analysis and modelling of immunological data and problems.", {"entities": []}], ["Different sequence- and structure-based immunoinformatics methods are reviewed in the paper.", {"entities": []}], ["The aim of this study was to assess the genotoxic effects of environmental chemicals on residents living near landfills.", {"entities": []}], ["The study was based on samples of amniotic fluid from women living in the intensely polluted areas around the Campania region of Italy compared to a nonexposed control group.", {"entities": []}], ["We evaluated the genetic effects that this amniotic fluids collected in contaminated sites had on Paracentrotus lividus embryos.", {"entities": []}], ["DNA damage was detected through changes in RAPD (Random Amplified Polymorphism DNA) profiles.", {"entities": []}], ["The absence of the amplified DNA fragments indicated deletions in Paracentrotus lividus DNA exposed to the contaminated amniotic fluids when compared to equal exposure to uncontaminated fluids.", {"entities": []}], ["These results show the ability of RAPD-PCR to detect and isolate DNA sequences representing genetic alterations induced in P. lividus embryos.", {"entities": []}], ["Using this method, we identified two candidate target regions for DNA alterations in the genome of P. lividus .", {"entities": []}], ["Our research indicates that RAPD-PCR in P. lividus embryo DNA can provide a molecular approach for studying DNA damage from pollutants that can impact human health.", {"entities": []}], ["To our knowledge, this is the first time that assessment of DNA damage in P. lividus embryos has been tested using the RAPD strategy after exposure to amniotic fluid from residents near waste landfill sites.", {"entities": []}], ["Group 2 innate lymphoid cells (ILC2s) have an important role in acute allergic lung inflammation.", {"entities": []}], ["Given their distribution and function, lung ILC2s are hypothesized to coordinate epithelial responses to the external environment; however, how barrier surveillance is linked to ILC2 activation remains unclear.", {"entities": []}], ["Here, we demonstrate that alveolar type II cells are the main source of interleukin (IL)-33 and thymic stromal lymphopoietin (TSLP) generated in response to chitin or migratory helminths.", {"entities": [[126, 130, "GENE"]]}], ["IL-33 and TSLP synergistically induce an interferon regulatory factor 4 (IRF4)-IL-9 program in ILC2s, and autocrine IL-9 promotes rapid IL-5 and IL-13 production required for optimal epithelial responses in the conducting airways.", {"entities": [[10, 14, "GENE"], [73, 77, "GENE"]]}], ["Thus, ILC2s link alveolar function to regulation of airway flow, revealing a key interaction between resident lymphoid and structural cells that might underlie similar organizational hierarchies in other organs.", {"entities": []}], ["Macrophages contribute in the initiation and progression of insulitis during type 1 diabetes (T1D).", {"entities": []}], ["However, the mechanisms governing their recruitment into the islets as well as the manner of retention and activation are incompletely understood.", {"entities": []}], ["Here, we investigated a role for macrophage migration inhibitory factor (MIF) and its transmembrane receptor, CD74, in the progression of T1D.", {"entities": [[73, 76, "GENE"], [110, 114, "GENE"]]}], ["Our data indicated elevated MIF concentrations especially in long-standing T1D patients and mice.", {"entities": [[28, 31, "GENE"]]}], ["Additionally, NOD mice featured increased MIF gene expression and CD74", {"entities": [[42, 45, "GENE"], [66, 70, "GENE"]]}], ["The diagnosis of childhood tuberculosis remains a challenge worldwide.", {"entities": [[27, 39, "DISEASE"]]}], ["The Xpert MTB/RIF test, a rapid mycobacteria tuberculosis diagnostic tool, was recommended for use in children based on data from adult studies.", {"entities": [[45, 57, "DISEASE"]]}], ["We evaluated the performance of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis using one induced sputum sample and described clinical characteristics associated with a positive Xpert MTB/RIF test.", {"entities": [[96, 108, "DISEASE"], [86, 108, "DISEASE"]]}], ["The sputum culture on both Lowenstein-Jensen (LJ) and Mycobacteria Growth Indicator Tube (MGIT) was the gold standard.", {"entities": []}], ["We consecutively enrolled 250 Ugandan children aged 2\u2009months to 12\u2009years with suspected pulmonary tuberculosis between January 2011 and January 2012 into a cross-sectional diagnostic study at a tertiary care facility in Uganda.", {"entities": [[98, 110, "DISEASE"], [88, 110, "DISEASE"]]}], ["We excluded data from 15 children (13 contaminated culture and 2 indeterminate MTB/RIF test results) and analysed 235 records.", {"entities": []}], ["The Xpert MTB/RIF test had a sensitivity of 79.4% (95% CI 63.2 - 89.7) and a specificity of 96.5% (95% CI 93 \u2013 98.3).", {"entities": []}], ["The Xpert MTB/RIF test identified 13 of the 14 (92.9%) smear positive-culture positive and 14 of the 20 (70%) smear negative -culture positive cases.", {"entities": []}], ["The Xpert MTB/RIF identified twice as many cases as the smear microscopy (79.4% Vs 41.2%).", {"entities": []}], ["Age\u2009>\u20095\u2009years (OR 3.3, 95% CI 1.4 \u2013 7.4, p value 0.005), a history of Tuberculosis (TB) contact (OR 2.4, 95% CI 1.1 \u2013 5.2, p value 0.03), and a positive tuberculin skin test (OR 4.1, 95% CI 1.7 \u2013 10, p value 0.02) was associated with a positive Xpert MTB/RIF test.", {"entities": [[70, 82, "DISEASE"]]}], ["The median time to TB detection was 49.5\u2009days (IQR 38.4-61.2) for LJ, and 6\u2009days (IQR 5 \u2013 11.5) for MGIT culture and 2\u2009hours for the Xpert MTB/RIF test.", {"entities": []}], ["The Xpert MTB/RIF test on one sputum sample rapidly and correctly identified the majority of children with culture confirmed pulmonary tuberculosis with high specificity.", {"entities": [[135, 147, "DISEASE"], [125, 147, "DISEASE"]]}], ["Chronic total occlusion percutaneous coronary intervention (CTO-PCI) can improve angina and left ventricular ejection fraction (LVEF).", {"entities": []}], ["These benefits were not assessed in populations with heart failure with reduced ejection fraction (HFrEF).", {"entities": []}], ["We studied the effect of CTO-PCI on left ventricular function and clinical parameters in patients with HFrEF.", {"entities": []}], ["Using cardiovascular magnetic resonance (CMR), we studied 29 patients with HFrEF and evidence of viability and/or ischemia in the territory supplied by a CTO who were successfully treated with CTO-PCI.", {"entities": [[114, 122, "DISEASE"]]}], ["In patients with multi-vessel disease, non-CTO PCI was also performed.", {"entities": []}], ["Imaging parameters, clinical status, and brain natriuretic peptide (BNP) levels were evaluated before and 6\u00a0months after CTO-PCI.", {"entities": []}], ["A decrease in left ventricular end-systolic volume (160\u2009\u00b1\u200954\u00a0ml vs. 143\u2009\u00b1\u200958\u00a0ml; p \u2009=\u20090.029) and an increase in LVEF (31.3\u2009\u00b1\u20097.4\u00a0% vs. 37.7\u2009\u00b1\u20098\u00a0%; p \u2009<\u20090.001) were observed.", {"entities": []}], ["There were no differences in LVEF improvement between patients who underwent non-CTO PCI ( n \u2009=\u200911) and those without this intervention ( n \u2009=\u200918); ( p \u2009=\u20090.73).", {"entities": []}], ["The number of segments showing perfusion defects was significantly reduced (0.5\u2009\u00b1\u20091 vs. 0.2\u2009\u00b1\u20090.5; p \u2009=\u20090.043).", {"entities": []}], ["Angina ( p \u2009=\u20090.002) and NYHA functional class ( p \u2009=\u20090.004) improved, and BNP levels decreased ( p \u2009=\u20090.004) after CTO-PCI.", {"entities": []}], ["In this group of patients with HFrEF showing CMR evidence of viability and/or ischemia within the territory supplied by the CTO, an improvement in ejection fraction, left ventricular end-systolic volume and ischemia burden was observed after CTO-PCI.", {"entities": [[78, 86, "DISEASE"], [207, 215, "DISEASE"]]}], ["Clinical and laboratory parameters also improved.", {"entities": []}], ["ClinicalTrials.gov NCT02570087 .", {"entities": []}], ["Registered 6 October 2015.", {"entities": []}], ["Investigate the role of latent strongyloidiasis infection in patients at the University Hospital, Honduras.", {"entities": [[31, 47, "DISEASE"]]}], ["Prospective observational cohort study during 20 non consecutive months from March 2009 to February 2011.", {"entities": []}], ["Epidemiological and clinical data obtained from patients excreting Strongyloides stercoralis larvae in stool who consulted at the hospital were recorded and analyzed.", {"entities": []}], ["Thirty five (5\u00a0%) of 712 patients had S. stercoralis larvae in one stool sample; 62.8\u00a0% came from rural areas and 91.7\u00a0% were poor; 68.5\u00a0% (24/35) were 21\u00a0years old or older.", {"entities": []}], ["Eight patients (22.8\u00a0%) had no predisposing illness; 3 (8.6\u00a0%) received steroid treatment, 29/35 (82.8\u00a0%) presented with persistent diarrhea and 24/35 (68.5\u00a0%) presented following comorbidities: HIV/AIDS (31.4\u00a0%), alcoholism alone (11.4\u00a0%) or with other associated illness (8.6\u00a0%), malignancy (8.6\u00a0%), renal failure (5.7\u00a0%) and hyperthyroidism (2.8\u00a0%).", {"entities": [[328, 343, "DISEASE"], [132, 140, "DISEASE"]]}], ["A combination of symptoms suggestive of strongyloidiasis but indistinguishable from those potentially associated to their comorbid condition included severe epigastric pain, diarrhea of weeks duration, peripheral eosinophilia, astenia, adynamia, fever, anemia and weight loss in 85.7\u00a0% of the cases, 3 of whom described skin lesions compatible with larva currens.", {"entities": [[40, 56, "DISEASE"], [174, 182, "DISEASE"], [213, 225, "DISEASE"], [253, 259, "DISEASE"]]}], ["None of the diagnostic clinical impressions mentioned Strongyloides infection.", {"entities": []}], ["Ten strongyloidiasis patients received partial treatment with albendazole or ivermectin.", {"entities": [[4, 20, "DISEASE"]]}], ["Incomplete data, underestimation of the parasitic infection and no laboratory follow-up of the patients limited our observations.", {"entities": []}], ["Strongyloides stercoralis is an unsuspected and neglected parasitic infection by health personnel in Honduras.", {"entities": []}], ["Lack of awareness of its importance represents a strong barrier to proper treatment and follow-up, posing a threat of possible fatal complications in patients with comorbid conditions.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is one of the main late complications of sulfur mustard poisoning.", {"entities": []}], ["The aim of this study was to evaluate serum levels of interleukin (IL)-6 in war veterans with pulmonary complications of sulfur mustard poisoning and their correlation with severity of airways disease.", {"entities": []}], ["Fifty consecutive patients with sulfur mustard poisoning and stable COPD, and of mean age 46.3 \u00b1 9.18 years were enrolled in this study.", {"entities": []}], ["Thirty healthy men were selected as controls and matched to cases by age and body mass index.", {"entities": []}], ["Spirometry, arterial blood gas, six- minute walk test, BODE (body mass index, obstruction, dyspnea, and exercise capacity), and St George\u2019s Respiratory Questionnaire about quality of life were evaluated.", {"entities": []}], ["Serum IL-6 was measured in both patient and control groups.", {"entities": []}], ["Fifty-four percent of patients had moderate COPD.", {"entities": []}], ["Mean serum IL-6 levels were 15.01 \u00b1 standard deviation (SD) 0.61 pg/dL and 4.59 \u00b1 3.40 pg/dL in the case and control groups, respectively ( P = 0.03).", {"entities": []}], ["There was a significant correlation between IL-6 levels and Global Initiative for Chronic Obstructive Lung Disease stage (r = 0.25, P = 0.04) and between IL-6 and BODE index (r = 0.38, P = 0.01).", {"entities": []}], ["There was also a significant negative correlation between serum IL-6 and forced expiratory volume in one second (FEV 1 , r = \u22120.36, P = 0.016).", {"entities": [[113, 116, "GENE"]]}], ["Our findings suggest that serum IL-6 is increased in patients with sulfur mustard poisoning and COPD, and may have a direct association with airflow limitation.", {"entities": []}], ["Epidemiology studies have shown that ambient concentrations of ozone and fine particulate matter (PM 2.5 ) are associated with increased emergency department (ED) visits and hospital admissions (HAs) for asthma.", {"entities": [[204, 210, "DISEASE"]]}], ["Evaluate the impact of outdoor pollen, respiratory infections, and socioeconomic status (SES) on the associations between ambient ozone and PM 2.5 and asthma HAs in New York City.", {"entities": [[151, 157, "DISEASE"]]}], ["Daily ozone, PM 2.5 , meteorological factors, pollen, and hospitalization records during 1999 to 2009 were obtained for New York City residents.", {"entities": []}], ["Daily counts of HAs for asthma and respiratory infections were calculated for all-age and specific age groups, and for high- and low-SES communities.", {"entities": [[24, 30, "DISEASE"]]}], ["Generalized additive models were used to examine ambient concentrations of ozone and PM 2.5 and asthma HAs, potential confounding effects of outdoor pollen and HAs for respiratory infections, and potential effect modification by neighborhood SES.", {"entities": [[96, 102, "DISEASE"]]}], ["Both ozone and PM 2.5 were statistically significantly associated with increased asthma HAs in children aged 6\u201318 years (per 10 ppb increase in ozone: RR = 1.0203, 95% CI: 1.0028\u20131.0382; per 10 \u03bcg/m 2.5 : RR = 1.0218, 95% CI: 1.0007\u20131.0434), but not with total asthma HAs, or asthma HAs in other age groups.", {"entities": [[81, 87, "DISEASE"], [261, 267, "DISEASE"], [276, 282, "DISEASE"]]}], ["These associations were stronger for children living in the high-SES areas.", {"entities": []}], ["Adjustment for respiratory infection HAs at various lags did not result in changes greater than 10% in the risk estimates for either ozone or PM 2.5 .", {"entities": []}], ["In contrast, adjustment for outdoor pollen generally attenuated the estimated RRs for both ozone and PM 2.5 .", {"entities": []}], ["Ambient ozone and PM 2.5 are associated with asthma HAs in school-age children, and these associations are not modified by SES.", {"entities": [[45, 51, "DISEASE"]]}], ["HAs for respiratory infections do not appear to be a confounder for observed ozone- and PM 2.5 -asthma HAs associations, but pollen may be a weak confounder.", {"entities": [[96, 102, "DISEASE"]]}], ["Background: Eczema herpeticum is an uncommon manifestation of an infection with herpes simplex virus (HSV).", {"entities": [[80, 94, "DISEASE"], [12, 29, "DISEASE"]]}], ["The disease is primarily seen in patients with histories of atopic eczema.", {"entities": []}], ["Eczema herpeticum may be a life-threatening illness, but the mortality is felt to be <10% with modern antiviral and antibacterial agents.", {"entities": [[0, 17, "DISEASE"]]}], ["The use of acyclovir for other viral infections secondary to herpesvirus in pregnancy has been well documented.", {"entities": []}], ["The authors now present a case report of eczema herpeticum treated with acyclovir during pregnancy.", {"entities": [[41, 58, "DISEASE"]]}], ["Case: A patient with a history of eczema herpeticum presented in pregnancy with a recurrence.", {"entities": [[34, 51, "DISEASE"]]}], ["She was successfully treated with intravenous (IV) acyclovir with good maternal and fetal outcome.", {"entities": []}], ["Conclusion: Acyclovir may be utilized in pregnancy for several manifestations of HSV including eczema herpeticum.", {"entities": [[95, 112, "DISEASE"]]}], ["Kidney and renal pelvis cancers account for 4% of all new cancer cases in the United States, among which 85% are renal cell carcinomas (RCC).", {"entities": [[58, 64, "DISEASE"]]}], ["While cigarette smoking is an established risk factor for RCC, little is known about the contribution of environmental tobacco smoke (ETS) to RCC incidence.", {"entities": []}], ["This study assesses the role of smoking and ETS on RCC incidence using a population-based case-control design in Florida and Georgia.", {"entities": []}], ["Incident cases (n = 335) were identified from hospital records and the Florida cancer registry, and population controls (n = 337) frequency-matched by age (+/- 5 years), gender, and race were identified through random-digit dialing.", {"entities": [[79, 85, "DISEASE"]]}], ["In-person interviews assessed smoking history and lifetime exposure to ETS at home, work, and public spaces.", {"entities": []}], ["Home ETS was measured in both years and hours of exposure.", {"entities": []}], ["Odds ratios and 95% confidence intervals were calculated using logistic regression, controlled for age, gender, race, and BMI.", {"entities": []}], ["Cases were more likely to have smoked 20 or more pack-years, compared with never-smokers (OR: 1.35, 95% CI: 0.93 \u2013 1.95).", {"entities": []}], ["A protective effect was found for smoking cessation, beginning with 11\u201320 years of cessation (OR: 0.39, 95% CI: 0.18\u20130.85) and ending with 51 or more years of cessation (OR: 0.11, 95% CI: 0.03\u20130.39) in comparison with those having quit for 1\u201310 years.", {"entities": []}], ["Among never-smokers, cases were more likely to report home ETS exposure of greater than 20 years, compared with those never exposed to home ETS (OR: 2.18; 95% CI: 1.14\u20134.18).", {"entities": []}], ["Home ETS associations were comparable when measured in lifetime hours of exposure, with cases more likely to report 30,000 or more hours of home ETS exposure (OR: 2.37; 95% CI: 1.20\u20134.69).", {"entities": []}], ["Highest quartiles of combined home/work ETS exposure among never-smokers, especially with public ETS exposure, increased RCC risk by 2 to 4 times.", {"entities": []}], ["These findings confirm known associations between smoking and RCC and establish a potential etiologic role for ETS, particularly in the home.", {"entities": []}], ["Differences in methods of retrospective measurement of lifetime smoking and ETS exposure may contribute to discrepancies in measures of associations across studies, and should be addressed in future research.", {"entities": []}], ["Chronic airway inflammation is one of the main features of asthma.", {"entities": [[59, 65, "DISEASE"]]}], ["Release of mediators from infiltrating inflammatory cells in the airway mucosa has been proposed to contribute directly or indirectly to changes in airway structure and function.", {"entities": []}], ["The airway smooth muscle, which has been regarded as a contractile component of the airways responding to various mediators and neurotransmitters, has recently been recognised as a rich source of pro-inflammatory cytokines, chemokines and growth factors.", {"entities": []}], ["In this review, we discuss the role of airway smooth muscle cells in the regulation and perpetuation of airway inflammation that contribute to the pathogenesis of asthma.", {"entities": [[163, 169, "DISEASE"]]}], ["Occupational exposure to irritants is associated with chronic bronchitis.", {"entities": [[62, 72, "DISEASE"]]}], ["The aim of this study was to elucidate whether repeated peak exposures with respiratory symptoms, gassings, to sulphur dioxide (SO 2 ) and other irritant gases could increase the risk of chronic bronchitis.", {"entities": [[195, 205, "DISEASE"]]}], ["The study population comprised 3,060 Swedish pulp mill workers (84% males) from a cohort study, who completed a comprehensive questionnaire with items on chronic bronchitis symptoms, smoking habit, occupational history, and specific exposures, including gassings.", {"entities": [[162, 172, "DISEASE"]]}], ["2,037 have worked in sulphite mills.", {"entities": []}], ["Incidence rates and hazard ratios (HRs) for the observation period, 1970\u20132000, in relation to exposure and the frequency of repeated gassings to SO 2 and other irritant gases were calculated.", {"entities": []}], ["The incidence rate for chronic bronchitis among workers with repeated gassings was 3.5/1,000 person-years compared with 1.5/1,000 person-years among unexposed workers (HR 2.1, 95% confidence interval (CI) 1.4-3.1).", {"entities": [[31, 41, "DISEASE"], [168, 170, "GENE"]]}], ["The risk was even higher in the subgroup with frequent gassings (HR 3.2, 95% CI 2.0-5.2), particularly among never-smokers (HR 8.7, 95% CI 3.5-22).", {"entities": [[65, 67, "GENE"], [124, 126, "GENE"], [65, 67, "GENE"], [124, 126, "GENE"]]}], ["Repeated gassings to irritant gases increased the incidence of chronic bronchitis in our study population during and after work in pulp mills, supporting the hypothesis that occupational exposures to irritants negatively affect the airways.", {"entities": [[71, 81, "DISEASE"]]}], ["These results underscore the importance of preventive actions in this work environment.", {"entities": []}], ["This paper proposes a mathematical framework for understanding how the structural changes in the COPD lung reflect in model parameters.", {"entities": []}], ["The core of the analysis is a correlation between the heterogeneity in the lung as COPD degree changes (GOLD II, III and IV) and the nonlinearity index evaluated using the forced oscillation technique.", {"entities": []}], ["A low frequency evaluation of respiratory impedance models and nonlinearity degree is performed since changes in tissue mechanics are related to viscoelastic properties.", {"entities": []}], ["Simulation analysis of our model indicates a good correlation to expected changes in heterogeneity and nonlinear effects.", {"entities": []}], ["A total of 43 COPD diagnosed patients are evaluated, distributed as GOLD II (18), GOLD III (15) and GOLD IV (10).", {"entities": []}], ["Experimental data supports the claims and indicate that the proposed model and index for nonlinearity is well-suited to capture COPD structural changes.", {"entities": []}], ["Native mass spectrometry (MS) methods permit the study of multiple protein species within solution equilibria, whereas ion mobility (IM)-MS can report on conformational behavior of specific states.", {"entities": []}], ["We used IM-MS to study a conformationally labile protein (\u03b1 1 -antitrypsin) that undergoes pathological polymerization in the context of point mutations.", {"entities": []}], ["The folded, native state of the Z -variant remains highly polymerogenic in physiological conditions despite only minor thermodynamic destabilization relative to the wild-type variant.", {"entities": []}], ["Various data implicate kinetic instability (conformational lability within a native state ensemble) as the basis of Z \u03b1 1 -antitrypsin polymerogenicity.", {"entities": []}], ["We show the ability of IM-MS to track such disease-relevant conformational behavior in detail by studying the effects of peptide binding on \u03b1 1 -antitrypsin conformation and dynamics.", {"entities": []}], ["IM-MS is, therefore, an ideal platform for the screening of compounds that result in therapeutically beneficial kinetic stabilization of native \u03b1 1 -antitrypsin.", {"entities": []}], ["Our findings are confirmed with high-resolution X-ray crystallographic and nuclear magnetic resonance spectroscopic studies of the same event, which together dissect structural changes from dynamic effects caused by peptide binding at a residue-specific level.", {"entities": []}], ["IM-MS methods, therefore, have great potential for further study of biologically relevant thermodynamic and kinetic instability of proteins and provide rapid and multidimensional characterization of ligand interactions of therapeutic interest.", {"entities": []}], ["PDB Code(s): 4PYW", {"entities": []}], ["Birth by cesarean delivery (CD) as opposed to vaginal delivery (VD) is associated with altered health outcomes later in life, including respiratory disorders, allergies and risk of developing type I diabetes.", {"entities": []}], ["Epigenetic gene regulation is a proposed mechanism by which early life exposures affect later health outcomes.", {"entities": []}], ["Previously, type of delivery has been found to be associated with differences in global methylation levels, but the sample sizes have been small.", {"entities": []}], ["We measured global methylation in a large birth cohort to identify whether type of delivery is associated with epigenetic changes.", {"entities": []}], ["DNA was isolated from cord blood collected from the University of Michigan Women\u2019s & Children Hospital and bisulfite-converted.", {"entities": []}], ["The Luminometric Methylation Assay (LUMA) and LINE-1 methylation assay were run on all samples in duplicate.", {"entities": []}], ["Global methylation data at CCGG sites throughout the genome, as measured by LUMA, were available from 392 births (52% male; 65% CD), and quantitative methylation levels at LINE-1 repetitive elements were available for 407 births (52% male; 64% CD).", {"entities": []}], ["LUMA and LINE-1 methylation measurements were negatively correlated in this population (Spearman\u2019s r\u2009=\u2009\u22120.13, p =0.01).", {"entities": []}], ["LUMA measurements were significantly lower for total CD and planned CD, but not emergency CD when compared to VD (median VD\u2009=\u200974.8, median total CD\u2009=\u200974.4, p \u2009=\u20090.03; median planned CD\u2009=\u200974.2, p \u2009=\u20090.02; median emergency CD\u2009=\u200975.3, p \u2009=\u20090.39).", {"entities": []}], ["However, this association did not persist when adjusting for maternal age, maternal smoking and infant gender.", {"entities": []}], ["Furthermore, total CD deliveries, planned CD and emergency CD deliveries were not associated with LINE-1 measurements as compared to VD (median VD\u2009=\u200982.2, median total CD\u2009=\u200981.9, p \u2009=\u20090.19; median planned CD\u2009=\u200981.9, p \u2009=\u20090.19; median emergency CD\u2009=\u200982.1, p \u2009=\u20090.52).", {"entities": []}], ["This lack of association held when adjusting for maternal age, maternal smoking and infant gender in a multivariable model.", {"entities": []}], ["Type of delivery was not associated with global methylation in our population, even after adjustment for maternal age, maternal smoking, and infant gender.", {"entities": []}], ["While type of birth may be associated with later health outcomes, our data suggest that it does not do so through changes in global genomic methylation.", {"entities": []}], ["To describe a practical method for family practitioners to stage chronic obstructive pulmonary disease (COPD) by the use of office spirometry.", {"entities": [[65, 102, "DISEASE"]]}], ["This is a review of the lessons learned from evaluations of the use of office spirometry in the primary care setting to identify best practices using the most recent published evaluations of office spirometry and the analysis of preliminary data from a recent spirometry mass screening project.", {"entities": []}], ["A mass screening study by the American Association for Respiratory Care and the COPD Foundation was used to identify the most effective way for general practitioners to implement office spirometry in order to stage COPD.", {"entities": []}], ["A simple three-step method is described to identify people with a high pre-test probability in an attempt to detect moderate to severe COPD: COPD questionnaire, measurement of peak expiratory flow, and office spirometry.", {"entities": []}], ["Clinical practice guidelines exist for office spirometry basics for safety, use of electronic peak flow devices, and portable spirometers.", {"entities": []}], ["Spirometry can be undertaken in primary care offices with acceptable levels of technical expertise.", {"entities": []}], ["Using office spirometry, primary care physicians can diagnose the presence and severity of COPD.", {"entities": []}], ["Spirometry can guide therapies for COPD and predict outcomes when used in general practice.", {"entities": []}], ["Environmental pollutant exposure may play certain roles in the pathogenesis and progression of diabetes mellitus including gestational diabetes mellitus (GDM).", {"entities": [[123, 143, "DISEASE"], [95, 112, "DISEASE"], [135, 152, "DISEASE"]]}], ["We hypothesize that heavy metal exposure may trigger GDM during pregnancy.", {"entities": []}], ["The objective of this study was to investigate the possible associations between selected heavy metal exposure and GDM risk.", {"entities": []}], ["This investigation is a retrospective case\u2013control study nested within a cohort of 1359 pregnant women.", {"entities": []}], ["These participants were recruited in Xiamen Maternity and Child Care Hospital, China, during June to July, 2012.", {"entities": []}], ["All their newborns\u2019 meconium samples were collected.", {"entities": []}], ["By reviewing the antenatal care records, 166 GDM mothers were screened out from the 1359 participants; 137 of 166 GDM mothers offered their newborns\u2019 meconium samples for the metal analysis.", {"entities": []}], ["Those 137 mothers were set as the case group.", {"entities": []}], ["Similarly, 294 healthy mothers without any gestational complication were initially screened out from the rest 1193 non-GDM mothers.", {"entities": []}], ["190 of the 294 healthy mothers offered their newborns\u2019 meconium samples for the metal analysis.", {"entities": []}], ["Those 190 mothers were set as the control group.", {"entities": []}], ["Arsenic (As), mercury (Hg), lead (Pb), cadmium (Cd), and chromium (Cr) levels in these case\u2013control meconium samples were measured by inductively coupled plasma mass spectrometry.", {"entities": []}], ["The possible association between the metal levels and maternal GDM risk of studied subjects was assessed by binary logistic regression.", {"entities": []}], ["GDM prevalence of 12.21% was observed in the investigated 1359 participants.", {"entities": []}], ["The concentrations of As, Hg, Cr and Cd in studied cases were significantly higher ( p\u2009<\u20090.05 ) than those of controls.", {"entities": []}], ["After adjustments for maternal age, pre-pregnant body mass index, gravidity, parity, hepatitis B virus infection, and newborn sex, As, Cd and Cr were found to be positively associated with GDM prevalence in dose-dependent manners.", {"entities": [[85, 94, "DISEASE"]]}], ["Among them, As was detected in all samples and its levels associated the maternal GDM with the adjusted odds ratios of 3.28 [95% CI 1.24, 8.71], 3.35 [95% CI 1.28, 8.75] and 5.25 [95% CI 1.99, 13.86] for the 2 The present work implies that exposure to some of the selected metals (noticeably As) may contribute to maternal GDM risk during pregnancy.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-015-0004-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["During the fall/winter season of 2004\u201305, we found 9 respiratory specimens positive for human parainfluenza virus type 4 (HPIV-4) in our laboratory (43% of all HPIVs) from patients with mild to moderate respiratory illnesses.", {"entities": []}], ["Sequencing studies identified 8 different HPIV-4A strains and 1 HPIV-4B strain.", {"entities": []}], ["A large body of evidence has emerged over the past years to show the critical role played by inflammation in the pathogenesis of several diseases including some cardiovascular, neoplastic, and neurodegenerative diseases, previously not considered inflammation-related.", {"entities": []}], ["The anti-inflammatory action of \u03c9 -3 polyunsaturated fatty acids (PUFAs), as well as their potential healthy effects against the development and progression of the same diseases, has been widely studied by our and others' laboratories.", {"entities": []}], ["As a result, a rethinking is taking place on the possible mechanisms underlying the beneficial effects of \u03c9 -3 PUFAs against these disorders, and, in particular, on the influence that they may exert on the molecular pathways involved in inflammatory process, including the production of inflammatory cytokines and lipid mediators active in the resolving phase of inflammation.", {"entities": []}], ["In the present review we will summarize and discuss the current knowledge regarding the modulating effects of \u03c9 -3 PUFAs on the production of inflammatory cytokines and proresolving or protective lipid mediators in the context of inflammatory, metabolic, neurodegenerative, and neoplastic diseases.", {"entities": []}], ["Although combination therapy with bronchodilators is recommended for chronic obstructive pulmonary disease (COPD), there is insufficient evidence for the efficacy of some combinations of long-acting bronchodilators.", {"entities": [[69, 106, "DISEASE"]]}], ["We investigated the effects of a combination therapy with tiotropium and theophylline in COPD patients.", {"entities": []}], ["In a 12-week, open-labeled, parallel-group randomized study, pulmonary functions and dyspnea scores were compared between the combination and theophylline alone therapy at baseline, and 4 and 8 weeks after randomization in COPD.", {"entities": []}], ["Sixty-one COPD patients completed the trial (31 combination therapy, 30 theophylline alone; mean age 70 years; 58 males; mean dyspnea score 2.0 and forced expiratory volume in one second (FEV 1 ) 1.5 L [62.5% predicted]).", {"entities": [[188, 191, "GENE"]]}], ["FEV 1 in the combination group, but not in the theophylline alone, was significantly increased at 4 (1.56 \u00b1 0.13 L, p < 0.001) and 8 weeks (1.60 \u00b1 0.13 L, p < 0.001) from the baseline (1.40 \u00b1 0.12 L).", {"entities": [[0, 3, "GENE"]]}], ["In the combination group, but not the theophylline alone group, the dyspnea score was significantly improved after 4 (p < 0.01) and 8 weeks (p < 0.05) compared with baseline.", {"entities": []}], ["In 17 patients who did not receive theophylline at screening, treatment with 4 or 8 weeks of theophylline alone did not improve dyspnea score or FEV 1 .", {"entities": [[145, 148, "GENE"]]}], ["Addition of tiotropium therapy to theophylline treatment can improve dyspnea and pulmonary function in COPD.", {"entities": []}], ["Although this study did not assess whether there was any benefit of adding theophylline to patients treated with tiotropium, tiotropium can be a useful addition in COPD already treated with theophylline.", {"entities": []}], ["Hyaluronan (HA) shows promise for detecting cancerous change in pleural effusion and urine.", {"entities": []}], ["However, there is uncertainty about the localization of HA in tumor tissue and its relationship with different histological types and other components of the extracellular matrix, such as angiogenesis.", {"entities": []}], ["We evaluated the association between HA and degree of malignancy through expression in lung tumor tissue and sputum.", {"entities": []}], ["Tumoral tissue had significantly increased HA compared to normal tissue.", {"entities": []}], ["Strong HA staining intensity associated with cancer cells was significant in squamous cell carcinoma compared to adenocarcinoma and large cell carcinoma.", {"entities": [[113, 127, "DISEASE"], [132, 152, "DISEASE"], [91, 100, "DISEASE"], [143, 152, "DISEASE"], [77, 100, "DISEASE"], [45, 51, "DISEASE"]]}], ["A significant direct association was found between tumors with a high percentage of HA and MVD (microvessel density) in tumoral stroma.", {"entities": [[91, 94, "GENE"]]}], ["Similarly significant was the direct association between N1 tumors and high levels of HA in cancer cells.", {"entities": [[92, 98, "DISEASE"]]}], ["Cox multivariate analysis showed significant association between better survival and low HA.", {"entities": []}], ["HA increased in sputum from lung cancer patients compared to cancer-free and healthy volunteers and a significant correlation was found between HA in sputum and HA in cancer tissue.", {"entities": [[28, 39, "DISEASE"], [33, 39, "DISEASE"], [61, 67, "DISEASE"], [167, 173, "DISEASE"]]}], ["Localization of HA in tumor tissue was related to malignancy and reflected in sputum, making this an emerging factor for an important diagnostic procedure in patients suspected to have lung cancer.", {"entities": [[185, 196, "DISEASE"], [190, 196, "DISEASE"]]}], ["Further study in additional patients in a randomized prospective trial is required to finalize these results and to validate our quantitative assessment of HA, as well as to couple it to gold standard sputum cytology.", {"entities": []}], ["Asthma is a multifactorial disease for which a variety of mouse models have been developed.", {"entities": [[0, 6, "DISEASE"]]}], ["A major drawback of these models is represented by the transient nature of the airway pathology peaking 24\u201372\u00a0h after challenge and resolving in 1\u20132\u00a0weeks.", {"entities": []}], ["We characterized the temporal evolution of pulmonary inflammation and tissue remodeling in a recently described mouse model of chronic asthma (8\u00a0week treatment with 3 allergens: Dust mite, Ragweed, and Aspergillus; DRA).", {"entities": [[135, 141, "DISEASE"]]}], ["We studied the DRA model taking advantage of fluorescence molecular tomography (FMT) imaging using near-infrared probes to non-invasively evaluate lung inflammation and airway remodeling.", {"entities": []}], ["At 4, 6, 8 or 11\u00a0weeks, cathepsin- and metalloproteinase-dependent fluorescence was evaluated in vivo.", {"entities": []}], ["A subgroup of animals, after 4\u00a0weeks of DRA, was treated with Budesonide (100\u00a0\u00b5g/kg intranasally) daily for 4\u00a0weeks.", {"entities": []}], ["Cathepsin-dependent fluorescence in DRA-sensitized mice resulted significantly increased at 6 and 8\u00a0weeks, and was markedly inhibited by budesonide.", {"entities": []}], ["This fluorescent signal well correlated with ex vivo analysis such as bronchoalveolar lavage eosinophils and pulmonary inflammatory cell infiltration.", {"entities": []}], ["Metalloproteinase-dependent fluorescence was significantly increased at 8 and 11\u00a0weeks, nicely correlated with collagen deposition, as evaluated histologically by Masson\u2019s Trichrome staining, and airway epithelium hypertrophy, and was only partly inhibited by budesonide.", {"entities": []}], ["FMT proved suitable for longitudinal studies to evaluate asthma progression, showing that cathepsin activity could be used to monitor inflammatory cell infiltration while metalloproteinase activity parallels airway remodeling, allowing the determination of steroid treatment efficacy in a chronic asthma model in mice.", {"entities": [[57, 63, "DISEASE"], [297, 303, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12967-015-0696-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In recent years, several hypotheses have emerged to explain the toxicologic activity of particulate matter.", {"entities": []}], ["Organic compounds, ultrafine particles, biologic components, and transition metals are some of the constituents that reportedly exert some type of adverse effect on human health.", {"entities": []}], ["A considerable fraction of the urban particulate matter consists of carbon compounds, which originate mostly from anthropogenic sources.", {"entities": []}], ["The toxicity of organic fractions from particulate matter have been mainly evaluated by considering their mutagenic activity.", {"entities": []}], ["This research expands on the toxicologic profile of organic compounds adsorbed to particulate matter, specifically in Puerto Rico, by using the cytotoxic neutral red bioassay (NRB).", {"entities": []}], ["The NRB uses normal human epidermal keratinocytes or other types of cells to measure the effect on cell viability when exposed to organic compounds associated to the particles in the air.", {"entities": []}], ["We validated the NRB for particulate matter by using a standard reference material (SRM 1649).", {"entities": [[84, 87, "GENE"]]}], ["We used the NRB to determine toxicologic differences of extracts between an urban industrialized site with anthropogenic activity versus a coastal region with less human activity.", {"entities": []}], ["The cytotoxicity associated with organic compounds in particulate matter collected at the urban industrialized site was detected in both the particulate matter (3/4) 10 microm in aerodynamic diameter (PM(10)) and particulate matter (3/4) 100 microm in aerodynamic diameter (PM(100)).", {"entities": []}], ["Greater toxic effects were observed in PM(10) extracts than in PM(100) extracts, but PM(10) toxic effects were not significantly different from those in PM(100).", {"entities": []}], ["The extracts from the industrialized site were more cytotoxic than the extracts from coastal reference site, although in the summer, extracts from both sites were significantly cytotoxic to normal human epidermal keratinocytes.", {"entities": []}], ["In addition, the nonpolar extracts of both PM(10) and PM(100) exerted the greatest cytotoxicity, followed by the polar, and, finally, the moderately polar extract.", {"entities": []}], ["This study demonstrates that extracts from the Guaynabo industrialized site were more toxic than similar extracts obtained from a reference coastal site in Fajardo, Puerto Rico.", {"entities": []}], ["Purpose Earlier research has shown that adaptation (i.e., the way in which employees cope with limitations resulting from their disease) is associated with sick leave.", {"entities": []}], ["Our aim was to investigate signs of adequate or inadequate adaptation in employees with asthma and COPD.", {"entities": [[88, 94, "DISEASE"]]}], ["Methods A Q-methodological study was carried out among 34 workers with asthma or COPD.", {"entities": [[71, 77, "DISEASE"]]}], ["Results Four adaptation profiles were distinguished: the eager, the adjusted, the cautious, and the worried workers.", {"entities": []}], ["The adaptation profiles provide insight into the different ways in which workers with asthma and COPD cope with their illness at work.", {"entities": [[86, 92, "DISEASE"]]}], ["Conclusions The adaptation profiles serve as a starting point for the design of appropriate (occupational) care.", {"entities": []}], ["The eager workers experience little difficulties at work; the cautious workers may need assistance in learning how to accept their disease; the worried workers need reassurance, and may need reactivation; the adjusted workers deserve extra attention, and, when necessary, advice on how to live with their asthma or COPD.", {"entities": [[305, 311, "DISEASE"]]}], ["Natural competence is the genetically encoded ability of some bacteria to take up DNA from the environment.", {"entities": []}], ["Although most of the incoming DNA is degraded, occasionally intact homologous fragments can recombine with the chromosome, displacing one resident strand.", {"entities": []}], ["This potential to use DNA as a source of both nutrients and genetic novelty has important implications for the ecology and evolution of competent bacteria.", {"entities": []}], ["However, it is not known how frequently competence changes during evolution, or whether non-competent strains can persist for long periods of time.", {"entities": []}], ["We have previously studied competence in H. influenzae and found that both the amount of DNA taken up and the amount recombined varies extensively between different strains.", {"entities": []}], ["In addition, several strains are unable to become competent, suggesting that competence has been lost at least once.", {"entities": []}], ["To investigate how many times competence has increased or decreased during the divergence of these strains, we inferred the evolutionary relationships of strains using the largest datasets currently available.", {"entities": []}], ["However, despite the use of three datasets and multiple inference methods, few nodes were resolved with high support, perhaps due to extensive mixing by recombination.", {"entities": []}], ["Tracing the evolution of competence in those clades that were well supported identified changes in DNA uptake and/or transformation in most strains.", {"entities": []}], ["The recency of these events suggests that competence has changed frequently during evolution but the poor support of basal relationships precludes the determination of whether non-competent strains can persist for long periods of time.", {"entities": []}], ["In some strains, changes in transformation have occurred that cannot be due to changes in DNA uptake, suggesting that selection can act on transformation independent of DNA uptake.", {"entities": []}], ["Platelets are thought to play a role in a variety of inflammatory conditions in the lung, some of which may lead to fibrosis.", {"entities": []}], ["In the current study we tested the hypothesis that whole platelets and platelet lysate can mediate remodelling of extracellular matrix in vitro by affecting fibroblast-mediated contraction of a collagen gel.", {"entities": []}], ["We also sought to determine to what extent platelet-derived growth factor (PDGF) and transforming growth factor-\u03b2 (TGF-\u03b2) contribute to this effect.", {"entities": []}], ["Washed platelets, isolated from healthy blood donors, and platelet lysate (freezing and thawing), were cast together with human lung fibroblasts in three-dimensional collagen gels.", {"entities": []}], ["The gels were then released and cultured for four days.", {"entities": []}], ["PDGF and TGF-\u03b2 1 concentrations were measured in culture supernatants by ELISA.", {"entities": []}], ["Both platelets and platelet lysate augmented fibroblast-mediated gel contraction in a time and concentration dependent manner (19.9% \u00b1 0.1 (mean \u00b1 SEM) of initial area vs. 48.0% \u00b1 0.4 at 48 hours; P < 0.001 and 41.5% \u00b1 0.6 vs. 60.6% \u00b1 0.3 at 48 hours; P < 0.001, respectively).", {"entities": []}], ["Fixed platelets had no effect in the system.", {"entities": []}], ["Both TGF-\u03b2 1 and PDGF-AA/AB were released in co-culture.", {"entities": []}], ["PDGF-AA/AB had a maximum release at 24 hours whereas TGF-\u03b2 1 release increased with longer culture periods.", {"entities": []}], ["Neutralising antibodies to these mediators partially inhibited platelet-induced gel contraction.", {"entities": []}], ["We conclude that platelets may promote remodelling of extracellular matrix in vitro and that PDGF and TGF-\u03b2 partially mediate this effect, also indicating a role for other mediators.", {"entities": []}], ["The findings may be an important mechanism in regulating repair processes after injury.", {"entities": []}], ["Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular smooth muscle proliferation, is absent in pulmonary arteries of patients with idiopathic pulmonary arterial hypertension (PAH).", {"entities": [[195, 207, "DISEASE"], [31, 34, "GENE"]]}], ["We previously determined that targeted deletion of the VIP gene in mice leads to PAH with pulmonary vascular remodeling and right ventricular (RV) dilatation.", {"entities": [[55, 58, "GENE"]]}], ["Whether the left ventricle is also affected by VIP gene deletion is unknown.", {"entities": [[47, 50, "GENE"]]}], ["In the current study, we examined if VIP knockout mice (VIP We examined VIP Lungs from VIP Critically-important heart failure-related genes are upregulated in VIP", {"entities": [[37, 40, "GENE"], [56, 59, "GENE"], [72, 75, "GENE"], [87, 90, "GENE"], [159, 162, "GENE"], [37, 40, "GENE"], [56, 59, "GENE"], [72, 75, "GENE"], [87, 90, "GENE"], [159, 162, "GENE"], [37, 40, "GENE"], [56, 59, "GENE"], [72, 75, "GENE"], [87, 90, "GENE"], [159, 162, "GENE"], [37, 40, "GENE"], [56, 59, "GENE"], [72, 75, "GENE"], [87, 90, "GENE"], [159, 162, "GENE"], [37, 40, "GENE"], [56, 59, "GENE"], [72, 75, "GENE"], [87, 90, "GENE"], [159, 162, "GENE"]]}], ["Genome-wide association studies identified a PTGER4 expression-modulating region on chromosome 5p13.1 as Crohn's disease (CD) susceptibility region.", {"entities": [[45, 51, "GENE"]]}], ["The study aim was to test this association in a large cohort of patients with inflammatory bowel disease (IBD) and to elucidate genotypic and phenotypic interactions with other IBD genes.", {"entities": [[78, 104, "DISEASE"]]}], ["A total of 7073 patients and controls were genotyped: 844 CD and 471 patients with ulcerative colitis and 1488 controls were analyzed for the single nucleotide polymorphisms (SNPs) rs4495224 and rs7720838 on chromosome 5p13.1 .", {"entities": [[83, 101, "DISEASE"]]}], ["The study included two replication cohorts of North American (CD: n\u200a=\u200a684; controls: n\u200a=\u200a1440) and of German origin (CD: n\u200a=\u200a1098; controls: n\u200a=\u200a1048).", {"entities": []}], ["Genotype-phenotype, epistasis and transcription factor binding analyses were performed.", {"entities": []}], ["In the discovery cohort, an association of rs4495224 (p\u200a=\u200a4.10\u00d710 In silico analysis predicted rs4495224 and rs7720838 as essential parts of binding sites for the transcription factors NF-\u03baB and XBP1 with higher binding scores for carriers of the CD risk alleles, providing an explanation of how these SNPs might contribute to increased PTGER4 expression.", {"entities": [[195, 199, "GENE"], [337, 343, "GENE"]]}], ["There was no association of the PTGER4 SNPs with IBD phenotypes.", {"entities": [[32, 38, "GENE"]]}], ["Epistasis detected between 5p13.1 and ATG16L1 for CD susceptibility in the discovery cohort (p\u200a=\u200a5.99\u00d710 We confirmed 5p13.1 as a major CD susceptibility locus and demonstrate by in silico analysis rs4495224 and rs7720838 as part of binding sites for NF-\u03baB and XBP1.", {"entities": [[38, 45, "GENE"], [261, 265, "GENE"]]}], ["Further functional studies are necessary to confirm the results of our in silico analysis and to analyze if changes in PTGER4 expression modulate CD susceptibility.", {"entities": [[119, 125, "GENE"]]}], ["Tuberculosis (TB) causes 1.45 million deaths annually world wide, the majority of which occur in the developing world.", {"entities": [[0, 12, "DISEASE"]]}], ["Active TB disease represents immune failure to control latent infection from airborne spread.", {"entities": []}], ["Acid-fast bacillus (AFB) seen on sputum smear is a biomarker for contagiousness.", {"entities": []}], ["We enrolled 73 tuberculosis patients with extensive infiltrates into a research study using bronchoalveolar lavage (BAL) to sample lung immune cells and assay BAL cell cytokine production.", {"entities": [[15, 27, "DISEASE"]]}], ["All patients had sputum culture demonstrating Mycobacterium tuberculosis and 59/73 (81%) had AFB identified by microscopy of the sputum.", {"entities": [[60, 72, "DISEASE"]]}], ["Compared with smear negative patients, smear positive patients at presentation had a higher proportion with smoking history, a higher proportion with temperature >38.5 Increasing IL-4 and IL-12p40 production by BAL cells are biomarkers for AFB in sputum of patients who present with radiographically advanced TB.", {"entities": []}], ["They likely reflect less effective immune control of pathways for controlling TB, leading to patients with increased infectiousness.", {"entities": []}], ["The aim of this study was to clarify the operative mortality and long\u2010term survival of gastrectomy for elderly patients with gastric cancer.", {"entities": [[133, 139, "DISEASE"]]}], ["A total of 461 patients who underwent gastrectomy for gastric cancer in our hospital were classified as elderly group (\u226580 years\u2010old, 95 patients) and control group (60\u201369 years\u2010old, 366 patients).", {"entities": [[62, 68, "DISEASE"]]}], ["The frequency of comorbidities was significantly ( P \u2009<\u20090.05) higher in elderly group (74.7%) than that in the control group (49.5%).", {"entities": []}], ["No significant difference of the postoperative complication rate was found between the elderly group (23.2%) and the control group (23.2%).", {"entities": []}], ["Adjuvant chemotherapy was 9.5% in the elderly group, which was significantly less than 29.0% of the control group ( P \u2009<\u20090.05).", {"entities": []}], ["Stage II and III elderly patients had worse disease specific survival (DSS) than controls did.", {"entities": []}], ["In the elderly, overall survival (OS) was significantly worse than DSS in stage I patients ( P \u2009<\u20090.05).", {"entities": []}], ["The operative complication rate of elderly patients was comparable to the control group.", {"entities": []}], ["Comorbidity and occurrence of secondary malignant disease should be followed for elderly patients at stage I.", {"entities": []}], ["For stage II and III disease patients, a novel drug which is acceptable for the elderly is needed as a postoperative therapy.", {"entities": []}], ["2015 111:848\u2013854 .", {"entities": []}], ["\u00a9 2015 The Authors.", {"entities": []}], ["Journal of Surgical Oncology Published by Wiley Periodicals, Inc.", {"entities": []}], ["Asthma is a chronic lung disease that affects more than 23 million people in the United States, including 7 million children.", {"entities": [[0, 6, "DISEASE"], [20, 32, "DISEASE"]]}], ["Asthma is a difficult to manage chronic condition associated with disparities in health outcomes, poor medical compliance, and high healthcare costs.", {"entities": [[0, 6, "DISEASE"]]}], ["The research network coordinating this project includes hospitals, urgent care centers, and outpatient clinics within Carolinas Healthcare System that share a common electronic medical record and billing system allowing for rapid collection of clinical and demographic data.", {"entities": []}], ["This study investigates the impact of three interventions on clinical outcomes for patients with asthma.", {"entities": [[97, 103, "DISEASE"]]}], ["Interventions are: an integrated approach to care that incorporates asthma management based on the chronic care model; a shared decision making intervention for asthma patients in underserved or disadvantaged populations; and a school based care approach that examines the efficacy of school-based programs to impact asthma outcomes including effectiveness of linkages between schools and the healthcare providers.", {"entities": [[68, 74, "DISEASE"], [161, 167, "DISEASE"], [317, 323, "DISEASE"]]}], ["This study will include 95 Practices, 171 schools, and over 30,000 asthmatic patients.", {"entities": []}], ["Five groups (A-E) will be evaluated to determine the effectiveness of three interventions.", {"entities": []}], ["Group A is the usual care control group without electronic medical record (EMR).", {"entities": []}], ["Group B practices are a second control group that has an EMR with decision support, asthma action plans, and population reports at baseline.", {"entities": [[84, 90, "DISEASE"]]}], ["A time delay design during year one converts practices in Group B to group C after receiving the integrated approach to care intervention.", {"entities": []}], ["Four practices within Group C will receive the shared decision making intervention (and become group D).", {"entities": []}], ["Group E will receive a school based care intervention through case management within the schools.", {"entities": []}], ["A centralized database will be created with the goal of facilitating comparative effectiveness research on asthma outcomes specifically for this study.", {"entities": [[107, 113, "DISEASE"]]}], ["Patient and community level analysis will include results from patient surveys, focus groups, and asthma patient density mapping.", {"entities": [[98, 104, "DISEASE"]]}], ["Community variables such as income and housing density will be mapped for comparison.", {"entities": []}], ["Outcomes to be measured are reduced hospitalizations and emergency department visits; improved adherence to medication; improved quality of life; reduced school absenteeism; improved self-efficacy and improved school performance.", {"entities": []}], ["Identifying new mechanisms that improve the delivery of asthma care is an important step towards advancing patient outcomes, avoiding preventable Emergency Department visits and hospitalizations, while simultaneously reducing overall healthcare costs.", {"entities": [[56, 62, "DISEASE"]]}], ["Glioma is one of the most aggressive and most common tumors of the central nervous system (CNS) in humans.", {"entities": []}], ["The exact causes of glioma are not well known, but evidence suggests the involvement of genetic factors in addition to environmental risk factors.", {"entities": []}], ["The present study aimed to determine whether polymorphisms in IL-10-1082A/G, IL-12p40 1188C/A, and IL-13+2044G/A (rs20541) are associated with the incidence of glioma in Iraqi patients.", {"entities": []}], ["Ninety-six patients with different grades of glioma and 40 apparently healthy individuals were recruited.", {"entities": []}], ["A blood sample and genomic DNA were collected from all subjects.", {"entities": []}], ["The amplification refractory mutation system and sequence-specific primer polymerase chain reaction (PCR) were used for genotyping of IL-10-1082A/G and IL-12p40 1188C/A, respectively; whereas, the IL-13+2044G/A was detected by DNA sequencing after amplification of the genes by PCR.", {"entities": []}], ["All SNPs were within Hardy-Weinberg equilibrium and each appeared in three genotypes in patients and controls.", {"entities": []}], ["In IL-10-1082A/G, these genotypes frequencies were AA (75%), AG (22.93%) and GG (2.07%) in patients as compared to similar frequencies (62.5%), (27.5%) and (10%) respectively, in controls.", {"entities": []}], ["The variant IL-12p40 1188C/A genotype was AA (72.92%), AC (23.96%), and CC (3.13%%) in patients as compared to 65%, 30%, and 5%, respectively, in controls.", {"entities": []}], ["The frequencies of IL-13+2044G/A genotypes (GG, GA, and AA) were 89.58%, 9.37%, and 1.04% among patients versus 47.5%, 32.5% and 20%, respectively, among controls.", {"entities": []}], ["These results suggest a protective role of mutant alleles G and A in IL-10-1082A/G and IL-13+2044G/A against gliomas.", {"entities": []}], ["Further studies with more rigorous parameter designs will be needed to confirm the current findings.", {"entities": []}], ["Background and objective Utilities (values representing preferences) for healthcare priority setting are typically obtained indirectly by asking patients to fill in a quality of life questionnaire and then converting the results to a utility using population values.", {"entities": []}], ["We compared such utilities with those obtained directly from patients or the public.", {"entities": []}], ["Design Review of studies providing both a direct and indirect utility estimate.", {"entities": []}], ["Selection criteria Papers reporting comparisons of utilities obtained directly (standard gamble or time trade off) or indirectly (European quality of life 5D [EQ-5D], short form 6D [SF-6D], or health utilities index [HUI]) from the same patient.", {"entities": []}], ["Data sources PubMed and Tufts database of utilities.", {"entities": []}], ["Statistical methods Sign test for paired comparisons between direct and indirect utilities; least squares regression to describe average relations between the different methods.", {"entities": []}], ["Main outcome measures Mean utility scores (or median if means unavailable) for each method, and differences in mean (median) scores between direct and indirect methods.", {"entities": []}], ["Results We found 32 studies yielding 83 instances where direct and indirect methods could be compared for health states experienced by adults.", {"entities": []}], ["The direct methods used were standard gamble in 57 cases and time trade off in 60 (34 used both); the indirect methods were EQ-5D (67 cases), SF-6D (13), HUI-2 (5), and HUI-3 (37).", {"entities": []}], ["Mean utility values were 0.81 (standard gamble) and 0.77 (time trade off) for the direct methods; for the indirect methods: 0.59 (EQ-5D), 0.63 (SF-6D), 0.75 (HUI-2) and 0.68 (HUI-3).", {"entities": []}], ["Discussion Direct methods of estimating utilities tend to result in higher health ratings than the more widely used indirect methods, and the difference can be substantial.", {"entities": []}], ["Use of indirect methods could have important implications for decisions about resource allocation: for example, non-lifesaving treatments are relatively more favoured in comparison with lifesaving interventions than when using direct methods.", {"entities": []}], ["Influenza-specific immune activity not only promotes virus clearance but also causes immunopathology, thereby underlining the importance of mounting a measured anti-viral immune response.", {"entities": [[0, 9, "DISEASE"]]}], ["Since complement bridges both the innate and adaptive immune systems and has been implicated in defence against influenza, the role of the complement regulator CD59a in modulating the response to influenza was explored.", {"entities": [[112, 121, "DISEASE"], [196, 205, "DISEASE"]]}], ["For this purpose, immune responses to influenza virus, strain E61-13-H17, in mice deficient in the complement regulator protein CD59a (Cd59a", {"entities": [[38, 47, "DISEASE"]]}], ["Chronic urticaria (CU) is defined as itchy wheals lasting 6 weeks or more.", {"entities": [[8, 17, "DISEASE"]]}], ["As the aged population increases worldwide, it is essential to identify the specific features of this disease in the elderly population.", {"entities": []}], ["We investigated the prevalence and clinical features of CU in elderly patients.", {"entities": []}], ["Medical records of 837 CU patients from the outpatient Allergy Clinic of Ajou University Hospital, Korea were analyzed retrospectively.", {"entities": []}], ["Patients with chronic spontaneous urticaria according to the EAACI/GA2LEN/EDF/WAO guidelines were included.", {"entities": [[34, 43, "DISEASE"]]}], ["Patients older than 60 years were defined as elderly.", {"entities": []}], ["Of the 837 patients, 37 (4.5%) were elderly.", {"entities": []}], ["In elderly versus nonelderly CU patients, the prevalence of atopic dermatitis (AD) was significantly higher (37.8% vs. 21.7%, respectively; p = 0.022), while that of aspirin intolerance was lower (18.9% vs. 43.6%, respectively; p = 0.003) in terms of comorbid conditions.", {"entities": [[60, 77, "DISEASE"], [67, 77, "DISEASE"]]}], ["The prevalences of serum specific immunoglobulin E antibodies to staphylococcal enterotoxin A and staphylococcal enterotoxin B were considerably higher in elderly CU patients with AD than in those without AD (37.5% vs. 0%, respectively).", {"entities": []}], ["Elderly patients with CU had a higher prevalence of AD.", {"entities": []}], ["Therefore, there is a need to recognize the existence of AD in elderly CU patients.", {"entities": []}], ["Oral steroids induce remission in about 90% of children with idiopathic nephrotic syndrome (INS), which is characterised by severe proteinuria and hypoalbuminaemia.", {"entities": [[72, 90, "DISEASE"], [131, 142, "DISEASE"], [82, 90, "DISEASE"], [92, 95, "GENE"]]}], ["Some children become steroid-dependent (SD) and require addition of calcineurin inhibitors (CNI) to maintain remission.", {"entities": []}], ["Since these oral agents are toxic, alternative interventions are needed for long-term treatment.", {"entities": []}], ["The anti-CD20 antibody rituximab has shown promising steroid-sparing properties in clinical trials, but benefits are less convincing in complicated forms of SD-INS.", {"entities": []}], ["Ofatumumab, a new anti-CD20 antibody with stronger affinity to CD20, may be superior to rituximab in maintaining oral steroid-free and CNI-free disease remission in children with SD-INS.", {"entities": []}], ["This open-label, two-parallel-arm, controlled, phase II randomised clinical trial will enrol children with SD-INS maintained in remission with oral steroids and CNI.", {"entities": []}], ["Children will be randomised to either ofatumumab or rituximab infusion.", {"entities": []}], ["After infusion of either antibody, steroids will be maintained for 30\u2005days and then tapered off by 0.3\u2005mg/kg/week until complete withdrawal.", {"entities": []}], ["1 week after complete steroid withdrawal, CNI will be decreased by 50% and withdrawn within 2 additional weeks.", {"entities": []}], ["We will enrol 140 children to detect as significant at the 2-sided p value of 0.01 with a power of >0.8, a reduction in the risk of 1-year relapse (primary end point) of at least 0.3 (ie, from 0.65 to 0.35; (risk ratio 0.54)) in the ofatumumab arm when compared with the rituximab arm.", {"entities": []}], ["We will compare the amount of steroids required to maintain complete disease remission at 6 and 24\u2005months, relapse-free period, relapse rate per year as secondary end points.", {"entities": []}], ["Circulating cell populations will be studied as biomarkers or predictors of the anti-CD20 response.", {"entities": []}], ["The trial received ethics approval from the local ethics board.", {"entities": []}], ["We will publish study results and present them at international scientific meetings.", {"entities": []}], ["NCT02394119; 2015-000624-28; Pre-results.", {"entities": []}], ["There is no clear consensus as to what constitutes an obstructive ventilatory defect (OVD): Is it FEV 1 /FVC<lower limit of normal (LLN) or<0.70 (respectively, physiological and operational definitions)?", {"entities": [[98, 101, "GENE"]]}], ["To determine, according to the two definitions, the percentage of subjects having an OVD among them explored in a lung function exploration laboratory.", {"entities": []}], ["This is a retrospective study including 4,730 subjects aged 17\u201385 years.", {"entities": []}], ["Subjects were divided according to the presence [physio (+) or operat (+)] or absence [physio (\u2212) or operat (\u2212)] of an OVD, and into younger (<45 years, n =2,076), older (\u226545 years, n =2,654), smokers ( n =1,208), and non-smokers ( n =3,522) groups.", {"entities": []}], ["For the total sample, the younger and older groups [mean\u00b1SD of age (years), respectively, 46.7\u00b114.1; 33.9\u00b17.4, and 56.8\u00b19.1], the \u2018physiological definition\u2019 detected, respectively, 13.46, 43.22, and 5.09% more OVD than the \u2018operational one\u2019 ( p <0.05).", {"entities": []}], ["In addition, the operational definition, compared with the physiological one, overdiagnosed OVD in 2.33 and 0.44% of smokers and non-smokers, respectively, and underdiagnosed it in 4.46% and 29.72% of smokers and non-smokers, respectively ( p <0.05).", {"entities": []}], ["Compared with the group \u2018physio (\u2212), operat (+)\u2019, the \u2018physio (+), operat (\u2212)\u2019 one was younger (74.2\u00b14.7 years vs. 40.9\u00b110.3 years) and had significantly higher FEV 1 (62\u00b113% vs. 78\u00b117%) and FVC (71\u00b115% vs. 93\u00b119%).", {"entities": [[161, 164, "GENE"]]}], ["The frequency of OVD much depends on the criteria used for its definition.", {"entities": []}], ["Eosinophil granule major basic protein (MBP), a potent toxin for helminths and various cell types, is a 13.8-kD single polypeptide rich in arginine with a calculated isoelectric point (pI) of 10.9.", {"entities": [[40, 43, "GENE"]]}], ["A cDNA for human MBP was isolated from a gamma GT10 HL-60 cDNA library.", {"entities": [[17, 20, "GENE"]]}], ["The nucleotide sequence of the MBP cDNA indicates that MBP is translated as a 25.2-kD preproprotein.", {"entities": [[31, 34, "GENE"], [55, 58, "GENE"], [31, 34, "GENE"], [55, 58, "GENE"]]}], ["The 9.9-kD pro-portion of proMBP is rich in glutamic and aspartic acids and has a calculated pI of 3.9, while proMBP itself has a calculated pI of 6.2.", {"entities": []}], ["We suggest that MBP is translated as a nontoxic precursor that protects the eosinophil from damage while the protein is processed through the endoplasmic reticulum to its sequestered site in the granule core toxic MBP, and we present results from the literature suggesting that other cationic toxins, which damage cell membranes, may also be processed from nontoxic precursors containing distinct anionic and cationic regions.", {"entities": [[16, 19, "GENE"], [214, 217, "GENE"], [16, 19, "GENE"], [214, 217, "GENE"]]}], ["The evaluation of collagen in the abdominal wall has been increasingly studied because of the relevance on collagen in the healing process after laparotomy.", {"entities": []}], ["To evaluate the amount of collagen in the linea alba of patients undergoing laparotomic bariatric surgery and comparing with non-obese cadavers.", {"entities": []}], ["Were evaluated 88 samples of aponeurosis from abdominal linea alba of 44 obese patients (obesity group) and 44 non-obese cadavers (control group).", {"entities": [[89, 96, "DISEASE"]]}], ["The samples were collected in 2013 and 2104, and were sorted according to age (18-30, 31-45 and 46-60), gender, BMI, waist and cervical circumference, and subcutaneous tissue thickness.", {"entities": []}], ["Material for biopsy was collected from the supraumbilical region of the linea alba for immunohistochemical analysis differentiating collagen type 1 and type 3 and the 1/3 ratio.", {"entities": []}], ["Image-Pro Plus pixel counting software was used to measure the amount of collagen.", {"entities": []}], ["The obesity group evidenced mean age 44.11\u00b19.90 years; 18-30 age group had three (6.8%) obese individuals; 31-45 had 22 (50%) and 46-60 had 19 (43.1%).", {"entities": [[4, 11, "DISEASE"]]}], ["Females were present in 81.8% (n=36); BMI (kg/m\u00b2) was 48.81\u00b16.5; waist circumference (cm) was 136.761\u00b113.55; subcutaneous tissue thickness (cm) 4.873\u00b10.916.", {"entities": []}], ["Considering age groups, gender and BMI, there were statistical differences in all tests when compared with the cadavers.", {"entities": []}], ["The amount of collagen in the linea alba above the umbilical region in the morbidly obese patients was smaller than in the non-obese cadavers in the same age group.", {"entities": []}], ["Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is associated with enhanced leukocyte infiltration to the gut, which is directly linked to the clinical aspects of these disorders.", {"entities": [[67, 85, "DISEASE"]]}], ["Thus, leukocyte trafficking is a major target for IBD therapy.", {"entities": []}], ["Past and emerging techniques to study leukocyte trafficking both in vitro and in vivo have expanded our knowledge of the leukocyte migration process and the role of inhibitors.", {"entities": []}], ["Various strategies have been employed to target chemokine- and integrin-ligand interactions within the multistep adhesion cascade and the S1P/S1PR1 axis in leukocyte migration.", {"entities": []}], ["Though there is an abundance of preclinical data demonstrating efficacy of leukocyte trafficking inhibitors, many have yet to be confirmed in clinical studies.", {"entities": []}], ["Vigilance for toxicity and further research is required into this complex and emerging area of IBD therapy.", {"entities": []}], ["Neurotrophins (NTs), which play an integral role in neuronal development and function, have been found in non-neuronal tissue (including lung), but their role is still under investigation.", {"entities": [[15, 18, "GENE"]]}], ["Recent reports show that NTs such as brain-derived neurotrophic factor (BDNF) as well as NT receptors are expressed in human airway smooth muscle (ASM).", {"entities": [[25, 28, "GENE"], [72, 76, "GENE"]]}], ["However, their function is still under investigation.", {"entities": []}], ["We hypothesized that NTs regulate ASM intracellular Ca i ) by altered expression of Ca i responses to acetylcholine (ACh) and histamine using the Ca 3 and RyR receptors, and SERCA following BDNF exposure, effects inhibited by inhibitors of the above cascades.", {"entities": [[21, 24, "GENE"], [190, 194, "GENE"]]}], ["The functional significance of BDNF effects were verified by siRNA or pharmacological inhibition of proteins that were altered by this NT.", {"entities": [[31, 35, "GENE"]]}], ["Overall, these data demonstrate that NTs activate signaling pathways in human ASM that lead to enhanced [Ca i responses via increased regulatory protein expression, thus enhancing airway contractility.", {"entities": [[37, 40, "GENE"]]}], ["Peanut allergy is the leading cause of deaths due to food-induced anaphylaxis but despite continued research, there are currently no specific treatments available.", {"entities": []}], ["Challenge testing is limited in patients due to the high risk of adverse reactions, emphasising the need for an appropriate animal model.", {"entities": []}], ["In the present study we examine the induction of allergic responses in a sheep model for peanut allergy.", {"entities": []}], ["Sheep were sensitised with peanut (PN) extract and in separate injections with ovalbumin (OVA) or house dust mite (HDM) extract.", {"entities": []}], ["Serum PN-specific IgE responses were detected in 40\u201350% of immunised sheep, while only 10% (1 of 10 sheep) showed detectable OVA-specific IgE.", {"entities": []}], ["All PN-allergic sheep tested showed an Ara h 1-specific IgE response, while four out of five allergic sheep showed an Ara h 2-specific IgE response.", {"entities": []}], ["Animals with high serum IgE levels to HDM were also PN IgE-positive.", {"entities": []}], ["Of the PN-sensitised animals with high PN-specific IgE, 80% also showed an immediate hypersensitivity reaction following an intradermal PN injection.", {"entities": []}], ["This new large animal model of peanut allergy may provide a useful tool for future investigations of allergen-associated immune mechanisms and specific immunotherapy.", {"entities": []}], ["Molar Incisor Hypomineralisation (MIH) and Hypomineralised Second Primary Molars (HSPM) involve prevalent qualitative structural developmental anomalies of tooth enamel affecting the first permanent molars (and often incisors) and the second primary molars, respectively.", {"entities": []}], ["These demarcated hypomineralised lesions of enamel manifest as white-cream or yellow-brown opacities, with possible post-eruptive localised loss of enamel.", {"entities": []}], ["Aetiological hypotheses have involved contemporary life factors (i.e.", {"entities": []}], ["environmental pollutant exposure or early childhood medications) in contrast to factors not limited to a specific time period (i.e.", {"entities": []}], ["hypoxia at birth or genetic predisposition).", {"entities": []}], ["Evidence of MIH in ancient populations would reinforce aetiological factors present for many centuries.", {"entities": []}], ["By means of microtomographic and X-ray fluorescence analyses the present study provides evidence that (i) two archaeological specimens: \u201cS407\u201d (Sains-en-Gohelle, France, 12", {"entities": []}], ["Urogenital infection with Chlamydia trachomatis can lead to development of an acute inflammatory arthritis, and this acute disease becomes chronic in some individuals.", {"entities": [[97, 106, "DISEASE"]]}], ["Research indicates that the organism is present in synovial tissue of patients with chronic disease in a persistent, rather than an actively growing, form.", {"entities": []}], ["Importantly, metabolic and other characteristics of persistent Chlamydia differ from those of actively growing bacteria.", {"entities": []}], ["Other studies suggest that Chlamydia pneumoniae can be found in a persistent state in the synovium and that it too may be involved in joint pathogenesis.", {"entities": []}], ["These and other observations suggest a more complex role for the Chlamydiae in joint disease than previously recognized.", {"entities": []}], ["This realization should engender a realignment of thinking among clinicians and researchers concerning both mechanisms of chlamydial pathogenesis in the synovium and design of new treatments for the disease.", {"entities": []}], ["Although the translational function of tRNA has long been established, extra translational functions of tRNA are still being discovered.", {"entities": []}], ["We previously developed a computational method to systematically predict new tRNA-protein complexes and experimentally validated six candidate proteins, including the mitogen-activated protein kinase kinase 2 (MEK2), that interact with tRNA in HEK293T cells.", {"entities": []}], ["However, consequences of the interaction between tRNA and these proteins remain to be elucidated.", {"entities": []}], ["Here we tested the consequence of the interaction between tRNA and MEK2 in pancreatic cancer cell lines.", {"entities": [[75, 92, "DISEASE"], [86, 92, "DISEASE"]]}], ["We also generated disease and drug resistance-derived MEK2 mutants (Q60P, P128Q, S154F, E207K) to evaluate the function of the tRNA-MEK2 interaction.", {"entities": []}], ["Our results demonstrate that tRNA interacts with the wild-type and mutant MEK2 in pancreatic cancer cells; furthermore, the MEK2 inhibitor U0126 significantly reduces the tRNA-MEK2 interaction.", {"entities": [[82, 99, "DISEASE"], [93, 99, "DISEASE"]]}], ["In addition, tRNA affects the catalytic activity of the wild type and mutant MEK2 proteins in different ways.", {"entities": []}], ["Overall, our findings demonstrate the interaction of tRNA with MEK2 in pancreatic cancer cells and suggest that tRNA may impact MEK2 activity in cancer cells.", {"entities": [[71, 88, "DISEASE"], [82, 88, "DISEASE"], [145, 151, "DISEASE"]]}], ["In the past 50 years there has been a substantial increase in the volume of published research and in the number of authors per scientific publication.", {"entities": []}], ["There is also significant pressure exerted on researchers to produce publications.", {"entities": []}], ["Thus, the purpose of this study was to survey corresponding authors in published medical journals to determine their opinion on publication impact in relation to performance review and promotion.", {"entities": []}], ["Cross-sectional survey of corresponding authors of original research articles published in June 2007 among 72 medical journals.", {"entities": []}], ["Measurement outcomes included the number of publications, number of authors, authorship order and journal impact factor in relation to performance review and promotion.", {"entities": []}], ["Of 687 surveys, 478 were analyzed (response rate 69.6%).", {"entities": []}], ["Corresponding authors self-reported that number of publications (78.7%), journal impact factor (67.8%) and being the first author (75.9%) were most influential for their annual performance review and assessment.", {"entities": []}], ["Only 17.6% of authors reported that the number of authors on a manuscript was important criteria for performance review and assessment.", {"entities": []}], ["A higher percentage of Asian authors reported that the number of authors was key to performance review and promotion (41.4% versus 7.8 to 22.2%).", {"entities": []}], ["compared to authors from other countries.", {"entities": []}], ["The number of publications, authorship order and journal impact factor were important factors for performance reviews and promotion at academic and non-academic institutes.", {"entities": []}], ["The number of authors was not identified as important criteria.", {"entities": []}], ["These factors may be contributing to the increase in the number of authors per publication.", {"entities": []}], ["Diabetes is a debilitating illness requiring lifelong management.", {"entities": []}], ["Treatments can be varied in terms of mode of administration as well as type of agent.", {"entities": []}], ["Unfortunately, most patient reported outcome measures currently available to assess the impact of treatment are specific to diabetes type, treatment modality or delivery systems and are designed to be either a HRQoL or treatment satisfaction measure.", {"entities": []}], ["To address these gaps, the Treatment Related Impact Measure-Diabetes and Device measures were developed.", {"entities": []}], ["This paper presents the item development and validation of the TRIM Diabetes/Device.", {"entities": []}], ["Patient interviews were conducted to collect the patient perspective and ensure high content validity.", {"entities": []}], ["Interviews were hand coded and qualitatively analyzed to identify common themes.", {"entities": []}], ["A conceptual model of the impact of diabetes medication was developed and preliminary items for the TRIM-Diabetes/Device were generated and cognitively debriefed.", {"entities": []}], ["Validation data was collected via an on-line survey and analyzed according to an a priori statistical analysis plan to validate the overall score as well as each domain.", {"entities": []}], ["Item level criteria were used to reduce the preliminary item pool.", {"entities": []}], ["Next, factor analysis to identify structural domains was performed.", {"entities": []}], ["Reliability and validity testing was then performed.", {"entities": []}], ["One hundred and five patients were interviewed in focus groups, individual interviews and for cognitive debriefing.", {"entities": []}], ["Five hundred seven patients participated in the validation study.", {"entities": []}], ["Factor analysis identified seven domains: Treatment Burden, Daily Life; Diabetes Management; Psychological Health; Compliance and Device Function and Bother.", {"entities": []}], ["Internal consistency reliability coefficients of the TRIM-Diabetes/Device ranged from 0.80 and 0.94.", {"entities": []}], ["Test-retest reliability of the TRIM-Diabetes/Device ranged from 0.71 to 0.89.", {"entities": []}], ["All convergent and known groups validity hypotheses were met for the TRIM-Diabetes/Device total scores and sub-scales.", {"entities": []}], ["Validation is an ongoing and iterative process.", {"entities": []}], ["These findings are the first step in that process and have shown that both the TRIM-Diabetes and the TRIM-Diabetes Device have acceptable psychometric properties.", {"entities": []}], ["Future research is needed to continue the validation process and examine responsiveness and the validity of the TRIM-Diabetes/Device in a clinical trial population.", {"entities": []}], ["It has been known that Dexmedetomidine pre-medication enhances the effects of volatile anesthetics, reduces the need of sevoflurane, and facilitates smooth extubation in anesthetized children.", {"entities": []}], ["This present study was designed to determine the effects of different doses of intravenous dexmedetomidine pre-medication on minimum alveolar concentration of sevoflurane for smooth tracheal extubation (MAC EX ) in anesthetized children.", {"entities": []}], ["A total of seventy-five pediatric patients, aged 3\u20137\u00a0years, ASA physical status I and II, and undergoing tonsillectomy were randomized to receive intravenous saline (Group D 0 ), dexmedetomidine 1\u00a0\u03bcg\u2219kg 1 ), or dexmedetomidine 2\u00a0\u03bcg\u2219kg 2 ) approximately 10\u00a0min before anesthesia start.", {"entities": []}], ["Sevoflurane was used for anesthesia induction and anesthesia maintenance.", {"entities": []}], ["At the end of surgery, the initial concentration of sevoflurane for smooth tracheal extubation was determined according to the modified Dixon\u2019s \u201cup-and-down\u201d method.", {"entities": []}], ["The starting sevoflurane for the first patient was 1.5% in Group D 0 , 1.0% in Group D 1 , and 0.8% in Group D 2 , with subsequent 0.1% up or down in next patient based on whether smooth extubation had been achieved or not in current patient.", {"entities": []}], ["The endotreacheal tube was removed after the predetermined concentration had been maintained constant for ten minutes.", {"entities": []}], ["All responses (\u201csmooth\u201d or \u201cnot smooth\u201d) to tracheal extubation and respiratory complications were assessed.", {"entities": []}], ["MAC EX values of sevoflurane in Group D 2 (0.51\u2009\u00b1\u20090.13%) was significantly lower than in Group D 1 (0.83\u2009\u00b1\u20090.10%; P \u2009<\u20090.001), the latter being significantly lower than in Group D 0 (1.40\u2009\u00b1\u20090.12%; P \u2009<\u20090.001).", {"entities": []}], ["EC 95 values of sevoflurane were 0.83%, 1.07%, and 1.73% in Group D 2 , Group D 1 , and Group D 0 , respectively.", {"entities": []}], ["No patient in the current study had laryngospasm.", {"entities": []}], ["Dexmedetomidine decreased the required MAC EX values of sevoflurane to achieve smooth extubation in a dose-dependent manner.", {"entities": []}], ["Intravenous dexmedetomidine 1\u00a0\u03bcg\u2219kg EX by 41% and 64%, respectively.", {"entities": []}], ["Chinese Clinical Trial Registry (ChiCTR): ChiCTR-IOD-17011601 , date of registration: 09 Jun 2017, retrospectively registered.", {"entities": [[89, 92, "GENE"]]}], ["To investigate the long-term effects of mild H1N1 influenza infection on the pulmonary function of a cohort of patients.", {"entities": [[50, 59, "DISEASE"]]}], ["Forty-eight patients, all diagnosed with influenza A virus subtype H1N1 in 2009, were retrospectively included in this study.", {"entities": [[41, 50, "DISEASE"]]}], ["Each patient in the study was monitored for 11-13 months by standard pulmonary function examination.", {"entities": []}], ["The examination included monitoring respiratory tract infection symptoms (cough, expectoration or gasping) and vital signs.", {"entities": []}], ["Long-term changes in symptoms and changes in vital signs were correlated back to and compared with the severity of the initial H1N1 influenza infection.", {"entities": [[132, 141, "DISEASE"]]}], ["One year post discharge, mild to moderate pulmonary dysfunction was observed in the majority of patients.", {"entities": []}], ["Further, 54.2% of patients had signs of severe abnormal pulmonary function, including diffusion disorder (33.3%) and small airway dysfunction (33.3%).", {"entities": []}], ["Fourteen patients presented with respiratory tract infection symptoms; 12 with abnormal pulmonary function and two with normal pulmonary function.", {"entities": []}], ["Our results indicated that the change in pulmonary function at one year post discharge was not significantly correlated with the severity of H1N1 influenza.", {"entities": [[146, 155, "DISEASE"]]}], ["Signs and symptoms of abnormal pulmonary function accompanied by respiratory tract infection symptoms remain for some patients after one year following discharge from the hospital for mild influenza A virus subtype H1N1 infection.", {"entities": [[189, 198, "DISEASE"]]}], ["These patients should continue to be monitored for any changes in condition and symptoms and rehabilitation treatment should be provided when necessary.", {"entities": []}], ["To be effective and sustain themselves over time, public-private partnerships must make evaluation a priority.", {"entities": []}], ["Specifically, partnerships should evaluate 1) their infrastructure, function, and processes; 2) programs designed to achieve their mission, goals, and objectives; and 3) changes in health and social status, organizations, systems, and the broader community.", {"entities": []}], ["This article describes how to 1) develop a comprehensive evaluation strategy based on partnership theory; 2) select short-term, intermediate, and long-term indicators to measure outcomes; 3) choose appropriate methods and tools; and 4) use evaluation results to provide accountability to stakeholders and improve partnership function and program implementation.", {"entities": []}], ["The \u03b2 2 adrenergic receptor (ADRB2) is a G protein-coupled transmembrane receptor expressed in the human respiratory tract and widely recognized as a pharmacological target for treatments of asthma and chronic obstructive pulmonary disorder (COPD).", {"entities": [[191, 197, "DISEASE"], [29, 34, "GENE"]]}], ["Although a number of ADRB2 agonists have been developed for use in asthma therapy, indacaterol is the only ultra-long-acting inhaled \u03b2 2 -agonist (LABA) approved by the FDA for relieving the symptoms in COPD patients.", {"entities": [[67, 73, "DISEASE"], [21, 26, "GENE"]]}], ["The precise molecular mechanism underlying the pharmacological effect of indacaterol, however, remains unclear.", {"entities": []}], ["Here, we show that \u03b2-arrestin-2 mediates the internalization of ADRB2 following indacaterol treatment.", {"entities": [[64, 69, "GENE"]]}], ["Moreover, we demonstrate that indacaterol significantly inhibits tumor necrosis factor-\u03b1 (TNF-\u03b1)-induced NF-\u03baB activity by reducing levels of both phosphorylated-IKK and -I\u03baB\u03b1, thereby decreasing NF-\u03baB nuclear translocation and the expression of MMP-9, an NF-\u03baB target gene.", {"entities": []}], ["Subsequently, we show that indacaterol significantly inhibits TNF-\u03b1/NF-\u03baB-induced cell invasiveness and migration in a human cancer cell line.", {"entities": [[125, 131, "DISEASE"]]}], ["In conclusion, we propose that indacaterol may inhibit NF-\u03baB activity in a \u03b2-arrestin2-dependent manner, preventing further lung damage and improving lung function in COPD patients.", {"entities": []}], ["Nuclease A (NucA) is an extracellular nuclease secreted from S. agalactiae and is required for full virulence during infection.", {"entities": []}], ["Crystal structures and biochemical characterization of NucA mutants reveal possible roles for surface residues in DNA substrate binding and catalysis.", {"entities": []}], ["These results may serve as a foundation for the design of targeted antibacterial therapeutic compounds.", {"entities": []}], ["The group B pathogen Streptococcus agalactiae commonly populates the human gut and urogenital tract, and is a major cause of infection-based mortality in neonatal infants and in elderly or immunocompromised adults.", {"entities": []}], ["Nuclease A (GBS_NucA), a secreted DNA/RNA nuclease, serves as a virulence factor for S. agalactiae , facilitating bacterial evasion of the human innate immune response.", {"entities": []}], ["GBS_NucA efficiently degrades the DNA matrix component of neutrophil extracellular traps (NETs), which attempt to kill and clear invading bacteria during the early stages of infection.", {"entities": []}], ["In order to better understand the mechanisms of DNA substrate binding and catalysis of GBS_NucA, the high-resolution structure of a catalytically inactive mutant (H148G) was solved by X-ray crystallography.", {"entities": []}], ["Several mutants on the surface of GBS_NucA which might influence DNA substrate binding and catalysis were generated and evaluated using an imidazole chemical rescue technique.", {"entities": []}], ["While several of these mutants severely inhibited nuclease activity, two mutants (K146R and Q183A) exhibited significantly increased activity.", {"entities": []}], ["These structural and biochemical studies have greatly increased our understanding of the mechanism of action of GBS_NucA in bacterial virulence and may serve as a foundation for the structure-based drug design of antibacterial compounds targeted to S. agalactiae .", {"entities": []}], ["To conduct an expert-led process for identifying research priorities for eight areas of adolescent health in low- and middle-income countries.", {"entities": []}], ["Specific adolescent health areas included communicable diseases prevention and management, injuries and violence, mental health, noncommunicable diseases management, nutrition, physical activity, substance use, and health policy.", {"entities": []}], ["We used a modified version of the Child Health and Nutrition Research Initiative methodology for reaching consensus on research priorities.", {"entities": []}], ["In a three phase process, we (1)\u00a0identified research and program experts with wide-ranging backgrounds and experiences from all geographic regions through systematic searches and key informants; (2) invited these experts to propose research questions related to descriptive epidemiology, interventions (discovery, development/testing, and delivery/implementation), and health policy/systems; and (3) asked the experts to prioritize the research questions based on five criteria: clarity, answerability, importance or impact, implementation, and equity.", {"entities": []}], ["A total of 142 experts submitted 512 questions which were edited and reduced to 303 for scoring.", {"entities": []}], ["Overall, the types of the top 10 research questions in each of the eight health areas included descriptive epidemiology (26%), interventions: discovery (11%), development/testing (25%), delivery (33%), and policy, health and social systems (5%).", {"entities": []}], ["Across health areas, the top questions highlighted integration of health services, vulnerable populations, and different health platforms (such as primary care, schools, families/parents, and interactive media).", {"entities": []}], ["Priority questions have been identified for research in eight key areas of adolescent health in low- and middle-income countries.", {"entities": []}], ["These expert-generated questions may be used by donors, program managers, and researchers to prioritize and stimulate research in adolescent health.", {"entities": []}], ["Background: The United States has experienced a boom in natural gas production due to recent technological innovations that have enabled this resource to be produced from shale formations.", {"entities": []}], ["Objectives: We reviewed the body of evidence related to exposure pathways in order to evaluate the potential environmental public health impacts of shale gas development.", {"entities": []}], ["We highlight what is currently known and identify data gaps and research limitations by addressing matters of toxicity, exposure pathways, air quality, and water quality.", {"entities": []}], ["Discussion: There is evidence of potential environmental public health risks associated with shale gas development.", {"entities": []}], ["Several studies suggest that shale gas development contributes to ambient air concentrations of pollutants known to be associated with increased risk of morbidity and mortality.", {"entities": []}], ["Similarly, an increasing body of studies suggest that water contamination risks exist through a variety of environmental pathways, most notably during wastewater transport and disposal, and via poor zonal isolation of gases and fluids due to structural integrity impairment of cement in gas wells.", {"entities": []}], ["Conclusion: Despite a growing body of evidence, data gaps persist.", {"entities": []}], ["Most important, there is a need for more epidemiological studies to assess associations between risk factors, such as air and water pollution, and health outcomes among populations living in close proximity to shale gas operations.", {"entities": []}], ["Citation: Shonkoff SB, Hays J, Finkel ML.", {"entities": []}], ["Environmental public health dimensions of shale and tight gas development.", {"entities": []}], ["Environ Health Perspect 122:787\u2013795;\u2002 http://dx.doi.org/10.1289/ehp.1307866", {"entities": []}], ["Medication non-adherence is a missed opportunity for therapeutic benefit.", {"entities": []}], ["We assessed \u201creal-world\u201d levels of self-reported non-adherence to conventional and biologic systemic therapies used for psoriasis and evaluated psychological and biomedical factors associated with non-adherence using multivariable analyses.", {"entities": [[120, 129, "DISEASE"]]}], ["Latent profile analysis was used to investigate whether patients can be categorized into groups with similar medication beliefs.", {"entities": []}], ["Latent profile analysis categorizes individuals with similar profiles on a set of continuous variables into discrete groups represented by a categorical latent variable.", {"entities": []}], ["Eight hundred and eleven patients enrolled in the British Association of Dermatologists Biologic Interventions Register were included.", {"entities": []}], ["Six hundred and seventeen patients were using a self-administered systemic therapy; 22.4% were classified as \u201cnon-adherent\u201d (12% intentionally and 10.9% unintentionally).", {"entities": []}], ["Patients using an oral conventional systemic agent were more likely to be non-adherent compared to those using etanercept or adalimumab (29.2% vs. 16.4%; P \u2264 0.001).", {"entities": []}], ["Latent profile analysis supported a three-group model; all groups held strong beliefs about their need for systemic therapy but differed in levels of medication concerns.", {"entities": []}], ["Group 1 (26.4% of the sample) reported the strongest concerns, followed by Group 2 (61%), with Group 3 (12.6%) reporting the weakest concerns.", {"entities": []}], ["Group 1 membership was associated with intentional non-adherence (odds ratio\u00a0= 2.27, 95% confidence interval\u00a0= 1.16\u22124.47) and weaker medication-taking routine or habit strength was associated with unintentional non-adherence (odds ratio\u00a0= 0.92, 95% confidence interval\u00a0= 0.89\u22120.96).", {"entities": []}], ["Medication beliefs and habit strength are modifiable targets for strategies to improve adherence in psoriasis.", {"entities": [[100, 109, "DISEASE"]]}], ["Exercise training is of benefit for patients with restrictive lung disease.", {"entities": [[62, 74, "DISEASE"]]}], ["However, it tends to be intolerable for those with severe disease.", {"entities": []}], ["We examined whether providing ventilatory assistance by using negative pressure ventilators (NPV) during exercise training is feasible for such patients and the effects of training.", {"entities": []}], ["36 patients with restrictive lung disease were prospectively enrolled for a 12-week multidisciplinary rehabilitation program.", {"entities": [[29, 41, "DISEASE"]]}], ["During this program, half of them (n:18; 60.3\u2009\u00b1\u200911.6\u00a0years; 6 men; FVC: 32.5\u2009\u00b1\u200911.7% predicted ) received regular sessions of exercise training under NPV, whilst the 18 others (59.6\u2009\u00b1\u200912.3\u00a0years; 8 men; FVC: 37.7\u2009\u00b1\u200910.2% predicted) did not.", {"entities": []}], ["Exercise capacity, pulmonary function, dyspnea and quality of life were measured.", {"entities": []}], ["The primary endpoint was the between-group difference in change of 6\u00a0minute-walk distance (6MWD) after 12\u00a0weeks of rehabilitation.", {"entities": []}], ["All patients in the NPV-exercise group were able to tolerate and completed the program.", {"entities": []}], ["The between-group differences were significantly better in the NPV-exercise group in changes of 6MWD (34.1\u2009\u00b1\u200912.7\u00a0m vs. -32.5\u2009\u00b1\u200917.5\u00a0m; P \u2009=\u20090.011) and St George Score (\u221214.5\u2009\u00b1\u20093.6 vs. 11.8\u2009\u00b1\u20096.0; P\u2009<\u20090.01).", {"entities": []}], ["There was an improvement in dyspnea sensation (Borg\u2019s scale, from 1.4\u2009\u00b1\u20091.5 point to 0.8\u2009\u00b1\u20091.3 point, P \u2009=\u20090.049) and a small increase in FVC (from 0.85\u2009\u00b1\u20090.09\u00a0L to 0.91\u2009\u00b1\u20090.08\u00a0L, P \u2009=\u20090.029) in the NPV-exercise group compared to the control group.", {"entities": []}], ["Exercise training with NPV support is feasible for patients with severe restrictive lung diseases, and improves exercise capacity and health-related quality of life.", {"entities": []}], ["A pilot study of indoor air pollution produced by biomass cookstoves was conducted in 53 homes in Sri Lanka to assess respiratory conditions associated with stove type (\u201cAnagi\u201d or \u201cTraditional\u201d), kitchen characteristics (e.g., presence of a chimney in the home, indoor cooking area), and concentrations of personal and indoor particulate matter less than 2.5 micrometers in diameter (PM 2.5 ).", {"entities": []}], ["Each primary cook reported respiratory conditions for herself (cough, phlegm, wheeze, or asthma) and for children (wheeze or asthma) living in her household.", {"entities": [[89, 95, "DISEASE"], [125, 131, "DISEASE"]]}], ["For cooks, the presence of at least one respiratory condition was significantly associated with 48-h log-transformed mean personal PM 2.5 concentration (PR = 1.35; p < 0.001).", {"entities": []}], ["The prevalence ratio (PR) was significantly elevated for cooks with one or more respiratory conditions if they cooked without a chimney (PR = 1.51, p = 0.025) and non-significantly elevated if they cooked in a separate but poorly ventilated building (PR = 1.51, p = 0.093).", {"entities": []}], ["The PRs were significantly elevated for children with wheeze or asthma if a traditional stove was used (PR = 2.08, p = 0.014) or if the cooking area was not partitioned from the rest of the home (PR = 2.46, p = 0.012).", {"entities": [[64, 70, "DISEASE"]]}], ["For the 13 children for whom the cooking area was not partitioned from the rest of the home, having a respiratory condition was significantly associated with log-transformed indoor PM 2.5 concentration (PR = 1.51; p = 0.014).", {"entities": []}], ["Background .", {"entities": []}], ["A positive association between genetic polymorphism and asthma may not be extrapolated from one ethnic group to another based on intra- and interethnic allelic and genotype frequencies differences.", {"entities": [[56, 62, "DISEASE"]]}], ["Objective .", {"entities": []}], ["We assessed whether polymorphisms of GST genes ( GSTM1 , GSTT1, and GSTP1 ) are associated with asthma and atopy among Tunisian children.", {"entities": [[96, 102, "DISEASE"], [49, 54, "GENE"], [57, 62, "GENE"], [68, 73, "GENE"]]}], ["112 unrelated healthy individuals and 105 asthmatic (73 atopic and 32 nonatopic) children were studied.", {"entities": []}], ["Genotyping the polymorphisms in the GSTT1 and GSTM1 genes was performed using the multiplex PCR.", {"entities": [[36, 41, "GENE"], [46, 51, "GENE"]]}], ["The GSTP1 ILe105Val polymorphism was determined using PCR-RFLP.", {"entities": [[4, 9, "GENE"]]}], ["GSTM1 null genotype was significantly associated with the increased risk of asthma ( P = .002).", {"entities": [[76, 82, "DISEASE"], [0, 5, "GENE"]]}], ["Asthmatic children had a higher prevalence of the GSTP1Ile105 allele than the control group (43.8% and 33.5%, respectively; P = .002).", {"entities": []}], ["Also, the presence of the GSTP1 homozygote Val/Val was less common in subjects with asthma than in control group.", {"entities": [[84, 90, "DISEASE"], [26, 31, "GENE"]]}], ["We have found that GSTT1 null genotype ( GSTT1 *0/*0) was significantly associated with atopy ( P = .008).", {"entities": [[19, 24, "GENE"], [41, 46, "GENE"], [19, 24, "GENE"], [41, 46, "GENE"]]}], ["Conclusion .", {"entities": []}], ["Polymorphisms within genes of the GST superfamily were associated with risk of asthma and atopy in Tunisia.", {"entities": [[79, 85, "DISEASE"]]}], ["Sometimes, protocol amendments that change the inclusion and exclusion criteria are required in clinical trials.", {"entities": []}], ["Then, the patient populations before and after the amendment may differ.", {"entities": []}], ["We propose to perform separate statistical tests for the different phases, i.e.", {"entities": []}], ["for the patients recruited before and after the amendment, and to combine the tests using Fisher's combination test.", {"entities": []}], ["After a significant combination test a multiple testing procedure can be applied to identify the phase(s) to which a proof of efficacy refers.", {"entities": []}], ["We assume that the amendment(s) are not based on any type of unblinded data.", {"entities": []}], ["The proposed method is investigated within a simulation study.", {"entities": []}], ["The proposed combination approach is superior to the 'na\u00efve' strategy to ignore the differences between the phases and pooling the data to perform just one statistical test.", {"entities": []}], ["This superiority disappears when there are hardly any differences between the two phases.", {"entities": []}], ["When one or more protocol amendments change the inclusion and exclusion criteria, one should realize that the populations may differ.", {"entities": []}], ["In this case, separate tests for the different phases together with a combination test are a powerful method that can be applied in a variety of settings.", {"entities": []}], ["The (first) amendment should specify the combination test to be applied in order to combine the different phases.", {"entities": []}], ["Narrowband ultraviolet B (NB-UVB) has been widely used in dermatological phototherapy.", {"entities": []}], ["As for the application of NB-UVB phototherapy to graft-versus-host disease (GVHD), we previously reported that it was highly efficacious for cutaneous lesions of acute GVHD (aGVHD) and that expansion of regulatory T (Treg) cells induced by NB-UVB might be one of the mechanisms.", {"entities": []}], ["In order to examine whether NB-UVB irradiation through expansion of Treg cells is effective for the treatment of not only cutaneous aGVHD but also aGVHD of inner organs such as the intestine or liver, we conducted experiments in which a murine lethal aGVHD model, characterized by severe involvement of the intestine, was irradiated with NB-UVB.", {"entities": []}], ["We found that NB-UVB irradiation improved the clinical score and survival rate.", {"entities": []}], ["The pathological score of aGVHD was improved in all affected organs: intestine, liver, and skin.", {"entities": []}], ["In the serum of mice irradiated with NB-UVB, the levels of Treg cells-associated cytokines such as transforming growth factor beta (TGF\u03b2) and interleukin-10 (IL-10) were elevated.", {"entities": []}], ["The numbers of infiltrating Treg cells in inflamed tissue of the intestine and those in spleen were increased in mice treated with NB-UVB.", {"entities": []}], ["This is the first report demonstrating that NB-UVB phototherapy has the ability to ameliorate intestinal aGVHD through the expansion of Treg cells.", {"entities": []}], ["Socheongryong-Tang (SCRT) is a natural medicine prescription that has been mainly used in East Asia for the treatment of inflammatory disorders, including asthma and allergic rhinitis.", {"entities": [[166, 183, "DISEASE"], [175, 183, "DISEASE"], [155, 161, "DISEASE"]]}], ["The present study evaluated the anti-inflammatory effects of SCRT on lipopolysaccharide (LPS)-stimulated RAW 264.7 cells and in a rat model of carrageenan (CA)-induced paw edema.", {"entities": []}], ["Levels of tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin (IL)-1\u03b2, IL-6 and prostaglandin E 2 (PGE 2 ) in the culture supernatant were quantified and nitric oxide (NO) production was monitored.", {"entities": []}], ["In addition, the effect of SCRT on the protein expression of nuclear factor-\u03baB (NF-\u03baB), mitogen-activated protein kinases (MAPKs), inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) was assessed by western blot analysis.", {"entities": []}], ["Furthermore, the effects of SCRT on acute inflammation in vivo and changes in the histomorphometry and histopathology of paw skin were observed using CA-treated rats.", {"entities": []}], ["SCRT (1 mg/ml) inhibited the LPS-induced changes in the protein expression of NF-\u03baB, JNK, ERK1/2, iNOS and COX-2, as well as the production of NO, PGE 2 and cytokines.", {"entities": []}], ["In the rat paw edema assay, administration of 1 g/kg of lyophilized powder obtained from the aqueous extracts of SCRT for 3 consecutive days inhibited the CA-induced increases in skin thickness, mast cell degranulation, and infiltration of inflammatory cells in the ventral and dorsal pedis skin within 4 h. These results demonstrated that SCRT exerts its anti-inflammatory activities in LPS-stimulated RAW 264.7 cells through decreasing the production of inflammatory mediators, including PGE 2 , NO and cytokines, via suppression of the NF-\u03baB and JNK and ERK1/2 signaling pathways.", {"entities": []}], ["In addition, the data of the CA-induced paw edema indicated an anti-edema effect of SCRT.", {"entities": []}], ["SCRT (1 g/kg) reduced acute edematous inflammation through inhibition of mast cell degranulation and infiltration of inflammatory cells.", {"entities": []}], ["Therefore, the present study provided scientific evidence for the anti-inflammatory activities of SCRT as well as the underlying mechanisms.", {"entities": []}], ["Although new molecular diagnostic tests such as GenoType MTBDR plus and Xpert\u00ae MTB/RIF have reduced multidrug-resistant tuberculosis (MDR-TB) treatment initiation times, patients\u2019 experiences of diagnosis and treatment initiation are not known.", {"entities": [[100, 132, "DISEASE"], [120, 132, "DISEASE"]]}], ["This study aimed to explore and compare MDR-TB patients\u2019 experiences of their diagnostic and treatment initiation pathway in GenoType MTBDR plus and Xpert\u00ae MTB/RIF-based diagnostic algorithms.", {"entities": []}], ["The study was undertaken in Cape Town, South Africa where primary health-care services provided free TB diagnosis and treatment.", {"entities": []}], ["A smear, culture and GenoType MTBDR plus diagnostic algorithm was used in 2010, with Xpert\u00ae MTB/RIF phased in from 2011\u20132013.", {"entities": []}], ["Participants diagnosed in each algorithm at four facilities were purposively sampled, stratifying by age, gender and MDR-TB risk profiles.", {"entities": []}], ["We conducted in-depth qualitative interviews using a semi-structured interview guide.", {"entities": []}], ["Through constant comparative analysis we induced common and divergent themes related to symptom recognition, health-care access, testing for MDR-TB and treatment initiation within and between groups.", {"entities": []}], ["Data were triangulated with clinical information and health visit data from a structured questionnaire.", {"entities": []}], ["We identified both enablers and barriers to early MDR-TB diagnosis and treatment.", {"entities": []}], ["Half the patients had previously been treated for TB; most recognised recurring symptoms and reported early health-seeking.", {"entities": []}], ["Those who attributed symptoms to other causes delayed health-seeking.", {"entities": []}], ["Perceptions of poor public sector services were prevalent and may have contributed both to deferred health-seeking and to patient\u2019s use of the private sector, contributing to delays.", {"entities": []}], ["However, once on treatment, most patients expressed satisfaction with public sector care.", {"entities": []}], ["Two patients in the Xpert\u00ae MTB/RIF-based algorithm exemplified its potential to reduce delays, commencing MDR-TB treatment within a week of their first health contact.", {"entities": []}], ["However, most patients in both algorithms experienced substantial delays.", {"entities": []}], ["Avoidable health system delays resulted from providers not testing for TB at initial health contact, non-adherence to testing algorithms, results not being available and failure to promptly recall patients with positive results.", {"entities": []}], ["Whilst the introduction of rapid tests such as Xpert\u00ae MTB/RIF can expedite MDR-TB diagnosis and treatment initiation, the full benefits are unlikely to be realised without reducing delays in health-seeking and addressing the structural barriers present in the health-care system.", {"entities": []}], ["To determine the socioeconomic impact of long-term glaucoma therapy.", {"entities": [[51, 59, "DISEASE"]]}], ["One hundred and fifty consecutive glaucoma patients on medical therapy, following up at our glaucoma service for at least 6 months were recruited.", {"entities": [[34, 42, "DISEASE"], [92, 100, "DISEASE"]]}], ["A questionnaire regarding monthly income, cost of glaucoma medications prescribed, availability of medications, travel time, time spent in review clinics, compliance, education status, medical insurance and systemic or local side-effects was administered.", {"entities": [[50, 58, "DISEASE"]]}], ["The patients seen at the tertiary government hospital had an average monthly income of Rs.", {"entities": []}], ["10,912/- (range: Rs.", {"entities": []}], ["500/- to Rs.", {"entities": []}], ["50,000/-) with approximately 56% of the patients having an income of less than Rs.", {"entities": []}], ["5000/month.", {"entities": []}], ["The expenditure on anti-glaucoma medications ranged from 0.3% in high income group to 123% of their monthly gross income in low income group ( P < 0.0001).", {"entities": [[24, 32, "DISEASE"]]}], ["The total expenditure including travel, stay, and loss of wages of patients and accompanying persons ranged from 1.6% in high income group to 137% of the monthly income in low income group ( P < 0.0001).", {"entities": []}], ["Mean time required for a glaucoma clinic visit was 15.66 h, (range: 6\u201396 h/month).", {"entities": [[25, 33, "DISEASE"]]}], ["About 2.7% experienced systemic side-effects and 21.3% had complaints of ocular adverse effects.", {"entities": []}], ["About 90% of the patients were compliant.", {"entities": []}], ["92% were not covered by any insurance plan/government reimbursement for their treatment.", {"entities": []}], ["Medical therapy for glaucoma is an economic burden to many patients and should be individualized, according to the socioeconomic status, availability of drugs and the required distance to travel to reach the specialist clinics.", {"entities": [[20, 28, "DISEASE"]]}], ["The paper offers a review and commentary, with particular reference to the production of fish from wild capture fisheries and aquaculture, on neglected aspects of health impact assessments which are viewed by a range of international and national health bodies and development agencies as valuable and necessary project tools.", {"entities": []}], ["Assessments sometimes include environmental health impact assessments but rarely include specific occupational health and safety impact assessments especially integrated into a wider public health assessment.", {"entities": []}], ["This is in contrast to the extensive application of environmental impact assessments to fishing and the comparatively large body of research now generated on the public health effects of eating fish.", {"entities": []}], ["The value of expanding and applying the broader assessments would be considerable because in 2004 the United Nations Food and Agriculture Organization reports there were 41,408,000 people in the total \u2018fishing\u2019 sector including 11,289,000 in aquaculture.", {"entities": []}], ["The paper explores some of the complex interactions that occur with regard to fishing activities and proposes the wider adoption of health impact assessment tools in these neglected sectors through an integrated public health impact assessment tool.", {"entities": []}], ["Sirt1, a key regulator of metabolism and longevity, has recently been implicated in the regulation of allergic reactions, although the underlying mechanism remains unclear.", {"entities": [[0, 5, "GENE"]]}], ["Here we show that Sirt1 negatively regulates Fc\u03b5RI-stimulated mast cell activation and anaphylaxis through two mutually regulated pathways involving AMP-activated protein kinase (AMPK) and protein tyrosine phosphatase 1B (PTP1B).", {"entities": [[18, 23, "GENE"]]}], ["Mast cell-specific knockout of Sirt1 dampened AMPK-dependent suppression of Fc\u03b5RI signaling, thereby augmenting mast cell activation both in vitro and in vivo .", {"entities": [[31, 36, "GENE"]]}], ["Sirt1 inhibition of Fc\u03b5RI signaling also involved an alternative component, PTP1B, which attenuated the inhibitory AMPK pathway and conversely enhanced the stimulatory Syk pathway, uncovering a novel role of this phosphatase.", {"entities": [[0, 5, "GENE"], [168, 171, "GENE"]]}], ["Moreover, a Sirt1 activator resveratrol stimulated the inhibitory AMPK axis, with reciprocal suppression of the stimulatory PTP1B/Syk axis, thus potently inhibiting anaphylaxis.", {"entities": [[12, 17, "GENE"]]}], ["Overall, our results provide a molecular explanation for the beneficial role of Sirt1 in allergy and underscore a potential application of Sirt1 activators as a new class of anti-allergic agents.", {"entities": [[80, 85, "GENE"], [139, 144, "GENE"], [80, 85, "GENE"], [139, 144, "GENE"]]}], ["This article provides new insights into the impact of social engagement on CVD risk factors in older adults.", {"entities": []}], ["We hypothesized that objective (social participation, social ties and marital status) and subjective (emotional support) aspects of social engagement are independently associated with objective measures of cardiovascular risk.", {"entities": []}], ["Data from the English Longitudinal Study on Ageing (ELSA) were analyzed.", {"entities": []}], ["The effects of social participation, social ties, marital status, and emotional support on hypertension, obesity, high sensitivity C-reactive protein, and fibrinogen were estimated by logistic regression controlling for age, sex, education, physical function, depression, cardiovascular disease, other chronic diseases, physical activity, and smoking.", {"entities": [[91, 103, "DISEASE"], [105, 112, "DISEASE"]]}], ["Social participation is a consistent predictor of low risk for four risk factors, even after controlling for a wide range of covariates.", {"entities": []}], ["Being married is associated with lower risk for hypertension.", {"entities": [[48, 60, "DISEASE"]]}], ["Social ties and emotional support are not significantly associated with any of the cardiovascular risk factors.", {"entities": []}], ["Our analysis suggests that participation in social activities has a stronger association with CV risk factors than marital status, social ties or emotional support.", {"entities": []}], ["Different forms of social engagement may therefore have different implications for the biological risk factors involved.", {"entities": []}], ["To improve adherence to physical activity (PA), behavioural support in the form of behavioural change counselling may be necessary.", {"entities": []}], ["However, limited evidence of the effectiveness of home-based PA combined with counselling in breast cancer patients exists.", {"entities": [[93, 106, "DISEASE"], [100, 106, "DISEASE"]]}], ["The aim of this current randomised controlled trial with a parallel group design was to evaluate the effectiveness of a home-based PA intervention on PA levels, anthropometric measures, health-related quality of life (HRQoL), and blood biomarkers in breast cancer survivors.", {"entities": [[250, 263, "DISEASE"], [257, 263, "DISEASE"]]}], ["Eighty post-adjuvant therapy invasive breast cancer patients (age\u2009=\u200953.6\u2009\u00b1\u20099.4\u00a0years; height\u2009=\u2009161.2\u2009\u00b1\u20096.8\u00a0cm; mass\u2009=\u200968.7\u2009\u00b1\u200910.5\u00a0kg) were randomly allocated to a 6-month home-based PA intervention or usual care.", {"entities": [[38, 51, "DISEASE"], [45, 51, "DISEASE"]]}], ["The intervention group received face-to-face and telephone PA counselling aimed at encouraging the achievement of current recommended PA guidelines.", {"entities": []}], ["All patients were evaluated for our primary outcome, PA (International PA Questionnaire) and secondary outcomes, mass, BMI, body fat %, HRQoL\u00a0(Functional assessment of Cancer Therapy-Breast), insulin resistance, triglycerides (TG) and total (TC), high-density lipoprotein (HDL-C) and low-density lipoprotein (LDL-C) cholesterol were assessed at baseline and at 6-months.", {"entities": [[168, 174, "DISEASE"], [227, 229, "GENE"]]}], ["On the basis of linear mixed-model analyses adjusted for baseline values performed on 40 patients in each group, total, leisure and vigorous PA significantly increased from baseline to post-intervention in the intervention compared to usual care (between-group differences, 578.5 MET-min\u2219wk p \u2009=\u2009.024, 382.2 MET-min\u2219wk p \u2009=\u2009.010, and 264.1 MET-min\u2219wk p \u2009=\u2009.007, respectively).", {"entities": []}], ["Both body mass and BMI decreased significantly in the intervention compared to usual care (between-group differences, \u22121.6\u00a0kg, p \u2009=\u2009.040, and \u2212.6\u00a0kg/m p \u2009=\u2009.020, respectively).", {"entities": []}], ["Of the HRQoL variables, FACT-Breast, Trial Outcome Index, functional wellbeing, and breast cancer subscale improved significantly in the PA group compared to the usual care group (between-group differences, 5.1, p\u2009= \u2009.024; 5.6, p \u2009=\u2009.001; 1.9 p \u2009=\u2009.025; and 2.8, p\u2009= \u2009.007, respectively).", {"entities": [[84, 97, "DISEASE"], [91, 97, "DISEASE"]]}], ["Finally, TC and LDL-C was significantly reduced in the PA group compared to the usual care group (between-group differences, \u2212.38\u00a0mmol\u2219L p\u2009= \u2009.001; and \u2212.3\u00a0mmol\u2219L p\u2009= \u2009.023, respectively).", {"entities": []}], ["We found that home-based PA resulted in significant albeit small to moderate improvements in self-reported PA, mass, BMI, breast cancer specific HRQoL, and TC and LDL-C compared with usual care.", {"entities": [[122, 135, "DISEASE"], [129, 135, "DISEASE"]]}], ["NCT02408107 (March 25, 2015)", {"entities": []}], ["Little research has investigated the role of migration as a potential contributor to the spatial concentration of homeless people with complex health and social needs.", {"entities": []}], ["In addition, little is known concerning the relationship between possible migration and changes in levels of service use over time.", {"entities": []}], ["We hypothesised that homeless, mentally ill individuals living in a concentrated urban setting had migrated from elsewhere over a 10-year period, in association with significant increases in the use of public services.", {"entities": []}], ["Recruitment was concentrated in the Downtown Eastside neighbourhood of Vancouver, Canada.", {"entities": []}], ["Participants (n=433) met criteria for chronic homelessness and serious mental illness, and provided consent to access administrative data.", {"entities": []}], ["Linked administrative data were used to retrospectively examine geographic relocation as well as rates of health, justice, and social welfare service utilisation in each of the 10\u2005years prior to recruitment.", {"entities": []}], ["Generalised estimating equations were used to estimate the effect of migration on service use.", {"entities": []}], ["Over a 10-year period there was significant movement into Vancouver's Downtown Eastside neighbourhood (from 17% to 52% of the cohort).", {"entities": []}], ["During the same period, there were significant annual increases in community medical services (adjusted rate ratio (ARR) per year=1.08; 95% CI 1.06 to 1.10), hospital admissions (ARR=1.08; 95% CI 1.04 to 1.11), criminal convictions (ARR=1.08; 95% CI 1.03 to 1.13), and financial assistance payments (ARR=1.04; 95% CI 1.03 to 1.06).", {"entities": []}], ["Migration was significantly associated with financial assistance, but not with other types of services.", {"entities": []}], ["Significant increases in service use over a 10-year period coincided with significant migration into an urban area where relevant services were concentrated.", {"entities": []}], ["These results highlight opportunities for early intervention in spatially diverse neighbourhoods to interrupt trajectories marked by worsening health and extremely high service involvement.", {"entities": []}], ["Further research is urgently needed to investigate the causal relationships between physical migration, health and social welfare, and escalating use of public services.", {"entities": []}], ["ISRCTN57595077 and ISRCTN66721740; Post-results.", {"entities": []}], ["Pneumonia poses a significant burden to the U.S. health-care system.", {"entities": [[0, 9, "DISEASE"]]}], ["However, there are few data focusing on severe pneumonia, particularly cases of pneumonia associated with specialized care in intensive care units (ICU).", {"entities": [[47, 56, "DISEASE"], [80, 89, "DISEASE"]]}], ["We used administrative and electronic medical record data from six integrated health care systems to estimate rates of pneumonia hospitalizations with ICU admissions among adults during 2006 through 2010.", {"entities": [[119, 128, "DISEASE"]]}], ["Pneumonia hospitalization was defined as either a primary discharge diagnosis of pneumonia or a primary discharge diagnosis of sepsis or respiratory failure with a secondary diagnosis of pneumonia in administrative data.", {"entities": [[137, 156, "DISEASE"], [0, 9, "DISEASE"], [81, 90, "DISEASE"], [187, 196, "DISEASE"]]}], ["ICU admissions were collected from internal electronic medical records from each system.", {"entities": []}], ["Comorbidities were identified by ICD-9-CM codes coded during the current pneumonia hospitalization, as well as during medical visits that occurred during the year prior to the date of admission.", {"entities": [[73, 82, "DISEASE"]]}], ["We identified 119,537 adult hospitalizations meeting our definition for pneumonia.", {"entities": [[72, 81, "DISEASE"]]}], ["Approximately 19% of adult pneumonia hospitalizations had an ICU admission.", {"entities": [[27, 36, "DISEASE"]]}], ["The rate of pneumonia hospitalizations requiring ICU admission during the study period was 76 per 100,000 population/year; rates increased for each age-group with the highest rates among adults aged \u226585\u00a0years.", {"entities": [[12, 21, "DISEASE"]]}], ["Having a co-morbidity approximately doubled the risk of ICU admission in all age-groups.", {"entities": []}], ["Our study indicates a significant burden of pneumonia hospitalizations with an ICU admission among adults in our cohort during 2006 through 2010, especially older age-groups and persons with underlying medical conditions.", {"entities": [[44, 53, "DISEASE"]]}], ["These findings reinforce current strategies aimed to prevent pneumonia among adults.", {"entities": [[61, 70, "DISEASE"]]}], ["The online version of this article (10.1186/s12890-017-0552-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We employed a population-based cohort sample to explore the risk of coronary heart disease (CHD) in relation to osteoporosis in an Asian population.", {"entities": [[77, 90, "DISEASE"], [68, 90, "DISEASE"], [112, 124, "DISEASE"]]}], ["We designed a retrospective population-based cohort study from 2000 to 2010 with data obtained from Taiwan's Longitudinal Health Insurance Database.", {"entities": []}], ["A total of 19,456 patients aged 45 years or older who had no history of CHD and had a diagnosis of osteoporosis were identified as the osteoporosis cohort.", {"entities": [[99, 111, "DISEASE"], [135, 147, "DISEASE"]]}], ["The patients in the comparison cohort were randomly selected and frequency matched according to age, sex, and year of index date at a 1:1 ratio.", {"entities": []}], ["Both cohorts were followed from the index date until a new diagnosis of CHD was made.", {"entities": []}], ["Baseline variables, comorbidities, and bisphosphonate and estrogen prescriptions were collected.", {"entities": []}], ["The overall incidence of CHD was 23.5 (per 1000 person-years) for the osteoporosis cohort and 16.7 for the comparison cohort, with a mean follow-up of 6.54 years and 6.63 years, respectively.", {"entities": [[70, 82, "DISEASE"]]}], ["The hazard ratio (HR) for developing CHD during follow-up was 1.30 (95% confidence interval [CI], 1.23\u20131.38) for the osteoporosis cohort compared with the comparison cohort after adjusting for age, sex, comorbidities, and estrogen medication.", {"entities": [[117, 129, "DISEASE"], [18, 20, "GENE"]]}], ["Patients with osteoporosis who received treatment with bisphosphonates or with both bisphosphonates and estrogen exhibited a significantly lower risk for CHD (adjusted HR\u200a=\u200a0.37 and 0.23) than those who did not receive either of these 2 medications.", {"entities": [[14, 26, "DISEASE"], [168, 170, "GENE"]]}], ["The results support an association between osteoporosis and CHD in Asian population.", {"entities": [[43, 55, "DISEASE"]]}], ["We sequenced RNA transcripts from the testicles of healthy male mice, divided into a control group with distilled water and two experimental groups with 50 and 100\u2009mg/l NaF in drinking water for 56 days.", {"entities": []}], ["Bowtie/Tophat were used to align 50-bp paired-end reads into transcripts, Cufflinks to measure the relative abundance of each transcript and IPA to analyze RNA-Sequencing data.", {"entities": []}], ["In the 100\u2009mg/l NaF-treated group, four pathways related to IL-17, TGF-\u03b2 and other cellular growth factor pathways were overexpressed.", {"entities": []}], ["The mRNA expression of IL-17RA , IL-17RC , MAP2K1 , MAP2K2 , MAP2K3 and MAPKAPK2 , monitored by qRT-PCR, increased remarkably in the 100\u2009mg/L NaF group and coincided with the result of RNA-Sequencing.", {"entities": [[43, 49, "GENE"], [52, 58, "GENE"], [61, 67, "GENE"], [72, 80, "GENE"]]}], ["Fluoride exposure could disrupt spermatogenesis and testicles in male mice by influencing many signaling pathways and genes, which work on the immune signal transduction and cellular metabolism.", {"entities": []}], ["The high expression of the IL-17 signal pathway was a response to the invasion of the testicular immune system due to extracellular fluoride.", {"entities": []}], ["The PI3-kinase/AKT, MAPKs and the cytokines in TGF-\u03b2 family were contributed to control the IL-17 pathway activation and maintain the immune privilege and spermatogenesis.", {"entities": []}], ["All the findings provided new ideas for further molecular researches of fluorosis on the reproduction and immune response mechanism.", {"entities": []}], ["Mitochondrial glucocorticoid (mtGR) and estrogen (mtER) receptors participate in the coordination of the cell\u2019s energy requirement and in the mitochondrial oxidative phosphorylation enzyme (OXPHOS) biosynthesis, affecting reactive oxygen species (ROS) generation and induction of apoptosis.", {"entities": []}], ["Although activation of mtGR and mtER is known to trigger anti-inflammatory signals, little information exists on the presence of these receptors in lung tissue and their role in respiratory physiology and disease.", {"entities": []}], ["Using a mouse model of allergic airway inflammation disease and applying confocal microscopy, subcellular fractionation, and Western blot analysis we showed mitochondrial localization of GR\u03b1 and ER\u03b2 in lung tissue.", {"entities": []}], ["Allergic airway inflammation caused reduction in mtGR\u03b1, mtER\u03b2, and OXPHOS enzyme biosynthesis in lung cells mitochondria and particularly in bronchial epithelial cells mitochondria, which was accompanied by decrease in lung mitochondrial mass and induction of apoptosis.", {"entities": []}], ["Confirmation and validation of the reduction of the mitochondrial receptors in lung epithelial cells in human asthma was achieved by analyzing autopsies from fatal asthma cases.", {"entities": [[110, 116, "DISEASE"], [164, 170, "DISEASE"]]}], ["The presence of the mitochondrial GR\u03b1 and ER\u03b2 in lung tissue cells and especially their reduction in bronchial epithelial cells during allergic airway inflammation suggests a crucial role of these receptors in the regulation of mitochondrial function in asthma, implicating their involvement in the pathophysiology of the disease.", {"entities": [[254, 260, "DISEASE"]]}], ["The bark of Mimosa tenuiflora (Willd.)", {"entities": []}], ["Poiret (Leguminosae family), popularly known as \u201cjurema preta\u201d in Brazil, is used by the population of Contendas of Sincor\u00e1 (Bahia State, Brazil) for the treatment of coughs and wound healing.", {"entities": []}], ["Thus, the aim of this study was to evaluate the antinociceptive and anti-inflammatory activities of the bark ethanol extract (EEMT) and solvent soluble fractions (hexane\u2014H, DCM\u2014D, EtOAc\u2014E and BuOH\u2014B) of the extract in vivo .", {"entities": []}], ["Additionally, we synthesized 5,7-dihidroxy-4\u2019-methoxyflavanone (isosakuranetin) and isolated the compound sakuranetin, and both compounds were also tested.", {"entities": []}], ["The anti-inflammatory and antinociceptive assays performed were: writhing test; nociception induced by intraplantar formalin injection; leukocyte recruitment to the peritoneal cavity; evaluation of vascular permeability (Evans blue test); and evaluation of mechanical hypernociception (von Frey test).", {"entities": []}], ["Production of TNF-\u03b1, IL-10, myeloperoxidase and the expression of ICAM-1 were also evaluated.", {"entities": []}], ["Statistical analysis was performed by one-way ANOVA followed by the Bonferroni post-test (n = 8), with P < 0.05.", {"entities": []}], ["The EEMT showed antinociceptive activities in writhing test (100\u2013200 mg/kg), in the second phase of the formalin test (50\u2013200 mg/kg), and in mechanical hypernociception (100 mg/kg).", {"entities": []}], ["EEMT showed an anti-inflammatory effect by reducing neutrophil migration to the peritoneal cavity and in the plantar tissue detected by the reduction of myeloperoxidase activity (100 mg/kg), reduction of IL-10 levels and expression of ICAM-1 in the peritoneal exudate and the mesentery (100 mg/kg), respectively.", {"entities": []}], ["The four soluble EEMT fractions showed good results in tests for antinociceptive (H, D, E, B) and anti-inflammation (H, D, E).", {"entities": []}], ["Only sakuranetin showed reduction of the writhing and neutrophil migration (200 mg/kg).", {"entities": []}], ["Thus, the EEMT and soluble fractions of M .", {"entities": []}], ["tenuiflora bark demonstrated great antinociceptive and anti-inflammatory activities, as also sakuranetin.", {"entities": []}], ["More studies should be conducted to elucidate the mechanism of action of this compound.", {"entities": []}], ["To the best of our knowledge, this is the first report on the antinociceptive activity of the M .", {"entities": []}], ["tenuiflora fractions and the bioactive isolated compound sakuranetin in vivo .", {"entities": []}], ["Crohn\u2019s disease (CD) and ulcerative colitis (UC) have different immunological mechanisms, while both of them are potential targets of vitamin D treatment.", {"entities": [[25, 43, "DISEASE"]]}], ["In this study, we have tried to address the role of vitamin D in CD and UC using two mouse models.", {"entities": []}], ["Mice of C57B6L were given vitamin D before the induction of colitis.", {"entities": []}], ["Our results showed that vitamin D attenuated 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis.", {"entities": []}], ["Vitamin D could preserve the local histology, alleviate inflammation, suppress apoptosis, maintain tight junction function and decrease permeability.", {"entities": []}], ["Interestingly, it has more of an effect on local structure preservation and inflammation inhibition in CD than in UC mice.", {"entities": []}], ["Vitamin D blocked the increase of helper T-cell type 1 (Th1)- and helper T-cell type 17 (Th17)-related cytokines in TNBS-induced colitis.", {"entities": []}], ["But the increase of helper T-cell type 2 (Th2)- and regulatory T cells (Treg)-related cytokines was augmented at the same time in oxazolone-induced colitis which counteracted each other.", {"entities": []}], ["Our study helps elucidate the differential protective effects of vitamin D on CD and UC patients, as reported in literature.", {"entities": []}], ["The complement system is crucial for the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).", {"entities": [[110, 120, "DISEASE"]]}], ["In particular, C5a plays a central role.", {"entities": []}], ["In this study, plasma and urinary levels of C5a as well as renal C5a receptors (CD88 and C5L2) expression were investigated in patients with AAV.", {"entities": []}], ["Twenty-four patients with AAV in the active phase, 19 patients with AAV in the remission phase, and 20 patients with lupus nephritis (LN) were included.", {"entities": [[123, 132, "DISEASE"]]}], ["Plasma and urinary levels of C5a were measured with enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["The staining of CD88 and C5L2 in renal specimens was detected with immunohistochemistry.", {"entities": []}], ["The level of plasma C5a was significantly higher in patients with AAV in the active phase than that in patients in remission, that in patients with LN, and that in normal controls.", {"entities": []}], ["The urinary C5a level was significantly higher in patients with AAV in the active phase than that in patients in remission and that in normal controls, but not significantly different between patients with active AAV and patients with LN.", {"entities": []}], ["The mean optical density of CD88 staining in the tubulointerstitium was significantly lower in AAV patients than that in normal controls (0.0052 \u00b1 0.0011 versus 0.029 \u00b1 0.0042; P = 0.005).", {"entities": []}], ["The mean optical density of C5L2 in glomeruli was significantly higher in AAV patients than that in normal controls (0.013 \u00b1 0.0027 versus 0.0032 \u00b1 0.0006; P < 0.001).", {"entities": []}], ["The mean optical density of CD88 staining closely correlated with the initial eGFR ( r = 0.835; P < 0.001) in AAV patients.", {"entities": [[78, 82, "GENE"]]}], ["Double-labeling immunofluorescence assay suggested that CD88 did not express on neutrophils, monocytes, or macrophages, but C5L2 expressed on neutrophils (or monocytes) and macrophages.", {"entities": []}], ["The elevated plasma and urinary C5a levels indicated complement activation in human AAV.", {"entities": []}], ["The level of renal CD88 expression could reflect the disease severity of ANCA-associated glomerulonephritis.", {"entities": [[89, 107, "DISEASE"]]}], ["CD88 expression was downregulated, and C5L2 was upregulated in ANCA-associated glomerulonephritis.", {"entities": [[79, 97, "DISEASE"]]}], ["To study the clinical effect of body mass index (BMI) in the optimal time of weaning from sequential invasive-noninvasive mechanical ventilation (MV) by treating severity chronic obstructive pulmonary disease (COPD) patients.", {"entities": [[171, 208, "DISEASE"]]}], ["94 patients with severity COPD were divided into the control group (BMI<21) and the study group (BMI>21).", {"entities": []}], ["These two groups were treated by similar symptomatic therapies such as mechanical ventilation, antibacterial, antispasmodic, relieving asthma, antitussive, expectorant, correction of electrolyte imbalance and acid-base balance disorders, strengthen nutritional support, etc.", {"entities": [[135, 141, "DISEASE"]]}], ["Compared with the control group, the study group had shorter duration of invasive mechanical ventilation, non-invasive mechanical ventilation time, total mechanical ventilation time, total hospital stay (P<0.01).", {"entities": []}], ["There are significant differences between these two groups in re-intubation rate, VAP occurred in the number of case, hospital mortality rate in 28 days (P<0.05).", {"entities": []}], ["It is difficult to wean successfully from sequential mechanical ventilation for severity COPD patients (BMI<21), so BMI as one of important reference index can be used to estimate the optimal time for weaning from sequential mechanical ventilation for severity COPD patients.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a progressive, inflammatory lung disease that affects a large number of patients and has significant impact.", {"entities": [[76, 88, "DISEASE"]]}], ["One hallmark of the disease is the presence of bacteria in the lower airways.", {"entities": []}], ["Objective: The aim of this study was to analyze the detailed structure of microbial communities found in the lungs of healthy individuals and patients with COPD.", {"entities": []}], ["Nine COPD patients as compared and 9 healthy individuals underwent flexible bronchoscopy and BAL was performed.", {"entities": []}], ["Bacterial nucleic acids were subjected to terminal restriction fragment (TRF) length polymorphism and clone library analysis.", {"entities": []}], ["Overall, we identified 326 T-RFLP band, 159 in patients and 167 in healthy controls.", {"entities": []}], ["The results of the TRF analysis correlated partly with the data obtained from clone sequencing.", {"entities": []}], ["Although the results of the sequencing showed high diversity, the genera Prevotella , Sphingomonas , Pseudomonas , Acinetobacter , Fusobacterium , Megasphaera , Veillonella , Staphylococcus , and Streptococcus constituted the major part of the core microbiome found in both groups.", {"entities": []}], ["A TRF band possibly representing Pseudomonas sp.", {"entities": []}], ["monoinfection was associated with a reduction of the microbial diversity.", {"entities": []}], ["Non-cultural methods reveal the complexity of the pulmonary microbiome in healthy individuals and in patients with COPD.", {"entities": []}], ["Alterations of the microbiome in pulmonary diseases are correlated with disease.", {"entities": []}], ["The t oll-like receptor (TLR)4-interleukin1\u03b2 (IL1\u03b2) signaling pathway is involved in the monosodium urate (MSU)-mediated inflammation.", {"entities": []}], ["The aim of this present study was to determine whether the TLR4 gene rs2149356 SNP is associated with gouty arthritis (GA) susceptibility and whether rs2149356 SNP impacts the TLR4-IL1\u03b2 signaling pathway molecules expression.", {"entities": [[108, 117, "DISEASE"], [59, 63, "GENE"], [176, 180, "GENE"]]}], ["The rs2149356 SNP was detected in 459 GA patients and 669 control subjects (containing 459 healthy and 210 hyperuricemic subjects).", {"entities": []}], ["Peripheral blood mononuclear cells (PBMCs) TLR4 mRNA and serum IL1\u03b2 were measured in different genotype carriers, and correlations between TLR4 gene SNP and TLR4 mRNA, IL1\u03b2 were investigated.", {"entities": [[43, 47, "GENE"], [139, 143, "GENE"], [157, 161, "GENE"], [43, 47, "GENE"], [139, 143, "GENE"], [157, 161, "GENE"], [43, 47, "GENE"], [139, 143, "GENE"], [157, 161, "GENE"]]}], ["The frequencies of the genotype and allele were significantly different between the GA and control groups ( P <0.01, respectively).", {"entities": []}], ["The TT genotype was associated with a significantly increased risk of GA (OR\u200a=\u200a1.88); this finding was not influenced by making adjustments for the components of possible confounders (adjusted OR\u200a=\u200a1.96).", {"entities": []}], ["TLR4 mRNA and IL1\u03b2 were significantly increased in the TT genotype from acute GA patients ( P <0.05, respectively), and lipids were significantly different among three genotypes in the GA patients ( P <0.05, respectively).", {"entities": [[0, 4, "GENE"]]}], ["The TLR4 gene rs2149356 SNP might be associated with GA susceptibility, and might participate in regulating immune, inflammation and lipid metabolism.", {"entities": [[4, 8, "GENE"]]}], ["Further studies are required to confirm these findings.", {"entities": []}], ["Staphylococcus aureus is the number one cause of hospital-acquired infections.", {"entities": []}], ["Understanding host pathogen interactions is paramount to the development of more effective treatment and prevention strategies.", {"entities": []}], ["Therefore, whole exome sequence and chip-based genotype data were used to conduct rare variant and genome-wide association analyses in a Mexican-American cohort from Starr County, Texas to identify genes and variants associated with S .", {"entities": []}], ["aureus nasal carriage.", {"entities": []}], ["Unlike most studies of S .", {"entities": []}], ["aureus that are based on hospitalized populations, this study used a representative community sample.", {"entities": []}], ["Two nasal swabs were collected from participants (n = 858) 11\u201317 days apart between October 2009 and December 2013, screened for the presence of S .", {"entities": []}], ["aureus , and then classified as either persistent, intermittent, or non-carriers.", {"entities": []}], ["The chip-based and exome sequence-based single variant association analyses identified 1 genome-wide significant region ( KAT2B ) for intermittent and 11 regions suggestively associated with persistent or intermittent S .", {"entities": [[122, 127, "GENE"]]}], ["aureus carriage.", {"entities": []}], ["We also report top findings from gene-based burden analyses of rare functional variation.", {"entities": []}], ["Notably, we observed marked differences between signals associated with persistent and intermittent carriage.", {"entities": []}], ["In single variant analyses of persistent carriage, 7 of 9 genes in suggestively associated regions and all 5 top gene-based findings are associated with cell growth or tight junction integrity or are structural constituents of the cytoskeleton, suggesting that variation in genes associated with persistent carriage impact cellular integrity and morphology.", {"entities": []}], ["Growth references are useful in monitoring a child's growth, which is an essential part of child care.", {"entities": []}], ["The aim of this paper was to provide updated growth references for Polish school-aged children and adolescents and show the prevalence of overweight and obesity among them.", {"entities": [[153, 160, "DISEASE"]]}], ["Growth references for height, weight, and body mass index (BMI) were constructed with the lambda, mu, sigma (LMS) method using data from a recent, large, population-representative sample of school-aged children and adolescents in Poland ( n \u2009=\u200917,573).", {"entities": []}], ["The prevalence of overweight and obesity according to the International Obesity Taskforce definition was determined with the use of LMSGrowth software.", {"entities": [[33, 40, "DISEASE"], [72, 79, "DISEASE"]]}], ["Updated growth references for Polish school-aged children and adolescents were compared with Polish growth references from the 1980s, the Warsaw 1996\u20131999 reference, German, and 2000 CDC references.", {"entities": []}], ["A positive secular trend in height was observed in children and adolescents from 7 to 15\u00a0years of age.", {"entities": []}], ["A significant shift of the upper tail of the BMI distribution occurred, especially in Polish boys at younger ages.", {"entities": []}], ["The prevalence of overweight or obesity was 18.7% and 14.1% in school-aged boys and girls, respectively.", {"entities": [[32, 39, "DISEASE"]]}], ["The presented height, weight, and BMI references are based on a current, nationally representative sample of Polish children and adolescents without known disorders affecting growth.", {"entities": []}], ["Changes in the body size of children and adolescents over the last three decades suggest an influence of the changing economical situation on anthropometric indices.", {"entities": []}], ["Personal smoking is widely regarded to be the primary cause of chronic bronchitis (CB) in adults, but with limited knowledge of contributions by other factors, including current asthma.", {"entities": [[178, 184, "DISEASE"], [71, 81, "DISEASE"]]}], ["We aimed to estimate the independent and relative contributions to adult CB from other potential influences spanning childhood to middle age.", {"entities": []}], ["The population-based Tasmanian Longitudinal Health Study cohort, people born in 1961, completed respiratory questionnaires and spirometry in 1968 (n=8,583).", {"entities": []}], ["Thirty-seven years later, in 2004, two-thirds responded to a detailed postal survey (n=5,729), from which the presence of CB was established in middle age.", {"entities": []}], ["A subsample (n=1,389) underwent postbronchodilator spirometry between 2006 and 2008 for the assessment of chronic airflow limitation, from which nonobstructive and obstructive CB were defined.", {"entities": []}], ["Multivariable and multinomial logistic regression models were used to estimate relevant associations.", {"entities": []}], ["The prevalence of CB in middle age was 6.1% (95% confidence interval [CI]: 5.5, 6.8).", {"entities": []}], ["Current asthma and/or wheezy breathing in middle age was independently associated with adult CB (odds ratio [OR]: 6.2 [95% CI: 4.6, 8.4]), and this estimate was significantly higher than for current smokers of at least 20 pack-years (OR: 3.0 [95% CI: 2.1, 4.3]).", {"entities": [[8, 14, "DISEASE"]]}], ["Current asthma and smoking in middle age were similarly associated with obstructive CB, in contrast to the association between allergy and nonobstructive CB.", {"entities": [[8, 14, "DISEASE"]]}], ["Childhood predictors included allergic history (OR: 1.3 [95% CI: 1.1, 1.7]), current asthma (OR: 1.8 [95% CI: 1.3, 2.7]), \u201cepisodic\u201d childhood asthma (OR: 2.3 [95% CI: 1.4, 3.9]), and parental bronchitis symptoms (OR: 2.5 [95% CI: 1.6, 4.1]).", {"entities": [[85, 91, "DISEASE"], [143, 149, "DISEASE"], [193, 203, "DISEASE"]]}], ["The strong independent association between current asthma and CB in middle age suggests that this condition may be even more influential than personal smoking in a general population.", {"entities": [[51, 57, "DISEASE"]]}], ["The independent associations of childhood allergy and asthma, though not childhood bronchitis, as clinical predictors of adult CB raise the possibility of some of this burden having originated in childhood.", {"entities": [[54, 60, "DISEASE"], [83, 93, "DISEASE"]]}], ["The rising prevalence of chronic conditions constitutes a major burden for patients and healthcare systems and is predicted to increase in the upcoming decades.", {"entities": []}], ["Improving the self-management skills of patients is a strategy to steer against this burden.", {"entities": []}], ["This could lead to better outcomes and lower healthcare costs.", {"entities": []}], ["Health coaching is one method for enhancing the self-management of patients and can be delivered by phone.", {"entities": []}], ["The effects of telephone-based health coaching are promising, but still inconclusive.", {"entities": []}], ["Economic evaluations and studies examining the transferability of effects to different healthcare systems are still rare.", {"entities": []}], ["Aim of this study is to evaluate telephone-based health coaching for chronically ill patients in Germany.", {"entities": []}], ["The study is a prospective randomized controlled trial comparing the effects of telephone-based health coaching with usual care during a 4-year time period.", {"entities": []}], ["Data are collected at baseline and after 12, 24 and 36 months.", {"entities": []}], ["Patients are selected based on one of the following chronic conditions: diabetes, coronary artery disease, asthma, hypertension, heart failure, COPD, chronic depression or schizophrenia.", {"entities": [[115, 127, "DISEASE"], [172, 185, "DISEASE"], [107, 113, "DISEASE"]]}], ["The health coaching intervention is carried out by trained nurses employed by a German statutory health insurance.", {"entities": []}], ["The frequency and the topics of the health coaching are manual-based but tailored to the patients\u2019 needs and medical condition, following the concepts of motivational interviewing, shared decision-making and evidence-based-medicine.", {"entities": []}], ["Approximately 12,000 insurants will be enrolled and randomized into intervention and control groups.", {"entities": []}], ["Primary outcome is the time until hospital readmission within two years after enrolling in the health coaching, assessed by routine data.", {"entities": []}], ["Secondary outcomes are patient-reported outcomes like changes in quality of life, depression and anxiety and clinical values assessed with questionnaires.", {"entities": []}], ["Additional secondary outcomes are further economic evaluations like health service use as well as costs and hospital readmission rates.", {"entities": []}], ["The statistical analyses includes intention-to-treat and as-treated principles.", {"entities": []}], ["The recruitment will be completed in September 2014.", {"entities": []}], ["This study will provide evidence regarding economic and clinical effects of telephone-delivered health coaching.", {"entities": []}], ["Additionally, this study will show whether health coaching is an adequate option for the German healthcare system to address the growing burden of chronic diseases.", {"entities": []}], ["German Clinical Trials Register (Deutsches Register Klinischer Studien; DRKS) DRKS00000584 .", {"entities": []}], ["A number of paramyxoviruses are responsible for acute respiratory infections in children, elderly and immuno-compromised individuals, resulting in airway inflammation and exacerbation of chronic diseases like asthma.", {"entities": [[209, 215, "DISEASE"]]}], ["To understand the molecular pathogenesis of these infections, we searched for cellular targets of the virulence protein C of human parainfluenza virus type 3 (hPIV3-C).", {"entities": []}], ["We found that hPIV3-C interacts directly through its C-terminal domain with STAT1 and GRB2, whereas C proteins from measles or Nipah viruses failed to do so.", {"entities": [[116, 123, "DISEASE"], [76, 81, "GENE"], [86, 90, "GENE"]]}], ["Binding to STAT1 explains the previously reported capacity of hPIV3-C to block type I interferon signaling, but the interaction with GRB2 was unexpected.", {"entities": [[11, 16, "GENE"], [133, 137, "GENE"]]}], ["This adaptor protein bridges Epidermal Growth Factor (EGF) receptor to MAPK/ERK pathway, a signaling cascade recently found to be involved in airway inflammatory response.", {"entities": [[54, 57, "GENE"]]}], ["We report that either hPIV3 infection or transient expression of hPIV3-C both increase cellular response to EGF, as assessed by Elk1 transactivation and phosphorylation levels of ERK1/2, 40S ribosomal subunit protein S6 and translation initiation factor 4E (eIF4E).", {"entities": [[108, 111, "GENE"], [128, 132, "GENE"], [258, 263, "GENE"]]}], ["Furthermore, inhibition of MAPK/ERK pathway with U0126 prevented viral protein expression in infected cells.", {"entities": []}], ["Altogether, our data provide molecular basis to explain the role of hPIV3-C as a virulence factor and determinant of pathogenesis and demonstrate that Paramyxoviridae have evolved a single virulence factor to block type I interferon signaling and to boost simultaneous cellular response to growth factors.", {"entities": []}], ["Respiroviruses are important pathogens responsible for acute respiratory tract infections associated with severe airway inflammation in children, elderly and immuno-compromised individuals.", {"entities": []}], ["Their RNA genome encodes for structural proteins that compose viral particles, but also for virulence factors that alter cell biology to enhance virus replication and spreading.", {"entities": []}], ["Among them, the C protein plays a critical role by blocking cellular response to type I interferons, the main antiviral cytokines secreted during virus infections.", {"entities": []}], ["To provide molecular basis to this activity, we found that the C protein of human parainfluenza virus type 3 (hPIV3-C), the most frequent human Respirovirus , interacts with STAT1, a key component of type I interferon receptor complex.", {"entities": [[174, 179, "GENE"]]}], ["But hPIV3-C was also found to interact with GRB2, an adaptor molecule involved in cellular response to Epidermal Growth Factor (EGF), and to enhance cell response to this cytokine.", {"entities": [[44, 48, "GENE"], [128, 131, "GENE"]]}], ["This pathway increases protein translation, promotes cell survival and contributes to airway inflammation and mucus secretion.", {"entities": []}], ["Thus, our findings show that hPIV3-C not only inhibits the antiviral response but also stimulates cellular response to EGF, which benefits virus replication and induces an excessive inflammation of airways during infection.", {"entities": [[119, 122, "GENE"]]}], ["Pollution, including polycyclic aromatic hydrocarbons (PAH), may contribute to increased prevalence of asthma.", {"entities": [[103, 109, "DISEASE"]]}], ["PAH can bind to the Aryl hydrocarbon Receptor (AhR), a transcription factor involved in Th17/Th22 type polarization.", {"entities": [[47, 50, "GENE"]]}], ["These cells produce IL17A and IL-22, which allow neutrophil recruitment, airway smooth muscle proliferation and tissue repair and remodeling.", {"entities": [[20, 25, "GENE"]]}], ["Increased IL-17 and IL-22 productions have been associated with asthma.", {"entities": [[64, 70, "DISEASE"]]}], ["We hypothesized that PAH might affect, through their effects on AhR, IL-17 and IL-22 production in allergic asthmatics.", {"entities": [[64, 67, "GENE"]]}], ["Activated peripheral blood mononuclear cells (PBMCs) from 16 nonallergic nonasthmatic (NA) and 16 intermittent allergic asthmatic (AA) subjects were incubated with PAH, and IL-17 and IL-22 productions were assessed.", {"entities": []}], ["At baseline, activated PBMCs from AA exhibited an increased IL-17/IL-22 profile compared with NA subjects.", {"entities": []}], ["Diesel exhaust particle (DEP)-PAH and Benzo[a]Pyrene (B[a]P) stimulation further increased IL-22 but decreased IL-17A production in both groups.", {"entities": []}], ["The PAH-induced IL-22 levels in asthmatic patients were significantly higher than in healthy subjects.", {"entities": []}], ["Among PBMCs, PAH-induced IL-22 expression originated principally from single IL-22- but not from IL-17- expressing CD4 T cells.", {"entities": [[115, 118, "GENE"]]}], ["The Th17 transcription factors RORA and RORC were down regulated, whereas AhR target gene CYP1A1 was upregulated.", {"entities": [[31, 35, "GENE"], [40, 44, "GENE"], [74, 77, "GENE"], [90, 96, "GENE"]]}], ["IL-22 induction by DEP-PAH was mainly dependent upon AhR whereas IL-22 induction by B[a]P was dependent upon activation of PI3K and JNK.", {"entities": [[53, 56, "GENE"]]}], ["Altogether, these data suggest that DEP-PAH and B[a]P may contribute to increased IL22 production in both healthy and asthmatic subjects through mechanisms involving both AhR -dependent and -independent pathways.", {"entities": [[82, 86, "GENE"], [171, 174, "GENE"]]}], ["To study associations between healthcare seeking in 15\u201316-year-olds and high school dropout 5\u2005years later.", {"entities": []}], ["Longitudinal community study.", {"entities": []}], ["Data from a comprehensive youth health survey conducted in 2000\u20132004, linked to data from national registries up to 2010.", {"entities": []}], ["13\u2005964 10th grade secondary school students in six Norwegian counties.", {"entities": []}], ["Logistic regression was used to compute ORs for high school dropout.", {"entities": []}], ["The total proportion of students not completing high school 5\u2005years after registering was 29% (girls 24%, boys 34%).", {"entities": []}], ["Frequent attenders to school health services and youth health clinics at age 15\u201316\u2005years had a higher dropout rate (37/48% and 45/71%), compared with those with no or moderate use.", {"entities": []}], ["Adolescents referred to mental health services were also more likely to drop out (47/62%).", {"entities": []}], ["Boys with moderate use of a general practitioner (GP) had a lower dropout rate (30%).", {"entities": []}], ["A multiple logistic regression analysis, in which we adjusted for selected health indicators and sociodemographic background variables, revealed that seeking help from the youth health clinic and consulting mental health services, were associated with increased level of high\u00a0school dropout 5\u2005years later.", {"entities": []}], ["Frequent attenders (\u22654 contacts) had the highest odds of dropping out.", {"entities": []}], ["Yet, boys who saw a GP and girls attending the school health services regularly over the previous year were less likely than their peers to drop out from high school.", {"entities": []}], ["Adolescents who seek help at certain healthcare services can be at risk of dropping out of high school later.", {"entities": []}], ["Health workers should pay particular attention to frequent attenders and offer follow-up when needed.", {"entities": []}], ["However, boys who attended a GP regularly were more likely to continue to high school graduation, which may indicate a protective effect of having a regular and stable relationship with a GP.", {"entities": []}], ["Allergic bronchopulmonary aspergillosis (ABPA) is an allergic pulmonary disease comprising a complex hypersensitivity reaction to Aspergillus fumigatus .", {"entities": [[26, 39, "DISEASE"]]}], ["Clinical features of ABPA are wheezing, mucoid impaction, and pulmonary infiltrates.", {"entities": []}], ["Oral corticosteroids and anti-fungal agents are standard therapy for ABPA, but long-term use of systemic corticosteroids often causes serious side effects.", {"entities": []}], ["A 64-year-old woman was diagnosed with ABPA based on a history of bronchial asthma (from 40\u00a0years of age), elevated total IgE, the presence of serum precipitating antibodies and elevated specific IgE antibody to A. fumigatus , and pulmonary infiltration.", {"entities": [[76, 82, "DISEASE"]]}], ["Bronchoscopy showed eosinophilic mucoid impaction.", {"entities": []}], ["Systemic corticosteroid therapy was initiated, and her symptoms disappeared.", {"entities": []}], ["Peripheral eosinophilia and pulmonary infiltration recurred five months after cessation of corticosteroid treatment.", {"entities": [[11, 23, "DISEASE"]]}], ["Systemic corticosteroids were re-initiated and itraconazole was added as an anti-fungal agent.", {"entities": []}], ["The patient was free of corticosteroids, aside from treatment with a short course of systemic corticosteroids for asthma exacerbation, and clinically stable with itraconazole and asthma treatments for 3\u00a0years.", {"entities": [[114, 120, "DISEASE"], [179, 185, "DISEASE"]]}], ["In 2017, she experienced significant deterioration.", {"entities": []}], ["Laboratory examination revealed marked eosinophilia (3017/\u03bcL) and a chest computed tomography (CT) scan demonstrated pulmonary infiltration in the left upper lobe and mucoid impaction in both lower lobes.", {"entities": [[39, 51, "DISEASE"]]}], ["The patient was treated with high-dose inhaled corticosteroid/long-acting beta-agonist, a long-acting muscarinic antagonist, a leukotriene receptor antagonist, and theophylline; spirometry revealed a forced expiratory volume in 1\u00a0s (FEV 1 ) of 1.01\u00a0L. An uncontrolled asthma state was indicated by an Asthma Control Test (ACT) score of 18.", {"entities": [[268, 274, "DISEASE"], [301, 307, "DISEASE"], [233, 236, "GENE"]]}], ["Mepolizumab, 100\u00a0mg every 4\u00a0weeks, was initiated for the treatment of severe bronchial asthma with ABPA exacerbation.", {"entities": [[87, 93, "DISEASE"]]}], ["Bronchial asthma symptoms dramatically improved, and ACT score increased to 24, by 4\u00a0weeks after mepolizumab treatment.", {"entities": [[10, 16, "DISEASE"]]}], ["Peripheral eosinophil count decreased to 174/\u03bcL.", {"entities": []}], ["Spirometry revealed improvement of lung function (FEV 1 : 1.28\u00a0L).", {"entities": [[50, 53, "GENE"]]}], ["A chest CT scan demonstrated the disappearance of pulmonary infiltration and mucoid impaction.", {"entities": []}], ["To our knowledge, this is the first case of ABPA to be treated with mepolizumab.", {"entities": []}], ["Dramatic improvements were observed in symptoms, lung function, peripheral eosinophil counts, and chest images.", {"entities": []}], ["Mepolizumab could serve as an alternative treatment with the potential to provide a systemic corticosteroid-sparing effect.", {"entities": []}], ["Mites can sensitize and induce atopic disease in predisposed individuals and are an important deteriorating factor in patients with allergic rhinitis, asthma, and atopic dermatitis.", {"entities": [[132, 149, "DISEASE"], [163, 180, "DISEASE"], [141, 149, "DISEASE"], [151, 157, "DISEASE"], [170, 180, "DISEASE"]]}], ["Although Pyroglyphidae mites have been extensively studied, very scarce reports are available on Cheyletidae spp.", {"entities": []}], ["especially regarding human respiratory pathology.", {"entities": []}], ["The main objective of the present study is to investigate the clinical role of this predator mite ( Cheyletus eruditus ) as a respiratory antigen in a selected sensitized human population.", {"entities": []}], ["Fifty-two adult patients were recruited from the outpatient allergy clinic to assess their eligibility for the study.", {"entities": []}], ["The thirty-seven subjects with persistent allergic rhinitis (PAR) who fulfilled the ARIA criteria had a positive IgE response confirmed by skin prick test (SPT) to C. eruditus .", {"entities": [[42, 59, "DISEASE"], [51, 59, "DISEASE"]]}], ["Only those individuals (37/47) with a positive SPT to C. eruditus showed a positive nasal provocation test (NPT), while 10 patients with nonallergic mild-to-moderate persistent rhinitis, control group , had a negative NPT with C. eruditus .", {"entities": [[177, 185, "DISEASE"]]}], ["The present paper describes a new role for the predator mite Cheyletus eruditus as a respiratory allergen in a selected subset of patients in a subtropical environment afflicted with persistent nonoccupational allergic rhinitis.", {"entities": [[210, 227, "DISEASE"], [219, 227, "DISEASE"]]}], ["In seeking to understand the relationship between housing and health, research attention is often focussed on separate components of people\u2019s whole housing \u2018bundles\u2019.", {"entities": []}], ["We propose in this paper that such conceptual and methodological abstraction of elements of the housing and health relationship limits our ability to understand the scale of the accumulated effect of housing on health and thereby contributes to the under-recognition of adequate housing as a social policy tool and powerful health intervention.", {"entities": []}], ["In this paper, we propose and describe an index to capture the means by which housing bundles influence health.", {"entities": []}], ["We conceptualise the index as reflecting accumulated housing \u201cinsults to health\u201d\u2014an Index of Housing Insults (IHI).", {"entities": []}], ["We apply the index to a sample of 1000 low-income households in Australia.", {"entities": []}], ["The analysis shows a graded association between housing insults and health on all outcome measures.", {"entities": []}], ["Further, after controlling for possible confounders, the IHI is shown to provide additional predictive power to the explanation of levels of mental health, general health and clinical depression beyond more traditional proxy measures.", {"entities": []}], ["Overall, this paper reinforces the need to look not just at separate housing components but to embrace a broader understanding of the relationship between housing and health.", {"entities": []}], ["During imaging of the normal esophagus, air is often detected.", {"entities": []}], ["The purpose of this study was to determine the correlation between the appearance of air bubbles on imaging and Gastroesophageal Reflux Disease (GERD) symptoms.", {"entities": []}], ["The cross-sectional imaging study was conducted at Rasole Akram Hospital, Tehran, Iran.", {"entities": []}], ["A total of 44 patients underwent X-ray computed tomography (CT) scanning; the presence of air in the esophagus and visible on CT imaging was scrutinized.", {"entities": []}], ["The average age of the subjects was 59 and the male to female ratio was 0.83.", {"entities": []}], ["We found a significant relationship between the presence of GERD symptoms, the size of air bubbles and esophageal dilation (ED) on the CT scan.", {"entities": []}], ["Air bubbles in the esophagus may be seen frequently in CT scans, but their size and location can vary.", {"entities": []}], ["The GERD symptoms can arise when a small diameter air column is present within the esophagus, especially in the middle and lower parts.", {"entities": []}], ["Many trials of nebulized therapy have used nebulized saline as a \"placebo\".", {"entities": []}], ["However, nebulized isotonic saline is sometimes used to assist sputum expectoration and relieve breathlessness in COPD patients.", {"entities": []}], ["We designed this study to establish if nebulized saline had a placebo effect or a clinical effect.", {"entities": []}], ["40 patients were studied following hospital admission for exacerbated COPD (mean FEV1 30% predicted).", {"entities": []}], ["Patients were randomised to single-blind administration of either 4 mls of nebulized isotonic saline using an efficient nebulizer (active group n = 20) or an inefficient nebulizer (placebo group n = 20).", {"entities": []}], ["Spirometry and subjective breathlessness scores (Modified Likert Scale) were measured before nebulized treatment and 10 minutes after treatment.", {"entities": []}], ["There was no significant change in FEV1 after active or placebo nebulized saline treatment.", {"entities": []}], ["Patients reported a 4% improvement in mean breathlessness score following placebo (Wilcoxon test; p = 0.37) compared with 23% improvement following active nebulized saline (p = 0.0001).", {"entities": []}], ["65% of patients given active nebulized saline but only 5% of the placebo group reported that mucus expectoration was easier after the treatment.", {"entities": []}], ["This study lends support to the current use of nebulized saline to relieve breathlessness (possibly by facilitating sputum clearance) in COPD patients.", {"entities": []}], ["Lung function was not affected.", {"entities": []}], ["Nebulized saline can therefore be used as a placebo in bronchodilator studies involving COPD patients but it cannot be used as a placebo in trials assessing symptom relief.", {"entities": []}], ["We present a methodology for a hybrid brain-computer interface (BCI) system, with the recognition of motor imagery (MI) based on EEG and blink EOG signals.", {"entities": []}], ["We tested the BCI system in a 3D Tetris and an analogous 2D game playing environment.", {"entities": []}], ["To enhance player's BCI control ability, the study focused on feature extraction from EEG and control strategy supporting Game-BCI system operation.", {"entities": []}], ["We compared the numerical differences between spatial features extracted with common spatial pattern (CSP) and the proposed multifeature extraction.", {"entities": []}], ["To demonstrate the effectiveness of 3D game environment at enhancing player's event-related desynchronization (ERD) and event-related synchronization (ERS) production ability, we set the 2D Screen Game as the comparison experiment.", {"entities": []}], ["According to a series of statistical results, the group performing MI in the 3D Tetris environment showed more significant improvements in generating MI-associated ERD/ERS.", {"entities": []}], ["Analysis results of game-score indicated that the players' scores presented an obvious uptrend in 3D Tetris environment but did not show an obvious downward trend in 2D Screen Game.", {"entities": []}], ["It suggested that the immersive and rich-control environment for MI would improve the associated mental imagery and enhance MI-based BCI skills.", {"entities": []}], ["Benzene is an occupational toxicant and an environmental pollutant that potentially causes hematotoxicity and leukemia in exposed populations.", {"entities": [[110, 118, "DISEASE"]]}], ["Epidemiological studies suggest an association between an increased incidence of childhood leukemia and benzene exposure during the early stages of pregnancy.", {"entities": [[91, 99, "DISEASE"], [81, 99, "DISEASE"]]}], ["However, experimental evidence supporting the association is lacking at the present time.", {"entities": []}], ["It is believed that benzene and its metabolites target hematopoietic stem cells (HSCs) to cause toxicity and cancer in the hematopoietic system.", {"entities": [[109, 115, "DISEASE"]]}], ["In the current study, we compared the effects of hydroquinone (HQ), a major metabolite of benzene in humans and animals, on mouse embryonic yolk sac hematopoietic stem cells (YS-HSCs) and adult bone marrow hematopoietic stem cells (BM-HSCs).", {"entities": []}], ["YS-HSCs and BM-HSCs were isolated and enriched, and were exposed to HQ at increasing concentrations.", {"entities": []}], ["HQ reduced the proliferation and the differentiation and colony formation, but increased the apoptosis of both YS-HSCs and BM-HSCs.", {"entities": []}], ["However, the cytotoxic and apoptotic effects of HQ were more apparent and reduction of colony formation by HQ was more severe in YS-HSCs than in BM-HSCs.", {"entities": []}], ["Differences in gene expression profiles were observed in HQ-treated YS-HSCs and BM-HSCs.", {"entities": []}], ["Cyp4f18 was induced by HQ both in YS-HSCs and BM-HSCs, whereas DNA-PKcs was induced in BM-HSCs only.", {"entities": []}], ["The results revealed differential effects of benzene metabolites on embryonic and adult HSCs.", {"entities": []}], ["The study established an experimental system for comparison of the hematopoietic toxicity and leukemogenicity of benzene and metabolites during mouse embryonic development and adulthood.", {"entities": []}], ["Background: Specific characteristics of particulate matter (PM) responsible for associations with respiratory health observed in epidemiological studies are not well established.", {"entities": []}], ["High correlations among, and differential measurement errors of, individual components contribute to this uncertainty.", {"entities": []}], ["Objectives: We investigated which characteristics of PM have the most consistent associations with acute changes in respiratory function in healthy volunteers.", {"entities": []}], ["Methods: We used a semiexperimental design to accurately assess exposure.", {"entities": []}], ["We increased exposure contrast and reduced correlations among PM characteristics by exposing volunteers at five different locations: an underground train station, two traffic sites, a farm, and an urban background site.", {"entities": []}], ["Each of the 31 participants was exposed for 5 hr while exercising intermittently, three to seven times at different locations during March\u2013October 2009.", {"entities": [[46, 48, "GENE"]]}], ["We measured PM 10 , PM 2.5 , particle number concentrations (PNC), absorbance, elemental/organic carbon, trace metals, secondary inorganic components, endotoxin content, gaseous pollutants, and PM oxidative potential.", {"entities": []}], ["Lung function [FEV 1 (forced expiratory volume in 1 sec), FVC (forced vital capacity), FEF 25\u201375 (forced expiratory flow at 25\u201375% of vital capacity), and PEF (peak expiratory flow)] and fractional exhaled nitric oxide (FE NO ) were measured before and at three time points after exposure.", {"entities": [[15, 18, "GENE"]]}], ["Data were analyzed with mixed linear regression.", {"entities": []}], ["Results: An interquartile increase in PNC (33,000 particles/cm NO increase over baseline immediately and at 2 hr postexposure, respectively.", {"entities": [[110, 112, "GENE"]]}], ["A 7% (95% CI: 0.5, 14%) increase persisted until the following morning.", {"entities": []}], ["These associations were robust and insensitive to adjustment for other pollutants.", {"entities": []}], ["Similarly consistent associations were seen between FVC and FEV 1 with PNC, NO 2 (nitrogen dioxide), and NO x (nitrogen oxides).", {"entities": [[60, 63, "GENE"]]}], ["Conclusions: Changes in PNC, NO 2 , and NO x were associated with evidence of acute airway inflammation (i.e., FE NO ) and impaired lung function.", {"entities": []}], ["PM mass concentration and PM 10 oxidative potential were not predictive of the observed acute responses.", {"entities": []}], ["Health literacy has become an increasingly important concept in public health.", {"entities": []}], ["We sought to develop a comprehensive measure of health literacy capable of diagnosing health literacy needs across individuals and organisations by utilizing perspectives from the general population, patients, practitioners and policymakers.", {"entities": []}], ["Using a validity-driven approach we undertook grounded consultations (workshops and interviews) to identify broad conceptually distinct domains.", {"entities": []}], ["Questionnaire items were developed directly from the consultation data following a strict process aiming to capture the full range of experiences of people currently engaged in healthcare through to people in the general population.", {"entities": []}], ["Psychometric analyses included confirmatory factor analysis (CFA) and item response theory.", {"entities": []}], ["Cognitive interviews were used to ensure questions were understood as intended.", {"entities": []}], ["Items were initially tested in a calibration sample from community health, home care and hospital settings (N=634) and then in a replication sample (N=405) comprising recent emergency department attendees.", {"entities": []}], ["Initially 91 items were generated across 6 scales with agree/disagree response options and 5 scales with difficulty in undertaking tasks response options.", {"entities": []}], ["Cognitive testing revealed that most items were well understood and only some minor re-wording was required.", {"entities": []}], ["Psychometric testing of the calibration sample identified 34 poorly performing or conceptually redundant items and they were removed resulting in 10 scales.", {"entities": []}], ["These were then tested in a replication sample and refined to yield 9 final scales comprising 44 items.", {"entities": []}], ["A 9-factor CFA model was fitted to these items with no cross-loadings or correlated residuals allowed.", {"entities": []}], ["Given the very restricted nature of the model, the fit was quite satisfactory: \u03c7 WLSMV (866 d.f.)", {"entities": []}], ["= 2927, p<0.000, CFI = 0.936, TLI = 0.930, RMSEA = 0.076, and WRMR = 1.698.", {"entities": [[17, 20, "GENE"]]}], ["Final scales included: Feeling understood and supported by healthcare providers; Having sufficient information to manage my health; Actively managing my health; Social support for health; Appraisal of health information; Ability to actively engage with healthcare providers; Navigating the healthcare system; Ability to find good health information; and Understand health information well enough to know what to do.", {"entities": []}], ["The HLQ covers 9 conceptually distinct areas of health literacy to assess the needs and challenges of a wide range of people and organisations.", {"entities": []}], ["Given the validity-driven approach, the HLQ is likely to be useful in surveys, intervention evaluation, and studies of the needs and capabilities of individuals.", {"entities": []}], ["Two primary causes of respiratory tract infections are respiratory syncytial virus (RSV) and influenza viruses, both of which remain major public health concerns.", {"entities": [[93, 102, "DISEASE"]]}], ["There are a limited number of antiviral drugs available for the treatment of RSV and influenza, each having limited effectiveness and each driving selective pressure for the emergence of drug-resistant viruses.", {"entities": [[85, 94, "DISEASE"]]}], ["Novel broad-spectrum antivirals are needed to circumvent problems with current disease intervention strategies, while improving the cytokine-induced immunopathology associated with RSV and influenza infections.", {"entities": [[189, 198, "DISEASE"]]}], ["In this review, we examine the use of Verdinexor (KPT-335, a novel orally bioavailable drug that functions as a selective inhibitor of nuclear export, SINE), as an antiviral with multifaceted therapeutic potential.", {"entities": []}], ["KPT-335 works to (1) block CRM1 (i.e., Chromosome Region Maintenance 1; exportin 1 or XPO1) mediated export of viral proteins critical for RSV and influenza pathogenesis; and (2) repress nuclear factor \u03baB (NF-\u03baB) activation, thus reducing cytokine production and eliminating virus-associated immunopathology.", {"entities": [[147, 156, "DISEASE"], [86, 90, "GENE"]]}], ["The repurposing of SINE compounds as antivirals shows promise not only against RSV and influenza virus but also against other viruses that exploit the nucleus as part of their viral life cycle.", {"entities": [[87, 96, "DISEASE"]]}], ["Platelet activating factor (PAF) is an important mediator of vascular leak in acute dengue.", {"entities": []}], ["Phospholipase A2s (PLA2) are inflammatory lipid enzymes that generate and regulate PAF and other mediators associated with mast cells.", {"entities": []}], ["We sought to investigate if mast cell activation and increases in secretory sPLA2s are associated with an increase in PAF and occurrence of dengue haemorrhagic fever (DHF).", {"entities": []}], ["The changes in the levels of mast cell tryptase, PAF and the activity of sPLA2 were determined throughout the course of illness in 13 adult patients with DHF, and 30 patients with dengue fever (DF).", {"entities": []}], ["We found that sPLA2 activity was significantly higher in patients with DHF when compared to those with DF, during the first 120\u2009h of clinical illness.", {"entities": []}], ["sPLA2 activity was significantly associated with PAF levels, which were also significantly higher in patients with DHF.", {"entities": []}], ["Although levels of mast cell tryptase were higher in patients with DHF, the difference was not significant, and the levels were not above the reference ranges.", {"entities": []}], ["sPLA2 activity significantly correlated with the degree of viraemia in patients with DHF but not in those with DF.", {"entities": []}], ["sPLA2 appears to play an important role in the pathogenesis of dengue.", {"entities": []}], ["Since its activity is significantly increased during the early phase of infection in patients with DHF, this suggests that understanding the underlying mechanisms may provide opportunities for early intervention.", {"entities": []}], ["Physical activity limitation is common in chronic obstructive pulmonary disease (COPD), and is associated with worse health status, and increased hospitalisation and mortality.", {"entities": [[42, 79, "DISEASE"]]}], ["Long-acting bronchodilators, either alone or in combination, have been shown to improve exercise intolerance.", {"entities": []}], ["However, none of these studies were designed with physical activity as primary outcome.", {"entities": []}], ["This study assessed the effect of indacaterol/glycopyrronium fixed dose combination (IND/GLY) 110/50\u00a0\u03bcg once daily (OD) versus placebo on lung hyperinflation (inspiratory capacity [IC]) and physical activity in patients with moderate-to-severe COPD.", {"entities": []}], ["In this multicentre, randomised, double-blind, placebo-controlled crossover study, patients received IND/GLY or placebo OD in two 21-day treatment periods (14-day washout between periods).", {"entities": []}], ["Eligible patients were \u226540\u00a0years of age, current or ex-smokers (smoking history \u226510 pack-years), with post-salbutamol forced expiratory volume in 1\u00a0s (FEV 1 ) 40\u201380\u00a0% predicted, and FEV 1 :forced vital capacity <0.70.", {"entities": [[151, 154, "GENE"], [182, 185, "GENE"], [151, 154, "GENE"], [182, 185, "GENE"]]}], ["The co-primary endpoints were peak IC after 21\u00a0days and average daily activity-related energy expenditure.", {"entities": []}], ["Key secondary endpoints were average number of steps per day and the duration of at least moderate activity per day.", {"entities": []}], ["Peak IC and FEV 1 on Day 1, and trough IC and FEV 1 after 21\u00a0days were other secondary endpoints.", {"entities": [[12, 15, "GENE"], [46, 49, "GENE"], [12, 15, "GENE"], [46, 49, "GENE"]]}], ["A total of 194 patients were randomised (65.5\u00a0% male, mean age 62.8\u00a0years, mean FEV 1 61.6\u00a0% predicted), with 183 (94.3\u00a0%) completing the study.", {"entities": [[80, 83, "GENE"]]}], ["Compared with placebo, IND/GLY significantly increased peak IC after 21\u00a0days (difference 202\u00a0mL, p \u2009<\u20090.0001), activity-related energy expenditure (difference 36.7\u00a0kcal/day, p \u2009=\u20090.040), and the average number of steps per day (difference 358, p \u2009=\u20090.029), with a trend towards an improvement in the duration of at least moderate activity (difference 4.4\u00a0min, p \u2009=\u20090.264).", {"entities": []}], ["IND/GLY was associated with statistically significant improvements versus placebo in peak IC and FEV 1 on Day 1, and trough IC and FEV 1 after 21\u00a0days.", {"entities": [[97, 100, "GENE"], [131, 134, "GENE"], [97, 100, "GENE"], [131, 134, "GENE"]]}], ["The incidence of treatment-emergent adverse events was 22.8\u00a0% with IND/GLY and 22.9\u00a0% with placebo.", {"entities": []}], ["In this study, compared with placebo, IND/GLY reduced hyperinflation, and, despite no patient education or lifestyle advice, improved daily physical activity levels.", {"entities": []}], ["This suggests that IND/GLY has the potential to impact two of the main clinical concerns in the care of patients with COPD.", {"entities": []}], ["ClinicalTrials.gov number: NCT01996319 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-016-0256-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chlamydia ( C. ) psittaci is the causative agent of psittacosis, a zoonotic disease in birds and man.", {"entities": []}], ["In addition, C. psittaci has been repeatedly found in domestic animals and is, at least in calves, also able to induce respiratory disease.", {"entities": []}], ["Knowledge about transmission routes in cattle herds is still deficient, and nothing is known about differences in host response after either experimental or natural exposure to C. psittaci .", {"entities": []}], ["Therefore, our recently developed respiratory infection model was exploited to evaluate (i) the presence of the pathogen in blood, excretions and air, (ii) the possibility of transmission and (iii) clinical symptoms, acute phase and immune response until 5 weeks after exposure.", {"entities": []}], ["In this prospective study, intrabronchial inoculation of 10 C. psittaci (n\u200a=\u200a21 calves) led to reproducible acute respiratory illness (of approximately one week), accompanied by a systemic inflammatory reaction with an innate immune response dominated by neutrophils.", {"entities": []}], ["Excretion and/or exhalation of the pathogen was sufficient to transmit the infection to na\u00efve sentinel calves (n\u200a=\u200a3) co-housed with the infected animals.", {"entities": []}], ["Sentinel calves developed mild to subclinical infections only.", {"entities": []}], ["Notably, excretion of the pathogen, predominantly via feces, occurred more frequently in animals naturally exposed to C. psittaci (i.e.", {"entities": []}], ["sentinels) as compared to experimentally-inoculated calves.", {"entities": []}], ["The humoral immune response was generally weak, and did not emerge regularly following experimental infection; however, it was largely absent after naturally acquired infection.", {"entities": []}], ["The primary cause of mortality at 5 years following a cardiac transplantation is the development of atherosclerosis, termed coronary allograft vasculopathy (CAV).", {"entities": [[100, 115, "DISEASE"]]}], ["This pathology is characterized by diffused intimal hyperplasia and emanates from coronary arterial injuries caused by immune inflammatory cells.", {"entities": []}], ["Neutrophils play an important role in this inflammatory process; however, their potential participation in the pathogenesis of CAV is poorly understood.", {"entities": []}], ["Despite their essential contribution to the prevention of graft rejection, immunosuppressive drugs could have detrimental effects owing to their pro-inflammatory activities.", {"entities": []}], ["Thus, we investigated the impact of different immunosuppressive drugs on the inflammatory response of neutrophils isolated from the blood of healthy volunteers.", {"entities": []}], ["Under basal conditions, mammalian target of rapamycin (mTOR) inhibitors (sirolimus and everolimus) had the most potent anti-inflammatory effect, decreasing both IL-8 release (\u2248\u221280%) and vascular endothelial growth factor (VEGF) release (\u2248\u221265%) and preserving the release of the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL-1RA).", {"entities": [[55, 59, "GENE"]]}], ["In TNF-\u03b1-treated neutrophils, pre-incubation with everolimus provided the most potent effect, simultaneously reducing the release of both VEGF and IL-8 while doubling the release of IL-1RA.", {"entities": []}], ["This latter effect of everolimus was maintained even when administered in combination with other immunosuppressive drugs.", {"entities": []}], ["Sirolimus and everolimus decreased the tumor necrosis factor (TNF)-\u03b1-induced adhesion of neutrophils to human endothelial cells and human extracellular matrix.", {"entities": [[62, 65, "GENE"]]}], ["This effect was largely dependent on the ability of these compounds to alter \u03b2 2 -integrin/CD18 activation.", {"entities": []}], ["Our results suggest a potential mechanism for the beneficial effect of everolimus in the prevention of CAV in heart transplant recipients.", {"entities": []}], ["Inhaled corticosteroids (ICS) are the most effective anti-inflammatory drugs for the treatment of persistent asthma in children.", {"entities": [[109, 115, "DISEASE"]]}], ["Treatment with ICS decreases asthma mortality and morbidity, reduces symptoms, improves lung function, reduces bronchial hyperresponsiveness and reduces the number of exacerbations.", {"entities": [[29, 35, "DISEASE"]]}], ["The efficacy of ICS in preschool wheezing is controversial.", {"entities": []}], ["A recent task force from the European Respiratory Society on preschool wheeze defined two different phenotypes: episodic viral wheeze, wheeze that occurs only during respiratory viral infections, and multiple-trigger wheeze, where wheeze also occurs in between viral episodes.", {"entities": []}], ["Treatment with ICS appears to be more efficacious in the latter phenotype.", {"entities": []}], ["Small particle ICS may offer a potential benefit in preschool children because of the favourable spray characteristics.", {"entities": []}], ["However, the efficacy of small particle ICS in preschool children has not yet been evaluated in prospective clinical trials.", {"entities": []}], ["The use of ICS in school children with asthma is safe with regard to systemic side effects on the hypothalamic\u2013pituitary\u2013adrenal axis, growth and bone metabolism, when used in low to medium doses.", {"entities": [[39, 45, "DISEASE"]]}], ["Although safety data in wheezing preschoolers is limited, the data are reassuring.", {"entities": []}], ["Also for this age group, adverse events tend to be minimal when the ICS is used in appropriate doses.", {"entities": []}], ["Whether exhaled NO helps to identify a specific phenotype of asthmatic patients remains debated.", {"entities": []}], ["Our aims were to evaluate whether exhaled NO (FENO 0.05 ) is independently associated (1) with underlying pathophysiological characteristics of asthma such as airway tone (bronchodilator response) and airway inflammation (inhaled corticosteroid [ICS]-dependant inflammation), and (2) with clinical phenotypes of asthma.", {"entities": [[144, 150, "DISEASE"], [312, 318, "DISEASE"]]}], ["We performed multivariate (exhaled NO as dependent variable) and k-means cluster analyses in a population of 169 asthmatic children (age \u00b1 SD: 10.5 \u00b1 2.6 years) recruited in a monocenter cohort that was characterized in a cross-sectional design using 28 parameters describing potentially different asthma domains: atopy, environment (tobacco), control, exacerbations, treatment (inhaled corticosteroid and long-acting bronchodilator agonist), and lung function (airway architecture and tone).", {"entities": [[298, 304, "DISEASE"]]}], ["Two subject-related characteristics (height and atopy) and two disease-related characteristics (bronchodilator response and ICS dose > 200 \u03bcg/d) explained 36% of exhaled NO variance.", {"entities": []}], ["Nine domains were isolated using principal component analysis.", {"entities": []}], ["Four clusters were further identified: cluster 1 (47%): boys, unexposed to tobacco, with well-controlled asthma; cluster 2 (26%): girls, unexposed to tobacco, with well-controlled asthma; cluster 3 (6%): girls or boys, unexposed to tobacco, with uncontrolled asthma associated with increased airway tone, and cluster 4 (21%): girls or boys, exposed to parental smoking, with small airway to lung size ratio and uncontrolled asthma.", {"entities": [[105, 111, "DISEASE"], [180, 186, "DISEASE"], [259, 265, "DISEASE"], [424, 430, "DISEASE"]]}], ["FENO 0.05 was not different in these four clusters.", {"entities": []}], ["In conclusion, FENO 0.05 is independently linked to two pathophysiological characteristics of asthma (ICS-dependant inflammation and bronchomotor tone) but does not help to identify a clinically relevant phenotype of asthmatic children.", {"entities": [[94, 100, "DISEASE"]]}], ["Generic drugs are assuming an increasingly important role in sustaining modern healthcare systems, as the cost of healthcare, including drug usage, is gradually expanding around the world.", {"entities": []}], ["To date, published articles comparing generic drug reviews between different countries are scarce.", {"entities": []}], ["The objective of this study was to examine generic drug reviews in Japan and Canada.", {"entities": []}], ["We surveyed generic drug reviews from Japan and Canada and compared the following points: general matter (application types, type of partial change or Supplement to an Abbreviated New Drug Submission, application and approval numbers, review period, application format, review report, responsibility for review), bioequivalence studies for solid oral dosage forms, and bioequivalence guidelines, guidance, or basic principles regarding various dosage forms.", {"entities": []}], ["This survey described the many similarities and differences in generic drug reviews between the two countries and points that should be improved to promote better generic drug reviews.", {"entities": []}], ["In particular, regulations for the definition of the same or different active pharmaceutical ingredients (APIs) are similar for both authorities.", {"entities": []}], ["The results clarified the future challenges of generic drug reviews, and the differences highlighted by this survey will be important considerations for the future.", {"entities": []}], ["This is the first article to present and discuss the details of generic drug reviews between Japan and Canada.", {"entities": []}], ["Osteoporosis and periodontal disease (PD) are frequently associated in the elderly, both concurring to the loss of jaw alveolar bone and finally of teeth.", {"entities": [[17, 36, "DISEASE"]]}], ["Bisphosphonates improve alveolar bone loss but have also been associated with osteonecrosis of the jaw (ONJ), particularly using oncological doses of zoledronate.", {"entities": [[78, 91, "DISEASE"]]}], ["The effects and therapeutic margin of zoledronate on jaw bone therefore remain uncertain.", {"entities": []}], ["We reappraised the efficacy and safety of Zoledronate (Zol) in ovariectomized (OVX) periostin (Postn)-deficient mice, a unique genetic model of systemic and jaw osteopenia.", {"entities": [[95, 100, "GENE"]]}], ["Compared to vehicle, Zol 1M (100 \u00b5g/kg/month) and Zol 1W (100 \u00b5g/kg/week) for 3 months both significantly improved femur BMD, trabecular bone volume on tissue volume (BV/TV) and cortical bone volume in both OVX Postn", {"entities": [[211, 216, "GENE"]]}], ["Infants and children are not little adults.", {"entities": []}], ["They are uniquely vulnerable to environmental toxicants.", {"entities": []}], ["To protect infants and children against toxicants, the National Research Council in 1993 called for development of an approach to risk assessment that considers children's unique patterns of exposure and their special vulnerabilities to pesticides.", {"entities": []}], ["Many aspects of that call were codified into federal law in the Food Quality Protection Act (FQPA) of 1996.", {"entities": []}], ["This report highlights the central elements needed for development of a child-protective approach to risk assessment: a) improved quantitative assessment of children's exposures at different life stages, from fetal life through adolescence, including acute and chronic exposures, exposures via multiple routes, and exposures to multiple agents; b) development of new approaches to toxicity testing of chemicals that can detect unanticipated and subtle outcomes and that evaluate experimental subjects over the entire life span from early exposure to natural death to replicate the human experience; c) development of new toxicodynamic and toxicokinetic models that account for the unique physiologic characteristics of infants and children; d) development of new approaches to assessment of outcomes, functional, organ, cellular and molecular, over the entire life span; these measures need to be incorporated into toxicity testing and into long-term prospective epidemiologic studies of children; and e) application of uncertainty and safety factors in risk assessment that specifically consider children's risks.", {"entities": []}], ["Under FQPA, children are presumed more vulnerable to pesticides than adults unless evidence exists to the contrary.", {"entities": []}], ["Uncertainty and safety factors that are protective of children must therefore be incorporated into risk assessment when data on developmental toxicity are lacking or when there is evidence of developmental toxicity.", {"entities": []}], ["The adequate protection of children against toxic agents in the environment will require fundamental and far-reaching revisions of current approaches to toxicity testing and risk assessment.", {"entities": []}], ["Tragia belongs to the family Euphorbiaceae which contains about 152 species.", {"entities": []}], ["Interestingly, most of the earlier investigations have been done using only five Tragia species, namely, Tragia involucrata , Tragia cannabina , Tragia spathulata , Tragia plukenetii , and Tragia benthamii .", {"entities": []}], ["The objective of the present review is to compile the phytochemical, pharmacological and biological studies of the selected five Tragia species reported in the literature.", {"entities": []}], ["The reported data/information was retrieved mainly from the online databases of PubMed (MEDLINE), EMBASE and Botanical Survey of India.", {"entities": []}], ["The present review elaborated the phytochemical, pharmacological and biological properties of the selected five Tragia species obtained from recent literature.", {"entities": []}], ["This review provides a basis for future investigation of Tragia species and, especially for those species that have not been explored for biological and pharmacological activities.", {"entities": []}], ["An important step in the production of inflammatory mediators of the leukotriene family is the Ca in vitro , the natural membrane mimicking environment of nanodiscs was used.", {"entities": []}], ["Nanodiscs with 10.5 nm inner diameter were made with the lipid POPC and membrane scaffolding protein MSP1E3D1.", {"entities": []}], ["Monomeric and dimeric 5LO were investigated.", {"entities": []}], ["Monomeric 5LO mixed with Ca", {"entities": []}], ["The GRADE method represents a new approach to grading the quality of evidence and strength of recommendations in the preparation of Clinical Practice Guidelines (CPG).", {"entities": []}], ["In the context of a pilot study to assess the implementability of the system in Spain, we considered it relevant to gain an insight into the significance of the perceptions and attitudes expressed by the actual experts participating in the system try-out.", {"entities": []}], ["Qualitative research with an ethnographic approach, through non-participant observation and focus groups within the context of a consensus workshop in which 19 CPG experts participated to evaluate the GRADE proposal using 12 evidence tables taken from hypertension, asthma and arthritis CPGs.", {"entities": [[252, 264, "DISEASE"], [277, 286, "DISEASE"], [266, 272, "DISEASE"]]}], ["The interventions were recorded, under a guarantee of confidentiality.", {"entities": []}], ["The transcriptions and field notes were analyzed, based on a sociological discourse analysis model, and the provisional findings were re-sent to participants in order to improve their validity.", {"entities": []}], ["1) Certain problems over procedure and terminology hindered the acceptance of this new method as a common reference system for the preparation of CPGs.", {"entities": []}], ["A greater closeness to clinical practice was accompanied by concerns over value judgments and subjectivity, with a demand for greater explicitness in the consensus process.", {"entities": []}], ["The type of \"evidence\" on which the guidelines are based, how and by whom the evidence is prepared, and what the role of the different actors should be, all constitute unresolved concerns in the CPG preparation and implementation processes.", {"entities": []}], ["The grading process is not neutral: professional background, prior experience and the degree of leadership all condition the participants' input and interactions.", {"entities": []}], ["The findings obtained allow the quantitative evaluation to be better interpreted and, in turn, go beyond the particularities of the GRADE method.", {"entities": []}], ["Adaptation to the complexities of clinical practice, the need for carefully designed multi-disciplinary work and the reflexivity present in the CPG preparation process, all represent lines of debate that are necessary to improve the CPG quality in the Spanish health care sector.", {"entities": []}], ["Cow's milk is one of the most common food allergens in children with atopic dermatitis (AD).", {"entities": [[69, 86, "DISEASE"], [76, 86, "DISEASE"]]}], ["This study was conducted to describe the natural course of cow's milk allergy in children with AD, and to identify factors predictive of outcome.", {"entities": []}], ["To accomplish this, we reviewed the medical records of 115 children who were diagnosed with AD and cow's milk allergy before 24 months of age to evaluate their clinical characteristics and prognostic factors.", {"entities": []}], ["During a follow-up period of 24 to114 months, the median age for tolerance to cow's milk was found to be 67 months.", {"entities": []}], ["Multivariate analysis using the Cox proportional hazard model revealed that the peak cow's milk-specific IgE level within 24 months after birth was the most important factor for prediction of the outcome of cow's milk allergy.", {"entities": []}], ["In conclusion, half of the children younger than 24 months of age with AD and cow's milk allergy could tolerate cow's milk at 67 months of age.", {"entities": []}], ["The peak cow's milk-specific IgE level within the first 24 months of birth is useful to predict the prognosis of cow's milk allergy in children with AD.", {"entities": []}], ["Ovine progressive pneumonia virus (OPPV) is an important virus that causes serious diseases in sheep and goats with a prevalence of 36% in the USA.", {"entities": [[18, 27, "DISEASE"]]}], ["Although OPPV was discovered more than half of a century ago, little is known about the infection and pathogenesis of this virus.", {"entities": []}], ["In this report, we used RNA-seq technology to conduct a genome-wide probe for cellular factors that are associated with OPPV infection.", {"entities": []}], ["A total of approximately 22,000 goat host genes were detected of which 657 were found to have been significantly up-regulated and 889 down-regulated at 12 hours post-infection.", {"entities": []}], ["In addition to previously known restriction factors from other viral infections, a number of factors which may be specific for OPPV infection were uncovered.", {"entities": []}], ["The data from this RNA-seq study will be helpful in our understanding of OPPV infection, and also for further study in the prevention and intervention of this viral disease.", {"entities": []}], ["Worldwide, eHealth is a rapidly growing technology.", {"entities": []}], ["It provides good quality health services at lower cost and increased availability.", {"entities": []}], ["Diabetes has reached an epidemic stage in Saudi Arabia and has a medical and economic impact at a countrywide level.", {"entities": []}], ["Data are greatly needed to better understand and plan to prevent and manage this medical problem.", {"entities": []}], ["The Saudi National Diabetes Registry (SNDR) is an electronic medical file supported by clinical, investigational, and management data.", {"entities": []}], ["It functions as a monitoring tool for medical, social, and cultural bases for primary and secondary prevention programs.", {"entities": []}], ["Economic impact, in the form of direct or indirect cost, is part of the registry\u2019s scope.", {"entities": []}], ["The registry\u2019s geographic information system (GIS) produces a variety of maps for diabetes and associated diseases.", {"entities": []}], ["In addition to availability and distribution of health facilities in the Kingdom, GIS data provide health planners with the necessary information to make informed decisions.", {"entities": []}], ["The electronic data bank serves as a research tool to help researchers for both prospective and retrospective studies.", {"entities": []}], ["A Web-based interactive GIS system was designed to serve as an electronic medical file for diabetic patients retrieving data from medical files by trained registrars.", {"entities": []}], ["Data was audited and cleaned before it was archived in the electronic filing system.", {"entities": []}], ["It was then used to produce epidemiologic, economic, and geographic reports.", {"entities": []}], ["A total of 84,942 patients were registered from 2000 to 2012, growing by 10% annually.", {"entities": []}], ["The SNDR reporting system for epidemiology data gives better understanding of the disease pattern, types, and gender characteristics.", {"entities": []}], ["Part of the reporting system is to assess quality of health care using different parameters, such as HbA1c, that gives an impression of good diabetes control for each institute.", {"entities": []}], ["Economic reports give accurate cost estimation of different services given to diabetic patients, such as the annual insulin cost per patient for type 1, type 2, and gestational diabetes, which are 1155 SR (US $308), 1406 SR (US $375), and 1002 SR (US $267), respectively.", {"entities": [[165, 185, "DISEASE"]]}], ["Of this, 72.02% of the total insulin cost is spent on type 2 patients and 55.39% is in the form of premixed insulin.", {"entities": []}], ["The SNDR can provide an accurate assessment of the services provided for research purposes.", {"entities": []}], ["For example, only 27.00% of registered patients had an ophthalmic examination and only 71.10% of patients with proliferative retinopathy had laser therapy.", {"entities": []}], ["The SNDR is an effective electronic medical file that can provide epidemiologic, economic, and geographic reports that can be used for disease management and health care planning.", {"entities": []}], ["It is a useful tool for research and disease health care quality monitoring.", {"entities": []}], ["Fatty acids (FA) play an integral role in brain function and alterations have been implicated in a variety of complex neurological disorders.", {"entities": []}], ["Several recent genomic studies have highlighted genetic variability in the fatty acid desaturase (FADS1/2/3) gene cluster as an important contributor to FA alterations in serum lipids as well as measures of FA desaturase index estimated by ratios of relevant FAs.", {"entities": [[259, 262, "GENE"]]}], ["The contribution to alterations of FAs within the brain by local synthesis is still a matter of debate.", {"entities": [[35, 38, "GENE"]]}], ["Thus, the impact of genetic variants in FADS genes on gene expression and brain FA levels is an important avenue to investigate.", {"entities": []}], ["Analyses were performed on brain tissue from prefrontal cortex Brodmann area 47 (BA47) of 61 male subjects of French Canadian ancestry ranging in age from young adulthood to middle age (18\u201358 years old), with the exception of one teenager (15 years old).", {"entities": []}], ["Haplotype tagging SNPs were selected using the publicly available HapMap genotyping dataset in conjunction with Haploview.", {"entities": []}], ["DNA sequencing was performed by the Sanger method and gene expression was measured by quantitative real-time PCR.", {"entities": []}], ["FAs in brain tissue were analysed by gas chromatography.", {"entities": [[0, 3, "GENE"]]}], ["Variants in the FADS1 gene region were sequenced and analyzed for their influence on both FADS gene expression and FAs in brain tissue.", {"entities": [[16, 21, "GENE"], [115, 118, "GENE"]]}], ["Our results suggest an association of the minor haplotype with alteration in estimated fatty acid desaturase activity.", {"entities": []}], ["Analysis of the impact of DNA variants on expression and alternative transcripts of FADS1 and FADS2, however, showed no differences.", {"entities": [[84, 89, "GENE"], [94, 99, "GENE"]]}], ["Furthermore, there was a significant interaction between haplotype and age on certain brain FA levels.", {"entities": []}], ["This study suggests that genetic variability in the FADS genes cluster, previously shown to be implicated in alterations in peripheral FA levels, may also affect FA composition in brain tissue, but not likely by local synthesis.", {"entities": []}], ["Nicotine exposure during pregnancy induces oxidative stress and leads to behavioral alterations in early childhood and young adulthood.", {"entities": []}], ["The current study aimed to investigate the possible protective effects of green tea ( Camellia sinensis ) against perinatal nicotine-induced behavioral alterations and oxidative stress in mice newborns.", {"entities": []}], ["Pregnant mice received 50\u2009mg/kg C. sinensis on gestational day 1 (PD1) to postnatal day 15 (D15) and were subcutaneously injected with 0.25\u2009mg/kg nicotine from PD12 to D15.", {"entities": []}], ["Nicotine-exposed newborns showed significant delay in eye opening and hair appearance and declined body weight at birth and at D21.", {"entities": []}], ["Nicotine induced neuromotor alterations in both male and female newborns evidenced by the suppressed righting, rotating, and cliff avoidance reflexes.", {"entities": []}], ["Nicotine-exposed newborns exhibited declined memory, learning, and equilibrium capabilities, as well as marked anxiety behavior.", {"entities": []}], ["C. sinensis significantly improved the physical development, neuromotor maturation, and behavioral performance in nicotine-exposed male and female newborns.", {"entities": []}], ["In addition, C. sinensis prevented nicotine-induced tissue injury and lipid peroxidation and enhanced antioxidant defenses in the cerebellum and medulla oblongata of male and female newborns.", {"entities": []}], ["In conclusion, this study shows that C. sinensis confers protective effects against perinatal nicotine-induced neurobehavioral alterations, tissue injury, and oxidative stress in mice newborns.", {"entities": []}], ["The association between systemic sclerosis and pulmonary arterial hypertension (PAH) is well recognized.", {"entities": [[66, 78, "DISEASE"]]}], ["Vascular endothelial growth factor (VEGF) has been reported to play an important role in pulmonary hypertension.", {"entities": [[99, 111, "DISEASE"], [89, 111, "DISEASE"]]}], ["The aim of the present study was to examine the relationship between systolic pulmonary artery pressure, clinical and functional manifestations of the disease and serum VEGF levels in systemic sclerosis.", {"entities": []}], ["Serum VEGF levels were measured in 40 patients with systemic sclerosis and 13 control subjects.", {"entities": []}], ["All patients underwent clinical examination, pulmonary function tests and echocardiography.", {"entities": []}], ["Serum VEGF levels were higher in systemic sclerosis patients with sPAP \u2265 35 mmHg than in those with sPAP < 35 mmHg (352 (266, 462 pg/ml)) vs (240 (201, 275 pg/ml)) (p < 0.01), while they did not differ between systemic sclerosis patients with sPAP < 35 mmHg and controls.", {"entities": []}], ["Serum VEGF levels correlated to systolic pulmonary artery pressure, to diffusing capacity for carbon monoxide and to MRC dyspnea score.", {"entities": []}], ["In multiple linear regression analysis, serum VEGF levels, MRC dyspnea score, and D LCO were independent predictors of systolic pulmonary artery pressure.", {"entities": []}], ["Serum VEGF levels are increased in systemic sclerosis patients with sPAP \u2265 35 mmHg.", {"entities": []}], ["The correlation between VEGF levels and systolic pulmonary artery pressure may suggest a possible role of VEGF in the pathogenesis of PAH in systemic sclerosis.", {"entities": []}], ["According to a large-scale international survey, Peru has one of the highest prevalences of asthma worldwide; however, data from this survey were limited to participants from urban Lima.", {"entities": [[92, 98, "DISEASE"]]}], ["The authors sought to characterise the epidemiology of asthma in Peru in two regions with disparate degrees of urbanisation.", {"entities": [[55, 61, "DISEASE"]]}], ["In this manuscript, the authors summarise the study design and implementation.", {"entities": []}], ["A cross-sectional study.", {"entities": []}], ["Using census data of 13\u201315-year-old adolescents from two communities in Peru, the authors invited a random sample of participants in Lima (n=725) and all adolescents in Tumbes (n=716) to participate in our study.", {"entities": []}], ["The authors asked participants to complete a questionnaire on asthma symptoms, environmental exposures and socio-demographics and to undergo spirometry before and after bronchodilator, skin allergy testing and exhaled nitric oxide testing.", {"entities": [[62, 68, "DISEASE"]]}], ["The authors obtained blood samples for haematocrit, total IgE levels, vitamin D levels and DNA in all participants and measured indoor particulate matter concentrations for 48\u2005h in a random subset of 70\u2013100 households at each site.", {"entities": []}], ["Of 1851 eligible participants, 1441 (78%) were enrolled and 1159 (80% of enrolled) completed all physical tests.", {"entities": []}], ["1283 (89%) performed spirometry according to standard guidelines, of which 86% of prebronchodilator tests and 92% of postbronchodilator tests were acceptable and reproducible.", {"entities": []}], ["92% of allergy skin tests had an adequate negative control.", {"entities": []}], ["The authors collected blood from 1146 participants (79%) and saliva samples from 148 participants (9%).", {"entities": []}], ["Overall amounts of DNA obtained from blood or saliva were 25.8\u2005\u03bcg, with a 260/280 ratio of 1.86.", {"entities": []}], ["This study will contribute to the characterisation of a variety of risk factors for asthma, including urbanisation, total IgE levels, vitamin D levels and candidate genes, in a resource-poor setting.", {"entities": [[84, 90, "DISEASE"]]}], ["The authors present data to support high quality of survey, allergic, spirometric and genetic data collected in our study.", {"entities": []}], ["We sought to characterise the epidemiology of asthma in Peru by studying two regions with disparate degrees of urbanisation.", {"entities": [[46, 52, "DISEASE"]]}], ["We summarise the study design, implementation and standard operating procedures and provide quality control data for important outcome and exposure variables.", {"entities": []}], ["We present data to support high quality of survey, allergic, spirometric and genetic data collected in our study.", {"entities": []}], ["This study will contribute to the characterisation of a variety of risk factors for asthma, including urbanisation, total IgE levels, vitamin D levels and candidate genes, in a resource-poor setting.", {"entities": [[84, 90, "DISEASE"]]}], ["This study is cross-sectional and therefore does not track symptoms over time to directly determine causality.", {"entities": []}], ["In addition, we did not collect stool samples to assess parasitic infections nor do we have information on respiratory infections in early childhood.", {"entities": []}], ["The primary objective was to identify possible risk factors for delirium in patients with critical limb ischemia undergoing surgery.", {"entities": [[104, 112, "DISEASE"]]}], ["The secondary objective was to study the effect of delirium on complications, the length of hospital stay, health care costs, and mortality.", {"entities": []}], ["All patients 65 years or older with critical limb ischemia undergoing surgery from February 2013 to July 2014 at Amphia Hospital, were included and followed up until December 31, 2014.", {"entities": [[50, 58, "DISEASE"]]}], ["Delirium was scored using the Delirium Observation Screening Scale (DOSS).", {"entities": []}], ["Perioperative risk factors (age, comorbidity, factors of frailty, operation type, hemoglobulin, and transfusion) were collected and analyzed using logistic regression.", {"entities": []}], ["Secondary outcomes were the number of complications, total hospital stay, extra health care costs per delirium, and mortality within 3 months and 6 months of surgery.", {"entities": []}], ["We included 92 patients with critical limb ischemia undergoing surgery.", {"entities": [[43, 51, "DISEASE"]]}], ["Twenty-nine (32%) patients developed a delirium during admission, of whom 17 (59%) developed delirium preoperatively.", {"entities": []}], ["After multivariable analysis, only diabetes mellitus (odds ratio [OR] =6.23; 95% confidence interval [CI]: 1.11\u201352.2; P =0.035) and Short Nutritional Assessment Questionnaire for Residential Care (SNAQ-RC) \u22653 (OR =5.55; 95% CI: 1.07\u201342.0; P =0.039) was significantly associated with the onset of delirium.", {"entities": [[35, 52, "DISEASE"]]}], ["Delirium was associated with longer hospital stay ( P =0.001), increased health care costs, and higher mortality after 6 months ( P <0.001).", {"entities": []}], ["Delirium is a common adverse event in patients with critical limb ischemia undergoing surgery with devastating outcome in the long term.", {"entities": [[66, 74, "DISEASE"]]}], ["Most patients developed delirium preoperatively, which indicates the need for early recognition and preventive strategies in the preoperative period.", {"entities": []}], ["This study identified undernourishment and diabetes mellitus as independent risk factors for delirium.", {"entities": [[43, 60, "DISEASE"]]}], ["Building prediction models based on complex omics datasets such as transcriptomics, proteomics, metabolomics remains a challenge in bioinformatics and biostatistics.", {"entities": []}], ["Regularized regression techniques are typically used to deal with the high dimensionality of these datasets.", {"entities": []}], ["However, due to the presence of correlation in the datasets, it is difficult to select the best model and application of these methods yields unstable results.", {"entities": []}], ["We propose a novel strategy for model selection where the obtained models also perform well in terms of overall predictability.", {"entities": []}], ["Several three step approaches are considered, where the steps are 1) network construction, 2) clustering to empirically derive modules or pathways, and 3) building a prediction model incorporating the information on the modules.", {"entities": []}], ["For the first step, we use weighted correlation networks and Gaussian graphical modelling.", {"entities": []}], ["Identification of groups of features is performed by hierarchical clustering.", {"entities": []}], ["The grouping information is included in the prediction model by using group-based variable selection or group-specific penalization.", {"entities": []}], ["We compare the performance of our new approaches with standard regularized regression via simulations.", {"entities": []}], ["Based on these results we provide recommendations for selecting a strategy for building a prediction model given the specific goal of the analysis and the sizes of the datasets.", {"entities": []}], ["Finally we illustrate the advantages of our approach by application of the methodology to two problems, namely prediction of body mass index in the DIetary, Lifestyle, and Genetic determinants of Obesity and Metabolic syndrome study (DILGOM) and prediction of response of each breast cancer cell line to treatment with specific drugs using a breast cancer cell lines pharmacogenomics dataset.", {"entities": [[277, 290, "DISEASE"], [342, 355, "DISEASE"], [218, 226, "DISEASE"], [284, 290, "DISEASE"], [349, 355, "DISEASE"]]}], ["Basal cells in nasal epithelium have stemness/progenitor characters and play essential roles in the epithelial remodeling in nasal polyps (NP).", {"entities": []}], ["We investigate whether the human nasal epithelial stem/progenitor cells (hNESPCs) from patients with NP are inherently distinct from those obtained from healthy controls.", {"entities": []}], ["Epithelial basal cells were isolated and cultured for four passages from NP tissues and control nasal mucosa.", {"entities": []}], ["hNESPCs from controls were stained positively with stem cell marker p63 and KRT5 and presented a consistent high Ki67 expression level over four passages.", {"entities": [[76, 80, "GENE"]]}], ["In contrast, hNESPCs from NP patients showed: i).", {"entities": []}], ["a reduced growth and proliferation rate at each passage by evaluating colony-forming efficiency and doubling time; ii).", {"entities": []}], ["a lower percentage of Ki67", {"entities": []}], ["Anaemia is a commonly diagnosed complication among patients suffering with chronic kidney disease.", {"entities": [[83, 97, "DISEASE"]]}], ["If left untreated, it may affect patient quality of life.", {"entities": []}], ["There are several causes for anaemia in this patient population.", {"entities": []}], ["As the kidney function deteriorates, together with medications and dietary restrictions, patients may develop iron deficiency, resulting in reduction of iron supply to the bone marrow (which is the body organ responsible for the production of different blood elements).", {"entities": []}], ["Chronic kidney disease patients may not be able to utilise their own body\u2019s iron stores effectively and hence, many patients, particularly those receiving haemodialysis, may require additional iron treatment, usually provided by infusion.", {"entities": [[8, 22, "DISEASE"]]}], ["With further weakening of kidney function, patients with chronic kidney disease may need additional treatment with a substance called erythropoietin which drives the bone marrow to produce its own blood.", {"entities": [[65, 79, "DISEASE"]]}], ["This substance, which is naturally produced by the kidneys, becomes relatively deficient in patients with chronic kidney disease.", {"entities": [[114, 128, "DISEASE"]]}], ["Any patients will eventually require treatment with erythropoietin or similar products that are given by injection.", {"entities": []}], ["Over the last few years, several iron and erythropoietin products have been licensed for treating anaemia in chronic kidney disease patients.", {"entities": [[117, 131, "DISEASE"]]}], ["In addition, several publications discussed the benefits of each treatment and possible risks associated with long term treatment.", {"entities": []}], ["The current guidelines provide advice to health care professionals on how to screen chronic kidney disease patients for anaemia, which patients to investigate for other causes of anaemia, when and how to treat patients with different medications, how to ensure safe prescribing of treatment and how to diagnose and manage complications associated with anaemia and the drugs used for its treatment.", {"entities": [[92, 106, "DISEASE"]]}], ["The STOP-Bang questionnaire is used to screen patients for obstructive sleep apnoea (OSA).", {"entities": []}], ["We evaluated the association between STOP-Bang scores and the probability of OSA.", {"entities": []}], ["After Institutional Review Board approval, patients who visited the preoperative clinics for a scheduled inpatient surgery were approached for informed consent.", {"entities": []}], ["Patients answered STOP questionnaire and underwent either laboratory or portable polysomnography (PSG).", {"entities": []}], ["PSG recordings were scored manually.", {"entities": []}], ["The BMI, age, neck circumference, and gender (Bang) were documented.", {"entities": []}], ["Over 4 yr, 6369 patients were approached and 1312 (20.6%) consented.", {"entities": []}], ["Of them, 930 completed PSG, and 746 patients with complete data on PSG and STOP-Bang questionnaire were included for data analysis.", {"entities": []}], ["The median age of 746 patients was 60 yr, 49% males, BMI 30 kg m In the surgical population, a STOP-Bang score of 5\u20138 identified patients with high probability of moderate/severe OSA.", {"entities": []}], ["The STOP-Bang score can help the healthcare team to stratify patients for unrecognized OSA, practice perioperative precautions, or triage patients for diagnosis and treatment.", {"entities": []}], ["Pregnant and postpartum women with severe hypertension are at increased risk of stroke and require blood pressure (BP) reduction.", {"entities": [[42, 54, "DISEASE"]]}], ["Parenteral antihypertensives have been most commonly studied, but oral agents would be ideal for use in busy and resource-constrained settings.", {"entities": []}], ["To review systematically, the effectiveness of oral antihypertensive agents for treatment of severe pregnancy/postpartum hypertension.", {"entities": [[121, 133, "DISEASE"]]}], ["A systematic search of MEDLINE, EMBASE and the Cochrane Library was performed.", {"entities": []}], ["Randomised controlled trials in pregnancy and postpartum with at least one arm consisting of a single oral antihypertensive agent to treat systolic BP\u00a0\u2265\u00a0160\u00a0mmHg and/or diastolic BP\u00a0\u2265\u00a0110\u00a0mmHg.", {"entities": []}], ["Cochrane R ev M an 5.1 was used to calculate relative risk (RR) and weighted mean difference by random effects.", {"entities": []}], ["We identified 15 randomised controlled trials (915 women) in pregnancy and one postpartum trial.", {"entities": []}], ["Most trials in pregnancy compared oral/sublingual nifedipine capsules (8\u201310\u00a0mg) with another agent, usually parenteral hydralazine or labetalol.", {"entities": []}], ["Nifedipine achieved treatment success in most women, similar to hydralazine (84% with nifedipine; relative risk [RR] 1.07, 95% confidence interval [95% CI] 0.98\u20131.17) or labetalol (100% with nifedipine; RR 1.02, 95% CI 0.95\u20131.09).", {"entities": []}], ["Less than 2% of women treated with nifedipine experienced hypotension.", {"entities": []}], ["There were no differences in adverse maternal or fetal outcomes.", {"entities": []}], ["Target BP was achieved \u223c\u00a050% of the time with oral labetalol (100\u00a0mg) or methyldopa (250\u00a0mg) (47% labetelol versus 56% methyldopa; RR 0.85 95% CI 0.54\u20131.33).", {"entities": []}], ["Oral nifedipine, and possibly labetalol and methyldopa, are suitable options for treatment of severe hypertension in pregnancy/postpartum.", {"entities": [[101, 113, "DISEASE"]]}], ["Venoarterial extracorporeal life support (VA-ECLS) is an effective support of acute hemodynamic collapse caused by miscellaneous diseases.", {"entities": []}], ["However, using VA-ECLS for post-traumatic shock is controversial and may induce a disastrous hemorrhage.", {"entities": []}], ["To investigate the feasibility of using VA-ECLS to treat post-traumatic shock or cardiac arrest (CA), a single-center experience of VA-ECLS in traumatology was reported.", {"entities": []}], ["This retrospective study included nine patients [median age: 37 years, interquartile range (IQR): 26.5-46] with post-traumatic shock/CA who were treated with VA-ECLS in a single institution between November 2003 and October 2012.", {"entities": []}], ["The causes of trauma were high-voltage electrocution (n = 1), penetrating chest trauma (n = 1), and blunt chest or poly-trauma (n = 7).", {"entities": []}], ["Medians of the injury severity score and the maximal chest abbreviated injury scale were 34 (IQR: 15.5-41) and 4 (IQR: 3-4), respectively.", {"entities": []}], ["All patients received peripheral VA-ECLS without heparin infusion for at least 24 hours.", {"entities": []}], ["The median time from arrival at our emergency department (ED) to VA-ECLS was 6 h (IQR: 4-47.5).", {"entities": []}], ["The median duration of VA-ECLS was 91 h (IQR: 43-187) with a duration < 24 h in 2 patients.", {"entities": []}], ["Among the 9 patients, 5 received VA-ECLS to treat the post-traumatic shock/CA presenting during (n = 2) or following (n = 3) damage-control surgeries for initial trauma, and another 4 patients were supported for non-surgical complications associated with initial trauma.", {"entities": []}], ["VA-ECLS was terminated in 2 non-survivors owing to uncontrolled hemothorax or retroperitoneal hemorrhage.", {"entities": []}], ["Three patients survived to hospital discharge.", {"entities": []}], ["All of them received damage-control surgeries for initial trauma and experienced a complicated hospitalization after weaning off VA-ECLS.", {"entities": []}], ["Using VA-ECLS to treat post-traumatic shock/CA is challenging and requires multidisciplinary expertise.", {"entities": []}], ["The acid sensitive ion channels TRPV1 (transient receptor potential vanilloid receptor-1) and ASIC3 (acid sensing ion channel-3) respond to tissue acidification in the range that occurs during painful conditions such as inflammation and ischemia.", {"entities": [[237, 245, "DISEASE"], [32, 37, "GENE"]]}], ["Here, we investigated to which extent they are expressed by rat dorsal root ganglion neurons projecting to lung and pleura, respectively.", {"entities": []}], ["The tracer DiI was either injected into the left lung or applied to the costal pleura.", {"entities": []}], ["Retrogradely labelled dorsal root ganglion neurons were subjected to triple-labelling immunohistochemistry using antisera against TRPV1, ASIC3 and neurofilament 68 (marker for myelinated neurons), and their soma diameter was measured.", {"entities": [[130, 135, "GENE"]]}], ["Whereas 22% of pulmonary spinal afferents contained neither channel-immunoreactivity, at least one is expressed by 97% of pleural afferents.", {"entities": []}], ["TRPV1 Rat pleural and pulmonary spinal afferents express at least two different acid-sensitive channels that make them suitable to monitor tissue acidification.", {"entities": [[0, 5, "GENE"]]}], ["Patterns of co-expression and structural markers define neuronal subgroups that can be inferred to subserve different functions and may initiate specific reflex responses.", {"entities": []}], ["The higher prevalence of TRPV1", {"entities": [[25, 30, "GENE"]]}], ["We examined the use of low (<400\u2005\u03bcg/day, including no use) and high folic acid supplement (FAS) dosages (\u22651000\u2005\u03bcg/day) among pregnant women in Spain, and explored factors associated with the use of these non-recommended dosages.", {"entities": [[91, 94, "GENE"]]}], ["Population-based cohort study.", {"entities": []}], ["We analysed data from 2332 pregnant women of the INMA study, a prospective mother-child cohort study in Spain.", {"entities": []}], ["We assessed usual dietary folate and the use of FAS from preconception to the 3rd month (first period) and from the 4th to the 7th month (second period), using a validated food frequency questionnaire.", {"entities": [[48, 51, "GENE"]]}], ["We used multinomial logistic regression to estimate relative risk ratios (RRRs).", {"entities": []}], ["Over a half of the women used low dosages of FAS in the first and second period while 29% and 17% took high dosages of FAS, respectively.", {"entities": [[45, 48, "GENE"], [119, 122, "GENE"], [45, 48, "GENE"], [119, 122, "GENE"]]}], ["In the first period, tobacco smoking (RRR=1.63), alcohol intake (RRR=1.40), multiparous (RRR=1.44), unplanned pregnancy (RRR=4.20) and previous spontaneous abortion (RRR=0.58, lower use of high FAS dosages among those with previous abortions) were significantly associated with low FAS dosages.", {"entities": [[194, 197, "GENE"], [282, 285, "GENE"], [194, 197, "GENE"], [282, 285, "GENE"]]}], ["Alcohol consumption (RRR=1.42), unplanned pregnancy (RRR=2.66) and previous spontaneous abortion (RRR=0.68) were associated with high dosage use.", {"entities": []}], ["In the second period, only tobacco smoking was significantly associated with high FAS dosage use (RRR=0.67).", {"entities": [[82, 85, "GENE"]]}], ["A high proportion of pregnant women did not reach the recommended dosages of FAS in periconception and a considerable proportion also used FAS dosages \u22651000\u2005\u03bcg/day.", {"entities": [[77, 80, "GENE"], [139, 142, "GENE"], [77, 80, "GENE"], [139, 142, "GENE"]]}], ["Action should be planned by the Health Care System and health professionals to improve the appropriate periconceptional use of FAS, taking into consideration the associated factors.", {"entities": [[127, 130, "GENE"]]}], ["Autoimmune conditions are associated with an elevated risk of lymphoproliferative malignancies, but few studies have investigated the risk of myeloid malignancies.", {"entities": []}], ["From the US Surveillance Epidemiology and End Results (SEER)-Medicare database, 13\u2009486 myeloid malignancy patients (aged 67+ years) and 160\u2009086 population-based controls were selected.", {"entities": []}], ["Logistic regression models adjusted for gender, age, race, calendar year and number of physician claims were used to estimate odds ratios (ORs) for myeloid malignancies in relation to autoimmune conditions.", {"entities": []}], ["Multiple comparisons were controlled for using the Bonferroni correction ( P <0.0005).", {"entities": []}], ["Autoimmune conditions, overall, were associated with an increased risk of acute myeloid leukaemia (AML) (OR 1.29) and myelodysplastic syndrome (MDS, OR 1.50).", {"entities": [[134, 142, "DISEASE"]]}], ["Specifically, AML was associated with rheumatoid arthritis (OR 1.28), systemic lupus erythematosus (OR 1.92), polymyalgia rheumatica (OR 1.73), autoimmune haemolytic anaemia (OR 3.74), systemic vasculitis (OR 6.23), ulcerative colitis (OR 1.72) and pernicious anaemia (OR 1.57).", {"entities": [[38, 58, "DISEASE"], [110, 132, "DISEASE"], [79, 98, "DISEASE"], [194, 204, "DISEASE"], [49, 58, "DISEASE"], [70, 98, "DISEASE"], [216, 234, "DISEASE"]]}], ["Myelodysplastic syndrome was associated with rheumatoid arthritis (OR1.52) and pernicious anaemia (OR 2.38).", {"entities": [[45, 65, "DISEASE"], [16, 24, "DISEASE"], [56, 65, "DISEASE"]]}], ["Overall, autoimmune conditions were not associated with chronic myeloid leukaemia (OR 1.09) or chronic myeloproliferative disorders (OR 1.15).", {"entities": []}], ["Medications used to treat autoimmune conditions, shared genetic predisposition and/or direct infiltration of bone marrow by autoimmune conditions, could explain these excess risks of myeloid malignancies.", {"entities": []}], ["Constitutive activation of the receptor tyrosine kinase Fms-like tyrosine kinase 3 (FLT3), via co-expression of its ligand or by genetic mutation, is common in acute myeloid leukemia (AML).", {"entities": [[166, 182, "DISEASE"], [160, 182, "DISEASE"], [174, 182, "DISEASE"], [84, 88, "GENE"]]}], ["In this study we show that FLT3 activation inhibits the activity of the tumor suppressor, protein phosphatase 2A (PP2A).", {"entities": [[27, 31, "GENE"]]}], ["Using BaF3 cells transduced with wildtype or mutant FLT3, we show that FLT3-induced PP2A inhibition sensitizes cells to the pharmacological PP2A activators, FTY720 and AAL(S).", {"entities": [[52, 56, "GENE"], [71, 75, "GENE"]]}], ["FTY720 and AAL(S) induced cell death and inhibited colony formation of FLT3 activated cells.", {"entities": [[71, 75, "GENE"]]}], ["Furthermore, PP2A activators reduced the phosphorylation of ERK and AKT, downstream targets shared by both FLT3 and PP2A, in FLT3/ITD", {"entities": [[107, 111, "GENE"], [125, 129, "GENE"]]}], ["Previous studies have demonstrated that regulatory T cells (Tregs) are pivotal in the regulation of T cell-mediated immune responses in atherosclerosis, a chronic autoimmune-like disease.", {"entities": [[136, 151, "DISEASE"]]}], ["In the authors' previous studies, it was demonstrated that amygdalin ameliorated atherosclerosis by the regulation of Tregs in apolipoprotein E-deficient (ApoE", {"entities": [[81, 96, "DISEASE"], [155, 159, "GENE"]]}], ["Surgery remains the preferred treatment for hydatid cyst (cystic echinococcosis, CE).", {"entities": [[65, 79, "DISEASE"], [58, 79, "DISEASE"]]}], ["Various scolicidal agents have been used for inactivation of protoscolices during surgery, but most of them are associated with adverse side effects.", {"entities": []}], ["The present study aimed to evaluate the in vitro scolicidal effect of Nigella sativa (Ranunculaceae) essential oil and also its active principle, thymoquinone, against protoscolices of hydatid cysts.", {"entities": []}], ["Protoscolices were aseptically aspirated from sheep livers having hydatid cysts.", {"entities": []}], ["Various concentrations of the essential oil (0.01-10 mg/ml) and thymoquinone (0.125-1.0 mg/ml) were used for 5 to 60 min.", {"entities": []}], ["Viability of protoscolices was confirmed by 0.1% eosin staining.", {"entities": []}], ["Furthermore, the components of the N. sativa essential oil were identified by gas chromatography/mass spectroscopy (GC/MS).", {"entities": []}], ["Our study revealed that the essential oil of N. sativa at the concentration of 10 mg/ml and its main component, thymoquinone, at the concentration of 1 mg/ml had potent scolicidal activities against protoscolices of Echinococcus granulosus after 10 min exposure.", {"entities": []}], ["Moreover, thymoquinone (42.4%), p-cymene (14.1%), carvacrol (10.3%), and longifolene (6.1%) were found to be the major components of N. sativa essential oil by GC/MS analysis.", {"entities": []}], ["The results of this study indicated the potential of N. sativa as a natural source for production of a new scolicidal agent for use in hydatid cyst surgery.", {"entities": []}], ["However, further studies will be needed to confirm these results by checking the essential oil and its active component in in vivo models.", {"entities": []}], ["The choroid plexus (CP) provides a barrier to entry of toxic molecules from the blood into the brain and transports vital molecules into the cerebrospinal fluid.", {"entities": [[20, 22, "GENE"]]}], ["While a great deal is known about CP physiology, relatively little is known about its immunology.", {"entities": [[34, 36, "GENE"]]}], ["Here, we show immunohistochemical data that help define the role of the CP in innate and adaptive humoral immunity.", {"entities": [[72, 74, "GENE"]]}], ["The results show that complement, in the form of C1q, C3d, C9, or C9neo, is preferentially deposited in stromal concretions.", {"entities": [[59, 61, "GENE"]]}], ["In contrast, immunoglobulin (Ig) G (IgG) and IgA are more often found in CP epithelial cells, and IgM is found in either locale.", {"entities": [[73, 75, "GENE"]]}], ["C4d, IgD, and IgE are rarely, if ever, seen in the CP.", {"entities": [[51, 53, "GENE"]]}], ["In multiple sclerosis CP, basement membrane C9 or stromal IgA patterns were common but were not specific for the disease.", {"entities": [[3, 21, "DISEASE"], [22, 24, "GENE"], [44, 46, "GENE"]]}], ["These findings indicate that the CP may orchestrate the clearance of complement, particularly by deposition in its concretions, IgA and IgG preferentially via its epithelium, and IgM by either mechanism.", {"entities": [[33, 35, "GENE"]]}], ["Respiratory illness caused by viral infection is associated with the development and exacerbation of childhood asthma.", {"entities": [[111, 117, "DISEASE"]]}], ["Little is known about the effects of respiratory viral infections in the absence of illness.", {"entities": []}], ["Using quantitative PCR (qPCR) for common respiratory viruses and for two genes known to be highly upregulated in viral infections ( CCL8 / CXCL11 ), we screened 92 asthmatic and 69 healthy children without illness for respiratory virus infections.", {"entities": [[132, 136, "GENE"], [139, 145, "GENE"]]}], ["We found 21 viral qPCR-positive and 2 suspected virus-infected subjects with high expression of CCL8/CXCL11 .", {"entities": []}], ["We applied a dual RNA-seq workflow to these subjects, together with 25 viral qPCR-negative subjects, to compare qPCR with sequencing-based virus detection and to generate the airway transcriptome for analysis.", {"entities": []}], ["RNA-seq virus detection achieved 86% sensitivity when compared to qPCR-based screening.", {"entities": []}], ["We detected additional respiratory viruses in the two CCL8/CXCL11 -high subjects and in two of the qPCR-negative subjects.", {"entities": []}], ["Viral read counts varied widely and were used to stratify subjects into Virus-High and Virus-Low groups.", {"entities": []}], ["Examination of the host airway transcriptome found that the Virus-High group was characterized by immune cell airway infiltration, downregulation of cilia genes, and dampening of type 2 inflammation.", {"entities": []}], ["Even the Virus-Low group was differentiated from the No-Virus group by 100 genes, some involved in eIF2 signaling.", {"entities": []}], ["Respiratory virus infection without illness is not innocuous but may determine the airway function of these subjects by driving immune cell airway infiltration, cellular remodeling, and alteration of asthmogenic gene expression.", {"entities": []}], ["The online version of this article (doi:10.1186/s13059-016-1140-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Prescription opioid and heroin abuse have been increasing steadily year after year, and continue to be a serious national problem.", {"entities": []}], ["A sequela of the increase in opioid abuse has been an increase in the number of infants born with opioid dependence.", {"entities": [[29, 41, "DISEASE"]]}], ["These infants often require costly, prolonged stays in the neonatal intensive care unit (NICU) for drug withdrawal treatment.", {"entities": []}], ["The authors studied a population of infants from a large Medicaid health plan who were born with neonatal abstinence syndrome (NAS) secondary to in utero opioid exposure to assess the average length of stay in the NICU, and to determine the variables that may account for differences in interinstitutional lengths of stay.", {"entities": [[97, 125, "DISEASE"], [117, 125, "DISEASE"]]}], ["The overall average length of stay for NAS was 21.1 days for the 139 infants included in the study.", {"entities": []}], ["Analysis of the medication used for treatment revealed that infants who were treated with a combined inpatient/outpatient regimen with methadone had an average length of stay of 11.4 days versus 25.1 days for infants who were treated entirely as inpatients ( P <0.001), a 55% reduction in average length of stay.", {"entities": []}], ["In 2009 there were an estimated 13,600 cases of NAS in the United States at a cost of $53,000 per case.", {"entities": []}], ["A 55% reduction in length of stay corresponds to $396 million in annual savings for the treatment of NAS.", {"entities": []}], ["Development of successful combined inpatient/outpatient management programs for NAS warrants further consideration.", {"entities": []}], ["( Population Health Management 2015;18:392\u2013397)", {"entities": []}], ["The culture supernatant of Paenibacillus sp.", {"entities": []}], ["TKU036, a bacterium isolated from Taiwanese soils, showed high antioxidant activity (85%) when cultured in a squid pen powder (SPP)-containing medium at 37 \u00b0C for three days.", {"entities": []}], ["Homogentisic acid (2,5-dihydroxyphenylacetic acid, HGA) was isolated and found to be the major antioxidant in the culture supernatant of the SPP-containing medium fermented by Paenibacillus sp.", {"entities": []}], ["Tryptophan was also present in the culture supernatant.", {"entities": []}], ["The results of high-performance liquid chromatography (HPLC) fingerprinting showed that HGA and tryptophan were produced via fermentation but did not pre-exist in the unfermented SPP-containing medium.", {"entities": []}], ["Neither HGA nor tryptophan was found in the culture supernatants obtained from the fermentation of nutrient broth or other chitinous material, i.e., medium containing shrimp head powder, by Paenibacillus sp.", {"entities": []}], ["The production of HGA via microorganisms has rarely been reported.", {"entities": []}], ["In this study, we found that squid pen was a potential carbon and nitrogen source for Paenibacillus sp.", {"entities": []}], ["Tryptophan (105 mg/L) and HGA (60 mg/L) were recovered from the culture supernatant.", {"entities": []}], ["The isolated HGA was found to have higher antioxidant activity (IC 50 = 6.9 \u03bcg/mL) than \u03b1-tocopherol (IC 50 = 17.6 \u03bcg/mL).", {"entities": []}], ["The anti-inflammatory activity of the isolated HGA (IC 50 = 10.14 \u03bcg/mL) was lower than that of quercetin (IC 50 = 1.14 \u03bcg/mL).", {"entities": []}], ["As a result, squid pen, a fishery processing byproduct, is a valuable material for the production of tryptophan and the antioxidant and anti-inflammatory HGA via microbial conversion.", {"entities": []}], ["We analyzed 12-month compliance for all ten oral osteoporosis drugs in the Netherlands by medication possession ratio (MPR\u2009\u2265\u200980%) in 105,506 patients, and persistence in 8,626 starters indicated high MPR (91%), low persistence (43%), and no restart in 78% of the stoppers after 18\u00a0months.", {"entities": [[49, 61, "DISEASE"]]}], ["We studied compliance and persistence for all available oral osteoporosis medications on a national scale in the Netherlands.", {"entities": [[61, 73, "DISEASE"]]}], ["We analyzed the IMS Health\u2019s longitudinal prescription database, which represents 73% of all pharmacies in the Netherlands.", {"entities": []}], ["Twelve-month compliance was measured by medication possession ratio (MPR) in a cross-sectional cohort of 105,506 patients who received at least three prescriptions.", {"entities": []}], ["Twelve-month persistence (no gap in refills for >6\u00a0months) was measured in all 8,626 consecutive patients starting therapy, with a further follow-up in non-persistent patients during an additional 18\u00a0months for evaluation of switching, restart, or definitive stopping oral medication.", {"entities": []}], ["Multivariate logistic regression analysis was used to analyze the odds ratios (ORs) with 95% confidence intervals (CI) of characteristics of non-persistence.", {"entities": []}], ["MPR of \u226580% was found in 91% of patients.", {"entities": []}], ["Persistence was 43% (range, 29\u201352%).", {"entities": []}], ["Persistence was related to age >60\u00a0years (ORs, 1.41 to 1.64), pharmacy outside very dense urban area (ORs, 1.39 to 1.44), additional use of calcium and/or vitamin D supplementation (OR, 1.26 and CI, 1.13, 1.39) and use of glucocorticoids (OR, 0.65 and CI, 0.59, 0.72) or cardiovascular medication (OR, 0.88 and CI, 0.79, 0.97).", {"entities": []}], ["Of non-persistent patients, 22% restarted within 18\u00a0months with oral osteoporosis drugs.", {"entities": [[69, 81, "DISEASE"]]}], ["One-year compliance for all available oral osteoporosis medications was high, but 1-year persistence was low.", {"entities": [[43, 55, "DISEASE"]]}], ["Most stoppers did not restart or switch during an additional 18-month follow-up.", {"entities": []}], ["These data indicate a major failure to adequately treat patients at high risk for fractures in daily practice.", {"entities": []}], ["Apigenin is a naturally occurring plant flavonoid that possesses antioxidant, anti-cancer and anti-inflammatory properties.", {"entities": [[83, 89, "DISEASE"]]}], ["However, there are few reports has been done on the ability of apigenin to induce apoptosis in macrophages.", {"entities": []}], ["In this study, mouse macrophage ANA-1 cells were incubated with different concentrations of apigenin.", {"entities": []}], ["The cell viability was determined by an MTT assay.", {"entities": []}], ["The cell apoptosis were analyzed by flow cytometric analysis.", {"entities": []}], ["Apoptosis were also analyzed using a TUNEL assay and a DNA ladder.", {"entities": []}], ["The level of intracellular ROS was detected using a dichlorofluorescein -diacetate probe.", {"entities": []}], ["The expression levels of apoptosis-related proteins were detected by western blot analysis.", {"entities": []}], ["The results showed that apigenin decreased the viability of ANA-1 cells and induced apoptosis in a dose- and time-dependent manner.", {"entities": []}], ["Apigenin increased the level of intracellular ROS, downregulated the expression of Bcl-2 and upregulated the expression of caspase-3 and caspase-8 in ANA-1 cells.", {"entities": []}], ["Furthermore, apigenin downregulated the expression of phospho-ERK and phospho-JNK, upregulated the expression of phospho-p38 and had no significant effect on the expression of Bax, ERK, JNK and p38.", {"entities": [[176, 179, "GENE"]]}], ["The results suggested that apigenin induced cell apoptosis in mouse macrophage ANA-1 cells may via increasing intracellular ROS, regulating the MAPK pathway, and then inhibiting Bcl-2 expression.", {"entities": []}], ["Sexual assault is a traumatic event with potentially devastating lifelong effects on physical and mental health.", {"entities": []}], ["Research has demonstrated that individuals who experience sexual assault during childhood are more likely to engage in risky behaviors later in life, such as smoking, alcohol and drug use, and disordered eating habits, which may increase the risk of developing a chronic disease.", {"entities": []}], ["Despite the high prevalence and economic burden of sexual assault, few studies have investigated the associations between sexual violence and chronic health conditions in the US.", {"entities": []}], ["The purpose of this study is to identify associations between sexual violence and health risk behaviors, chronic health conditions and mental health conditions utilizing population based data in Kansas.", {"entities": []}], ["Secondary analysis was done using data from the 2011 Kansas Behavioral Risk Factor Surveillance System sexual violence module (N\u2009=\u20094,886).", {"entities": []}], ["Crude and adjusted prevalence rate ratios were computed to examine associations between sexual assault and health risk behaviors, chronic health conditions and mental health conditions, overall and after adjusting for social demographic characteristics.", {"entities": []}], ["Additional logistic regression models were implemented to examine the association between sexual assault and health risk behaviors with further adjustment for history of anxiety or depression.", {"entities": []}], ["There was a significantly higher prevalence of health risk behaviors (heavy drinking, binge drinking and current smoking), chronic health conditions (disability, and current asthma) and mental health conditions (depression, anxiety, and suicidal ideation) among women who ever experienced sexual assault compared to women who did not, even after adjustment for potential confounders.", {"entities": [[174, 180, "DISEASE"]]}], ["Study findings highlight the need for chronic disease prevention services for victims of sexual violence.", {"entities": []}], ["There are important implications for policies and practices related to primary, secondary, and tertiary prevention, as well as collaborations between sexual violence, chronic disease, and health risk behavior programs.", {"entities": []}], ["Influenza-related hospitalizations impose a considerable economic and social burden.", {"entities": [[0, 9, "DISEASE"]]}], ["This study aimed to better understand the economic burden of influenza-related hospitalizations among patients in China in different age and risk categories.", {"entities": [[61, 70, "DISEASE"]]}], ["Laboratory-confirmed influenza-related hospitalizations between December 2009 and June 2011 from three hospitals participating in the Chinese Severe Acute Respiratory Infections (SARI) sentinel surveillance system were included in this study.", {"entities": [[21, 30, "DISEASE"]]}], ["Hospital billing data were collected from each hospital\u2019s Hospital Information System (HIS) and divided into five cost categories.", {"entities": []}], ["Demographic and clinical information was collected from medical records.", {"entities": []}], ["Mean (range) and median (interquartile range [IQR]) costs were calculated and compared among children (\u226415 years), adults (16\u201364 years) and elderly (\u226565 years) groups.", {"entities": []}], ["Factors influencing cost were analyzed.", {"entities": []}], ["A total of 106 laboratory-confirmed influenza-related hospitalizations were identified, 60% of which were children.", {"entities": [[36, 45, "DISEASE"]]}], ["The mean (range) direct medical cost was $1,797 ($80\u2013$27,545) for all hospitalizations, and the median (IQR) direct medical cost was $231 ($164), $854 ($890), and $2,263 ($7,803) for children, adults, and elderly, respectively.", {"entities": []}], ["Therapeutics and diagnostics were the two largest components of direct medical cost, comprising 57% and 23%, respectively.", {"entities": []}], ["Cost of physician services was the lowest at less than 1%.", {"entities": []}], ["Direct medical cost of influenza-related hospitalizations imposes a heavy burden on patients and their families in China.", {"entities": [[23, 32, "DISEASE"]]}], ["Further study is needed to provide more comprehensive evidence on the economic burden of influenza.", {"entities": [[89, 98, "DISEASE"]]}], ["Our study highlights the need to increase vaccination rate and develop targeted national preventive strategies.", {"entities": []}], ["Tax1-binding protein 1 (Tax1bp1) negatively regulates NF-\u03baB by editing the ubiquitylation of target molecules by its catalytic partner A20.", {"entities": [[24, 31, "GENE"]]}], ["Genetically engineered TAX1BP1 -deficient (KO) mice develop age-dependent inflammatory constitutions in multiple organs manifested as valvulitis or dermatitis and succumb to premature death.", {"entities": [[148, 158, "DISEASE"], [23, 30, "GENE"]]}], ["Laser capture dissection and gene expression microarray analysis on the mitral valves of TAX1BP1- KO mice (8 and 16 week old) revealed 588 gene transcription alterations from the wild type.", {"entities": []}], ["SAA3 (serum amyloid A3), CHI3L1 , HP , IL1B and SPP1/OPN were induced 1,180-, 361-, 187-, 122- and 101-fold respectively.", {"entities": [[25, 31, "GENE"], [34, 36, "GENE"], [39, 43, "GENE"]]}], ["WIF1 (Wnt inhibitory factor 1) exhibited 11-fold reduction.", {"entities": [[0, 4, "GENE"]]}], ["Intense Saa3 staining and significant I-\u03baB\u03b1 reduction were reconfirmed and massive infiltration of inflammatory lymphocytes and edema formation were seen in the area.", {"entities": []}], ["Antibiotics-induced \u2018germ free\u2019 status or the additional MyD88 deficiency significantly ameliorated TAX1BP1- KO mice's inflammatory lesions.", {"entities": [[57, 62, "GENE"]]}], ["These pathological conditions, as we named \u2018pseudo-infective endocarditis\u2019 were boosted by the commensal microbiota who are usually harmless by their nature.", {"entities": [[61, 73, "DISEASE"], [51, 73, "DISEASE"]]}], ["This experimental outcome raises a novel mechanistic linkage between endothelial inflammation caused by the ubiquitin remodeling immune regulators and fatal cardiac dysfunction.", {"entities": []}], ["Adenosine stress cardiovascular magnetic resonance (CMR) has been proven an effective tool in detection of reversible ischemia.", {"entities": [[118, 126, "DISEASE"]]}], ["Limited evidence is available regarding its accuracy in the setting of acute coronary syndromes, particularly in evaluating the significance of non-culprit vessel ischaemia.", {"entities": []}], ["Adenosine stress CMR and recent advances in semi-quantitative image analysis may prove effective in this area.", {"entities": []}], ["We sought to determine the diagnostic accuracy of semi-quantitative versus visual assessment of adenosine stress CMR in detecting ischemia in non-culprit territory vessels early after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).", {"entities": [[130, 138, "DISEASE"], [258, 279, "DISEASE"]]}], ["Patients were prospectively enrolled in a CMR imaging protocol with rest and adenosine stress perfusion, viability and cardiac functional assessment 3 days after successful primary-PCI for STEMI.", {"entities": []}], ["Three short axis slices each divided into 6 segments on first pass adenosine perfusion were visually and semi-quantitatively analysed.", {"entities": []}], ["Diagnostic accuracy of both methods was compared with non-culprit territory vessels utilising quantitative coronary angiography (QCA) with significant stenosis defined as \u226570%.", {"entities": []}], ["Fifty patients (age 59 \u00b1 12 years) admitted with STEMI were evaluated.", {"entities": []}], ["All subjects tolerated the adenosine stress CMR imaging protocol with no significant complications.", {"entities": []}], ["The cohort consisted of 41% anterior and 59% non anterior infarctions.", {"entities": []}], ["There were a total of 100 non-culprit territory vessels, identified on QCA.", {"entities": []}], ["The diagnostic accuracy of semi-quantitative analysis was 96% with sensitivity of 99%, specificity of 67%, positive predictive value (PPV) of 97% and negative predictive value (NPV) of 86%.", {"entities": []}], ["Visual analysis had a diagnostic accuracy of 93% with sensitivity of 96%, specificity of 50%, PPV of 97% and NPV of 43%.", {"entities": []}], ["Adenosine stress CMR allows accurate detection of non-culprit territory stenosis in patients successfully treated with primary-PCI post STEMI.", {"entities": []}], ["Semi-quantitative analysis may be required for improved accuracy.", {"entities": []}], ["Larger studies are however required to demonstrate that early detection of non-culprit vessel ischemia in the post STEMI setting provides a meaningful test to guide clinical decision making and ultimately improved patient outcomes.", {"entities": [[94, 102, "DISEASE"]]}], ["Members of the calcium-activated chloride channel (CLCA) gene family have been suggested to possess a variety of functions including cell adhesion and tumor suppression.", {"entities": []}], ["Expression of CLCA family members has mostly been analyzed in non-neural tissues.", {"entities": []}], ["Here we describe the expression of mouse and human CLCA genes in the nervous system.", {"entities": []}], ["We show that from the six mouse CLCA family members only Clca1, Clca2 and Clca4 mRNAs are expressed in the adult brain, predominantly in olfactory ensheathing cells.", {"entities": [[57, 62, "GENE"], [64, 69, "GENE"], [74, 79, "GENE"]]}], ["During mouse nervous system development Clca1/2 is more widely expressed, particularly in cranial nerves, the diencephalon and in the cerebral cortex.", {"entities": []}], ["While human CLCA2 and CLCA4 genes are widely expressed in brain, and at particularly high levels in the optic nerve, human CLCA3, the closest homologue of mouse Clca1, Clca2 and Clca4, is not expressed in the brain.", {"entities": [[12, 17, "GENE"], [168, 173, "GENE"], [22, 27, "GENE"], [178, 183, "GENE"], [161, 166, "GENE"], [12, 17, "GENE"], [168, 173, "GENE"], [22, 27, "GENE"], [178, 183, "GENE"]]}], ["Furthermore, we characterize the expression pattern of mouse Clca1/2 genes during embryonic development by in situ hybridization.", {"entities": []}], ["The data published in this article indicate that within the nervous system mouse Clca1/2 genes are highly expressed in the cells ensheathing cranial nerves.", {"entities": []}], ["Human CLCA2 and CLCA4 mRNAs are expressed at high level in optic nerve.", {"entities": [[6, 11, "GENE"], [16, 21, "GENE"]]}], ["High level expression of CLCA family members in mouse and human glial cells ensheathing nerves suggests a specific role for CLCA proteins in the development and homeostasis of these cells.", {"entities": []}], ["Chronic bronchitis (CB), emphysematous (EM) and asthma\u2013chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) phenotypes in COPD are well recognized.", {"entities": [[55, 92, "DISEASE"], [108, 116, "DISEASE"], [48, 54, "DISEASE"], [8, 18, "DISEASE"]]}], ["This study aimed to investigate distinguishing characteristics of these phenotypes in COPD patients with frequent exacerbations (FE).", {"entities": []}], ["A retrospective study was carried out.", {"entities": []}], ["COPD patients with acute exacerbations were consecutively reviewed from November 2015 to October 2016.", {"entities": []}], ["Patients were divided into FE and infrequent exacerbations (iFE) subgroups.", {"entities": []}], ["A total of 142 eligible COPD subjects were reviewed.", {"entities": []}], ["In the CB phenotype subgroup, age, body mass index, forced expiratory volume in 1 second (FEV 1 ) % predicted, COPD assessment test (CAT), modified Medical Research Council breathlessness measurement (mMRC) dyspnea scale, emphysema scores and arterial carbon dioxide pressure (PaCO 2 ) were significantly different in subjects with FE when compared to those in subjects with iFE of CB.", {"entities": [[90, 93, "GENE"]]}], ["In the EM phenotype subgroup, age, CAT, mMRC scores and history of COPD were different in subjects with FE when compared to those in CB subjects with iFE.", {"entities": []}], ["Multivariate analysis indicated that FEV 1 % predicted (odds ratio [OR] =0.90, P =0.04) and PaCO 2 (OR =1.22, P =0.02) were independent risk factors for FE in COPD with CB phenotype, and CAT (OR =2.601, P =0.001) was the independent risk factor for FE in COPD with EM phenotype.", {"entities": [[37, 40, "GENE"]]}], ["No significant differences in characteristics were observed in ACOS phenotype subgroups with FE or iFE.", {"entities": []}], ["In CB or EM phenotypes, COPD patients with FE present several differential clinical characteristics compared to patients with iFE, while the characteristics of ACOS phenotype in patients with FE need more investigation.", {"entities": []}], ["Racial/ethnic minorities are 1.5 to 2.0 times more likely than whites to have most of the major chronic diseases.", {"entities": []}], ["Chronic diseases are also more common in the poor than the nonpoor and this association is frequently mediated by race/ethnicity.", {"entities": []}], ["Specifically, children are disproportionately affected by racial/ethnic health disparities.", {"entities": []}], ["Between 1960 and 2005 the percentage of children with a chronic disease in the United States almost quadrupled with racial/ethnic minority youth having higher likelihood for these diseases.", {"entities": []}], ["The most common major chronic diseases of youth in the United States are asthma, diabetes mellitus, obesity, hypertension, dental disease, attention-deficit/hyperactivity disorder, mental illness, cancers, sickle-cell anemia, cystic fibrosis, and a variety of genetic and other birth defects.", {"entities": [[109, 121, "DISEASE"], [100, 107, "DISEASE"], [226, 241, "DISEASE"], [73, 79, "DISEASE"], [218, 224, "DISEASE"], [81, 98, "DISEASE"]]}], ["This review will focus on the psychosocial rather than biological factors that play important roles in the etiology and subsequent solutions to these health disparities because they should be avoidable and they are inherently unjust.", {"entities": []}], ["Finally, this review examines access to health services by focusing on health insurance and dental insurance coverage and access to school health services.", {"entities": []}], ["The objective of this study was to determine the cell surface hydrophobicity of 40 oral Candida albicans isolates obtained from smokers, diabetics, asthmatics using steroid inhalers, and healthy individuals, following brief exposure to subtherapeutic concentrations of chlorhexidine gluconate.", {"entities": []}], ["Forty C. albicans oral isolates (10 isolates each from smokers, diabetics, asthmatics using steroid inhalers, and healthy individuals) were exposed to 3 subtherapeutic concentrations of chlorhexidine gluconate (0.00125, 0.0025, and 0.005%) for 30 min.", {"entities": []}], ["Thereafter, the antiseptic was removed and the cell surface hydrophobicity was measured by a biphasic aqueous-hydrocarbon assay.", {"entities": []}], ["Compared to the unexposed controls, the cell surface hydrophobicity of C. albicans isolates was suppressed by 5.40% (p > 0.05), 21.17% (p < 0.05), and 44.67% (p < 0.05) following exposure to 0.00125, 0.0025, and 0.005% chlorhexidine gluconate, respectively.", {"entities": []}], ["A brief period of transient exposure to subtherapeutic concentrations of chlorhexidine gluconate may modulate the cell surface hydrophobicity of C. albicans isolates and thereby may reduce candidal pathogenicity.", {"entities": []}], ["Bacterial Lipopolysaccharide (LPS) is a strong inducer of inflammation and does so by inducing polarization of macrophages to the classic inflammatory M1 population.", {"entities": []}], ["Given the role of Btk as a critical signal transducer downstream of TLR4, we investigated its role in M1/M2 induction.", {"entities": [[18, 21, "GENE"], [68, 72, "GENE"]]}], ["In Btk deficient ( Btk Ex vivo analysis demonstrated an impaired ability of Btk Btk Schistosoma mansoni eggs or chitin resulted in increased recruitment of M2 macrophages and induction of M2-associated genes.", {"entities": [[3, 6, "GENE"], [19, 22, "GENE"], [76, 79, "GENE"], [80, 83, "GENE"], [3, 6, "GENE"], [19, 22, "GENE"], [76, 79, "GENE"], [80, 83, "GENE"], [3, 6, "GENE"], [19, 22, "GENE"], [76, 79, "GENE"], [80, 83, "GENE"], [3, 6, "GENE"], [19, 22, "GENE"], [76, 79, "GENE"], [80, 83, "GENE"]]}], ["This demonstrates an enhanced M2 skew in the absence of Btk, thus promoting the development of allergic inflammation.", {"entities": [[56, 59, "GENE"]]}], ["Cessation services have been recommended to complement smoke-free policies in subsidized multiunit housing, but little is known about smoking- and cessation-related characteristics among subsidized housing tenants.", {"entities": []}], ["This study examined smoking behaviors and cessation-related interests in a population of subsidized housing tenants.", {"entities": []}], ["A face-to-face survey was conducted in August to October 2011 with a probability sample of private subsidized housing lease holders in Columbus, Ohio (N = 301, 64% response rate).", {"entities": []}], ["Almost half (47.5%) of respondents were current smokers, including smokers of cigarettes or small cigars.", {"entities": []}], ["Smokers were less likely than nonsmokers to have health insurance and more likely to be at risk for food insecurity.", {"entities": []}], ["Among smokers, 20.3% did not smoke daily and 35.0% smoked 5 or fewer cigarettes per day.", {"entities": []}], ["More than half (61.3%) purchased single cigarettes in the past month, with higher rates among nondaily smokers.", {"entities": []}], ["Most smokers intended to quit within 6 months or less (60.1%) and were interested in using nicotine replacement therapy (NRT) (65.0%).", {"entities": []}], ["Most respondents had Medicaid but only 30.4% knew Medicaid covered cessation medications.", {"entities": []}], ["This population of subsidized housing tenants had high rates of smoking, including light smoking.", {"entities": []}], ["Interest in NRT was high and access can be improved by increasing awareness of Medicaid coverage among clients and health care providers.", {"entities": []}], ["However, more research is needed about scalable, evidence-based cessation strategies for low-socioeconomic status and light smokers.", {"entities": []}], ["Strategies to address environmental factors such as availability of single cigarettes should also be considered in parallel with smoke-free policies.", {"entities": []}], ["This study aimed to characterize patients with chronic obstructive pulmonary disease (COPD) newly prescribed a long-acting bronchodilator (LABD), and to assess changes in medication over 24 months.", {"entities": [[47, 84, "DISEASE"]]}], ["A cohort of patients with COPD aged \u226540 years newly prescribed an LABD between January 1, 2007 and December 31, 2009 were identified from the Truven Marketscan 2 -agonists (LABAs) were also assessed.", {"entities": []}], ["A cohort of 3,268 patients aged 40\u201365 years was identified (mean age 55.8 years, 48% male).", {"entities": []}], ["LAMA monotherapy was prescribed to 93% of patients who received an LABD.", {"entities": []}], ["During the 24-month follow-up, 16% of these patients added COPD medication, 10% switched to an inhaled corticosteroid-containing medication, and 25% discontinued after one LAMA prescription at baseline.", {"entities": []}], ["Over 12 and 24 months, adherence to LAMA was 40% and 33%, respectively, and adherence to LABA was 29% and 24%, respectively.", {"entities": []}], ["Over the same time periods, persistence with LAMA monotherapy was 19% and 15%, respectively, and persistence with LABA was 9% and 7%, respectively.", {"entities": []}], ["Adherence to newly initiated LAMA monotherapy was low, with one in four patients adding to or switching from LAMA and many patients discontinuing therapy.", {"entities": []}], ["Adherence to LABA was also low.", {"entities": []}], ["These results suggest that additional medication to a single LABD may be required in some patients with COPD to achieve optimal disease control.", {"entities": []}], ["This study examines the relationship between laryngopharyngeal reflux (LPR) symptoms and oropharyngeal pH levels in singers.", {"entities": []}], ["We hypothesized that reported symptoms would correlate with objective measures of pH levels from the oropharynx, including the number and total duration of reflux episodes.", {"entities": []}], ["Twenty professional/semiprofessional singers completed the Reflux Symptom Index (RSI) and underwent oropharyngeal pH monitoring.", {"entities": []}], ["Mild, moderate, or severe pH exposure was recorded during oropharyngeal pH monitoring.", {"entities": []}], ["Correlations were performed to examine potential relationships between reflux symptoms and duration of LPR episodes.", {"entities": []}], ["Symptom severity did not correlate with pH levels; however, we found a number of covariances of interest.", {"entities": []}], ["Large sample sizes are necessary to determine if true correlations exist.", {"entities": []}], ["Our results suggest that singers may exhibit enhanced sensitivity to LPR and may therefore manifest symptoms, even in response to subtle changes in pH.", {"entities": []}], ["This study emphasizes the importance of sensitive and objective measures of reflux severity as well as consideration of the cumulative time of reflux exposure in addition to the number of reflux episodes.", {"entities": []}], ["Dyspnoea consists of multiple dimensions including the intensity, unpleasantness, sensory qualities and emotional responses which may differ between patient groups, settings and in relation to treatment.", {"entities": []}], ["The Dyspnoea-12 is a validated and convenient instrument for multidimensional measurement in English.", {"entities": []}], ["We aimed to take forward a Swedish version of the Dyspnoea-12.", {"entities": []}], ["The linguistic validation of the Dyspnoea-12 was performed (Mapi Language Services, Lyon, France).", {"entities": []}], ["The standardised procedure involved forward and backward translations by three independent certified translators and revisions after feedback from an in-country linguistic consultant, the developerand three native physicians.", {"entities": []}], ["The understanding and convenience of the translated version was evaluated using qualitative in-depth interviews with five patients with dyspnoea.", {"entities": []}], ["A Swedish version of the Dyspnoea-12 was elaborated and evaluated carefully according to international guidelines.", {"entities": []}], ["The Swedish version, \u2018Dyspn\u00e9\u221212\u2019, has the same layout as the original version, including 12 items distributed on seven physical and five affective items.", {"entities": []}], ["The Dyspnoea-12 is copyrighted by the developer but can be used free of charge after permission for not industry-funded research.", {"entities": []}], ["A Swedish version of the Dyspnoea-12 is now available for clinical validation and multidimensional measurement across diseases and settings with the aim of improved evaluation and management of dyspnoea.", {"entities": []}], ["Introduction .", {"entities": []}], ["Awareness of the healthcare providers on chronic obstructive pulmonary disease (COPD), which is an important cause of mortality and morbidity in our country and all over the world, and on pulmonary rehabilitation (PR) which plays an important role in its nonpharmacological treatment will provide effectiveness in diagnosis and treatment of COPD.", {"entities": [[41, 78, "DISEASE"]]}], ["The present study aimed at determining knowledge level of the healthcare providers about COPD and PR.", {"entities": []}], ["Materials and Methods .", {"entities": []}], ["In this cross-sectional study, family practitioners and staff of home-care in central county of Manisa City were applied a questionnaire in order to determine their knowledge level on COPD and pulmonary rehabilitation during the in-service training on \u201cpulmonary rehabilitation, home-care services for the pulmonary diseases, and respiratory exercises.\u201d Results .", {"entities": []}], ["65.5% of the healthcare providers responded to the survey.", {"entities": []}], ["Rate of those correctly knowing at least one of four items was 97.2%.", {"entities": []}], ["No responder knew all items correctly.", {"entities": []}], ["Average value for correct answers was 5.30 \u00b1 2.1 (range: 1\u201310).", {"entities": []}], ["The physicians, men, and those working in family health centers had higher level of knowledge on COPD compared to nonphysician healthcare providers ( p = 0.006), women ( p = 0.002), and those working in other practices ( p = 0.019), respectively.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Knowledge level of the primary healthcare providers on COPD and PR remains inadequate.", {"entities": []}], ["Dynamic postgraduate training on this topic will be useful in referring the patients to centers giving service for this condition.", {"entities": []}], ["In this study, we evaluated the anti-inflammatory effect of PM014 on cigarette smoke induced lung disease in the murine animal model of chronic obstructive pulmonary disease (COPD).", {"entities": [[136, 173, "DISEASE"], [93, 105, "DISEASE"]]}], ["Mice were exposed to cigarette smoke (CS) for 2\u00a0weeks to induce COPD-like lung inflammation.", {"entities": [[38, 40, "GENE"]]}], ["Two hours prior to cigarette smoke exposure, the treatment group was administered PM014 via an oral injection.", {"entities": []}], ["To investigate the effects of PM014, we assessed PM014 functions in vivo , including immune cell infiltration, cytokine profiles in bronchoalveolar lavage (BAL) fluid and histopathological changes in the lung.", {"entities": []}], ["The efficacy of PM014 was compared with that of the recently developed anti-COPD drug, roflumilast.", {"entities": []}], ["PM014 substantially inhibited immune cell infiltration (neutrophils, macrophages, and lymphocytes) into the airway.", {"entities": []}], ["In addition, IL-6, TNF-\u03b1 and MCP-1 were decreased in the BAL fluid of PM014-treated mice compared to cigarette smoke stimulated mice.", {"entities": []}], ["These changes were more prominent than roflumilast treated mice.", {"entities": []}], ["The expression of PAS-positive cells in the bronchial layer was also significantly reduced in both PM014 and roflumilast treated mice.", {"entities": []}], ["These data suggest that PM014 exerts strong therapeutic effects against CS induced, COPD-like lung inflammation.", {"entities": [[72, 74, "GENE"]]}], ["Therefore, this herbal medicine may represent a novel therapeutic agent for lung inflammation in general, as well as a specific agent for COPD treatment.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) is defined by post-bronchodilator spirometry.", {"entities": []}], ["Data on \u201cnormal values\u201d come predominantly from pre-bronchodilator spirometry.", {"entities": []}], ["The effects of this on diagnosis are unknown.", {"entities": []}], ["Lower limits of normal (LLN) were estimated from \u201cnormal\u201d participants in the Burden of Obstructive Lung Disease (BOLD) programme.", {"entities": []}], ["Values separately derived using pre- and post-bronchodilator spirometry were compared.", {"entities": []}], ["Sensitivity and specificity of criteria derived from pre-bronchodilator spirometry and pre-bronchodilator spirometry adjusted by a constant were assessed in the remaining population.", {"entities": []}], ["The \u201cgold standard\u201d was the LLN for the post-bronchodilator spirometry in the \u201cnormal population\u201d.", {"entities": []}], ["For FEV1/FVC, sensitivity and specificity of criteria were also assessed when a fixed value of < 70% was used rather than LLN.", {"entities": []}], ["Of 6,600 participants with full data, 1,354 were defined as \u201cnormal\u201d.", {"entities": []}], ["Mean differences between pre- and post- bronchodilator measurements were small and the Bland-Altman plots showed no association between difference and mean value.", {"entities": []}], ["Compared with using the gold standard, however, tests using pre-bronchodilator spirometry had a sensitivity and specificity of detecting a low FEV1 of 78.4% and 100%, a low FVC of 99.8% and 99.1% and a low FEV1/FVC ratio of 65% and 100%.", {"entities": []}], ["Adjusting this by a constant improved the sensitivity without substantially altering the specificity for FEV1 (99%, 99.8%), FVC (97.4%, 99.9%) and FEV1/FVC (98.7%, 99.5%).", {"entities": []}], ["Using pre-bronchodilator spirometry to derive norms for lung function reduces sensitivity compared to a post-bronchodilator gold standard.", {"entities": []}], ["Adjustment of these values by a constant can improve validity of the test.", {"entities": []}], ["Many studies have been carried out to test the hypothesis that the NQO1 C609T polymorphism might be associated with the risk of esophageal cancer.", {"entities": [[128, 145, "DISEASE"], [139, 145, "DISEASE"], [67, 71, "GENE"]]}], ["However, the results are poorly consistent, partly due to genetic or other sources of heterogeneity.", {"entities": []}], ["To investigate the association between this polymorphism and the risk of esophageal cancer, a meta-analysis was performed.", {"entities": [[73, 90, "DISEASE"], [84, 90, "DISEASE"]]}], ["We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of association.", {"entities": []}], ["The frequency of the putative risk allele in the controls was estimated by the inverse-variance method.", {"entities": []}], ["Cochran\u2019s Q statistic and the inconsistency index (I Our study included eight published case-control studies about the NQO1 C609T polymorphism and esophageal cancer, including a total of 1,217 esophageal cancer patients and 1,560 controls.", {"entities": [[147, 164, "DISEASE"], [193, 210, "DISEASE"], [158, 164, "DISEASE"], [204, 210, "DISEASE"], [119, 123, "GENE"]]}], ["Overall, a significant association was found between the NQO1 C609T variant and esophageal cancer under a recessive model (OR\u2009=\u20091.647; 95% CI\u2009=\u20091.233-2.200).", {"entities": [[80, 97, "DISEASE"], [91, 97, "DISEASE"], [57, 61, "GENE"]]}], ["Regarding histological type, more significant evidence was found for esophageal squamous cell carcinoma (ESCC) (OR\u2009=\u20092.03; 95% CI\u2009=\u20091.29-3.19) than esophageal adenocarcinoma (EAC) (OR\u2009=\u20091.61; 95% CI\u2009=\u20091.01-2.56) under a recessive model.", {"entities": [[159, 173, "DISEASE"], [94, 103, "DISEASE"], [80, 103, "DISEASE"]]}], ["The meta-analysis suggests that the NQO1 C609T polymorphism considerably increases the risk of esophageal cancer.", {"entities": [[95, 112, "DISEASE"], [106, 112, "DISEASE"], [36, 40, "GENE"]]}], ["Zoledronic acid is a highly effective treatment in Paget's disease for persistent bone pain and prevention of further progression of the disease.", {"entities": []}], ["The commonest electrolyte abnormality is hypocalcemia.", {"entities": []}], ["To the best of our knowledge this is the first case of hyperkalemia secondary to zoledronic acid to be published in the world literature.", {"entities": []}], ["The commonest arrhythmia related to zoledronic acid is atrial fibrillation.", {"entities": []}], ["We describe the case of an 80-year-old Caucasian man, with a history of ischemic heart disease, who had an in-hospital cardiac arrest related to hyperkalemia.", {"entities": [[72, 94, "DISEASE"], [81, 94, "DISEASE"]]}], ["Increasing potassium levels were noted following his first zoledronic acid infusion for symptomatic control of bone pain secondary to Paget's disease.", {"entities": []}], ["Our patient suffered a cardiac arrest 10 days following the zoledronic acid infusion.", {"entities": []}], ["Our patient's biochemistry and electrocardiogram output were monitored until his death 26 days after his cardiac arrest.", {"entities": []}], ["Our patient developed paroxysmal atrial fibrillation in the post-resuscitation period and there was persistent hyperkalemia that required prolonged treatment with calcium resonium.", {"entities": []}], ["All other possible causes of hyperkalemia were excluded.", {"entities": []}], ["In our patient's case persistent hyperkalemia and life-threatening arrhythmias were associated with use of zoledronic acid.", {"entities": []}], ["These side effects have not been reported before and the causative mechanism is far from clear as there are no obvious systemic effects of zoledronic acid.", {"entities": []}], ["The combination of zoledronic acid with predisposing factors such as structural heart disease might account for the clinical picture we witnessed.", {"entities": [[80, 93, "DISEASE"]]}], ["As a result, electrolyte monitoring should be adopted early in zoledronic acid use.", {"entities": []}], ["Further studies are required to elucidate the underlying mechanism of hyperkalemia and identify the target group of patients where zoledronic acid can be safely administered.", {"entities": []}], ["Great caution is advised in patients with underlying heart conditions.", {"entities": []}], ["It is unclear whether cell culture methodology affects the corticosteroid sensitivity of chronic obstructive pulmonary disease (COPD) alveolar macrophages.", {"entities": [[89, 126, "DISEASE"]]}], ["We compared the effect of a short and a long isolation procedure on corticosteroid inhibition of lipopolysaccharide (LPS) stimulated cytokine release from COPD alveolar macrophages.", {"entities": []}], ["We also investigated signalling pathways associated with macrophage activation during cell isolation.", {"entities": []}], ["Macrophages cultured using a short isolation protocol released higher unstimulated levels of tumour necrosis factor (TNF)-\u03b1 and chemokine C\u2013X\u2013C motif ligand (CXCL) 8; these macrophages were less sensitive to corticosteroid inhibition of LPS stimulated TNF-\u03b1 and CXCL8 release when compared to a long isolation procedure.", {"entities": [[117, 120, "GENE"], [252, 255, "GENE"]]}], ["This was associated with increased p38 mitogen activated kinase (MAPK) activation.", {"entities": []}], ["The p38 MAPK inhibitor, BIRB-796, significantly reduced unstimulated cytokine release.", {"entities": []}], ["A key finding of this study was that both cell culture methods showed no difference in the corticosteroid sensitivity between COPD and control macrophages.", {"entities": []}], ["We conclude that the culture of alveolar macrophages using a short isolation procedure alters cytokine production through p38 MAPK activation; this is associated with a change in corticosteroid sensitivity.", {"entities": []}], ["IL-6 plays diverse roles in normal and disease-associated immunity such as that associated with Graves\u2019 disease (GD).", {"entities": []}], ["In that syndrome, the orbit undergoes remodeling during a process known as thyroid-associated ophthalmopathy (TAO).", {"entities": [[8, 16, "DISEASE"]]}], ["Recently, CD34", {"entities": [[10, 14, "GENE"]]}], ["The proinflammatory cytokine interleukin (IL)-17A is associated with eosinophil infiltration into the nasal mucosa in a mouse model of ovalbumin-induced allergic rhinitis.", {"entities": [[153, 170, "DISEASE"], [162, 170, "DISEASE"]]}], ["Chemotaxis of eosinophils is mediated primarily through C-C chemokine receptor type 3 (CCR3).", {"entities": [[87, 91, "GENE"]]}], ["However, the mechanism underlying the IL-17A-mediated enhancement of eosinophil recruitment via chemoattractants/chemokines remains unknown.", {"entities": []}], ["In this study, we assessed the contribution of IL-17A to eosinophil-related inflammation via the CCL7/CCR3 pathway in experimental allergic rhinitis.", {"entities": [[131, 148, "DISEASE"], [140, 148, "DISEASE"]]}], ["IL-17A knockout (KO) and wild-type (WT) BALB/c mice were injected intraperitoneally and challenged intranasally with OVA to induce allergic rhinitis.", {"entities": [[131, 148, "DISEASE"], [140, 148, "DISEASE"]]}], ["Various parameters of the allergic response were evaluated, and mRNA and protein levels of CCL7 and CCR3 in nasal tissue and serum were compared between the two groups.", {"entities": [[91, 95, "GENE"], [100, 104, "GENE"]]}], ["The chemotactic response to CCL7 with or without IL-17A in bone marrow-derived eosinophils (bmEos) from BALB/c mice was measured.", {"entities": [[28, 32, "GENE"]]}], ["In the allergic rhinitis model, IL-17A deficiency significantly decreased nasal symptoms, serum IgE levels, and eosinophil recruitment to the nasal mucosa.", {"entities": [[7, 24, "DISEASE"], [16, 24, "DISEASE"]]}], ["CCL7 and CCR3 mRNA and protein levels were decreased in the nasal mucosa of IL-17A KO mice compared with the WT mice.", {"entities": [[0, 4, "GENE"], [9, 13, "GENE"]]}], ["BmEos showed a significantly increased chemotactic response to -low concentration of CCL7 in the presence of IL-17A compared with its absence.", {"entities": [[85, 89, "GENE"]]}], ["The suppression of nasal inflammation due of IL-17A deficiency in allergic rhinitis is partly responsible for the regulation of CCL7 secretion and eosinophil infiltration, which may be regulated via the CCL7/CCR3 pathway.", {"entities": [[66, 83, "DISEASE"], [75, 83, "DISEASE"], [128, 132, "GENE"], [203, 207, "GENE"]]}], ["The estimate of the prevalence of the most common chronic conditions (CCs) is calculated using direct methods such as prevalence surveys but also indirect methods using health administrative databases.", {"entities": [[70, 73, "GENE"]]}], ["The aim of this study is to provide estimates prevalence of CCs in Lazio region of Italy (including Rome), using the drug prescription's database and to compare these estimates with those obtained using other health administrative databases.", {"entities": [[60, 63, "GENE"]]}], ["Prevalence of CCs was estimated using pharmacy data (PD) using the Anathomical Therapeutic Chemical Classification System (ATC).", {"entities": [[14, 17, "GENE"]]}], ["Prevalences estimate were compared with those estimated by hospital information system (HIS) using list of ICD9-CM diagnosis coding, registry of exempt patients from health care cost for pathology (REP) and national health survey performed by the Italian bureau of census (ISTAT).", {"entities": []}], ["From the PD we identified 20 CCs.", {"entities": [[29, 32, "GENE"]]}], ["About one fourth of the population received a drug for treating a cardiovascular disease, 9% for treating a rheumatologic conditions.", {"entities": []}], ["The estimated prevalences using the PD were usually higher that those obtained with one of the other sources.", {"entities": []}], ["Regarding the comparison with the ISTAT survey there was a good agreement for cardiovascular disease, diabetes and thyroid disorder whereas for rheumatologic conditions, chronic respiratory illnesses, migraine and Alzheimer's disease, the prevalence estimates were lower than those estimated by ISTAT survey.", {"entities": [[201, 209, "DISEASE"]]}], ["Estimates of prevalences derived by the HIS and by the REP were usually lower than those of the PD (but malignancies, chronic renal diseases).", {"entities": []}], ["Our study showed that PD can be used to provide reliable prevalence estimates of several CCs in the general population.", {"entities": [[89, 92, "GENE"]]}], ["Background: Air pollution is known to cause respiratory disease.", {"entities": []}], ["Unlike motor vehicle sources, fuel-fired power plants are stationary.", {"entities": []}], ["Objective: Using hospitalization data, we examined whether living near a fuel-fired power plant increases the likelihood of hospitalization for respiratory disease.", {"entities": []}], ["Methods: Rates of hospitalization for asthma, acute respiratory infection (ARI), and chronic obstructive pulmonary disease (COPD) were estimated using hospitalization data for 1993\u20132008 from New York State in relation to data for residences near fuel-fired power plants.", {"entities": [[85, 122, "DISEASE"], [38, 44, "DISEASE"]]}], ["We also explored data for residential proximity to hazardous waste sites.", {"entities": []}], ["Results: After adjusting for age, sex, race, median household income, and rural/urban residence, there were significant 11%, 15%, and 17% increases in estimated rates of hospitalization for asthma, ARI, and COPD, respectively, among individuals > 10 years of age living in a ZIP code containing a fuel-fired power plant compared with one that had no power plant.", {"entities": [[190, 196, "DISEASE"]]}], ["Living in a ZIP code with a fuel-fired power plant was not significantly associated with hospitalization for asthma or ARI among children < 10 years of age.", {"entities": [[109, 115, "DISEASE"]]}], ["Living in a ZIP code with a hazardous waste site was associated with hospitalization for all outcomes in both age groups, and joint effect estimates were approximately additive for living in a ZIP code that contained a fuel-fired power plant and a hazardous waste site.", {"entities": []}], ["Conclusions: Our results are consistent with the hypothesis that exposure to air pollution from fuel-fired power plants and volatile compounds coming from hazardous waste sites increases the risk of hospitalization for respiratory diseases.", {"entities": []}], ["Healthcare institutions face widespread challenges of delivering high-quality and cost-effective care, while keeping up with rapid advances in biomedical knowledge and technologies.", {"entities": []}], ["Moreover, there is increased emphasis on developing personalized or precision medicine targeted to individuals or groups of patients who share a certain biomarker signature.", {"entities": []}], ["Learning healthcare systems (LHS) have been proposed for integration of research and clinical practice to fill major knowledge gaps, improve care, reduce healthcare costs, and provide precision care.", {"entities": []}], ["To date, much discussion in this context has focused on the potential of human genomic data, and not yet on human microbiome data.", {"entities": []}], ["Rapid advances in human microbiome research suggest that profiling of, and interventions on, the human microbiome can provide substantial opportunity for improved diagnosis, therapeutics, risk management, and risk stratification.", {"entities": []}], ["In this study, we discuss a potential role for microbiome science in LHSs.", {"entities": []}], ["We first review the key elements of LHSs, and discuss possibilities of Big Data and patient engagement.", {"entities": []}], ["We then consider potentials and challenges of integrating human microbiome research into clinical practice as part of an LHS.", {"entities": []}], ["With rapid growth in human microbiome research, patient-specific microbial data will begin to contribute in important ways to precision medicine.", {"entities": []}], ["Hence, we discuss how patient-specific microbial data can help guide therapeutic decisions and identify novel effective approaches for precision care of inflammatory bowel disease.", {"entities": [[153, 179, "DISEASE"]]}], ["To the best of our knowledge, this expert analysis makes an original contribution with new insights poised at the emerging intersection of LHSs, microbiome science, and postgenomics medicine.", {"entities": []}], ["Several studies have verified body fat distribution in association with pulmonary function (PF), mainly waist circumference, but few have used measures able to distinguish abdominal fat compartments.", {"entities": []}], ["The present study aims to verify the association of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) with PF measures.", {"entities": []}], ["In 1982, all hospital births occurring in Pelotas, Brazil, were identified and those livebirths have been followed.", {"entities": []}], ["In 2012\u201313, the cohort participants were evaluated and VAT and SAT measured using ultrasound; forced expiratory volume in the first second (FEV 1 ) or forced vital capacity (FVC) were patronized in z-scores stratified by sex.", {"entities": [[140, 143, "GENE"]]}], ["The associations were verified using crude and adjusted linear regressions.", {"entities": []}], ["The present analyses comprised 3438 individuals (1721 women).", {"entities": []}], ["VAT was inversely associated with spirometric parameters, in both crude and adjusted models.", {"entities": []}], ["SAT showed inverse associations in the crude analyzes in males and a positive trend after adjustment, except for SAT and FVC in males.", {"entities": []}], ["To each centimeter of VAT, mean adjusted FEV 1 z-scores decreased 0.072 (95% CI -0.107; \u22120.036) in men and 0.127 (95% CI -0.164; \u22120.090) in women, and FVC z-scores decreased \u22120.075 (95% CI -0.111; \u22120.039) and 0.121 (95% CI -0.158; \u22120.083), in men and women, respectively.", {"entities": [[41, 44, "GENE"]]}], ["VAT has a consistent inverse association with FEV 1 and FVC in both sexes.", {"entities": [[46, 49, "GENE"]]}], ["On the other hand, SAT showed inconsistent results with PF parameters.", {"entities": []}], ["The online version of this article (10.1186/s12890-017-0510-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In addition to the acute manifestations of respiratory syncytial virus (RSV), persistent infection may be associated with long-term complications in the development of chronic respiratory diseases.", {"entities": []}], ["To understand the mechanisms underlying RSV-induced long-term consequences, we established an in vitro RSV (strain A2) infection model using human bronchial epithelial (16HBE) cells that persists over four generations and analyzed cell inflammation and matrix adherence.", {"entities": []}], ["Cells infected with RSV at multiplicity of infection ( MOI ) 0.0067 experienced cytolytic or abortive infections in the second generation (G2) or G3 but mostly survived up to G4.", {"entities": []}], ["Cell morphology, leukocyte and matrix adherence of the cells did not change in G1 or G2, but subsequently, leukocyte adherence and cytokine/chemokine secretion, partially mediated by intercellular adhesion molecule-1 (ICAM-1), increased drastically, and matrix adherence, partially mediated by E-cadherin, decreased until the cells died.", {"entities": []}], ["Tumor necrosis factor-\u03b1 (TNF-\u03b1) secretion was inhibited by ICAM-1 antibody in infected-16HBE cells, suggesting that positive feedback between TNF-\u03b1 secretion and ICAM-1 expression may be significant in exacerbated inflammation.", {"entities": []}], ["These data demonstrate the susceptibility of 16HBE cells to RSV and their capacity to produce long-term progressive RSV infection, which may contribute to inflammation mobilization and epithelial shedding.", {"entities": []}], ["Biomarkers are highly specific and sensitive indicators of disease activity.", {"entities": []}], ["Resistin is a recently discovered adipocytokine, having a potent biomarker quality.", {"entities": []}], ["Initially resistin was thought to be produced by adipocytes alone; however, emerging evidence suggests that it is also produced in abundance by various cells of the immunoinflammatory system, indicating its role in various chronic inflammatory diseases.", {"entities": []}], ["Data suggests that resistin plays a role in obesity, insulin resistance, cardiovascular diseases, and periodontitis.", {"entities": [[44, 51, "DISEASE"], [102, 115, "DISEASE"]]}], ["Resistin derived its name from the original observation that it induced insulin resistance ( resist-in: resist insulin ) in mice and is downregulated in mature murine adipocytes cultured in the presence of insulin sensitizing drugs like thiazolidinediones.", {"entities": []}], ["It is well recognized that obesity, is associated with insulin resistance and diabetes.", {"entities": [[27, 34, "DISEASE"]]}], ["A three-way relationship has been established between diabetes, obesity and periodontitis.", {"entities": [[64, 71, "DISEASE"], [76, 89, "DISEASE"]]}], ["Recent evidence also suggests an association between obesity and increased risk for periodontitis.", {"entities": [[53, 60, "DISEASE"], [84, 97, "DISEASE"]]}], ["Our previous research showed incremental elevation of resistin with periodontal disease activity and a reduced level of resistin, after periodontal therapy.", {"entities": [[68, 87, "DISEASE"]]}], ["Thus resistin would be one of the molecular links connecting obesity, periodontitis, and diabetes and may serve as a marker that links periodontal disease with other systemic diseases.", {"entities": [[61, 68, "DISEASE"], [70, 83, "DISEASE"], [135, 154, "DISEASE"]]}], ["A Medline/PubMed search was carried out for keywords \u201cDiabetes Mellitus,\u201d \u201cPeriodontitis,\u201d and \u201cResistin,\u201d and all relevant research papers from 1990 in English were shortlisted and finalized based on their importance.", {"entities": [[75, 88, "DISEASE"], [54, 71, "DISEASE"]]}], ["This review provides an insight into the biological action of resistin and its possible role in periodontitis influenced diabetes mellitus and diabetes induced periodontitis.", {"entities": [[96, 109, "DISEASE"], [160, 173, "DISEASE"], [121, 138, "DISEASE"]]}], ["Daily weather conditions for an entire city are usually represented by a single weather station, often located at a nearby airport.", {"entities": []}], ["This resolution of atmospheric data fails to recognize the microscale climatic variability associated with land use decisions across and within urban neighborhoods.", {"entities": []}], ["This study uses heat index, a measure of the combined effects of temperature and humidity, to assess the variability of heat exposure from ten weather stations across four urban neighborhoods and two control locations (downtown and in a nearby nature center) in Knoxville, Tennessee, USA.", {"entities": []}], ["Results suggest that trees may negate a portion of excess urban heat, but are also associated with greater humidity.", {"entities": []}], ["As a result, the heat index of locations with more trees is significantly higher than downtown and areas with fewer trees.", {"entities": []}], ["Trees may also reduce heat stress by shading individuals from incoming radiation, though this is not considered in this study.", {"entities": []}], ["Greater amounts of impervious surfaces correspond with reduced evapotranspiration and greater runoff, in terms of overall mass balance, leading to a higher temperature, but lower relative humidity.", {"entities": []}], ["Heat index and relative humidity were found to significantly vary between locations with different tree cover and neighborhood characteristics for the full study time period as well as for the top 10% of heat index days.", {"entities": []}], ["This work demonstrates the need for high-resolution climate data and the use of additional measures beyond temperature to understand urban neighborhood exposure to extreme heat, and expresses the importance of considering vulnerability differences among residents when analyzing neighborhood-scale impacts.", {"entities": []}], ["Pulmonary involvement in rheumatoid arthritis is directly responsible for 10% to 20% of all mortality.", {"entities": [[25, 45, "DISEASE"], [36, 45, "DISEASE"]]}], ["The best way to improve the prognosis is early detection and treatment.", {"entities": []}], ["The forced oscillation technique is easy to perform and offers a detailed exam, which may be helpful in the early detection of respiratory changes.", {"entities": []}], ["This study was undertaken to ( A total of 40 individuals were analyzed: 20 healthy and 20 with rheumatoid arthritis (90% with respiratory complaints).", {"entities": [[95, 115, "DISEASE"], [106, 115, "DISEASE"]]}], ["The clinical usefulness of the parameters was evaluated by investigating the sensibility, the specificity and the area under the receiver operating characteristic curve.", {"entities": []}], ["ClinicalTrials.gov: NCT01641705.", {"entities": []}], ["The early adverse respiratory effects of rheumatoid arthritis were adequately detected by the forced oscillation technique parameters, and a high accuracy for clinical use was obtained (AUC>0.9, Se\u200a=\u200a80%, Sp \u200a=\u200a 95%).", {"entities": [[41, 61, "DISEASE"], [52, 61, "DISEASE"]]}], ["The use of spirometric parameters did not obtain an appropriate accuracy for clinical use.", {"entities": []}], ["The diagnostic performance of the forced oscillation technique parameters was significantly higher than that of spirometry.", {"entities": []}], ["The results of the present study provide substantial evidence that the forced oscillation technique can contribute to the easy identification of initial respiratory abnormalities in rheumatoid arthritis patients that are not detectable by spirometric exams.", {"entities": [[182, 202, "DISEASE"], [193, 202, "DISEASE"]]}], ["Therefore, we believe that the forced oscillation technique can be used as a complementary exam that may help to improve the treatment of breathing disorders in rheumatoid arthritis patients.", {"entities": [[161, 181, "DISEASE"], [172, 181, "DISEASE"]]}], ["Opioid painkillers are a promising treatment for chronic breathlessness, but are associated with potentially fatal side effects.", {"entities": []}], ["In the treatment of breathlessness, their mechanisms of action are unclear.", {"entities": []}], ["A better understanding might help to identify safer alternatives.", {"entities": []}], ["Learned associations between previously neutral stimuli (e.g.", {"entities": []}], ["stairs) and repeated breathlessness induce an anticipatory threat response that may worsen breathlessness, contributing to the downward spiral of decline seen in clinical populations.", {"entities": []}], ["As opioids are known to influence associative learning, we hypothesized that they may interfere with the brain processes underlying a conditioned anticipatory response to breathlessness in relevant brain areas, including the amygdala and the hippocampus.", {"entities": []}], ["Healthy volunteers viewed visual cues (neutral stimuli) immediately before induction of experimental breathlessness with inspiratory resistive loading.", {"entities": []}], ["Thus, an association was formed between the cue and breathlessness.", {"entities": []}], ["Subsequently, this paradigm was repeated in two identical neuroimaging sessions with intravenous infusions of either low-dose remifentanil (0.7\u00a0ng/ml target-controlled infusion) or saline (randomised).", {"entities": []}], ["During saline infusion, breathlessness anticipation activated the right anterior insula and the adjacent operculum.", {"entities": []}], ["Breathlessness was associated with activity in a network including the insula, operculum, dorsolateral prefrontal cortex, anterior cingulate cortex and the primary sensory and motor cortices.", {"entities": []}], ["Remifentanil reduced breathlessness unpleasantness but not breathlessness intensity.", {"entities": []}], ["Remifentanil depressed anticipatory activity in the amygdala and the hippocampus that correlated with reductions in breathlessness unpleasantness.", {"entities": []}], ["During breathlessness, remifentanil decreased activity in the anterior insula, anterior cingulate cortex and sensory motor cortices.", {"entities": []}], ["Remifentanil-induced reduction in breathlessness unpleasantness was associated with increased activity in the rostral anterior cingulate cortex and nucleus accumbens, components of the endogenous opioid system known to decrease the perception of aversive stimuli.", {"entities": []}], ["These findings suggest that in addition to effects on brainstem respiratory control, opioids palliate breathlessness through an interplay of altered associative learning mechanisms.", {"entities": []}], ["These mechanisms provide potential targets for novel ways to develop and assess treatments for chronic breathlessness.", {"entities": []}], ["\u2022 The mechanisms of how low-dose opioids relieve breathlessness are unknown.", {"entities": []}], ["\u2022 We tested whether low-dose opioids affect conditioned anticipation and perception of breathlessness.", {"entities": []}], ["\u2022 Low-dose opioids reduced unpleasantness, but not intensity of breathlessness.", {"entities": []}], ["\u2022 Reduced breathlessness unpleasantness was associated with activation of the endogenous opioid system.", {"entities": []}], ["\u2022 Breathlessness relief was predicted by decreased anticipatory activity in amygdala/hippocampus.", {"entities": []}], ["The mechanisms of how low-dose opioids relieve breathlessness are unknown.", {"entities": []}], ["We tested whether low-dose opioids affect conditioned anticipation and perception of breathlessness.", {"entities": []}], ["Low-dose opioids reduced unpleasantness, but not intensity of breathlessness.", {"entities": []}], ["Reduced breathlessness unpleasantness was associated with activation of the endogenous opioid system.", {"entities": []}], ["Breathlessness relief was predicted by decreased anticipatory activity in amygdala/hippocampus.", {"entities": []}], ["There is substantial evidence for the links between poverty and both physical and mental health; but limited research on the relationship of physical and mental health problems exists in low- and middle-income countries.", {"entities": []}], ["The objective of this paper is to evaluate the prevalence and co-morbidity of psychological distress among women with common physical diseases in a socio-economically disadvantaged urban area of South Africa.", {"entities": []}], ["Women enrolled in the Birth to twenty (Bt20) cohort study were evaluated for this paper.", {"entities": []}], ["Bt20 was founded in 1990 and has followed more than 3,000 children and their caregivers since birth; this study evaluates the health of the caregivers (average age 44) of these children.", {"entities": []}], ["Psychological distress was evaluated by administering the General Health Questionnaire (GHQ-28) and we evaluated the presence of physical disease by self-report.", {"entities": []}], ["Forty percent of the sample presented with psychological distress using the GHQ scoring method.", {"entities": []}], ["More than half of the women who reported a history of a physical disease, including diabetes, heart attack, asthma, arthritis, osteoporosis, epilepsy, and tuberculosis, reported psychological disorder.", {"entities": [[155, 167, "DISEASE"], [127, 139, "DISEASE"], [116, 125, "DISEASE"], [108, 114, "DISEASE"]]}], ["Presence of one physical disease was not associated with increased rates of psychological distress.", {"entities": []}], ["However, women who reported two diseases had increased rates of psychological symptoms, and this upward trend continued with each additional physical disease reported (measured to five).", {"entities": []}], ["These data indicate high prevalence rates of co-morbid psychological distress among women with physical disease.", {"entities": []}], ["This argues for the need of greater mental health support for women living with physical diseases.", {"entities": []}], ["Global climate change will have multiple effects on human health.", {"entities": []}], ["Vulnerable populations\u2014children, the elderly, and the poor\u2014will be disproportionately affected.", {"entities": []}], ["We reviewed projected impacts of climate change on children\u2019s health, the pathways involved in these effects, and prevention strategies.", {"entities": []}], ["We assessed primary studies, review articles, and organizational reports.", {"entities": []}], ["Climate change is increasing the global burden of disease and in the year 2000 was responsible for > 150,000 deaths worldwide.", {"entities": []}], ["Of this disease burden, 88% fell upon children.", {"entities": []}], ["Documented health effects include changing ranges of vector-borne diseases such as malaria and dengue; increased diarrheal and respiratory disease; increased morbidity and mortality from extreme weather; changed exposures to toxic chemicals; worsened poverty; food and physical insecurity; and threats to human habitation.", {"entities": [[83, 90, "DISEASE"]]}], ["Heat-related health effects for which research is emerging include diminished school performance, increased rates of pregnancy complications, and renal effects.", {"entities": []}], ["Stark variation in these outcomes is evident by geographic region and socioeconomic status, and these impacts will exacerbate health disparities.", {"entities": []}], ["Prevention strategies to reduce health impacts of climate change include reduction of greenhouse gas emissions and adaptation through multiple public health interventions.", {"entities": []}], ["Further quantification of the effects of climate change on children\u2019s health is needed globally and also at regional and local levels through enhanced monitoring of children\u2019s environmental health and by tracking selected indicators.", {"entities": []}], ["Climate change preparedness strategies need to be incorporated into public health programs.", {"entities": []}], ["A first analysis of the genome sequence of the common marmoset ( Callithrix jacchus ), assembled using traditional Sanger methods and Ensembl annotation, has permitted genomic comparison with apes and old world monkeys and the identification of specific molecular features that may contribute to the unique biology of this diminutive primate.", {"entities": []}], ["The common marmoset has a rapid reproductive capacity partly due to prevalence of dizygotic twins.", {"entities": []}], ["Remarkably, these twins share placental circulation and exchange hematopoietic stem cells in utero , resulting in adults that are hematopoietic chimeras.", {"entities": []}], ["We observed positive selection or non-synonymous substitutions for genes encoding growth hormone/insulin-like growth factor (growth pathways), respiratory complex I (metabolic pathways), immunobiology, and proteases (reproductive and immunity pathways).", {"entities": []}], ["In addition, both protein-coding and microRNA genes related to reproduction exhibit rapid sequence evolution.", {"entities": []}], ["This New World monkey genome sequence enables significantly increased power for comparative analyses among available primate genomes and facilitates biomedical research application.", {"entities": []}], ["Hypertrophy of the lingual tonsil tissue in the adult patient is thought to contribute to the pathophysiology of obstructive sleep apnea.", {"entities": []}], ["The underlying etiology of lingual tonsil hypertrophy (LTH) in the adult patient is unclear and likely multifactorial.", {"entities": []}], ["Previous studies have suggested that the lingual tonsils may undergo compensatory hyperplasia post-tonsillectomy in children, although it is unknown if this occurs or persists into adulthood.", {"entities": []}], ["The purpose of this study was to determine what factors are associated with LTH in a population of Canadian adults.", {"entities": []}], ["Adult patients presenting for consultation to an academic Rhinology/General Otolaryngology practice were eligible for enrollment.", {"entities": []}], ["Demographic data including age, body mass index (BMI), Reflux Symptom Index (RSI), history of allergy, and history of tonsillectomy was collected via questionnaire.", {"entities": []}], ["Endoscopic photographs of the base of tongue and larynx were captured.", {"entities": []}], ["These were graded for LTH and Reflux Finding Scale (RFS) by blinded examiners.", {"entities": []}], ["Statistical analysis was performed by comparing the mean LTH value to the variables of interest using two-tailed T -test.", {"entities": []}], ["P \u2009<\u2009.05 was considered significant.", {"entities": []}], ["One hundred two subjects were enrolled.", {"entities": []}], ["Age ranged from 18 to 78.", {"entities": []}], ["28 patients had previous tonsillectomy.", {"entities": []}], ["This was not associated with a significant increase in lingual tonsil tissue ( r \u2009=\u2009\u22120.05, p \u2009=\u20090.61).", {"entities": []}], ["RFS >7 or RSI >13 was considered positive for laryngopharyngeal reflux.", {"entities": []}], ["There was no difference in LTH based on RSI positivity ( p \u2009=\u20090.44).", {"entities": []}], ["RFS positivity correlated with increased lingual tonsil tissue ( p \u2009<\u20090.05).", {"entities": []}], ["BMI >30 was associated with increased lingual tonsil hypertrophy ( p \u2009<\u20090.05).", {"entities": []}], ["An elevated body mass index and positive Reflux Finding Score are associated with lingual tonsil hypertrophy in adults.", {"entities": []}], ["Reflux symptom index, history of allergy and history of childhood tonsillectomy are not associated with LTH.", {"entities": []}], ["A number of environmental factors can affect the development and severity of allergy and asthma; however, it can be argued that the most significant inhaled agents that modulate the development of these conditions are biologics.", {"entities": [[89, 95, "DISEASE"]]}], ["Sensitization to environmental allergens is an important risk factor for the development of asthma.", {"entities": [[92, 98, "DISEASE"]]}], ["Innate immune responses are often mediated by receptors on mononuclear cells whose primary ligands arise from microorganisms.", {"entities": []}], ["Many pathogens, especially viruses, target epithelial cells and affect the host immune response to those pathogens.", {"entities": []}], ["The acquired immune response to an allergen is influenced by the nature of the innate immune system.", {"entities": []}], ["Products of innate immune responses to microbes promote T H 1-acquired responses.", {"entities": []}], ["In the absence of T H 1 responses, T H 2 responses can dominate.", {"entities": []}], ["Central to T H 1/T H 2 balance is the composition of contaminants that derive from microbes.", {"entities": []}], ["In this review we examine the biology of the response to allergens, viruses, and bacterial products in the context of the development of allergy and asthma.", {"entities": [[149, 155, "DISEASE"]]}], ["The ubiquitous use of mobile phones in sending and receiving text messages has become a norm for young people.", {"entities": []}], ["Undeniably, text messaging has become a new and important communication medium not only in the social realm but in education as well.", {"entities": []}], ["The aim of this study is to evaluate the effectiveness of using text messaging as a means to collect data for a medical research project.", {"entities": []}], ["A cross sectional study was carried out during a double blind, randomized controlled trial to assess the efficacy and safety of a probiotic in the management of Irritable Bowel Syndrome (IBS).", {"entities": []}], ["The study aim was to assess the response rate of weekly symptom reports via Short Message Service (SMS).", {"entities": [[99, 102, "GENE"]]}], ["The subjects were undergraduates in a private medical university in Malaysia.", {"entities": []}], ["They were identified through a previous university wide study as suffering from IBS based on Rome III criteria.", {"entities": []}], ["The subjects were randomly assigned to either the treatment arm receiving a daily probiotic, or the placebo arm.", {"entities": []}], ["They were required to score their symptoms using eight-item-questionnaires at baseline, and thereafter weekly, for a total of 8 weeks.", {"entities": []}], ["All subjects were given the choice to communicate their symptom scores by text messaging via mobile phones or by email.", {"entities": []}], ["SMS text messages were sent to remind trial subjects to attend face-to-face visits and to complete a paper based 34-item-questionnaires on IBS quality of life assessment at baseline and at end of 8 weeks.", {"entities": [[0, 3, "GENE"]]}], ["The response rate of weekly symptom scores via Short Message Service (SMS) from a total of 38 subjects was 100%.", {"entities": [[70, 73, "GENE"]]}], ["Through the study, 342 reports were submitted: 33.3% of these were received on the due date without reminder, 60.0% one day after the deadline, after a single reminder, 6.1% 2-3 days after the deadline, after 2-3 reminders and 0.6% 5 days after the deadline, after SMS, phone reminder and face-to-face encounter.", {"entities": [[265, 268, "GENE"]]}], ["All SMS symptom reports, whether on time or late, were complete.", {"entities": [[4, 7, "GENE"]]}], ["With the help of SMS reminder, all trial subjects completed the paper based IBS quality of life assessment at baseline and at end of study.", {"entities": [[17, 20, "GENE"]]}], ["This study found using text messaging via mobile phone an excellent instrument for collecting weekly symptom reports in response to trial medication, reminding trial subjects to attend face to face visits and completing more complex paper based evaluation.", {"entities": []}], ["The 100% response rate of weekly symptom reports was facilitated by using simple number codes for SMS submission.", {"entities": [[98, 101, "GENE"]]}], ["Not appropriate.", {"entities": []}], ["Combination analgesics are effective in acute pain, and a theoretical framework predicts efficacy for combinations.", {"entities": []}], ["The combination of dexketoprofen and tramadol is untested, but predicted to be highly effective.", {"entities": []}], ["This was a randomised, double-blind, double-dummy, parallel-group, placebo-controlled, single-dose trial in patients with moderate or severe pain following third molar extraction.", {"entities": []}], ["There were ten treatment arms, including dexketoprofen trometamol (12.5\u00a0mg and 25\u00a0mg) and tramadol hydrochloride (37.5\u00a0mg and 75\u00a0mg), given as four different fixed combinations and single components, with ibuprofen 400\u00a0mg as active control as well as a placebo control.", {"entities": []}], ["The study objective was to evaluate the superior analgesic efficacy and safety of each combination and each single agent versus placebo.", {"entities": []}], ["The primary outcome was the proportion of patients with at least 50\u00a0% max TOTPAR over six hours.", {"entities": [[70, 73, "GENE"]]}], ["606 patients were randomised and provided at least one post-dose assessment.", {"entities": []}], ["All combinations were significantly better than placebo.", {"entities": []}], ["The highest percentage of responders (72\u00a0%) was achieved in the dexketoprofen trometamol 25\u00a0mg plus tramadol hydrochloride 75\u00a0mg group (NNT 1.6, 95\u00a0% confidence interval 1.3 to 2.1).", {"entities": [[136, 139, "GENE"]]}], ["Addition of tramadol to dexketoprofen resulted in greater peak pain relief and greater pain relief over the longer term, particularly at times longer than six hours (median duration of 8.1\u00a0h).", {"entities": []}], ["Adverse events were unremarkable.", {"entities": []}], ["Dexketoprofen trometamol 25\u00a0mg combined with tramadol hydrochloride 75\u00a0mg provided good analgesia with rapid onset and long duration in a model of moderate to severe pain.", {"entities": []}], ["The results of the dose finding study are consistent with pre-trial calculations based on empirical formulae.", {"entities": []}], ["EudraCT (2010-022798-32); Clinicaltrials.gov ( NCT01307020 ).", {"entities": []}], ["The online version of this article (doi:10.1186/s10194-015-0541-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Historically, immunology emerged as a biomedical science, concerned with host defense and production of anti-infectious vaccines.", {"entities": []}], ["In the late 50s, selective theories were proposed and from then on, immunology has been based in a close association with the neo-Darwinian principles, such as random generation of variants (lymphocyte clones), selection by extrinsic factors (antigens)\u2014and, more generally, on genetic determinism and functionalism.", {"entities": []}], ["This association has had major consequences: (1) immunological jargon is full of \u201ccognitive\u201d metaphors, founded in the idea of \u201cforeignness\u201d; (2) the immune system is described with a random clonal origin, coupled to selection by random encounters; and (3) physiological events are virtually absent from immunological descriptions.", {"entities": []}], ["In the present manuscript, we apply systemic notions to bring forth an explanation including systemic mechanisms able to generate immunological phenomena.", {"entities": []}], ["We replace \u201crandomness plus selection\u201d and the notion of foreignness by a history of structural changes which are determined by the coherences of the system internal architecture at any given moment.", {"entities": []}], ["The importance of this systemic way of seeing is that it explicitly attends to the organization that defines the immune system, within which it is possible to describe the conservative physiology of the immune system.", {"entities": []}], ["Understanding immune physiology in a systemic way of seeing also suggests mechanisms underlying the origin of immunopathogeny and therefore suggests new insights to therapeutic approaches.", {"entities": []}], ["However, if seriously acknowledged, this systemic/historic approach to immunology goes along with a global conceptual change which modifies virtually everything in the domain of biology, as suggested by Maturana.", {"entities": []}], ["We aimed to investigate the efficacy of four severity-of-disease scoring systems in predicting the 28-day survival rate among patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) requiring emergency care.", {"entities": [[162, 199, "DISEASE"]]}], ["Clinical data of patients with AECOPD who required emergency care were recorded over 2 years.", {"entities": []}], ["APACHE II, SAPS II, SOFA, and MEDS scores were calculated from severity-of-disease indicators recorded at admission and compared between patients who died within 28 days of admission (death group; 46 patients) and those who did not (survival group; 336 patients).", {"entities": []}], ["Compared to the survival group, the death group had a significantly higher GCS score, frequency of comorbidities including hypertension and heart failure, and age ( P < 0.05 for all).", {"entities": [[123, 135, "DISEASE"]]}], ["With all four systems, scores of age, gender, renal inadequacy, hypertension, coronary heart disease, heart failure, arrhythmia, anemia, fracture leading to bedridden status, tumor, and the GCS were significantly higher in the death group than the survival group.", {"entities": [[64, 76, "DISEASE"], [87, 100, "DISEASE"], [78, 100, "DISEASE"], [129, 135, "DISEASE"]]}], ["The prediction efficacy of the APACHE II and SAPS II scores was 88.4%.", {"entities": []}], ["The survival rates did not differ significantly between APACHE II and SAPS II ( P = 1.519).", {"entities": []}], ["Our results may guide triage for early identification of critically ill patients with AECOPD in the emergency department.", {"entities": []}], ["The cysteinyl leukotrienes receptors (CysLTRs) are implicated in many different pathological conditions, such as inflammation and cancer.", {"entities": [[130, 136, "DISEASE"]]}], ["We have previously shown that colon cancer patients with high CysLT 1 R and low CysLT 2 R expression demonstrate poor prognosis.", {"entities": [[30, 42, "DISEASE"], [36, 42, "DISEASE"]]}], ["Therefore, we wanted to investigate ways for the transcriptional regulation of CysLT 2 R , which still remains to be poorly understood.", {"entities": []}], ["We investigated the potential role of the anti-tumorigenic interferon \u03b1 (IFN-\u03b1) and the mitogenic epidermal growth factor (EGF) on CysLT 2 R regulation using non-transformed intestinal epithelial cell lines and colon cancer cells to elucidate the effects on the CysLT 2 R expression and regulation.", {"entities": [[211, 223, "DISEASE"], [217, 223, "DISEASE"], [123, 126, "GENE"]]}], ["This was done using Western blot, qPCR, luciferase reporter assay and a colon cancer patient array.", {"entities": [[72, 84, "DISEASE"], [78, 84, "DISEASE"]]}], ["We found a binding site for the transcription factor IRF-7 in the putative promoter region of CysLT 2 R .", {"entities": []}], ["This site was involved in the IFN-\u03b1 induced activity of the CysLT 2 R luciferase reporter assay.", {"entities": []}], ["In addition, IFN-\u03b1 induced the activity of the differentiation marker alkaline phosphatase along with the expression of mucin-2, which protects the epithelial layer from damage.", {"entities": []}], ["Interestingly, EGF suppressed both the expression and promoter activity of the CysLT 2 R .", {"entities": [[15, 18, "GENE"]]}], ["E-boxes present in the CysLT 2 R putative promoter region were involved in the suppressing effect.", {"entities": []}], ["CysLT 2 R signaling was able to suppress cell migration that was induced by EGF signaling.", {"entities": [[76, 79, "GENE"]]}], ["The patient array showed that aggressive tumors generally expressed less IFN-\u03b1 receptor and more EGFR.", {"entities": [[97, 101, "GENE"]]}], ["Interestingly, there was a negative correlation between CysLT 2 R and EGFR expression.", {"entities": [[70, 74, "GENE"]]}], ["Our data strengthens the idea that there is a protective role against tumor progression for CysLT 2 R and that it highlights new possibilities to regulate the CysLT 2 R .", {"entities": []}], ["The successful recruitment and retention of participants is integral to the translation of research findings.", {"entities": []}], ["We examined the recruitment and retention rates of racial/ethnic minority adolescents at a center involved in the National Institutes of Health Obesity Research for Behavioral Intervention Trials (ORBIT) initiative by the 3 recruitment strategies used: clinic, informatics, and community.", {"entities": []}], ["During the 9-month study, 186 family dyads, each composed of an obese African American adolescent and a caregiver, enrolled in a 6-month weight-loss intervention, a sequential multiple assignment randomized trial.", {"entities": []}], ["We compared recruitment and retention rates by recruitment strategy and examined whether recruitment strategy was related to dyad baseline characteristics.", {"entities": []}], ["Of the 186 enrolled families, 110 (59.1%) were recruited through clinics, 53 (28.5%) through informatics, and 23 (12.4%) through community.", {"entities": []}], ["Of those recruited through community, 40.4% enrolled in the study, compared with 32.7% through clinics and 8.2% through informatics.", {"entities": []}], ["Active refusal rate was 3%.", {"entities": []}], ["Of the 1,036 families identified for the study, 402 passively refused to participate: 290 (45.1%) identified through informatics, 17 (29.8%) through community, and 95 (28.3%) through clinics.", {"entities": []}], ["Recruitment strategy was not related to the age of the adolescent, adolescent comorbidities, body mass index of the adolescent or caregiver, income or education of the caregiver, or retention rates at 3 months, 7 months, or 9 months.", {"entities": []}], ["Study retention rate was 87.8%.", {"entities": []}], ["Using multiple recruitment strategies is beneficial when working with racial/ethnic minority adolescents, and each strategy can yield good retention.", {"entities": []}], ["Research affiliated with health care systems would benefit from the continued specification, refinement, and dissemination of these strategies.", {"entities": []}], ["There is an ongoing debate on the potential association between obesity and atopy.", {"entities": [[64, 71, "DISEASE"]]}], ["However, no previous studies have investigated whether this relationship depends on sex and smoking status in Chinese adults.", {"entities": []}], ["In this hospital-based, case\u2013control study, we recruited 1150 atopic cases aged 18\u00a0years or older and 1245 healthy control participants during April 2009 and December 2012 in Harbin, China.", {"entities": []}], ["We conducted structured questionnaire interviews, anthropometry measurements and serum allergen-specific immunoglobulin E (IgE) testing.", {"entities": []}], ["Univariate and multivariate logistic regression models were used to explore the relationship between obesity and atopy risk stratified by sex and smoking status.", {"entities": [[101, 108, "DISEASE"]]}], ["There was an association between obesity and an increased risk of atopic sensitization after adjusting for age, educational, family history, smoking and alcohol consumption (OR: 2.61, 3.25; 95% CI: 1.57-4.33,1.91-5.56 in males and females, respectively).", {"entities": [[33, 40, "DISEASE"]]}], ["The association between BMI and allergic sensitization depended on smoking status.", {"entities": []}], ["In both genders, the association of obesity with atopic sensitization risk was stronger in non-smokers than in current smokers.", {"entities": [[36, 43, "DISEASE"]]}], ["In males, ORs of atopic sensitization for obesity were 3.15 (95% CI, 1.46-6.68) for non-smokers and 2.22 (95% CI, 1.10-4.48) for current smokers.", {"entities": [[42, 49, "DISEASE"]]}], ["The corresponding ORs in females were 3.51 (95% CI, 1.98-6.24) and 2.22 (95% CI, 0.46-10.68) for non-smokers and current smokers, respectively.", {"entities": []}], ["After excluding those subjects who with pre-existing allergic conditions, the same relationship still remained.", {"entities": []}], ["Obesity is positively and significantly associated with the risk of atopy in both men and women as well in both smokers and non-smokers in China.", {"entities": [[0, 7, "DISEASE"]]}], ["In addition, the relationship between obesity and atopic sensitization is stronger in non-smokers than in current smokers.", {"entities": [[38, 45, "DISEASE"]]}], ["General anesthesia usually requires mechanical ventilation, which is traditionally accomplished with constant tidal volumes in volume- or pressure-controlled modes.", {"entities": []}], ["Experimental studies suggest that the use of variable tidal volumes (variable ventilation) recruits lung tissue, improves pulmonary function and reduces systemic inflammatory response.", {"entities": []}], ["However, it is currently not known whether patients undergoing open abdominal surgery might benefit from intraoperative variable ventilation.", {"entities": []}], ["The PROtective VARiable ventilation trial (\u2018PROVAR\u2019) is a single center, randomized controlled trial enrolling 50 patients who are planning for open abdominal surgery expected to last longer than 3\u00a0hours.", {"entities": []}], ["PROVAR compares conventional (non-variable) lung protective ventilation (CV) with variable lung protective ventilation (VV) regarding pulmonary function and inflammatory response.", {"entities": []}], ["The primary endpoint of the study is the forced vital capacity on the first postoperative day.", {"entities": []}], ["Secondary endpoints include further lung function tests, plasma cytokine levels, spatial distribution of ventilation assessed by means of electrical impedance tomography and postoperative pulmonary complications.", {"entities": []}], ["We hypothesize that VV improves lung function and reduces systemic inflammatory response compared to CV in patients receiving mechanical ventilation during general anesthesia for open abdominal surgery longer than 3\u00a0hours.", {"entities": []}], ["PROVAR is the first randomized controlled trial aiming at intra- and postoperative effects of VV on lung function.", {"entities": []}], ["This study may help to define the role of VV during general anesthesia requiring mechanical ventilation.", {"entities": []}], ["Clinicaltrials.gov NCT01683578 (registered on September 3 3012).", {"entities": []}], ["Caffeine, theophylline, and theobromine are the most well-known members of methylxanthines.", {"entities": []}], ["Caffeine-induced serine/arginine-rich splicing factor 2, SRSF2, and SRSF3 are required for the alternative splicing of a subset of cancer-associated genes.", {"entities": [[131, 137, "DISEASE"], [57, 62, "GENE"], [68, 73, "GENE"]]}], ["However, it remains to be investigated whether and how theophylline and theobromine as well as caffeine exert their antitumor effects through mediating the alternative splicing process.", {"entities": []}], ["Here, we reveal that theophylline down-regulated SRSF3 expression and switched p53 from alpha into a beta isoform as caffeine did in HeLa and MCF-7 cells via the reverse-transcriptase polymerase chain reaction and Western blot analysis.", {"entities": [[49, 54, "GENE"]]}], ["Further functional studies show that theophylline induced cellular apoptosis, senescence, and decreased colony formation.", {"entities": []}], ["Interestingly, theophylline had a suppressive effect on cellular proliferation, whereas caffeine enhanced cellular proliferation rates via the 5-bromo-2-deoxyuridine analysis.", {"entities": []}], ["Theophylline and caffeine had no effect on MCF-10A cells, which is a normal breast cell line.", {"entities": []}], ["Our results provide an insight that theophylline as well as caffeine could be repurposed as antitumor leading compounds via the downregulation of splicing factor SRSF3 and its target genes.", {"entities": [[162, 167, "GENE"]]}], ["Outdoor air pollution, given its demonstrated negative effects on the respiratory system, is a growing public health concern worldwide, particularly in urban cities.", {"entities": []}], ["Human exposure to pollutants such as ozone, nitrogen oxides, combustion-related particulate matter and oxides of sulfur is responsible for significant cardiopulmonary morbidity and mortality in both adults and children.", {"entities": []}], ["Several antioxidants have shown an ability to partially attenuate the negative physiological and functional impacts of air pollutants.", {"entities": []}], ["This study systematically presents current data on the potential benefits of antioxidant supplementation on lung function outcomes associated with air pollutant exposures in intact humans.", {"entities": []}], ["Electronic databases (MEDLINE, EMBASE, BIOSIS Previews, Web of Sciences, Environmental Sciences & Pollution Management and TOXNET) were systematically searched for all studies published up to April 2009.", {"entities": []}], ["Search terms relating to the concepts of respiratory tract diseases, respiratory function tests, air pollution, and antioxidants were used.", {"entities": []}], ["Data was systematically abstracted from original articles that satisfied selection criteria for inclusion.", {"entities": []}], ["For inclusion, the studies needed to have evaluated human subjects, given supplemental antioxidants, under conditions of known levels of air pollutants with measured lung function before and after antioxidant administration and/or air pollution exposure.", {"entities": []}], ["Selected studies were summarized and conclusions presented.", {"entities": []}], ["Eight studies investigated the role of antioxidant supplementation on measured lung function outcomes after subject exposure to air pollutants under controlled conditions; 5 of these studies concluded that pollutant-induced airway hyper-responsiveness and diminution in lung function measurements were attenuated by antioxidant supplementation.", {"entities": []}], ["The remaining five studies took place under ambient (uncontrolled) exposures and unanimously concluded that antioxidant supplementations attenuate the negative effects of urban air pollution on lung function.", {"entities": []}], ["The data evaluating modification of changes in lung function associated with air pollutant exposure by antioxidant supplementation, in intact humans, is limited.", {"entities": []}], ["Of 13 studies dedicated to this concern, ten demonstrated an attenuation of pollution-associated decrements.", {"entities": []}], ["There is growing evidence for the benefit of anti-oxidant supplementation in moderating the effects of air pollution on lung function, but more research on human participants is needed to inform this topic.", {"entities": []}], ["Studies have suggested that selective microbial targets prevail in the fecal microbiota of infants with eczema.", {"entities": []}], ["This study evaluated the composition of fecal microbiota of infants who developed eczema in the first 5\u00a0years of life and compared these with those of healthy controls.", {"entities": []}], ["Children who developed eczema in the first 2\u00a0years, those with eczema at 5\u00a0years of age and healthy controls were selected from the placebo arm of a birth cohort of at-risk infants participating in a randomized double-blind trial on the protective effects of supplemental probiotics in early life on allergic outcomes.", {"entities": []}], ["Molecular evaluation of fecal microbiota were conducted using Fluorescence In Situ Hybridization-Flow Cytometry (FISH-FC) for fecal samples collected.", {"entities": []}], ["Longitudinal analysis of fecal microbiota composition at three days, one and three months and one year of life revealed higher abundance of Enterobacteriaceae [coefficient (B): 1.081, 95% CI: 0.229-1.933, adj p\u2009=\u20090.014] and Clostridium perfringens [coefficient (B): 0.521, 95% CI: 0.556-0.988, adj p\u2009=\u20090.03] in those who developed eczema in the first 2\u00a0years life.", {"entities": []}], ["In those with eczema at 5\u00a0years of age, a lower abundance of Bifidobacterium was observed [coefficient (B): -27.635, 95% CI: -50.040 - -5.231, adj p\u2009=\u20090.018].", {"entities": []}], ["The differences in infant fecal microbiota observed in eczema subjects in this study support the notion that relative abundance of selective microbial targets may contribute to the subsequent development of eczema in childhood.", {"entities": []}], ["Influenza causes substantial morbidity and mortality worldwide each year.", {"entities": [[0, 9, "DISEASE"]]}], ["Healthcare-associated influenza is a frequent event.", {"entities": [[22, 31, "DISEASE"]]}], ["Health care personnel (HCP) may be the source for infecting patients and may propagate nosocomial outbreaks.", {"entities": []}], ["All HCP should receive a dose of influenza vaccine each year to protect themselves and others.", {"entities": [[33, 42, "DISEASE"]]}], ["This commentary will discuss the study recently published in the IJHPR by Nutman and Yoeli which assessed the beliefs and attitudes of HCP in an Israel hospital regarding influenza and the influenza vaccine.", {"entities": [[171, 180, "DISEASE"], [189, 198, "DISEASE"]]}], ["Unfortunately, as noted by Nutman and Yoeli in this issue many HCP in Israel choose not to receive influenza immunization and many harbor misconceptions regarding their risk for influenza as well as the benefits of influenza vaccine.", {"entities": [[99, 108, "DISEASE"], [178, 187, "DISEASE"], [215, 224, "DISEASE"]]}], ["We also discuss proven methods to increase acceptance by HCP for receiving an annual influenza vaccine.", {"entities": [[85, 94, "DISEASE"]]}], ["Childhood minimal change nephrotic syndrome (MCNS) has often been associated with allergic symptoms such as urticaria, bronchial asthma, atopic dermatitis, allergic rhinitis and elevated IgE levels and referred to involve immune dysfunction.", {"entities": [[156, 173, "DISEASE"], [108, 117, "DISEASE"], [25, 43, "DISEASE"], [137, 154, "DISEASE"], [165, 173, "DISEASE"], [35, 43, "DISEASE"], [129, 135, "DISEASE"], [144, 154, "DISEASE"]]}], ["Fc epsilon RII is known to be involved in IgE production and response.", {"entities": []}], ["Interleukin-4 is being recognized as a major cytokine up-regulating IgE production.", {"entities": []}], ["Hence the present study is aimed at investigating the role of interleukin-4 and Fc epsilon RII in the pathogenesis of MCNS.", {"entities": []}], ["IgE was measured by ELISA.", {"entities": []}], ["Fc epsilon RII was analyzed by fluorescence activated cell scanner (FAC-scan) by double antibody staining with anti Leu16-FITC and anti Leu20-PE.", {"entities": []}], ["Soluble IgE receptor was measured by ELISA using anti CD23 antibody (3-5-14).", {"entities": []}], ["Interleukin-4 activities were measured by CD23 expression on purified human tonsillar B cells.", {"entities": []}], ["Serum IgE levels were significantly higher in MCNS (1,507 +/- 680 IU/dl) than in normal controls (123 +/- 99.2 IU/dl).", {"entities": []}], ["A significantly higher expression of membrane Fc epsilon RII was noted for MCNS (41 +/- 12%) than that in normal controls (18 +/- 6.2%) (p < 0.001).", {"entities": []}], ["Soluble CD23 levels were also significantly higher in MCNS (198 +/- 39.3%) than in normal controls (153 +/- 13.4) (p < 0.01).", {"entities": []}], ["Interleukin-4 activity in sera of MCNS (12U/ml) was also significantly higher than normal controls (4.5U/ml).", {"entities": []}], ["These results indicate that increased production of Fc epsilon RII and interleukin-4 may play an important role in the pathogenesis of MCNS.", {"entities": []}], ["Verbal autopsies provide valuable information for studying mortality patterns in populations that lack reliable vital registration data.", {"entities": []}], ["Methods for transforming verbal autopsy results into meaningful information for health workers and policymakers, however, are often costly or complicated to use.", {"entities": []}], ["We present a simple additive algorithm, the Tariff Method (termed Tariff), which can be used for assigning individual cause of death and for determining cause-specific mortality fractions (CSMFs) from verbal autopsy data.", {"entities": []}], ["Tariff calculates a score, or \"tariff,\" for each cause, for each sign/symptom, across a pool of validated verbal autopsy data.", {"entities": []}], ["The tariffs are summed for a given response pattern in a verbal autopsy, and this sum (score) provides the basis for predicting the cause of death in a dataset.", {"entities": []}], ["We implemented this algorithm and evaluated the method's predictive ability, both in terms of chance-corrected concordance at the individual cause assignment level and in terms of CSMF accuracy at the population level.", {"entities": []}], ["The analysis was conducted separately for adult, child, and neonatal verbal autopsies across 500 pairs of train-test validation verbal autopsy data.", {"entities": []}], ["Tariff is capable of outperforming physician-certified verbal autopsy in most cases.", {"entities": []}], ["In terms of chance-corrected concordance, the method achieves 44.5% in adults, 39% in children, and 23.9% in neonates.", {"entities": []}], ["CSMF accuracy was 0.745 in adults, 0.709 in children, and 0.679 in neonates.", {"entities": []}], ["Verbal autopsies can be an efficient means of obtaining cause of death data, and Tariff provides an intuitive, reliable method for generating individual cause assignment and CSMFs.", {"entities": []}], ["The method is transparent and flexible and can be readily implemented by users without training in statistics or computer science.", {"entities": []}], ["Osteoarthritis (OA) belongs to a group of degenerative diseases.", {"entities": [[0, 14, "DISEASE"]]}], ["Synovial inflammation, cartilage abrasion, and subchondral sclerosis are characteristics of OA.", {"entities": []}], ["Researchers do not fully understand the exact etiology of OA.", {"entities": []}], ["However, matrix metalloproteinases (MMPs), which are responsible for cartilage matrix degradation, play a pivotal role in the progression of OA.", {"entities": []}], ["Amphiregulin (AREG) binds to the EGF receptor (EGFR) and activates downstream proteins.", {"entities": [[14, 18, "GENE"], [33, 36, "GENE"], [47, 51, "GENE"]]}], ["AREG is involved in a variety of pathological processes, such as the development of tumors, inflammatory diseases, and rheumatoid arthritis.", {"entities": [[119, 139, "DISEASE"], [130, 139, "DISEASE"], [0, 4, "GENE"]]}], ["However, the relationship between AREG and MMP-13 in OA synovial fibroblasts (SFs) remains unclear.", {"entities": [[34, 38, "GENE"]]}], ["We investigated the signaling pathway involved in AREG-induced MMP-13 production in SFs.", {"entities": []}], ["AREG caused MMP-13 production in a concentration- and time-dependent manner.", {"entities": [[0, 4, "GENE"]]}], ["The results of using pharmacological inhibitors and EGFR siRNA to block EGFR revealed that the EGFR receptor was involved in the AREG-mediated upregulation of MMP-13.", {"entities": [[52, 56, "GENE"], [72, 76, "GENE"], [95, 99, "GENE"], [52, 56, "GENE"], [72, 76, "GENE"], [95, 99, "GENE"], [52, 56, "GENE"], [72, 76, "GENE"], [95, 99, "GENE"]]}], ["AREG-mediated MMP-13 production was attenuated by PI3K and Akt inhibitors.", {"entities": []}], ["The stimulation of cells by using AREG activated p65 phosphorylation and p65 translocation from the cytosol to the nucleus.", {"entities": [[34, 38, "GENE"]]}], ["Our results provide evidence that AREG acts through the EGFR and activates PI3K, Akt, and finally NF-kappaB on the MMP-13 promoter, thus contributing to cartilage destruction during osteoarthritis.", {"entities": [[182, 196, "DISEASE"], [34, 38, "GENE"], [56, 60, "GENE"]]}], ["Conventional lung cancer therapies are associated with poor survival rates; therefore, new approaches such as gene therapy are required for treating cancer.", {"entities": [[13, 24, "DISEASE"], [18, 24, "DISEASE"], [149, 155, "DISEASE"]]}], ["Gene therapies for treating lung cancer patients can involve several approaches.", {"entities": [[28, 39, "DISEASE"], [33, 39, "DISEASE"]]}], ["Among these, aerosol gene delivery is a potentially more effective approach.", {"entities": []}], ["In this study, Akt1 kinase-deficient (KD) and wild-type (WT) Akt1 were delivered to the lungs of CMV-LucR-cMyc-IRES-LucF dual reporter mice through a nose only inhalation system using glucosylated polyethylenimine and naphthalene was administrated to the mice via intraperitoneal injection.", {"entities": [[15, 19, "GENE"], [61, 65, "GENE"], [15, 19, "GENE"], [61, 65, "GENE"]]}], ["Aerosol delivery of Akt1 WT and naphthalene treatment increased protein levels of downstream substrates of Akt signaling pathway while aerosol delivery of Akt1 KD did not.", {"entities": [[20, 24, "GENE"], [155, 159, "GENE"], [20, 24, "GENE"], [155, 159, "GENE"]]}], ["Our results showed that naphthalene affected extracellular signal-regulated kinase (ERK) protein levels, ERK-related signaling, and induced Clara cell injury.", {"entities": []}], ["However, Clara cell injury induced by naphthalene was considerably attenuated in mice exposed to Akt1 KD.", {"entities": [[97, 101, "GENE"]]}], ["Furthermore, a dual luciferase activity assay showed that aerosol delivery of Akt1 WT and naphthalene treatment enhanced cap-dependent protein translation, while reduced cap-dependent protein translation was observed after delivering Akt1 KD.", {"entities": [[78, 82, "GENE"], [234, 238, "GENE"], [78, 82, "GENE"], [234, 238, "GENE"]]}], ["These studies demonstrated that our aerosol delivery is compatible for in vivo gene delivery.", {"entities": []}], ["Please cite this paper as: Regan et\u00a0al.", {"entities": []}], ["(2012) Epidemiology of influenza A (H1N1)pdm09\u2010associated deaths in the United States, September\u2013October 2009.", {"entities": [[23, 32, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(601), e169\u2013e177.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 From April to July 2009, the United States experienced a wave of influenza A (H1N1)pdm09 virus (H1N1pdm09) infection.", {"entities": [[77, 86, "DISEASE"]]}], ["The majority of the deaths during that period occurred in persons <65\u2003years of age with underlying medical conditions.", {"entities": []}], ["Objective\u2002 To describe the epidemiology of H1N1pdm09\u2010associated deaths in the US during the fall of 2009.", {"entities": []}], ["Methods\u2002 We collected demographic, medical history, and cause of death information on a nationally representative, stratified random sample of 323 H1N1pdm09\u2010associated deaths that occurred during September 1\u2013October 31, 2009.", {"entities": []}], ["Results\u2002 Data were available for 302/323 (93%) deaths.", {"entities": []}], ["Most cases (74%) were 18\u201364\u2003years of age and had \u22651 underlying medical condition (72%).", {"entities": []}], ["Among cases aged <18\u2003years, 16/43 (37%) had a chronic lung disease, and 15/43 (35%) a neurological disorder; among cases aged \u226518\u2003years, 94/254 (37%) had a chronic lung disease and 84/254 (33%) had a metabolic disorder.", {"entities": [[54, 66, "DISEASE"], [164, 176, "DISEASE"]]}], ["The median number of days between symptom onset and death was six among children (range, 1\u201348) and 12 among adults (range, 0\u2013109).", {"entities": []}], ["Influenza antiviral agents were prescribed for 187/268 (70%) of cases, but only 48/153 (31%) received treatment within 2\u2003days of illness onset.", {"entities": [[0, 9, "DISEASE"]]}], ["Conclusions\u2002 The characteristics of H1N1pdm09 deaths identified during the fall of 2009 were similar to those occurring April\u2013July 2009.", {"entities": []}], ["While most cases had conditions that were known to increase the risk for severe outcomes and were recommended to receive antiviral therapy, a minority of cases received antivirals early in the course of illness.", {"entities": []}], ["Enablement is an intervention by which the health care provider recognizes, promotes and enhances patients' ability to control their health and life.", {"entities": []}], ["An abundant health literature suggests that enablement is associated with good outcomes.", {"entities": []}], ["In this review, we aimed at identifying and comparing instruments that assess enablement in the health care context.", {"entities": []}], ["We conducted a systematic literature review using Medline, Embase, Cochrane, Cinahl and PsycINFO databases, 1980 through March 2009, with specific search strategy for each database.", {"entities": []}], ["Citations were included if they reported: (1) development and/or validation of an instrument; (2) evaluation of enablement in a health care context; and (3) quantitative results following administration of the instrument.", {"entities": []}], ["The quality of each main retained citation was assessed using a modified version of the Standards for Reporting of Diagnostic Accuracy.", {"entities": []}], ["Of 3135 citations identified, 53 were retrieved for detailed evaluation.", {"entities": []}], ["Four articles were included.", {"entities": []}], ["Two instruments were found: the Patient Empowerment Scale (PES) and the Empowering Speech Practices Scale (ESPS).", {"entities": []}], ["Both instruments assessed enablement in hospital setting, one from the inpatient's perspective (PES) and the other from both perspectives (ESPS).", {"entities": []}], ["Two instruments assess enablement in hospital setting.", {"entities": []}], ["No instrument is currently available to assess enablement in an ambulatory care context.", {"entities": []}], ["Physicians do not routinely recommend smokers to undergo spirometry unless they are symptomatic.", {"entities": []}], ["To test the hypothesis that there are a significant number of asymptomatic smokers with chronic obstructive pulmonary disease (COPD), we estimated the prevalence of COPD in a group of asymptomatic smokers.", {"entities": [[88, 125, "DISEASE"]]}], ["Two thousand nine hundred and sixty-one smokers with a cumulative consumption history of at least 10 pack-years, either smokers with symptoms or smokers without symptoms (WOS) were invited to perform a spirometry and complete a symptom questionnaire.", {"entities": []}], ["Six hundred and thirty-seven (21.5%) smokers had no symptoms, whereas 2,324 (78.5%) had at least one symptom.", {"entities": []}], ["The prevalence of COPD in subjects WOS was 1.5% when considering the whole group of smokers (45/2,961) and 7% when considering only the group WOS (45/637).", {"entities": []}], ["From 329 smokers with COPD, 13.7% were WOS.", {"entities": []}], ["Subjects WOS were younger, had better lung function and lower cumulative consumption of cigarettes, estimated as both cigarettes per day and pack-years.", {"entities": []}], ["According to severity of airflow limitation, 69% vs 87% of subjects were classified as Global Initiative for Chronic Obstructive Lung Disease stages I\u2013II in the WOS and smokers with symptoms groups, respectively ( P <0.001).", {"entities": []}], ["A multivariate analysis showed that forced expiratory volume in 1 second (mL) was the only predictive factor for COPD in asymptomatic smokers.", {"entities": []}], ["Prevalence of COPD in asymptomatic smokers is 1.5%.", {"entities": []}], ["This number of asymptomatic smokers may be excluded from the benefit of an \u201cearly\u201d intervention, not just pharmacological but also from smoking cessation counseling.", {"entities": []}], ["The higher forced expiratory volume in 1 second may contribute to prevent early diagnosis.", {"entities": []}], ["Sepsis is currently a leading cause of death in hospital intensive care units.", {"entities": []}], ["Previous studies suggest that the pathophysiology of sepsis involves the hyperactivation of complex proinflammatory cascades that include the activation of various immune cells and the exuberant secretion of proinflammatory cytokines by these cells.", {"entities": []}], ["Natural killer T-cells (NKTs) are a sublineage of T cells that share characteristics of conventional T cells and NK cells and bridge innate and adaptive immunity.", {"entities": []}], ["More recently, NKT cells have been implicated in microbial immunity, including the onset of sepsis.", {"entities": []}], ["Moreover, apolipoprotein E (apoE), a component of triglyceride-rich lipoproteins, has been shown to be protective in endotoxemia and gram-negative infections in addition to its well-known role in lipid metabolism.", {"entities": [[28, 32, "GENE"]]}], ["Here, we will review the role of NKT cells in sepsis and septic shock, the immunoregulatory role of apoE in the host immune response to infection, and propose a mechanism for this immunoregulation.", {"entities": [[100, 104, "GENE"]]}], ["Alkaloids extracted from lotus leaves (AELL) can relax vascular smooth muscle.", {"entities": []}], ["However, whether AELL has a similar relaxant role on airway smooth muscle (ASM) remains unknown.", {"entities": []}], ["This study aimed to explore the relaxant property of AELL on ASM and the underlying mechanism.", {"entities": []}], ["Alkaloids were extracted from dried lotus leaves using the high temperature rotary evaporation extraction method.", {"entities": []}], ["The effects of AELL on mouse ASM tension were studied using force measuring and patch-clamp techniques.", {"entities": []}], ["It was found that AELL inhibited the high K AELL, which plays a relaxant role in ASM, might be a new complementary treatment to treat abnormal contractions of the trachea and asthma.", {"entities": [[175, 181, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12906-017-1674-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Observational studies of type 2 diabetes (T2D) and lung cancer risk are limited and controversial.", {"entities": [[51, 62, "DISEASE"], [56, 62, "DISEASE"]]}], ["We thus examined the association between T2D and risk of incident lung cancer using a cohort design.", {"entities": [[66, 77, "DISEASE"], [71, 77, "DISEASE"]]}], ["Data from two ongoing population-based cohorts (the Shanghai Men's Health Study, SMHS, 2002\u20132006 and the Shanghai Women's Health Study, SWHS, 1996\u20132000) were used.", {"entities": []}], ["Cox proportional-hazards regression models with T2D as a time-varying exposure were modelled to estimate HRs and 95% CIs.", {"entities": []}], ["The study population included 61\u2005491 male participants aged 40\u201374\u2005years from SMHS and 74\u2005941 female participants aged 40\u201370\u2005years from SWHS.", {"entities": []}], ["Lung cancer cases were identified through annual record linkage to the Shanghai Cancer Registry and Shanghai Municipal Registry of Vital Statistics, and were further verified through home visits and a review of medical charts by clinical and/or pathological experts.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"], [80, 86, "DISEASE"]]}], ["Outcome data until 31 December 2010 for men and women were used for the present analysis.", {"entities": []}], ["After a median follow-up of 6.3\u2005years for SMHS and 12.2\u2005years for SWHS, incident lung cancer cases were detected in 492 men and 525 women.", {"entities": [[81, 92, "DISEASE"], [86, 92, "DISEASE"]]}], ["A null association between T2D and lung cancer risk was observed in men (HR=0.87, 95% CI 0.62 to 1.21) and women (HR=0.92, 95% CI 0.69 to 1.24) after adjustments for potential confounders.", {"entities": [[35, 46, "DISEASE"], [40, 46, "DISEASE"]]}], ["Similar results were observed among never smokers.", {"entities": []}], ["There is little evidence that pre-existing T2D may influence the incidence of lung cancer.", {"entities": [[78, 89, "DISEASE"], [83, 89, "DISEASE"]]}], ["PAPRICA is a research program designed to estimate the impact on the health of patients with chronic respiratory insufficiency of a prevention strategy based on notification of ozone pollution.", {"entities": []}], ["The first year of this study was conducted during the 2003 heat wave, and high temperatures were therefore considered as a confounding factor in the data analysis.", {"entities": []}], ["The aim of the present study was to assess the relationship between ozone and temperature in order to propose a methodology to distinguish between the effects of ozone and temperature on the impact of a prevention strategy with regard to ozone pollution.", {"entities": []}], ["Multivariate analyses were used to identify associated climate and ozone pollution profiles.", {"entities": []}], ["This descriptive method is of great value to highlight the complexity of interactions between these parameters.", {"entities": []}], ["Ozone concentration and temperature were strongly correlated, but the health impact of ozone pollution alone will be evaluated by focusing on situations characterized by ozone concentrations above 110 \u03bcg/m The precise relationship between ambient ozone concentration and temperature identified during the PAPRICA 2003 study period will be used in analysing the PAPRICA health data.", {"entities": []}], ["Childhood obesity is a serious public health problem and epidemiological studies are important to identify predictive factors.", {"entities": [[10, 17, "DISEASE"]]}], ["It is the aim of this study to analyse factors associated with overweight/obesity in samples of German children.", {"entities": [[74, 81, "DISEASE"]]}], ["35,434 five to seven year-old children (50.9% boys) participated in cross-sectional studies between 1991 and 2000 in several rural and urban areas in East and West Germany.", {"entities": []}], ["Weight and height were measured and body mass index was calculated.", {"entities": []}], ["International cut-off points, recommended by the International Obesity Task Force, were used to classify childhood overweight and obesity.", {"entities": [[63, 70, "DISEASE"], [130, 137, "DISEASE"]]}], ["Predictive modelling was employed to analyse independently associated factors, using logistic regression to adjust for confounding.", {"entities": []}], ["15.5% were overweight, and 4.3% were obese.", {"entities": []}], ["Female sex, other than German nationality, smoking in the living place and increasing birth weight were found to increase the odds of overweight and obesity, while increasing educational level, living space > 75 m The findings add to the evidence informing public health action, both through health promotion strategies (promoting breastfeeding, tackling smoking) and wider societal change management (addressing children from migrant families and families with low educational level).", {"entities": [[149, 156, "DISEASE"]]}], ["The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands.", {"entities": []}], ["The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, oncological, and respiratory diseases.", {"entities": []}], ["As of 2008, 14,926 subjects aged 45\u00a0years or over comprise the Rotterdam Study cohort.", {"entities": []}], ["The findings of the Rotterdam Study have been presented in over a 1,000 research articles and reports (see www.erasmus-epidemiology.nl/rotterdamstudy ).", {"entities": []}], ["This article gives the rationale of the study and its design.", {"entities": []}], ["It also presents a summary of the major findings and an update of the objectives and methods.", {"entities": []}], ["Chemical allergens represent a significant health burden in the workplace.", {"entities": []}], ["Exposures to such chemicals can cause the onset of a diverse group of adverse health effects triggered by immune-mediated responses.", {"entities": []}], ["Common responses associated with workplace exposures to low molecular weight (LMW) chemical allergens range from allergic contact dermatitis to life-threatening cases of asthma.", {"entities": [[122, 140, "DISEASE"], [113, 140, "DISEASE"], [170, 176, "DISEASE"], [130, 140, "DISEASE"]]}], ["Establishing occupational exposure limits (OELs) for chemical allergens presents numerous difficulties for occupational hygiene professionals.", {"entities": []}], ["Few OELs have been developed for LMW allergens because of the unique biological mechanisms that govern the immune-mediated responses.", {"entities": []}], ["The purpose of this article is to explore the primary challenges confronting the establishment of OELs for LMW allergens.", {"entities": []}], ["Specific topics include: (1) understanding the biology of LMW chemical allergies as it applies to setting OELs; (2) selecting the appropriate immune-mediated response (i.e., sensitization versus elicitation); (3) characterizing the dose (concentration)-response relationship of immune-mediated responses; (4) determining the impact of temporal exposure patterns (i.e., cumulative versus acute exposures); and (5) understanding the role of individual susceptibility and exposure route.", {"entities": []}], ["Additional information is presented on the importance of using alternative exposure recommendations and risk management practices, including medical surveillance, to aid in protecting workers from exposures to LMW allergens when OELs cannot be established.", {"entities": []}], ["Beta - carotene 15,15 \u2032- monooxygenase 1 knockout ( Bcmo1 Bcmo1 Bcmo1 Bcmo1 Bcmo1 Bcmo1 Bcmo1 Bcmo1 Bcmo1 BCMO1 .", {"entities": [[52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"], [52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"], [52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"], [52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"], [52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"], [52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"], [52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"], [52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"], [52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"], [52, 57, "GENE"], [58, 63, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [76, 81, "GENE"], [82, 87, "GENE"], [88, 93, "GENE"], [94, 99, "GENE"], [100, 105, "GENE"], [106, 111, "GENE"]]}], ["Exposure to environmental hazards has been associated with diseases in humans.", {"entities": []}], ["The identification of single nucleotide polymorphisms (SNPs) in human populations exposed to different environmental hazards, is vital for detecting the genetic risks of some important human diseases.", {"entities": []}], ["Several studies in this field have been conducted on glutathione S-transferases (GSTs), a phase II detoxification superfamily, to investigate its role in the occurrence of diseases.", {"entities": []}], ["Human GSTs consist of cytosolic and microsomal superfamilies that are further divided into subfamilies.", {"entities": []}], ["Based on scientific search engines and a review of the literature, we have found a large amount of published articles on human GST super- and subfamilies that have greatly assisted in our efforts to examine their role in health and disease.", {"entities": []}], ["Because of its polymorphic variations in relation to environmental hazards such as air pollutants, cigarette smoke, pesticides, heavy metals, carcinogens, pharmaceutical drugs, and xenobiotics, GST is considered as a significant biomarker.", {"entities": []}], ["This review examines the studies on gene-environment interactions related to various diseases with respect to single nucleotide polymorphisms (SNPs) found in the GST superfamily.", {"entities": []}], ["Overall, it can be concluded that interactions between GST genes and environmental factors play an important role in human diseases.", {"entities": []}], ["High-quality care delivery for frail older persons, many of whom have multiple complex needs, is among the greatest challenges faced by healthcare systems today.", {"entities": []}], ["The Chronic Care Model (CCM) may guide quality improvement efforts for primary care delivery to frail older populations.", {"entities": []}], ["Objectives of this study were to assess the implementation of interventions in CCM dimensions, and to investigate the quality of primary care as perceived by healthcare professionals, in practices following the Finding and Follow-up of Frail older persons (FFF) integrated care approach and those providing usual care.", {"entities": []}], ["Structured interviews were conducted with general practitioners (GPs) from 11 intervention practices and 4 control practices to assess the implementation of interventions.", {"entities": []}], ["A longitudinal survey (12-month period, 2 measurement timepoints) was conducted to assess the quality of primary care as perceived by healthcare professionals (intervention and control GP practices) using the Assessment of Chronic Illness Care Short version (ACIC-S).", {"entities": []}], ["Independent-samples t -tests were used to assess differences in ACIC-S scores between groups.", {"entities": []}], ["Interviews were conducted with GPs from the intervention practices to gain a deeper understanding of their experiences with the FFF approach.", {"entities": []}], ["Intervention practices implemented significantly more interventions congruent with (dimensions of) the CCM compared with control GP practices.", {"entities": []}], ["With respect to the quality of primary care as perceived by healthcare professionals, mean ACIC-S scores for all CCM dimensions and overall mean ACIC-S scores were significantly higher in the intervention group than in the control group at the follow-up timepoint.", {"entities": []}], ["The number of implemented interventions was associated positively with perceived quality of primary care (ACIC-S scores) at follow-up.", {"entities": []}], ["Important motives of GPs to implement the FFF approach were the aging of the population and transformations in the primary care sector.", {"entities": []}], ["Proactive care delivery and multidisciplinary collaboration were considered to be essential.", {"entities": []}], ["Major challenges to the implementation and embedding of the FFF approach were structural financing and manpower, and the availability of a facilitating information\u00a0and communication technology system.", {"entities": []}], ["Our study showed that proactive, integrated care that is based on (elements of) the CCM may be a step forward in improving quality of care for frail older persons.", {"entities": []}], ["Safe drug prescribing and administration are essential elements within undergraduate healthcare curricula, but medication errors, especially in paediatric practice, continue to compromise patient safety.", {"entities": []}], ["In this area of clinical care, collective responsibility, team working and communication between health professionals have been identified as key elements in safe clinical practice.", {"entities": []}], ["To date, there is limited research evidence as to how best to deliver teaching and learning of these competencies to practitioners of the future.", {"entities": []}], ["An interprofessional workshop to facilitate learning of knowledge, core competencies, communication and team working skills in paediatric drug prescribing and administration at undergraduate level was developed and evaluated.", {"entities": []}], ["The practical, ward-based workshop was delivered to 4 Following the workshop, students reported an increase in their knowledge and awareness of paediatric medication safety and the causes of medication errors (p < 0.001), with the greatest increase noted among medical students.", {"entities": []}], ["Highly significant changes in students' attitudes to shared learning were observed, indicating that safe medication practice is learnt more effectively with students from other healthcare disciplines.", {"entities": []}], ["Qualitative data revealed that students' participation in the workshop improved communication and teamworking skills, and led to greater awareness of the role of other healthcare professionals.", {"entities": []}], ["This study has helped bridge the knowledge-skills gap, demonstrating how an interprofessional approach to drug prescribing and administration has the potential to improve quality and safety within healthcare.", {"entities": []}], ["Previous studies indicate that maternal anxiety is associated with asthma in the adolescent child, but mechanisms are unclear.", {"entities": [[67, 73, "DISEASE"]]}], ["To investigate the association between maternal anxiety and maternal, self- and register-based report of asthma in the adolescent child, and whether the association remains after control of familial confounding (shared environmental and genetic factors).", {"entities": [[105, 111, "DISEASE"]]}], ["From the Twin and Offspring Study of Sweden, 1691 mothers (1058 twins) and their adolescent child were included.", {"entities": []}], ["The association between maternal self-reported anxiety (Beck Anxiety Inventory (BAI) and Karolinska Scales of Personality (KSP) somatic or psychic anxiety) and asthma based on subjective (maternal or child report) or objective (register-based diagnosis and medication) measures were analysed using logistic regression.", {"entities": [[160, 166, "DISEASE"]]}], ["The children-of-twins design was used to explore whether genes or environment contribute to the association.", {"entities": []}], ["Maternal BAI anxiety (OR 2.02, CI 1.15\u20133.55) was significantly associated with adolescent asthma reported by the mother.", {"entities": [[90, 96, "DISEASE"]]}], ["Maternal KSP somatic anxiety (OR 1.74, CI 1.04\u20132.91) and psychic anxiety (OR 1.74, CI 1.05\u20132.86) was significantly associated with breathlessness reported by the adolescent child.", {"entities": []}], ["In contrast, maternal anxiety was not associated with increased risk for the register-based outcomes of asthma diagnosis or medication.", {"entities": [[104, 110, "DISEASE"]]}], ["The results remained also after adjusting for covariates and the children-of-twins analyses which indicate that the association was due to familial confounding.", {"entities": []}], ["We found some associations between maternal anxiety and subjectively reported offspring asthma or breathlessness which may be due to familial effects.", {"entities": [[88, 94, "DISEASE"]]}], ["A likely candidate for explaining this familial confounding is heritable personality traits associated with both anxiety and subjective measures of asthma.", {"entities": [[148, 154, "DISEASE"]]}], ["After an increase in the number of reported cases of Pneumocystis jirovecii pneumonia in England, we investigated data from 2000\u20132010 to verify the increase.", {"entities": [[76, 85, "DISEASE"]]}], ["We analyzed national databases for microbiological and clinical diagnoses of P. jirovecii pneumonia and associated deaths.", {"entities": [[90, 99, "DISEASE"]]}], ["We found that laboratory-confirmed cases in England had increased an average of 7% per year and that death certifications and hospital admissions also increased.", {"entities": []}], ["Hospital admissions indicated increased P. jirovecii pneumonia diagnoses among patients not infected with HIV, particularly among those who had received a transplant or had a hematologic malignancy.", {"entities": [[53, 62, "DISEASE"]]}], ["A new risk was identified: preexisting lung disease.", {"entities": [[39, 51, "DISEASE"]]}], ["Infection rates among HIV-positive adults decreased.", {"entities": []}], ["The results confirm that diagnoses of potentially preventable P. jirovecii pneumonia among persons outside the known risk group of persons with HIV infection have increased.", {"entities": [[75, 84, "DISEASE"]]}], ["This finding warrants further characterization of risk groups and a review of P. jirovecii pneumonia prevention strategies.", {"entities": [[91, 100, "DISEASE"]]}], ["Severe equine asthma is a naturally occurring lung inflammatory disease of mature animals characterized by neutrophilic inflammation, bronchoconstriction, mucus hypersecretion and airway remodeling.", {"entities": [[14, 20, "DISEASE"]]}], ["Exacerbations are triggered by inhalation of dust and microbial components.", {"entities": []}], ["Affected animals eventually are unable of aerobic performance.", {"entities": []}], ["In this study transcriptomic differences between asthmatic and non-asthmatic animals in the response of the bronchial epithelium to an inhaled challenge were determined.", {"entities": []}], ["Paired endobronchial biopsies were obtained pre- and post-challenge from asthmatic and non-asthmatic animals.", {"entities": []}], ["The transcriptome, determined by RNA-seq and analyzed with edgeR, contained 111 genes differentially expressed (DE) after challenge between horses with and without asthma, and 81 of these were upregulated.", {"entities": [[164, 170, "DISEASE"]]}], ["Genes involved in neutrophil migration and activation were in central location in interaction networks, and related gene ontology terms were significantly overrepresented.", {"entities": []}], ["Relative abundance of specific gene products as determined by immunohistochemistry was correlated with differential gene expression.", {"entities": []}], ["Gene sets involved in neutrophil chemotaxis, immune and inflammatory response, secretion, blood coagulation and apoptosis were overrepresented among up-regulated genes, while the rhythmic process gene set was overrepresented among down-regulated genes.", {"entities": []}], ["MMP1, IL8, TLR4 and MMP9 appeared to be the most important proteins in connecting the STRING protein network of DE genes.", {"entities": [[0, 4, "GENE"], [6, 9, "GENE"], [11, 15, "GENE"], [20, 24, "GENE"]]}], ["Several differentially expressed genes and networks in horses with asthma also contribute to human asthma, highlighting similarities between severe human adult and equine asthma.", {"entities": [[67, 73, "DISEASE"], [99, 105, "DISEASE"], [171, 177, "DISEASE"]]}], ["Neutrophil activation by the bronchial epithelium is suggested as the trigger of the inflammatory cascade in equine asthma, followed by epithelial injury and impaired repair and differentiation.", {"entities": [[116, 122, "DISEASE"]]}], ["Circadian rhythm dysregulation and the sonic Hedgehog pathway were identified as potential novel contributory factors in equine asthma.", {"entities": [[128, 134, "DISEASE"]]}], ["The online version of this article (10.1186/s12864-017-4107-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Mucosal-associated invariant T (MAIT) cells are abundant in humans and recognize bacterial ligands.", {"entities": []}], ["Here, we demonstrate that MAIT cells are also activated during human viral infections in vivo .", {"entities": []}], ["MAIT cells activation was observed during infection with dengue virus, hepatitis C virus and influenza virus.", {"entities": [[93, 102, "DISEASE"], [71, 80, "DISEASE"]]}], ["This activation\u2014driving cytokine release and Granzyme B upregulation\u2014is TCR-independent but dependent on IL-18 in synergy with IL-12, IL-15 and/or interferon-\u03b1/\u03b2.", {"entities": []}], ["IL-18 levels and MAIT cell activation correlate with disease severity in acute dengue infection.", {"entities": []}], ["Furthermore, HCV treatment with interferon-\u03b1 leads to specific MAIT cell activation in vivo in parallel with an enhanced therapeutic response.", {"entities": []}], ["Moreover, TCR-independent activation of MAIT cells leads to a reduction of HCV replication in vitro mediated by IFN-\u03b3.", {"entities": []}], ["Together these data demonstrate MAIT cells are activated following viral infections, and suggest a potential role in both host defence and immunopathology.", {"entities": []}], ["Mucosal Associated Invariant T cells have been implicated in response to bacterial pathogens.", {"entities": []}], ["Here the authors show that in human viral infections, these cells are activated by IL-18 in cooperation with other pro-inflammatory cytokines, producing interferon gamma and granzyme B.", {"entities": []}], ["This prospective study sought to investigate serum levels of trace elements (cobalt, copper, zinc, and selenium) and to assess their effects on pregnancy and neonatal outcomes.", {"entities": []}], ["Serum levels of trace elements in 245 Korean pregnant women (median gestational age at delivery was 39 + 4 weeks and interquartile range was 38 + 4\u201340 + 1 weeks) were compared with those of 527 general adults and those of previous studies in other ethnic groups.", {"entities": []}], ["Pregnancy and neonatal outcomes including gestational diabetes, preeclampsia, neonatal birth weight, and congenital abnormalities were assessed.", {"entities": [[42, 62, "DISEASE"]]}], ["The median serum trace element concentrations of all pregnant women were: cobalt: 0.39 \u03bcg/L (interquartile range, IQR 0.29\u20130.53), copper: 165.0 \u03bcg/dL (IQR 144.0\u2013187.0), zinc: 57.0 \u03bcg/dL (IQR 50.0\u201364.0), and selenium: 94.0 \u03bcg/L (IQR 87.0\u2013101.0).", {"entities": []}], ["Serum cobalt and copper concentrations were higher in pregnant women than in the general population, whereas zinc and selenium levels were lower ( p < 0.01).", {"entities": []}], ["Concentrations of all four trace elements varied significantly during the three trimesters ( p < 0.05), and seasonal variation was found in copper, zinc, and selenium, but was not observed for cobalt.", {"entities": []}], ["The prevalence of preeclampsia was significantly lower with high copper ( p = 0.03).", {"entities": []}], ["Trace element levels varied by pregnancy trimester and season, and alteration in copper status during pregnancy might influence pregnancy outcomes such as preeclampsia.", {"entities": []}], ["Deep whole genome sequencing (WGS) allows for the comprehensive study of genetic landscapes at finer resolution than array based methods.", {"entities": []}], ["We conducted deep WGS on children with the polyarticular form of juvenile idiopathic arthritis (JIA), using 2 independent cohorts to ascertain the sequencing fidelity.", {"entities": [[85, 94, "DISEASE"]]}], ["Genome wide SNP density analysis identified 18 SNP hotspots with comparison to the 1000 Genome Projects (1KGP) data.", {"entities": []}], ["A subset of the genes adjacent to SNP hotspots showed statistically significant enrichment in immunological processes.", {"entities": []}], ["Genes adjacent to indel hotspots were functionally related to G-protein coupled signaling pathways.", {"entities": []}], ["Further analyses elucidated significantly more JIA SNPs with regulatory potential compared to 1KGP data.", {"entities": []}], ["Furthermore, SNPs located within linkage disequibilium (LD) blocks containing previously identified JIA-associated SNPs demonstrated higher regulation potential compared to SNPs outside LD blocks.", {"entities": []}], ["We also demonstrated enrichment of novel JIA variants in histone modification peaks and DNase hypersensitivity sites in B cells.", {"entities": []}], ["This study greatly expands the number of genetic variants that may contribute to JIA and give us some clues into what may trigger this disease.", {"entities": []}], ["To date, this study is the first deep WGS effort on children with JIA and provides useful genetic resources for research communities particularly in understanding JIA etiology.", {"entities": []}], ["Cysteinyl leukotrienes (CysLTs) are potent pro-inflammatory mediators that are increased in samples from patients with inflammatory bowel diseases (IBDs).", {"entities": []}], ["Individuals with IBDs have enhanced susceptibility to colon carcinogenesis.", {"entities": []}], ["In colorectal cancer, the balance between the pro-mitogenic cysteinyl leukotriene 1 receptor (CysLT 1 R) and the differentiation-promoting cysteinyl leukotriene 2 receptor (CysLT 2 R) is lost.", {"entities": [[3, 20, "DISEASE"], [14, 20, "DISEASE"]]}], ["Further, our previous data indicate that patients with high CysLT 1 R and low CysLT 2 R expression have a poor prognosis.", {"entities": []}], ["In this study, we examined whether the balance between CysLT 1 R and CysLT 2 R could be restored by treatment with the cancer chemopreventive agent all- trans retinoic acid (ATRA).", {"entities": [[119, 125, "DISEASE"]]}], ["To determine the effect of ATRA on CysLT 2 R promoter activation, mRNA level, and protein level, we performed luciferase gene reporter assays, real-time polymerase chain reactions, and Western blots in colon cancer cell lines under various conditions.", {"entities": [[202, 214, "DISEASE"], [208, 214, "DISEASE"]]}], ["ATRA treatment induces CysLT 2 R mRNA and protein expression without affecting CysLT 1 R levels.", {"entities": []}], ["Experiments using siRNA and mutant cell lines indicate that the up-regulation is retinoic acid receptor (RAR) dependent.", {"entities": []}], ["Interestingly, ATRA also up-regulates mRNA expression of leukotriene C 4 synthase, the enzyme responsible for the production of the ligand for CysLT 2 R. Importantly, ATRA-induced differentiation of colorectal cancer cells as shown by increased expression of MUC-2 and production of alkaline phosphatase, both of which could be reduced by a CysLT 2 R-specific inhibitor.", {"entities": [[199, 216, "DISEASE"], [210, 216, "DISEASE"]]}], ["This study identifies a novel mechanism of action for ATRA in colorectal cancer cell differentiation and demonstrates that retinoids can have anti-tumorigenic effects through their action on the cysteinyl leukotriene pathway.", {"entities": [[62, 79, "DISEASE"], [73, 79, "DISEASE"]]}], ["Cigarette smoke exposure is linked to the development of a variety of chronic lung and systemic diseases in susceptible individuals.", {"entities": []}], ["Metabolomics approaches may aid in defining disease phenotypes, may help predict responses to treatment, and could identify biomarkers of risk for developing disease.", {"entities": []}], ["Using a mouse model of chronic cigarette smoke exposure sufficient to cause mild emphysema, we investigated whether cigarette smoke induces distinct metabolic profiles and determined their persistence following smoking cessation.", {"entities": []}], ["Metabolites were extracted from plasma and fractionated based on chemical class using liquid-liquid and solid-phase extraction prior to performing liquid chromatography mass spectrometry-based metabolomics.", {"entities": []}], ["Metabolites were evaluated for statistically significant differences among group means ( p -value\u22640.05) and fold change \u22651.5).", {"entities": []}], ["Cigarette smoke exposure was associated with significant differences in amino acid, purine, lipid, fatty acid, and steroid metabolite levels compared to air exposed animals.", {"entities": []}], ["Whereas 60% of the metabolite changes were reversible, 40% of metabolites remained persistently altered even following 2 months of smoking cessation, including nicotine metabolites.", {"entities": []}], ["Validation of metabolite species and translation of these findings to human plasma metabolite signatures induced by cigarette smoking may lead to the discovery of biomarkers or pathogenic pathways of smoking-induced disease.", {"entities": []}], ["Gastric cancer is one of the most common malignant diseases and has one of the highest mortality rates worldwide.", {"entities": [[8, 14, "DISEASE"]]}], ["Its molecular mechanisms are poorly understood.", {"entities": []}], ["Recently, the functions of non-coding RNAs (ncRNAs) in gastric cancer have attracted wide attention.", {"entities": [[63, 69, "DISEASE"]]}], ["Although the expression levels of various ncRNAs are different, they may work together in a network and contribute to gastric carcinogenesis by altering the expression of oncogenes or tumor suppressor genes.", {"entities": []}], ["They affect the cell cycle, apoptosis, motility, invasion, and metastasis.", {"entities": []}], ["Dysregulated microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), including miR-21, miR-106, H19, and ANRIL, directly or indirectly regulate carcinogenic factors or signaling pathways such as PTEN, CDK, caspase, E-cadherin, Akt, and P53.", {"entities": [[78, 84, "GENE"], [194, 198, "GENE"]]}], ["Greater recognition of the roles of miRNAs and lncRNAs in gastric carcinogenesis can provide new insight into the mechanisms of tumor development and identify targets for anticancer drug development.", {"entities": []}], ["Epidemiologic and occupational studies indicate adverse health effects due to inhalation of particulate air pollutants, but precise biologic mechanisms responsible have yet to be fully established.", {"entities": []}], ["The tracheobronchial epithelium forms the body's first physiologic barrier to such airborne pollutants, where ciliary movement functions to remove the offending substances caught in the overlying mucus layer.", {"entities": []}], ["Resident and infiltrating phagocytic cells also function in this removal process.", {"entities": []}], ["In this paper, we examine the role of reactive oxygen and nitrogen species (ROS/RNS) in the response of airway epithelium to particulates.", {"entities": []}], ["Some particulates themselves can generate ROS, as can the epithelial cells, in response to appropriate stimulation.", {"entities": []}], ["In addition, resident macrophages in the airways and the alveolar spaces can release ROS/RNS after phagocytosis of inhaled particles.", {"entities": []}], ["These macrophages also release large amounts of tumor necrosis factor alpha (TNF-alpha), a cytokine that can generate responses within the airway epithelium dependent upon intracellular generation of ROS/RNS.", {"entities": []}], ["As a result, signal transduction pathways are set in motion that may contribute to inflammation and other pathobiology in the airway.", {"entities": []}], ["Such effects include increased expression of intercellular adhesion molecule 1, interleukin-6, cytosolic and inducible nitric oxide synthase, manganese superoxide dismutase, cytosolic phospholipase A2, and hypersecretion of mucus.", {"entities": []}], ["Ultimately, ROS/RNS may play a role in the global response of the airway epithelium to particulate pollutants via activation of kinases and transcription factors common to many response genes.", {"entities": []}], ["Thus, defense mechanisms involved in responding to offending particulates may result in a complex cascade of events that can contribute to airway pathology.", {"entities": []}], ["Background: Exposure to traffic-related air pollution is a risk factor for cardiovascular events, probably involving mechanisms of inflammation and coagulation.", {"entities": []}], ["Little is known about effects of the short exposures encountered while participating in traffic.", {"entities": []}], ["Objectives: The objective of the study was to examine effects of exposure of commuters to air pollution on cardiovascular biomarkers.", {"entities": []}], ["Methods: Thirty-four healthy adult volunteers commuted for 2 hr by bus, car, or bicycle during the morning rush hour.", {"entities": [[61, 63, "GENE"]]}], ["During the commute, exposure to particle number, particulate matter (PM) \u2264 2.5 \u00b5m in aerodynamic diameter (PM 2.5 ), PM \u2264 10 \u00b5m in diameter (PM 10 ), and soot was measured.", {"entities": []}], ["We estimated inhaled doses based on heart rate monitoring.", {"entities": []}], ["Shortly before exposure and 6 hr after exposure, blood samples were taken and analyzed for CC16 (Clara cell protein 16), blood cell count, coagulation markers, and inflammation markers.", {"entities": [[30, 32, "GENE"]]}], ["Between June 2007 and June 2008, 352 pre- and postexposure blood samples were collected on 47 test days.", {"entities": []}], ["We used mixed models to analyze the associations between exposure and changes in health parameters.", {"entities": []}], ["Results: We observed no consistent associations between the air pollution exposures and doses and the various biomarkers that we investigated.", {"entities": []}], ["Conclusions: Air pollution exposure during commuting was not consistently associated with acute changes in inflammation markers, blood cell counts, or blood coagulation markers.", {"entities": []}], ["Asthma and iron deficiency are common conditions.", {"entities": [[0, 6, "DISEASE"]]}], ["Whether iron status affects the risk of asthma is unclear.", {"entities": [[40, 46, "DISEASE"]]}], ["To determine the relationship between iron status and asthma, lung function, and pulmonary inflammation.", {"entities": [[54, 60, "DISEASE"]]}], ["Relationships between measures of iron status (serum ferritin, serum soluble transferrin receptor (sTfR), and sTfR/log10ferritin (sTfR-F Index)) and asthma, lung function, and pulmonary inflammation were examined in women 20-49 years in the National Health and Nutrition Examination Survey.", {"entities": [[149, 155, "DISEASE"]]}], ["Logistic, linear, and quadratic regression models accounting for the survey design of NHANES were used to evaluate associations between iron status and asthma-related outcomes and were adjusted for race/ethnicity, age, smoking status, income, and BMI.", {"entities": [[152, 158, "DISEASE"]]}], ["Approximately 16% reported a lifetime history of asthma, 9% reported current asthma, and 5% reported a recent asthma episode/attack (n = 2906).", {"entities": [[49, 55, "DISEASE"], [77, 83, "DISEASE"], [110, 116, "DISEASE"]]}], ["Increased ferritin (iron stores) was associated with decreased odds of lifetime asthma, current asthma, and asthma attacks/episodes in the range of ferritin linearly correlated with iron stores (20-300ng/ml).", {"entities": [[80, 86, "DISEASE"], [96, 102, "DISEASE"], [108, 114, "DISEASE"]]}], ["The highest quintile of ferritin (>76 ng/ml) was also associated with a decreased odds of asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["Ferritin levels were not associated with FEV1.", {"entities": []}], ["Increased values of the sTfR-F Index and sTfR, indicating lower body iron and higher tissue iron need, respectively, were associated with decreased FEV1, but neither was associated with asthma.", {"entities": [[186, 192, "DISEASE"]]}], ["None of the iron indices were associated with FeNO.", {"entities": []}], ["In US women, higher iron stores were inversely associated with asthma and lower body iron and higher tissue iron need were associated with lower lung function.", {"entities": [[63, 69, "DISEASE"]]}], ["Together, these findings suggest that iron status may play a role in asthma and lung function in US women.", {"entities": [[69, 75, "DISEASE"]]}], ["Dendritic cells (DCs) are the most potent antigen-presenting cells, but the ontogeny and functions of lung DCs are not known during prenatal period.", {"entities": []}], ["Here, we isolated lung DC population from fetal (125 \u2212175dGA) and adult baboons.", {"entities": []}], ["The cells were stained with fluorochrome-conjugated-HLA-DP, DQ, DR, CD1a, CD11c, CD14, CD40, CD80, CD86, CD209, CMKLR1, ILT7-specific antibodies, and staining was analyzed by Flow-cytometry.", {"entities": [[68, 72, "GENE"], [81, 85, "GENE"], [87, 91, "GENE"], [93, 97, "GENE"], [99, 103, "GENE"], [105, 110, "GENE"], [112, 118, "GENE"]]}], ["The phagocytic function was investigated by incubating the cells with fluorescent-labeled E scherichia coli bioparticles and analyzed by Flow-cytometry and fluorescence microscopy.", {"entities": []}], ["The fetal baboon lung DCs expressed low levels of HLA-DP, DQ, DR, CD11c and CD86 as compared to adult baboon lung DCs and showed distinct DC morphology.", {"entities": [[50, 56, "GENE"], [76, 80, "GENE"]]}], ["The fetal lung DCs were also less capable of phagocytosing E. coli as compared to the adult lung DCs (p<0.05).", {"entities": []}], ["In conclusion, the fetal lung DCs are not only phenotypically immature, but also less efficient in phagocytosing E. coli .", {"entities": []}], ["To determine whether single nucleotide polymorphisms (SNPs) in FAS and related genes are associated with acute kidney injury (AKI) in patients with acute respiratory distress syndrome (ARDS).", {"entities": [[175, 183, "DISEASE"], [63, 66, "GENE"]]}], ["We studied 401 (Caucasian N\u2009=\u2009310 and African-American N\u2009=\u200991) patients aged\u2009\u2265\u200913\u00a0years with ALI who enrolled in the Fluid and Catheter Treatment Trial (FACTT) between 2000 and 2005 from 20 North American centers.", {"entities": []}], ["We genotyped 367 SNPs in 45 genes of the Fas/Fas ligand pathway to identify associations between SNPs in Fas pathway genes and the development of AKI by day 2 after enrollment in FACTT, adapting Acute Kidney Injury Network (AKIN) criteria.", {"entities": [[41, 44, "GENE"], [45, 48, "GENE"], [105, 108, "GENE"]]}], ["Written informed consent was obtained from participants or legally authorized surrogates in the original FACTT study and available to use for secondary analysis.", {"entities": []}], ["In Caucasian patients, we identified associations between two SNPs and the incidence of AKI (stage 1 and above): rs1050851 and rs2233417; both are found within the gene for nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha ( NFKBIA ).", {"entities": [[259, 265, "GENE"]]}], ["For rs1050851 and rs2233417, the odds ratios (ORs) were 2.34 (95\u00a0% confidence interval (CI)\u2009=\u20091.58\u20133.46, p\u2009=\u20091.06\u2009\u00d7\u200910 In Caucasian patients with ALI, the presence of minor alleles in two SNPs in NFKBIA was strongly associated with the development of AKI.", {"entities": [[196, 202, "GENE"]]}], ["NCT00281268 .", {"entities": []}], ["Registered 20/01/2006.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-015-1084-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["It is generally recognized that synthetic glucocorticoids induce skeletal muscle weakness, and endogenous glucocorticoid levels increase in patients with muscle atrophy.", {"entities": []}], ["It is reported that heat stress attenuates glucocorticoid\u2010induced muscle atrophy; however, the mechanisms involved are unknown.", {"entities": []}], ["Therefore, we examined the mechanisms underlying the effects of heat stress against glucocorticoid\u2010induced muscle atrophy using C2C12 myotubes in vitro, focusing on expression of key molecules and signaling pathways involved in regulating protein synthesis and degradation.", {"entities": []}], ["The synthetic glucocorticoid dexamethasone decreased myotube diameter and protein content, and heat stress prevented the morphological and biochemical glucocorticoid effects.", {"entities": []}], ["Heat stress also attenuated increases in mRNAs of regulated in development and DNA damage responses 1 (REDD1) and Kruppel\u2010like factor 15 (KLF15).", {"entities": [[138, 143, "GENE"]]}], ["Heat stress recovered the dexamethasone\u2010induced inhibition of PI3K/Akt signaling.", {"entities": []}], ["These data suggest that changes in anabolic and catabolic signals are involved in heat stress\u2010induced protection against glucocorticoid\u2010induced muscle atrophy.", {"entities": []}], ["These results have a potentially broad clinical impact because elevated glucocorticoid levels are implicated in a wide range of diseases associated with muscle wasting.", {"entities": []}], ["232: 650\u2013664, 2017.", {"entities": []}], ["\u00a9 2016 The Authors.", {"entities": []}], ["Journal of Cellular Physiology published by Wiley Periodicals, Inc.", {"entities": []}], ["Inhibition of epidermal growth factor receptor during viral infection augments IRF1-dependent IFN-\u03bb production and decreases viral titers.", {"entities": []}], ["Viruses suppress host responses to increase infection, and understanding these mechanisms has provided insights into cellular signaling and led to novel therapies.", {"entities": []}], ["Many viruses (e.g., Influenza virus, Rhinovirus [RV], Cytomegalovirus, Epstein-Barr virus, and Hepatitis C virus) activate epithelial epidermal growth factor receptor (EGFR), a tyrosine kinase receptor, but the role of EGFR in viral pathogenesis is not clear.", {"entities": [[168, 172, "GENE"], [219, 223, "GENE"], [168, 172, "GENE"], [219, 223, "GENE"]]}], ["Interferon (IFN) signaling is a critical innate antiviral host response and recent experiments have implicated IFN-\u03bb, a type III IFN, as the most significant IFN for mucosal antiviral immune responses.", {"entities": []}], ["Despite the importance of IFN-\u03bb in epithelial antiviral responses, the role and mechanisms of epithelial IFN-\u03bb signaling have not been fully elucidated.", {"entities": []}], ["We report that respiratory virus-induced EGFR activation suppresses endogenous airway epithelial antiviral signaling.", {"entities": [[41, 45, "GENE"]]}], ["We found that Influenza virus\u2013 and RV-induced EGFR activation suppressed IFN regulatory factor (IRF) 1\u2013induced IFN-\u03bb production and increased viral infection.", {"entities": [[46, 50, "GENE"]]}], ["In addition, inhibition of EGFR during viral infection augmented IRF1 and IFN-\u03bb, which resulted in decreased viral titers in vitro and in vivo.", {"entities": [[27, 31, "GENE"], [65, 69, "GENE"]]}], ["These findings describe a novel mechanism that viruses use to suppress endogenous antiviral defenses, and provide potential targets for future therapies.", {"entities": []}], ["Release of ambient metals during ferroalloy production may be an important source of environmental exposure for nearby communities and exposure to these metals has been linked to adverse respiratory outcomes.", {"entities": []}], ["We sought to characterize the association between personal air levels of metals and respiratory health in Italian adolescents living in communities with historic and current ferroalloy activity.", {"entities": []}], ["As part of a study in the industrial province of Brescia, Italy, 410 adolescents aged 11\u201314 years were recruited.", {"entities": []}], ["Participants were enrolled from three different communities with varying manganese (Mn) levels: Bagnolo Mella which has current ferroalloy activity, Valcamonica, which has historic ferroalloy activity and Garda Lake which has no history of ferroalloy activity.", {"entities": []}], ["Particulate matter <10\u00a0\u03bcm in diameter (PM 10 ) was collected for 24\u00a0h in filters using personal sampling.", {"entities": []}], ["Mn, nickel (Ni), zinc (Zn), chromium (Cr) and iron (Fe) were measured in filters using x-ray fluorescence.", {"entities": []}], ["Data on respiratory health was collected through questionnaire.", {"entities": []}], ["Data for 280 adolescents were analyzed using a modified Poisson regression, and risk ratios were calculated for an interquartile (IQR) range increase in each pollutant.", {"entities": []}], ["In adjusted models including PM 10 as a co-pollutant, we found significant associations between concentrations of Mn (RR: 1.09, 95\u00a0% CI [1.00, 1.18] per 42\u00a0ng/m Our findings suggest that exposure to ambient Mn, Ni and Cr may be associated with adverse respiratory outcomes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-016-0173-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Previous studies have shown that enhanced accumulation of contractile proteins such as smooth muscle myosin light chain kinase (smMLCK) plays a major role in human airway smooth muscle cells (HASM) cell hypercontractility and hypertrophy.", {"entities": []}], ["Furthermore, serum IgE levels play an important role in smooth muscle hyperreactivity.", {"entities": []}], ["However, the effect of IgE on smMLCK expression has not been investigated.", {"entities": []}], ["In this study, we demonstrate that IgE increases the expression of smMLCK at mRNA and protein levels.", {"entities": []}], ["This effect was inhibited significantly with neutralizing abs directed against Fc\u03b5RI but not with anti-Fc\u03b5RII/CD23.", {"entities": []}], ["Furthermore, Syk knock down and pharmacological inhibition of mitogen activated protein kinases (MAPK) (ERK1/2, p38, and JNK) and phosphatidylinositol 3-kinase (PI3K) significantly diminished the IgE-mediated upregulation of smMLCK expression in HASM cells.", {"entities": [[13, 16, "GENE"]]}], ["Taken together, our data suggest a role of IgE in regulating smMLCK in HASM cells.", {"entities": []}], ["Therefore, targeting the Fc\u03b5RI activation on HASM cells may offer a novel approach in controlling the bronchomotor tone in allergic asthma.", {"entities": [[123, 138, "DISEASE"], [132, 138, "DISEASE"]]}], ["Acidic mammalian chitinase (AMCase) has been shown to be associated with asthma in mouse models, allergic inflammation and food processing.", {"entities": [[73, 79, "DISEASE"]]}], ["Here, we describe an E. coli -expression system that allows for the periplasmic production of active AMCase fused to Protein A at the N-terminus and V5 epitope and (His) 6 tag (V5-His) at the C-terminus (Protein A-AMCase-V5-His) in E. coli .", {"entities": []}], ["The mouse AMCase cDNA was cloned into the vector pEZZ18, which is an expression vector containing the Staphylococcus Protein A promoter, with the signal sequence and truncated form of Protein A for extracellular expression in E. coli .", {"entities": []}], ["Most of the Protein A-AMCase-V5-His was present in the periplasmic space with chitinolytic activity, which was measured using a chromogenic substrate, 4-nitrophenyl N,N \u2032-diacetyl-\u03b2-D-chitobioside.", {"entities": []}], ["The Protein A-AMCase-V5-His was purified from periplasmic fractions using an IgG Sepharose column followed by a Ni Sepharose chromatography.", {"entities": []}], ["The recombinant protein showed a robust peak of activity with a maximum observed activity at pH 2.0, where an optimal temperature was 54\u00b0C.", {"entities": []}], ["When this protein was preincubated between pH 1.0 and pH 11.0 on ice for 1 h, full chitinolytic activity was retained.", {"entities": []}], ["This protein was also heat-stable till 54\u00b0C, both at pH 2.0 and 7.0.", {"entities": []}], ["The chitinolytic activity of the recombinant AMCase against 4-nitrophenyl N,N \u2032-diacetyl-\u03b2-D-chitobioside was comparable to the CHO-expressed AMCase.", {"entities": []}], ["Furthermore, the recombinant AMCase bound to chitin beads, cleaved colloidal chitin and released mainly N,N\u2032 -diacetylchitobiose fragments.", {"entities": []}], ["Thus, the E. coli -expressed Protein A-mouse AMCase-V5-His fusion protein possesses chitinase functions comparable to the CHO-expressed AMCase.", {"entities": []}], ["This recombinant protein can be used to elucidate detailed biomedical functions of the mouse AMCase.", {"entities": []}], ["Electronic health record (EHR) systems provide an opportunity to use a novel data source for population health surveillance.", {"entities": []}], ["Validation studies that compare prevalence estimates from EHRs and surveys most often use difference testing, which can, because of large sample sizes, lead to detection of significant differences that are not meaningful.", {"entities": []}], ["We explored a novel application of the two one-sided t test (TOST) to assess the equivalence of prevalence estimates in 2 population-based surveys to inform margin selection for validating EHR-based surveillance prevalence estimates derived from large samples.", {"entities": []}], ["We compared prevalence estimates of health indicators in the 2013 Community Health Survey (CHS) and the 2013\u20132014 New York City Health and Nutrition Examination Survey (NYC HANES) by using TOST, a 2-tailed t test, and other goodness-of-fit measures.", {"entities": []}], ["A \u00b15 percentage-point equivalence margin for a TOST performed well for most health indicators.", {"entities": []}], ["For health indicators with a prevalence estimate of less than 10% (extreme obesity [CHS, 3.5%; NYC HANES, 5.1%] and serious psychological distress [CHS, 5.2%; NYC HANES, 4.8%]), a \u00b12.5 percentage-point margin was more consistent with other goodness-of-fit measures than the larger percentage-point margins.", {"entities": [[75, 82, "DISEASE"]]}], ["A TOST with a \u00b15 percentage-point margin was useful in establishing equivalence, but a \u00b12.5 percentage-point margin may be appropriate for health indicators with a prevalence estimate of less than 10%.", {"entities": []}], ["Equivalence testing can guide future efforts to validate EHR data.", {"entities": []}], ["The aim of this study was to determine (i) the effect of maternal obesity and gestational diabetes mellitus (GDM) on (i) the circulating levels of omentin-1 in cord and maternal plasma, and (ii) gene expression and release of omentin-1 from human placenta and adipose tissue.", {"entities": [[78, 98, "DISEASE"], [66, 73, "DISEASE"], [90, 107, "DISEASE"]]}], ["The effect of pregnancy on circulating omentin-1 levels was also determined.", {"entities": []}], ["Omentin-1 levels were measured in maternal and cord plasma from obese and non-obese normal glucose tolerant women (NGT; n\u200a=\u200a44) and women with GDM (n\u200a=\u200a39) at the time of term elective Caesarean section.", {"entities": []}], ["Placenta and adipose tissue expression and release of omentin-1 was measured from 22 NGT and 22 GDM women collected at the time of term elective Caesarean section.", {"entities": []}], ["Omentin-1 levels were also measured in maternal plasma from 13 NGT women at 11 and 28 weeks gestation and 7 weeks postpartum.", {"entities": []}], ["Maternal obesity was associated with significantly lower omentin-1 levels in maternal plasma; however, there was no effect of maternal obesity on cord omentin levels.", {"entities": [[9, 16, "DISEASE"], [135, 142, "DISEASE"]]}], ["Omentin-1 gene expression was lower in placenta and adipose tissue obtained from women with pre-existing obesity.", {"entities": [[105, 112, "DISEASE"]]}], ["In addition to this, adipose tissue release of omentin-1 was significantly lower from obese pregnant women.", {"entities": []}], ["Omentin-1 levels were significantly lower in non-obese GDM compared to non-obese NGT women.", {"entities": []}], ["However, there was no difference in omentin-1 levels between obese NGT and obese GDM women.", {"entities": []}], ["There was no effect of GDM on cord omentin levels, and placental and adipose tissue omentin-1 expression.", {"entities": []}], ["Maternal omentin-1 levels were negatively correlated with fetal birthweight and fetal ponderal index.", {"entities": []}], ["The data presented in this study demonstrate that pre-existing maternal obesity is associated with lower omentin-1 expression in placenta, adipose tissue and maternal plasma.", {"entities": [[72, 79, "DISEASE"]]}], ["Alteration in omentin-1 in pregnancy may influence the development of metabolic disorders in offspring later in life.", {"entities": []}], ["Inhaled corticosteroids (ICS) reduce exacerbation rates and improve health status but can increase the risk of pneumonia in COPD.", {"entities": [[111, 120, "DISEASE"]]}], ["The GLUCOLD study, investigating patients with mild-to-moderate COPD, has shown that long-term (2.5-year) ICS therapy induces anti-inflammatory effects.", {"entities": []}], ["The literature suggests that cigarette smoking causes ICS insensitivity.", {"entities": []}], ["The aim of this study is to compare anti-inflammatory effects of ICS in persistent smokers and persistent ex-smokers in a post-hoc analysis of the GLUCOLD study.", {"entities": []}], ["Persistent smokers (n\u200a=\u200a41) and persistent ex-smokers (n\u200a=\u200a31) from the GLUCOLD cohort were investigated.", {"entities": []}], ["Effects of ICS treatment compared with placebo were estimated by analysing changes in lung function, hyperresponsiveness, and inflammatory cells in sputum and bronchial biopsies during short-term (0\u20136 months) and long-term (6\u201330 months) treatment using multiple regression analyses.", {"entities": []}], ["Bronchial mast cells were reduced by short-term and long-term ICS treatment in both smokers and ex-smokers.", {"entities": []}], ["In contrast, CD3 Even in the presence of smoking, long-term ICS treatment may lead to anti-inflammatory effects in the lung.", {"entities": []}], ["Some anti-inflammatory ICS effects are comparable in smokers and ex-smokers with COPD, other effects are cell-specific.", {"entities": []}], ["The clinical relevance of these findings, however, are uncertain.", {"entities": []}], ["The prevalence of vitamin D deficiency in the kingdom of Saudi Arabia is rising unexpectedly in every age group.", {"entities": []}], ["Apart from several risk factors, the lack of awareness is posing a serious threat for low vitamin D levels in children as well.", {"entities": []}], ["The aim of our study was to compare the knowledge and status of vitamin D in Saudi school children.", {"entities": []}], ["Saudi students, 1188 boys (15.1\u2009\u00b1\u20092.2\u00a0years) and 1038 girls (15.1\u2009\u00b1\u20092.0\u00a0years), were recruited and a pre-designed questionnaire with regards to knowledge about vitamin D was administered.", {"entities": []}], ["Blood samples were collected and serum 25hydroxyvitamin D (25(OH)D was measured.", {"entities": []}], ["A significantly higher percentage of boys answered correctly than girls regarding knowledge questions as sun exposure (p\u2009=\u20090.002, and 0.011), breastfeeding (p\u2009<\u20090.001) and diseases (p\u2009<\u20090.001).", {"entities": []}], ["The percentage of girls was significantly higher who thought that fruits and vegetables are not rich sources of vitamin D (24.7% girls vs. 15.4% boys; p\u2009<\u20090.001and 29.6% girls vs. 20.9% boys p\u2009<\u20090.001), respectively.", {"entities": []}], ["Boys had a higher prevalence and frequency of sun exposure than girls (p\u2009<\u20090.001 for both).", {"entities": []}], ["Girls showed a significantly higher percentage of sunscreen use and full covering during sun exposure (p\u2009=\u20090.001 for both).Vitamin D deficiency was significantly higher in girls than boys (47.0% versus 19.4.0%; p\u2009<\u20090.001).", {"entities": []}], ["Vitamin D status in boys was significantly higher than girls (p\u2009<\u20090.001).", {"entities": []}], ["In girls, those who answered correctly about vitamin D related disease (p\u2009=\u20090.03) and sources (p\u2009=\u20090.015), demonstrated significantly higher vitamin D levels.", {"entities": []}], ["The awareness of vitamin D and sunlight in children needs to be improved by provision of trained physicians and school teachers.", {"entities": []}], ["Creating more areas where girls can uncover freely during routine works and outdoor activities will help increase their vitamin D levels.", {"entities": []}], ["Subjects exposed to laboratory animals are at a heightened risk of developing respiratory and allergic diseases.", {"entities": []}], ["These diseases can be prevented by simple measures such as the use of personal protective equipment.", {"entities": []}], ["We report here the primary findings of the Laboratory Animals and Respiratory Allergies Study regarding the prevalence of allergic diseases among laboratory animal workers, the routine use of preventive measures in laboratories and animal facilities, and the need for prevention programs.", {"entities": []}], ["Animal handlers and non-animal handlers from 2 Brazilian universities (University of S\u00e3o Paulo and State University of Campinas) answered specific questionnaires to assess work conditions and symptoms.", {"entities": []}], ["These subjects also underwent spirometry, a bronchial challenge test with mannitol, and skin prick tests for 11 common allergens and 5 occupational allergens (rat, mouse, guinea pig, hamster, and rabbit).", {"entities": []}], ["Four hundred fifty-five animal handlers (32\u00b110 years old [mean\u00b1SD], 209 men) and 387 non-animal handlers (33\u00b111 years old, 121 men) were evaluated.", {"entities": []}], ["Sensitization to occupational allergens was higher among animal handlers (16%) than non-animal handlers (3%, p <0.01).", {"entities": []}], ["Accessibility to personal protective equipment was measured at 85% (median, considering 73 workplaces of the animal handler group).", {"entities": []}], ["Nineteen percent of the animal handlers indicated that they wear a respirator at all times while handling animals or working in the animal room, and only 25% of the animal handlers had received an orientation about animal-induced allergies, asthma, or rhinitis.", {"entities": [[252, 260, "DISEASE"], [241, 247, "DISEASE"]]}], ["In conclusion, our data indicate that preventive programs are necessary.", {"entities": []}], ["We suggest providing individual advice to workers associated with institutional programs to promote a safer work environment.", {"entities": []}], ["Prolonged monitoring by cardiac electrocardiogram (ECG) sensors is useful for patients with emergency heart conditions.", {"entities": []}], ["However, implant monitoring systems are limited by lack of tissue biocompatibility.", {"entities": []}], ["Here, we developed an implantable ECG sensor for real-time monitoring of ventricular fibrillation and evaluated its biocompatibility using an animal model.", {"entities": []}], ["The implantable sensor comprised transplant sensors with two electrodes, a wireless power transmission system, and a monitoring system.", {"entities": []}], ["The sensor was inserted into the subcutaneous tissue of the abdominal area and operated for 1 h/day for 5 days using a wireless power system.", {"entities": []}], ["Importantly, the sensor was encapsulated by subcutaneous tissue and induced angiogenesis, inflammation, and phagocytosis.", {"entities": []}], ["In addition, we observed that the levels of inflammation-related markers increased with wireless-powered transmission via the ECG sensor; in particular, levels of the Th-1 cytokine interleukin-12 were significantly increased.", {"entities": []}], ["The results showed that induced tissue damage was associated with the use of wireless-powered sensors.", {"entities": []}], ["We also investigated research strategies for the prevention of adverse effects caused by lack of tissue biocompatibility of a wireless-powered ECG monitoring system and provided information on the clinical applications of inflammatory reactions in implant treatment using the wireless-powered transmission system.", {"entities": []}], ["Asthma is associated with enormous healthcare expenditures that include both direct and indirect costs.", {"entities": [[0, 6, "DISEASE"]]}], ["It is also associated with the loss of future potential earnings related to both morbidity and mortality.", {"entities": []}], ["The objective of the study is to determine the burden of disease costs associated with asthma.", {"entities": [[87, 93, "DISEASE"]]}], ["We performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008.", {"entities": []}], ["Sixty-eight studies met the inclusion criteria.", {"entities": []}], ["Hospitalization and medications were found to be the most important cost driver of direct costs.", {"entities": []}], ["Work and school loss accounted for the greatest percentage of indirect costs.", {"entities": []}], ["The cost of asthma was correlated with comorbidities, age, and disease severity.", {"entities": [[12, 18, "DISEASE"]]}], ["Despite the availability of effective preventive therapy, costs associated with asthma are increasing.", {"entities": [[80, 86, "DISEASE"]]}], ["Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.", {"entities": [[127, 133, "DISEASE"]]}], ["Reduced physical activity is an important feature of Chronic Obstructive Pulmonary Disease (COPD).", {"entities": []}], ["Various activity monitors are available but their validity is poorly established.", {"entities": []}], ["The aim was to evaluate the validity of six monitors in patients with COPD.", {"entities": []}], ["We hypothesized triaxial monitors to be more valid compared to uniaxial monitors.", {"entities": []}], ["Thirty-nine patients (age 68\u00b17years, FEV 1 54\u00b118%predicted) performed a one-hour standardized activity protocol.", {"entities": [[37, 40, "GENE"]]}], ["Patients wore 6 monitors (Kenz Lifecorder (Kenz), Actiwatch, RT3, Actigraph GT3X (Actigraph), Dynaport MiniMod (MiniMod), and SenseWear Armband (SenseWear)) as well as a portable metabolic system (Oxycon Mobile).", {"entities": []}], ["Validity was evaluated by correlation analysis between indirect calorimetry (VO 2 ) and the monitor outputs: Metabolic Equivalent of Task [METs] (SenseWear, MiniMod), activity counts (Actiwatch), vector magnitude units (Actigraph, RT3) and arbitrary units (Kenz) over the whole protocol and slow versus fast walking.", {"entities": []}], ["Minute-by-minute correlations were highest for the MiniMod (r\u200a=\u200a0.82), Actigraph (r\u200a=\u200a0.79), SenseWear (r\u200a=\u200a0.73) and RT3 (r\u200a=\u200a0.73).", {"entities": []}], ["Over the whole protocol, the mean correlations were best for the SenseWear (r\u200a=\u200a0.76), Kenz (r\u200a=\u200a0.52), Actigraph (r\u200a=\u200a0.49) and MiniMod (r\u200a=\u200a0.45).", {"entities": []}], ["The MiniMod (r\u200a=\u200a0.94) and Actigraph (r\u200a=\u200a0.88) performed better in detecting different walking speeds.", {"entities": []}], ["The Dynaport MiniMod, Actigraph GT3X and SenseWear Armband (all triaxial monitors) are the most valid monitors during standardized physical activities.", {"entities": []}], ["The Dynaport MiniMod and Actigraph GT3X discriminate best between different walking speeds.", {"entities": []}], ["During pregnancy asthma may remain stable, improve or worsen.", {"entities": [[17, 23, "DISEASE"]]}], ["The factors underlying the deleterious effect of pregnancy on asthma remain unknown.", {"entities": [[62, 68, "DISEASE"]]}], ["Oxytocin is a neurohypophyseal protein that regulates a number of central and peripheral responses such as uterine contractions and milk ejection.", {"entities": []}], ["Additional evidence suggests that oxytocin regulates inflammatory processes in other tissues given the ubiquitous expression of the oxytocin receptor.", {"entities": []}], ["The purpose of this study was to define the role of oxytocin in modulating human airway smooth muscle (HASMCs) function in the presence and absence of IL-13 and TNF\u03b1, cytokines known to be important in asthma.", {"entities": [[202, 208, "DISEASE"]]}], ["Expression of oxytocin receptor in cultured HASMCs was performed by real time PCR and flow cytomery assays.", {"entities": []}], ["Responses to oxytocin was assessed by fluorimetry to detect calcium signals while isolated tracheal rings and precision cut lung slices (PCLS) were used to measure contractile responses.", {"entities": []}], ["Finally, ELISA was used to compare oxytocin levels in the bronchoalveloar lavage (BAL) samples from healthy subjects and those with asthma.", {"entities": [[132, 138, "DISEASE"]]}], ["PCR analysis demonstrates that OXTR is expressed in HASMCs under basal conditions and that both interleukin (IL)-13 and tumor necrosis factor (TNF\u03b1) stimulate a time-dependent increase in OXTR expression at 6 and 18 hr.", {"entities": [[31, 35, "GENE"], [188, 192, "GENE"], [31, 35, "GENE"], [188, 192, "GENE"], [216, 218, "GENE"]]}], ["Additionally, oxytocin increases cytosolic calcium levels in fura-2-loaded HASMCs that were enhanced in cells treated for 24 hr with IL-13.", {"entities": [[125, 127, "GENE"]]}], ["Interestingly, TNF\u03b1 had little effect on oxytocin-induced calcium response despite increasing receptor expression.", {"entities": []}], ["Using isolated murine tracheal rings and PCLS, oxytocin also promoted force generation and airway narrowing.", {"entities": []}], ["Further, oxytocin levels are detectable in bronchoalveolar lavage (BAL) fluid derived from healthy subjects as well as from those with asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["Taken together, we show that cytokines modulate the expression of functional oxytocin receptors in HASMCs suggesting a potential role for inflammation-induced changes in oxytocin receptor signaling in the regulation of airway hyper-responsiveness in asthma.", {"entities": [[250, 256, "DISEASE"]]}], ["The aim of this study was to explore whether recording in primary care of a previously recorded hospital diagnosis was associated with increased patient utilisation of recommended medications.", {"entities": []}], ["Registry-based prospective cohort study.", {"entities": []}], ["19 072 patients with a hospital discharge diagnosis of transient ischaemic attack (TIA), stroke or acute coronary syndrome from hospitals in Stockholm County 2010\u20132013 were included in the study.", {"entities": [[114, 122, "DISEASE"]]}], ["The outcome of the study was medication dispensation as a marker of adherence to recommended medications.", {"entities": []}], ["Adherence was defined as having had at least two filled prescriptions in the third year following hospital discharge.", {"entities": []}], ["Recording a diagnosis was associated with higher utilisation of all recommended medications with the exception of antihypertensives in patients with TIA.", {"entities": []}], ["The differences between the groups with and without a recorded diagnosis remained after adjusting for age, sex, index year and visits to private practitioners.", {"entities": []}], ["Dispensation of antithrombotics was high overall, 80%\u201390% in patients without a recorded diagnosis and 90%\u201394% for those with a diagnosis.", {"entities": []}], ["Women with recorded ischaemic stroke/TIA/acute coronary syndrome were dispensed more statins (56%\u201371%) than those with no recorded diagnosis (46%\u201359%).", {"entities": [[56, 64, "DISEASE"]]}], ["Similarly, 68%\u201383% of men with a recorded diagnosis were dispensed statins (57%\u201377% in men with no recorded diagnosis).", {"entities": []}], ["The rate of diagnosis recording spanned from 15% to 47%\u2009and was especially low in TIA (men 15%, women 16%).", {"entities": []}], ["Recording a diagnosis of TIA/stroke or acute coronary syndrome in primary care was found to be associated with higher dispensation of recommended secondary preventive medications.", {"entities": [[54, 62, "DISEASE"]]}], ["Further study is necessary in order to determine the mechanisms underlying our results and to establish the utility of our findings.", {"entities": []}], ["Newly identified nuocytes or group 2 innate lymphoid cells (ILC2s) play an important role in Th2 cell mediated immunity such as protective immune responses to helminth parasites, allergic asthma, and chronic rhinosinusitis.", {"entities": [[179, 194, "DISEASE"], [188, 194, "DISEASE"]]}], ["However, the contributions of ILC2s in the occurrence and development of cancer remain unknown.", {"entities": [[73, 79, "DISEASE"]]}], ["Our previous study found that there was a predominant Th2 phenotype in patients with gastric cancer.", {"entities": [[93, 99, "DISEASE"]]}], ["In this study, the ILC2s related genes or molecules in PBMC from patients with gastric cancer were measured, and the potential correlation between them was analyzed.", {"entities": [[87, 93, "DISEASE"]]}], ["The expression levels of ROR \u03b1 , GATA3, T1/ST2, IL-17RB, CRTH2, IL-33, IL-5, and IL-4 mRNA were significantly increased in patients, but no significant changes were found in ICOS, CD45, and IL-13 expression, and there was a positive correlation between ROR \u03b1 or IL-13 and other related factors, such as ICOS and CD45.", {"entities": [[33, 38, "GENE"], [174, 178, "GENE"], [303, 307, "GENE"], [174, 178, "GENE"], [303, 307, "GENE"]]}], ["The increased frequency of ILC2s was also found in PBMC of patients by flow cytometry.", {"entities": []}], ["In addition, the mRNA of Arg1 and iNOS were also significantly increased in patients.", {"entities": [[25, 29, "GENE"]]}], ["These results suggested that there are polarized ILC2s in gastric cancer patients which might contribute to immunosuppressive microenvironment and closely related to the upregulation of MDSCs and M2 macrophages.", {"entities": [[66, 72, "DISEASE"]]}], ["Phenotypic variation results from variation in gene expression, which is modulated by genetic and/or epigenetic factors.", {"entities": []}], ["To understand the molecular basis of human disease, interaction between genetic and epigenetic factors needs to be taken into account.", {"entities": []}], ["The asthma-associated region 17q12-q21 harbors three genes, the zona pellucida binding protein 2 ( ZPBP2 ), gasdermin B ( GSDMB) and ORM1-like 3 ( ORMDL3 ), that show allele-specific differences in expression levels in lymphoblastoid cell lines (LCLs) and CD4+ T cells.", {"entities": [[4, 10, "DISEASE"], [99, 104, "GENE"], [122, 127, "GENE"], [147, 153, "GENE"]]}], ["Here, we report a molecular dissection of allele-specific transcriptional regulation of the genes within the chromosomal region 17q12-q21 combining in vitro transfection, formaldehyde-assisted isolation of regulatory elements, chromatin immunoprecipitation and DNA methylation assays in LCLs.", {"entities": []}], ["We found that a single nucleotide polymorphism rs4795397 influences the activity of ZPBP2 promoter in vitro in an allele-dependent fashion, and also leads to nucleosome repositioning on the asthma-associated allele .", {"entities": [[190, 196, "DISEASE"], [84, 89, "GENE"]]}], ["However, variable methylation of exon 1 of ZPBP2 masks the strong genetic effect on ZPBP2 promoter activity in LCLs.", {"entities": [[43, 48, "GENE"], [84, 89, "GENE"], [43, 48, "GENE"], [84, 89, "GENE"]]}], ["In contrast, the ORMDL3 promoter is fully unmethylated, which allows detection of genetic effects on its transcription.", {"entities": [[17, 23, "GENE"]]}], ["We conclude that the cis -regulatory effects on 17q12-q21 gene expression result from interaction between several regulatory polymorphisms and epigenetic factors within the cis -regulatory haplotype region.", {"entities": []}], ["The online version of this article (doi:10.1007/s00439-012-1142-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The lung is one of several moderately radiosensitive organs.", {"entities": []}], ["Radiation-induced lung injury (RILI), including acute radiation pneumonitis and chronic radiation-induced pulmonary fibrosis, occurs most often in radiotherapy of lung cancer, esophageal cancer, and other thoracic cancers.", {"entities": [[163, 174, "DISEASE"], [176, 193, "DISEASE"], [106, 124, "DISEASE"], [168, 174, "DISEASE"], [187, 193, "DISEASE"]]}], ["Clinical symptoms of RILI include dry cough, shortness of breath, chest pain, fever, and even severe respiratory failure and death.", {"entities": [[101, 120, "DISEASE"]]}], ["The occurrence of RILI is a complex process that includes a variety of cellular and molecular interactions which ultimately leads to large fibroblast accumulation, proliferation, and differentiation, resulting in excessive extracellular matrix deposits, causing pulmonary fibrosis.", {"entities": [[262, 280, "DISEASE"]]}], ["The progress that has been made in recent years in the understanding of cellular and molecular mechanisms of RILI is summarized in this review.", {"entities": []}], ["Improving care for people with long-term conditions is central to NHS policy.", {"entities": [[66, 69, "GENE"]]}], ["It has been suggested that the Quality and Outcomes Framework (QOF), a primary care pay-for-performance scheme that rewards practices for delivering effective interventions in long-term conditions, does not encourage high-quality care for this group of patients.", {"entities": []}], ["To examine the evidence that the QOF has improved quality of care for patients with long-term conditions.", {"entities": []}], ["This was a systematic review of research on the effectiveness of the QOF in the UK.", {"entities": []}], ["The authors searched electronic databases for peer-reviewed empirical quantitative research studying the effect of the QOF on a broad range of processes and outcomes of care, including coordination and integration of care, holistic and personalised care, self-care, patient experience, physiological and biochemical outcomes, health service utilisation, and mortality.", {"entities": []}], ["Because the studies were heterogeneous, a narrative synthesis was carried out.", {"entities": []}], ["The authors identified three systematic reviews and five primary research studies that met the inclusion criteria.", {"entities": []}], ["The QOF was associated with a modest slowing of both the increase in emergency admissions and the increase in consultations in severe mental illness (SMI), and modest improvements in diabetes care.", {"entities": []}], ["The nature of the evidence means that the authors cannot be sure that any of these associations is causal.", {"entities": []}], ["No clear effect on mortality was found.", {"entities": []}], ["The authors found no evidence that the QOF influences integration or coordination of care, holistic care, self-care, or patient experience.", {"entities": []}], ["The NHS should consider more broadly what constitutes high-quality primary care for people with long-term conditions, and consider other ways of motivating primary care to deliver it.", {"entities": [[4, 7, "GENE"]]}], ["High-sensitivity cardiac troponin I (hs-cTnI) and the soluble isoform of suppression of tumorigenicity 2 (sST2) are useful prognostic biomarkers in acute coronary syndrome (ACS).", {"entities": [[163, 171, "DISEASE"]]}], ["The aim of this study was to test the short term prognostic value of sST2 compared with hs-cTnI in patients with chest pain.", {"entities": []}], ["Assays for hs-cTnI and sST2 were performed in 157 patients admitted to the Emergency Department (ED) for chest pain at arrival.", {"entities": []}], ["In-hospital and 30-day follow-up mortalities were assessed.", {"entities": []}], ["The incidence of ACS was 37%; 33 patients were diagnosed with ST elevation myocardial infarction (STEMI), and 25 were diagnosed with non-ST elevation myocardial infarction (NSTEMI).", {"entities": [[75, 96, "DISEASE"], [150, 171, "DISEASE"]]}], ["Compared with the no acute coronary syndrome (NO ACS) group, the median level of hs-cTnI was higher in ACS patients: 7.22 (5.24-14) pg/mL vs 68 (15.33-163.50) pg/mL ( P <0.0001).", {"entities": [[36, 44, "DISEASE"]]}], ["In all patients, the sST2 level at arrival showed higher independent predictive power than hs-cTnI (odds ratio [OR] 20.13, P <0.0001 and OR 2.61, P <0.0008, respectively).", {"entities": []}], ["sST2 at ED arrival showed a greater prognostic value for cardiovascular events in STEMI (area under the curve [AUC] 0.80, P <0.001) than NSTEMI patients (AUC 0.72, P <0.05).", {"entities": []}], ["Overall, 51% of the STEMI patients with an sST2 value>35 ng/mL at ED arrival died during the 30-day follow-up.", {"entities": []}], ["sST2 has a greater prognostic value for 30-day cardiac mortality after discharge in patients presenting to the ED for chest pain compared with hs-cTnI.", {"entities": []}], ["In STEMI patients, an sST2 value >35 ng/mL at ED arrival showed the highest predictive power for short-term mortality.", {"entities": []}], ["We present 2 patients with free perforation of the anterior wall of the Roux limb due to marginal ulceration after an antecolic laparoscopic gastric bypass and describe the surgical management and laparoscopic repair technique.", {"entities": []}], ["A 15 mm Hg pneumoperitoneum was established with a Veress needle via the left subcostal approach in both patients.", {"entities": []}], ["Entrance into the abdomen was achieved with the 5 mm Optiview blunt trocar.", {"entities": []}], ["The Genzyme liver retractor was used to lift the left lobe of the liver and expose the gastrojejunal anastomosis.", {"entities": []}], ["A 30\u00b0 5 mm telescope was used for visualization.", {"entities": []}], ["In both cases, free fluid and purulent material were noted in the subdiaphragmatic region and along the right paracolic gutter, but the gastrojejunal anastomoses was intact.A1cm perforation with surrounding inflammatory exudate was identified on the anterior surface of the Roux limb distal to the gastrojejunostomy.", {"entities": []}], ["The edges were debrided and intracorporeal 1-layer repair of the ulcer was performed with simple interrupted 2- 0 Vicryl sutures.", {"entities": []}], ["Fibrin glue was applied to the suture line and covered with an omental onlay patch.", {"entities": []}], ["The anastomosis was tested with air insufflation and methylene blue dye with no evidence of a leak.", {"entities": []}], ["A Jackson-Pratt drain was placed in the left upper quadrant.", {"entities": []}], ["Both patients underwent an unremarkable hospital course, and follow-up EGD examination after 3 months revealed no evidence of ulceration.", {"entities": []}], ["Laparoscopic exploration and the repair of the gastrointestinal perforations in patients with a recent history of laparoscopic RYGBP is safe, if patients are hemodynamically stable and present within the first 24 hours of the onset of symptoms.", {"entities": []}], ["Medication-related problems are a serious concern in Australian primary care.", {"entities": []}], ["Pharmacist interventions have been shown to be effective in identifying and resolving these problems.", {"entities": []}], ["Collaborative general practitioner-pharmacist services currently available in Australia are limited and underused.", {"entities": []}], ["Limitations include geographical isolation of pharmacists and lack of communication and access to patient information.", {"entities": []}], ["Co-location of pharmacists within the general practice clinics is a possible solution.", {"entities": []}], ["There have been no studies in the Australian setting exploring the role of pharmacists within general practice clinics.", {"entities": []}], ["The aim of this study is to develop and test a multifaceted practice pharmacist role in primary care practices to improve the quality use of medicines by patients and clinic staff.", {"entities": []}], ["This is a multi-centre, prospective intervention study with a pre-post design and a qualitative component.", {"entities": []}], ["A practice pharmacist will be located in each of two clinics and provide short and long patient consultations, drug information services and quality assurance activities.", {"entities": []}], ["Patients receiving long consultation with a pharmacist will be followed up at 3 and 6\u2009months.", {"entities": []}], ["Based on sample size calculations, at least 50 patients will be recruited for long patient consultations across both sites.", {"entities": []}], ["Outcome measures include the number, type and severity of medication-related problems identified and resolved; medication adherence; and patient satisfaction.", {"entities": []}], ["Brief structured interviews will be conducted with patients participating in the study to evaluate their experiences with the service.", {"entities": []}], ["Staff collaboration and satisfaction with the service will be assessed.", {"entities": []}], ["This intervention has the potential to optimise medication use in primary care clinics leading to better health outcomes.", {"entities": []}], ["This study will provide data about the effectiveness of the proposed model for pharmacist involvement in Australian general practice clinics, that will be useful to guide further research and development in this area.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry: ACTRN12612000742875", {"entities": []}], ["Pain contributes to health care costs, missed work and school, and lower quality of life.", {"entities": []}], ["Extant research on psychological interventions for pain has focused primarily on developing skills that individuals can apply to manage their pain.", {"entities": []}], ["Rather than examining internal factors that influence pain tolerance (e.g., pain management skills), the current work examines factors external to an individual that can increase pain tolerance.", {"entities": []}], ["Specifically, the current study examined the nonconscious influence of exposure to meaningful objects on the perception of pain.", {"entities": []}], ["Participants (N \u200a=\u200a 54) completed a cold pressor test, examined either ibuprofen or a control object, then completed another cold pressor test.", {"entities": []}], ["In the second test, participants who previously examined ibuprofen reported experiencing less intense pain and tolerated immersion longer (relative to baseline) than those who examined the control object.", {"entities": []}], ["Theoretical and applied implications of these findings are discussed.", {"entities": []}], ["Human rhinoviruses (HRVs) are the most prevalent human pathogens, and consist of 101 serotypes that are classified into groups A and B according to sequence variations.", {"entities": []}], ["HRV infections cause a wide spectrum of clinical outcomes ranging from asymptomatic infection to severe lower respiratory symptoms.", {"entities": []}], ["Defining the role of specific strains in various HRV illnesses has been difficult because traditional serology, which requires viral culture and neutralization tests using 101 serotype-specific antisera, is insensitive and laborious.", {"entities": []}], ["To directly type HRVs in nasal secretions of infants with frequent respiratory illnesses, we developed a sensitive molecular typing assay based on phylogenetic comparisons of a 260-bp variable sequence in the 5' noncoding region with homologous sequences of the 101 known serotypes.", {"entities": []}], ["Nasal samples from 26 infants were first tested with a multiplex PCR assay for respiratory viruses, and HRV was the most common virus found (108 of 181 samples).", {"entities": []}], ["Typing was completed for 101 samples and 103 HRVs were identified.", {"entities": []}], ["Surprisingly, 54 (52.4%) HRVs did not match any of the known serotypes and had 12\u201335% nucleotide divergence from the nearest reference HRVs.", {"entities": []}], ["Of these novel viruses, 9 strains (17 HRVs) segregated from HRVA, HRVB and human enterovirus into a distinct genetic group (\u201cC\u201d).", {"entities": []}], ["None of these new strains could be cultured in traditional cell lines.", {"entities": []}], ["By molecular analysis, over 50% of HRV detected in sick infants were previously unrecognized strains, including 9 strains that may represent a new HRV group.", {"entities": []}], ["These findings indicate that the number of HRV strains is considerably larger than the 101 serotypes identified with traditional diagnostic techniques, and provide evidence of a new HRV group.", {"entities": []}], ["The English community pharmacy New Medicine Service (NMS) significantly increases patient adherence to medicines, compared with normal practice.", {"entities": [[53, 56, "GENE"]]}], ["We examined the cost effectiveness of NMS compared with normal practice by combining adherence improvement and intervention costs with the effect of increased adherence on patient outcomes and healthcare costs.", {"entities": [[38, 41, "GENE"]]}], ["We developed Markov models for diseases targeted by the NMS (hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma and antiplatelet regimens) to assess the impact of patients\u2019 non-adherence.", {"entities": [[61, 73, "DISEASE"], [101, 138, "DISEASE"], [140, 146, "DISEASE"], [82, 99, "DISEASE"], [75, 99, "DISEASE"], [56, 59, "GENE"]]}], ["Clinical event probability, treatment pathway, resource use and costs were extracted from literature and costing tariffs.", {"entities": []}], ["Incremental costs and outcomes associated with each disease were incorporated additively into a composite probabilistic model and combined with adherence rates and intervention costs from the trial.", {"entities": []}], ["Costs per extra quality-adjusted life-year (QALY) were calculated from the perspective of NHS England, using a lifetime horizon.", {"entities": [[90, 93, "GENE"]]}], ["NMS generated a mean of 0.05 (95% CI 0.00\u20130.13) more QALYs per patient, at a mean reduced cost of \u2212\u00a3144 (95% CI \u2212769 to 73).", {"entities": [[0, 3, "GENE"]]}], ["The NMS dominates normal practice with a probability of 0.78 [incremental cost-effectiveness ratio (ICER) \u2212\u00a33166 per QALY].", {"entities": [[4, 7, "GENE"]]}], ["NMS has a 96.7% probability of cost effectiveness compared with normal practice at a willingness to pay of \u00a320,000 per QALY.", {"entities": [[0, 3, "GENE"]]}], ["Sensitivity analysis demonstrated that targeting each disease with NMS has a probability over 0.90 of cost effectiveness compared with normal practice at a willingness to pay of \u00a320,000 per QALY.", {"entities": [[67, 70, "GENE"]]}], ["Our study suggests that the NMS increased patient medicine adherence compared with normal practice, which translated into increased health gain at reduced overall cost.", {"entities": [[28, 31, "GENE"]]}], ["ClinicalTrials.gov Trial reference number NCT01635361 ( http://clinicaltrials.gov/ct2/show/NCT01635361 ).", {"entities": []}], ["Current Controlled trials: Trial reference number ISRCTN 23560818 ( http://www.controlled-trials.com/ISRCTN23560818/ ; DOI 10.1186/ISRCTN23560818).", {"entities": []}], ["UK Clinical Research Network (UKCRN) study 12494 ( http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=12494 ).", {"entities": []}], ["Department of Health Policy Research Programme.", {"entities": []}], ["The online version of this article (doi:10.1007/s40273-017-0554-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Electronic health records stored in primary care databases might be a valuable source to study the epidemiology of atopic disorders and their impact on health-care systems and costs.", {"entities": []}], ["However, the prevalence of atopic disorders in such databases varies considerably and needs to be addressed.", {"entities": []}], ["For this study, all children aged 0\u201318 years listed in a representative primary care database in the period 2002\u20132014, with sufficient data quality, were selected.", {"entities": []}], ["The effects of four different strategies on the prevalences of atopic disorders were examined: (1) the first strategy examined the diagnosis as recorded in the electronic health records, whereas the (2) second used additional requirements (i.e., the patient had at least two relevant consultations and at least two relevant prescriptions).", {"entities": []}], ["Strategies (3) and (4) assumed the atopic disorders to be chronic based on strategy 1 and 2, respectively.", {"entities": []}], ["When interested in cases with a higher probability of a clinically relevant disorder, strategy 2 yields a realistic estimation of the prevalence of atopic disorders derived from primary care data.", {"entities": []}], ["Using this strategy, of the 478,076 included children, 28,946 (6.1%) had eczema, 29,182 (6.1%) had asthma, and 28,064 (5.9%) had allergic rhinitis; only 1251 (0.3%) children had all three atopic disorders.", {"entities": [[129, 146, "DISEASE"], [138, 146, "DISEASE"], [99, 105, "DISEASE"]]}], ["Prevalence rates are highly dependent on the clinical atopic definitions used.", {"entities": []}], ["The strategy using cases with a higher probability of clinically relevant cases, yields realistic prevalences to establish the impact of atopic disorders on health-care systems.", {"entities": []}], ["However, studies are needed to solve the problem of identifying atopic disorders that are missed or misclassified.", {"entities": []}], ["The prevalence of atopic disorders in children can be more reliably calculated by incorporating clinical information with diagnosis data.", {"entities": []}], ["Researchers in the Netherlands, led by David Pols from the Erasmus University Medical Center Rotterdam, examined the electronic health records of more than 660,000 children, aged 0 to 18, from a Dutch primary care database to determine the number of cases of atopic eczema, asthma, and allergic rhinitis.", {"entities": [[286, 303, "DISEASE"], [295, 303, "DISEASE"], [274, 280, "DISEASE"]]}], ["They looked for diagnosed children who also had at least two relevant clinical consultations and at least two relevant prescriptions.", {"entities": []}], ["This strategy helps correct for the problem of overestimation, because it doesnot assume that a child, once diagnosed, will have an atopic disorder for life.", {"entities": []}], ["However, other methods are still needed to identify cases that are missed or misclassified in the health database.", {"entities": []}], ["Non-communicable diseases (NCDs) are an emerging global health concern.", {"entities": []}], ["Reports have shown that, in Zambia, NCDs are also an emerging problem and the government has begun initiating a policy response.", {"entities": []}], ["The present study explores the policy response to NCDs by the Ministry of Health in Zambia using the policy triangle framework of Walt and Gilson.", {"entities": []}], ["A qualitative approach was used for the study.", {"entities": []}], ["Data collected through key informant interviews with stakeholders who were involved in the NCD health policy development process as well as review of key planning and policy documents were analysed using thematic analysis.", {"entities": []}], ["The government\u2019s policy response was as a result of international strategies from WHO, evidence of increasing disease burden from NCDs and pressure from interest groups.", {"entities": []}], ["The government developed the NCD strategic plan based on the WHO Global Action Plan for NCDs 2013\u20132030.", {"entities": []}], ["Development of the NCD strategic plan was driven by the government through the Ministry of Health, who set the agenda and adopted the final document.", {"entities": []}], ["Stakeholders participated in the fine tuning of the draft document from the Ministry of Health.", {"entities": []}], ["The policy development process was lengthy and this affected consistency in composition of the stakeholders and policy development momentum.", {"entities": []}], ["Lack of representative research evidence for some prioritised NCDs and use of generic targets and indicators resulted in the NCD strategic plan being inadequate for the Zambian context.", {"entities": []}], ["The interventions in the strategic plan also underutilised the potential of preventing NCDs through health education.", {"entities": []}], ["Recent government pronouncements were also seen to be conflicting the risk factor reduction strategies outlined in the NCD strategic plan.", {"entities": []}], ["The content of the NCD strategic plan inadequately covered all the major NCDs in Zambia.", {"entities": []}], ["Although contextual factors like international strategies and commitments are crucial catalysts to policy development, there is need for domestication of international guidelines and frameworks to match the disease burden, resources and capacities in the local context if policy measures are to be comprehensive, relevant and measurable.", {"entities": []}], ["Such domestication should be guided by representative local research evidence.", {"entities": []}], ["The joint distribution of asthma and chronic obstructive pulmonary disease (COPD) has not been well described.", {"entities": [[37, 74, "DISEASE"], [26, 32, "DISEASE"]]}], ["This study aims at determining the prevalence of self-reported physician diagnoses of asthma, COPD and of the asthma-COPD overlap syndrome and to assess whether these conditions share a common set of risk factors.", {"entities": [[130, 138, "DISEASE"], [86, 92, "DISEASE"], [110, 116, "DISEASE"]]}], ["A screening questionnaire on respiratory symptoms, diagnoses and risk factors was administered by mail or phone to random samples of the general Italian population aged 20\u201344 (n\u200a=\u200a5163) 45\u201364 (n\u200a=\u200a2167) and 65\u201384 (n\u200a=\u200a1030) in the frame of the multicentre Gene Environment Interactions in Respiratory Diseases (GEIRD) study.", {"entities": []}], ["A physician diagnosis of asthma or COPD (emphysema/chronic bronchitis/COPD) was reported by 13% and 21% of subjects aged <65 and 65\u201384 years respectively.", {"entities": [[25, 31, "DISEASE"], [59, 69, "DISEASE"]]}], ["Aging was associated with a marked decrease in the prevalence of diagnosed asthma (from 8.2% to 1.6%) and with a marked increase in the prevalence of diagnosed COPD (from 3.3% to 13.3%).", {"entities": [[75, 81, "DISEASE"]]}], ["The prevalence of the overlap of asthma and COPD was 1.6% (1.3%\u20132.0%), 2.1% (1.5%\u20132.8%) and 4.5% (3.2%\u20135.9%) in the 20\u201344, 45\u201364 and 65\u201384 age groups.", {"entities": [[33, 39, "DISEASE"]]}], ["Subjects with both asthma and COPD diagnoses were more likely to have respiratory symptoms, physical impairment, and to report hospital admissions compared to asthma or COPD alone (p<0.01).", {"entities": [[19, 25, "DISEASE"], [159, 165, "DISEASE"]]}], ["Age, sex, education and smoking showed different and sometimes opposite associations with the three conditions.", {"entities": []}], ["Asthma and COPD are common in the general population, and they coexist in a substantial proportion of subjects.", {"entities": [[0, 6, "DISEASE"]]}], ["The asthma-COPD overlap syndrome represents an important clinical phenotype that deserves more medical attention and further research.", {"entities": [[24, 32, "DISEASE"], [4, 10, "DISEASE"]]}], ["Little is known about the role of guidelines for the practical management of chronic obstructive pulmonary disease (COPD) by office-based pulmonary specialists.", {"entities": [[77, 114, "DISEASE"]]}], ["The aim of this study was to assess their outpatient management in relation to current guideline recommendations for COPD.", {"entities": []}], ["A nationwide prospective cross-sectional COPD questionnaire survey in the form of a multiple-choice questionnaire was sent to 1000 office-based respiratory specialists in Germany.", {"entities": []}], ["The product-neutral questions focused on routine COPD management and were based on current national and international COPD guideline recommendations being consistent in severity classification and treatment recommendations.", {"entities": []}], ["A total of 590 pulmonary specialists (59%) participated in the survey.", {"entities": []}], ["Body plethysmography was considered the standard for diagnosis (65.9%), followed by spirometry (32%).", {"entities": []}], ["Most respondents were able to cite the correct spirometric criteria for classifying moderate (87%) to very severe COPD (77%).", {"entities": []}], ["A quarter of the respondents equated the World Health Organization (WHO) definition of chronic bronchitis with COPD.", {"entities": [[95, 105, "DISEASE"]]}], ["Notably, most participants preferred the updated national COPD guidelines (51.4%) to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines (40.2%).", {"entities": []}], ["Improvement of functional exercise capacity and quality of life were considered the two most relevant treatment goals; whereas impact on mortality was secondary.", {"entities": []}], ["Treatment of COPD largely complied with the guidelines.", {"entities": []}], ["However, a significant percentage of the pulmonary specialists differed in their assessment of the benefits of various therapeutic measures from evidence-based results.", {"entities": []}], ["Referral for pulmonary rehabilitation was uncommon, regardless of the severity of COPD.", {"entities": []}], ["The findings of this large national survey suggest that most pulmonary specialists adhere to the current COPD guideline recommendations in daily practice.", {"entities": []}], ["However, physicians\u2019 knowledge of guidelines is not sufficient as the sole benchmark when assessing their implementation in day-to-day practice.", {"entities": []}], ["Necessary changes in the health care system must include more effective ways to transfer knowledge to clinical practice and to give access to interventions of proven clinical benefit.", {"entities": []}], ["The aim was to create pathological changes in mice relevant to human smoke exposure that can be used to further understand the mechanisms and pathology of smoke-induced inflammatory disease.", {"entities": []}], ["Mice were exposed to tobacco smoke or lipopolysaccharide (LPS) to generate an inflammatory infiltrate within the lungs.", {"entities": []}], ["Tobacco smoke exposure over a 4\u00a0day period led to neutrophilia in the lungs of BALB/c mice.", {"entities": []}], ["Within the inflammatory exudates, significant changes were also seen in protein levels of IL-1B, IL-6, MIP-2, KC (IL-8) and TIMP-1 as measured by ELISA.", {"entities": []}], ["Further protein changes, as measured via multiplex analysis revealed increased levels of MMP-9, MDC, LIF and MCP-1, amongst other mediators.", {"entities": [[101, 104, "GENE"]]}], ["Major changes in whole lung tissue gene expression patterns were observed.", {"entities": []}], ["The neutrophilia seen after smoke exposure was steroid-insensitive, relative to doses of steroid needed to reduce LPS-driven neutrophilia in controls.", {"entities": []}], ["This exposes pathological switches that are changed upon exposure to tobacco smoke, rendering steroids less effective under these conditions.", {"entities": []}], ["Challenge of chemokine receptor type 1 (CCR1) KO mice in the tobacco smoke model showed that lack of this gene protected the mice from smoke-induced inflammation.", {"entities": [[40, 44, "GENE"]]}], ["This suggests the CCR1 receptor has a key role in the pathogenesis of smoke-induced inflammation.", {"entities": [[18, 22, "GENE"]]}], ["Combat-intense, lengthy, and multiple deployments in Iraq and Afghanistan have characterized the new millennium.", {"entities": []}], ["The US military's all-volunteer force has never been better trained and technologically equipped to engage enemy combatants in multiple theaters of operations.", {"entities": []}], ["Nonetheless, concerns over potential lasting effects of deployment on long-term health continue to mount and are yet to be elucidated.", {"entities": []}], ["This report outlines how findings from the first 7 years of the Millennium Cohort Study have helped to address health concerns related to military service including deployments.", {"entities": []}], ["The Millennium Cohort Study was designed in the late 1990s to address veteran and public concerns for the first time using prospectively collected health and behavioral data.", {"entities": []}], ["Over 150 000 active-duty, reserve, and National Guard personnel from all service branches have enrolled, and more than 70% of the first 2 enrollment panels submitted at least 1 follow-up survey.", {"entities": []}], ["Approximately half of the Cohort has deployed in support of operations in Iraq and Afghanistan.", {"entities": []}], ["The Millennium Cohort Study is providing prospective data that will guide public health policymakers for years to come by exploring associations between military exposures and important health outcomes.", {"entities": []}], ["Strategic studies aim to identify, reduce, and prevent adverse health outcomes that may be associated with military service, including those related to deployment.", {"entities": []}], ["Plants are the valuable source of natural products with important medicinal properties.", {"entities": []}], ["Most of the approved anti cancer drugs have a natural product origin or are natural products.", {"entities": [[26, 32, "DISEASE"]]}], ["Retinoblastoma is the most common ocular cancer of children.", {"entities": [[34, 47, "DISEASE"], [0, 14, "DISEASE"], [41, 47, "DISEASE"]]}], ["Although chemotherapy is the preferred mode of therapy, a successful treatment for retinoblastoma requires enucleation.", {"entities": [[83, 97, "DISEASE"]]}], ["Chebulagic acid (CA) from Terminalia chebula was shown to have anti-proliferative properties in the studies on cancerous cell lines.", {"entities": []}], ["Due to anti cancer properties of CA and due to limitation in treatment options for retinoblastoma, the present study is undertaken to understand the role of CA on the proliferation of retinoblastoma cells.", {"entities": [[83, 97, "DISEASE"], [184, 198, "DISEASE"], [12, 18, "DISEASE"]]}], ["Anti proliferative potential of CA was determined by MTT assay.", {"entities": []}], ["The expression levels of various cell death mediators in retinoblastoma cells with CA treatment were assessed by Western blotting.", {"entities": [[57, 71, "DISEASE"]]}], ["Flowcytometer analysis was used to estimate the mitochondrial membrane potential (MMP) and to determine the percentage of cells undergoing apoptosis.", {"entities": []}], ["The present study showed CA inhibited the proliferation of retinoblastoma cells in a dose dependent manner.", {"entities": [[59, 73, "DISEASE"]]}], ["CA modulated MMP, induced release of Cytochrome c , activated caspase 3 and shifted the ratio of BAX and Bcl2 towards cell death.", {"entities": [[97, 100, "GENE"], [105, 109, "GENE"]]}], ["G1 arrest, noticed in CA treated cells, is mediated by the increase in the expression of CDK inhibitor p27.", {"entities": []}], ["CA treatment also decreased the levels of NF\u03baB in the nucleus.", {"entities": []}], ["This decrease is mediated by suppression in degradation of I\u03baB\u03b1.", {"entities": []}], ["CA has shown significant anti proliferative potential on retinoblastoma cells.", {"entities": [[57, 71, "DISEASE"]]}], ["Our findings clearly demonstrate that CA induces G1 arrest, inhibits NF\u03baB and induces apoptosis of retinoblastoma cells.", {"entities": [[99, 113, "DISEASE"]]}], ["Respiratory syncytial virus (RSV) is a major viral pathogen that causes severe lower respiratory tract infections in infants and the elderly worldwide.", {"entities": []}], ["Infants with severe RSV bronchiolitis tend to experience more wheezing and asthma in later childhood.", {"entities": [[75, 81, "DISEASE"], [24, 37, "DISEASE"]]}], ["Because invariant natural killer T (iNKT) cells are associated with the asthma pathology, we investigated whether neonatal iNKT cells are involved in the aggravation of pulmonary diseases following RSV infection in mice.", {"entities": [[72, 78, "DISEASE"]]}], ["Intranasal exposure to the iNKT cell ligand \u03b1-galactosylceramide (\u03b1-GC) with RSV primary infection in neonatal mice elicited neither cytokine production (except for a slight increase of IL-5) nor pulmonary eosinophilia, despite the presence of both CD1d cd1d knockout mice.", {"entities": [[206, 218, "DISEASE"], [196, 218, "DISEASE"], [249, 253, "GENE"], [254, 258, "GENE"], [249, 253, "GENE"], [254, 258, "GENE"]]}], ["In contrast, \u03b1-GC priming of adults during RSV re-infection did not induce more severe airway symptoms than RSV re-infection in the absence of \u03b1-GC.", {"entities": []}], ["\u03b1-GC co-administration during RSV primary infection facilitated RSV clearance regardless of age, but viral clearance following re-infection was not iNKT cell-dependent.", {"entities": []}], ["This study clearly demonstrates that RSV-induced immune responses can be altered by iNKT cells, suggesting that neonatal iNKT cell sensitization during RSV primary infection is associated with exacerbation of pulmonary diseases following RSV re-infection in adulthood.", {"entities": []}], ["Although impaired health-related quality of life (HRQOL) has been reported in patients with sarcoidosis, there is currently no sarcoidosis-specific questionnaire in Japan.", {"entities": [[92, 103, "DISEASE"], [127, 138, "DISEASE"]]}], ["The 29-item Sarcoidosis Health Questionnaire (SHQ), originally developed in the United States, is the only sarcoidosis-specific HRQOL questionnaire currently available.", {"entities": [[12, 23, "DISEASE"], [107, 118, "DISEASE"]]}], ["The primary aim of this study was to develop and validate a Japanese version of the SHQ.", {"entities": []}], ["The SHQ was translated into Japanese following the forward-backward procedure.", {"entities": []}], ["The reliability and validity of the Japanese version of the SHQ were examined.", {"entities": []}], ["One hundred twenty-two Japanese patients with biopsy-proven sarcoidosis were evaluated by the SHQ, the Medical Outcomes Study 36-item short form (SF-36), the St. George's Respiratory Questionnaire (SGRQ), chest radiography, an electrocardiogram, laboratory blood tests, pulmonary function tests, an echocardiogram, and assessments of dyspnea and depressive symptoms.", {"entities": [[60, 71, "DISEASE"]]}], ["The SHQ was found to have acceptable levels of internal consistency (Cronbach's coefficient \u03b1 values = 0.68 to 0.91).", {"entities": []}], ["SHQ scores correlated significantly with scores on the SF-36 and SGRQ.", {"entities": []}], ["The domain or total scores on the SHQ also significantly correlated with serum levels of the soluble interleukin-2 receptor, the percentage of the predicted forced vital capacity, pulmonary arterial systolic pressure, dyspnea, and depressive symptoms.", {"entities": []}], ["Also, the SHQ scores of patients who had one or two organ systems affected by sarcoidosis were significantly different from those of patients who had three or more organ systems involvement.", {"entities": [[78, 89, "DISEASE"]]}], ["The Japanese version of the SHQ can be used to assess the HRQOL of patients with sarcoidosis.", {"entities": [[81, 92, "DISEASE"]]}], ["Larvae of several common species of parasitic nematodes obligately migrate through, and often damage, host lungs.", {"entities": []}], ["The larvae induce strong pulmonary Type 2 immune responses, including T-helper (Th)2 cells as well as alternatively activated macrophages (AAM\u03c6) and associated chitinase and Fizz/resistin family members (ChaFFs), which are thought to promote tissue repair processes.", {"entities": []}], ["Given the prevalence of systemic or lung-resident Type 1-inducing pathogens in geographical areas in which nematodes are endemic, we wished to investigate the impact of concurrent Type 1 responses on the development of these Type 2 responses to nematode larval migration.", {"entities": []}], ["We therefore infected BALB/c mice with the nematode Nippostrongylus brasiliensis , in the presence or absence of Plasmodium chabaudi chabaudi malaria parasites.", {"entities": [[142, 149, "DISEASE"]]}], ["Co-infected animals received both infections on the same day, and disease was assessed daily before immunological measurements were taken at 3, 5, 7 or 20 days post-infection.", {"entities": []}], ["We observed that the nematodes themselves caused transient loss of body mass and red blood cell density, but co-infection then slightly ameliorated the severity of malarial anaemia.", {"entities": []}], ["We also tracked the development of immune responses in the lung and thoracic lymph node.", {"entities": []}], ["By the time of onset of the adaptive immune response around 7 days post-infection, malaria co-infection had reduced pulmonary expression of ChaFFs.", {"entities": [[83, 90, "DISEASE"]]}], ["Assessment of the T cell response demonstrated that the Th2 response to the nematode was also significantly impaired by malaria co-infection.", {"entities": [[120, 127, "DISEASE"]]}], ["P. c. chabaudi co-infection altered both local and lymph node Type 2 immune activation due to migration of N. brasiliensis larvae.", {"entities": []}], ["Given recent work from other laboratories showing that N. brasiliensis -induced ChaFFs correlate to the extent of long-term lung damage, our results raise the possibility that co-infection with malaria might alter pulmonary repair processes following nematode migration.", {"entities": [[194, 201, "DISEASE"]]}], ["Further experimentation in the co-infection model developed here will reveal the longer-term consequences of the presence of both malaria and helminths in the lung.", {"entities": [[130, 137, "DISEASE"]]}], ["The effect of smoking cessation on the oxidative stress in patients with chronic obstructive pulmonary disease (COPD) was assessed.", {"entities": [[73, 110, "DISEASE"]]}], ["We recruited 73 smokers with COPD (study group), whose blood was analysed before smoking cessation, after the 1st, 2nd, and 3rd months of abstinence, 35 healthy nonsmokers (Control I), and 35 smokers with COPD (Control II).", {"entities": []}], ["Blood was taken once in Control I and 4 times (every month) in Control II.", {"entities": []}], ["In the study group conjugated dienes (CDs) level in plasma and erythrocytes before smoking cessation was 3 and 6.5 times higher than in Control I, respectively ( P < 0.001), while thiobarbituric acid-reactive substances (TBARS) level was 89% ( P < 0.001) and 51% higher ( P < 0.01), respectively.", {"entities": []}], ["Superoxide dismutase (SOD) activity was 40% higher ( P < 0.05) while glutathione peroxidase (GPx) was 41% lower ( P < 0.001) than in Control I.", {"entities": []}], ["In Control II, the similar differences as compared to Control I were observed throughout the study.", {"entities": []}], ["Smoking cessation resulted in decrease of CDs, TBARS, and SOD and GPx increase, with no changes in catalase and vitamins A and E. COPD is accompanied by oxidative stress.", {"entities": []}], ["A three-month tobacco abstinence facilitated restoring the oxidant-antioxidant balance systemically, but it did not affect spirometric parameters.", {"entities": []}], ["Both veterinarians caring for dolphins in managed populations and researchers monitoring wild populations use blood-based diagnostics to monitor bottlenose dolphin ( Tursiops truncatus ) health.", {"entities": []}], ["Quantitative PCR (qPCR) can be used to assess cytokine transcription patterns of peripheral blood mononuclear cells (PBMC).", {"entities": []}], ["This can supplement currently available blood tests with information on immune status.", {"entities": []}], ["Full realization of this potential requires establishment of normal ranges of cytokine gene transcription levels in bottlenose dolphins.", {"entities": []}], ["We surveyed four dolphins over the span of seven months by serial bleeds.", {"entities": []}], ["PBMC were stimulated with phytohaemagglutinin (1, 5, and 10 \u03bcg/mL) and concanavalin A (1 \u03bcg/mL) for 48 H in vitro.", {"entities": []}], ["RNA from these cultures was probed by qPCR using Tursiops truncatus -specific primers (IL-1\u03b1, IL-1\u03b2, IL-1RA, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-13, IL-18, IFN-\u03b3 and TNF-\u03b1).", {"entities": []}], ["Two blood samples from an additional bottlenose dolphin diagnosed with acute pulmonary disease add further perspective to the data.", {"entities": []}], ["We observed that mitogen choice made a significant difference in the magnitude of gene transcription observed.", {"entities": []}], ["On the other hand, most cytokines tested exhibited limited intra-animal variation.", {"entities": []}], ["However, IL-6 and IL-12p40 differed between older and younger dolphins.", {"entities": []}], ["Furthermore, the magnitude of mitogenic response clusters the tested cytokines into three groups.", {"entities": []}], ["The data provide a reference for the selection of target cytokine mRNAs and their expected range of mitogen-stimulated cytokine gene transcription for future studies.", {"entities": []}], ["ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3) has been previously implicated in asthma pathogenesis, its effect on airway remodeling remains to be elucidated.", {"entities": [[87, 93, "DISEASE"], [45, 51, "GENE"]]}], ["The present study examined the expression levels of ORMDL3 in a mouse model of asthma.", {"entities": [[79, 85, "DISEASE"], [52, 58, "GENE"]]}], ["Mice were divided into three groups: Asthmatic model (n=10), budesonide-treated (n=10) and a control group (n=8).", {"entities": []}], ["Asthma was induced by sensitization with ovalbumin (OVA) and aluminum hydroxide on day 1, 7 and 14.", {"entities": [[0, 6, "DISEASE"]]}], ["Subsequently mice were exposed to OVA three times per week from day 28.", {"entities": []}], ["In order to investigate the mechanism of airway remodeling 100 \u00b5g/kg aerosol budesonide was administered to 6 animals prior to exposure to OVA.", {"entities": []}], ["The condition of lung tissues was assessed through histology, and the expression levels of ORMDL3, phosphorylated-extracellular-signal regulated kinase (p-ERK) and matrix metallopeptidase-9 (MMP-9) were quantified using immunohistochemistry, reverse transcription-quantitative polymerase chain reaction and western blotting.", {"entities": [[91, 97, "GENE"]]}], ["A severe inflammatory response and airway remodeling were pretreatment with budesonide.", {"entities": []}], ["Expression levels of ORMDL3, phosphorylated (p)-ERK and MMP-9 were significantly greater in the asthma-model group; however, in the group pretreated with budesonide their expression was reduced.", {"entities": [[96, 102, "DISEASE"], [21, 27, "GENE"]]}], ["Expression levels of ORMDL3, p-ERK and MMP-9 were significantly positively correlated with bronchial wall thickness.", {"entities": [[21, 27, "GENE"]]}], ["ORMDL3 expression was significantly positively correlated with p-ERK and MMP-9.", {"entities": [[0, 6, "GENE"]]}], ["Therefore, increased ORMDL3 expression may induce the p-ERK/MMP-9 pathway to promote pathological airway remodeling in patients with asthma.", {"entities": [[133, 139, "DISEASE"], [21, 27, "GENE"]]}], ["Our aim was to assess the differences in intraregional prevalence of asthma in adolescents in Split-Dalmatia County to determine asthma risk factors in our population and estimate the specificity and sensitivity of the questionnaire used.", {"entities": [[69, 75, "DISEASE"], [129, 135, "DISEASE"]]}], ["We conducted the study using the European Community Respiratory Health Survey II short questionnaire supplemented by some questions from the International Study of Asthma in Childhood questionnaire.", {"entities": [[164, 170, "DISEASE"]]}], ["The participants suspected to have asthma were invited for examination by an asthma specialist who established the final diagnosis of asthma according to the medical history, physical examination, skin-prick tests, and peak flow measurements.", {"entities": [[35, 41, "DISEASE"], [77, 83, "DISEASE"], [134, 140, "DISEASE"]]}], ["A total of 4027 students (51.2% male) participated in the study.", {"entities": []}], ["According to the prevalence of wheezing during the last 12 months, asthma prevalence was estimated at 9.7%.", {"entities": [[67, 73, "DISEASE"]]}], ["The total prevalence of asthma confirmed by an asthma specialist in the selected population was 5.60% (95% CI, 4.93\u20136.36%); 6.18% in Split (95% CI, 5.37\u20137.09), 5.63% in Imotski (95% CI, 3.48\u20138.58), and 2.90% in Sinj (95% CI, 1.67\u20134.68) (P=0.0028).", {"entities": [[24, 30, "DISEASE"], [47, 53, "DISEASE"]]}], ["We found sensitization to aeroallergens and peanuts, and active smoking to be independent risk factors for asthma.", {"entities": [[107, 113, "DISEASE"]]}], ["Split-Dalmatia County has moderate asthma prevalence, with a significant intraregional difference.", {"entities": [[35, 41, "DISEASE"]]}], ["Asthma prevalence estimated by a questionnaire (9.7%) overestimates the prevalence of asthma confirmed by an asthma specialist (5.6%) in adolescents in Croatia.", {"entities": [[0, 6, "DISEASE"], [86, 92, "DISEASE"], [109, 115, "DISEASE"]]}], ["Our data confirmed the need of a more complex questionnaire to evaluate the accurate prevalence of current asthma or the need for subsequent clinical evaluation of the questionnaire obtained data.", {"entities": [[107, 113, "DISEASE"]]}], ["Allergic sensitization to aeroallergens and active smoking were important risk factors for asthma.", {"entities": [[91, 97, "DISEASE"]]}], ["At present, nothing is known of the role of miRNAs in the immune response in vivo despite the fact that inflammation is thought to underlie multiple acute and chronic diseases.", {"entities": []}], ["In these circumstances, patients are commonly treated with corticosteroids such as dexamethasone.", {"entities": []}], ["To address this question, we have examined the differential expression of 104 miRNAs using real-time PCR during the innate immune response in mouse lung following exposure to aerosilised lipopolysaccharide (LPS).", {"entities": []}], ["Following challenge, we observed rapid and transient increase in both the mean (4.3-fold) and individual levels of miRNA expression (46 miRNAs) which peaked at 3 hrs.", {"entities": []}], ["Crucially, this increase was correlated with a reduction in the expression of tumour necrosis factor (TNF)-\u03b1, keratinocyte-derived chemokine (KC) and macrophage inflammatory protein (MIP)-2, suggesting a potential role for miRNAs in the regulation of inflammatory cytokine production.", {"entities": [[102, 105, "GENE"], [183, 186, "GENE"]]}], ["Examination of the individual miRNA expression profiles showed time dependent increases in miR-21, -25, -27b, -100, 140, -142-3p, -181c, 187, -194, -214, -223 and -224.", {"entities": [[91, 97, "GENE"]]}], ["Corticosteroid studies showed that pre-treatment with dexamethasone at concentrations that inhibited TNF-\u03b1 production, had no effect either alone or upon the LPS-induced miRNA expression profile.", {"entities": []}], ["We have shown that the LPS-induced innate immune response is associated with widespread, rapid and transient increases in miRNA expression in the mouse lung and we speculate that these changes might be involved in the regulation of the inflammatory response.", {"entities": []}], ["In contrast, the lack of effect of dexamethasone in either control or challenged animals implies that the actions of glucocorticoids per se are not mediated through changes in miRNAs expression and that LPS-induced increases in miRNA expression are not mediated via classical inflammatory transcription factors.", {"entities": []}], ["Urinary incontinence (UI) is a prevalent symptom in middle-aged women, but data on incidence is limited and rarely reported.", {"entities": []}], ["In order to analyze incidence, remission, or development patterns of severity and types of UI, we have established a 15-year prospective cohort (1997\u20132012).", {"entities": []}], ["The Cohort is based on the national collection of health data gathered from county studies (CONOR).", {"entities": []}], ["Hordaland Health Study (HUSK) is one of them from Hordaland County.", {"entities": []}], ["Each of the county studies may have local sub-studies and our Cohort is one of them.", {"entities": []}], ["The Cohort included women aged 40\u201345 in order to have a broad approach to women's health including UI and other lower urinary tract symptoms (LUTS).", {"entities": []}], ["A onefifth random sampling from HUSK was used to create the Cohort in 1997\u20131999.", {"entities": []}], ["For the necessary sample size a preliminary power calculation, based on a 70% response rate at inclusion and 5% annual attrition rates was used.", {"entities": []}], ["The Cohort is planned to collect data through questionnaires every second year for the 15-year period from 1997\u20132012.", {"entities": []}], ["The Cohort represents a relatively large random sample (N = 2,230) of about 15% of the total population of women born between 1953\u201357 in the county of Hordaland.", {"entities": []}], ["Our data shows that the cohort population is very similar to the source population.", {"entities": []}], ["The baseline demographic, social and medical characteristics of the Cohort are compared with the rest of women in HUSK (N = 7,746) and there were no significant differences between them except for the level of education (P = 0.001) and yearly income (P = 0.018), which were higher in the Cohort population.", {"entities": []}], ["Urological characteristics of participants from the Cohort (N = 1,920) were also compared with the other participants (N = 3,400).", {"entities": []}], ["There were no significant statistical differences except for somewhat more urinary continence (P = 0.04), more stress incontinence (P = 0.048) and smaller amount of leakage (P = 0.015) in the Cohort.", {"entities": []}], ["In conclusion, the Cohort ispopulation-based, with little selection bias, and thus is a rather unique study forinvestigating UI and LUTS in comparison with many other projects with similar purposes.", {"entities": []}], ["There is a substantial body of evidence on the efficacy of yoga in the management of bronchial asthma.", {"entities": [[95, 101, "DISEASE"]]}], ["Many studies have reported, as the effects of yoga on bronchial asthma, significant improvements in pulmonary functions, quality of life and reduction in airway hyper-reactivity, frequency of attacks and medication use.", {"entities": [[64, 70, "DISEASE"]]}], ["In addition, a few studies have attempted to understand the effects of yoga on exercise-induced bronchoconstriction (EIB) or exercise tolerance capacity.", {"entities": []}], ["However, none of these studies has investigated any immunological mechanisms by which yoga improves these variables in bronchial asthma.", {"entities": [[129, 135, "DISEASE"]]}], ["The present randomized controlled trial (RCT) was conducted on 57 adult subjects with mild or moderate bronchial asthma who were allocated randomly to either the yoga (intervention) group (n = 29) or the wait-listed control group (n = 28).", {"entities": [[113, 119, "DISEASE"]]}], ["The control group received only conventional care and the yoga group received an intervention based on yoga, in addition to the conventional care.", {"entities": []}], ["The intervention consisted of 2-wk supervised training in lifestyle modification and stress management based on yoga followed by closely monitored continuation of the practices at home for 6-wk.", {"entities": []}], ["The outcome measures were assessed in both the groups at 0 wk (baseline), 2, 4 and 8 wk by using Generalized Linear Model (GLM) repeated measures followed by post-hoc analysis.", {"entities": []}], ["In the yoga group, there was a steady and progressive improvement in pulmonary function, the change being statistically significant in case of the first second of forced expiratory volume (FEV 1 ) at 8 wk, and peak expiratory flow rate (PEFR) at 2, 4 and 8 wk as compared to the corresponding baseline values.", {"entities": [[189, 192, "GENE"]]}], ["There was a significant reduction in EIB in the yoga group.", {"entities": []}], ["However, there was no corresponding reduction in the urinary prostaglandin D 2 metabolite (11\u03b2 prostaglandin F2\u03b1) levels in response to the exercise challenge.", {"entities": []}], ["There was also no significant change in serum eosinophilic cationic protein levels during the 8-wk study period in either group.", {"entities": []}], ["There was a significant improvement in Asthma Quality of Life (AQOL) scores in both groups over the 8-wk study period.", {"entities": [[39, 45, "DISEASE"]]}], ["But the improvement was achieved earlier and was more complete in the yoga group.", {"entities": []}], ["The number-needed-to-treat worked out to be 1.82 for the total AQOL score.", {"entities": []}], ["An improvement in total AQOL score was greater than the minimal important difference and the same outcome was achieved for the sub-domains of the AQOL.", {"entities": []}], ["The frequency of rescue medication use showed a significant decrease over the study period in both the groups.", {"entities": []}], ["However, the decrease was achieved relatively earlier and was more marked in the yoga group than in the control group.", {"entities": []}], ["The present RCT has demonstrated that adding the mind-body approach of yoga to the predominantly physical approach of conventional care results in measurable improvement in subjective as well as objective outcomes in bronchial asthma.", {"entities": [[227, 233, "DISEASE"]]}], ["The trial supports the efficacy of yoga in the management of bronchial asthma.", {"entities": [[71, 77, "DISEASE"]]}], ["However, the preliminary efforts made towards working out the mechanism of action of the intervention have not thrown much light on how yoga works in bronchial asthma.", {"entities": [[160, 166, "DISEASE"]]}], ["Current Controlled Trials ISRCTN00815962", {"entities": []}], ["The protozoan parasite Giardia intestinalis and the pathogenic bacterium Helicobacter pylori are well known for their high prevalences in human hosts worldwide.", {"entities": []}], ["The prevalence of both organisms is known to peak in densely populated, low resource settings and children are infected early in life.", {"entities": []}], ["Different Giardia genotypes/assemblages have been associated with different symptoms and H. pylori with induction of cancer.", {"entities": [[117, 123, "DISEASE"]]}], ["Despite this, not much data are available from sub-Saharan Africa with regards to the prevalence of different G. intestinalis assemblages and their potential association with H. pylori infections.", {"entities": []}], ["Fecal samples from 427 apparently healthy children, 0\u201312 years of age, living in urban Kampala, Uganda were analyzed for the presence of H. pylori and G. intestinalis .", {"entities": []}], ["G. intestinalis was found in 86 (20.1%) out of the children and children age 1<5 years had the highest rates of colonization.", {"entities": []}], ["H. pylori was found in 189 (44.3%) out of the 427 children and there was a 3-fold higher risk of concomitant G. intestinalis and H. pylori infections compared to non-concomitant G. intestinalis infection, OR\u200a=\u200a2.9 (1.7\u20134.8).", {"entities": []}], ["No significant association was found in the studied population with regard to the presence of Giardia and gender, type of toilet, source of drinking water or type of housing.", {"entities": []}], ["A panel of 45 G. intestinalis positive samples was further analyzed using multi-locus genotyping (MLG) on three loci, combined with assemblage-specific analyses.", {"entities": []}], ["Giardia MLG analysis yielded a total of five assemblage AII, 25 assemblage B, and four mixed assemblage infections.", {"entities": []}], ["The assemblage B isolates were highly genetically variable but no significant association was found between Giardia assemblage type and H. pylori infection.", {"entities": []}], ["This study shows that Giardia assemblage B dominates in children in Kampala, Uganda and that the presence of H. pylori is an associated risk factor for G. intestinalis infection.", {"entities": []}], ["G. intestinalis and H. pylori are known to infect the gastrointestinal tract of humans early in life and to be very prevalent in endemic areas throughout life.", {"entities": []}], ["H. pylori colonizes the gastric mucosa and may give rise to peptic ulcers, chronic gastritis and gastric cancer whereas Giardia causes diarrhea, bloating, flatulence and malnutrition.", {"entities": [[83, 92, "DISEASE"], [135, 143, "DISEASE"], [105, 111, "DISEASE"]]}], ["The genetic variability within G. intestinalis is high with two genotypes or assemblages (A and B) infecting humans.", {"entities": []}], ["These two different genetic types of humans have also been associated with differences in symptoms.", {"entities": []}], ["Here we have studied these two infections in non-symptomatic children in Kampala, Uganda.", {"entities": []}], ["H. pylori was found in 44% out of the 427 children and G. intestinalis was found in 20% with children age 3<6 years showing the highest rates of colonization.", {"entities": []}], ["The children were primarily infected with Giardia assemblage B parasites and Giardia infected children had a 3-fold higher risk of also having H. pylori infection.", {"entities": []}], ["However, this was independent of Giardia assemblage type.", {"entities": []}], ["This information will be important in the development of new control measures of these prevalent pathogens in Uganda and other low-income countries.", {"entities": []}], ["Cardiac autonomic modulation (CAM) is impaired in patients with stable COPD.", {"entities": []}], ["Exacerbation aggravates the patients\u2019 health status and functional capacity.", {"entities": []}], ["While the clinical and functional effects of exacerbation are known, no studies investigated CAM during exacerbation and whether there is a relationship between CAM and functional capacity and dyspnea.", {"entities": []}], ["Thirty-two patients with moderate to severe COPD were enrolled into two groups: stable COPD (GSta, n=16) and acute exacerbation of COPD (GAE, n=16).", {"entities": []}], ["The GAE patients were evaluated 24\u201348 hours after starting standard therapy for COPD exacerbation during hospitalization; the GSta patients were evaluated in an outpatient clinic and included in the study if no decompensation episodes had occurred during the previous month.", {"entities": []}], ["The heart rate (HR) and R-wave peak detection intervals in ms (RRi) were registered using a heart rate monitor (Polar GAE presented higher parasympathetic CAM values compared with GSta for square root of the mean squared differences of successive RRi (RMSSD; 17.8\u00b15.6 ms vs 11.7\u00b19.5 ms); high frequency (HF; 111.3\u00b174.9 ms r =\u22120.58; P =0.01) and between LF (ms r =\u22120.53; P =0.03).", {"entities": [[16, 18, "GENE"]]}], ["COPD exacerbated patients have higher parasympathetic CAM than stable patients.", {"entities": []}], ["This should be interpreted with caution since vagal influence on the airways determines a narrowing and not a better clinical condition.", {"entities": []}], ["Additionally, functional capacity was negatively associated with parasympathetic CAM in COPD exacerbation.", {"entities": []}], ["Cystic echinococcosis (CE), caused by infection with Echinococcus granulosus larvae, is a potentially life-threatening disease in humans.", {"entities": [[7, 21, "DISEASE"]]}], ["Anaphylactic shock caused by CE is very dangerous, and is highly prevalent during surgery.", {"entities": []}], ["Dexamethasone (DEX) is used clinically before operations to prevent allergic reactions; Regulatory T cells (Treg cells) are believed to be associated with negative immune response, which play an important role in alleviating allergic reactions.", {"entities": []}], ["However, the association of Treg cells with DEX remains unknown.", {"entities": []}], ["In this study, C57BL/6 mice were divided into uninfected group, untreated group and DEX group which were inoculated with protoscoleces from E. granulosus and sensitized using a cyst fluid suspension to induce anaphylactic shock.", {"entities": []}], ["In addition, the mice in DEX group were treated with 10\u00a0mg/kg DEX by intraperitoneal injection 30\u00a0min before being sensitized.", {"entities": []}], ["It was found that 93.75\u00a0% of all sensitized mice experienced allergic symptoms.", {"entities": []}], ["The levels of IgE, IgE/IgG, and IgE/IgG1 were significantly higher in both untreated group and DEX group.", {"entities": []}], ["The proportion of CD4\u2009+\u2009CD25\u2009+\u2009FOXP3\u2009+\u2009Treg cells relative to CD4+ Treg cells, and the levels of interleukin-10 (IL-10) and tumor growth factor-\u03b2 (TGF-\u03b21) were significantly higher in DEX group.", {"entities": [[18, 21, "GENE"], [62, 65, "GENE"], [31, 36, "GENE"]]}], ["The level of IL-13 was significantly higher in the sensitized mice than in the other groups.", {"entities": []}], ["These cells may play a key role in alleviating the immune response in CE-induced anaphylactic shock.", {"entities": []}], ["The protective effect of DEX may be due to Treg cell upregulating IL-10 and TGF-\u03b21 levels, and inhibiting helper T cell 2 cytokines.", {"entities": []}], ["Functional Neurology (FN), a seemingly attractive treatment approach used by some chiropractors, proposes to have an effect on a multitude of conditions but some of its concepts are controversial.", {"entities": []}], ["A scoping review was performed to describe, in the context of chiropractic manual therapy, 1) the FN theories, and 2) its clinical applications (i.e.", {"entities": []}], ["its indications, examination procedures, treatment modalities, treatment plans, and clinical outcomes) using four sources: i) one key textbook, ii) the scientific peer-reviewed literature, iii) websites from chiropractors using FN, and iv) semi-structured interviews of chiropractors using FN.", {"entities": []}], ["The scientific literature was searched in PubMed, PsycINFO, and SPORTDiscus, completed by a hand search in the journal Functional Neurology, Rehabilitation and Ergonomics (November 2016 and March 2017, respectively).", {"entities": []}], ["The only textbook on the topic we found was included and articles were chosen if they had an element of manual therapy.", {"entities": []}], ["There was no restriction for study design but discussion papers were excluded.", {"entities": []}], ["Websites were found in Google using the search term \u201cFunctional Neurology\u201d.", {"entities": []}], ["Chiropractors, known to use FN, were invited based on their geographical location.", {"entities": []}], ["Theories were mainly uncovered in the textbook as were all aspects of the clinical applications except treatment plans.", {"entities": []}], ["The other three sources were used for the five aspects of clinical applications.", {"entities": []}], ["Results were summarized and reported extensively in tables.", {"entities": []}], ["Eleven articles were included, five websites scrutinized, and four semi-structured interviews performed.", {"entities": []}], ["FN is based on the belief that reversible lesions in the nervous system are the cause of a multitude of conditions and that specific clusters of neurons can be positively affected by manipulative therapy, but also by many other stimuli.", {"entities": []}], ["Diagnostic procedures include both conventional and unusual tests, with an interpretation specific to FN.", {"entities": []}], ["Initial treatment is intense and clinical outcomes reported as positive.", {"entities": []}], ["FN gives the impression to be a complex alternative to the old variant of the chiropractic subluxation model, in which the vertebral subluxation is replaced by \u201cphysiological lesions\u201d of the brain, and the treatment, spinal adjustments, are complemented by various neurological stimuli.", {"entities": []}], ["Both models purport to treat not the symptoms but the cause.", {"entities": []}], ["We conclude there is a need for more scientific documentation on the validity of FN.", {"entities": []}], ["The online version of this article (doi:10.1186/s12998-017-0151-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Community-based approaches have been increasing in the effort to raise awareness and early detection for cancer and other chronic disease.", {"entities": [[105, 111, "DISEASE"]]}], ["However, many times, such interventions are tested in randomized trials, become evidence-based, and then fail to reach further use in the community.", {"entities": []}], ["Project HEAL (Health through Early Awareness and Learning) is an implementation trial that aims to compare two strategies of implementing evidence-based cancer communication interventions in African American faith-based organizations.", {"entities": [[153, 159, "DISEASE"]]}], ["This article describes the community-engaged process of transforming three evidence-based cancer communication interventions into a coherent, branded strategy for training community health advisors with two delivery mechanisms.", {"entities": [[90, 96, "DISEASE"]]}], ["Peer community health advisors receive training through either a traditional classroom approach (with high technical assistance/support) or a web-based training portal (with low technical assistance/support).", {"entities": []}], ["We describe the process, outline the intervention components, report on the pilot test, and conclude with lessons learned from each of these phases.", {"entities": []}], ["Though the pilot phase showed feasibility, it resulted in modifications to data collection protocols and team and community member roles and expectations.", {"entities": []}], ["Project HEAL offers a promising strategy to implement evidence-based interventions in community settings through the use of technology.", {"entities": []}], ["There could be wider implications for chronic disease prevention and control.", {"entities": []}], ["Prior studies have shown age-related macular degeneration (AMD) to be associated with falls.", {"entities": [[37, 57, "DISEASE"]]}], ["The purpose of this study is to determine if (AMD) and AMD-related vision loss are associated with fear of falling, an important and distinct outcome.", {"entities": []}], ["Sixty-five persons with AMD with evidence of vision loss in one or both eyes and 60 glaucoma suspects with normal vision completed the University of Illinois at Chicago Fear of Falling questionnaire.", {"entities": [[84, 92, "DISEASE"]]}], ["Responses were Rasch analyzed.", {"entities": []}], ["Scores were expressed in logit units, with lower scores demonstrating lesser ability and greater fear of falling.", {"entities": []}], ["Compared to glaucoma suspect controls, AMD subjects had worse visual acuity (VA) (median better-eye VA\u2009=\u200920/48 vs. 20/24, p\u2009<\u20090.001) and worse contrast sensitivity (CS) (binocular CS\u2009=\u20091.9 vs. 1.5 log units, p\u2009<\u20090.001).", {"entities": [[12, 20, "DISEASE"], [165, 167, "GENE"], [180, 182, "GENE"], [165, 167, "GENE"], [180, 182, "GENE"]]}], ["AMD subjects were also older, more likely to be Caucasian, and less likely to be employed (p\u2009<\u20090.05 for all), but were similar with regards to other demographic and health measures.", {"entities": []}], ["In multivariable models controlling for age, gender, body habitus, strength, and comorbid illnesses, AMD subjects reported greater fear of falling as compared to controls (\u03b2\u2009=\u2009-0.77 logits, 95% CI\u2009=\u2009-1.5 to -0.002, p\u2009=\u20090.045).", {"entities": []}], ["In separate multivariable models, fear of falling increased with worse VA (\u03b2\u2009=\u2009-0.15 logits/1 line decrement, 95% CI\u2009=\u2009-0.28 to -0.03, p\u2009=\u20090.02) and CS (\u03b2\u2009=\u2009-0.20 logits/0.1 log unit decrement, 95% CI\u2009=\u2009-0.31 to -0.09, p\u2009=\u20090.001).", {"entities": [[149, 151, "GENE"]]}], ["Greater fear of falling was also associated with higher BMI, weaker grip, and more comorbid illnesses (p\u2009<\u20090.05 for all).", {"entities": []}], ["AMD and AMD-related vision loss are associated with greater fear of falling in the elderly.", {"entities": []}], ["Development, validation, and implementation of methods to address falls and fear of falling for individuals with vision loss from AMD are important goals for future work.", {"entities": []}], ["Asbestos and related fibers are associated with a number of adverse health effects, including malignant mesothelioma (MM), an aggressive cancer that generally develops in the surface serosal cells of the pleural, pericardial, and peritoneal cavities.", {"entities": [[137, 143, "DISEASE"], [94, 116, "DISEASE"]]}], ["Although approximately 80% of individuals with MM are exposed to asbestos, fewer than 5% of asbestos workers develop MM.", {"entities": []}], ["In addition to asbestos, other mineralogical, environmental, genetic, and possibly viral factors might contribute to MM susceptibility.", {"entities": []}], ["Given this complex etiology of MM, understanding susceptibility to MM needs to be a priority for investigators in order to reduce exposure of those most at risk to known environmental carcinogens.", {"entities": []}], ["In this review, the current body of literature related to fiber-associated disease susceptibility including age, sex, nutrition, genetics, asbestos, and other mineral exposure is addressed with a focus on MM, and critical areas for further study are recommended.", {"entities": []}], ["\u2022 Bacterial respiratory tract infections have a strong association with worsening or increased severity of symptoms in asthma patients.", {"entities": [[119, 125, "DISEASE"]]}], ["\u2022 The asthma airway is characterized by an altered microbiota composition, compared with healthy individuals.", {"entities": [[6, 12, "DISEASE"]]}], ["\u2022 Microbial stimuli and the composition of the airway microbiota can contribute to the shaping of inflammatory responses seen in asthma.", {"entities": [[129, 135, "DISEASE"]]}], ["\u2022 Approaches to rapidly diagnose or modulate the microbiota associated with the asthmatic airway may represent powerful tools to improve disease prognosis.", {"entities": []}], ["Bacterial respiratory tract infections have a strong association with worsening or increased severity of symptoms in asthma patients.", {"entities": [[117, 123, "DISEASE"]]}], ["The asthma airway is characterized by an altered microbiota composition, compared with healthy individuals.", {"entities": [[4, 10, "DISEASE"]]}], ["Microbial stimuli and the composition of the airway microbiota can contribute to the shaping of inflammatory responses seen in asthma.", {"entities": [[127, 133, "DISEASE"]]}], ["Approaches to rapidly diagnose or modulate the microbiota associated with the asthmatic airway may represent powerful tools to improve disease prognosis.", {"entities": []}], ["During the past 50 years, the prevalence of asthma has increased and this has coincided with our changing relation with microorganisms.", {"entities": [[44, 50, "DISEASE"]]}], ["Asthma is a complex disease associated with local tissue inflammation of the airway that is determined by environmental, immunological, and host genetic factors.", {"entities": [[0, 6, "DISEASE"]]}], ["In a subgroup of sufferers, respiratory infections are associated with the development of chronic disease and more frequent inflammatory exacerbations.", {"entities": []}], ["Recent studies suggest that these infections are polymicrobial in nature.", {"entities": []}], ["Furthermore, there is increasing evidence that the recently discovered asthma airway microbiota may play a critical role in pathophysiological processes associated with the disease.", {"entities": [[71, 77, "DISEASE"]]}], ["Here, we discuss the current data regarding a possible role for infection in chronic asthma with a particular focus on the role bacteria may play.", {"entities": [[85, 91, "DISEASE"]]}], ["We discuss recent advances that are beginning to elucidate the complex relations between the microbiota and the immune response in asthma patients.", {"entities": [[131, 137, "DISEASE"]]}], ["We also highlight the clinical implications of these recent findings in regards to the development of novel therapeutic strategies.", {"entities": []}], ["Chlamydophila pneumoniae is a respiratory pathogen known to infect the upper and lower respiratory tracts.", {"entities": []}], ["Infection severity can range from sub-clinical pulmonary infection to acute respiratory distress syndrome.", {"entities": [[97, 105, "DISEASE"]]}], ["A previously healthy 62-year-old Caucasian man was admitted to our hospital for acute respiratory failure.", {"entities": [[86, 105, "DISEASE"]]}], ["Serum samples obtained every week starting from the day of admission showed clear-cut seroconversion for C. pneumoniae antibodies.", {"entities": []}], ["All other cultures obtained during the first days of hospitalization were negative.", {"entities": []}], ["Despite maximal ventilatory support (high positive end expiratory pressure, fraction of inspired oxygen of 1.0, nitric oxide inhalation, neuromuscular blocking agents and prone positioning), our patient remained severely hypoxemic, which led us to initiate an extracorporeal membrane oxygenation treatment.", {"entities": []}], ["Extracorporeal membrane oxygenation and hemodiafiltration were withdrawn on day 12.", {"entities": []}], ["Our patient was extubated on day 18 and discharged from our Intensive Care Unit on day 20.", {"entities": []}], ["He went home a month later.", {"entities": []}], ["We describe the first published case of acute respiratory distress syndrome due to C. pneumoniae infection successfully treated by extracorporeal membrane oxygenation, a very useful tool in this syndrome.", {"entities": [[67, 75, "DISEASE"], [195, 203, "DISEASE"]]}], ["A quick and specific method for the definite diagnosis of Chlamydophila infection should be developed.", {"entities": []}], ["MPS encompasses a group of rare lysosomal storage disorders that are associated with the accumulation of glycosaminoglycans (GAG) in organs and tissues.", {"entities": []}], ["This accumulation can lead to the progressive development of a variety of clinical manifestations.", {"entities": []}], ["Ear, nose, throat (ENT) and respiratory problems are very common in patients with MPS and are often among the first symptoms to appear.", {"entities": []}], ["Typical features of MPS include upper and lower airway obstruction and restrictive pulmonary disease, which can lead to chronic rhinosinusitis or chronic ear infections, recurrent upper and lower respiratory tract infections, obstructive sleep apnoea, impaired exercise tolerance, and respiratory failure.", {"entities": [[285, 304, "DISEASE"]]}], ["This review provides a detailed overview of the ENT and respiratory manifestations that can occur in patients with MPS and discusses the issues related to their evaluation and management.", {"entities": []}], ["The online version of this article (doi:10.1007/s10545-012-9555-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Vascular Ehlers\u2013Danlos syndrome (vEDS) is a rare autosomal dominant inherited collagen disorder caused by defects or deficiency of pro-alpha 1 chain of type III procollagen encoded by COL3A1 .", {"entities": [[23, 31, "DISEASE"], [184, 190, "GENE"]]}], ["vEDS is characterized not only by soft tissue manifestations including hyperextensibility of skin and joint hypermobility but also by early mortality due to rupture of arteries or vital organs.", {"entities": []}], ["Although pulmonary complications are not common, vEDS cases complicated by pneumothorax, hemothorax, or intrapulmonary hematoma have been reported.", {"entities": [[75, 87, "DISEASE"]]}], ["When a patient initially presents only with pulmonary complications, it is not easy for clinicians to suspect vEDS.", {"entities": []}], ["We report a case of an 18-year-old high school student, with a past history of cryptorchidism, presenting with recurrent pneumothorax.", {"entities": [[79, 93, "DISEASE"], [121, 133, "DISEASE"]]}], ["Routine laboratory findings were unremarkable.", {"entities": []}], ["Chest high resolution computed tomographic scan showed age-unmatched hyperinflation of both lungs, atypical cystic changes and multifocal ground glass opacities scattered in both lower lobes.", {"entities": []}], ["His slender body shape, hyperflexible joints, and hyperextensible skin provided clue to suspicion of a possible connective tissue disorder.", {"entities": []}], ["The histological examination of the lung lesions showed excessive capillary proliferation in the pulmonary interstitium and pleura allowing the diagnosis of pulmonary capillary hemangiomatosis (PCH)-like foci.", {"entities": []}], ["Genetic study revealed COL3A1 gene splicing site mutation confirming his diagnosis as vEDS.", {"entities": [[23, 29, "GENE"]]}], ["Although his diagnosis vEDS is notorious for fatal vascular complication, there was no evidence of such complication at presentation.", {"entities": []}], ["Fortunately, he has been followed up for 10 months without pulmonary or vascular complications.", {"entities": []}], ["To the best of our knowledge, both cryptorchidism and PCH-like foci have never been reported yet as complications of vEDS, suggesting our case might be a new variant of this condition.", {"entities": [[35, 49, "DISEASE"]]}], ["This case emphasizes the importance of comprehensive physical examination and history-taking, and the clinical suspicion of a possible connective tissue disorder when we encounter cases with atypical presentation and/or unique chest radiologic findings especially in young patients.", {"entities": []}], ["Obesity has become a major threat to public health and is accompanied by chronic low-grade inflammation, which leads to various pathological developments.", {"entities": [[0, 7, "DISEASE"]]}], ["Lunasin, a natural seed peptide, exhibits several biological activities, such as anti-carcinogenesis, anti-inflammatory, and antioxidant activities.", {"entities": []}], ["However, the mechanism of action of lunasin in obesity-related inflammation has not been investigated.", {"entities": [[47, 54, "DISEASE"]]}], ["The aim of this study was to explore whether lunasin could reduce the inflammation induced by obesity-related mediators in RAW264.7 cells and 3T3-L1 adipocytes and whether it could attenuate the crosstalk between the two cell lines.", {"entities": [[94, 101, "DISEASE"]]}], ["RAW264.7 cells were cultured in leptin-containing medium, adipocyte-conditioned medium (Ad-CM), or co-cultured with 3T3-L1 cells to mimic the physiology of obesity.", {"entities": [[156, 163, "DISEASE"]]}], ["The data showed that the secretion of pro-inflammatory cytokine interleukin-1\u03b2 (IL-1\u03b2) was inhibited by lunasin after leptin activation of RAW264.7 cells.", {"entities": []}], ["In addition, lunasin decreased monocyte chemoattractant protein-1 (MCP-1) and IL-1\u03b2 secretions in the Ad-CM model.", {"entities": []}], ["Cytokine MCP-1, IL-6, tumor necrosis factor (TNF)-\u03b1, and IL-1\u03b2 secretions were significantly decreased by leptin or Ad-CM plus lipopolysaccharide stimulation.", {"entities": [[45, 48, "GENE"]]}], ["Subsequently, the co-culture of the two cells refined the direct relation between them, resulting in apparently increased MCP-1, and decreased IL-6 levels after lunasin treatment.", {"entities": []}], ["In 3T3-L1 adipocytes, lunasin also exhibited anti-inflammatory property by inhibiting MCP-1, plasminogen activator inhibitor-1, and leptin productions stimulated by (TNF)-\u03b1, lipopolysaccharide, or RAW264.7 cell-conditioned medium.", {"entities": [[166, 169, "GENE"]]}], ["This result revealed that lunasin acts as a potential anti-inflammatory agent not only in macrophages but also in adipocytes, disrupting the crosstalk between these two cells.", {"entities": []}], ["Therefore, this study suggests the intake of lunasin from diet or as a supplement, for auxiliary prevention or therapy in obesity-related inflammatory applications.", {"entities": [[122, 129, "DISEASE"]]}], ["Inhibition of proapoptotic pathways in synovial fibroblasts is one of the major causes of synovial proliferation and hyperplasia in rheumatic diseases.", {"entities": []}], ["We have shown previously that NF-\u03baB inhibitor BAY 11-7085, through inactivation of PPAR-\u03b3, induces apoptosis in human synovial fibroblasts.", {"entities": []}], ["In this work we showed that BAY 11-7085 induced autophagy that preceded BAY 11-7085-induced apoptosis.", {"entities": []}], ["Of interest, BAY 11-7085 induced Serine 211 phosphorylation and degradation of glucocorticoid receptor (GR).", {"entities": []}], ["Glucocorticoid prednisolone induced both activation and degradation of GR, as well as autophagy in synovial fibroblasts.", {"entities": []}], ["BAY 11-7085-induced cell death was significantly decreased with glucocorticoid inhibitor mifepristone and with inhibitors of autophagy.", {"entities": []}], ["Both BAY 11-7085-induced autophagy and GR activation were down regulated with PPAR-\u03b3 agonist, 15d-PGJ2 and MEK/ERK inhibitor UO126.", {"entities": []}], ["Inhibition of autophagy markedly decreased endogenous and BAY 11-7085-induced ERK phosphorylation, suggesting a positive feed back loop between ERK activation and autophagy in synovial fibroblasts.", {"entities": []}], ["Co-transfection of MEK1 with PPAR-\u03b31 in HEK293 cells caused known inhibitory phosphorylation of PPAR-\u03b31 (Serine 112) and enhanced GR degradation, in the absence or presence of prednisolone.", {"entities": []}], ["Furthermore, GR was both phosphorylated on Serine 211 and down regulated in synovial fibroblasts during serum starvation induced autophagy.", {"entities": []}], ["These results showed that GR activation and PPAR-\u03b3 inactivation mediated BAY 11-7085-induced autophagy.", {"entities": []}], ["Asthma is often poorly controlled and guidelines are often inadequately followed in medical practice.", {"entities": [[0, 6, "DISEASE"]]}], ["In particular, the prescription of non-asthma-specific drugs can affect the quality of care.", {"entities": [[39, 45, "DISEASE"]]}], ["The goal of this study was to measure the frequency of the prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients and to look for associations between sex or age and the prescription of these drugs.", {"entities": []}], ["A cross-sectional study was conducted using computerised medical records from French and Italian general practitioners\u2019 networks.", {"entities": []}], ["Patients were selected according to criteria adapted from the HEDIS (Healthcare Effectiveness Data and Information Set) criteria.", {"entities": []}], ["The outcome measure was the number of antibiotics or anxiolytics/hypnotics prescriptions per patient in 1 year.", {"entities": []}], ["Parallel multivariate models were developed.", {"entities": []}], ["The final sample included 3,093 French patients (mean age 27.6 years, 49.7% women) and 3,872 Italian patients (mean age 29.1 years, 48.7% women).", {"entities": []}], ["In the univariate analysis, the French patients were prescribed fewer antibiotics than the Italian patients (37.1% vs. 42.2%, p\u2009<\u20090.00001) but more anxiolytics/hypnotics (17.8% vs. 6.9%, p\u2009<\u20090.0001).", {"entities": []}], ["In the multivariate models, the female patients were more likely to receive antibiotics (odds ratio: 1.5 [1.3\u20131.7]) and anxiolytics/hypnotics (odds ratio: 1.8 [1.5\u20132.1]).", {"entities": []}], ["The prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients is frequent, especially in women.", {"entities": []}], ["Asthma guidelines should address this issue by referring to other guidelines covering the prescription of non-asthma-specific drugs, and alternative non-pharmacological interventions should be considered.", {"entities": [[0, 6, "DISEASE"], [110, 116, "DISEASE"]]}], ["Tertiary lymphoid organs (TLOs) are organized aggregates of B and T cells formed in postembryonic life in response to chronic immune responses to infectious agents or self-antigens.", {"entities": []}], ["Although CD11c", {"entities": []}], ["Background: It is unknown whether habitual intake of dietary flavonoids, known for their antioxidative and anti-inflammatory properties, affects longitudinal change in lung function.", {"entities": []}], ["Objective: We investigated whether different flavonoid subclasses present in the habitual diet were associated with beneficial changes in lung function over time in the elderly.", {"entities": []}], ["Design: This longitudinal analysis included 839 participants from the VA (Veterans Affairs) Normative Aging Study whose lung function [forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC)] was measured at 2 and up to 5 visits between 1992 and 2008 ( n = 2623 measurements).", {"entities": [[168, 171, "GENE"]]}], ["Yearly average intake of major flavonoid subclasses (anthocyanins, flavanones, flavan-3-ols, flavonols, flavones, and polymers) was calculated from food-frequency questionnaires at each visit.", {"entities": []}], ["We estimated adjusted differences in annual change in lung function associated with each flavonoid subclass, categorized into quartiles, in linear mixed-effects regression models after adjustment for lifestyle and dietary confounders.", {"entities": []}], ["Results: Strong inverse associations were found between anthocyanin intake and age-related decline in lung function.", {"entities": []}], ["Independent of dietary and nondietary risk factors, slower rates of FEV 1 and FVC decline by 23.6 (95% CI: 16.6, 30.7) and 37.3 (95% CI: 27.8, 46.8) mL/y, respectively, were observed in participants in the fourth quartile of intake compared with participants in the first quartile ( P -trend < 0.0001).", {"entities": [[68, 71, "GENE"]]}], ["The protective associations observed for anthocyanin intake were present in both current/former and never smokers.", {"entities": []}], ["Compared with no or very low intakes, an intake of \u22652 servings of anthocyanin-rich blueberries/wk was associated with slower decline in FEV 1 and FVC by 22.5 (95% CI: 10.8, 34.2) and 37.9 (95% CI: 22.1, 53.7) mL/y, respectively.", {"entities": [[136, 139, "GENE"]]}], ["To a lesser extent, higher flavan-3-ol intake was also associated with slower lung function decline.", {"entities": []}], ["Conclusions: An attenuation of age-related lung function decline was associated with higher dietary anthocyanin intake in this longitudinal sample of predominantly elderly men.", {"entities": []}], ["Further prospective studies are needed to confirm these novel associations.", {"entities": []}], ["The importance of a properly functioning and well-balanced immune system for maintaining health has become strikingly evident over the past decades.", {"entities": []}], ["Roughly since World War II, there has been an apparent decrease in the prevalence of \u201ctraditional\u201d infectious diseases, with a concomitant increase in immune-related disorders, such as allergies.", {"entities": []}], ["Causally, a relationship with changes in life-style-related factors such as the increasing use of hygienic practices seems likely.", {"entities": []}], ["Diet and nutrition can affect the functioning of various immune parameters.", {"entities": []}], ["This concept can be utilised in attempts to prevent or mitigate allergic reactions via the development of targeted food products or ingredients.", {"entities": []}], ["This review describes recent findings with respect to food products and ingredients that show potential in this respect, with special emphasis on pro- and prebiotics, \u03b2-glucans and fungal immunomodulatory proteins.", {"entities": []}], ["What all of these approaches have in common is that they appear to strengthen Th1-mediated immunity, thus possibly restoring defective immune maturation due to overly hygienic living conditions: a little bit of dirt does not seem bad!", {"entities": []}], ["Work disability is a major personal, financial and public health burden.", {"entities": []}], ["Predicting future work success is a major focus of research.", {"entities": []}], ["To identify common prognostic factors for return-to-work across different health and injury conditions and to describe their association with return-to-work outcomes.", {"entities": []}], ["Medline, Embase, PsychINFO, Cinahl, and Cochrane Database of Systematic Reviews and the grey literature were searched from January 1, 2004 to September 1, 2013.", {"entities": []}], ["Systematic reviews addressing return-to-work in various conditions and injuries were selected.", {"entities": []}], ["Eligible studies were critically appraised using the Scottish Intercollegiate Guidelines Network criteria to identify low risk of bias reviews.", {"entities": []}], ["Of the 36,193 titles screened and the 94 eligible studies reviewed, 56 systematic reviews were accepted as low risk of bias.", {"entities": []}], ["Over half of these focused on musculoskeletal disorders, which were primarily spine related (e.g., neck and low back pain).", {"entities": []}], ["The other half of studies assessed workers with mental health or cardiovascular conditions, stroke, cancer, multiple sclerosis or other non-specified health conditions.", {"entities": [[108, 126, "DISEASE"], [100, 106, "DISEASE"]]}], ["Many factors have been assessed, but few consistently across conditions.", {"entities": []}], ["Common factors associated with positive return-to-work outcomes were higher education and socioeconomic status, higher self-efficacy and optimistic expectations for recovery and return-to-work, lower severity of the injury/illness, return-to-work coordination, and multidisciplinary interventions that include the workplace and stakeholders.", {"entities": []}], ["Common factors associated with negative return-to-work outcomes were older age, being female, higher pain or disability, depression, higher physical work demands, previous sick leave and unemployment, and activity limitations.", {"entities": []}], ["Expectations of recovery and return-to-work, pain and disability levels, depression, workplace factors, and access to multidisciplinary resources are important modifiable factors in progressing return-to-work across health and injury conditions.", {"entities": []}], ["Employers, healthcare providers and other stakeholders can use this information to facilitate return-to-work for injured/ill workers regardless of the specific injury or illness.", {"entities": []}], ["Future studies should investigate novel interventions, and other factors that may be common across health conditions.", {"entities": []}], ["To assess differences in outpatient costs among pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting.", {"entities": []}], ["A retrospective case control study over 3 years (2002-2004).", {"entities": []}], ["Data on 7128 depressed patients and 23772 non-depressed matched controls were available from the electronic medical record system of 20 general practices organized in one large primary care organization in the Netherlands.", {"entities": []}], ["A total of 393 depressed patients with diabetes and 494 non-depressed patients with diabetes were identified in these records.", {"entities": []}], ["The data that were extracted from the medical record system concerned only outpatient costs, which included GP care, referrals, and medication.", {"entities": []}], ["Mean total outpatient costs per year in depressed diabetes patients were \u20ac1039 (SD 743) in the period 2002-2004, which was more than two times as high as in non-depressed diabetes patients (\u20ac492, SD 434).", {"entities": []}], ["After correction for age, sex, type of insurance, diabetes treatment, and comorbidity, the difference in total annual costs between depressed and non-depressed diabetes patients changed from \u20ac408 (uncorrected) to \u20ac463 (corrected) in multilevel analyses.", {"entities": []}], ["Correction for comorbidity had the largest impact on the difference in costs between both groups.", {"entities": []}], ["Outpatient costs in depressed patients with diabetes are substantially higher than in non-depressed patients with diabetes even after adjusting for confounders.", {"entities": []}], ["Future research should investigate whether effective treatment of depression among diabetes patients can reduce health care costs in the long term.", {"entities": []}], ["Objectives .", {"entities": []}], ["To undertake a critical review describing key strategies supporting development of participatory research (PR) teams to engage partners for creation and translation of action-oriented knowledge.", {"entities": []}], ["Sources are four leading PR practitioners identified via bibliometric analysis.", {"entities": []}], ["Authors' publications were identified in January 1995\u2013October 2009 in PubMed, Embase, ISI Web of Science and CAB databases, and books.", {"entities": []}], ["Works were limited to those with a process description describing a research project and practitioners were first, second, third, or last author.", {"entities": []}], ["Adapting and applying the \u201c Reliability Tested Guidelines for Assessing Participatory Research Projects \u201d to retained records identified five key strategies: developing advisory committees of researchers and intended research users; developing research agreements; using formal and informal group facilitation techniques; hiring co-researchers/partners from community; and ensuring frequent communication.", {"entities": []}], ["Other less frequently mentioned strategies were also identified.", {"entities": []}], ["Conclusion .", {"entities": []}], ["This review is the first time these guidelines were used to identify key strategies supporting PR projects.", {"entities": []}], ["They proved effective at identifying and evaluating engagement strategies as reported by completed research projects.", {"entities": []}], ["Adapting these guidelines identified gaps where the tool was unable to assess fundamental PR elements of power dynamics, equity of resources, and member turnover.", {"entities": []}], ["Our resulting template serves as a new tool to measure partnerships.", {"entities": []}], ["Many patients with asthma have poorly controlled symptoms, and particularly for those with severe disease, there is a clear need for improved treatments.", {"entities": [[19, 25, "DISEASE"]]}], ["Two recent therapies licensed for use in asthma are omalizumab, a humanized monoclonal antibody that binds circulating IgE antibody, and bronchial thermoplasty, which involves the delivery of radio frequency energy to the airways to reduce airway smooth muscle mass.", {"entities": [[41, 47, "DISEASE"]]}], ["In addition, there are new therapies under development for asthma that have good potential to reach the clinic in the next five years.", {"entities": [[59, 65, "DISEASE"]]}], ["These include biological agents targeting pro-inflammatory cytokines such as interleukin-5 and interleukin-13, inhaled ultra long-acting \u03b2 2 -agonists and once daily inhaled corticosteroids.", {"entities": []}], ["In addition, drugs that block components of the arachidonic acid pathway that targets neutrophilic asthma and CRTH2 receptor antagonists that inhibit the proinflammatory actions of prostaglandin D 2 may become available.", {"entities": [[99, 105, "DISEASE"]]}], ["We review the recent progress made in developing viable therapies for severe asthma and briefly discuss the idea that development of novel therapies for asthma is likely to increasingly involve the assessment of genotypic and/or phenotypic factors.", {"entities": [[77, 83, "DISEASE"], [153, 159, "DISEASE"]]}], ["Clostridium difficile , the most commonly recognized diarrheagenic pathogen among hospitalized persons, can cause outpatient diarrhea.", {"entities": [[125, 133, "DISEASE"]]}], ["Of 1,091 outpatients with diarrhea, we found 43 (3.9%) who were positive for C. difficile toxin.", {"entities": [[26, 34, "DISEASE"]]}], ["Only 7 had no recognized risk factors, and 3 had neither risk factors nor co-infection with another enteric pathogen.", {"entities": []}], ["The research compared and contrasted hand-scoring and computerized methods of evaluating the grade level of patient education materials that are distributed at an academic medical center in east Tennessee and sought to determine if these materials adhered to the American Medical Association\u2019s (AMA\u2019s) recommended reading level of sixth grade.", {"entities": []}], ["Librarians at an academic medical center located in the heart of Appalachian Tennessee initiated the assessment of 150 of the most used printed patient education materials.", {"entities": []}], ["Based on the Flesch-Kincaid (F-K) scoring rubric, 2 of the 150 documents were excluded from statistical comparisons due to the absence of text (images only).", {"entities": []}], ["Researchers assessed the remaining 148 documents using the hand-scored Simple Measure of Gobbledygook (SMOG) method and the computerized F-K grade level method.", {"entities": []}], ["For SMOG, 3 independent reviewers hand-scored each of the 150 documents.", {"entities": []}], ["For F-K, documents were analyzed using Microsoft Word.", {"entities": []}], ["Reading grade levels scores were entered into a database for statistical analysis.", {"entities": []}], ["Inter-rater reliability was calculated using intra-class correlation coefficients (ICC).", {"entities": []}], ["Paired t -tests were used to compare readability means.", {"entities": []}], ["Acceptable inter-rater reliability was found for SMOG (ICC=0.95).", {"entities": []}], ["For the 148 documents assessed, SMOG produced a significantly higher mean reading grade level (M=9.6, SD=1.3) than F-K (M=6.5, SD=1.3; p <0.001).", {"entities": []}], ["Additionally, when using the SMOG method of assessment, 147 of the 148 documents (99.3%) scored above the AMA\u2019s recommended reading level of sixth grade.", {"entities": []}], ["Computerized health literacy assessment tools, used by many national patient education material providers, might not be representative of the actual reading grade levels of patient education materials.", {"entities": []}], ["This is problematic in regions like Appalachia because materials may not be comprehensible to the area\u2019s low-literacy patients.", {"entities": []}], ["Medical librarians have the potential to advance their role in patient education to better serve their patient populations.", {"entities": []}], ["MicroRNAs (miRNAs) can group together along the human genome to form stable secondary structures made of several hairpins hosting miRNAs in their stems.", {"entities": []}], ["The few known examples of such structures are all involved in cancer development.", {"entities": [[62, 68, "DISEASE"]]}], ["A large scale computational analysis of human chromosomes crossing sequence analysis and deep sequencing data revealed the presence of >400 structural clusters of miRNAs in the human genome.", {"entities": []}], ["An a posteriori analysis validates predictions as bona fide miRNAs.", {"entities": []}], ["A functional analysis of structural clusters position along the chromosomes co-localizes them with genes involved in several key cellular processes like immune systems, sensory systems, signal transduction and development.", {"entities": []}], ["Immune systems diseases, infectious diseases and neurodegenerative diseases are characterized by genes that are especially well organized around structural clusters of miRNAs.", {"entities": []}], ["Target genes functional analysis strongly supports a regulatory role of most predicted miRNAs and, notably, a strong involvement of predicted miRNAs in the regulation of cancer pathways.", {"entities": [[170, 176, "DISEASE"]]}], ["This analysis provides new fundamental insights on the genomic organization of miRNAs in human chromosomes.", {"entities": []}], ["In patients with acute hypercapnic respiratory failure (AHRF) during exacerbations of COPD, mortality can be high despite noninvasive ventilation (NIV).", {"entities": [[35, 54, "DISEASE"]]}], ["For some, AHRF is terminal and NIV is inappropriate.", {"entities": []}], ["However there is no definitive method of identifying patients who are unlikely to survive.", {"entities": []}], ["The aim of this study was to identify factors associated with inpatient mortality from AHRF with respiratory acidosis due to COPD.", {"entities": []}], ["COPD patients presenting with AHRF and who were treated with NIV were studied prospectively.", {"entities": []}], ["The forced expiratory volume in 1 second (FEV 1 ), World Health Organization performance status (WHO-PS), clinical observations, a composite physiological score (Early Warning Score), routine hematology and biochemistry, and arterial blood gases prior to commencing NIV, were recorded.", {"entities": [[42, 45, "GENE"]]}], ["In total, 65 patients were included for study, 29 males and 36 females, with a mean age of 71 \u00b1 10.5 years.", {"entities": []}], ["Inpatient mortality in the group was 33.8%.", {"entities": []}], ["Mortality at 30 days and 12 months after admission were 38.5% and 58.5%, respectively.", {"entities": []}], ["On univariate analysis, the variables associated with inpatient death were: WHO-PS \u2265 3, long-term oxygen therapy, anemia, diastolic blood pressure < 70 mmHg, Early Warning Score \u2265 3, severe acidosis (pH < 7.20), and serum albumin < 35 g/L.", {"entities": [[114, 120, "DISEASE"]]}], ["On multivariate analysis, only anemia and WHO-PS \u2265 3 were significant.", {"entities": [[31, 37, "DISEASE"]]}], ["The presence of both predicted 68% of inpatient deaths, with a specificity of 98%.", {"entities": []}], ["WHO-PS \u2265 3 and anemia are prognostic factors in AHRF with respiratory acidosis due to COPD.", {"entities": [[15, 21, "DISEASE"]]}], ["A combination of the two provides a simple method of identifying patients unlikely to benefit from NIV.", {"entities": []}], ["In our examinations, only 38 per cent.", {"entities": []}], ["of the infections of the respiratory tract below the glottis were pure, and this percentage was reached only by carefully following Kitasato's method of handling sputa.", {"entities": []}], ["Lobar pneumonia may produce sputum free from pneumococci, and may undoubtedly be caused by organisms other than thepneumococcus.", {"entities": [[6, 15, "DISEASE"]]}], ["There is found a marked yearly variation in the organisms which excite inflammation of the respiratory tract.", {"entities": []}], ["Micrococcus catarrhalis is usually considered a common secondary invader; but it may, and probably frequently does, assume pathogenic properties.", {"entities": []}], ["The goal of the current study was to examine the formation of phospholipids, 1-radyl-2-lysosn-glycero-phospholipids (lyso-PL) and 2- acetylated phospholipids (such as PAF) as well as mechanisms responsible for generating these phospholipids in bronchoalveolar lavage fluid (BAI.F) from allergic subjects challenged with antigen.", {"entities": []}], ["Bronchoalveolar lavage was performed in normal and allergic subjects before, 5-30 min, 6 h, and 20 h after segmental antigen challenge via a wedged bronchoscope.", {"entities": []}], ["Levels of 1-hexadecyl-2-lyso-phospholipids and 1- hexadecyl-2-acetyl-phospholipids were initially determined by negative ion chemical ionization gas chromatography/mass spectrometry (NICI- GC/MS).", {"entities": []}], ["Antigen dramatically elevated quantities of 1-hexadecyl-2-lyso- phospholipids in allergic subjects 20 h after challenge when compared to non-allergic controls.", {"entities": []}], ["In contrast, there was not a significant increase in levels of 1-hexadecyl-2-acetyl-phospholipids after antigen challenge.", {"entities": []}], ["Closer examination of 1-radyl-2-lyso-sn-glycero-3- phosphocholine (GPC) revealed that 1-palmitoyl-2-lyso-GPC, 1-myristoyl- 2-lyso-GPC and 1-hexadecyl-2-lyso-GPC were three major molecular species produced after antigen challenge.", {"entities": []}], ["1-palmitoyl-2-lyso-GPC increased sevenfold to levels of 222 +/- 75 ng/ml of BALF 20 h after antigen challenge.", {"entities": []}], ["The elevated levels of lyso-PL correlated with levels of albumin used to assess plasma exudation induced by allergen challenge.", {"entities": []}], ["In contrast, the time course of prostaglandin D2 (PGD2) or 9 alpha, 11 beta PGF2 (11 beta PGF2) formation did not correlate with lyso-PL generation.", {"entities": []}], ["To examine the mechanism leading to lyso- phospholipid formation in antigen-challenged allergic subjects, secretory phospholipase A2 (PI.A2) and acetyl hydrolase activities were measured.", {"entities": []}], ["There was a significant increase in PLA2 activity found in BALF of allergic subjects challenged with antigen when compared to saline controls.", {"entities": []}], ["This activity was neutralized by an antibody directed against low molecular mass, (14 kD) human synovial PLA2 and dithiothreitol.", {"entities": []}], ["Acetyl hydrolase activity also markedly increased in BALF obtained after antigen challenge.", {"entities": []}], ["This study indicates that high levels of lyso-PLs are present in airways of allergic subjects challenged with antigen and provides evidence for two distinct mechanisms that could induce lyso-PL formation.", {"entities": []}], ["Future studies will be necessary to determine the ramifications of these high levels of lyso- phospholipids on airway function.", {"entities": []}], ["Childhood maltreatment (CM) can increase the risk of adverse health consequences in adulthood.", {"entities": []}], ["A deeper insight in underlying biological pathways would be of high clinical relevance for early detection and intervention.", {"entities": []}], ["The untargeted investigation of all detectable metabolites and lipids in biological samples represents a promising new avenue to identify so far unknown biological pathways associated with CM.", {"entities": []}], ["Using an untargeted approach, liquid chromatography-mass spectrometry (LC-MS) was performed on peripheral blood serum samples collected three months postpartum from 105 women with varying degrees of CM exposure.", {"entities": []}], ["Comprehensive univariate and multivariate statistical analyses consistently identified eight biomarker candidates putatively belonging to antioxidant-, lipid-, and endocannabinoid-associated pathways, which differentiated between women with and without CM.", {"entities": []}], ["Classification algorithms allowed for clear prediction of the CM status with high accuracy scores (~80\u201390%).", {"entities": []}], ["Similar results were obtained when excluding all women with a lifetime psychiatric diagnosis.", {"entities": []}], ["In order to confirm the identities of these promising biomarker candidates, LC-MS/MS analysis was applied, confirming one of the metabolites as bilirubin IXa, a potent antioxidant with immunomodulatory properties.", {"entities": []}], ["In sum, our results suggest novel pathways that could explain long-term effects of CM on health and disease by influencing biological patterns associated with energy metabolism, inflammation, and oxidative stress.", {"entities": []}], ["While yoga is gaining increased popularity in North America and Europe, its safety has been questioned in the lay press.", {"entities": []}], ["The aim of this systematic review was to assess published case reports and case series on adverse events associated with yoga.", {"entities": []}], ["Medline/Pubmed, Scopus, CAMBase, IndMed and the Cases Database were screened through February 2013; and 35 case reports and 2 case series reporting a total of 76 cases were included.", {"entities": []}], ["Ten cases had medical preconditions, mainly glaucoma and osteopenia.", {"entities": [[44, 52, "DISEASE"]]}], ["Pranayama, hatha yoga, and Bikram yoga were the most common yoga practices; headstand, shoulder stand, lotus position, and forceful breathing were the most common yoga postures and breathing techniques cited.", {"entities": []}], ["Twenty-seven adverse events (35.5%) affected the musculoskeletal system; 14 (18.4%) the nervous system; and 9 (11.8%) the eyes.", {"entities": []}], ["Fifteen cases (19.7%) reached full recovery; 9 cases (11.3%) partial recovery; 1 case (1.3%) no recovery; and 1 case (1.3%) died.", {"entities": []}], ["As any other physical or mental practice, yoga should be practiced carefully under the guidance of a qualified instructor.", {"entities": []}], ["Beginners should avoid extreme practices such as headstand, lotus position and forceful breathing.", {"entities": []}], ["Individuals with medical preconditions should work with their physician and yoga teacher to appropriately adapt postures; patients with glaucoma should avoid inversions and patients with compromised bone should avoid forceful yoga practices.", {"entities": [[136, 144, "DISEASE"]]}], ["Treatment of acute (\u22643\u00a0weeks) acromioclavicular joint dislocation type III\u2013VI is still controversial.", {"entities": []}], ["Currently, the two modern techniques that are widely used are hook plate (HP) fixation and coracoclavicular ligament fixation using a suspensory loop device that consists of either a tightrope (single or double), endo-button (single or double), or synthetic ligament and absorbable polydioxansulfate sling.", {"entities": [[74, 76, "GENE"]]}], ["This systematic review was conducted according to the PRISMA guidelines.", {"entities": []}], ["Relevant studies that reported Constant-Murley score (CMS), Pain Visual Analog score (VAS) and postoperative complications of either technique were identified from Medline and Scopus from inception to 5 October 2015.", {"entities": []}], ["Sixteen studies were included for the analysis of HP fixation, and 25 studies were included for analysis of loop suspensory fixation (LSF).", {"entities": [[50, 52, "GENE"]]}], ["Pooling of mean CMS and VAS scores gave 90.35 (95% CI 87.16, 93.54), 1.51 (95% CI 0.73, 2) in the HP group, and 92.48 (95% CI 90.91, 94.05), 0.32 (95% CI 0, 0.64) in the suspensory loop devices group, respectively.", {"entities": [[98, 100, "GENE"]]}], ["The pooled unstandardized mean differences (UMD) scores of CMS and VAS in LSF were 2.13 (95% CI \u22121.43, 5.69) and \u22121.19 (95% CI \u22122.03, \u22120.35) when compared to hook plating.", {"entities": []}], ["The pooled prevalence of LSF and hook plating were 0.08 (95% CI 0.06, 0.10) and 0.05 (95% CI 0.02, 0.08) scores.", {"entities": []}], ["The chance of having complications in the LSF group was 1.69 (95% CI 1.07, 2.60), which was statistically significantly higher than in the HP group.", {"entities": [[139, 141, "GENE"]]}], ["LSF have higher shoulder function scores (CMS) and lower postoperative pain when compared to HP fixation; however, there are higher complication rates with LSF when compared to hook plating.", {"entities": [[93, 95, "GENE"]]}], ["The aim of this study was to investigate the effects of lithium on brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and glial cell line-derived neurotrophic factor (GDNF) expression in the hippocampus and on memory in experimental pneumococcal meningitis.", {"entities": [[264, 274, "DISEASE"], [102, 106, "GENE"], [130, 133, "GENE"], [185, 189, "GENE"]]}], ["The mood-stabilizer lithium is known as a neuroprotective agent with many effects on the brain.", {"entities": []}], ["In this study, animals received either artificial cerebrospinal fluid or Streptococcus pneumoniae suspension at a concentration of 5\u2009\u00d7\u200910", {"entities": []}], ["To define a population-level cohort of individuals infected with the human immunodeficiency virus (HIV) in the province of British Columbia from available registries and administrative datasets using a validated case-finding algorithm.", {"entities": []}], ["Individuals were identified for possible cohort inclusion from the BC Centre for Excellence in HIV/AIDS (CfE) drug treatment program (antiretroviral therapy) and laboratory testing datasets (plasma viral load (pVL) and CD4 diagnostic test results), the BC Centre for Disease Control (CDC) provincial HIV surveillance database (positive HIV tests), as well as databases held by the BC Ministry of Health (MoH); the Discharge Abstract Database (hospitalizations), the Medical Services Plan (physician billing) and PharmaNet databases (additional HIV-related medications).", {"entities": [[219, 222, "GENE"]]}], ["A validated case-finding algorithm was applied to distinguish true HIV cases from those likely to have been misclassified.", {"entities": []}], ["The sensitivity of the algorithms was assessed as the proportion of confirmed cases (those with records in the CfE, CDC and MoH databases) positively identified by each algorithm.", {"entities": []}], ["A priori hypotheses were generated and tested to verify excluded cases.", {"entities": []}], ["A total of 25,673 individuals were identified as having at least one HIV-related health record.", {"entities": []}], ["Among 9,454 unconfirmed cases, the selected case-finding algorithm identified 849 individuals believed to be HIV-positive.", {"entities": []}], ["The sensitivity of this algorithm among confirmed cases was 88%.", {"entities": []}], ["Those excluded from the cohort were more likely to be female (44.4% vs. 22.5%; p<0.01), had a lower mortality rate (2.18 per 100 person years (100PY) vs. 3.14/100PY; p<0.01), and had lower median rates of health service utilization (days of medications dispensed: 9745/100PY vs. 10266/100PY; p<0.01; days of inpatient care: 29/100PY vs. 98/100PY; p<0.01; physician billings: 602/100PY vs. 2,056/100PY; p<0.01).", {"entities": []}], ["The application of validated case-finding algorithms and subsequent hypothesis testing provided a strong framework for defining a population-level cohort of HIV infected people in BC using administrative databases.", {"entities": []}], ["This work was undertaken to delineate intracellular signaling pathways for the PDE4 inhibitor apremilast and to examine interactions between apremilast, methotrexate and adenosine A 2A receptors (A 2A R).", {"entities": []}], ["After apremilast and LPS incubation, intracellular cAMP, TNF-\u03b1, IL-10, IL-6 and IL-1\u03b1 were measured in the Raw264.7 monocytic murine cell line.", {"entities": []}], ["PKA, Epac1/2 (signaling intermediates for cAMP) and A 2A R knockdowns were performed by shRNA transfection and interactions with A2AR and A2BR, as well as with methotrexate were tested in vitro and in the murine air pouch model.", {"entities": []}], ["Statistical differences were determined using one or two-way ANOVA or Student\u2019s t test.", {"entities": []}], ["The alpha nominal level was set at 0.05 in all cases.", {"entities": []}], ["A P value of < 0.05 was considered significant.", {"entities": []}], ["In vitro , apremilast increased intracellular cAMP and inhibited TNF-\u03b1 release (IC 50 =104nM) and the specific A 2A R-agonist CGS21680 (1\u03bcM) increased apremilast potency (IC 50 =25nM).", {"entities": []}], ["In this cell line, apremilast increased IL-10 production.", {"entities": []}], ["PKA, Epac1 and Epac2 knockdowns prevented TNF-\u03b1 inhibition and IL-10 stimulation by apremilast.", {"entities": []}], ["In the murine air pouch model, both apremilast and MTX significantly inhibited leukocyte infiltration, while apremilast, but not MTX, significantly inhibited TNF-\u03b1 release.", {"entities": []}], ["The addition of MTX (1 mg/kg) to apremilast (5 mg/kg) yielded no more inhibition of leukocyte infiltration or TNF-\u03b1 release than with apremilast alone.", {"entities": []}], ["The immunoregulatory effects of apremilast appear to be mediated by cAMP through the downstream effectors PKA, Epac1, and Epac2.", {"entities": []}], ["A2AR agonism potentiated TNF-\u03b1 inhibition by apremilast, consistent with the cAMP-elevating effects of that receptor.", {"entities": []}], ["Because the A2AR is also involved in the anti-inflammatory effects of MTX, the mechanism of action of both drugs involves cAMP-dependent pathways and is therefore partially overlapping in nature.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-015-0771-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cysteinyl leukotriene (CysLT) is one of the proinflammatory mediators released by the bronchi during inflammation.", {"entities": []}], ["CysLTs exert their biological effects via specific G-protein-coupled receptors.", {"entities": []}], ["CysLT 1 receptor antagonists are available for clinical use for the treatment of asthma.", {"entities": [[81, 87, "DISEASE"]]}], ["Recently, crosstalk between CysLT 1 and P2Y 6 receptors has been delineated.", {"entities": []}], ["P2Y receptors are expressed in apical and/or basolateral membranes of virtually all polarized epithelia to control the transport of fluid and electrolytes.", {"entities": []}], ["Previous research suggests that CysLT 1 receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors.", {"entities": []}], ["However, the detailed molecular mechanism underlying the inhibition remains unresolved.", {"entities": []}], ["In this study, western blot analysis confirmed that both CysLT 1 and P2Y 6 receptors were expressed in the human bronchial epithelial cell line 16HBE14o-.", {"entities": []}], ["All three CysLT 1 antagonists inhibited the uridine diphosphate (UDP)-evoked I SC , but only montelukast inhibited the UDP-evoked [Ca i increase.", {"entities": []}], ["In the presence of forskolin or 8-bromoadenosine 3\u20325\u2032 cyclic monophosphate (8-Br-cAMP), the UDP-induced I SC was potentiated but was reduced by pranlukast and zafirlukast but not montelukast.", {"entities": []}], ["Pranlukast inhibited the UDP-evoked I SC potentiated by an Epac activator, 8-(4-Chlorophenylthio)-2\u2032-O-methyladenosine-3\u2032,5\u2032-cyclic monophosphate (8-CPT-2\u2032- O -Me-cAMP), while montelukast and zafirlukast had no such effect.", {"entities": []}], ["Pranlukast inhibited the real-time increase in cAMP changes activated by 8-CPT-2\u2032- O -Me-cAMP as monitored by fluorescence resonance energy transfer imaging.", {"entities": []}], ["Zafirlukast inhibited the UDP-induced I SC potentiated by N In summary, our data strongly suggest for the first time that in human airway epithelia, the three specific CysLT 1 receptor antagonists exert differential inhibitory effects on P2Y 6 receptor-coupled Ca I SC mediated by cAMP and Epac, leading to the modulation of ion transport activities across the epithelia.", {"entities": []}], ["The Bifibobacterium longum subsp.", {"entities": []}], ["longum 35624 Bifidobacterium longum subsp.", {"entities": []}], ["infantis ) is a well described probiotic with clinical efficacy in Irritable Bowel Syndrome clinical trials and induces immunoregulatory effects in mice and in humans.", {"entities": []}], ["This paper presents (a) the genome sequence of the organism allowing the assignment to its correct subspeciation longum ; (b) a comparative genome assessment with other B .", {"entities": []}], ["longum strains and (c) the molecular structure of the 35624 exopolysaccharide (EPS 624 ).", {"entities": []}], ["Comparative genome analysis of the 35624 strain with other B .", {"entities": []}], ["longum strains determined that the sub-speciation of the strain is longum and revealed the presence of a 35624 -specific gene cluster, predicted to encode the biosynthetic machinery for EPS 624 .", {"entities": []}], ["Following isolation and acid treatment of the EPS, its chemical structure was determined using gas and liquid chromatography for sugar constituent and linkage analysis, electrospray and matrix assisted laser desorption ionization mass spectrometry for sequencing and NMR.", {"entities": []}], ["The EPS consists of a branched hexasaccharide repeating unit containing two galactose and two glucose moieties, galacturonic acid and the unusual sugar 6-deoxy-L-talose.", {"entities": []}], ["These data demonstrate that the B .", {"entities": []}], ["longum 35624 strain has specific genetic features, one of which leads to the generation of a characteristic exopolysaccharide.", {"entities": []}], ["To assess the current health of the Deaf community in the UK and compare with the general population.", {"entities": []}], ["A quota sample of adult Deaf British Sign Language (BSL) users underwent a health assessment and interview in 2012\u20132013.", {"entities": []}], ["Comparative data were obtained from the Health Survey for England (HSE) 2011 and the Quality Outcomes Framework (QOF) 2012.", {"entities": []}], ["Participants completed a structured interview and health assessment at seven Bupa centres across the UK, supported in BSL by Deaf advisers and interpreters.", {"entities": []}], ["298 Deaf people, 20\u201382\u2005years old, 47% male, with 12% from ethnic minorities.", {"entities": []}], ["Self\u2013reported health conditions, medication usage, tobacco and alcohol consumption; measured blood pressure (BP), body mass index, fasting blood sugar and lipid profile.", {"entities": []}], ["Rates of obesity in the Deaf sample were high, especially in those over 65\u2005years, and 48% were in a high risk group for serious illness.", {"entities": [[9, 16, "DISEASE"]]}], ["High BP readings were obtained in 37% of Deaf people (21% in HSE): 29% were unaware of this (6% in HSE).", {"entities": []}], ["Only 42% of Deaf people being treated for hypertension had adequate control, compared with 62% of the general population.", {"entities": [[42, 54, "DISEASE"]]}], ["Deaf people with self-reported cardiovascular disease (CVD) were significantly less than the general population.", {"entities": []}], ["One-third of Deaf participants had total cholesterol >5\u2005mmol/L but although control rates were high compared with HSE, treatment rates for self-reported CVD were half the general population rate.", {"entities": []}], ["Eleven per cent of Deaf participants had blood sugar at prediabetic or diabetic levels, and 77% of those at prediabetic levels were unaware of it.", {"entities": []}], ["Deaf respondents self-reported more depression (31% of women, 14% of men), but less smoking (8%) and alcohol intake (2\u20138 units/week).", {"entities": []}], ["Deaf people's health is poorer than that of the general population, with probable underdiagnosis and undertreatment of chronic conditions putting them at risk of preventable ill health.", {"entities": []}], ["Deciphering the mechanisms regulating the generation of new neurons and new oligodendrocytes, the myelinating cells of the central nervous system, is of paramount importance to address new strategies to replace endogenous damaged cells in the adult brain and foster repair in neurodegenerative diseases.", {"entities": []}], ["Upon brain injury, the extracellular concentrations of nucleotides and cysteinyl-leukotrienes (cysLTs), two families of endogenous signaling molecules, are markedly increased at the site of damage, suggesting that they may act as \u201cdanger signals\u201d to alert responses to tissue damage and start repair.", {"entities": []}], ["Here we show that, in brain telencephalon, GPR17, a recently deorphanized receptor for both uracil nucleotides and cysLTs (e.g., UDP-glucose and LTD 4 ), is normally present on neurons and on a subset of parenchymal quiescent oligodendrocyte precursor cells.", {"entities": [[43, 48, "GENE"]]}], ["We also show that induction of brain injury using an established focal ischemia model in the rodent induces profound spatiotemporal-dependent changes of GPR17.", {"entities": [[71, 79, "DISEASE"], [153, 158, "GENE"]]}], ["In the lesioned area, we observed an early and transient up-regulation of GPR17 in neurons expressing the cellular stress marker heat shock protein 70.", {"entities": [[74, 79, "GENE"]]}], ["Magnetic Resonance Imaging in living mice showed that the in vivo pharmacological or biotechnological knock down of GPR17 markedly prevents brain infarct evolution, suggesting GPR17 as a mediator of neuronal death at this early ischemic stage.", {"entities": [[116, 121, "GENE"], [176, 181, "GENE"], [116, 121, "GENE"], [176, 181, "GENE"]]}], ["At later times after ischemia, GPR17 immuno-labeling appeared on microglia/macrophages infiltrating the lesioned area to indicate that GPR17 may also acts as a player in the remodeling of brain circuitries by microglia.", {"entities": [[21, 29, "DISEASE"], [31, 36, "GENE"], [135, 140, "GENE"], [31, 36, "GENE"], [135, 140, "GENE"]]}], ["At this later stage, parenchymal GPR17 in vitro exposure of cortical pre-oligodendrocytes to the GPR17 endogenous ligands UDP-glucose and LTD 4 promoted the expression of myelin basic protein, confirming progression toward mature oligodendrocytes.", {"entities": [[33, 38, "GENE"], [97, 102, "GENE"], [33, 38, "GENE"], [97, 102, "GENE"]]}], ["Thus, GPR17 may act as a \u201csensor\u201d that is activated upon brain injury on several embryonically distinct cell types, and may play a key role in both inducing neuronal death inside the ischemic core and in orchestrating the local remodeling/repair response.", {"entities": [[6, 11, "GENE"]]}], ["Specifically, we suggest GPR17 as a novel target for therapeutic manipulation to foster repair of demyelinating wounds, the types of lesions that also occur in patients with multiple sclerosis.", {"entities": [[174, 192, "DISEASE"], [25, 30, "GENE"]]}], ["Pesticides have been widely used to control pest and pest-related diseases in agriculture, fishery, forestry and the food industry.", {"entities": []}], ["In this review, we identify a number of respiratory symptoms and diseases that have been associated with occupational pesticide exposures.", {"entities": []}], ["Impaired lung function has also been observed among people occupationally exposed to pesticides.", {"entities": []}], ["There was strong evidence for an association between occupational pesticide exposure and asthma, especially in agricultural occupations.", {"entities": [[89, 95, "DISEASE"]]}], ["In addition, we found suggestive evidence for a link between occupational pesticide exposure and chronic bronchitis or COPD.", {"entities": [[105, 115, "DISEASE"]]}], ["There was inconclusive evidence for the association between occupational pesticide exposure and lung cancer.", {"entities": [[96, 107, "DISEASE"], [101, 107, "DISEASE"]]}], ["Better control of pesticide uses and enforcement of safety behaviors, such as using personal protection equipment (PPE) in the workplace, are critical for reducing the risk of developing pesticide-related symptoms and diseases.", {"entities": []}], ["Educational training programs focusing on basic safety precautions and proper uses of personal protection equipment (PPE) are possible interventions that could be used to control the respiratory diseases associated with pesticide exposure in occupational setting.", {"entities": []}], ["GLUCOCORTICOIDS are steroid hormones that strongly influence intermediary carbohydrate metabolism by increasing the transcription rate of glucose-6-phosphatase (G6Pase), a key enzyme of gluconeogenesis, and suppress the immune system through the glucocorticoid receptor (GR).", {"entities": []}], ["The liver X receptors (LXRs), on the other hand, bind to cholesterol metabolites, heterodimerize with the retinoid X receptor (RXR), and regulate the cholesterol turnover, the hepatic glucose metabolism by decreasing the expression of G6Pase, and repress a set of inflammatory genes in immune cells.", {"entities": []}], ["Since the actions of these receptors overlap with each other, we evaluated the crosstalk between the GR- and LXR-mediated signaling systems.", {"entities": []}], ["Transient transfection-based reporter assays and gene silencing methods using siRNAs for LXRs showed that overexpression/ligand (GW3965) activation of LXRs/RXRs repressed GR-stimulated transactivation of certain glucocorticoid response element (GRE)-driven promoters in a gene-specific fashion.", {"entities": []}], ["Activation of LXRs by GW3965 attenuated dexamethasone-stimulated elevation of circulating glucose in rats.", {"entities": []}], ["It also suppressed dexamethasone-induced mRNA expression of hepatic glucose-6-phosphatase (G6Pase) in rats, mice and human hepatoma HepG2 cells, whereas endogenous, unliganded LXRs were required for dexamethasone-induced mRNA expression of phosphoenolpyruvate carboxylase.", {"entities": []}], ["In microarray transcriptomic analysis of rat liver, GW3965 differentially regulated glucocorticoid-induced transcriptional activity of about 15% of endogenous glucocorticoid-responsive genes.", {"entities": []}], ["To examine the mechanism through which activated LXRs attenuated GR transcriptional activity, we examined LXR\u03b1/RXR\u03b1 binding to GREs.", {"entities": []}], ["Endogenous LXR\u03b1/RXR\u03b1 bound GREs and inhibited GR binding to these DNA sequences both in in vitro and in vivo chromatin immunoprecipitation assays, while their recombinant proteins did so on classic or G6Pase GREs in gel mobility shift assays.", {"entities": []}], ["We propose that administration of LXR agonists may be beneficial in glucocorticoid treatment- or stress-associated dysmetabolic states by directly and gene-specifically attenuating the transcriptional activity of the GR on glucose and/or lipid metabolism.", {"entities": []}], ["OBJECTIVE \u2014Cardiovascular disease (CVD) is prevalent and expensive.", {"entities": []}], ["While many interventions are recommended to prevent CVD, the potential effects of a comprehensive set of prevention activities on CVD morbidity, mortality, and costs have never been evaluated.", {"entities": []}], ["We therefore determined the effects of 11 nationally recommended prevention activities on CVD-related morbidity, mortality, and costs in the U.S. RESEARCH DESIGN AND METHODS \u2014We used person-specific data from a representative sample of the U.S. population (National Health and Nutrition Education Survey IV) to determine the number and characteristics of adults aged 20\u201380 years in the U.S. today who are candidates for different prevention activities related to CVD.", {"entities": []}], ["We used the Archimedes model to create a simulated population that matched the real U.S. population, person by person.", {"entities": []}], ["We then used the model to simulate a series of clinical trials that examined the effects over the next 30 years of applying each prevention activity one by one, or altogether, to those who are candidates for the various activities and compared the health outcomes, quality of life, and direct medical costs to current levels of prevention and care.", {"entities": []}], ["We did this under two sets of assumptions about performance and compliance: 100% success for each activity and lower levels of success considered aggressive but still feasible.", {"entities": []}], ["RESULTS \u2014Approximately 78% of adults aged 20\u201380 years alive today in the U.S. are candidates for at least one prevention activity.", {"entities": []}], ["If everyone received the activities for which they are eligible, myocardial infarctions and strokes would be reduced by \u223c63% and 31%, respectively.", {"entities": []}], ["If more feasible levels of performance are assumed, myocardial infarctions and strokes would be reduced \u223c36% and 20%, respectively.", {"entities": []}], ["Implementation of all prevention activities would add \u223c221 million life-years and 244 million quality-adjusted life-years to the U.S. adult population over the coming 30 years, or an average of 1.3 years of life expectancy for all adults.", {"entities": []}], ["Of the specific prevention activities, the greatest benefits to the U.S. population come from providing aspirin to high-risk individuals, controlling pre-diabetes, weight reduction in obese individuals, lowering blood pressure in people with diabetes, and lowering LDL cholesterol in people with existing coronary artery disease (CAD).", {"entities": []}], ["As currently delivered and at current prices, most prevention activities are expensive when considering direct medical costs; smoking cessation is the only prevention strategy that is cost-saving over 30 years.", {"entities": []}], ["CONCLUSIONS \u2014Aggressive application of nationally recommended prevention activities could prevent a high proportion of the CAD events and strokes that are otherwise expected to occur in adults in the U.S. today.", {"entities": []}], ["However, as they are currently delivered, most of the prevention activities will substantially increase costs.", {"entities": []}], ["If preventive strategies are to achieve their full potential, ways must be found to reduce the costs and deliver prevention activities more efficiently.", {"entities": []}], ["In protein-coding genes, synonymous mutations are often thought not to affect fitness and therefore are not subject to natural selection.", {"entities": []}], ["Yet increasingly, cases of non-neutral evolution at certain synonymous sites were reported over the last decade.", {"entities": []}], ["To evaluate the extent and the nature of site-specific selection on synonymous codons, we computed the site-to-site synonymous rate variation (SRV) and identified gene properties that make SRV more likely in a large database of protein-coding gene families and protein domains.", {"entities": []}], ["To our knowledge, this is the first study that explores the determinants and patterns of the SRV in real data.", {"entities": []}], ["We show that the SRV is widespread in the evolution of protein-coding sequences, putting in doubt the validity of the synonymous rate as a standard neutral proxy.", {"entities": []}], ["While protein domains rarely undergo adaptive evolution, the SRV appears to play important role in optimizing the domain function at the level of DNA.", {"entities": []}], ["In contrast, protein families are more likely to evolve by positive selection, but are less likely to exhibit SRV.", {"entities": []}], ["Stronger SRV was detected in genes with stronger codon bias and tRNA reusage, those coding for proteins with larger number of interactions or forming larger number of structures, located in intracellular components and those involved in typically conserved complex processes and functions.", {"entities": []}], ["Genes with extreme SRV show higher expression levels in nearly all tissues.", {"entities": []}], ["This indicates that codon bias in a gene, which often correlates with gene expression, may often be a site-specific phenomenon regulating the speed of translation along the sequence, consistent with the co-translational folding hypothesis.", {"entities": []}], ["Strikingly, genes with SRV were strongly overrepresented for metabolic pathways and those associated with several genetic diseases, particularly cancers and diabetes.", {"entities": []}], ["This study was a prospective cross-sectional cohort study of 125 patients with sickle cell anemia (SS) between the ages of 16 to 60 years.", {"entities": [[79, 97, "DISEASE"], [91, 97, "DISEASE"]]}], ["Enrolled patients were followed-up prospectively for 15 months.", {"entities": []}], ["Demographic, clinical, hematological and routine biochemical data were obtained on all patients.", {"entities": []}], ["Six-minute walk test and Doppler Echocardiography were performed on all patients.", {"entities": []}], ["A tricuspid regurgitant jet velocity (TRJV) < 2.5 m/sec was considered normal, 2.5 \u2264 TRJV \u2264 3.0 was considered mild-moderate and > 3.0 m/sec, severe.", {"entities": []}], ["Patients with abnormal TRJV were significantly older and more anemic, had significantly higher lactate dehydrogenase (LDH) levels, reticulocyte count and incidence of death.", {"entities": []}], ["The logistic multimodal model implemented for the 125 patients indicated that age was the covariate that influenced the outcome of normal or abnormal TRJV with a cutoff age of thirty-two years.", {"entities": []}], ["The survival rate for the group of patients with creatinine (Cr) > 1.0 mg/dL was lower than the group with Cr \u2264 1 and normal TRJV.", {"entities": []}], ["A coefficient matrix showed that the LDH values were weakly correlated with the reticulocyte count but strongly correlated with hemoglobin suggesting that the TRJV values were not correlated with the hemolytic rate but with anemia.", {"entities": [[224, 230, "DISEASE"]]}], ["Ten patients died during the follow-up of whom 7 had TRJV > 2.5 m/sec.", {"entities": []}], ["Acute chest syndrome was the most common cause of death followed by sepsis.", {"entities": [[12, 20, "DISEASE"]]}], ["In conclusion, this study shows that patients with SS older than thirty-two years with high LDH, elevated TRJV, severe anemia and Cr > 1 have poor prognosis and may be at risk of having pulmonary hypertension and should undergo RHC.", {"entities": [[196, 208, "DISEASE"], [186, 208, "DISEASE"], [119, 125, "DISEASE"]]}], ["Multimorbidity, that is, the coexistence of chronic diseases, is associated with mental health issues among elderly people.", {"entities": []}], ["In Sweden, seniors with multimorbidity often live at home and receive care from nursing aides and district nurses.", {"entities": []}], ["The aim of this study was to describe the variation in how community-dwelling seniors with multimorbidity perceive the concept of mental health and what may influence it.", {"entities": []}], ["Thirteen semi-structured interviews were analysed using a phenomenographic approach.", {"entities": []}], ["Six qualitatively different ways of understanding the concept of mental health and factors that may influence it, reflecting key variations of meaning, were identified.", {"entities": []}], ["The discerned categories were: mental health is dependent on desirable feelings and social contacts, mental health is dependent on undesirable feelings and social isolation, mental health is dependent on power of the mind and ability to control thoughts, mental health is dependent on powerlessness of the mind and inability to control thoughts, mental health is dependent on active behaviour and a healthy lifestyle, and mental health is dependent on passive behaviour and physical inactivity.", {"entities": []}], ["According to the respondents\u2019 view, the concept of mental health can be defined as how an individual feels, thinks, and acts and also includes a positive as well as a negative aspect.", {"entities": []}], ["Social contacts, physical activity, and optimism may improve mental health while social isolation, ageing, and chronic pain may worsen it.", {"entities": []}], ["Findings highlight the importance of individually definitions of mental health and that community-dwelling seniors with multimorbidity may describe how multiple chronic conditions can affect their life situation.", {"entities": []}], ["It is essential to organize the health care system to provide individual health promotion dialogues, and future research should address the prerequisites for conducting mental health promotion dialogues.", {"entities": []}], ["Promoting and supporting smoking reduction in smokers with no immediate intention of stopping smoking is controversial given existing fears that this will deter cessation and that reduction itself may not improve health outcomes.", {"entities": []}], ["Evidence shows that smokers who reduce the number of daily cigarettes smoked are more likely to attempt and actually achieve smoking cessation.", {"entities": []}], ["Further, clinical trials have shown that nicotine replacement therapy benefits both reduction and cessation.", {"entities": []}], ["Worldwide data suggests that \u2018non-medical\u2019 nicotine is more attractive to people who smoke, with electronic cigarettes now being widely used.", {"entities": []}], ["Nevertheless, only one small trial has examined the use of electronic cigarettes to promote reduction, with direct evidence remaining inconclusive.", {"entities": []}], ["It has been suggested that long-term reduced smoking may directly benefit health, although the benefits are small compared with cessation.", {"entities": []}], ["The combined data imply that smoking reduction is a promising intervention, particularly when supported by clean nicotine; however, the benefits are only observed when it leads to permanent cessation.", {"entities": []}], ["Common mental health problems are mainly treated in primary care settings and collaboration with mental health services is needed.", {"entities": []}], ["Prior to re-organisation of the mental health care offer in a geographical area, a study was organized: 1) to evaluate GPs' opinions on their day-to-day practice with Patients with Mental Health Problems (PMHP) and on relationships with Mental Health Professionals (MHPro); 2) to identify factors associated with perceived need for collaboration with MHPro and with actual collaboration.", {"entities": []}], ["All GPs in the South Yvelines area in France (n = 492) were informed of the implementation of a local mental health program.", {"entities": []}], ["GPs interested in taking part (n = 180) were invited to complete a satisfaction questionnaire on their practice in the field of Mental Health and to include prospectively all PMHP consultants over an 8-day period (n = 1519).", {"entities": []}], ["For each PMHP, data was collected on demographic and clinical profile, and on needs (met v. unmet) for collaboration with MHPro.", {"entities": []}], ["A majority of GPs rated PMHP as requiring more care (83.4%), more time (92.3%), more frequent consultations (64.0%) and as being more difficult to refer (87.7%) than other patients.", {"entities": []}], ["A minority of GPs had a satisfactory relationship with private psychiatrists (49.5%), public psychiatrists (35%) and social workers (27.8%).", {"entities": []}], ["53.9% had a less satisfactory relationship with MHPro than with other physicians.", {"entities": []}], ["Needs for collaboration with a MHPro were more often felt in caring for PMHP who were young, not in employment, with mental health problems lasting for more than one year, with a history of psychiatric hospitalization, and showing reluctance to talk of psychological problems and to consult a MHPro.", {"entities": []}], ["Needs for collaboration were more often met among PMHP with past psychiatric consultation or hospitalization and when the patient was not reluctant to consult a MHPro.", {"entities": []}], ["Where needs were not met, GP would opt for the classic procedure of mental health referral for only 31.3% of their PMHP.", {"entities": []}], ["GPs need targeted collaboration with MHPro to support their management of PMHP, whom they are willing to care for without systematic referral to specialists as the major therapeutic option.", {"entities": []}], ["The well-known genetic polymorphisms in ADH1B(His47Arg) and ALDH2(Glu487Lys) have dramatic effects on the rate of metabolizing alcohol and acetaldehyde.", {"entities": [[40, 45, "GENE"], [60, 65, "GENE"]]}], ["We investigated possible involvement of these functional polymorphisms in other common complex-trait diseases.", {"entities": []}], ["The genetic effects of these two polymorphisms on hepatitis, asthma, type-2 diabetes mellitus (T2DM), and tuberculosis (TB) were examined in a Korean population.", {"entities": [[106, 118, "DISEASE"], [50, 59, "DISEASE"], [61, 67, "DISEASE"], [76, 93, "DISEASE"]]}], ["We demonstrated that the well-known functional polymorphism of a primary alcohol-metabolizing enzyme (ALDH2 Glu487Lys) has a strong genetic association with the risk of TB.", {"entities": [[102, 107, "GENE"]]}], ["The frequency of the minor allele (ALDH2*487Lys) was found to be much lower in TB patients (freq.", {"entities": []}], ["=\u20090.099/n\u2009=\u2009477) than among controls (freq.", {"entities": []}], ["=\u20090.162/n\u2009=\u2009796) (P\u2009=\u20090.00001, OR (95% confidential interval)\u2009=\u20090.57 (0.45-0.74)).", {"entities": []}], ["Our data may indicate that TB was once an endemic disease, which exerted selection pressure for higher frequencies of ALDH2*487Lys in Asian populations.", {"entities": []}], ["In addition, the calculated attributable fraction (AF) indicates that 39.5% of TB patients can attribute their disease to the detrimental effects of ALDH2Glu487Glu.", {"entities": []}], ["Our results suggest that this polymorphism is one of the genetic components of TB, at least in the Korean population.", {"entities": []}], ["Signaling through the beta-2 adrenergic receptor (B2AR) on the osteoblast influences bone remodeling in rodents.", {"entities": []}], ["In the B2AR gene, three polymorphisms influence receptor function.", {"entities": []}], ["We show that these polymorphisms are not associated with fracture risk or bone mineral density in the UCP, Rotterdam Study, and GEFOS cohorts.", {"entities": []}], ["Signaling through the beta-2 adrenergic receptor (B2AR) on the osteoblast influences bone remodeling in rodents.", {"entities": []}], ["In the B2AR gene, three polymorphisms are known to influence receptor function in vitro and in vivo (rs1042713, rs1042714, and rs1800888).", {"entities": []}], ["We examined the role of these polymorphisms in the B2AR gene on human bone metabolism.", {"entities": []}], ["We performed nested case\u2013control studies to determine the association of these polymorphisms with fracture risk in the Utrecht Cardiovascular Pharmacogenetics (UCP) cohort and in three cohorts of the Rotterdam Study.", {"entities": []}], ["We also determined the association of these polymorphisms with bone mineral density (BMD) in the GEFOS Consortium.", {"entities": []}], ["UCP contains drug-dispensing histories from community pharmacies linked to national registrations of hospital discharges in the Netherlands.", {"entities": []}], ["The Rotterdam Study is a prospective cohort study investigating demographics and risk factors of chronic diseases.", {"entities": []}], ["GEFOS is a large international collaboration studying the genetics of osteoporosis.", {"entities": [[70, 82, "DISEASE"]]}], ["Fractures were defined by ICD-9 codes 800\u2013829 in the UCP cohort (158 cases and 2617 unmatched controls) and by regular X-ray examinations, general practitioner, and hospital records in the Rotterdam Study (2209 cases and 8559 unmatched controls).", {"entities": []}], ["BMD was measured at the femoral neck and lumbar spine using dual-energy X-ray absorptiometry in GEFOS ( N \u2009=\u200932,961).", {"entities": []}], ["Meta-analysis of the two nested case\u2013control studies showed pooled odds ratios of 0.98 (0.91\u20131.05, p \u2009=\u20090.52), 1.04 (0.97\u20131.12, p \u2009=\u20090.28), and 1.16 (0.83\u20131.62, p \u2009=\u20090.38) for the associations between rs1042713, rs1042714, and rs1800888 per minor allele and fractures, respectively.", {"entities": []}], ["There were no significant associations of the polymorphisms and BMD in GEFOS.", {"entities": []}], ["In conclusion, polymorphisms in the beta-2 adrenergic receptor gene are not associated with fracture risk or BMD.", {"entities": []}], ["Decision support systems for differential diagnosis have traditionally been evaluated on the basis of criteria how sensitively and specifically they are able to identify the correct diagnosis established by expert clinicians.", {"entities": []}], ["This article questions whether evaluation criteria pertaining to identifying the correct diagnosis are most appropriate or useful.", {"entities": []}], ["Instead it advocates evaluation of decision support systems for differential diagnosis based on the criterion of maximizing value of information.", {"entities": []}], ["This approach quantitatively and systematically integrates several important clinical management priorities, including avoiding serious diagnostic errors of omission and avoiding harmful or expensive tests.", {"entities": []}], ["Metabolomics-genome-wide association studies (mGWAS) have uncovered many metabolic quantitative trait loci (mQTLs) influencing human metabolic individuality, though predominantly in European cohorts.", {"entities": []}], ["By combining whole-exome sequencing with a high-resolution metabolomics profiling for a highly consanguineous Middle Eastern population, we discover 21 common variant and 12 functional rare variant mQTLs, of which 45% are novel altogether.", {"entities": []}], ["We fine-map 10 common variant mQTLs to new metabolite ratio associations, and 11 common variant mQTLs to putative protein-altering variants.", {"entities": []}], ["This is the first work to report common and rare variant mQTLs linked to diseases and/or pharmacological targets in a consanguineous Arab cohort, with wide implications for precision medicine in the Middle East.", {"entities": []}], ["Blood metabolites are influenced by a combination of genetic and environmental factors.", {"entities": []}], ["Here, Yousri and colleagues perform a whole-exome sequencing study in combination with a metabolomics analysis to identify metabolic quantitative trait loci in a Middle Eastern population.", {"entities": []}], ["A worker with occupational exposure to aluminum powder developed asthmatic symptoms three years and six months after starting work.", {"entities": []}], ["Skin tests (prick and intradermal) to aluminum chloride (AlCl 3 ) were negative.", {"entities": []}], ["Inhalation challenge test with 10 mg of aluminum powder and 10 mg/ml of AlCl 3 solution induced an early asthmatic response.", {"entities": []}], ["Sodium cromoglycate pre-treatment reduced AlCl 3 -induced bronchoconstriction.", {"entities": []}], ["Neutrophil chemotactic activity was markedly increased one and seven hours after the challenge procedure, which was lessened with sodium cromoglycate pre-treatment.", {"entities": []}], ["Aluminum can induce occupational asthma in exposed worker, which may be mediated by a non-immunologic mechanism and the possible role of neutrophils was suggested.", {"entities": [[33, 39, "DISEASE"]]}], ["Fibrosis is a debilitating condition that can lead to impairment of the affected organ's function.", {"entities": []}], ["Excessive deposition of extracellular matrix (ECM) molecules is characteristic of most fibrotic tissues.", {"entities": []}], ["Fibroblasts activated by cytokines or growth factors differentiate into myofibroblasts that drive fibrosis by depositing ECM molecules, such as collagen, fibronectin, and connective tissue growth factor.", {"entities": []}], ["Transforming growth factor- \u03b2 (TGF- \u03b2 ) is one of the major profibrotic cytokines which promotes fibrosis by signaling abnormal ECM regulation.", {"entities": []}], ["Hyaluronan (HA) is a major ECM glycosaminoglycan that is regulated by TGF- \u03b2 and whose role in fibrosis is emerging.", {"entities": []}], ["Aside from its role as a hydrating, space filling polymer, HA regulates different cellular functions and is known to have a role in wound healing and inflammation.", {"entities": []}], ["Importantly, HA deposition is increased in multiple fibrotic diseases.", {"entities": []}], ["In this review we highlight studies that link HA to fibrosis and discuss what is known about the role of HA, its receptors, and its anabolic and catabolic enzymes in different fibrotic diseases.", {"entities": []}], ["The airway epithelium is a broad interface with the environment, mandating well-orchestrated responses to properly modulate inflammation.", {"entities": []}], ["Classically, autophagy is a homeostatic pathway triggered in response to external cellular stresses, and is elevated in chronic airway diseases.", {"entities": []}], ["Recent findings highlight the additional role of autophagy in vesicle trafficking and protein secretion, implicating autophagy pathways in complex cellular responses in disease.", {"entities": []}], ["Th2 cytokines, IL-13 and IL-4, are increased in asthma and other airway diseases contributing to chronic inflammation.", {"entities": [[48, 54, "DISEASE"]]}], ["Previously, we observed that IL-13 increases reactive oxygen species (ROS) in airway epithelial cells in an autophagy-dependent fashion.", {"entities": []}], ["Here, we tested our hypothesis that autophagy is required for IL-13-mediated superoxide production via the NADPH oxidase DUOX1.", {"entities": [[121, 126, "GENE"]]}], ["Using a mouse model of Th2-mediated inflammation induced by OVA-allergen, we observed elevated lung amounts of IL-13 and IL-4 accompanied by increased autophagosome levels, determined by LC3BII protein levels and immunostaining.", {"entities": []}], ["ROS levels were elevated and DUOX1 expression was increased 70-fold in OVA-challenged lungs.", {"entities": [[29, 34, "GENE"]]}], ["To address the role of autophagy and ROS in the airway epithelium, we treated primary human tracheobronchial epithelial cells with IL-13 or IL-4.", {"entities": []}], ["Prolonged, 7-day treatment increased autophagosome formation and degradation, while brief activation had no effect.", {"entities": []}], ["Under parallel culture conditions, IL-13 and IL-4 increased intracellular superoxide levels as determined by electron paramagnetic resonance (EPR) spectroscopy.", {"entities": []}], ["Prolonged IL-13 activation increased DUOX1, localized at the apical membrane.", {"entities": [[37, 42, "GENE"]]}], ["Silencing DUOX1 by siRNA attenuated IL-13-mediated increases in superoxide, but did not reduce autophagy activities.", {"entities": [[10, 15, "GENE"]]}], ["Notably, depletion of autophagy regulatory protein ATG5 significantly reduced superoxide without diminishing total DUOX1 levels.", {"entities": [[51, 55, "GENE"], [115, 120, "GENE"]]}], ["Depletion of ATG5, however, diminished DUOX1 localization at the apical membrane.", {"entities": [[13, 17, "GENE"], [39, 44, "GENE"]]}], ["The findings suggest non-canonical autophagy activity regulates DUOX1-dependent localization required for intracellular superoxide production during Th2 inflammation.", {"entities": []}], ["Thus, in chronic Th2 inflammatory airway disease, autophagy proteins may be responsible for persistent intracellular superoxide production.", {"entities": []}], ["fx1 \u2022 The airway epithelium is a significant source of ROS during Th2 inflammation.", {"entities": []}], ["\u2022 IL-13/IL-4 cytokines increase both superoxide and autophagy in airway epithelium.", {"entities": []}], ["\u2022 IL-13-mediated increase in intracellular superoxide is DUOX1 dependent.", {"entities": [[57, 62, "GENE"]]}], ["\u2022 The IL-13-mediated increase in superoxide levels depends on autophagy.", {"entities": []}], ["\u2022 Autophagy is required for proper intracellular DUOX1 localization.", {"entities": [[49, 54, "GENE"]]}], ["The airway epithelium is a significant source of ROS during Th2 inflammation.", {"entities": []}], ["IL-13/IL-4 cytokines increase both superoxide and autophagy in airway epithelium.", {"entities": []}], ["IL-13-mediated increase in intracellular superoxide is DUOX1 dependent.", {"entities": [[55, 60, "GENE"]]}], ["The IL-13-mediated increase in superoxide levels depends on autophagy.", {"entities": []}], ["Autophagy is required for proper intracellular DUOX1 localization.", {"entities": [[47, 52, "GENE"]]}], ["In an observational cohort study, we found that adults hospitalized for oseltamivir\u2010resistant (H275Y) seasonal H1N1 influenza ( n \u2003=\u200346) were older than those infected with oseltamivir\u2010susceptible strains ( n \u2003=\u200331) [74(IQR 59\u201383) versus 64(IQR 48\u201376) years; P \u2003=\u20030\u00b7045], and most had major comorbidities (78% versus 65%).", {"entities": [[116, 125, "DISEASE"]]}], ["Disease severity and clinical outcomes were comparable between the two groups: radiographic pneumonia 40\u201342%, supplemental oxygen use 47\u201348%, critical illness 11\u201313%, median duration of hospitalization 5\u20136\u2003days, death rate 6\u20139%.", {"entities": [[92, 101, "DISEASE"]]}], ["Failure to receive effective antiviral therapy was associated with progression to critical illness (23% versus 0%, P \u2003=\u20030\u00b7016) and death (20% versus 0%, P \u2003=\u20030\u00b7033) in hospitalized patients with seasonal H1N1 influenza.", {"entities": [[209, 218, "DISEASE"]]}], ["The use of IL-2/JES6-1 Ab complex (IL-2 Ab Cx) has been considered as a potential therapeutic for inflammatory diseases due to its selective expansion of regulatory T cells (Tregs) in mice.", {"entities": []}], ["Here, IL-2 Ab Cx was explored as a therapeutic agent to reduce joint inflammation induced by chikungunya virus, an alphavirus causing debilitating joint disease globally.", {"entities": [[93, 104, "DISEASE"]]}], ["Virus-infected mice treated with IL-2 Ab Cx exhibited exacerbated joint inflammation due to infiltration of highly activated CD4", {"entities": [[125, 128, "GENE"]]}], ["Asthma is characterized by airway inflammation, mucus secretion, remodeling and hyperresponsiveness (AHR).", {"entities": [[0, 6, "DISEASE"], [101, 104, "GENE"]]}], ["Recent research has established the bronchodilatory effect of bitter taste receptor (TAS2R) agonists in various models.", {"entities": []}], ["Comprehensive pre-clinical studies aimed at establishing effectiveness of TAS2R agonists in disease models are lacking.", {"entities": []}], ["Here we aimed to determine the effect of TAS2R agonists on features of asthma.", {"entities": [[71, 77, "DISEASE"]]}], ["Further, we elucidated a mechanism by which TAS2R agonists mitigate features of asthma.", {"entities": [[80, 86, "DISEASE"]]}], ["Asthma was induced in mice using intranasal house dust mite or aerosol ova-albumin challenge, and chloroquine or quinine were tested in both prophylactic and treatment models.", {"entities": [[0, 6, "DISEASE"]]}], ["Allergen challenge resulted in airway inflammation as evidenced by increased immune cells infiltration and release of cytokines and chemokines in the lungs, which were significantly attenuated in TAS2R agonists treated mice.", {"entities": []}], ["TAS2R agonists attenuated features of airway remodeling including smooth muscle mass, extracellular matrix deposition and pro-fibrotic signaling, and also prevented mucus accumulation and development of AHR in mice.", {"entities": [[203, 206, "GENE"]]}], ["Mechanistic studies using human neutrophils demonstrated that inhibition of immune cell chemotaxis is a key mechanism by which TAS2R agonists blocked allergic airway inflammation and exerted anti-asthma effects.", {"entities": [[196, 202, "DISEASE"]]}], ["Our comprehensive studies establish the effectiveness of TAS2R agonists in mitigating multiple features of allergic asthma.", {"entities": [[107, 122, "DISEASE"], [116, 122, "DISEASE"]]}], ["Acute lung injury (ALI) is a critical illness syndrome with a mortality rate of 25\u201340%.", {"entities": [[46, 54, "DISEASE"]]}], ["Despite recent advances of our understanding of the pathophysiology of ALI, no pharmacologic therapies have been proven effective.", {"entities": []}], ["The key pathogenesis of ALI is the activation of the coagulation cascade and impaired fibrinolysis, resulting in extensive fibrin and hyaline membrane deposition.", {"entities": []}], ["Activated protein C (APC), an endogenous protein that promotes fibrinolysis and inhibits thrombosis, can modulate the coagulation and inflammation associated with ALI.", {"entities": [[21, 24, "GENE"]]}], ["It is therefore reasonable to suggest that preventing the progression of pulmonary coagulopathy, by restoring normal intraalveolar levels of protein C, will be of therapeutic benefit to patients with ALI.", {"entities": []}], ["However, a recent clinical trial demonstrated that APC did not improve outcomes from ALI, raising the possibility that the method of APC administration, intravenous infusion or inhalation, may influence the outcomes.", {"entities": [[51, 54, "GENE"], [133, 136, "GENE"], [51, 54, "GENE"], [133, 136, "GENE"]]}], ["In this article we propose the hypothesis that APC inhalation might be a promising and novel choice in the treatment of ALI.", {"entities": [[47, 50, "GENE"]]}], ["Activation of the glucocorticoid receptor (GR) by endogenous and synthetic glucocorticoids regulates hundreds of genes to control regulatory networks in development, metabolism, cognition and inflammation.", {"entities": []}], ["Elucidation of the mechanisms that regulate glucocorticoid action has highlighted the dynamic nature of hormone signalling and provides novel insights into genomic glucocorticoid actions.", {"entities": []}], ["The major factors that regulate GR function include chromatin structure, epigenetics, genetic variation and the pattern of glucocorticoid hormone secretion.", {"entities": []}], ["We review our current understanding of the mechanisms that contribute to GR signalling and how these contribute to glucocorticoid sensitivity, resistance and side effects.", {"entities": []}], ["Th17 cells and IL-17A play a role in the development and progression of allergic diseases.", {"entities": []}], ["We analyzed the IL-17A levels in sputum supernatants (Ss), nasal wash (NW) and plasma (P) from Healthy Controls (HC) and children with Asthma/Rhinitis.", {"entities": [[142, 150, "DISEASE"], [135, 141, "DISEASE"]]}], ["We tested the expression of IL-17A, ROR\u03b3(t) and FOXP3 in peripheral blood T-lymphocytes from intermittent and mild-moderate asthma.", {"entities": [[124, 130, "DISEASE"], [48, 53, "GENE"]]}], ["The effect of Budesonide and Formoterol was tested \u201c in vitro \u201d on IL-17A, ROR\u03b3(t) and FOXP3 expression in cultured T-lymphocytes from mild-moderate asthma/persistent rhinitis patients, and on nasal and bronchial epithelial cells stimulated with NW and Ss from mild-moderate asthma/persistent rhinitis.", {"entities": [[167, 175, "DISEASE"], [293, 301, "DISEASE"], [149, 155, "DISEASE"], [275, 281, "DISEASE"], [87, 92, "GENE"]]}], ["Further, the effect of 12 weeks of treatment with Budesonide and Formoterol was tested \u201c in vivo \u201d in T-lymphocytes from mild-moderate asthma/persistent rhinitis patients.", {"entities": [[153, 161, "DISEASE"], [135, 141, "DISEASE"]]}], ["IL-17A was increased in Ss, NW and P from children with mild-moderate asthma compared with intermittent and HC.", {"entities": [[70, 76, "DISEASE"]]}], ["In cultured T-lymphocytes IL-17A and ROR\u03b3(t) expression were higher in mild-moderate asthma/persistent rhinitis than in mild-moderate asthma/intermittent rhinitis, while FOXP3 was reduced.", {"entities": [[103, 111, "DISEASE"], [154, 162, "DISEASE"], [85, 91, "DISEASE"], [134, 140, "DISEASE"], [170, 175, "GENE"]]}], ["Budesonide with Formoterol reduced IL-17A and ROR\u03b3(t), while increased FOXP3 in cultured T-lymphocytes from mild-moderate asthma/persistent rhinitis, and reduced the IL-8 release mediated by IL-17A present in NW and Ss from mild-moderate asthma/persistent rhinitis in nasal and bronchial epithelial cells.", {"entities": [[140, 148, "DISEASE"], [256, 264, "DISEASE"], [122, 128, "DISEASE"], [238, 244, "DISEASE"], [71, 76, "GENE"]]}], ["Finally, Budesonide with Formoterol reduced IL-17A levels in P and Ss, CD4", {"entities": [[71, 74, "GENE"]]}], ["Nanotechnologies have become a significant priority worldwide.", {"entities": []}], ["Several manufactured nanoparticles - particles with one dimension less than 100 nm - are increasingly used in consumer products.", {"entities": []}], ["At nanosize range, the properties of materials differ substantially from bulk materials of the same composition, mostly due to the increased specific surface area and reactivity, which may lead to increased bioavailability and toxicity.", {"entities": []}], ["Thus, for the assessment of sustainability of nanotechnologies, hazards of manufactured nanoparticles have to be studied.", {"entities": []}], ["Despite all the above mentioned, the data on the potential environmental effects of nanoparticles are rare.", {"entities": []}], ["This mini-review is summarizing the emerging information on different aspects of ecotoxicological hazard of metal oxide nanoparticles, focusing on TiO 2 , ZnO and CuO.", {"entities": []}], ["Various biotests that have been successfully used for evaluation of ecotoxic properties of pollutants to invertebrates, algae and bacteria and now increasingly applied for evaluation of hazard of nanoparticles at different levels of the aquatic food-web are discussed.", {"entities": []}], ["Knowing the benefits and potential drawbacks of these systems, a suite of tests for evaluation of environmental hazard of nanoparticles is proposed.", {"entities": []}], ["Special attention is paid to the influence of particle solubility and to recombinant metal-sensing bacteria as powerful tools for quantification of metal bioavailability.", {"entities": []}], ["Using recombinant metal-specific bacterial biosensors and multitrophic ecotoxicity assays in tandem will create new scientific knowledge on the respective role of ionic species and of particles in toxicity of metal oxide nanoparticles.", {"entities": []}], ["The objective of this study was to measure health-related quality of life (HRQL) in outpatients with chronic obstructive pulmonary disease (COPD) and to assess differences in HRQL according to age, gender, and severity of COPD.", {"entities": [[101, 138, "DISEASE"]]}], ["A total of 9405 patients (79% men, mean age 68 years) participated in a cross-sectional study.", {"entities": []}], ["HRQL was measured with the Short Form 12 Health Survey Questionnaire (SF-12).", {"entities": []}], ["Severity of COPD was graded into three levels according to forced expiratory volume in one second value.", {"entities": []}], ["COPD severity was mild in 33.8% of cases, moderate in 49.3% and severe in 16.8%.", {"entities": []}], ["The mean physical component summary (PCS-12) and mental component summary (MCS-12) scores were 36.8 \u00b1 10.4 and 47.2 \u00b1 11.2, respectively.", {"entities": []}], ["General health and physical functioning domains were those with the lowest scores.", {"entities": []}], ["The mean MCS-12 scores were significantly higher in men (47.9 \u00b1 10.9) than in women (44.1 \u00b1 11.8) ( P < 0.001).", {"entities": []}], ["Patients older than 60 years rated HRQL worse than patients aged 40\u201359 years.", {"entities": []}], ["There were statistically significant differences according to severity of disease in the mean scores of all domains of the PCS-12 and MCS-12 scales.", {"entities": []}], ["The present findings show the influence of female gender, older age and moderate-to-severe of airflow limitation on HRQL in outpatients with COPD attended in daily practice.", {"entities": []}], ["The forthcoming post-Millennium Development Goals era will bring about new challenges in global health.", {"entities": []}], ["Low- and middle-income countries will have to contend with a dual burden of infectious and non-communicable diseases (NCDs).", {"entities": []}], ["Some of these NCDs, such as neoplasms, COPD, cardiovascular diseases and diabetes, cause much health loss worldwide and are already widely recognised as doing so.", {"entities": []}], ["However, 55% of the global NCD burden arises from other NCDs, which tend to be ignored in terms of premature mortality and quality of life reduction.", {"entities": []}], ["Here, experts in some of these \u2018forgotten NCDs\u2019 review the clinical impact of these diseases along with the consequences of their ignoring their medical importance, and discuss ways in which they can be given higher global health priority in order to decrease the growing burden of disease and disability.", {"entities": []}], ["Mechanisms linked to actin filaments have long been thought to cooperate in smooth muscle contraction, although key molecules were unclear.", {"entities": []}], ["We show evidence that cardiac troponin T (cTnT) substantially contributes to Ca i ).", {"entities": []}], ["cTnT was detected in various smooth muscles of the aorta, trachea, gut and urinary bladder, including in humans.", {"entities": []}], ["Also, cTnT was distributed along with tropomyosin in smooth muscle cells, suggesting that these proteins are ready to cause smooth muscle contraction.", {"entities": []}], ["In chemically permeabilised smooth muscle of cTnT mice in which cTnT reduced to ~50%, the Ca i , indicating a sizeable contribution of cTnT to smooth muscle contraction at [Ca i < 1\u2005\u03bcM.", {"entities": []}], ["Furthermore, addition of supplemental TnI and TnC reconstructed a troponin system to enhance contraction.", {"entities": [[46, 49, "GENE"]]}], ["The results indicated that a Tn/Tn-like system on actin-filaments cooperates together with the thick-filament pathway.", {"entities": []}], ["Food allergy is an increasingly important health problem in the world.", {"entities": [[0, 12, "DISEASE"]]}], ["Several genome-wide association studies (GWAS) focused on European ancestry samples have identified food allergy-specific loci in the HLA class II region.", {"entities": [[100, 112, "DISEASE"], [134, 137, "GENE"]]}], ["We conducted GWAS of self-reported reactivity with common foods using the data from 11011 Japanese women and identified shrimp and peach allergy-specific loci in the HLA-DR/DQ gene region tagged by rs74995702 ( P \u2009=\u20096.30\u2009\u00d7\u200910 OR \u2009=\u20091.91) and rs28359884 ( P \u2009=\u20092.3\u2009\u00d7\u200910 OR \u2009=\u20091.80), respectively.", {"entities": []}], ["After HLA imputation using a Japanese population-specific reference, the most strongly associated haplotype was HLA-DRB1*04:05-HLA-DQB1*04:01 for shrimp allergy ( P \u2009=\u20093.92\u2009\u00d7\u200910 OR \u2009=\u20091.99) and HLA-DRB1*09:01-HLA-DQB1*03:03 for peach allergy ( P \u2009=\u20091.15\u2009\u00d7\u200910 OR \u2009=\u20091.68).", {"entities": [[6, 9, "GENE"], [112, 115, "GENE"], [127, 130, "GENE"], [194, 197, "GENE"], [209, 212, "GENE"]]}], ["Additionally, both allergies\u2019 associated variants were eQTLs for several HLA genes, with HLA-DQA 2 the single eQTL gene shared between the two traits.", {"entities": [[73, 76, "GENE"], [89, 92, "GENE"]]}], ["Our study suggests that allergy to certain foods may be related to genetic differences that tag both HLA alleles having particular epitope binding specificities as well as variants modulating expression of particular HLA genes.", {"entities": [[101, 104, "GENE"], [217, 220, "GENE"], [101, 104, "GENE"], [217, 220, "GENE"]]}], ["Investigating this further could increase our understanding of food allergy aetiology and potentially lead to better therapeutic strategies for allergen immunotherapies.", {"entities": [[63, 75, "DISEASE"]]}], ["Normal pregnancy is associated with a mild systemic inflammatory response and an immune bias towards type 2 cytokine production, whereas pre-eclampsia is characterized by a more intense inflammatory response, associated with endothelial dysfunction and a type 1 cytokine dominance.", {"entities": [[141, 150, "DISEASE"], [137, 150, "DISEASE"]]}], ["Interleukin (IL)-33 is a newly described member of the IL-1 family, which binds its receptor ST2L to induce type 2 cytokines.", {"entities": []}], ["A soluble variant of ST2 (sST2) acts as a decoy receptor to regulate the activity of IL-33.", {"entities": []}], ["In this study circulating IL-33 and sST2 were measured in each trimester of normal pregnancy and in women with pre-eclampsia.", {"entities": [[115, 124, "DISEASE"], [111, 124, "DISEASE"]]}], ["While IL-33 did not change throughout normal pregnancy, or between non-pregnant, normal pregnant or pre-eclamptic women, sST2 was significantly altered.", {"entities": []}], ["sST2 was increased in the third trimester of normal pregnancy (p<0.001) and was further increased in pre-eclampsia (p<0.001).", {"entities": [[105, 114, "DISEASE"], [101, 114, "DISEASE"]]}], ["This increase was seen prior to the onset of disease (p<0.01).", {"entities": []}], ["Pre-eclampsia is a disease caused by placental derived factors, and we show that IL-33 and ST2 can be detected in lysates from both normal and pre-eclampsia placentas.", {"entities": [[4, 13, "DISEASE"], [147, 156, "DISEASE"], [0, 13, "DISEASE"], [143, 156, "DISEASE"]]}], ["ST2, but not IL-33, was identified on the syncytiotrophoblast layer, whereas IL-33 was expressed on perivascular tissue.", {"entities": []}], ["In an in vitro placental perfusion model, sST2 was secreted by the placenta into the \u2018maternal\u2019 eluate, and placental explants treated with pro-inflammatory cytokines or subjected to hypoxia/reperfusion injury release more sST2, suggesting the origin of at least some of the increased amounts of circulating sST2 in pre-eclamptic women is the placenta.", {"entities": []}], ["These results suggest that sST2 may play a significant role in pregnancies complicated by pre-eclampsia and increased sST2 could contribute to the type 1 bias seen in this disorder.", {"entities": [[94, 103, "DISEASE"], [90, 103, "DISEASE"]]}], ["Although some studies have explained the immunomodulatory effects of statins, the exact mechanisms and the therapeutic significance of these molecules remain to be elucidated.", {"entities": []}], ["This study not only evaluated the therapeutic potential and inhibitory mechanism of simvastatin in an ovalbumin (OVA)-specific asthma model in mice but also sought to clarify the future directions indicated by previous studies through a thorough review of the literature.", {"entities": [[127, 133, "DISEASE"]]}], ["BALB/c mice were sensitized to OVA and then administered three OVA challenges.", {"entities": []}], ["On each challenge day, 40\u2009mg\u2009kg P <0.05).", {"entities": []}], ["Histologically, the number of inflammatory cells and mucus-containing goblet cells in lung tissues also decreased in the simvastatin-treated mice.", {"entities": []}], ["Flow cytometry showed that simvastatin treatment significantly reduced the percentage of pulmonary CD4 P <0.05).", {"entities": [[99, 102, "GENE"]]}], ["Simvastatin treatment also decreased the expression of the vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 proteins, as measured in homogenized lung tissues ( P <0.05) and human epithelial cells.", {"entities": []}], ["The reduction in the T cell influx as a result of the decreased expression of cell adhesion molecules is one of the mechanisms by which simvastatin attenuates airway responsiveness and allergic inflammation.", {"entities": []}], ["Rigorous review of the literature together with our findings suggested that simvastatin should be further developed as a potential therapeutic strategy for allergic asthma.", {"entities": [[156, 171, "DISEASE"], [165, 171, "DISEASE"]]}], ["Animal data suggest that tobacco smoke exposure of a mother when she is in utero influences DNA methylation patterns in her offspring and that there is an effect on the respiratory system, particularly airway responsiveness.", {"entities": []}], ["The only study, to our knowledge, in humans suggests that there is a similar effect on asthma.", {"entities": [[87, 93, "DISEASE"]]}], ["The present study tests whether an association with respiratory problems can be confirmed in a large population study and aims to determine whether in utero exposure of the father has similar effects on his offspring.", {"entities": []}], ["Information from the Avon Longitudinal Study of Parents and Children was used to compare the offspring of women and of men who had themselves been exposed to cigarette smoke in utero; separate analyses were performed for children of women smokers and nonsmokers.", {"entities": []}], ["The outcome measures were trajectories of history of early wheezing, doctor-diagnosed asthma by age 7 years, and results of lung function and methacholine challenge tests at 8 years.", {"entities": [[86, 92, "DISEASE"]]}], ["A variety of social and environmental factors were taken into account; offspring sexes were examined separately.", {"entities": []}], ["There was no association with any outcome in relation to maternal prenatal exposure.", {"entities": []}], ["There was some evidence of an increase in asthma risk with paternal prenatal exposure when the study mother was a nonsmoker (adjusted OR, 1.17; 95% CI, 0.97-1.41).", {"entities": [[42, 48, "DISEASE"]]}], ["This was particularly strong for girls (adjusted OR, 1.39; 95% CI, 1.04-1.86).", {"entities": []}], ["We did not find that maternal prenatal exposure to her mother\u2019s smoking had any effect on her children\u2019s respiratory outcomes.", {"entities": []}], ["There was suggestive evidence of paternal prenatal exposure being associated with asthma and persistent wheezing in the granddaughters.", {"entities": [[82, 88, "DISEASE"]]}], ["Multiple lines of evidence suggest a serotoninergic dysfunction in autism.", {"entities": []}], ["The role of LMX1B in the development and maintenance of serotoninergic neurons is well known.", {"entities": [[12, 17, "GENE"]]}], ["In order to examine the role, if any, of LMX1B with autism pathophysiology, a trio-based SNP association study using 252 family samples from the AGRE was performed.", {"entities": [[41, 46, "GENE"]]}], ["Using pair-wise tagging method, 24 SNPs were selected from the HapMap data, based on their location and minor allele frequency.", {"entities": []}], ["Two SNPs (rs10732392 and rs12336217) showed moderate association with autism with p values 0.018 and 0.022 respectively in transmission disequilibrium test.", {"entities": []}], ["The haplotype AGCGTG also showed significant association (p\u200a=\u200a0.008).", {"entities": []}], ["Further, LMX1B mRNA expressions were studied in the postmortem brain tissues of autism subjects and healthy controls samples.", {"entities": [[9, 14, "GENE"]]}], ["LMX1B transcripts was found to be significantly lower in the anterior cingulate gyrus region of autism patients compared with controls (p\u200a=\u200a0.049).", {"entities": [[0, 5, "GENE"]]}], ["Our study suggests a possible role of LMX1B in the pathophysiology of autism.", {"entities": [[38, 43, "GENE"]]}], ["Based on previous reports, it is likely to be mediated through a seretoninergic mechanism.", {"entities": []}], ["This is the first report on the association of LMX1B with autism, though it should be viewed with some caution considering the modest associations we report.", {"entities": [[47, 52, "GENE"]]}], ["Patients with stroke suffer from physical disabilities, followed by mental instability.", {"entities": []}], ["Their caregivers also suffer from mental instability.", {"entities": []}], ["The present study attempted to address the degree and the change of the level of Purpose in Life (PIL) in patients with stroke and caregivers by applying art therapy using colors.", {"entities": []}], ["Twenty-eight stroke patients with a good functional recovery or a moderate disability and their 28 caregivers were selected and evaluated.", {"entities": []}], ["The period of the study between the stroke and color therapy was more than 6 months.", {"entities": []}], ["Patients and caregivers were divided into the color therapy (28) and control groups (28).", {"entities": []}], ["A questionnaire, which measures the level of PIL was conducted separately for patients and caregivers prior to the first session of color therapy (2 hours per week, total 16 sessions).", {"entities": []}], ["The final examination was performed 5 months after the last color therapy session.", {"entities": []}], ["There was significant difference between before and after color therapy when the level of PIL was measured both in patients and caregivers ( p <0.01).", {"entities": []}], ["These were the same between the color therapy group, compared with the control group ( p <0.01).", {"entities": []}], ["As color therapy progressed to the late phase, patients and caregivers applied increasing number of colors and color intensity.", {"entities": []}], ["These results prove that color therapy will improve PIL of the patients with post-stroke disability and caregivers.", {"entities": []}], ["Furthermore, color therapy would be a useful adjuvant for improving the quality of life of the patients with stroke and their caregivers.", {"entities": []}], ["Nighttime symptoms can negatively impact the quality of life of patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[78, 115, "DISEASE"]]}], ["The Nighttime Symptoms of COPD Instrument (NiSCI) was designed to measure the occurrence and severity of nighttime symptoms in patients with COPD, the impact of symptoms on nighttime awakenings, and rescue medication use.", {"entities": []}], ["The objective of this study was to explore item reduction, inform scoring recommendations, and evaluate the psychometric properties of the NiSCI.", {"entities": []}], ["COPD patients participating in a Phase III clinical trial completed the NiSCI daily.", {"entities": []}], ["Item analyses were conducted using weekly mean and single day scores.", {"entities": []}], ["Descriptive statistics (including percentage of respondents at floor/ceiling and inter-item correlations), factor analyses, and Rasch model analyses were conducted to examine item performance and scoring.", {"entities": []}], ["Test\u2013retest reliability was assessed for the final instrument using the intraclass correlation coefficient (ICC).", {"entities": []}], ["Correlations with assessments conducted during study visits were used to evaluate convergent and known-groups validity.", {"entities": []}], ["Data from 1,663 COPD patients aged 40\u201393 years were analyzed.", {"entities": []}], ["Item analyses supported the generation of four scores.", {"entities": []}], ["A one-factor structure was confirmed with factor analysis and Rasch analysis for the symptom severity score.", {"entities": []}], ["Test\u2013retest reliability was confirmed for the six-item symptom severity (ICC, 0.85), number of nighttime awakenings (ICC, 0.82), and rescue medication (ICC, 0.68) scores.", {"entities": []}], ["Convergent validity was supported by significant correlations between the NiSCI, St George\u2019s Respiratory Questionnaire, and Exacerbations of Chronic Obstructive Pulmonary Disease Tool-Respiratory Symptoms scores.", {"entities": [[141, 178, "DISEASE"]]}], ["The results suggest that the NiSCI can be used to determine the severity of nighttime COPD symptoms, the number of nighttime awakenings due to COPD symptoms, and the nighttime use of rescue medication.", {"entities": []}], ["The NiSCI is a reliable and valid instrument to evaluate these concepts in COPD patients in clinical trials and clinical practice.", {"entities": []}], ["Scoring recommendations and steps for further research are discussed.", {"entities": []}], ["Proteinase-activated receptor-1 (PAR-1) plays a key role in mediating the interplay between coagulation and inflammation in response to injury.", {"entities": []}], ["The aim of this study was to investigate the role of the promoter single-nucleotide polymorphism (SNP) rs2227744G>A in modulating PAR-1/ F2R gene expression in the context of chronic obstructive pulmonary disease (COPD) and COPD exacerbations.", {"entities": [[175, 212, "DISEASE"], [137, 140, "GENE"]]}], ["The function of the rs2227744G>A SNP was investigated by using reporter gene assays.", {"entities": []}], ["The frequency of the polymorphism in the UK population was assessed by genotyping 8,579 healthy individuals from the Whitehall II and English Longitudinal Study of Ageing cohorts.", {"entities": []}], ["The rs2227744G>A SNP was genotyped in a carefully phenotyped cohort of 203 COPD cases and matched controls.", {"entities": []}], ["The results were further replicated in two different COPD cohorts.", {"entities": []}], ["The minor allele of the rs2227744G>A polymorphism was found to increase F2R expression by 2.6-fold ( P < 0.001).", {"entities": [[72, 75, "GENE"]]}], ["The rs2227744G>A SNP was not significantly associated with COPD, or with lung function, in all cohorts.", {"entities": []}], ["The minor allele of the SNP was found to be associated with protection from frequent exacerbations ( P = 0.04) in the cohort of COPD patients for which exacerbation frequency was available.", {"entities": []}], ["Considering exacerbations as a continuous variable, the presence of the minor allele was associated with a significantly lower COPD exacerbation rate (3.03 vs. 1.98 exacerbations/year, Mann-Whitney U -test P = 0.04).", {"entities": []}], ["Taken together, these data do not support a role for the rs2227744G>A F2R polymorphism in the development of COPD but suggest a protective role for this polymorphism from frequent exacerbations.", {"entities": [[70, 73, "GENE"]]}], ["Studies in separate cohorts to replicate these findings are warranted.", {"entities": []}], ["This study describes for the first time the expression levels of genes encoding membrane transporters and drug-metabolizing enzymes in the lungs of ex-smoking patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[173, 210, "DISEASE"]]}], ["Membrane transporters and drug-metabolizing enzymes are key determinants of drug uptake, metabolism, and elimination for systemically administered as well as inhaled drugs, with consequent influence on clinical efficacy and patient safety.", {"entities": []}], ["In this study, while no difference in gene expression was found between healthy and COPD subjects, we identified a significant regional difference in mRNA expression of both membrane transporters and drug-metabolizing enzymes between central and peripheral tissue in both healthy and COPD subjects.", {"entities": []}], ["The majority of the differentially expressed genes were higher expressed in the central airways such as the transporters SLC2A1 (GLUT1), SLC28A3 (CNT3), and SLC22A4 (OCTN1) and the drug-metabolizing enzymes GSTZ1 , GSTO2 , and CYP2F1 .", {"entities": [[121, 127, "GENE"], [137, 144, "GENE"], [157, 164, "GENE"], [207, 212, "GENE"], [215, 220, "GENE"], [227, 233, "GENE"]]}], ["Together, this increased knowledge of local pharmacokinetics in diseased and normal lung may improve modeling of clinical outcomes of new chemical entities intended for inhalation therapy delivered to COPD patients.", {"entities": []}], ["In addition, based on the similarities between COPD and healthy subjects regarding gene expression of membrane transporters and drug-metabolizing enzymes, our results suggest that clinical pharmacological studies in healthy volunteers could be a valid model of COPD patients regarding drug disposition of inhaled drugs in terms of drug metabolism and drug transporters.", {"entities": []}], ["Anxious depression is a prevalent disease with devastating consequences and a poor prognosis.", {"entities": []}], ["Nevertheless, the neurobiological mechanisms underlying this mood disorder remain poorly characterized.", {"entities": [[61, 74, "DISEASE"]]}], ["The LPA1 receptor is one of the six characterized G protein-coupled receptors (LPA1\u20136) through which lysophosphatidic acid acts as an intracellular signalling molecule.", {"entities": []}], ["The loss of this receptor induces anxiety and several behavioural and neurobiological changes that have been strongly associated with depression.", {"entities": []}], ["In this study, we sought to investigate the involvement of the LPA1 receptor in mood.", {"entities": []}], ["We first examined hedonic and despair-like behaviours in wild-type and maLPA1 receptor null mice.", {"entities": []}], ["Owing to the behavioural response exhibited by the maLPA1-null mice, the panic-like reaction was assessed.", {"entities": []}], ["In addition, c-Fos expression was evaluated as a measure of the functional activity, followed by interregional correlation matrices to establish the brain map of functional activation.", {"entities": []}], ["maLPA1-null mice exhibited anhedonia, agitation and increased stress reactivity, behaviours that are strongly associated with the psychopathological endophenotype of depression with anxiety features.", {"entities": []}], ["Furthermore, the functional brain maps differed between the genotypes.", {"entities": []}], ["The maLPA1-null mice showed increased limbic-system activation, similar to that observed in depressive patients.", {"entities": []}], ["Antidepressant treatment induced behavioural improvements and functional brain normalisation.", {"entities": []}], ["Finally, based on validity criteria, maLPA1-null mice are proposed as an animal model of anxious depression.", {"entities": []}], ["Here, for we believe the first time, we have identified a possible relationship between the LPA1 receptor and anxious depression, shedding light on the unknown neurobiological basis of this subtype of depression and providing an opportunity to explore new therapeutic targets for the treatment of mood disorders, especially for the anxious subtype of depression.", {"entities": []}], ["The mast cell, located at mucosal surfaces and surrounding venules, is uniquely positioned to respond rapidly to insults to the host by mediating the development of a wide-ranging inflammatory response.", {"entities": []}], ["Activaton of the mast cell releases preformed granule-associated chemical mediators and generates de novo biologically active materials.", {"entities": []}], ["The properties of the mast cell mediators permit development of both acute and prolonged inflammatory responses.", {"entities": []}], ["the immediate response is characterized by edema and the delayed response by leukocyte infiltration and vascular damage.", {"entities": []}], ["the mast cell mediators responsible for these inflammatory events are characterized functionally.", {"entities": []}], ["The vasoactive/smooth muscle reactive mediators include preformed histamine and serotonin and newly-generated platelet activating factor, slow reacting substance of anaphylaxis and prostaglandins.", {"entities": []}], ["Chemotactic mediators include eosinophil-selective ECF-A and ECF-oligopeptides, neutrophil-selective NCF, and lipid chemotactic mediators with broad specificity.", {"entities": []}], ["These factors induce directed migration and localization of leukocytes.", {"entities": []}], ["The mast cell releases the structural proteoglycan, heparin, which is anticoagulant and inhibits complement.", {"entities": []}], ["Released mast cell enzymes include chymotryptic and tryptic proteases, arylsulfatase, beta-glucuronidase, and hexosaminidase.", {"entities": []}], ["The proteolytic enzymes may activate inflammatory pathways while the others degrade ground substance.", {"entities": []}], ["The capacity of the mast cell to enhance vascular permeability, to cause the influx of regulatory or inflammatory leukocytes, and to provide a variety of active enzymes permits regulation of inflammatory events at the site of tissue injury.", {"entities": []}], ["Because the world population is aging, it has become increasingly important to focus on and meet the healthcare needs of elderly individuals.", {"entities": []}], ["This study aims to evaluate the relationships among common symptoms experienced by the elderly, including fatigue, pain, sleep disturbance, indigestion, and depression/anger/anxiety, and to assess how these symptoms affect health-related quality of life (HRQoL) in the elderly population after adjusting for sociodemographic characteristics and diagnosed diseases.", {"entities": []}], ["In a cross-sectional study conducted in 2014 in a rural area of Korea, we extracted data on 1328 elderly individuals aged 60\u00a0years or older.", {"entities": []}], ["Their HRQoL was assessed using the EuroQol Five-Dimension (EQ-5D) questionnaire.", {"entities": []}], ["The pairwise associations between each symptom and the influence of the symptoms on HRQoL were measured using logistic regression and multiple regression analysis.", {"entities": []}], ["Each symptom was positively correlated with the other symptoms.", {"entities": []}], ["The strongest association was observed between fatigue and pain (adjusted odds ratio\u2009=\u20098.127), and the weakest correlation was observed between sleep and indigestion (adjusted odds ratio\u2009=\u20092.521).", {"entities": []}], ["Of the individuals experiencing symptoms other than sleep disturbance, those who reported comorbid symptoms tended to report higher symptom severity and a higher prevalence of symptoms persisting for \u2265\u20093\u00a0days compared with individuals who reported only one symptom.", {"entities": []}], ["The number of symptoms was significantly correlated with the EQ-5D index (Spearman correlation coefficient\u2009=\u2009\u22120.370, p \u2009<\u20090.01) and the EQ Visual Analog Scale (EQ VAS) scores (Spearman correlation coefficient\u2009=\u2009\u22120.226, p \u2009<\u20090.01).", {"entities": []}], ["Fatigue, pain, and sleep disturbance showed negative effects on all dimensions of EQ-5D.", {"entities": []}], ["In multiple regression analysis, fatigue ( \u03b2 \u2009=\u2009\u22120.073, p \u2009<\u20090.01), pain ( \u03b2 \u2009=\u2009\u22120.140, p \u2009<\u20090.01), sleep disturbance ( \u03b2 \u2009=\u2009\u22120.061, p \u2009<\u20090.05), and depression/anger/anxiety ( \u03b2 \u2009=\u2009\u22120.065, p \u2009<\u20090.05) showed significant independent effects on the EQ-5D index when we adjusted for socioeconomic characteristics and diagnosed diseases.", {"entities": []}], ["Fatigue, pain, sleep disturbance, and depression/anger/anxiety were correlated with one another, and they presented significant independent effects on the HRQoL of elderly individuals.", {"entities": []}], ["Thus, multidisciplinary healthcare programs are required to address these common symptoms.", {"entities": []}], ["Small molecule S-nitrosothiols are a class of endogenous chemicals in the body, which have been implicated in a variety of biological functions.", {"entities": []}], ["However, the labile nature of NO and the limits of current detection assays have made studying these molecules difficult.", {"entities": []}], ["Here we present a method for detecting trace concentrations of S-nitrosothiols in biological fluids.", {"entities": []}], ["Capacitive sensors when coupled to a semiconducting material represent a method for detecting trace quantities of a chemical in complex solutions.", {"entities": []}], ["We have taken advantage of the semiconducting and chemical properties of polydopamine to construct a capacitive sensor and associated method of use, which specifically senses S-nitrosothiols in complex biological solutions.", {"entities": []}], ["To investigate the associations of secondhand smoke (SHS) exposure with medical consultation and hospitalisation among adolescents in Hong Kong.", {"entities": []}], ["A total of 35827 secondary 1 (US grade 7) to secondary 5 students from 85 randomly selected schools completed an anonymous questionnaire on smoking, SHS at home, SHS outside home, medical consultation in the past 14 days, hospitalisation in the past 12 months, and socio-demographic characteristics.", {"entities": []}], ["Current smoking was defined as any smoking in the past 30 days.", {"entities": []}], ["SHS exposure was classified as none (reference), 1\u20134 and 5\u20137 days/week.", {"entities": []}], ["Logistic regression yielded adjusted odds ratios (AORs) for medical consultation and hospitalisation in relation to SHS exposure at home and outside home in current smokers.", {"entities": []}], ["Analyses were also done among never-smokers for comparison.", {"entities": []}], ["Among all students, 15.9% had medical consultation and 5.2% had been hospitalised.", {"entities": []}], ["Any SHS exposure at home was associated with AORs (95% CI) for medical consultation and hospitalisation of 1.69 (1.14\u20132.51) and 2.85 (1.47\u20135.52) in current smokers, and 1.03 (0.91\u20131.15) and 1.25 (1.02\u20131.54) in never-smokers, respectively, (P<0.01 for interaction between smoking status and SHS exposure at home).", {"entities": []}], ["SHS exposure outside home was generally not associated with medical consultation and hospitalisation in smokers and never-smokers.", {"entities": []}], ["SHS exposure at home was associated with health services use among adolescent current smokers.", {"entities": []}], ["Adolescent smokers should be aware of the harm of SHS in addition to that from their own smoking.", {"entities": []}], ["The evidence helps health care professionals to advise adolescent smokers to avoid SHS exposure and stop smoking.", {"entities": []}], ["This is a prospective study to establish prediction models that map the refined Scoliosis Research Society 22-item (SRS-22r) onto EuroQoL-5 dimension 5-level (EQ-5D-5L) utility scores in adolescent idiopathic scoliosis (AIS) patients.", {"entities": []}], ["Comparison of treatment outcomes in AIS can be determined by cost-utility analysis.", {"entities": []}], ["However, the mainstay spine-specific health-related quality of life outcome measure, the SRS-22r questionnaire does not provide utility assessment.", {"entities": []}], ["In this study, AIS patients were prospectively recruited to complete both the EQ-5D-5L and SRS-22r questionnaires by trained interviewers.", {"entities": []}], ["Ordinary least squares regression was undertaken to develop mapping models, which the validity and robustness were assessed by using the 10-fold cross-validation procedure.", {"entities": []}], ["EQ-5D-5L utility scores were regressed on demographics, Cobb angle, curve types, treatment modalities, and five domains of the SRS-22r questionnaire.", {"entities": []}], ["Three models were developed using stepwise selection method.", {"entities": []}], ["EQ-5D-5L scores were regressed on 1) main effects of SRS-22r subscale scores, 2) as per 1 plus squared and interaction terms, and 3) as per 2 plus demographic and clinical characteristics.", {"entities": []}], ["Model goodness-of-fit was assessed using R-square, adjusted R-square, and information criteria; whereas the predictive performance was evaluated using root mean square error (RMSE), mean absolute error (MAE), and the proportion of absolute error within the threshold of 0.05 and 0.10.", {"entities": []}], ["A total of 227 AIS patients with mean age of 15.6 years were recruited.", {"entities": []}], ["The EQ-5D-5L scores were predicted by four domains of SRS-22r (main effects of \u2018Function\u2019, \u2018Pain\u2019, \u2018Appearance\u2019 and \u2018Mental Health\u2019, and squared term of \u2018Function\u2019 and \u2018Pain\u2019), and Cobb angle in Model 3 with the best goodness-of-fit (R-square/adjusted R-square: 62.1%/60.9%).", {"entities": []}], ["Three models demonstrated an acceptance predictive performance in error analysis applying 10-fold cross-validation to three models where RMSE and MAE were between 0.063\u20130.065 and between 0.039\u20130.044, respectively.", {"entities": []}], ["Model 3 was therefore recommended out of three mapping models established in this paper.", {"entities": []}], ["To our knowledge, this is the first study to map a spine-specific health-related quality of life measure onto EQ-5D-5L for AIS patients.", {"entities": []}], ["With the consideration and incorporation of demographic and clinical characteristics, over 60% variance explained by mapping model 3 enabled the satisfactory prediction of EQ-5D-5L utility scores from existing SRS-22r data for health economic appraisal of different treatment options.", {"entities": []}], ["Neuroinflammation is thought to be important in Alzheimer's disease pathogenesis.", {"entities": []}], ["Mast cells are a key component of the inflammatory network and participate in the regulation of the blood-brain barrier's permeability.", {"entities": []}], ["Masitinib, a selective oral tyrosine kinase inhibitor, effectively inhibits the survival, migration and activity of mast cells.", {"entities": []}], ["As the brain is rich in mast cells, the therapeutic potential of masitinib as an adjunct therapy to standard care was investigated.", {"entities": []}], ["A randomised, placebo-controlled, phase 2 study was performed in patients with mild-to-moderate Alzheimer's disease, receiving masitinib as an adjunct to cholinesterase inhibitor and/or memantine.", {"entities": []}], ["Patients were randomly assigned to receive masitinib ( n = 26) (starting dose of 3 or 6 mg/kg/day) or placebo ( n = 8), administered twice daily for 24 weeks.", {"entities": []}], ["The primary endpoint was change from baseline in the Alzheimer's Disease Assessment Scale - cognitive subscale (ADAS-Cog) to assess cognitive function and the related patient response rate.", {"entities": []}], ["The rate of clinically relevant cognitive decline according to the ADAS-Cog response (increase >4 points) after 12 and 24 weeks was significantly lower with masitinib adjunctive treatment compared with placebo (6% vs. 50% for both time points; P = 0.040 and P = 0.046, respectively).", {"entities": []}], ["Moreover, whilst the placebo treatment arm showed worsening mean ADAS-Cog, Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory, and Mini-Mental State Examination scores, the masitinib treatment arm reported improvements, with statistical significance between treatment arms at week 12 and/or week 24 (respectively, P = 0.016 and 0.030; P = 0.035 and 0.128; and P = 0.047 and 0.031).", {"entities": []}], ["The mean treatment effect according to change in ADAS-Cog score relative to baseline at weeks 12 and 24 was 6.8 and 7.6, respectively.", {"entities": []}], ["Adverse events occurred more frequently with masitinib treatment (65% vs. 38% of patients); however, the majority of events were of mild or moderate intensity and transitory.", {"entities": []}], ["Severe adverse events occurred at a similar frequency in the masitinib and placebo arms (15% vs. 13% of patients, respectively).", {"entities": []}], ["Masitinib-associated events included gastrointestinal disorders, oedema, and rash.", {"entities": []}], ["Masitinib administered as add-on therapy to standard care during 24 weeks was associated with slower cognitive decline in Alzheimer's disease, with an acceptable tolerance profile.", {"entities": []}], ["Masitinib may therefore represent an innovative avenue of treatment in Alzheimer's disease.", {"entities": []}], ["This trial provides evidence that may support a larger placebo-controlled investigation.", {"entities": []}], ["Clinicaltrials.gov NCT00976118", {"entities": []}], ["Several societies have produced and disseminated clinical practice guidelines (CPGs) for the symptomatic management of fever in children.", {"entities": []}], ["However, to date, the quality of such guidelines has not been appraised.", {"entities": []}], ["To identify and evaluate guidelines for the symptomatic management of fever in children.", {"entities": []}], ["The research was conducted using PubMed, guideline websites, and Google (January 2010 to July 2016).", {"entities": []}], ["The quality of the CPGs was independently assessed by two assessors using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument, and specific recommendations in guidelines were summarised and evaluated.", {"entities": []}], ["Domain scores were considered of sufficient quality when >60% and of good quality when >80%.", {"entities": []}], ["Seven guidelines were retrieved.", {"entities": []}], ["The median score for the scope and purpose domain was 85.3% (range 66.6\u2013100%).", {"entities": []}], ["The median score for the stakeholder involvement domain was 57.5% (range 33.3\u201383.3%) and four guidelines scored >60%.", {"entities": []}], ["The median score for the rigour of development domain was 52.0% (range 14.6\u201398.9%), and only three guidelines scored >60%.", {"entities": []}], ["The median score for the clarity of presentation domain was 80.9% (range 50.0\u201394.4%).", {"entities": []}], ["The median score for the applicability domain was 39.3% (8.3\u2013100%).", {"entities": []}], ["Only one guideline scored >60%.", {"entities": []}], ["The median score for the editorial independence domain was 48.84% (0\u201391.6%); only three guidelines scored >60%.", {"entities": []}], ["Most guidelines were recommended for use even if with modification, especially in the methodology, the applicability and the editorial independence domains.", {"entities": []}], ["Our results could help improve reporting of future guidelines, and affect the selection and use of guidelines in clinical practice.", {"entities": []}], ["Obesity and the associated metabolic syndrome are among the most common and detrimental metabolic diseases of the modern era, affecting over 50% of the adult population in the United States.", {"entities": [[0, 7, "DISEASE"], [37, 45, "DISEASE"]]}], ["Surgeries designed to promote weight loss, known as bariatric surgery, typically involve a gastric bypass procedure and have shown high success rates for treating morbid obesity.", {"entities": [[170, 177, "DISEASE"], [163, 177, "DISEASE"]]}], ["However, following gastric bypass surgery, many patients develop chronic anemia, most commonly due to iron deficiency.", {"entities": [[73, 79, "DISEASE"]]}], ["Deficiencies of vitamins B1, B12, folate, A, K, D, and E and copper have also been reported after surgery.", {"entities": []}], ["Copper deficiency can cause hematological abnormalities with or without neurological complications.", {"entities": []}], ["Despite oral supplementation and normal serum concentrations of iron, copper, folate, and vitamin B12, some patients present with persistent anemia after surgery.", {"entities": [[141, 147, "DISEASE"]]}], ["The evaluation of hematologic disorders after gastric bypass surgery must take into account issues unique to the postsurgery setting that influence the development of anemia and other cytopenias.", {"entities": [[167, 173, "DISEASE"]]}], ["In this paper, the clinical characteristics and differential diagnosis of the hematological disorders associated with gastric bypass surgery are reviewed, and the underlying molecular mechanisms are discussed.", {"entities": []}], ["The usage of Artificial Neural Networks (ANNs) for genome-enabled classifications and establishing genome-phenotype correlations have been investigated more extensively over the past few years.", {"entities": []}], ["The reason for this is that ANNs are good approximates of complex functions, so classification can be performed without the need for explicitly defined input-output model.", {"entities": []}], ["This engineering tool can be applied for optimization of existing methods for disease/syndrome classification.", {"entities": [[86, 94, "DISEASE"]]}], ["Cytogenetic and molecular analyses are the most frequent tests used in prenatal diagnostic for the early detection of Turner, Klinefelter, Patau, Edwards and Down syndrome.", {"entities": [[163, 171, "DISEASE"]]}], ["These procedures can be lengthy, repetitive; and often employ invasive techniques so a robust automated method for classifying and reporting prenatal diagnostics would greatly help the clinicians with their routine work.", {"entities": []}], ["The database consisted of data collected from 2500 pregnant woman that came to the Institute of Gynecology, Infertility and Perinatology \u201cMehmedbasic\u201d for routine antenatal care between January 2000 and December 2016.", {"entities": []}], ["During first trimester all women were subject to screening test where values of maternal serum pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (\u03b2-hCG) were measured.", {"entities": []}], ["Also, fetal nuchal translucency thickness and the presence or absence of the nasal bone was observed using ultrasound.", {"entities": []}], ["The architectures of linear feedforward and feedback neural networks were investigated for various training data distributions and number of neurons in hidden layer.", {"entities": []}], ["Feedback neural network architecture out performed feedforward neural network architecture in predictive ability for all five aneuploidy prenatal syndrome classes.", {"entities": [[146, 154, "DISEASE"]]}], ["Feedforward neural network with 15 neurons in hidden layer achieved classification sensitivity of 92.00%.", {"entities": []}], ["Classification sensitivity of feedback (Elman\u2019s) neural network was 99.00%.", {"entities": []}], ["Average accuracy of feedforward neural network was 89.6% and for feedback was 98.8%.", {"entities": []}], ["The results presented in this paper prove that an expert diagnostic system based on neural networks can be efficiently used for classification of five aneuploidy syndromes, covered with this study, based on first trimester maternal serum screening data, ultrasonographic findings and patient demographics.", {"entities": []}], ["Developed Expert System proved to be simple, robust, and powerful in properly classifying prenatal aneuploidy syndromes.", {"entities": []}], ["Pentraxin 3 (PTX3) is a soluble pattern recognition receptor with non-redundant functions in inflammation and innate immunity.", {"entities": [[13, 17, "GENE"]]}], ["PTX3 is produced by immune and structural cells.", {"entities": [[0, 4, "GENE"]]}], ["However, very little is known about the expression of PTX3 and its role in allergic asthma.", {"entities": [[75, 90, "DISEASE"], [84, 90, "DISEASE"], [54, 58, "GENE"]]}], ["We sought to determine the PTX3 expression in asthmatic airways and its function in human airway smooth muscle cells (HASMC).", {"entities": [[27, 31, "GENE"]]}], ["In vivo PTX3 expression in bronchial biopsies of mild, moderate and severe asthmatics was analyzed by immunohistochemistry.", {"entities": [[8, 12, "GENE"]]}], ["PTX3 mRNA and protein were measured by real-time RT-PCR and ELISA, respectively.", {"entities": [[0, 4, "GENE"]]}], ["Proliferation and migration were examined using PTX3 immunoreactivity was increased in bronchial tissues of allergic asthmatics compared to healthy controls, and mainly localized in the smooth muscle bundle.", {"entities": [[48, 52, "GENE"]]}], ["PTX3 protein was expressed constitutively by HASMC and was significantly up-regulated by TNF, and IL-1\u03b2 but not by Th2 (IL-4, IL-9, IL-13), Th1 (IFN-\u03b3), or Th-17 (IL-17) cytokines.", {"entities": [[0, 4, "GENE"], [89, 92, "GENE"]]}], ["In vitro , HASMC released significantly higher levels of PTX3 at the baseline and upon TNF stimulation compared to airway epithelial cells (EC).", {"entities": [[57, 61, "GENE"], [87, 90, "GENE"]]}], ["Moreover, PTX3 induced CCL11/eotaxin-1 release whilst inhibited the fibroblast growth factor-2 (FGF-2)-driven HASMC chemotactic activity.", {"entities": [[10, 14, "GENE"]]}], ["Our data provide the first evidence that PTX3 expression is increased in asthmatic airways.", {"entities": [[41, 45, "GENE"]]}], ["HASMC can both produce and respond to PTX3.", {"entities": [[38, 42, "GENE"]]}], ["PTX3 is a potent inhibitor of HASMC migration induced by FGF-2 and can upregulate CCL11/eotaxin-1 release.", {"entities": [[0, 4, "GENE"]]}], ["These results raise the possibility that PTX3 may play a dual role in allergic asthma.", {"entities": [[70, 85, "DISEASE"], [79, 85, "DISEASE"], [41, 45, "GENE"]]}], ["Tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6) binds to hyaluronan and can reorganize/stabilize its structure, also enhancing the binding of this glycosaminoglycan to its cell surface receptor, CD44.", {"entities": [[23, 26, "GENE"], [201, 205, "GENE"]]}], ["TSG-6 is rapidly up-regulated in response to inflammatory cytokines protecting tissues from the damaging effects of inflammation.", {"entities": []}], ["Despite TSG-6 treatment having been shown to improve outcomes in an experimental model of traumatic brain injury, TSG-6 expression has not been extensively studied in the central nervous system (CNS).", {"entities": []}], ["We hereby analyzed the expression profile of TSG-6 in the developing CNS and following injury.", {"entities": []}], ["We show that TSG-6 is expressed in the rat CNS by GFAP TSG-6 TSG-6", {"entities": [[50, 54, "GENE"]]}], ["COPD is characterized by an ongoing inflammatory process of the airways that leads to obstruction or limitation of airflow.", {"entities": []}], ["It is mainly associated with exposure to cigarette smoke.", {"entities": []}], ["In addition, it is considered, at present, a serious public health problem, ranking fourth in mortality worldwide.", {"entities": []}], ["Many cells participate in the pathophysiology of COPD, the most important are neutrophils, macrophages and CD4+ and CD8+ T cells.", {"entities": []}], ["Neutrophil migration to the inflammation area could be mediated largely by cytokines related to CD4+ Th17 lymphocytes, because it has been shown that IL-17A, IL-17F and IL-22 act as inducers for CXCL8, CXCL1, CXCL5, G-CSF, and GM-CSF secretion by epithelial cells of the airways.", {"entities": [[202, 207, "GENE"], [209, 214, "GENE"]]}], ["The aims of these molecules are differentiation, proliferation and recruitment of neutrophils.", {"entities": []}], ["Furthermore, it is believed that CD4+ lymphocytes Th17 may be involved in protection against pathogens for which Th1 and Th2 are not prepared to fight.", {"entities": []}], ["In COPD exacerbations, there is an increased cellularity in the lung region and respiratory tract.", {"entities": []}], ["Therefore, the increase in the number of neutrophils and macrophages in the airways and the increase in proinflammatory cytokines are directly related to the severity of exacerbations and that is the importance of the functions of Th17 profile in this entity.", {"entities": []}], ["Pneumonia may be caused by a wide range of pathogens and is considered the most common infectious cause of death in humans.", {"entities": [[0, 9, "DISEASE"]]}], ["Murine acute lung infection models mirror human pathologies in many aspects and contribute to our understanding of the disease and the development of novel treatment strategies.", {"entities": []}], ["Despite progress in other fields of tissue imaging, histopathology remains the most conclusive and practical read out tool for the descriptive and semiquantitative evaluation of mouse pneumonia and therapeutic interventions.", {"entities": [[184, 193, "DISEASE"]]}], ["Here, we systematically describe and compare the distinctive histopathological features of established models of acute pneumonia in mice induced by Streptococcus (S . )", {"entities": [[119, 128, "DISEASE"]]}], ["pneumoniae , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Legionella pneumophila , Escherichia coli , Middle East respiratory syndrome (MERS) coronavirus, influenza A virus (IAV) and superinfection of IAV-incuced pneumonia with S .", {"entities": [[184, 193, "DISEASE"], [242, 251, "DISEASE"], [155, 163, "DISEASE"]]}], ["pneumoniae .", {"entities": []}], ["Systematic comparisons of the models revealed striking differences in the distribution of lesions, the characteristics of pneumonia induced, principal inflammatory cell types, lesions in adjacent tissues, and the detectability of the pathogens in histological sections.", {"entities": [[122, 131, "DISEASE"]]}], ["We therefore identified core criteria for each model suitable for practical semiquantitative scoring systems that take into account the pathogen- and model-specific patterns of pneumonia.", {"entities": [[177, 186, "DISEASE"]]}], ["Other critical factors that affect experimental pathologies are discussed, including infectious dose, time kinetics, and the genetic background of the mouse strain.", {"entities": []}], ["The substantial differences between the model-specific pathologies underscore the necessity of pathogen- and model-adapted criteria for the comparative quantification of experimental outcomes.", {"entities": []}], ["These criteria also allow for the standardized validation and comparison of treatment strategies in preclinical models.", {"entities": []}], ["European medical students should have acquired adequate prescribing competencies before graduation, but it is not known whether this is the case.", {"entities": []}], ["In this international multicenter study, we evaluated the essential knowledge, skills, and attitudes in clinical pharmacology and therapeutics (CPT) of final\u2010year medical students across Europe.", {"entities": []}], ["In a cross\u2010sectional design, 26 medical schools from 17 European countries were asked to administer a standardized assessment and questionnaire to 50 final\u2010year students.", {"entities": []}], ["Although there were differences between schools, our results show an overall lack of essential prescribing competencies among final\u2010year students in Europe.", {"entities": []}], ["Students had a poor knowledge of drug interactions and contraindications, and chose inappropriate therapies for common diseases or made prescribing errors.", {"entities": []}], ["Our results suggest that undergraduate teaching in CPT is inadequate in many European schools, leading to incompetent prescribers and potentially unsafe patient care.", {"entities": []}], ["A European core curriculum with clear learning outcomes and assessments should be urgently developed.", {"entities": []}], ["The aim of the study was to assess the concordance of care for age related macular degeneration with the evidence-based framework for care for chronic medical conditions known as the chronic care model.", {"entities": [[63, 95, "DISEASE"], [75, 95, "DISEASE"]]}], ["Furthermore we aimed to identify factors associated with the concordance of care with the chronic care model.", {"entities": []}], ["Multi-centered cross-sectional study.", {"entities": []}], ["169 patients beginning medical treatment for age related macular degeneration were recruited and analyzed.", {"entities": [[45, 77, "DISEASE"], [57, 77, "DISEASE"]]}], ["Patients completed the Patient Assessment of Chronic Illness Care (PACIC) questionnaire, reflecting accordance to the chronic care model from a patient\u2019s perspective, the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25) and Patient Health Questionnaire (PHQ-9).", {"entities": []}], ["Visual acuity and chronic medical conditions were assessed.", {"entities": []}], ["Nonparametric tests and correlation analyses were performed, also multivariable regression analysis.", {"entities": []}], ["The median PACIC summary score was 2.4 (interquartile range 1.75 to 3.25), the lowest PACIC subscale score was \u201cfollow-up/coordination\u201d with a median of 1.8 (interquartile range 1.00 to 2.60).", {"entities": []}], ["In multivariable regression analysis the presence of diabetes type 2 was strongly associated with low PACIC scores (coefficient\u200a=\u200a\u22120.85, p\u200a=\u200a0.007).", {"entities": []}], ["Generally, care for patients with age related macular degeneration by ophthalmologists is in moderate concordance with the chronic care model.", {"entities": [[34, 66, "DISEASE"], [46, 66, "DISEASE"]]}], ["Concerning follow-up and coordination of health service, large improvements are possible.", {"entities": []}], ["Future research should answer the question how healthcare delivery can be improved effecting relevant benefits to patients with AMD.", {"entities": []}], ["To increase our understanding of the genetic basis of adiposity and its links to cardiometabolic disease risk, we conducted a genome-wide association meta-analysis of body fat percentage (BF%) in up to 100,716 individuals.", {"entities": []}], ["Twelve loci reached genome-wide significance ( P <5 \u00d7 10 COBLL1/GRB14 , IGF2BP1 , PLA2G6 , CRTC1 ) were novel associations with BF%.", {"entities": [[72, 79, "GENE"], [82, 88, "GENE"], [91, 96, "GENE"]]}], ["Seven loci showed a larger effect on BF% than on BMI, suggestive of a primary association with adiposity, while five loci showed larger effects on BMI than on BF%, suggesting association with both fat and lean mass.", {"entities": []}], ["In particular, the loci more strongly associated with BF% showed distinct cross-phenotype association signatures with a range of cardiometabolic traits revealing new insights in the link between adiposity and disease risk.", {"entities": []}], ["A genome-wide association meta-analysis study here shows novel genetic loci to be associated to body fat percentage, and describes cross-phenotype association that further demonstrate a close relationship between adiposity and cardiovascular disease risk.", {"entities": []}], ["Domestic fuel combustion from cooking and heating is an important public health issue because roughly 3 billion people are exposed worldwide.", {"entities": []}], ["Recently, the International Agency for Research on Cancer classified indoor emissions from household coal combustion as a human carcinogen (group 1) and from biomass fuel (primarily wood) as a probable human carcinogen (group 2A).", {"entities": [[51, 57, "DISEASE"]]}], ["We pooled seven studies from the International Lung Cancer Consortium (5,105 cases and 6,535 controls) to provide further epidemiological evaluation of the association between in-home solid-fuel use, particularly wood, and lung cancer risk.", {"entities": [[47, 58, "DISEASE"], [223, 234, "DISEASE"], [52, 58, "DISEASE"], [228, 234, "DISEASE"]]}], ["Using questionnaire data, we classified subjects as predominant solid-fuel users (e.g., coal, wood) or nonsolid-fuel users (e.g., oil, gas, electricity).", {"entities": []}], ["Unconditional logistic regression was used to estimate the odds ratios (ORs) and to compute 95% confidence intervals (CIs), adjusting for age, sex, education, smoking status, race/ethnicity, and study center.", {"entities": []}], ["Compared with nonsolid-fuel users, predominant coal users (OR = 1.64; 95% CI, 1.49\u20131.81), particularly coal users in Asia (OR = 4.93; 95% CI, 3.73\u20136.52), and predominant wood users in North American and European countries (OR = 1.21; 95% CI, 1.06\u20131.38) experienced higher risk of lung cancer.", {"entities": [[280, 291, "DISEASE"], [285, 291, "DISEASE"]]}], ["The results were similar in never-smoking women and other subgroups.", {"entities": []}], ["Our results are consistent with previous observations pertaining to in-home coal use and lung cancer risk, support the hypothesis of a carcinogenic potential of in-home wood use, and point to the need for more detailed study of factors affecting these associations.", {"entities": [[89, 100, "DISEASE"], [94, 100, "DISEASE"]]}], ["Regulation of a persistently-activated inflammatory response in macrophages is an important target for treatment of various chronic diseases.", {"entities": []}], ["Pine needle extracts are well known to have potent immunomodulatory effects.", {"entities": []}], ["The current study was designed to evaluate the effects of Pinus densiflora needle supercritical fluid extract (PDN-SCFE) on bacterial lipopolysaccharide (LPS)-induced inflammatory response in RAW 264.7 murine macrophages.", {"entities": []}], ["Cytotoxic effect of PDN-SCFE was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.", {"entities": []}], ["The levels of nitric oxide (NO) and the corresponding enzyme, inducible nitric oxide synthase (iNOS), were quantified by Griess and immunoblotting methods, respectively.", {"entities": []}], ["The levels of cytokines were quantified using commercial ELISA kits.", {"entities": []}], ["Quantitative real-time PCR (qRT-PCR) analysis was performed to assess the mRNA expression of iNOS and cytokines.", {"entities": []}], ["To elucidate the mechanism of action, the involvement of nuclear transcription factor-kappa B (NF\u03baB), mitogen activated protein kinases (MAPKs) and Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathways were examined by an immunoblotting method.", {"entities": []}], ["In addition, the cellular localization of NF\u03baB was analyzed by immunofluorescence staining.", {"entities": []}], ["MTT assay results indicated that PDN-SCFE is non-toxic to RAW 264.7 cells up to a maximum assayed concentration of 40\u00a0\u03bcg/mL.", {"entities": []}], ["The PDN-SCFE exhibited a concentration-dependent inhibitory effect on LPS-induced NO production by down regulating the expression of iNOS.", {"entities": []}], ["In addition, the extract suppressed the LPS-induced expression of interleukin-6 (IL-6) and interleukin-1\u03b2 (IL-1\u03b2) but not tumour necrosis factor-\u03b1 (TNF\u03b1).", {"entities": []}], ["Mechanistic studies revealed that PDN-SCFE does not influence the NF\u03baB and MAPK pathways.", {"entities": []}], ["However, it showed a significant inhibitory effect on LPS-induced activation of STAT1 and STAT3 proteins in macrophages.", {"entities": [[80, 85, "GENE"], [90, 95, "GENE"]]}], ["The present findings revealed that the anti-inflammatory activity of PDN-SCFE in LPS-challenged RAW 264.7 macrophages is probably caused by the suppression of the JAK-STAT signaling pathway.", {"entities": []}], ["This study was designed to investigate the clinical effect of montelukast sodium combined with inhaled corticosteroids in the treatment of children with obstructive sleep apnea syndrome (OSAS).", {"entities": [[177, 185, "DISEASE"]]}], ["One hundred ninety-five children were enrolled and divided into 3 groups: groups A, B, and C; the group A (oral use of montelukast sodium), group B (nasal spray of mometasone furoate), and group C (oral use of montelukast sodium + nasal spray of mometasone furoate).", {"entities": []}], ["Telephone questionnaire surveys were carried out.", {"entities": []}], ["Polysomnography monitoring was performed and lateral x-ray radiographs of the cervical spine were taken before treatment and at 12 weeks after treatment.", {"entities": []}], ["The improvement of clinical symptoms after treatment and its effective rate were analyzed.", {"entities": []}], ["The difference in clinical characteristics between groups C1 and C2 was analyzed.", {"entities": [[65, 67, "GENE"]]}], ["In the 3 groups, clinical symptoms improved at 12 weeks after treatment compared with before ( P \u200a<\u200a.05 or P \u200a<\u200a.01).", {"entities": []}], ["Apnea-hypopnea index value decreased ( P \u200a<\u200a.05) and minimal SaO 2 increased ( P \u200a<\u200a.05), while adenoidal/nasopharyngeal ratio was reduced ( P \u200a<\u200a.05).", {"entities": []}], ["Compared with groups A and B, group C had a shortened response duration of snoring, apnea, and restless sleep ( P \u200a<\u200a.05).", {"entities": []}], ["Differences in the response duration of buccal respiration and hyperhidrosis were not statistically significant ( P \u200a>\u200a.05).", {"entities": []}], ["The total effective rate was higher in group C than in A and B ( P \u200a<\u200a.05), while the differences in all indices between groups A and B were not statistically significant ( P \u200a>\u200a.05).", {"entities": []}], ["The difference in the grade of the size of the tonsil between groups C1 and C2 was statistically significant ( P \u200a<\u200a.05).", {"entities": [[76, 78, "GENE"]]}], ["The total effective rate of the combined treatment was higher than that of the single use of any of the 2 drugs, which allowed the rapid relief of symptoms.", {"entities": []}], ["Drug treatment may have a poor curative effect in the treatment of OSAS patients with \u2265 grade 3 tonsil hypertrophy.", {"entities": []}], ["Tissue eosinophilia is a characteristic feature of a number of inflammatory diseases including asthma and nasal polyposis.", {"entities": [[7, 19, "DISEASE"], [95, 101, "DISEASE"]]}], ["Eosinophil migration into tissues is controlled in part by interactions between eosinophil adhesion receptors and counter-structures on the vascular endothelium.", {"entities": []}], ["To determine the receptors used by eosinophils to adhere to vascular endothelium in allergic inflammation we have adapted the Stamper-Woodruff frozen section assay (FSA) to study eosinophil adhesion to nasal polyp endothelium.", {"entities": []}], ["Immunohistology indicated that intercellular adhesion molecule 1 (ICAM-1), E-selectin and P-selectin were well expressed by nasal polyp endothelium, whereas expression of vascular cell adhesion molecule 1 (VCAM-1) was weak or absent.", {"entities": []}], ["Unstimulated human peripheral blood eosinophils adhered specifically to nasal polyp endothelium.", {"entities": []}], ["Adherence was temperature and divalent cation- dependent and saturable at cell densities > 5 x 10(6) cells/ml.", {"entities": []}], ["Eosinophil adhesion was almost completely inhibited by a monoclonal antibody (mAb) against P-selectin and by a chimeric molecule consisting of the Fc portion of human IgG and the lectin binding domain of P- selectin, which binds to the P-selectin ligand on leucocytes.", {"entities": []}], ["Anti-Mac- 1 mAb partially inhibited eosinophil adhesion whereas mAb against E- selectin, L-selectin, ICAM-1, VCAM-1, very late activation antigen 4, and lymphocyte function-associated antigen 1 had no effect.", {"entities": []}], ["P-selectin is stored in intracellular granules within the endothelial cell and in vitro is only transiently expressed.", {"entities": []}], ["To determine if P-selectin was expressed on the membrane of the nasal polyp endothelium we compared P- selectin expression in normal skin and nasal polyps after acetone fixation, which permeabilizes cells, and paraformaldehyde, which only allows staining of membrane expressed receptors.", {"entities": []}], ["In the skin, good expression was seen with acetone fixation but no expression was seen after paraformaldehyde treatment, whereas in nasal polyps, similar expression was observed with both fixatives.", {"entities": []}], ["In addition immunofluorescence with confocal microscopy demonstrated lumenal staining of nasal polyp endothelium indicating that P-selectin was located on the surface of endothelial cells while in skin only an intracellular granular distribution was apparent.", {"entities": []}], ["Lastly, whereas eosinophils bound consistently to nasal polyp endothelium, no binding was observed to blood vessels in normal skin further supporting the idea that eosinophils were binding to membrane expressed and not intracellular P-selectin.", {"entities": []}], ["The importance of P-selectin in eosinophil adhesion to nasal polyp endothelium suggests that P-selectin antagonists may be effective at inhibiting eosinophil accumulation at sites of allergic inflammation.", {"entities": []}], ["Ethnopharmacology is at the intersection of the medical, natural, and social sciences.", {"entities": []}], ["Despite its interdisciplinary nature, most ethnopharmacological research has been based on the combination of the chemical, biological, and pharmacological sciences.", {"entities": []}], ["Far less attention has been given to the social sciences, including anthropology and the study of traditional knowledge systems.", {"entities": []}], ["I reviewed the literature on traditional knowledge systems highlighting its potential theoretical and methodological contributions to ethnopharmacology.", {"entities": []}], ["I discuss three potential theoretical contributions of traditional knowledge systems to ethnopharmacological research.", {"entities": []}], ["First, while many plants used in indigenous pharmacopoeias have active compounds, those compounds do not always act alone in indigenous healing systems.", {"entities": []}], ["Research highlights the holistic nature of traditional knowledge systems and helps understand plant's efficacy in its cultural context.", {"entities": []}], ["Second, research on traditional knowledge systems can improve our understanding of how ethnopharmacological knowledge is distributed in a society, and who benefits from it.", {"entities": []}], ["Third, research on traditional knowledge systems can enhance the study of the social relations that enable the generation, maintenance, spread, and devolution of cultural traits and innovations, including ethnopharmacological knowledge.", {"entities": []}], ["At a methodological level, some ethnopharmacologists have used anthropological tools to understand the context of plant use and local meanings of health and disease.", {"entities": []}], ["I discuss two more potential methodological contributions of research on traditional knowledge systems to ethnopharmacological research.", {"entities": []}], ["First, traditional knowledge systems research has developed methods that would help ethnopharmacologists understand how people classify illnesses and remedies, a fundamental aspect of folk medicinal plant selection criteria.", {"entities": []}], ["Second, ethnopharmacologists could also borrow methods derived from cultural consensus theory to have a broader look at intracultural variation and at the analysis of transmission and loss of traditional ethnopharmacological knowledge.", {"entities": []}], ["Ethical considerations in the ethnopharmacology of the 21st century should go beyond the recognition of the Intellectual Property Rights or the acquisition of research permits, to include considerations on the healthcare of the original holders of ethnopharmacological knowledge.", {"entities": []}], ["Ethnopharmacology can do more than speed up to recover the traditional knowledge of indigenous peoples to make it available for the development of new drugs.", {"entities": []}], ["Ethnopharmacologists can work with health care providers in the developing world for the local implementation of ethnopharmacological research results.", {"entities": []}], ["Epidemiological studies have revealed that intrauterine growth retardation (IUGR) or low birth weight is linked to the later development of asthma.", {"entities": [[140, 146, "DISEASE"]]}], ["Epigenetic regulatory mechanisms play an important role in the fetal origins of adult disease.", {"entities": []}], ["However, little is known regarding the correlation between epigenetic regulation and the development of asthma following IUGR.", {"entities": [[104, 110, "DISEASE"]]}], ["An IUGR and ovalbumin (OVA)-sensitization/challenge rat model was used to study whether epigenetic mechanisms play a role in the development of asthma following IUGR.", {"entities": [[144, 150, "DISEASE"]]}], ["Maternal nutrient restriction increased histone acetylation levels of the endothelin-1 (ET-1) gene promoter in lung tissue of offspring, but did not cause significant alterations of DNA methylation.", {"entities": []}], ["The effect was maintained until 10\u00a0weeks after birth.", {"entities": []}], ["Furthermore, these epigenetic changes may have induced IUGR individuals to be highly sensitive to OVA challenge later in life, resulting in more significant changes related to asthma.", {"entities": [[176, 182, "DISEASE"]]}], ["These findings suggest that epigenetic mechanisms might be closely associated with the development of asthma following IUGR, providing further insight for improved prevention of asthma induced by environmental factors.", {"entities": [[102, 108, "DISEASE"], [178, 184, "DISEASE"]]}], ["Introduction: Repair of inguinal hernia is a common procedure, but there is a lack of consensus as to the optimal repair technique along with the use of mesh and methods of mesh fixation.", {"entities": []}], ["The objective of this study was to evaluate the efficacy and safety of fibrin sealant for mesh fixation in laparoscopic totally extraperitoneal (TEP) inguinal hernia repair.", {"entities": []}], ["Materials and Methods: A study was conducted of the first 200 patients undergoing TEP hernia repair with mesh fixation using fibrin sealant between March 2012 and January 2014.", {"entities": []}], ["The primary outcome measures were (1) chronic pain (persisting for >3 months), (2) persistence of hernia (recurrence identified within first 2 weeks postoperatively), (3) hernia recurrence, and (4) any additional perioperative complications.", {"entities": []}], ["The mean follow-up in the series was 34.4\u2009\u00b1\u20096.1 months (range 22.2\u201344.1).", {"entities": []}], ["Results: Of the 278 hernias repaired in 204 patients (74 bilateral, 130 unilateral), 38 were recurrent and 240 were primary.", {"entities": []}], ["Three patients (1.5%) had a persistent hernia, including one with a planned return to the operating room the next day due to poor visualization.", {"entities": []}], ["Three patients (1.5%) had a hernia recurrence.", {"entities": []}], ["Twelve patients (5.9%) reported experiencing chronic pain.", {"entities": []}], ["The remaining complications were minor and resolved over time.", {"entities": []}], ["Conclusions: TEP repair of inguinal hernia using mesh secured with fibrin sealant can be effectively used to treat primary, recurrent, unilateral, and bilateral inguinal hernias in adults with minimal recurrence rates and complications during almost 3 years of follow-up.", {"entities": []}], ["Melioidosis is endemic in tropical Australia and Southeast Asian countries and its causative organism Burkholderia pseudomallei is a recognized cause of pneumonia in these regions.", {"entities": [[0, 11, "DISEASE"], [153, 162, "DISEASE"]]}], ["Recent isolation of the organism in the soil of Kapasia, Gazipur, Bangladesh has proven its exposure among the population residing in endemic areas of our country.", {"entities": []}], ["Pneumonia is the most common presentation of melioidosis.", {"entities": [[45, 56, "DISEASE"], [0, 9, "DISEASE"]]}], ["Acute, subacute and chronic pneumonia due to B. pseudomallei can present as primary or secondary pneumonia.", {"entities": [[28, 37, "DISEASE"], [97, 106, "DISEASE"]]}], ["Treatment of such cases are challenging as well.", {"entities": []}], ["Till date, few cases of acute and chronic pneumonia due to melioidosis occurring in local Bangladeshis as well as in returning travelers to Europe have been reported.", {"entities": [[59, 70, "DISEASE"], [42, 51, "DISEASE"]]}], ["To the best of our knowledge, this is the first reported case of primary melioidosis pneumonia declared cured after a 27\u00a0weeks of treatment regimen from Bangladesh.", {"entities": [[73, 84, "DISEASE"], [85, 94, "DISEASE"]]}], ["A 43-year-old Bangladeshi gentleman, known diabetic, hypertensive, smoker, presented with the complaints of recurrent episodes of low to high grade intermittent fever, productive cough with occasional haemoptysis and 10\u00a0kg weight loss over one and half months.", {"entities": []}], ["Poorly responding to conventional antibiotics, he was suspected as a case of pulmonary tuberculosis.", {"entities": [[87, 99, "DISEASE"], [77, 99, "DISEASE"]]}], ["Examination and investigations revealed left sided consolidation with cavitary lesion, hepato-splenomegaly and sputum analysis confirmed growth of Burkholderia pseudomallei .", {"entities": []}], ["The patient was successfully treated as a case of primary melioidosis pneumonia.", {"entities": [[58, 69, "DISEASE"], [70, 79, "DISEASE"]]}], ["Often misdiagnosed and empirically treated as tuberculosis, untreated melioidosis pneumonia may even lead to death.", {"entities": [[70, 81, "DISEASE"], [82, 91, "DISEASE"], [46, 58, "DISEASE"]]}], ["Therefore, melioidosis should be suspected in appropriate clinical scenario in patients with a history of residing in or traveling to endemic areas.", {"entities": [[11, 22, "DISEASE"]]}], ["In Bangladesh, time has come to explore whether melioidosis should be considered as an emerging infectious disease.", {"entities": [[48, 59, "DISEASE"]]}], ["Persons with severe mental illness (e.g.", {"entities": []}], ["schizophrenia, bipolar disorder) have a high prevalence of somatic conditions compared to the general population.", {"entities": [[0, 13, "DISEASE"], [15, 31, "DISEASE"]]}], ["Mortality data in the Nordic countries reveal that these persons die 15\u201320\u00a0years earlier than the general population.", {"entities": []}], ["Some factors explaining this high prevalence may be related to the individuals in question; others arise from the health care system\u2019s difficulty in offering somatic health care to these patient groups.", {"entities": []}], ["The aim of the present study was therefore to explore the experiences and views of patients, relatives and clinicians regarding individual and organizational factors which facilitate or hinder access to somatic health care for persons with severe mental illness.", {"entities": []}], ["Flexible qualitative design.", {"entities": []}], ["Data was collected by means of semi-structured individual interviews with patients with severe mental illness, relatives and clinicians representing primary and specialized health care.", {"entities": []}], ["In all, 50 participants participated.", {"entities": []}], ["The main barrier to accessing somatic care is the gap between the organization of the health care system and the patients\u2019 individual health care needs.", {"entities": []}], ["This is observed at both individual and organizational level.", {"entities": []}], ["The health care system seems unable to support patients with severe mental illness and their psychiatric-somatic comorbidity.", {"entities": []}], ["The main facilitators are the links between severe mental illness patients and medical departments.", {"entities": []}], ["These links take the form of functions (i.e.", {"entities": []}], ["systems which ensure that patients receive regular reminders), or persons (i.e.", {"entities": []}], ["professional contacts who facilitate patients\u2019 access the health care).", {"entities": []}], ["Health care services for patients with severe mental illness need reorganization.", {"entities": []}], ["Organizational structures and systems that facilitate cooperation between different departments must be put in place, along with training for health care professionals about somatic disease among psychiatric patients.", {"entities": []}], ["The links between individual and organizational levels could be strengthened by introducing professional contacts, such as liaison physicians and case managers.", {"entities": []}], ["This is also important to reduce stress and responsibility among relatives.", {"entities": []}], ["The online version of this article (10.1186/s12875-017-0687-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Disparities in treatment adherence based on race and ethnicity are well documented but poorly understood.", {"entities": []}], ["Specifically, the causes of treatment nonadherence among Latino patients living in the USA are complex and include cultural and language barriers.", {"entities": []}], ["The purpose of this study was to examine whether patients\u2019 perceptions in patient-provider interactions (i.e., trust in provider, patient satisfaction, and patient sense of interpersonal control in patient-provider interactions) mediate any found association between patient-perceived provider cultural sensitivity (PCS) and treatment adherence among English-preferred Latino (EPL) and Spanish-preferred Latino (SPL) patients.", {"entities": []}], ["Data from 194 EPL patients and 361 SPL patients were obtained using questionnaires.", {"entities": []}], ["A series of language-specific structural equation models were conducted to test the relationship between patient-perceived PCS and patient treatment adherence and the examined mediators of this relationship among the Latino patients.", {"entities": []}], ["No significant direct effects of patient-perceived PCS on general treatment adherence were found.", {"entities": []}], ["However, as hypothesized, several significant indirect effects emerged.", {"entities": []}], ["Preferred language appeared to have moderating effects on the relationships between patient-perceived PCS and general treatment adherence.", {"entities": []}], ["These results suggest that interventions to promote treatment adherence among Latino patients should likely include provider training to foster patient-defined PCS, trust in provider, and patient satisfaction with care.", {"entities": []}], ["Furthermore, this training needs to be customized to be suitable for providing care to Latino patients who prefer speaking Spanish and Latino patients who prefer speaking English.", {"entities": []}], ["The content of arachidonic acid in adipose tissue is positively associated with the risk of myocardial infarction, whereas the content of eicosapentaenoic acid in adipose tissue has been reported to be negatively associated with the risk of myocardial infarction.", {"entities": [[92, 113, "DISEASE"], [241, 262, "DISEASE"]]}], ["Both arachidonic acid and eicosapentaenoic acid are substrates for the synthesis of pro-inflammatory leukotrienes and leukotrienes derived from eicosapentaenoic acid are generally much less potent.", {"entities": []}], ["In this study we hypothesized that a high content of arachidonic acid in adipose tissue would reflect a high formation of arachidonic acid derived leukotrienes and a high expression of 5-lipoxygenase in atherosclerotic plaques.", {"entities": []}], ["Likewise, we hypothesized that a high content of eicosapentaenoic acid in adipose tissue would reflect a low formation of arachidonic acid derived leukotrienes and a low expression of 5-lipoxygenase in plaques.", {"entities": []}], ["In a cross sectional study we included 45 consecutive subjects undergoing femoral thrombendarterectomy.", {"entities": []}], ["The expression of 5-lipoxygenase in plaques was assessed by a semi-automated image analysis computer programme after immunohistochemical staining with mono-clonal 5-lipoxygenase antibodies.", {"entities": []}], ["Leukotriene B 4 and cysteinyl leukotriene formation from stimulated femoral artery plaques was quantified using ELISA methods.", {"entities": []}], ["The fatty acid content of adipose tissue biopsies from the thigh was analyzed using gas chromatography.", {"entities": []}], ["Associations between variables were assessed by Pearson correlations and were further explored in a multivariable linear regression model adjusting for potential confounders.", {"entities": []}], ["A high content of arachidonic acid in adipose tissue was associated with a higher expression of 5-lipoxygenase in plaques (r\u2009=\u20090.32, p\u2009=\u20090.03), but no significant associations with leukotriene B 4 (r\u2009=\u20090.22, p\u2009=\u20090.14) and cysteinyl leukotriene (r\u2009=\u2009\u22120.11, p\u2009=\u20090.46) formation was seen.", {"entities": []}], ["No significant associations were found between the content of eicosapentaenoic acid in adipose tissue and 5-lipoxygenase expression or leukotriene formation in plaque.", {"entities": []}], ["Adipose tissue arachidonic acid contents correlated positively with the expression of 5-lipoxygenase in plaques.", {"entities": []}], ["This association might represent a causal link between adipose tissue arachidonic acid and the risk of myocardial infarction but confirmatory studies are needed.", {"entities": [[103, 124, "DISEASE"]]}], ["Understanding the mechanisms underlying the process of regeneration and repair of airway epithelial structures demands close characterization of the associated cellular and molecular events.", {"entities": []}], ["The choice of an animal model system to study these processes and the role of lung stem cells is debatable since ideally the chosen animal model should offer a valid comparison with the human lung.", {"entities": []}], ["Species differences may include the complex three-dimensional lung structures, cellular composition of the lung airway as well as transcriptional control of the molecular events in response to airway epithelium regeneration, and repair following injury.", {"entities": []}], ["In this paper, we discuss issues related to the study of the lung repair and regeneration including the role of putative stem cells in small- and large-animal models.", {"entities": []}], ["At the end of this paper, the author discuss the potential for using sheep as a model which can help bridge the gap between small-animal model systems and humans.", {"entities": []}], ["Self-management is an established, effective approach to controlling asthma, recommended in guidelines.", {"entities": [[69, 75, "DISEASE"]]}], ["However, promotion, uptake and use among patients and health-care professionals remain low.", {"entities": []}], ["Many barriers and facilitators to effective self-management have been reported, and views and beliefs of patients and health care professionals have been explored in qualitative studies.", {"entities": []}], ["We conducted a systematic review and thematic synthesis of qualitative research into self-management in patients, carers and health care professionals regarding self-management of asthma, to identify perceived barriers and facilitators associated with reduced effectiveness of asthma self-management interventions.", {"entities": [[180, 186, "DISEASE"], [277, 283, "DISEASE"]]}], ["Electronic databases and guidelines were searched systematically for qualitative literature that explored factors relevant to facilitators and barriers to uptake, adherence, or outcomes of self-management in patients with asthma.", {"entities": [[222, 228, "DISEASE"]]}], ["Thematic synthesis of the 56 included studies identified 11 themes: (1) partnership between patient and health care professional; (2) issues around medication; (3) education about asthma and its management; (4) health beliefs; (5) self-management interventions; (6) co-morbidities (7) mood disorders and anxiety; (8) social support; (9) non-pharmacological methods; (10) access to healthcare; (11) professional factors.", {"entities": [[180, 186, "DISEASE"]]}], ["From this, perceived barriers and facilitators were identified at the level of individuals with asthma (and carers), and health-care professionals.", {"entities": [[96, 102, "DISEASE"]]}], ["Future work addressing the concerns and beliefs of adults, adolescents and children (and carers) with asthma, effective communication and partnership, tailored support and education (including for ethnic minorities and at risk groups), and telehealthcare may improve how self-management is recommended by professionals and used by patients.", {"entities": [[102, 108, "DISEASE"]]}], ["Ultimately, this may achieve better outcomes for people with asthma.", {"entities": [[61, 67, "DISEASE"]]}], ["Lung cancer is the most lethal neoplasia, and an early diagnosis is the best way for improving survival.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"]]}], ["Symptomatic patients attending Pulmonary Services could be diagnosed with lung cancer earlier if high-risk individuals are promptly separated from healthy individuals and patients with benign respiratory pathologies.", {"entities": [[74, 85, "DISEASE"], [79, 85, "DISEASE"]]}], ["We searched for a convenient non-invasive serum test to define which patients should have more immediate clinical tests.", {"entities": []}], ["Six cancer-associated molecules (HB-EGF, EGF, EGFR, sCD26, VEGF, and Calprotectin) were investigated in this study.", {"entities": [[4, 10, "DISEASE"], [36, 39, "GENE"], [41, 44, "GENE"], [46, 50, "GENE"]]}], ["Markers were measured in serum by specific ELISAs, in an unselected population that included 72 lung cancer patients of different histological types and 56 control subjects (healthy individuals and patients with benign pulmonary pathologies).", {"entities": [[96, 107, "DISEASE"], [101, 107, "DISEASE"]]}], ["Boosted regression and random forests analysis were conducted for the selection of the best candidate biomarkers.", {"entities": []}], ["A remarkable discriminatory capacity was observed for EGF, sCD26, and especially for Calprotectin, these three molecules constituting a marker panel boasting a sensitivity of 83% and specificity of 87%, resulting in an associated misclassification rate of 15%.", {"entities": [[54, 57, "GENE"]]}], ["Finally, an algorithm derived by logistic regression and a nomogram allowed generating classification scores in terms of the risk of a patient of suffering lung cancer.", {"entities": [[156, 167, "DISEASE"], [161, 167, "DISEASE"]]}], ["In conclusion, we propose a non-invasive test to identify patients at high-risk for lung cancer from a non-selected population attending a Pulmonary Service.", {"entities": [[84, 95, "DISEASE"], [89, 95, "DISEASE"]]}], ["The efficacy of this three-marker panel must be tested in a larger population for lung cancer.", {"entities": [[82, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["Hospitalisations for ambulatory care-sensitive conditions (ACSCs), a group of chronic and acute illnesses considered not to require inpatient treatment if timely and appropriate ambulatory care is received, and early rehospitalisations are common and costly.", {"entities": []}], ["We sought to determine whether individuals with depression are at increased risk of hospitalisations for ACSCs, and rehospitalisation for the same or another ACSC, within 30\u2005days.", {"entities": []}], ["National, population-based cohort study.", {"entities": []}], ["5\u2005049\u2005353 individuals \u226518\u2005years of age between 1 January 2005 and 31 December 2013.", {"entities": []}], ["Depression was ascertained via psychiatrist diagnoses in the Danish Psychiatric Central Register or antidepressant prescription redemption from the Danish National Prescription Registry.", {"entities": []}], ["Hospitalisations for ACSCs and rehospitalisations within 30\u2005days were identified using the Danish National Patient Register.", {"entities": []}], ["Overall, individuals with depression were 2.35 times more likely to be hospitalised for an ACSC (95% CI 2.32 to 2.37) versus those without depression after adjusting for age, sex and calendar period, and 1.45 times more likely after adjusting for socioeconomic factors, comorbidities and primary care utilisation (95% CI 1.43 to 1.46).", {"entities": []}], ["After adjusting for ACSC-predisposing comorbidity, depression was associated with significantly greater risk of hospitalisations for all chronic (eg, angina, diabetes complications, congestive heart failure exacerbation) and acute ACSCs (eg, pneumonia) compared to those without depression.", {"entities": [[182, 206, "DISEASE"], [242, 251, "DISEASE"]]}], ["Compared to those without depression, persons with depression were 1.21 times more likely to be rehospitalised within 30\u2005days for the same ACSC (95% CI 1.18 to 1.24) and 1.19 times more likely to be rehospitalised within 30\u2005days for a different ACSC (95% CI 1.15 to 1.23).", {"entities": []}], ["Individuals with depression are at increased risk of hospitalisations for ACSCs, and once discharged are at elevated risk of rehospitalisations within 30\u2005days for ACSCs.", {"entities": []}], ["Errors in community medication histories increase the risk of adverse events.", {"entities": []}], ["The objectives of this study were to estimate the extent to which access to community-based pharmacy records provided more information about prescription drug use than conventional medication histories.", {"entities": []}], ["A prospective cohort of patients with public drug insurance who visited the emergency departments (ED) in two teaching hospitals in Montreal, Quebec was recruited.", {"entities": []}], ["Drug lists recorded in the patients\u2019 ED charts were compared with pharmacy records of dispensed medications retrieved from the public drug insurer.", {"entities": []}], ["Patient and drug-related predictors of discrepancies were estimated using general estimating equation multivariate logistic regression.", {"entities": []}], ["613 patients participated in the study (mean age 63.1\u2005years, 59.2% women).", {"entities": []}], ["Pharmacy records identified 41.5% more prescribed medications than were noted in the ED chart.", {"entities": []}], ["Concordance was highest for anticoagulants, cardiovascular drugs and diuretics.", {"entities": []}], ["Omissions in the ED chart were more common for drugs that may be taken episodically.", {"entities": []}], ["Patients with more than 12 medications (OR 2.92, 95% CI 1.71 to 4.97) and more than one pharmacy (OR 3.85, 95% CI 1.80 to 6.59) were more likely to have omissions in the ED chart.", {"entities": []}], ["The development of health information exchanges could improve the efficiency and accuracy of information about community medication histories if they enable automated access to dispensed medication records from community pharmacies, particularly for the most vulnerable populations with multiple morbidities.", {"entities": []}], ["Pharmacy records identified a substantial number of medications that were not in the ED chart.", {"entities": []}], ["There is potential for greater safety and efficiency with automated access to pharmacy records.", {"entities": []}], ["GSK961081 (batefenterol) is a novel bifunctional molecule composed of a muscarinic antagonist and a \u03b2 2 \u2010agonist.", {"entities": []}], ["The aims of this substudy were (1)\u00a0to characterize the population pharmacokinetics (PK) and pharmacodynamics (PD) of GSK961081 in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD); and (2)\u00a0to investigate the relationship between systemic exposure to GSK961081 and key cardiac-related safety parameters.", {"entities": [[163, 200, "DISEASE"]]}], ["Three once-daily doses (100, 400, and 800\u00a0\u03bcg) and three twice-daily doses (100, 200, and 400\u00a0\u03bcg) of GSK961081 DISKUS were investigated.", {"entities": []}], ["A two-compartment disposition PK model with first-order absorption adequately described the plasma GSK961081 concentration\u2013time data.", {"entities": []}], ["An empirical maximum-effects PD model adequately described the forced expiratory volume in 1\u00a0s (FEV 1 ) response relationship with the covariate baseline FEV 1 on day\u00a01.", {"entities": [[96, 99, "GENE"], [154, 157, "GENE"], [96, 99, "GENE"], [154, 157, "GENE"]]}], ["No clear relationships between GSK961081 plasma drug levels and cardiac-related safety parameters were apparent.", {"entities": []}], ["The PK and PD models will be used to guide the dose selection and development of GSK961081 in patients with COPD.", {"entities": []}], ["In Korea, common whelk ( Buccinum undatum ) is a popular edible shellfish.", {"entities": []}], ["The aim of this study was to observe the sensitization rate to common whelk and to characterize its allergens.", {"entities": []}], ["We carried out skin prick test (SPT) in 1,700 patients with various allergic diseases.", {"entities": []}], ["Specific IgE were detected by ELISA in the patient sera and ELISA inhibition tests were conducted.", {"entities": []}], ["IgE-binding components were identified by means of SDS-PAGE and IgE-immunoblotting.", {"entities": []}], ["The effects of digestive enzymes were evaluated in both raw and thermally treated extracts.", {"entities": []}], ["SPT to common whelk was positive (\u22652+) in 83 (4.9%) patients studied.", {"entities": []}], ["Twenty-four (38.7%) out of 62 SPT positive patients had high serum specific IgE to common whelk.", {"entities": []}], ["ELISA inhibition test showed significant inhibitions by abalone as well as by common whelk.", {"entities": []}], ["IgE-immunoblotting demonstrated three IgE-binding components (40, 71, 82 kDa), which were digested by simulated intestinal fluid and moderately digested by simulated gastric fluid, and the digestibility of allergens remained unchanged after thermal treatment.", {"entities": []}], ["In conclusion, IgE-sensitization rate to common whelk was 4.9% in allergy patients.", {"entities": []}], ["IgE-immunoblotting demonstrated three IgE-binding components, which were degraded by digestive enzymes.", {"entities": []}], ["Further studies are needed to evaluate the clinical significance of the sensitized patients to common whelk.", {"entities": []}], ["A receptor for advanced glycation end products (RAGE) and its ligand high mobility group box 1 (HMGB1) protein has been linked to several chronic diseases, and acts as a trigger for inflammation signaling.", {"entities": [[96, 101, "GENE"]]}], ["Here, we study RAGE and HMGB1 expression in chronic, recalcitrant rhinosinusitis with nasal polyps (CRSwNP) to determine its potential clinical significance, i.e., disease recurrence and severity.", {"entities": [[24, 29, "GENE"]]}], ["RAGE and HMGB1 expression in CRSwNP was evaluated by immunohistochemistry in epithelial cells of fresh sinonasal mucosa samples obtained from the patients diagnosed with recalcitrant CRSwNP ( n \u00a0=\u00a025) and normal control mucosa (NC) ( n \u00a0=\u00a026).", {"entities": [[9, 14, "GENE"]]}], ["RAGE and HMGB1 expression levels in tissues were correlated with disease severity assessed by nasal endoscopy, CT scan, number of previous sinus surgeries, allergy status and nasosinusal microbiology.", {"entities": [[9, 14, "GENE"]]}], ["RAGE and HMGB1 were moderately or strongly expressed in CRSwNP tissue.", {"entities": [[9, 14, "GENE"]]}], ["No or weak RAGE expression was found in NC.", {"entities": []}], ["HMGB1 was equally strongly expressed in NC.", {"entities": [[0, 5, "GENE"]]}], ["We observed a strong correlation between RAGE and disease severity, recurrence, undergone operations, asthma and aspirin exacerbated respiratory disease (AERD).", {"entities": [[102, 108, "DISEASE"]]}], ["Elevated RAGE expression is associated with increased disease severity, as well as allergy and AERD in patients with recalcitrant CRSwNP.", {"entities": []}], ["It is possible that the explanation for recurrent CRSwNP pathogenesis might be related to RAGE overexpression with subsequent sinus mucosa hyperproliferation, necessitating several operations.", {"entities": []}], ["To assess the frequency of chronic kidney disease (CKD), define the associated demographics, and evaluate its association with use of evidence-based drug therapy in a contemporary global study of patients with stable coronary artery disease.", {"entities": [[35, 49, "DISEASE"]]}], ["22,272 patients from the ProspeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) were included.", {"entities": []}], ["Baseline estimated glomerular filtration rate (eGFR) was calculated (CKD-Epidemiology Collaboration formula) and patients categorised according to CKD stage: >89, 60\u201389, 45\u201359 and <45 mL/min/1.73 m Mean (SD) age was 63.9\u00b110.4 years, 77.3% were male, 61.8% had a history of myocardial infarction, 71.9% hypertension, 30.4% diabetes and 75.4% dyslipidaemia.", {"entities": [[302, 314, "DISEASE"], [273, 294, "DISEASE"], [47, 51, "GENE"]]}], ["Chronic kidney disease (eGFR<60 mL/min/1.73 m Chronic kidney disease is common in patients with stable coronary artery disease and is associated with comorbidities.", {"entities": [[8, 22, "DISEASE"], [54, 68, "DISEASE"], [24, 28, "GENE"]]}], ["Whilst use of individual evidence-based medications for secondary prevention was high across all CKD categories, there remains an opportunity to improve the proportion who take all three classes of preventive therapies.", {"entities": []}], ["Angiotensin-converting enzyme inhibitors were used less frequently in lower eGRF categories.", {"entities": []}], ["Surprisingly the reverse was seen for angiotensin-receptor blockers.", {"entities": []}], ["Further evaluation is required to fully understand these associations.", {"entities": []}], ["The CLARIFY (ProspeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease) Registry is registered in the ISRCTN registry of clinical trials with the number ISRCTN43070564.", {"entities": []}], ["http://www.controlled-trials.com/ISRCTN43070564 .", {"entities": []}], ["Omega-3 long chain polyunsaturated fatty acid supplementation ( n -3 LCPUFA) for treatment of Autism Spectrum Disorder (ASD) is popular.", {"entities": []}], ["The results of previous systematic reviews and meta-analyses of n -3 LCPUFA supplementation on ASD outcomes were inconclusive.", {"entities": []}], ["Two meta-analyses were conducted; meta-analysis 1 compared blood levels of LCPUFA and their ratios arachidonic acid (ARA) to docosahexaenoic acid (DHA), ARA to eicosapentaenoic acid (EPA), or total n -6 to total n -3 LCPUFA in ASD to those of typically developing individuals (with no neurodevelopmental disorders), and meta-analysis 2 compared the effects of n -3 LCPUFA supplementation to placebo on symptoms of ASD.", {"entities": []}], ["Case-control studies and randomised controlled trials (RCTs) were identified searching electronic databases up to May, 2016.", {"entities": []}], ["Mean differences were pooled and analysed using inverse variance models.", {"entities": []}], ["Heterogeneity was assessed using I n = 1193) were reviewed.", {"entities": []}], ["Compared with typically developed, ASD populations had lower DHA (\u22122.14 [95% CI \u22123.22 to \u22121.07]; p < 0.0001; I p = 0.008; I p = 0.01; I n -6 LCPUFA to n -3 LCPUFA ratio (0.42 [95% CI 0.06 to 0.78]; p = 0.02; I n = 107).", {"entities": []}], ["Compared with placebo, n -3 LCPUFA improved social interaction (\u22121.96 [95% CI \u22123.5 to \u22120.34]; p = 0.02; I p = 0.05; I n -3 LCPUFA status and n -3 LCPUFA supplementation can potentially improve some ASD symptoms.", {"entities": []}], ["Further research with large sample size and adequate study duration is warranted to confirm the efficacy of n -3 LCPUFA.", {"entities": []}], ["We conducted a case-control study in the greater Toronto area to evaluate potential lung cancer risk factors including environmental tobacco smoke (ETS) exposure, family history of cancer, indoor air pollution, workplace exposures and history of previous respiratory diseases with special consideration given to never smokers.", {"entities": [[84, 95, "DISEASE"], [89, 95, "DISEASE"], [181, 187, "DISEASE"]]}], ["445 cases (35% of which were never smokers oversampled by design) between the ages of 20-84 were identified through four major tertiary care hospitals in metropolitan Toronto between 1997 and 2002 and were frequency matched on sex and ethnicity with 425 population controls and 523 hospital controls.", {"entities": []}], ["Unconditional logistic regression models were used to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI) for the associations between exposures and lung cancer risk.", {"entities": [[166, 177, "DISEASE"], [171, 177, "DISEASE"]]}], ["Any previous exposure to occupational exposures (OR total population 1.6, 95% CI 1.4-2.1, OR never smokers 2.1, 95% CI 1.3-3.3), a previous diagnosis of emphysema in the total population (OR 4.8, 95% CI 2.0-11.1) or a first degree family member with a previous cancer diagnosis before age 50 among never smokers (OR 1.8, 95% CI 1.0-3.2) were associated with increased lung cancer risk.", {"entities": [[368, 379, "DISEASE"], [261, 267, "DISEASE"], [373, 379, "DISEASE"]]}], ["Occupational exposures and family history of cancer with young onset were important risk factors among never smokers.", {"entities": [[45, 51, "DISEASE"]]}], ["Public objection to autopsy has led to a search for minimally invasive alternatives.", {"entities": []}], ["Imaging has potential, but its accuracy is unknown.", {"entities": []}], ["We aimed to identify the accuracy of post-mortem CT and MRI compared with full autopsy in a large series of adult deaths.", {"entities": []}], ["This study was undertaken at two UK centres in Manchester and Oxford between April, 2006, and November, 2008.", {"entities": []}], ["We used whole-body CT and MRI followed by full autopsy to investigate a series of adult deaths that were reported to the coroner.", {"entities": []}], ["CT and MRI scans were reported independently, each by two radiologists who were masked to the autopsy findings.", {"entities": []}], ["All four radiologists then produced a consensus report based on both techniques, recorded their confidence in cause of death, and identified whether autopsy was needed.", {"entities": []}], ["We assessed 182 unselected cases.", {"entities": []}], ["The major discrepancy rate between cause of death identified by radiology and autopsy was 32% (95% CI 26\u201340) for CT, 43% (36\u201350) for MRI, and 30% (24\u201337) for the consensus radiology report; 10% (3\u201317) lower for CT than for MRI.", {"entities": []}], ["Radiologists indicated that autopsy was not needed in 62 (34%; 95% CI 28\u201341) of 182 cases for CT reports, 76 (42%; 35\u201349) of 182 cases for MRI reports, and 88 (48%; 41\u201356) of 182 cases for consensus reports.", {"entities": []}], ["Of these cases, the major discrepancy rate compared with autopsy was 16% (95% CI 9\u201327), 21% (13\u201332), and 16% (10\u201325), respectively, which is significantly lower (p<0\u00b70001) than for cases with no definite cause of death.", {"entities": []}], ["The most common imaging errors in identification of cause of death were ischaemic heart disease (n=27), pulmonary embolism (11), pneumonia (13), and intra-abdominal lesions (16).", {"entities": [[82, 95, "DISEASE"], [129, 138, "DISEASE"], [104, 122, "DISEASE"]]}], ["We found that, compared with traditional autopsy, CT was a more accurate imaging technique than MRI for providing a cause of death.", {"entities": []}], ["The error rate when radiologists provided a confident cause of death was similar to that for clinical death certificates, and could therefore be acceptable for medicolegal purposes.", {"entities": []}], ["However, common causes of sudden death are frequently missed on CT and MRI, and, unless these weaknesses are addressed, systematic errors in mortality statistics would result if imaging were to replace conventional autopsy.", {"entities": []}], ["Policy Research Programme, Department of Health, UK.", {"entities": []}], ["Genotoxic stress and RAS induce the expression of CD155, a ligand for the immune receptors DNAM-1, CD96 and TIGIT.", {"entities": [[99, 103, "GENE"], [108, 113, "GENE"]]}], ["Here we show that antigen-presenting cells upregulate CD155 expression in response to Toll-like receptor activation.", {"entities": []}], ["Induction of CD155 by Toll-like receptors depended on MYD88, TRIF and NF-\u03baB.", {"entities": [[54, 59, "GENE"]]}], ["In addition, IRF3, but not IRF7, modulated CD155 upregulation in response to TLR3 signals.", {"entities": [[13, 17, "GENE"], [27, 31, "GENE"], [77, 81, "GENE"]]}], ["Immunization of CD155-deficient mice with OVA and the TLR9 agonist CpG resulted in increased OVA-specific IgG2a/c titers when compared to wild type mice.", {"entities": [[54, 58, "GENE"]]}], ["Splenocytes of immunized CD155-deficient mice secreted lower levels of IL-4 and fewer IL-4 and GATA-3 expressing CD4 Cd155 mice.", {"entities": [[113, 116, "GENE"]]}], ["Our data suggest that CD155 regulates T h 2 differentiation.", {"entities": []}], ["Targeting of CD155 in immunization protocols using peptides may represent a promising new approach to boost protective humoral immunity in viral vaccines.", {"entities": []}], ["Human adenoviruses (HAdV) play a significant role in pediatric respiratory tract infections.", {"entities": []}], ["To date, over 60 types of HAdV have been identified.", {"entities": []}], ["Here, HAdV types are characterized in children in the Beijing area with acute lower respiratory tract infections (ALRTIs) and the clinical features and laboratory findings of hospitalized HAdV-infected cases are described.", {"entities": []}], ["Respiratory specimens were collected from pediatric patients with ALRTIs in the emergency department or from those admitted to Beijing Children\u2019s Hospital between March 2007 and December 2012.", {"entities": []}], ["Infections with common respiratory viruses were determined by PCR or RT-PCR.", {"entities": []}], ["HAdV positive samples were further typed by PCR and sequencing.", {"entities": []}], ["Among 3356 patients with ALRTIs, 194 (5.8 %) were found to have HAdV infection.", {"entities": []}], ["HAdV infection was primarily confined to children (88.35 %) less than 5\u00a0years of age.", {"entities": []}], ["A total of 11 different types of HAdV were detected throughout the study period, with HAdV-B7 (49.0 %) and HAdV-B3 (26.3 %) as the most prevalent types, followed by HAdV-C2 (7.7 %) and HAdVC1 (4.6 %).", {"entities": []}], ["Newly emerging and re-emergent types or variants, HAdV-B55 ( n \u2009=\u20095), HAdV-C57 ( n \u2009=\u20093), and HAdV-B14p1 ( n \u2009=\u20091), were identified.", {"entities": []}], ["Results also included the reported first case of co-infection with HAdV-C2 and HAdV-C57.", {"entities": []}], ["Clinical entities of patients with single HAdV infection ( n \u2009=\u200949) were similar to those with mixed HAdV/respiratory syncytial virus (RSV) infections ( n \u2009=\u200941).", {"entities": []}], ["Patients with HAdV-B7 infection had longer duration of fever and higher serum levels of muscle enzymes than HAdV-B3-infected patients.", {"entities": []}], ["During the study period, HAdV-B7 and HAdV-B3 were the predominant types identified in pediatric ALRTIs.", {"entities": []}], ["HAdV-B7 infection tends to have more severe clinical consequences.", {"entities": []}], ["The presence of newly emerging types or variants and co-infection with different types of HAdV highlights the need for constant and close surveillance of HAdV infection.", {"entities": []}], ["The CD40 ligand/CD40 pathway is widely recognized for its prominent role in immune regulation and homeostasis.", {"entities": [[4, 8, "GENE"], [16, 20, "GENE"]]}], ["CD40, a member of the tumor necrosis factor receptor family, is expressed by antigen-presenting cells, as well as non-immune cells and tumors.", {"entities": [[0, 4, "GENE"]]}], ["The engagement of the CD40 and CD40 ligands, which are transiently expressed on T cells and other non-immune cells under inflammatory conditions, regulates a wide spectrum of molecular and cellular processes, including the initiation and progression of cellular and humoral adaptive immunity.", {"entities": [[22, 26, "GENE"], [31, 35, "GENE"], [22, 26, "GENE"], [31, 35, "GENE"]]}], ["Based on recent research findings, the engagement of the CD40 with a deregulated amount of CD40 ligand has been implicated in a number of inflammatory diseases.", {"entities": [[57, 61, "GENE"], [91, 95, "GENE"], [57, 61, "GENE"], [91, 95, "GENE"]]}], ["We will discuss the involvement of the CD40 ligand/CD40 interaction in the pathophysiology of inflammatory diseases, including autoimmune diseases, atherothrombosis, cancer, and respiratory diseases.", {"entities": [[166, 172, "DISEASE"], [39, 43, "GENE"], [51, 55, "GENE"]]}], ["To examine the relationship between gastroesophageal reflux (GER) and COPD exacerbations.", {"entities": []}], ["We conducted a systematic search of various electronic databases for articles published up through December of 2012.", {"entities": []}], ["Studies considered eligible for inclusion were those dealing with COPD, COPD exacerbations, and GER; comparing at least two groups (COPD vs. controls or GER vs. controls); and describing relative risks (RRs) and prevalence ratios-or ORs and their respective 95% CIs (or presenting enough data to allow further calculations) for the association between GER and COPD-as well as exacerbation rates.", {"entities": []}], ["Using a standardized form, we extracted data related to the study design; criteria for GER diagnosis; age, gender, and number of participants; randomization method; severity scores; methods of evaluating GER symptoms; criteria for defining exacerbations; exacerbation rates (hospitalizations, ER visits, unscheduled clinic visits, prednisone use, and antibiotic use); GER symptoms in COPD group vs. controls; mean number of COPD exacerbations (with symptoms vs. without symptoms); annual frequency of exacerbations; GER treatment; and severity of airflow obstruction.", {"entities": []}], ["Overall, GER was clearly identified as a risk factor for COPD exacerbations (RR = 7.57; 95% CI: 3.84-14.94), with an increased mean number of exacerbations per year (mean difference: 0.79; 95% CI: 0.22-1.36).", {"entities": []}], ["The prevalence of GER was significantly higher in patients with COPD than in those without (RR = 13.06; 95% CI: 3.64-46.87; p < 0.001).", {"entities": []}], ["GER is a risk factor for COPD exacerbations.", {"entities": []}], ["The role of GER in COPD management should be studied in greater detail.", {"entities": []}], ["Currently licensed vaccines against the influenza A virus (IAV) need to be updated annually to match the constantly evolving antigenicity of the influenza virus glycoproteins, hemagglutinin (HA), and neuramidiase (NA).", {"entities": [[40, 49, "DISEASE"], [145, 154, "DISEASE"]]}], ["Attempts to develop universal vaccines that provide broad protection have resulted in some success.", {"entities": []}], ["Herein, we have shown that a replication-deficient adenovirus expressing H5/M2e induced significant humoral immunity against the conserved HA stalk.", {"entities": []}], ["Compared to the humoral responses induced by an inactivated influenza vaccine, the humoral responses induced by the adenovirus-vectored vaccine against the conserved stalk domain mediated cross-protection against heterosubtypic influenza viruses.", {"entities": [[60, 69, "DISEASE"], [228, 237, "DISEASE"]]}], ["Importantly, virus inactivation by formaldehyde significantly reduced the binding of monoclonal antibodies (mAbs) to the conserved nucleoprotein (NP), M2e, and HA stalk.", {"entities": []}], ["These results suggest that inactivation by formaldehyde significantly alters the antigenicity of the HA stalk, and suggest that the conformation of the intact HA stalk provided by vector-based vaccines is important for induction of HA stalk-binding Abs.", {"entities": []}], ["Our study provides insight into the mechanism by which a vector-based vaccine induces broad protection by stimulation of cross-protective Abs targeting conserved domains of viral proteins.", {"entities": []}], ["The findings support further strategies to develop a vectored vaccine as a universal influenza vaccine for the control of influenza epidemics and unpredicted pandemics.", {"entities": [[85, 94, "DISEASE"], [122, 131, "DISEASE"]]}], ["Vaccines and prophylactic antibodies against respiratory syncytial virus (RSV) are in development and likely to be available in the next 5\u201310 years.", {"entities": []}], ["The most efficient way to use these products when they become available is an important consideration for public health decision makers.", {"entities": []}], ["We performed a multivariate regression analysis to estimate the burden of RSV in children younger than 5 years in England (UK), a representative high-income temperate country, and used these results to assess the potential effect of different RSV immunisation strategies (targeting vaccination for infants, or pregnant women, or prophylactic antibodies for neonates).", {"entities": []}], ["We did a cost-effectiveness analysis for these strategies, implemented either separately or concurrently, and assessed the effect of restricting vaccination to certain months of the year.", {"entities": []}], ["We estimated that RSV is responsible for 12 primary care consultations (95% CI 11\u00b79\u201312\u00b71) and 0\u00b79 admissions to hospital annually per 100 children younger than 5 years (95% CI 0\u00b789\u20130\u00b790), with the major burden occurring in infants younger than 6 months.", {"entities": []}], ["The most cost-effective strategy was to selectively immunise all children born before the start of the RSV season (maximum price of \u00a3220 [95% uncertainty interval (UI) 208\u2013232] per vaccine, for an incremental cost-effectiveness ratio of \u00a320\u2008000 per quality-adjusted life-year).", {"entities": []}], ["The maximum price per fully protected person that should be paid for the infant, newborn, and maternal strategies without seasonal restrictions was \u00a3192 (95% UI 168\u2013219), \u00a381 (76\u201386), and \u00a354 (51\u201357), respectively.", {"entities": []}], ["Nearly double the number of primary care consultations, and nearly five times the number of admissions to hospital occurred with RSV compared with influenza.", {"entities": [[147, 156, "DISEASE"]]}], ["RSV vaccine and antibody strategies are likely to be cost-effective if they can be priced below around \u00a3200 per fully protected person.", {"entities": []}], ["A seasonal vaccination strategy is likely to provide the most direct benefits.", {"entities": []}], ["Herd effects might render a year-round infant vaccination strategy more appealing, although it is currently unclear whether such a programme would induce herd effects.", {"entities": []}], ["UK National Institute for Health Research.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a widespread disease.", {"entities": []}], ["It produces some night symptoms such as nighttime cough and dyspnea.", {"entities": []}], ["Then subjective and objective changes in sleep pattern are expected.", {"entities": []}], ["Present study was conducted to determine frequency of sleepiness and quality of sleep in patients with COPD.", {"entities": []}], ["Present case-control study has been performed on 120 patients with diagnosis of COPD who had been referred to pulmonary disease clinic in a University teaching hospital.", {"entities": []}], ["One hundred twenty age- and sex- matched healthy individuals were recruited in the study and served as control.", {"entities": []}], ["Spirometry (PFT) was performed for all patients.", {"entities": []}], ["Patients were categorized under 3 groups in relation to their PFT as follow: mild COPD (FEV1/FVC<70% and FEV1\u226580%), moderate COPD (FEV1/FVC<70% and 50%\u2264FEV1<80%), and severe COPD (FEV1/FVC<70% and FEV1<50%).", {"entities": []}], ["Pittsburgh Sleep Quality questionnaire (PSQI) and Epworth Sleepiness Scale (ESS) were used to estimate quality of sleep and daytime sleepiness in the patients and control group.", {"entities": []}], ["The collected data were analyzed using version 16 SPSS software.", {"entities": []}], ["Student\u2019s T- test, Chi- square and multiple logistic regressions were used as appropriated.", {"entities": []}], ["120 patients with COPD (79 males and 41 females) and 120 normal individuals responded to the questionnaires.", {"entities": []}], ["Mean scores of quality of sleep were 8.03\u00b13.66 and 4.2\u00b12.8 in COPD patients and control group respectively.", {"entities": []}], ["32.1% of the patients had good sleep quality (PSQI score less than 5) and 67.9% had poor sleep quality.", {"entities": []}], ["Daytime sleepiness (ESS\u2265 10) was present in 34.8% of the patients and 15% of control people.", {"entities": []}], ["Multiple logistic regressions showed that the patients reported significantly worse sleep quality and more daytime sleepiness than control group [OR=2.9; 95% CI (1.6-3.7) & OR=3.5; 95% CI (2.5-4.3) respectively].", {"entities": []}], ["Results of present study confirmed that COPD is associated with daytime sleepiness and poor quality of sleep, possibly attributable to nighttime respiratory difficulties and concomitant sleep apnea.", {"entities": []}], ["Assessment of the patients for symptoms of sleep apnea, daytime sleepiness should be a part of regular follow up visits of patients with COPD.", {"entities": []}], ["As manuka honey (MH) exhibits immunoregulatory and anti\u2010staphylococcal activities, we aimed to investigate if it could be effective in the treatment of atopic dermatitis (AD).", {"entities": [[152, 169, "DISEASE"], [159, 169, "DISEASE"]]}], ["Adult volunteers with bilateral AD lesions were asked to apply MH on one site overnight for seven consecutive days and leave the contralateral site untreated as possible.", {"entities": []}], ["Three Item Severity score was used to evaluate the response.", {"entities": []}], ["Skin swabs were obtained from both sites before and after treatment to investigate the presence of staphylococci and enterotoxin production.", {"entities": []}], ["In addition, the ability of MH and its methanolic and hexane extracts to down regulate IL4\u2010induced CCL26 protein release from HaCaT cells was evaluated by enzyme linked immunosorbent assay.", {"entities": [[99, 104, "GENE"]]}], ["Also, the ability of MH to modulate calcium ionophore\u2010induced mast cell degranulation was assessed by enzyme immunoassay.", {"entities": []}], ["In 14 patients, AD lesions significantly improved post MH treatment versus pre\u2010treatment as compared to control lesions.", {"entities": []}], ["No significant changes in the skin staphylococci were observed after day 7, irrespective of honey treatment.", {"entities": []}], ["Consistent with the clinical observation, MH significantly down regulated IL4\u2010induced CCL26 release from HaCaT cells in a dose\u2010dependent manner.", {"entities": [[86, 91, "GENE"]]}], ["This effect was partially lost, though remained significant, when methanolic and hexane extracts of MH were utilized.", {"entities": []}], ["In addition, mast cell degranulation was significantly inhibited following treatment with MH.", {"entities": []}], ["MH is potentially effective in the treatment of AD lesions based on both clinical and cellular studies through different mechanisms.", {"entities": []}], ["This needs to be confirmed by randomized and controlled clinical trials.", {"entities": []}], ["During the occurrence and development of injury (trauma, hemorrhagic shock, ischemia and hypoxia), the neuroendocrine and immune system act as a prominent navigation leader and possess an inter-system crosstalk between the reciprocal information dissemination.", {"entities": [[76, 84, "DISEASE"]]}], ["The fundamental reason that neuroendocrinology and immunology could mix each other and permeate toward the field of traumatology is owing to their same biological languages or chemical information molecules (hormones, neurotransmitters, neuropeptides, cytokines and their corresponding receptors) shared by the neuroendocrine and immune systems.", {"entities": []}], ["The immune system is not only modulated by the neuroendocrine system, but also can modulate the biological functions of the neuroendocrine system.", {"entities": []}], ["The interactive linkage of these three systems precipitates the complicated space-time patterns for the courses of traumatic inflammation.", {"entities": []}], ["Recently, compelling evidence indicates that the network linkage pattern that initiating agents of neuroendocrine responses, regulatory elements of immune cells and effecter targets for immune regulatory molecules arouse the resistance mechanism disorders, which supplies the beneficial enlightenment for the diagnosis and therapy of traumatic complications from the view of translational medicine.", {"entities": []}], ["Here we review the alternative protective and detrimental roles as well as possible mechanisms of the neuroendocrine immune responses in traumatic inflammation.", {"entities": []}], ["Mycetoma is caused by the subcutaneous inoculation of filamentous fungi or aerobic filamentous bacteria that form grains in the tissue.", {"entities": []}], ["The purpose of this study is to describe the epidemiologic, clinic, laboratory, and therapeutic characteristics of patients with mycetoma at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil, between 1991 and 2014.", {"entities": []}], ["Twenty-one cases of mycetoma were included in the study.", {"entities": []}], ["There was a predominance of male patients (1.3:1) and the average patient age was 46 years.", {"entities": []}], ["The majority of the cases were from the Southeast region of Brazil and the feet were the most affected anatomical region (80.95%).", {"entities": []}], ["Eumycetoma prevailed over actinomycetoma (61.9% and 38.1% respectively).", {"entities": []}], ["Eumycetoma patients had positive cultures in 8 of 13 cases, with isolation of Scedosporium apiospermum species complex (n = 3), Madurella mycetomatis (n = 2) and Acremonium spp.", {"entities": []}], ["Two cases presented sterile mycelium and five were negative.", {"entities": []}], ["Six of 8 actinomycetoma cases had cultures that were identified as Nocardia spp.", {"entities": []}], ["(n = 3), Nocardia brasiliensis (n = 2), and Nocardia asteroides (n = 1).", {"entities": []}], ["Imaging tests were performed on all but one patients, and bone destruction was identified in 9 cases (42.68%).", {"entities": []}], ["All eumycetoma cases were treated with itraconazole monotherapy or combined with fluconazole, terbinafine, or amphotericin B. Actinomycetoma cases were treated with sulfamethoxazole plus trimethoprim or combined with cycles of amikacin sulphate.", {"entities": []}], ["Surgical procedures were performed in 9 (69.2%) eumycetoma and in 3 (37.5%) actinomycetoma cases, with one amputation case in each group.", {"entities": []}], ["Clinical cure occurred in 11 cases (7 for eumycetoma and 4 for actinomycetoma), and recurrence was documented in 4 of 21 cases.", {"entities": []}], ["No deaths were recorded during the study.", {"entities": []}], ["Despite of the scarcity of mycetoma in our institution the cases presented reflect the wide clinical spectrum and difficulties to take care of this neglected disease.", {"entities": []}], ["Mycetoma is a major health problem in tropical areas and is prevalent among people of low socio-economic status.", {"entities": []}], ["As in many other regions of the world, the incidence and prevalence of mycetoma in Brazil is unknown.", {"entities": []}], ["This study describes some aspects of mycetoma patients in 24 years of experience at the National Institute of Infectious Diseases at the Oswaldo Cruz Foundation, Rio de Janeiro, Brazil and contribute to the knowledge on mycetoma epidemiology globally.", {"entities": []}], ["The human gut is heavily colonized by a community of microbiota, primarily bacteria, that exists in a symbiotic relationship with the host and plays a critical role in maintaining host homeostasis.", {"entities": []}], ["The consumption of a high-fat (HF) diet has been shown to induce gut dysbiosis and reduce intestinal integrity.", {"entities": []}], ["Recent studies have revealed that dysbiosis contributes to the progression of cardiovascular diseases (CVDs) by promoting two major CVD risk factors\u2014atherosclerosis and hypertension.", {"entities": [[169, 181, "DISEASE"], [149, 164, "DISEASE"]]}], ["Imbalances in host\u2013microbial interaction impair homeostatic mechanisms that regulate health and can activate multiple pathways leading to CVD risk factor progression.", {"entities": []}], ["Dysbiosis has been implicated in the development of atherosclerosis through metabolism-independent and metabolite-dependent pathways.", {"entities": [[52, 67, "DISEASE"]]}], ["This review will illustrate how these pathways contribute to the various stages of atherosclerotic plaque progression.", {"entities": []}], ["In addition, dysbiosis can promote hypertension through vascular fibrosis and an alteration of vascular tone.", {"entities": [[35, 47, "DISEASE"]]}], ["As CVD is the number one cause of death globally, investigating the gut microbiota as a locus of intervention presents a novel and clinically relevant avenue for future research, with vast therapeutic potential.", {"entities": []}], ["Several studies have reported that the GT dinucleotide repeat length polymorphism and the G2964A polymorphism in signal transducer and activator of transcriptional factor 6 gene are associated with asthma susceptibility, but others have conflicting results.", {"entities": [[198, 204, "DISEASE"]]}], ["Our meta-analysis aimed to elucidate the emerging paradigms.", {"entities": []}], ["We searched PUBMED, EMBASE, ISI web of knowledge, Chinese National Knowledge Infrastructure, and Wanfang databases.", {"entities": []}], ["Odds ratios (ORs) and 95% confidence intervals (95% CIs) were used to evaluate the strength of association.", {"entities": []}], ["We applied Bonferroni step-down and Benjamini-Hochberg step-up methods to adjust the values for multiple comparisons.", {"entities": []}], ["A total of 12 individual studies in 11 articles were included in the meta-analysis.", {"entities": []}], ["For GT repeat polymorphism, the S allele had approximately 45% increased risk of asthma ( S vs. L : OR\u200a=\u200a1.45, 95% CI\u200a=\u200a1.22\u20131.71, P UNCORRECTED <0.001, P Bon <0.001, P FDR <0.001).", {"entities": [[81, 87, "DISEASE"]]}], ["Further analysis indicated that GT 13 and GT 14 contributed to asthma risk, whereas GT 15 and GT 16 were protective ( GT 13 vs. GT 15 : OR\u200a=\u200a1.38, 95% CI\u200a=\u200a1.16\u20131.65, P UNCORRECTED\u200a=\u200a 0.001, P Bon\u200a=\u200a 0.005, P FDR\u200a=\u200a 0.002).", {"entities": [[63, 69, "DISEASE"]]}], ["Similar results were obtained in the subgroup analysis of Asian population.", {"entities": []}], ["G2964A polymorphism analysis showed that the AA genotype moderately increased the risk of asthma by 47% compared with the GG genotype (OR\u200a=\u200a1.47, p\u200a=\u200a0.068) in Chinese population, whereas the 2964A allele moderately increased the risk of asthma in Chinese population by 18% ( 2964A vs. 2964G : OR\u200a=\u200a1.18, p\u200a=\u200a0.08).", {"entities": [[90, 96, "DISEASE"], [238, 244, "DISEASE"]]}], ["However, none of the associations reached statistically significant levels particularly after correction for multiple testing.", {"entities": []}], ["This meta-analysis suggests that S allele ( GT 13 and GT 14 ) of the GT repeat polymorphism confers significant risks to asthma.", {"entities": [[121, 127, "DISEASE"]]}], ["However, the G2964A polymorphism does not have an association with the susceptibility to asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["Chromatin structure at a given site can differ between chromosome copies in a cell, and such imbalances in chromatin structure have been shown to be important in understanding the molecular mechanisms controlling several disease loci.", {"entities": []}], ["Human genetic variation, DNA methylation, and disease have been intensely studied, uncovering many sites of allele-specific DNA methylation (ASM).", {"entities": []}], ["However, little is known about the genome-wide occurrence of sites of allele-specific histone modification (ASHM) and their relationship to human disease.", {"entities": []}], ["The aim of this study was to investigate the extent and characteristics of sites of ASHM in human embryonic stem cells (hESCs).", {"entities": []}], ["Using a statistically rigorous protocol, we investigated the genomic distribution of ASHM in hESCs, and their relationship to sites of allele-specific expression (ASE) and DNA methylation.", {"entities": []}], ["We found that, although they were rare, sites of ASHM were substantially enriched at loci displaying ASE.", {"entities": []}], ["Many were also found at known imprinted regions, hence sites of ASHM are likely to be better markers of imprinted regions than sites of ASM.", {"entities": []}], ["We also found that sites of ASHM and ASE in hESCs colocalize at risk loci for developmental syndromes mediated by deletions, providing insights into the etiology of these disorders.", {"entities": []}], ["These results demonstrate the potential importance of ASHM patterns in the interpretation of disease loci, and the protocol described provides a basis for similar studies of ASHM in other cell types to further our understanding of human disease susceptibility.", {"entities": []}], ["Information regarding the characteristics and health of women who do and do not attend for breast cancer screening is limited and representative data are difficult to obtain.", {"entities": [[91, 104, "DISEASE"], [98, 104, "DISEASE"]]}], ["Information on age, deprivation and prescriptions for various medications was obtained for all women at two UK general practices who were invited to breast cancer screening through the National Health Service Breast Screening Programme.", {"entities": [[149, 162, "DISEASE"], [156, 162, "DISEASE"]]}], ["The characteristics of women who attended and did not attend screening were compared.", {"entities": []}], ["Of the 1064 women invited to screening from the two practices, 882 (83%) attended screening.", {"entities": []}], ["Screening attenders were of a similar age to non-attenders but came from significantly less deprived areas (30% of attenders versus 50% of non-attenders came from the most deprived areas, P < 0.0001) and were more likely to have a current prescription for hormone replacement therapy (32% versus 19%, P < 0.0001).", {"entities": []}], ["No significant differences in recent prescriptions of medication for hypertension, heart disease, hypercholesterolaemia, diabetes mellitus, asthma, thyroid disease or depression/anxiety were observed between attenders and non-attenders.", {"entities": [[69, 81, "DISEASE"], [83, 96, "DISEASE"], [140, 146, "DISEASE"], [121, 138, "DISEASE"]]}], ["Women who attend the National Health Service Breast Screening Programme come from less deprived areas and are more likely to have a current prescription for hormone replacement therapy than non-attenders, but do not differ in terms of age or recent prescriptions for various other medications.", {"entities": []}], ["Platinum sulfate was administered intragastrically (IG) to adult male Swiss mice in a single dose at the 7 day LD5 or LD25 level.", {"entities": []}], ["Control groups received 0.25M H2SO4 (pH 0.85) or 0.14M NaCl.", {"entities": []}], ["Open field behavior (ambulations, rearings) was measured, and tissue/organ Pt levels determined at 4 hr, or 1, 3, or 7 days post administration.", {"entities": [[101, 103, "GENE"]]}], ["At all times, the LD25 depressed ambulations significantly and rearings marginally.", {"entities": []}], ["It did not effect exploratory (\"hole-in-board\") behavior.", {"entities": []}], ["The LD25 resulted in disproportionately high tissue Pt levels relateive to the LD5.", {"entities": []}], ["There were significant inverse correlations between behavior and tissue Pt levels for most tissues, but not for brain.", {"entities": []}], ["In related experiments, adult male mice were subjected to repeated IG administration of Pt(SO4)2 at the LD1 level (one dose every 72 hr for up to 10 doses).", {"entities": [[133, 135, "GENE"]]}], ["Three days after administration of the final dose of each series, open-field and exploratory performance were measured and tissue/organ Pt levels determined.", {"entities": []}], ["Tissue/organ Pt levels were variable but generally increased with dose number.", {"entities": []}], ["No Pt was detected in the brain.", {"entities": []}], ["Activity and explorations were marginally depressed.", {"entities": []}], ["Only rearings correlated significantly with tissue Pt levels.", {"entities": []}], ["It is important to include large sample sizes and different factors that influence the six-minute walking distance (6MWD) in order to propose reference equations for the six-minute walking test (6MWT).", {"entities": []}], ["To evaluate the influence of anthropometric, demographic, and physiologic variables on the 6MWD of healthy subjects from different regions of Brazil to establish a reference equation for the Brazilian population.", {"entities": []}], ["In a multicenter study, 617 healthy subjects performed two 6MWTs and had their weight, height, and body mass index (BMI) measured, as well as their physiologic responses to the test.", {"entities": []}], ["Delta heart rate (\u2206HR), perceived effort, and peripheral oxygen saturation were calculated by the difference between the respective values at the end of the test minus the baseline value.", {"entities": []}], ["Walking distance averaged 586\u00b1106m, 54m greater in male compared to female subjects (p<0.001).", {"entities": []}], ["No differences were observed among the 6MWD from different regions.", {"entities": []}], ["The quadratic regression analysis considering only anthropometric and demographic data explained 46% of the variability in the 6MWT (p<0.001) and derived the equation: 6MWD pred =890.46-(6.11\u00d7age)+(0.0345\u00d7age pred =356.658-(2.303\u00d7age)+(36.648\u00d7gender)+(1.704\u00d7height)+(1.365\u00d7\u2206HR).", {"entities": []}], ["The equations proposed in this study, especially the second one, seem adequate to accurately predict the 6MWD for Brazilians.", {"entities": []}], ["Several studies have shown a reduced efficacy of influenza vaccines in the elderly compared to young adults.", {"entities": [[49, 58, "DISEASE"]]}], ["In this study, we evaluated the immunogenicity and protective efficacy of a commercially available inactivated influenza vaccine (Fluzone in vitro stimulation by Fluzone and CpG which may partially explain this result.", {"entities": [[111, 120, "DISEASE"]]}], ["Our data are supportive of studies that have shown limited effectiveness of influenza vaccines in the elderly and provide important information relevant to the design of more immunogenic vaccines in this age group.", {"entities": [[76, 85, "DISEASE"]]}], ["Tumor immunosuppression is commonly braided with chronic inflammation during tumor development.", {"entities": []}], ["However, the relationship between immunosuppression and inflammation in tumor microenvironment is still unclear.", {"entities": []}], ["We have demonstrated that mast cells are accumulated and exacerbate the inflammation and immunosuppression in tumor microenvironment via SCF/c-kit signaling pathway.", {"entities": []}], ["Here, we further elucidate the underlying mechanism, which involves both myeloid-derived suppressor cells (MDSCs) and regulatory T (Treg) cells.", {"entities": []}], ["Our data showed that mast cells mobilized the infiltration of MDSCs to tumor and induced the production of IL-17 by MDSCs; MDSCs-derived IL-17 indirectly attracted Treg cells, enhanced their suppressor function, and induced the IL-9 production by Treg cells; in turn, IL-9 strengthened the survival and protumor effect of mast cells in tumor microenvironment.", {"entities": []}], ["Our findings disclose a closed loop among mast cells, MDSCs and Treg cells in tumor microenvironment, which provides a new insight into the paralleled developments of inflammation and immunosuppression in tumor microenvironment.", {"entities": []}], ["Based on these findings, we propose that targeting tumor inflammation might be a potential strategy to reverse the immunosuppression of tumor microenvironment, thus facilitating cancer immunotherapy.", {"entities": [[178, 184, "DISEASE"]]}], ["Studies have suggested that children living close to busy roads may have impaired respiratory health.", {"entities": []}], ["This study was designed to test the hypothesis that exposure to exhaust from heavy traffic in particular is related to childhood respiratory health.", {"entities": []}], ["Children attending 24 schools located within 400 m from busy motorways were investigated.", {"entities": []}], ["The motorways carried between 5,190 and 22,326 trucks per weekday and between 30,399 and 155,656 cars per day.", {"entities": [[97, 101, "GENE"]]}], ["Locations were chosen so that the correlation between truck and car traffic counts was low.", {"entities": []}], ["Air pollution measurements were performed at the schools for 1 year.", {"entities": []}], ["Respiratory symptoms were collected by parent-completed questionnaire.", {"entities": []}], ["Sensitization to common allergens was measured by serum immunoglobulin E and skin prick tests.", {"entities": []}], ["Bronchial hyperresponsiveness (BHR) was measured with a hypertonic saline challenge.", {"entities": []}], ["Respiratory symptoms were increased near motorways with high truck but not high car traffic counts.", {"entities": []}], ["They were also related to air pollutants that increased near motorways with high truck traffic counts.", {"entities": []}], ["Lung function and BHR were not related to pollution.", {"entities": []}], ["Sensitization to pollen increased in relation to truck but not car traffic counts.", {"entities": []}], ["The relation between symptoms and measures of exposure to (truck) traffic-related air pollution were almost entirely restricted to children with BHR and/or sensitization to common allergens, indicating that these are a sensitive subgroup among all children for these effects.", {"entities": []}], ["Data on baseline characteristics of children with asthma to predict individual treatment responses are lacking.", {"entities": [[50, 56, "DISEASE"]]}], ["We aimed to set up a data-collection system which can easily fill this gap in clinical practice.", {"entities": []}], ["A web-based application was developed, named 'Portal for children with respiratory and allergic symptoms', hereafter called Electronic Portal (EP).", {"entities": []}], ["It contains health- and disease-related questionnaires on respiratory- and allergic diseases.", {"entities": []}], ["All patients, 1\u201318\u00a0years of age, with respiratory- and/or allergic complaints are invited to enter the EP before their first visit.", {"entities": []}], ["By using the EP large amounts of data, gathered during routine patient care can be used for research purposes.", {"entities": []}], ["This may help to further investigate the different treatment related asthma phenotypes and will be helpful to monitor risk factors for other atopic diseases and respiratory infections.", {"entities": [[69, 75, "DISEASE"]]}], ["Churg-Strauss syndrome (CSS) is a rare systemic necrotizing small-vessel vasculitis, with accompanying bronchial asthma, eosinophilia, and eosinophilic infiltration of various tissues.", {"entities": [[14, 22, "DISEASE"], [73, 83, "DISEASE"], [121, 133, "DISEASE"], [113, 119, "DISEASE"]]}], ["The purposes of our study were to characterize the clinical features of CSS and to identify factors associated with CSS prognosis in Koreans.", {"entities": []}], ["Medical records were reviewed retrospectively for all physician-diagnosed CSS patients in the Seoul National University Hospital between January 1990 and March 2011.", {"entities": []}], ["Data from 52 CSS patients were analyzed.", {"entities": []}], ["The respiratory tract was the most commonly involved organ (90.4%).", {"entities": []}], ["Renal involvement was less frequent in antineutrophilic cytoplasmic antibody (ANCA)(-) patients than in ANCA(+) patients ( p = 0.048).", {"entities": []}], ["Clinical remission occurred in 95.3% of patients, but 16.3% of them relapsed.", {"entities": []}], ["Patients who maintained remission for more than 6 months were relatively older (median, 51 years) at diagnosis ( p = 0.004), had been diagnosed in earlier stages ( p = 0.027), showed more frequent respiratory involvement ( p = 0.024) and generalized symptoms ( p = 0.039), and showed less frequent cutaneous involvement ( p = 0.030) than those who did not achieve persistent (> 6 months) remission.", {"entities": []}], ["Patients who achieved persistent remission also showed higher C-reactive protein (CRP) levels ( p = 0.031) than those who did not.", {"entities": [[82, 85, "GENE"]]}], ["ANCA(-) CSS patients showed less frequent renal involvement.", {"entities": []}], ["Characteristics of good responders were older age, diagnosis at earlier stages, less cutaneous involvement, more respiratory involvement, high CRP values, and more generalized symptoms.", {"entities": [[143, 146, "GENE"]]}], ["Tranilast, in addition to its capacity to inhibit mast cell degranulation, has other biological effects, including inhibition of reactive oxygen species, cytokines, leukotrienes and prostaglandin release.", {"entities": []}], ["In the current study, we analyzed whether tranilast could alter endothelial function in rat mesenteric resistance arteries (MRA).", {"entities": []}], ["Acetylcholine-induced relaxation was analyzed in MRA (untreated and 1-hour tranilast treatment) from 6 month-old Wistar rats.", {"entities": []}], ["To assess the possible participation of endothelial nitric oxide or prostanoids, acetylcholine-induced relaxation was analyzed in the presence of L-NAME or indomethacin.", {"entities": []}], ["The participation of endothelium-derived hyperpolarizing factor (EDHF) in acetylcholine-induced response was analyzed by preincubation with TRAM-34 plus apamin or by precontraction with a high K Acetylcholine-induced relaxation was greater in tranilast-incubated MRA.", {"entities": []}], ["Acetylcholine-induced vasodilation was decreased by L-NAME in a similar manner in both experimental groups.", {"entities": []}], ["Indomethacin did not modify vasodilation.", {"entities": []}], ["Preincubation with a high K Tranilast increased the endothelium-dependent relaxation to acetylcholine in rat MRA.", {"entities": []}], ["This effect is independent of the nitric oxide and cyclooxygenase pathways but involves EDHF, and is mediated by an increased role of small conductance calcium-activated K+ channels.", {"entities": []}], ["Idiopathic systemic capillary leak syndrome (SCLS) is a rare and potentially fatal vascular disorder characterized by reversible bouts of hypotension and edema resulting from fluid and solute escape into soft tissues.", {"entities": [[35, 43, "DISEASE"], [20, 43, "DISEASE"]]}], ["Although spikes in permeability-inducing factors have been linked to acute SCLS flares, whether or not they act on an inherently dysfunctional endothelium is unknown.", {"entities": []}], ["To assess the contribution of endothelial-intrinsic mechanisms in SCLS, we derived blood-outgrowth endothelial cells (BOEC) from patients and healthy controls and examined gene expression patterns.", {"entities": []}], ["Ednra , encoding Endothelin receptor A (ETA)\u2014the target of Endothelin 1 (ET-1)\u2014was significantly increased in SCLS BOEC compared to healthy controls.", {"entities": [[0, 5, "GENE"]]}], ["Although vasoconstriction mediated by ET-1 through ETA activation on vascular smooth muscle cells has been well characterized, the expression and function of ETA receptors in endothelial cells (ECs) has not been described.", {"entities": []}], ["To determine the role of ETA and its ligand ET-1 in SCLS, if any, we examined ET-1 levels in SCLS sera and functional effects of endothelial ETA expression.", {"entities": []}], ["ETA overexpression in EAhy926 endothelioma cells led to ET-1-induced hyper-permeability through canonical mechanisms.", {"entities": []}], ["Serum ET-1 levels were elevated in acute SCLS sera compared to remission and healthy control sera, suggesting a possible role for ET-1 and ETA in SCLS pathogenesis.", {"entities": []}], ["However, although ET-1 alone did not induce hyper-permeability of patient-derived BOEC, an SCLS-related mediator (CXCL10) increased Edrna quantities in BOEC, suggesting a link between SCLS and endothelial ETA expression.", {"entities": [[114, 120, "GENE"]]}], ["These results demonstrate that ET-1 triggers classical mechanisms of vascular barrier dysfunction in ECs through ETA.", {"entities": []}], ["Further studies of the ET-1-ETA axis in SCLS and in more common plasma leakage syndromes including sepsis and filovirus infection would advance our understanding of vascular integrity mechanisms and potentially uncover new treatment strategies.", {"entities": []}], ["Inflammation is a hot topic in medical research, because it plays a key role in inflammatory diseases: rheumatoid arthritis (RA) and other forms of arthritis, diabetes, heart diseases, irritable bowel syndrome, Alzheimer\u2019s disease, Parkinson\u2019s disease, allergies, asthma, even cancer and many others.", {"entities": [[185, 209, "DISEASE"], [103, 123, "DISEASE"], [201, 209, "DISEASE"], [114, 123, "DISEASE"], [148, 157, "DISEASE"], [264, 270, "DISEASE"], [277, 283, "DISEASE"]]}], ["Over the past few decades, it was realized that the process of inflammation is virtually the same in different disorders, and a better understanding of inflammation may lead to better treatments for numerous diseases.", {"entities": []}], ["Inflammation is the activation of the immune system in response to infection, irritation, or injury, with an influx of white blood cells, redness, heat, swelling, pain, and dysfunction of the organs involved.", {"entities": []}], ["Although the pathophysiological basis of these conditions is not yet fully understood, reactive oxygen species (ROS) have often been implicated in their pathogenesis.", {"entities": []}], ["In fact, in inflammatory diseases the antioxidant defense system is compromised, as evidenced by increased markers of oxidative stress, and decreased levels of protective antioxidant enzymes in patients with rheumatoid arthritis (RA).", {"entities": [[208, 228, "DISEASE"], [219, 228, "DISEASE"]]}], ["An enriched diet containing antioxidants, such as vitamin E, vitamin C, \u03b2-carotene and phenolic substances, has been suggested to improve symptoms by reducing disease-related oxidative stress.", {"entities": []}], ["In this respect, the marine world represents a largely untapped reserve of bioactive ingredients, and considerable potential exists for exploitation of these bioactives as functional food ingredients.", {"entities": []}], ["Substances such as n -3 oils, carotenoids, vitamins, minerals and peptides provide a myriad of health benefits, including reduction of cardiovascular diseases, anticarcinogenic and anti-inflammatory activities.", {"entities": []}], ["New marine bioactives are recently gaining attention, since they could be helpful in combating chronic inflammatory degenerative conditions.", {"entities": []}], ["The aim of this review is to examine the published studies concerning the potential pharmacological properties and application of many marine bioactives against inflammatory diseases.", {"entities": []}], ["The Health Literacy Questionnaire (HLQ), developed in Australia in 2012 using a \u2018validity-driven\u2019 approach, has been rapidly adopted and is being applied in many countries and languages.", {"entities": []}], ["It is a multidimensional measure comprising nine distinct domains that may be used for surveys, needs assessment, evaluation and outcomes assessment as well as for informing service improvement and the development of interventions.", {"entities": []}], ["The aim of this paper is to describe the German translation of the HLQ and to present the results of the validation of the culturally adapted version.", {"entities": []}], ["The HLQ comprises 44 items, which were translated and culturally adapted to the German context.", {"entities": []}], ["This study uses data collected from a sample of 1,058 persons with chronic conditions.", {"entities": []}], ["Statistical analyses include descriptive and confirmatory factor analyses.", {"entities": []}], ["In one-factor congeneric models, all scales demonstrated good fit after few model adjustments.", {"entities": []}], ["In a single, highly restrictive nine-factor model (no cross-loadings, no correlated errors) replication of the original English-language version was achieved with fit indices and psychometric properties similar to the original HLQ.", {"entities": []}], ["Reliability for all scales was excellent, with a Cronbach\u2019s Alpha of at least 0.77.", {"entities": []}], ["High to very high correlations between some HLQ factors were observed, suggesting that higher order factors may be present.", {"entities": []}], ["Our rigorous development and validation protocol, as well as strict adaptation processes, have generated a remarkable reproduction of the HLQ in German.", {"entities": []}], ["The results of this validation provide evidence that the HLQ is robust and can be recommended for use in German-speaking populations.", {"entities": []}], ["Trial Registration : German Clinical Trial Registration (DRKS): DRKS00000584 .", {"entities": []}], ["Registered 23 March 2011.", {"entities": []}], ["The aim of this study was to assess the effects of ursodeoxycholic acid composite ( URSA \u2010S) on fatigue in patients with elevated liver function tests and/or fatty liver disease.", {"entities": [[158, 177, "DISEASE"], [164, 177, "DISEASE"]]}], ["In this multi\u2010centre randomised double\u2010blinded placebo\u2010controlled trial, 168 adults who were diagnosed with fatigue based on our criteria and had elevated liver function tests (but not > 5 times the normal level) and/or fatty liver on ultrasonography, were randomised to either the placebo or URSA \u2010S administration group.", {"entities": []}], ["The rate of improvement of checklist individual strength ( CIS ) using a cut\u2010off of 76 points at the end of the study (8 weeks), the change in fatigue scale [ CIS score and visual analogue scale ( VAS )] were evaluated.", {"entities": []}], ["The adverse effects of URSA \u2010S were also recorded.", {"entities": []}], ["The rate of CIS improvement at the end\u2010point was 79.76% and 45.68% in the therapy and placebo groups, respectively (p < 0.05).", {"entities": []}], ["The fatigue recovery rate of the CIS score and VAS were higher in the therapy (\u221225.44 \u00b1 18.57, \u221227.84 \u00b1 2.70) than in the placebo group (\u221216.59 \u00b1 17.29, \u221219.46 \u00b1 2.81) (p < 0.05).", {"entities": []}], ["The difference in fatigue recovery rate between the therapy and placebo groups was significant after 8 weeks.", {"entities": []}], ["When analysed separately in patients with abnormal liver function tests and fatty liver disease, the fatigue recovery rate of the CIS score and VAS at 8 weeks was higher in the therapy than in the placebo group (p < 0.05).", {"entities": [[76, 95, "DISEASE"], [82, 95, "DISEASE"]]}], ["The frequency of adverse events in the therapy group was not significantly higher than that in the placebo group.", {"entities": []}], ["URSA \u2010S is effective for alleviating fatigue in patients with liver dysfunction and/or fatty liver.", {"entities": []}], ["The adverse effects of URSA \u2010S are not significant.", {"entities": []}], ["This study is registered at https://clinicaltrials.gov/ct2/show/ NCT 02415777.", {"entities": []}], ["Mechanical ventilation (MV) can induce or worsen pulmonary oedema.", {"entities": []}], ["Aquaporins (AQPs) facilitate the selective and rapid bi-directional movement of water.", {"entities": []}], ["Their role in the development and resolution of pulmonary oedema is controversial.", {"entities": []}], ["Our objectives are to determine if prolonged MV causes lung oedema and changes in the expression of AQP 1 and AQP 5 in rats.", {"entities": []}], ["25 male Wistar rats were subjected to MV with a tidal volume of 10 ml/kg, during 2 hours (n\u200a=\u200a12) and 4 hours (n\u200a=\u200a13).", {"entities": []}], ["Degree of oedema was compared with a group of non-ventilated rats (n\u200a=\u200a5).", {"entities": []}], ["The expression of AQP 1 and AQP 5 were determined by western immunoblotting, measuring the amount of mRNA (previously amplified by RT-PCR) and immunohistochemical staining of AQPs 1 and 5 in lung samples from all groups.", {"entities": []}], ["Lung oedema and alveolar-capillary membrane permeability did not change during MV.", {"entities": []}], ["AQP-5 steady state levels in the western blot were increased (p<0.01) at 2 h and 4 h of MV.", {"entities": []}], ["But in AQP-1 expression these differences were not found.", {"entities": []}], ["However, the amount of mRNA for AQP-1 was increased at 2 h and 4 h of MV; and for AQP 5 at 4 h of MV.", {"entities": []}], ["These findings were corroborated by representative immunohistochemical lung samples.", {"entities": []}], ["In lungs from rats ventilated with a low tidal volume the expression of AQP 5 increases gradually with MV duration, but does not cause pulmonary oedema or changes in lung permeability.", {"entities": []}], ["AQPs may have a protective effect against the oedema induced by MV.", {"entities": []}], ["Insulin-like growth factor-I (IGF-I)/IGF-I receptor (IGF-IR) system has been largely involved in the pathogenesis and development of various tumors.", {"entities": []}], ["We have previously demonstrated that IGF-IR cooperates with the G-protein estrogen receptor (GPER) and the collagen receptor discoidin domain 1 (DDR1) that are implicated in cancer progression.", {"entities": [[174, 180, "DISEASE"], [93, 97, "GENE"], [145, 149, "GENE"]]}], ["Here, we provide novel evidence regarding the molecular mechanisms through which IGF-I/IGF-IR signaling triggers a functional cross-talk with GPER and DDR1 in both mesothelioma and lung cancer cells.", {"entities": [[181, 192, "DISEASE"], [186, 192, "DISEASE"], [142, 146, "GENE"], [151, 155, "GENE"]]}], ["In particular, we show that IGF-I activates the transduction network mediated by IGF-IR leading to the up-regulation of GPER and its main target genes CTGF and EGR1 as well as the induction of DDR1 target genes like MATN-2, FBN-1, NOTCH 1 and HES-1.", {"entities": [[120, 124, "GENE"], [151, 155, "GENE"], [160, 164, "GENE"], [193, 197, "GENE"]]}], ["Of note, certain DDR1-mediated effects upon IGF-I stimulation required both IGF-IR and GPER as determined knocking-down the expression of these receptors.", {"entities": [[87, 91, "GENE"]]}], ["The aforementioned findings were nicely recapitulated in important biological outcomes like IGF-I promoted chemotaxis and migration of both mesothelioma and lung cancer cells.", {"entities": [[157, 168, "DISEASE"], [162, 168, "DISEASE"]]}], ["Overall, our data suggest that IGF-I/IGF-IR system triggers stimulatory actions through both GPER and DDR1 in aggressive tumors as mesothelioma and lung tumors.", {"entities": [[93, 97, "GENE"], [102, 106, "GENE"]]}], ["Hence, this novel signaling pathway may represent a further target in setting innovative anticancer strategies.", {"entities": []}], ["Essentials Tissue factor (TF) represents a central link between hemostasis and inflammation.", {"entities": [[26, 28, "GENE"]]}], ["We studied the roles of myeloid and airway epithelial TF in acid\u2010caused acute lung injury (ALI).", {"entities": [[54, 56, "GENE"]]}], ["TF on myeloid cells displays a non\u2010coagulatory role regulating the inflammatory response in ALI.", {"entities": [[0, 2, "GENE"]]}], ["Airway epithelial TF contributes to hemostatic functions, but is dispensable in ALI pathogenesis.", {"entities": [[18, 20, "GENE"]]}], ["Tissue factor (TF) represents a central link between hemostasis and inflammation.", {"entities": [[15, 17, "GENE"]]}], ["We studied the roles of myeloid and airway epithelial TF in acid\u2010caused acute lung injury (ALI).", {"entities": [[54, 56, "GENE"]]}], ["TF on myeloid cells displays a non\u2010coagulatory role regulating the inflammatory response in ALI.", {"entities": [[0, 2, "GENE"]]}], ["Airway epithelial TF contributes to hemostatic functions, but is dispensable in ALI pathogenesis.", {"entities": [[18, 20, "GENE"]]}], ["Tissue factor (TF) represents a central link between hemostasis and inflammation.", {"entities": [[15, 17, "GENE"]]}], ["We studied the roles of myeloid and airway epithelial TF in acid\u2010caused acute lung injury (ALI).", {"entities": [[54, 56, "GENE"]]}], ["TF on myeloid cells displays a non\u2010coagulatory role regulating the inflammatory response in ALI.", {"entities": [[0, 2, "GENE"]]}], ["Airway epithelial TF contributes to hemostatic functions, but is dispensable in ALI pathogenesis.", {"entities": [[18, 20, "GENE"]]}], ["Acute lung injury ( ALI ) is a life\u2010threatening condition characterized by damaged alveolar\u2013capillary structures and activation of inflammatory and hemostatic processes.", {"entities": []}], ["Tissue factor ( TF ) represents a crucial link between inflammation and coagulation, as inflammatory mediators induce myeloid TF expression, and TF initiates extrinsic coagulation.", {"entities": [[16, 18, "GENE"], [126, 128, "GENE"], [145, 147, "GENE"], [16, 18, "GENE"], [126, 128, "GENE"], [145, 147, "GENE"], [16, 18, "GENE"], [126, 128, "GENE"], [145, 147, "GENE"]]}], ["As pulmonary inflammation stimulates TF expression and TF modulates immune responses, we aimed to elucidate its impact on ALI .", {"entities": [[37, 39, "GENE"], [55, 57, "GENE"], [37, 39, "GENE"], [55, 57, "GENE"]]}], ["In particular, we wanted to distinguish the contributions of TF expressed on airway epithelial cells and TF expressed on myeloid cells.", {"entities": [[61, 63, "GENE"], [105, 107, "GENE"], [61, 63, "GENE"], [105, 107, "GENE"]]}], ["Mice with different cell type\u2010specific TF deficiency and wild\u2010type littermates were intratracheally treated with hydrochloric acid, and leukocyte recruitment, cytokine levels, thrombin\u2013antithrombin ( TAT ) complexes and pulmonary protein\u2010rich infiltrates were analyzed.", {"entities": [[39, 41, "GENE"]]}], ["Our data demonstrate that a lack of epithelial TF did not influence acute responses, as bronchoalveolar neutrophil accumulation 8 h after ALI induction was unaltered.", {"entities": [[47, 49, "GENE"]]}], ["However, it led to mild, prolonged inflammation, as pulmonary leukocyte and erythrocyte numbers were still increased after 24 h, whereas those in wild\u2010type mice had returned to basal levels.", {"entities": []}], ["In contrast, myeloid TF was primarily involved in regulating the acute phase of ALI without affecting local coagulation, as indicated by increased bronchoalveolar neutrophil infiltration, pulmonary interleukin\u20106 levels, and edema formation, but equal TAT complex formation, 8 h after ALI induction.", {"entities": [[21, 23, "GENE"]]}], ["This augmented inflammatory response associated with myeloid TF deficiency was confirmed in vitro , as lipopolysaccharide\u2010stimulated TF \u2010deficient alveolar macrophages released increased levels of chemokine (C\u2010X\u2010C motif) ligand 1 and tumor necrosis factor\u2010\u03b1 as compared with wild\u2010type macrophages.", {"entities": [[61, 63, "GENE"], [133, 135, "GENE"], [61, 63, "GENE"], [133, 135, "GENE"]]}], ["We conclude that myeloid TF dampens inflammation in acid\u2010induced ALI .", {"entities": [[25, 27, "GENE"]]}], ["Consumption of sugar-sweetened beverages, such as soda, have been shown to play an important role in weight gain.", {"entities": []}], ["Although soda consumption has been associated with body mass index (BMI) in many studies, it has been difficult to ascertain a true causal relationship between soda consumption and BMI for two reasons.", {"entities": []}], ["First, findings have been based largely on observational and cross-sectional studies, with much less evidence from randomized controlled trials.", {"entities": []}], ["Second, the reported relationships may be confounded by genetic and shared environmental factors that affect both soda consumption and BMI.", {"entities": []}], ["In the present study, we used the twin design to better understand the relationship between soda consumption and BMI by accounting for measured and unmeasured confounds in non-experimental data.", {"entities": []}], ["Associations from genetically informed tests in twins are considered \u201cquasi-causal,\u201d suggesting that our confidence in the causal underpinning of the association between soda consumption and BMI has been strengthened.", {"entities": []}], ["We hypothesized that the association between soda consumption and BMI would be significant both between and within twins.", {"entities": []}], ["This was a cross sectional study of 5787 same sex adult twin pairs (18\u201397\u00a0years, 66% female) from the community based Washington State Twin Registry.", {"entities": []}], ["Structural equation modeling (SEM) was employed to investigate associations between soda consumption and BMI in the population (the phenotypic association between exposure and outcome among all twins treated as individuals) and within pairs of identical and fraternal twins (the quasi-causal association controlling for between pair genetic and environmental confounds).", {"entities": []}], ["Among all twins, there was a significant phenotypic association between soda consumption and BMI that held when controlling for age, sex, race, annual household income, and education level ( P \u00a0<\u00a00.05).", {"entities": []}], ["In the quasi-causal model, however, the effect of soda consumption on BMI was greatly reduced and no longer significant, with a large genetic confound in both men and women ( P \u00a0<\u00a00.05).", {"entities": []}], ["Among a large group of adult twin pairs, increased soda consumption was associated with increased BMI; however, the observed association was mediated by a genetic background common to both.", {"entities": []}], ["To evaluate the impact of using a \u2018virtual clinic\u2019 on patient experience and cost in the care of women with urinary incontinence.", {"entities": []}], ["Women, aged > 18 years referred to a urogynaecology unit were randomised to either (1) A Standard Clinic or (2) A Virtual Clinic.", {"entities": []}], ["Both groups completed a validated, web-based interactive, patient-reported outome measure (ePAQ-Pelvic Floor), in advance of their appointment followed by either a telephone consultation (Virtual Clinic) or face-to-face consultation (Standard Care).", {"entities": []}], ["The primary outcome was the mean \u2018short-term outcome scale\u2019 score on the Patient Experience Questionnaire (PEQ).", {"entities": []}], ["Secondary Outcome Measures included the other domains of the PEQ (Communications, Emotions and Barriers), Client Satisfaction Questionnaire (CSQ), Short-Form 12 (SF-12), personal, societal and NHS costs.", {"entities": [[193, 196, "GENE"]]}], ["195 women were randomised: 98 received the intervention and 97 received standard care.", {"entities": []}], ["The primary outcome showed a non-significant difference between the two study arms.", {"entities": []}], ["No significant differences were also observed on the CSQ and SF-12.", {"entities": []}], ["However, the intervention group showed significantly higher PEQ domain scores for Communications, Emotions and Barriers (including following adjustment for age and parity).", {"entities": []}], ["Whilst standard care was overall more cost-effective, this was minimal (\u00a338.04).", {"entities": []}], ["The virtual clinic also significantly reduced consultation time (10.94 minutes, compared with a mean duration of 25.9 minutes respectively) and consultation costs compared to usual care (\u00a331.75 versus \u00a372.17 respectively), thus presenting potential cost-savings in out-patient management.", {"entities": []}], ["The virtual clinical had no impact on the short-term dimension of the PEQ and overall was not as cost-effective as standard care, due to greater clinic re-attendances in this group.", {"entities": []}], ["In the virtual clinic group, consultation times were briefer, communication experience was enhanced and personal costs lower.", {"entities": []}], ["For medical conditions of a sensitive or intimate nature, a virtual clinic has potential to support patients to communicate with health professionals about their condition.", {"entities": []}], ["The number of patients with autoimmune diseases and severe allergies and recipients of transplants increases worldwide.", {"entities": []}], ["Currently, these patients require lifelong administration of immunomodulatory drugs.", {"entities": []}], ["Often, these drugs are expensive and show immediate or late-occurring severe side effects.", {"entities": []}], ["Treatment would be greatly improved by targeting the cause of autoimmunity, that is, loss of tolerance to self-antigens.", {"entities": []}], ["Accumulating knowledge on immune mechanisms has led to the development of tolerogenic dendritic cells (tolDC), with the specific objective to restrain unwanted immune reactions in the long term.", {"entities": []}], ["The first clinical trials with tolDC have recently been conducted and more tolDC trials are underway.", {"entities": []}], ["Although the safety trials have been encouraging, many questions relating to tolDC, for example, cell-manufacturing protocols, administration route, amount and frequency, or mechanism of action, remain to be answered.", {"entities": []}], ["Aiming to join efforts in translating tolDC and other tolerogenic cellular products (e.g., Tregs and macrophages) to the clinic, a European COST (European Cooperation in Science and Technology) network has been initiated\u2014A FACTT (action to focus and accelerate cell-based tolerance-inducing therapies).", {"entities": []}], ["A FACTT aims to minimize overlap and maximize comparison of tolDC approaches through establishment of minimum information models and consensus monitoring parameters, ensuring that progress will be in an efficient, safe, and cost-effective way.", {"entities": []}], ["The burden of H1N1 among socially disadvantaged populations is unclear.", {"entities": []}], ["We aimed to synthesize hospitalization, severe illness, and mortality data associated with pandemic A/H1N1/2009 among socially disadvantaged populations.", {"entities": []}], ["Studies were identified through searching MEDLINE, EMBASE, scanning reference lists, and contacting experts.", {"entities": []}], ["Studies reporting hospitalization, severe illness, and mortality attributable to laboratory-confirmed 2009 H1N1 pandemic among socially disadvantaged populations (e.g., ethnic minorities, low-income or lower-middle-income economy countries [LIC/LMIC]) were included.", {"entities": []}], ["Two independent reviewers conducted screening, data abstraction, and quality appraisal (Newcastle Ottawa Scale).", {"entities": []}], ["Random effects meta-analysis was conducted using SAS and Review Manager.", {"entities": []}], ["Sixty-two studies including 44,777 patients were included after screening 787 citations and 164 full-text articles.", {"entities": []}], ["The prevalence of hospitalization for H1N1 ranged from 17\u201387% in high-income economy countries (HIC) and 11\u201345% in LIC/LMIC.", {"entities": []}], ["Of those hospitalized, the prevalence of intensive care unit (ICU) admission and mortality was 6\u201376% and 1\u201325% in HIC; and 30% and 8\u201315%, in LIC/LMIC, respectively.", {"entities": []}], ["There were significantly more hospitalizations among ethnic minorities versus non-ethnic minorities in two studies conducted in North America (1,313 patients, OR 2.26 [95% CI: 1.53\u20133.32]).", {"entities": []}], ["There were no differences in ICU admissions (n\u200a=\u200a8 studies, 15,352 patients, OR 0.84 [0.69\u20131.02]) or deaths (n\u200a=\u200a6 studies, 14,757 patients, OR 0.85 [95% CI: 0.73\u20131.01]) among hospitalized patients in HIC.", {"entities": []}], ["Sub-group analysis indicated that the meta-analysis results were not likely affected by confounding.", {"entities": []}], ["Overall, the prevalence of hospitalization, severe illness, and mortality due to H1N1 was high for ethnic minorities in HIC and individuals from LIC/LMIC.", {"entities": []}], ["However, our results suggest that there were little differences in the proportion of hospitalization, severe illness, and mortality between ethnic minorities and non-ethnic minorities living in HIC.", {"entities": []}], ["Since its discovery, ADAM17, also known as TNF \u03b1 converting enzyme or TACE, is now known to process over 80 different substrates.", {"entities": [[21, 27, "GENE"], [43, 46, "GENE"]]}], ["Many of these substrates are mediators of cancer and inflammation.", {"entities": [[42, 48, "DISEASE"]]}], ["The field of ADAM metalloproteinases is at a crossroad with many of the new potential therapeutic agents for ADAM17 advancing into the clinic.", {"entities": [[109, 115, "GENE"]]}], ["Researchers have now developed potential drugs for ADAM17 that are selective and do not have the side effects which were seen in earlier chemical entities that targeted this enzyme.", {"entities": [[51, 57, "GENE"]]}], ["ADAM17 inhibitors have broad therapeutic potential, with properties ranging from tumor immunosurveillance and overcoming drug and radiation resistance in cancer, as treatments for cardiac hypertrophy and inflammatory conditions such as inflammatory bowel disease and rheumatoid arthritis.", {"entities": [[236, 262, "DISEASE"], [267, 287, "DISEASE"], [278, 287, "DISEASE"], [154, 160, "DISEASE"], [0, 6, "GENE"]]}], ["This review focuses on substrates and inhibitors identified more recently for ADAM17 and their role in cancer and inflammation.", {"entities": [[103, 109, "DISEASE"], [78, 84, "GENE"]]}], ["Jaboticaba is a fruit from a native tree to Brazil, Plinia peruviana .", {"entities": []}], ["Jaboticaba peels are an important source of antioxidant molecules such as phenolic compounds.", {"entities": []}], ["This study aimed to evaluate in vitro the activity of a hydroalcoholic extract of jaboticaba fruit peels (HEJFP) in wound healing processes and antioxidant activity in murine fibroblasts (L929 cell line).", {"entities": []}], ["HEJFP concentrations (0.5, 1, 5, 10, 25, 50, 100, and 200\u2009 \u00b5 g/mL) were tested in MTT assay and cell proliferation was verified at 100\u2009 \u00b5 g/mL after 24\u2009h and at 25, 50, and 100\u2009 \u00b5 g/mL after 48\u2009h of extract exposure.", {"entities": []}], ["Evaluation of antioxidant activity was performed at 0.5, 5, 25, 50, and 100\u2009 \u00b5 g/mL HEJFP concentrations.", {"entities": []}], ["Cell treatment with HEJFP at 25, 50, and 100\u2009 \u00b5 g/mL for 24\u2009h followed by H 2 O 2 exposure for 3\u2009h showed a strong cytoprotective effect.", {"entities": []}], ["In vitro scratch wound healing assay indicated that none of tested HEJFP concentrations (0.5, 5, 25, 50, and 100\u2009 \u00b5 g/mL) were capable of increasing migration rate after 12\u2009h of incubation.", {"entities": []}], ["These results demonstrate a positive effect of HEJFP on the wound healing process on L929 fibroblasts cell line, probably due to the antioxidant activity exhibited by phytochemicals in the extract.", {"entities": []}], ["Linkage analysis methods that incorporate etiological heterogeneity of complex diseases are likely to demonstrate greater power than traditional linkage analysis methods.", {"entities": []}], ["Several such methods use covariates to discriminate between linked and unlinked pedigrees with respect to a certain disease locus.", {"entities": []}], ["Here we apply several such methods including two mixture models, ordered subset analysis, and a conditional logistic model to genome scan data on the DSM-IV alcohol dependence phenotype on the Collaborative Studies on Genetics of Alcoholism families, and compare the results to traditional nonparametric linkage analysis.", {"entities": [[157, 175, "DISEASE"]]}], ["In general, there was little agreement among the various covariate-based linkage statistics.", {"entities": []}], ["Linkage signals with empirical p -values less than 0.001 were detected on chromosomes 3, 4, 7, 10, and 12, with the highest peak occurring at the GABRB1 gene using the ecb21 covariate.", {"entities": [[146, 152, "GENE"]]}], ["Human rhinovirus is the causative agent of the common cold and belongs to the non-enveloped picornavirus family.", {"entities": [[47, 58, "DISEASE"]]}], ["A trigger such as receptor binding or low pH initiates conformational changes in the capsid that allow the virus to attach to membranes and form a pore for the translocation of viral RNA into the cytoplasm.", {"entities": []}], ["We previously showed that recombinant capsid protein VP4 was able to form membrane pores.", {"entities": []}], ["In this study, we show the N-terminus but not C-terminus of VP4 formed pores with properties similar to full-length VP4 and consistent with the size required for transfer of RNA.", {"entities": []}], ["Sera against the N-terminus but not C-terminus of VP4 were shown to neutralize virus infectivity.", {"entities": []}], ["Together, this suggests that the N-terminus of VP4 is responsible for membrane activity.", {"entities": []}], ["This study contributes to an improved understanding of the mechanisms for involvement of VP4 in entry and its potential as an antiviral target.", {"entities": []}], ["Human enterovirus 71 (EV71) is an important pathogen caused large outbreaks in Asian-Pacific region with severe neurological complications and may lead to death in young children.", {"entities": []}], ["Understanding of the etiological spectrum and epidemic changes of enterovirus and population\u2019s immunity against EV71 are crucial for the implementation of future therapeutic and prophylactic intervention.", {"entities": []}], ["A total of 1,182 patients who presented with the symptoms of hand foot and mouth disease (67.3%) or herpangina (HA) (16.7%) and admitted to the hospitals during 2008-2013 were tested for enterovirus using pan-enterovirus PCR targeting 5\u2032-untranslated region and specific PCR for viral capsid protein 1 gene.", {"entities": [[75, 88, "DISEASE"], [100, 110, "DISEASE"]]}], ["Overall, 59.7% were pan-enterovirus positive comprising 9.1% EV71 and 31.2% coxsackievirus species A (CV-A) including 70.5% CV-A6, 27.6% CV-A16, 1.1% CV-A10, and 0.8% CV-A5.", {"entities": []}], ["HFMD and HA occurred endemically during 2008-2011.", {"entities": []}], ["The number of cases increased dramatically in June 2012 with the percentage of the recently emerged CV-A6 significantly rose to 28.4%.", {"entities": []}], ["Co-circulation between different EV71 genotypes was observed during the outbreak.", {"entities": []}], ["Total of 161 sera obtained from healthy individuals were tested for neutralizing antibodies (NAb) against EV71 subgenotype B5 (EV71-B5) using microneutralization assay.", {"entities": []}], ["The seropositive rate of EV71-B5 was 65.8%.", {"entities": []}], ["The age-adjusted seroprevalence for individuals was found to be lowest in children aged >6\u00a0months to 2\u00a0years (42.5%).", {"entities": []}], ["The seropositive rate remained relatively low in preschool children aged\u2009>\u20092\u00a0years to 6\u00a0years (48.3%) and thereafter increased sharply to more than 80% in individuals aged\u2009>\u20096\u00a0years.", {"entities": []}], ["This study describes longitudinal data reflecting changing patterns of enterovirus prevalence over 6\u00a0years and demonstrates high seroprevalences of EV71-B5 NAb among Thai individuals.", {"entities": []}], ["The rate of EV71 seropositive increased with age but without gender-specific significant difference.", {"entities": []}], ["We identified that relative lower EV71 seropositive rate in early 2012 may demonstrate widely presented of EV71-B5 in the population before account for a large outbreak scale epidemic occurred in 2012 with due to a relatively high susceptibility of the younger population.", {"entities": []}], ["We compared the performances of 3 Multiple Allergen Simultaneous Test (MAST) assays: RIDA Allergy Screen (R-Biopharm, Darmstadt, Germany), MAST Optigen allergy system (Hitachi Chemical Diagnostics, Mountain View, CA), and Polycheck Allergy (Biocheck GmbH, Munster, Germany).", {"entities": []}], ["Forty sera that tested positive with the RIDA Allergy Screen (20 for food and 20 for inhalant panel) were subjected to MAST Optigen and Polycheck Allergy.", {"entities": []}], ["For 26 available sera with discrepant results, 62 ImmunoCAP allergen-specific IgE tests (Pharmacia Diagnostics, Uppsala, Sweden) were performed.", {"entities": []}], ["Percent agreements (kappa value) were 87.6% (0.59) and 91.3% (0.60) between RIDA and MAST; 89.9% (0.55) and 88.3% (0.46) between RIDA and Polycheck; and 86.8% (0.51) and 90.6% (0.61) between MAST and Polycheck.", {"entities": []}], ["Compared with ImmunoCAP, agreements (kappa value) of inhalant and food panels were 51.7% (0.04) and 33.3% (\u22120.38) for RIDA; 60.7% (0.27) and 81.8% (0.59) for MAST; and 65.5% (0.26) and 45.5% (0.07) for Polycheck.", {"entities": []}], ["The agreements between RIDA, MAST, and Polycheck and ImmunoCAP-positivity were 45.7%, 88.2%, and 28.6%, respectively, and the agreements for ImmunoCAP-negativity were 37.0%, 51.9%, and 88.9%.", {"entities": []}], ["MAST Optigen showed better agreement with ImmunoCAP than other assays in the food panel.", {"entities": []}], ["Better sensitivity of MAST Optigen and better specificity of Polycheck Allergy were suspected.", {"entities": []}], ["To determine the implementation of National Institute for Health and Care Excellence guidance (NICE CG83) for posthospital discharge critical illness follow-up and rehabilitation programmes.", {"entities": []}], ["Closed-question postal survey.", {"entities": []}], ["Adult intensive care units (ICUs) across the UK, identified from national databases of organisations.", {"entities": []}], ["Specialist-only and private ICUs were not included.", {"entities": []}], ["Senior respiratory critical care physiotherapy clinicians.", {"entities": []}], ["A representative sample of 182 surveys was returned from the 240 distributed (75.8% (95% CI 70.4 to 81.2)).", {"entities": []}], ["Only 48 organisations (27.3% (95% CI 20.7 to 33.9)) offered a follow-up service 2\u20133\u2005months following hospital discharge, the majority (n=39, 84.8%) in clinic format.", {"entities": []}], ["12 organisations reported posthospital discharge rehabilitation programmes (6.8% (95% CI 3.1 to 10.5)), albeit only 10 of these operated on a regular basis.", {"entities": []}], ["Lack of funding was reported as the most frequent (n=149/164, 90%) and main barrier (n=99/156, 63.5%) to providing services.", {"entities": []}], ["Insufficient resources (n=71/164, 43.3%) and lack of priority by the clinical management team (n=66/164, 40.2%) were also highly cited barriers to service delivery.", {"entities": []}], ["NICE CG83 has been successful in profiling the importance of rehabilitation for survivors of critical illness.", {"entities": []}], ["However, 4\u2005years following publication of CG83 there has been limited development of this clinical service across the UK.", {"entities": []}], ["Strategies to support delivery of such quality improvement programmes are urgently required to enhance patient care.", {"entities": []}], ["Interleukin-4 (IL-4) mediates important pro-inflammatory functions in asthma including induction of the IgE isotype switch, expression of vascular cell adhesion molecule-1 (VCAM-1), promotion of eosinophil transmigration across endothelium, mucus secretion, and differentiation of T helper type 2 lymphocytes leading to cytokine release.", {"entities": [[70, 76, "DISEASE"]]}], ["Asthma is a complex genetic disorder that has been linked to polymorphisms in the IL-4 gene promoter and proteins involved in IL-4 signaling.", {"entities": [[0, 6, "DISEASE"], [20, 36, "DISEASE"]]}], ["Soluble recombinant IL-4 receptor lacks transmembrane and cytoplasmic activating domains and can therefore sequester IL-4 without mediating cellular activation.", {"entities": []}], ["We report the results of initial clinical trials, which demonstrate clinical efficacy of this naturally occurring IL-4 antagonist as a therapeutic agent in asthma.", {"entities": [[156, 162, "DISEASE"]]}], ["Results of this study suggest that surgeon experience is more important than the absolute number of procedures performed each year as regards operative morbidity and mortality.", {"entities": []}], ["Surgical treatment of esophageal cancer is associated with a high rate of morbidity, even in specialized centers.", {"entities": [[22, 39, "DISEASE"], [33, 39, "DISEASE"]]}], ["Minimally invasive esophageal resection has become increasingly feasible and is gaining popularity in some high-volume institutions.", {"entities": []}], ["This study assesses the short-term outcomes of laparoscopic transhiatal esophagectomy performed by a single surgeon at a single low-volume institution over a 20-month period.", {"entities": []}], ["Over the study period, 16 patients underwent laparoscopic transhiatal esophagectomy.", {"entities": []}], ["All patients were men with an average age of 70 years (range, 50 to 81).", {"entities": []}], ["Two patients required intraoperative conversion to alternative surgical techniques, 1 to an Ivor-Lewis esophagectomy and 1 to an open transhiatal approach.", {"entities": []}], ["Average operative time was 198 minutes (range, 147 to 303).", {"entities": []}], ["Mean hospital stay was 16.7 days (range, 9 to 30).", {"entities": []}], ["The average number of resected lymph nodes was 11.7, and 2 patients had benign pathology.", {"entities": []}], ["No deaths occurred in the 30-day postoperative period.", {"entities": []}], ["Laparoscopic transhiatal esophagectomy is an advanced laparoscopic procedure that can be performed with equivalent morbidity and mortality by a low-volume surgeon in a low-volume center with results comparable to those of high-volume centers.", {"entities": []}], ["While several authors have demonstrated a correlation between lower mortality rates and high-volume esophagectomy hospitals, our results support surgeon experience as more important than the absolute number of procedures performed each year.", {"entities": []}], ["Different reports have highlighted the potential use of helminths and their secretions in the treatment of inflammatory bowel disease (IBD) conditions; however, no reports have investigated their effects at a proteome level.", {"entities": [[107, 133, "DISEASE"]]}], ["Herein, we characterise the protein expression changes that occur in lamina propria (LP) and the intestinal epithelial cells (IEC) of mice with dextran sulfate sodium (DSS)-induced colitis treated with Ancylostoma caninum excretory/secretory (ES) products using a quantitative proteomic approach.", {"entities": []}], ["We have shown how parasite products can significantly alter the expression of proteins involved in immune responses, cell death and with an antioxidant activity.", {"entities": []}], ["Interestingly, significant changes in the expression levels of different mucins were observed in this study.", {"entities": []}], ["MUC13, a mucin implicated in gastrointestinal homeostasis, was upregulated in the LP of mice with DSS-induced colitis treated with ES, while MUC2, a major component of mucus, was upregulated in the IEC.", {"entities": [[0, 5, "GENE"], [141, 145, "GENE"]]}], ["In addition, A. caninum proteins have an important effect on proteins with antioxidant functions and proteins involved in intestinal homeostasis and tissue integrity and regeneration.", {"entities": []}], ["Understanding how parasites can ameliorate IBD pathogenesis can help us design novel treatments for autoimmune diseases.", {"entities": []}], ["Accidental and intended Ricinus communis intoxications in humans and animals have been known for centuries but the causative agent remained elusive until 1888 when Stillmark attributed the toxicity to the lectin ricin.", {"entities": []}], ["Ricinus communis is grown worldwide on an industrial scale for the production of castor oil.", {"entities": []}], ["As by-product in castor oil production ricin is mass produced above 1 million tons per year.", {"entities": []}], ["On the basis of its availability, toxicity, ease of preparation and the current lack of medical countermeasures, ricin has gained attention as potential biological warfare agent.", {"entities": []}], ["The seeds also contain the less toxic, but highly homologous Ricinus communis agglutinin and the alkaloid ricinine, and especially the latter can be used to track intoxications.", {"entities": []}], ["After oil extraction and detoxification, the defatted press cake is used as organic fertilizer and as low-value feed.", {"entities": []}], ["In this context there have been sporadic reports from different countries describing animal intoxications after uptake of obviously insufficiently detoxified fertilizer.", {"entities": []}], ["Observations in Germany over several years, however, have led us to speculate that the detoxification process is not always performed thoroughly and controlled, calling for international regulations which clearly state a ricin threshold in fertilizer.", {"entities": []}], ["In this review we summarize knowledge on intended and unintended poisoning with ricin or castor seeds both in humans and animals, with a particular emphasis on intoxications due to improperly detoxified castor bean meal and forensic analysis.", {"entities": []}], ["To develop a clinic-relevant protocol for systemic up-regulation of NFE2-related factor 2 (Nrf2) to prevent diabetic cardiomyopathy (DCM), male db / db and age-matched wild-type (WT) mice were given sulforaphane (SFN, an Nrf2 activator) and its natural source, broccoli sprout extract (BSE) by gavage every other day for 3 months, with four groups: vehicle (0.1\u2009ml/10\u2009g), BSE-low dose (estimated SFN availability at 0.5\u2009mg/kg), BSE-high dose (estimated SFN availability at 1.0\u2009mg/kg), and SFN (0.5\u2009mg/kg).", {"entities": [[117, 131, "DISEASE"], [213, 216, "GENE"], [396, 399, "GENE"], [453, 456, "GENE"], [489, 492, "GENE"], [213, 216, "GENE"], [396, 399, "GENE"], [453, 456, "GENE"], [489, 492, "GENE"], [213, 216, "GENE"], [396, 399, "GENE"], [453, 456, "GENE"], [489, 492, "GENE"], [213, 216, "GENE"], [396, 399, "GENE"], [453, 456, "GENE"], [489, 492, "GENE"]]}], ["Cardiac function and pathological changes (hypertrophy, fibrosis, inflammation and oxidative damage) were assessed by echocardiography and histopathological examination along with Western blot and real-time PCR, respectively.", {"entities": []}], ["Both BSE and SFN significantly prevented diabetes-induced cardiac dysfunction, hypertrophy and fibrosis.", {"entities": [[13, 16, "GENE"]]}], ["Mechanistically, BSE, like SFN, significantly up-regulated Nrf2 transcriptional activity, evidenced by the increased Nrf2 nuclear accumulation and its downstream gene expression.", {"entities": [[27, 30, "GENE"]]}], ["This resulted in a significant prevention of cardiac oxidative damage and inflammation.", {"entities": []}], ["For all these preventive effects, BSE at high dose provided a similar effect as did SFN.", {"entities": [[84, 87, "GENE"]]}], ["These results indicated that BSE at high dose prevents DCM in a manner congruent with SFN treatment.", {"entities": [[86, 89, "GENE"]]}], ["Therefore, it suggests that BSE could potentially be used as a natural and safe treatment against DCM via Nrf2 activation.", {"entities": []}], ["Atrial natriuretic peptide (ANP) and its receptor, NPRA, have been extensively studied in terms of cardiovascular effects.", {"entities": []}], ["We have found that the ANP-NPRA signaling pathway is also involved in airway allergic inflammation and asthma.", {"entities": [[103, 109, "DISEASE"]]}], ["ANP, a C-terminal peptide (amino acid 99\u2013126) of pro-atrial natriuretic factor (proANF) and a recombinant peptide, NP73-102 (amino acid 73\u2013102 of proANF) have been reported to induce bronchoprotective effects in a mouse model of allergic asthma.", {"entities": [[229, 244, "DISEASE"], [238, 244, "DISEASE"]]}], ["In this report, we evaluated the effects of vessel dilator (VD), another N-terminal natriuretic peptide covering amino acids 31\u201367 of proANF, on acute lung inflammation in a mouse model of allergic asthma.", {"entities": [[189, 204, "DISEASE"], [198, 204, "DISEASE"]]}], ["A549 cells were transfected with pVD or the pVAX1 control plasmid and cells were collected 24 hrs after transfection to analyze the effect of VD on inactivation of the extracellular-signal regulated receptor kinase (ERK1/2) through western blot.", {"entities": []}], ["Luciferase assay, western blot and RT-PCR were also performed to analyze the effect of VD on NPRA expression.", {"entities": []}], ["For determination of VD's attenuation of lung inflammation, BALB/c mice were sensitized and challenged with ovalbumin and then treated intranasally with chitosan nanoparticles containing pVD.", {"entities": []}], ["Parameters of airway inflammation, such as airway hyperreactivity, proinflammatory cytokine levels, eosinophil recruitment and lung histopathology were compared with control mice receiving nanoparticles containing pVAX1 control plasmid.", {"entities": []}], ["pVD nanoparticles inactivated ERK1/2 and downregulated NPRA expression in vitro, and intranasal treatment with pVD nanoparticles protected mice from airway inflammation.", {"entities": []}], ["VD's modulation of airway inflammation may result from its inactivation of ERK1/2 and downregulation of NPRA expression.", {"entities": []}], ["Chitosan nanoparticles containing pVD may be therapeutically effective in preventing allergic airway inflammation.", {"entities": []}], ["Glucocorticoids (GCs)\u2014ligands of the glucocorticoid receptor (GR)\u2014are widely used to treat inflammatory diseases, but suffer from significant side effects and poor responsiveness in certain patient populations.", {"entities": []}], ["Identification of chemical GR modulators may provide insights into the regulatory mechanisms of anti-inflammatory functions of GR and help improve GC-based therapy.", {"entities": []}], ["Here we report the development and application of a high-throughput screening to identify compounds that either enhance or suppress the anti-inflammatory effect of GR function.", {"entities": []}], ["Using a cell-based GR activity assay that measures Dexamethasone (Dex)-mediated NF-\u03baB repression, we have screened ~8,000 compounds and identified several compounds that suppressed GR activity, including multiple GSK3\u03b2 inhibitors and anti-cancer agent camptothecin.", {"entities": [[239, 245, "DISEASE"]]}], ["Notably, we also identified two kinase IKK2 inhibitors, including TPCA-1, as GR enhancers that improve the anti-inflammatory effect of GR.", {"entities": []}], ["In particular, TPCA-1 augmented the activity of Dex in NF-\u03baB repression by attenuating GR down-regulation.", {"entities": []}], ["Consistent with the observation, siRNA-mediated IKK2 knockdown decreased GR down-regulation and increased GR expression.", {"entities": []}], ["Together, our results identified chemical compounds as novel modulators of GR and revealed an unexpected role for IKK2 in GR down-regulation.", {"entities": []}], ["Furthermore, we have established a high-throughput screening platform for discovering GR-modulating compounds that may be repurposed to improve current GC-based therapies.", {"entities": []}], ["A cutaneous force-frequency relation recording system based on first heart sound amplitude vibrations has been recently validated.", {"entities": []}], ["Second heart sound can be simultaneously recorded in order to quantify both systole and diastole duration.", {"entities": []}], ["1- To assess the feasibility and extra-value of operator-independent, force sensor-based, diastolic time recording during stress.", {"entities": []}], ["We enrolled 161 patients referred for stress echocardiography (exercise 115, dipyridamole 40, pacing 6 patients).", {"entities": []}], ["The sensor was fastened in the precordial region by a standard ECG electrode.", {"entities": []}], ["The acceleration signal was converted into digital and recorded together with ECG signal.", {"entities": []}], ["Both systolic and diastolic times were acquired continuously during stress and were displayed by plotting times vs. heart rate.", {"entities": []}], ["Diastolic filling rate was calculated as echo-measured mitral filling volume/sensor-monitored diastolic time.", {"entities": []}], ["Diastolic time decreased during stress more markedly than systolic time.", {"entities": []}], ["At peak stress 62 of the 161 pts showed reversal of the systolic/diastolic ratio with the duration of systole longer than diastole.", {"entities": [[29, 32, "GENE"]]}], ["In the exercise group, at 100 bpm HR, systolic/diastolic time ratio was lower in the 17 controls (0.74 \u00b1 0.12) than in patients (0.86 \u00b1 0.10, p < 0.05 vs. controls).", {"entities": [[34, 36, "GENE"]]}], ["Diastolic filling rate increased from 101 \u00b1 36 (rest) to 219 \u00b1 92 ml/m Cardiological systolic and diastolic duration can be monitored during stress by using an acceleration force sensor.", {"entities": []}], ["Simultaneous calculation of stroke volume allows monitoring diastolic filling rate.", {"entities": []}], ["Stress-induced \"systolic-diastolic mismatch\" can be easily quantified and is associated to several cardiac diseases, possibly expanding the spectrum of information obtainable during stress.", {"entities": []}], ["The use of extracorporeal membrane oxygenation (ECMO) in cases of near-fatal asthma (NFA) has increased, but the benefits and potential complications of this therapy have yet to be fully investigated.", {"entities": [[77, 83, "DISEASE"]]}], ["Cases were extracted from the Extracorporeal Life Support Organization Registry between March 1992 and March 2016.", {"entities": []}], ["All patients with a diagnosis of asthma (according to the International Classification of Diseases 9th edition), who also received ECMO, were extracted.", {"entities": [[33, 39, "DISEASE"]]}], ["Exclusion criteria included patients who underwent multiple courses of ECMO; those who received ECMO for cardiopulmonary resuscitation or cardiac dysfunction; and those with another primary diagnosis, such as sepsis.", {"entities": []}], ["We analyzed survival to hospital discharge, complications, and clinical factors associated with in-hospital mortality, in patients with severe life-threatening NFA requiring ECMO support.", {"entities": []}], ["In total 272 patients were included.", {"entities": []}], ["The mean time spent on ECMO was 176.4\u00a0hours.", {"entities": []}], ["Ventilator settings, including rate, fraction of inspired oxygen (FiO 2 ), peak inspiratory pressure (PIP), and mean airway pressure, significantly improved after ECMO initiation (rate (breaths/min), 19.0 vs. 11.3, p \u2009<\u20090.001; FiO 2 (%), 81.2 vs. 48.8, p \u2009<\u20090.001; PIP (cmH 2 O), 38.2 vs. 25.0, p \u2009<\u20090.001; mean airway pressure (cmH 2 O): 21.4 vs. 14.2, p \u2009<\u20090.001).", {"entities": []}], ["In particular, driving pressure was significantly decreased after ECMO support (29.5 vs. 16.8 cmH 2 O, p \u2009<\u20090.001).", {"entities": []}], ["The weaning success rate was 86.7%, and the rate of survival to hospital discharge was 83.5%.", {"entities": []}], ["The total complication rate was 65.1%, with hemorrhagic complications being the most common (28.3%).", {"entities": []}], ["Other complications included renal (26.8%), cardiovascular (26.1%), mechanical (24.6%), metabolic (22.4%), infection (16.5%), neurologic (4.8%), and limb ischemia (2.6%).", {"entities": [[154, 162, "DISEASE"]]}], ["Of the hemorrhagic complications, cannulation site hemorrhage was the most common (13.6%).", {"entities": []}], ["Using multivariate logistic regression analysis, it was found that hemorrhage was associated with increased in-hospital mortality (odds ratio, 2.97; 95% confidence interval, 1.07\u20138.24; p \u2009=\u20090.036).", {"entities": []}], ["Hemorrhage-induced death occurred in four patients (1.5%).", {"entities": []}], ["The most common reason for death was organ failure (37.8%).", {"entities": []}], ["ECMO can provide adequate gas exchange and prevent lung injury induced by mechanical ventilation, and may be an effective bridging strategy to avoid aggressive ventilation in refractory NFA.", {"entities": []}], ["However, careful management is required to avoid complications.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-017-1886-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A strong relationship exists between disability and poor health.", {"entities": []}], ["This relationship could exist as a result of disabilities emerging from chronic conditions; conversely, people with disabilities may be at increased risk of developing chronic conditions.", {"entities": []}], ["Studying health in relation to age of disability onset can illuminate the extent to which disability may be a risk factor for future poor health.", {"entities": []}], ["We used data from the 2006\u20132012 National Health Interview Survey and conducted weighted logistic regression analyses to compare chronic conditions in adults with lifelong disabilities (n = 2,619) and adults with no limitations (n = 122,395).", {"entities": []}], ["After adjusting for sociodemographic differences, adults with lifelong disabilities had increased odds of having the following chronic conditions compared with adults with no limitations: coronary heart disease (adjusted odds ratio [AOR] = 2.92; 95% confidence interval [CI], 2.33\u20133.66) cancer (AOR = 1.61; 95% CI, 1.34\u20131.94), diabetes (AOR = 2.57; 95% CI, 2.10\u20133.15), obesity (AOR = 1.81; 95% CI, 1.63\u20132.01), and hypertension (AOR = 2.18; 95% CI, 1.94\u20132.45).", {"entities": [[414, 426, "DISEASE"], [197, 210, "DISEASE"], [188, 210, "DISEASE"], [369, 376, "DISEASE"], [287, 293, "DISEASE"]]}], ["Subpopulations of people with lifelong disabilities (ie, physical, mental, intellectual/developmental, and sensory) experienced similar increased odds for chronic conditions compared with people with no limitations.", {"entities": []}], ["Adults with lifelong disabilities were more likely to have chronic conditions than adults with no limitations, indicating that disability likely increases risk of developing poor health.", {"entities": []}], ["This distinction is critical in understanding how to prevent health risks for people with disabilities.", {"entities": []}], ["Health promotion efforts that target people living with a disability are needed.", {"entities": []}], ["Successful smoke-free legislation is dependent on political will, enforcement and societal support.", {"entities": []}], ["We report the success and pitfalls of a non-enforced nationwide smoke-free legislation in Greece, as well as ways in which compliance and enforcement-related factors, including ashtrays and signage, may impact indoor secondhand smoke (SHS) concentrations.", {"entities": []}], ["A follow-up study of venues (n\u200a=\u200a150, at baseline, n\u200a=\u200a75 at 2-year follow-up) in Greece assessed indoor particulate matter with a diameter less than 2.5 micrometers (PM 2.5 ) concentrations attributable to SHS smoke every six months for two years (n\u200a=\u200a455 venue/measurements).", {"entities": []}], ["Following the implementation of the 2010 smoke-free legislation, mean PM 2.5 concentrations attributable to SHS fell from 175.3 \u00b5g/m While the public may be supportive of smoke-free legislation, adherence may decline rapidly if enforcement is limited or nonexistent.", {"entities": []}], ["Moreover, enforcement agencies should also focus on the comprehensive removal of ashtray equivalents that could act as cues for smoking within a venue.", {"entities": []}], ["Activator protein (AP)-1 and nuclear factor (NF)-\u03baB largely control T-cell activation, following binding of foreign antigens to the T-cell receptor leading to cytokine secretion.", {"entities": []}], ["Elevated levels of pro-inflammatory cytokines and chemokines such as TNF, IL-6 and CXCL8 are associated with several human diseases including cystic fibrosis, pulmonary fibrosis and AIDS.", {"entities": [[142, 157, "DISEASE"], [159, 177, "DISEASE"], [69, 72, "GENE"]]}], ["The aim of this study was to investigate the role of the transcription factors, AP-1 and NF-\u03baB, in IL-6 and CXCL8 regulation in Jurkat T-cells.", {"entities": []}], ["Phorbol myristate acetate (PMA) exposure resulted in an up-regulation of AP-1 and down-regulation of NF-\u03baB activity, however, exposure to heat killed (HK) Escherichia.", {"entities": []}], ["coli MG1655 resulted in a dose-dependent increase in NF-\u03baB activity without affecting AP-1.", {"entities": []}], ["The cytokine profile revealed an up-regulation of the chemokine CXCL8 and the pro-inflammatory cytokines TNF, IL-2 and IL-6 following treatment with both PMA and HK E. coli , while the levels of the anti-inflammatory cytokine IL-10 were not affected by PMA but were significantly down-regulated by HK E. coli .", {"entities": [[105, 108, "GENE"]]}], ["AP-1 activation was significantly increased 2 h after PMA exposure and continued to increase thereafter.", {"entities": []}], ["In contrast, NF-\u03baB responded to PMA exposure by a rapid up-regulation followed by a subsequent down-regulation.", {"entities": []}], ["Increased intracellular Ca E. coli .", {"entities": []}], ["In order to further study NF-\u03baB activation, we considered two up-stream signalling proteins, PKC and Bcl10.", {"entities": [[101, 106, "GENE"]]}], ["Phosphorylated-PKC levels increased in response to PMA and HK E. coli , while Bcl10 levels significantly decreased following PMA treatment.", {"entities": [[78, 83, "GENE"]]}], ["Using an NF-\u03baB activation inhibitor, we observed complete inhibition of IL-6 expression while CXCL8 levels only decreased by 40% at the highest concentration.", {"entities": []}], ["Treatment of Jurkat T-cells with PMA in the presence of JNK-inhibitor suppressed both CXCL8 and IL-6 while PKC-inhibitor primarily decreased CXCL8 expression.", {"entities": []}], ["The present study shows that NF-\u03baB regulated IL-6 but not CXCL8.", {"entities": []}], ["This complex regulation of CXCL8 suggests that there is a need to further evaluate the signalling pathways in order to develop new treatment for diseases with elevated CXCL8 levels, such as AIDS and autoimmune diseases.", {"entities": []}], ["Corticosteroids have been used for decades to modulate inflammation therapeutically, yet there is a paucity of data on their effects in humans.", {"entities": []}], ["We examined the changes in cellular and molecular immune system parameters, or \u201cimmunome\u201d, in healthy humans after systemic corticosteroid administration.", {"entities": []}], ["We used multiplexed techniques to query the immunome in 20 volunteers at baseline, and after intravenous hydrocortisone (HC) administered at moderate (250\u2009mg) and low (50 mg) doses, to provide insight into how corticosteroids exert their effects.", {"entities": []}], ["We performed comprehensive phenotyping of 120 lymphocyte subsets by high dimensional flow cytometry, and observed a decline in circulating specific B and T cell subsets, which reached their nadir 4\u20138\u2009hours after administration of HC.", {"entities": []}], ["However, B and T cells rebounded above baseline 24\u2009hours after HC infusion, while NK cell numbers remained stable.", {"entities": []}], ["Whole transcriptome profiling revealed down regulation of NF-\u03baB signaling, apoptosis, and cell death signaling transcripts that preceded lymphocyte population changes, with activation of NK cell and glucocorticoid receptor signaling transcripts.", {"entities": []}], ["Our study is the first to systematically characterize the effects of corticosteroids on the human immunome, and we demonstrate that HC exerts differential effects on B and T lymphocytes and natural killer cells in humans.", {"entities": []}], ["Porcine reproductive and respiratory syndrome virus (PRRSV) is an important arterivirus that can cause significant losses in swine industry.", {"entities": [[37, 45, "DISEASE"]]}], ["At present, there are no adequate control strategies against PRRSV.", {"entities": []}], ["Thus, there is an urgent need for new treatment regimens that have efficacious antiviral activity to compensate for vaccines.", {"entities": []}], ["Cryptoporus volvatus commonly serves as an anti-infective agent in Tradational Chinese Medicines.", {"entities": []}], ["In this report, we exploited whether the aqueous extract from the fruiting body of Cryptoporus volvatus had the potential to inhibit PRRSV infection.", {"entities": []}], ["Our results showed that the extract significantly inhibited PRRSV infection by repressing virus entry, viral RNA expression, and possibly viral protein synthesis, cell-to-cell spread, and releasing of virus particles.", {"entities": []}], ["However, it did not block PRRSV binding to cells.", {"entities": []}], ["Further studies confirmed that the extract directly inhibited PRRSV RNA-dependent RNA polymerase (RdRp) activity, thus interfering with PRRSV RNA and protein synthesis.", {"entities": []}], ["More importantly, the extract efficiently inhibited highly pathologic PRRSV (HP-PRRSV) infection in vivo , reduced virus load in serum, and increased the survival rate of pigs inoculated with HP-PRRSV strain.", {"entities": []}], ["Collectively, our findings imply that the aqueous extract from the fruiting body of Cryptoporus volvatus has the potential to be used for anti-PRRSV therapies.", {"entities": []}], ["To remediate indoor fungal growth, understanding the moisture relations of common indoor fungi is crucial.", {"entities": []}], ["Indoor moisture conditions are commonly quantified by the relative humidity ( RH ).", {"entities": []}], ["RH is a major determinant of the availability of water in porous indoor surfaces that fungi grow on.", {"entities": []}], ["The influence of steady\u2010state RH on growth is well understood.", {"entities": []}], ["Typically, however, the indoor RH constantly changes so that fungi have to endure frequent periods of alternating low and high RH .", {"entities": []}], ["Knowledge of how common indoor fungi survive and are affected by the low\u2010 RH periods is limited.", {"entities": []}], ["In particular, the specific effects of a drop in RH on the growth of the mycelium remain unclear.", {"entities": []}], ["In this work, video microscopy was used to monitor hyphal growth of Penicillium rubens on gypsum substrates under controlled dynamic humidity conditions.", {"entities": []}], ["The effect of a single period of low RH ( RH \u00a0=\u00a050\u201390%) interrupting favourable conditions ( RH \u00a0=\u00a097%) was tested.", {"entities": []}], ["It was found that hyphal tips ceased to extend when exposed to any tested decrease in RH .", {"entities": []}], ["However, new hyphal growth always emerges, seemingly from the old mycelium, suggesting that this indoor fungus does not rely only on conidia to survive the humidity patterns considered.", {"entities": []}], ["These findings are a fundamental step in unravelling the effect of RH on indoor fungal growth.", {"entities": []}], ["Background: Secondhand Smoke (SHS) exposure is a leading cause of childhood illness and premature death.", {"entities": []}], ["Pediatricians play an important role in helping parents to quit smoking and reducing children\u2019s SHS exposure.", {"entities": []}], ["This study examined Chinese pediatricians\u2019 attitudes and practices regarding children\u2019s exposure to SHS and clinical efforts against SHS exposure.", {"entities": []}], ["Methods: A cross-sectional survey of pediatricians was conducted in thirteen conveniently selected hospitals in southern China, during September to December 2013.", {"entities": []}], ["Five hundred and four pediatricians completed self-administered questionnaires with a response rate of 92%.", {"entities": []}], ["\u03c7 tests were used to compare categorical variables differences between smokers and non-smokers and other categorical variables.", {"entities": []}], ["Results: Pediatricians thought that the key barriers to encouraging parents to quit smoking were: lack of professional training (94%), lack of time (84%), resistance to discussions about smoking (77%).", {"entities": []}], ["94% of the pediatricians agreed that smoking in enclosed public places should be prohibited and more than 70% agreed that smoking should not be allowed in any indoor places and in cars.", {"entities": [[180, 184, "GENE"]]}], ["Most of the pediatricians thought that their current knowledge on helping people to quit smoking and SHS exposure reduction counseling was insufficient.", {"entities": []}], ["Conclusions: Many Chinese pediatricians did not have adequate knowledge about smoking and SHS, and many lacked confidence about giving cessation or SHS exposure reduction counseling to smoking parents.", {"entities": []}], ["Lack of professional training and time were the most important barriers to help parents quit smoking among the Chinese pediatricians.", {"entities": []}], ["Intensified efforts are called for to provide the necessary professional training and increase pediatricians\u2019 participation in the training.", {"entities": []}], ["The etiology of chronic urticaria (CU) is diverse, with chronic infections and inflammation being reported as considerable contributing factors.", {"entities": [[24, 33, "DISEASE"]]}], ["Although the prevalence of metabolic syndrome was found to be significantly elevated in patients with CU, no one has specifically estimated the effects on CU following hyperlipidemia.", {"entities": [[37, 45, "DISEASE"]]}], ["This study aimed to examine the association between hyperlipidemia and CU using a population-based dataset in Taiwan.", {"entities": []}], ["This study included 9798 adults with CU as cases and 9798 sex- and age-matched controls.", {"entities": []}], ["These patients were examined for whether they had received a prior diagnosis of hyperlipidemia.", {"entities": []}], ["We used conditional logistic regression analyses to calculate the odds ratio (OR) and its corresponding 95% confidence interval (CI) for having been previously diagnosed with hyperlipidemia between cases and controls.", {"entities": []}], ["In total, 7066 (36.1%) patients had received a prior diagnosis of hyperlipidemia, including 4287 (43.8%) among CU cases and 2779 (28.4%) among controls.", {"entities": []}], ["The conditional logistic regression revealed that the OR of prior hyperlipidemia for cases was 1.97 (95% CI: 1.85~2.09) compared to the controls.", {"entities": []}], ["Furthermore, compared to patients without CU, patients with CU independently experienced a 1.65-fold (95% CI = 1.55~1.76; p <0.001) increased risk of having a prior hyperlipidemia diagnosis, after adjustments were made.", {"entities": []}], ["We concluded that CU was associated with having received a prior diagnosis of hyperlipidemia.", {"entities": []}], ["Activation of the phosphoinositide 3\u2010kinase (PI3K) pathway is a key signaling event in cancer, inflammation, and other proliferative diseases.", {"entities": [[87, 93, "DISEASE"]]}], ["PI3K inhibitors are already approved for some specific clinical indications, but their systemic on\u2010target toxicity limits their larger use.", {"entities": []}], ["In particular, whereas toxicity is tolerable in acute treatment of life\u2010threatening diseases, this is less acceptable in chronic conditions.", {"entities": []}], ["In the past, the strategy to overcome this drawback was to block selected isoforms mainly expressed in leukocytes, but redundancy within the PI3K family members challenges the effectiveness of this approach.", {"entities": []}], ["On the other hand, decreasing exposure to selected target cells represents a so\u2010far unexplored alternative to circumvent systemic toxicity.", {"entities": []}], ["In this manuscript, we describe the generation of a library of triazolylquinolones and the development of the first prodrug pan\u2010PI3K inhibitor.", {"entities": []}], ["The most common cause of chronic periodontitis is poor oral hygiene.", {"entities": [[33, 46, "DISEASE"]]}], ["Gastroesophageal reflux disease (GERD) enhances the proximal migration of gastric contents and may cause poor oral hygiene.", {"entities": []}], ["We hypothesized that GERD may increase thse risk of chronic periodontitis and investigated this potential relationship.", {"entities": [[60, 73, "DISEASE"]]}], ["A retrospective cross-sectional study was conducted in outpatients between January 1, 2010, and April 30, 2012.", {"entities": []}], ["GERD was defined as being present based on at least two of the following criteria: etiologic agent(s), identifiable signs and symptoms, and consistent anatomic alterations.", {"entities": []}], ["A total of 280 patients with chronic periodontitis and 280 controls were analyzed.", {"entities": [[37, 50, "DISEASE"]]}], ["Information regarding patient demographics and other potential confounding factors for chronic periodontitis were collected through individual medical records.", {"entities": [[95, 108, "DISEASE"]]}], ["GERD was revealed to be independently associated with an increased incidence of chronic periodontitis (odds ratio [OR], 2.883; 95% confidence interval [CI], 1.775 to 4.682).", {"entities": [[88, 101, "DISEASE"]]}], ["The other three variables of dental caries (OR, 1.531; 95% CI, 1.042 to 2.249), tobacco use (OR, 2.335; 95% CI, 1.461 to 3.730), and history of medication (calcium channel blocker, cyclosporine, or phenytoin) (OR, 2.114; 95% CI, 1.160 to 3.854) were also determined to be independent risk factors.", {"entities": [[29, 42, "DISEASE"]]}], ["The present study supported our hypothesis that GERD can be a risk factor for chronic periodontitis.", {"entities": [[86, 99, "DISEASE"]]}], ["Atopic dermatitis (AD) is an inflammatory skin disorder with a childhood prevalence reaching 20%.", {"entities": [[7, 17, "DISEASE"]]}], ["An estimated 50% of patients have a life-long chronic course.", {"entities": []}], ["The purpose of this study was to estimate the risk of first-time myocardial infarction (MI) in patients with AD compared with a general population cohort.", {"entities": [[65, 86, "DISEASE"]]}], ["Cohort study.", {"entities": []}], ["Using population-based medical registries, we identified individuals born in Denmark from 1947 to 1983 with at least two hospital-diagnoses of AD following inpatient admissions or hospital-based outpatient visits at any age from 1977 to 2013.", {"entities": []}], ["Individuals with AD were matched with general population controls (10:1) for birth-year and gender.", {"entities": []}], ["Unique personal identifiers permitted unambiguous data linkage.", {"entities": []}], ["Follow-up began on the date of AD diagnosis (index date for general population controls) and continued until death, emigration, MI or the year 2013.", {"entities": []}], ["We computed the 15-year-cumulative incidence of MI following a diagnosis of AD.", {"entities": []}], ["Comparing patients with AD with the general population cohort, we computed HRs of MI presented with 95% CIs and adjusted for history of diabetes mellitus, hypertension, hyperlipidaemia or stroke, educational level, birth-year and sex.", {"entities": [[155, 167, "DISEASE"], [136, 153, "DISEASE"]]}], ["We identified 4814 patients diagnosed with AD.", {"entities": []}], ["The cumulative incidence of MI was 0.6% for patients with AD and 0.4% for their matched controls.", {"entities": []}], ["The corresponding adjusted HR was 1.74 (1.21 to 2.49).", {"entities": [[27, 29, "GENE"]]}], ["The HR for patients who were not in need of systemic treatment was 1.58 (1.02 to 2.45) and it was 2.40 (1.27 to 4.45) for those who were treated with azathioprine, methotrexate or cyclosporine.", {"entities": [[4, 6, "GENE"]]}], ["Hospital-diagnosed AD was associated with increased risk of MI compared with the general population.", {"entities": []}], ["Mucosal\u2010associated invariant T ( MAIT ) cells are a novel class of innate\u2010like T cells, expressing a semi\u2010invariant T\u2010cell receptor ( TCR ) and able to recognize small molecules presented on the non\u2010polymorphic MHC \u2010related protein 1.", {"entities": []}], ["Their intrinsic effector\u2010memory phenotype, enabling secretion of pro\u2010inflammatory cytokines, and their relative abundance in humans imply a significant potential to contribute to autoimmune processes.", {"entities": []}], ["However, as MAIT cells were unknown until recently and specific immunological tools were unavailable, little is known of their roles in disease.", {"entities": []}], ["Here I review observations from clinical studies and animal models of autoimmune and immune\u2010mediated diseases including the roles of MAIT cells in systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease and airways diseases.", {"entities": [[219, 245, "DISEASE"], [199, 217, "DISEASE"], [177, 197, "DISEASE"], [156, 175, "DISEASE"], [188, 197, "DISEASE"], [147, 175, "DISEASE"]]}], ["MAIT cell deficiencies are frequently observed in peripheral blood, and at sites of disease such as the airways in asthma.", {"entities": [[115, 121, "DISEASE"]]}], ["However, MAIT cells have a specific sensitivity to suppression by therapeutic corticosteroids that may confound many of these observations, as may the tendency of the surface marker CD 161 to activation\u2010induced down\u2010regulation.", {"entities": []}], ["Nonetheless, the dependence on bacteria for the development of MAIT cells suggests a potentially important protective role linking the influences of early life microbial exposures and subsequent development of autoimmunity.", {"entities": []}], ["Conversely, MAIT cells could contribute to chronic inflammation either through TCR \u2010independent activation, or potentially by TCR recognition of as yet undiscovered ligands.", {"entities": []}], ["Future research will be greatly facilitated by the immunological tools that are now available, including murine genetic models and human and murine specific tetramers.", {"entities": []}], ["Glycomics is an international initiative aimed to understand the structure and function of the glycans from a given type of cell, tissue, organism, kingdom or even environment, as found under certain conditions.", {"entities": []}], ["Glycomics is one of the latest areas of intense biological research.", {"entities": []}], ["Glycans of marine sources are unique in terms of structure and function.", {"entities": []}], ["They differ considerably from those of terrestrial origin.", {"entities": []}], ["This review discusses the most known marine glycans of potential therapeutic properties.", {"entities": []}], ["They are chitin, chitosan, and sulfated polysaccharides named glycosaminoglycans, sulfated fucans, and sulfated galactans.", {"entities": []}], ["Their medical actions are very broad.", {"entities": []}], ["When certain structural requirements are found, these glycans can exhibit beneficial effects in inflammation, coagulation, thrombosis, cancer growth/metastasis, and vascular biology.", {"entities": [[135, 141, "DISEASE"]]}], ["Both structure and therapeutic mechanisms of action of these marine glycans are discussed here in straight context with the current glycomic age through a project suggestively named marine medicinal glycomics.", {"entities": []}], ["Myosin light chain (MLC) phosphorylation plays important roles in various cellular functions such as cellular morphogenesis, motility, and smooth muscle contraction.", {"entities": []}], ["MLC phosphorylation is determined by the balance between activities of Rho-associated kinase (Rho-kinase) and myosin phosphatase.", {"entities": []}], ["An impaired balance between Rho-kinase and myosin phosphatase activities induces the abnormal sustained phosphorylation of MLC, which contributes to the pathogenesis of certain vascular diseases, such as vasospasm and hypertension.", {"entities": [[218, 230, "DISEASE"]]}], ["However, the dynamic principle of the system underlying the regulation of MLC phosphorylation remains to be clarified.", {"entities": []}], ["Here, to elucidate this dynamic principle whereby Rho-kinase regulates MLC phosphorylation, we developed a mathematical model based on the behavior of thrombin-dependent MLC phosphorylation, which is regulated by the Rho-kinase signaling network.", {"entities": []}], ["Through analyzing our mathematical model, we predict that MLC phosphorylation and myosin phosphatase activity exhibit bistability, and that a novel signaling pathway leading to the auto-activation of myosin phosphatase is required for the regulatory system of MLC phosphorylation.", {"entities": []}], ["In addition, on the basis of experimental data, we propose that the auto-activation pathway of myosin phosphatase occurs in vivo.", {"entities": []}], ["These results indicate that bistability of myosin phosphatase activity is responsible for the bistability of MLC phosphorylation, and the sustained phosphorylation of MLC is attributed to this feature of bistability.", {"entities": []}], ["In this paper, we aim to present an overview of the scientific literature on the link between smoke-free legislation and early-life health outcomes.", {"entities": []}], ["Exposure to second-hand smoke is responsible for an estimated 166\u2009,000 child deaths each year worldwide.", {"entities": []}], ["To protect people from tobacco smoke, the World Health Organization recommends the implementation of comprehensive smoke-free legislation that prohibits smoking in all public indoor spaces, including workplaces, bars and restaurants.", {"entities": []}], ["The implementation of such legislation has been found to reduce tobacco smoke exposure, encourage people to quit smoking and improve adult health outcomes.", {"entities": []}], ["There is an increasing body of evidence that shows that children also experience health benefits after implementation of smoke-free legislation.", {"entities": []}], ["In addition to protecting children from tobacco smoke in public, the link between smoke-free legislation and improved child health is likely to be mediated via a decline in smoking during pregnancy and reduced exposure in the home environment.", {"entities": []}], ["Recent studies have found that the implementation of smoke-free legislation is associated with a substantial decrease in the number of perinatal deaths, preterm births and hospital attendance for respiratory tract infections and asthma in children, although such benefits are not found in each study.", {"entities": [[229, 235, "DISEASE"]]}], ["With over 80% of the world\u2019s population currently unprotected by comprehensive smoke-free laws, protecting (unborn) children from the adverse impact of tobacco smoking and SHS exposure holds great potential to benefit public health and should therefore be a key priority for policymakers and health workers alike.", {"entities": []}], ["Invasive aspergillosis by Aspergillus fumigatus is a leading cause of infection-related mortality in immune-compromised patients.", {"entities": [[9, 22, "DISEASE"]]}], ["In order to discover potential genetic targets to control A .", {"entities": []}], ["fumigatus infections we characterized rtfA , a gene encoding a putative RNA polymerase II transcription elongation factor-like protein.", {"entities": []}], ["Our recent work has shown that the rtfA ortholog in the model fungus Aspergillus nidulans regulates morphogenesis and secondary metabolism.", {"entities": []}], ["The present study on the opportunistic pathogen A .", {"entities": []}], ["fumigatus rtfA gene revealed that this gene influences fungal growth and conidiation, as well as production of the secondary metabolites tryptoquivaline F, pseurotin A, fumiquinazoline C, festuclavine, and fumigaclavines A, B and C. Additionally, rtfA influences protease activity levels, the sensitivity to oxidative stress and adhesion capacity, all factors important in pathogenicity.", {"entities": []}], ["Furthermore, rtfA was shown to be indispensable for normal virulence using Galleria mellonella as well as murine infection model systems.", {"entities": []}], ["Nonadherence to antipsychotic treatment increases the likelihood of relapse and progressive symptomatology in patients with schizophrenia.", {"entities": [[124, 137, "DISEASE"]]}], ["Atypical long-acting injectables, including paliperidone palmitate (PP), may increase adherence and improve symptoms.", {"entities": []}], ["This study compared and assessed predictors of treatment patterns and symptom remission among schizophrenia patients treated with PP versus atypical oral antipsychotic therapy (OAT) in community behavioral health organizations (CBHOs).", {"entities": [[94, 107, "DISEASE"]]}], ["This retrospective cohort analysis evaluated 763 patients with schizophrenia and new (PP-N; N \u00a0=\u00a0174) or continuing (PP-C; N \u00a0=\u00a0308) users of PP, or new users of OAT ( N \u00a0=\u00a0281) at enrollment in the REACH-OUT study (2010\u20132013).", {"entities": [[63, 76, "DISEASE"]]}], ["Treatment outcomes assessed at 1\u00a0year were discontinuation, and adherence, measured by proportion of days covered (PDC) or medication possession ratio (MPR).", {"entities": [[115, 118, "GENE"]]}], ["Remission status was assessed using the Structured Clinical Interview for Symptoms of Remission (SCI-SR).", {"entities": []}], ["A machine learning platform, Reverse Engineering and Forward Simulation (REFS\u2122), was used to identify predictors of study outcomes.", {"entities": []}], ["Multivariate Cox and generalized linear regressions estimated the adjusted hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals.", {"entities": []}], ["Among PP-N users, 27% discontinued their initial treatment regimen versus 51% ( p \u00a0<\u00a00.001) of OAT users.", {"entities": []}], ["PP-N (vs OAT; HR\u00a0=\u00a00.49 [0.31\u20130.76]) users and males (HR\u00a0=\u00a00.65 [0.46\u20130.92]) had significantly lower rates of discontinuation.", {"entities": [[14, 16, "GENE"], [54, 56, "GENE"], [14, 16, "GENE"], [54, 56, "GENE"]]}], ["Relative to OAT, PP-N had a 36% [31%\u201342%] higher MPR and a 10-fold increased achievement of PDC \u226580% (OR\u00a0=\u00a010.46 [5.72\u201319.76]).", {"entities": [[92, 95, "GENE"]]}], ["PP users were significantly more likely to achieve remission in follow-up (PP-N vs OAT: OR\u00a0=\u00a02.65 [1.39\u20135.05]; PP-C vs OAT: OR\u00a0=\u00a01.83 [1.03\u20133.25]).", {"entities": []}], ["Relative to OAT, PP was associated with improved adherence, less frequent treatment discontinuation, and improved symptom remission in this CBHO study population.", {"entities": []}], ["A report on the meeting 'Why we can't wait: conference to eliminate health disparities in genomic medicine', Miami, Florida, USA, 31 May to 1 June 2012.", {"entities": []}], ["Please cite this paper as: Karlsson et\u00a0al.", {"entities": []}], ["(2012) Review on the impact of pregnancy and obesity on influenza virus infection.", {"entities": [[56, 65, "DISEASE"], [45, 52, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(6), 449\u2013460.", {"entities": [[0, 9, "DISEASE"]]}], ["A myriad of risk factors have been linked to an increase in the severity of the pandemic H1N1 2009 influenza A virus [A(H1N1)pdm09] including pregnancy and obesity where death rates can be elevated as compared to the general population.", {"entities": [[99, 108, "DISEASE"], [156, 163, "DISEASE"]]}], ["The goal of this review is to provide an overview of the influence of pregnancy and obesity on the reported cases of A(H1N1)pdm09 virus infection and of how the concurrent presence of these factors may have an exacerbating effect on infection outcome.", {"entities": [[84, 91, "DISEASE"]]}], ["Also, the hypothesized immunologic mechanisms that contribute to A(H1N1)pdm09 virus severity during pregnant or obese states are outlined.", {"entities": []}], ["Identifying the mechanisms underlying the increased disease severity in these populations may result in improved therapeutic approaches and future pandemic preparedness.", {"entities": []}], ["In November 2002, the National Center for Healthy Housing convened a 2-day workshop to review the state of knowledge in the field of healthy housing.", {"entities": []}], ["The workshop, supported with funds from the U.S. Centers for Disease Control and Prevention\u2019s National Center for Injury Prevention and Control and National Center for Environmental Health, was unique in that it focused solely on the effect of housing on children\u2019s health and the translation of research findings into practical activities in home construction, rehabilitation, and maintenance.", {"entities": []}], ["Participants included experts and practitioners representing the health, housing, and environmental arenas.", {"entities": []}], ["Presentations by subject-matter experts covered four key areas: asthma, neurotoxicants, injury, and translational research.", {"entities": [[64, 70, "DISEASE"]]}], ["Panel discussions followed the presentations, which generated robust dialogue on potential future research opportunities and overall policy gaps.", {"entities": []}], ["Lack of consensus on standard measurements, incomplete understanding about the interaction of home hazards, inadequate research on the effectiveness of interventions, and insufficient political support limit current efforts to achieve healthy housing.", {"entities": []}], ["However, change is forthcoming and achievable.", {"entities": []}], ["Adverse drug reactions (ADRs) recorded in national pharmacovigilance databases in developed countries have been analyzed.", {"entities": []}], ["However, adverse reactions to fluoroquinolones were observed globally despite their wide use and safety concerns.", {"entities": []}], ["We provided information on the pattern of adverse reactions to fluoroquinolones reported spontaneously to the National Pharmacovigilance Centre (NPC), Nigeria.", {"entities": []}], ["ADRs to fluoroquinolones reported to the NPC, over a period of 12\u00a0years, were analyzed.", {"entities": []}], ["Evaluation was done for annual reports, age and gender of patients, type of reporter, suspected fluoroquinolones and adverse reactions, onset and outcome of ADRs, and causality.", {"entities": []}], ["A total of 18527 ADR reports were received by the NPC.", {"entities": []}], ["Antibiotics accounted for 1371(7.4%) of the total reports and fluoroquinolones accounted for 256 (18.7%) cases.", {"entities": []}], ["A total of 540 ADRs due to fluoroquinolones was experienced by the patients.", {"entities": []}], ["Multiple ADRs were experienced by 165 (65%) patients.", {"entities": []}], ["Norfloxacin (2; 0.8%), moxifloxacin (3; 1.2%), ofloxacin (10; 3.9%), ciprofloxacin (112; 43.8%), and levofloxacin (129; 50.4%) were responsible for the ADRs.", {"entities": []}], ["Neurological disorders (121; 22.4%), gastrointestinal disorders (118; 21.9%), and skin\u2010appendage disorders (116; 21.5%) were the most reported ADRs, while pruritus (41; 7.6%), abdominal pain (34; 6.3%), vomiting (34; 6.3%), and skin rash (27; 5.0%) were the most frequently reported specific ADRs.", {"entities": []}], ["Thirty\u2010four (6.4%) patients experienced serious ADRs.", {"entities": []}], ["Fluoroquinolones accounted for a small but significant proportion of ADRs spontaneously reported to the NPC in Nigeria.", {"entities": []}], ["Ciprofloxacin and levofloxacin were the two most culpable fluoroquinolones due to their inappropriate use or increased use in multi\u2010drug resistant tuberculosis (MDR\u2010TB) treatment.", {"entities": [[147, 159, "DISEASE"]]}], ["Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer, with 600,000 new cases every year worldwide.", {"entities": [[28, 37, "DISEASE"], [14, 37, "DISEASE"], [71, 77, "DISEASE"]]}], ["Although chemotherapeutics exist, five-year survival is only 50%.", {"entities": []}], ["New strategies to overcome drug resistance are required to improve HNSCC treatment.", {"entities": []}], ["Curcumin-difluorinated (CDF), a synthetic analog of curcumin, was packaged in liposomes and used to evaluate growth inhibition of cisplatin resistant HNSCC cell lines CCL-23R and UM-SCC-1R generated from the parental cell lines CCL-23 and UM-SCC-1 respectively.", {"entities": []}], ["Growth inhibition in vitro and expression levels of the CD44 (cancer stem cell marker), cytokines, and growth factors were investigated after liposomal CDF treatment.", {"entities": [[62, 68, "DISEASE"], [56, 60, "GENE"]]}], ["The in vivo growth inhibitory effect of liposomal CDF was evaluated in the nude mice xenograft tumor model of UM-SCC-1R and the inhibition of CD44 was measured.", {"entities": [[142, 146, "GENE"]]}], ["Treatment of the resistant cell lines in vitro with liposomal CDF resulted in a statistically significant growth inhibition ( p < 0.05).", {"entities": []}], ["The nude mice xenograft study showed a statistically significant tumor growth inhibition of UM-SCC-1R cells and a reduction in the expression of CD44 ( p < 0.05), indicating an inhibitory effect of liposomal CDF on CSCs.", {"entities": [[145, 149, "GENE"]]}], ["Our results demonstrate that delivery of CDF through liposomes may be an effective method for the treatment of cisplatin resistant HNSCC.", {"entities": []}], ["Respiratory infections are the leading cause of childhood deaths in Bangladesh.", {"entities": []}], ["Promoting respiratory hygiene may reduce infection transmission.", {"entities": []}], ["This formative research explored community perceptions about respiratory infections.", {"entities": []}], ["We conducted 34 in-depth interviews and 16 focus group discussions with community members and school children to explore respiratory hygiene related perceptions, practices, and social norms in an urban and a rural setting.", {"entities": []}], ["We conducted unstructured observations on respiratory hygiene practices in public markets.", {"entities": []}], ["Informants were not familiar with the term \"respiratory infection\"; most named diseases that had no relation to respiratory dysfunction.", {"entities": []}], ["Informants reported that their community identified a number of 'good behaviors' related to respiratory hygiene, but they also noted, and we observed, that very few people practiced these.", {"entities": []}], ["All informants cited hot/cold weather changes or using cold water as causes for catching cold.", {"entities": []}], ["They associated transmission of respiratory infections with close contact with a sick person's breath, cough droplets, or spit; sharing a sick person's utensils and food.", {"entities": []}], ["Informants suggested that avoiding such contact was the most effective method to prevent respiratory infection.", {"entities": []}], ["Although informants perceived that handwashing after coughing or sneezing might prevent illness, they felt this was not typically feasible or practical.", {"entities": []}], ["Community perceptions of respiratory infections include both concerns with imbalances between hot and cold, and with person-to-person transmission.", {"entities": []}], ["Many people were aware of measures that could prevent respiratory infection, but did not practice them.", {"entities": []}], ["Interventions that leverage community understanding of person-to-person transmission and that encourage the practice of their identified 'good behaviors' related to respiratory hygiene may reduce respiratory disease transmission.", {"entities": []}], ["Both Kupffer cells and invariant natural killer T (iNKT) cells suppress neutrophil-dependent liver injury in a mouse model of biliary obstruction.", {"entities": []}], ["We hypothesize that these roles are interdependent and require iNKT cell-Kupffer cell cross-activation.", {"entities": []}], ["Female, wild-type and iNKT cell-deficient C57Bl/6 mice were injected with magnetic beads 3 days prior to bile duct ligation (BDL) in order to facilitate subsequent Kupffer cell isolation.", {"entities": []}], ["On day three post-BDL, the animals were euthanized and the livers dissected.", {"entities": []}], ["Necrosis was scored; Kupffer cells were isolated and cell surface marker expression (flow cytometry), mRNA expression (qtPCR), nitric oxide (NO ) production (Griess reaction), and protein secretion (cytometric bead-array or ELISAs) were determined.", {"entities": []}], ["To address the potential role of NO in suppressing neutrophil accumulation, a group of WT mice received 1400W, a specific inducible nitric oxide synthase (iNOS) inhibitor, prior to BDL.", {"entities": []}], ["To clarify the mechanisms underlying Kupffer cell-iNKT cell cross-activation, WT animals were administered anti-IFN-\u03b3 or anti-lymphocyte function-associated antigen (LFA)-1 antibody prior to BDL.", {"entities": []}], ["Compared to their WT counterparts, Kupffer cells obtained from BDL iNKT cell-deficient mice expressed lower iNOS mRNA levels, produced less NO , and secreted more neutrophil chemoattractants.", {"entities": []}], ["Both iNOS inhibition and IFN-\u03b3 neutralization increased neutrophil accumulation in the livers of BDL WT mice.", {"entities": []}], ["Anti-LFA-1 pre-treatment reduced iNKT cell accumulation in these same animals.", {"entities": []}], ["These data indicate that the LFA-1-dependent cross-activation of iNKT cells and Kupffer cells inhibits neutrophil accumulation and cholestatic liver injury.", {"entities": []}], ["To examine medication use in male top-level football players prior to and during international tournaments.", {"entities": []}], ["Prospective survey.", {"entities": []}], ["2944 team physicians\u2019 reports on players\u2019 medication intake.", {"entities": []}], ["Each team physician was asked to document all medication and nutritional supplements taken in the 72 h prior to each match.", {"entities": []}], ["A total of 10\u2009384 substances were reported (1.8 substances/player/match); 4450 (42.9%) of these were medicinal and 5934 (57.1%) nutritional supplements.", {"entities": []}], ["The medications prescribed most frequently were non-steroidal anti-inflammatory agents (n\u200a=\u200a2092; 20.1%); more than half of the players took these at least once during a tournament and more than 10% prior to every match (156 out of 1472).", {"entities": []}], ["\u03b2-2-Agonists were reported for 1.4% (n\u200a=\u200a20) and inhaled corticosteroids for 1.6% (n\u200a=\u200a23) of participating players.", {"entities": []}], ["Injected corticosteroids were reported for 73 players.", {"entities": []}], ["The high intake of medication in international football \u2013 especially of non-steroidal anti-inflammatory drugs \u2013 is alarming and should be addressed.", {"entities": []}], ["The results raise questions as to whether the medication was taken solely for therapeutic reasons.", {"entities": []}], ["In view of the potential side effects, more restrictive recommendations for sport need to be developed.", {"entities": []}], ["Macrophages play a key role in immunity.", {"entities": []}], ["In this review, we consider the traditional notion of macrophage plasticity, data that do not fit into existing concepts, and a hypothesis for existence of a new switch macrophage phenotype.", {"entities": []}], ["Depending on the microenvironment, macrophages can reprogram their phenotype toward the proinflammatory M1 phenotype or toward the anti-inflammatory M2 phenotype.", {"entities": []}], ["Macrophage reprogramming involves well-coordinated changes in activities of signalling and posttranslational mechanisms.", {"entities": []}], ["Macrophage reprogramming is provided by JNK-, PI3K/Akt-, Notch-, JAK/STAT-, TGF- \u03b2 -, TLR/NF- \u03ba B-, and hypoxia-dependent pathways.", {"entities": []}], ["Posttranscriptional regulation is based on micro-mRNA.", {"entities": []}], ["We have hypothesized that, in addition to the M1 and M2 phenotypes, an M3 switch phenotype exists.", {"entities": []}], ["This switch phenotype responds to proinflammatory stimuli with reprogramming towards the anti-inflammatory M2 phenotype or, contrarily, it responds to anti-inflammatory stimuli with reprogramming towards the proinflammatory M1 phenotype.", {"entities": []}], ["We have found signs of such a switch phenotype in lung diseases.", {"entities": []}], ["Understanding the mechanisms of macrophage reprogramming will assist in the selection of new therapeutic targets for correction of impaired immunity.", {"entities": []}], ["Whether inhaled corticosteroids suppress airway inflammation in chronic obstructive pulmonary disease (COPD) remains controversial.", {"entities": [[64, 101, "DISEASE"]]}], ["We sought to determine the effects of inhaled corticosteroids on sputum indices of inflammation in stable COPD.", {"entities": []}], ["We searched MEDLINE, EMBASE, CINAHL, and the Cochrane Databases for randomized, controlled clinical trials that used induced sputum to evaluate the effect of inhaled corticosteroids in stable COPD.", {"entities": []}], ["For each chosen study, we calculated the mean differences in the concentrations of sputum cells before and after treatment in both intervention and control groups.", {"entities": []}], ["These values were then converted into standardized mean differences to accommodate the differences in patient selection, clinical treatment, and biochemical procedures that were employed across original studies.", {"entities": []}], ["If significant heterogeneity was present (p < 0.10), then a random effects model was used to pool the original data.", {"entities": []}], ["In the absence of significant heterogeneity, a fixed effects model was used.", {"entities": []}], ["We identified six original studies that met the inclusion criteria (N = 162 participants).", {"entities": []}], ["In studies with higher cumulative dose (\u2265 60 mg) or longer duration of therapy (\u2265 6 weeks), inhaled corticosteroids were uniformly effective in reducing the total cell, neutrophil, and lymphocyte counts.", {"entities": []}], ["In contrast, studies with lower cumulative dose (< 60 mg) or shorter duration of therapy (< 6 weeks) did not demonstrate a favorable effect of inhaled corticosteroids on these sputum indices.", {"entities": []}], ["Our study suggests that prolonged therapy with inhaled corticosteroids is effective in reducing airway inflammation in stable COPD.", {"entities": []}], ["The smoking rate among non-elderly Medicaid enrollees is more than double the rate for those privately insured; smoking-related conditions account for 15% of Medicaid expenditures.", {"entities": []}], ["Under state health reform, Massachusetts Medicaid (MassHealth) made tobacco cessation treatment available beginning in 2006.", {"entities": []}], ["We used surveys conducted in 2008 and 2014 to examine changes in smoking abstinence rates among MassHealth members identified as smokers and to identify factors associated with being a former smoker.", {"entities": []}], ["Members previously identified as smokers were surveyed by mail or phone; 2008 and 2014 samples included 3,116 and 2,971 members, respectively.", {"entities": []}], ["Surveys collected demographic and health information, asked members whether they smoked cigarettes \u201cevery day, some days or not at all\u2019, and asked questions to assess smoking intensity among current smokers.", {"entities": []}], ["The 2014 survey included an open ended-question asking members \u201cwhat helped the most\u201d in quitting or quit attempts.", {"entities": []}], ["We observed a significant decrease in members reporting smoking \u201cevery/some days\u201d of 15.5 percentage points (p < .0001) from 2008 to 2014, and a significant decrease in smokers reporting smoking \u201cmore than 10 cigarettes on days smoked\u201d of 16.7 percentage points (p < .0001).", {"entities": []}], ["Compared to smokers, former smokers more frequently reported health concerns, the influence of family members, and the use of e-cigarettes as helping the most in quitting.", {"entities": []}], ["Expanded access to tobacco cessation treatment under the Affordable Care Act may have help to reduce the high smoking rates among Medicaid enrollees.", {"entities": []}], ["Additionally, smokers\u2019 concerns about health and the influence of family and friends provide opportunities for targeted intervention and messaging about quitting.", {"entities": []}], ["The invasive nature of the current methods for monitoring of intracranial pressure (ICP) has prevented their use in many clinical situations.", {"entities": []}], ["Several attempts have been made to develop methods to monitor ICP non-invasively.", {"entities": []}], ["The aim of this study is to assess the relationship between ultrasound-based non-invasive ICP (nICP) and invasive ICP measurement in neurocritical care patients.", {"entities": []}], ["This was a prospective, single-cohort observational study of patients admitted to a tertiary neurocritical care unit.", {"entities": []}], ["Patients with brain injury requiring invasive ICP monitoring were considered for inclusion.", {"entities": []}], ["nICP was assessed using optic nerve sheath diameter (ONSD), venous transcranial Doppler (vTCD) of straight sinus systolic flow velocity (FV sv ), and methods derived from arterial transcranial Doppler (aTCD) on the middle cerebral artery (MCA): MCA pulsatility index (PI a ) and an estimator based on diastolic flow velocity (FV d ).", {"entities": []}], ["A total of 445 ultrasound examinations from 64 patients performed from 1 January to 1 November 2016 were included.", {"entities": []}], ["The median age of the patients was 53 years (range 37\u201364).", {"entities": []}], ["Median Glasgow Coma Scale at admission was 7 (range 3\u201314), and median Glasgow Outcome Scale was 3 (range 1\u20135).", {"entities": []}], ["The mortality rate was 20%.", {"entities": []}], ["ONSD and FV sv demonstrated the strongest correlation with ICP ( R = 0.76 for ONSD versus ICP; R = 0.72 for FV sv versus ICP), whereas PI a and the estimator based on FV d did not correlate with ICP significantly.", {"entities": []}], ["Combining the 2 strongest nICP predictors (ONSD and FV sv ) resulted in an even stronger correlation with ICP ( R = 0.80).", {"entities": []}], ["The ability to detect intracranial hypertension (ICP \u2265 20 mm Hg) was highest for ONSD (area under the curve [AUC] 0.91, 95% CI 0.88\u20130.95).", {"entities": [[35, 47, "DISEASE"], [22, 47, "DISEASE"]]}], ["The combination of ONSD and FV sv methods showed a statistically significant improvement of AUC values compared with the ONSD method alone (0.93, 95% CI 0.90\u20130.97, p = 0.01).", {"entities": []}], ["Major limitations are the heterogeneity and small number of patients included in this study, the need for specialised training to perform and interpret the ultrasound tests, and the variability in performance among different ultrasound operators.", {"entities": []}], ["Of the studied ultrasound nICP methods, ONSD is the best estimator of ICP.", {"entities": []}], ["The novel combination of ONSD ultrasonography and vTCD of the straight sinus is a promising and easily available technique for identifying critically ill patients with intracranial hypertension.", {"entities": [[181, 193, "DISEASE"], [168, 193, "DISEASE"]]}], ["In a observational study, Chiara Robba and colleagues examine the association between ultrasound based non-invasive intracranial pressure and invasive intracranial pressure measurement in neurocritical care patients.", {"entities": []}], ["Intracranial pressure (ICP) monitoring is necessary in many clinical scenarios.", {"entities": []}], ["Invasive ICP methods are the gold standard, but have many contraindications.", {"entities": []}], ["Nevertheless, non-invasive ICP (nICP) measurement is a poorly developed technique.", {"entities": []}], ["We present a study comparing ultrasound-based nICP measurement techniques with the gold standard.", {"entities": []}], ["In a cohort of 64 patients with brain injury, we compared invasive ICP measurement with 3 different ultrasound-based measurements of nICP: optic nerve sheath diameter (ONSD) ultrasonography, arterial transcranial doppler (aTCD)\u2013derived methods, and straight sinus systolic flow velocity (FV sv ).", {"entities": []}], ["We found that both optic nerve sheath diameter ultrasonography (ONSD) and straight sinus systolic flow velocity (FV sv ) are strongly correlated with invasive ICP.", {"entities": []}], ["In addition, the combination of these 2 nICP parameters (ONSD and FV sv ) resulted in stronger correlation with ICP.", {"entities": []}], ["A novel nICP monitoring method based on combined ONSD ultrasonography and venous transcranial Doppler has shown promising results for the measurement of intracranial pressure in patients with brain injury.", {"entities": []}], ["This ultrasound-based method is low-cost, quick, and based on technology widely available.", {"entities": []}], ["Future prospective studies will be needed to validate these results.", {"entities": []}], ["This article discusses the value of high-resolution computed tomography (HRCT) in the diagnosis and treatment of pulmonary infections.", {"entities": []}], ["Lung infection caused by pathogens is an important cause of death.", {"entities": []}], ["Traditional methods to treat lung infection involved empirical antibiotic therapy.", {"entities": []}], ["Thin-slice CT scanning is widely used in the clinical setting, and HRCT scan can very clearly show alveolar and bronchiolar involvement of infection.", {"entities": []}], ["In total, 178 patients with community-acquired pneumonia (CAP) were enrolled.", {"entities": [[47, 56, "DISEASE"]]}], ["All the patients underwent CT scan, qualified sputum, and blood samples for culture or immunological biochemical tests.", {"entities": []}], ["CT imaging features, pathogenic bacteria, and treatment results were used for statistical analysis.", {"entities": []}], ["In 77 patients with lobar consolidation, the rate of detection was 43.26% (77/178), and in 101 patients with lobular pneumonia it was 56.74% (101/178).", {"entities": [[117, 126, "DISEASE"]]}], ["In 51 patients, pathogenic bacteria were detected (28.65%, 51/178).", {"entities": []}], ["Sixteen of 33 patients detected with bacteria had cavities (48.5%, 16/33) and 35 of 145 patients detected with bacteria had no cavities (24.1%, 35/145).", {"entities": []}], ["The difference between the 2 groups was statistically significant (\u03c7 P =0.005).", {"entities": []}], ["According to the pathogenic bacteria, 38 patients were cured (74.51%, 38/51), and according to the CT imaging features 81 patients were cured (71.05%, 81/114).", {"entities": []}], ["No statistically significant difference was found between them (\u03c7 P= 0.647).", {"entities": []}], ["Treatment effect of CAP based on HRCT findings is not inferior to treatment effect guided by microbial characterization.", {"entities": []}], ["Suppressor of cytokine signaling (SOCS) proteins are inducible feedback inhibitors of cytokine signaling.", {"entities": []}], ["SOCS1 Cytokines are critical in regulating the balance between protective immunity and detrimental inflammation during influenza infection.", {"entities": [[119, 128, "DISEASE"], [0, 5, "GENE"]]}], ["Suppressor of cytokine signaling (SOCS) proteins are inducible feedback inhibitors of cytokine signaling.", {"entities": []}], ["Using gene-deficient and infectious animal models, we determined how SOCS1 regulates immune defense against influenza infection.", {"entities": [[108, 117, "DISEASE"], [69, 74, "GENE"]]}], ["We show that the intracellular protein SOCS1 not only inhibits adaptive antiviral immune responses but also exacerbates inflammatory lung damage.", {"entities": [[39, 44, "GENE"]]}], ["These detrimental effects of SOCS1 are conveyed through discrete cell populations.", {"entities": [[29, 34, "GENE"]]}], ["Specifically, while SOCS1 expression in adaptive immune cells is sufficient to inhibit antiviral immunity, SOCS1 in innate/stromal cells is responsible for aggravated lung injury.", {"entities": [[20, 25, "GENE"], [107, 112, "GENE"], [20, 25, "GENE"], [107, 112, "GENE"]]}], ["To our knowledge, there is no report showing the regulatory role of SOCS1 during the course of influenza infection, and importantly, no evidence directly linking SOCS1 with excessive inflammation in other infectious disease models.", {"entities": [[95, 104, "DISEASE"], [68, 73, "GENE"], [162, 167, "GENE"], [68, 73, "GENE"], [162, 167, "GENE"]]}], ["The distinct and non-competing detrimental roles of SOCS1, as revealed in this study, make it an appealing target in the design of effective immunotherapies for combating influenza infection.", {"entities": [[171, 180, "DISEASE"], [52, 57, "GENE"]]}], ["Galectin-3 (Gal-3, LGALS3) is a pleotropic versatile, 29\u201335 kDa chimeric gene product, and involved in diverse physiological and pathological processes, including cell growth, homeostasis, apoptosis, pre-mRNA splicing, cell-cell and cell-matrix adhesion, cellular polarity, motility, adhesion, activation, differentiation, transformation, signaling, regulation of innate/adaptive immunity, and angiogenesis.", {"entities": [[19, 25, "GENE"]]}], ["In multiple diseases, it was found that the level of circulating Gal-3 is markedly elevated, suggesting that Gal-3-dependent function is mediated by specific interaction with yet an unknown ubiquitous cell-surface protein.", {"entities": []}], ["Recently, we showed that Gal-3 attenuated drug-induced apoptosis, which is one of the mechanisms underlying multidrug resistance (MDR).", {"entities": []}], ["Here, we document that MDR could be mediated by Gal-3 interaction with the house-keeping gene product e.g., Na", {"entities": []}], ["Mechanical ventilation of preterm neonates causes lung inflammation and injury, with potential life-long consequences.", {"entities": []}], ["Inert 50-nm polystyrene nanoparticles (PS50G) reduce allergic inflammation in the lungs of adult mice.", {"entities": []}], ["We aimed to confirm the anti-inflammatory effects of PS50G in a sheep asthma model, and investigate the effects of prophylactic administration of PS50G on ventilation-induced lung injury (VILI) in preterm lambs.", {"entities": [[70, 76, "DISEASE"]]}], ["We assessed lung inflammatory cell infiltration, with and without PS50G, after airway allergen challenge in ewes sensitised to house dust mite.", {"entities": []}], ["Preterm lambs (0.83 gestation) were delivered by caesarean section for immediate tissue collection (n\u2009=\u20095) or ventilation either with (n\u2009=\u20096) or without (n\u2009=\u20095) prophylactic intra-tracheal administration of PS50G nanoparticles (3% in 2\u2009ml).", {"entities": []}], ["Ventilation was continued for a total of 2\u2009h before tissue collection for histological and biomolecular assessment of lung injury and inflammation.", {"entities": []}], ["In ewes with experimental asthma, PS50G decreased eosinophilic infiltration of the lungs.", {"entities": [[26, 32, "DISEASE"]]}], ["Ventilated preterm lambs showed molecular and histological signs of lung injury and inflammation, which were exacerbated in lambs that received PSG50G.", {"entities": []}], ["PS50G treatment decreased established inflammation in the lungs of asthmatic sheep.", {"entities": []}], ["However, prophylactic administration of PSG50 exacerbated ventilation-induced lung injury and lung inflammation in preterm lambs.", {"entities": []}], ["Objectives To investigate the effect of withdrawing incentives on recorded quality of care, in the context of the UK Quality and Outcomes Framework pay for performance scheme.", {"entities": []}], ["Design Retrospective longitudinal study.", {"entities": []}], ["Setting Data for 644 general practices, from 2004/05 to 2011/12, extracted from the Clinical Practice Research Datalink.", {"entities": []}], ["Participants All patients registered with any of the practices over the study period\u201413\u2009772\u2009992 in total.", {"entities": []}], ["Intervention Removal of financial incentives for aspects of care for patients with asthma, coronary heart disease, diabetes, stroke, and psychosis.", {"entities": [[100, 113, "DISEASE"], [91, 113, "DISEASE"], [83, 89, "DISEASE"]]}], ["Main outcome measures Performance on eight clinical quality indicators withdrawn from a national incentive scheme: influenza immunisation (asthma) and lithium treatment monitoring (psychosis), removed in April 2006; blood pressure monitoring (coronary heart disease, diabetes, stroke), cholesterol concentration monitoring (coronary heart disease, diabetes), and blood glucose monitoring (diabetes), removed in April 2011.", {"entities": [[115, 124, "DISEASE"], [252, 265, "DISEASE"], [333, 346, "DISEASE"], [243, 265, "DISEASE"], [324, 346, "DISEASE"], [139, 145, "DISEASE"]]}], ["Multilevel mixed effects multiple linear regression models were used to quantify the effect of incentive withdrawal.", {"entities": []}], ["Results Mean levels of performance were generally stable after the removal of the incentives, in both the short and long term.", {"entities": []}], ["For the two indicators removed in April 2006, levels in 2011/12 were very close to 2005/06 levels, although a small but statistically significant drop was estimated for influenza immunisation.", {"entities": [[169, 178, "DISEASE"]]}], ["For five of the six indicators withdrawn from April 2011, no significant effect on performance was seen following removal and differences between predicted and observed scores were small.", {"entities": []}], ["Performance on related outcome indicators retained in the scheme (such as blood pressure control) was generally unaffected.", {"entities": []}], ["Conclusions Following the removal of incentives, levels of performance across a range of clinical activities generally remained stable.", {"entities": []}], ["This indicates that health benefits from incentive schemes can potentially be increased by periodically replacing existing indicators with new indicators relating to alternative aspects of care.", {"entities": []}], ["However, all aspects of care investigated remained indirectly or partly incentivised in other indicators, and further work is needed to assess the generalisability of the findings when incentives are fully withdrawn.", {"entities": []}], ["Plastic bronchitis is an extremely rare disease characterized by the formation of tracheobronchial airway casts, which are composed of a fibrinous exudate with rubber-like consistency and cause respiratory distress as a result of severe airflow obstruction.", {"entities": [[8, 18, "DISEASE"]]}], ["Bronchial casts may be associated with congenital and acquired cardiopathies, bronchopulmonary diseases leading to mucus hypersecretion, and pulmonary lymphatic abnormalities.", {"entities": []}], ["In recent years, however, there is growing evidence that plastic bronchitis can also be triggered by common respiratory tract infections and thereby cause atelectasis even in otherwise healthy children.", {"entities": [[65, 75, "DISEASE"]]}], ["We report on 22-month-old monozygotic twins presenting with atelectasis triggered by a simple respiratory tract infection.", {"entities": []}], ["The clinical, laboratory, and radiographic findings given, bronchial cast formation was suspected in both infants but could only be confirmed after bronchoscopy in the first case.", {"entities": []}], ["Real-time polymerase chain reaction of the removed cast as well as nasal lavage fluid of both infants demonstrated strong positivity for human bocavirus.", {"entities": []}], ["Our case report is the first to describe two simultaneously affected monozygotic twins and substantiates the hypothesis of a contributing genetic factor in the pathophysiology of this disease.", {"entities": []}], ["In this second report related to human bocavirus, we show additional evidence that this condition can be triggered by a simple respiratory tract infection in previously healthy infants.", {"entities": []}], ["Since interferon-\u03b3 (IFN-\u03b3) tunes both innate and adaptive immune systems, it was expected to enter clinical practice as an immunomodulatory drug.", {"entities": []}], ["However, the use of IFN-\u03b3 has been limited by its dose-dependent side effects.", {"entities": []}], ["Low-dose medicine, which is emerging as a novel strategy to treat diseases, might circumvent this restriction.", {"entities": []}], ["Several clinical studies have proved the efficacy of therapies with a low dose of cytokines subjected to kinetic activation, while no in vitro data are available.", {"entities": []}], ["To fill this gap, we investigated whether low concentrations, in the femtogram range, of kinetically activated IFN-\u03b3 modulate the behavior of Jurkat cells, a widely used experimental model that has importantly contributed to the present knowledge about T cell signaling.", {"entities": []}], ["In parallel, IFN-\u03b3 in the nanogram range was used and shown to activate Signal transducer and activator of transcription (STAT)-1 and then to induce suppressor of cytokine signaling-1 (SOCS-1), which inhibits downstream signaling.", {"entities": [[185, 191, "GENE"]]}], ["When added together, femtograms of IFN-\u03b3 interfere with the transduction cascade activated by nanograms of IFN-\u03b3 by prolonging the activation of STAT-1 through the downregulation of SOCS-1.", {"entities": [[182, 188, "GENE"]]}], ["We conclude that femtograms of IFN-\u03b3 exert an immunomodulatory action in Jurkat cells.", {"entities": []}], ["The respiratory system represents the main gateway for nanoparticles\u2019 entry into the human body.", {"entities": []}], ["Although there is a myriad of engineered nanoparticles, carbon nanoparticles/nanotubes (CNPs/CNTs) have received much attention mainly due to their light weight, very high surface area, durability, and their diverse applications.", {"entities": []}], ["Since their discovery and manufacture over two decades ago, much has been learned about nanoparticles\u2019 interactions with diverse biological system models.", {"entities": []}], ["In particular, the respiratory system has been of great interest because various natural and man-made fibrous particles are known to be responsible for chronic and debilitating lung diseases.", {"entities": []}], ["In this review, we present up-to-date the literature regarding the effects of CNTs or carbon nanofibers (CNFs) on the human respiratory system with respect to respiratory toxicity pathways and associated pathologies.", {"entities": []}], ["This article is intended to emphasize the potentially dangerous effects to the human respiratory system if inadequate measures are used in the manufacture, handling, and preparation and applications of CNP or CNP-based products.", {"entities": [[202, 205, "GENE"], [209, 212, "GENE"]]}], ["Zingiberaceae rhizomes commonly used in the Malaysian traditional medicine were screened for anti-tumour promoter activity using the short-term assay of inhibition of 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced Epstein-Barr virus early antigen (EBV-EA) in Raji cells.", {"entities": []}], ["The inhibition of TPA-induced EBV-EA was detected using the indirect immunofluorescence assay (IFA) and Western blot technique.", {"entities": []}], ["The indirect IFA detected the expression/inhibition of EBV-EA-D (diffused EA antigen), whereas the Western blot technique detected the expression/inhibition of both EBV-EA-D and EA-R (restricted EA antigen).", {"entities": []}], ["Seven rhizomes were found to possess inhibitory activity towards EBV activation, induced by TPA; they are: Curcuma domestica , C .", {"entities": []}], ["xanthorrhiza , Kaempferia galanga , Zingiber cassumunar , Z .", {"entities": []}], ["officinale , Z .", {"entities": []}], ["officinale (red variety), and Z .", {"entities": []}], ["A cytotoxicity assay was carried out to determine the toxicity of the Zingiberaceae rhizome extracts.", {"entities": []}], ["The rhizome extracts that exhibited EBV activation inhibitory activity had no cytotoxicity effect in Raji cells.", {"entities": []}], ["Therefore, the present study shows that several Zingiberaceae species used in Malaysian traditional medicine contain naturally occurring non-toxic compounds that inhibit the EBV activation, which, if further investigated, could contribute in the development of cancer prevention methods at the tumour-promoting stage.", {"entities": [[261, 267, "DISEASE"]]}], ["\u00a9 1999 Cancer Research Campaign", {"entities": [[7, 13, "DISEASE"]]}], ["It has been suggested that mode of delivery, a potentially powerful influence upon long-term health, may affect later life body mass index (BMI).", {"entities": []}], ["We conducted a systematic review and meta-analysis of the effect of Caesarean section (CS) and vaginal delivery (VD) on offspring BMI, overweight (BMI>25) and obesity (BMI>30) in adulthood.", {"entities": [[159, 166, "DISEASE"], [87, 89, "GENE"]]}], ["Secondary outcomes were subgroup analyses by gender and type of CS (in-labour/emergency, pre-labour/elective).", {"entities": [[64, 66, "GENE"]]}], ["Using a predefined search strategy, Pubmed, Google Scholar and Web of Science were searched for any article published before 31 Thirty-five studies were identified through the search, and 15 studies with a combined population of 163,753 were suitable for inclusion in the meta-analysis.", {"entities": []}], ["Comparing all CS to VD in pooled-gender unadjusted analyses, mean BMI difference was 0\u00b744 kg\u00b7m p \u200a=\u200a0\u00b7002), OR for incidence of overweight was 1\u00b726 (1\u00b716, 1\u00b738; p <0\u00b700001) and OR for incidence of obesity was 1\u00b722 (1\u00b705, 1\u00b742; p\u200a=\u200a 0\u00b701).", {"entities": [[197, 204, "DISEASE"], [14, 16, "GENE"]]}], ["Heterogeneity was low in all primary analyses.", {"entities": []}], ["Similar results were found in gender-specific subgroup analyses.", {"entities": []}], ["Subgroup analyses comparing type of CS to VD showed no significant impact on any outcome.", {"entities": [[36, 38, "GENE"]]}], ["There is a strong association between CS and increased offspring BMI, overweight and obesity in adulthood.", {"entities": [[85, 92, "DISEASE"], [38, 40, "GENE"]]}], ["Given the rising CS rate worldwide there is a need to determine whether this is causal, or reflective of confounding influences.", {"entities": [[17, 19, "GENE"]]}], ["An a priori protocol was registered on PROSPERO (registration number: CRD42011001851)", {"entities": []}], ["In Cameroon, the use of edible plants is an integral part of dietary behavior.", {"entities": []}], ["However, evidence of the antimicrobial as well as the cytotoxic effects of many of them has not been investigated.", {"entities": []}], ["In the present study, aqueous and methanol extracts from barks, seeds, leaves and roots of three Cameroonian edible plants namely Garcina lucida, Fagara heitzii and Hymenocardia lyrata were evaluated for their cytotoxic and antimicrobial activities.", {"entities": []}], ["Antibacterial and antifungal activities were assessed by the broth micro-dilution method meanwhile the cytotoxicity was performed using sulphorhodamine B assay (SRB) against the human leukemia THP-1, the alveolar epithelial A549, prostate cancer PC-3, breast adenocarcinoma MCF-7 and cervical cancer HeLa cell lines.", {"entities": [[259, 273, "DISEASE"], [252, 273, "DISEASE"], [184, 192, "DISEASE"], [239, 245, "DISEASE"], [293, 299, "DISEASE"], [284, 299, "DISEASE"], [230, 245, "DISEASE"]]}], ["The minimum inhibitory concentration (MIC) values of the seven tested extracts ranged from 62.5\u00a0\u03bcg/ml to 1000\u00a0\u03bcg/ml.", {"entities": []}], ["The methanol (MeOH) extract from the roots of H. lyrata showed the highest antibacterial activity against Gram-positive bacteria S. aureus and S. epidermitis.", {"entities": []}], ["The best antifungal activity was obtained with the MeOH extract from the leaves of G. lucida against C. tropicalis (MIC value of 62.5\u00a0\u03bcg/ml).", {"entities": []}], ["The in vitro antiproliferative activity revealed that, extract from the bark of F. heitzii and extract from H. lyrata roots had significant cytotoxic activity on THP-1 (IC 50 8.4\u00a0\u03bcg/ml) and PC-3 (IC 50 9.5\u00a0\u03bcg/ml) respectively.", {"entities": []}], ["Our findings suggest that Cameroonian spices herein studied could be potentially useful for the development of therapeutic agents against bacterial infections as well as for prostate and leukemia cancer.", {"entities": [[187, 195, "DISEASE"], [196, 202, "DISEASE"]]}], ["Drug\u2010induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms ( DIHS / DRESS ) and Stevens\u2013Johnson syndrome ( SJS )/toxic epidermal necrolysis ( TEN ) represent contrasting poles of severe drug eruptions, and sequential reactivations of several herpesviruses have exclusively been demonstrated in the former.", {"entities": [[30, 38, "DISEASE"], [126, 134, "DISEASE"], [54, 66, "DISEASE"]]}], ["No previous studies, however, were extended beyond the acute stage.", {"entities": []}], ["We sought to investigate whether herpesvirus reactivations could also be observed in SJS / TEN and beyond the acute stage of both diseases.", {"entities": []}], ["Patients with SJS ( n \u00a0=\u00a016), SJS / TEN overlap ( n \u00a0=\u00a02), TEN ( n \u00a0=\u00a010), and DIHS / DRESS ( n \u00a0=\u00a034) were enrolled.", {"entities": []}], ["We performed a retrospective analysis of Epstein\u2013Barr virus ( EBV ), human herpesvirus 6 ( HHV \u20106), and cytomegalovirus ( CMV ) DNA loads sequentially determined by real\u2010time polymerase chain reaction during a 2\u2010year period after onset.", {"entities": []}], ["Persistently increased EBV loads were detected in SJS during the acute stage and long after resolution, but not in others.", {"entities": []}], ["In contrast, high HHV \u20106 loads were exclusively detected in DIHS / DRESS during the acute stage.", {"entities": []}], ["The dynamics of herpesvirus reactivation varied in DIHS / DRESS according to the use of systemic corticosteroids: While EBV loads were higher in patients not receiving systemic corticosteroids, CMV and HHV \u20106 loads were higher in those receiving them.", {"entities": []}], ["Distinct patterns of herpesvirus reactivation according to the pathological phenotype and to the use of systemic corticosteroids were observed during the acute stage and follow\u2010up period, which may contribute, at least in part, to the difference in the clinical manifestations and long\u2010term outcomes.", {"entities": []}], ["Systemic corticosteroids during the acute stage may improve the outcomes in DIHS / DRESS .", {"entities": []}], ["Accumulation of mast cells can be causally related to several allergic inflammations.", {"entities": []}], ["Stem cell factor (SCF) as a mast cell chemotaxin induces mast cell migration.", {"entities": []}], ["To clarify a new effect of Pyeongwee-San extract (KMP6, a drug for indigestion) for the treatment of allergy, we investigated the effects of KMP6 on SCF-induced migration of rat peritoneal mast cells (RPMCs).", {"entities": []}], ["A molecular docking simulation showed that hesperidin, a major component of KMP6, controls the SCF and c-kit binding by interaction with the active site of the c-kit.", {"entities": []}], ["KMP6 and hesperidin significantly inhibited SCF-induced migration of RPMCs ( P <0.05).", {"entities": []}], ["The ability of the SCF to enhance morphological alteration and F-actin formation was also abolished by treatment with KMP6 or hesperidin.", {"entities": []}], ["KMP6 and hesperidin inhibited SCF-induced p38 MAPK activation.", {"entities": []}], ["In addition, SCF-induced inflammatory cytokine production was significantly inhibited by treatment with KMP6 or hesperidin ( P <0.05).", {"entities": []}], ["Our results show for the first time that KMP6 potently regulates SCF-induced migration, p38 MAPK activation and inflammatory cytokines production through hindrance of SCF and c-kit binding in RPMCs.", {"entities": []}], ["Such modulation may have functional consequences during KMP6 treatment, especially mast cell-mediated allergic inflammation disorders.", {"entities": []}], ["This paper examines the challenges and opportunities in establishing and sustaining north\u2013south research partnerships in Africa through a case study of the UK-Africa Academic Partnership on Chronic Disease.", {"entities": []}], ["Established in 2006 with seed funding from the British Academy, the partnership aimed to bring together multidisciplinary chronic disease researchers based in the UK and Africa to collaborate on research, inform policymaking, train and support postgraduates and create a platform for research dissemination.", {"entities": []}], ["We review the partnership\u2019s achievements and challenges, applying established criteria for developing successful partnerships.", {"entities": []}], ["During the funded period we achieved major success in creating a platform for research dissemination through international meetings and publications.", {"entities": []}], ["Other goals, such as engaging in collaborative research and training postgraduates, were not as successfully realised.", {"entities": []}], ["Enabling factors included trust and respect between core working group members, a shared commitment to achieving partnership goals, and the collective ability to develop creative strategies to overcome funding challenges.", {"entities": []}], ["Barriers included limited funding, administrative support, and framework for monitoring and evaluating some goals.", {"entities": []}], ["Chronic disease research partnerships in low-income regions operate within health research, practice, funding and policy environments that prioritise infectious diseases and other pressing public health and developmental challenges.", {"entities": []}], ["Their long-term sustainability will therefore depend on integrated funding systems that provide a crucial capacity building bridge.", {"entities": []}], ["Beyond the specific challenges of chronic disease research, we identify social capital, measurable goals, administrative support, creativity and innovation and funding as five key ingredients that are essential for sustaining research partnerships.", {"entities": []}], ["CXCR4 regulates cell proliferation, enhances cell survival and induces chemotaxis, yet molecular mechanisms underlying its signaling remain elusive.", {"entities": [[0, 5, "GENE"]]}], ["Like all other G-protein coupled receptors (GPCRs), CXCR4 delivers signals through G-protein-dependent and -independent pathways, the latter involving its serine-rich cytoplasmic tail.", {"entities": [[52, 57, "GENE"]]}], ["To evaluate the signaling and biological contribution of this G-protein-independent pathway, we generated mutant mice that express cytoplasmic tail-truncated CXCR4 (\u0394T) by a gene knock-in approach.", {"entities": [[158, 163, "GENE"]]}], ["We found that \u0394T mice exhibited multiple developmental defects, with not only G-protein-independent but also G-protein-dependent signaling events completely abolished, despite \u0394T's ability to still associate with G-proteins.", {"entities": []}], ["These results reveal an essential positive regulatory role of the cytoplasmic tail in CXCR4 signaling and suggest the tail is crucial for mediating G-protein activation and initiating crosstalk between G-protein-dependent and G-protein-independent pathways for correct GPCR signaling.", {"entities": [[86, 91, "GENE"]]}], ["Glucocorticoids are widely regarded as the most effective treatment for asthma.", {"entities": [[72, 78, "DISEASE"]]}], ["However, the direct impact of glucocorticoids on the innate immune system and antibacterial host defense during asthma remain unclear.", {"entities": [[112, 118, "DISEASE"]]}], ["Understanding the mechanisms underlying this process is critical to the clinical application of glucocorticoids for asthma therapy.", {"entities": [[116, 122, "DISEASE"]]}], ["After sensitization and challenge with ovalbumin (OVA), BALB/c mice were treated with inhaled budesonide and infected with Pseudomonas aeruginosa ( P .", {"entities": []}], ["aeruginosa ).", {"entities": []}], ["The number of viable bacteria in enflamed lungs was evaluated, and levels of interleukin-4 (IL-4) and interferon-\u03b3 (IFN-\u03b3) in serum were measured.", {"entities": []}], ["A lung epithelial cell line was pretreated with budesonide.", {"entities": []}], ["Levels of cathelicidin-related antimicrobial peptide (CRAMP) were measured by immunohistochemistry and western blot analysis.", {"entities": []}], ["Intracellular bacteria were observed in lung epithelial cells.", {"entities": []}], ["Inhaled budesonide enhanced lung infection in allergic mice exposed to P .", {"entities": []}], ["aeruginosa and increased the number of viable bacteria in lung tissue.", {"entities": []}], ["Higher levels of IL-4 and lower levels of IFN-\u03b3 were observed in the serum.", {"entities": []}], ["Budesonide decreased the expression of CRAMP, increased the number of internalized P .", {"entities": []}], ["aeruginosa in OVA-challenged mice and in lung epithelial cell lines.", {"entities": []}], ["These data indicate that inhaled budesonide can suppress pulmonary antibacterial host defense by down-regulating CRAMP in allergic inflammation mice and in cells in vitro .", {"entities": []}], ["Inhaled budesonide suppressed pulmonary antibacterial host defense in an asthmatic mouse model and in lung epithelium cells in vitro .", {"entities": []}], ["This effect was dependent on the down-regulation of CRAMP.", {"entities": []}], ["The distribution of lipoprotein(a) [Lp(a)] levels can differ dramatically across diverse racial/ethnic populations.", {"entities": []}], ["The extent to which genetic variation in LPA can explain these differences is not fully understood.", {"entities": [[41, 44, "GENE"]]}], ["To explore this, 19 LPA tagSNPs were genotyped in 7,159 participants from the Third National Health and Nutrition Examination Survey (NHANES III).", {"entities": [[20, 23, "GENE"]]}], ["NHANES III is a diverse population-based survey with DNA samples linked to hundreds of quantitative traits, including serum Lp(a).", {"entities": []}], ["Tests of association between LPA variants and transformed Lp(a) levels were performed across the three different NHANES subpopulations (non-Hispanic whites, non-Hispanic blacks, and Mexican Americans).", {"entities": [[29, 32, "GENE"]]}], ["At a significance threshold of p<0.0001, 15 of the 19 SNPs tested were strongly associated with Lp(a) levels in at least one subpopulation, six in at least two subpopulations, and none in all three subpopulations.", {"entities": []}], ["In non-Hispanic whites, three variants were associated with Lp(a) levels, including previously known rs6919246 (p\u200a=\u200a1.18\u00d710 LPA is an important contributor to Lp(a) levels regardless of race/ethnicity, the lack of generalization of associations across all subpopulations suggests that specific LPA variants may be contributing to the observed Lp(a) between-population variance.", {"entities": [[124, 127, "GENE"], [294, 297, "GENE"], [124, 127, "GENE"], [294, 297, "GENE"]]}], ["Effector T\u00a0cell migration through tissues can enable control of infection or mediate inflammatory damage.", {"entities": []}], ["Nevertheless, the molecular mechanisms that regulate migration of effector T cells within the interstitial space of inflamed lungs are incompletely understood.", {"entities": []}], ["Here, we show T\u00a0cell migration in a mouse model of acute lung injury with two-photon imaging of intact lung tissue.", {"entities": []}], ["Computational analysis indicates that T cells migrate with an intermittent mode, switching between confined and almost straight migration, guided by lung-associated vasculature.", {"entities": []}], ["Rho-associated protein kinase (ROCK) is required for both high-speed migration and straight motion.", {"entities": []}], ["By contrast, inhibition of G\u03b1 i signaling with pertussis toxin affects speed but not the intermittent migration of lung-infiltrating T cells.", {"entities": [[47, 56, "DISEASE"]]}], ["Computational modeling shows that an intermittent migration pattern balances both search area and the duration of contacts between T cells and target cells.", {"entities": []}], ["These data identify that ROCK-dependent intermittent T\u00a0cell migration regulates tissue-sampling during acute lung injury.", {"entities": []}], ["ROCK is associated with T cell movement in lymph nodes.", {"entities": []}], ["Here the authors use an LPS lung damage model and two-photon imaging to show that CD8", {"entities": []}], ["Children with low birth weight show an increased prevalence of developmental defects of enamel in the primary dentition that subsequently may predispose to early childhood caries (ECC).", {"entities": []}], ["Focusing 6\u201336 months old, the purpose of this study was to assess the frequency of enamel defects in the primary dentition and identify influences of early life course factors; socio-demographics, birth weight, child\u2019s early illness episodes and mothers\u2019 perceived size of the child at birth, whilst controlling for more recent life course events in terms of current breastfeeding and oral hygiene.", {"entities": []}], ["A cross-sectional study was conducted in the high fluoride area of Manyara, northern Tanzania including 1221 child-mother pairs who attended Reproductive and Child Health (RCH) clinics for immunization and/or growth monitoring.", {"entities": []}], ["After the primary caregivers had completed face to face interviews at the health care facility, children underwent oral clinical examination whereby ECC and developmental defects of enamel were recorded using field criteria.", {"entities": []}], ["All erupted teeth were examined and the enamel defects were assessed on buccal surfaces according to the modified DDE Index.", {"entities": []}], ["The prevalence of enamel defects was 33.3%.", {"entities": []}], ["Diffuse opacities were the most common defects identified (23.1%), followed by hypoplasia (7.6%) and demarcated opacities (5.0%).", {"entities": []}], ["The most frequently affected teeth were the upper central incisors (29.0% - 30.5%), whereas lower central incisors (4.3% to 4.5%) were least frequently affected.", {"entities": []}], ["Multiple logistic regression analysis, adjusting for confounding the factors revealed that having normal birth weight (equal or more than 2500 g) associated with lower odds of having enamel hypoplasia [OR 0.2 (95% CI 0.1-0.7)].", {"entities": []}], ["No statistically significant association occurred between birth weight and diffuse opacities, demarcated opacities or combined DDE.", {"entities": []}], ["Children with the history of low birth weight were more likely than their normal birth weight counterparts to present with enamel hypoplasia.", {"entities": []}], ["In view of the frequent occurrence of enamel defects and the fact that hypoplasia may constitute a risk factor for future ECC, enamel defects should be included as a dental health indicator in epidemiological studies of children in northern Tanzania.", {"entities": []}], ["The sugar alcohol xylitol inhibits the growth of some bacterial species including Streptococcus mutans .", {"entities": []}], ["It is used as a food additive to prevent caries.", {"entities": []}], ["We previously showed that 1.5\u20134.0 g/kg body weight/day xylitol as part of a high-fat diet (HFD) improved lipid metabolism in rats.", {"entities": []}], ["However, the effects of lower daily doses of dietary xylitol on gut microbiota and lipid metabolism are unclear.", {"entities": []}], ["We examined the effect of 40 and 200 mg/kg body weight/day xylitol intake on gut microbiota and lipid metabolism in mice.", {"entities": []}], ["Bacterial compositions were characterized by denaturing gradient gel electrophoresis and targeted real-time PCR.", {"entities": []}], ["Luminal metabolites were determined by capillary electrophoresis electrospray ionization time-of-flight mass spectrometry.", {"entities": []}], ["Plasma lipid parameters and glucose tolerance were examined.", {"entities": []}], ["Dietary supplementation with low- or medium-dose xylitol (40 or 194 mg/kg body weight/day, respectively) significantly altered the fecal microbiota composition in mice.", {"entities": []}], ["Relative to mice not fed xylitol, the addition of medium-dose xylitol to a regular and HFD in experimental mice reduced the abundance of fecal Bacteroidetes phylum and the genus Barnesiella , whereas the abundance of Firmicutes phylum and the genus Prevotella was increased in mice fed an HFD with medium-dose dietary xylitol.", {"entities": []}], ["Body composition, hepatic and serum lipid parameters, oral glucose tolerance, and luminal metabolites were unaffected by xylitol consumption.", {"entities": []}], ["In mice, 40 and 194 mg/kg body weight/day xylitol in the diet induced gradual changes in gut microbiota but not in lipid metabolism.", {"entities": []}], ["Association of oxidative stress with carcinogenesis is well known, but not understood well, as is pathophysiology of oxidative stress generated during different types of anti-cancer treatments.", {"entities": [[175, 181, "DISEASE"]]}], ["Moreover, recent findings indicate that cancer associated lipid peroxidation might eventually help defending adjacent nonmalignant cells from cancer invasion.", {"entities": [[40, 46, "DISEASE"], [142, 148, "DISEASE"]]}], ["Therefore, untargeted metabolomics studies designed for advanced translational and clinical studies are needed to understand the existing paradoxes in oncology, including those related to controversial usage of antioxidants aiming to prevent or treat cancer.", {"entities": [[251, 257, "DISEASE"]]}], ["In this short review we have tried to put emphasis on the importance of pathophysiology of oxidative stress and lipid peroxidation in cancer development in relation to metabolic adaptation of particular types of cancer allowing us to conclude that adaptation to oxidative stress is one of the main driving forces of cancer pathophysiology.", {"entities": [[134, 140, "DISEASE"], [212, 218, "DISEASE"], [316, 322, "DISEASE"]]}], ["With the help of metabolomics many novel findings are being achieved thus encouraging further scientific breakthroughs.", {"entities": []}], ["Combined with targeted qualitative and quantitative methods, especially immunochemistry, further research might reveal bio-signatures of individual patients and respective malignant diseases, leading to individualized treatment approach, according to the concepts of modern integrative medicine.", {"entities": []}], ["A possible involvement of autoimmune mechanism in the pathogenesis of bronchial asthma has been proposed.", {"entities": [[80, 86, "DISEASE"]]}], ["Recently, alpha-enolase protein was identified as a major autoantigen recognized by circulating IgG autoantibodies in patients with severe asthma.", {"entities": [[139, 145, "DISEASE"]]}], ["To evaluate a possible pathogenetic significance of these autoantibodies in severe asthma, isotype (IgG, IgA, IgM, and IgE) and IgG subclass (IgG1, IgG2, IgG3, and IgG4) distributions of autoantibodies to recombinant human alpha-enolase protein were analyzed.", {"entities": [[83, 89, "DISEASE"]]}], ["We examined serum samples from 10 patients with severe asthma and 7 patients with mild-to-moderate asthma, and 5 healthy controls by immunoblot analysis.", {"entities": [[55, 61, "DISEASE"], [99, 105, "DISEASE"]]}], ["Severe asthma was defined as patients having at least 1 severe asthmatic exacerbation requiring an emergency department visit or admission in the last year despite continuous typical therapies.", {"entities": [[7, 13, "DISEASE"]]}], ["IgG1 was the predominant IgG subclass antibody response to alpha-enolase protein in patients with severe asthma.", {"entities": [[105, 111, "DISEASE"]]}], ["IgG1 autoantibody to alpha-enolase protein was detected in 7 of 10 patients with severe asthma (70%), 1 of 7 patients with mild-to-moderate asthma (14.3%), and none of 5 healthy controls (0%) (chi-square test; p < 0.05).", {"entities": [[88, 94, "DISEASE"], [140, 146, "DISEASE"]]}], ["IgA, IgM, and IgE autoantibodies to alpha-enolase protein could not be detected in patients with severe asthma.", {"entities": [[104, 110, "DISEASE"]]}], ["IgG1 subclass was the predominant type of autoantibody response to alpha-enolase protein in patients with severe asthma, suggests a possibility of IgG1 autoantibody-mediated complement activation in the pathogenesis of severe asthma.", {"entities": [[113, 119, "DISEASE"], [226, 232, "DISEASE"]]}], ["New recruits within military barracks present conditions favorable for the spread of respiratory pathogens.", {"entities": []}], ["However, respiratory pathogen transmission in such confined settings in the tropics has not been well studied.", {"entities": []}], ["Recruits in four successive Royal Thai Army basic training classes living in military barracks were monitored for the symptoms of influenza-like illness (ILI) or upper respiratory illness (URI).", {"entities": [[130, 139, "DISEASE"]]}], ["Classes 1 and 2 were also monitored after basic training.", {"entities": []}], ["Nasal/throat swabs from acute illnesses were collected and tested by influenza RT-PCR (all four classes).", {"entities": [[69, 78, "DISEASE"]]}], ["In addition, class 1 had multiplex PCR performed along with the analysis of bed locations within the barracks.", {"entities": []}], ["Influenza-like illness/upper respiratory illness rates ranged from 4\u00b77 to 6\u00b79 per 100 recruit-weeks in the four classes and generally decreased during the course of basic training ( P \u00a0<\u00a00\u00b705 in three of four classes).", {"entities": [[0, 9, "DISEASE"]]}], ["Rates during basic training were 1\u00b77 (95% CI: 1\u00b729, 2\u00b729) and 2\u00b75 (95% CI: 1\u00b75, 4\u00b71) times higher than after basic training (classes 1 and 2, respectively).", {"entities": []}], ["In class 1, coronavirus, parainfluenza virus, and rhinovirus were the most commonly identified respiratory pathogens; only one influenza PCR-positive infection was detected in all four classes.", {"entities": [[127, 136, "DISEASE"]]}], ["Bed locations of URI/ILI cases in class 1 tended to be in closer proximity to each other.", {"entities": []}], ["Basic training recruits in military barracks in the tropics had high rates of acute respiratory illnesses with illness patterns consistent with external seeding followed by substantial internal transmission.", {"entities": []}], ["Our findings may contribute to control measures in similar confined settings both within and outside the military.", {"entities": []}], ["Cecropin A is a natural antimicrobial peptide that exhibits fast and potent activity against a broad spectrum of pathogens and neoplastic cells, and that has important biotechnological applications.", {"entities": []}], ["However, cecropin A exploitation, as for other antimicrobial peptides, is limited by their production and purification costs.", {"entities": []}], ["Here, we report the efficient production of this bioactive peptide in rice bran using the rice oleosin 18 as a carrier protein.", {"entities": []}], ["High cecropin A levels were reached in rice seeds driving the expression of the chimeric gene by the strong embryo-specific oleosin 18 own promoter, and targeting the peptide to the oil body organelle as an oleosin 18-cecropin A fusion protein.", {"entities": []}], ["The accumulation of cecropin A in oil bodies had no deleterious effects on seed viability and seedling growth, as well as on seed yield.", {"entities": []}], ["We also show that biologically active cecropin A can be easily purified from the transgenic rice seeds by homogenization and simple flotation centrifugation methods.", {"entities": []}], ["Our results demonstrate that the oleosin fusion technology is suitable for the production of cecropin A in rice seeds, which can potentially be extended to other antimicrobial peptides to assist their exploitation.", {"entities": []}], ["Despite a 92-99% national vaccination coverage since 2000, the former Yugoslav Republic of Macedonia experienced a large measles outbreak between 2010 and 2011.", {"entities": [[121, 128, "DISEASE"]]}], ["Here we investigate the characteristics of patients hospitalized during this outbreak at the Clinic of Infectious Diseases in Skopje.", {"entities": []}], ["Epidemiological, clinical and laboratory data of 284 measles patients, including 251 from Skopje (43.80% of the 573 reported cases) and 33 from elsewhere in Macedonia were collected.", {"entities": [[53, 60, "DISEASE"]]}], ["The most affected age groups were children up to 4 years of age and adolescents/adults of 15 years and older.", {"entities": []}], ["Most patients were unvaccinated (n=263, 92.61%) and many had non-Macedonian nationalities (n=156, 54.93%) or belonged to the Roma ethnicity (n=73, 25.70%).", {"entities": []}], ["Bronchopneumonia and diarrhea were the most common complications.", {"entities": [[21, 29, "DISEASE"]]}], ["Eighty-two out of 86 tested patients (95.35%) had measles-specific IgM antibodies.", {"entities": [[50, 57, "DISEASE"]]}], ["The outbreak was caused by the measles variant D4-Hamburg.", {"entities": [[31, 38, "DISEASE"]]}], ["The epidemic identified pockets of susceptibles in Skopje and indicated that additional vaccination opportunities in particular for people with non-Macedonian nationality and traveler communities are warranted to ensure efficient measles control in Macedonia.", {"entities": [[230, 237, "DISEASE"]]}], ["The high attack rate among children of less than 1 year suggests that vaccination before 12 months of age should be considered in high risk settings.", {"entities": []}], ["The bioactive lipid mediator leukotriene B 4 (LTB 4 ) greatly enhances phagocyte antimicrobial functions against a myriad of pathogens.", {"entities": [[46, 49, "GENE"]]}], ["In murine histoplasmosis, inhibition of the LT-generating enzyme 5-lypoxigenase (5-LO) increases the susceptibility of the host to infection.", {"entities": [[10, 24, "DISEASE"]]}], ["In this study, we investigated whether murine resistance or susceptibility to Histoplasma capsulatum infection is associated with leukotriene production and an enhancement of in vivo and/or in vitro antimicrobial effector function.", {"entities": []}], ["We show that susceptible C57BL/6 mice exhibit a higher fungal burden in the lung and spleen, increased mortality, lower expression levels of 5-LO and leukotriene B 4 receptor 1 (BLT 1 ) and decreased LTB 4 production compared to the resistant 129/Sv mice.", {"entities": [[200, 203, "GENE"]]}], ["Moreover, we demonstrate that endogenous and exogenous LTs are required for the optimal phagocytosis of H. capsulatum by macrophages from both murine strains, although C57BL/6 macrophages are more sensitive to the effects of LTB 4 than 129/Sv macrophages.", {"entities": [[225, 228, "GENE"]]}], ["Therefore, our results provide novel evidence that LTB 4 production and BLT 1 signaling are required for a histoplasmosis-resistant phenotype.", {"entities": [[107, 121, "DISEASE"], [51, 54, "GENE"]]}], ["Ozone exposure induces airway neutrophilia and modifies innate immune monocytic cell-surface phenotypes in healthy individuals.", {"entities": []}], ["High-dose inhaled corticosteroids can reduce O 3 -induced airway inflammation, but their effect on innate immune activation is unknown.", {"entities": []}], ["We used a human O 3 inhalation challenge model to examine the effectiveness of clinically relevant doses of inhaled corticosteroids on airway inflammation and markers of innate immune activation in healthy volunteers.", {"entities": []}], ["Seventeen O 3 -responsive subjects [> 10% increase in the percentage of polymorphonuclear leukocytes (PMNs) in sputum, PMNs per milligram vs. baseline sputum] received placebo, or either a single therapeutic dose (0.5 mg) or a high dose (2 mg) of inhaled fluticasone proprionate (FP) 1 hr before a 3-hr O 3 challenge (0.25 ppm) on three separate occasions at least 2 weeks apart.", {"entities": [[286, 288, "GENE"], [300, 302, "GENE"]]}], ["Lung function, exhaled nitric oxide, sputum, and systemic biomarkers were assessed 1\u20135 hr after the O 3 challenge.", {"entities": [[87, 89, "GENE"]]}], ["To determine the effect of FP on cellular function, we assessed sputum cells from seven subjects by flow cytometry for cell-surface marker activation.", {"entities": []}], ["FP had no effect on O 3 -induced lung function decline.", {"entities": []}], ["Compared with placebo, 0.5 mg and 2 mg FP reduced O 3 -induced sputum neutrophilia by 18% and 35%, respectively.", {"entities": []}], ["A similar effect was observed on the airway-specific serum biomarker Clara cell protein 16 (CCP16).", {"entities": []}], ["Furthermore, FP pretreatment significantly reduced O 3 -induced modification of CD11b, mCD14, CD64, CD16, HLA-DR, and CD86 on sputum monocytes in a dose-dependent manner.", {"entities": [[118, 122, "GENE"]]}], ["This study confirmed and extended data demonstrating the protective effect of FP against O 3 -induced airway inflammation and immune cell activation.", {"entities": []}], ["Smad3 is a key protein in the transforming growth factor-beta (TGF-\u03b2)/Smad signaling pathway, which is involved in fibrosis in many organs.", {"entities": [[0, 5, "GENE"]]}], ["We investigated the relationship between Smad3 gene methylation and pulmonary fibrosis in pigeon breeder's lung (PBL).", {"entities": [[68, 86, "DISEASE"], [41, 46, "GENE"]]}], ["Twenty Uygur PBL patients with pulmonary fibrosis in Kashi between October 2015 and March 2016 were enrolled.", {"entities": [[31, 49, "DISEASE"]]}], ["Twenty PBL-free pigeon breeders and 20 healthy non-pigeon breeders enrolled during the same period constituted the negative and normal control groups, respectively.", {"entities": []}], ["Participants\u2019 data and peripheral blood samples were collected, and three Smad3 CpG loci were examined.", {"entities": [[74, 79, "GENE"]]}], ["Distributions of CpG_2 and CpG_4 methylation rates did not differ across groups, whereas distributions of CpG_3 methylation rates were significantly different among the three groups.", {"entities": []}], ["The CpG_3 methylation rate was significantly lower in the patient group than in the negative control group.", {"entities": []}], ["Smad3 mRNA expression was significantly higher in the patient group than in the negative control group but did not differ between the two control groups.", {"entities": [[0, 5, "GENE"]]}], ["TGF-\u03b2levels were significantly higher in the patient group than in either control group (both P<0.01).", {"entities": []}], ["Smad3 gene methylation and Smad3 mRNA expression were negatively correlated, with a correlation coefficient of -0.84.", {"entities": [[0, 5, "GENE"], [27, 32, "GENE"], [0, 5, "GENE"], [27, 32, "GENE"]]}], ["The number of pigeons bred during the preceding three months was positively correlated with Smad3 mRNA expression, with a correlation coefficient of 0.77.", {"entities": [[92, 97, "GENE"]]}], ["Smad3 gene hypomethylation might promote pulmonary fibrosis in Uygur PBL patients via increased Smad3 mRNA expression.", {"entities": [[41, 59, "DISEASE"], [0, 5, "GENE"], [96, 101, "GENE"], [0, 5, "GENE"], [96, 101, "GENE"]]}], ["Smad3 methylation, Smad3 mRNA expression and TGF-\u03b2 level were correlated with the number of pigeons bred by patients.", {"entities": [[0, 5, "GENE"], [19, 24, "GENE"], [0, 5, "GENE"], [19, 24, "GENE"]]}], ["Mast cells are immune cells critical in the pathogenesis of allergic, but also inflammatory and autoimmune diseases through release of many pro-inflammatory cytokines such as IL-8 and TNF.", {"entities": [[184, 187, "GENE"]]}], ["Contact dermatitis and photosensitivity are skin conditions that involve non-immune triggers such as substance P (SP), and do not respond to conventional treatment.", {"entities": [[0, 18, "DISEASE"], [8, 18, "DISEASE"]]}], ["Inhibition of mast cell cytokine release could be effective therapy for such diseases.", {"entities": []}], ["Unfortunately, disodium cromoglycate (cromolyn), the only compound marketed as a mast cell \u201cstabilizer\u201d, is not particularly effective in blocking human mast cells.", {"entities": []}], ["Instead, flavonoids are potent anti-oxidant and anti-inflammatory compounds with mast cell inhibitory actions.", {"entities": []}], ["Here, we first compared the flavonoid quercetin (Que) and cromolyn on cultured human mast cells.", {"entities": []}], ["Que and cromolyn (100 \u00b5M) can effectively inhibit secretion of histamine and PGD 2 .", {"entities": [[77, 80, "GENE"]]}], ["Que and cromolyn also inhibit histamine, leukotrienes and PGD 2 from primary human cord blood-derived cultured mast cells (hCBMCs) stimulated by IgE/Anti-IgE.", {"entities": [[58, 61, "GENE"]]}], ["However, Que is more effective than cromolyn in inhibiting IL-8 and TNF release from LAD2 mast cells stimulated by SP.", {"entities": [[68, 71, "GENE"]]}], ["Moreover, Que reduces IL-6 release from hCBMCs in a dose-dependent manner.", {"entities": []}], ["Que inhibits cytosolic calcium level increase and NF-kappa B activation.", {"entities": []}], ["Interestingly, Que is effective prophylactically, while cromolyn must be added together with the trigger or it rapidly loses its effect.", {"entities": []}], ["In two pilot, open-label, clinical trials, Que significantly decreased contact dermatitis and photosensitivity, skin conditions that do not respond to conventional treatment.", {"entities": [[71, 89, "DISEASE"], [79, 89, "DISEASE"]]}], ["In summary, Que is a promising candidate as an effective mast cell inhibitor for allergic and inflammatory diseases, especially in formulations that permit more sufficient oral absorption.", {"entities": []}], ["All the enzymatic factors/cofactors involved in nitric oxide (NO) metabolism have been recently found in red blood cells.", {"entities": []}], ["Increased oxidative stress impairs NO bioavailability and has been described in plasma of coronary artery disease (CAD) patients.", {"entities": []}], ["The aim of the study was to highlight a potential dysfunction of the metabolic profile of NO in red blood cells and in plasma from CAD patients compared with healthy controls.", {"entities": []}], ["We determined L-arginine/NO pathway by liquid-chromatography tandem mass spectrometry and high performance liquid chromatography methods.", {"entities": []}], ["The ratio of oxidized and reduced forms of glutathione, as index of oxidative stress, was measured by liquid-chromatography tandem mass spectrometry method.", {"entities": []}], ["NO synthase expression and activity were evaluated by immunofluorescence staining and ex-vivo experiments of L-[ 2 ]arginine conversion to L-[ Increased amounts of asymmetric and symmetric dimethylarginines were found both in red blood cells and in plasma of CAD patients in respect to controls.", {"entities": []}], ["Interestingly NO synthase expression and activity were reduced in CAD red blood cells.", {"entities": []}], ["In contrast, oxidized/reduced glutathione ratio was increased in CAD and was associated to arginase activity.", {"entities": []}], ["Our study analyzed for the first time the whole metabolic pathway of L-arginine/NO, both in red blood cells and in plasma, highlighting an impairment of NO pathway in erythrocytes from CAD patients, associated with decreased NO synthase expression/activity and increased oxidative stress.", {"entities": []}], ["IgG4-related dacryoadenitis and sialoadenitis (IgG4-DS), so-called Mikulicz\u2019s disease, is characterized by elevated serum IgG4 and infiltration of IgG4-positive plasma cells in glandular tissues.", {"entities": [[13, 27, "DISEASE"]]}], ["Recently, several studies reported both malignant lymphoma developed on the background of IgG4-associated conditions and IgG4-producing malignant lymphoma (non-IgG4-related disease).", {"entities": [[50, 58, "DISEASE"], [146, 154, "DISEASE"]]}], ["We report on the case of a 70-year-old man who was strongly suspected IgG4-DS because of high serum IgG4 concentration (215\u00a0mg/dl) and bilateral swelling of parotid and submandibular glands.", {"entities": []}], ["Biopsies of cervical lymph node and a portion of submandibular gland were performed.", {"entities": []}], ["These histopathological findings subsequently confirmed a diagnosis of marginal zone B cell lymphoma.", {"entities": [[92, 100, "DISEASE"]]}], ["Differential diagnosis of IgG4-DS is necessary from other disorders, including Sj\u00f6gren\u2019s syndrome, sarcoidosis, Castleman\u2019s disease, Wegener\u2019s granulomatosis, lymphoma, and cancer.", {"entities": [[89, 97, "DISEASE"], [159, 167, "DISEASE"], [99, 110, "DISEASE"], [173, 179, "DISEASE"]]}], ["We suggest that biopsy of swollen lesions is important for a definitive diagnosis of IgG4-DS and discuss the mechanism of development in this case.", {"entities": []}], ["Treatment for cancer can induce a series of secreted factors into the tumor microenvironment, which can affect cancer progression.", {"entities": [[14, 20, "DISEASE"], [111, 117, "DISEASE"]]}], ["Wingless-type MMTV (mouse mammary tumor virus) integration site 16B (WNT16B) is a new member of the WNT family and has been reported to play growth-related roles in previous studies.", {"entities": []}], ["In this study, we found WNT16B could be expressed and secreted into the microenvironment by human ovarian fibroblasts after DNA damage-associated treatment, including chemotherapy drugs and radiation.", {"entities": []}], ["We also demonstrated that fibroblast-derived WNT16B could result in accumulation of \u03b2-catenin in dendritic cells and secretion of interleukin-10 (IL-10) and transforming growth factor beta (TGF-\u03b2), which contributed to the differentiation of regulatory T cells in a co-culture environment.", {"entities": []}], ["These results shed light on the roles of WNT16B in immune regulation, especially in regard to cancer treatment.", {"entities": [[94, 100, "DISEASE"]]}], ["Upon infection, many RNA viruses reorganize their capsid for release of the genome into the host cell cytosol for replication.", {"entities": []}], ["Often, this process is triggered by receptor binding and/or by the acidic environment in endosomes.", {"entities": []}], ["In the genus Enterovirus , which includes more than 150 human rhinovirus (HRV) serotypes causing the common cold, there is persuasive evidence that the viral RNA exits single-stranded through channels formed in the protein shell.", {"entities": [[101, 112, "DISEASE"]]}], ["We have determined the time-dependent emergence of the RNA ends from HRV2 on incubation of virions at 56\u00b0C using hybridization with specific oligonucleotides and detection by fluorescence correlation spectroscopy.", {"entities": []}], ["We report that psoralen UV crosslinking prevents complete RNA release, allowing for identification of the sequences remaining inside the capsid.", {"entities": []}], ["We also present the structure of uncoating intermediates in which parts of the RNA are condensed and take the form of a rod that is directed roughly towards a two-fold icosahedral axis, the presumed RNA exit point.", {"entities": []}], ["Taken together, in contrast to schemes frequently depicted in textbooks and reviews, our findings demonstrate that exit of the RNA starts from the 3\u2032-end.", {"entities": []}], ["This suggests that packaging also occurs in an ordered manner resulting in the 3\u2032-poly-(A) tail becoming located close to a position of pore formation during conversion of the virion into a subviral particle.", {"entities": []}], ["This directional genome release may be common to many icosahedral non-enveloped single-stranded RNA viruses.", {"entities": []}], ["Viral infection requires safe transfer of the viral genome from within the protective protein shell into the host cell's cytosol.", {"entities": []}], ["For many viruses this happens after uptake into endosomes, where receptor-binding and/or the acidic pH trigger conformational modifications or disassembly of the shell, allowing the nucleic acids to escape.", {"entities": []}], ["For example, common cold viruses are converted into subviral particles still containing the single-stranded positive sense RNA genome; subsequently, the RNA escapes into the cytoplasm, leaving behind empty capsids.", {"entities": [[13, 24, "DISEASE"]]}], ["We triggered this process by heating HRV2 to 56\u00b0C and found that 3\u2032- and 5\u2032-end emerged with different kinetics.", {"entities": []}], ["Crosslinking prevented complete RNA egress and upon nuclease digestion only sequences derived from the 5\u2032-end were protected.", {"entities": []}], ["Part of the RNA remaining within the viral shell adopted a rod-like shape pointing towards one of the two-fold axes where the RNA is presumed to exit in single-stranded form.", {"entities": []}], ["Egress thus commences with the poly-(A) tail and not with the genome-linked peptide VPg.", {"entities": []}], ["This suggests that assembly and uncoating are well-coordinated to avoid tangling, kinetic traps, and/or simultaneous exit of the two RNA ends at different sites.", {"entities": []}], ["Worksite smoking cessation programs offer accessibility of the target population, availability of occupational health support, and the potential for peer pressure and peer support.", {"entities": []}], ["The purpose of this study was to identify the efficacy of the financial incentives given to various teams in the workplace.", {"entities": []}], ["St. Paul's Hospital's employees were enrolled.", {"entities": []}], ["Each team of employees consisted of smoking participants and non-smoking fellow workers from the same department.", {"entities": []}], ["The financial incentive of 50000 won (about $45) was rewarded to the team for each successful participant-not to individual members-after the first week and then after one month.", {"entities": []}], ["If the smokers in the team remained abstinent for a longer time period, the team was given an incentive of 100000 won for each successful participant after 3 and 6 months.", {"entities": []}], ["A total 28 smoking participants and 6 teams were enrolled.", {"entities": []}], ["Self-reported abstinence rates validated by urinary cotinine test at 3, 6, and 12 months after the initial cessation were 61%, 54%, and 50%, respectively.", {"entities": []}], ["Smokers with high nicotine dependence scores or those who began participation 1 month after enrollment initiation had a lower abstinence rate at 3 months, but not at 6 and 12 months.", {"entities": [[18, 37, "DISEASE"]]}], ["Participants who succeeded at smoking cessation at 12 months were more likely to be older and have a longer smoking duration history.", {"entities": []}], ["The financial incentives given to teams could be promising and effective to improve long-term rates of smoking cessation.", {"entities": []}], ["This approach could use peer pressure and peer support in the workplace over a longer period.", {"entities": []}], ["Interstitial cells of Cajal (ICCs) are the pacemaker cells that generate slow waves in the gastrointestinal (GI) tract.", {"entities": []}], ["We have aimed to investigate the effects of Socheongryong-Tang (SCRT) in ICCs from mouse's small intestine.", {"entities": []}], ["The whole-cell patch-clamp configuration was used to record membrane potentials from cultured ICCs.", {"entities": []}], ["Intracellular Ca i ) increase was studied in cultured ICCs using fura-2 AM.", {"entities": []}], ["ICCs generated pacemaker potentials in mouse's small intestine.", {"entities": []}], ["SCRT produced membrane depolarization in current clamp mode.", {"entities": []}], ["Y25130 (5-HT 3 receptor antagonist) and RS39604 (5-HT 4 receptor antagonist) blocked SCRT-induced membrane depolarizations, whereas SB269970 (5-HT 7 receptor antagonist) did not.", {"entities": []}], ["When GDP- \u03b2 -S (1\u2009mM) was in the pipette solution, SCRT did not induce the membrane depolarizations.", {"entities": []}], ["[Ca i analysis showed that SCRT increased [Ca i .", {"entities": []}], ["In the presence of PD98059 (p42/44 MAPK inhibitor), SCRT did not produce membrane depolarizations.", {"entities": []}], ["In addition, SB203580 (p38 MAPK inhibitor) and JNK inhibitors blocked the depolarizations by SCRT in pacemaker potentials.", {"entities": []}], ["Furthermore, the membrane depolarizations by SCRT were not inhibited by U-73122, an active phospholipase C (PLC) inhibitor, but by U-73343, an inactive PLC inhibitor.", {"entities": []}], ["Conclusion .", {"entities": []}], ["These results suggest that SCRT might affect GI motility by the modulation of pacemaker activity through MAPKs and PLC pathways in the ICCs.", {"entities": []}], ["Alcohol-related neurodevelopmental disorder (ARND) falls under the umbrella of fetal alcohol spectrum disorder (FASD).", {"entities": [[79, 110, "DISEASE"]]}], ["Diagnosis of ARND is difficult because individuals do not demonstrate the characteristic facial features associated with fetal alcohol syndrome (FAS).", {"entities": [[121, 143, "DISEASE"], [135, 143, "DISEASE"], [145, 148, "GENE"]]}], ["While attentional problems in ARND are similar to those found in attention-deficit/hyperactivity disorder (ADHD), the underlying impairment in attention pathways may be different.", {"entities": []}], ["Functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) was conducted at 3\u00a0T. Sixty-three children aged 10 to 14\u00a0years diagnosed with ARND, ADHD, and typically developing (TD) controls performed a single-feature and a feature-conjunction visual search task.", {"entities": []}], ["Dorsal and ventral attention pathways were activated during both attention tasks in all groups.", {"entities": []}], ["Significantly greater activation was observed in ARND subjects during a single-feature search as compared to TD and ADHD groups, suggesting ARND subjects require greater neural recruitment to perform this simple task.", {"entities": []}], ["ARND subjects appear unable to effectively use the very efficient automatic perceptual \u2018pop-out\u2019 mechanism employed by TD and ADHD groups during presentation of the disjunction array.", {"entities": []}], ["By comparison, activation was lower in ARND compared to TD and ADHD subjects during the more difficult conjunction search task as compared to the single-feature search.", {"entities": []}], ["Analysis of DTI data using tract-based spatial statistics (TBSS) showed areas of significantly lower fractional anisotropy (FA) and higher mean diffusivity (MD) in the right inferior longitudinal fasciculus (ILF) in ARND compared to TD subjects.", {"entities": []}], ["Damage to the white matter of the ILF may compromise the ventral attention pathway and may require subjects to use the dorsal attention pathway, which is associated with effortful top-down processing, for tasks that should be automatic.", {"entities": []}], ["Decreased functional activity in the right temporoparietal junction (TPJ) of ARND subjects may be due to a reduction in the white matter tract\u2019s ability to efficiently convey information critical to performance of the attention tasks.", {"entities": []}], ["Limited activation patterns in ARND suggest problems in information processing along the ventral frontoparietal attention pathway.", {"entities": []}], ["Poor integrity of the ILF, which connects the functional components of the ventral attention network, in ARND subjects may contribute to the attention deficits characteristic of the disorder.", {"entities": []}], ["Background: Few studies have directly assessed the association of secondhand smoke (SHS) with cardiovascular disease\u2013related inflammatory markers, and the findings are inconsistent.", {"entities": []}], ["Objectives: We assessed the association between SHS exposure and the inflammatory markers high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and soluble intercellular adhesion molecule-1 (sICAM-1) in 199 nonsmoking U.S. trucking industry workers.", {"entities": []}], ["Methods: Participants provided blood samples either by mail (blood drawn at local health care provider near home) or at the work site (blood drawn by research staff on-site) and completed a health and work history questionnaire at the time of blood draw.", {"entities": []}], ["Exposure to SHS was measured by plasma cotinine concentrations.", {"entities": []}], ["We used multivariate regression analyses to assess the associations between levels of cotinine and inflammatory markers.", {"entities": []}], ["Results: The median cotinine level was 0.10 ng/mL (interquartile range, 0.04\u20130.23 ng/mL).", {"entities": []}], ["The odds ratios of elevated hs-CRP (above highest CRP tertile, 1.5 mg/L) were 2.85 [95% confidence interval (CI), 1.03\u20137.89] for the high-cotinine group (> 0.215 ng/mL) and 2.80 (95% CI, 1.11\u20137.10) for the moderate-cotinine group (0.05\u20130.215 ng/mL), compared with the low-cotinine group (< 0.05 ng/mL), adjusting for age, sex, race, educational level, obesity, previous smoking history, job title, and medical history.", {"entities": [[352, 359, "DISEASE"], [31, 34, "GENE"], [50, 53, "GENE"]]}], ["Plasma cotinine levels were not associated with IL-6 or sICAM-1.", {"entities": []}], ["Conclusions: SHS exposure, as assessed by plasma cotinine, was positively associated with hs-CRP in this group of blue-collar workers.", {"entities": []}], ["The strength of the association with hs-CRP depended on the cut points selected for analysis.", {"entities": []}], ["Allergic asthma is thought to stem largely from maladaptive T helper (Th)2 responses to inhaled allergens, which in turn lead to airway eosinophilia and airway hyperresponsiveness.", {"entities": [[136, 148, "DISEASE"], [9, 15, "DISEASE"]]}], ["However, many individuals with asthma have airway inflammation that is predominantly neutrophilic and resistant to treatment with inhaled glucocorticoids.", {"entities": [[31, 37, "DISEASE"]]}], ["An improved understanding of the molecular basis of this form of asthma might lead to improved strategies for its treatment.", {"entities": [[65, 71, "DISEASE"]]}], ["Here, we identify novel roles of the adaptor protein, TRIF, in neutrophilic responses to inhaled allergens.", {"entities": []}], ["In different mouse models of asthma, Trif -deficient animals had marked reductions in interleukin (IL)-17, airway neutrophils, and airway hyperresponsiveness compared with WT mice, whereas airway eosinophils were generally similar in these two strains.", {"entities": [[29, 35, "DISEASE"]]}], ["Compared with lung dendritic cells (DCs) from WT mice, lung DCs from Trif -deficient mice displayed impaired LPS-induced migration to regional lymph nodes, lower levels of the costimulatory molecule, CD40, and produced smaller amounts of the Th17-promoting cytokines, IL-6 and IL-1\u03b2.", {"entities": [[200, 204, "GENE"]]}], ["When cultured with allergen-specific, na\u00efve T cells, Trif -deficient lung DCs stimulated robust Th2 cell differentiation, but very weak Th1 and Th17 cell differentiation.", {"entities": []}], ["Together, these findings reveal a TRIF-CD40-Th17 axis in the development of IL-17-associated, neutrophilic asthma.", {"entities": [[107, 113, "DISEASE"]]}], ["Severe asthma accounts for a small number of asthmatics but represents a disproportionate cost to health care systems.", {"entities": [[7, 13, "DISEASE"]]}], ["The underlying mechanism in severe asthma remains unknown but several mechanisms are likely to be involved because of a very heterogeneous profile.", {"entities": [[35, 41, "DISEASE"]]}], ["We investigated the effects of a p38MAPK inhibitor in corticosteroid sensitivity in peripheral blood mononuclear cells (PBMCs) from severe asthmatics and the profile of its responders.", {"entities": []}], ["Corticosteroid sensitivity was determined by measuring dexamethasone inhibition of CD3/28 and TNF-\u03b1 induced IL-8 production in PBMCs by using ELISA.", {"entities": []}], ["PBMCs from severe asthmatics were relatively less sensitive to dexamethasone (Dex) as compared to those of non-severe asthmatics and healthy volunteers.", {"entities": []}], ["The IC 50 values of Dex negatively correlated with decreased glucocorticoid receptor (GR) nuclear translocation assessed using immunocytochemistry (r\u200a=\u200a\u22120.65; p<0.0005) and with decreased FEV 1 (% predicted) (r\u200a=\u200a0.6; p<0.0005).", {"entities": [[188, 191, "GENE"]]}], ["A p38\u03b1/\u03b2 inhibitor (SB203580) restored Dex-sensitivity in a subpopulation of severe asthma that was characterized by a defective GR nuclear translocation, clinically by lower FEV 1 and higher use of oral prednisolone.", {"entities": [[84, 90, "DISEASE"], [175, 178, "GENE"]]}], ["We also found that SB203580 partially inhibited GR phosphorylation at serine 226, resulting in increased GR nuclear translocation in IL-2/IL-4 treated corticosteroid insensitive U937s.", {"entities": []}], ["p38MAPK\u03b1/\u03b2 is involved in defective GR nuclear translocation due to phosphorylation at Ser226 and this will be a useful biomarker to identify responders to p38MAPK\u03b1/\u03b2 inhibitor in the future.", {"entities": []}], ["The relevance of tyrosine kinase inhibitors (TKIs) in the treatment of malignancies has been already defined.", {"entities": []}], ["Aberrant activation of tyrosine kinase signaling pathways has been causally linked not only to cancers but also to other non-oncological diseases.", {"entities": []}], ["This review concentrates on the novel plausible usage of this group of drugs in neurological disorders, such as ischemic brain stroke, subarachnoid hemorrhage, Alzheimer\u2019s disease, multiple sclerosis.", {"entities": [[181, 199, "DISEASE"]]}], ["The drugs considered here are representatives of both receptor and non-receptor TKIs.", {"entities": []}], ["Among them imatinib and masitinib have the broadest spectrum of therapeutic usage.", {"entities": []}], ["Both drugs are effective in ischemic brain stroke and multiple sclerosis, but only imatinib produces a therapeutic effect in subarachnoid hemorrhage.", {"entities": [[54, 72, "DISEASE"]]}], ["Masitinib and dasatinib reduce the symptoms of Alzheimer\u2019s disease.", {"entities": []}], ["In the case of multiple sclerosis several TKIs are useful, including apart from imatinib and masitinib, also sunitinib, sorafenib, lestaurtinib.", {"entities": [[15, 33, "DISEASE"]]}], ["Furthermore, the possible molecular targets for the drugs are described in connection with the underlying pathophysiological mechanisms in the diseases in question.", {"entities": []}], ["The most frequent target for the TKIs is PDGFR which plays a pivotal role particularly in ischemic brain stroke and subarachnoid hemorrhage.", {"entities": []}], ["The collected data indicates that TKIs are very promising candidates for new therapeutic interventions in neurological diseases.", {"entities": []}], ["The ECUAVIDA birth cohort is studying the impact of exposures to soil-transmitted helminth (STH) parasites and early-life microbial exposures on the development of atopy, allergic diseases and immune responses in childhood.", {"entities": []}], ["A total of 2404 newborns were recruited between 2006 and 2009 in a public hospital serving the rural district of Quininde, Esmeraldas Province, in a tropical region of coastal Ecuador.", {"entities": []}], ["Detailed measurements were done around the time of the birth, at 7 and 13 months and at 2 and 3 years, and data collection is ongoing at 5 and 8 years.", {"entities": []}], ["Data being collected include questionnaires for: sociodemographic, lifestyle, psychosocial (at 4\u20136 years only) and dietary (at 6\u20137 years only) factors; childhood morbidity and clinical outcomes; stool samples for parasites; blood samples for DNA, measurements of vaccine responses and other measures of immune function/inflammation; and anthropometrics.", {"entities": []}], ["Allergen skin prick test reactivity is done from 2 years and measures of airway function and inflammation at 8 years.", {"entities": []}], ["Background: Exposure to household air pollution (HAP) from inefficient biomass and coal stoves kills nearly 4 million people every year worldwide.", {"entities": []}], ["HAP is an environmental risk associated with poverty that affects an estimated 3 billion people mostly in low- and middle-income countries.", {"entities": []}], ["Objectives: Our goal was to estimate the number of low-income Americans exposed to potentially health-damaging concentrations of HAP.", {"entities": []}], ["Methods: We mapped county-level data for the percentage of households using wood, coal, and/or coke as their primary heating fuel along with percent of the population below the federal poverty level.", {"entities": []}], ["Using U.S. Census data and the likelihood of fugitive emissions as reported in the literature, we estimated the number of low-income Americans potentially exposed to HAP.", {"entities": []}], ["Results: Solid fuel is the primary heating source for > 2.5 million U.S. households, or 6.5 million people.", {"entities": []}], ["The mapping exercise showed several rural areas, primarily in the northern and western regions, that have high levels of solid-fuel use and poverty.", {"entities": []}], ["We then identified 117 counties with high co-incident poverty and solid-fuel use as high-priority counties for research into potential health risks from HAP.", {"entities": []}], ["We estimate that between 500,000 and 600,000 low-income people in the United States are likely exposed to HAP from burning solid fuels within their homes.", {"entities": []}], ["Conclusion: HAP occurs within the United States and should be further investigated for adverse health risks, especially among those living in areas with rural poverty.", {"entities": []}], ["Citation: Rogalsky DK, Mendola P, Metts TA, Martin WJ II.", {"entities": []}], ["Estimating the number of low-income Americans exposed to household air pollution from burning solid fuels.", {"entities": []}], ["Environ Health Perspect 122:806\u2013810;\u2002 http://dx.doi.org/10.1289/ehp.1306709", {"entities": []}], ["The TNF-related apoptosis inducing ligand TRAIL is a member of the TNF superfamily that has been firstly studied and evaluated for its anti-cancer activity, and the insights into its biology have already led to the identification of several TRAIL-based anticancer strategies with strong clinical therapeutic potentials.", {"entities": [[140, 146, "DISEASE"], [4, 7, "GENE"], [67, 70, "GENE"]]}], ["Nonetheless, the TRAIL system is far more complex and it can lead to a wider range of biological effects other than the ability of inducing apoptosis in cancer cells.", {"entities": [[153, 159, "DISEASE"]]}], ["By virtue of the different receptors and the different signalling pathways involved, TRAIL plays indeed a role in the regulation of different processes of the innate and adaptive immune system and this feature makes it an intriguing molecule under consideration in the development/progression/treatment of several immunological disorders.", {"entities": []}], ["In this context, central nervous system represents a peculiar anatomic site where, despite its \u201cstatus\u201d of immune-privileged site, both innate and adaptive inflammatory responses occur and are involved in several pathological conditions.", {"entities": []}], ["A number of studies have evaluated the role of TRAIL and of TRAIL-related pathways as pro-inflammatory or protective stimuli, depending on the specific pathological condition, confirming a twofold nature of this molecule.", {"entities": []}], ["In this light, the aim of this review is to summarize the main preclinical evidences of the potential/involvement of TRAIL molecule and TRAIL pathways for the treatment of central nervous system disorders and the key suggestions coming from their assessment in preclinical models as proof of concept for future clinical studies.", {"entities": []}], ["This study aims to analyze clinical and pathological characteristics of ocular adnexal extranodal marginal zone B-cell lymphoma (EMZL) accompanying IgG4-positive cells.", {"entities": [[119, 127, "DISEASE"]]}], ["Fifty patients with a diagnosis of primary non-conjunctival ocular adnexal EMZL were enrolled in this study.", {"entities": []}], ["The number of IgG4-positive cells and the ratio of IgG/IgG4 were evaluated by immunohistochemistry in the biopsy specimens.", {"entities": []}], ["The patients were divided into two groups based on the absolute number and the ratio of IgG4-positive cells (IgG4-posivite vs IgG4-negative groups).", {"entities": []}], ["The demographic data, clinical staging at diagnosis, histopathological characteristics, and response to initial treatment were comparatively analyzed between the 2 groups.", {"entities": []}], ["Five (10%) of 50 patients were defined as IgG4-positive group, and all the cases showed characteristic histological features such as extensive plasma cell infiltration and dense fibrosis.", {"entities": []}], ["Most of these patients (4 of 5 patients) had lymphoma of the lacrimal gland.", {"entities": [[45, 53, "DISEASE"]]}], ["The patients from the IgG4-positive group showed a lower response rate to initial treatment (87.5 vs 33%, p = 0.03) than IgG4-negative group with a median follow-up period of 38 months.", {"entities": []}], ["A part of the ocular adnexal EMZLs were accompanied with IgG4-positive cells.", {"entities": []}], ["Significantly, most IgG4-positive ocular adnexal EMZLs occurred in the lacrimal gland, and can be related with a more frequent treatment failure.", {"entities": []}], ["Allergic bronchopulmonary aspergillosis (ABPA), an asthmatic disease, is caused primarily by hypersensitivity to Aspergillus species.", {"entities": [[26, 39, "DISEASE"]]}], ["ABPA is rarely observed in the absence of asthma, which is, in fact, the principle criterion for its diagnosis.", {"entities": [[42, 48, "DISEASE"]]}], ["Here, we report the case of a 36-yr-old woman without a history of bronchial asthma, who manifested a localized pneumonic consolidation, coupled with broncholithiasis.", {"entities": [[77, 83, "DISEASE"]]}], ["Pathologic examinations of bronchoscopic biopsy specimens and resected surgical specimens revealed features typical of ABPA.", {"entities": []}], ["This is a very rare case of ABPA coupled with broncholithiasis in a non-asthmatic individual.", {"entities": []}], ["Many users search the Internet for answers to health questions.", {"entities": []}], ["Complementary and alternative medicine (CAM) is a particularly common search topic.", {"entities": []}], ["Because many CAM therapies do not require a clinician's prescription, false or misleading CAM information may be more dangerous than information about traditional therapies.", {"entities": []}], ["Many quality criteria have been suggested to filter out potentially harmful online health information.", {"entities": []}], ["However, assessing the accuracy of CAM information is uniquely challenging since CAM is generally not supported by conventional literature.", {"entities": []}], ["The purpose of this study is to determine whether domain-independent technical quality criteria can identify potentially harmful online CAM content.", {"entities": []}], ["We analyzed 150 Web sites retrieved from a search for the three most popular herbs: ginseng, ginkgo and St. John's wort and their purported uses on the ten most commonly used search engines.", {"entities": []}], ["The presence of technical quality criteria as well as potentially harmful statements (commissions) and vital information that should have been mentioned (omissions) was recorded.", {"entities": []}], ["Thirty-eight sites (25%) contained statements that could lead to direct physical harm if acted upon.", {"entities": []}], ["One hundred forty five sites (97%) had omitted information.", {"entities": []}], ["We found no relationship between technical quality criteria and potentially harmful information.", {"entities": []}], ["Current technical quality criteria do not identify potentially harmful CAM information online.", {"entities": []}], ["Consumers should be warned to use other means of validation or to trust only known sites.", {"entities": []}], ["Quality criteria that consider the uniqueness of CAM must be developed and validated.", {"entities": []}], ["This study examined the efficacy and safety of N-acetylcysteine (NAC) augmentation for treating irritability in children and adolescents with autism spectrum disorders (ASD).", {"entities": []}], ["Forty children and adolescents met diagnostic criteria for ASD according to DSM-IV.", {"entities": []}], ["They were randomly allocated into one of the two groups of NAC (1200\u2009mg/day)+risperidone or placebo+risperidone.", {"entities": []}], ["NAC and placebo were administered in the form of effervescent and in two divided doses for 8 weeks.", {"entities": []}], ["Irritability subscale score of Aberrant Behavior Checklist (ABC) was considered as the main outcome measure.", {"entities": []}], ["Adverse effects were also checked.", {"entities": []}], ["The mean score of irritability in the NAC+risperidone and placebo+risperidone groups at baseline was 13.2(5.3) and 16.7(7.8), respectively.", {"entities": []}], ["The scores after 8 weeks were 9.7(4.1) and 15.1(7.8), respectively.", {"entities": []}], ["Repeated measures of ANOVA showed that there was a significant difference between the two groups after 8 weeks.", {"entities": []}], ["The most common adverse effects in the NAC+risperidone group were constipation (16.1%), increased appetite (16.1%), fatigue (12.9%), nervousness (12.9%), and daytime drowsiness (12.9%).", {"entities": [[66, 78, "DISEASE"]]}], ["There was no fatal adverse effect.", {"entities": []}], ["Risperidone plus NAC more than risperidone plus placebo decreased irritability in children and adolescents with ASD.", {"entities": []}], ["Meanwhile, it did not change the core symptoms of autism.", {"entities": []}], ["Adverse effects were not common and NAC was generally tolerated well.", {"entities": []}], ["This trial was registered at http://www.irct.ir .", {"entities": []}], ["The registration number of this trial was IRC T201106103930N6", {"entities": []}], ["COPD is a major cause of mortality and morbidity worldwide with an estimated 2.75 million deaths in 2000 (fourth leading cause of death).", {"entities": []}], ["In addition to the considerable morbidity and mortality associated with COPD, this disease incurs significant healthcare and societal costs.", {"entities": []}], ["Current COPD guidelines acknowledge that the following can improve COPD mortality: smoking cessation; long-term oxygen therapy; and lung volume reduction surgery in small subsets of COPD patients.", {"entities": []}], ["To date, no randomized controlled trials have demonstrated an effect of pharmacological treatment on mortality, although several observational studies suggest that both long-acting bronchodilators and inhaled corticosteroids may provide a survival benefit.", {"entities": []}], ["The possibility that these treatments reduce mortality is being investigated in ongoing large-scale clinical trials.", {"entities": []}], ["Serelaxin showed beneficial effects on clinical outcome and trajectories of renal markers in patients with acute heart failure.", {"entities": []}], ["We aimed to study the interaction between renal function and the treatment effect of serelaxin.", {"entities": []}], ["In the current post hoc analysis of the RELAX-AHF trial, we included all patients with available estimated glomerular filtration rate (eGFR) at baseline ( n \u00a0=\u00a01132).", {"entities": [[135, 139, "GENE"]]}], ["Renal impairment was defined as an eGFR <60\u00a0ml/min/1.73\u00a0m 817 (72.2\u00a0%) patients had a baseline eGFR\u00a0<60\u00a0ml/min/1.73\u00a0m p for interaction\u00a0=\u00a00.106, and HR 1.15 95\u00a0% CI 0.56\u20132.34 respectively; p for interaction\u00a0=\u00a00.088).", {"entities": [[35, 39, "GENE"], [95, 99, "GENE"], [35, 39, "GENE"], [95, 99, "GENE"], [149, 151, "GENE"]]}], ["In patients with renal impairment, treatment with serelaxin resulted in a more pronounced all-cause mortality reduction (HR 0.53, 95\u00a0% CI 0.34\u20130.83), compared with patients without renal impairment (HR 1.30, 95\u00a0% CI 0.51\u20133.29).", {"entities": [[121, 123, "GENE"], [199, 201, "GENE"], [121, 123, "GENE"], [199, 201, "GENE"]]}], ["Renal dysfunction was associated with higher cardiovascular and all-cause mortality in placebo-treated patients, but not in serelaxin-treated patients.", {"entities": []}], ["The observed reduction in (cardiovascular) mortality in RELAX-AHF was more pronounced in patients with renal dysfunction.", {"entities": []}], ["These observations need to be confirmed in the ongoing RELAX-AHF-2 trial.", {"entities": []}], ["Air pollution increases the risk of cardiovascular diseases.", {"entities": []}], ["A proposed mechanism is that local airway inflammation leads to systemic inflammation, affecting coagulation and the long-term risk of atherosclerosis.", {"entities": [[135, 150, "DISEASE"]]}], ["One major source of air pollution is wood burning.", {"entities": []}], ["Here we investigate whether exposure to two kinds of wood smoke, previously shown to cause airway effects, affects biomarkers of systemic inflammation, coagulation and lipid peroxidation.", {"entities": []}], ["Thirteen healthy adults were exposed to filtered air followed by two sessions of wood smoke for three hours, one week apart.", {"entities": []}], ["One session used smoke from the start-up phase of the wood-burning cycle, and the other smoke from the burn-out phase.", {"entities": []}], ["Mean particle mass concentrations were 295\u2009\u00b5g/m Markers of systemic inflammation and soluble adhesion molecules did not increase after wood smoke exposure.", {"entities": []}], ["Effects on markers of coagulation were ambiguous, with minor decreases in fibrinogen and platelet counts and mixed results concerning the coagulation factors VII and VIII.", {"entities": []}], ["Urinary F 2 -isoprostane, a consistent marker of in vivo lipid peroxidation, unexpectedly decreased after wood smoke exposure.", {"entities": []}], ["The effects on biomarkers of inflammation, coagulation and lipid peroxidation do not indicate an increased risk of cardiovascular diseases in healthy adults by short-term exposure to wood smoke at these moderate doses, previously shown to cause airway effects.", {"entities": []}], ["Accurate monitoring of health conditions and behaviours, and health service usage in the population, using an effective and economical method is important for planning and evaluation.", {"entities": []}], ["This study examines the reliability of questions asked in a telephone survey by conducting a test/retest analysis of a range of questions covering demographic variables, health risk factors and self-reported chronic conditions among people aged 16\u2009years and over.", {"entities": []}], ["A Computer Assisted Telephone Interviewing (CATI) survey on health issues of South Australians was re-administered to a random sub-sample of 154 respondents between 13-35\u2009days (mean 17) after the original survey.", {"entities": []}], ["Reliability between questions was assessed using Cohen\u2019s kappa and intraclass correlation coefficients.", {"entities": []}], ["Demographic questions (age, gender, number of adults and children in the household, country of birth) showed extremely high reliability (0.97 to 1.00).", {"entities": []}], ["Health service use (ICC\u2009=\u20090.90 95% CI 0.86-0.93) and overall health status (Kappa\u2009=\u20090.60 95% CI 0.46-0.75) displayed moderate agreement.", {"entities": []}], ["Questions relating to self-reported risk factors such as smoking (Kappa\u2009=\u20090.81 95% CI 0.72-0.89) and alcohol drinking (ICC 0.75\u2009=\u200995% CI 0.63-0.83) behaviour showed good to excellent agreement, while questions relating to self-reported risk factors such as time spent walking for physical activity (ICC 0.47\u2009=\u200995% CI 0.27-0.61), fruit (Kappa w \u2009=\u20090.60 95% CI 0.45-0.76) and vegetable consumption (Kappa w \u2009=\u20090.50 95% CI 0.32-0.69) showed only moderate agreement.", {"entities": []}], ["Self-reported chronic conditions displayed substantial to almost perfect agreement (0.72 to 1.00) with the exception of moderate agreement for heart disease (Kappa\u2009=\u20090.82 95% CI 0.57-0.99).", {"entities": [[143, 156, "DISEASE"]]}], ["These results show the questions assessed to be reliable in South Australia for estimating health conditions and monitoring health related behaviours using a CATI survey.", {"entities": []}], ["Expression of the SASH1 protein is reduced in a range of human cancers and has been implicated in apoptotic cancer cell death.", {"entities": [[108, 114, "DISEASE"], [18, 23, "GENE"]]}], ["This study investigated whether increasing SASH1 expression could be a useful therapeutic strategy in breast cancer.", {"entities": [[102, 115, "DISEASE"], [109, 115, "DISEASE"], [43, 48, "GENE"]]}], ["Ectopic SASH1 expression increased apoptosis in 7/8 breast cancer cell lines.", {"entities": [[52, 65, "DISEASE"], [59, 65, "DISEASE"], [8, 13, "GENE"]]}], ["Subsequent in silico connectivity screening demonstrated that the clinically approved antihistamine drug, chloropyramine, increased SASH1 mRNA levels.", {"entities": [[132, 137, "GENE"]]}], ["Chloropyramine has previously been shown to have anti-tumour activity in breast cancer in part through modulation of FAK signalling, a pathway also regulated by SASH1.", {"entities": [[73, 86, "DISEASE"], [80, 86, "DISEASE"], [161, 166, "GENE"]]}], ["This study demonstrated that chloropyramine increased SASH1 protein levels in breast cancer cells.", {"entities": [[78, 91, "DISEASE"], [85, 91, "DISEASE"], [54, 59, "GENE"]]}], ["Consistent with this the agent reduced cell confluency in 7/8 cell lines treated irrespective of their ER status but not apoptosis incompetent MCF7 cells.", {"entities": []}], ["In contrast SASH1 siRNA-transfected breast cancer cells exhibited reduced chloropyramine sensitivity.", {"entities": [[36, 49, "DISEASE"], [43, 49, "DISEASE"], [12, 17, "GENE"]]}], ["The prognostic significance of SASH1 expression was also investigated in two breast cancer cohorts.", {"entities": [[77, 90, "DISEASE"], [84, 90, "DISEASE"], [31, 36, "GENE"]]}], ["Expression was associated with favourable outcome in ER-positive cases, but only those of low histological grade/proliferative status.", {"entities": []}], ["Conversely, we found a very strong inverse association in HER2+ disease irrespective of ER status, and in triple-negative, basal-like cases.", {"entities": []}], ["Overall, the data suggest that SASH1 is prognostic in breast cancer and could have subtype-dependent effects on breast cancer progression.", {"entities": [[54, 67, "DISEASE"], [112, 125, "DISEASE"], [61, 67, "DISEASE"], [119, 125, "DISEASE"], [31, 36, "GENE"]]}], ["Pharmacologic induction of SASH1 by chloropyramine treatment of breast cancer warrants further preclinical and clinical investigation.", {"entities": [[64, 77, "DISEASE"], [71, 77, "DISEASE"], [27, 32, "GENE"]]}], ["Suicide is a leading cause of death among Korean adolescents.", {"entities": []}], ["Many suicide attempting adolescents often are discharged against medical advice in the emergency department.", {"entities": []}], ["The aim of the present study was to determine the risk factors for discharge against medical advice (DAMA) after self-inflicted injury or attempted suicide in the emergency department.", {"entities": []}], ["We extracted data on adolescents (10-19 yr old) from the national emergency department information system; we used data from 2007 and 2011.", {"entities": []}], ["A total of 6,394 adolescents visited EDs after self-inflicted injury or attempted suicide.", {"entities": []}], ["Among these patients, the median age was 17 yr (Interquatile range, 15-18 yr), 83.2% were between 15-19 yr of age, and 63.3% were female.", {"entities": []}], ["Poisoning was the most common method of attempted suicide, while hanging and fall were the most common methods of fatality.", {"entities": []}], ["The rate of DAMA from the ED was 22.8%.", {"entities": []}], ["Independent risk factors for DAMA included female gender (odds ratio [OR], 1.49), older age adolescents (OR, 1.96), residence in a metropolitan/large city area (OR, 1.49), and discharge at night (OR, 1.38).", {"entities": []}], ["These risk factors should be considered in establishing management and counseling plans for patients discharged against medical advice by community services and EDs.", {"entities": []}], ["While talking about traumatic experiences is considered central to psychological recovery, little is known about how these conversations occur in daily life.", {"entities": []}], ["We investigated spontaneous injury talk among parents and children in the aftermath of a child\u2019s hospitalisation due to physical trauma, and its relationship with children\u2019s socioemotional functioning.", {"entities": []}], ["In a prospective naturalistic observation study, we audio-sampled the daily life of 71 families with the Electronically Activated Recorder after their child (3\u201316 years old) was discharged from hospital.", {"entities": []}], ["We collected close to 20\u2009000 snippets of audio information, which were double-coded for conversation characteristics, and measured children\u2019s socioemotional functioning with the Strengths and Difficulties Questionnaire (SDQ) at 6 weeks and 3 months postinjury.", {"entities": []}], ["The children were involved in injury talk for, on average, 46\u2009min/day, 9\u2009min of which referred to emotions.", {"entities": []}], ["Children had significantly more injury conversations with their mothers than with their fathers.", {"entities": []}], ["The tone of injury conversations was significantly more positive than that of non-injury conversations.", {"entities": []}], ["More direct injury talk was associated with fewer problems on the emotion subscale of the SDQ at 3 months.", {"entities": []}], ["Other associations between aspects of injury talk and children\u2019s socioemotional functioning were mostly non-significant, although they appeared to be stronger at 3 months than at 6 weeks.", {"entities": []}], ["Families spontaneously talked about the injury and associated issues for about the same amount of time per day as a therapist might within a session (a \u2018therapy hour\u2019).", {"entities": []}], ["Making full use of naturally occurring injury talk may be a valuable direction for parent and family-focused postinjury interventions.", {"entities": []}], ["However, the study design prevents causal inference, and further exploration is warranted.", {"entities": []}], ["Evolving standards of good publication practice (GPP) and a survey conducted in 2009 of authors, who were investigators and researchers not employed by the company prompted changes to GSK Vaccines\u2019 publication practices.", {"entities": []}], ["We conducted a follow-up survey in 2012 to assess the company\u2019s revised practices and to evaluate understanding of GPP among investigators and researchers who had previously authored at least one publication in collaboration with GSK Vaccines.", {"entities": []}], ["The 50-question web-based survey addressed authoring practices and transparency of decision-making.", {"entities": []}], ["Investigators and researchers (n = 1,273) who had authored at least one publication reporting on GSK Vaccines-sponsored human research since 2007, were invited to participate.", {"entities": []}], ["Responses to 37 closed questions are presented.", {"entities": []}], ["The remaining 13 questions were open-ended or did not concern publication practices.", {"entities": []}], ["A total of 415 external authors (32.6%) responded.", {"entities": []}], ["International Committee of Medical Journal Editors (ICMJE) authorship criteria were clear to most respondents (78.1%); 7.7% found they were unclear.", {"entities": []}], ["The majority of participants (86.8%) found GSK Vaccines\u2019 authorship questionnaire a suitable tool to assess eligibility for authorship as per the ICMJE criteria.", {"entities": []}], ["However, only 68.5% felt that the outcome of the questionnaire is communicated appropriately and 58.3% felt well informed on changes in authorship.", {"entities": []}], ["Nearly two-thirds (62.9%) of respondents felt that having a pharmaceutical company employee as lead author makes manuscript acceptance less likely.", {"entities": []}], ["Access to relevant data was regarded as sufficient by 78.5% of respondents.", {"entities": []}], ["Briefing meetings before publication start, publication steering committees and core writing teams were recognized as valuable publication practices.", {"entities": []}], ["Professional medical writing support was seen as adding value to publication development by 87.7% of participants.", {"entities": []}], ["Most respondents agreed that manuscript discussions should start early, with 81.7% stating that they were in favor of introducing a formalized \u2018author agreement\u2019 at the publication start.", {"entities": []}], ["GSK Vaccines made changes to its publication practices to ensure improved transparency and better involvement of external authors.", {"entities": []}], ["The results of this survey suggest that these changes have been effective to a large extent.", {"entities": []}], ["They confirm the need for effective and timely communication, as well as transparent processes for authorship and decision-making during publication development.", {"entities": []}], ["The identified gaps in GPP will help to guide further improvements to the company\u2019s policies on publication practices.", {"entities": []}], ["The online version of this article (doi:10.1186/1745-6215-15-446) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Absenteeism due to communicable illness is a major problem encountered by North American elementary school children.", {"entities": []}], ["Although handwashing is a proven infection control measure, barriers exist in the school environment, which hinder compliance to this routine.", {"entities": []}], ["Currently, alternative hand hygiene techniques are being considered, and one such technique is the use of antimicrobial rinse-free hand sanitizers.", {"entities": []}], ["A systematic review was conducted to examine the effectiveness of antimicrobial rinse-free hand sanitizer interventions in the elementary school setting.", {"entities": []}], ["MEDLINE, EMBASE, Biological Abstract, CINAHL, HealthSTAR and Cochrane Controlled Trials Register were searched for both randomized and non-randomized controlled trials.", {"entities": []}], ["Absenteeism due to communicable illness was the primary outcome variable.", {"entities": []}], ["Six eligible studies, two of which were randomized, were identified (5 published studies, 1 published abstract).", {"entities": []}], ["The quality of reporting was low.", {"entities": []}], ["Due to a large amount of heterogeneity and low quality of reporting, no pooled estimates were calculated.", {"entities": []}], ["There was a significant difference reported in favor of the intervention in all 5 published studies.", {"entities": []}], ["The available evidence for the effectiveness of antimicrobial rinse-free hand sanitizer in the school environment is of low quality.", {"entities": []}], ["The results suggest that the strength of the benefit should be interpreted with caution.", {"entities": []}], ["Given the potential to reduce student absenteeism, teacher absenteeism, school operating costs, healthcare costs and parental absenteeism, a well-designed and analyzed trial is needed to optimize this hand hygiene technique.", {"entities": []}], ["C5a plays an crucial role in antineutrophil cytoplasmic antibody (ANCA)-mediated neutrophil recruitment and activation.", {"entities": []}], ["The current study further investigated the interaction between C5a and sphingosine-1-phosphate (S1P) in neutrophils for ANCA-mediated activation.", {"entities": []}], ["The plasma levels of S1P from 29 patients with ANCA-associated vasculitis (AAV) in active stage and in remission were tested by enzyme-linked immunosorbent assay (ELISA).", {"entities": [[63, 73, "DISEASE"]]}], ["The generation of S1P was tested in C5a-triggered neutrophils.", {"entities": []}], ["The effect S1P receptor antagonist was tested on respiratory burst and degranulation of C5a-primed neutrophils activated with ANCA.", {"entities": []}], ["The plasma level of circulating S1P was significantly higher in patients with AAV with active disease compared with patients in remission (2034.2\u2009\u00b1\u2009438.5 versus 1489.3\u2009\u00b1\u2009547.4\u00a0nmol/L, P \u2009<\u20090.001).", {"entities": []}], ["S1P can prime neutrophils for ANCA-induced respiratory burst and degranulation.", {"entities": []}], ["Compared with non-triggered neutrophils, the mean fluorescence intensity (MFI) value for CD88 expression was up-regulated significantly in S1P-triggered neutrophils.", {"entities": []}], ["S1P receptor antagonist decreased oxygen radical production in C5a primed neutrophils induced by ANCA-positive IgG from patients.", {"entities": []}], ["Blocking S1P inhibited C5a-primed neutrophil migration.", {"entities": []}], ["S1P triggered by C5a-primed neutrophils could further activate neutrophils.", {"entities": []}], ["Blocking S1P could attenuate C5a-induced activation of neutrophils by ANCA.", {"entities": []}], ["The interaction between S1P and C5a plays an important role in neutrophils for ANCA-mediated activation.", {"entities": []}], ["Biomass fuels, charcoal and kerosene are the most used cooking fuels in Tanzania.", {"entities": []}], ["Biomass fuel use has been linked to Acute Respiratory Infections (ARI) in children.", {"entities": []}], ["It is not clear whether the use of charcoal and kerosene has health advantage over biomass fuels.", {"entities": []}], ["In this study, the effects of biomass fuels, charcoal/kerosene on ARI in children under five years old in Tanzania are quantified and compared based on data from Tanzania Demographic and Health survey conducted between 2004 and 2005.", {"entities": []}], ["Approximately 85% and 15% of children were from biomass fuels and charcoal/kerosene using homes respectively.", {"entities": []}], ["Average ARI prevalence was about 11%.", {"entities": []}], ["The prevalence of ARI across various fuel types used for cooking did not vary much from the national prevalence.", {"entities": []}], ["Odds ratio for ARI, adjusting for child\u2019s sex, age and place of residence; mother\u2019s education, mother\u2019s age at child birth and household living standard, indicated that the effect of biomass fuels on ARI is the same as the effect of charcoal/kerosene (OR 1.01; 95% CI: 0.78\u20131.42).", {"entities": []}], ["The findings suggest that to achieve meaningful reduction of ARI prevalence in Tanzania, a shift from the use of biomass fuels, charcoal and kerosene for cooking to clean fuels such as gas and electricity may be essential.", {"entities": []}], ["Further studies, however, are needed for concrete policy recommendation.", {"entities": []}], ["Given the immuno-modulatory activity of native haemozoin (Hz), the effects of constitutive Hz components on immune response are of interest.", {"entities": []}], ["Recently, gene expression changes mediated by HNE and the synthetic analogue of Hz, beta-haematin (BH), were identified and implicated a significant role for lipid peroxidation products in Hz's activity.", {"entities": []}], ["The study presented herein examines gene expression changes in response to 15(S)-hydroxyeicosatetraenoic acid (HETE) in a model macrophage cell line.", {"entities": []}], ["LPS-stimulated RAW 264.7 macrophage-like cells were treated with 40 \u03bcM 15(S)-HETE for 24 h, and microarray analysis was used to identify global gene expression alterations.", {"entities": []}], ["Fold changes were calculated relative to LPS-stimulated cells and those genes altered at least 1.8-fold ( p value \u2264 0.025) were considered to be differentially expressed.", {"entities": []}], ["Expression levels of a subset of genes were assessed by qRT-PCR and used to confirm the microarray results.", {"entities": []}], ["Network analysis revealed that altered genes were primarily associated with \"lipid metabolism\" and \"small molecule biochemistry\".", {"entities": []}], ["While several genes associated with PPAR-gamma receptor-mediated signaling were differentially expressed, a number of genes indicated the activation of secondary signaling cascades.", {"entities": []}], ["Genes related to cytoadherence (cell-cell and cell-matrix), leukocyte extravasation, and inflammatory response were also differentially regulated by treatment, supporting a potential role for 15(S)-HETE in malaria pathogenesis.", {"entities": [[206, 213, "DISEASE"]]}], ["These results add insight and detail to 15-HETE's effects on gene expression in macrophage-like cells.", {"entities": []}], ["Data indicate that while 15-HETE exerts biological activity and may participate in Hz-mediated immuno-modulation, the gene expression changes are modest relative to those altered by the lipid peroxidation product HNE.", {"entities": []}], ["Dengue infection is one of the most important mosquito-borne diseases.", {"entities": []}], ["More data regarding the disease burden and the prevalence of each clinical spectrum among symptomatic infections and the clinical manifestations are needed.", {"entities": []}], ["This study aims to describe the incidence and clinical manifestations of symptomatic dengue infection in Thai children during 2006 through 2008.", {"entities": []}], ["This study is a school-based prospective open cohort study with a 9,448 person-year follow-up in children aged 3\u201314 years.", {"entities": []}], ["Active surveillance for febrile illnesses was done in the studied subjects.", {"entities": []}], ["Subjects who had febrile illness were asked to visit the study hospital for clinical and laboratory evaluation, treatment, and serological tests for dengue infection.", {"entities": []}], ["The clinical data from medical records, diary cards, and data collection forms were collected and analyzed.", {"entities": []}], ["Dengue infections were the causes of 12.1% of febrile illnesses attending the hospital, including undifferentiated fever (UF) (49.8%), dengue fever (DF) (39.3%) and dengue hemorrhagic fever (DHF) (10.9%).", {"entities": [[165, 189, "DISEASE"]]}], ["Headache, anorexia, nausea/vomiting and myalgia were common symptoms occurring in more than half of the patients.", {"entities": []}], ["The more severe dengue spectrum (i.e., DHF) had higher temperature, higher prevalence of nausea/vomiting, abdominal pain, rash, diarrhea, petechiae, hepatomegaly and lower platelet count.", {"entities": [[128, 136, "DISEASE"]]}], ["DHF cases also had significantly higher prevalence of anorexia, nausea/vomiting and abdominal pain during day 3\u20136 and diarrhea during day 4\u20136 of illness.", {"entities": [[118, 126, "DISEASE"]]}], ["The absence of nausea/vomiting, abdominal pain, diarrhea, petechiae, hepatomegaly and positive tourniquet test may predict non-DHF.", {"entities": [[48, 56, "DISEASE"]]}], ["Among symptomatic dengue infection, UF is most common followed by DF and DHF.", {"entities": []}], ["Some clinical manifestations may be useful to predict the more severe disease (i.e., DHF).", {"entities": []}], ["This study presents additional information in the clinical spectra of symptomatic dengue infection.", {"entities": []}], ["Dengue infection is one of the most important diseases transmitted to human by mosquito bite.", {"entities": []}], ["The disease may be mild or severe.", {"entities": []}], ["This study reveals the occurrence and clinical features of diseases caused by dengue infection in a 3-year follow-up in school-children aged 3\u201314 years in Ratchaburi Province, Thailand using an active surveillance for the episodes of fever.", {"entities": []}], ["Children who had fever were laboratory tested for the evidence of dengue infection and recorded for clinical features.", {"entities": []}], ["It was found that most of dengue infected patients had headache, anorexia, nausea/vomiting, and muscle ache.", {"entities": []}], ["About half of the patients had clinical symptoms that closely mimic other diseases, especially respiratory tract infection, and were incorrectly diagnosed by pediatricians.", {"entities": []}], ["Only 11% of the patients had more a severe disease called \u201cdengue hemorrhagic fever.\u201d This severe disease may be predicted by the presence of anorexia, nausea/vomiting, and abdominal pain after the second day of illness.", {"entities": [[59, 83, "DISEASE"]]}], ["This study provides better understanding in this disease.", {"entities": []}], ["Variance is a statistical parameter used to characterize heterogeneity or variability in data sets.", {"entities": []}], ["However, measurements commonly include noise, as random errors superimposed to the actual value, which may substantially increase the variance compared to a noise-free data set.", {"entities": []}], ["Our aim was to develop and validate a method to estimate noise-free spatial heterogeneity of pulmonary perfusion using dynamic positron emission tomography (PET) scans.", {"entities": []}], ["On theoretical grounds, we demonstrate a linear relationship between the total variance of a data set derived from averages of n multiple measurements, and the reciprocal of n .", {"entities": []}], ["Using multiple measurements with varying n yields estimates of the linear relationship including the noise-free variance as the constant parameter.", {"entities": []}], ["In PET images, n is proportional to the number of registered decay events, and the variance of the image is typically normalized by the square of its mean value yielding a coefficient of variation squared ( CV r CV t CV t CV r CV t CV CV t CV CV t CV t CV t", {"entities": []}], ["In this paper, we introduce the Intervention Mapping (IM) taxonomy of behaviour change methods and its potential to be developed into a coding taxonomy.", {"entities": []}], ["That is, although IM and its taxonomy of behaviour change methods are not in fact new, because IM was originally developed as a tool for intervention development, this potential was not immediately apparent.", {"entities": []}], ["Second, in explaining the IM taxonomy and defining the relevant constructs, we call attention to the existence of parameters for effectiveness of methods, and explicate the related distinction between theory-based methods and practical applications and the probability that poor translation of methods may lead to erroneous conclusions as to method-effectiveness.", {"entities": []}], ["Third, we recommend a minimal set of intervention characteristics that may be reported when intervention descriptions and evaluations are published.", {"entities": []}], ["Specifying these characteristics can greatly enhance the quality of our meta-analyses and other literature syntheses.", {"entities": []}], ["In conclusion, the dynamics of behaviour change are such that any taxonomy of methods of behaviour change needs to acknowledge the importance of, and provide instruments for dealing with, three conditions for effectiveness for behaviour change methods.", {"entities": []}], ["For a behaviour change method to be effective: (1) it must target a determinant that predicts behaviour; (2) it must be able to change that determinant; (3) it must be translated into a practical application in a way that preserves the parameters for effectiveness and fits with the target population, culture, and context.", {"entities": []}], ["Thus, taxonomies of methods of behaviour change must distinguish the specific determinants that are targeted, practical, specific applications, and the theory-based methods they embody.", {"entities": []}], ["In addition, taxonomies should acknowledge that the lists of behaviour change methods will be used by, and should be used by, intervention developers.", {"entities": []}], ["Ideally, the taxonomy should be readily usable for this goal; but alternatively, it should be clear how the information in the taxonomy can be used in practice.", {"entities": []}], ["The IM taxonomy satisfies these requirements, and it would be beneficial if other taxonomies would be extended to also meet these needs.", {"entities": []}], ["Current genome-wide association studies (GWAS) are normally implemented in a univariate framework and analyze different phenotypes in isolation.", {"entities": []}], ["This univariate approach ignores the potential genetic correlation between important disease traits.", {"entities": []}], ["Hence this approach is difficult to detect pleiotropic genes, which may exist for obesity and osteoporosis, two common diseases of major public health importance that are closely correlated genetically.", {"entities": [[82, 89, "DISEASE"], [94, 106, "DISEASE"]]}], ["To identify such pleiotropic genes and the key mechanistic links between the two diseases, we here performed the first bivariate GWAS of obesity and osteoporosis.", {"entities": [[137, 144, "DISEASE"], [149, 161, "DISEASE"]]}], ["We searched for genes underlying co-variation of the obesity phenotype, body mass index (BMI), with the osteoporosis risk phenotype, hip bone mineral density (BMD), scanning \u223c380,000 SNPs in 1,000 unrelated homogeneous Caucasians, including 499 males and 501 females.", {"entities": [[53, 60, "DISEASE"], [104, 116, "DISEASE"]]}], ["We identified in the male subjects two SNPs in intron 1 of the SOX6 (SRY-box 6) gene, rs297325 and rs4756846 , which were bivariately associated with both BMI and hip BMD, achieving p values of 6.82\u00d710 p values of 0.03 and 0.02, respectively, for bivariate association with BMI and femoral neck BMD.", {"entities": [[63, 67, "GENE"]]}], ["Interestingly, SOX6 was previously found to be essential to both cartilage formation/chondrogenesis and obesity-related insulin resistance, suggesting the gene's dual role in both bone and fat.", {"entities": [[104, 111, "DISEASE"], [15, 19, "GENE"]]}], ["Our findings, together with the prior biological evidence, suggest the SOX6 gene's importance in co-regulation of obesity and osteoporosis.", {"entities": [[114, 121, "DISEASE"], [126, 138, "DISEASE"], [71, 75, "GENE"]]}], ["Tyrosine kinase inhibitors (TKIs) have dramatically improved the life expectancy of patients suffering from chronic myeloid leukemia (CML); however, patients will eventually develop resistance to TKI therapy or adverse side effects due to secondary off-target mechanisms associated with TKIs.", {"entities": [[108, 132, "DISEASE"], [116, 132, "DISEASE"], [124, 132, "DISEASE"]]}], ["CML patients exhibiting TKI resistance are at greater risk of developing an aggressive and drug-insensitive disease.", {"entities": []}], ["Drug-resistant CML typically arises in response to spontaneous mutations within the drug binding sites of the targeted oncoproteins.", {"entities": []}], ["To better understand the mechanism of drug resistance in TKI-resistant CML patients, the BCR-ABL transformed cell line KCL22 was grown with increasing concentrations of imatinib for a period of 6\u00a0weeks.", {"entities": []}], ["Subsequently, a drug-resistant derivative of the parental KCL22 cell line harboring the T315I gatekeeper mutation was isolated and investigated for TKI drug sensitivity via multi-agent drug screens.", {"entities": []}], ["A synergistic combination of ponatinib- and forskolin-reduced cell viability was identified in this clinically relevant imatinib-resistant CML cell line, which also proved efficacious in other CML cell lines.", {"entities": []}], ["In summary, this study provides new insight into the biological underpinnings of BCR-ABL-driven CML and potential rationale for investigating novel treatment strategies for patients with T315I CML.", {"entities": []}], ["Phenotypes of lung smooth muscle cells in health and disease are poorly characterized.", {"entities": []}], ["This is due, in part, to a lack of methodologies that allow for the independent and direct isolation of bronchial smooth muscle cells (BSMCs) and vascular smooth muscle cells (VSMCs) from the lung.", {"entities": []}], ["In this paper, we describe the development of a bi-fluorescent mouse that permits purification of these two cell populations by cell sorting.", {"entities": []}], ["By subjecting this mouse to an acute allergen based-model of airway inflammation that exhibits many features of asthma, we utilized this tool to characterize the phenotype of so-called asthmatic BSMCs.", {"entities": [[112, 118, "DISEASE"]]}], ["First, we examined the biophysical properties of single BSMCs from allergen sensitized mice and found increases in basal tone and cell size that were sustained ex vivo .", {"entities": []}], ["We then generated for the first time, a comprehensive characterization of the global gene expression changes in BSMCs isolated from the bi-fluorescent mice with allergic airway inflammation.", {"entities": []}], ["Using statistical methods and pathway analysis, we identified a number of differentially expressed mRNAs in BSMCs from allergen sensitized mice that code for key candidate proteins underlying changes in matrix formation, contractility, and immune responses.", {"entities": []}], ["Ultimately, this tool will provide direction and guidance for the logical development of new markers and approaches for studying human lung smooth muscle.", {"entities": []}], ["Nanotitanium dioxide particle (nTiO 2 ) inhalation has been reported to induce lung parenchymal injury.", {"entities": []}], ["After inhalation of nTiO 2 , we monitored changes in 5-lipoxygenase, endothelial nitric oxide synthase (eNOS), and inducible nitric oxide synthase (iNOS) mRNA in rat lung tissue.", {"entities": []}], ["Lung function parameters include specific airway resistance (SRaw), peak expiratory flow rate (PEF), functional residual capacity (FRC), and lung compliance (Cchord); blood white blood cell count (WBC), nitric oxide (NO), hydrogen peroxide, and lactic dehydrogenase (LDH); and lung lavage leukotriene C4, interleukin 6 (IL6), tumor necrotic factor \u03b1 (TNF \u03b1 ), hydroxyl radicals, and NO.", {"entities": [[320, 323, "GENE"], [351, 354, "GENE"]]}], ["Leukotriene receptor antagonist MK571 and 5-lipoxygenase inhibitor MK886 were used for pharmacologic intervention.", {"entities": []}], ["Compared to control, nTiO 2 exposure induced near 5-fold increase in 5-lipoxygenase mRNA expression in lung tissue.", {"entities": []}], ["iNOS mRNA increased while eNOS mRNA decreased.", {"entities": []}], ["Lavage leukotriene C4; IL6; TNF \u03b1 ; NO; hydroxyl radicals; and blood WBC, NO, hydrogen peroxide, and LDH levels rose.", {"entities": [[23, 26, "GENE"], [28, 31, "GENE"]]}], ["Obstructive ventilatory insufficiency was observed.", {"entities": []}], ["MK571 and MK886 both attenuated the systemic inflammation and lung function changes.", {"entities": []}], ["We conclude that inhaled nTiO 2 induces systemic inflammation, cytokine release, and oxidative and nitrosative stress in the lung.", {"entities": []}], ["The lipoxygenase pathway products, mediated by oxygen radicals and WBC, play a critical role in the obstructive ventilatory insufficiency induced by nTiO 2 .", {"entities": []}], ["Progressive midlife weight gain is associated with multiple adverse health outcomes and may represent an early manifestation of insulin resistance in a distinct subset of women.", {"entities": []}], ["Emerging data implicate hyperinsulinema as a proximate cause of weight gain and support strategies that attenuate insulin secretion.", {"entities": []}], ["To assess a previously reported novel hypocaloric carbohydrate modified diet alone (D), and in combination with metformin (M) and metformin plus low-dose rosiglitazone (MR), in diverse women with midlife weight gain (defined as >20lbs since the twenties), normal glucose tolerance, and hyperinsulinemia.", {"entities": []}], ["46 women, mean age 46.6\u00b11.0, BMI 30.5\u00b10.04 kg/m A dietary intervention designed to reduce insulin excursions was implemented in 4 weekly nutritional group workshops prior to randomization.", {"entities": []}], ["Change in 6-month fasting insulin.", {"entities": []}], ["Pre-specified secondary outcomes were changes in body weight, HOMA - IR, metabolic syndrome (MS) measures, leptin, and adiponectin.", {"entities": [[83, 91, "DISEASE"]]}], ["Six-month fasting insulin declined significantly in the M group: 12.5 to 8.0 \u00b5U/ml, p \u200a=\u200a.026.", {"entities": []}], ["Mean 6-month weight decreased significantly and comparably in D, M, and MR groups: 4.7, 5.4, and 5.5% ( p\u2019s .049, .002, and.032).", {"entities": []}], ["HOMA\u2013IR decreased in M and MR groups (2.5 to 1.6 and 1.9 to 1.3, p\u2019s\u200a=\u200a .054, .013).", {"entities": []}], ["Additional improvement in MS measures included reduced waist circumference in D and MR groups and increased HDL in the D and M groups.", {"entities": []}], ["Notably, mean fasting leptin did not decline in a subset of subjects with weight loss (26.15\u00b12.01 ng/ml to 25.99\u00b12.61 ng/ml, p \u200a=\u200a.907.", {"entities": []}], ["Adiponectin increased significantly in the MR group (11.1\u00b11.0 to 18.5\u00b17.4, p <.001) Study medications were well tolerated.", {"entities": []}], ["These findings suggest that EMPOWIR\u2019s easily implemented dietary interventions, alone and in combination with pharmacotherapies that target hyperinsulinemia, merit additional investigation in larger, long-term studies.", {"entities": []}], ["ClinicalTrials.gov NCT00618072", {"entities": []}], ["Since adaptive immunity is thought to be central to immunity against influenza A virus (IAV) pneumonias, preventive strategies have focused primarily on vaccines.", {"entities": [[69, 78, "DISEASE"]]}], ["However, vaccine efficacy has been variable, in part because of antigenic shift and drift in circulating influenza viruses.", {"entities": [[105, 114, "DISEASE"]]}], ["Recent studies have highlighted the importance of innate immunity in protecting against influenza.", {"entities": [[88, 97, "DISEASE"]]}], ["Granulocyte-macrophage colony stimulating factor (GM-CSF) contributes to maturation of mononuclear phagocytes, enhancing their capacity for phagocytosis and cytokine production.", {"entities": []}], ["Overexpression of granulocyte macrophage-colony stimulating factor (GM-CSF) in the lung of transgenic mice provides remarkable protection against IAV, which depends on alveolar macrophages (AM).", {"entities": []}], ["In this study, we report that pulmonary delivery of GM-CSF to wild type young and aged mice abrogated mortality from IAV.", {"entities": []}], ["We also demonstrate that protection is species specific and human GM-CSF do not protect the mice nor stimulates mouse immunity.", {"entities": []}], ["We also show that IAV-induced lung injury is the culprit for side-effects of GM-CSF in treating mice after IAV infection, and introduce a novel strategy to deliver the GM-CSF to and retain it in the alveolar space even after IAV infection.", {"entities": []}], ["The genetic diversity and geographic structure of the human fungal pathogen A.\u00a0fumigatus have been the subject of many studies.", {"entities": []}], ["However, most previous studies had relatively limited sample ranges and sizes and/or used genetic markers with low-level polymorphisms.", {"entities": []}], ["In this paper, we characterize a global collection of strains of A.\u00a0fumigatus using a panel of 9 highly polymorphic microsatellite markers.", {"entities": []}], ["Using these markers, we analyze 2,026 isolates, which is ~3 times the number of isolates reported so far in previous studies.", {"entities": []}], ["Our analyses suggest that A.\u00a0fumigatus contains historically differentiated genetic populations but that its evolution is significantly impacted by contemporary forces such as widespread gene flow and local antifungal drug pressure.", {"entities": []}], ["In the wake of a global rise in resistance to azoles in fungal pathogens, our findings should aid in developing management strategies to mitigate current increases to azole resistance.", {"entities": []}], ["Aspergillus fumigatus is a ubiquitous opportunistic fungal pathogen capable of causing invasive aspergillosis, a globally distributed disease with a mortality rate of up to 90% in high-risk populations.", {"entities": [[96, 109, "DISEASE"], [87, 109, "DISEASE"]]}], ["Effective control and prevention of this disease require a thorough understanding of its epidemiology.", {"entities": []}], ["However, despite significant efforts, the global molecular epidemiology of A.\u00a0fumigatus remains poorly understood.", {"entities": []}], ["In this study, we analyzed 2,026 A.\u00a0fumigatus isolates from 13 countries in four continents using nine highly polymorphic microsatellite markers.", {"entities": []}], ["Genetic cluster analyses suggest that our global sample of A.\u00a0fumigatus isolates belonged to eight genetic clusters, with seven of the eight clusters showing broad geographic distributions.", {"entities": []}], ["We found common signatures of sexual recombination within individual genetic clusters and clear evidence of hybridization between several clusters.", {"entities": []}], ["Limited but statistically significant genetic differentiations were found among geographic and ecological populations.", {"entities": []}], ["However, there was abundant evidence for gene flow at the local, regional, and global scales.", {"entities": []}], ["Interestingly, the triazole-susceptible and triazole-resistant populations showed different population structures, consistent with antifungal drug pressure playing a significant role in local adaptation.", {"entities": []}], ["Our results suggest that global populations of A.\u00a0fumigatus are shaped by historical differentiation, contemporary gene flow, sexual reproduction, and the localized antifungal drug selection that is driving clonal expansion of genotypes resistant to multiple triazole drugs.", {"entities": []}], ["IMPORTANCE The genetic diversity and geographic structure of the human fungal pathogen A.\u00a0fumigatus have been the subject of many studies.", {"entities": []}], ["However, most previous studies had relatively limited sample ranges and sizes and/or used genetic markers with low-level polymorphisms.", {"entities": []}], ["In this paper, we characterize a global collection of strains of A.\u00a0fumigatus using a panel of 9 highly polymorphic microsatellite markers.", {"entities": []}], ["Using these markers, we analyze 2,026 isolates, which is ~3 times the number of isolates reported so far in previous studies.", {"entities": []}], ["Our analyses suggest that A.\u00a0fumigatus contains historically differentiated genetic populations but that its evolution is significantly impacted by contemporary forces such as widespread gene flow and local antifungal drug pressure.", {"entities": []}], ["In the wake of a global rise in resistance to azoles in fungal pathogens, our findings should aid in developing management strategies to mitigate current increases to azole resistance.", {"entities": []}], ["Airway epithelial cell-derived thymic stromal lymphopoietin (TSLP) and IL-33 can enhance lung-resident group 2 innate lymphoid cells (ILC2s), and they play an important role in the development of allergic diseases.", {"entities": [[61, 65, "GENE"]]}], ["This study tests the hypothesis that Der f 31 ( Dermatophagoides farinae -31), an allergen, modulates airway epithelial cell functions and increases the frequency of lung ILC2s.", {"entities": []}], ["Our previous research identified cofilin (Der f 31) as a novel allergen.", {"entities": []}], ["In this study, we found that recombinant Der f 31 (r-Der f 31) upregulated the expression of co-stimulatory molecules in DCs and promoted Th2-skewed polarization.", {"entities": []}], ["The levels of TSLP and IL-33 in epithelial cells were upregulated by r-Der f 31 via the activation of Toll-like receptor 2.", {"entities": [[14, 18, "GENE"]]}], ["Furthermore, in in vivo studies, r-Der f 31 induced eosinophil-like airway allergy and increased the number of lung-resident ILC2s.", {"entities": []}], ["In summary, Der f 31 can modulate the functions of airway epithelial cells and increase levels of lung-resident ILC2s.", {"entities": []}], ["Graves\u2019 ophthalmopathy (GO) is the commonest extra-thyroidal manifestation of Graves\u2019 disease (GD).", {"entities": []}], ["Associations between interleukin-related (IL) gene polymorphisms and GO have been reported in different populations.", {"entities": []}], ["We aim to confirm such associations by conducting a meta-analysis.", {"entities": []}], ["Totally 382 publications were retrieved in MEDLINE and EMBASE up to 25/2/2015.", {"entities": []}], ["After removing the duplicates and assessing the studies, we retrieved 16 studies that met the selection criteria for meta-analysis, involving 12 polymorphisms in 8 IL-related genes, and 1650 GO cases and 2909 GD controls.", {"entities": []}], ["The summary odds ratio (OR) and 95% confidence intervals (CI) were estimated.", {"entities": []}], ["We found one polymorphism in IL1A (rs1800587, c.-889C>T) showing a suggestive association with GO in the meta-analysis (allelic model [T vs. C]: OR\u2009=\u20091.62, 95% CI: 1.00\u20132.62, P\u2009=\u20090.050, I I I IL1B , IL1RA , IL4 , IL6 , IL12B , IL13 and IL23R ).", {"entities": [[29, 33, "GENE"], [192, 196, "GENE"], [207, 210, "GENE"], [213, 216, "GENE"], [219, 224, "GENE"], [227, 231, "GENE"], [236, 241, "GENE"]]}], ["Our results thus indicate that IL1A is likely to be a genetic biomarker for GO.", {"entities": [[31, 35, "GENE"]]}], ["Further studies with larger sample sizes are warranted to confirm the associations of IL1A and other IL-related genes with GO.", {"entities": [[86, 90, "GENE"]]}], ["The perioperative administration of selective cyclooxygenase-2 (COX-2)-inhibitors to avoid postoperative pain is an attractive option: they show favorable gastro-intestinal tolerability, lack inhibition of blood coagulation, and carry a low risk of asthmatic attacks.", {"entities": []}], ["The purpose of this study was to determine the cerebrospinal fluid (CSF), plasma, and tissue pharmacokinetics of orally administered etoricoxib and to compare it with effect data, i.e., COX-2-inhibition in patients after hip surgery.", {"entities": []}], ["The study was performed in a blinded, randomized, parallel group design.", {"entities": []}], ["A total of 12 adult patients were included who received 120\u00a0mg etoricoxib ( n \u2009=\u20098) or placebo ( n \u2009=\u20094) on day 1 post-surgery.", {"entities": []}], ["Samples from plasma, CSF, and tissue exudates were collected over a period of 24\u00a0h post-dosing and analyzed for etoricoxib and prostaglandin E 2 (PGE 2 ) using liquid chromatography-tandem mass spectrometry and immuno-assay techniques.", {"entities": []}], ["CSF area under the curve (AUC) [AUCs (O\u201324h) ] for etoricoxib amounted to about 5% of the total AUC in plasma (range: 2\u20137%).", {"entities": []}], ["Individual CSF lag times with respect to (50%) peak plasma concentration were \u22642\u00a0h in all but one case (median: 1\u00a0h).", {"entities": []}], ["PGE 2 production in tissue was significantly blocked by the COX-2 inhibitor starting with the appearance of etoricoxib in tissue and lasting for the whole observation period of 24\u00a0h ( P \u2009<\u20090.01).", {"entities": []}], ["In conclusion, etoricoxib reaches the CSF and site of surgery at effective concentrations and reduces PGE 2 production at the presumed site of action.", {"entities": []}], ["Praeruptorins belonging to the angular-type pyranocoumarins are bioactive constituents that have been isolated from some Peucedanum species such as P. praeruptorum , which is used in traditional Chinese medicine for treatment of cold, cough, upper respiratory infections, and so forth.", {"entities": []}], ["Many reports have demonstrated that the beneficial pharmacological effects of P. praeruptorum root on cardiovascular, pulmonary, immune, and nervous system diseases were attributed to the presence of praeruptorins.", {"entities": []}], ["The aim of this review is to explain the recent efforts of scientists in pharmacological screening of natural and synthetic praeruptorin derivatives, studying the mechanisms of some praeruptorins action, pharmacokinetics, toxicity, and relevant structure-activity relationships.", {"entities": []}], ["Based on reported data about the pharmacological properties of praeruptorins and semisynthetic derivatives of them, it is hopeful that in the near future more studies focus on the discovery of the new application and therapeutic uses of these bioactive compounds and understanding the specific mechanisms of them.", {"entities": []}], ["The present discusses the reports on molecular and biological activities of praeruptorins of the genus Peucedanum , from 1976 onwards.", {"entities": []}], ["Exercise-induced bronchoconstriction (EIB) is a highly prevalent condition, whose pathophysiology is not well understood.", {"entities": []}], ["Endothelins are proinflammatory, profibrotic, broncho- and vasoconstrictive peptides which play an important role in the development of airway inflammation and remodeling in asthma.", {"entities": [[174, 180, "DISEASE"]]}], ["The aim of the study was to evaluate the changes in endothelin-1 levels in exhaled breath condensate following intensive exercise in asthmatic patients.", {"entities": []}], ["The study was conducted in a group of 19 asthmatic patients (11 with EIB, 8 without EIB) and 7 healthy volunteers.", {"entities": []}], ["Changes induced by intensive exercise in the concentrations of endothelin-1 (ET-1) in exhaled breath condensate (EBC) during 24 hours after an exercise challenge test were determined.", {"entities": []}], ["Moreover, the possible correlations of these measurements with the results of other tests commonly associated with asthma and with the changes of airway inflammation after exercise were observed.", {"entities": [[115, 121, "DISEASE"]]}], ["In asthmatic patients with EIB a statistically significant increase in the concentration of ET-1 in EBC collected between 10 minutes and 6 hours after an exercise test was observed.", {"entities": []}], ["The concentration of ET-1 had returned to its initial level 24 hours after exercise.", {"entities": []}], ["No effects of the exercise test on changes in the concentrations of ET-1 in EBC in either asthmatic patients without EIB or healthy volunteers were observed.", {"entities": []}], ["A statistically significant correlation between the maximum increase in ET-1 concentrations in EBC after exercise and either baseline F ENO and the increase in F ENO or BHR to histamine 24 hours after exercise in the groups of asthmatics with EIB was revealed.", {"entities": []}], ["The release of ET-1 from bronchial epithelium through the influence of many inflammatory cells essential in asthma and interactions with other cytokines, may play an important role in increase of airway inflammation which was observed after postexercise bronchoconstriction in asthmatic patients.", {"entities": [[108, 114, "DISEASE"]]}], ["Current asthma prevalence among adults in the United States has reached historically high levels.", {"entities": [[8, 14, "DISEASE"]]}], ["Although national-level estimates indicate that asthma prevalence among adults increased by 33% from 2000 to 2009, state-specific temporal trends of current asthma prevalence and their contributing risk factors have not been explored.", {"entities": [[48, 54, "DISEASE"], [157, 163, "DISEASE"]]}], ["We used 2000\u20132009 Behavioral Risk Factor Surveillance System data from all 50 states and the District of Columbia (D.C.) to estimate state-specific current asthma prevalence by 2-year periods (2000\u20132001, 2002\u20132003, 2004\u20132005, 2006\u20132007, 2008\u20132009).", {"entities": [[156, 162, "DISEASE"]]}], ["We fitted a series of four logistic-regression models for each state to evaluate whether there was a statistically significant linear change in the current asthma prevalence over time, accounting for sociodemographic factors, smoking status, and weight status (using body mass index as the indicator).", {"entities": [[156, 162, "DISEASE"]]}], ["During 2000\u20132009, current asthma prevalence increased in all 50 states and D.C., with significant increases in 46/50 (92%) states and D.C. After accounting for weight status in the model series with sociodemographic factors, and smoking status, 10 states (AR, AZ, IA, IL, KS, ME, MT, UT, WV, and WY) that had previously shown a significant increase did not show a significant increase in current asthma prevalence.", {"entities": [[26, 32, "DISEASE"], [396, 402, "DISEASE"]]}], ["There was a significant increasing trend in state-specific current asthma prevalence among adults from 2000 to 2009 in most states in the United States.", {"entities": [[67, 73, "DISEASE"]]}], ["Obesity prevalence appears to contribute to increased current asthma prevalence in some states.", {"entities": [[62, 68, "DISEASE"]]}], ["Particulate matter (PM) contains heavy metals that affect various cellular functions and gene expression associated with a range of acute and chronic diseases in humans.", {"entities": []}], ["However, the specific effects they exert on the stem cells remain unclear.", {"entities": []}], ["Here, we report the effects of PM collected from the city of Jeddah on proliferation, cell death, related gene expression and systems of biological analysis in bone marrow mesenchymal stem cells (BM-MSCs), with the aim of understanding the underlying mechanisms.", {"entities": []}], ["PM 2.5 and PM 10 were tested in vitro at various concentrations (15 to 300 \u00b5g/mL) and durations (24 to 72 h).", {"entities": []}], ["PMs induced cellular stress including membrane damage, shrinkage and death.", {"entities": []}], ["Lower concentrations of PM 2.5 increased proliferation of BM-MSCs, while higher concentrations served to decrease it.", {"entities": []}], ["PM 10 decreased BM-MSCs proliferation in a concentration-dependent manner.", {"entities": []}], ["The X-ray fluorescence spectrometric analysis showed that PM contains high levels of heavy metals.", {"entities": []}], ["Ingenuity Pathway Analysis (IPA) and hierarchical clustering analyses demonstrated that heavy metals were associated with signaling pathways involving cell stress/death, cancer and chronic diseases.", {"entities": [[170, 176, "DISEASE"]]}], ["qRT-PCR results showed differential expression of the apoptosis genes (BCL2, BAX); inflammation associated genes (TNF-\u03b1 and IL-6) and the cell cycle regulation gene (p53).", {"entities": [[71, 75, "GENE"], [77, 80, "GENE"]]}], ["We conclude that PM causes inflammation and cell death, and thereby predisposes to chronic debilitating diseases.", {"entities": []}], ["Oocyte donation has been associated to gestational diabetes, hypertensive disorders, placental abnormalities, preterm delivery and increased rate of caesarean delivery while simultaneously being characterized by high rates of primiparity, advanced maternal age and multiple gestation constituting the individual risk of mode of conception difficult to assess.", {"entities": [[39, 59, "DISEASE"]]}], ["This study aims to explore obstetrical outcomes among relatively young women with optimal health status conceiving singletons with donated versus autologous oocytes (via IVF and spontaneously).", {"entities": []}], ["National retrospective cohort case study involving 76 women conceiving with donated oocytes, 150 nulliparous women without infertility conceiving spontaneously and 63 women conceiving after non-donor IVF.", {"entities": [[123, 134, "DISEASE"]]}], ["Data on obstetric outcomes were retrieved from the National Birth Medical Register and the medical records of oocyte recipients from the treating University Hospitals of Sweden.", {"entities": []}], ["Demographic and logistic regression analysis were performed to examine the association of mode of conception and obstetric outcomes.", {"entities": []}], ["Women conceiving with donated oocytes (OD) had a higher risk of hypertensive disorders [adjusted Odds Ratio (aOR) 2.84, 95\u00a0% CI (1.04\u20137.81)], oligohydramnios [aOR 12.74, 95\u00a0% CI (1.24\u2013130.49)], postpartum hemorrhage [aOR 7.11, 95\u00a0% CI (2.02\u201324.97)] and retained placenta [aOR 6.71, 95\u00a0% CI (1.58\u201328.40)] when compared to women who conceived spontaneously, after adjusting for relevant covariates.", {"entities": [[142, 157, "DISEASE"]]}], ["Similar trends, though not statistically significant, were noted when comparing OD pregnant women to women who had undergone non-donor IVF.", {"entities": []}], ["Caesarean delivery [aOR 2.95, 95\u00a0% CI (1.52\u20135.71); aOR 5.20, 95\u00a0% CI (2.21\u201312.22)] and induction of labor [aOR 3.00, 95\u00a0% CI (1.39\u20136.44); aOR 2.80, 95\u00a0% CI (1.10\u20137.08)] occurred more frequently in the OD group, compared to the group conceiving spontaneously and through IVF respectively.", {"entities": []}], ["No differences in gestational length were noted between the groups.", {"entities": []}], ["With regard to the indication of OD treatment, higher intervention was observed in women with diminished ovarian reserve but the risk for hypertensive disorders did not differ after adjustment.", {"entities": []}], ["The selection process of recipients for medically indicated oocyte donation treatment in Sweden seems to be effective in excluding women with severe comorbidities.", {"entities": []}], ["Nevertheless, oocyte recipients-despite being relatively young and of optimal health status- need careful counseling preconceptionally and closer monitoring prenatally for the development of hypertensive disorders.", {"entities": []}], ["Patients with recurrent or refractory head and neck squamous cell carcinoma received cisplatin/epinephrine injectable gel or placebo gel injected directly into the clinically dominant tumour.", {"entities": [[66, 75, "DISEASE"], [52, 75, "DISEASE"]]}], ["The double-blind phase III trial comprised of up to 6 weekly treatments over 8 weeks, 4 weekly evaluation visits, and then monthly follow-up; open-label dosing began as needed after three blinded treatments.", {"entities": []}], ["Tumour response was defined as complete (100% regression) or partial (50\u201399% regression) sustained for \u2a7e28 day, and patient benefit as attainment of palliative or preventive goals prospectively selected by investigators and patients.", {"entities": []}], ["With cisplatin/epinephrine gel, 25% (14 out of 57) of tumours responded (16% complete regression, 9% partial regression), vs 3% (one out of 35, complete regression) with placebo ( P =0.007).", {"entities": []}], ["Patient benefit was positively associated with target tumour response in the blinded period among cisplatin/epinephrine gel recipients ( P =0.024): 43% (six out of 14) of responders benefited, vs 12% (five out of 43) of non-responders.", {"entities": []}], ["The most frequent adverse event was pain during injection and the next most frequent was local cytotoxic effects consistent with the gel's mode of action.", {"entities": []}], ["Systemic adverse events typical of intravenous cisplatin were uncommon.", {"entities": []}], ["Intratumoural therapy with cisplatin/epinephrine gel provided safe, well-tolerated, effective palliative treatment for patients with locally advanced head and neck squamous cell carcinoma, who lack other satisfactory treatment options.", {"entities": [[178, 187, "DISEASE"], [164, 187, "DISEASE"]]}], ["British Journal of Cancer (2002) 87 , 938\u2013944.", {"entities": [[19, 25, "DISEASE"]]}], ["doi: 10.1038/sj.bjc.6600588 www.bjcancer.com \u00a9 2002 Cancer Research UK", {"entities": [[52, 58, "DISEASE"]]}], ["Heart Healthy Lenoir is a transdisciplinary project aimed at creating long-term, sustainable approaches to reduce cardiovascular disease risk disparities in Lenoir County, North Carolina using a design spanning genomic analysis and clinical intervention.", {"entities": []}], ["We hypothesized that residents of Lenoir County would be unfamiliar and mistrustful of genomic research, and therefore reluctant to participate; additionally, these feelings would be higher in African-Americans.", {"entities": []}], ["To test our hypothesis, we conducted qualitative research using community-based participatory research principles to ensure our genomic research strategies addressed the needs, priorities, and concerns of the community.", {"entities": []}], ["African-American (n = 19) and White (n = 16) adults in Lenoir County participated in four focus groups exploring perceptions about genomics and cardiovascular disease.", {"entities": []}], ["Demographic surveys were administered and a semi-structured interview guide was used to facilitate discussions.", {"entities": []}], ["The discussions were digitally recorded, transcribed verbatim, and analyzed in ATLAS.ti.", {"entities": []}], ["From our analysis, key themes emerged: transparent communication, privacy, participation incentives and barriers, knowledge, and the impact of knowing.", {"entities": []}], ["African-Americans were more concerned about privacy and community impact compared to Whites, however, African-Americans were still eager to participate in our genomic research project.", {"entities": []}], ["The results from our formative study were used to improve the informed consent and recruitment processes by: 1) reducing misconceptions of genomic studies; and 2) helping to foster participant understanding and trust with the researchers.", {"entities": []}], ["Our study demonstrates how community-based participatory research principles can be used to gain deeper insight into the community and increase participation in genomic research studies.", {"entities": []}], ["Due in part to these efforts 80.3% of eligible African-American participants and 86.9% of eligible White participants enrolled in the Heart Healthy Lenoir Genomics study making our overall enrollment 57.8% African-American.", {"entities": []}], ["Future research will investigate return of genomic results in the Lenoir community.", {"entities": []}], ["A Phase II, multicentre, randomised, double-blind, placebo-controlled, crossover trial comparing the 24-h forced expiratory volume in 1\u00a0s (FEV 1 ) time profile after 3\u00a0weeks\u2019 treatment with once-daily (QD) or twice-daily (BID) olodaterol (at the same total daily dose) versus placebo delivered via Respimat\u00ae in patients with moderate to severe asthma.", {"entities": [[344, 350, "DISEASE"], [139, 142, "GENE"]]}], ["Patients were randomised to different sequences of olodaterol with 2-week washout, either as a total daily dose of 5\u00a0\u03bcg (5\u00a0\u03bcg QD [AM] or 2.5\u00a0\u03bcg BID) or placebo, or 10\u00a0\u03bcg (10\u00a0\u03bcg QD [AM] or 5\u00a0\u03bcg BID) or placebo.", {"entities": []}], ["Primary end point was FEV 1 area under the curve from 0 to 24 h (AUC 0\u201324 ) response (defined as change from study baseline FEV 1 ) after 3\u00a0weeks.", {"entities": [[22, 25, "GENE"], [124, 127, "GENE"], [22, 25, "GENE"], [124, 127, "GENE"]]}], ["Key secondary end points were FEV 1 AUC 0\u201312 and AUC 12\u201324 responses.", {"entities": [[30, 33, "GENE"]]}], ["Two hundred and six patients received treatment.", {"entities": []}], ["All olodaterol treatments demonstrated statistically significant improvements in FEV 1 AUC 0\u201324 response at 3\u00a0weeks versus placebo ( p \u2009<\u20090.0001); adjusted mean treatment difference versus placebo was 0.191\u00a0L for olodaterol 2.5\u00a0\u03bcg BID (95\u00a0% confidence interval [CI] 0.152, 0.229), 0.150\u00a0L for 5\u00a0\u03bcg QD (95\u00a0% CI 0.111, 0.189), 0.228\u00a0L for 5\u00a0\u03bcg BID (95\u00a0% CI 0.190, 0.266) and 0.209\u00a0L for 10\u00a0\u03bcg QD (95\u00a0% CI 0.170, 0.247).", {"entities": [[81, 84, "GENE"]]}], ["These results were supported by the key secondary end points.", {"entities": []}], ["Olodaterol 5\u00a0\u03bcg QD provided numerically lower mean values for 24-h bronchodilation than olodaterol 2.5\u00a0\u03bcg BID ( p \u2009=\u20090.0465), with no statistically significant difference between treatment with olodaterol 10\u00a0\u03bcg QD and 5\u00a0\u03bcg BID.", {"entities": []}], ["No relevant differences in morning and evening peak expiratory flow or Asthma Control Questionnaire scores at 3\u00a0weeks were observed between different doses and regimens.", {"entities": [[71, 77, "DISEASE"]]}], ["Adverse events were generally mild to moderate and comparable between groups.", {"entities": []}], ["All doses and dose frequencies provided adequate 24-h bronchodilation superior to placebo.", {"entities": []}], ["Based on the results of this study, it would be reasonable to include both posologies of 5\u00a0\u03bcg olodaterol daily (5\u00a0\u03bcg QD or 2.5\u00a0\u03bcg BID, both delivered in two puffs per dose from the Respimat\u00ae inhaler) in subsequent studies.", {"entities": []}], ["Further studies are necessary to confirm the optimum dosing regimen in asthma.", {"entities": [[71, 77, "DISEASE"]]}], ["No safety concerns were identified.", {"entities": []}], ["ClinicalTrials.gov NCT01311661 The online version of this article (doi:10.1186/s12931-015-0243-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The UN's Sustainable Development Goals (SDGs) are grounded in the global ambition of \u201cleaving no one behind\u201d.", {"entities": []}], ["Understanding today's gains and gaps for the health-related SDGs is essential for decision makers as they aim to improve the health of populations.", {"entities": []}], ["As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016), we measured 37 of the 50 health-related SDG indicators over the period 1990\u20132016 for 188 countries, and then on the basis of these past trends, we projected indicators to 2030.", {"entities": []}], ["We used standardised GBD 2016 methods to measure 37 health-related indicators from 1990 to 2016, an increase of four indicators since GBD 2015.", {"entities": []}], ["We substantially revised the universal health coverage (UHC) measure, which focuses on coverage of essential health services, to also represent personal health-care access and quality for several non-communicable diseases.", {"entities": []}], ["We transformed each indicator on a scale of 0\u2013100, with 0 as the 2\u00b75th percentile estimated between 1990 and 2030, and 100 as the 97\u00b75th percentile during that time.", {"entities": []}], ["An index representing all 37 health-related SDG indicators was constructed by taking the geometric mean of scaled indicators by target.", {"entities": []}], ["On the basis of past trends, we produced projections of indicator values, using a weighted average of the indicator and country-specific annualised rates of change from 1990 to 2016 with weights for each annual rate of change based on out-of-sample validity.", {"entities": []}], ["24 of the currently measured health-related SDG indicators have defined SDG targets, against which we assessed attainment.", {"entities": []}], ["Globally, the median health-related SDG index was 56\u00b77 (IQR 31\u00b79\u201366\u00b78) in 2016 and country-level performance markedly varied, with Singapore (86\u00b78, 95% uncertainty interval 84\u00b76\u201388\u00b79), Iceland (86\u00b70, 84\u00b71\u201387\u00b76), and Sweden (85\u00b76, 81\u00b78\u201387\u00b78) having the highest levels in 2016 and Afghanistan (10\u00b79, 9\u00b76\u201311\u00b79), the Central African Republic (11\u00b70, 8\u00b78\u201313\u00b78), and Somalia (11\u00b73, 9\u00b75\u201313\u00b71) recording the lowest.", {"entities": []}], ["Between 2000 and 2016, notable improvements in the UHC index were achieved by several countries, including Cambodia, Rwanda, Equatorial Guinea, Laos, Turkey, and China; however, a number of countries, such as Lesotho and the Central African Republic, but also high-income countries, such as the USA, showed minimal gains.", {"entities": []}], ["Based on projections of past trends, the median number of SDG targets attained in 2030 was five (IQR 2\u20138) of the 24 defined targets currently measured.", {"entities": []}], ["Globally, projected target attainment considerably varied by SDG indicator, ranging from more than 60% of countries projected to reach targets for under-5 mortality, neonatal mortality, maternal mortality ratio, and malaria, to less than 5% of countries projected to achieve targets linked to 11 indicator targets, including those for childhood overweight, tuberculosis, and road injury mortality.", {"entities": [[357, 369, "DISEASE"], [216, 223, "DISEASE"]]}], ["For several of the health-related SDGs, meeting defined targets hinges upon substantially faster progress than what most countries have achieved in the past.", {"entities": []}], ["GBD 2016 provides an updated and expanded evidence base on where the world currently stands in terms of the health-related SDGs.", {"entities": []}], ["Our improved measure of UHC offers a basis to monitor the expansion of health services necessary to meet the SDGs.", {"entities": []}], ["Based on past rates of progress, many places are facing challenges in meeting defined health-related SDG targets, particularly among countries that are the worst off.", {"entities": []}], ["In view of the early stages of SDG implementation, however, opportunity remains to take actions to accelerate progress, as shown by the catalytic effects of adopting the Millennium Development Goals after 2000.", {"entities": []}], ["With the SDGs' broader, bolder development agenda, multisectoral commitments and investments are vital to make the health-related SDGs within reach of all populations.", {"entities": []}], ["Bill & Melinda Gates Foundation.", {"entities": []}], ["Highly active antiretroviral therapy produces a significant decrease in HIV-1 replication and allows an increase in the CD4 T-cell count, leading to a decrease in the incidence of opportunistic infections and mortality.", {"entities": [[120, 123, "GENE"]]}], ["However, the cost, side effects and complexity of antiretroviral regimens have underscored the immediate need for additional therapeutic approaches.", {"entities": []}], ["Statins exert pleiotropic effects through a variety of mechanisms, among which there are several immunoregulatory effects, related and unrelated to their cholesterol-lowering activity that can be useful to control HIV-1 infection.", {"entities": []}], ["Randomized, double-blinded, placebo controlled, single-center, phase-II clinical trial.", {"entities": []}], ["One hundred and ten chronically HIV-1-infected patients, older than 18 years and na\u00efve for antirretroviral therapy (i.e., without prior or current management with antiretroviral drugs) will be enrolled at the outpatient services from the most important centres for health insurance care in Medellin-Colombia.", {"entities": []}], ["The interventions will be lovastatin (40 mg/day, orally, for 12 months; 55 patients) or placebo (55 patients).", {"entities": []}], ["Our primary aim will be to determine the effect of lovastatin on viral replication.", {"entities": []}], ["The secondary aim will be to determine the effect of lovastatin on CD4+ T-cell count in peripheral blood.", {"entities": []}], ["As tertiary aims we will explore differences in CD8+ T-cell count, expression of activation markers (CD38 and HLA-DR) on CD4 and CD8 T cells, cholesterol metabolism, LFA-1/ICAM-1 function, Rho GTPases function and clinical evolution between treated and not treated HIV-1-infected individuals.", {"entities": [[101, 105, "GENE"], [121, 124, "GENE"]]}], ["Preliminary descriptive studies have suggested that statins (lovastatin) may have anti HIV-1 activity and that their administration is safe, with the potential effect of controlling HIV-1 replication in chronically infected individuals who had not received antiretroviral medications.", {"entities": []}], ["Considering that there is limited clinical data available on this topic, all these findings warrant further evaluation to determine if long-term administration of statins may benefit the virological and immunological evolution in HIV-1-infected individuals before the use of antiretroviral therapy is required.", {"entities": []}], ["Registration number NCT00721305.", {"entities": []}], ["Objective To examine the effect of \u03b2 blockers in the management of chronic obstructive pulmonary disease (COPD), assessing their effect on mortality, hospital admissions, and exacerbations of COPD when added to established treatment for COPD.", {"entities": [[67, 104, "DISEASE"]]}], ["Design Retrospective cohort study using a disease specific database of COPD patients (TARDIS) linked to the Scottish morbidity records of acute hospital admissions, the Tayside community pharmacy prescription records, and the General Register Office for Scotland death registry.", {"entities": []}], ["Setting Tayside, Scotland (2001\u20132010) Population 5977 patients aged >50 years with a diagnosis of COPD.", {"entities": []}], ["Main outcome measures Hazard ratios for all cause mortality, emergency oral corticosteroid use, and respiratory related hospital admissions calculated through Cox proportional hazard regression after correction for influential covariates.", {"entities": []}], ["Results Mean follow-up was 4.35 years, mean age at diagnosis was 69.1 years, and 88% of \u03b2 blockers used were cardioselective.", {"entities": []}], ["There was a 22% overall reduction in all cause mortality with \u03b2 blocker use.", {"entities": []}], ["Furthermore, there were additive benefits of \u03b2 blockers on all cause mortality at all treatment steps for COPD.", {"entities": []}], ["Compared with controls (given only inhaled therapy with either short acting \u03b2 agonists or short acting antimuscarinics), the adjusted hazard ratio for all cause mortality was 0.28 (95% CI 0.21 to 0.39) for treatment with inhaled corticosteroid, long acting \u03b2 agonist, and long acting antimuscarinic plus \u03b2 blocker versus 0.43 (0.38 to 0.48) without \u03b2 blocker.", {"entities": []}], ["There were similar trends showing additive benefits of \u03b2 blockers in reducing oral corticosteroid use and hospital admissions due to respiratory disease.", {"entities": []}], ["\u03b2 blockers had no deleterious impact on lung function at all treatment steps when given in conjunction with either a long acting \u03b2 agonist or antimuscarinic agent Conclusions \u03b2 blockers may reduce mortality and COPD exacerbations when added to established inhaled stepwise therapy for COPD, independently of overt cardiovascular disease and cardiac drugs, and without adverse effects on pulmonary function.", {"entities": []}], ["Human T-cell leukemia virus type 1 (HTLV-1) infection is linked to the development of adult T-cell leukemia (ATL) and the neuroinflammatory disease HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).", {"entities": [[177, 205, "DISEASE"], [13, 21, "DISEASE"], [99, 107, "DISEASE"]]}], ["The HTLV-1 Tax protein functions as a potent viral oncogene that constitutively activates the NF-\u03baB transcription factor to transform T cells; however, the underlying mechanisms remain obscure.", {"entities": []}], ["Here, using next-generation RNA sequencing we identified the IL-25 receptor subunit IL-17RB as an aberrantly overexpressed gene in HTLV-1 immortalized T cells.", {"entities": []}], ["Tax induced the expression of IL-17RB in an I\u03baB kinase (IKK) and NF-\u03baB-dependent manner.", {"entities": []}], ["Remarkably, Tax activation of the canonical NF-\u03baB pathway in T cells was critically dependent on IL-17RB expression.", {"entities": []}], ["IL-17RB and IL-25 were required for HTLV-1-induced immortalization of primary T cells, and the constitutive NF-\u03baB activation and survival of HTLV-1 transformed T cells.", {"entities": []}], ["IL-9 was identified as an important downstream target gene of the IL-17RB pathway that drives the proliferation of HTLV-1 transformed cells.", {"entities": []}], ["Furthermore, IL-17RB was overexpressed in leukemic cells from a subset of ATL patients and also regulated NF-\u03baB activation in some, but not all, Tax-negative ATL cell lines.", {"entities": []}], ["Together, our results support a model whereby Tax instigates an IL-17RB-NF-\u03baB feed-forward autocrine loop that is obligatory for HTLV-1 leukemogenesis.", {"entities": []}], ["The retrovirus HTLV-1 is the causative agent of an aggressive lymphoproliferative disorder known as adult T-cell leukemia (ATL).", {"entities": [[113, 121, "DISEASE"]]}], ["The HTLV-1 Tax regulatory protein constitutively activates the host NF-\u03baB transcription factor to promote T-cell proliferation, survival and cell transformation.", {"entities": []}], ["However, it remains unknown precisely how Tax persistently activates NF-\u03baB in T cells.", {"entities": []}], ["In this study, we used next-generation sequencing to identify genes that were differentially expressed upon HTLV-1 infection and immortalization of primary T cells.", {"entities": []}], ["We found that IL-17RB, the receptor for the IL-25 cytokine, was highly induced in HTLV-1 transformed T cells and was required for NF-\u03baB activation, cell proliferation and survival.", {"entities": []}], ["Tax induced the expression of IL-17RB and established a positive feedback loop together with IL-25 that triggered persistent NF-\u03baB activation and the upregulation of IL-9 and other genes critical for T-cell proliferation and survival.", {"entities": []}], ["IL-17RB was also overexpressed in a subset of acute ATL patient specimens and therefore may potentially be targeted by monoclonal antibodies as a novel ATL therapy.", {"entities": []}], ["The aim of this study was to evaluate the effect of Ginkgolide B (GB) on doxorubicin (DOX) induced cardiotoxicity in vitro and in vivo .", {"entities": []}], ["Rat cardiomyocyte cell line H9c2 was pretreated with GB and subsequently subjected to doxorubicin treatment.", {"entities": []}], ["Cell viability and cell apoptosis were assessed by MTT assay and Hoechst staining, respectively.", {"entities": []}], ["Reactive oxygen species (ROS), Akt phosphorylation and intracellular calcium were equally determined in order to explore the underlying molecular mechanism.", {"entities": []}], ["To verify the in vivo therapeutic effect of GB, we established a mouse model of cardiotoxicity and determined left ventricle ejection fraction (LVEF) and left ventricular mass (LVM).", {"entities": []}], ["The in vitro experimental results indicated that pretreatment with GB significantly decreases the viability and apoptosis of H9c2 cells by decreasing ROS and intracellular calcium levels and activating Akt phosphorylation.", {"entities": []}], ["In the in vivo study, we recorded an improved LVEF and a decreased LVM in the group of cardiotoxic rats treated with GB.", {"entities": []}], ["Altogether, our findings anticipate that GB exerts a cardioprotective effect through possible regulation of the ROS, Akt and calcium pathways.", {"entities": []}], ["The findings suggest that combination of GB with DOX in chemotherapy could help avoid the cardiotoxic side effects of GB.", {"entities": []}], ["Invariant Natural Killer T (iNKT) cells have been implicated in lung inflammation in humans and also shown to be a key cell type in inducing allergic lung inflammation in mouse models.", {"entities": []}], ["iNKT cells differentiate and acquire functional characteristics during development in the thymus.", {"entities": []}], ["However, the correlation between development of iNKT cells in the thymus and role in lung inflammation remains unknown.", {"entities": []}], ["In addition, transcriptional control of differentiation of iNKT cells into iNKT cell effector subsets in the thymus during development is also unclear.", {"entities": []}], ["In this report we show that \u03b2-catenin dependent mechanisms direct differentiation of iNKT2 and iNKT17 subsets but not iNKT1 cells.", {"entities": []}], ["To study the role for \u03b2-catenin in lung inflammation we utilize mice with conditional deletion and enforced expression of \u03b2-catenin in a well-established mouse model for IL-25-dependen lung inflammation.", {"entities": []}], ["Specifically, we demonstrate that conditional deletion of \u03b2-catenin permitted development of mature iNKT1 cells while impeding maturation of iNKT2 and 17 cells.", {"entities": []}], ["A role for \u03b2-catenin expression in promoting iNKT2 and iNKT17 subsets was confirmed when we noted that enforced transgenic expression of \u03b2-catenin in iNKT cell precursors enhanced the frequency and number of iNKT2 and iNKT17 cells at the cost of iNKT1 cells.", {"entities": []}], ["This effect of expression of \u03b2-catenin in iNKT cell precursors was cell autonomous.", {"entities": []}], ["Furthermore, iNKT2 cells acquired greater capability to produce type-2 cytokines when \u03b2-catenin expression was enhanced.", {"entities": []}], ["This report shows that \u03b2-catenin deficiency resulted in a profound decrease in iNKT2 and iNKT17 subsets of iNKT cells whereas iNKT1 cells developed normally.", {"entities": []}], ["By contrast, enforced expression of \u03b2-catenin promoted the development of iNKT2 and iNKT17 cells.", {"entities": []}], ["It was important to note that the majority of iNKT cells in the thymus of C57BL/6 mice were iNKT1 cells and enforced expression of \u03b2-catenin altered the pattern to iNKT2 and iNKT17 cells suggesting that \u03b2-catenin may be a major factor in the distinct pathways that critically direct differentiation of iNKT effector subsets.", {"entities": []}], ["Thus, we demonstrate that \u03b2-catenin expression in iNKT cell precursors promotes differentiation toward iNKT2 and iNKT17 effector subsets and supports enhanced capacity to produce type 2 and 17 cytokines which in turn augment lung inflammation in mice.", {"entities": []}], ["CD14 N \u2009=\u2009152) and asthmatic subjects ( N \u2009=\u2009133) using multi-parametric flow cytometry.", {"entities": [[0, 4, "GENE"]]}], ["Nuclear erythroid factor 2 like 2 (Nrf2) has been described as a transcription factor that serves as a master regulator of the adaptive response to exogenous and endogenous oxidative and electrophilic stresses.", {"entities": []}], ["Evidence of Nrf2 crosstalk with other molecular pathways is increasing; recent publications have proposed a role of Nrf2 in the development of obesity and in the highly regulated process of adipocyte differentiation through its interaction with other transcription factors and receptors implicated in metabolic regulation.", {"entities": [[143, 150, "DISEASE"]]}], ["In the present review, we discuss the available data on the possible role of Nrf2 in obesity and metabolic syndrome and the feasibility of using Nrf2 as a therapeutic target in the clinical setting.", {"entities": [[85, 92, "DISEASE"], [107, 115, "DISEASE"]]}], ["Human metapneumovirus (hMPV) is a recently discovered respiratory virus associated with bronchiolitis, pneumonia, croup and exacerbations of asthma.", {"entities": [[114, 119, "DISEASE"], [103, 112, "DISEASE"], [141, 147, "DISEASE"], [88, 101, "DISEASE"]]}], ["Since respiratory viruses are frequently detected in patients with acute exacerbations of COPD (AE-COPD) it was our aim to investigate the frequency of hMPV detection in a prospective cohort of hospitalized patients with AE-COPD compared to patients with stable COPD and to smokers without by means of quantitative real-time RT-PCR.", {"entities": []}], ["We analysed nasal lavage and induced sputum of 130 patients with AE-COPD, 65 patients with stable COPD and 34 smokers without COPD.", {"entities": []}], ["HMPV was detected in 3/130 (2.3%) AE-COPD patients with a mean of 6.5 \u00d7 10 HMPV is only found in a very small number of patients with AE-COPD.", {"entities": []}], ["However it should be considered as a further possible viral trigger of AE-COPD because asymptomatic carriage is unlikely.", {"entities": []}], ["The development of effective vaccines against life\u2010threatening pathogens in human diseases represents one of the biggest challenges in biomedical science.", {"entities": []}], ["Vaccines traditionally make use of the body's own immune armoury to combat pathogens.", {"entities": []}], ["Yet, while our immune system is mostly effective in eliminating or controlling a diverse range of microorganisms, its responses are incomplete or somewhat limited in several other cases.", {"entities": []}], ["How immune responses are restrained during certain infections has been a matter of debate for many years.", {"entities": []}], ["The discovery of regulatory T cells (Tregs), an immune cell type that plays a central role in maintaining immune homeostasis and controlling appropriate immune responses, has shed light into many questions.", {"entities": []}], ["Indeed, it has been proposed that while Tregs might be beneficial in preventing excessive tissue damage during infection, they might also favour pathogen persistence by restraining effector immune responses.", {"entities": []}], ["In addition, Tregs are believed to limit immune responses upon vaccination.", {"entities": []}], ["Different strategies have been pursued to circumvent Treg activity during immunization, but the lack of specific tools for their study has led sometimes to controversial conclusions.", {"entities": []}], ["With the advent of novel mouse models that allow specific depletion and/or tracking of Treg populations in vivo , novel aspects of Treg biology during infection have been unravelled.", {"entities": []}], ["In this review, we describe the new advances in understanding Treg biology during infection and evaluate Treg depletion as a novel adjuvant strategy for vaccination.", {"entities": []}], ["Increasing evidence suggests that the metabolism of arachidonic acid (AA) may be different in inflammatory cells isolated from blood or migrating into tissues.", {"entities": []}], ["To explore the possibility that changes in AA metabolism between blood and tissue inflammatory cells could be due in part to a different content or distribution of AA in glycerolipid classes, we studied these parameters in six human inflammatory cells isolated from blood (eosinophils, monocytes, neutrophils, and platelets) or from the lung tissue (mast cells and macrophages).", {"entities": []}], ["Lung cells generally had a higher total cellular content of AA than that found in the blood cells.", {"entities": []}], ["In addition, both mast cells and macrophages had a large endogenous pool of AA associated with triglycerides (TG), containing 45 and 22% of their total cellular AA, respectively.", {"entities": [[110, 112, "GENE"]]}], ["To address the hypothesis that cells migrating into the lung had a higher cellular level of AA and a larger AA pool in TG, we studied neutrophils isolated from the bronchoalveolar lavage (BAL) of patients with adult respiratory distress syndrome.", {"entities": [[237, 245, "DISEASE"], [210, 245, "DISEASE"], [119, 121, "GENE"]]}], ["BAL neutrophils had a fourfold increase in cellular AA as compared with blood neutrophils and contained 25% of their AA in TG versus 3% in blood neutrophils.", {"entities": [[123, 125, "GENE"]]}], ["BAL neutrophils also had a higher number of cytoplasmic lipid bodies (8 +/- 3/cell) relative to blood neutrophils (2 +/- 1/cell).", {"entities": []}], ["High concentrations of free AA were also found in the cell-free BAL fluid of adult respiratory distress syndrome patients.", {"entities": [[104, 112, "DISEASE"], [77, 112, "DISEASE"]]}], ["To explore whether changes in BAL neutrophils may be due to the exposure of the cells to high concentrations of exogenous AA found in BAL, we incubated blood neutrophils in culture with AA (10-100 microM) for 24 h. Neutrophils supplemented with AA had a 10-fold increase in the amount of AA associated with TG and a sixfold increase in the number of lipid bodies.", {"entities": [[307, 309, "GENE"]]}], ["In addition, supplementation with AA induced a dose-dependent formation of hypodense cells.", {"entities": []}], ["Taken together, these data indicate that human inflammatory cells undergo a fundamental and consistent remodeling of AA pools as they mature or enter the lung from the blood.", {"entities": []}], ["These biochemical and morphological changes can be mimicked in vitro by exposing the cells to high levels of AA.", {"entities": []}], ["This mechanism may be responsible for the changes in AA mobilization and eicosanoid metabolism observed in tissue inflammatory cells.", {"entities": []}], ["The time taken, or \u2018time lags\u2019, between biomedical/health research and its translation into health improvements is receiving growing attention.", {"entities": []}], ["Reducing time lags should increase rates of return to such research.", {"entities": []}], ["However, ways to measure time lags are under-developed, with little attention on where time lags arise within overall timelines.", {"entities": []}], ["The process marker model has been proposed as a better way forward than the current focus on an increasingly complex series of translation \u2018gaps\u2019.", {"entities": []}], ["Starting from that model, we aimed to develop better methods to measure and understand time lags and develop ways to identify policy options and produce recommendations for future studies.", {"entities": []}], ["Following reviews of the literature on time lags and of relevant policy documents, we developed a new approach to conduct case studies of time lags.", {"entities": []}], ["We built on the process marker model, including developing a matrix with a series of overlapping tracks to allow us to present and measure elements within any overall time lag.", {"entities": []}], ["We identified a reduced number of key markers or calibration points and tested our new approach in seven case studies of research leading to interventions in cardiovascular disease and mental health.", {"entities": []}], ["Finally, we analysed the data to address our study\u2019s key aims.", {"entities": []}], ["The literature review illustrated the lack of agreement on starting points for measuring time lags.", {"entities": []}], ["We mapped points from policy documents onto our matrix and thus highlighted key areas of concern, for example around delays before new therapies become widely available.", {"entities": []}], ["Our seven completed case studies demonstrate we have made considerable progress in developing methods to measure and understand time lags.", {"entities": []}], ["The matrix of overlapping tracks of activity in the research and implementation processes facilitated analysis of time lags along each track, and at the cross-over points where the next track started.", {"entities": []}], ["We identified some factors that speed up translation through the actions of companies, researchers, funders, policymakers, and regulators.", {"entities": []}], ["Recommendations for further work are built on progress made, limitations identified and revised terminology.", {"entities": []}], ["Our advances identify complexities, provide a firm basis for further methodological work along and between tracks, and begin to indicate potential ways of reducing lags.", {"entities": []}], ["The online version of this article (doi:10.1186/1478-4505-13-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["R egulator of G -protein S ignaling 4 (RGS4) plays an important role in regulating smooth muscle contraction, cardiac development, neural plasticity and psychiatric disorder.", {"entities": [[39, 43, "GENE"]]}], ["However, the underlying regulatory mechanisms remain elusive.", {"entities": []}], ["Our recent studies have shown that upregulation of Rgs4 by interleukin (IL)-1\u03b2 is mediated by the activation of NF\u03baB signaling and modulated by extracellular signal-regulated kinases, p38 mitogen-activated protein kinase, and phosphoinositide-3 kinase.", {"entities": [[51, 55, "GENE"]]}], ["Here we investigate the effect of the c-Jun N-terminal kinase (JNK) pathway on Rgs4 expression in rabbit colonic smooth muscle cells.", {"entities": [[79, 83, "GENE"]]}], ["Cultured cells at first passage were treated with or without IL-1\u03b2 (10 ng/ml) in the presence or absence of the selective JNK inhibitor (SP600125) or JNK small hairpin RNA (shRNA).", {"entities": []}], ["The expression levels of Rgs4 mRNA and protein were determined by real-time RT-PCR and Western blot respectively.", {"entities": [[25, 29, "GENE"]]}], ["SP600125 or JNK shRNA increased Rgs4 expression in the absence or presence of IL-1\u03b2 stimulation.", {"entities": [[32, 36, "GENE"]]}], ["Overexpression of MEKK1, the key upstream kinase of JNK, inhibited Rgs4 expression, which was reversed by co-expression of JNK shRNA or dominant-negative mutants for MKK4 or JNK.", {"entities": [[67, 71, "GENE"]]}], ["Both constitutive and inducible upregulation of Rgs4 expression by SP600125 was significantly inhibited by pretreatment with the transcription inhibitor, actinomycin D. Dual reporter assay showed that pretreatment with SP600125 sensitized the promoter activity of Rgs4 in response to IL-1\u03b2.", {"entities": [[48, 52, "GENE"], [264, 268, "GENE"], [48, 52, "GENE"], [264, 268, "GENE"]]}], ["Mutation of the AP1-binding site within Rgs4 promoter increased the promoter activity.", {"entities": [[40, 44, "GENE"]]}], ["Western blot analysis confirmed that IL-1\u03b2 treatment increased the phosphorylation of JNK, ATF-2 and c-Jun.", {"entities": []}], ["Gel shift and chromatin immunoprecipitation assays validated that IL-1\u03b2 increased the in vitro and ex vivo binding activities of AP1 within rabbit Rgs4 promoter.", {"entities": [[147, 151, "GENE"]]}], ["Activation of MEKK1-MKK4-JNK-AP1 signal pathway plays a tonic inhibitory role in regulating Rgs4 transcription in rabbit colonic smooth muscle cells.", {"entities": [[92, 96, "GENE"]]}], ["This negative regulation may aid in maintaining the transient level of RGS4 expression.", {"entities": [[71, 75, "GENE"]]}], ["Although the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) for panic disorder (PD) has been studied previously, data on the predictors of treatment outcomes in MBCT for PD are scarce.", {"entities": [[77, 91, "DISEASE"]]}], ["Eighty patients with PD were screened to analyze treatment outcomes such as MBCT completion, treatment response, and remission after undergoing MBCT for PD.", {"entities": []}], ["Sociodemographic characteristics, comorbid personality disorders, and baseline medication doses were examined.", {"entities": []}], ["The study administered the Panic Disorder Severity Scale, Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale and Anxiety Sensitivity Inventory-Revised to patients at baseline and at eight weeks.", {"entities": [[27, 41, "DISEASE"]]}], ["Sixty-five participants were enrolled in the present study.", {"entities": []}], ["Comorbid personality disorder was significantly associated with MBCT non-completion.", {"entities": [[9, 29, "DISEASE"]]}], ["We found that anxiety sensitivity (AS) improvement after an eight week MBCT program was a statistically significant factor associated with treatment response.", {"entities": []}], ["Using logistic regression analysis, AS improvement after MBCT showed significant association with PD remission after MBCT.", {"entities": []}], ["Comorbid personality disorders of participants could be a potential predictor of MBCT non-completion.", {"entities": []}], ["Furthermore, AS improvement after MBCT may predict treatment response and remission after MBCT for PD.", {"entities": []}], ["However, better designed studies with a larger number of patients are needed to confirm our findings.", {"entities": []}], ["Cesarean birth is associated with altered composition of the neonate's microbiota and with increased risk for obesity and other diseases later in life.", {"entities": [[110, 117, "DISEASE"]]}], ["The mechanisms of these associations, and whether cesarean birth is associated with an altered adult microbiota, are unknown.", {"entities": []}], ["In 1097 adult volunteers without diabetes, inflammatory bowel disease, or recent antibiotic use, fecal microbiome metrics were compared by history of cesarean birth (N\u00a0=\u00a092) or appendectomy (N\u00a0=\u00a0115).", {"entities": [[43, 69, "DISEASE"]]}], ["Associations with potential confounders, microbiome alpha diversity, and individual microbial taxa were estimated by logistic regression.", {"entities": []}], ["Permutation tests assessed differences in microbial composition (beta diversity) based on Jensen\u2013Shannon divergence.", {"entities": []}], ["Cesarean birth history was associated with younger age; appendectomy with older age and higher body mass index.", {"entities": []}], ["Neither was associated with fecal microbiome alpha diversity.", {"entities": []}], ["Microbial composition at all taxonomic levels differed significantly with cesarean birth (P\u00a0\u2264\u00a00.008) but not with appendectomy (P\u00a0\u2265\u00a00.29).", {"entities": []}], ["Relative abundance differed nominally for 17 taxa with cesarean birth and for 22 taxa with appendectomy, none of which was significant with adjustment for multiple comparisons.", {"entities": []}], ["Adults born by cesarean section appear to have a distinctly different composition of their fecal microbial population.", {"entities": []}], ["Whether this distinction was acquired during birth, and whether it affects risk of disease during adulthood, are unknown.", {"entities": []}], ["Supported by the Intramural Research Program, National Cancer Institute, National Institutes of Health (Z01-CP-010214).", {"entities": []}], ["\u2022 Fecal microbiome differed in composition for adults who had been born by cesarean section versus vaginal delivery.", {"entities": []}], ["\u2022 No difference was found for adults with a history of appendectomy.", {"entities": []}], ["\u2022 Source of the cesarean-associated microbiome distinction, and possible effects on disease during adulthood, is unknown.", {"entities": []}], ["Fecal microbiome differed in composition for adults who had been born by cesarean section versus vaginal delivery.", {"entities": []}], ["No difference was found for adults with a history of appendectomy.", {"entities": []}], ["Source of the cesarean-associated microbiome distinction, and possible effects on disease during adulthood, is unknown.", {"entities": []}], ["Sensitisation with Aspergillus fumigatus ( Af ) is known to be associated with severe allergic lung inflammation, but the mechanism remains to be clarified.", {"entities": []}], ["Phosphoinositide 3-kinase (PI3K)-\u03b4 and endoplasmic reticulum (ER) stress are suggested to be involved in steroid-resistant lung inflammation.", {"entities": []}], ["We aimed to elucidate the role of PI3K-\u03b4 and its relationship with ER stress in fungus-induced allergic lung inflammation.", {"entities": []}], ["Using Af -exposed in vivo and in vitro experimental systems, we examined whether PI3K-\u03b4 regulates ER stress, thereby contributing to steroid resistance in fungus-induced allergic lung inflammation.", {"entities": []}], ["Moreover, we checked expression of an ER stress marker in lung tissues isolated from patients with allergic bronchopulmonary aspergillosis.", {"entities": [[125, 138, "DISEASE"], [99, 138, "DISEASE"]]}], ["Af -exposed mice showed that ER stress markers, unfolded protein response (UPR)-related proteins, phosphorylated Akt, generation of mitochondrial reactive oxygen species (mtROS), eosinophilic allergic inflammation, and airway hyperresponsiveness (AHR) were increased in the lung.", {"entities": [[247, 250, "GENE"]]}], ["Similarly, glucose-regulated protein 78 was increased in lung tissues of patients with ABPA.", {"entities": []}], ["A PI3K-\u03b4 inhibitor reduced Af -induced increases in ER stress markers, UPR-related proteins, allergic inflammation and AHR in mice.", {"entities": [[119, 122, "GENE"]]}], ["However, dexamethasone failed to reduce Af -induced allergic inflammation, AHR and elevation of ER stress.", {"entities": [[75, 78, "GENE"]]}], ["Administration of an ER stress inhibitor or a mtROS scavenger improved Af -induced allergic inflammation.", {"entities": []}], ["The PI3K-\u03b4 inhibitor reduced Af -induced mtROS generation and the mtROS scavenger ameliorated ER stress.", {"entities": []}], ["In primary cultured tracheal epithelial cells, Af -induced ER stress was inhibited by blockade of PI3K-\u03b4.", {"entities": []}], ["These findings suggest that PI3K-\u03b4 regulates Af -induced steroid-resistant eosinophilic allergic lung inflammation through ER stress.", {"entities": []}], ["To investigate the performance of laboratory methods and clinical case definitions in detecting the viral pathogens for acute respiratory infections (ARIs) from a prospective community cohort and hospital inpatients, nasopharyngeal swabs from cohort members reporting ARIs (community-ARI) and inpatients admitted with ARIs (inpatient-ARI) were tested by Singleplex Real Time-Polymerase Chain Reaction (SRT-PCR), multiplex RT-PCR (MRT-PCR) and pathogen-chip system (PathChip) between April 2012 and December 2013.", {"entities": []}], ["Community-ARI and inpatient-ARI was also combined with mild and severe cases of influenza from a historical prospective study as mild-ARI and severe-ARI respectively to evaluate the performance of clinical case definitions.", {"entities": [[80, 89, "DISEASE"]]}], ["We analysed 130 community-ARI and 140 inpatient-ARI episodes (5 inpatient-ARI excluded because multiple pathogens were detected), involving 138 and 207 samples respectively.", {"entities": []}], ["Detection by PCR declined with days post-onset for influenza virus; decrease was faster for community-ARI than for inpatient-ARI.", {"entities": [[51, 60, "DISEASE"]]}], ["No such patterns were observed for non-influenza respiratory virus infections.", {"entities": [[39, 48, "DISEASE"]]}], ["PathChip added substantially to viruses detected for community-ARI only.", {"entities": []}], ["Clinical case definitions discriminated influenza from other mild-ARI but performed poorly for severe-ARI and for older participants.", {"entities": [[40, 49, "DISEASE"]]}], ["Rational strategies for diagnosis and surveillance of influenza and other respiratory virus must acknowledge the differences between ARIs presenting in community and hospital settings.", {"entities": [[54, 63, "DISEASE"]]}], ["Chitosan has been the subject of interest for its use as a polymeric drug carrier material in dosage form design due to its appealing properties such as biocompatibility, biodegradability, low toxicity and relatively low production cost from abundant natural sources.", {"entities": []}], ["However, one drawback of using this natural polysaccharide in modified release dosage forms for oral administration is its fast dissolution rate in the stomach.", {"entities": []}], ["Since chitosan is positively charged at low pH values (below its pK a value), it spontaneously associates with negatively charged polyions in solution to form polyelectrolyte complexes.", {"entities": []}], ["These chitosan based polyelectrolyte complexes exhibit favourable physicochemical properties with preservation of chitosan\u2019s biocompatible characteristics.", {"entities": []}], ["These complexes are therefore good candidate excipient materials for the design of different types of dosage forms.", {"entities": []}], ["It is the aim of this review to describe complexation of chitosan with selected natural and synthetic polyanions and to indicate some of the factors that influence the formation and stability of these polyelectrolyte complexes.", {"entities": []}], ["Furthermore, recent investigations into the use of these complexes as excipients in drug delivery systems such as nano- and microparticles, beads, fibers, sponges and matrix type tablets are briefly described.", {"entities": []}], ["Short sleep confers a higher risk of obesity in humans.", {"entities": [[37, 44, "DISEASE"]]}], ["Restricted sleep increases appetite, promotes higher calorie intake from fat and carbohydrate sources, and induces insulin resistance.", {"entities": []}], ["However, the effects of fragmented sleep (SF), such as occurs in sleep apnea, on body weight, metabolic rates, and adipose tissue distribution are unknown.", {"entities": []}], ["C57BL/6 mice were exposed to SF for 8 weeks.", {"entities": []}], ["Their body weight, food consumption, and metabolic expenditure were monitored over time, and their plasma leptin levels measured after exposure to SF for 1 day as well as for 2 weeks.", {"entities": []}], ["In addition, adipose tissue distribution was assessed at the end of the SF exposure using MRI techniques.", {"entities": []}], ["Chronic SF induced obesogenic behaviors and increased weight gain in mice by promoting increased caloric intake without changing caloric expenditure.", {"entities": []}], ["Plasma leptin levels initially decreased and subsequently increased.", {"entities": []}], ["Furthermore, increases in both visceral and subcutaneous adipose tissue volumes occurred.", {"entities": []}], ["These results suggest that SF, a frequent occurrence in many disorders and more specifically in sleep apnea, is a potent inducer of obesity via activation of obesogenic behaviors and possibly leptin resistance, in the absence of global changes in energy expenditure.", {"entities": [[132, 139, "DISEASE"]]}], ["Human bocavirus (HBoV) was recently discovered in children with respiratory distress and/or diarrhea.", {"entities": [[92, 100, "DISEASE"]]}], ["To our knowledge, no previous study has reported the existence of bocavirus in Saudi Arabia.", {"entities": []}], ["Swabs samples from 80 children with respiratory tract infections were examined for the presence of HBoV.", {"entities": []}], ["Real-time polymerase chain reaction was used as a sensitive method to detect the HBoV.", {"entities": []}], ["Direct gene sequencing was used to determine the genotype of the detected virus isolates.", {"entities": []}], ["HBoV was detected in 22.5% of the examined patients.", {"entities": []}], ["The NP1 partial gene sequence from all patients showed that the circulated strains were related to HBoV-1 genotype.", {"entities": []}], ["Most of HBoV infected patients showed evidence of mixed coinfection with other viral pathogens.", {"entities": []}], ["The current study clearly demonstrated that genetically conserved HBoV1 circulates in Saudi Arabia.", {"entities": []}], ["Interestingly, most of the HBoV1 infected cases were associated with high rates of co-infections with other viruses.", {"entities": []}], ["The present study was carried out to investigate the in vivo antimycobacterial activity of methanol extract of Alstonia scholaris and Mucuna imbricata in murine model.", {"entities": []}], ["Female BALB/c mice were infected with the Mycobacterium tuberculosis H 37 Rv suspension.", {"entities": [[56, 68, "DISEASE"]]}], ["Extracts were administered orally for 2 weeks from 7 The final body weight of mycobacteria-infected group was significantly reduced (15.41 \u00b1 0.42, P < 0.01), but following treatment with the plant extract plus rifampicin could elevate the body weight.", {"entities": []}], ["Colony forming unit (CFU) count of lung (8.71 \u00b1 0.01) and spleen (8.59 \u00b1 0.01) was significantly higher in infected and untreated group ( P < 0.01).", {"entities": []}], ["It was observed that activity of the synergistic group displayed powerful and maximum response against tuberculosis (TB) infection with lower CFU counts.", {"entities": [[103, 115, "DISEASE"]]}], ["Histopathology study showed cells such as lymphocytes, epithelioid, Langhans giant cell, and fibrous tissue proliferation in lungs; depletion of lymphocytes in the spleen.", {"entities": []}], ["The data indicate that methanol extract of A. scholaris has potential antimycobacterial activity, and the synergistic group consisting of rifampicin and A. scholaris could be a rational choice for the treatment of TB.", {"entities": []}], ["Mouse breast regression protein 39 (BRP-39; Chi3l1) and its human homologue YKL-40 are chitinase-like proteins that lack chitinase activity.", {"entities": [[44, 50, "GENE"]]}], ["Although YKL-40 is expressed in exaggerated quantities and correlates with disease activity in asthma and many other disorders, the biological properties of BRP-39/YKL-40 have only been rudimentarily defined.", {"entities": [[95, 101, "DISEASE"]]}], ["We describe the generation and characterization of BRP-39", {"entities": []}], ["There is evidence that lipids can be allosteric regulators of membrane protein structure and activation.", {"entities": []}], ["However, there are no data showing how exactly the regulation emerges from specific lipid-protein interactions.", {"entities": []}], ["Here we show in atomistic detail how the human \u03b2 2 -adrenergic receptor (\u03b2 2 AR) \u2013 a prototypical G protein-coupled receptor \u2013 is modulated by cholesterol in an allosteric fashion.", {"entities": []}], ["Extensive atomistic simulations show that cholesterol regulates \u03b2 2 AR by limiting its conformational variability.", {"entities": []}], ["The mechanism of action is based on the binding of cholesterol at specific high-affinity sites located near the transmembrane helices 5\u20137 of the receptor.", {"entities": []}], ["The alternative mechanism, where the \u03b2 2 AR conformation would be modulated by membrane-mediated interactions, plays only a minor role.", {"entities": []}], ["Cholesterol analogues also bind to cholesterol binding sites and impede the structural flexibility of \u03b2 2 AR, however cholesterol generates the strongest effect.", {"entities": []}], ["The results highlight the capacity of lipids to regulate the conformation of membrane receptors through specific interactions.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.18432.001 Proteins known as G protein-coupled receptors, or GPCRs for short, detect and respond to hormones and other signaling molecules found outside cells.", {"entities": []}], ["A signaling molecule activates a GPCR by binding to it and causing the receptor to change its shape.", {"entities": []}], ["This triggers a cascade of signals inside the cell that leads to the cell responding in a particular way.", {"entities": []}], ["There are over 800 different GPCRs in human cells, making them the largest family of cell surface proteins.", {"entities": []}], ["GPCRs span the membrane that surrounds each cell.", {"entities": []}], ["This membrane is made of molecules called lipids and previous studies have shown that many lipids are able to bind to GPCRs and influence their shape and activity.", {"entities": []}], ["Lipids can cause these changes via so-called \u2018allosteric\u2019 regulation, in which the lipid binds to a site on the receptor that is separate to where the signal molecule binds.", {"entities": []}], ["Lipid binding can either enhance or inhibit the activity of the receptor.", {"entities": []}], ["Human \u03b2 2 -adrenergic receptor is one of the best-studied GPCRs.", {"entities": []}], ["It responds to a hormone called epinephrine (also known as adrenaline), which plays important roles in many organs in the body, including the heart and lungs.", {"entities": []}], ["A lipid called cholesterol, which is plentiful in the cell membrane, can also bind to this receptor and influence its shape, but how this happens was not fully understood.", {"entities": []}], ["Manna et al.", {"entities": []}], ["now use computer simulations to analyze the interaction between cholesterol and \u03b2 2 -adrenergic receptor in more detail.", {"entities": []}], ["The simulations reveal that cholesterol makes the \u03b2 2 -adrenergic receptor less flexible so that it can only adopt certain shapes.", {"entities": []}], ["This helps to stabilize both the inactive and active states of the receptor so that it is not as easy for the receptor to switch between them.", {"entities": []}], ["The cholesterol molecules bind to specific sites on the receptor within the region of the protein that crosses the cell membrane.", {"entities": []}], ["The new findings of Manna et al.", {"entities": []}], ["provide detailed insights into how cholesterol governs the shape and activity of the \u03b2 2 -adrenergic receptor.", {"entities": []}], ["The next step is to extend this analysis to other types of lipids and GPCRs.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.18432.002", {"entities": []}], ["It is well known that there is a social gradient in mental health, the prevalence of mental disorders stepwise increasing by lower social status.", {"entities": []}], ["The reason for this, however, is not clear, and the purpose of the present study was to explore possible mediating factors between social status and mental health.", {"entities": []}], ["The study has a cross-sectional design, and was based on a nationwide survey in Oslo, Norway, counting 12 310 people in the age of 30\u201360 years.", {"entities": []}], ["Immigrants from non-western countries were excluded.", {"entities": []}], ["Socio-demographic data were gathered from existing registers, whereas data on health, psychosocial variables and life style were gathered by structured interview.", {"entities": []}], ["As indicator of mental health was used a 10-items version of Hopkins Symptom Checklist, measuring psychological distress.", {"entities": []}], ["Measures of general self-efficacy and sense of powerlessness was used as indicators of control of own life situation.", {"entities": []}], ["A strong social gradient in mental health was found, the prevalence of psychological distress increasing by decreasing social status.", {"entities": []}], ["Psychosocial factors, including self-efficacy, sense of powerlessness, control of work, social support and negative life events, in particular economic problems, as well as life style factors (physical exercise, BMI, smoking) and somatic health, likewise showed a social gradient, all risk factors increasing by decreasing social status.", {"entities": []}], ["When adjusting for the risk factors in multivariate statistical analyses, the social gradient in mental health was eliminated.", {"entities": []}], ["Low self-efficacy and sense of powerlessness emerged as important explanatory factors, alongside with poor social support, economic problems, smoking and somatic disorder.", {"entities": []}], ["Both individual characteristics, supposedly linked to the personality, like low self-efficacy, and factors related to the actual life situation, like economic problems and a feeling of powerlessness, contribute to the social gradient in mental health, and both aspects should be addressed in preventive work.", {"entities": []}], ["We describe a young adult male presenting with cardiac failure necessitating cardiac transplantation 7 months after presentation.", {"entities": []}], ["Skeletal muscle biopsy showed mosaic immunostaining for dystrophin.", {"entities": []}], ["DNA studies showed somatic mosaicism for a nonsense mutation in the dystrophin gene (Arg2905X).", {"entities": []}], ["The frequency of normal versus mutant genes were determined in blood/DNA (50:50), muscle/DNA (80:20) and muscle/mRNA (90:10).", {"entities": []}], ["These data are consistent with genetic normalization processes that may biochemically rescue skeletal muscle in male somatic mosaic patients mitigating muscle symptoms (gradual loss of dystrophin-negative skeletal muscle tissue replaced by dystrophin-positive stem cells).", {"entities": []}], ["To our knowledge, this is only the second reported case of a clinically ascertained patient showing somatic mosaicism for Duchenne muscular dystrophy (DMD).", {"entities": [[131, 149, "DISEASE"], [151, 154, "GENE"]]}], ["We hypothesize that many somatic mosaic males for DMD exist, yet they are not detected clinically due to genetic normalization.", {"entities": [[50, 53, "GENE"]]}], ["Somatic mosaicism for DMD should be considered in acute heart failure with dilated cardiomyopathy, as genetic normalization in heart is unlikely to occur.", {"entities": [[83, 97, "DISEASE"], [75, 97, "DISEASE"], [22, 25, "GENE"]]}], ["This study investigates the relationships between life events and chronic physical conditions among left behind farmers, a newly emerged weak group in vast rural China.", {"entities": []}], ["The study collected information about life events, chronic physical conditions, blood pressure and fasting blood glucose from 4681 famers living in 18 randomly selected villages (Lu\u2019an, Anhui, China) from early November 2013 to the end of December 2013.", {"entities": []}], ["It compared the risk and odds ratios (RRs/ORs) among different subgroups divided according two life event indices derived by adding up un-weighted-ratings and weighted-ratings based on multivariate logistic regression coefficients respectively.", {"entities": []}], ["A total of 4040 (86.3\u00a0% eligible) farmers completed the survey.", {"entities": []}], ["RRs between farmers with lower than the first 1/15-percentile of life event index and with higher life event index scores ranged 1.43\u20135.79 for chronic gastritis and 0.42\u20139.07 for prostatitis, 1.01\u20134.97 for cervicitis/vaginitis, 1.45\u20133.28 for cardio-cerebrovascular diseases, 1.12\u20131.58 for hypertension, 1.00\u20131.66 for diabetes, 1.07\u20133.35 for pre-diabetes and 5.00\u201355.00 for \u201cother chronic physical conditions\u201d.", {"entities": [[179, 190, "DISEASE"], [289, 301, "DISEASE"], [151, 160, "DISEASE"], [206, 216, "DISEASE"], [217, 226, "DISEASE"]]}], ["Life events were independently linked with most of the chronic physical conditions in a dose-effectiveness way.", {"entities": []}], ["RRs between subgroups divided by given percentile cutoff points of life event index compiled using logistic regression models turned out to be substantially higher than that between subgroups divided by same cutoff points of life event index produced via summing up the un-weighted Likert ratings of all the events studied.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-1877-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Imbalance between antioxidant and oxidative stress is a major risk factor for pathogenesis of some chronic diseases such as chronic obstructive pulmonary disease (COPD).", {"entities": [[124, 161, "DISEASE"]]}], ["This study aimed to determine antioxidant and oxidative stress status, and also theirs association with respiratory function of male COPD patients to find the antioxidant predictors\u2019 factors.", {"entities": []}], ["A total of 149 subjects were involved in a cross-sectional study.", {"entities": []}], ["The study was conducted at two medical centers in Kuala Lumpur, Malaysia.", {"entities": []}], ["Results of the study showed that plasma vitamin C was low in most of the subjects (86.6%).", {"entities": []}], ["Total antioxidant capacity was the lowest in COPD stage IV compare to other stages (p < 0.05).", {"entities": []}], ["Level of plasma vitamin A (p= 0.012) and vitamin C (p= 0.007) were low in malnourished subjects.", {"entities": []}], ["The predictors for total antioxidant capacity were forced vital capacity (FVC) % predicted and intake of \u03b2-carotene (R", {"entities": []}], ["How na\u00efve CD4 H 2) lineage is poorly understood.", {"entities": [[10, 13, "GENE"]]}], ["Here we show that the basic helix-loop-helix transcription factor Dec2 is selectively expressed in T H 2 cells.", {"entities": []}], ["CD4 H 2 differentiation in vitro and in vivo in an asthma model and in response to challenge with a parasite antigen.", {"entities": [[51, 57, "DISEASE"], [0, 3, "GENE"]]}], ["Dec2 promotes interleukin 4 (IL-4), IL-5 and IL-13 expression during early T H 2 differentiation, and directly binds to and activates transcription of the Junb and Gata3 genes.", {"entities": [[155, 159, "GENE"], [164, 169, "GENE"]]}], ["As GATA3 induces Dec2 expression, these findings also indicate a feed-forward regulatory circuit during T H 2 differentiation.", {"entities": [[3, 8, "GENE"]]}], ["The hypothesis is that hemoglobin-based metrics are useful tools for estimating malaria endemicity and for monitoring malaria control strategies.", {"entities": [[80, 87, "DISEASE"], [118, 125, "DISEASE"]]}], ["The aim of this study is to compare population hemoglobin mean and anemia prevalence to established indicators of malaria endemicity, including parasite rates, rates of enlarged spleens in children, and records of (presumptive) malaria diagnosis among populations living with different levels of malaria transmission.", {"entities": [[114, 121, "DISEASE"], [228, 235, "DISEASE"], [296, 303, "DISEASE"], [67, 73, "DISEASE"]]}], ["Convenience sample, multisite cross-sectional household surveys conducted in Papua New Guinea.", {"entities": []}], ["Correlations (r In PNG, where Plasmodium vivax accounts for an important part of all malaria infections, population hemoglobin mean and anemia prevalence correlate well with altitude, parasite, and spleen rates.", {"entities": [[85, 92, "DISEASE"], [136, 142, "DISEASE"]]}], ["Hb measurement is simple and affordable, and may be a useful new tool, alone or in association with other metrics, for estimating malaria endemicity and monitoring effectiveness of malaria control programs.", {"entities": [[130, 137, "DISEASE"], [181, 188, "DISEASE"]]}], ["Further prospective studies in areas with different malaria epidemiology and different factors contributing to the burden of anemia are warranted to investigate the usefulness of Hb metrics in monitoring malaria transmission intensity.", {"entities": [[52, 59, "DISEASE"], [204, 211, "DISEASE"], [125, 131, "DISEASE"]]}], ["Assess the feasibility, safety and efficacy of TACE with irinotecan loaded micro particles (debiri) for the treatment of locally advanced rectal cancer patients.", {"entities": [[145, 151, "DISEASE"]]}], ["We assessed the Edmonton Symptom Assessment System (ESAS).", {"entities": []}], ["The tool is designed to assess nine common symptoms in cancer patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, wellbeing and shortness of breath.", {"entities": [[55, 61, "DISEASE"]]}], ["The ESAS score was 7 in 10/12 (83%) patients before treatment and 6 in 2/12 (16.5%) patients.", {"entities": []}], ["After treatment in 6/12 (50%) patients the score dropped to 3; 3/12 (33%) reported 4, 1/12 (8%) reported 2.", {"entities": []}], ["All patients experienced local control disease with a degree of citoreduction; in 4 cases (33%) we observed outstanding responses with a dramatic reduction in the tumors size which led us to surgical radical resections.", {"entities": []}], ["We run a prospective mono-institutional study where we recruited, 12 non- consecutive patients with histology confirmation of rectal cancer, inoperable and not treatable due to severe comorbidities, or pelvic recurrence/progression after curative treatment, chemotherapy, radiotherapy and/or surgery.", {"entities": [[133, 139, "DISEASE"]]}], ["Their performance status (PS) ECOG was 2-3.", {"entities": []}], ["Twelve patients (10 male and 2 female) with a median age 71 (range 56-89) were recruited in the study.", {"entities": []}], ["The study has met the primary endpoint and showed encouraging activity.", {"entities": []}], ["Debiri could be a possible option for locally advanced/inoperable or recurred rectal cancer patients.", {"entities": [[85, 91, "DISEASE"]]}], ["Further trials are warranted to validate this methodic in early stages.", {"entities": []}], ["To estimate and compare the cost-effectiveness and safety of nebivolol with sustained-release metoprolol in reducing blood pressure by 1 mm of Hg per day in hypertensive patients.", {"entities": []}], ["This was a prospective, randomized, open label, observational analysis of cost-effectiveness, in a questionnaire-based fashion to compare the cost of nebivolol (2.5 mg, 5 mg, 10 mg) and sustained released metoprolol succinate (25 mg, 50 mg, 100 mg) in hypertensive patients using either of the two drugs.", {"entities": []}], ["A total of 60 newly detected drug na\u00efve hypertensive patients were considered for the comparison, of which 30 patients were prescribed nebivolol and the other 30 were prescribed metoprolol succinate as per the recommended dosage.", {"entities": []}], ["Based on the data, statistical analysis was carried out using GraphPad Prism 5 and MS Excel Spreadsheet 2007.", {"entities": []}], ["The cost of reducing 1 mm of Hg blood pressure per day with nebivolol was 0.60, 0.70, and 1.06 INR, whereas that of metoprolol succinate was 0.93, 1.18, and 1.25 INR at their respective equivalent doses, hence significantly lower with the nebivolol group as compared to the metoprolol group ( P < 0.05).", {"entities": []}], ["This pharmacoeconomic analysis shows that nebivolol is more cost-effective as compared to metoprolol when the cost per reduction in blood pressure per day is considered.", {"entities": []}], ["This may affect the patients economically during their long-term use of these molecules for the treatment of hypertension.", {"entities": [[109, 121, "DISEASE"]]}], ["After the SMART trial evaluating the safety of salmeterol (long-acting beta-2-agonist (LABA)) in asthma patients, regulatory actions were taken to promote a guideline-adherent prescribing of LABA only to patients receiving inhaled corticosteroids (ICS).", {"entities": [[97, 103, "DISEASE"]]}], ["We aim to analyse LABA- and ICS-related prescription patterns after the SMART trial in Germany.", {"entities": []}], ["Patients documented in the Bavarian Association of Statutory Health Insurance Physicians database (approximately 10.5 million people) were included if they had a diagnosis of asthma and at least one prescription of LABA and/or ICS between 2004 and 2008.", {"entities": [[175, 181, "DISEASE"]]}], ["Annual period prevalence rates (PPRs) were estimated and Cochrane Armitage tests were used for time trend analyses.", {"entities": []}], ["Highest annual PPRs were found for budesonide and the fixed combination of salmeterol/fluticasone.", {"entities": []}], ["The proportion of \u201cconcomitant LABA and ICS users\u201d increased from 52.0 to 57.6% within the study period, whereas for \u201cLABA users without ICS\u201d a slight decrease from 6.5 to 5.4% was found.", {"entities": []}], ["In 2008, the proportion of patients with at least one quarter with a LABA prescription without concomitant ICS was highest in elderly, male patients (\u224820%).", {"entities": []}], ["In the majority of these patients, a concomitant diagnosis of COPD (i.e.", {"entities": []}], ["asthma-COPD overlap syndrome [ACOS]) was present.", {"entities": [[20, 28, "DISEASE"], [0, 6, "DISEASE"]]}], ["Between 2004 and 2008, we found a moderate increase in guideline-adherent LABA prescribing in a representative German population.", {"entities": []}], ["Elderly men received a significant number of LABA prescriptions without concomitant ICS probably due to ACOS.", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-015-0051-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Toll-like receptors (TLRs) are part of the innate immune system, able to recognize pathogen-associated molecular patterns and activate immune system upon pathogen challenge.", {"entities": []}], ["Respiratory syncytial virus (RSV) is a RNA virus particularly detrimental in infancy.", {"entities": []}], ["It could cause severe lower respiratory tract disease and recurrent infections related to inadequate development of anti-viral immunity.", {"entities": [[22, 53, "DISEASE"]]}], ["The reason could be inadequate multiple TLRs engagement, including TLR8 in recognition of single-stranded viral RNA and diminished synthesis of inflammatory mediators due to a lower expression.", {"entities": [[67, 71, "GENE"]]}], ["Intracellular TLR8 expression in peripheral blood monocytes from RSV-infected infants was profiled and compared to healthy adults and age matched controls.", {"entities": [[14, 18, "GENE"]]}], ["Whether the observed difference in TLR8 expression is a transitory effect, infants in convalescent phase (4-6 weeks later) were retested.", {"entities": [[35, 39, "GENE"]]}], ["Specific TLR8-mediated TNF-\u03b1 production in monocytes during an acute and convalescent phase was analyzed.", {"entities": []}], ["RSV-infected and healthy infants had lower percentage of TLR8-expressing monocytes than healthy adults whereas decreased of TLR8 protein levels were detected only for RSV-infected infant group.", {"entities": [[57, 61, "GENE"], [124, 128, "GENE"]]}], ["Lower protein levels of TLR8 in monocytes from RSV-infected infants, compared to healthy infants, negatively correlated with respiratory frequency and resulted in lower TNF-\u03b1 synthesis upon a specific TLR8 stimulation.", {"entities": [[24, 28, "GENE"], [201, 205, "GENE"], [24, 28, "GENE"], [201, 205, "GENE"]]}], ["In the convalescent phase, levels of TLR8 increased, accompanied by increased TNF-\u03b1 synthesis compared to acute infection.", {"entities": [[37, 41, "GENE"]]}], ["Lower TLR8 expression observed in monocytes, during an acute RSV infection, might have a dampening impact on early anti-viral cytokine production necessary to control RSV replication, and subsequently initiate an adaptive Th1 type immune response leading to severe disease in infected infants.", {"entities": [[6, 10, "GENE"]]}], ["Eosinophilic chronic frontal sinusitis is difficult to treat compared with non-eosinophilic sinusitis because of recurring inflammation and polyp formation in the frontal recess after the post-operative follow-up period.", {"entities": [[29, 38, "DISEASE"], [92, 101, "DISEASE"], [21, 38, "DISEASE"], [13, 38, "DISEASE"]]}], ["Studying inflammatory mediators in the frontal recess of eosinophilic chronic rhinosinusitis (ECRS) patients and non-eosinophilic chronic rhinosinusitis (non-ECRS) patients may lead to a better understanding of the pathogenesis of chronic frontal sinusitis.", {"entities": [[247, 256, "DISEASE"], [239, 256, "DISEASE"], [231, 256, "DISEASE"]]}], ["Homogenates of sinonasal mucosa from 20 non-ECRS patients and 36 ECRS patients were measured for levels of transforming growth factor (TGF)-\u03b2, interleukin (IL)-5, IL-6, and inducible nitric oxide synthase (iNOS) using real-time RT-PCR and TaqMan gene expression assays.", {"entities": []}], ["Sinonasal mucosal specimens were obtained from the frontal recess, ethmoid sinus, and nasal polyp separately.", {"entities": []}], ["The expression of IL-5 was significantly elevated in all sinonasal regions tested in the ECRS group, but absent in non-ECRS patients.", {"entities": []}], ["Furthermore, the ECRS patients showed significantly increased levels of IL-5 in the frontal recess mucosa compared with ethmoid sinus mucosa.", {"entities": []}], ["IL-6 was also significantly increased in the frontal recess mucosa compared with ethmoid sinus mucosa and nasal polyps in these patients.", {"entities": []}], ["There were no significant differences in the levels of TGF-\u03b2 or iNOS between the ECRS and non-ECRS groups in any sinonasal region tested.", {"entities": []}], ["This study is the first to characterize the cytokine milieu in the frontal recess of ECRS patients.", {"entities": []}], ["We should keep these cytokine profiles in mind when we treat ECRS patients with frontal sinusitis.", {"entities": [[88, 97, "DISEASE"], [80, 97, "DISEASE"]]}], ["This study is to identify, summarise and synthesise literature on the causes of the evidence to practice gap for complex interventions in primary care.", {"entities": []}], ["This study is a systematic review of reviews.", {"entities": []}], ["MEDLINE, EMBASE, CINAHL, Cochrane Library and PsychINFO were searched, from inception to December 2013.", {"entities": []}], ["Eligible reviews addressed causes of the evidence to practice gap in primary care in developed countries.", {"entities": []}], ["Data from included reviews were extracted and synthesised using guidelines for meta-synthesis.", {"entities": []}], ["Seventy reviews fulfilled the inclusion criteria and encompassed a wide range of topics, e.g.", {"entities": []}], ["guideline implementation, integration of new roles, technology implementation, public health and preventative medicine.", {"entities": []}], ["None of the included papers used the term \u201ccause\u201d or stated an intention to investigate causes at all.", {"entities": []}], ["A descriptive approach was often used, and the included papers expressed \u201ccauses\u201d in terms of \u201cbarriers and facilitators\u201d to implementation.", {"entities": []}], ["We developed a four-level framework covering external context, organisation, professionals and intervention.", {"entities": []}], ["External contextual factors included policies, incentivisation structures, dominant paradigms, stakeholders\u2019 buy-in, infrastructure and advances in technology.", {"entities": []}], ["Organisation-related factors included culture, available resources, integration with existing processes, relationships, skill mix and staff involvement.", {"entities": []}], ["At the level of individual professionals, professional role, underlying philosophy of care and competencies were important.", {"entities": []}], ["Characteristics of the intervention that impacted on implementation included evidence of benefit, ease of use and adaptability to local circumstances.", {"entities": []}], ["We postulate that the \u201cfit\u201d between the intervention and the context is critical in determining the success of implementation.", {"entities": []}], ["This comprehensive review of reviews summarises current knowledge on the barriers and facilitators to implementation of diverse complex interventions in primary care.", {"entities": []}], ["To maximise the uptake of complex interventions in primary care, health care professionals and commissioning organisations should consider the range of contextual factors, remaining aware of the dynamic nature of context.", {"entities": []}], ["Future studies should place an emphasis on describing context and articulating the relationships between the factors identified here.", {"entities": []}], ["PROSPERO CRD42014009410 The online version of this article (doi:10.1186/s13012-016-0396-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Dynamic gas compression during forced expiration has an influence on conventional flow-volume spirometry results.", {"entities": []}], ["The extent of gas compression in different pulmonary disorders remains obscure.", {"entities": []}], ["Utilizing a flow plethysmograph we determined the difference between thoracic and mouth flows during forced expiration as an indication of thoracic gas compression in subjects with different pulmonary diseases characterized by limitations in pulmonary mechanics.", {"entities": []}], ["Patients with emphysema (N = 16), interstitial lung disease (ILD) (N = 15), obesity (N = 15) and healthy controls (N = 16) were included.", {"entities": [[76, 83, "DISEASE"], [34, 59, "DISEASE"], [47, 59, "DISEASE"]]}], ["Compressed expiratory flow-volume curves (at mouth) and corresponding compression-free curves (thoracic) were recorded.", {"entities": []}], ["Peak flow (PEF) and maximal flows at 75%, 50% and 25% of remaining forced vital capacity (MEF75, MEF50 and MEF25) were derived from both recordings.", {"entities": []}], ["Their respective difference was assessed as an indicator of gas compression.", {"entities": []}], ["In all groups, significant differences between thoracic and mouth flows were found at MEF50 (p < 0.01).", {"entities": []}], ["In controls, a significant difference was also measured at MEF75 (p <0.005), in emphysema subjects, at PEF and MEF75 (p < 0.05, p < 0.005) and in obese subjects at MEF75 (p <0.005) and MEF25 (p < 0.01).", {"entities": []}], ["ILD patients showed the lowest difference between thoracic and mouth flows at MEF75 relative to controls and emphysema patients (p < 0.005, p < 0.001).", {"entities": []}], ["Obese subjects did not differ from controls, however, the difference between thoracic and mouth flows was significantly higher than in patients with emphysema at MEF50 (p < 0.001) and MEF25 (p < 0.005).", {"entities": []}], ["Alveolar gas compression distorts the forced expiratory flow volume curve in all studied groups at the middle fraction of forced expiratory flow.", {"entities": []}], ["Consequently, mouth flows are underestimated and the reduction of flow measured at 75% and 50% of vital capacity is often considerable.", {"entities": []}], ["However, gas compression profiles in stiff lungs, in patients with decreased elastic recoil in emphysema and in obesity differ; the difference between thoracic and mouth flows in forced expiration was minimal in ILD at the first part of forced expiration and was higher in obesity than in emphysema at the middle and last parts of forced expiration.", {"entities": [[112, 119, "DISEASE"], [273, 280, "DISEASE"]]}], ["Although tumor-associated macrophages (TAMs) are involved in tumor growth and metastasis, the mechanisms controlling their pro-tumoral activities remain largely unknown.", {"entities": []}], ["The transcription factor c-MYC has been recently shown to regulate in vitro human macrophage polarization and be expressed in macrophages infiltrating human tumors.", {"entities": []}], ["In this study, we exploited the predominant expression of LysM in myeloid cells to generate c-Myc mice, which lack c-Myc in macrophages, to investigate the role of macrophage c-MYC expression in cancer.", {"entities": [[195, 201, "DISEASE"]]}], ["Under steady-state conditions, immune system parameters in c-Myc mice appeared normal, including the abundance of different subsets of bone marrow hematopoietic stem cells, precursors and circulating cells, macrophage density, and immune organ structure.", {"entities": []}], ["In a model of melanoma, however, TAMs lacking c-Myc displayed a delay in maturation and showed an attenuation of pro-tumoral functions (e.g., reduced expression of VEGF, MMP9, and HIF1\u03b1) that was associated with impaired tissue remodeling and angiogenesis and limited tumor growth in c-Myc mice.", {"entities": [[14, 22, "DISEASE"], [170, 174, "GENE"]]}], ["Macrophage c-Myc deletion also diminished fibrosarcoma growth.", {"entities": [[42, 54, "DISEASE"]]}], ["These data identify c-Myc as a positive regulator of the pro-tumoral program of TAMs and suggest c-Myc inactivation as an attractive target for anti-cancer therapy.", {"entities": [[149, 155, "DISEASE"]]}], ["This status report overviews activities of the German gas sensor research community.", {"entities": []}], ["It highlights recent progress in the field of potentiometric, amperometric, conductometric, impedimetric, and field effect-based gas sensors.", {"entities": []}], ["It is shown that besides step-by-step improvements of conventional principles, e.g.", {"entities": []}], ["by the application of novel materials, novel principles turned out to enable new markets.", {"entities": []}], ["In the field of mixed potential gas sensors, novel materials allow for selective detection of combustion exhaust components.", {"entities": []}], ["The same goal can be reached by using zeolites for impedimetric gas sensors.", {"entities": []}], ["Operando spectroscopy is a powerful tool to learn about the mechanisms in n-type and in p-type conductometric sensors and to design knowledge-based improved sensor devices.", {"entities": []}], ["Novel deposition methods are applied to gain direct access to the material morphology as well as to obtain dense thick metal oxide films without high temperature steps.", {"entities": []}], ["Since conductometric and impedimetric sensors have the disadvantage that a current has to pass the gas sensitive film, film morphology, electrode materials, and geometrical issues affect the sensor signal.", {"entities": []}], ["Therefore, one tries to measure directly the Fermi level position either by measuring the gas-dependent Seebeck coefficient at high temperatures or at room temperature by applying a modified miniaturized Kelvin probe method, where surface adsorption-based work function changes drive the drain-source current of a field effect transistor.", {"entities": []}], ["Fibrocytes are bone marrow\u2010derived mesenchymal progenitors that have been linked to various fibrotic disorders.", {"entities": []}], ["This study was undertaken to investigate whether fibrocytes are increased in diffuse myocardial fibrosis in humans.", {"entities": []}], ["Thirty\u2010seven patients with hypertrophic cardiomyopathy (HCM) and 20 healthy controls were recruited.", {"entities": [[40, 54, "DISEASE"], [27, 54, "DISEASE"]]}], ["Cardiac magnetic resonance imaging with postcontrast T 1 mapping was performed to non\u2010invasively quantify diffuse myocardial fibrosis and these patients were classified into 2 groups (T 1 <470 ms or T 1 \u2265470 ms, as likely or unlikely to have diffuse fibrosis, respectively).", {"entities": []}], ["Circulating fibrocytes (CD45+/CD34+/collagen I+) were measured by flow cytometry.", {"entities": []}], ["Peripheral blood mononuclear cells (PBMCs) were cultured for 13 days and fibrocytes were quantitated by flow cytometry (CD45+/collagen I+) and real\u2010time PCR (gene expression of matrix proteins).", {"entities": []}], ["Plasma cytokines/chemokines mediating fibrocyte trafficking and differentiation were measured by multiplex assays.", {"entities": []}], ["Circulating fibrocytes were decreased in HCM patients compared to controls.", {"entities": []}], ["The proportion of fibrocytes derived from PBMCs was increased in patients with diffuse fibrosis compared with those without or controls (31.1\u00b14.1% versus 18.9\u00b13.9% and 10.9\u00b12.0%, P <0.05 and P <0.001, respectively), and the proportion of fibrocytes was inversely correlated with T 1 time ( r =\u22120.37, P =0.03).", {"entities": []}], ["Plasma levels of stromal cell\u2010derived factor\u20101 were elevated in patients with diffuse fibrosis compared with those without or controls (5131\u00b1271 pg/mL versus 3893\u00b1356 pg/mL and 4172\u00b1185 pg/mL, respectively, both P <0.05).", {"entities": []}], ["HCM patients with diffuse fibrosis as assessed by postcontrast T 1 mapping have elevated plasma SDF and an enhanced ability of PBMCs to differentiate into fibrocytes, suggesting that fibrocytes may contribute to the pathogenesis of myocardial fibrosis.", {"entities": []}], ["Health information technology (HIT) systems have the potential to reduce delayed, missed or incorrect diagnoses.", {"entities": []}], ["We describe and classify the current state of diagnostic HIT and identify future research directions.", {"entities": []}], ["A multi-pronged literature search was conducted using PubMed, Web of Science, backwards and forwards reference searches and contributions from domain experts.", {"entities": []}], ["We included HIT systems evaluated in clinical and experimental settings as well as previous reviews, and excluded radiology computer-aided diagnosis, monitor alerts and alarms, and studies focused on disease staging and prognosis.", {"entities": []}], ["Articles were organised within a conceptual framework of the diagnostic process and areas requiring further investigation were identified.", {"entities": []}], ["HIT approaches, tools and algorithms were identified and organised into 10 categories related to those assisting: (1) information gathering; (2) information organisation and display; (3) differential diagnosis generation; (4) weighing of diagnoses; (5) generation of diagnostic plan; (6) access to diagnostic reference information; (7) facilitating follow-up; (8) screening for early detection in asymptomatic patients; (9) collaborative diagnosis; and (10) facilitating diagnostic feedback to clinicians.", {"entities": []}], ["We found many studies characterising potential interventions, but relatively few evaluating the interventions in actual clinical settings and even fewer demonstrating clinical impact.", {"entities": []}], ["Diagnostic HIT research is still in its early stages with few demonstrations of measurable clinical impact.", {"entities": []}], ["Future efforts need to focus on: (1) improving methods and criteria for measurement of the diagnostic process using electronic data; (2) better usability and interfaces in electronic health records; (3) more meaningful incorporation of evidence-based diagnostic protocols within clinical workflows; and (4) systematic feedback of diagnostic performance.", {"entities": []}], ["The present study investigated whether erythromycin (ERY) reduces cigarette smoke (CS)-induced emphysema in rats and aimed to determine the anti-inflammatory effect of ERY, which may identify potential treatments for chronic obstructive pulmonary disease.", {"entities": [[217, 254, "DISEASE"], [83, 85, "GENE"]]}], ["Furthermore, the current study focused on the potential effects on the imbalance between matrix metalloprotease (MMP) and anti-MMP activity, the phosphorylation of mitogen-activated protein kinases (MAPKs) and the nuclear factor-\u03baB (NF-\u03baB) signaling pathway.", {"entities": []}], ["Wistar rats were divided into the following three groups (n=12 each): control (ERY vehicle only, without any CS exposure), CS (animals were exposed to CS for 12 weeks) and CS + ERY (animals were exposed to CS for 12 weeks and received 100 mg/kg/day ERY).", {"entities": [[109, 111, "GENE"], [123, 125, "GENE"], [151, 153, "GENE"], [172, 174, "GENE"], [206, 208, "GENE"], [109, 111, "GENE"], [123, 125, "GENE"], [151, 153, "GENE"], [172, 174, "GENE"], [206, 208, "GENE"], [109, 111, "GENE"], [123, 125, "GENE"], [151, 153, "GENE"], [172, 174, "GENE"], [206, 208, "GENE"], [109, 111, "GENE"], [123, 125, "GENE"], [151, 153, "GENE"], [172, 174, "GENE"], [206, 208, "GENE"], [109, 111, "GENE"], [123, 125, "GENE"], [151, 153, "GENE"], [172, 174, "GENE"], [206, 208, "GENE"]]}], ["The recruitment of inflammatory cells into the bronchoalveolar lavage fluid (BALF) and the histopathology of lung tissue from all groups was evaluated to grade the severity of the emphysema.", {"entities": []}], ["The expression of MMP-2, MMP-9 and tissue inhibitor of metalloproteinase-1 was evaluated by immunohistochemistry and western blotting.", {"entities": []}], ["The activation of MAPKs, NF-\u03baB and inhibitor of NF-\u03baB (I\u03baB\u03b1), in lung tissues was examined by western blotting.", {"entities": []}], ["Treatment with ERY resulted in fewer inflammatory cells and cytokines in the BALF, and fewer emphysema-associated changes in the lungs compared with control.", {"entities": []}], ["The stimulus of CS promoted the phosphorylation of extracellular signal-regulated kinase (ERK)1/2 and p38, but not c-Jun NH2-terminal kinase, thereby inducing the activation of the ERK/MAPK signaling pathway in rats.", {"entities": [[16, 18, "GENE"]]}], ["Furthermore, CS exposure increased the expression of NF-\u03baB and decreased the expression of I\u03baB\u03b1.", {"entities": [[13, 15, "GENE"]]}], ["The levels of phosphorylated ERK1/2 and p38 were significantly reduced in rats with CS-induced emphysema when treated with ERY compared with the CS group.", {"entities": [[84, 86, "GENE"], [145, 147, "GENE"]]}], ["The results of the present study therefore indicate that oral administration of ERY may suppress CS-induced emphysema by regulating inflammatory cytokines and the MMP/anti-MMP imbalance via the MAPK/NF-\u03baB pathway.", {"entities": []}], ["Medicare beneficiaries who have chronic conditions are responsible for a disproportionate share of Medicare fee-for-service expenditures.", {"entities": []}], ["The objective of this study was to analyze the change in the health of Medicare beneficiaries enrolled in Part A (hospital insurance) between 2008 and 2010 by comparing the prevalence of 11 chronic conditions.", {"entities": []}], ["We conducted descriptive analyses using the 2008 and 2010 Chronic Conditions Public Use Files, which are newly available from the Centers for Medicare and Medicaid Services and have administrative (claims) data on 100% of the Medicare fee-for-service population.", {"entities": []}], ["We examined the data by age, sex, and dual eligibility (eligibility for both Medicare and Medicaid).", {"entities": []}], ["Medicare Part A beneficiaries had more chronic conditions on average in 2010 than in 2008.", {"entities": []}], ["The percentage increase in the average number of chronic conditions was larger for dual-eligible beneficiaries (2.8%) than for nondual-eligible beneficiaries (1.2%).", {"entities": []}], ["The prevalence of some chronic conditions, such as congestive heart failure, ischemic heart disease, and stroke/transient ischemic attack, decreased.", {"entities": [[51, 75, "DISEASE"], [77, 99, "DISEASE"], [86, 99, "DISEASE"]]}], ["The deterioration of average health was due to other chronic conditions: chronic kidney disease, depression, diabetes, osteoporosis, rheumatoid arthritis/osteoarthritis.", {"entities": [[81, 95, "DISEASE"], [133, 153, "DISEASE"], [119, 131, "DISEASE"], [144, 153, "DISEASE"], [154, 168, "DISEASE"]]}], ["Trends in Alzheimer\u2019s disease, cancer, and chronic obstructive pulmonary disease showed differences by sex or dual eligibility or both.", {"entities": [[43, 80, "DISEASE"], [31, 37, "DISEASE"]]}], ["Analyzing the prevalence of 11 chronic conditions by using Medicare claims data provides a monitoring tool that can guide health care providers and policy makers in devising strategies to address chronic conditions and rising health care costs.", {"entities": []}], ["Pain control is a factor in the sideline treatment of competitive athletes.", {"entities": []}], ["Ketorolac injections by team physicians as a pain control measure are seemingly becoming more mainstream, although there have been very little data published on its use.", {"entities": []}], ["Intramuscular ketorolac injections are being used regularly by orthopaedic surgeons and primary care sports medicine physicians in their care of athletes.", {"entities": []}], ["Descriptive epidemiology study.", {"entities": []}], ["A 19-question survey was generated online for physician members of the American Orthopaedic Society for Sports Medicine, the Arthroscopy Association of North America, and the American Medical Society for Sports Medicine.", {"entities": []}], ["The survey link was e-mailed, with reminders sent every 1 to 2 weeks, and results were collected from April to June 2011.", {"entities": []}], ["The survey was e-mailed to 6950 physicians, with 1100 respondents completing it (60% orthopaedic surgeons, 40% nonsurgical sports medicine physicians).", {"entities": []}], ["Approximately 49% use intramuscular ketorolac in the treatment of athletes, primarily at the collegiate and professional levels; 95.8% reported effective pain control after administration; 2.9% reported bleeding complications; and 1.9% reported kidney complications from its use.", {"entities": []}], ["Intramuscular ketorolac injections are used by approximately half of all team physicians in their sideline treatment of competitive athletes.", {"entities": []}], ["To be honest, I thought this would be a lost cause.", {"entities": []}], ["Even after skipping a New Drugs and Devices essay in 2012, I figured that I would have to search long and hard to find 10 new things that emergency practitioners needed to know about.", {"entities": []}], ["Although there were no true blockbuster medications for emergency physicians, I nonetheless found 10 medicines that we probably should know, along with a new device that may change the way we work up patients with palpitations, and a clever new delivery system for subcutaneous epinephrine.", {"entities": []}], ["Painful peripheral electrical stimulation to acupuncture points was found to cause sensitization if delivered randomly (EStim), but induced habituation if triggered by voluntary breathing (BreEStim).", {"entities": []}], ["The objective was to systematically compare the effectiveness of BreEStim and EStim and to investigate the possible mechanisms mediating the habituation effect of BreEStim.", {"entities": []}], ["Eleven pain-free, healthy subjects (6 males, 5 females) participated in the study.", {"entities": []}], ["Each subject received the BreEStim and EStim treatments in a random order at least three days apart.", {"entities": []}], ["Both treatments consisted of 120 painful but tolerable stimuli to the ulnar nerve at the elbow on the dominant arm.", {"entities": []}], ["BreEStim was triggered by voluntary breathing while EStim was delivered randomly.", {"entities": []}], ["Electrical sensation threshold (EST) and electrical pain threshold (EPT) were measured from the thenar and hypothenar eminences on both hands at pre-intervention and 10-minutes post-intervention.", {"entities": []}], ["There was no difference in the pre-intervention baseline measurement of EST and EPT between BreEStim and EStim.", {"entities": []}], ["BreEStim increased EPT in all tested sites on both hands, while EStim increased EPT in the dominant hypothenar eminence distal to the stimulating site and had no effect on EPT in other sites.", {"entities": []}], ["There was no difference in the intensity of electrical stimulation between EStim and BreEStim.", {"entities": []}], ["Our findings support the important role human voluntary breathing plays in the systemic habituation effect of BreEStim to peripheral painful electrical stimulation.", {"entities": []}], ["The implementation of health technology is a national priority in the United States and widely discussed in the literature.", {"entities": []}], ["However, literature about the use of this technology by historically underserved populations is limited.", {"entities": []}], ["Information on culturally informed health and wellness technology and the use of these technologies to reduce health disparities facing historically underserved populations in the United States is sparse in the literature.", {"entities": []}], ["To examine ways in which technology is being used by historically underserved populations to decrease health disparities through facilitating or improving health care access and health and wellness outcomes.", {"entities": []}], ["We conducted a systematic review in four library databases (PubMed, PsycINFO, Web of Science, and Engineering Village) to investigate the use of technology by historically underserved populations.", {"entities": []}], ["Search strings consisted of three topics (eg, technology, historically underserved populations, and health).", {"entities": []}], ["A total of 424 search phrases applied in the four databases returned 16,108 papers.", {"entities": []}], ["After review, 125 papers met the selection criteria.", {"entities": []}], ["Within the selected papers, 30 types of technology, 19 historically underserved groups, and 23 health issues were discussed.", {"entities": []}], ["Further, almost half of the papers (62 papers) examined the use of technology to create effective and culturally informed interventions or educational tools.", {"entities": []}], ["Finally, 12 evaluation techniques were used to assess the technology.", {"entities": []}], ["While the reviewed studies show how technology can be used to positively affect the health of historically underserved populations, the technology must be tailored toward the intended population, as personally relevant and contextually situated health technology is more likely than broader technology to create behavior changes.", {"entities": []}], ["Social media, cell phones, and videotapes are types of technology that should be used more often in the future.", {"entities": []}], ["Further, culturally informed health information technology should be used more for chronic diseases and disease management, as it is an innovative way to provide holistic care and reminders to otherwise underserved populations.", {"entities": []}], ["Additionally, design processes should be stated regularly so that best practices can be created.", {"entities": []}], ["Finally, the evaluation process should be standardized to create a benchmark for culturally informed health information technology.", {"entities": []}], ["Poor adherence to therapy and the failure of current smoking cessation programs demonstrate that the current management of COPD can be improved, and it is necessary to educate physicians about new approaches for taking care of patients.", {"entities": []}], ["Parallel chart is a narrative medicine tool that improves the doctor\u2013patient relationship by asking physicians to write about their patients\u2019 lives, thereby encouraging reflective thoughts on care.", {"entities": []}], ["Between October 2015 and March 2016, 50 Italian pulmonologists were involved in the collection of parallel charts of anonymous patients with COPD.", {"entities": []}], ["The narratives were analyzed according to the Grounded Theory methodology.", {"entities": []}], ["In the 243 parallel charts collected, the patients (mean age 69 years, 68% men) are described as still active and as a resource for their families (71%).", {"entities": []}], ["The doctor\u2013patient relationship started as difficult in 50% of cases, and younger age and smoking were the main risk factors.", {"entities": []}], ["The conversations turned positive in 78% of narratives, displaying deeper mutual knowledge, trust for the clinicians\u2019 ability to establish effective therapy (92%), support efforts to quit smoking (63%), or restore patients\u2019 activities (78%).", {"entities": []}], ["All the physicians concurred that the adoption of innovative parallel charts was useful for improving clinical care and worthy of official inclusion in protocols for the management of COPD.", {"entities": []}], ["Please see Additional file Currently, in Brazil, there is a co-circulation of the four dengue (DENV-1 to DENV-4) serotypes.", {"entities": []}], ["This study aimed to assess whether different serotypes and antibody response patterns were associated with the severity of the disease during a dengue outbreak, which occurred in 2012/2013 in centre of Brazil.", {"entities": []}], ["We conducted a prospective study with 452 patients with laboratory confirmed dengue in central Brazil, from January 2012 to July 2013.", {"entities": []}], ["The clinical outcome was the severity of cases: dengue, dengue with warning signs, and severe dengue.", {"entities": []}], ["The patients were evaluated at three different moments.", {"entities": []}], ["Blood sampling for laboratory testing and confirmatory tests for dengue infection were performed.", {"entities": []}], ["We performed a multinomial analysis considering the three categories of the dependent variable, as outlined above.", {"entities": []}], ["The odds ratios ( OR s) were calculated.", {"entities": []}], ["A multinomial logistic regression model was applied for variables with a P -value <0.20.", {"entities": []}], ["Statistical analysis was performed with STATA 12.0 software.", {"entities": []}], ["Four hundred fifty-two patients (452/632, 71.5%) were diagnosed with dengue.", {"entities": []}], ["The dengue virus (DENV) serotypes were identified in 243 cases.", {"entities": []}], ["DENV-4 was detected in 135 patients (55.6%), DENV-1 in 91 (37.4%), DENV-3 in 13 (5.3%), and DENV-2 in 4 (1.6%).", {"entities": []}], ["Patients with the DENV-1 serotype were more prone to present with several clinical and laboratory features as compared with DENV-4 patients, including spontaneous bleeding ( P \u00a0=\u00a00.03), intense abdominal pain ( P \u00a0=\u00a00.004), neurological symptoms ( P \u00a0=\u00a00.09), and thrombocytopenia ( P \u00a0=\u00a00.01).", {"entities": [[264, 280, "DISEASE"]]}], ["Secondary infection was more predominant among DENV-4 cases (80.0%) compared with DENV-1 cases (62.3%) ( P \u00a0=\u00a00.03).", {"entities": []}], ["The univariate analysis showed that females ( OR \u00a0=\u00a02.12; 95% CI : 1.44\u20133.13; P \u00a0<\u00a00.01) had a higher risk of having dengue with warning signs.", {"entities": []}], ["The multinomial analysis showed that severe dengue cases with secondary infection had an adjusted OR of 2.80 (95% CI : 0.78\u201310.00; P \u00a0=\u00a00.113) as compared with dengue fever with primary infection when adjusted for age and sex.", {"entities": []}], ["The current data show that 5.8% of patients recruited for treatment in healthcare centres and hospitals during the study period had severe dengue.", {"entities": []}], ["DENV-4 was the predominant serotype, followed by DENV-1, in a large outbreak of dengue in central Brazil.", {"entities": []}], ["Our findings contribute to the understanding of clinical differences and immune status related to the serotypes DENV-1 and DENV-4 in central of Brazil.", {"entities": []}], ["The online version of this article (doi:10.1186/s40249-017-0328-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Bisphenol A (BPA) is used in numerous products, such as plastic bottles and food containers, from which it frequently leaches out and is consumed by humans.", {"entities": []}], ["There is a growing public concern that BPA exposure may pose a significant threat to human health.", {"entities": []}], ["Moreover, due to the widespread and constant nature of BPA exposure, not only adults but fetuses and neonates are also exposed to BPA.", {"entities": []}], ["There is mounting evidence that developmental exposures to chemicals from our environment, including BPA, contribute to diseases late in life; yet, studies of how early life exposures specifically alter the immune system are limited.", {"entities": []}], ["Herein we report an examination of how maternal exposure to a low, environmentally relevant dose of BPA affects the immune response to infection with influenza A virus.", {"entities": [[150, 159, "DISEASE"]]}], ["We exposed female mice during pregnancy and through lactation to the oral reference dose for BPA listed by the US Environmental Protection Agency, and comprehensively examined immune parameters directly linked to disease outcomes in adult offspring following infection with influenza A virus.", {"entities": [[274, 283, "DISEASE"]]}], ["We found that developmental exposure to BPA did not compromise disease-specific adaptive immunity against virus infection, or reduce the host\u2019s ability to clear the virus from the infected lung.", {"entities": []}], ["However, maternal exposure to BPA transiently reduced the extent of infection-associated pulmonary inflammation and anti-viral gene expression in lung tissue.", {"entities": []}], ["From these observations, we conclude that maternal exposure to BPA slightly modulates innate immunity in adult offspring, but does not impair the anti-viral adaptive immune response, which is critical for virus clearance and survival following influenza virus infection.", {"entities": [[244, 253, "DISEASE"]]}], ["Aspergillosis infection is common in the patients with insufficient immunity.", {"entities": [[0, 13, "DISEASE"]]}], ["The role of mammalian target of rapamycin (mTOR), T-box expressed in T-cells (T-bet), and eomesodermin (EOMES) in mediating T lymphocytes differentiation in response to Aspergillus fumigatus infection in immunocompromised rats was investigated in this study.", {"entities": [[43, 47, "GENE"], [104, 109, "GENE"]]}], ["Invasive pulmonary aspergillosis (IPA) of immunosuppressive twenty male rats were established and sacrificed at 24 h ( n = 5), 48 h ( n = 5), 72 h ( n = 5), and 96 h ( n = 5) after A. fumigatus infection.", {"entities": [[19, 32, "DISEASE"]]}], ["In addition, control ( n = 5), cyclophosphamide (CTX) ( n = 5), and aspergillosis ( n = 5) group were also established the tissues and pathology of lung tissue was examined by hematoxylin and eosin staining.", {"entities": [[68, 81, "DISEASE"]]}], ["CD8 Histology of lung tissue indicated severe lung tissue injury including infiltration of inflammatory cells, alveolar wall damage or degradation, blood congestion, and hemorrhage in the CTX, IPA, and CTX + IPA rats.", {"entities": []}], ["Hyphae were seen in the IPA, and CTX + IPA groups.", {"entities": []}], ["The proportion of CD8 P < 0.001), but decreased in the late phase of fungal infection (72 h and 96 h) in the animals of CTX + IPA.", {"entities": []}], ["In addition, at early stage of fungal infection (24 h and 48 h), serum mTOR ( P < 0.001), S6K ( P < 0.001), and T-bet ( P < 0.05) was significantly higher, while EOMES was significantly lower ( P < 0.001), in CTX + IPA group than that in control, CTX alone or IPA alone group.", {"entities": [[71, 75, "GENE"], [162, 167, "GENE"]]}], ["Conversely, serum mTOR, S6K, T-bet, and EOMES showed opposite changed in the late stage (72 h and 96 h).", {"entities": [[18, 22, "GENE"], [40, 45, "GENE"]]}], ["Pearson's correlation analysis indicated that mTOR and S6K were significantly correlated with T-bet ( r = 0.901 and 0.91, respectively, P < 0.001), but negatively and significantly correlated with EOMES ( r = \u22120.758 and \u22120.751, respectively, P < 0.001).", {"entities": [[46, 50, "GENE"], [197, 202, "GENE"]]}], ["mTOR may regulate transcription factors of EOMES and T-bet, and by which mechanism, it may modulate lymphocytes differentiation in animals with immune suppression and fungal infection.", {"entities": [[0, 4, "GENE"], [43, 48, "GENE"]]}], ["The present study was designed to test the hypothesis that chronic very mild prenatal carbon monoxide (CO) exposure (25 parts per million) subverts the normal development of the rat cerebellar cortex.", {"entities": []}], ["Studies at this chronic low CO exposure over the earliest periods of mammalian development have not been performed to date.", {"entities": []}], ["Pregnant rats were exposed chronically to CO from gestational day E5 to E20.", {"entities": []}], ["In the postnatal period, rat pups were grouped as follows: Group A: prenatal exposure to CO only; group B: prenatal exposure to CO then exposed to CO from postnatal day 5 (P5) to P20; group C: postnatal exposure only, from P5 to P20, and group D, controls (air without CO).", {"entities": []}], ["At P20, immunocytochemical analyses of oxidative stress markers, and structural and functional proteins were assessed in the cerebellar cortex of the four groups.", {"entities": []}], ["Quantitative real time PCR assays were performed for inducible (iNOS), neuronal (nNOS), and endothelial (eNOS) nitric oxide synthases.", {"entities": []}], ["Superoxide dismutase-1 (SOD1), SOD2, and hemeoxygenase-1 (HO-1) immunoreactivity increased in cells of the cerebellar cortex of CO-exposed pups.", {"entities": [[24, 28, "GENE"], [31, 35, "GENE"]]}], ["INOS and nitrotyrosine immunoreactivity also increased in blood vessels and Purkinje cells (PCs) of pups from group-A, B and C. By contrast, nNOS immunoreactivity decreased in PCs from group-B.", {"entities": []}], ["Endothelial NOS immunoreactivity showed no changes in any CO-exposed group.", {"entities": []}], ["The mRNA levels for iNOS were significantly up-regulated in the cerebellum of rats from group B; however, mRNA levels for nNOS and eNOS remained relatively unchanged in groups A, B and C. Ferritin-H immunoreactivity increased in group-B.", {"entities": []}], ["Immunocytochemistry for neurofilaments (structural protein), synapsin-1 (functional protein), and glutamic acid decarboxylase (the enzyme responsible for the synthesis of the inhibitory neurotransmitter GABA), were decreased in groups A and B. Immunoreactivity for two calcium binding proteins, parvalbumin and calbindin, remained unchanged.", {"entities": []}], ["The immunoreactivity of the astrocytic marker GFAP increased after prenatal exposure.", {"entities": [[46, 50, "GENE"]]}], ["We conclude that exogenously supplied CO during the prenatal period promotes oxidative stress as indicated by the up-regulation of SOD-1, SOD-2, HO-1, Ferritin-H, and iNOS with increased nitrotyrosine in the rat cerebella suggesting that deleterious and protective mechanisms were activated.", {"entities": []}], ["These changes correlate with reductions of proteins important to cerebellar function: pre-synaptic terminals proteins (synapsin-1), proteins for the maintenance of neuronal size, shape and axonal quality (neurofilaments) and protein involved in GABAergic neurotransmission (GAD).", {"entities": []}], ["Increased GFAP immunoreactivity after prenatal CO-exposure suggests a glial mediated response to the constant presence of CO.", {"entities": [[10, 14, "GENE"]]}], ["There were differential responses to prenatal vs. postnatal CO exposure: Prenatal exposure seems to be more damaging; a feature exemplified by the persistence of markers indicating oxidative stress in pups at P20, following prenatal only CO-exposure.", {"entities": []}], ["The continuation of this cellular environment up to day 20 after CO exposure suggests the condition is chronic.", {"entities": []}], ["Postnatal exposure without prenatal exposure shows the least impact, whereas prenatal followed by postnatal exposure exhibits the most pronounced outcome among the groups.", {"entities": []}], ["Osteoarthritis is a degenerative disease of the joint affecting aging populations worldwide.", {"entities": [[0, 14, "DISEASE"]]}], ["It has an underlying inflammatory cause, which contributes to the loss of chondrocytes, leading to diminished cartilage layer at the affected joints.", {"entities": []}], ["Compounds with anti-inflammatory properties are potential treatment agents for osteoarthritis.", {"entities": [[79, 93, "DISEASE"]]}], ["Curcumin derived from Curcuma species is an anti-inflammatory compound as such.", {"entities": []}], ["This review aims to summarize the antiosteoarthritic effects of curcumin derived from clinical and preclinical studies.", {"entities": []}], ["Many clinical trials have been conducted to determine the effectiveness of curcumin in osteoarthritic patients.", {"entities": []}], ["Extracts of Curcuma species, curcuminoids and enhanced curcumin, were used in these studies.", {"entities": []}], ["Patients with osteoarthritis showed improvement in pain, physical function, and quality of life after taking curcumin.", {"entities": [[14, 28, "DISEASE"]]}], ["They also reported reduced concomitant usage of analgesics and side effects during treatment.", {"entities": []}], ["In vitro studies demonstrated that curcumin could prevent the apoptosis of chondrocytes, suppress the release of proteoglycans and metal metalloproteases and expression of cyclooxygenase, prostaglandin E-2, and inflammatory cytokines in chondrocytes.", {"entities": []}], ["These were achieved by blocking the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) system in the chondrocytes, by preventing the activation of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha, phosphorylation, and translocation of the p65 subunit of NF-\u03baB complexes into the nucleus.", {"entities": []}], ["In conclusion, curcumin is a potential candidate for the treatment of osteoarthritis.", {"entities": [[70, 84, "DISEASE"]]}], ["More well-planned randomized control trials and enhanced curcumin formulation are required to justify the use of curcumin in treating osteoarthritis.", {"entities": [[134, 148, "DISEASE"]]}], ["Type 1 diabetes mellitus is a serious disorder characterized by destruction of pancreatic \u03b2-cells, culminating in absolute insulin deficiency.", {"entities": [[0, 24, "DISEASE"], [7, 24, "DISEASE"]]}], ["Genetic factors contribute to the susceptibility of type 1 diabetes mellitus.", {"entities": [[52, 76, "DISEASE"], [59, 76, "DISEASE"]]}], ["The aim of the present study was to identify more susceptibility genes of type 1 diabetes mellitus.", {"entities": [[74, 98, "DISEASE"], [81, 98, "DISEASE"]]}], ["We carried out an initial gene-based genome-wide association study in a total of 4,075 type 1 diabetes mellitus cases and 2,604 controls by using the Gene-based Association Test using Extended Simes procedure.", {"entities": [[87, 111, "DISEASE"], [94, 111, "DISEASE"]]}], ["Furthermore, we carried out replication studies, differential expression analysis and functional annotation clustering analysis to support the significance of the identified susceptibility genes.", {"entities": []}], ["We identified 452 genes associated with type 1 diabetes mellitus, even after adapting the genome-wide threshold for significance ( P \u00a0<\u00a09.05E-04).", {"entities": [[40, 64, "DISEASE"], [47, 64, "DISEASE"]]}], ["Among these genes, 171 were newly identified for type 1 diabetes mellitus, which were ignored in single-nucleotide polymorphism-based association analysis and were not previously reported.", {"entities": [[49, 73, "DISEASE"], [56, 73, "DISEASE"]]}], ["We found that 53 genes have supportive evidence from replication studies and/or differential expression studies.", {"entities": []}], ["In particular, seven genes including four non-human leukocyte antigen (HLA) genes ( RASIP1 , STRN4 , BCAR1 and MYL2 ) are replicated in at least one independent population and also differentially expressed in peripheral blood mononuclear cells or monocytes.", {"entities": [[71, 74, "GENE"], [84, 90, "GENE"], [93, 98, "GENE"], [101, 106, "GENE"], [111, 115, "GENE"]]}], ["Furthermore, the associated genes tend to enrich in immune-related pathways or Gene Ontology project terms.", {"entities": []}], ["The present results suggest the high power of gene-based association analysis in detecting disease-susceptibility genes.", {"entities": []}], ["Our findings provide more insights into the genetic basis of type\u00a01 diabetes mellitus.", {"entities": [[68, 85, "DISEASE"]]}], ["Determinants of active tuberculosis among People Living with HIV/AIDS (PLHA) are not well elucidated in countries with limited resources.", {"entities": [[23, 35, "DISEASE"]]}], ["The objective of this study was to assess distal and proximate determinants of active tuberculosis among people living with HIV/AIDS in southwest Ethiopia.", {"entities": [[86, 98, "DISEASE"]]}], ["A case-control study was conducted from January to March, 2009 in South West Ethiopia.", {"entities": []}], ["The study population consisted of 162 cases and 647 controls.", {"entities": []}], ["Cases were adult people living with HIV/AIDS who developed active pulmonary tuberculosis and controls were people living with HIV/AIDS without active tuberculosis.", {"entities": [[76, 88, "DISEASE"], [150, 162, "DISEASE"], [66, 88, "DISEASE"]]}], ["An interviewer administered structured questionnaire was used to collect information on potential risk factors.", {"entities": []}], ["After adjustment for potential confounders, male gender (OR=1.7; 95%CI: 1.1, 2.7), a low level of education (OR=2.8; 95% CI: 1.1, 7.1), a body mass index less than 18.5 kg/m2 (OR=4.1; 95% CI: 2.3, 7.4), hemoglobin level less than 10.0 g/dl (OR=2.8; 95%CI: 1.5, 5.2), a CD4 lymphocyte count less than 200 cells/\u00b5L (OR=9.8\u201895% CI: 5.5, 17.5), a WHO clinical stage IV (OR=4.3; 95% CI: 2.6, 6.8), not taking antiretroviral treatment (OR=3.1; 95%CI: 1.9,4.9), an infection with helminthes (OR=2.2; 95% CI: 1.4, 3.4), a history of contact with a tuberculosis patient in the family (OR=2.0; 95% CI: 1.2, 3.3), and living in a house made of mud wall (OR=3.7; 95% CI: 1.5, 7.5) were independently associated with the development of active tuberculosis in people living with HIV/AIDS.", {"entities": [[540, 552, "DISEASE"], [730, 742, "DISEASE"], [269, 272, "GENE"]]}], ["All people living with HIV/AIDS should be screened for tuberculosis but in the presence of the risk factors mentioned above, intensified screening is recommended.", {"entities": [[55, 67, "DISEASE"]]}], ["To evaluate the impact of lung function, measured as forced expiratory volume in 1 second (FEV 1 ) % predicted, on health care resource utilization and costs among patients with COPD in a real-world US managed-care population.", {"entities": [[91, 94, "GENE"]]}], ["This observational retrospective cohort study utilized administrative claim data augmented with medical record data.", {"entities": []}], ["The study population consisted of patients with one or more medical claims for pre- and postbronchodilator spirometry during the intake period (July 1, 2012 to June 30, 2013).", {"entities": []}], ["The index date was the date of the earliest medical claim for pre- and postbronchodilator spirometry.", {"entities": []}], ["Spirometry results were abstracted from patients\u2019 medical records.", {"entities": []}], ["Patients were divided into two groups (low FEV 1 % predicted [,50%] and high FEV 1 % predicted [\u226550%]) based on the 2014 Global Initiative for Chronic Obstructive Lung Disease report.", {"entities": [[43, 46, "GENE"], [77, 80, "GENE"], [43, 46, "GENE"], [77, 80, "GENE"]]}], ["Health care resource utilization and costs were based on the prevalence and number of discrete encounters during the 12-month postindex follow-up period.", {"entities": []}], ["Costs were adjusted to 2014 US dollars.", {"entities": []}], ["A total of 754 patients were included (n=297 low FEV 1 % predicted group, n=457 high FEV 1 % predicted group).", {"entities": [[49, 52, "GENE"], [85, 88, "GENE"], [49, 52, "GENE"], [85, 88, "GENE"]]}], ["COPD exacerbations were more prevalent in the low FEV 1 % predicted group compared with the high group during the 12-month pre- (52.5% vs 39.6%) and postindex periods (49.8% vs 36.8%).", {"entities": [[50, 53, "GENE"]]}], ["Mean (standard deviation) follow-up all-cause and COPD-related costs were $27,380 ($38,199) and $15,873 ($29,609) for patients in the low FEV 1 % predicted group, and $22,075 ($28,108) and $10,174 ($18,521) for patients in the high group.", {"entities": [[138, 141, "GENE"]]}], ["In the multivariable analyses, patients in the low FEV 1 % predicted group were more likely to have COPD exacerbations and tended to have higher COPD-related costs when compared with patients in the high group.", {"entities": [[51, 54, "GENE"]]}], ["Real-world data demonstrate that patients with COPD who have low FEV 1 % predicted levels use more COPD medications, have more COPD exacerbations, and incur higher COPD-related health care costs than those with high FEV 1 % predicted levels.", {"entities": [[65, 68, "GENE"], [216, 219, "GENE"], [65, 68, "GENE"], [216, 219, "GENE"]]}], ["To date, genome-wide association studies (GWAS) permit a comprehensive scan of the genome in an unbiased manner, with high sensitivity, and thereby have the potential to identify candidate genes for the prevalence or development of multifactorial diseases such as bronchial asthma.", {"entities": [[274, 280, "DISEASE"]]}], ["However, most studies have only managed to explain a small additional percentage of hereditability estimates, and often fail to show consistent results among studies despite large sample sizes.", {"entities": []}], ["Epistasis is defined as the interaction between multiple different genes affecting phenotypes.", {"entities": []}], ["By applying epistatic analysis to clinical genetic research, we can analyze interactions among more than 2 molecules (genes) considering the whole system of the human body, illuminating dynamic molecular mechanisms.", {"entities": []}], ["An increasing number of genetic studies have investigated epistatic effects on the risk for development of asthma.", {"entities": [[107, 113, "DISEASE"]]}], ["The present review highlights a concept of epistasis to overcome traditional genetic studies in humans and provides an update of evidence on epistatic effects on asthma.", {"entities": [[162, 168, "DISEASE"]]}], ["Furthermore, we review concerns regarding recent trends in epistatic analyses from the perspective of clinical physicians.", {"entities": []}], ["These concerns include biological plausibility of genes identified by computational statistics, and definition of the diagnostic label of \u2018physician-diagnosed asthma\u2019.", {"entities": [[159, 165, "DISEASE"]]}], ["In terms of these issues, further application of epistatic analysis will prompt identification of susceptibility of diseases and lead to the development of a new generation of pharmacological strategies to treat asthma.", {"entities": [[212, 218, "DISEASE"]]}], ["The pace of change from volume-based to value-based payment in health care varies dramatically among markets.", {"entities": []}], ["Regardless of the ultimate disposition of the Affordable Care Act, employers and public\u2013private payers will continue to increase pressure on health care providers to assume financial risk for populations in the form of shared savings, bundled payments, downside risk, or even capitation.", {"entities": []}], ["This article outlines a suggested road map and practical considerations for health systems that are building or planning to build population health capabilities to meet the needs of their local markets.", {"entities": []}], ["The authors review the traditional core capabilities needed to address the medical determinants of health for a population.", {"entities": []}], ["They also share an innovative approach to community service integration to address the social determinants of health and the engagement of families to improve their own health and well-being.", {"entities": []}], ["The foundational approach is to connect insurance products, the health care delivery system, and community service agencies around the family's well-being goals using human-centered design strategy.", {"entities": []}], ["A 62-year-old patient with chronic bronchitis had treatment-resistant atrial fibrillation.", {"entities": [[35, 45, "DISEASE"]]}], ["Electrical cardioversion was performed, but sinus rhythm (SR) lasted only for some minutes.", {"entities": []}], ["Administration of amiodarone was withheld in favour of a course of acupuncture treatment in order to increase the success rate of a second attempt of electrical cardioversion.", {"entities": []}], ["After two acupuncture treatments, spontaneous conversion to SR occurred.", {"entities": []}], ["Relapses into atrial fibrillation in the following five winters, associated with attacks of bronchitis, also responded to acupuncture.", {"entities": [[92, 102, "DISEASE"]]}], ["The mechanisms of action of the acupuncture treatment and the value of this integrated approach to treatment are discussed.", {"entities": []}], ["Background .", {"entities": []}], ["Individuals who make a living through agriculture and animal husbandry are faced with a variety of physical and psychological health risks.", {"entities": []}], ["In many international studies, it has been shown that these risks can result in disease.", {"entities": []}], ["The purpose of this study is to summarize the health risks faced by Turkish agricultural workers.", {"entities": []}], ["Materials and Methods .", {"entities": []}], ["This study used a nonrandom, convenience sample.", {"entities": []}], ["The biopsychosocial health statuses of 177 farmers from 11 central villages in Kars, Turkey, were examined.", {"entities": [[79, 83, "GENE"]]}], ["It was determined that the depression rate among the study group was 62.1%, the rate of physical health problems was 52.0%, and the rate of social isolation was 53.7%.", {"entities": []}], ["There was a statistically significant difference between the depression scale scores and lower education levels, having \u2265 three children, and physical health problems, as well as the physical condition of the farmers' homes.", {"entities": []}], ["There was a significant difference between poor physical health and older age, lower education levels, having \u2265 three children, and social isolation.", {"entities": []}], ["Conclusions .", {"entities": []}], ["In providing data-based evidence, it is believed that this study will contribute considerably to understanding the causality of health problems in this population and in planning the development of public health and veterinary services based on regional needs.", {"entities": []}], ["Physical exercise may affect levels of blood-based biomarkers.", {"entities": []}], ["However, exercise status is seldom considered in the interpretation of laboratory results.", {"entities": []}], ["This study reports the associations between habitual exercise participation and clinical laboratory test results.", {"entities": []}], ["The effects of days per week of aerobic and strength exercise participation on laboratory test results for 26 biomarkers in young adults aged 18 to 34 years (n = 80,111) were evaluated using percentile distribution analyses and multivariate regression.", {"entities": []}], ["In both men and women, more days per week of either aerobic or strength exercise were significantly associated with lower levels of glucose, hemoglobin A1c, LDL cholesterol, total cholesterol, triglycerides, estimated glomerular filtration rate, globulin, and C-reactive protein, and significantly higher levels of HDL cholesterol, creatinine, iron, and percent saturation (all p < .05).", {"entities": []}], ["Type of exercise or gender influenced the observed relationships with exercise frequency for total cholesterol, aspartate aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, uric acid, bilirubin, and iron binding capacity.", {"entities": []}], ["Physical exercise shifted the distribution of results into the direction suggestive of better health.", {"entities": []}], ["Reported relationships may help clinicians and patients to better understand and interpret laboratory results in athletic populations and possibly re-evaluate interpretation of reference intervals for physically active populations.", {"entities": []}], ["Interleukin-4 (IL-4) polymorphisms have been reported to influence an individual's susceptibility to liver disease as it is a central anti-inflammatory Th2 cytokine; however, these results remain controversial.", {"entities": [[101, 114, "DISEASE"]]}], ["A comprehensive meta-analysis of the relevant literature was thus performed to better estimate the relationship between IL-4 polymorphisms and liver disease.", {"entities": [[143, 156, "DISEASE"]]}], ["Systematic searches of various databases (PubMed, Embase, Cochrane Library, and China National Knowledge Infrastructure) for studies published before July 5, 2015 were performed.", {"entities": []}], ["Odds ratios (ORs) with 95% confidence intervals (CIs) calculated in fixed or random-effects models were used to estimate the strength of the association.", {"entities": []}], ["Subgroup analyses, meta-regression, Galbraith plots, and sensitivity analyses were also performed.", {"entities": []}], ["A total of 16 case\u2013control studies, of which 15 involved the -590C/T polymorphism and 3 involved the -33T/C polymorphism, were included in the study.", {"entities": []}], ["With respect to the -590C/T polymorphism, a significantly increased risk of liver diseases was found in the overall population (TT\u200a+\u200aCT vs CC: OR\u200a=\u200a1.25, 95% CI\u200a=\u200a1.06\u20131.49, P \u200a=\u200a0.009 and CT vs CC: OR\u200a=\u200a1.22, 95% CI\u200a=\u200a1.00\u20131.48, P \u200a=\u200a0.048) and the Asian population (TT\u200a+\u200aCT vs CC: OR\u200a=\u200a1.28, 95% CI\u200a=\u200a1.04\u20131.57, P \u200a=\u200a0.020).", {"entities": []}], ["Further subgroup analyses also showed significant associations between the -590C > T polymorphism and the risk of hepatitis C infection and hepatocellular carcinoma.", {"entities": [[140, 164, "DISEASE"], [155, 164, "DISEASE"], [114, 123, "DISEASE"]]}], ["However, no association was found between the -33T/C polymorphism and risk of liver diseases in all comparison models.", {"entities": []}], ["This meta-analysis suggested that the IL-4 -590C > T polymorphism is associated with an increased risk of hepatitis C infection and hepatocellular carcinoma, especially among the Asian population.", {"entities": [[132, 156, "DISEASE"], [147, 156, "DISEASE"], [106, 115, "DISEASE"]]}], ["Monoclonal antibodies represent some of the most promising molecular targeted immunotherapies.", {"entities": []}], ["However, understanding mechanisms by which tumors evade elimination by the immune system of the host presents a significant challenge for developing effective cancer immunotherapies.", {"entities": [[159, 165, "DISEASE"]]}], ["The interaction of cancer cells with the host is a complex process that is distributed across a variety of time and length scales.", {"entities": [[19, 25, "DISEASE"]]}], ["The time scales range from the dynamics of protein refolding (i.e., microseconds) to the dynamics of disease progression (i.e., years).", {"entities": []}], ["The length scales span the farthest reaches of the human body (i.e., meters) down to the range of molecular interactions (i.e., nanometers).", {"entities": []}], ["Limited ranges of time and length scales are used experimentally to observe and quantify changes in physiology due to cancer.", {"entities": [[118, 124, "DISEASE"]]}], ["Translating knowledge obtained from the limited scales observed experimentally to predict patient response is an essential prerequisite for the rational design of cancer immunotherapies that improve clinical outcomes.", {"entities": [[163, 169, "DISEASE"]]}], ["In studying multiscale systems, engineers use systems analysis and design to identify important components in a complex system and to test conceptual understanding of the integrated system behavior using simulation.", {"entities": []}], ["The objective of this review is to summarize interactions between the tumor and cell-mediated immunity from a multiscale perspective.", {"entities": []}], ["Interleukin-12 and its role in coordinating antibody-dependent cell-mediated cytotoxicity is used illustrate the different time and length scale that underpin cancer immunoediting.", {"entities": [[159, 165, "DISEASE"]]}], ["An underlying theme in this review is the potential role that simulation can play in translating knowledge across scales.", {"entities": []}], ["The efficacy and safety of ketotifen eye drop treatment in allergic conjunctivitis (AC) management is perfectly known by several studies, but the mechanism of action at the biochemical levels is poorly understood so we decided to perform an open, uncontrolled study in order to investigate the effect of the topical administration of ketotifen fumarate 0.05% on biochemical markers of inflammation on conjunctival cells in patients with AC.", {"entities": [[59, 82, "DISEASE"], [68, 82, "DISEASE"]]}], ["Nineteen patients with symptoms and signs of AC (itching, discharge, burning, redness, increase in the watery discharge, swelling and follicles) and with a history of allergy were prescribed with two daily instillation of one drop of eyewash ketotifen fumarate 0,05% in both eyes during thirty days.", {"entities": []}], ["They were studied by measuring clinical and immunologic parameters.", {"entities": []}], ["Ketotifen fumarate treatment significantly reduced the total symptoms and signs score for each patient as well as each symptoms and signs at all time points compared with day 0 (p < 0.0001 and p < 0.016, respectively).", {"entities": []}], ["Although the percentage of HLA-DR+ epithelial cells diminished only in 58% of patients, the numbers of CD29+ and eotaxin+ epithelial cells dropped significantly in 68% and 73 % of them (p < 0.0062 and <0.0082, respectively) as a consequence of the treatment.", {"entities": []}], ["In 9 out of 19 patients a simultaneous decrease in the percentage of epithelial cells positive for CD29 and eotaxin was observed.", {"entities": []}], ["Ketotifen besides the well-known effect in reducing signs and symptoms of AC significantly diminished production of eotaxin and expression of CD29 by epithelial cells in patients with seasonal AC.", {"entities": []}], ["Fingolimod is a first in class oral compound approved for the treatment of relapsing-remitting multiple sclerosis (RR-MS).", {"entities": [[95, 113, "DISEASE"], [75, 113, "DISEASE"]]}], ["The aim of this study was to evaluate clinical and neuroradiological responses to fingolimod as well as the safety and tolerability in RR-MS patients in clinical practice.", {"entities": []}], ["In addition, a panel of pro-inflammatory serum cytokines was explored as potential biomarker for treatment response.", {"entities": []}], ["We conducted a retrospective, non-randomized, open-label, observational study in 105 patients with RR-MS and measured cytokines in longitudinal serum samples.", {"entities": []}], ["Compared to the year before fingolimod start the annualized relapse rate was reduced by 44%.", {"entities": []}], ["Also, the percentage of patients with a worsening of the EDSS decreased.", {"entities": []}], ["Accordingly, the fraction of patients with no evidence of disease activity (no relapse, stable EDSS, no new active lesions in MRI) increased from 11% to 38%.", {"entities": []}], ["The efficacy and safety were comparable between highly active patients or patients with relevant comorbidities and our general patient population.", {"entities": []}], ["The efficacy in reducing relapses was comparable to that observed in the phase III trials.", {"entities": []}], ["In our cohort fingolimod was safe and efficacious irrespective of comorbidities and previous treatment.", {"entities": []}], ["Promoting unstructured outside play is a promising vehicle to increase children\u2019s physical activity (PA).", {"entities": []}], ["This study investigates if factors of the social environment moderate the relationship between the perceived physical environment and outside play.", {"entities": []}], ["1875 parents from the KOALA Birth Cohort Study reported on their child\u2019s outside play around age five years, and 1516 parents around age seven years.", {"entities": []}], ["Linear mixed model analyses were performed to evaluate (moderating) relationships among factors of the social environment (parenting influences and social capital), the perceived physical environment, and outside play at age five and seven.", {"entities": []}], ["Season was entered as a random factor in these analyses.", {"entities": []}], ["Accessibility of PA facilities, positive parental attitude towards PA and social capital were associated with more outside play, while parental concern and restriction of screen time were related with less outside play.", {"entities": []}], ["We found two significant interactions; both involving parent perceived responsibility towards child PA participation.", {"entities": []}], ["Although we found a limited number of interactions, this study demonstrated that the impact of the perceived physical environment may differ across levels of parent responsibility.", {"entities": []}], ["The online version of this article (doi:10.1186/s12966-014-0150-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Internet is becoming increasingly important as a way for patients to acquire medical information and as a means for patient-physician communication.", {"entities": []}], ["Questions about appropriate use of this new technology have been brought to the fore by the many patients using the Internet to seek sildenafil prescriptions.", {"entities": []}], ["To present the first description of a physician designed and directed Internet-based prescribing system of sildenafil, together with data covering more than 2,100 patient encounters.", {"entities": []}], ["Retrospective analysis of a large case series from a medical practice that prescribes sildenafil based on medical and sexual histories obtained through a physician designed and directed World Wide Web (WWW) site, compared against patients from clinics at a Midwestern inner city medical center.", {"entities": []}], ["We compared all 2,104 Internet patients seeking sildenafil prescriptions online between June 14, 1998, and March 1, 1999, with all 36 medical center patients obtaining sildenafil prescriptions during the same period.", {"entities": []}], ["The outcome measures compared were: completeness of medical record; patient safety as noted by the follow up responses of all patients requesting refills, any comments received by the internet site (webmaster), and patient or physician comments noted in the clinic medical record; satisfaction as noted by the follow up responses of all patients requesting refills, any comments received by the internet site (webmaster), and patient or physician comments noted in the clinic medical record; examinations and laboratory tests.", {"entities": []}], ["Fifty-six percent of Internet requests came from 46 states, and 44% from eight foreign countries.", {"entities": []}], ["Of 2,104 requests, 2,100 were granted.", {"entities": []}], ["Three hundred ten patients have requested medication refills: all reported erections sufficient for intercourse and 69% said their satisfaction exceeded all expectations; none were at all dissatisfied.", {"entities": []}], ["Side effect rates were comparable to those in the literature.", {"entities": []}], ["Comparison of the medical history obtained from Internet patients with that recorded in clinic patients' charts revealed that the former was far more complete.", {"entities": []}], ["No clinic patient received any examination or laboratory test specific for erectile dysfunction or its causes.", {"entities": []}], ["There were no reported deaths or serious complications in either group.", {"entities": []}], ["Internet-based prescription of sildenafil provides the physician with a complete and very detailed medical and sexual history for 100% of patients without denying any information routinely obtained in a direct patient contact setting.", {"entities": []}], ["Internet-based practice, which may be expected to require far fewer healthcare resources than traditional settings, rates very high in patient satisfaction among patients requesting a refill; no negative comments were received from all other patients.", {"entities": []}], ["Overall, these data support the safety and effectiveness of Internet prescribing of selected medications.", {"entities": []}], ["Over 90% of adults aged 20 years or older with permanent teeth have suffered from dental caries leading to pain, infection, or even tooth loss.", {"entities": [[82, 95, "DISEASE"]]}], ["Although caries prevalence has decreased over the past decade, there are still about 23% of dentate adults who have untreated carious lesions in the US.", {"entities": []}], ["Dental caries is a complex disorder affected by both individual susceptibility and environmental factors.", {"entities": [[0, 13, "DISEASE"]]}], ["Approximately 35-55% of caries phenotypic variation in the permanent dentition is attributable to genes, though few specific caries genes have been identified.", {"entities": []}], ["Therefore, we conducted the first genome-wide association study (GWAS) to identify genes affecting susceptibility to caries in adults.", {"entities": []}], ["Five independent cohorts were included in this study, totaling more than 7000 participants.", {"entities": []}], ["For each participant, dental caries was assessed and genetic markers (single nucleotide polymorphisms, SNPs) were genotyped or imputed across the entire genome.", {"entities": [[22, 35, "DISEASE"]]}], ["Due to the heterogeneity among the five cohorts regarding age, genotyping platform, quality of dental caries assessment, and study design, we first conducted genome-wide association (GWA) analyses on each of the five independent cohorts separately.", {"entities": [[95, 108, "DISEASE"]]}], ["We then performed three meta-analyses to combine results for: (i) the comparatively younger, Appalachian cohorts (N\u2009=\u20091483) with well-assessed caries phenotype, (ii) the comparatively older, non-Appalachian cohorts (N\u2009=\u20095960) with inferior caries phenotypes, and (iii) all five cohorts (N\u2009=\u20097443).", {"entities": []}], ["Top ranking genetic loci within and across meta-analyses were scrutinized for biologically plausible roles on caries.", {"entities": []}], ["Different sets of genes were nominated across the three meta-analyses, especially between the younger and older age cohorts.", {"entities": []}], ["In general, we identified several suggestive loci (P-value\u2009\u2264\u200910E-05) within or near genes with plausible biological roles for dental caries, including RPS6KA2 and PTK2B, involved in p38-depenedent MAPK signaling, and RHOU and FZD1, involved in the Wnt signaling cascade.", {"entities": [[126, 139, "DISEASE"], [151, 158, "GENE"], [163, 168, "GENE"], [217, 221, "GENE"], [226, 230, "GENE"]]}], ["Both of these pathways have been implicated in dental caries.", {"entities": [[47, 60, "DISEASE"]]}], ["ADMTS3 and ISL1 are involved in tooth development, and TLR2 is involved in immune response to oral pathogens.", {"entities": [[11, 15, "GENE"], [55, 59, "GENE"]]}], ["As the first GWAS for dental caries in adults, this study nominated several novel caries genes for future study, which may lead to better understanding of cariogenesis, and ultimately, to improved disease predictions, prevention, and/or treatment.", {"entities": [[22, 35, "DISEASE"]]}], ["Injury to the distal respiratory epithelium has been implicated as an underlying cause of idiopathic lung diseases.", {"entities": []}], ["Mutations that result in SP-C deficiencies are linked to a small subset of spontaneous and familial cases of interstitial lung disease (ILD) and interstitial pulmonary fibrosis (IPF).", {"entities": [[109, 134, "DISEASE"], [158, 176, "DISEASE"], [122, 134, "DISEASE"]]}], ["Gene-targeted mice that lack SP-C ( Sftpc Sftpc Sftpc Sftpc Sftpc Sftpc \u03b3 .", {"entities": [[36, 41, "GENE"], [42, 47, "GENE"], [48, 53, "GENE"], [54, 59, "GENE"], [60, 65, "GENE"], [66, 71, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"], [48, 53, "GENE"], [54, 59, "GENE"], [60, 65, "GENE"], [66, 71, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"], [48, 53, "GENE"], [54, 59, "GENE"], [60, 65, "GENE"], [66, 71, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"], [48, 53, "GENE"], [54, 59, "GENE"], [60, 65, "GENE"], [66, 71, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"], [48, 53, "GENE"], [54, 59, "GENE"], [60, 65, "GENE"], [66, 71, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"], [48, 53, "GENE"], [54, 59, "GENE"], [60, 65, "GENE"], [66, 71, "GENE"]]}], ["These findings indicate that novel therapeutics will be required to treat individuals with SP-C deficient ILD/IPF.", {"entities": []}], ["Effective selection of coronary lesions for revascularisation is pivotal in the management of symptoms and adverse outcomes in patients with coronary artery disease.", {"entities": []}], ["Recently, instantaneous \u2018wave-free\u2019 ratio (iFR) has been proposed as a new diagnostic index for assessing the severity of coronary stenoses without the need of pharmacological vasodilation.", {"entities": []}], ["Evidence of the effectiveness of iFR-guided revascularisation is emerging and a systematic review is warranted.", {"entities": []}], ["This is a protocol for a systematic review of randomised controlled trials and controlled observational studies.", {"entities": []}], ["Electronic sources including MEDLINE via Ovid, Embase, Cochrane databases and ClinicalTrials.gov will be searched for potentially eligible studies investigating the effects of iFR-guided strategy in patients undergoing coronary revascularisation.", {"entities": []}], ["Studies will be selected against transparent eligibility criteria and data will be extracted using a prestandardised data collection form by two independent authors.", {"entities": []}], ["Risk of bias in included studies and overall quality of evidence will be assessed using validated methodological tools.", {"entities": []}], ["Meta-analysis will be performed using the Review Manager software.", {"entities": []}], ["Our systematic review will be performed according to the guidance from the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.", {"entities": []}], ["Ethics approval is not required.", {"entities": []}], ["Results of the systematic review will be disseminated as conference proceedings and peer-reviewed journal publication.", {"entities": []}], ["This protocol is registered in the International Prospective Register of Systematic Reviews (PROSPERO), registration number CRD42017065460.", {"entities": []}], ["Occupational diseases affect more and more people every year.", {"entities": []}], ["According to the International Labour Organization (ILO), in 2000 an estimated amount of at least 160 million people became ill as a result of occupational-related hazards or injuries.", {"entities": []}], ["Globally, occupational deaths, diseases and injuries account for an estimated loss of 4% of the Gross Domestic Product.", {"entities": []}], ["Important substances that are related to occupational diseases are isocyanates and their products.", {"entities": []}], ["These substances, which are used in a lot of different industrial processes, are not only toxic and irritant, but also allergenic.", {"entities": []}], ["Although the exposure to higher concentrations could be monitored and restricted by technical means, very low concentrations are difficult to monitor and may, over time, lead to allergic reactions in some workers, ending in an occupational disease.", {"entities": []}], ["In order to prevent the people from sickening, the mechanisms underlying the disease, by patho-physiological and genetical means, have to be known and understood so that high risk groups and early signs in the development of an allergic reaction could be detected before the exposure to isocyanates leads to an occupational disease.", {"entities": []}], ["Therefore, this paper reviews the so far known facts concerning the patho-physiologic appearance and mechanisms of isocyanate-associated toxic reactions and possible genetic involvement that might trigger the allergic reactions.", {"entities": []}], ["Ultrafine particles (UFPs; aerodynamic diameter < 100 nm) may contribute to the respiratory and cardiovascular morbidity and mortality associated with particulate air pollution.", {"entities": []}], ["We tested the hypothesis that inhalation of carbon UFPs has vascular effects in healthy and asthmatic subjects, detectable as alterations in blood leukocyte expression of adhesion molecules.", {"entities": []}], ["Healthy subjects inhaled filtered air and freshly generated elemental carbon particles (count median diameter ~ 25 nm, geometric standard deviation ~ 1.6), for 2 hr, in three separate protocols: 10 \u03bcg/m", {"entities": [[162, 164, "GENE"]]}], ["Carbon nanotubes (CNTs) are of great interest for the development of drugs and vaccines due to their unique physicochemical properties.", {"entities": []}], ["The high surface area to volume ratio and delocalized pi-electron cloud of CNTs promote binding of proteins to the surface forming a protein corona.", {"entities": []}], ["This unique feature of CNTs has been recognized for potential delivery of antigens for strong and long-lasting antigen-specific immune responses.", {"entities": []}], ["Based on an earlier study that demonstrated increased protein binding, we propose that carboxylated multiwalled CNTs (MWCNTs) can function as an improved carrier to deliver antigens such as ovalbumin (OVA).", {"entities": []}], ["To test this hypothesis, we coated carboxylated MWCNTs with OVA and measured uptake and activation of antigen-presenting cells (macrophages) and their ability to stimulate CD4 I D / I G ) were 0.97 and 1.37 for MWCNT-2 and MWCNT-30, respectively, samples showing that MWCNT-30 contained more defects.", {"entities": [[172, 175, "GENE"]]}], ["The increase in defects in MWCNT-30 led to increased binding of OVA as compared to MWCNT-2 (1,066\u00b1182 \u03bcg/mL vs 582\u00b141 \u03bcg/mL, respectively).", {"entities": []}], ["Both types of MWCNTs, along with MWCNT\u2013OVA complexes, showed no observable toxicity to bone-marrow-derived macrophages up to 5 days.", {"entities": []}], ["Surprisingly, we found that MWCNT\u2013OVA complex significantly increased the expression of major histocompatibility complex class II on macrophages and production of pro-inflammatory cytokines (tumor necrosis factor-\u03b1 and interleukin 6), while MWCNTs without OVA protein corona did not.", {"entities": []}], ["The coculture of MWCNT\u2013OVA-complex-treated macrophages and OVA-specific CD4", {"entities": [[72, 75, "GENE"]]}], ["Systematic reviews and meta-analyses that do not include unpublished data in their analyses may be prone to publication bias, which in some cases has been shown to have deleterious consequences on determining the efficacy of interventions.", {"entities": []}], ["We retrieved systematic reviews and meta-analyses published in the past 8\u00a0years (January 1, 2007\u2013December 31, 2015) from the top 20 journals in the Pregnancy and Childbirth literature, as rated by Google Scholar\u2019s h5-index.", {"entities": []}], ["A meta-epidemiologic analysis was performed to determine the frequency with which authors searched clinical trials registries for unpublished data.", {"entities": []}], ["A PubMed search retrieved 372 citations, 297 of which were deemed to be either a systematic review or a meta-analysis and were included for analysis.", {"entities": []}], ["Twelve (4\u00a0%) of these searched at least one WHO-approved clinical trials registry or clinicaltrials.gov.", {"entities": []}], ["Systematic reviews and meta-analyses published in pregnancy and childbirth journals do not routinely report searches of clinical trials registries.", {"entities": []}], ["Including these registries in systematic reviews may be a promising avenue to limit publication bias if registry searches locate unpublished trial data that could be used in the systematic review.", {"entities": []}], ["Activation signals can be negatively regulated by cell surface receptors bearing immunoreceptor tyrosine-based inhibitory motifs (ITIMs).", {"entities": []}], ["CD300a, an ITIM bearing type I transmembrane protein, is expressed on many hematopoietic cells, including subsets of lymphocytes.", {"entities": [[0, 6, "GENE"]]}], ["We have taken two approaches to further define the mechanism by which CD300a acts as an inhibitor of immune cell receptor signaling.", {"entities": [[70, 76, "GENE"]]}], ["First, we have expressed in Jurkat T cells a chimeric receptor consisting of the extracellular domains of killer-cell immunoglobulin-like receptor (KIR)2DL2 fused to the transmembrane and cytoplasmic segments of CD300a (KIR-CD300a) to explore surrogate ligand-stimulated inhibition of superantigen stimulated T cell receptor (TCR) mediated cell signaling.", {"entities": [[212, 218, "GENE"], [224, 230, "GENE"]]}], ["We found that intact CD300a ITIMs were essential for inhibition and that the tyrosine phosphorylation of these ITIMs required the src tyrosine kinase Lck.", {"entities": [[21, 27, "GENE"], [130, 133, "GENE"], [150, 153, "GENE"]]}], ["Tyrosine phosphorylation of the CD300a ITIMs created docking sites for both src homology 2 domain containing protein tyrosine phosphatase (SHP)-1 and SHP-2.", {"entities": [[32, 38, "GENE"], [76, 79, "GENE"]]}], ["Suppression of SHP-1 and SHP-2 expression in KIR-CD300a Jurkat T cells with siRNA and the use of DT40 chicken B cell lines expressing CD300a and deficient in several phosphatases revealed that SHP-1, but not SHP-2 or the src homology 2 domain containing inositol 5\u2019 phosphatase SHIP, was utilized by CD300a for its inhibitory activity.", {"entities": [[49, 55, "GENE"], [134, 140, "GENE"], [300, 306, "GENE"], [221, 224, "GENE"], [49, 55, "GENE"], [134, 140, "GENE"], [300, 306, "GENE"]]}], ["These studies provide new insights into the function of CD300a in tuning T and B cell responses.", {"entities": [[56, 62, "GENE"]]}], ["Patients with chronic obstructive pulmonary disease (COPD) frequently suffer from comorbidities.", {"entities": [[14, 51, "DISEASE"]]}], ["COPD severity may be evaluated by the Global initiative for chronic Obstructive Lung Disease (GOLD) combined risk assessment score (GOLD score).", {"entities": []}], ["Spirometry, body plethysmography, diffusing capacity of the lung for carbon monoxide (DLCO), and high-resolution computed tomography (HR-CT) measure lung function and elucidate pulmonary pathology.", {"entities": []}], ["This study assesses associations between GOLD score and measurements of lung function in COPD patients with and without (\u22641) comorbidities.", {"entities": []}], ["It evaluates whether the presence of comorbidities influences evaluation by GOLD score of COPD severity, and questions whether GOLD score describes morbidity rather than COPD severity.", {"entities": []}], ["In this prospective study, 106 patients with stable COPD were included.", {"entities": []}], ["Patients treated for lung cancer were excluded.", {"entities": [[21, 32, "DISEASE"], [26, 32, "DISEASE"]]}], ["Demographics, oxygen saturation (SpO 2 ), modified Medical Research Council Dyspnea Scale, COPD exacerbations, and comorbidities were recorded.", {"entities": []}], ["Body plethysmography and DLCO were measured, and HR-CT performed and evaluated for emphysema and airways disease.", {"entities": []}], ["COPD severity was stratified by the GOLD score.", {"entities": []}], ["Correlation analyses: 1) GOLD score, 2) emphysema grade, and 3) airways disease and lung function parameters, described by: forced expiratory volume in the first second in percent of expected value (FEV 1 %), inspiratory capacity (IC%), total lung volume (TLC%), IC/TLC, and SpO 2 .", {"entities": [[199, 202, "GENE"]]}], ["Correlation analyses between subgroups and hierarchical cluster analysis were performed.", {"entities": []}], ["Significant associations were found between GOLD score and both emphysema grade (correlation coefficients [cc]: \u22120.2, P =0.03) and lung function parameters (cc: \u22120.5 to \u22120.7, P -values all <0.001) weakened in patients with >1 comorbidity (cc: \u22120.4 to \u22120.5, P -values all 0.001).", {"entities": []}], ["Significant differences between subgroups were found in GOLD score and both FEV 1 % (cc: \u22120.2, P =0.02) and IC/TLC (cc: \u22120.2, P =0.02).", {"entities": [[76, 79, "GENE"]]}], ["Comorbidities were associated with GOLD score and composite measures in hierarchical cluster analysis.", {"entities": []}], ["The presence of comorbidities influences the relationship between GOLD score and lung function measurements.", {"entities": []}], ["GOLD score may be more representative of morbidity than of COPD severity.", {"entities": []}], ["There are 2 major factors responsible for vaccine failures, the first is vaccine-related such as failures in vaccine attenuation, vaccination regimes or administration.", {"entities": []}], ["The other is host-related, of which host genetics, immune status, age, health or nutritional status can be associated with primary or secondary vaccine failures.", {"entities": []}], ["The first describes the inability to respond to primary vaccination, the latter is characterized by a loss of protection after initial effectiveness.", {"entities": []}], ["Our studies concentrate on the evaluation of immunological characteristics responsible for primary vaccine failures in different (risk) populations for which the underlying mechanisms are currently unknown.", {"entities": []}], ["Here we summarise current knowledge and findings from our studies.", {"entities": []}], ["About 2\u201310% of healthy individuals fail to mount antibody levels to routine vaccines.", {"entities": []}], ["Comparing the immune responses to different vaccines in non-responder and high-responder vaccinees revealed that hypo-responsiveness is antigen/vaccine-specific at the humoral but not at the cellular level.", {"entities": []}], ["We found that T-regulatory as well as B-regulatory cells and the production of IL-10 are involved in non/hypo-responsiveness.", {"entities": []}], ["Non-responsiveness increases with age and in particular vaccination to a novel vaccine in persons > 65 years is associated with a high low/non-responder rate, indicating that vaccine schedules and doses (at least for primary vaccination) should be adapted according to age.", {"entities": []}], ["In light of the growing number of allergic but also obese people, our current studies concentrate on these risk groups to reveal whether different vaccination approaches are necessary for optimal protection compared to healthy individuals.", {"entities": []}], ["These studies are in line with the significant paradigm shift taking place in many fields of medical research and care, and will extend the concept of personalised medicine into the field of vaccinology.", {"entities": []}], ["Mina is a JmjC family 2\u2010oxoglutarate oxygenase with pleiotropic roles in cell proliferation, cancer, T cell differentiation, pulmonary inflammation, and intestinal parasite expulsion.", {"entities": [[93, 99, "DISEASE"]]}], ["Although Mina expression varies according to cell\u2010type, developmental stage and activation state, its transcriptional regulation is poorly understood.", {"entities": []}], ["Across inbred mouse strains, Mina protein level exhibits a bimodal distribution, correlating with inheritance of a biallelic haplotype block comprising 21 promoter/intron 1\u2010region SNPs.", {"entities": []}], ["We previously showed that heritable differences in Mina protein level are transcriptionally regulated.", {"entities": []}], ["Accordingly, we decided to test the hypothesis that at least one of the promoter/intron 1\u2010region SNPs perturbs a Mina cis\u2010regulatory element (CRE).", {"entities": []}], ["Here, we have comprehensively scanned for CREs across a Mina locus\u2010spanning 26\u2010kilobase genomic interval.", {"entities": []}], ["We discovered 8 potential CREs and functionally validated 4 of these, the strongest of which (E2), residing in intron 1, contained a SNP whose BALB/c\u2014but not C57Bl/6 allele\u2014abolished both Smad3 binding and transforming growth factor beta (TGF\u03b2) responsiveness.", {"entities": [[188, 193, "GENE"]]}], ["Our results demonstrate the TGF\u03b2 signaling pathway plays a critical role in regulating Mina expression and SNP rs4191790 controls heritable variation in Mina expression level, raising important questions regarding the evolution of an allele that uncouples Mina expression from the TGF\u03b2 signaling pathway.", {"entities": []}], ["Isocitrate dehydrogenase-1 (Idh1) is an important metabolic enzyme that produces NADPH by converting isocitrate to \u03b1 -ketoglutarate.", {"entities": [[28, 32, "GENE"]]}], ["Idh1 is known to reduce reactive oxygen species (ROS) induced in cells by treatment with lipopolysaccharide (LPS) in vitro .", {"entities": [[0, 4, "GENE"]]}], ["Here, we used Idh1-deficient knockout (Idh1 KO) mice to investigate the role of Idh1 in antioxidant defense in vivo .", {"entities": [[14, 18, "GENE"], [39, 43, "GENE"], [80, 84, "GENE"], [14, 18, "GENE"], [39, 43, "GENE"], [80, 84, "GENE"]]}], ["Idh1 KO mice showed heightened susceptibility to death induced by LPS and exhibited increased serum levels of inflammatory cytokines such as tumor necrosis factor- \u03b1 and interleukin-6.", {"entities": [[0, 4, "GENE"]]}], ["The serum of LPS-injected Idh1 KO mice also contained elevated levels of AST, a marker of inflammatory liver damage.", {"entities": [[26, 30, "GENE"]]}], ["Furthermore, after LPS injection, livers of Idh1 KO mice showed histological evidence of elevated oxidative DNA damage compared with livers of wild-type (WT) mice.", {"entities": [[44, 48, "GENE"]]}], ["Idh1 KO livers showed a faster and more pronounced oxidative stress than WT livers.", {"entities": [[0, 4, "GENE"]]}], ["In line with that, Idh1 KO hepatocytes showed higher ROS levels and an increase in the NADP", {"entities": [[19, 23, "GENE"]]}], ["The most important trigger for immune system development is the exposure to microbial components immediately after birth.", {"entities": []}], ["Moreover, targeted manipulation of the microbiota can be used to change host susceptibility to immune-mediated diseases.", {"entities": []}], ["Our aim was to analyze how differences in early gut colonization patterns change the composition of the resident microbiota and future immune system reactivity.", {"entities": []}], ["Germ-free (GF) mice were either inoculated by single oral gavage of caecal content or let colonized by co-housing with specific pathogen-free (SPF) mice at different time points in the postnatal period.", {"entities": []}], ["The microbiota composition was analyzed by denaturing gradient gel electrophoresis for 16S rRNA gene followed by principal component analysis.", {"entities": []}], ["Furthermore, immune functions and cytokine concentrations were analyzed using flow cytometry, ELISA or multiplex bead assay.", {"entities": []}], ["We found that a single oral inoculation of GF mice at three weeks of age permanently changed the gut microbiota composition, which was not possible to achieve at one week of age.", {"entities": []}], ["Interestingly, the ex-GF mice inoculated at three weeks of age were also the only mice with an increased pro-inflammatory immune response.", {"entities": []}], ["In contrast, the composition of the gut microbiota of ex-GF mice that were co-housed with SPF mice at different time points was similar to the gut microbiota in the barrier maintained SPF mice.", {"entities": []}], ["The existence of a short GF postnatal period permanently changed levels of systemic regulatory T cells, NK and NKT cells, and cytokine production.", {"entities": []}], ["In conclusion, a time window exists that enables the artificial colonization of GF mice by a single oral dose of caecal content, which may modify the future immune phenotype of the host.", {"entities": []}], ["Moreover, delayed microbial colonization of the gut causes permanent changes in the immune system.", {"entities": []}], ["Agonists of the nuclear receptor PPAR\u03b3 are therapeutically used to combat hyperglycaemia associated with the metabolic syndrome and type 2 diabetes.", {"entities": [[119, 127, "DISEASE"]]}], ["In spite of being effective in normalization of blood glucose levels, the currently used PPAR\u03b3 agonists from the thiazolidinedione type have serious side effects, making the discovery of novel ligands highly relevant.", {"entities": []}], ["Natural products have proven historically to be a promising pool of structures for drug discovery, and a significant research effort has recently been undertaken to explore the PPAR\u03b3-activating potential of a wide range of natural products originating from traditionally used medicinal plants or dietary sources.", {"entities": []}], ["The majority of identified compounds are selective PPAR\u03b3 modulators (SPPARMs), transactivating the expression of PPAR\u03b3-dependent reporter genes as partial agonists.", {"entities": []}], ["Those natural PPAR\u03b3 ligands have different binding modes to the receptor in comparison to the full thiazolidinedione agonists, and on some occasions activate in addition PPAR\u03b1 (e.g.", {"entities": []}], ["genistein, biochanin A, sargaquinoic acid, sargahydroquinoic acid, resveratrol, amorphastilbol) or the PPAR\u03b3-dimer partner retinoid X receptor (RXR; e.g.", {"entities": []}], ["the neolignans magnolol and honokiol).", {"entities": []}], ["A number of in vivo studies suggest that some of the natural product activators of PPAR\u03b3 (e.g.", {"entities": []}], ["honokiol, amorfrutin 1, amorfrutin B, amorphastilbol) improve metabolic parameters in diabetic animal models, partly with reduced side effects in comparison to full thiazolidinedione agonists.", {"entities": []}], ["The bioactivity pattern as well as the dietary use of several of the identified active compounds and plant extracts warrants future research regarding their therapeutic potential and the possibility to modulate PPAR\u03b3 activation by dietary interventions or food supplements.", {"entities": []}], ["Exposure to traffic is an established risk factor for the triggering of myocardial infarction (MI).", {"entities": [[72, 93, "DISEASE"]]}], ["Particulate matter, mainly emitted by diesel vehicles, appears to be the most important stressor.", {"entities": []}], ["However, the possible influence of benzene from gasoline-fueled cars has not been explored so far.", {"entities": [[64, 68, "GENE"]]}], ["We conducted a case-crossover study from 2,134 MI cases recorded by the local Coronary Heart Disease Registry (2000\u20132007) in the Strasbourg Metropolitan Area (France).", {"entities": [[87, 100, "DISEASE"]]}], ["Available individual data were age, gender, previous history of ischemic heart disease and address of residence at the time of the event.", {"entities": [[64, 86, "DISEASE"], [73, 86, "DISEASE"]]}], ["Nitrogen dioxide, particles of median aerodynamic diameter <10 \u00b5m (PM 10 ), ozone, carbon monoxide and benzene air concentrations were modeled on an hourly basis at the census block level over the study period using the deterministic ADMS-Urban air dispersion model.", {"entities": []}], ["Model input data were emissions inventories, background pollution measurements, and meteorological data.", {"entities": []}], ["We have found a positive, statistically significant association between concentrations of benzene and the onset of MI: per cent increase in risk for a 1 \u00b5g/m We have observed that benzene in ambient air is strongly associated with the triggering of MI.", {"entities": []}], ["This novel finding needs confirmation.", {"entities": []}], ["If so, this would mean that not only diesel vehicles, the main particulate matter emitters, but also gasoline-fueled cars \u2013main benzene emitters\u2013, should be taken into account for public health action.", {"entities": [[117, 121, "GENE"]]}], ["Cigarette smoking ( CS ) is associated with vascular endothelial dysfunction in a causative way primarily related to the TS content of reactive oxygen species ( ROS ), nicotine, and inflammation.", {"entities": [[20, 22, "GENE"]]}], ["TS promotes glucose intolerance and increases the risk of developing type-2 diabetes mellitus ( 2DM ) with which it shares other pathogenic traits including the high risk of cerebrovascular and neurological disorders like stroke via ROS generation, inflammation, and blood-brain barrier ( BBB ) impairment.", {"entities": [[12, 31, "DISEASE"], [76, 93, "DISEASE"]]}], ["Herein we provide evidence of the role played by nuclear factor erythroid 2-related factor ( Nrf2 ) in CS-induced cerebrobvascular/BBB impairments and how these cerebrovascular harmful effects can be circumvented by the use of metformin ( MF ; a widely prescribed, firstline anti-diabetic drug) treatment.", {"entities": []}], ["Our data in fact revealed that MF activates counteractive mechanisms primarily associated with the Nrf2 pathway which drastically reduce CS toxicity at the cerebrovascular level.", {"entities": [[137, 139, "GENE"]]}], ["These include the suppression of tight junction ( TJ ) protein downregulation and loss of BBB integrity induced by CS, reduction of inflammation and oxidative stress, renormalization of the expression levels of the major BBB glucose transporter Glut-1 and that of the anticoagulant factor thrombomodulin.", {"entities": [[115, 117, "GENE"]]}], ["Further, we provide additional insights on the controversial interplay between Nrf2 and AMPK.", {"entities": []}], ["fx1 \u2022 Prolonged cigarette smoke exposure causes cerebrovascular impairment and decreases thrombomodulin release.", {"entities": []}], ["\u2022 Metformin prevents cigarette smoke extract-induced BBB endothelial cells dysfunction and loss of BBB integrity.", {"entities": []}], ["\u2022 Metformin prevents cigarette smoke extract-induced cerebrovascular impairment in vivo.", {"entities": []}], ["\u2022 Nrf2 activation by Metformin enhances ZO-1 and Glut-1 protein expression and is independent of AMPK phosphorylation.", {"entities": []}], ["Prolonged cigarette smoke exposure causes cerebrovascular impairment and decreases thrombomodulin release.", {"entities": []}], ["Metformin prevents cigarette smoke extract-induced BBB endothelial cells dysfunction and loss of BBB integrity.", {"entities": []}], ["Metformin prevents cigarette smoke extract-induced cerebrovascular impairment in vivo.", {"entities": []}], ["Nrf2 activation by Metformin enhances ZO-1 and Glut-1 protein expression and is independent of AMPK phosphorylation.", {"entities": []}], ["Thioredoxin (Trx) and thioredoxin reductase 1 (TR1) are among the major redox regulators in mammalian cells and have a wide variety of roles, including removal of intracellular reactive oxygen species (ROS) and prevention of cell death.", {"entities": []}], ["Tumor necrosis factor-\u03b1 (TNF-\u03b1) induces cancer cell death.", {"entities": [[40, 46, "DISEASE"]]}], ["Although ROS have been proposed to participate in this process, the role of the thioredoxin system in TNF-\u03b1 stimulated cell death remains unclear.", {"entities": []}], ["We investigated the possibility that the thioredoxin system protects against TNF-\u03b1-induced cancer cell death by examining whether TR1/Trx1 status controls TNF-\u03b1-induced apoptosis in EMT6 murine breast cancer cells.", {"entities": [[194, 207, "DISEASE"], [91, 97, "DISEASE"], [201, 207, "DISEASE"]]}], ["TR1-deficient cells were more sensitive to TNF-\u03b1 than control cells.", {"entities": []}], ["Increased sensitivity to TNF-\u03b1 was most pronounced in Trx1-deficient cells.", {"entities": []}], ["TNF-\u03b1-induced nuclear localization of phosphorylated ERK 1/2 (p-ERK 1/2) correlated with increased apoptosis in TR1- and Trx1-deficient cells, suggesting a pro-apoptotic role for nuclear p-ERK 1/2 in TNF-\u03b1-induced apoptosis.", {"entities": []}], ["In addition, phosphoinositide 3-kinase (PI3K) inhibition dramatically reduced TNF-\u03b1-stimulated apoptosis and nuclear localization of p-ERK 1/2.", {"entities": []}], ["In contrast, inhibition of ROS, MEK, JNK, or p38 did not significantly alter p-ERK 1/2 localization or apoptosis in TR1- and Trx1-deficient cells compared to control cells.", {"entities": []}], ["Further, NF-\u03baB p65 localization was not changed in TR1- and Trx1-deficient cells in response to TNF-\u03b1 relative to control cells.", {"entities": []}], ["Our data suggest that the thioredoxin system plays a critical role in protecting against TNF-\u03b1-induced apoptosis by regulating the levels of nuclear p-ERK 1/2 in a PI3K-dependent manner.", {"entities": []}], ["Klebsiella pneumoniae is a leading cause of severe hospital-acquired respiratory tract infections and death but little is known regarding the modulation of respiratory dendritic cell (DC) subsets.", {"entities": []}], ["Plasmacytoid DC (pDC) are specialized type 1 interferon producing cells and considered to be classical mediators of antiviral immunity.", {"entities": [[17, 20, "GENE"]]}], ["By using multiparameter flow cytometry analysis we have analysed the modulation of respiratory DC subsets after intratracheal Klebsiella pneumonia infection.", {"entities": [[137, 146, "DISEASE"]]}], ["Data indicate that pDCs and MoDC were markedly elevated in the post acute pneumonia phase when compared to mock-infected controls.", {"entities": [[74, 83, "DISEASE"]]}], ["Analysis of draining mediastinal lymph nodes revealed a rapid increase of activated CD103 ex vivo -sorted respiratory DC subpopulations from infected animals revealed elevated Interferon-alpha in pDC, elevated IFN-gamma, IL-4 and IL-13 in CD103 These results provide novel insight into the activation of respiratory DC subsets during Klebsiella pneumonia infection.", {"entities": [[345, 354, "DISEASE"], [196, 199, "GENE"]]}], ["The detection of increased respiratory pDC numbers in bacterial pneumonia may indicate possible novel pDC functions with respect to lung repair and regeneration.", {"entities": [[64, 73, "DISEASE"], [54, 73, "DISEASE"], [39, 42, "GENE"], [102, 105, "GENE"], [39, 42, "GENE"], [102, 105, "GENE"]]}], ["The Internet is becoming an increasingly important resource for health-information seekers.", {"entities": []}], ["However, consumers often do not use effective search strategies.", {"entities": []}], ["Query reformulation is one potential intervention to improve the effectiveness of consumer searches.", {"entities": []}], ["We endeavored to answer the research question: \"Does reformulating original consumer queries with preferred terminology from the Unified Medical Language System (UMLS) Metathesaurus lead to better search returns?\"", {"entities": []}], ["Consumer-generated queries with known goals (n=16) that could be mapped to UMLS Metathesaurus terminology were used as test samples.", {"entities": []}], ["Reformulated queries were generated by replacing user terms with Metathesaurus-preferred synonyms (n=18).", {"entities": []}], ["Searches (n=36) were performed using both a consumer information site and a general search engine.", {"entities": []}], ["Top 30 precision was used as a performance indicator to compare the performance of the original and reformulated queries.", {"entities": []}], ["Forty-two percent of the searches utilizing reformulated queries yielded better search returns than their associated original queries, 19% yielded worse results, and the results for the remaining 39% did not change.", {"entities": []}], ["We identified ambiguous lay terms, expansion of acronyms, and arcane professional terms as causes for changes in performance.", {"entities": []}], ["We noted a trend towards increased precision when providing substitutions for lay terms, abbreviations, and acronyms.", {"entities": []}], ["We have found qualitative evidence that reformulating queries with professional terminology may be a promising strategy to improve consumer health-information searches, although we caution that automated reformulation could in fact worsen search performance when the terminology is ill-fitted or arcane.", {"entities": []}], ["Enhancer RNAs (eRNAs) are a novel class of non-coding RNA (ncRNA) molecules transcribed from the DNA sequences of enhancer regions.", {"entities": []}], ["Despite extensive efforts devoted to revealing the potential functions and underlying mechanisms of eRNAs, it remains an open question whether eRNAs are mere transcriptional noise or relevant biologically functional species.", {"entities": []}], ["Here, we identified a catalogue of eRNAs in a broad range of human cell/tissue types and extended our understanding of eRNAs by demonstrating their multi-omic signatures.", {"entities": []}], ["Gene Ontology (GO) analysis revealed that eRNAs play key roles in human cell identity.", {"entities": []}], ["Furthermore, we detected numerous known and novel functional RNA structures within eRNA regions.", {"entities": []}], ["To better characterize the cis -regulatory effects of non-coding variation in these structural ncRNAs, we performed a comprehensive analysis of the genetic variants of structural ncRNAs in eRNA regions that are associated with inflammatory autoimmune diseases.", {"entities": []}], ["Disease-associated variants of the structural ncRNAs were disproportionately enriched in immune-specific cell types.", {"entities": []}], ["We also identified riboSNitches in lymphoid eRNAs and investigated the potential pathogenic mechanisms by which eRNAs might function in autoimmune diseases.", {"entities": []}], ["Collectively, our findings offer valuable insights into the function of eRNAs and suggest that eRNAs might be effective diagnostic and therapeutic targets for human diseases.", {"entities": []}], ["Background.", {"entities": []}], ["Food protein-induced proctitis/proctocolitis (FPIP) is the most common noninfectious colitis in children in the first year of life.", {"entities": [[21, 30, "DISEASE"]]}], ["Along with the overall clinical symptoms, diarrhoea and rectal bleeding are the main manifestations of the disease.", {"entities": []}], ["There is no routine noninvasive test that would be specific for this type of colitis.", {"entities": []}], ["The aim of our study was to find a noninvasive laboratory test or tests that may be helpful in differential diagnosis of food protein-induced proctitis/proctocolitis.", {"entities": [[142, 151, "DISEASE"]]}], ["ANA, ANCA, ASCA, a-EMA, a-tTg, specific IgE, total IgE, IgG, IgA, IgM, and concentration of serum calprotectin were measured in a group of 25 patients with colitis and 18 children with other diagnoses.", {"entities": []}], ["Atypical-pANCA antibodies of IgG isotype were detected in the sera of 24 patients by the method of indirect immunofluorescence, and 5 patients showed also the positivity of IgA isotype.", {"entities": []}], ["In control samples these autoantibodies were not detected.", {"entities": []}], ["Other autoantibodies were not demonstrated in either patient or control group.", {"entities": []}], ["Conclusions.", {"entities": []}], ["Of the parameters tested in noninfectious colitis, atypical-pANCA on ethanol-fixed granulocytes appears to be a suitable serological marker of food protein-induced proctitis/proctocolitis and suggests a possible involvement of an autoimmune mechanisms in the pathogenesis of this disease.", {"entities": [[164, 173, "DISEASE"]]}], ["Methicillin-resistant Staphylococcus aureus (MRSA) is the predominant cause of bone infection.", {"entities": []}], ["Toll like receptors (TLRs) are an important segments of host response to infection and are expressed by a variety of cells including human mesenchymal stem cells (hMSCs).", {"entities": []}], ["The active form of Vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH) 2 D 3 ) has potent immunoregulatory properties, but the mechanism remains poorly understood.", {"entities": []}], ["The genomic action of 1,25(OH) 2 D 3 is mediated by vitamin D receptor (VDR), hormone-regulated transcription factor.", {"entities": [[72, 75, "GENE"]]}], ["VDR interacts with co-activators and co-repressors are associated with chromatin histone modifications and transcriptional regulation.", {"entities": [[0, 3, "GENE"]]}], ["The aim of our study is to explore MRSA-induced TLRs-mediated pro-inflammatory cytokines expression in hMSCs.", {"entities": []}], ["Further, we hypothesized that 1,25(OH) 2 D 3 inhibits MRSA-induced cytokines synthesis in hMSCs via inhibition of NF-\u043aB transcription factor.", {"entities": []}], ["Finally, we explored the regulatory role of 1,25(OH) 2 D 3 in MRSA-mediated global epigenetic histone H3 mark, such as, trimethylated histone H3 lysine 9 (H3K9me3), which is linked to gene silencing.", {"entities": []}], ["Quantitative PCR data revealed that MRSA-infection predominantly induced expression of TLRs 1, 2, 6, NR4A2, and inflammatory cytokines IL-8, IL-6, TNF\u03b1 in hMSCs.", {"entities": [[101, 106, "GENE"]]}], ["MRSA-mediated TLR ligands reduced osteoblast differentiation and increased hMSCs proliferation, indicating the disrupted multipotency function of hMSCs.", {"entities": []}], ["Pretreatment of 1,25(OH) 2 D 3 followed by MRSA co-culture inhibited nuclear translocation of NF-\u043aB-p65, reduced expression of NR4A2 and pro-inflammatory cytokines IL-8, IL-6, and TNF\u03b1 in hMSCs.", {"entities": [[127, 132, "GENE"]]}], ["Further, NF-\u03baB-p65, VDR, and NR4A2 were present in the same nuclear protein complex, indicating that VDR is an active part of the nuclear protein complexes for transcriptional regulation.", {"entities": [[20, 23, "GENE"], [101, 104, "GENE"], [29, 34, "GENE"], [20, 23, "GENE"], [101, 104, "GENE"]]}], ["Finally, 1,25(OH) 2 D 3 activated VDR, restores the global level of H3K9me3, to repress MRSA-stimulated inflammatory cytokine IL-8 expression.", {"entities": [[34, 37, "GENE"]]}], ["Pretreatment of 5-dAZA, DNA methylatransferases (Dnmts) inhibitor, dramatically re-expresses 1,25(OH) 2 D 3 -MRSA-mediated silenced IL-8 gene.", {"entities": []}], ["This data indicates that TLR 1, 2, and 6 can be used as markers for localized S. aureus bone infection.", {"entities": []}], ["1,25(OH) 2 D 3 -VDR may exhibits its anti-inflammatory properties in MRSA-stimulated infection by inhibiting nuclear translocation of NF-kB-p65 and transcripts of IL-8, IL-6, TNF\u03b1, and NR4A2 in hMSCs.", {"entities": [[185, 190, "GENE"]]}], ["Finally, 1,25(OH) 2 D 3 -activated VDR, acting as an epigenetic regulator, inhibits synthesis of cytokines in MRSA-stimulated infection by restoring the global level of H3K9me3, a histone H3 mark for gene silencing.", {"entities": [[35, 38, "GENE"]]}], ["Crotonaldehyde is a highly noxious \u03b1,\u03b2-unsaturated aldehyde in cigarette smoke that causes edematous acute lung injury.", {"entities": []}], ["To understand how crotonaldehyde impairs lung function, we examined its effects on human epithelial sodium channels (ENaC), which are major contributors to alveolar fluid clearance.", {"entities": []}], ["We studied alveolar fluid clearance in C57 mice and ENaC activity was examined in H441 cells.", {"entities": []}], ["Expression of \u03b1- and \u03b3-ENaC was measured at protein and mRNA levels by western blot and real-time PCR, respectively.", {"entities": []}], ["Intracellular ROS levels were detected by the dichlorofluorescein assay.", {"entities": []}], ["Heterologous \u03b1\u03b2\u03b3-ENaC activity was observed in an oocyte model.", {"entities": []}], ["Our results showed that crotonaldehyde reduced transalveolar fluid clearance in mice.", {"entities": []}], ["Furthermore, ENaC activity in H441 cells was inhibited by crotonaldehyde dose-dependently.", {"entities": []}], ["Expression of \u03b1- and \u03b3-subunits of ENaC was decreased at the protein and mRNA level in H441 cells exposed to crotonaldehyde, which was probably mediated by the increase in phosphorylated extracellular signal-regulated protein kinases 1 and 2.", {"entities": []}], ["ROS levels increased time-dependently in cells exposed to crotonaldehyde.", {"entities": []}], ["Heterologous \u03b1\u03b2\u03b3-ENaC activity was rapidly eliminated by crotonaldehyde.", {"entities": []}], ["Our findings suggest that crotonaldehyde causes edematous acute lung injury by eliminating ENaC activity at least partly via facilitating the phosphorylation of extracellular signal-regulated protein kinases 1 and 2 signal molecules.", {"entities": []}], ["Long-term exposure may decrease the expression of ENaC subunits and damage the cell membrane integrity, as well as increase the levels of cellular ROS products.", {"entities": []}], ["Early life epigenetic programming influences adult health outcomes.", {"entities": []}], ["Moreover, DNA methylation levels have been found to change more rapidly during the first years of life.", {"entities": []}], ["Our aim was the identification and characterization of the CpG sites that are modified with time during the first years of life.", {"entities": []}], ["We hypothesize that these DNA methylation changes would lead to the detection of genes that might be epigenetically modulated by environmental factors during early childhood and which, if disturbed, might contribute to susceptibility to diseases later in life.", {"entities": []}], ["The study of the DNA methylation pattern of 485577 CpG sites was performed on 30 blood samples from 15 subjects, collected both at birth and at 5\u00a0years old, using Illumina t test implemented in the limma package of R/Bioconductor .", {"entities": []}], ["Surogate variable analysis was used to account for batch effects.", {"entities": []}], ["DNA methylation levels significantly changed from birth to 5\u00a0years of age in 6641 CpG sites.", {"entities": []}], ["Of these, 36.79\u00a0% were hypermethylated and were associated with genes related mainly to developmental ontology terms, while 63.21\u00a0% were hypomethylated probes and associated with genes related to immune function.", {"entities": []}], ["Our results suggest that DNA methylation alterations with age during the first years of life might play a significant role in development and the regulation of leukocyte-specific functions.", {"entities": []}], ["This supports the idea that blood leukocytes experience genome remodeling related to their interaction with environmental factors, underlining the importance of environmental exposures during the first years of life and suggesting that new strategies should be take into consideration for disease prevention.", {"entities": []}]]